data_1ure_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1ure _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . 0.494 ' CD1' ' N ' ' A' ' 2' ' ' PHE . 2.2 m-30 . . . . . 0 N--CA 1.444 -0.765 0 N-CA-C 117.866 2.543 . . . . 0.0 117.866 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -36.74 91.18 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 124.489 2.09 . . . . 0.0 115.749 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 164.13 -176.35 40.12 Favored Glycine 0 C--O 1.209 -1.433 0 C-N-CA 117.668 -2.206 . . . . 0.0 111.147 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.444 HG21 ' CG2' ' A' ' 39' ' ' THR 0.56 0.1 OUTLIER -91.35 155.33 18.58 Favored 'General case' 0 N--CA 1.443 -0.802 0 O-C-N 127.146 2.321 . . . . 0.0 110.63 -179.787 . . . . . . . . 4 4 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.483 ' CH2' ' HE2' ' A' ' 130' ' ' LYS . 69.7 m95 -141.67 149.78 41.04 Favored 'General case' 0 N--CA 1.436 -1.147 0 O-C-N 127.874 3.234 . . . . 0.0 106.405 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 10.0 tmtt? -152.46 93.31 1.78 Allowed 'General case' 0 CA--C 1.5 -0.977 0 O-C-N 126.913 2.633 . . . . 0.0 107.14 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.475 ' HB ' ' CD1' ' A' ' 128' ' ' PHE 0.305 0.4 OUTLIER -42.56 137.0 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.0 0 CA-C-O 117.124 -1.417 . . . . 0.0 113.115 -179.998 . . . . . . . . 4 4 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -118.27 -60.68 1.76 Allowed 'General case' 0 C--O 1.214 -0.807 0 O-C-N 126.405 2.316 . . . . 0.0 108.827 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -118.98 155.04 32.07 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . 0.363 0.1 OUTLIER -121.1 -165.76 1.26 Allowed 'General case' 0 C--N 1.324 -0.524 0 O-C-N 126.011 2.07 . . . . 0.0 107.459 -179.78 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.405 ' HB3' ' HB2' ' A' ' 125' ' ' LYS . 3.7 tp10 -176.35 89.3 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.523 0 C-N-CA 117.604 -1.638 . . . . 0.0 107.197 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 97.95 -3.6 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 126.143 1.777 . . . . 0.0 114.132 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.472 ' HA ' ' CB ' ' A' ' 124' ' ' ALA 0.27 76.9 t80 -62.07 -28.08 69.35 Favored 'General case' 0 C--O 1.241 0.618 0 O-C-N 127.908 3.255 . . . . 0.0 114.307 -179.834 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -68.18 -40.37 82.28 Favored 'General case' 0 CA--C 1.5 -0.949 0 O-C-N 124.672 1.232 . . . . 0.0 113.442 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.3 -26.03 55.42 Favored 'General case' 0 N--CA 1.441 -0.921 0 O-C-N 125.053 1.47 . . . . 0.0 111.216 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.477 ' CB ' ' HB3' ' A' ' 124' ' ' ALA . 4.7 t80 -68.59 -25.28 64.8 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 123.467 1.603 . . . . 0.0 112.773 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.416 ' HB3' ' HB ' ' A' ' 23' ' ' ILE . 0.6 OUTLIER -77.74 -24.91 48.95 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-O 124.018 1.866 . . . . 0.0 107.698 -179.91 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.7 tt0 -74.45 -20.28 60.08 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 125.297 2.475 . . . . 0.0 110.07 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.414 ' CE ' ' HB2' ' A' ' 120' ' ' GLU . 2.8 tmtm? -77.67 -48.3 17.11 Favored 'General case' 0 C--O 1.209 -1.032 0 CA-C-N 111.998 -2.364 . . . . 0.0 110.152 179.461 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 3.1 mtt -65.48 -20.25 66.27 Favored 'General case' 0 C--O 1.208 -1.12 0 C-N-CA 127.519 2.328 . . . . 0.0 107.507 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.13 31.35 5.96 Favored Glycine 0 C--N 1.298 -1.563 0 C-N-CA 125.221 1.391 . . . . 0.0 111.812 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.445 ' CG2' ' HB2' ' A' ' 27' ' ' LYS . 0.5 OUTLIER -91.56 132.75 35.2 Favored 'Isoleucine or valine' 0 C--N 1.351 0.643 0 CA-C-O 116.154 -1.879 . . . . 0.0 105.99 -179.863 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -90.76 -85.67 0.22 Allowed 'General case' 0 CA--C 1.508 -0.672 0 N-CA-C 116.365 1.987 . . . . 0.0 116.365 -179.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . 0.354 3.5 p -117.4 -72.41 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.495 -1.17 0 N-CA-C 120.022 3.341 . . . . 0.0 120.022 -179.508 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.579 2.2 m -63.43 -28.51 45.16 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.871 0 N-CA-C 118.619 2.822 . . . . 0.0 118.619 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.445 ' HB2' ' CG2' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -74.3 -42.66 59.15 Favored 'General case' 0 CA--C 1.508 -0.653 0 O-C-N 127.789 3.18 . . . . 0.0 114.146 -179.839 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 38.1 ptt180 -78.38 -23.43 46.83 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 123.41 1.576 . . . . 0.0 108.793 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 31.1 tttp -74.86 -39.55 61.49 Favored 'General case' 0 CA--C 1.509 -0.63 0 CA-C-N 114.15 -1.386 . . . . 0.0 111.029 179.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -74.65 -21.81 59.23 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 114.039 -1.437 . . . . 0.0 110.712 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -79.45 -30.71 44.04 Favored Glycine 0 CA--C 1.524 0.596 0 O-C-N 128.23 3.456 . . . . 0.0 110.929 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -77.09 -57.58 3.76 Favored 'General case' 0 N--CA 1.436 -1.167 0 C-N-CA 127.182 2.193 . . . . 0.0 112.1 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 22.4 m80 -75.18 -1.99 25.79 Favored 'General case' 0 N--CA 1.438 -1.054 0 CA-C-O 117.112 -1.423 . . . . 0.0 113.606 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.419 ' HA ' ' HB2' ' A' ' 54' ' ' ASN . 35.6 p-10 -38.6 -36.67 0.27 Allowed 'General case' 0 CA--C 1.495 -1.171 0 N-CA-C 119.888 3.292 . . . . 0.0 119.888 179.604 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . 0.263 13.4 m120 79.96 21.3 0.54 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 120.108 1.322 . . . . 0.0 113.422 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.419 HD22 ' CZ ' ' A' ' 128' ' ' PHE . 27.0 tp -37.08 93.47 0.01 OUTLIER 'General case' 0 C--N 1.351 0.643 0 O-C-N 126.993 2.683 . . . . 0.0 110.313 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.412 ' HB3' ' HB3' ' A' ' 52' ' ' SER . 2.4 ttmp? -92.82 105.47 17.59 Favored 'General case' 0 C--O 1.218 -0.602 0 N-CA-C 101.92 -3.363 . . . . 0.0 101.92 179.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . 0.252 1.3 tp -95.3 127.11 41.08 Favored 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 116.212 -2.195 . . . . 0.0 108.735 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.444 ' CG2' HG21 ' A' ' 5' ' ' THR . 89.0 m -109.97 83.14 1.71 Allowed 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 104.226 -2.509 . . . . 0.0 104.226 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 24.0 mm -63.91 132.93 29.85 Favored 'Isoleucine or valine' 0 C--O 1.247 0.94 0 CA-C-N 112.983 -1.917 . . . . 0.0 108.952 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 30.5 m -143.62 96.84 2.97 Favored 'General case' 0 CA--C 1.502 -0.874 0 CA-C-N 111.419 -2.628 . . . . 0.0 113.582 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 59.8 tt0 -89.5 131.94 35.29 Favored 'General case' 0 N--CA 1.447 -0.613 0 O-C-N 124.794 1.309 . . . . 0.0 110.272 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 46.3 tt0 -101.98 -52.33 3.19 Favored 'General case' 0 CA--C 1.49 -1.349 0 CA-C-O 125.172 2.415 . . . . 0.0 110.156 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -165.74 -69.19 0.03 OUTLIER Glycine 0 N--CA 1.433 -1.551 0 N-CA-C 105.422 -3.071 . . . . 0.0 105.422 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.364 0.0 OUTLIER -106.53 -22.7 12.69 Favored 'General case' 0 C--O 1.218 -0.602 0 CA-C-N 113.095 -1.552 . . . . 0.0 111.168 179.906 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.445 ' CD ' ' HG3' ' A' ' 63' ' ' GLU . 0.0 OUTLIER -98.32 156.23 16.82 Favored 'General case' 0 N--CA 1.435 -1.203 0 C-N-CA 120.318 -0.553 . . . . 0.0 111.931 -179.879 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -129.79 92.72 3.37 Favored 'General case' 0 N--CA 1.441 -0.893 0 C-N-CA 123.465 0.706 . . . . 0.0 109.436 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.441 ' CA ' HG11 ' A' ' 61' ' ' VAL 0.455 1.3 p -67.18 141.51 57.31 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 116.8 -1.96 . . . . 0.0 111.45 -179.903 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.549 ' CG1' ' CZ ' ' A' ' 62' ' ' PHE 0.695 0.4 OUTLIER -120.91 83.82 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.424 -1.726 0 CA-C-N 111.877 -2.42 . . . . 0.0 111.167 179.916 . . . . . . . . 4 4 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.411 ' CB ' ' HB ' ' A' ' 39' ' ' THR . 2.1 ttpp -62.84 142.89 58.05 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 101.229 -3.619 . . . . 0.0 101.229 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -138.55 93.92 2.79 Favored 'General case' 0 C--O 1.217 -0.632 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.412 ' HB3' ' HB3' ' A' ' 37' ' ' LYS 0.287 3.9 t -91.64 60.8 4.1 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 106.722 -1.584 . . . . 0.0 106.722 179.81 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.409 ' HB2' ' HB2' ' A' ' 34' ' ' ASP . 1.7 p -89.59 -178.46 5.56 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 125.897 1.998 . . . . 0.0 112.447 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.419 ' HB2' ' HA ' ' A' ' 34' ' ' ASP . 0.1 OUTLIER -61.44 -28.59 69.38 Favored 'General case' 0 C--O 1.212 -0.878 0 CA-C-O 115.525 -2.178 . . . . 0.0 109.932 179.789 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.453 ' CD2' ' CB ' ' A' ' 73' ' ' ALA . 95.8 m-85 -70.93 -51.08 28.09 Favored 'General case' 0 C--O 1.221 -0.398 0 C-N-CA 117.285 -1.766 . . . . 0.0 114.13 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 6.3 ttm180 179.72 153.7 0.49 Allowed 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 120.702 1.592 . . . . 0.0 108.256 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 42.8 t-20 -88.89 85.98 6.85 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 102.336 -3.209 . . . . 0.0 102.336 -179.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 6.3 tp -117.57 107.31 21.83 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.866 1 C-N-CA 133.19 4.596 . . . . 0.0 118.477 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -66.2 134.07 51.95 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 104.606 -2.368 . . . . 0.0 104.606 178.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 22.3 t -86.16 -68.8 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 CA-C-O 125.517 2.58 . . . . 0.0 110.874 -179.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.441 HG11 ' CA ' ' A' ' 48' ' ' THR 0.497 0.0 OUTLIER 74.57 128.02 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.14 0 CA-C-N 113.825 -1.534 . . . . 0.0 113.347 179.995 . . . . . . . . 4 4 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.549 ' CZ ' ' CG1' ' A' ' 49' ' ' VAL . 0.0 OUTLIER -160.11 99.95 1.37 Allowed 'General case' 0 C--N 1.313 -1.002 0 CA-C-O 117.756 -1.116 . . . . 0.0 111.141 -179.781 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.445 ' HG3' ' CD ' ' A' ' 46' ' ' LYS . 3.7 tt0 -49.59 137.61 15.16 Favored 'General case' 0 N--CA 1.439 -0.999 0 O-C-N 126.592 2.433 . . . . 0.0 104.564 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -60.33 129.69 42.9 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 123.395 1.569 . . . . 0.0 108.469 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 63.38 26.95 70.02 Favored Glycine 0 C--N 1.343 0.948 0 CA-C-N 111.437 -2.62 . . . . 0.0 118.849 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.428 HG22 ' HB3' ' A' ' 63' ' ' GLU 0.423 3.0 t -102.63 101.61 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 -179.962 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -58.03 126.45 27.52 Favored 'General case' 0 CA--C 1.49 -1.332 0 CA-C-O 116.816 -1.564 . . . . 0.0 111.391 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.549 ' CZ ' ' CB ' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -131.91 -174.24 3.37 Favored 'General case' 0 N--CA 1.437 -1.097 0 CA-C-N 119.289 0.949 . . . . 0.0 110.968 -179.84 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -125.81 118.38 25.38 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 -179.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 16.2 t80 -126.63 115.39 19.4 Favored 'General case' 0 C--O 1.209 -1.028 0 CA-C-N 120.503 1.501 . . . . 0.0 111.711 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 10.6 t -80.93 142.62 33.34 Favored 'General case' 0 CA--C 1.491 -1.327 0 O-C-N 120.352 -1.468 . . . . 0.0 109.434 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -97.83 -174.2 2.82 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 106.043 -1.836 . . . . 0.0 106.043 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.453 ' CB ' ' CD2' ' A' ' 55' ' ' PHE . . . -84.33 -49.28 8.88 Favored 'General case' 0 C--O 1.211 -0.973 0 O-C-N 125.355 1.659 . . . . 0.0 110.717 179.409 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.436 ' HB2' ' HD3' ' A' ' 27' ' ' LYS . 4.9 t70 -121.7 -10.06 8.8 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.079 -1.419 . . . . 0.0 109.72 179.182 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -89.19 -17.59 55.36 Favored Glycine 0 CA--C 1.546 1.982 0 CA-C-N 118.66 0.664 . . . . 0.0 112.763 179.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . 0.355 0.0 OUTLIER 71.96 -169.03 0.14 Allowed 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 116.495 -2.082 . . . . 0.0 113.302 179.922 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.431 ' HB3' HG12 ' A' ' 96' ' ' VAL . 4.0 mp0 -46.22 140.71 3.82 Favored 'General case' 0 C--N 1.319 -0.729 0 O-C-N 128.253 3.471 . . . . 0.0 112.039 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.462 ' HG ' ' CG ' ' A' ' 93' ' ' PHE 0.42 0.4 OUTLIER -156.83 100.67 1.92 Allowed 'General case' 0 C--O 1.243 0.734 0 N-CA-C 102.798 -3.038 . . . . 0.0 102.798 179.963 . . . . . . . . 4 4 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 27.6 m -109.13 135.37 50.38 Favored 'General case' 0 CA--C 1.481 -1.686 0 O-C-N 125.009 1.443 . . . . 0.0 108.238 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 173.6 -168.0 40.78 Favored Glycine 0 C--N 1.303 -1.276 1 C-N-CA 113.805 -4.045 . . . . 0.0 108.775 -179.682 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.7 p -137.69 177.14 8.1 Favored 'General case' 0 CA--C 1.493 -1.218 0 CA-C-N 119.129 1.465 . . . . 0.0 110.981 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . 0.546 ' CE3' ' CA ' ' A' ' 91' ' ' GLY . 83.5 m95 -128.12 141.45 51.49 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 102.078 -3.304 . . . . 0.0 102.078 179.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 5.4 t -142.86 138.67 30.44 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-O 122.033 0.921 . . . . 0.0 109.312 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 13.6 ttt -83.44 105.24 14.22 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . 0.603 4.7 mt-10 -56.8 -28.74 61.89 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-O 124.986 2.327 . . . . 0.0 112.661 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 140.49 -46.71 0.91 Allowed Glycine 0 C--N 1.347 1.146 0 N-CA-C 104.081 -3.608 . . . . 0.0 104.081 179.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 17.3 t30 -113.28 -19.23 11.85 Favored 'General case' 0 N--CA 1.44 -0.937 0 O-C-N 127.109 2.299 . . . . 0.0 114.109 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . 0.385 20.3 mttt -136.93 151.41 49.01 Favored 'General case' 0 N--CA 1.44 -0.958 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 179.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.47 HD21 ' CD ' ' A' ' 106' ' ' ARG . 1.0 OUTLIER -98.74 129.56 45.18 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 101.313 -3.588 . . . . 0.0 101.313 179.634 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -120.26 114.75 44.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 C-N-CA 118.363 -1.335 . . . . 0.0 108.14 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.546 ' CA ' ' CE3' ' A' ' 82' ' ' TRP . . . -84.16 91.52 1.65 Allowed Glycine 0 C--N 1.354 1.582 0 C-N-CA 129.652 3.501 . . . . 0.0 107.819 -179.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -92.39 124.33 36.37 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 102.509 -3.145 . . . . 0.0 102.509 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.462 ' CG ' ' HG ' ' A' ' 78' ' ' LEU . 2.4 m-85 -136.23 108.99 7.53 Favored 'General case' 0 CA--C 1.502 -0.865 0 O-C-N 125.902 2.001 . . . . 0.0 111.941 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.04 -173.22 3.98 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . 0.42 0.6 OUTLIER -131.56 151.83 51.27 Favored 'General case' 0 CA--C 1.487 -1.459 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.859 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.431 HG12 ' HB3' ' A' ' 77' ' ' GLU . 17.4 m -82.03 -33.62 11.86 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 N-CA-C 114.176 1.176 . . . . 0.0 114.176 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . 0.436 0.5 OUTLIER -74.13 10.32 1.27 Allowed 'General case' 0 C--O 1.247 0.957 0 N-CA-C 116.226 1.936 . . . . 0.0 116.226 179.844 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -168.54 -33.99 0.02 OUTLIER 'General case' 0 CA--C 1.497 -1.084 0 N-CA-C 114.812 1.412 . . . . 0.0 114.812 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 76.7 41.63 23.52 Favored Glycine 0 C--N 1.339 0.733 0 N-CA-C 116.423 1.329 . . . . 0.0 116.423 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 69.4 mttt -81.97 -112.01 0.03 OUTLIER 'General case' 0 C--O 1.198 -1.647 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 166.17 142.4 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.391 0 C-N-CA 125.212 1.405 . . . . 0.0 109.897 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.425 ' HA ' ' HA ' ' A' ' 119' ' ' TYR . 0.8 OUTLIER -131.25 151.68 51.25 Favored 'General case' 0 C--O 1.247 0.94 0 O-C-N 128.289 3.493 . . . . 0.0 104.761 -179.723 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.432 ' CG2' ' HB ' ' A' ' 118' ' ' THR . 9.2 tt -132.23 174.69 12.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 CA-C-N 120.405 1.457 . . . . 0.0 107.891 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.418 ' N ' ' CG1' ' A' ' 103' ' ' ILE . . . -155.98 111.19 2.95 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 116.351 -1.785 . . . . 0.0 106.269 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -95.95 111.72 26.79 Favored 'Isoleucine or valine' 0 C--O 1.245 0.852 0 CA-C-N 121.44 1.927 . . . . 0.0 113.199 -179.416 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.47 ' CD ' HD21 ' A' ' 89' ' ' LEU . 37.3 mtt180 -91.24 94.1 9.39 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 106.327 -1.731 . . . . 0.0 106.327 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -94.03 74.96 4.11 Favored 'General case' 0 N--CA 1.42 -1.948 0 N-CA-C 116.915 2.191 . . . . 0.0 116.915 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.42 HD12 ' CH2' ' A' ' 6' ' ' TRP . 0.3 OUTLIER -61.07 128.73 22.83 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 C-N-CA 115.292 -2.563 . . . . 0.0 111.763 179.872 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 3.9 t -87.42 -65.71 0.99 Allowed 'General case' 0 C--O 1.218 -0.581 0 N-CA-C 104.575 -2.38 . . . . 0.0 104.575 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -167.39 -62.36 0.03 OUTLIER Glycine 0 C--N 1.348 1.213 0 C-N-CA 129.985 3.66 . . . . 0.0 112.683 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . 0.309 0.8 OUTLIER -101.96 -9.33 20.75 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-O 116.448 -1.739 . . . . 0.0 110.737 179.844 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -126.94 131.77 51.01 Favored 'General case' 0 CA--C 1.495 -1.159 0 O-C-N 128.078 3.361 . . . . 0.0 116.888 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.467 HD23 ' CE2' ' A' ' 128' ' ' PHE . 10.4 tt -105.32 117.0 32.9 Favored 'General case' 0 C--N 1.321 -0.669 0 O-C-N 127.739 3.149 . . . . 0.0 105.912 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.474 HG13 ' CD1' ' A' ' 127' ' ' ILE 0.281 1.2 mp -108.32 128.34 63.92 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 CA-C-O 116.212 -1.852 . . . . 0.0 107.574 -179.747 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . 0.412 ' HG2' ' HG2' ' A' ' 106' ' ' ARG . 37.4 mt-30 -114.32 105.89 13.68 Favored 'General case' 0 N--CA 1.441 -0.897 0 O-C-N 126.543 2.402 . . . . 0.0 107.783 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 12.3 p -75.64 -179.0 4.43 Favored 'General case' 0 N--CA 1.429 -1.518 0 O-C-N 127.595 3.06 . . . . 0.0 105.409 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -165.96 112.1 0.88 Allowed 'General case' 0 C--O 1.198 -1.623 0 CA-C-O 116.605 -1.664 . . . . 0.0 113.19 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.432 ' HB ' ' CG2' ' A' ' 103' ' ' ILE . 54.0 m -122.73 129.33 51.65 Favored 'General case' 0 N--CA 1.425 -1.68 1 O-C-N 131.289 5.368 . . . . 0.0 113.661 179.77 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.425 ' HA ' ' HA ' ' A' ' 102' ' ' LEU . 2.1 t80 -109.14 12.85 24.82 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.414 ' HB2' ' CE ' ' A' ' 20' ' ' LYS . 0.7 OUTLIER 163.52 -84.95 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.566 0 O-C-N 127.818 3.199 . . . . 0.0 111.357 -179.796 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -128.59 24.27 4.95 Favored Glycine 0 CA--C 1.539 1.547 0 N-CA-C 119.892 2.717 . . . . 0.0 119.892 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 62.1 t -133.0 104.07 6.55 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.628 0 O-C-N 119.122 -2.399 . . . . 0.0 107.371 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -81.14 171.54 14.78 Favored 'General case' 0 N--CA 1.426 -1.647 0 CA-C-O 124.203 1.954 . . . . 0.0 108.623 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.477 ' HB3' ' CB ' ' A' ' 17' ' ' PHE . . . -162.72 97.08 0.95 Allowed 'General case' 0 C--O 1.211 -0.94 0 C-N-CA 117.746 -1.582 . . . . 0.0 107.194 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.405 ' HB2' ' HB3' ' A' ' 12' ' ' GLU 0.32 1.8 mptm? -83.88 132.91 34.75 Favored 'General case' 0 CA--C 1.506 -0.729 0 CA-C-O 122.331 1.063 . . . . 0.0 110.121 -179.903 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 4.6 mtm180 -119.94 81.47 1.74 Allowed 'General case' 0 C--O 1.209 -1.042 0 C-N-CA 127.158 2.183 . . . . 0.0 107.867 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.474 ' CD1' HG13 ' A' ' 114' ' ' ILE . 10.4 mm -63.97 126.32 22.41 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.861 0 O-C-N 128.522 3.639 . . . . 0.0 111.649 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.475 ' CD1' ' HB ' ' A' ' 8' ' ' VAL . 5.6 m-30 -112.66 139.47 48.23 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 113.25 -1.795 . . . . 0.0 107.681 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . 0.263 3.0 mmtp -104.11 13.73 31.87 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 116.947 -1.502 . . . . 0.0 111.206 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.483 ' HE2' ' CH2' ' A' ' 6' ' ' TRP . 0.1 OUTLIER 55.83 97.53 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 115.394 -2.241 . . . . 0.0 113.176 179.716 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . 0.88 2.4 tt0 . . . . . 0 N--CA 1.443 -0.814 0 C-N-CA 115.407 -2.517 . . . . 0.0 115.683 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . 0.445 ' CD1' ' N ' ' A' ' 2' ' ' PHE . 10.6 m-85 . . . . . 0 CA--C 1.511 -0.529 0 CA-C-O 121.074 0.464 . . . . 0.0 111.908 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -145.53 100.9 3.51 Favored 'General case' 0 CA--C 1.495 -1.172 0 C-N-CA 119.528 -0.869 . . . . 0.0 111.629 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 143.65 -171.79 25.19 Favored Glycine 0 CA--C 1.503 -0.718 0 O-C-N 126.512 2.382 . . . . 0.0 111.603 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.416 ' C ' ' CG ' ' A' ' 6' ' ' TRP 0.587 0.5 OUTLIER -81.45 164.27 22.16 Favored 'General case' 0 N--CA 1.439 -1.006 0 CA-C-O 123.026 1.393 . . . . 0.0 111.523 179.931 . . . . . . . . 4 4 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.581 ' CH2' ' CD1' ' A' ' 108' ' ' ILE . 63.2 m95 -157.03 117.01 3.48 Favored 'General case' 0 N--CA 1.428 -1.563 0 CA-C-O 114.276 -2.773 . . . . 0.0 106.419 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 5.1 tttt -122.47 95.71 4.75 Favored 'General case' 0 N--CA 1.441 -0.902 0 O-C-N 126.062 2.101 . . . . 0.0 108.908 -179.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.422 HG13 ' HB3' ' A' ' 36' ' ' LEU 0.267 14.1 p -34.76 119.19 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.216 0 O-C-N 125.391 1.682 . . . . 0.0 114.561 -179.951 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -114.38 -46.99 2.94 Favored 'General case' 0 C--O 1.204 -1.296 0 O-C-N 125.484 1.74 . . . . 0.0 110.24 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.462 ' HG3' ' CG2' ' A' ' 127' ' ' ILE 0.27 0.0 OUTLIER -106.78 170.72 7.77 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-O 118.663 -0.684 . . . . 0.0 109.866 179.861 . . . . . . . . 4 4 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.645 ' CB ' ' CZ ' ' A' ' 14' ' ' TYR 0.391 20.0 m120 -169.62 179.39 3.78 Favored 'General case' 0 N--CA 1.437 -1.083 0 O-C-N 128.06 3.35 . . . . 0.0 109.962 -178.201 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.418 ' HB3' ' HD3' ' A' ' 125' ' ' LYS . 0.0 OUTLIER -150.38 -90.07 0.07 Allowed 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 121.839 2.109 . . . . 0.0 112.083 -179.782 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 17.2 t30 -85.04 4.91 31.71 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-N 122.449 2.386 . . . . 0.0 112.182 179.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.645 ' CZ ' ' CB ' ' A' ' 11' ' ' ASN . 0.4 OUTLIER -59.55 -21.82 60.82 Favored 'General case' 0 C--N 1.308 -1.238 0 C-N-CA 127.274 2.23 . . . . 0.0 113.301 -178.628 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -73.92 -26.63 60.61 Favored 'General case' 0 C--O 1.21 -0.983 0 CA-C-N 120.51 1.504 . . . . 0.0 111.424 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 37.2 tttm -79.97 -31.92 39.84 Favored 'General case' 0 N--CA 1.432 -1.339 0 CA-C-O 125.448 2.546 . . . . 0.0 110.665 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.538 ' CB ' ' HB1' ' A' ' 124' ' ' ALA . 0.0 OUTLIER -60.78 -33.89 73.66 Favored 'General case' 0 N--CA 1.428 -1.564 0 O-C-N 118.397 -2.689 . . . . 0.0 113.264 -179.755 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 19.2 mtt -72.88 -23.77 60.77 Favored 'General case' 0 N--CA 1.438 -1.073 0 O-C-N 119.229 -2.17 . . . . 0.0 108.465 179.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -76.13 -32.28 59.06 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 125.027 2.346 . . . . 0.0 111.379 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -64.72 -41.2 96.15 Favored 'General case' 0 N--CA 1.436 -1.171 0 O-C-N 117.55 -3.219 . . . . 0.0 112.379 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -73.66 -21.88 60.13 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 86.73 61.64 1.59 Allowed Glycine 0 C--N 1.314 -0.666 0 CA-C-O 115.263 -2.965 . . . . 0.0 109.998 179.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.483 HG21 ' CB ' ' A' ' 27' ' ' LYS . 7.2 mm -90.77 -7.21 10.77 Favored 'Isoleucine or valine' 0 C--N 1.358 0.943 0 CA-C-N 119.537 1.668 . . . . 0.0 108.408 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.1 m120 76.11 -106.01 0.02 OUTLIER 'General case' 0 N--CA 1.441 -0.882 0 CA-C-O 116.006 -1.95 . . . . 0.0 114.384 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . 0.343 69.2 t -133.74 -55.26 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.499 -0.995 0 N-CA-C 118.001 2.593 . . . . 0.0 118.001 -179.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.568 34.5 m -69.23 -35.21 66.81 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.079 0 N-CA-C 118.975 2.954 . . . . 0.0 118.975 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.483 ' CB ' HG21 ' A' ' 23' ' ' ILE . 27.7 mttt -74.72 -26.56 59.89 Favored 'General case' 0 C--N 1.32 -0.7 0 O-C-N 126.08 2.113 . . . . 0.0 113.326 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.401 ' N ' HG23 ' A' ' 23' ' ' ILE . 21.3 ptt180 -79.4 -23.75 43.05 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 120.347 1.43 . . . . 0.0 108.794 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 15.1 tttp -78.19 -44.0 26.99 Favored 'General case' 0 C--O 1.211 -0.959 0 CA-C-O 122.809 1.29 . . . . 0.0 110.599 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 76.1 mt -73.83 -23.42 59.64 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 114.498 -1.228 . . . . 0.0 109.149 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -66.97 -51.28 40.79 Favored Glycine 0 C--O 1.212 -1.268 0 CA-C-O 123.816 1.787 . . . . 0.0 112.96 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.505 ' CB ' ' CE2' ' A' ' 14' ' ' TYR . . . -55.2 -35.27 64.67 Favored 'General case' 0 N--CA 1.436 -1.174 0 C-N-CA 128.574 2.749 . . . . 0.0 115.707 179.116 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.427 ' C ' ' CD2' ' A' ' 33' ' ' HIS . 12.0 t-160 -130.63 60.55 1.63 Allowed 'General case' 0 CA--C 1.506 -0.732 0 CA-C-N 112.028 -2.351 . . . . 0.0 111.996 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -96.37 -15.45 21.83 Favored 'General case' 0 C--O 1.216 -0.696 0 N-CA-C 117.281 2.326 . . . . 0.0 117.281 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 97.07 29.13 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.842 0 O-C-N 125.9 2.0 . . . . 0.0 111.921 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.422 ' HB3' HG13 ' A' ' 8' ' ' VAL . 12.2 tp -65.94 81.8 0.08 Allowed 'General case' 0 CA--C 1.503 -0.84 0 CA-C-O 124.471 2.081 . . . . 0.0 110.396 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -90.24 88.97 7.44 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 101.873 -3.38 . . . . 0.0 101.873 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.43 ' N ' ' O ' ' A' ' 6' ' ' TRP . 1.0 OUTLIER -67.78 95.35 0.5 Allowed 'General case' 0 C--N 1.292 -1.932 0 C-N-CA 118.518 -1.273 . . . . 0.0 111.011 -179.18 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 39.6 m -81.4 104.83 12.12 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 101.781 -3.415 . . . . 0.0 101.781 179.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.409 HG21 ' N ' ' A' ' 41' ' ' THR . 83.7 mt -91.45 147.34 5.33 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 O-C-N 120.613 -1.304 . . . . 0.0 111.635 -179.457 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.409 ' N ' HG21 ' A' ' 40' ' ' ILE . 4.3 m -145.43 101.87 3.64 Favored 'General case' 0 C--O 1.22 -0.494 0 O-C-N 127.062 2.726 . . . . 0.0 112.609 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 15.1 tp60 -82.97 98.64 9.35 Favored 'General case' 0 N--CA 1.443 -0.804 0 O-C-N 125.557 1.785 . . . . 0.0 110.678 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 49.2 tt0 -107.34 84.36 1.96 Allowed 'General case' 0 N--CA 1.438 -1.04 0 CA-C-O 125.657 2.646 . . . . 0.0 105.066 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 70.43 -87.62 0.34 Allowed Glycine 0 C--N 1.296 -1.646 0 CA-C-O 115.814 -2.659 . . . . 0.0 106.582 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.331 0.1 OUTLIER -124.39 -11.99 7.34 Favored 'General case' 0 C--N 1.32 -0.679 0 O-C-N 127.332 2.43 . . . . 0.0 112.535 179.917 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.62 138.61 31.43 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 119.854 -1.779 . . . . 0.0 106.732 179.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.482 ' O ' ' N ' ' A' ' 49' ' ' VAL 0.342 3.8 m-85 -115.12 95.64 5.3 Favored 'General case' 0 N--CA 1.433 -1.285 0 C-N-CA 126.222 1.809 . . . . 0.0 107.633 179.777 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.471 HG21 ' CG1' ' A' ' 61' ' ' VAL 0.451 0.1 OUTLIER -67.38 79.53 0.16 Allowed 'General case' 0 N--CA 1.441 -0.875 0 CA-C-O 124.337 2.018 . . . . 0.0 110.594 179.477 . . . . . . . . 4 4 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.482 ' N ' ' O ' ' A' ' 47' ' ' PHE 0.753 0.8 OUTLIER -59.57 75.83 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 CA-C-N 109.845 -3.343 . . . . 0.0 115.332 179.794 . . . . . . . . 4 4 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.432 ' HA ' ' HA ' ' A' ' 59' ' ' ASP . 8.9 tttt -61.09 138.56 58.2 Favored 'General case' 0 C--N 1.317 -0.811 1 N-CA-C 99.964 -4.087 . . . . 0.0 99.964 179.742 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -133.71 105.16 6.67 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 102.431 -3.174 . . . . 0.0 102.431 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 54.1 p -104.1 44.85 0.99 Allowed 'General case' 0 C--N 1.288 -2.101 0 N-CA-C 105.95 -1.87 . . . . 0.0 105.95 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.7 t -67.89 149.03 50.35 Favored 'General case' 0 N--CA 1.466 0.335 0 O-C-N 127.322 2.889 . . . . 0.0 107.745 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -50.38 -21.78 1.58 Allowed 'General case' 0 C--O 1.221 -0.424 0 CA-C-N 120.656 1.571 . . . . 0.0 110.129 -179.425 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.404 ' CD1' ' CB ' ' A' ' 73' ' ' ALA . 19.8 m-85 -72.23 -49.96 31.07 Favored 'General case' 0 C--O 1.219 -0.529 0 C-N-CA 115.431 -2.507 . . . . 0.0 110.469 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.42 ' HB2' HG21 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -159.37 141.31 13.41 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 123.779 2.99 . . . . 0.0 110.522 -179.984 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 7.9 m-80 -97.56 78.4 2.65 Favored 'General case' 0 C--N 1.353 0.724 0 N-CA-C 100.36 -3.941 . . . . 0.0 100.36 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.42 HG21 ' HB2' ' A' ' 56' ' ' ARG . 2.6 tp -118.53 113.34 41.55 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.017 0 C-N-CA 131.155 3.782 . . . . 0.0 117.792 -179.243 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.432 ' HA ' ' HA ' ' A' ' 50' ' ' LYS . 3.9 p30 -59.18 149.39 28.41 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 104.357 -2.461 . . . . 0.0 104.357 178.619 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.466 ' HB ' ' CG1' ' A' ' 49' ' ' VAL . 3.2 t -101.89 -60.98 2.58 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 CA-C-O 124.696 2.189 . . . . 0.0 107.683 -177.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.471 ' CG1' HG21 ' A' ' 48' ' ' THR 0.458 0.0 OUTLIER 66.14 109.11 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.433 -1.319 0 CA-C-N 113.014 -1.903 . . . . 0.0 108.992 -179.519 . . . . . . . . 4 4 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.478 ' CZ ' ' HA ' ' A' ' 81' ' ' THR . 2.3 t80 -145.53 114.76 7.07 Favored 'General case' 0 C--N 1.312 -1.06 0 C-N-CA 115.694 -2.402 . . . . 0.0 106.651 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -68.28 141.83 55.75 Favored 'General case' 0 C--O 1.247 0.95 0 N-CA-C 102.49 -3.152 . . . . 0.0 102.49 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.82 137.23 55.15 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 120.266 1.393 . . . . 0.0 107.944 -179.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 57.98 25.0 55.84 Favored Glycine 0 CA--C 1.531 1.056 0 N-CA-C 117.925 1.93 . . . . 0.0 117.925 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . 0.296 37.2 t -111.37 84.6 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 104.851 -2.277 . . . . 0.0 104.851 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -39.36 113.43 0.32 Allowed 'General case' 0 C--O 1.202 -1.424 0 O-C-N 126.41 2.319 . . . . 0.0 114.648 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.449 ' CD1' ' C ' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -106.8 -166.26 1.15 Allowed 'General case' 0 N--CA 1.422 -1.839 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 -179.599 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -131.53 137.09 48.36 Favored 'General case' 0 CA--C 1.51 -0.583 0 CA-C-O 116.872 -1.537 . . . . 0.0 107.025 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -146.94 113.04 5.82 Favored 'General case' 0 C--O 1.216 -0.672 0 C-N-CA 117.966 -1.493 . . . . 0.0 113.808 -179.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 47.1 t -91.18 151.34 20.99 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.6 mp -96.58 -169.93 1.98 Allowed 'General case' 0 CA--C 1.498 -1.049 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.404 ' CB ' ' CD1' ' A' ' 55' ' ' PHE . . . -89.45 -6.19 56.71 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-O 124.774 2.226 . . . . 0.0 111.691 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -153.79 -44.75 0.09 Allowed 'General case' 0 N--CA 1.433 -1.29 0 CA-C-N 112.787 -2.006 . . . . 0.0 112.133 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -64.85 -8.0 32.17 Favored Glycine 0 C--O 1.205 -1.692 0 O-C-N 124.769 1.293 . . . . 0.0 114.839 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . 0.372 0.1 OUTLIER 71.46 172.3 0.31 Allowed 'General case' 0 C--N 1.308 -1.219 0 O-C-N 118.197 -2.943 . . . . 0.0 114.947 -179.982 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.417 ' HB3' HG22 ' A' ' 96' ' ' VAL . 5.8 mm-40 -35.77 151.99 0.01 OUTLIER 'General case' 0 N--CA 1.434 -1.245 1 O-C-N 130.051 4.594 . . . . 0.0 116.407 179.856 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . 0.388 8.8 tp -153.63 165.25 36.51 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-N 112.715 -2.039 . . . . 0.0 105.782 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -167.05 120.04 0.97 Allowed 'General case' 0 CA--C 1.503 -0.834 0 N-CA-C 105.201 -2.148 . . . . 0.0 105.201 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.415 ' HA3' ' HA ' ' A' ' 93' ' ' PHE . . . -168.65 -157.15 11.08 Favored Glycine 0 C--N 1.296 -1.669 0 C-N-CA 116.684 -2.674 . . . . 0.0 109.765 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.478 ' HA ' ' CZ ' ' A' ' 62' ' ' PHE . 2.8 p -144.98 159.91 42.18 Favored 'General case' 0 C--O 1.191 -2.026 0 O-C-N 126.553 1.973 . . . . 0.0 112.63 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . 0.478 ' CZ3' ' HG3' ' A' ' 106' ' ' ARG . 39.8 m95 -117.97 113.93 22.41 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 103.136 -2.913 . . . . 0.0 103.136 -179.725 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 4.0 t -122.85 139.09 54.4 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-O 122.199 1.0 . . . . 0.0 111.093 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 1.9 ttt -92.94 105.08 17.24 Favored 'General case' 0 N--CA 1.426 -1.674 0 CA-C-N 113.442 -1.708 . . . . 0.0 112.494 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . 0.532 0.6 OUTLIER -72.66 -143.98 0.01 OUTLIER 'General case' 0 N--CA 1.425 -1.719 0 O-C-N 125.008 1.443 . . . . 0.0 108.162 179.808 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -82.59 66.94 3.81 Favored Glycine 0 N--CA 1.45 -0.369 0 N-CA-C 105.447 -3.061 . . . . 0.0 105.447 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 96.74 -13.79 0.08 Allowed 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 117.293 2.331 . . . . 0.0 117.293 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . 0.409 0.0 OUTLIER -111.65 141.89 44.66 Favored 'General case' 0 C--O 1.215 -0.756 0 O-C-N 125.204 1.565 . . . . 0.0 107.714 179.869 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.456 ' CB ' ' HB2' ' A' ' 106' ' ' ARG . 1.0 OUTLIER -96.48 145.56 25.57 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 101.503 -3.517 . . . . 0.0 101.503 179.965 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.8 m -132.6 120.27 41.48 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 O-C-N 125.043 1.464 . . . . 0.0 109.596 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -100.27 87.08 0.69 Allowed Glycine 0 C--N 1.338 0.686 0 C-N-CA 128.358 2.885 . . . . 0.0 114.109 -179.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -90.67 148.11 22.83 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 102.388 -3.19 . . . . 0.0 102.388 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.494 ' CD2' HD22 ' A' ' 102' ' ' LEU . 15.7 m-85 -152.64 117.98 5.25 Favored 'General case' 0 CA--C 1.501 -0.906 0 C-N-CA 117.678 -1.609 . . . . 0.0 113.45 -179.654 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -88.36 -163.46 0.97 Allowed 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 -179.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . 0.334 0.2 OUTLIER -138.25 164.73 28.48 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 106.085 -1.82 . . . . 0.0 106.085 179.824 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.417 HG22 ' HB3' ' A' ' 77' ' ' GLU . 37.0 t -94.3 -40.01 11.0 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 C-N-CA 124.63 1.172 . . . . 0.0 108.537 -179.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . 0.287 0.2 OUTLIER -55.19 -30.66 60.38 Favored 'General case' 0 C--O 1.25 1.126 0 N-CA-C 114.681 1.363 . . . . 0.0 114.681 179.786 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -160.02 6.08 0.09 Allowed 'General case' 0 N--CA 1.44 -0.94 0 CA-C-O 115.809 -2.044 . . . . 0.0 116.428 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 54.02 85.01 0.03 OUTLIER Glycine 0 CA--C 1.524 0.612 0 N-CA-C 118.675 2.23 . . . . 0.0 118.675 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.0 mmtp -113.28 -111.37 0.34 Allowed 'General case' 0 C--O 1.213 -0.862 0 O-C-N 120.951 -1.323 . . . . 0.0 111.392 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 54.3 tt0 -177.75 162.24 1.72 Allowed 'General case' 0 C--O 1.211 -0.965 0 C-N-CA 127.954 2.502 . . . . 0.0 109.069 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.494 HD22 ' CD2' ' A' ' 93' ' ' PHE . 1.9 tp -158.29 109.16 2.15 Favored 'General case' 0 C--N 1.316 -0.887 0 C-N-CA 131.255 3.822 . . . . 0.0 102.653 -179.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.433 ' N ' ' O ' ' A' ' 118' ' ' THR . 0.8 OUTLIER -98.83 152.56 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.091 0 C-N-CA 115.093 -2.643 . . . . 0.0 105.532 -179.439 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.475 ' HA ' ' O ' ' A' ' 116' ' ' THR . . . -160.93 147.25 14.89 Favored 'General case' 0 C--N 1.309 -1.165 0 C-N-CA 124.733 1.213 . . . . 0.0 109.123 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.451 ' HB ' ' CE2' ' A' ' 117' ' ' TYR . 0.9 OUTLIER -137.11 102.46 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 116.033 -2.267 . . . . 0.0 111.461 -179.028 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.478 ' HG3' ' CZ3' ' A' ' 82' ' ' TRP 0.277 48.9 mtt180 -68.18 85.16 0.25 Allowed 'General case' 0 C--N 1.312 -1.029 0 O-C-N 126.562 2.414 . . . . 0.0 104.838 179.696 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.416 ' N ' ' O ' ' A' ' 105' ' ' VAL . 4.9 tt0 -79.52 76.38 6.13 Favored 'General case' 0 N--CA 1.424 -1.738 0 O-C-N 127.163 2.789 . . . . 0.0 117.765 -179.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.581 ' CD1' ' CH2' ' A' ' 6' ' ' TRP 0.426 0.9 OUTLIER -61.91 123.07 13.99 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 C-N-CA 116.112 -2.235 . . . . 0.0 108.41 179.65 . . . . . . . . 4 4 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 7.0 m -102.63 10.67 38.56 Favored 'General case' 0 C--O 1.219 -0.54 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 119.78 -60.21 0.52 Allowed Glycine 0 N--CA 1.444 -0.8 1 C-N-CA 132.266 4.746 . . . . 0.0 112.713 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -115.3 22.05 13.6 Favored 'General case' 0 C--N 1.314 -0.936 0 O-C-N 127.121 2.307 . . . . 0.0 111.681 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -149.42 99.62 2.93 Favored 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 120.299 -0.56 . . . . 0.0 111.33 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.411 ' HA ' ' CG1' ' A' ' 108' ' ' ILE . 7.0 tt -84.02 101.61 11.88 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 100.878 -3.749 . . . . 0.0 100.878 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.498 HG12 ' CG2' ' A' ' 127' ' ' ILE 0.295 3.7 mt -107.2 118.67 55.41 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.09 0 O-C-N 126.013 2.07 . . . . 0.0 111.145 -179.416 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . 0.509 ' O ' ' N ' ' A' ' 126' ' ' ARG 0.316 76.1 mt-30 -89.83 149.67 22.57 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 100.433 -3.914 . . . . 0.0 100.433 177.487 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.623 ' OG1' ' CE2' ' A' ' 117' ' ' TYR . 79.9 p -160.65 179.09 8.85 Favored 'General case' 0 N--CA 1.422 -1.867 1 O-C-N 130.784 5.052 . . . . 0.0 106.615 -179.865 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . 0.623 ' CE2' ' OG1' ' A' ' 116' ' ' THR 0.297 33.2 m-85 96.6 -142.76 0.0 OUTLIER 'General case' 0 CA--C 1.442 -3.205 0 N-CA-C 120.314 3.45 . . . . 0.0 120.314 174.922 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.433 ' O ' ' N ' ' A' ' 103' ' ' ILE . 11.2 t -133.87 -174.11 3.44 Favored 'General case' 0 N--CA 1.417 -2.101 0 N-CA-C 120.342 3.46 . . . . 0.0 120.342 -174.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.488 ' CA ' HD11 ' A' ' 102' ' ' LEU 0.339 7.0 t80 -117.98 0.76 11.94 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 111.528 -2.578 . . . . 0.0 106.663 178.092 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -174.74 -84.03 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.274 0 O-C-N 119.537 -1.977 . . . . 0.0 111.256 179.456 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -138.87 32.99 2.24 Favored Glycine 0 CA--C 1.537 1.454 0 C-N-CA 127.432 2.444 . . . . 0.0 116.576 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 78.7 t -141.49 101.15 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 N-CA-C 105.73 -1.952 . . . . 0.0 105.73 -179.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.404 ' HA ' ' C ' ' A' ' 117' ' ' TYR . 1.8 mp0 -59.13 -179.67 0.08 Allowed 'General case' 0 C--O 1.207 -1.172 0 CA-C-O 123.785 1.755 . . . . 0.0 111.797 -179.464 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.568 ' N ' ' O ' ' A' ' 117' ' ' TYR . . . -168.08 76.21 0.13 Allowed 'General case' 0 CA--C 1.503 -0.847 0 C-N-CA 113.602 -3.239 . . . . 0.0 110.877 -178.043 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.539 ' HA ' ' CB ' ' A' ' 116' ' ' THR . 1.4 mptp? -57.58 144.69 36.35 Favored 'General case' 0 CA--C 1.508 -0.654 0 CA-C-N 123.897 3.044 . . . . 0.0 112.258 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.509 ' N ' ' O ' ' A' ' 115' ' ' GLN . 11.1 mtp180 -144.83 77.03 1.52 Allowed 'General case' 0 C--O 1.21 -0.978 0 C-N-CA 127.259 2.224 . . . . 0.0 105.565 178.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.498 ' CG2' HG12 ' A' ' 114' ' ' ILE . 0.8 OUTLIER -78.62 128.59 38.32 Favored 'Isoleucine or valine' 0 C--O 1.253 1.289 0 O-C-N 127.767 3.167 . . . . 0.0 116.794 179.77 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.42 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 0.1 OUTLIER -109.8 145.38 36.81 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 128.499 2.72 . . . . 0.0 107.122 179.917 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . 0.254 0.3 OUTLIER -112.67 29.13 8.2 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 117.051 -1.452 . . . . 0.0 112.286 -179.79 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.555 ' HB2' ' CZ3' ' A' ' 6' ' ' TRP . 3.3 tttp 50.37 89.26 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 127.397 2.279 . . . . 0.0 108.641 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . 0.773 64.0 mt-10 . . . . . 0 N--CA 1.426 -1.639 0 O-C-N 125.846 1.966 . . . . 0.0 113.6 -179.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.445 -0.716 0 N-CA-C 116.067 1.877 . . . . 0.0 116.067 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -43.85 93.74 0.01 OUTLIER 'General case' 0 CA--C 1.496 -1.126 0 O-C-N 126.141 2.15 . . . . 0.0 111.691 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 176.3 -178.28 47.71 Favored Glycine 0 C--N 1.31 -0.886 0 C-N-CA 117.343 -2.36 . . . . 0.0 111.527 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.434 ' C ' ' CD1' ' A' ' 6' ' ' TRP 0.377 1.2 p -94.02 155.12 17.29 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 128.641 3.201 . . . . 0.0 111.951 -179.735 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.61 ' CE3' ' CB ' ' A' ' 113' ' ' LEU . 49.2 m95 -159.75 -158.98 0.69 Allowed 'General case' 0 N--CA 1.426 -1.667 0 CA-C-O 114.63 -2.605 . . . . 0.0 106.393 177.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.733 ' HB3' ' CZ ' ' A' ' 128' ' ' PHE . 6.9 ttmt 178.91 -99.64 0.0 OUTLIER 'General case' 0 C--O 1.209 -1.073 0 O-C-N 129.007 3.942 . . . . 0.0 105.17 179.387 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.594 ' CG1' ' HB3' ' A' ' 36' ' ' LEU 0.263 0.3 OUTLIER 159.3 120.13 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 O-C-N 126.329 2.268 . . . . 0.0 109.348 179.514 . . . . . . . . 4 4 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 61.5 t0 -125.55 -76.48 0.59 Allowed 'General case' 0 CA--C 1.506 -0.746 0 CA-C-O 125.965 2.793 . . . . 0.0 108.043 -179.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -83.83 122.97 29.41 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 118.626 -2.547 . . . . 0.0 108.269 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . 0.319 0.0 OUTLIER -114.76 -171.12 1.87 Allowed 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 107.151 -1.425 . . . . 0.0 107.151 179.685 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -170.53 109.89 0.36 Allowed 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 115.723 -2.391 . . . . 0.0 106.75 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.407 ' ND2' ' O ' ' A' ' 123' ' ' GLU 0.259 0.2 OUTLIER 87.65 -8.08 0.59 Allowed 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 -179.852 . . . . . . . . 4 4 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.532 ' CD1' ' HB2' ' A' ' 124' ' ' ALA 0.407 0.3 OUTLIER -68.09 -33.81 75.23 Favored 'General case' 0 C--N 1.321 -0.645 0 O-C-N 126.939 2.65 . . . . 0.0 115.6 179.882 . . . . . . . . 4 4 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -71.97 -20.51 61.72 Favored 'General case' 0 C--O 1.213 -0.832 0 O-C-N 119.072 -2.268 . . . . 0.0 110.556 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 24.5 mttt -78.61 -40.88 33.23 Favored 'General case' 0 N--CA 1.443 -0.777 0 O-C-N 126.765 2.541 . . . . 0.0 112.494 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.519 ' CE1' ' HG2' ' A' ' 21' ' ' MET . 0.6 OUTLIER -68.41 -31.79 71.38 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-O 126.076 2.846 . . . . 0.0 110.681 179.702 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 28.4 mtm -69.23 -23.64 63.9 Favored 'General case' 0 C--O 1.22 -0.459 1 O-C-N 114.918 -4.864 . . . . 0.0 108.793 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -79.33 -32.97 43.45 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-O 127.603 3.573 . . . . 0.0 110.647 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 16.6 tptt -74.16 -25.4 59.7 Favored 'General case' 0 N--CA 1.433 -1.302 0 O-C-N 118.257 -2.777 . . . . 0.0 112.728 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.519 ' HG2' ' CE1' ' A' ' 17' ' ' PHE 0.257 13.6 mmm -75.73 -29.1 58.78 Favored 'General case' 0 C--O 1.202 -1.415 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 -179.933 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 103.95 29.12 5.63 Favored Glycine 0 CA--C 1.504 -0.619 0 CA-C-O 115.94 -2.589 . . . . 0.0 109.583 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.2 mm -69.42 141.78 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.956 0 CA-C-N 118.857 1.328 . . . . 0.0 109.863 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 24.9 t30 -80.65 131.99 35.54 Favored 'General case' 0 C--N 1.345 0.399 0 CA-C-O 113.742 -3.028 . . . . 0.0 108.503 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . 0.454 99.1 t -11.01 -51.54 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.503 -0.86 0 O-C-N 128.513 3.633 . . . . 0.0 119.262 -179.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.614 13.7 t -72.84 -40.1 59.96 Favored 'Isoleucine or valine' 0 C--O 1.249 1.044 0 N-CA-C 116.637 2.088 . . . . 0.0 116.637 -179.467 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 11.3 mttm -67.09 -32.35 73.45 Favored 'General case' 0 C--O 1.213 -0.853 0 O-C-N 125.632 1.832 . . . . 0.0 113.369 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.401 ' HG3' ' N ' ' A' ' 29' ' ' LYS . 16.4 ptt180 -78.96 -29.28 43.86 Favored 'General case' 0 CA--C 1.514 -0.432 0 O-C-N 120.337 -1.477 . . . . 0.0 109.449 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.401 ' N ' ' HG3' ' A' ' 28' ' ' ARG . 0.2 OUTLIER -72.66 -40.85 66.01 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-O 122.626 1.203 . . . . 0.0 110.67 179.955 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.0 tp -73.2 -28.61 62.29 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 113.484 -1.689 . . . . 0.0 108.625 -179.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -74.57 -28.98 62.32 Favored Glycine 0 C--N 1.348 1.219 0 CA-C-N 113.897 -1.501 . . . . 0.0 113.969 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -71.63 -37.97 70.82 Favored 'General case' 0 C--O 1.241 0.655 0 C-N-CA 126.89 2.076 . . . . 0.0 111.563 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 6.6 m80 -111.28 30.27 7.07 Favored 'General case' 0 N--CA 1.447 -0.594 0 O-C-N 126.786 2.554 . . . . 0.0 110.186 179.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -49.68 -36.63 25.69 Favored 'General case' 0 CA--C 1.501 -0.912 0 N-CA-C 116.813 2.153 . . . . 0.0 116.813 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . 0.261 22.3 m120 70.42 54.22 0.3 Allowed 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 116.114 -2.234 . . . . 0.0 107.122 -179.196 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.594 ' HB3' ' CG1' ' A' ' 8' ' ' VAL 0.293 1.7 tp -85.8 107.45 17.65 Favored 'General case' 0 N--CA 1.479 0.992 0 O-C-N 128.7 3.75 . . . . 0.0 103.747 179.911 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.458 ' HA ' ' CB ' ' A' ' 7' ' ' LYS . 24.4 tttm -92.77 127.98 38.46 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 100.473 -3.899 . . . . 0.0 100.473 179.614 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.472 HD13 ' CD1' ' A' ' 36' ' ' LEU 0.377 0.5 OUTLIER -112.05 121.4 44.87 Favored 'General case' 0 C--N 1.288 -2.09 0 C-N-CA 116.011 -2.275 . . . . 0.0 107.004 -178.5 . . . . . . . . 4 4 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.48 ' HB ' ' CB ' ' A' ' 50' ' ' LYS . 28.0 m -116.12 90.86 3.43 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 117.287 -3.383 . . . . 0.0 104.588 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.547 HG22 ' CE2' ' A' ' 47' ' ' PHE . 26.5 mt -70.36 130.16 34.6 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 11.6 m -126.75 105.91 9.0 Favored 'General case' 0 N--CA 1.477 0.886 0 O-C-N 127.801 3.188 . . . . 0.0 109.734 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.521 ' HG2' ' CE1' ' A' ' 47' ' ' PHE . 1.0 OUTLIER -84.69 109.1 17.77 Favored 'General case' 0 C--O 1.24 0.6 0 N-CA-C 114.368 1.247 . . . . 0.0 114.368 -179.906 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -96.66 31.08 2.4 Favored 'General case' 0 N--CA 1.419 -1.991 0 O-C-N 121.214 -0.929 . . . . 0.0 109.857 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 97.41 -13.12 64.69 Favored Glycine 0 C--N 1.29 -1.99 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.376 0.0 OUTLIER -175.6 -50.59 0.01 OUTLIER 'General case' 0 C--O 1.213 -0.823 0 CA-C-O 126.132 2.872 . . . . 0.0 109.168 179.901 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 28.1 ttmt -64.89 115.9 5.81 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 113.048 -1.887 . . . . 0.0 110.504 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.547 ' CE2' HG22 ' A' ' 40' ' ' ILE . 0.9 OUTLIER -100.71 93.85 5.78 Favored 'General case' 0 CA--C 1.499 -0.995 0 CA-C-O 123.312 1.529 . . . . 0.0 107.271 179.803 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . 0.388 3.1 t -89.72 87.39 6.98 Favored 'General case' 0 N--CA 1.432 -1.347 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 179.623 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.468 HG13 ' CG1' ' A' ' 60' ' ' VAL 0.596 0.5 OUTLIER -70.09 107.93 2.03 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.12 0 O-C-N 125.884 1.99 . . . . 0.0 110.334 179.981 . . . . . . . . 4 4 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.48 ' CB ' ' HB ' ' A' ' 39' ' ' THR . 26.0 tttm -68.9 115.97 8.83 Favored 'General case' 0 C--N 1.302 -1.46 1 N-CA-C 100.192 -4.003 . . . . 0.0 100.192 -179.731 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.276 69.9 tt0 -107.29 96.32 6.33 Favored 'General case' 0 C--N 1.322 -0.63 0 O-C-N 126.659 2.474 . . . . 0.0 108.484 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.424 ' HA ' ' HA ' ' A' ' 57' ' ' ASN 0.261 0.1 OUTLIER -96.48 52.37 1.23 Allowed 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 105.201 -2.148 . . . . 0.0 105.201 179.378 . . . . . . . . 4 4 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.418 ' HA ' ' HA ' ' A' ' 36' ' ' LEU . 0.1 OUTLIER -77.97 160.23 28.32 Favored 'General case' 0 C--O 1.214 -0.781 0 O-C-N 127.552 3.032 . . . . 0.0 109.882 -179.537 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -53.65 -28.26 32.07 Favored 'General case' 0 C--O 1.215 -0.724 0 O-C-N 126.477 2.361 . . . . 0.0 108.633 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -62.27 -58.8 6.39 Favored 'General case' 0 C--N 1.351 0.639 0 CA-C-O 115.201 -2.333 . . . . 0.0 109.612 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.485 ' HB2' ' CG2' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -156.85 155.91 32.27 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-N 123.399 2.818 . . . . 0.0 106.102 179.414 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.424 ' HA ' ' HA ' ' A' ' 52' ' ' SER 0.262 21.2 t30 -101.07 70.94 1.37 Allowed 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 100.364 -3.939 . . . . 0.0 100.364 179.67 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.485 ' CG2' ' HB2' ' A' ' 56' ' ' ARG . 8.4 tp -120.03 122.98 69.88 Favored 'Isoleucine or valine' 0 C--O 1.243 0.728 0 C-N-CA 130.146 3.378 . . . . 0.0 118.697 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -72.58 135.66 45.6 Favored 'General case' 0 N--CA 1.468 0.441 0 O-C-N 118.694 -2.504 . . . . 0.0 105.466 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.468 ' CG1' HG13 ' A' ' 49' ' ' VAL . 4.4 p -109.96 101.13 12.13 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-O 126.177 2.894 . . . . 0.0 111.407 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . 0.311 2.0 m -88.56 131.2 36.62 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 O-C-N 116.684 -3.76 . . . . 0.0 113.061 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 22.1 p90 -151.58 89.02 1.45 Allowed 'General case' 0 N--CA 1.442 -0.827 0 C-N-CA 116.579 -2.049 . . . . 0.0 107.128 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -56.08 134.64 52.79 Favored 'General case' 0 N--CA 1.432 -1.362 0 N-CA-C 104.438 -2.43 . . . . 0.0 104.438 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -49.63 102.81 0.04 OUTLIER 'General case' 0 N--CA 1.428 -1.565 0 O-C-N 126.407 2.317 . . . . 0.0 110.515 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 89.73 32.19 10.4 Favored Glycine 0 C--N 1.346 1.115 0 C-N-CA 128.289 2.852 . . . . 0.0 119.924 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . 0.364 0.4 OUTLIER -111.42 99.16 8.1 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 N-CA-C 104.902 -2.258 . . . . 0.0 104.902 179.91 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -51.47 136.93 25.01 Favored 'General case' 0 CA--C 1.487 -1.45 0 O-C-N 126.079 2.112 . . . . 0.0 114.153 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 9.9 p90 -145.62 175.08 10.63 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -129.46 146.77 51.26 Favored 'General case' 0 CA--C 1.501 -0.924 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.454 ' HB3' ' CD2' ' A' ' 78' ' ' LEU . 16.5 t80 -129.96 -39.78 1.38 Allowed 'General case' 0 C--O 1.213 -0.863 0 CA-C-O 116.118 -1.896 . . . . 0.0 111.806 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.499 ' CB ' HD12 ' A' ' 72' ' ' LEU . 0.7 OUTLIER 64.39 158.44 0.09 Allowed 'General case' 0 C--N 1.308 -1.2 0 O-C-N 125.366 1.666 . . . . 0.0 112.056 -179.904 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.552 ' CD1' ' N ' ' A' ' 72' ' ' LEU . 0.0 OUTLIER 41.55 -158.7 0.01 OUTLIER 'General case' 0 C--N 1.293 -1.873 0 O-C-N 128.351 3.532 . . . . 0.0 110.424 178.369 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.404 ' O ' ' CB ' ' A' ' 74' ' ' ASP . . . 53.97 35.93 23.16 Favored 'General case' 0 C--O 1.208 -1.094 0 CA-C-N 114.237 -1.347 . . . . 0.0 111.444 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.404 ' CB ' ' O ' ' A' ' 73' ' ' ALA . 0.3 OUTLIER 102.34 19.84 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.365 0 O-C-N 126.565 2.415 . . . . 0.0 113.89 179.22 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.493 ' HA3' ' CD1' ' A' ' 78' ' ' LEU . . . -136.87 -38.63 0.15 Allowed Glycine 0 CA--C 1.549 2.174 0 N-CA-C 118.434 2.134 . . . . 0.0 118.434 179.025 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . 0.308 0.0 OUTLIER 59.28 65.95 1.1 Allowed 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 119.662 1.731 . . . . 0.0 107.897 -179.026 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.445 ' HB3' ' CG2' ' A' ' 96' ' ' VAL . 31.0 mt-10 71.81 76.39 0.17 Allowed 'General case' 0 C--O 1.218 -0.594 0 O-C-N 126.518 2.386 . . . . 0.0 108.529 -178.212 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.493 ' CD1' ' HA3' ' A' ' 75' ' ' GLY 0.436 0.7 OUTLIER -97.63 135.11 39.92 Favored 'General case' 0 CA--C 1.5 -0.978 0 O-C-N 127.764 3.165 . . . . 0.0 104.38 -178.162 . . . . . . . . 4 4 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 20.2 m -158.13 124.72 4.82 Favored 'General case' 0 CA--C 1.481 -1.696 0 N-CA-C 103.919 -2.623 . . . . 0.0 103.919 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -168.61 -155.49 9.66 Favored Glycine 0 C--N 1.302 -1.313 0 O-C-N 119.748 -1.845 . . . . 0.0 109.316 -179.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 4.2 p -145.17 -179.97 6.98 Favored 'General case' 0 C--O 1.196 -1.73 0 C-N-CA 117.23 -1.788 . . . . 0.0 106.965 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . 0.469 ' CZ3' ' NE ' ' A' ' 106' ' ' ARG . 19.7 m95 -132.27 142.88 49.55 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 101.689 -3.449 . . . . 0.0 101.689 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 14.4 t -143.77 160.96 39.82 Favored 'General case' 0 N--CA 1.417 -2.078 0 CA-C-O 124.948 2.309 . . . . 0.0 113.195 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -94.91 126.97 40.6 Favored 'General case' 0 C--N 1.354 0.8 0 CA-C-N 110.774 -2.921 . . . . 0.0 105.775 -179.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . 0.685 0.5 OUTLIER -107.24 33.72 3.85 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.88 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 95.26 -93.43 1.6 Allowed Glycine 0 N--CA 1.427 -1.953 0 N-CA-C 103.986 -3.646 . . . . 0.0 103.986 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -88.96 -5.84 57.68 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 120.154 3.39 . . . . 0.0 120.154 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . 0.265 0.2 OUTLIER -129.91 152.53 49.28 Favored 'General case' 0 CA--C 1.49 -1.354 0 O-C-N 125.163 1.54 . . . . 0.0 107.182 179.678 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.536 HD13 ' CE2' ' A' ' 47' ' ' PHE . 0.3 OUTLIER -106.21 134.15 49.79 Favored 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 105.039 -2.208 . . . . 0.0 105.039 -179.864 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -121.76 154.1 25.94 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.941 0 N-CA-C 105.276 -2.12 . . . . 0.0 105.276 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.435 ' HA3' ' CE2' ' A' ' 82' ' ' TRP . . . -134.96 111.61 0.94 Allowed Glycine 0 CA--C 1.531 1.04 1 C-N-CA 131.06 4.171 . . . . 0.0 109.509 179.898 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 24.8 mtmt -109.16 158.53 17.71 Favored 'General case' 0 N--CA 1.426 -1.651 0 N-CA-C 104.374 -2.454 . . . . 0.0 104.374 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -148.36 112.95 5.34 Favored 'General case' 0 CA--C 1.508 -0.635 0 CA-C-O 123.378 1.561 . . . . 0.0 108.079 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 57.0 mttm -93.39 138.91 31.27 Favored 'General case' 0 N--CA 1.437 -1.104 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . 0.302 0.3 OUTLIER -92.15 136.61 33.04 Favored 'General case' 0 CA--C 1.491 -1.293 0 CA-C-N 113.55 -1.659 . . . . 0.0 109.106 179.75 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.445 ' CG2' ' HB3' ' A' ' 77' ' ' GLU . 38.4 t -71.98 -38.13 63.12 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 C-N-CA 125.277 1.431 . . . . 0.0 111.166 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . 0.319 0.8 OUTLIER -83.24 2.64 34.85 Favored 'General case' 0 C--O 1.261 1.665 0 N-CA-C 118.103 2.631 . . . . 0.0 118.103 -179.959 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -144.28 -29.22 0.49 Allowed 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 116.197 -2.201 . . . . 0.0 114.843 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 92.48 -0.16 70.72 Favored Glycine 0 CA--C 1.532 1.129 0 N-CA-C 118.956 2.343 . . . . 0.0 118.956 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 6.4 mmtt -77.61 -155.1 0.07 Allowed 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 119.299 1.55 . . . . 0.0 111.331 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.55 118.58 4.7 Favored 'General case' 0 CA--C 1.489 -1.375 0 C-N-CA 128.983 2.913 . . . . 0.0 114.541 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.57 ' CB ' ' HA ' ' A' ' 119' ' ' TYR . 0.7 OUTLIER -92.23 135.87 33.65 Favored 'General case' 0 C--N 1.317 -0.812 1 C-N-CA 132.484 4.314 . . . . 0.0 102.741 179.073 . . . . . . . . 4 4 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.497 ' N ' ' O ' ' A' ' 118' ' ' THR . 14.0 tt -129.34 163.72 33.76 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.003 0 C-N-CA 116.524 -2.07 . . . . 0.0 109.395 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -150.39 146.77 26.9 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-O 115.658 -2.115 . . . . 0.0 107.808 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.561 ' HB ' ' CE2' ' A' ' 117' ' ' TYR . 8.8 p -136.53 120.8 24.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 122.915 2.598 . . . . 0.0 110.466 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.469 ' NE ' ' CZ3' ' A' ' 82' ' ' TRP . 1.2 mtt-85 -76.95 86.65 3.48 Favored 'General case' 0 CA--C 1.496 -1.105 0 O-C-N 126.66 2.475 . . . . 0.0 106.689 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 10.7 tt0 -81.65 78.67 8.37 Favored 'General case' 0 N--CA 1.424 -1.742 0 CA-C-O 123.104 1.431 . . . . 0.0 113.031 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.525 ' CD1' ' CZ2' ' A' ' 6' ' ' TRP . 2.3 mm -69.01 98.06 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 C-N-CA 115.537 -2.465 . . . . 0.0 110.296 179.693 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -100.1 101.43 12.49 Favored 'General case' 0 C--O 1.215 -0.742 0 N-CA-C 103.254 -2.869 . . . . 0.0 103.254 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 65.41 -88.8 0.1 Allowed Glycine 0 C--N 1.339 0.695 0 O-C-N 126.061 2.101 . . . . 0.0 112.138 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . 0.368 0.4 OUTLIER -117.82 -13.57 10.12 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-O 113.313 -3.232 . . . . 0.0 111.158 179.562 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . 0.251 2.2 mp0 -93.6 133.42 36.95 Favored 'General case' 0 C--O 1.212 -0.879 0 O-C-N 128.905 3.878 . . . . 0.0 110.89 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.61 ' CB ' ' CE3' ' A' ' 6' ' ' TRP 0.284 0.4 OUTLIER -103.06 141.74 35.3 Favored 'General case' 0 C--O 1.21 -1.011 0 N-CA-C 101.321 -3.585 . . . . 0.0 101.321 179.721 . . . . . . . . 4 4 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.493 HG13 ' CD1' ' A' ' 127' ' ' ILE 0.297 1.4 mp -129.95 139.0 52.64 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 N-CA-C 101.706 -3.442 . . . . 0.0 101.706 179.385 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . 0.511 ' HB2' ' CD ' ' A' ' 126' ' ' ARG . 3.4 mt-30 -119.24 104.91 10.83 Favored 'General case' 0 C--N 1.316 -0.851 1 O-C-N 129.621 4.325 . . . . 0.0 101.492 179.699 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.445 ' O ' ' N ' ' A' ' 105' ' ' VAL . 3.4 t -140.68 157.68 45.09 Favored 'General case' 0 N--CA 1.412 -2.371 0 C-N-CA 116.924 -1.91 . . . . 0.0 112.357 -178.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . 0.561 ' CE2' ' HB ' ' A' ' 105' ' ' VAL 0.372 22.2 m-30 137.93 -138.36 0.0 OUTLIER 'General case' 0 CA--C 1.484 -1.584 1 O-C-N 129.408 4.193 . . . . 0.0 113.171 176.246 . . . . . . . . 4 3 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.497 ' O ' ' N ' ' A' ' 103' ' ' ILE . 10.2 t -158.67 -154.33 0.42 Allowed 'General case' 0 C--N 1.308 -1.229 0 O-C-N 127.674 3.109 . . . . 0.0 115.756 -174.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.57 ' HA ' ' CB ' ' A' ' 102' ' ' LEU . 1.7 t80 -114.9 -55.94 2.43 Favored 'General case' 0 C--N 1.346 0.417 0 N-CA-C 105.126 -2.176 . . . . 0.0 105.126 178.305 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.88 -83.37 0.65 Allowed 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 111.59 -2.55 . . . . 0.0 112.396 179.203 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -143.55 25.29 2.15 Favored Glycine 0 C--N 1.366 2.238 0 N-CA-C 121.359 3.303 . . . . 0.0 121.359 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 15.0 t -123.34 97.35 4.63 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 N-CA-C 103.011 -2.959 . . . . 0.0 103.011 179.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.414 ' HA ' ' HB ' ' A' ' 118' ' ' THR . 13.6 mt-10 -56.86 179.77 0.04 OUTLIER 'General case' 0 C--O 1.205 -1.289 0 CA-C-O 126.554 3.073 . . . . 0.0 113.093 -177.418 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.532 ' HB2' ' CD1' ' A' ' 14' ' ' TYR . . . -169.17 94.5 0.31 Allowed 'General case' 0 C--O 1.211 -0.961 0 O-C-N 118.821 -2.424 . . . . 0.0 107.987 -179.661 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.426 ' HG3' ' HB ' ' A' ' 116' ' ' THR 0.391 0.1 OUTLIER -84.92 153.72 22.67 Favored 'General case' 0 N--CA 1.444 -0.727 0 O-C-N 125.923 2.014 . . . . 0.0 112.529 -179.572 . . . . . . . . 4 4 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.511 ' CD ' ' HB2' ' A' ' 115' ' ' GLN . 1.0 OUTLIER -137.81 77.83 1.65 Allowed 'General case' 0 N--CA 1.427 -1.598 0 O-C-N 127.57 3.044 . . . . 0.0 105.297 177.114 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.493 ' CD1' HG13 ' A' ' 114' ' ' ILE . 50.8 mm -66.99 82.79 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.259 1.557 0 O-C-N 128.051 3.344 . . . . 0.0 111.202 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.733 ' CZ ' ' HB3' ' A' ' 7' ' ' LYS 0.368 5.7 t80 -84.44 144.39 28.79 Favored 'General case' 0 N--CA 1.419 -2.001 0 CA-C-O 125.256 2.455 . . . . 0.0 113.753 -179.641 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.407 ' N ' ' CG ' ' A' ' 128' ' ' PHE 0.391 8.7 mmtt -95.28 10.53 35.82 Favored 'General case' 0 N--CA 1.436 -1.147 0 CA-C-N 110.996 -2.82 . . . . 0.0 113.996 -177.666 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.489 ' HB2' ' CZ3' ' A' ' 6' ' ' TRP . 18.4 tttt 61.53 111.7 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 122.555 2.434 . . . . 0.0 113.666 -178.39 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . 0.857 2.3 tm-20 . . . . . 0 C--O 1.217 -0.612 0 O-C-N 117.167 -3.458 . . . . 0.0 114.508 -179.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 . . . . . 0 N--CA 1.451 -0.406 0 N-CA-C 116.353 1.983 . . . . 0.0 116.353 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -39.78 91.39 0.0 OUTLIER 'General case' 0 CA--C 1.499 -0.984 0 O-C-N 126.678 2.486 . . . . 0.0 111.34 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . 0.4 ' O ' ' N ' ' A' ' 40' ' ' ILE . . . 158.69 -174.71 35.78 Favored Glycine 0 C--O 1.214 -1.114 0 CA-C-N 113.824 -1.534 . . . . 0.0 110.91 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . 0.549 0.5 OUTLIER -81.93 156.88 24.52 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-O 124.426 2.06 . . . . 0.0 115.774 -179.697 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.505 ' CZ3' ' HB2' ' A' ' 130' ' ' LYS . 73.1 m95 -149.8 157.3 43.07 Favored 'General case' 0 N--CA 1.435 -1.182 0 CA-C-N 110.647 -2.979 . . . . 0.0 106.858 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -160.27 102.54 1.41 Allowed 'General case' 0 C--O 1.214 -0.79 1 O-C-N 129.59 4.306 . . . . 0.0 107.081 179.922 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.541 ' HB ' ' CD1' ' A' ' 128' ' ' PHE 0.38 9.3 p -47.12 139.35 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.289 0 CA-C-N 121.593 1.997 . . . . 0.0 113.131 179.992 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -131.61 0.98 4.03 Favored 'General case' 0 CA--C 1.496 -1.099 0 C-N-CA 119.785 -0.766 . . . . 0.0 112.55 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 16.6 ptp180 -160.79 -39.06 0.05 OUTLIER 'General case' 0 CA--C 1.474 -1.967 0 O-C-N 116.946 -3.596 . . . . 0.0 113.301 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . 0.278 0.6 OUTLIER 62.09 178.79 0.13 Allowed 'General case' 0 C--O 1.243 0.742 0 C-N-CA 125.293 1.437 . . . . 0.0 108.193 179.613 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -132.34 -80.2 0.5 Allowed 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 122.478 2.399 . . . . 0.0 109.635 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.404 ' HB3' ' HA ' ' A' ' 124' ' ' ALA . 16.5 t30 -96.05 15.46 20.62 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 124.799 1.312 . . . . 0.0 113.576 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.559 ' CE2' ' HG2' ' A' ' 126' ' ' ARG 0.26 0.1 OUTLIER -58.0 -26.87 62.94 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 117.978 2.584 . . . . 0.0 117.978 -179.952 . . . . . . . . 4 4 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -72.12 -41.32 67.37 Favored 'General case' 0 C--O 1.207 -1.168 0 O-C-N 120.822 -1.174 . . . . 0.0 110.794 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 17.8 tttm -79.72 -26.37 40.83 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-O 123.175 1.464 . . . . 0.0 114.161 -179.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.428 ' HB3' ' HB3' ' A' ' 124' ' ' ALA . 7.8 t80 -67.05 -35.67 80.37 Favored 'General case' 0 N--CA 1.422 -1.838 0 C-N-CA 118.509 -1.276 . . . . 0.0 113.752 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.448 ' CB ' HG13 ' A' ' 23' ' ' ILE . 24.2 mtt -72.51 -23.7 61.05 Favored 'General case' 0 N--CA 1.425 -1.714 0 CA-C-O 124.561 2.124 . . . . 0.0 107.81 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -76.85 -22.94 52.78 Favored 'General case' 0 CA--C 1.507 -0.689 0 C-N-CA 116.54 -2.064 . . . . 0.0 112.777 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 18.9 tptp -68.0 -39.69 83.17 Favored 'General case' 0 C--N 1.314 -0.936 0 O-C-N 118.827 -2.42 . . . . 0.0 114.889 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.53 ' HG3' ' CD2' ' A' ' 119' ' ' TYR . 3.2 mpp? -76.03 -37.57 58.23 Favored 'General case' 0 C--O 1.207 -1.132 0 C-N-CA 124.527 1.131 . . . . 0.0 109.429 179.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 118.73 47.91 0.39 Allowed Glycine 0 C--N 1.308 -1.016 0 CA-C-N 113.05 -1.886 . . . . 0.0 110.01 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.448 HG13 ' CB ' ' A' ' 18' ' ' MET . 5.4 mm -73.15 106.56 3.22 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.784 0 CA-C-N 121.735 2.768 . . . . 0.0 110.565 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -44.82 111.21 0.29 Allowed 'General case' 0 N--CA 1.44 -0.94 0 CA-C-O 114.136 -2.84 . . . . 0.0 113.019 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . 0.421 0.2 OUTLIER 3.76 -61.78 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.497 -1.076 1 O-C-N 129.463 4.227 . . . . 0.0 119.309 179.89 . . . . . . . . 4 3 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.579 13.3 m -72.59 -22.24 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.906 0 N-CA-C 117.53 2.419 . . . . 0.0 117.53 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.42 ' HB2' ' CG2' ' A' ' 23' ' ' ILE . 26.5 mttp -77.0 -25.97 53.31 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-O 118.406 -0.807 . . . . 0.0 110.918 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -79.98 -24.44 40.91 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 117.934 -1.506 . . . . 0.0 107.495 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.8 ttpt -74.84 -49.76 19.45 Favored 'General case' 0 C--O 1.212 -0.893 0 CA-C-O 123.819 1.771 . . . . 0.0 108.711 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 7.3 tp -73.25 -28.85 62.37 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 114.56 -1.2 . . . . 0.0 108.348 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -67.55 -32.64 79.23 Favored Glycine 0 CA--C 1.538 1.474 0 O-C-N 124.843 1.34 . . . . 0.0 112.219 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -78.05 -24.35 47.8 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -112.81 2.41 15.96 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-O 115.903 -1.999 . . . . 0.0 112.363 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 21.5 p-10 -33.46 -32.51 0.01 OUTLIER 'General case' 0 CA--C 1.505 -0.766 0 N-CA-C 117.922 2.564 . . . . 0.0 117.922 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . 0.259 4.5 t-20 75.42 31.03 0.79 Allowed 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 121.386 1.903 . . . . 0.0 109.561 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.468 ' HA ' ' CB ' ' A' ' 53' ' ' SER . 1.2 tp -60.97 87.83 0.02 OUTLIER 'General case' 0 C--O 1.213 -0.863 0 O-C-N 126.925 2.641 . . . . 0.0 109.602 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.82 104.15 16.63 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 102.122 -3.288 . . . . 0.0 102.122 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.402 ' N ' ' O ' ' A' ' 6' ' ' TRP 0.265 0.6 OUTLIER -90.47 104.13 16.74 Favored 'General case' 0 C--N 1.288 -2.089 0 O-C-N 125.921 2.013 . . . . 0.0 109.384 -179.901 . . . . . . . . 4 4 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.428 ' HB ' ' CB ' ' A' ' 50' ' ' LYS . 6.9 m -87.18 85.62 7.22 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 102.021 -3.326 . . . . 0.0 102.021 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.588 ' CG2' ' CE1' ' A' ' 47' ' ' PHE . 6.4 mm -60.0 131.44 24.66 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 CA-C-O 124.191 1.948 . . . . 0.0 110.68 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.0 m -150.34 103.4 3.15 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 112.915 -1.948 . . . . 0.0 114.575 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.436 ' HG2' ' CE1' ' A' ' 47' ' ' PHE . 1.6 mm-40 -49.21 117.73 2.31 Favored 'General case' 0 CA--C 1.547 0.847 0 O-C-N 126.479 2.362 . . . . 0.0 107.992 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.427 ' HB2' HG21 ' A' ' 48' ' ' THR 0.252 1.2 tp10 -90.86 45.65 1.27 Allowed 'General case' 0 CA--C 1.484 -1.562 0 O-C-N 124.816 1.322 . . . . 0.0 107.494 -179.46 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.02 -55.82 5.05 Favored Glycine 0 C--N 1.292 -1.912 0 N-CA-C 105.657 -2.977 . . . . 0.0 105.657 -179.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.455 ' HB2' ' CG ' ' A' ' 63' ' ' GLU 0.318 4.5 m-20 -108.13 -76.9 0.6 Allowed 'General case' 0 CA--C 1.504 -0.805 0 N-CA-C 115.158 1.54 . . . . 0.0 115.158 -179.449 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.632 ' HG3' ' N ' ' A' ' 47' ' ' PHE . 26.1 tptt -83.64 -76.85 0.27 Allowed 'General case' 0 N--CA 1.417 -2.093 0 C-N-CA 114.594 -2.842 . . . . 0.0 115.112 -178.346 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.632 ' N ' ' HG3' ' A' ' 46' ' ' LYS 0.422 0.1 OUTLIER 162.77 108.78 0.0 OUTLIER 'General case' 0 CA--C 1.496 -1.127 0 O-C-N 128.398 3.561 . . . . 0.0 109.423 -174.761 . . . . . . . . 4 4 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.474 ' HB ' ' CB ' ' A' ' 61' ' ' VAL 0.407 9.0 t -81.63 112.33 18.73 Favored 'General case' 0 C--O 1.248 0.992 0 O-C-N 119.458 -2.026 . . . . 0.0 106.118 178.316 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.414 HG23 ' HB ' ' A' ' 60' ' ' VAL 0.615 1.0 OUTLIER -90.47 105.04 15.9 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 N-CA-C 116.117 1.895 . . . . 0.0 116.117 -179.606 . . . . . . . . 4 4 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.428 ' CB ' ' HB ' ' A' ' 39' ' ' THR . 0.4 OUTLIER -67.4 111.3 3.98 Favored 'General case' 0 C--N 1.302 -1.487 1 N-CA-C 99.836 -4.135 . . . . 0.0 99.836 179.351 . . . . . . . . 4 4 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -96.82 67.9 2.33 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 104.173 -2.528 . . . . 0.0 104.173 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.7 m -78.67 68.4 4.64 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 105.417 -2.068 . . . . 0.0 105.417 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.468 ' CB ' ' HA ' ' A' ' 36' ' ' LEU . 1.1 p -109.66 -167.51 1.21 Allowed 'General case' 0 N--CA 1.438 -1.033 0 CA-C-N 114.76 -1.109 . . . . 0.0 110.057 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -75.58 -24.22 56.59 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 117.867 -1.533 . . . . 0.0 111.457 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.415 ' CE2' ' HA ' ' A' ' 73' ' ' ALA . 31.8 m-85 -69.29 -50.55 45.71 Favored 'General case' 0 C--O 1.221 -0.423 0 C-N-CA 115.47 -2.492 . . . . 0.0 111.042 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 168.6 151.82 0.03 OUTLIER 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 123.916 3.053 . . . . 0.0 110.351 179.208 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -84.34 116.36 22.98 Favored 'General case' 0 C--N 1.348 0.535 1 N-CA-C 99.892 -4.114 . . . . 0.0 99.892 179.056 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . 0.299 0.0 OUTLIER -136.52 -28.02 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 O-C-N 128.524 3.64 . . . . 0.0 116.622 -178.223 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 67.46 79.05 0.23 Allowed 'General case' 0 C--N 1.352 0.701 0 N-CA-C 104.096 -2.557 . . . . 0.0 104.096 -178.57 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.583 ' CG1' ' CE2' ' A' ' 62' ' ' PHE . 94.2 t -86.72 77.61 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.408 0 CA-C-N 114.3 -1.318 . . . . 0.0 114.257 -177.254 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.511 ' O ' ' CD1' ' A' ' 62' ' ' PHE . 0.4 OUTLIER -69.6 143.03 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.378 0 O-C-N 118.749 -2.469 . . . . 0.0 106.923 177.334 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.656 ' CE1' ' CB ' ' A' ' 68' ' ' PHE . 1.6 m-30 -144.31 57.88 1.32 Allowed 'General case' 0 N--CA 1.44 -0.945 0 C-N-CA 114.392 -2.923 . . . . 0.0 111.839 178.235 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.611 ' HA ' ' CB ' ' A' ' 46' ' ' LYS . 1.2 mt-10 -19.61 119.66 0.02 OUTLIER 'General case' 0 C--N 1.311 -1.071 0 O-C-N 128.601 3.688 . . . . 0.0 108.682 -178.115 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.536 ' N ' ' HB2' ' A' ' 46' ' ' LYS . 0.4 OUTLIER -48.11 101.83 0.03 OUTLIER 'General case' 0 N--CA 1.438 -1.032 0 CA-C-O 122.761 1.267 . . . . 0.0 110.979 -177.387 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 93.38 22.25 27.4 Favored Glycine 0 C--N 1.351 1.415 0 CA-C-N 110.793 -2.912 . . . . 0.0 114.0 -179.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.411 ' N ' ' O ' ' A' ' 63' ' ' GLU 0.364 0.9 OUTLIER -102.7 77.79 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 N-CA-C 104.015 -2.587 . . . . 0.0 104.015 179.796 . . . . . . . . 4 4 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -39.17 111.71 0.2 Allowed 'General case' 0 CA--C 1.485 -1.55 0 O-C-N 126.895 2.622 . . . . 0.0 115.929 -179.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.656 ' CB ' ' CE1' ' A' ' 62' ' ' PHE . 17.1 p90 -106.7 -179.68 4.01 Favored 'General case' 0 N--CA 1.433 -1.306 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.533 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -144.69 148.3 34.05 Favored 'General case' 0 CA--C 1.521 -0.161 0 O-C-N 126.702 2.501 . . . . 0.0 109.183 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -146.31 118.94 8.55 Favored 'General case' 0 C--O 1.216 -0.679 0 O-C-N 125.274 1.609 . . . . 0.0 107.28 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.452 ' C ' ' CD1' ' A' ' 72' ' ' LEU . 0.7 OUTLIER -99.84 37.68 1.58 Allowed 'General case' 0 CA--C 1.489 -1.37 0 CA-C-N 121.366 1.893 . . . . 0.0 112.133 -179.255 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.46 ' CD1' ' N ' ' A' ' 72' ' ' LEU . 0.0 OUTLIER 173.61 -167.59 0.03 OUTLIER 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 125.14 1.376 . . . . 0.0 109.199 -179.094 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.465 ' O ' ' CB ' ' A' ' 74' ' ' ASP . . . 69.74 24.82 5.28 Favored 'General case' 0 C--O 1.208 -1.101 0 O-C-N 124.711 1.257 . . . . 0.0 110.352 -179.307 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.465 ' CB ' ' O ' ' A' ' 73' ' ' ALA . 27.8 t0 106.89 41.26 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.403 0 O-C-N 126.726 2.516 . . . . 0.0 113.692 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -155.53 -40.31 0.02 OUTLIER Glycine 0 CA--C 1.543 1.8 0 N-CA-C 118.301 2.08 . . . . 0.0 118.301 179.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . 0.257 0.1 OUTLIER 61.91 25.62 15.41 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-O 115.188 -2.339 . . . . 0.0 108.097 -179.554 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.484 ' CB ' ' HB ' ' A' ' 96' ' ' VAL . 3.9 mm-40 112.74 113.14 0.0 OUTLIER 'General case' 0 C--N 1.313 -1.02 1 O-C-N 133.923 7.014 . . . . 0.0 109.45 -177.659 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.44 ' HG ' ' HB3' ' A' ' 93' ' ' PHE 0.451 7.4 tt -139.53 119.68 13.66 Favored 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 102.662 -3.088 . . . . 0.0 102.662 -178.272 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 21.8 m -141.63 120.66 12.86 Favored 'General case' 0 C--O 1.197 -1.687 0 N-CA-C 103.38 -2.822 . . . . 0.0 103.38 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.422 ' HA3' ' HA ' ' A' ' 93' ' ' PHE . . . -160.9 -163.25 13.64 Favored Glycine 0 C--O 1.215 -1.051 0 C-N-CA 116.972 -2.537 . . . . 0.0 114.057 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 13.9 p -141.95 165.71 26.72 Favored 'General case' 0 C--O 1.188 -2.175 0 O-C-N 127.296 2.41 . . . . 0.0 110.616 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 93.9 m95 -107.36 147.46 30.31 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 103.76 -2.682 . . . . 0.0 103.76 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 5.0 t -147.15 127.53 13.99 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 125.093 1.495 . . . . 0.0 109.612 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -79.48 117.54 20.53 Favored 'General case' 0 N--CA 1.427 -1.606 0 CA-C-N 112.536 -2.12 . . . . 0.0 108.597 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . 0.608 3.4 mm-40 -78.03 -20.09 53.09 Favored 'General case' 0 N--CA 1.426 -1.662 0 O-C-N 123.766 0.666 . . . . 0.0 109.267 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 126.64 -53.2 0.8 Allowed Glycine 0 N--CA 1.436 -1.339 0 N-CA-C 104.921 -3.272 . . . . 0.0 104.921 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -112.54 -3.41 14.39 Favored 'General case' 0 C--O 1.245 0.834 0 CA-C-O 116.7 -1.619 . . . . 0.0 114.183 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . 0.379 10.2 mtpt -154.75 120.64 5.19 Favored 'General case' 0 CA--C 1.503 -0.837 0 O-C-N 125.574 1.796 . . . . 0.0 110.468 179.767 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.8 tp -76.56 144.55 39.61 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 103.512 -2.773 . . . . 0.0 103.512 179.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.449 HG11 ' CG2' ' A' ' 105' ' ' VAL . 2.7 m -141.56 153.35 19.5 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.052 0 N-CA-C 105.235 -2.135 . . . . 0.0 105.235 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -123.38 104.51 0.86 Allowed Glycine 0 CA--C 1.534 1.227 1 C-N-CA 130.794 4.045 . . . . 0.0 108.132 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -105.95 95.57 5.88 Favored 'General case' 0 N--CA 1.428 -1.565 0 C-N-CA 119.521 -0.872 . . . . 0.0 109.841 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.44 ' HB3' ' HG ' ' A' ' 78' ' ' LEU . 2.3 m-85 -92.96 123.32 36.13 Favored 'General case' 0 N--CA 1.435 -1.185 0 O-C-N 125.4 1.688 . . . . 0.0 114.092 179.672 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 24.7 mttt -91.5 146.77 23.53 Favored 'General case' 0 N--CA 1.429 -1.503 0 O-C-N 126.0 2.062 . . . . 0.0 110.059 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . 0.355 9.0 ttt180 -103.73 142.24 34.7 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-N 114.04 -1.436 . . . . 0.0 107.376 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.484 ' HB ' ' CB ' ' A' ' 77' ' ' GLU . 69.0 t -81.66 -36.04 14.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-O 124.793 2.235 . . . . 0.0 109.618 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . 0.32 1.3 t70 -72.82 -12.96 61.19 Favored 'General case' 0 C--O 1.256 1.405 0 N-CA-C 118.354 2.724 . . . . 0.0 118.354 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -141.36 -27.51 0.68 Allowed 'General case' 0 CA--C 1.502 -0.876 0 C-N-CA 116.854 -1.938 . . . . 0.0 115.671 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 94.77 9.98 58.14 Favored Glycine 0 C--N 1.337 0.625 0 O-C-N 125.555 1.784 . . . . 0.0 117.041 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 5.4 mmtm -106.04 172.29 6.89 Favored 'General case' 0 C--O 1.2 -1.544 0 CA-C-N 119.072 1.436 . . . . 0.0 109.278 179.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.96 126.14 50.15 Favored 'General case' 0 N--CA 1.436 -1.142 0 O-C-N 125.955 2.034 . . . . 0.0 114.841 -179.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.597 ' CB ' ' HA ' ' A' ' 119' ' ' TYR . 0.2 OUTLIER -79.38 116.44 19.62 Favored 'General case' 0 C--O 1.246 0.894 0 C-N-CA 130.456 3.502 . . . . 0.0 102.686 179.43 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.43 HG21 ' CB ' ' A' ' 117' ' ' TYR . 4.3 tt -97.8 150.15 4.83 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.116 0 C-N-CA 114.616 -2.833 . . . . 0.0 104.732 -179.245 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -143.29 145.03 32.37 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 116.533 -1.698 . . . . 0.0 109.312 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.54 ' CG1' ' CE2' ' A' ' 117' ' ' TYR . 7.6 p -134.5 113.83 17.49 Favored 'Isoleucine or valine' 0 C--O 1.248 1.012 0 CA-C-N 123.604 2.911 . . . . 0.0 113.528 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.464 ' CB ' HD23 ' A' ' 113' ' ' LEU . 63.0 mtt180 -81.37 95.67 7.1 Favored 'General case' 0 C--O 1.216 -0.667 0 N-CA-C 104.948 -2.242 . . . . 0.0 104.948 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 64.4 tt0 -102.31 81.97 2.13 Favored 'General case' 0 N--CA 1.419 -2.007 0 CA-C-N 111.49 -2.596 . . . . 0.0 114.727 -179.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.407 HG13 ' HA ' ' A' ' 113' ' ' LEU 0.29 0.3 OUTLIER -58.51 110.98 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 C-N-CA 117.448 -1.701 . . . . 0.0 107.853 179.516 . . . . . . . . 4 4 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 2.9 m -75.36 -17.93 60.1 Favored 'General case' 0 C--O 1.214 -0.776 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 -179.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 150.63 -109.35 0.42 Allowed Glycine 0 C--O 1.238 0.37 1 C-N-CA 132.087 4.661 . . . . 0.0 111.75 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 38.0 m-20 -59.77 -17.4 35.21 Favored 'General case' 0 C--O 1.213 -0.858 0 C-N-CA 116.778 -1.969 . . . . 0.0 111.61 179.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -110.64 135.23 51.58 Favored 'General case' 0 CA--C 1.496 -1.126 0 O-C-N 127.02 2.7 . . . . 0.0 117.476 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.505 HD12 ' CE2' ' A' ' 128' ' ' PHE . 0.1 OUTLIER -101.96 113.06 25.95 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 102.793 -3.04 . . . . 0.0 102.793 -179.938 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.466 ' CD1' HD13 ' A' ' 127' ' ' ILE . 78.0 mt -113.94 106.45 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.026 0 O-C-N 125.663 1.852 . . . . 0.0 110.309 -179.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . 0.485 ' HB2' ' CG ' ' A' ' 126' ' ' ARG . 30.1 mt-30 -74.16 169.92 16.58 Favored 'General case' 0 C--O 1.244 0.791 0 N-CA-C 101.505 -3.517 . . . . 0.0 101.505 178.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.495 ' O ' ' N ' ' A' ' 105' ' ' VAL . 0.2 OUTLIER 173.75 155.04 0.11 Allowed 'General case' 0 N--CA 1.414 -2.254 0 C-N-CA 118.037 -1.465 . . . . 0.0 111.508 179.992 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . 0.54 ' CE2' ' CG1' ' A' ' 105' ' ' VAL 0.393 23.4 m-30 125.38 -141.91 0.0 OUTLIER 'General case' 0 CA--C 1.475 -1.934 1 O-C-N 130.475 4.859 . . . . 0.0 113.875 175.93 . . . . . . . . 4 3 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.428 ' O ' ' N ' ' A' ' 103' ' ' ILE . 0.0 OUTLIER -138.53 -165.18 1.77 Allowed 'General case' 0 N--CA 1.431 -1.38 0 CA-C-O 126.831 3.205 . . . . 0.0 117.656 -174.911 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.597 ' HA ' ' CB ' ' A' ' 102' ' ' LEU 0.259 0.0 OUTLIER -109.19 -55.42 2.41 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 111.463 -2.608 . . . . 0.0 105.287 177.872 . . . . . . . . 4 4 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.515 ' HB2' ' CD2' ' A' ' 119' ' ' TYR . 0.6 OUTLIER -129.12 -53.96 1.2 Allowed 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 111.516 -2.584 . . . . 0.0 112.744 179.526 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -162.01 15.91 0.15 Allowed Glycine 0 C--N 1.362 2.011 0 N-CA-C 118.928 2.331 . . . . 0.0 118.928 -179.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 82.9 t -120.7 112.58 36.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 N-CA-C 104.172 -2.529 . . . . 0.0 104.172 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.429 ' HA ' ' O ' ' A' ' 117' ' ' TYR . 1.2 mt-10 -71.42 177.51 3.93 Favored 'General case' 0 C--O 1.208 -1.116 0 C-N-CA 118.359 -1.337 . . . . 0.0 112.298 -178.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.438 ' CB ' ' HA ' ' A' ' 14' ' ' TYR . . . 179.71 97.83 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 116.525 -1.702 . . . . 0.0 110.284 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.426 ' HA ' ' HB ' ' A' ' 116' ' ' THR 0.327 0.0 OUTLIER -71.02 165.08 24.25 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 120.803 1.638 . . . . 0.0 111.192 179.656 . . . . . . . . 4 4 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.559 ' HG2' ' CE2' ' A' ' 14' ' ' TYR . 0.1 OUTLIER -140.56 77.09 1.59 Allowed 'General case' 0 N--CA 1.436 -1.128 1 O-C-N 129.661 4.351 . . . . 0.0 108.664 179.476 . . . . . . . . 4 4 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.466 HD13 ' CD1' ' A' ' 114' ' ' ILE . 0.6 OUTLIER -70.03 112.82 5.18 Favored 'Isoleucine or valine' 0 C--O 1.254 1.298 0 O-C-N 128.341 3.525 . . . . 0.0 112.824 179.752 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.541 ' CD1' ' HB ' ' A' ' 8' ' ' VAL . 1.8 m-30 -98.2 138.74 35.02 Favored 'General case' 0 C--O 1.221 -0.427 0 C-N-CA 127.298 2.239 . . . . 0.0 109.34 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . 0.266 26.6 mmtt -103.73 34.67 2.9 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 117.139 -1.41 . . . . 0.0 112.311 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.505 ' HB2' ' CZ3' ' A' ' 6' ' ' TRP . 10.0 tttp 29.83 100.78 0.0 OUTLIER 'General case' 0 CA--C 1.508 -0.65 0 N-CA-C 116.695 2.109 . . . . 0.0 116.695 179.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . 0.852 5.6 tt0 . . . . . 0 N--CA 1.439 -1.013 0 N-CA-C 119.502 3.149 . . . . 0.0 119.502 -179.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 . . . . . 0 N--CA 1.449 -0.481 0 N-CA-C 114.816 1.413 . . . . 0.0 114.816 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.38 101.08 0.07 Allowed 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 118.63 -1.228 . . . . 0.0 112.401 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 166.12 -155.32 26.49 Favored Glycine 0 C--O 1.217 -0.941 0 C-N-CA 115.809 -3.091 . . . . 0.0 113.267 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . 0.543 1.2 p -105.48 150.92 24.88 Favored 'General case' 0 CA--C 1.504 -0.823 0 CA-C-N 112.657 -1.772 . . . . 0.0 114.494 -179.728 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.51 ' CZ3' ' HB2' ' A' ' 130' ' ' LYS . 85.5 m95 -150.54 152.69 34.54 Favored 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 125.513 1.758 . . . . 0.0 108.576 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 5.6 tttp -153.13 103.01 2.68 Favored 'General case' 0 C--O 1.205 -1.268 0 CA-C-O 116.678 -1.629 . . . . 0.0 109.103 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.479 ' CG1' ' HB3' ' A' ' 36' ' ' LEU 0.396 13.9 p -48.98 124.39 2.26 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.066 0 O-C-N 126.464 2.353 . . . . 0.0 111.722 179.819 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 51.4 t0 -123.81 1.26 8.73 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 125.218 2.437 . . . . 0.0 108.717 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.9 ttt180 -169.28 133.51 1.4 Allowed 'General case' 0 C--N 1.294 -1.811 0 O-C-N 118.184 -2.822 . . . . 0.0 107.398 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . 0.299 0.0 OUTLIER -116.22 -171.89 2.08 Favored 'General case' 0 CA--C 1.501 -0.941 0 CA-C-N 114.394 -1.276 . . . . 0.0 108.513 179.894 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.432 ' CB ' ' HB2' ' A' ' 125' ' ' LYS . 0.5 OUTLIER -167.51 94.82 0.44 Allowed 'General case' 0 C--N 1.3 -1.579 0 CA-C-N 122.2 2.273 . . . . 0.0 107.917 179.907 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . 0.259 0.1 OUTLIER 97.68 -5.87 0.05 Allowed 'General case' 0 N--CA 1.486 1.359 0 O-C-N 126.984 2.678 . . . . 0.0 111.63 -179.636 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.519 ' CD2' ' HG2' ' A' ' 126' ' ' ARG . 0.4 OUTLIER -71.87 -16.36 62.14 Favored 'General case' 0 N--CA 1.432 -1.349 0 O-C-N 126.188 2.18 . . . . 0.0 116.103 -179.852 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -76.98 -37.68 54.71 Favored 'General case' 0 C--O 1.206 -1.201 0 CA-C-N 121.74 2.064 . . . . 0.0 109.25 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.42 -34.57 63.29 Favored 'General case' 0 N--CA 1.427 -1.617 0 CA-C-N 112.846 -1.979 . . . . 0.0 113.178 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.44 ' CA ' HG13 ' A' ' 122' ' ' VAL . 43.4 t80 -65.85 -24.79 66.96 Favored 'General case' 0 N--CA 1.421 -1.916 0 CA-C-O 123.213 1.482 . . . . 0.0 112.607 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.424 ' CB ' HG13 ' A' ' 23' ' ' ILE . 29.6 mtt -74.33 -28.56 61.2 Favored 'General case' 0 N--CA 1.443 -0.806 0 O-C-N 118.511 -2.618 . . . . 0.0 107.449 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -70.12 -32.62 70.72 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 125.665 2.65 . . . . 0.0 113.31 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 7.9 tttm -77.82 -43.9 29.03 Favored 'General case' 0 C--N 1.313 -0.984 0 O-C-N 119.855 -1.778 . . . . 0.0 112.086 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 11.1 mmm -62.29 -26.7 68.55 Favored 'General case' 0 C--O 1.205 -1.247 0 C-N-CA 126.098 1.759 . . . . 0.0 109.782 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 105.34 62.38 0.64 Allowed Glycine 0 N--CA 1.433 -1.521 0 CA-C-N 114.792 -1.095 . . . . 0.0 112.89 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.427 HG22 ' HB3' ' A' ' 27' ' ' LYS . 2.2 mm -118.31 134.9 60.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -79.35 157.35 27.67 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-O 113.872 -2.966 . . . . 0.0 112.391 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . 0.343 2.1 m -33.73 -39.1 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.21 -0.978 0 O-C-N 126.809 2.568 . . . . 0.0 114.318 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.488 2.5 m -78.18 -50.48 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.106 0 O-C-N 126.959 2.662 . . . . 0.0 115.129 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.427 ' HB3' HG22 ' A' ' 23' ' ' ILE . 13.7 mttm -64.25 -23.54 67.34 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.149 -0.932 . . . . 0.0 112.67 -179.635 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 6.9 ptt-85 -79.51 -26.19 41.6 Favored 'General case' 0 CA--C 1.532 0.27 0 O-C-N 119.826 -1.796 . . . . 0.0 107.753 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 7.0 ttmm -74.91 -38.45 61.81 Favored 'General case' 0 C--O 1.212 -0.905 0 O-C-N 125.086 1.492 . . . . 0.0 112.248 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.0 mp -78.08 -24.97 47.41 Favored 'General case' 0 N--CA 1.431 -1.404 0 C-N-CA 124.101 0.96 . . . . 0.0 110.579 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -79.42 -27.46 54.93 Favored Glycine 0 C--O 1.213 -1.165 0 O-C-N 125.238 1.586 . . . . 0.0 111.251 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -75.38 -41.8 55.49 Favored 'General case' 0 CA--C 1.514 -0.409 0 C-N-CA 125.912 1.685 . . . . 0.0 111.371 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 6.7 m-70 -101.03 14.32 32.35 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-O 116.152 -1.88 . . . . 0.0 115.408 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 14.9 p30 -40.34 -26.25 0.03 OUTLIER 'General case' 0 CA--C 1.499 -1.002 0 O-C-N 127.391 2.932 . . . . 0.0 118.763 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 6.9 p30 72.95 12.12 5.16 Favored 'General case' 0 C--N 1.311 -1.089 0 O-C-N 125.264 1.602 . . . . 0.0 109.155 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.479 ' HB3' ' CG1' ' A' ' 8' ' ' VAL . 2.6 tp -30.23 92.83 0.01 OUTLIER 'General case' 0 CA--C 1.503 -0.839 0 C-N-CA 129.298 3.039 . . . . 0.0 110.34 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 5.9 ttpm? -94.15 115.61 27.92 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 102.336 -3.209 . . . . 0.0 102.336 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.511 HD11 ' CE2' ' A' ' 128' ' ' PHE 0.26 0.1 OUTLIER -104.02 116.76 32.81 Favored 'General case' 0 C--N 1.291 -1.974 0 C-N-CA 116.923 -1.911 . . . . 0.0 110.01 -179.819 . . . . . . . . 4 4 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.422 ' HB ' ' HB2' ' A' ' 50' ' ' LYS . 10.5 m -106.3 99.11 8.71 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 124.748 2.213 . . . . 0.0 105.158 179.68 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 1.2 mt -88.17 128.42 40.52 Favored 'Isoleucine or valine' 0 C--O 1.251 1.184 0 CA-C-N 113.233 -1.803 . . . . 0.0 110.814 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 4.5 m -115.44 70.78 0.75 Allowed 'General case' 0 C--N 1.346 0.448 0 O-C-N 127.306 2.879 . . . . 0.0 107.567 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -65.69 112.96 3.93 Favored 'General case' 0 C--N 1.316 -0.854 0 C-N-CA 123.948 0.899 . . . . 0.0 109.716 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.408 ' HG2' ' N ' ' A' ' 44' ' ' GLY . 10.7 tt0 -99.16 -103.19 0.22 Allowed 'General case' 0 N--CA 1.423 -1.822 0 N-CA-C 105.312 -2.107 . . . . 0.0 105.312 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.408 ' N ' ' HG2' ' A' ' 43' ' ' GLU . . . -113.48 -48.41 0.6 Allowed Glycine 0 C--N 1.295 -1.743 0 N-CA-C 109.092 -1.603 . . . . 0.0 109.092 -179.702 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.532 ' ND2' ' N ' ' A' ' 45' ' ' ASN . 0.0 OUTLIER -127.58 -20.4 3.98 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 -179.942 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -90.14 161.23 15.86 Favored 'General case' 0 C--N 1.308 -1.217 0 C-N-CA 116.723 -1.991 . . . . 0.0 113.098 179.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -135.24 69.44 1.44 Allowed 'General case' 0 CA--C 1.512 -0.49 0 CA-C-O 124.273 1.987 . . . . 0.0 109.698 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.419 ' HB ' HG13 ' A' ' 61' ' ' VAL . 14.0 t -74.74 122.88 23.96 Favored 'General case' 0 N--CA 1.432 -1.362 0 O-C-N 119.562 -1.961 . . . . 0.0 106.753 179.345 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.475 HG21 ' CG1' ' A' ' 60' ' ' VAL 0.685 0.9 OUTLIER -116.44 120.9 66.33 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.727 0 N-CA-C 117.551 2.426 . . . . 0.0 117.551 -179.058 . . . . . . . . 4 4 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.422 ' HB2' ' HB ' ' A' ' 39' ' ' THR . 0.9 OUTLIER -64.87 145.15 56.69 Favored 'General case' 0 C--N 1.308 -1.235 1 N-CA-C 99.101 -4.407 . . . . 0.0 99.101 177.749 . . . . . . . . 4 4 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.472 ' O ' ' N ' ' A' ' 53' ' ' SER . 5.3 tt0 -133.87 51.69 2.12 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 104.279 -2.489 . . . . 0.0 104.279 -178.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . 0.26 4.6 m -61.95 86.6 0.02 OUTLIER 'General case' 0 C--N 1.289 -2.06 0 N-CA-C 104.736 -2.32 . . . . 0.0 104.736 179.348 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.472 ' N ' ' O ' ' A' ' 51' ' ' GLU . 1.3 m -122.48 44.34 2.65 Favored 'General case' 0 N--CA 1.443 -0.816 0 O-C-N 126.1 2.125 . . . . 0.0 114.607 -179.121 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 65.66 -54.04 0.36 Allowed 'General case' 0 N--CA 1.44 -0.957 0 O-C-N 126.717 2.51 . . . . 0.0 108.996 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.522 ' CE1' ' HB3' ' A' ' 73' ' ' ALA . 7.4 m-85 -62.81 -56.99 12.48 Favored 'General case' 0 C--O 1.217 -0.654 0 CA-C-O 114.699 -2.572 . . . . 0.0 109.186 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.459 ' HB3' ' CG2' ' A' ' 58' ' ' ILE . 23.1 ttt-85 -148.98 144.48 26.8 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 123.709 2.959 . . . . 0.0 112.054 179.665 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -97.66 81.84 2.98 Favored 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 100.623 -3.843 . . . . 0.0 100.623 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.459 ' CG2' ' HB3' ' A' ' 56' ' ' ARG . 1.5 tt -120.65 100.6 9.38 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.77 1 O-C-N 129.26 4.1 . . . . 0.0 118.927 -179.213 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -63.02 117.98 7.21 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 103.492 -2.781 . . . . 0.0 103.492 178.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.475 ' CG1' HG21 ' A' ' 49' ' ' VAL . 2.4 p -101.43 102.32 13.33 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 C-N-CA 119.672 -0.811 . . . . 0.0 111.103 -177.283 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.419 HG13 ' HB ' ' A' ' 48' ' ' THR 0.36 0.8 OUTLIER -87.12 138.06 19.76 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 CA-C-O 125.966 2.794 . . . . 0.0 113.58 -179.807 . . . . . . . . 4 4 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 23.7 p90 -153.49 100.62 2.43 Favored 'General case' 0 N--CA 1.437 -1.103 0 O-C-N 120.204 -1.56 . . . . 0.0 110.719 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.49 130.44 46.88 Favored 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 102.862 -3.014 . . . . 0.0 102.862 179.683 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 7.2 mt -52.31 118.09 3.29 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-O 122.886 1.327 . . . . 0.0 110.492 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 86.38 13.41 68.16 Favored Glycine 0 C--N 1.347 1.191 0 CA-C-N 111.627 -2.533 . . . . 0.0 117.39 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . 0.419 0.5 OUTLIER -101.1 129.5 51.98 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 N-CA-C 105.547 -2.02 . . . . 0.0 105.547 179.963 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -86.61 115.31 23.99 Favored 'General case' 0 CA--C 1.483 -1.625 0 N-CA-C 115.146 1.536 . . . . 0.0 115.146 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -111.7 155.04 24.08 Favored 'General case' 0 N--CA 1.427 -1.609 0 CA-C-O 116.276 -1.821 . . . . 0.0 106.798 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -109.51 130.07 55.53 Favored 'General case' 0 CA--C 1.51 -0.591 0 O-C-N 126.138 2.149 . . . . 0.0 106.783 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -130.87 101.16 5.52 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-O 116.67 -1.634 . . . . 0.0 113.903 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 26.8 m -67.18 119.41 12.04 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 105.78 -1.933 . . . . 0.0 105.78 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 16.7 mt -65.61 -175.81 0.3 Allowed 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 114.265 -1.334 . . . . 0.0 109.136 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.522 ' HB3' ' CE1' ' A' ' 55' ' ' PHE . . . -75.42 -35.76 60.92 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-O 124.773 2.225 . . . . 0.0 111.814 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -153.11 23.91 0.55 Allowed 'General case' 0 C--O 1.239 0.514 0 CA-C-N 112.662 -2.063 . . . . 0.0 108.4 179.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -120.18 -10.0 7.67 Favored Glycine 0 C--O 1.213 -1.19 0 C-N-CA 125.052 1.31 . . . . 0.0 114.786 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER 74.51 -175.57 0.14 Allowed 'General case' 0 C--N 1.317 -0.811 0 C-N-CA 117.699 -1.601 . . . . 0.0 112.933 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -44.87 123.88 4.05 Favored 'General case' 0 N--CA 1.446 -0.64 0 O-C-N 127.467 2.979 . . . . 0.0 111.195 179.669 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.437 ' HG ' ' HB3' ' A' ' 93' ' ' PHE 0.423 0.6 OUTLIER -144.38 90.14 2.07 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 102.414 -3.18 . . . . 0.0 102.414 -179.819 . . . . . . . . 4 4 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 95.6 m -103.55 135.86 44.35 Favored 'General case' 0 CA--C 1.481 -1.678 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -170.78 -159.66 17.35 Favored Glycine 0 C--N 1.291 -1.917 0 C-N-CA 116.568 -2.729 . . . . 0.0 110.596 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -147.54 175.46 10.83 Favored 'General case' 0 C--O 1.197 -1.699 0 CA-C-O 122.554 1.169 . . . . 0.0 108.453 179.726 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . 0.505 ' CZ3' ' N ' ' A' ' 91' ' ' GLY . 54.6 m95 -130.02 135.43 48.27 Favored 'General case' 0 N--CA 1.427 -1.577 0 N-CA-C 104.078 -2.564 . . . . 0.0 104.078 179.506 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.471 ' CG2' HG21 ' A' ' 90' ' ' VAL . 8.8 t -135.87 134.76 39.13 Favored 'General case' 0 N--CA 1.425 -1.693 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.885 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' MET . . . . . 0.414 ' CA ' HD13 ' A' ' 89' ' ' LEU . 5.4 ttt -83.96 121.46 27.41 Favored 'General case' 0 N--CA 1.429 -1.523 0 O-C-N 125.793 1.933 . . . . 0.0 106.103 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . 0.539 0.5 OUTLIER -79.87 -24.24 41.36 Favored 'General case' 0 N--CA 1.426 -1.652 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 179.788 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 154.64 -85.43 0.14 Allowed Glycine 0 N--CA 1.447 -0.568 0 N-CA-C 105.047 -3.221 . . . . 0.0 105.047 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 13.2 m-80 -91.32 -0.72 57.71 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-O 116.385 -1.769 . . . . 0.0 115.264 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . 0.382 0.3 OUTLIER -141.55 146.91 36.9 Favored 'General case' 0 CA--C 1.489 -1.39 0 O-C-N 127.095 2.747 . . . . 0.0 106.973 -179.854 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.439 HD21 ' HD3' ' A' ' 106' ' ' ARG . 0.7 OUTLIER -109.88 141.88 41.97 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 104.934 -2.247 . . . . 0.0 104.934 -179.864 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.471 HG21 ' CG2' ' A' ' 83' ' ' THR . 0.3 OUTLIER -123.21 124.75 70.7 Favored 'Isoleucine or valine' 0 C--O 1.244 0.771 0 N-CA-C 105.007 -2.219 . . . . 0.0 105.007 -179.582 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.505 ' N ' ' CZ3' ' A' ' 82' ' ' TRP . . . -103.36 109.06 3.37 Favored Glycine 0 C--N 1.349 1.268 0 N-CA-C 108.892 -1.683 . . . . 0.0 108.892 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.472 ' C ' ' CD1' ' A' ' 93' ' ' PHE . 24.2 mtpp -102.71 152.77 20.83 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 105.175 -2.158 . . . . 0.0 105.175 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.472 ' CD1' ' C ' ' A' ' 92' ' ' LYS . 64.6 m-85 -148.73 111.61 4.84 Favored 'General case' 0 CA--C 1.508 -0.658 0 CA-C-O 122.931 1.348 . . . . 0.0 110.873 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 12.8 mttm -92.86 130.53 38.43 Favored 'General case' 0 N--CA 1.44 -0.942 0 C-N-CA 126.456 1.902 . . . . 0.0 107.626 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.414 ' HB3' ' ND2' ' A' ' 98' ' ' ASN 0.381 0.0 OUTLIER -95.62 143.4 26.93 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 104.917 -2.253 . . . . 0.0 104.917 -179.923 . . . . . . . . 4 4 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 29.6 m -70.24 -37.76 72.38 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 O-C-N 123.935 0.772 . . . . 0.0 111.081 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . 0.345 0.5 OUTLIER -56.82 -12.29 1.85 Allowed 'General case' 0 C--O 1.254 1.333 0 N-CA-C 114.825 1.417 . . . . 0.0 114.825 179.896 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.414 ' ND2' ' HB3' ' A' ' 95' ' ' ARG . 0.1 OUTLIER -159.52 5.91 0.09 Allowed 'General case' 0 N--CA 1.426 -1.647 0 N-CA-C 116.646 2.091 . . . . 0.0 116.646 179.93 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 44.65 25.39 0.86 Allowed Glycine 0 C--O 1.243 0.692 0 CA-C-O 124.0 1.889 . . . . 0.0 114.357 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 6.7 mmmt -70.91 -97.96 0.01 OUTLIER 'General case' 0 CA--C 1.554 1.129 0 O-C-N 119.185 -2.362 . . . . 0.0 109.611 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.454 ' CG ' ' N ' ' A' ' 102' ' ' LEU . 36.8 tt0 152.26 168.77 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 128.719 2.808 . . . . 0.0 109.345 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.6 ' CB ' ' HA ' ' A' ' 119' ' ' TYR . 0.9 OUTLIER -151.07 134.66 16.34 Favored 'General case' 0 C--O 1.246 0.909 1 C-N-CA 132.613 4.365 . . . . 0.0 103.986 -179.669 . . . . . . . . 4 4 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.562 ' N ' ' O ' ' A' ' 118' ' ' THR . 1.3 tp -118.17 159.9 18.22 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.09 0 N-CA-C 106.314 -1.736 . . . . 0.0 106.314 -179.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.447 ' N ' HG13 ' A' ' 103' ' ' ILE . . . -154.31 150.59 28.15 Favored 'General case' 0 C--O 1.242 0.708 0 CA-C-O 115.995 -1.955 . . . . 0.0 107.454 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.511 HG13 ' CE2' ' A' ' 117' ' ' TYR . 8.4 p -137.01 109.68 7.57 Favored 'Isoleucine or valine' 0 C--O 1.248 0.979 0 C-N-CA 116.439 -2.105 . . . . 0.0 114.301 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.439 ' HD3' HD21 ' A' ' 89' ' ' LEU 0.253 50.7 mtt180 -71.08 96.85 1.39 Allowed 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 104.347 -2.464 . . . . 0.0 104.347 179.498 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -94.75 73.89 3.63 Favored 'General case' 0 N--CA 1.422 -1.858 0 O-C-N 126.438 2.336 . . . . 0.0 112.082 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.427 HD12 ' CH2' ' A' ' 6' ' ' TRP 0.355 1.9 tt -59.55 97.65 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 C-N-CA 114.425 -2.91 . . . . 0.0 113.701 179.891 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 39.4 t -84.23 71.99 10.57 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 105.475 -2.046 . . . . 0.0 105.475 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 72.61 -89.59 0.54 Allowed Glycine 0 C--O 1.241 0.544 0 O-C-N 128.722 3.764 . . . . 0.0 113.26 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . 0.329 1.0 OUTLIER -95.01 -14.76 24.05 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 116.358 -1.782 . . . . 0.0 113.172 -179.891 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -108.9 134.64 51.3 Favored 'General case' 0 N--CA 1.431 -1.411 0 O-C-N 127.553 3.033 . . . . 0.0 112.897 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.439 ' HB2' ' CZ3' ' A' ' 6' ' ' TRP . 0.7 OUTLIER -99.29 141.83 31.56 Favored 'General case' 0 C--O 1.209 -1.064 0 N-CA-C 101.836 -3.394 . . . . 0.0 101.836 -179.647 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.419 HG12 HG22 ' A' ' 127' ' ' ILE . 63.6 mt -142.18 134.79 27.56 Favored 'Isoleucine or valine' 0 C--O 1.246 0.901 0 N-CA-C 103.729 -2.693 . . . . 0.0 103.729 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . 0.485 ' HB2' ' CD ' ' A' ' 126' ' ' ARG . 24.2 mt-30 -117.23 118.48 32.43 Favored 'General case' 0 CA--C 1.497 -1.083 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.442 ' O ' ' N ' ' A' ' 105' ' ' VAL . 0.7 OUTLIER -137.53 156.86 47.64 Favored 'General case' 0 N--CA 1.413 -2.281 0 CA-C-N 114.247 -1.342 . . . . 0.0 112.397 -179.643 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . 0.511 ' CE2' HG13 ' A' ' 105' ' ' VAL 0.384 24.3 m-85 134.73 -141.5 0.0 OUTLIER 'General case' 0 CA--C 1.48 -1.736 1 O-C-N 130.708 5.005 . . . . 0.0 113.485 176.249 . . . . . . . . 4 3 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.562 ' O ' ' N ' ' A' ' 103' ' ' ILE . 4.4 t -156.04 -156.07 0.6 Allowed 'General case' 0 C--N 1.311 -1.072 0 O-C-N 127.268 2.855 . . . . 0.0 116.389 -174.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.6 ' HA ' ' CB ' ' A' ' 102' ' ' LEU . 0.0 OUTLIER -105.16 -62.86 1.29 Allowed 'General case' 0 C--N 1.347 0.485 0 N-CA-C 102.69 -3.078 . . . . 0.0 102.69 176.573 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.415 ' N ' HG22 ' A' ' 118' ' ' THR . 0.0 OUTLIER -120.56 -71.53 0.73 Allowed 'General case' 0 N--CA 1.426 -1.635 0 CA-C-N 111.857 -2.429 . . . . 0.0 116.039 179.488 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -140.7 10.78 2.91 Favored Glycine 0 C--N 1.355 1.633 0 N-CA-C 120.083 2.793 . . . . 0.0 120.083 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.44 HG13 ' CA ' ' A' ' 17' ' ' PHE . 72.3 t -114.12 94.69 3.28 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 O-C-N 117.39 -3.418 . . . . 0.0 103.163 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -58.02 177.36 0.12 Allowed 'General case' 0 C--O 1.213 -0.857 0 C-N-CA 118.36 -1.336 . . . . 0.0 112.637 -178.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.511 ' HB2' ' CD1' ' A' ' 14' ' ' TYR . . . -173.87 103.44 0.11 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 115.914 -1.993 . . . . 0.0 109.221 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.432 ' HB2' ' CB ' ' A' ' 12' ' ' GLU 0.343 1.5 mptt -79.49 162.15 25.6 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 121.661 2.028 . . . . 0.0 112.665 -179.91 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.519 ' HG2' ' CD2' ' A' ' 14' ' ' TYR . 0.2 OUTLIER -145.07 78.97 1.58 Allowed 'General case' 0 C--O 1.208 -1.104 0 CA-C-O 115.236 -2.316 . . . . 0.0 106.015 179.623 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.419 HG22 HG12 ' A' ' 114' ' ' ILE . 4.4 mm -77.32 111.05 13.68 Favored 'Isoleucine or valine' 0 C--O 1.246 0.888 1 O-C-N 131.973 5.796 . . . . 0.0 110.996 179.703 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.511 ' CE2' HD11 ' A' ' 38' ' ' LEU . 15.0 m-85 -92.52 169.21 10.72 Favored 'General case' 0 C--N 1.318 -0.783 0 O-C-N 127.255 2.847 . . . . 0.0 108.417 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . 0.305 19.8 mmtt -124.07 -6.21 7.82 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 115.406 -2.235 . . . . 0.0 110.634 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.51 ' HB2' ' CZ3' ' A' ' 6' ' ' TRP . 0.0 OUTLIER 71.82 102.04 0.07 Allowed 'General case' 0 N--CA 1.472 0.631 0 O-C-N 126.811 2.569 . . . . 0.0 109.597 179.823 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . 0.923 7.6 mt-10 . . . . . 0 N--CA 1.434 -1.232 0 N-CA-C 116.223 1.934 . . . . 0.0 116.223 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . 0.499 ' CD1' ' N ' ' A' ' 2' ' ' PHE . 13.5 m-85 . . . . . 0 N--CA 1.443 -0.797 0 CA-C-O 122.587 1.184 . . . . 0.0 112.438 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -144.05 98.27 3.19 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.521 -1.218 . . . . 0.0 110.594 179.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 161.12 -130.03 2.26 Favored Glycine 0 C--O 1.222 -0.623 0 C-N-CA 115.331 -3.318 . . . . 0.0 110.296 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . 0.609 0.1 OUTLIER -134.1 157.94 44.87 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 119.154 -1.018 . . . . 0.0 112.637 -179.812 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.523 ' CD1' HD13 ' A' ' 40' ' ' ILE 0.254 95.1 m95 -142.19 146.63 35.46 Favored 'General case' 0 C--O 1.212 -0.875 0 O-C-N 127.98 3.3 . . . . 0.0 106.253 -179.87 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -139.97 92.9 2.59 Favored 'General case' 0 C--O 1.21 -0.994 0 O-C-N 127.069 2.731 . . . . 0.0 106.452 -179.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.444 ' CG1' ' HB3' ' A' ' 36' ' ' LEU 0.396 2.1 p -43.77 125.84 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 CA-C-O 116.744 -1.598 . . . . 0.0 112.966 179.836 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -115.4 -31.96 5.76 Favored 'General case' 0 N--CA 1.439 -0.984 0 O-C-N 126.306 2.254 . . . . 0.0 108.846 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.1 149.22 32.6 Favored 'General case' 0 CA--C 1.482 -1.672 0 C-N-CA 116.526 -2.07 . . . . 0.0 108.6 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . 0.386 3.4 m-80 -120.32 -175.45 3.0 Favored 'General case' 0 N--CA 1.454 -0.227 0 O-C-N 126.909 2.631 . . . . 0.0 108.619 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -141.89 -78.42 0.26 Allowed 'General case' 0 N--CA 1.432 -1.326 0 C-N-CA 116.651 -2.02 . . . . 0.0 111.055 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -88.79 17.75 5.33 Favored 'General case' 0 N--CA 1.475 0.803 0 O-C-N 125.613 1.821 . . . . 0.0 114.291 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.461 ' CE2' ' HE1' ' A' ' 18' ' ' MET . 9.0 t80 -63.93 -39.08 93.34 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 119.084 2.994 . . . . 0.0 119.084 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.46 -35.29 78.85 Favored 'General case' 0 C--O 1.212 -0.918 0 CA-C-N 121.846 2.112 . . . . 0.0 112.171 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.93 -31.66 45.29 Favored 'General case' 0 N--CA 1.435 -1.185 0 O-C-N 126.492 2.37 . . . . 0.0 113.578 179.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.412 ' CD2' ' CB ' ' A' ' 124' ' ' ALA . 0.0 OUTLIER -70.59 -30.35 67.01 Favored 'General case' 0 N--CA 1.423 -1.788 0 CA-C-O 125.873 2.749 . . . . 0.0 114.185 -179.405 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.461 ' HE1' ' CE2' ' A' ' 14' ' ' TYR . 19.5 mmt -76.58 -22.75 53.83 Favored 'General case' 0 N--CA 1.431 -1.379 0 O-C-N 116.303 -3.998 . . . . 0.0 107.541 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -68.53 -25.29 64.85 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 119.384 -2.073 . . . . 0.0 112.004 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.479 ' CE ' ' CB ' ' A' ' 120' ' ' GLU . 2.2 tttp -79.06 -31.94 44.63 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-O 117.469 -1.253 . . . . 0.0 113.15 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 29.1 mtp -75.64 -23.2 56.31 Favored 'General case' 0 N--CA 1.437 -1.105 0 O-C-N 126.076 2.11 . . . . 0.0 109.006 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 105.26 31.02 4.5 Favored Glycine 0 C--O 1.225 -0.461 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 179.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.497 ' CG2' ' N ' ' A' ' 28' ' ' ARG . 2.7 mm -77.49 141.95 14.88 Favored 'Isoleucine or valine' 0 C--N 1.352 0.699 0 C-N-CA 124.97 1.308 . . . . 0.0 108.911 -179.664 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -101.69 154.34 18.97 Favored 'General case' 0 C--O 1.245 0.839 0 CA-C-O 115.944 -1.979 . . . . 0.0 110.171 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . 0.429 4.2 p -28.92 -40.95 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.518 -0.276 0 O-C-N 128.414 3.571 . . . . 0.0 119.231 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.65 2.5 t -79.83 -40.95 21.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 123.034 1.397 . . . . 0.0 112.572 179.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.0 ttmt -68.67 -43.64 75.72 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 110.469 -3.06 . . . . 0.0 114.548 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.497 ' N ' ' CG2' ' A' ' 23' ' ' ILE . 31.6 ptt85 -76.5 -20.82 56.55 Favored 'General case' 0 C--N 1.321 -0.659 0 O-C-N 119.625 -1.922 . . . . 0.0 108.653 -179.562 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.1 ttmt -76.21 -38.3 56.65 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-N 114.381 -1.282 . . . . 0.0 108.334 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -72.38 -35.76 68.55 Favored 'General case' 0 C--O 1.214 -0.766 0 CA-C-N 114.621 -1.172 . . . . 0.0 108.442 -179.729 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -73.67 -26.87 68.46 Favored Glycine 0 CA--C 1.532 1.118 0 O-C-N 126.239 2.212 . . . . 0.0 111.955 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -75.7 -39.26 57.72 Favored 'General case' 0 N--CA 1.434 -1.23 0 C-N-CA 125.681 1.592 . . . . 0.0 110.774 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -90.58 29.98 1.22 Allowed 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 124.237 1.015 . . . . 0.0 112.538 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 31.2 p-10 -81.02 98.63 8.05 Favored 'General case' 0 CA--C 1.508 -0.655 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -76.93 61.84 2.01 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 120.058 1.299 . . . . 0.0 109.27 179.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.521 HD22 ' CZ ' ' A' ' 128' ' ' PHE . 0.1 OUTLIER -61.87 124.92 22.08 Favored 'General case' 0 CA--C 1.492 -1.262 0 C-N-CA 126.836 2.054 . . . . 0.0 108.695 -179.519 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 21.8 ttmt -108.71 106.14 16.04 Favored 'General case' 0 N--CA 1.431 -1.398 0 N-CA-C 104.482 -2.414 . . . . 0.0 104.482 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.476 ' CD1' HD12 ' A' ' 36' ' ' LEU . 1.3 tp -91.82 111.14 22.55 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 120.844 1.656 . . . . 0.0 108.964 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.2 m -96.69 91.36 5.68 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 101.732 -3.432 . . . . 0.0 101.732 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.523 HD13 ' CD1' ' A' ' 6' ' ' TRP . 58.5 mt -72.05 120.58 20.67 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 -179.368 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -115.01 113.3 23.92 Favored 'General case' 0 CA--C 1.5 -0.976 0 O-C-N 128.221 3.451 . . . . 0.0 114.666 179.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.451 ' HG2' ' CE1' ' A' ' 47' ' ' PHE . 1.6 mm-40 -92.91 96.0 9.84 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-O 117.507 -1.235 . . . . 0.0 108.289 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -76.34 -13.47 60.14 Favored 'General case' 0 N--CA 1.42 -1.953 0 CA-C-N 120.505 1.502 . . . . 0.0 110.699 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 150.74 -30.28 1.02 Allowed Glycine 0 C--N 1.294 -1.767 0 N-CA-C 106.048 -2.821 . . . . 0.0 106.048 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -150.83 -52.82 0.14 Allowed 'General case' 0 N--CA 1.441 -0.896 0 O-C-N 127.045 2.262 . . . . 0.0 110.21 -179.677 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.36 148.69 49.82 Favored 'General case' 0 N--CA 1.436 -1.161 0 CA-C-N 113.765 -1.561 . . . . 0.0 109.023 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.451 ' CE1' ' HG2' ' A' ' 42' ' ' GLN . 0.9 OUTLIER -113.77 81.79 1.58 Allowed 'General case' 0 C--O 1.218 -0.574 0 N-CA-C 105.871 -1.9 . . . . 0.0 105.871 179.861 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.469 HG23 ' CG1' ' A' ' 61' ' ' VAL 0.441 0.9 OUTLIER -63.48 90.25 0.05 OUTLIER 'General case' 0 CA--C 1.503 -0.85 0 C-N-CA 115.477 -2.489 . . . . 0.0 111.591 -179.639 . . . . . . . . 4 4 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.488 ' HB ' ' CE1' ' A' ' 62' ' ' PHE 0.652 0.7 OUTLIER -78.05 86.36 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.58 0 CA-C-O 117.929 -1.034 . . . . 0.0 111.411 -179.874 . . . . . . . . 4 4 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 3.2 tttp -62.44 113.45 2.95 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 102.076 -3.305 . . . . 0.0 102.076 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.401 ' HG3' HD11 ' A' ' 36' ' ' LEU 0.271 2.4 tt0 -103.73 94.73 5.59 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 120.23 1.377 . . . . 0.0 107.834 -179.983 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 7.6 t -93.2 55.01 2.22 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 105.216 -2.142 . . . . 0.0 105.216 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 87.3 p -67.66 167.49 13.04 Favored 'General case' 0 C--N 1.348 0.541 0 O-C-N 125.633 1.833 . . . . 0.0 111.384 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -58.28 -27.12 63.75 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 119.363 0.983 . . . . 0.0 109.191 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.461 ' CE2' ' HB2' ' A' ' 73' ' ' ALA . 0.2 OUTLIER -69.13 -62.94 1.17 Allowed 'General case' 0 C--O 1.21 -1.026 0 CA-C-O 114.301 -2.761 . . . . 0.0 108.418 179.971 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.25 174.1 15.96 Favored 'General case' 0 C--O 1.244 0.813 0 CA-C-N 121.691 2.041 . . . . 0.0 109.947 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -104.43 85.14 2.3 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 103.453 -2.795 . . . . 0.0 103.453 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -114.21 106.81 21.39 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.323 0 C-N-CA 128.675 2.79 . . . . 0.0 115.806 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -59.84 135.44 57.69 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 104.465 -2.42 . . . . 0.0 104.465 179.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.441 HG22 HG13 ' A' ' 49' ' ' VAL . 36.5 t -96.17 -67.71 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.066 0 CA-C-O 126.066 2.841 . . . . 0.0 112.082 -178.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.469 ' CG1' HG23 ' A' ' 48' ' ' THR 0.442 0.1 OUTLIER 69.98 140.07 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 CA-C-N 113.512 -1.676 . . . . 0.0 113.601 -179.947 . . . . . . . . 4 4 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.512 ' HB3' ' CZ ' ' A' ' 68' ' ' PHE . 1.8 p90 -170.22 98.76 0.27 Allowed 'General case' 0 C--N 1.317 -0.814 0 C-N-CA 115.624 -2.43 . . . . 0.0 107.534 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -57.99 131.17 49.63 Favored 'General case' 0 C--O 1.246 0.897 0 N-CA-C 102.737 -3.06 . . . . 0.0 102.737 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -51.98 121.22 6.34 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 114.944 -1.025 . . . . 0.0 110.985 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 68.44 8.14 54.84 Favored Glycine 0 CA--C 1.531 1.061 0 N-CA-C 119.137 2.415 . . . . 0.0 119.137 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . 0.382 15.1 t -80.79 -108.28 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 N-CA-C 104.189 -2.523 . . . . 0.0 104.189 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 170.07 149.61 0.04 OUTLIER 'General case' 0 C--O 1.205 -1.243 0 O-C-N 124.509 1.13 . . . . 0.0 112.108 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.512 ' CZ ' ' HB3' ' A' ' 62' ' ' PHE . 2.1 p90 -161.69 135.46 6.6 Favored 'General case' 0 N--CA 1.431 -1.397 0 O-C-N 124.787 1.305 . . . . 0.0 109.907 -179.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.13 100.76 13.2 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 105.495 -2.039 . . . . 0.0 105.495 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -106.75 92.69 4.2 Favored 'General case' 0 C--O 1.216 -0.68 0 O-C-N 125.006 1.441 . . . . 0.0 114.179 -179.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 27.6 m -63.12 139.23 58.75 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 120.849 1.659 . . . . 0.0 107.083 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 5.3 mp -80.72 -157.85 0.17 Allowed 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 104.808 -2.293 . . . . 0.0 104.808 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.461 ' HB2' ' CE2' ' A' ' 55' ' ' PHE . . . -106.56 -8.92 16.79 Favored 'General case' 0 N--CA 1.439 -1.009 0 CA-C-O 122.499 1.143 . . . . 0.0 113.839 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -140.0 -39.53 0.45 Allowed 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 114.996 -1.002 . . . . 0.0 111.479 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -86.66 -16.53 61.63 Favored Glycine 0 CA--C 1.534 1.245 0 O-C-N 120.466 -1.396 . . . . 0.0 114.145 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . 0.342 0.1 OUTLIER 72.82 164.23 0.28 Allowed 'General case' 0 N--CA 1.432 -1.338 0 O-C-N 118.49 -2.77 . . . . 0.0 115.794 179.908 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -2.14 120.51 0.0 OUTLIER 'General case' 0 N--CA 1.439 -0.981 0 O-C-N 127.77 3.169 . . . . 0.0 117.505 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . 0.409 7.1 tp -134.97 134.95 41.06 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 103.049 -2.945 . . . . 0.0 103.049 179.721 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 6.1 m -145.52 121.2 10.49 Favored 'General case' 0 CA--C 1.485 -1.544 0 O-C-N 125.33 1.644 . . . . 0.0 106.782 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.411 ' HA3' ' HA ' ' A' ' 93' ' ' PHE . . . -175.99 -145.07 5.38 Favored Glycine 0 C--N 1.295 -1.72 0 O-C-N 118.871 -2.393 . . . . 0.0 110.24 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -154.24 177.45 11.11 Favored 'General case' 0 C--O 1.188 -2.157 0 CA-C-N 119.695 1.747 . . . . 0.0 110.976 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . 0.437 ' HA ' ' HA2' ' A' ' 91' ' ' GLY . 12.1 m95 -127.18 142.12 51.57 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 100.568 -3.864 . . . . 0.0 100.568 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 8.9 t -146.91 144.31 29.15 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 125.532 1.77 . . . . 0.0 111.744 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' MET . . . . . 0.4 ' HA ' HD21 ' A' ' 89' ' ' LEU . 20.7 ttt -83.76 101.36 11.53 Favored 'General case' 0 N--CA 1.436 -1.15 0 CA-C-N 110.996 -2.82 . . . . 0.0 107.854 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.449 ' CG ' HG12 ' A' ' 90' ' ' VAL 0.712 0.0 OUTLIER -90.17 70.07 7.24 Favored 'General case' 0 N--CA 1.427 -1.58 0 C-N-CA 122.8 0.44 . . . . 0.0 112.051 179.952 . . . . . . . . 4 4 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 54.52 -97.57 0.04 OUTLIER Glycine 0 C--N 1.349 1.298 0 N-CA-C 107.635 -2.186 . . . . 0.0 107.635 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -74.56 3.49 7.62 Favored 'General case' 0 CA--C 1.52 -0.178 0 N-CA-C 118.036 2.606 . . . . 0.0 118.036 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . 0.402 0.0 OUTLIER -156.0 166.62 32.92 Favored 'General case' 0 C--O 1.215 -0.745 0 CA-C-N 120.698 1.59 . . . . 0.0 110.682 -179.699 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.422 HD13 ' CE2' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -115.59 116.42 28.1 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 101.6 -3.481 . . . . 0.0 101.6 179.75 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.451 HG11 HG21 ' A' ' 105' ' ' VAL . 11.1 m -117.36 155.3 19.04 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 O-C-N 125.465 1.728 . . . . 0.0 106.632 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.437 ' HA2' ' HA ' ' A' ' 82' ' ' TRP . . . -126.88 110.67 1.25 Allowed Glycine 0 CA--C 1.53 0.989 0 O-C-N 128.352 3.532 . . . . 0.0 108.789 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.43 145.67 38.55 Favored 'General case' 0 N--CA 1.429 -1.517 0 N-CA-C 103.815 -2.661 . . . . 0.0 103.815 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.411 ' HA ' ' HA3' ' A' ' 80' ' ' GLY . 15.3 m-85 -148.82 130.1 14.65 Favored 'General case' 0 CA--C 1.504 -0.818 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 13.8 mttp -99.18 159.02 15.29 Favored 'General case' 0 C--N 1.313 -1.004 0 O-C-N 125.59 1.806 . . . . 0.0 106.496 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . 0.325 0.1 OUTLIER -107.97 142.86 37.45 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 120.944 -1.097 . . . . 0.0 108.192 179.715 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 25.2 t -82.22 -32.55 10.83 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 C-N-CA 125.829 1.651 . . . . 0.0 108.318 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . 0.364 34.9 p-10 -99.5 6.47 45.87 Favored 'General case' 0 C--O 1.25 1.107 0 CA-C-O 124.399 2.047 . . . . 0.0 115.502 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -133.45 -44.2 0.83 Allowed 'General case' 0 N--CA 1.439 -1.008 0 O-C-N 120.792 -1.193 . . . . 0.0 112.465 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 77.45 12.03 84.93 Favored Glycine 0 C--N 1.347 1.185 0 O-C-N 124.526 1.141 . . . . 0.0 114.313 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 6.1 mttt -81.59 -116.1 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 176.65 158.83 0.32 Allowed 'General case' 0 CA--C 1.5 -0.943 0 C-N-CA 128.068 2.547 . . . . 0.0 111.091 -179.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.475 ' CD1' ' HB2' ' A' ' 119' ' ' TYR . 3.1 tp -142.52 141.33 32.07 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 128.297 3.498 . . . . 0.0 106.952 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.503 ' CG2' ' HB ' ' A' ' 118' ' ' THR . 4.1 tt -127.17 165.07 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.766 0 N-CA-C 104.971 -2.233 . . . . 0.0 104.971 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.457 ' N ' ' CG1' ' A' ' 103' ' ' ILE . . . -151.15 157.39 42.63 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-O 116.798 -1.573 . . . . 0.0 109.533 179.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.451 HG21 HG11 ' A' ' 90' ' ' VAL . 1.2 t -147.77 96.15 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-O 125.561 2.6 . . . . 0.0 110.63 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.42 ' HB2' ' HB3' ' A' ' 89' ' ' LEU . 16.8 mtt180 -71.81 90.52 1.1 Allowed 'General case' 0 C--O 1.236 0.368 0 N-CA-C 104.941 -2.244 . . . . 0.0 104.941 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -97.73 89.52 4.65 Favored 'General case' 0 N--CA 1.425 -1.725 0 C-N-CA 119.425 -0.91 . . . . 0.0 110.991 179.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.483 HD12 ' CH2' ' A' ' 6' ' ' TRP 0.439 0.0 OUTLIER -58.41 91.93 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 C-N-CA 117.117 -1.833 . . . . 0.0 114.171 -179.74 . . . . . . . . 4 4 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -78.28 76.86 4.78 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 102.56 -3.126 . . . . 0.0 102.56 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 60.93 -123.79 33.67 Favored Glycine 0 C--O 1.245 0.801 0 O-C-N 128.473 3.608 . . . . 0.0 110.705 -179.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . 0.31 28.5 m-80 -71.88 0.96 7.87 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-O 112.381 -3.676 . . . . 0.0 113.76 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.416 ' HG3' ' HA ' ' A' ' 129' ' ' LYS . 4.5 mp0 -118.18 117.75 29.99 Favored 'General case' 0 CA--C 1.511 -0.527 0 O-C-N 128.042 3.339 . . . . 0.0 110.615 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.431 ' HA ' ' HA ' ' A' ' 108' ' ' ILE . 0.5 OUTLIER -87.83 124.27 33.47 Favored 'General case' 0 C--O 1.216 -0.672 0 O-C-N 127.102 2.751 . . . . 0.0 103.969 179.761 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.473 ' CD1' HG22 ' A' ' 127' ' ' ILE 0.296 1.8 mm -114.55 133.43 60.7 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.33 0 N-CA-C 103.854 -2.647 . . . . 0.0 103.854 -179.68 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 10.7 mt-30 -115.4 97.36 6.13 Favored 'General case' 0 CA--C 1.489 -1.387 0 O-C-N 125.385 1.678 . . . . 0.0 109.461 -179.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 19.2 p -75.09 174.33 9.54 Favored 'General case' 0 C--O 1.247 0.929 0 N-CA-C 105.004 -2.221 . . . . 0.0 105.004 179.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 16.9 m-85 -162.5 115.31 1.68 Allowed 'General case' 0 CA--C 1.483 -1.631 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.503 ' HB ' ' CG2' ' A' ' 103' ' ' ILE . 88.4 m -113.68 88.84 2.94 Favored 'General case' 0 N--CA 1.42 -1.945 0 N-CA-C 116.95 2.204 . . . . 0.0 116.95 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.475 ' HB2' ' CD1' ' A' ' 102' ' ' LEU . 3.2 t80 -83.68 130.01 34.96 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 103.884 -2.635 . . . . 0.0 103.884 178.037 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.479 ' CB ' ' CE ' ' A' ' 20' ' ' LYS . 3.0 mm-40 61.89 -62.9 0.09 Allowed 'General case' 0 C--N 1.289 -2.037 0 O-C-N 125.293 1.621 . . . . 0.0 112.191 -179.088 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 179.64 33.34 0.06 OUTLIER Glycine 0 CA--C 1.542 1.78 0 C-N-CA 128.853 3.121 . . . . 0.0 116.173 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.401 HG22 ' HD2' ' A' ' 20' ' ' LYS . 10.7 t -125.68 97.85 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.65 0 O-C-N 120.744 -1.445 . . . . 0.0 107.637 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . 0.257 10.0 mt-10 -62.69 -175.56 0.09 Allowed 'General case' 0 N--CA 1.438 -1.067 0 CA-C-O 117.381 -1.295 . . . . 0.0 111.784 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.412 ' CB ' ' CD2' ' A' ' 17' ' ' PHE . . . -176.75 88.07 0.03 OUTLIER 'General case' 0 N--CA 1.436 -1.131 0 CA-C-O 114.911 -2.471 . . . . 0.0 107.076 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.424 ' N ' ' HE2' ' A' ' 125' ' ' LYS . 0.0 OUTLIER -68.43 139.99 55.76 Favored 'General case' 0 CA--C 1.487 -1.469 0 O-C-N 125.788 1.93 . . . . 0.0 110.546 179.989 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.42 ' NH2' HD21 ' A' ' 36' ' ' LEU . 5.0 mmm-85 -133.56 85.12 2.18 Favored 'General case' 0 N--CA 1.429 -1.504 0 O-C-N 126.34 2.275 . . . . 0.0 106.581 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.473 HG22 ' CD1' ' A' ' 114' ' ' ILE . 13.2 mt -83.79 112.47 21.27 Favored 'Isoleucine or valine' 0 C--O 1.249 1.067 0 O-C-N 127.86 3.225 . . . . 0.0 117.305 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.521 ' CZ ' HD22 ' A' ' 36' ' ' LEU . 0.0 OUTLIER -102.39 137.29 40.83 Favored 'General case' 0 N--CA 1.441 -0.9 0 O-C-N 126.642 2.464 . . . . 0.0 108.136 179.414 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.416 ' HA ' ' HG3' ' A' ' 112' ' ' GLU 0.284 12.2 mmtm -92.64 5.58 50.47 Favored 'General case' 0 C--O 1.244 0.78 0 CA-C-O 116.626 -1.655 . . . . 0.0 111.748 179.884 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.508 ' HA ' ' CE3' ' A' ' 6' ' ' TRP . 0.1 OUTLIER 76.59 138.95 0.07 Allowed 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 121.125 1.784 . . . . 0.0 108.424 179.79 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . 0.763 61.4 tt0 . . . . . 0 N--CA 1.443 -0.776 0 C-N-CA 116.563 -2.055 . . . . 0.0 113.789 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . 0.492 ' CD2' HD13 ' A' ' 113' ' ' LEU . 62.1 m-85 . . . . . 0 N--CA 1.448 -0.568 0 CA-C-O 124.523 2.106 . . . . 0.0 113.776 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -156.73 96.33 1.62 Allowed 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 113.563 -1.653 . . . . 0.0 115.014 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 148.29 -152.44 24.51 Favored Glycine 0 C--N 1.313 -0.738 0 C-N-CA 116.778 -2.629 . . . . 0.0 112.942 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . 0.547 0.0 OUTLIER -111.48 158.12 19.52 Favored 'General case' 0 C--N 1.314 -0.968 0 O-C-N 127.53 2.547 . . . . 0.0 113.096 -179.782 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.56 ' CH2' ' CD1' ' A' ' 108' ' ' ILE . 85.1 m95 -149.37 113.02 5.05 Favored 'General case' 0 N--CA 1.433 -1.304 0 CA-C-N 112.618 -2.083 . . . . 0.0 110.173 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.9 101.83 11.39 Favored 'General case' 0 C--O 1.211 -0.961 0 CA-C-N 120.886 1.676 . . . . 0.0 107.365 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.484 ' CG1' ' HB3' ' A' ' 36' ' ' LEU . 0.3 OUTLIER -47.43 135.8 3.67 Favored 'Isoleucine or valine' 0 C--O 1.246 0.877 0 CA-C-N 120.76 1.618 . . . . 0.0 110.205 179.913 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -145.05 -11.45 0.56 Allowed 'General case' 0 N--CA 1.433 -1.29 0 C-N-CA 118.676 -1.209 . . . . 0.0 112.997 -179.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.426 ' HB3' ' HB ' ' A' ' 127' ' ' ILE . 5.6 tpp180 -111.05 -56.07 2.41 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-N 121.326 1.876 . . . . 0.0 113.245 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.507 ' ND2' ' CD2' ' A' ' 14' ' ' TYR . 1.2 m-20 62.7 165.84 0.11 Allowed 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 124.244 1.018 . . . . 0.0 110.454 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.406 ' N ' ' O ' ' A' ' 125' ' ' LYS . 2.4 mm-40 -171.26 103.05 0.21 Allowed 'General case' 0 C--N 1.314 -0.952 0 O-C-N 117.3 -3.375 . . . . 0.0 107.201 -179.6 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.411 ' HB3' ' HA ' ' A' ' 124' ' ' ALA . 0.3 OUTLIER 97.5 -27.28 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.18 0 O-C-N 125.447 1.717 . . . . 0.0 111.923 -179.238 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.507 ' CD2' ' ND2' ' A' ' 11' ' ' ASN . 2.4 p90 -29.96 -36.39 0.01 OUTLIER 'General case' 0 N--CA 1.435 -1.186 0 O-C-N 127.619 3.074 . . . . 0.0 118.03 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -75.77 -34.21 60.23 Favored 'General case' 0 CA--C 1.498 -1.024 0 C-N-CA 120.58 -0.448 . . . . 0.0 110.793 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -73.04 -28.7 62.49 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-O 124.304 2.002 . . . . 0.0 113.138 179.685 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.455 ' CB ' ' HB1' ' A' ' 124' ' ' ALA . 0.0 OUTLIER -71.45 -29.29 64.7 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-O 125.658 2.646 . . . . 0.0 110.393 179.908 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.409 ' HB3' HG13 ' A' ' 23' ' ' ILE . 29.6 mtm -79.88 -20.38 45.99 Favored 'General case' 0 C--N 1.318 -0.77 0 O-C-N 116.654 -3.779 . . . . 0.0 106.445 179.503 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.04 -31.13 39.51 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 123.103 1.43 . . . . 0.0 112.655 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.502 ' CE ' ' HB3' ' A' ' 119' ' ' TYR . 0.5 OUTLIER -73.49 -21.18 60.49 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 115.754 1.761 . . . . 0.0 115.754 -178.144 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 3.4 mtp -79.03 -47.6 15.91 Favored 'General case' 0 C--O 1.206 -1.192 0 N-CA-C 103.592 -2.744 . . . . 0.0 103.592 179.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 124.08 43.64 0.32 Allowed Glycine 0 N--CA 1.433 -1.537 0 CA-C-N 113.902 -1.499 . . . . 0.0 111.234 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.409 HG13 ' HB3' ' A' ' 18' ' ' MET . 1.9 mm -75.09 126.24 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.967 0 CA-C-O 115.813 -2.041 . . . . 0.0 112.173 -179.645 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -52.57 145.02 12.47 Favored 'General case' 0 C--N 1.348 0.527 0 CA-C-O 115.233 -2.318 . . . . 0.0 111.573 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . 0.445 26.9 m -36.39 -47.99 0.25 Allowed 'Isoleucine or valine' 0 C--O 1.216 -0.707 0 N-CA-C 119.162 3.023 . . . . 0.0 119.162 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.537 5.4 m -79.84 -28.38 12.62 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.995 0 N-CA-C 115.217 1.562 . . . . 0.0 115.217 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.9 ttmm -71.41 -31.58 67.42 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 112.147 -2.297 . . . . 0.0 114.904 179.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 7.5 ptt180 -79.35 -21.28 46.03 Favored 'General case' 0 C--O 1.219 -0.543 0 C-N-CA 117.721 -1.592 . . . . 0.0 109.303 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 9.3 tttm -72.13 -46.22 57.47 Favored 'General case' 0 CA--C 1.5 -0.959 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.64 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.3 tp -76.38 -28.61 56.82 Favored 'General case' 0 CA--C 1.505 -0.755 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -74.43 -20.99 79.45 Favored Glycine 0 C--N 1.345 1.055 0 CA-C-O 124.017 1.898 . . . . 0.0 111.981 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.452 ' HB3' ' CE2' ' A' ' 14' ' ' TYR . . . -75.25 -48.96 20.9 Favored 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 127.484 2.314 . . . . 0.0 111.02 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 8.5 m170 -96.35 7.66 45.92 Favored 'General case' 0 N--CA 1.429 -1.509 0 O-C-N 127.152 2.782 . . . . 0.0 110.672 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 29.8 p30 -33.6 -27.22 0.01 OUTLIER 'General case' 0 CA--C 1.507 -0.702 0 N-CA-C 116.774 2.139 . . . . 0.0 116.774 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.2 t30 77.1 26.7 0.72 Allowed 'General case' 0 C--O 1.244 0.778 0 CA-C-N 120.641 1.564 . . . . 0.0 112.351 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.484 ' HB3' ' CG1' ' A' ' 8' ' ' VAL . 1.3 tp -52.22 116.52 2.26 Favored 'General case' 0 CA--C 1.5 -0.962 0 CA-C-O 123.981 1.848 . . . . 0.0 109.341 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 6.3 ttmm -111.43 95.6 5.61 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 101.865 -3.383 . . . . 0.0 101.865 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.501 HD13 ' CZ ' ' A' ' 128' ' ' PHE 0.284 2.4 mt -78.58 141.52 38.02 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 119.041 -2.287 . . . . 0.0 108.292 -179.928 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.474 ' HB ' ' CB ' ' A' ' 50' ' ' LYS . 9.3 m -128.51 76.82 1.73 Allowed 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 102.213 -3.254 . . . . 0.0 102.213 179.23 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.486 ' CD1' HD12 ' A' ' 113' ' ' LEU . 6.0 mt -65.81 134.94 29.19 Favored 'Isoleucine or valine' 0 C--O 1.251 1.142 0 CA-C-N 112.401 -2.182 . . . . 0.0 106.359 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -145.91 113.81 6.48 Favored 'General case' 0 CA--C 1.504 -0.792 0 O-C-N 126.849 2.593 . . . . 0.0 110.648 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -90.09 134.35 34.31 Favored 'General case' 0 C--O 1.22 -0.465 0 CA-C-N 114.259 -1.337 . . . . 0.0 113.765 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 33.9 tp10 -135.55 91.01 2.67 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 105.578 -2.008 . . . . 0.0 105.578 179.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 67.13 -97.67 0.39 Allowed Glycine 0 C--N 1.292 -1.871 0 CA-C-O 116.367 -2.352 . . . . 0.0 109.313 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.335 0.0 OUTLIER -117.8 -1.93 11.46 Favored 'General case' 0 C--N 1.315 -0.917 0 O-C-N 129.712 3.83 . . . . 0.0 113.377 -179.895 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -99.62 136.66 39.23 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 106.997 -1.482 . . . . 0.0 106.997 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . 0.313 0.1 OUTLIER -121.48 108.27 13.44 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 105.616 -1.994 . . . . 0.0 105.616 -179.929 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.48 ' HB ' ' CG1' ' A' ' 61' ' ' VAL 0.386 0.1 OUTLIER -99.94 89.94 4.24 Favored 'General case' 0 N--CA 1.423 -1.789 0 O-C-N 124.804 1.315 . . . . 0.0 108.445 -179.68 . . . . . . . . 4 4 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.418 HG23 ' HB ' ' A' ' 60' ' ' VAL 0.714 1.0 OUTLIER -65.7 94.59 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.503 -0.858 0 O-C-N 127.246 2.841 . . . . 0.0 108.596 178.792 . . . . . . . . 4 4 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.474 ' CB ' ' HB ' ' A' ' 39' ' ' THR . 0.0 OUTLIER -63.35 140.46 58.87 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 102.448 -3.168 . . . . 0.0 102.448 -179.439 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.422 ' HB2' ' CG2' ' A' ' 60' ' ' VAL . 11.8 tt0 -130.04 73.0 1.5 Allowed 'General case' 0 CA--C 1.51 -0.559 0 N-CA-C 105.998 -1.853 . . . . 0.0 105.998 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.99 69.36 5.13 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 105.957 -1.868 . . . . 0.0 105.957 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.32 175.77 6.98 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.984 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.403 ' O ' ' ND2' ' A' ' 54' ' ' ASN . 2.7 t-20 -62.19 -26.58 68.43 Favored 'General case' 0 C--O 1.216 -0.674 0 O-C-N 125.441 1.713 . . . . 0.0 107.831 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.511 ' CZ ' ' HB2' ' A' ' 73' ' ' ALA . 0.3 OUTLIER -69.1 -64.38 0.88 Allowed 'General case' 0 C--O 1.222 -0.385 0 CA-C-O 114.473 -2.679 . . . . 0.0 108.659 179.821 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -173.05 172.52 3.91 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 122.8 2.545 . . . . 0.0 110.844 179.537 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -90.76 65.94 5.96 Favored 'General case' 0 CA--C 1.498 -1.02 0 O-C-N 128.46 3.6 . . . . 0.0 105.067 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -87.48 -41.11 14.32 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 O-C-N 127.353 2.908 . . . . 0.0 115.746 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 50.6 t0 79.58 141.66 0.07 Allowed 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 104.649 -2.352 . . . . 0.0 104.649 -179.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.422 ' CG2' ' HB2' ' A' ' 51' ' ' GLU . 1.5 t -129.38 84.77 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 N-CA-C 105.464 -2.05 . . . . 0.0 105.464 -179.543 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.48 ' CG1' ' HB ' ' A' ' 48' ' ' THR 0.314 1.5 m -90.18 136.56 23.55 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.519 0 N-CA-C 116.889 2.181 . . . . 0.0 116.889 -178.188 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.642 ' HB3' ' CZ ' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -137.25 95.0 3.01 Favored 'General case' 0 N--CA 1.422 -1.83 0 CA-C-O 114.18 -2.819 . . . . 0.0 110.8 177.263 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.492 ' O ' ' N ' ' A' ' 65' ' ' GLY . 24.0 tt0 -54.58 117.73 3.59 Favored 'General case' 0 C--N 1.32 -0.698 1 N-CA-C 98.813 -4.514 . . . . 0.0 98.813 175.998 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.724 ' HB3' ' CD2' ' A' ' 82' ' ' TRP . 0.0 OUTLIER -47.76 93.48 0.01 OUTLIER 'General case' 0 N--CA 1.429 -1.511 0 O-C-N 125.686 1.866 . . . . 0.0 107.69 -175.68 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.685 ' N ' ' NE1' ' A' ' 82' ' ' TRP . . . 94.71 50.33 2.16 Favored Glycine 0 C--N 1.353 1.517 0 N-CA-C 121.592 3.397 . . . . 0.0 121.592 178.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . 0.305 7.3 p -103.94 -19.91 6.03 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 CA-C-O 115.237 -2.316 . . . . 0.0 109.826 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.403 ' HA ' HG23 ' A' ' 81' ' ' THR . 64.8 t0 65.19 105.04 0.04 OUTLIER 'General case' 0 C--O 1.204 -1.305 0 CA-C-O 123.074 1.416 . . . . 0.0 107.409 -178.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.642 ' CZ ' ' HB3' ' A' ' 62' ' ' PHE . 0.1 OUTLIER -131.64 161.26 33.15 Favored 'General case' 0 C--N 1.307 -1.245 0 C-N-CA 125.876 1.67 . . . . 0.0 111.619 -176.876 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -110.75 130.07 55.67 Favored 'General case' 0 C--O 1.245 0.843 0 O-C-N 127.031 2.707 . . . . 0.0 105.122 179.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 83.9 t80 -132.6 96.5 3.84 Favored 'General case' 0 C--O 1.208 -1.104 0 O-C-N 125.353 1.658 . . . . 0.0 114.41 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 25.1 t -66.97 140.84 57.75 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 105.372 -2.084 . . . . 0.0 105.372 179.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -77.39 -174.68 3.41 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 103.257 -2.868 . . . . 0.0 103.257 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.511 ' HB2' ' CZ ' ' A' ' 55' ' ' PHE . . . -80.48 -19.71 45.34 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-O 124.836 2.255 . . . . 0.0 111.3 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -153.86 -37.61 0.1 Allowed 'General case' 0 C--O 1.222 -0.375 0 CA-C-N 112.669 -2.06 . . . . 0.0 111.129 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -69.72 -0.91 28.09 Favored Glycine 0 CA--C 1.533 1.207 0 N-CA-C 118.512 2.165 . . . . 0.0 118.512 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . 0.386 0.3 OUTLIER 77.27 164.44 0.24 Allowed 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 120.376 2.088 . . . . 0.0 114.857 -179.908 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.564 ' CB ' ' HB ' ' A' ' 96' ' ' VAL . 0.3 OUTLIER -30.31 145.21 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 111.763 -2.471 . . . . 0.0 116.567 -179.805 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.402 ' HG ' ' HB3' ' A' ' 93' ' ' PHE 0.386 0.6 OUTLIER -160.62 101.74 1.34 Allowed 'General case' 0 C--O 1.24 0.602 0 CA-C-N 109.924 -3.307 . . . . 0.0 107.142 179.982 . . . . . . . . 4 4 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.409 HG21 ' N ' ' A' ' 80' ' ' GLY . 91.6 m -105.82 -172.78 2.15 Favored 'General case' 0 CA--C 1.498 -1.037 0 N-CA-C 101.772 -3.418 . . . . 0.0 101.772 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.419 ' HA3' ' HA ' ' A' ' 93' ' ' PHE . . . 118.8 -148.07 18.4 Favored Glycine 0 C--N 1.292 -1.872 0 CA-C-O 116.571 -2.238 . . . . 0.0 113.191 179.629 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.403 HG23 ' HA ' ' A' ' 67' ' ' ASP . 60.3 p -165.46 166.73 18.2 Favored 'General case' 0 C--O 1.188 -2.155 0 CA-C-O 124.232 1.967 . . . . 0.0 110.712 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . 0.777 ' CG ' ' N ' ' A' ' 83' ' ' THR 0.399 4.0 p-90 -73.03 -162.39 0.11 Allowed 'General case' 0 N--CA 1.438 -1.063 0 N-CA-C 100.244 -3.984 . . . . 0.0 100.244 175.43 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.777 ' N ' ' CG ' ' A' ' 82' ' ' TRP . 4.7 t 159.43 129.51 0.0 OUTLIER 'General case' 0 N--CA 1.415 -2.219 0 CA-C-O 125.733 2.682 . . . . 0.0 112.657 174.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' MET . . . . . 0.54 ' N ' ' CZ3' ' A' ' 82' ' ' TRP . 0.0 OUTLIER -88.53 121.93 31.45 Favored 'General case' 0 N--CA 1.422 -1.836 0 CA-C-N 110.566 -3.015 . . . . 0.0 105.524 179.047 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.426 ' HG3' ' CG2' ' A' ' 90' ' ' VAL 0.622 2.5 pp20? -111.59 44.48 1.35 Allowed 'General case' 0 N--CA 1.421 -1.912 0 CA-C-O 123.574 1.654 . . . . 0.0 114.394 179.735 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 71.61 110.94 0.05 OUTLIER Glycine 0 N--CA 1.443 -0.854 0 N-CA-C 107.595 -2.202 . . . . 0.0 107.595 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 50.9 t30 66.67 -22.05 0.1 Allowed 'General case' 0 N--CA 1.44 -0.942 0 CA-C-O 114.948 -2.453 . . . . 0.0 116.347 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.403 ' HG3' ' HA ' ' A' ' 107' ' ' GLU 0.33 0.1 OUTLIER -129.1 142.76 50.79 Favored 'General case' 0 CA--C 1.491 -1.311 0 CA-C-N 120.903 1.683 . . . . 0.0 107.465 -179.97 . . . . . . . . 4 4 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.465 HD23 ' CE3' ' A' ' 82' ' ' TRP . 0.2 OUTLIER -94.85 152.55 18.3 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 101.715 -3.439 . . . . 0.0 101.715 -179.821 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.427 ' HB ' HG21 ' A' ' 83' ' ' THR . 1.4 t -136.75 164.65 30.17 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 N-CA-C 105.507 -2.035 . . . . 0.0 105.507 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -133.79 99.06 0.34 Allowed Glycine 0 C--N 1.363 2.079 0 C-N-CA 128.554 2.978 . . . . 0.0 108.865 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -98.45 127.93 44.6 Favored 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 103.343 -2.836 . . . . 0.0 103.343 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.461 ' O ' ' N ' ' A' ' 102' ' ' LEU . 19.4 m-85 -140.5 130.49 24.69 Favored 'General case' 0 N--CA 1.442 -0.869 0 O-C-N 124.429 1.081 . . . . 0.0 113.279 179.484 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -115.27 124.2 50.73 Favored 'General case' 0 N--CA 1.422 -1.832 0 C-N-CA 130.159 3.384 . . . . 0.0 105.54 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.653 ' HE ' ' N ' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -54.74 -168.02 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.721 0 O-C-N 128.339 3.525 . . . . 0.0 110.573 178.647 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.564 ' HB ' ' CB ' ' A' ' 77' ' ' GLU . 20.5 t -124.56 -50.11 2.1 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 O-C-N 119.754 -1.841 . . . . 0.0 106.489 176.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . 0.293 0.3 OUTLIER -110.0 9.7 24.27 Favored 'General case' 0 C--O 1.255 1.348 0 CA-C-N 113.102 -1.863 . . . . 0.0 113.465 -179.939 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.422 ' HB3' ' HG2' ' A' ' 95' ' ' ARG 0.268 27.4 t30 -101.46 -23.91 14.25 Favored 'General case' 0 CA--C 1.494 -1.195 0 CA-C-O 116.281 -1.819 . . . . 0.0 111.322 -179.962 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.541 ' HA2' ' CZ ' ' A' ' 95' ' ' ARG . . . 71.87 11.1 73.55 Favored Glycine 0 CA--C 1.542 1.767 0 N-CA-C 118.38 2.112 . . . . 0.0 118.38 179.181 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.653 ' N ' ' HE ' ' A' ' 95' ' ' ARG . 3.8 mtpp -110.73 -148.04 0.42 Allowed 'General case' 0 C--N 1.3 -1.578 0 O-C-N 125.801 1.53 . . . . 0.0 111.004 -177.45 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 57.2 tt0 -160.65 161.91 32.53 Favored 'General case' 0 N--CA 1.433 -1.295 0 C-N-CA 131.385 3.874 . . . . 0.0 109.687 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.493 HD11 ' CG ' ' A' ' 119' ' ' TYR . 9.3 tp -142.33 157.75 44.47 Favored 'General case' 0 N--CA 1.438 -1.045 1 C-N-CA 132.014 4.125 . . . . 0.0 106.527 -179.243 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.576 ' CG2' ' HB ' ' A' ' 118' ' ' THR . 4.1 tt -150.25 154.63 8.67 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.993 0 N-CA-C 103.941 -2.615 . . . . 0.0 103.941 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -131.5 -172.0 2.74 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.452 HG11 ' CG2' ' A' ' 116' ' ' THR . 0.5 OUTLIER -169.72 77.02 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 CA-C-O 127.544 3.545 . . . . 0.0 107.539 179.647 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.409 ' HD3' HD22 ' A' ' 113' ' ' LEU . 0.1 OUTLIER -65.84 91.71 0.15 Allowed 'General case' 0 C--O 1.217 -0.617 0 N-CA-C 104.668 -2.345 . . . . 0.0 104.668 179.571 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.437 ' N ' ' O ' ' A' ' 105' ' ' VAL . 25.8 tt0 -72.75 -35.42 67.48 Favored 'General case' 0 C--O 1.202 -1.414 0 CA-C-N 110.994 -2.821 . . . . 0.0 115.044 -179.581 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.56 ' CD1' ' CH2' ' A' ' 6' ' ' TRP 0.428 3.2 tp 52.55 43.38 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 C-N-CA 112.927 -3.509 . . . . 0.0 113.236 179.956 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -66.73 103.19 1.05 Allowed 'General case' 0 CA--C 1.505 -0.782 0 O-C-N 120.494 -1.379 . . . . 0.0 108.193 -179.487 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 56.85 -73.29 0.01 OUTLIER Glycine 0 C--N 1.342 0.893 0 C-N-CA 127.206 2.336 . . . . 0.0 111.848 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . 0.351 0.0 OUTLIER -136.97 36.8 2.58 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 117.494 -1.241 . . . . 0.0 110.32 179.671 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -146.43 97.62 2.95 Favored 'General case' 0 C--N 1.363 1.162 0 O-C-N 126.521 2.388 . . . . 0.0 110.388 -179.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.492 HD13 ' CD2' ' A' ' 2' ' ' PHE . 0.4 OUTLIER -75.27 68.33 1.99 Allowed 'General case' 0 C--O 1.209 -1.068 1 O-C-N 129.353 4.158 . . . . 0.0 107.479 -179.51 . . . . . . . . 4 4 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.492 HG12 ' CD1' ' A' ' 127' ' ' ILE . 54.6 mt -72.07 128.27 34.86 Favored 'Isoleucine or valine' 0 C--O 1.25 1.114 0 N-CA-C 105.006 -2.22 . . . . 0.0 105.006 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -113.17 108.14 16.89 Favored 'General case' 0 CA--C 1.493 -1.232 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 -179.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.452 ' CG2' HG11 ' A' ' 105' ' ' VAL . 66.8 p -76.28 169.06 18.94 Favored 'General case' 0 C--O 1.245 0.846 0 C-N-CA 115.912 -2.315 . . . . 0.0 105.443 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -148.85 93.82 2.17 Favored 'General case' 0 CA--C 1.491 -1.298 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.576 ' HB ' ' CG2' ' A' ' 103' ' ' ILE . 0.2 OUTLIER -96.84 81.68 3.16 Favored 'General case' 0 N--CA 1.424 -1.762 0 O-C-N 126.702 2.501 . . . . 0.0 116.322 -179.781 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.502 ' HB3' ' CE ' ' A' ' 20' ' ' LYS . 0.2 OUTLIER -85.8 101.57 12.92 Favored 'General case' 0 N--CA 1.479 0.975 0 N-CA-C 103.278 -2.86 . . . . 0.0 103.278 178.625 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 65.25 -82.15 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.412 0 CA-C-N 113.88 -1.509 . . . . 0.0 114.178 -179.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -132.8 24.09 3.89 Favored Glycine 0 CA--C 1.54 1.623 0 N-CA-C 117.401 1.72 . . . . 0.0 117.401 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.461 ' HB ' ' HD3' ' A' ' 20' ' ' LYS . 3.3 t -133.14 87.36 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -68.62 129.97 41.49 Favored 'General case' 0 N--CA 1.436 -1.144 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.455 ' HB1' ' CB ' ' A' ' 17' ' ' PHE . . . -115.54 115.6 26.74 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-O 116.307 -1.806 . . . . 0.0 108.4 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.406 ' O ' ' N ' ' A' ' 12' ' ' GLU . 0.1 OUTLIER -92.7 129.94 38.48 Favored 'General case' 0 C--O 1.252 1.202 0 C-N-CA 116.991 -1.883 . . . . 0.0 109.932 -179.998 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 7.4 mtm180 -119.89 86.77 2.62 Favored 'General case' 0 N--CA 1.437 -1.122 0 CA-C-N 112.082 -2.326 . . . . 0.0 106.028 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.492 ' CD1' HG12 ' A' ' 114' ' ' ILE . 0.8 OUTLIER -84.28 125.9 40.23 Favored 'Isoleucine or valine' 0 C--O 1.252 1.23 0 CA-C-N 114.306 -1.316 . . . . 0.0 112.893 179.983 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.501 ' CZ ' HD13 ' A' ' 38' ' ' LEU . 0.2 OUTLIER -106.39 155.71 19.27 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-O 123.722 1.725 . . . . 0.0 107.926 179.709 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . 0.268 15.9 mtpp -117.3 16.99 14.79 Favored 'General case' 0 C--O 1.244 0.797 0 O-C-N 118.594 -2.566 . . . . 0.0 110.704 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.528 ' HG3' ' CH2' ' A' ' 6' ' ' TRP . 1.4 tttt 57.26 113.25 0.01 OUTLIER 'General case' 0 C--O 1.219 -0.527 0 N-CA-C 115.991 1.849 . . . . 0.0 115.991 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . 0.836 15.0 tt0 . . . . . 0 N--CA 1.429 -1.519 0 O-C-N 118.422 -2.674 . . . . 0.0 116.023 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 19.2 p90 . . . . . 0 N--CA 1.429 -1.513 0 N-CA-C 118.541 2.793 . . . . 0.0 118.541 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -167.45 96.92 0.48 Allowed 'General case' 0 N--CA 1.435 -1.191 0 O-C-N 119.605 -1.934 . . . . 0.0 112.091 -179.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 142.91 -152.48 23.99 Favored Glycine 0 C--O 1.212 -1.229 0 C-N-CA 118.587 -1.768 . . . . 0.0 109.435 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.4 ' C ' ' CG ' ' A' ' 6' ' ' TRP 0.567 13.2 p -89.69 155.08 19.46 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 123.358 0.663 . . . . 0.0 111.417 179.946 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.524 ' CZ3' ' HB2' ' A' ' 130' ' ' LYS . 91.9 m95 -152.69 105.17 2.95 Favored 'General case' 0 C--N 1.319 -0.747 0 O-C-N 127.652 3.095 . . . . 0.0 106.848 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 13.1 ttpt -106.04 101.85 11.31 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-O 114.991 -2.433 . . . . 0.0 108.313 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . 0.284 2.8 p -45.89 144.27 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 120.441 1.473 . . . . 0.0 111.015 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -146.55 -30.25 0.37 Allowed 'General case' 0 N--CA 1.438 -1.053 0 O-C-N 127.82 3.2 . . . . 0.0 112.371 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.41 ' HB2' ' HB ' ' A' ' 127' ' ' ILE . 17.9 mmt180 -82.84 -80.76 0.17 Allowed 'General case' 0 C--N 1.297 -1.684 0 O-C-N 119.022 -2.299 . . . . 0.0 114.286 -179.652 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.42 ' HA ' ' HA ' ' A' ' 126' ' ' ARG 0.284 8.2 m120 77.13 147.19 0.09 Allowed 'General case' 0 C--O 1.247 0.964 1 O-C-N 129.592 4.307 . . . . 0.0 106.275 -177.206 . . . . . . . . 4 3 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.408 ' N ' ' O ' ' A' ' 125' ' ' LYS . 2.8 tp10 -125.9 -69.54 0.77 Allowed 'General case' 0 C--N 1.296 -1.724 0 CA-C-N 122.398 2.363 . . . . 0.0 108.113 -179.595 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.402 ' HB3' ' HA ' ' A' ' 124' ' ' ALA . 5.2 t30 -112.17 29.37 7.95 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 127.325 2.891 . . . . 0.0 113.157 179.7 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.528 ' CE1' ' HG2' ' A' ' 126' ' ' ARG 0.376 1.1 m-85 -73.18 -27.68 61.78 Favored 'General case' 0 N--CA 1.44 -0.974 0 O-C-N 127.282 2.863 . . . . 0.0 117.488 179.708 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -74.36 -36.48 63.58 Favored 'General case' 0 C--O 1.209 -1.032 0 CA-C-N 120.479 1.49 . . . . 0.0 111.391 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 12.4 tptp -71.77 -32.14 67.35 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 111.537 -2.574 . . . . 0.0 115.216 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -70.76 -24.27 62.57 Favored 'General case' 0 N--CA 1.441 -0.88 0 O-C-N 124.868 1.355 . . . . 0.0 111.472 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 7.7 mmt -77.21 -34.65 56.04 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-O 123.841 1.781 . . . . 0.0 106.422 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -65.54 -31.14 72.04 Favored 'General case' 0 N--CA 1.473 0.709 0 O-C-N 118.199 -2.813 . . . . 0.0 112.529 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.437 ' HA ' ' HD2' ' A' ' 20' ' ' LYS . 11.6 tptm -77.04 -30.91 55.9 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 112.836 -1.984 . . . . 0.0 110.581 179.352 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.84 -21.08 55.55 Favored 'General case' 0 N--CA 1.435 -1.221 0 O-C-N 125.148 1.53 . . . . 0.0 107.792 179.373 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 123.01 1.64 9.49 Favored Glycine 0 C--N 1.301 -1.387 0 CA-C-O 117.674 -1.625 . . . . 0.0 113.258 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.404 HG21 ' HB2' ' A' ' 27' ' ' LYS . 0.6 OUTLIER -77.75 107.33 9.35 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.313 0 CA-C-O 117.73 -1.129 . . . . 0.0 108.605 179.913 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -118.67 1.49 11.64 Favored 'General case' 0 C--N 1.352 0.68 0 CA-C-O 116.001 -1.952 . . . . 0.0 114.154 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . 0.393 0.6 OUTLIER -112.72 -140.14 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.358 0.969 0 O-C-N 128.974 3.921 . . . . 0.0 116.34 -179.981 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.561 0.0 OUTLIER -72.76 -21.08 19.45 Favored 'Isoleucine or valine' 0 C--O 1.243 0.722 0 CA-C-N 120.689 1.586 . . . . 0.0 114.792 -179.926 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.404 ' HB2' HG21 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -62.14 -30.78 71.28 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 114.29 1.219 . . . . 0.0 114.29 179.89 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . 0.268 0.1 OUTLIER -78.97 -20.95 47.87 Favored 'General case' 0 N--CA 1.454 -0.247 0 O-C-N 119.502 -1.998 . . . . 0.0 108.31 180.0 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.6 tttm -78.9 -46.66 17.99 Favored 'General case' 0 C--O 1.215 -0.716 0 CA-C-N 113.318 -1.764 . . . . 0.0 108.768 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 11.0 mp -73.46 -22.69 60.12 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 113.746 -1.57 . . . . 0.0 110.248 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -68.79 -34.0 76.73 Favored Glycine 0 C--N 1.344 1.018 0 C-N-CA 123.638 0.637 . . . . 0.0 112.559 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -79.85 -34.86 38.97 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 127.625 2.37 . . . . 0.0 109.107 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 10.6 m170 -118.4 42.03 2.82 Favored 'General case' 0 C--O 1.24 0.573 0 C-N-CA 126.617 1.967 . . . . 0.0 114.338 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.8 p30 -71.29 -23.59 61.99 Favored 'General case' 0 C--O 1.215 -0.754 0 N-CA-C 119.17 3.026 . . . . 0.0 119.17 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 78.13 9.1 2.25 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 -179.635 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.479 HD13 ' CG ' ' A' ' 51' ' ' GLU . 0.9 OUTLIER -41.77 116.32 0.77 Allowed 'General case' 0 CA--C 1.51 -0.591 0 O-C-N 126.962 2.664 . . . . 0.0 110.873 -179.791 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 11.4 ttmm -113.86 92.11 3.87 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 105.166 -2.161 . . . . 0.0 105.166 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.423 ' HG ' ' CG2' ' A' ' 49' ' ' VAL 0.276 0.8 OUTLIER -75.17 114.08 13.25 Favored 'General case' 0 C--N 1.292 -1.91 0 C-N-CA 117.497 -1.681 . . . . 0.0 109.115 -179.983 . . . . . . . . 4 4 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.46 ' HB ' ' CB ' ' A' ' 50' ' ' LYS . 91.8 m -94.87 84.47 4.18 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 102.012 -3.329 . . . . 0.0 102.012 179.44 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.42 HD13 ' CD1' ' A' ' 6' ' ' TRP . 96.0 mt -71.73 116.14 13.04 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 CA-C-O 123.69 1.71 . . . . 0.0 110.81 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.3 m -110.38 118.01 35.14 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 110.324 -3.125 . . . . 0.0 109.348 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 2.7 tp60 -94.46 125.62 39.22 Favored 'General case' 0 C--N 1.311 -1.082 0 O-C-N 126.074 2.108 . . . . 0.0 107.794 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -135.08 68.31 1.47 Allowed 'General case' 0 N--CA 1.433 -1.31 0 CA-C-O 125.257 2.456 . . . . 0.0 105.684 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.17 -76.59 2.22 Favored Glycine 0 C--N 1.298 -1.559 0 N-CA-C 104.44 -3.464 . . . . 0.0 104.44 179.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.348 0.0 OUTLIER -130.51 -36.58 1.44 Allowed 'General case' 0 C--N 1.326 -0.449 0 O-C-N 126.608 2.005 . . . . 0.0 113.976 179.947 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.4 ttmt -57.38 109.26 0.65 Allowed 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 114.102 -1.408 . . . . 0.0 113.56 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.44 ' HB2' ' CD1' ' A' ' 62' ' ' PHE 0.254 3.2 m-30 -100.4 78.23 2.01 Favored 'General case' 0 CA--C 1.507 -0.684 0 CA-C-O 125.578 2.608 . . . . 0.0 106.942 179.639 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . 0.417 9.8 t -76.48 80.13 3.19 Favored 'General case' 0 N--CA 1.435 -1.216 0 O-C-N 118.832 -2.417 . . . . 0.0 113.439 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.423 ' CG2' ' HG ' ' A' ' 38' ' ' LEU 0.596 2.0 m -56.78 96.99 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.428 -1.532 0 CA-C-N 114.189 -1.369 . . . . 0.0 114.466 179.652 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.46 ' CB ' ' HB ' ' A' ' 39' ' ' THR . 1.1 ttmt -67.51 116.26 8.04 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 101.59 -3.485 . . . . 0.0 101.59 179.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.479 ' CG ' HD13 ' A' ' 36' ' ' LEU 0.263 1.9 tt0 -107.44 107.0 17.67 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 103.753 -2.684 . . . . 0.0 103.753 -179.997 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.402 ' HA ' ' HA ' ' A' ' 57' ' ' ASN . 3.0 m -106.56 48.79 0.82 Allowed 'General case' 0 C--N 1.285 -2.196 0 N-CA-C 105.004 -2.221 . . . . 0.0 105.004 179.722 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.3 m -76.36 162.54 27.8 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-O 115.431 -2.223 . . . . 0.0 109.106 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -48.57 -37.12 17.08 Favored 'General case' 0 C--O 1.211 -0.958 0 O-C-N 125.238 1.586 . . . . 0.0 107.531 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -52.88 -65.35 0.57 Allowed 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 116.459 -1.734 . . . . 0.0 109.54 179.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.408 ' HG3' ' N ' ' A' ' 57' ' ' ASN . 1.2 ttm-85 -173.08 148.02 1.67 Allowed 'General case' 0 CA--C 1.498 -1.028 0 CA-C-N 120.525 1.511 . . . . 0.0 110.462 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.408 ' N ' ' HG3' ' A' ' 56' ' ' ARG . 3.3 m-20 -78.4 86.64 4.45 Favored 'General case' 0 CA--C 1.499 -1.011 0 N-CA-C 102.338 -3.208 . . . . 0.0 102.338 -179.652 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -122.95 115.42 45.74 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.188 0 N-CA-C 117.864 2.542 . . . . 0.0 117.864 -179.475 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.404 ' OD1' ' N ' ' A' ' 59' ' ' ASP . 0.1 OUTLIER -64.69 147.6 52.71 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 104.024 -2.584 . . . . 0.0 104.024 178.909 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.461 ' CG2' ' HB2' ' A' ' 51' ' ' GLU . 1.8 t -124.71 46.43 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.019 0 CA-C-O 123.847 1.784 . . . . 0.0 106.523 -179.496 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . 0.304 0.5 OUTLIER -43.9 144.88 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.568 0 N-CA-C 116.414 2.005 . . . . 0.0 116.414 -179.309 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.552 ' HB3' ' CE1' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -154.51 92.79 1.52 Allowed 'General case' 0 N--CA 1.419 -2.022 0 CA-C-O 115.958 -1.972 . . . . 0.0 109.258 175.911 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . 0.263 1.2 mt-10 -66.45 94.77 0.29 Allowed 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 100.538 -3.875 . . . . 0.0 100.538 178.541 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.662 ' CB ' ' CE2' ' A' ' 82' ' ' TRP . 0.0 OUTLIER -12.22 89.08 0.01 OUTLIER 'General case' 0 N--CA 1.426 -1.664 0 O-C-N 128.006 3.316 . . . . 0.0 112.135 -178.566 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.565 ' N ' ' CD1' ' A' ' 82' ' ' TRP . . . 96.16 36.65 5.13 Favored Glycine 0 C--N 1.351 1.368 0 N-CA-C 121.586 3.395 . . . . 0.0 121.586 179.2 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . 0.409 38.1 t -121.48 77.99 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 N-CA-C 105.039 -2.208 . . . . 0.0 105.039 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -14.38 127.8 0.01 OUTLIER 'General case' 0 CA--C 1.48 -1.733 0 O-C-N 128.077 3.361 . . . . 0.0 116.513 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.552 ' CE1' ' HB3' ' A' ' 62' ' ' PHE . 8.9 p90 -147.93 164.05 34.95 Favored 'General case' 0 N--CA 1.441 -0.899 0 O-C-N 119.072 -2.267 . . . . 0.0 112.544 -178.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -116.11 148.41 40.31 Favored 'General case' 0 C--O 1.243 0.729 0 O-C-N 126.47 2.356 . . . . 0.0 105.445 179.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -116.65 -47.6 2.71 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-O 116.637 -1.649 . . . . 0.0 114.2 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.43 ' HA ' ' N ' ' A' ' 77' ' ' GLU . 2.5 t 70.01 104.43 0.06 Allowed 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 -179.507 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 6.1 mt -69.53 -175.81 0.9 Allowed 'General case' 0 C--N 1.302 -1.476 0 O-C-N 128.441 3.588 . . . . 0.0 109.172 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -105.97 -2.92 22.31 Favored 'General case' 0 N--CA 1.443 -0.817 0 O-C-N 128.089 3.368 . . . . 0.0 114.276 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -121.74 -47.15 2.21 Favored 'General case' 0 N--CA 1.435 -1.175 0 O-C-N 121.677 -0.639 . . . . 0.0 110.848 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -110.15 -10.11 22.87 Favored Glycine 0 CA--C 1.537 1.443 0 O-C-N 124.455 1.097 . . . . 0.0 115.774 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.482 ' CG2' ' N ' ' A' ' 77' ' ' GLU 0.349 0.7 OUTLIER 72.28 172.47 0.31 Allowed 'General case' 0 CA--C 1.501 -0.915 0 C-N-CA 115.793 -2.363 . . . . 0.0 110.27 -179.838 . . . . . . . . 4 4 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.482 ' N ' ' CG2' ' A' ' 76' ' ' THR . 0.2 OUTLIER 47.01 -171.28 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.818 1 O-C-N 129.391 4.182 . . . . 0.0 110.309 179.947 . . . . . . . . 4 4 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.432 ' HG ' ' HB3' ' A' ' 93' ' ' PHE 0.339 4.8 tt 130.9 141.62 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.808 0 O-C-N 128.423 3.577 . . . . 0.0 102.247 180.0 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 17.3 m -163.48 128.74 3.03 Favored 'General case' 0 C--O 1.199 -1.56 0 N-CA-C 103.17 -2.9 . . . . 0.0 103.17 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 179.56 -135.25 2.46 Favored Glycine 0 C--N 1.31 -0.905 0 C-N-CA 118.583 -1.77 . . . . 0.0 110.315 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.552 ' HA ' ' CZ ' ' A' ' 68' ' ' PHE . 33.6 p -164.59 164.27 21.64 Favored 'General case' 0 C--O 1.188 -2.132 0 C-N-CA 117.214 -1.794 . . . . 0.0 111.779 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . 0.688 ' CG ' ' N ' ' A' ' 83' ' ' THR 0.408 1.4 p-90 -74.67 -171.59 1.31 Allowed 'General case' 0 C--N 1.31 -1.112 1 N-CA-C 100.025 -4.065 . . . . 0.0 100.025 175.735 . . . . . . . . 4 3 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.688 ' N ' ' CG ' ' A' ' 82' ' ' TRP . 0.3 OUTLIER 172.4 118.17 0.02 OUTLIER 'General case' 0 N--CA 1.432 -1.331 0 CA-C-O 124.404 2.05 . . . . 0.0 113.316 174.913 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' MET . . . . . 0.529 ' HB2' ' CZ3' ' A' ' 82' ' ' TRP . 2.8 ttp -84.86 101.23 12.13 Favored 'General case' 0 N--CA 1.433 -1.275 0 O-C-N 120.852 -1.155 . . . . 0.0 108.076 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.429 ' CG ' ' CG2' ' A' ' 90' ' ' VAL 0.673 0.8 OUTLIER -54.82 -87.1 0.0 OUTLIER 'General case' 0 N--CA 1.432 -1.368 0 CA-C-O 125.918 2.77 . . . . 0.0 111.076 179.982 . . . . . . . . 4 4 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -138.65 -80.04 0.08 OUTLIER Glycine 0 N--CA 1.443 -0.852 0 N-CA-C 104.238 -3.545 . . . . 0.0 104.238 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -95.1 5.34 52.13 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 116.404 -1.76 . . . . 0.0 115.054 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . 0.371 0.6 OUTLIER -147.55 162.89 38.18 Favored 'General case' 0 CA--C 1.493 -1.215 0 O-C-N 126.281 2.238 . . . . 0.0 110.892 -179.967 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.416 ' HA ' ' HA ' ' A' ' 84' ' ' MET . 5.5 tt -104.76 150.6 24.63 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 103.322 -2.844 . . . . 0.0 103.322 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.47 HG11 ' CB ' ' A' ' 105' ' ' VAL . 0.0 OUTLIER -136.61 165.42 28.62 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.913 0 CA-C-O 123.849 1.785 . . . . 0.0 106.247 -179.808 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -128.83 97.4 0.43 Allowed Glycine 0 C--N 1.345 1.051 0 C-N-CA 128.636 3.017 . . . . 0.0 109.718 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 16.7 mtpt -95.29 139.74 31.17 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 102.375 -3.194 . . . . 0.0 102.375 179.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.432 ' HB3' ' HG ' ' A' ' 78' ' ' LEU . 75.6 m-85 -149.84 121.4 7.99 Favored 'General case' 0 CA--C 1.501 -0.936 0 CA-C-O 124.284 1.992 . . . . 0.0 111.724 -179.717 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.409 ' HA ' ' HA ' ' A' ' 101' ' ' GLU . 31.0 mttt -91.15 -175.61 4.34 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-N 113.885 -1.507 . . . . 0.0 110.129 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . 0.366 1.4 mmt85 -128.63 128.32 43.94 Favored 'General case' 0 CA--C 1.489 -1.398 0 O-C-N 124.817 1.323 . . . . 0.0 107.879 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -33.11 -63.26 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 C-N-CA 126.841 2.056 . . . . 0.0 113.938 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . 0.368 0.0 OUTLIER -101.44 -22.24 14.6 Favored 'General case' 0 C--O 1.258 1.535 0 O-C-N 119.892 -1.755 . . . . 0.0 115.293 -179.811 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 46.5 t30 -77.45 -26.39 51.46 Favored 'General case' 0 N--CA 1.422 -1.827 0 CA-C-N 113.576 -1.647 . . . . 0.0 113.678 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 48.18 22.96 2.53 Favored Glycine 0 CA--C 1.531 1.05 0 O-C-N 127.287 2.867 . . . . 0.0 118.05 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 15.5 mmtp -75.36 -108.72 0.01 OUTLIER 'General case' 0 C--O 1.199 -1.592 0 O-C-N 119.842 -1.976 . . . . 0.0 108.17 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.421 ' HG2' ' N ' ' A' ' 102' ' ' LEU . 1.0 OUTLIER 173.22 179.18 0.09 Allowed 'General case' 0 C--N 1.316 -0.861 0 C-N-CA 129.286 3.034 . . . . 0.0 109.425 179.993 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.557 ' CB ' ' HA ' ' A' ' 119' ' ' TYR . 3.5 tt -166.15 139.94 4.26 Favored 'General case' 0 C--O 1.245 0.859 1 O-C-N 129.139 4.024 . . . . 0.0 106.231 179.34 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.506 ' N ' ' O ' ' A' ' 118' ' ' THR . 4.2 tp -128.16 156.07 40.09 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.068 0 N-CA-C 105.039 -2.208 . . . . 0.0 105.039 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.406 ' N ' HG13 ' A' ' 103' ' ' ILE . . . -153.25 145.2 23.64 Favored 'General case' 0 C--N 1.313 -0.998 0 O-C-N 119.213 -2.179 . . . . 0.0 106.714 -179.599 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.525 ' HB ' ' CE2' ' A' ' 117' ' ' TYR . 8.4 p -124.8 113.09 34.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 121.642 2.019 . . . . 0.0 111.709 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.473 ' CB ' HD13 ' A' ' 113' ' ' LEU . 0.2 OUTLIER -82.0 83.89 7.13 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 105.296 -2.113 . . . . 0.0 105.296 179.99 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 69.7 tt0 -90.66 77.5 6.35 Favored 'General case' 0 N--CA 1.418 -2.052 0 O-C-N 128.071 3.357 . . . . 0.0 112.357 -179.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.429 HG13 ' HA ' ' A' ' 113' ' ' LEU 0.406 2.1 tt -57.13 118.55 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 C-N-CA 115.652 -2.419 . . . . 0.0 112.313 179.736 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 36.6 m -109.6 60.74 0.6 Allowed 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 117.695 -1.145 . . . . 0.0 108.397 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 83.53 -108.33 3.03 Favored Glycine 0 C--N 1.347 1.193 0 O-C-N 126.701 2.501 . . . . 0.0 111.391 -179.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.435 ' ND2' ' N ' ' A' ' 111' ' ' ASN 0.323 0.0 OUTLIER -89.05 13.38 13.13 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 115.78 -2.057 . . . . 0.0 111.38 -179.823 . . . . . . . . 4 4 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -136.52 115.93 12.73 Favored 'General case' 0 C--O 1.208 -1.124 0 O-C-N 127.968 3.292 . . . . 0.0 113.515 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.473 HD13 ' CB ' ' A' ' 106' ' ' ARG . 0.1 OUTLIER -88.85 143.34 26.95 Favored 'General case' 0 C--O 1.213 -0.83 0 N-CA-C 100.725 -3.806 . . . . 0.0 100.725 179.719 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.422 HG23 HG23 ' A' ' 116' ' ' THR . 71.3 mt -138.77 118.85 14.85 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.973 0 O-C-N 127.661 3.1 . . . . 0.0 105.269 179.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 12.4 mt-30 -100.97 122.28 43.24 Favored 'General case' 0 CA--C 1.505 -0.759 0 O-C-N 126.036 2.085 . . . . 0.0 105.812 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.481 ' HB ' ' CG ' ' A' ' 125' ' ' LYS . 0.6 OUTLIER -140.55 152.16 45.31 Favored 'General case' 0 N--CA 1.419 -2.013 0 O-C-N 121.098 -1.001 . . . . 0.0 112.328 -179.644 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . 0.525 ' CE2' ' HB ' ' A' ' 105' ' ' VAL 0.377 22.4 m-85 135.69 -140.97 0.0 OUTLIER 'General case' 0 CA--C 1.478 -1.795 0 O-C-N 128.852 3.845 . . . . 0.0 113.493 176.58 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.506 ' O ' ' N ' ' A' ' 103' ' ' ILE . 4.8 t -151.71 -155.76 0.65 Allowed 'General case' 0 C--N 1.312 -1.055 0 O-C-N 127.278 2.861 . . . . 0.0 116.044 -174.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.557 ' HA ' ' CB ' ' A' ' 102' ' ' LEU 0.282 2.6 t80 -109.53 -57.46 2.17 Favored 'General case' 0 C--O 1.217 -0.636 0 CA-C-O 125.434 2.54 . . . . 0.0 104.82 177.721 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.522 ' HG3' ' CE2' ' A' ' 119' ' ' TYR . 3.7 mt-10 -123.38 -80.7 0.63 Allowed 'General case' 0 N--CA 1.436 -1.126 0 CA-C-N 112.591 -2.095 . . . . 0.0 111.981 179.416 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -137.03 36.07 2.01 Favored Glycine 0 C--N 1.36 1.872 0 N-CA-C 119.259 2.464 . . . . 0.0 119.259 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 65.3 t -137.02 91.26 0.83 Allowed 'Isoleucine or valine' 0 C--O 1.215 -0.739 0 N-CA-C 103.535 -2.765 . . . . 0.0 103.535 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.429 ' HA ' ' HB ' ' A' ' 118' ' ' THR . 1.5 mp0 -63.02 178.61 0.46 Allowed 'General case' 0 C--N 1.311 -1.102 0 CA-C-O 125.525 2.584 . . . . 0.0 113.955 -178.223 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.402 ' HA ' ' HB3' ' A' ' 13' ' ' ASN . . . -163.67 177.21 8.9 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 112.572 -3.585 . . . . 0.0 106.799 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.481 ' CG ' ' HB ' ' A' ' 116' ' ' THR 0.337 0.0 OUTLIER -161.92 131.44 4.58 Favored 'General case' 0 C--O 1.249 1.047 1 O-C-N 129.454 4.221 . . . . 0.0 107.423 -179.906 . . . . . . . . 5 4 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.528 ' HG2' ' CE1' ' A' ' 14' ' ' TYR . 7.7 ptm180 -132.02 85.78 2.28 Favored 'General case' 0 N--CA 1.426 -1.634 0 CA-C-O 114.556 -2.64 . . . . 0.0 111.653 -179.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.438 ' N ' HD12 ' A' ' 127' ' ' ILE . 1.0 OUTLIER -64.82 105.21 0.52 Allowed 'Isoleucine or valine' 0 C--O 1.25 1.121 1 O-C-N 132.138 5.899 . . . . 0.0 113.75 178.827 . . . . . . . . 4 4 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.472 ' CD2' ' HB3' ' A' ' 6' ' ' TRP . 0.0 OUTLIER -87.74 131.96 34.31 Favored 'General case' 0 N--CA 1.432 -1.352 0 CA-C-N 111.71 -2.495 . . . . 0.0 107.029 179.957 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 3.1 mmmp? -100.09 47.68 0.94 Allowed 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 114.394 -2.717 . . . . 0.0 110.059 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.524 ' HB2' ' CZ3' ' A' ' 6' ' ' TRP . 2.0 ttpm? 26.09 98.49 0.0 OUTLIER 'General case' 0 CA--C 1.518 -0.283 0 O-C-N 126.441 2.338 . . . . 0.0 115.401 179.378 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . 0.914 25.5 tt0 . . . . . 0 N--CA 1.446 -0.629 0 CA-C-N 120.327 1.422 . . . . 0.0 113.327 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . 0.476 ' CD1' ' N ' ' A' ' 2' ' ' PHE . 2.2 p90 . . . . . 0 N--CA 1.448 -0.564 0 N-CA-C 116.645 2.091 . . . . 0.0 116.645 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -143.56 99.83 3.49 Favored 'General case' 0 CA--C 1.501 -0.942 0 CA-C-N 114.621 -1.172 . . . . 0.0 110.96 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 151.12 -107.5 0.34 Allowed Glycine 0 C--O 1.213 -1.161 0 CA-C-O 117.844 -1.531 . . . . 0.0 113.0 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.406 ' OG1' ' N ' ' A' ' 6' ' ' TRP 0.482 1.1 t -137.01 173.55 11.58 Favored 'General case' 0 C--N 1.309 -1.157 0 O-C-N 127.397 2.469 . . . . 0.0 110.011 179.797 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.532 ' CZ3' ' HG3' ' A' ' 130' ' ' LYS . 91.6 m95 -161.56 150.19 15.7 Favored 'General case' 0 N--CA 1.427 -1.584 0 O-C-N 126.247 2.217 . . . . 0.0 108.287 -179.751 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 12.9 tttt -151.89 102.65 2.85 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-O 115.014 -2.422 . . . . 0.0 107.066 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.418 ' HA ' ' HA ' ' A' ' 128' ' ' PHE 0.323 5.7 p -46.84 138.94 1.82 Allowed 'Isoleucine or valine' 0 C--O 1.249 1.038 0 CA-C-N 121.024 1.738 . . . . 0.0 112.685 179.816 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -153.44 21.05 0.55 Allowed 'General case' 0 CA--C 1.498 -1.044 0 CA-C-O 123.427 1.584 . . . . 0.0 112.425 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.4 ' CG ' ' HB ' ' A' ' 127' ' ' ILE 0.259 1.2 ptp85 -155.63 -49.48 0.08 Allowed 'General case' 0 C--N 1.301 -1.52 0 O-C-N 117.285 -3.384 . . . . 0.0 110.468 179.727 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . 0.373 0.5 OUTLIER 51.11 -176.09 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.67 0 O-C-N 126.411 2.319 . . . . 0.0 110.719 179.8 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -146.88 -85.42 0.11 Allowed 'General case' 0 C--N 1.301 -1.542 0 O-C-N 119.36 -2.087 . . . . 0.0 107.773 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -89.74 18.04 5.96 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 120.111 1.323 . . . . 0.0 114.207 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 79.4 t80 -59.45 -32.54 70.32 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 118.898 2.925 . . . . 0.0 118.898 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -76.13 -29.3 57.77 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 121.816 2.098 . . . . 0.0 111.436 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 16.2 mttp -75.52 -24.64 56.82 Favored 'General case' 0 N--CA 1.425 -1.68 0 O-C-N 126.801 2.563 . . . . 0.0 113.398 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.435 ' CB ' ' HB3' ' A' ' 124' ' ' ALA . 11.6 t80 -79.17 -20.39 48.58 Favored 'General case' 0 N--CA 1.428 -1.538 0 O-C-N 121.763 -0.586 . . . . 0.0 110.944 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.426 ' HA ' HG13 ' A' ' 23' ' ' ILE . 0.4 OUTLIER -74.48 -35.07 63.25 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-O 122.902 1.334 . . . . 0.0 107.881 179.99 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . 0.267 7.1 tt0 -72.87 -25.67 61.18 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 126.232 2.92 . . . . 0.0 112.232 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 27.2 tptt -79.9 -29.73 39.96 Favored 'General case' 0 C--N 1.319 -0.753 0 O-C-N 119.423 -2.048 . . . . 0.0 111.361 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 1.1 mmm -75.73 -28.91 58.73 Favored 'General case' 0 C--O 1.217 -0.651 0 CA-C-O 124.552 2.12 . . . . 0.0 108.885 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 109.01 43.42 1.2 Allowed Glycine 0 N--CA 1.443 -0.896 0 CA-C-O 116.171 -2.46 . . . . 0.0 109.928 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.426 HG13 ' HA ' ' A' ' 18' ' ' MET . 3.5 mm -90.76 134.47 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 CA-C-N 119.551 1.676 . . . . 0.0 108.689 -179.443 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -78.47 132.64 37.34 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-O 114.387 -2.721 . . . . 0.0 113.614 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . 0.375 60.5 t -8.68 -53.59 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 O-C-N 128.889 3.868 . . . . 0.0 117.605 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.608 0.3 OUTLIER -79.75 -40.17 20.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 115.154 1.538 . . . . 0.0 115.154 -179.728 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 8.5 ttmm -60.67 -24.1 65.33 Favored 'General case' 0 N--CA 1.443 -0.783 0 O-C-N 127.237 2.836 . . . . 0.0 113.233 179.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 5.4 ptt85 -76.95 -30.88 56.23 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 15.0 ttmt -75.65 -29.01 58.98 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-O 123.47 1.605 . . . . 0.0 110.327 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.416 ' N ' HD21 ' A' ' 30' ' ' LEU . 1.4 mm? -76.1 -34.46 59.51 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 116.086 -1.912 . . . . 0.0 110.018 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -70.99 -25.06 76.46 Favored Glycine 0 C--O 1.21 -1.401 0 O-C-N 125.032 1.457 . . . . 0.0 112.255 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -77.52 -34.51 53.97 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 116.457 -1.735 . . . . 0.0 111.322 179.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 5.3 t-160 -103.63 21.63 15.81 Favored 'General case' 0 N--CA 1.445 -0.676 0 O-C-N 126.958 2.661 . . . . 0.0 113.918 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.78 -29.79 67.19 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 114.709 1.374 . . . . 0.0 114.709 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . 0.283 18.7 m120 76.55 27.86 0.77 Allowed 'General case' 0 C--O 1.245 0.821 0 O-C-N 118.63 -2.544 . . . . 0.0 109.542 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.2 tt -44.73 91.6 0.0 OUTLIER 'General case' 0 C--O 1.212 -0.876 0 O-C-N 126.156 2.16 . . . . 0.0 111.033 -179.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 8.7 tttt -97.33 103.22 15.13 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 101.682 -3.451 . . . . 0.0 101.682 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.475 ' HG ' ' CG2' ' A' ' 49' ' ' VAL 0.292 0.1 OUTLIER -91.29 147.32 23.13 Favored 'General case' 0 C--N 1.289 -2.03 0 CA-C-O 123.932 1.825 . . . . 0.0 106.591 -179.58 . . . . . . . . 4 4 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.424 ' HB ' ' HB3' ' A' ' 50' ' ' LYS . 2.4 m -129.19 103.15 6.79 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 102.498 -3.149 . . . . 0.0 102.498 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 59.3 mt -92.5 119.18 39.62 Favored 'Isoleucine or valine' 0 C--O 1.253 1.254 0 CA-C-O 124.13 1.919 . . . . 0.0 111.883 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 74.5 m -119.91 95.39 4.74 Favored 'General case' 0 C--N 1.348 0.542 0 CA-C-N 110.733 -2.939 . . . . 0.0 110.087 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.59 125.71 29.74 Favored 'General case' 0 C--N 1.313 -1.017 0 O-C-N 127.153 2.783 . . . . 0.0 108.705 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -158.1 112.7 2.59 Favored 'General case' 0 N--CA 1.417 -2.097 0 O-C-N 119.26 -2.15 . . . . 0.0 111.954 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 54.03 42.08 70.27 Favored Glycine 0 N--CA 1.428 -1.889 0 CA-C-N 114.386 -1.279 . . . . 0.0 109.934 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.311 4.4 m-20 83.26 -25.36 0.14 Allowed 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 112.556 -1.822 . . . . 0.0 112.224 179.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 5.7 ttmt -76.37 144.16 40.27 Favored 'General case' 0 C--N 1.307 -1.271 0 C-N-CA 115.639 -2.424 . . . . 0.0 108.681 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -119.59 87.85 2.82 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 118.164 -0.922 . . . . 0.0 111.534 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.486 ' CG2' HG12 ' A' ' 61' ' ' VAL 0.427 0.1 OUTLIER -61.04 118.54 6.89 Favored 'General case' 0 C--O 1.244 0.812 0 C-N-CA 115.206 -2.598 . . . . 0.0 109.502 -179.721 . . . . . . . . 4 4 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.489 ' CG1' ' HB ' ' A' ' 60' ' ' VAL 0.713 8.4 p -101.27 85.94 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 O-C-N 125.173 1.546 . . . . 0.0 108.592 179.557 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.424 ' HB3' ' HB ' ' A' ' 39' ' ' THR . 2.5 tttp -77.41 103.68 7.48 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 105.383 -2.08 . . . . 0.0 105.383 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -95.36 89.48 5.47 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 127.2 2.2 . . . . 0.0 105.413 -179.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -88.27 57.51 4.3 Favored 'General case' 0 C--N 1.289 -2.061 0 O-C-N 119.91 -1.744 . . . . 0.0 106.975 -179.66 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 80.7 p -83.11 160.17 21.94 Favored 'General case' 0 C--O 1.209 -1.065 0 CA-C-O 116.529 -1.701 . . . . 0.0 108.466 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 56.6 t30 -50.54 -32.64 18.98 Favored 'General case' 0 N--CA 1.435 -1.182 0 O-C-N 125.287 1.617 . . . . 0.0 109.498 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -62.66 -50.75 69.94 Favored 'General case' 0 C--N 1.352 0.71 0 C-N-CA 116.223 -2.191 . . . . 0.0 111.193 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.417 ' HG2' ' HB ' ' A' ' 58' ' ' ILE . 29.8 ttm-85 -176.11 148.8 0.83 Allowed 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 121.663 2.029 . . . . 0.0 106.959 178.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -95.3 83.35 3.84 Favored 'General case' 0 C--O 1.22 -0.467 0 N-CA-C 100.441 -3.911 . . . . 0.0 100.441 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.417 ' HB ' ' HG2' ' A' ' 56' ' ' ARG . 3.5 tp -105.58 101.42 12.37 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.238 0 O-C-N 128.015 3.322 . . . . 0.0 116.527 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 29.2 t0 -58.21 137.21 57.23 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 103.229 -2.878 . . . . 0.0 103.229 177.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.489 ' HB ' ' CG1' ' A' ' 49' ' ' VAL . 2.2 t -101.33 -67.75 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 N-CA-C 106.506 -1.664 . . . . 0.0 106.506 -176.419 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.486 HG12 ' CG2' ' A' ' 48' ' ' THR 0.506 0.0 OUTLIER 75.44 134.04 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 CA-C-O 124.065 1.888 . . . . 0.0 112.582 179.557 . . . . . . . . 4 4 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.64 ' CE2' ' CD1' ' A' ' 82' ' ' TRP . 3.9 p90 -168.98 110.71 0.5 Allowed 'General case' 0 N--CA 1.436 -1.17 0 CA-C-N 112.332 -2.213 . . . . 0.0 111.911 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -62.04 125.64 24.57 Favored 'General case' 0 N--CA 1.441 -0.914 0 N-CA-C 102.462 -3.162 . . . . 0.0 102.462 179.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -48.21 125.59 9.59 Favored 'General case' 0 N--CA 1.428 -1.559 0 O-C-N 124.466 1.104 . . . . 0.0 111.503 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' 82' ' ' TRP . . . 73.61 12.36 80.47 Favored Glycine 0 C--N 1.344 1.006 0 O-C-N 126.73 2.519 . . . . 0.0 117.036 -179.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . 0.419 44.0 t -81.18 -99.91 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.431 -1.389 0 CA-C-O 118.373 -0.822 . . . . 0.0 109.053 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.9 t70 165.37 130.08 0.01 OUTLIER 'General case' 0 CA--C 1.49 -1.346 0 CA-C-N 119.285 0.948 . . . . 0.0 110.567 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -135.48 174.75 10.27 Favored 'General case' 0 N--CA 1.428 -1.545 0 CA-C-N 120.156 1.344 . . . . 0.0 109.281 179.683 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -132.65 127.45 34.91 Favored 'General case' 0 C--O 1.244 0.801 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -157.19 125.23 5.5 Favored 'General case' 0 N--CA 1.443 -0.784 0 C-N-CA 118.632 -1.227 . . . . 0.0 113.563 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 18.3 t -57.67 156.92 7.78 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 105.124 -2.176 . . . . 0.0 105.124 179.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.482 ' CD1' HD13 ' A' ' 78' ' ' LEU . 8.4 mt -101.77 9.7 40.63 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-O 118.148 -0.93 . . . . 0.0 109.873 -179.35 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . 79.61 -4.24 2.0 Favored 'General case' 0 N--CA 1.438 -1.071 0 O-C-N 126.802 2.564 . . . . 0.0 113.174 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -165.96 -51.06 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 123.825 1.774 . . . . 0.0 110.259 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -67.8 -6.65 44.98 Favored Glycine 0 C--N 1.347 1.192 0 CA-C-N 113.704 -1.589 . . . . 0.0 112.98 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . 0.274 0.2 OUTLIER 78.62 163.31 0.21 Allowed 'General case' 0 N--CA 1.435 -1.204 0 CA-C-N 119.699 1.75 . . . . 0.0 115.298 179.678 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.443 ' HB3' ' HB ' ' A' ' 96' ' ' VAL . 1.1 mt-10 -36.61 98.43 0.01 OUTLIER 'General case' 0 N--CA 1.44 -0.945 0 O-C-N 128.392 3.558 . . . . 0.0 113.091 179.63 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.482 HD13 ' CD1' ' A' ' 72' ' ' LEU 0.472 5.5 tt -97.04 158.19 15.55 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 101.929 -3.36 . . . . 0.0 101.929 179.621 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 14.5 m -157.82 124.14 4.8 Favored 'General case' 0 CA--C 1.498 -1.054 0 N-CA-C 102.047 -3.316 . . . . 0.0 102.047 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -162.97 -175.83 34.4 Favored Glycine 0 C--N 1.292 -1.89 0 C-N-CA 115.746 -3.121 . . . . 0.0 111.959 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 15.7 p -137.87 159.82 40.97 Favored 'General case' 0 C--O 1.192 -1.965 0 C-N-CA 119.313 -0.955 . . . . 0.0 110.116 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . 0.64 ' CD1' ' CE2' ' A' ' 62' ' ' PHE . 72.2 m95 -118.74 137.75 53.14 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 100.624 -3.843 . . . . 0.0 100.624 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 13.5 t -147.74 143.15 27.36 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 123.597 1.665 . . . . 0.0 109.497 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.98 139.02 41.31 Favored 'General case' 0 N--CA 1.44 -0.965 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . 0.72 5.2 mt-10 -127.81 30.57 5.27 Favored 'General case' 0 C--N 1.307 -1.254 0 C-N-CA 116.687 -2.005 . . . . 0.0 109.686 179.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 71.5 97.68 0.06 OUTLIER Glycine 0 N--CA 1.436 -1.358 0 N-CA-C 106.147 -2.781 . . . . 0.0 106.147 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . 0.28 61.2 m-80 79.06 -7.53 1.75 Allowed 'General case' 0 C--O 1.236 0.387 0 N-CA-C 117.893 2.553 . . . . 0.0 117.893 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . 0.341 0.4 OUTLIER -143.73 133.13 23.33 Favored 'General case' 0 CA--C 1.498 -1.043 0 O-C-N 125.713 1.883 . . . . 0.0 106.575 179.988 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.418 ' HB3' ' HD2' ' A' ' 106' ' ' ARG . 0.2 OUTLIER -97.21 107.28 19.76 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 102.516 -3.142 . . . . 0.0 102.516 179.839 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.464 HG11 ' CG2' ' A' ' 105' ' ' VAL . 1.0 OUTLIER -98.55 156.42 3.72 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.939 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 179.888 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -134.55 104.95 0.53 Allowed Glycine 0 C--N 1.347 1.162 0 C-N-CA 129.969 3.652 . . . . 0.0 110.45 179.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 18.1 mtmt -102.92 117.09 33.83 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 104.541 -2.392 . . . . 0.0 104.541 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.438 ' CD2' HD12 ' A' ' 78' ' ' LEU . 16.0 m-30 -107.58 118.19 36.08 Favored 'General case' 0 C--N 1.328 -0.327 0 O-C-N 125.288 1.617 . . . . 0.0 111.839 -179.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 4.6 mtmt -102.03 161.56 13.59 Favored 'General case' 0 C--O 1.21 -0.981 0 CA-C-N 114.215 -1.357 . . . . 0.0 110.372 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . 0.377 0.0 OUTLIER -107.48 144.98 33.67 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-O 116.849 -1.548 . . . . 0.0 107.672 179.936 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.443 ' HB ' ' HB3' ' A' ' 77' ' ' GLU . 57.0 t -82.24 -30.55 9.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 C-N-CA 126.641 1.976 . . . . 0.0 114.094 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . 0.343 0.1 OUTLIER -110.0 -3.96 16.18 Favored 'General case' 0 C--O 1.259 1.568 0 N-CA-C 115.413 1.634 . . . . 0.0 115.413 179.925 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 44.1 t30 -112.46 -22.49 10.81 Favored 'General case' 0 N--CA 1.422 -1.857 0 N-CA-C 115.258 1.577 . . . . 0.0 115.258 -179.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 60.22 26.97 64.53 Favored Glycine 0 CA--C 1.53 0.985 0 N-CA-C 117.489 1.756 . . . . 0.0 117.489 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 15.2 mmtm -90.91 -113.33 0.08 Allowed 'General case' 0 CA--C 1.553 1.072 0 O-C-N 120.237 -1.743 . . . . 0.0 112.015 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 151.79 144.04 0.0 OUTLIER 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 129.882 3.273 . . . . 0.0 108.778 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.496 HD13 ' CD1' ' A' ' 119' ' ' TYR . 2.4 tt -127.87 176.34 7.65 Favored 'General case' 0 CA--C 1.511 -0.551 2 O-C-N 129.787 4.429 . . . . 0.0 106.835 -179.808 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.446 HG13 ' N ' ' A' ' 104' ' ' ALA . 0.1 OUTLIER -149.14 173.21 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.502 -0.869 0 C-N-CA 117.93 -1.508 . . . . 0.0 109.491 -179.725 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.463 ' HB3' ' CD1' ' A' ' 117' ' ' TYR . . . -154.46 133.36 12.3 Favored 'General case' 0 C--N 1.313 -1.013 0 O-C-N 117.709 -3.119 . . . . 0.0 107.418 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.464 ' CG2' HG11 ' A' ' 90' ' ' VAL . 0.9 OUTLIER -121.1 99.18 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 CA-C-N 122.113 2.233 . . . . 0.0 108.615 179.97 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.464 ' HG3' ' CZ3' ' A' ' 82' ' ' TRP 0.259 75.3 mtt180 -71.62 91.83 1.11 Allowed 'General case' 0 CA--C 1.503 -0.834 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 179.944 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.432 ' O ' ' N ' ' A' ' 109' ' ' SER . 0.1 OUTLIER -89.85 83.53 6.18 Favored 'General case' 0 N--CA 1.432 -1.359 0 CA-C-N 112.316 -2.22 . . . . 0.0 114.758 -179.638 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . 0.276 8.5 mm -62.17 93.81 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 C-N-CA 116.926 -1.909 . . . . 0.0 106.865 179.435 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.432 ' N ' ' O ' ' A' ' 107' ' ' GLU . 6.1 m -65.8 -20.85 66.4 Favored 'General case' 0 N--CA 1.439 -0.992 0 C-N-CA 125.426 1.491 . . . . 0.0 109.605 -179.462 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 123.01 97.8 1.35 Allowed Glycine 0 C--O 1.218 -0.845 0 C-N-CA 129.907 3.622 . . . . 0.0 110.387 -179.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . 0.326 0.8 OUTLIER 90.49 -27.27 0.05 OUTLIER 'General case' 0 C--N 1.308 -1.199 0 O-C-N 128.235 2.962 . . . . 0.0 109.944 -179.068 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -115.51 124.15 50.35 Favored 'General case' 0 C--N 1.361 1.072 0 CA-C-O 117.014 -1.469 . . . . 0.0 110.986 179.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 30.2 tp -96.82 116.85 29.87 Favored 'General case' 0 C--O 1.217 -0.627 0 N-CA-C 104.593 -2.373 . . . . 0.0 104.593 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.489 ' CD1' HG22 ' A' ' 127' ' ' ILE 0.27 2.9 mm -102.58 128.44 55.34 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 O-C-N 128.047 3.342 . . . . 0.0 104.417 -179.929 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -111.31 79.77 1.24 Allowed 'General case' 0 CA--C 1.494 -1.174 0 CA-C-O 124.041 1.877 . . . . 0.0 106.027 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -73.13 115.0 11.93 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 104.633 -2.358 . . . . 0.0 104.633 179.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . 0.463 ' CD1' ' HB3' ' A' ' 104' ' ' ALA 0.262 78.5 m-85 -106.53 145.71 31.52 Favored 'General case' 0 C--O 1.207 -1.168 0 O-C-N 126.818 2.574 . . . . 0.0 113.269 -179.562 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . 0.289 0.8 OUTLIER -141.2 126.48 18.59 Favored 'General case' 0 N--CA 1.446 -0.633 1 O-C-N 130.594 4.934 . . . . 0.0 108.439 179.577 . . . . . . . . 4 3 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.496 ' CD1' HD13 ' A' ' 102' ' ' LEU 0.277 22.4 t80 -101.07 -0.13 36.87 Favored 'General case' 0 C--O 1.245 0.851 0 CA-C-N 119.818 1.19 . . . . 0.0 107.835 -179.71 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 171.98 -79.95 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.543 0 O-C-N 126.211 2.194 . . . . 0.0 115.863 -179.527 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -130.47 30.47 3.44 Favored Glycine 0 C--N 1.353 1.513 0 N-CA-C 118.838 2.295 . . . . 0.0 118.838 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 54.9 t -145.65 113.88 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 103.972 -2.603 . . . . 0.0 103.972 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -83.51 -178.89 7.2 Favored 'General case' 0 C--O 1.21 -0.985 0 CA-C-O 124.727 2.203 . . . . 0.0 112.533 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.435 ' HB3' ' CB ' ' A' ' 17' ' ' PHE . . . -167.34 85.48 0.24 Allowed 'General case' 0 C--O 1.216 -0.687 0 CA-C-O 114.223 -2.799 . . . . 0.0 108.501 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.01 128.27 36.1 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 121.256 1.844 . . . . 0.0 109.631 -179.647 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.21 82.2 1.83 Allowed 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 125.959 1.704 . . . . 0.0 107.232 -179.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.489 HG22 ' CD1' ' A' ' 114' ' ' ILE . 2.1 mt -78.9 117.68 24.9 Favored 'Isoleucine or valine' 0 C--O 1.245 0.837 0 O-C-N 127.426 2.954 . . . . 0.0 116.448 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.461 ' CD2' ' HB3' ' A' ' 6' ' ' TRP . 1.3 m-30 -94.55 166.42 12.04 Favored 'General case' 0 N--CA 1.432 -1.347 0 O-C-N 128.102 3.376 . . . . 0.0 107.926 -179.725 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . 0.258 8.5 mmtt -119.44 -4.17 10.4 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 119.573 -0.251 . . . . 0.0 111.235 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.532 ' HG3' ' CZ3' ' A' ' 6' ' ' TRP . 4.2 tttp 73.28 116.18 0.05 Allowed 'General case' 0 C--O 1.215 -0.72 0 CA-C-O 115.765 -2.064 . . . . 0.0 108.024 -179.533 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . 0.797 3.4 mm-40 . . . . . 0 N--CA 1.424 -1.758 0 O-C-N 126.83 2.581 . . . . 0.0 115.126 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.435 -1.207 0 CA-C-O 121.493 0.663 . . . . 0.0 112.743 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -160.0 88.16 0.82 Allowed 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 112.513 -2.131 . . . . 0.0 111.878 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 153.07 -163.25 30.47 Favored Glycine 0 CA--C 1.495 -1.158 0 C-N-CA 115.635 -3.174 . . . . 0.0 109.168 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . 0.49 22.0 m -97.18 161.42 13.82 Favored 'General case' 0 C--N 1.314 -0.954 0 O-C-N 126.281 1.812 . . . . 0.0 110.503 -179.658 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.447 ' CH2' ' HD2' ' A' ' 130' ' ' LYS . 87.9 m95 -139.75 156.67 46.65 Favored 'General case' 0 N--CA 1.434 -1.249 0 CA-C-N 112.665 -2.062 . . . . 0.0 106.72 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 24.0 tttt -159.92 90.97 0.94 Allowed 'General case' 0 C--O 1.203 -1.346 0 O-C-N 126.283 2.239 . . . . 0.0 107.217 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.497 ' HB ' ' CD1' ' A' ' 128' ' ' PHE 0.315 0.1 OUTLIER -37.65 127.4 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 O-C-N 126.634 2.458 . . . . 0.0 112.063 179.957 . . . . . . . . 4 4 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.433 ' HB2' ' CG ' ' A' ' 129' ' ' LYS . 40.1 t0 -100.0 -32.38 10.98 Favored 'General case' 0 C--O 1.208 -1.092 0 O-C-N 126.793 2.558 . . . . 0.0 105.293 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 5.7 ptp180 -170.73 153.69 4.14 Favored 'General case' 0 C--N 1.296 -1.748 0 C-N-CA 115.846 -2.342 . . . . 0.0 109.189 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . 0.293 0.0 OUTLIER -106.77 -171.38 1.88 Allowed 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 111.297 -2.683 . . . . 0.0 107.675 179.514 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.471 ' CB ' ' HB2' ' A' ' 125' ' ' LYS . 4.1 tm-20 -131.67 -71.68 0.55 Allowed 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 117.468 -1.693 . . . . 0.0 108.293 179.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 23.5 t30 -113.43 28.41 8.8 Favored 'General case' 0 N--CA 1.474 0.774 0 O-C-N 125.246 1.591 . . . . 0.0 113.197 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.443 ' CA ' ' HB2' ' A' ' 124' ' ' ALA 0.347 0.2 OUTLIER -72.49 -19.79 61.48 Favored 'General case' 0 C--N 1.312 -1.037 0 O-C-N 128.416 3.572 . . . . 0.0 115.421 179.994 . . . . . . . . 4 4 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -76.85 -30.7 56.4 Favored 'General case' 0 C--O 1.218 -0.588 0 CA-C-N 120.984 1.72 . . . . 0.0 108.683 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -79.83 -32.32 40.59 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 111.529 -2.578 . . . . 0.0 114.286 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.553 ' CE2' ' HA ' ' A' ' 118' ' ' THR . 0.0 OUTLIER -70.78 -37.63 73.35 Favored 'General case' 0 C--O 1.217 -0.625 0 CA-C-O 123.889 1.804 . . . . 0.0 108.466 179.87 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 3.3 mtm -75.21 -22.47 57.92 Favored 'General case' 0 N--CA 1.432 -1.334 0 CA-C-O 123.263 1.506 . . . . 0.0 109.617 -179.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.26 -31.58 58.39 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 126.229 2.919 . . . . 0.0 111.143 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 5.4 tptp -67.83 -29.59 68.78 Favored 'General case' 0 C--O 1.209 -1.065 0 O-C-N 119.431 -2.043 . . . . 0.0 112.846 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.424 ' HA ' ' CE2' ' A' ' 119' ' ' TYR . 56.7 mtp -79.38 -30.41 42.52 Favored 'General case' 0 C--N 1.346 0.452 0 N-CA-C 105.325 -2.102 . . . . 0.0 105.325 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 101.89 34.23 4.4 Favored Glycine 0 C--N 1.31 -0.871 0 CA-C-O 117.948 -1.474 . . . . 0.0 110.211 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.415 ' CG2' ' HB2' ' A' ' 27' ' ' LYS . 1.5 mm -67.73 135.74 27.92 Favored 'Isoleucine or valine' 0 C--N 1.361 1.102 0 CA-C-O 116.426 -1.749 . . . . 0.0 108.313 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 38.0 m-20 -74.95 147.82 40.55 Favored 'General case' 0 C--O 1.244 0.788 0 CA-C-O 115.255 -2.307 . . . . 0.0 113.555 179.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . 0.372 1.5 t -20.87 -57.3 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.508 -0.645 0 O-C-N 127.365 2.915 . . . . 0.0 117.819 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.547 1.9 m -73.67 -36.95 48.27 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.814 0 O-C-N 125.233 1.583 . . . . 0.0 112.073 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.415 ' HB2' ' CG2' ' A' ' 23' ' ' ILE . 6.7 mttm -63.69 -42.69 97.96 Favored 'General case' 0 CA--C 1.51 -0.57 0 O-C-N 125.057 1.473 . . . . 0.0 114.487 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.402 ' N ' HG21 ' A' ' 23' ' ' ILE . 23.3 ptt85 -78.93 -23.68 44.52 Favored 'General case' 0 C--O 1.217 -0.638 0 CA-C-N 121.413 1.915 . . . . 0.0 108.464 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.9 ttpm? -76.09 -37.96 57.55 Favored 'General case' 0 N--CA 1.437 -1.096 0 CA-C-N 114.23 -1.35 . . . . 0.0 112.666 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.519 HD23 ' CE1' ' A' ' 33' ' ' HIS . 0.2 OUTLIER -77.05 -31.57 56.3 Favored 'General case' 0 N--CA 1.432 -1.327 0 CA-C-O 114.31 -2.757 . . . . 0.0 107.101 179.756 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -75.23 -21.53 77.75 Favored Glycine 0 CA--C 1.534 1.225 0 O-C-N 128.129 3.393 . . . . 0.0 114.425 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -78.37 -32.11 48.82 Favored 'General case' 0 C--N 1.314 -0.935 0 O-C-N 127.28 2.4 . . . . 0.0 110.898 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.519 ' CE1' HD23 ' A' ' 30' ' ' LEU . 6.7 p-80 -120.38 1.47 10.72 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 114.665 -1.152 . . . . 0.0 113.596 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 18.0 p30 -42.01 -19.92 0.01 OUTLIER 'General case' 0 CA--C 1.495 -1.156 0 N-CA-C 116.035 1.865 . . . . 0.0 116.035 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . 0.286 70.3 m-80 75.07 31.32 0.84 Allowed 'General case' 0 C--N 1.311 -1.092 0 CA-C-O 115.635 -2.126 . . . . 0.0 109.198 179.668 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.475 ' CG ' HD11 ' A' ' 38' ' ' LEU . 0.3 OUTLIER -45.64 103.48 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.964 0 O-C-N 127.559 3.037 . . . . 0.0 107.179 179.971 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 30.9 tttp -96.79 112.13 24.01 Favored 'General case' 0 C--O 1.219 -0.517 0 N-CA-C 102.067 -3.309 . . . . 0.0 102.067 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.528 HD21 ' CE2' ' A' ' 128' ' ' PHE 0.279 1.0 OUTLIER -103.6 112.12 24.89 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 121.399 1.909 . . . . 0.0 110.577 -179.947 . . . . . . . . 4 4 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.46 ' HB ' ' CB ' ' A' ' 50' ' ' LYS . 38.6 m -89.85 92.25 8.95 Favored 'General case' 0 N--CA 1.448 -0.557 0 O-C-N 118.003 -2.936 . . . . 0.0 106.675 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 5.3 mt -75.58 125.09 34.81 Favored 'Isoleucine or valine' 0 C--O 1.253 1.264 0 O-C-N 124.318 1.011 . . . . 0.0 111.016 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 53.2 m -128.3 95.16 4.08 Favored 'General case' 0 C--O 1.221 -0.445 0 O-C-N 127.037 2.711 . . . . 0.0 108.866 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -85.61 128.41 34.76 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-O 116.741 -1.599 . . . . 0.0 112.392 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -139.33 91.89 2.54 Favored 'General case' 0 N--CA 1.426 -1.671 0 CA-C-N 120.919 1.69 . . . . 0.0 110.589 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 50.0 68.07 1.56 Allowed Glycine 0 C--N 1.292 -1.881 0 O-C-N 126.013 2.071 . . . . 0.0 110.383 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.315 0.4 OUTLIER 83.4 -26.42 0.12 Allowed 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 114.258 1.207 . . . . 0.0 114.258 179.8 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 21.5 ttpt -87.25 143.03 27.47 Favored 'General case' 0 C--N 1.312 -1.05 0 C-N-CA 117.014 -1.875 . . . . 0.0 108.411 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -124.02 101.2 7.11 Favored 'General case' 0 C--N 1.34 0.18 0 O-C-N 124.844 1.34 . . . . 0.0 111.077 179.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.475 ' HB ' ' CG1' ' A' ' 61' ' ' VAL 0.432 0.1 OUTLIER -83.19 82.93 8.05 Favored 'General case' 0 N--CA 1.441 -0.899 0 O-C-N 125.774 1.921 . . . . 0.0 110.281 179.909 . . . . . . . . 4 4 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.505 HG13 ' CH2' ' A' ' 82' ' ' TRP 0.692 0.3 OUTLIER -62.96 89.12 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.493 -1.231 0 CA-C-N 110.687 -2.96 . . . . 0.0 115.788 179.971 . . . . . . . . 4 4 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.46 ' CB ' ' HB ' ' A' ' 39' ' ' THR . 1.7 tttm -63.83 146.29 54.23 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 100.672 -3.825 . . . . 0.0 100.672 179.468 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -144.15 75.0 1.44 Allowed 'General case' 0 C--O 1.215 -0.739 0 CA-C-N 120.582 1.537 . . . . 0.0 109.378 -179.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 51.4 m -77.4 73.2 3.97 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 105.454 -2.054 . . . . 0.0 105.454 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.403 ' HA ' ' HA ' ' A' ' 36' ' ' LEU . 5.8 p -93.19 39.5 1.05 Allowed 'General case' 0 CA--C 1.505 -0.77 0 C-N-CA 117.809 -1.556 . . . . 0.0 111.868 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.403 ' OD1' ' N ' ' A' ' 55' ' ' PHE . 0.1 OUTLIER 72.16 -52.43 0.7 Allowed 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 115.242 -2.313 . . . . 0.0 108.509 -179.915 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.411 ' CB ' ' HD2' ' A' ' 56' ' ' ARG . 81.5 m-85 -57.5 -73.89 0.06 Allowed 'General case' 0 C--O 1.22 -0.492 0 CA-C-N 122.311 2.323 . . . . 0.0 109.403 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.411 ' HD2' ' CB ' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -136.59 146.19 45.8 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 120.472 1.487 . . . . 0.0 110.631 179.847 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -95.57 80.58 3.46 Favored 'General case' 0 C--N 1.352 0.697 0 N-CA-C 101.214 -3.625 . . . . 0.0 101.214 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.0 tp -110.71 117.67 55.46 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 O-C-N 127.827 3.205 . . . . 0.0 118.826 -179.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.75 119.6 12.73 Favored 'General case' 0 C--O 1.217 -0.643 0 N-CA-C 104.211 -2.514 . . . . 0.0 104.211 178.305 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.58 ' CG1' ' CE2' ' A' ' 62' ' ' PHE . 42.8 t -97.27 69.49 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 CA-C-O 122.163 0.982 . . . . 0.0 110.828 -178.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.475 ' CG1' ' HB ' ' A' ' 48' ' ' THR 0.404 0.7 OUTLIER -64.02 111.86 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 C-N-CA 118.028 -1.469 . . . . 0.0 113.138 -179.795 . . . . . . . . 4 4 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.606 ' CE2' ' CE2' ' A' ' 68' ' ' PHE . 11.5 m-30 -136.99 97.25 3.46 Favored 'General case' 0 N--CA 1.431 -1.386 0 O-C-N 119.122 -2.236 . . . . 0.0 108.665 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -63.57 138.79 58.64 Favored 'General case' 0 C--O 1.246 0.886 0 N-CA-C 105.003 -2.221 . . . . 0.0 105.003 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -60.54 134.92 57.55 Favored 'General case' 0 C--O 1.252 1.2 0 N-CA-C 105.354 -2.091 . . . . 0.0 105.354 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 75.19 2.96 68.19 Favored Glycine 0 C--N 1.341 0.832 0 C-N-CA 127.892 2.663 . . . . 0.0 114.896 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . 0.39 2.1 t -89.64 83.63 2.18 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 N-CA-C 105.189 -2.152 . . . . 0.0 105.189 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -52.77 95.81 0.01 OUTLIER 'General case' 0 CA--C 1.479 -1.756 0 N-CA-C 115.579 1.696 . . . . 0.0 115.579 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.606 ' CE2' ' CE2' ' A' ' 62' ' ' PHE . 13.2 p90 -89.94 178.07 6.31 Favored 'General case' 0 C--N 1.309 -1.153 0 O-C-N 120.438 -1.414 . . . . 0.0 110.109 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -123.95 136.27 54.21 Favored 'General case' 0 C--O 1.244 0.777 0 O-C-N 127.269 2.856 . . . . 0.0 105.441 179.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -156.04 113.87 3.31 Favored 'General case' 0 C--O 1.21 -0.98 0 C-N-CA 118.002 -1.479 . . . . 0.0 114.37 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 9.0 p -67.0 176.5 2.08 Favored 'General case' 0 C--N 1.314 -0.97 0 O-C-N 119.617 -1.927 . . . . 0.0 107.183 179.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.46 ' CD2' HD21 ' A' ' 78' ' ' LEU . 2.9 mt -119.04 -154.5 0.57 Allowed 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 116.345 -1.788 . . . . 0.0 109.339 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -118.5 12.07 13.12 Favored 'General case' 0 N--CA 1.436 -1.165 0 O-C-N 125.627 1.829 . . . . 0.0 113.224 179.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -143.68 -49.41 0.3 Allowed 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 120.541 -0.464 . . . . 0.0 112.178 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -107.96 -9.81 27.49 Favored Glycine 0 CA--C 1.541 1.662 0 N-CA-C 117.192 1.637 . . . . 0.0 117.192 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . 0.412 0.0 OUTLIER 71.58 153.46 0.13 Allowed 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 122.004 2.902 . . . . 0.0 115.257 179.684 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.484 ' HB3' ' CG2' ' A' ' 96' ' ' VAL . 30.9 mt-10 48.76 154.5 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.676 1 O-C-N 129.885 4.491 . . . . 0.0 117.145 179.536 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.46 HD21 ' CD2' ' A' ' 72' ' ' LEU 0.401 11.9 tp 177.15 152.47 0.21 Allowed 'General case' 0 CA--C 1.51 -0.584 0 CA-C-N 110.949 -2.841 . . . . 0.0 107.016 -179.819 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 10.9 m -161.56 119.04 2.25 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 103.297 -2.853 . . . . 0.0 103.297 -179.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.408 ' HA3' ' HA ' ' A' ' 93' ' ' PHE . . . -165.13 -162.59 16.55 Favored Glycine 0 C--N 1.303 -1.256 0 C-N-CA 116.932 -2.556 . . . . 0.0 111.193 -179.647 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 17.4 p -145.21 164.36 31.58 Favored 'General case' 0 C--O 1.193 -1.915 0 C-N-CA 119.112 -1.035 . . . . 0.0 111.531 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . 0.505 ' CH2' HG13 ' A' ' 49' ' ' VAL 0.302 11.8 m0 -106.46 151.72 24.58 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 100.68 -3.822 . . . . 0.0 100.68 179.924 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.401 HG21 HG22 ' A' ' 90' ' ' VAL . 2.4 t -150.96 141.11 22.19 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-O 122.587 1.184 . . . . 0.0 111.766 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 6.9 ttp -91.41 110.36 21.66 Favored 'General case' 0 N--CA 1.429 -1.519 0 CA-C-N 113.037 -1.892 . . . . 0.0 109.705 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . 0.634 10.2 mt-10 -87.58 -133.43 0.08 Allowed 'General case' 0 N--CA 1.434 -1.265 0 O-C-N 124.315 1.009 . . . . 0.0 110.391 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -87.34 92.71 1.83 Allowed Glycine 0 C--N 1.336 0.531 0 N-CA-C 103.207 -3.957 . . . . 0.0 103.207 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 53.68 10.46 0.24 Allowed 'General case' 0 C--O 1.24 0.602 0 N-CA-C 118.059 2.614 . . . . 0.0 118.059 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . 0.335 0.0 OUTLIER -133.58 135.13 44.09 Favored 'General case' 0 CA--C 1.501 -0.933 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 -179.975 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -88.31 134.6 33.77 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 103.953 -2.61 . . . . 0.0 103.953 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.401 HG22 HG21 ' A' ' 83' ' ' THR . 0.0 OUTLIER -113.54 -172.77 0.54 Allowed 'Isoleucine or valine' 0 C--O 1.246 0.88 0 C-N-CA 119.218 -0.993 . . . . 0.0 108.5 179.924 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -164.69 109.11 0.35 Allowed Glycine 0 C--N 1.35 1.335 0 C-N-CA 126.767 2.127 . . . . 0.0 111.696 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 4.7 mmmt -112.33 135.79 52.59 Favored 'General case' 0 N--CA 1.426 -1.636 0 N-CA-C 106.511 -1.662 . . . . 0.0 106.511 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.443 ' HB3' ' HG ' ' A' ' 78' ' ' LEU . 39.2 m-85 -137.57 115.9 11.87 Favored 'General case' 0 CA--C 1.504 -0.806 0 O-C-N 126.306 2.254 . . . . 0.0 113.034 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.4 mtmt -99.58 138.89 36.04 Favored 'General case' 0 N--CA 1.436 -1.157 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . 0.369 0.0 OUTLIER -74.29 174.51 8.7 Favored 'General case' 0 N--CA 1.428 -1.526 0 N-CA-C 105.647 -1.983 . . . . 0.0 105.647 179.819 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.484 ' CG2' ' HB3' ' A' ' 77' ' ' GLU 0.258 2.7 t -86.35 -61.69 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 O-C-N 126.702 2.501 . . . . 0.0 110.862 179.606 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . 0.398 0.6 OUTLIER -57.88 -29.17 64.82 Favored 'General case' 0 C--O 1.26 1.609 0 N-CA-C 118.46 2.763 . . . . 0.0 118.46 -179.926 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -131.24 -4.92 3.85 Favored 'General case' 0 N--CA 1.425 -1.712 0 N-CA-C 116.435 2.013 . . . . 0.0 116.435 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 49.56 42.73 35.71 Favored Glycine 0 C--N 1.348 1.198 0 C-N-CA 118.953 -1.594 . . . . 0.0 114.658 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 26.1 mmtm -71.41 -103.25 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.339 0 CA-C-O 115.835 -2.031 . . . . 0.0 111.226 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 158.92 136.11 0.0 OUTLIER 'General case' 0 N--CA 1.433 -1.308 0 C-N-CA 131.197 3.799 . . . . 0.0 110.191 179.692 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.467 ' HG ' ' HA ' ' A' ' 119' ' ' TYR . 7.2 tt -125.13 111.19 15.03 Favored 'General case' 0 C--N 1.316 -0.868 1 C-N-CA 133.764 4.826 . . . . 0.0 102.744 178.947 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.488 ' N ' ' O ' ' A' ' 118' ' ' THR . 0.1 OUTLIER -101.31 160.72 3.79 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.185 0 C-N-CA 115.472 -2.491 . . . . 0.0 106.975 -179.222 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.405 ' N ' HG13 ' A' ' 103' ' ' ILE . . . -157.8 131.95 8.17 Favored 'General case' 0 C--N 1.322 -0.604 0 O-C-N 118.729 -2.482 . . . . 0.0 112.471 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.549 ' HB ' ' CE2' ' A' ' 117' ' ' TYR . 5.6 p -120.56 118.33 56.2 Favored 'Isoleucine or valine' 0 C--O 1.252 1.226 0 CA-C-N 122.452 2.387 . . . . 0.0 108.915 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.414 ' NH1' ' HG3' ' A' ' 106' ' ' ARG . 9.6 mtt85 -86.34 88.12 7.56 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 105.301 -2.111 . . . . 0.0 105.301 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -91.36 85.6 5.85 Favored 'General case' 0 N--CA 1.429 -1.513 0 CA-C-N 113.023 -1.899 . . . . 0.0 114.458 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.438 HG13 ' CA ' ' A' ' 113' ' ' LEU 0.388 4.9 tt -65.27 92.12 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 C-N-CA 113.95 -3.1 . . . . 0.0 115.191 -179.927 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 38.9 t -76.54 77.53 3.23 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 102.929 -2.989 . . . . 0.0 102.929 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 62.4 -98.02 0.19 Allowed Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 127.162 2.315 . . . . 0.0 114.715 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . 0.325 7.0 m-20 -86.42 -0.9 56.96 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 114.726 -2.559 . . . . 0.0 110.717 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 6.3 mp0 -124.42 123.49 40.27 Favored 'General case' 0 C--O 1.205 -1.253 0 O-C-N 126.285 2.241 . . . . 0.0 112.451 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.454 HD23 ' CD2' ' A' ' 128' ' ' PHE . 10.0 tt -93.02 133.29 36.32 Favored 'General case' 0 C--O 1.222 -0.375 0 N-CA-C 101.286 -3.598 . . . . 0.0 101.286 -179.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.453 ' CG2' HG23 ' A' ' 116' ' ' THR 0.285 47.5 mt -138.03 120.85 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.301 0 O-C-N 125.976 2.048 . . . . 0.0 108.976 -179.79 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . 0.481 ' HB2' ' CD ' ' A' ' 126' ' ' ARG . 72.6 mt-30 -91.74 150.04 21.31 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 101.772 -3.418 . . . . 0.0 101.772 -179.511 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.453 HG23 ' CG2' ' A' ' 114' ' ' ILE . 0.1 OUTLIER -166.15 148.68 7.1 Favored 'General case' 0 N--CA 1.414 -2.244 0 O-C-N 128.389 3.556 . . . . 0.0 111.181 -179.236 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . 0.549 ' CE2' ' HB ' ' A' ' 105' ' ' VAL 0.382 23.3 m-85 132.1 -142.86 0.0 OUTLIER 'General case' 0 CA--C 1.478 -1.793 0 O-C-N 128.682 3.739 . . . . 0.0 113.312 177.31 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.553 ' HA ' ' CE2' ' A' ' 17' ' ' PHE . 13.4 t -136.62 -173.66 3.49 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-O 127.165 3.364 . . . . 0.0 117.218 -174.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.467 ' HA ' ' HG ' ' A' ' 102' ' ' LEU 0.276 2.2 t80 -112.16 -15.99 13.11 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 112.56 -2.109 . . . . 0.0 109.055 177.644 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.452 ' HB2' ' CD2' ' A' ' 119' ' ' TYR . 0.4 OUTLIER -153.71 -71.17 0.14 Allowed 'General case' 0 C--N 1.298 -1.641 0 O-C-N 119.64 -1.912 . . . . 0.0 109.492 -179.916 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -160.51 34.1 0.42 Allowed Glycine 0 C--N 1.363 2.049 0 N-CA-C 120.59 2.996 . . . . 0.0 120.59 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 90.2 t -139.57 103.54 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.193 0 N-CA-C 103.476 -2.786 . . . . 0.0 103.476 179.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 6.6 mp0 -68.47 177.63 2.33 Favored 'General case' 0 CA--C 1.503 -0.852 0 CA-C-O 123.778 1.751 . . . . 0.0 113.264 -178.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.443 ' HB2' ' CA ' ' A' ' 14' ' ' TYR . . . -167.77 176.74 6.15 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-O 114.379 -2.724 . . . . 0.0 104.906 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.471 ' HB2' ' CB ' ' A' ' 12' ' ' GLU 0.328 2.8 mptp? -145.3 156.17 43.65 Favored 'General case' 0 CA--C 1.506 -0.732 0 O-C-N 127.55 3.031 . . . . 0.0 107.818 -179.68 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.481 ' CD ' ' HB2' ' A' ' 115' ' ' GLN . 0.0 OUTLIER -142.13 76.15 1.52 Allowed 'General case' 0 N--CA 1.432 -1.361 0 CA-C-N 112.556 -2.111 . . . . 0.0 110.411 179.753 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 6.7 mm -63.8 116.33 3.34 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 O-C-N 126.313 2.258 . . . . 0.0 115.209 179.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.528 ' CE2' HD21 ' A' ' 38' ' ' LEU . 2.7 m-30 -109.24 125.93 52.78 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 126.011 1.724 . . . . 0.0 107.57 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.433 ' CG ' ' HB2' ' A' ' 9' ' ' ASP 0.279 14.8 mmmt -91.16 3.22 55.35 Favored 'General case' 0 N--CA 1.441 -0.897 0 O-C-N 119.961 -1.712 . . . . 0.0 112.213 -179.649 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.447 ' HD2' ' CH2' ' A' ' 6' ' ' TRP . 4.3 tttp 74.14 143.26 0.07 Allowed 'General case' 0 C--N 1.349 0.561 0 O-C-N 124.501 1.126 . . . . 0.0 108.763 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . 0.835 1.0 OUTLIER . . . . . 0 N--CA 1.431 -1.419 0 N-CA-C 115.401 1.63 . . . . 0.0 115.401 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.428 -1.534 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -156.94 88.41 1.03 Allowed 'General case' 0 N--CA 1.44 -0.94 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.904 179.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . 0.4 ' O ' ' N ' ' A' ' 40' ' ' ILE . . . 160.09 -130.72 2.48 Favored Glycine 0 CA--C 1.5 -0.86 0 C-N-CA 117.017 -2.516 . . . . 0.0 109.373 -179.789 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.403 HG22 ' HA ' ' A' ' 131' ' ' GLU 0.499 5.3 t -117.73 171.11 8.26 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 123.197 1.475 . . . . 0.0 114.123 -179.958 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.527 ' CZ3' ' HB2' ' A' ' 130' ' ' LYS . 80.3 m95 -152.13 147.61 26.65 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-N 110.227 -3.17 . . . . 0.0 105.816 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 4.8 ttmm -139.61 122.19 16.27 Favored 'General case' 0 C--O 1.205 -1.246 0 O-C-N 127.767 3.167 . . . . 0.0 105.514 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.517 ' HB ' ' CD1' ' A' ' 128' ' ' PHE 0.379 8.0 p -69.02 139.21 20.85 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.022 0 CA-C-N 121.143 1.792 . . . . 0.0 110.773 179.996 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -129.39 -46.82 1.19 Allowed 'General case' 0 C--O 1.212 -0.91 0 O-C-N 127.387 2.929 . . . . 0.0 106.373 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.421 ' O ' ' N ' ' A' ' 127' ' ' ILE . 9.2 ttt180 -129.21 144.85 51.37 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 106.962 -1.495 . . . . 0.0 106.962 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.409 ' N ' ' HG3' ' A' ' 10' ' ' ARG 0.385 97.7 m-20 -131.59 -171.12 2.53 Favored 'General case' 0 CA--C 1.501 -0.936 0 O-C-N 128.604 3.69 . . . . 0.0 107.886 179.956 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -146.43 -85.69 0.11 Allowed 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 122.595 2.452 . . . . 0.0 110.897 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.424 ' HB3' ' HA ' ' A' ' 124' ' ' ALA . 2.8 t30 -90.64 16.74 8.55 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-N 121.342 1.883 . . . . 0.0 114.154 179.445 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.517 ' CD2' ' HG2' ' A' ' 126' ' ' ARG 0.283 0.2 OUTLIER -63.98 -20.98 66.29 Favored 'General case' 0 C--O 1.242 0.665 0 O-C-N 127.595 3.06 . . . . 0.0 115.11 179.858 . . . . . . . . 4 4 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -76.19 -36.91 58.43 Favored 'General case' 0 C--O 1.205 -1.261 0 O-C-N 118.909 -2.369 . . . . 0.0 108.186 179.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.408 ' HB3' ' ND2' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -77.3 -33.76 55.62 Favored 'General case' 0 N--CA 1.435 -1.189 0 CA-C-N 112.855 -1.975 . . . . 0.0 113.194 179.981 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -70.27 -21.44 62.97 Favored 'General case' 0 N--CA 1.438 -1.046 0 O-C-N 118.798 -2.439 . . . . 0.0 109.666 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.433 ' CB ' HG13 ' A' ' 23' ' ' ILE . 4.8 mtt -76.86 -35.19 57.65 Favored 'General case' 0 CA--C 1.503 -0.852 0 CA-C-O 125.868 2.747 . . . . 0.0 107.268 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -70.79 -29.62 65.87 Favored 'General case' 0 C--O 1.244 0.771 0 CA-C-O 127.295 3.426 . . . . 0.0 112.007 179.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 42.3 tptt -80.07 -27.78 39.28 Favored 'General case' 0 N--CA 1.437 -1.118 0 O-C-N 119.252 -2.155 . . . . 0.0 110.383 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 17.8 mtp -71.5 -30.88 66.47 Favored 'General case' 0 C--O 1.202 -1.436 0 O-C-N 119.554 -1.966 . . . . 0.0 106.669 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.31 32.52 2.75 Favored Glycine 0 C--N 1.306 -1.129 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.479 HG21 ' CB ' ' A' ' 27' ' ' LYS . 6.0 mm -78.33 -71.38 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.362 1.124 0 CA-C-O 115.561 -2.161 . . . . 0.0 106.901 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 66.53 152.17 0.07 Allowed 'General case' 0 N--CA 1.445 -0.716 0 O-C-N 126.777 2.548 . . . . 0.0 114.755 179.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . 0.4 2.6 t 50.18 -122.94 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.355 0.835 0 N-CA-C 120.268 3.432 . . . . 0.0 120.268 179.679 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.542 3.4 m -65.43 -36.86 78.68 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.037 0 N-CA-C 118.379 2.733 . . . . 0.0 118.379 -179.776 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.479 ' CB ' HG21 ' A' ' 23' ' ' ILE . 62.8 mttm -60.93 -25.89 67.1 Favored 'General case' 0 N--CA 1.438 -1.067 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 4.7 mtm-85 -78.08 -31.26 50.04 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 117.435 -1.706 . . . . 0.0 108.178 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 8.1 tptm -71.36 -45.85 61.89 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 114.02 -1.446 . . . . 0.0 111.798 179.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 12.2 mt -78.02 -29.2 49.36 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 -179.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.16 -36.07 60.43 Favored Glycine 0 C--N 1.338 0.641 0 CA-C-O 123.089 1.383 . . . . 0.0 111.681 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -75.63 -22.84 56.45 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-O 116.738 -1.601 . . . . 0.0 112.946 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 18.0 t60 -120.78 46.2 2.07 Favored 'General case' 0 N--CA 1.447 -0.615 0 O-C-N 128.829 3.831 . . . . 0.0 114.125 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -72.05 -19.19 61.87 Favored 'General case' 0 C--O 1.21 -0.991 0 O-C-N 128.544 3.653 . . . . 0.0 117.703 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . 0.255 2.0 t-20 65.93 38.99 4.73 Favored 'General case' 0 C--N 1.312 -1.037 0 C-N-CA 118.593 -1.243 . . . . 0.0 109.454 -179.314 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.435 HD22 ' N ' ' A' ' 38' ' ' LEU . 3.0 tt -61.2 137.29 58.24 Favored 'General case' 0 C--O 1.216 -0.698 0 O-C-N 125.632 1.833 . . . . 0.0 112.847 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.3 ttpt -139.2 100.83 4.11 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 101.55 -3.5 . . . . 0.0 101.55 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.435 ' N ' HD22 ' A' ' 36' ' ' LEU 0.277 0.4 OUTLIER -93.08 117.19 29.78 Favored 'General case' 0 C--N 1.293 -1.88 0 O-C-N 119.349 -2.095 . . . . 0.0 107.008 -179.578 . . . . . . . . 4 4 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.461 ' HB ' ' CB ' ' A' ' 50' ' ' LYS . 85.2 m -104.44 100.47 10.16 Favored 'General case' 0 N--CA 1.436 -1.135 0 N-CA-C 104.192 -2.522 . . . . 0.0 104.192 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.4 ' N ' ' O ' ' A' ' 4' ' ' GLY . 7.9 mt -71.29 149.86 9.56 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 179.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 89.3 m -142.71 63.44 1.39 Allowed 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 113.68 -1.6 . . . . 0.0 112.519 -179.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -62.35 119.85 9.88 Favored 'General case' 0 C--O 1.222 -0.362 0 O-C-N 125.228 1.58 . . . . 0.0 109.723 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -153.48 108.68 3.19 Favored 'General case' 0 CA--C 1.489 -1.392 0 CA-C-O 122.951 1.358 . . . . 0.0 110.079 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 61.35 31.73 78.32 Favored Glycine 0 C--N 1.306 -1.108 0 N-CA-C 108.888 -1.685 . . . . 0.0 108.888 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.31 0.2 OUTLIER 87.63 -14.05 0.44 Allowed 'General case' 0 C--O 1.225 -0.189 0 CA-C-N 112.978 -1.611 . . . . 0.0 110.856 179.728 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -80.09 121.1 25.12 Favored 'General case' 0 N--CA 1.428 -1.542 0 C-N-CA 116.333 -2.147 . . . . 0.0 110.094 -179.557 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.538 ' CD2' HD21 ' A' ' 64' ' ' LEU 0.311 0.4 OUTLIER -101.77 104.93 15.74 Favored 'General case' 0 C--O 1.217 -0.634 0 N-CA-C 105.985 -1.857 . . . . 0.0 105.985 179.963 . . . . . . . . 4 4 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . 0.432 1.6 t -105.29 73.2 1.02 Allowed 'General case' 0 C--N 1.313 -1.002 0 CA-C-O 125.542 2.591 . . . . 0.0 111.979 -179.596 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . 0.626 0.5 OUTLIER -52.37 94.47 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.425 -1.703 0 CA-C-N 108.704 -3.862 . . . . 0.0 112.636 -179.866 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.461 ' CB ' ' HB ' ' A' ' 39' ' ' THR . 5.1 ttmt -64.6 153.88 37.98 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 100.631 -3.84 . . . . 0.0 100.631 179.381 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -149.42 92.92 1.99 Allowed 'General case' 0 C--O 1.215 -0.733 0 N-CA-C 103.774 -2.676 . . . . 0.0 103.774 -179.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -88.06 77.88 8.29 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-O 125.025 2.345 . . . . 0.0 106.696 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -95.11 -176.51 3.84 Favored 'General case' 0 N--CA 1.439 -1.003 0 O-C-N 119.883 -1.761 . . . . 0.0 112.411 -179.401 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -65.21 -19.41 65.96 Favored 'General case' 0 N--CA 1.444 -0.772 0 O-C-N 126.681 2.488 . . . . 0.0 108.612 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.4 ' CD1' ' N ' ' A' ' 55' ' ' PHE . 6.1 m-85 -90.04 -56.52 3.19 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-O 115.22 -2.324 . . . . 0.0 115.165 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -155.62 168.58 26.69 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 123.833 3.015 . . . . 0.0 107.947 179.418 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -106.29 63.16 0.65 Allowed 'General case' 0 C--O 1.216 -0.696 2 N-CA-C 100.007 -4.071 . . . . 0.0 100.007 179.645 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 12.1 tt -91.95 97.8 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 O-C-N 127.99 3.306 . . . . 0.0 114.509 -179.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . 0.273 0.0 OUTLIER -62.88 125.9 25.54 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 104.935 -2.246 . . . . 0.0 104.935 179.136 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.52 HG13 ' CE2' ' A' ' 62' ' ' PHE . 2.5 t -105.2 85.38 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 C-N-CA 119.035 -1.066 . . . . 0.0 109.735 -178.641 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . 0.399 2.0 m -74.44 150.84 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.37 0 CA-C-O 125.865 2.745 . . . . 0.0 115.163 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.626 ' CZ ' ' CZ2' ' A' ' 82' ' ' TRP . 0.0 OUTLIER -168.21 95.65 0.4 Allowed 'General case' 0 N--CA 1.43 -1.473 0 CA-C-N 112.673 -2.058 . . . . 0.0 111.639 179.7 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.74 99.91 0.06 Allowed 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 102.477 -3.157 . . . . 0.0 102.477 179.572 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.538 HD21 ' CD2' ' A' ' 47' ' ' PHE . 0.2 OUTLIER -33.86 100.02 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 127.052 2.72 . . . . 0.0 112.683 -179.865 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 102.46 23.44 8.92 Favored Glycine 0 CA--C 1.528 0.881 0 O-C-N 128.453 3.596 . . . . 0.0 116.842 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.435 ' O ' ' CE2' ' A' ' 68' ' ' PHE 0.269 2.4 t -113.88 79.4 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.505 0 CA-C-O 115.184 -2.341 . . . . 0.0 105.301 -179.99 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . 0.278 23.5 m-20 -27.92 118.5 0.1 Allowed 'General case' 0 CA--C 1.498 -1.035 0 N-CA-C 115.682 1.734 . . . . 0.0 115.682 -179.806 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.571 ' CZ ' ' CB ' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -129.0 -173.57 3.02 Favored 'General case' 0 N--CA 1.442 -0.837 0 O-C-N 118.602 -2.561 . . . . 0.0 107.72 -179.922 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -128.84 138.15 51.88 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -138.85 95.17 2.92 Favored 'General case' 0 C--O 1.215 -0.727 0 C-N-CA 119.26 -0.976 . . . . 0.0 113.026 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -74.36 115.71 14.2 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 105.103 -2.184 . . . . 0.0 105.103 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 46.8 mt -71.16 -169.1 0.35 Allowed 'General case' 0 C--N 1.298 -1.637 0 CA-C-O 117.795 -1.098 . . . . 0.0 109.745 -179.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -85.26 -35.95 21.22 Favored 'General case' 0 C--O 1.214 -0.784 0 O-C-N 128.666 3.729 . . . . 0.0 113.332 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -143.17 21.88 1.9 Allowed 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 113.982 -1.463 . . . . 0.0 108.555 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -130.92 -15.42 1.72 Allowed Glycine 0 CA--C 1.544 1.851 0 CA-C-O 117.797 -1.557 . . . . 0.0 116.829 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER 64.7 -177.65 0.17 Allowed 'General case' 0 N--CA 1.433 -1.306 0 CA-C-N 119.994 1.897 . . . . 0.0 114.204 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.488 ' CB ' ' HB ' ' A' ' 96' ' ' VAL . 4.7 mp0 -26.94 119.71 0.09 Allowed 'General case' 0 CA--C 1.5 -0.958 1 O-C-N 129.626 4.329 . . . . 0.0 115.608 179.923 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.434 ' HG ' ' CD1' ' A' ' 93' ' ' PHE 0.433 0.9 OUTLIER -142.67 78.01 1.6 Allowed 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 101.9 -3.37 . . . . 0.0 101.9 179.997 . . . . . . . . 4 4 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 3.7 m -82.74 165.88 19.55 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 101.804 -3.406 . . . . 0.0 101.804 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 144.31 -170.65 25.99 Favored Glycine 0 CA--C 1.538 1.519 0 C-N-CA 119.345 -1.407 . . . . 0.0 112.336 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -146.38 171.32 15.19 Favored 'General case' 0 C--O 1.203 -1.364 0 C-N-CA 117.668 -1.613 . . . . 0.0 111.386 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . 0.626 ' CZ2' ' CZ ' ' A' ' 62' ' ' PHE 0.335 13.3 m0 -114.46 141.52 47.58 Favored 'General case' 0 N--CA 1.424 -1.771 0 N-CA-C 101.388 -3.56 . . . . 0.0 101.388 179.63 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.403 HG22 HG21 ' A' ' 90' ' ' VAL . 9.9 t -146.85 141.4 26.57 Favored 'General case' 0 N--CA 1.427 -1.581 0 O-C-N 124.261 0.975 . . . . 0.0 109.797 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 12.4 ttm -81.64 129.62 34.76 Favored 'General case' 0 CA--C 1.496 -1.133 0 C-N-CA 121.2 -0.2 . . . . 0.0 110.897 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . 0.597 3.7 pt-20 -122.51 54.75 1.19 Allowed 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 96.6 -127.82 9.32 Favored Glycine 0 N--CA 1.439 -1.111 0 O-C-N 126.008 2.067 . . . . 0.0 108.503 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -80.65 9.47 6.11 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 115.502 1.668 . . . . 0.0 115.502 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . 0.275 0.1 OUTLIER -132.49 172.8 12.02 Favored 'General case' 0 CA--C 1.503 -0.836 0 O-C-N 125.712 1.882 . . . . 0.0 106.667 179.623 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.487 HD22 ' CE2' ' A' ' 47' ' ' PHE . 2.6 tp -127.74 159.11 35.77 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 105.339 -2.097 . . . . 0.0 105.339 179.76 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.436 HG13 HG21 ' A' ' 105' ' ' VAL . 17.4 m -142.83 122.61 9.52 Favored 'Isoleucine or valine' 0 C--O 1.245 0.864 0 C-N-CA 116.09 -2.244 . . . . 0.0 110.107 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -92.64 97.49 2.27 Favored Glycine 0 C--N 1.35 1.338 0 N-CA-C 108.031 -2.028 . . . . 0.0 108.031 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.489 ' CG ' ' CD1' ' A' ' 103' ' ' ILE . 2.0 mttt -92.62 126.88 37.9 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 102.78 -3.045 . . . . 0.0 102.78 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.434 ' CD1' ' HG ' ' A' ' 78' ' ' LEU . 53.2 m-85 -127.96 110.74 12.83 Favored 'General case' 0 N--CA 1.444 -0.758 0 O-C-N 126.201 2.188 . . . . 0.0 112.621 -179.82 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -103.65 126.82 51.04 Favored 'General case' 0 N--CA 1.435 -1.203 0 N-CA-C 105.407 -2.071 . . . . 0.0 105.407 179.854 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . 0.433 3.3 mmm180 -81.64 156.49 25.08 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 127.227 2.829 . . . . 0.0 109.69 -179.778 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.488 ' HB ' ' CB ' ' A' ' 77' ' ' GLU . 3.3 t -78.4 -54.54 11.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 C-N-CA 124.552 1.141 . . . . 0.0 113.152 -179.682 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . 0.452 14.9 m-20 -68.53 -9.44 49.29 Favored 'General case' 0 C--O 1.254 1.311 0 N-CA-C 117.952 2.575 . . . . 0.0 117.952 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.401 ' ND2' ' HG3' ' A' ' 100' ' ' LYS . 19.5 p-10 -145.04 6.48 1.16 Allowed 'General case' 0 N--CA 1.438 -1.071 0 CA-C-O 115.328 -2.272 . . . . 0.0 114.069 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 39.98 40.64 1.76 Allowed Glycine 0 CA--C 1.542 1.773 0 O-C-N 125.285 1.616 . . . . 0.0 114.485 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.401 ' HG3' ' ND2' ' A' ' 98' ' ' ASN . 32.2 mmtm -78.18 -127.32 0.01 OUTLIER 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 114.14 -1.03 . . . . 0.0 109.293 -179.56 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 171.36 97.59 0.01 OUTLIER 'General case' 0 N--CA 1.433 -1.276 0 C-N-CA 130.019 3.327 . . . . 0.0 115.125 -179.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.562 ' CG ' ' HA ' ' A' ' 119' ' ' TYR . 0.3 OUTLIER -89.52 121.67 31.96 Favored 'General case' 0 N--CA 1.442 -0.875 2 C-N-CA 132.566 4.347 . . . . 0.0 103.871 178.863 . . . . . . . . 4 4 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.508 ' N ' ' O ' ' A' ' 118' ' ' THR . 4.6 tp -120.21 157.53 22.71 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.742 0 C-N-CA 115.844 -2.343 . . . . 0.0 105.864 179.276 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.451 ' HA ' ' HB2' ' A' ' 117' ' ' TYR . . . -141.33 136.69 31.77 Favored 'General case' 0 C--N 1.313 -1.001 0 O-C-N 118.557 -2.589 . . . . 0.0 108.16 -179.152 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.615 ' HB ' ' CD2' ' A' ' 117' ' ' TYR . 0.5 OUTLIER -125.63 104.56 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 CA-C-N 122.856 2.571 . . . . 0.0 112.837 -179.709 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.518 ' NH2' ' CZ2' ' A' ' 82' ' ' TRP . 4.9 mtt-85 -74.06 94.24 2.37 Favored 'General case' 0 C--N 1.307 -1.275 0 O-C-N 119.729 -1.857 . . . . 0.0 106.831 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -98.53 84.87 3.25 Favored 'General case' 0 N--CA 1.419 -2.002 0 O-C-N 126.058 2.099 . . . . 0.0 114.394 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.438 ' HA ' ' HA ' ' A' ' 113' ' ' LEU 0.38 0.1 OUTLIER -60.89 101.09 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 C-N-CA 116.403 -2.119 . . . . 0.0 108.503 179.897 . . . . . . . . 4 4 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 10.4 p -87.85 70.09 9.52 Favored 'General case' 0 CA--C 1.504 -0.79 0 N-CA-C 104.511 -2.404 . . . . 0.0 104.511 -179.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 76.99 -115.05 4.22 Favored Glycine 0 C--N 1.339 0.734 0 O-C-N 127.601 3.063 . . . . 0.0 111.677 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 48.8 m-20 -69.13 -25.24 64.29 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 120.014 1.907 . . . . 0.0 112.264 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.22 143.77 29.1 Favored 'General case' 0 CA--C 1.494 -1.19 0 CA-C-O 116.295 -1.812 . . . . 0.0 115.523 -179.592 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.491 ' HB2' ' CZ3' ' A' ' 6' ' ' TRP . 0.3 OUTLIER -104.79 146.12 29.42 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 100.741 -3.8 . . . . 0.0 100.741 179.979 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.474 ' CG2' HD11 ' A' ' 127' ' ' ILE 0.284 81.7 mt -149.26 110.74 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.171 0 CA-C-O 117.164 -1.398 . . . . 0.0 109.163 -179.904 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . 0.515 ' HB2' ' HD2' ' A' ' 126' ' ' ARG . 55.3 mt-30 -86.2 167.0 15.28 Favored 'General case' 0 C--N 1.345 0.378 0 N-CA-C 104.035 -2.58 . . . . 0.0 104.035 179.857 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.475 ' CG2' ' C ' ' A' ' 115' ' ' GLN . 5.0 p -159.75 -152.33 0.3 Allowed 'General case' 0 CA--C 1.494 -1.184 1 O-C-N 130.516 4.885 . . . . 0.0 106.501 -177.198 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . 0.615 ' CD2' ' HB ' ' A' ' 105' ' ' VAL . 8.7 m-30 76.88 -165.74 0.05 Allowed 'General case' 0 CA--C 1.46 -2.488 1 O-C-N 129.379 4.175 . . . . 0.0 114.309 175.144 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.508 ' O ' ' N ' ' A' ' 103' ' ' ILE . 6.9 t -138.87 -162.37 1.31 Allowed 'General case' 0 N--CA 1.437 -1.11 0 CA-C-O 127.384 3.469 . . . . 0.0 117.116 -174.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.562 ' HA ' ' CG ' ' A' ' 102' ' ' LEU . 1.6 t80 -111.57 -25.79 9.38 Favored 'General case' 0 C--N 1.348 0.525 0 CA-C-N 111.769 -2.469 . . . . 0.0 109.773 178.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.503 ' HB2' ' CD2' ' A' ' 119' ' ' TYR . 0.2 OUTLIER -153.23 -59.83 0.14 Allowed 'General case' 0 C--N 1.29 -2.004 0 C-N-CA 126.498 1.919 . . . . 0.0 110.017 -179.876 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -153.76 1.56 0.23 Allowed Glycine 0 C--N 1.362 1.988 0 N-CA-C 121.178 3.231 . . . . 0.0 121.178 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 37.0 t -110.39 98.91 7.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 O-C-N 117.49 -3.359 . . . . 0.0 104.915 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -64.87 -175.54 0.2 Allowed 'General case' 0 C--O 1.21 -0.984 0 O-C-N 120.001 -1.687 . . . . 0.0 112.435 -179.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.424 ' HA ' ' HB3' ' A' ' 13' ' ' ASN . . . -170.19 -167.83 0.67 Allowed 'General case' 0 C--O 1.21 -0.992 0 CA-C-O 113.872 -2.966 . . . . 0.0 106.991 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . 0.29 0.0 OUTLIER -157.88 143.84 17.32 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 122.775 2.534 . . . . 0.0 111.867 179.901 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.517 ' HG2' ' CD2' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -137.39 78.22 1.68 Allowed 'General case' 0 C--O 1.209 -1.052 0 O-C-N 128.058 3.349 . . . . 0.0 110.573 179.752 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.474 HD11 ' CG2' ' A' ' 114' ' ' ILE . 1.7 mm -66.44 96.18 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 O-C-N 125.311 1.632 . . . . 0.0 114.422 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.517 ' CD1' ' HB ' ' A' ' 8' ' ' VAL . 26.5 m-85 -84.49 137.69 33.21 Favored 'General case' 0 C--O 1.219 -0.503 0 C-N-CA 126.524 1.93 . . . . 0.0 106.709 179.775 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 10.0 mmtt -101.12 41.24 1.2 Allowed 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 115.455 -2.212 . . . . 0.0 112.465 -179.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.527 ' HB2' ' CZ3' ' A' ' 6' ' ' TRP . 3.2 tttm 27.36 98.22 0.0 OUTLIER 'General case' 0 C--O 1.238 0.491 0 C-N-CA 127.462 2.305 . . . . 0.0 116.401 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.403 ' HA ' HG22 ' A' ' 5' ' ' THR 0.858 2.6 tm-20 . . . . . 0 N--CA 1.439 -1.022 0 O-C-N 117.912 -2.992 . . . . 0.0 116.892 -179.763 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . 0.528 ' CZ ' HG13 ' A' ' 108' ' ' ILE . 96.6 m-85 . . . . . 0 CA--C 1.508 -0.659 0 CA-C-O 124.147 1.927 . . . . 0.0 116.128 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -156.27 90.72 1.21 Allowed 'General case' 0 N--CA 1.436 -1.132 0 CA-C-N 113.66 -1.609 . . . . 0.0 113.205 179.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 155.98 -148.19 17.91 Favored Glycine 0 N--CA 1.432 -1.589 0 C-N-CA 114.992 -3.48 . . . . 0.0 114.395 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . 0.576 32.9 p -103.76 150.35 24.16 Favored 'General case' 0 C--N 1.311 -1.088 0 O-C-N 126.935 2.197 . . . . 0.0 114.182 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.531 ' CZ2' HD12 ' A' ' 108' ' ' ILE . 93.7 m95 -148.11 141.21 24.97 Favored 'General case' 0 N--CA 1.431 -1.405 0 O-C-N 126.346 2.279 . . . . 0.0 106.087 179.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 18.3 tttt -141.47 93.54 2.58 Favored 'General case' 0 C--O 1.204 -1.32 0 CA-C-O 116.778 -1.582 . . . . 0.0 107.257 179.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.484 ' CG1' ' HB3' ' A' ' 36' ' ' LEU 0.32 1.5 p -43.78 136.9 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-O 117.127 -1.416 . . . . 0.0 113.341 -179.96 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.419 ' N ' HG21 ' A' ' 8' ' ' VAL . 14.6 t70 -126.15 -18.45 4.99 Favored 'General case' 0 CA--C 1.503 -0.853 0 O-C-N 124.671 1.232 . . . . 0.0 111.321 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.02 145.65 15.4 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 119.753 -1.842 . . . . 0.0 106.496 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . 0.298 0.2 OUTLIER -109.09 -169.83 1.55 Allowed 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 112.452 -2.158 . . . . 0.0 109.54 179.715 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -176.87 90.35 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 100.7 -7.39 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 125.132 1.373 . . . . 0.0 112.229 -179.575 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.566 ' CD2' ' CG ' ' A' ' 126' ' ' ARG 0.252 0.2 OUTLIER -69.96 -38.67 76.17 Favored 'General case' 0 C--O 1.222 -0.386 0 O-C-N 128.314 3.509 . . . . 0.0 114.185 179.584 . . . . . . . . 4 4 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.52 -29.24 68.98 Favored 'General case' 0 CA--C 1.509 -0.602 0 CA-C-N 121.539 1.972 . . . . 0.0 113.043 179.696 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.9 -37.42 34.77 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 113.504 -1.68 . . . . 0.0 110.391 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.545 ' CD2' ' CE1' ' A' ' 14' ' ' TYR . 0.9 OUTLIER -70.73 -28.62 64.86 Favored 'General case' 0 C--O 1.244 0.765 0 CA-C-O 124.765 2.222 . . . . 0.0 111.747 -179.981 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 32.1 mtt -72.15 -26.04 61.95 Favored 'General case' 0 C--N 1.324 -0.521 1 O-C-N 115.36 -4.588 . . . . 0.0 108.466 -179.686 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -79.68 -24.16 41.96 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 116.138 -2.225 . . . . 0.0 111.937 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 12.4 tptp -79.19 -30.53 43.43 Favored 'General case' 0 C--N 1.31 -1.145 0 O-C-N 120.68 -1.262 . . . . 0.0 109.379 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.545 ' CE ' ' CD1' ' A' ' 119' ' ' TYR 0.304 0.7 OUTLIER -78.41 -23.49 46.68 Favored 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 179.783 . . . . . . . . 4 4 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 88.33 56.87 1.96 Allowed Glycine 0 C--N 1.307 -1.049 0 CA-C-O 116.301 -2.389 . . . . 0.0 108.793 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.409 HG22 ' HA ' ' A' ' 28' ' ' ARG . 1.6 mm -81.26 -34.17 13.22 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 CA-C-O 115.081 -2.39 . . . . 0.0 111.719 -179.68 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 89.61 98.64 0.02 OUTLIER 'General case' 0 C--N 1.346 0.426 0 O-C-N 125.877 1.985 . . . . 0.0 113.431 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . 0.475 4.1 p 12.86 -62.08 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.349 0.577 0 N-CA-C 119.292 3.071 . . . . 0.0 119.292 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.605 0.0 OUTLIER -72.07 -42.08 67.7 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.876 0 N-CA-C 118.212 2.671 . . . . 0.0 118.212 -179.465 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.4 mtpp -64.4 -24.59 67.69 Favored 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 114.787 1.403 . . . . 0.0 114.787 -179.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.409 ' HA ' HG22 ' A' ' 23' ' ' ILE . 5.0 ptt85 -79.8 -25.68 40.8 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 119.207 -2.183 . . . . 0.0 108.239 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 8.8 tttt -73.99 -46.39 44.08 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.609 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.1 mp -72.81 -31.96 65.19 Favored 'General case' 0 N--CA 1.438 -1.058 0 O-C-N 124.872 1.358 . . . . 0.0 107.387 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -74.95 -34.49 52.65 Favored Glycine 0 C--N 1.346 1.102 0 O-C-N 124.576 1.172 . . . . 0.0 111.779 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -73.35 -26.71 61.13 Favored 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 114.476 1.288 . . . . 0.0 114.476 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -124.8 57.83 1.26 Allowed 'General case' 0 C--N 1.348 0.502 0 O-C-N 127.343 2.902 . . . . 0.0 111.175 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -90.78 -17.82 25.99 Favored 'General case' 0 C--O 1.211 -0.948 0 N-CA-C 118.511 2.782 . . . . 0.0 118.511 -179.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 10.3 t30 75.32 27.12 1.11 Allowed 'General case' 0 C--O 1.24 0.6 0 C-N-CA 117.992 -1.483 . . . . 0.0 110.092 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.484 ' HB3' ' CG1' ' A' ' 8' ' ' VAL . 13.8 tp -52.77 106.54 0.16 Allowed 'General case' 0 C--O 1.216 -0.682 0 C-N-CA 126.542 1.937 . . . . 0.0 107.587 179.676 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 6.1 ttpt -104.58 103.91 13.65 Favored 'General case' 0 C--N 1.309 -1.183 0 O-C-N 127.086 2.741 . . . . 0.0 104.156 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . 0.271 1.0 OUTLIER -88.2 117.11 26.87 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 179.434 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.478 ' HB ' ' CB ' ' A' ' 50' ' ' LYS . 31.3 m -108.81 98.46 7.95 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 104.118 -2.549 . . . . 0.0 104.118 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.466 ' CG1' ' CG2' ' A' ' 49' ' ' VAL . 29.0 mt -81.38 142.33 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.38 0 O-C-N 126.143 2.152 . . . . 0.0 109.213 -179.717 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 20.9 m -145.33 83.14 1.66 Allowed 'General case' 0 CA--C 1.508 -0.639 0 O-C-N 128.091 3.369 . . . . 0.0 109.247 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.479 ' NE2' ' CE2' ' A' ' 47' ' ' PHE . 4.1 tt0 -82.85 132.18 35.17 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 114.375 -1.284 . . . . 0.0 108.312 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -117.67 67.53 0.75 Allowed 'General case' 0 CA--C 1.485 -1.527 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.91 -86.38 1.52 Allowed Glycine 0 N--CA 1.429 -1.82 0 N-CA-C 106.417 -2.673 . . . . 0.0 106.417 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.288 0.0 OUTLIER -111.08 -40.32 4.51 Favored 'General case' 0 N--CA 1.451 -0.417 0 O-C-N 125.541 1.377 . . . . 0.0 113.167 -179.912 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.408 ' HG3' ' HG3' ' A' ' 63' ' ' GLU . 5.3 ttmm -62.2 148.87 43.3 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.524 ' HB3' ' CE1' ' A' ' 62' ' ' PHE 0.306 1.7 m-85 -137.08 105.56 5.79 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 114.98 -1.009 . . . . 0.0 109.196 179.962 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.412 ' HB ' ' CG1' ' A' ' 61' ' ' VAL 0.423 9.5 t -99.38 126.05 45.18 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 105.712 -1.959 . . . . 0.0 105.712 179.43 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.466 ' CG2' ' CG1' ' A' ' 40' ' ' ILE 0.671 0.6 OUTLIER -107.23 115.89 49.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 O-C-N 126.801 2.563 . . . . 0.0 113.303 -179.84 . . . . . . . . 4 4 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.478 ' CB ' ' HB ' ' A' ' 39' ' ' THR . 7.3 tttt -78.63 100.37 6.97 Favored 'General case' 0 C--N 1.307 -1.267 1 N-CA-C 100.182 -4.006 . . . . 0.0 100.182 179.909 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 55.4 tt0 -95.64 63.75 2.47 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 102.446 -3.168 . . . . 0.0 102.446 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 11.0 m -74.92 60.27 0.96 Allowed 'General case' 0 C--N 1.289 -2.025 0 O-C-N 125.763 1.914 . . . . 0.0 106.725 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -82.13 179.36 7.84 Favored 'General case' 0 C--O 1.209 -1.073 0 C-N-CA 117.215 -1.794 . . . . 0.0 109.778 179.696 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -63.39 -30.43 71.56 Favored 'General case' 0 C--O 1.214 -0.789 0 O-C-N 125.329 1.643 . . . . 0.0 107.867 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.499 ' CD2' ' HB2' ' A' ' 73' ' ' ALA . 33.9 m-85 -68.16 -65.26 0.72 Allowed 'General case' 0 C--O 1.218 -0.6 0 C-N-CA 115.064 -2.654 . . . . 0.0 109.245 179.591 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.486 ' HB2' ' CG2' ' A' ' 58' ' ' ILE . 7.9 mtm-85 -139.81 170.88 15.07 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 123.98 3.082 . . . . 0.0 110.733 179.45 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -116.87 70.71 0.78 Allowed 'General case' 0 C--O 1.217 -0.636 1 N-CA-C 100.083 -4.043 . . . . 0.0 100.083 179.573 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.486 ' CG2' ' HB2' ' A' ' 56' ' ' ARG . 0.5 OUTLIER -107.05 91.41 1.76 Allowed 'Isoleucine or valine' 0 CA--C 1.561 1.382 0 C-N-CA 130.312 3.445 . . . . 0.0 117.432 -179.336 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -60.95 116.53 4.55 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 104.768 -2.308 . . . . 0.0 104.768 179.052 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 13.3 p -104.0 105.75 19.02 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 O-C-N 124.64 1.212 . . . . 0.0 112.73 -178.132 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.412 ' CG1' ' HB ' ' A' ' 48' ' ' THR 0.412 0.6 OUTLIER -82.44 152.3 4.05 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 O-C-N 118.676 -2.515 . . . . 0.0 109.317 179.797 . . . . . . . . 4 4 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.641 ' CE1' ' CZ2' ' A' ' 82' ' ' TRP . 16.4 p90 -162.45 95.39 0.92 Allowed 'General case' 0 N--CA 1.445 -0.722 0 O-C-N 120.55 -1.344 . . . . 0.0 108.991 179.694 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.422 ' HB2' ' HB ' ' A' ' 66' ' ' VAL . 1.8 mt-10 -65.96 128.95 38.08 Favored 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 104.053 -2.573 . . . . 0.0 104.053 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.67 121.02 11.77 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-O 122.984 1.373 . . . . 0.0 110.857 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 71.09 25.55 75.47 Favored Glycine 0 N--CA 1.471 0.981 0 N-CA-C 117.525 1.77 . . . . 0.0 117.525 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.422 ' HB ' ' HB2' ' A' ' 63' ' ' GLU 0.409 78.3 t -102.99 -21.0 5.4 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 CA-C-O 116.958 -1.496 . . . . 0.0 108.049 179.712 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . 0.253 1.4 m-20 77.41 145.02 0.08 Allowed 'General case' 0 C--N 1.307 -1.279 0 O-C-N 126.081 2.113 . . . . 0.0 113.044 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.481 ' CE2' ' HB3' ' A' ' 62' ' ' PHE . 0.1 OUTLIER -167.25 177.0 6.37 Favored 'General case' 0 N--CA 1.419 -2.02 0 CA-C-N 119.691 1.132 . . . . 0.0 108.189 179.874 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -128.79 132.04 47.84 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 117.41 -1.281 . . . . 0.0 109.717 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 16.2 t80 -125.77 111.52 14.98 Favored 'General case' 0 N--CA 1.435 -1.206 0 O-C-N 125.46 1.725 . . . . 0.0 114.231 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.1 m -73.74 145.13 45.36 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 123.089 2.677 . . . . 0.0 106.699 179.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.1 mt -107.43 -171.48 1.88 Allowed 'General case' 0 CA--C 1.495 -1.155 0 N-CA-C 106.072 -1.825 . . . . 0.0 106.072 -179.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.499 ' HB2' ' CD2' ' A' ' 55' ' ' PHE . . . -109.31 11.97 25.01 Favored 'General case' 0 C--O 1.235 0.336 0 O-C-N 126.64 2.463 . . . . 0.0 114.822 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -132.12 -38.59 1.09 Allowed 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 113.499 0.926 . . . . 0.0 113.499 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -130.11 -4.7 4.51 Favored Glycine 0 CA--C 1.538 1.518 0 N-CA-C 117.252 1.661 . . . . 0.0 117.252 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . 0.363 0.0 OUTLIER 67.5 171.24 0.27 Allowed 'General case' 0 N--CA 1.441 -0.879 0 C-N-CA 116.793 -1.963 . . . . 0.0 113.35 179.953 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 12.02 111.37 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.891 1 O-C-N 130.192 4.682 . . . . 0.0 115.085 179.626 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.42 ' HG ' ' HB3' ' A' ' 93' ' ' PHE 0.406 0.7 OUTLIER -145.7 104.81 3.91 Favored 'General case' 0 C--O 1.219 -0.547 0 N-CA-C 101.863 -3.384 . . . . 0.0 101.863 179.939 . . . . . . . . 4 4 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 24.1 m -106.27 170.79 7.71 Favored 'General case' 0 CA--C 1.483 -1.597 0 CA-C-N 113.658 -1.61 . . . . 0.0 106.691 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 154.27 -171.45 32.82 Favored Glycine 0 N--CA 1.441 -0.98 0 C-N-CA 117.03 -2.509 . . . . 0.0 111.837 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 44.1 p -144.1 160.89 40.13 Favored 'General case' 0 C--O 1.199 -1.584 0 C-N-CA 117.701 -1.6 . . . . 0.0 109.899 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . 0.641 ' CZ2' ' CE1' ' A' ' 62' ' ' PHE . 10.5 m0 -101.94 156.51 17.49 Favored 'General case' 0 N--CA 1.426 -1.648 0 N-CA-C 102.055 -3.313 . . . . 0.0 102.055 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 3.2 t -150.42 124.18 9.19 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 117.751 -1.58 . . . . 0.0 106.932 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -84.32 111.68 19.63 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 112.714 -2.039 . . . . 0.0 111.733 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.426 ' HG3' ' CG2' ' A' ' 90' ' ' VAL 0.573 5.0 mt-10 -67.95 -49.69 60.29 Favored 'General case' 0 N--CA 1.421 -1.905 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -179.755 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 161.55 -61.2 0.29 Allowed Glycine 0 C--O 1.216 -1.028 0 N-CA-C 103.283 -3.927 . . . . 0.0 103.283 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -110.04 8.04 23.85 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 125.66 1.447 . . . . 0.0 113.675 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . 0.317 0.0 OUTLIER -156.87 126.73 6.29 Favored 'General case' 0 CA--C 1.503 -0.864 0 O-C-N 126.551 2.407 . . . . 0.0 107.571 179.953 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.2 mt -83.6 147.8 27.52 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 111.329 -2.669 . . . . 0.0 103.953 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.426 ' CG2' ' HG3' ' A' ' 85' ' ' GLU . 0.2 OUTLIER -137.35 133.54 46.6 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.889 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 -179.994 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -111.56 103.6 1.57 Allowed Glycine 0 CA--C 1.528 0.9 0 C-N-CA 125.649 1.595 . . . . 0.0 113.35 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 37.8 mtpt -98.65 118.57 35.66 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 102.935 -2.987 . . . . 0.0 102.935 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.42 ' HB3' ' HG ' ' A' ' 78' ' ' LEU . 15.6 m-85 -122.9 115.23 21.59 Favored 'General case' 0 CA--C 1.501 -0.916 0 O-C-N 126.416 2.322 . . . . 0.0 111.521 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 19.9 mttp -98.47 140.45 32.7 Favored 'General case' 0 CA--C 1.505 -0.762 0 CA-C-O 125.192 2.425 . . . . 0.0 108.434 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . 0.407 15.3 ttt180 -97.15 129.74 44.49 Favored 'General case' 0 CA--C 1.487 -1.475 0 CA-C-O 124.031 1.872 . . . . 0.0 106.102 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.476 ' CG2' ' N ' ' A' ' 97' ' ' ASP . 14.7 m -69.77 -34.73 62.04 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.934 0 CA-C-O 125.551 2.596 . . . . 0.0 114.675 -179.766 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.476 ' N ' ' CG2' ' A' ' 96' ' ' VAL 0.401 0.9 OUTLIER -63.75 -8.36 10.3 Favored 'General case' 0 C--O 1.255 1.39 0 CA-C-N 113.936 -1.484 . . . . 0.0 114.377 179.814 . . . . . . . . 4 4 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.407 ' ND2' ' OH ' ' A' ' 119' ' ' TYR . 13.3 p-10 -150.54 1.77 0.45 Allowed 'General case' 0 N--CA 1.433 -1.302 0 C-N-CA 116.196 -2.202 . . . . 0.0 116.732 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 65.83 21.94 69.79 Favored Glycine 0 CA--C 1.542 1.774 0 N-CA-C 115.673 1.029 . . . . 0.0 115.673 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 49.0 mmtt -89.68 -178.82 5.63 Favored 'General case' 0 C--O 1.202 -1.417 0 C-N-CA 119.823 -0.751 . . . . 0.0 112.802 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -143.48 119.42 10.63 Favored 'General case' 0 C--O 1.212 -0.885 0 C-N-CA 128.264 2.626 . . . . 0.0 113.866 179.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.532 ' CB ' ' HA ' ' A' ' 119' ' ' TYR . 5.5 tt -98.37 133.76 42.32 Favored 'General case' 0 N--CA 1.44 -0.972 1 C-N-CA 135.337 5.455 . . . . 0.0 106.211 -179.679 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.528 ' N ' ' O ' ' A' ' 118' ' ' THR . 7.1 tt -122.55 159.29 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.702 0 C-N-CA 115.855 -2.338 . . . . 0.0 104.726 179.489 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -156.39 145.54 20.49 Favored 'General case' 0 C--N 1.315 -0.902 0 O-C-N 118.844 -2.41 . . . . 0.0 107.542 -179.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.51 ' HB ' ' CE2' ' A' ' 117' ' ' TYR . 6.4 p -131.66 115.12 26.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-O 126.078 2.847 . . . . 0.0 110.287 -179.527 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.586 ' CZ ' ' CH2' ' A' ' 82' ' ' TRP . 2.3 mtt-85 -76.44 90.48 3.26 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 112.299 -2.228 . . . . 0.0 105.462 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.47 ' CG ' HG11 ' A' ' 105' ' ' VAL . 1.2 mt-10 -86.66 77.62 9.31 Favored 'General case' 0 N--CA 1.419 -2.015 0 CA-C-N 109.985 -3.28 . . . . 0.0 114.928 -179.682 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.531 HD12 ' CZ2' ' A' ' 6' ' ' TRP 0.257 0.6 OUTLIER -54.94 90.75 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 CA-C-O 122.931 1.348 . . . . 0.0 111.417 179.264 . . . . . . . . 4 4 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.459 ' N ' ' O ' ' A' ' 107' ' ' GLU . 23.9 m -80.97 66.99 6.71 Favored 'General case' 0 N--CA 1.432 -1.339 0 N-CA-C 103.822 -2.659 . . . . 0.0 103.822 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 52.7 -90.97 0.01 OUTLIER Glycine 0 N--CA 1.463 0.493 1 O-C-N 129.191 4.057 . . . . 0.0 111.113 -179.817 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . 0.322 4.5 m120 -82.29 -25.89 33.6 Favored 'General case' 0 C--N 1.309 -1.196 0 CA-C-O 115.935 -1.983 . . . . 0.0 110.675 179.805 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -110.28 125.63 53.33 Favored 'General case' 0 C--O 1.205 -1.256 0 N-CA-C 115.878 1.807 . . . . 0.0 115.878 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.413 HD21 ' N ' ' A' ' 114' ' ' ILE . 0.0 OUTLIER -87.04 143.6 27.26 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 100.633 -3.84 . . . . 0.0 100.633 179.983 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.462 ' CG2' HD12 ' A' ' 127' ' ' ILE 0.312 0.6 OUTLIER -142.13 136.57 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.585 0 N-CA-C 105.067 -2.197 . . . . 0.0 105.067 179.989 . . . . . . . . 4 4 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -109.54 123.24 49.08 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 100.926 -3.731 . . . . 0.0 100.926 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.463 ' O ' ' CG ' ' A' ' 117' ' ' TYR . 0.1 OUTLIER -135.39 147.73 49.12 Favored 'General case' 0 N--CA 1.417 -2.11 0 C-N-CA 118.091 -1.443 . . . . 0.0 111.829 -179.12 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . 0.51 ' CE2' ' HB ' ' A' ' 105' ' ' VAL 0.352 18.5 m-85 127.81 -144.95 0.0 OUTLIER 'General case' 0 CA--C 1.471 -2.08 1 O-C-N 131.892 5.745 . . . . 0.0 113.945 177.656 . . . . . . . . 4 3 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.528 ' O ' ' N ' ' A' ' 103' ' ' ILE . 7.9 t -150.13 -159.84 1.09 Allowed 'General case' 0 N--CA 1.437 -1.086 0 CA-C-O 125.825 2.726 . . . . 0.0 116.789 -174.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.545 ' CD1' ' CE ' ' A' ' 21' ' ' MET 0.25 38.1 t80 -108.5 -31.55 7.75 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 112.436 -2.165 . . . . 0.0 108.791 177.428 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.444 ' N ' HG22 ' A' ' 118' ' ' THR . 0.5 OUTLIER -148.16 -70.91 0.22 Allowed 'General case' 0 C--N 1.291 -1.955 0 C-N-CA 126.862 2.065 . . . . 0.0 109.605 179.112 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -147.3 18.55 1.52 Allowed Glycine 0 C--N 1.351 1.388 0 N-CA-C 120.887 3.115 . . . . 0.0 120.887 -179.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 50.7 t -117.24 93.08 2.35 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 N-CA-C 103.547 -2.76 . . . . 0.0 103.547 179.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.408 ' HA ' ' HB ' ' A' ' 118' ' ' THR . 6.6 mt-10 -57.99 178.82 0.08 Allowed 'General case' 0 CA--C 1.513 -0.467 0 CA-C-O 124.021 1.867 . . . . 0.0 112.368 -178.191 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.462 ' HB2' ' CG ' ' A' ' 14' ' ' TYR . . . -172.58 104.26 0.15 Allowed 'General case' 0 N--CA 1.436 -1.138 0 O-C-N 116.535 -3.853 . . . . 0.0 109.453 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.27 141.33 33.03 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 119.804 1.184 . . . . 0.0 108.997 179.49 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.566 ' CG ' ' CD2' ' A' ' 14' ' ' TYR . 3.8 mtp180 -129.13 79.21 1.9 Allowed 'General case' 0 C--O 1.214 -0.798 0 CA-C-O 116.126 -1.892 . . . . 0.0 110.509 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.462 HD12 ' CG2' ' A' ' 114' ' ' ILE . 3.8 mm -65.29 118.23 7.38 Favored 'Isoleucine or valine' 0 C--O 1.256 1.429 1 O-C-N 130.35 4.781 . . . . 0.0 115.201 179.64 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -104.67 137.46 42.46 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 126.362 1.865 . . . . 0.0 108.072 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . 0.363 0.6 OUTLIER -108.93 42.57 1.39 Allowed 'General case' 0 N--CA 1.439 -1.025 0 CA-C-O 116.475 -1.726 . . . . 0.0 111.47 -179.964 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.525 ' HB2' ' CZ3' ' A' ' 6' ' ' TRP . 0.0 OUTLIER 21.63 101.16 0.0 OUTLIER 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 128.404 2.682 . . . . 0.0 116.472 -179.904 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . 0.934 16.5 tt0 . . . . . 0 C--N 1.32 -0.697 0 N-CA-C 115.882 1.808 . . . . 0.0 115.882 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . 0.518 ' CE1' HG13 ' A' ' 108' ' ' ILE . 2.5 m-85 . . . . . 0 N--CA 1.434 -1.255 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -49.53 95.11 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.362 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 155.33 178.98 30.12 Favored Glycine 0 N--CA 1.441 -0.982 0 C-N-CA 118.024 -2.036 . . . . 0.0 112.324 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . 0.531 1.3 p -86.1 147.93 25.93 Favored 'General case' 0 C--N 1.312 -1.041 0 C-N-CA 124.82 1.248 . . . . 0.0 108.46 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.517 ' CH2' ' HD2' ' A' ' 130' ' ' LYS . 74.9 m95 -143.29 140.24 30.52 Favored 'General case' 0 CA--C 1.504 -0.804 0 CA-C-O 115.202 -2.332 . . . . 0.0 105.961 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 18.5 tttt -144.34 92.77 2.35 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 114.398 -2.715 . . . . 0.0 105.838 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.516 ' HB ' ' CE1' ' A' ' 128' ' ' PHE 0.258 7.4 p -34.38 128.13 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.16 0 CA-C-O 116.426 -1.749 . . . . 0.0 113.054 -179.998 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -126.35 -22.8 3.94 Favored 'General case' 0 N--CA 1.451 -0.406 0 O-C-N 125.922 2.014 . . . . 0.0 111.335 -179.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.4 ' HG2' ' HB ' ' A' ' 127' ' ' ILE . 0.0 OUTLIER -141.36 63.7 1.43 Allowed 'General case' 0 CA--C 1.49 -1.362 0 C-N-CA 118.758 -1.177 . . . . 0.0 113.409 -179.78 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . 0.473 16.4 m-20 -48.23 156.27 0.41 Allowed 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 124.023 0.929 . . . . 0.0 108.733 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.414 ' O ' ' N ' ' A' ' 125' ' ' LYS . 11.6 mt-10 -143.76 136.94 27.71 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-O 115.77 -2.062 . . . . 0.0 107.294 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.428 ' HB3' ' HA ' ' A' ' 124' ' ' ALA . 1.0 OUTLIER 53.76 20.7 2.36 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 122.127 2.239 . . . . 0.0 113.238 -179.691 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.402 ' HA ' ' HB2' ' A' ' 124' ' ' ALA 0.261 4.3 t80 -79.81 -35.81 37.88 Favored 'General case' 0 N--CA 1.442 -0.873 0 O-C-N 126.592 2.433 . . . . 0.0 114.858 179.529 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -77.37 -24.14 50.67 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 116.849 -1.548 . . . . 0.0 108.886 -179.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 8.3 ttmm -78.52 -29.41 46.51 Favored 'General case' 0 N--CA 1.431 -1.387 0 O-C-N 126.012 2.07 . . . . 0.0 111.669 179.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.447 ' CB ' ' HB3' ' A' ' 124' ' ' ALA . 0.2 OUTLIER -69.25 -34.98 75.64 Favored 'General case' 0 N--CA 1.429 -1.516 0 O-C-N 120.384 -1.448 . . . . 0.0 112.065 179.914 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 10.8 mtt -75.76 -26.49 57.44 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-O 124.903 2.287 . . . . 0.0 109.232 -179.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -79.61 -25.34 41.51 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 124.682 2.182 . . . . 0.0 112.347 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.508 ' HE3' ' CG ' ' A' ' 119' ' ' TYR . 3.5 tmtm? -70.61 -30.52 67.2 Favored 'General case' 0 C--O 1.209 -1.063 0 O-C-N 118.23 -2.794 . . . . 0.0 112.864 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -79.95 -33.86 39.28 Favored 'General case' 0 C--O 1.215 -0.745 0 O-C-N 126.132 2.145 . . . . 0.0 108.86 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 108.07 37.53 2.15 Favored Glycine 0 C--N 1.306 -1.1 0 CA-C-O 116.051 -2.527 . . . . 0.0 111.862 -179.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.5 mm -70.31 84.68 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.909 0 CA-C-O 113.253 -3.26 . . . . 0.0 105.033 179.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 10.9 m-20 -3.29 -90.07 0.0 OUTLIER 'General case' 0 C--O 1.247 0.933 0 O-C-N 128.484 3.615 . . . . 0.0 115.24 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . 0.359 20.3 m -155.86 -49.98 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.221 -0.419 0 N-CA-C 117.416 2.376 . . . . 0.0 117.416 179.716 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.569 14.4 m -76.4 -23.01 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.277 0 N-CA-C 116.837 2.162 . . . . 0.0 116.837 179.633 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.9 mtpt -74.98 -25.55 58.93 Favored 'General case' 0 N--CA 1.437 -1.1 0 O-C-N 127.253 2.845 . . . . 0.0 113.175 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.37 -22.22 44.69 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 118.317 -1.353 . . . . 0.0 108.784 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.7 ttpt -65.27 -50.35 66.1 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 122.251 1.024 . . . . 0.0 112.551 -179.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -76.01 -24.45 55.26 Favored 'General case' 0 C--O 1.214 -0.775 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 179.745 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -76.32 -31.56 54.38 Favored Glycine 0 N--CA 1.441 -1.021 0 O-C-N 128.643 3.714 . . . . 0.0 109.832 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -76.94 -38.99 52.27 Favored 'General case' 0 C--O 1.242 0.692 0 O-C-N 125.379 1.281 . . . . 0.0 111.026 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -108.07 47.54 0.89 Allowed 'General case' 0 N--CA 1.433 -1.277 0 CA-C-O 116.646 -1.645 . . . . 0.0 111.077 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -70.12 -37.23 75.27 Favored 'General case' 0 CA--C 1.495 -1.162 0 N-CA-C 118.63 2.826 . . . . 0.0 118.63 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . 0.262 0.1 OUTLIER 81.86 28.77 0.15 Allowed 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 117.709 -1.138 . . . . 0.0 110.629 -179.999 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -48.41 94.74 0.01 OUTLIER 'General case' 0 CA--C 1.507 -0.693 0 C-N-CA 125.05 1.34 . . . . 0.0 108.51 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 10.3 tttt -96.92 101.94 13.63 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 102.555 -3.128 . . . . 0.0 102.555 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.408 ' CB ' ' HB2' ' A' ' 6' ' ' TRP 0.322 2.1 tp -87.33 130.56 34.58 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 119.86 1.209 . . . . 0.0 110.157 -179.915 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.462 ' HB ' ' CB ' ' A' ' 50' ' ' LYS . 69.3 m -119.25 98.66 6.27 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 102.451 -3.166 . . . . 0.0 102.451 179.607 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.464 HG13 ' CD1' ' A' ' 6' ' ' TRP . 1.1 mt -91.42 141.01 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.368 0 CA-C-O 123.661 1.696 . . . . 0.0 111.121 179.595 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.2 m -133.46 93.02 3.07 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 111.04 -2.8 . . . . 0.0 108.45 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -80.31 100.99 8.66 Favored 'General case' 0 C--O 1.218 -0.588 0 O-C-N 125.723 1.89 . . . . 0.0 110.635 179.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -103.48 67.2 0.9 Allowed 'General case' 0 N--CA 1.436 -1.159 0 CA-C-O 125.635 2.636 . . . . 0.0 108.559 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 90.01 -101.03 2.73 Favored Glycine 0 C--N 1.302 -1.353 0 N-CA-C 108.107 -1.997 . . . . 0.0 108.107 179.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.314 83.5 m-20 -111.52 -13.04 13.89 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 128.321 3.012 . . . . 0.0 111.041 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.403 ' HA ' ' HA ' ' A' ' 63' ' ' GLU . 10.8 tttt -82.27 143.91 31.0 Favored 'General case' 0 C--N 1.31 -1.123 0 O-C-N 118.363 -2.711 . . . . 0.0 108.071 179.714 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -122.52 86.59 2.61 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 113.845 -1.525 . . . . 0.0 110.982 179.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.4 ' HB ' HG13 ' A' ' 61' ' ' VAL 0.336 9.5 t -91.76 104.28 16.75 Favored 'General case' 0 C--N 1.316 -0.882 0 O-C-N 126.796 2.56 . . . . 0.0 106.321 179.914 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.435 HG13 HG22 ' A' ' 40' ' ' ILE 0.702 0.7 OUTLIER -100.62 116.76 44.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 126.965 2.665 . . . . 0.0 116.401 -179.685 . . . . . . . . 4 4 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.462 ' CB ' ' HB ' ' A' ' 39' ' ' THR . 26.7 tttp -62.81 149.57 43.81 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 101.018 -3.697 . . . . 0.0 101.018 179.279 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.41 ' O ' ' N ' ' A' ' 53' ' ' SER . 49.4 tt0 -137.21 64.26 1.54 Allowed 'General case' 0 CA--C 1.511 -0.531 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 -179.487 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . 0.256 5.6 m -74.88 73.97 2.13 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 105.16 -2.163 . . . . 0.0 105.16 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.41 ' N ' ' O ' ' A' ' 51' ' ' GLU . 33.1 t -102.82 25.35 9.38 Favored 'General case' 0 CA--C 1.506 -0.715 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 -179.782 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.513 ' ND2' ' N ' ' A' ' 55' ' ' PHE . 0.0 OUTLIER 78.31 -48.23 0.46 Allowed 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 115.272 -2.299 . . . . 0.0 108.988 179.857 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.513 ' N ' ' ND2' ' A' ' 54' ' ' ASN . 96.9 m-85 -58.86 -45.1 90.94 Favored 'General case' 0 C--O 1.213 -0.849 0 C-N-CA 117.428 -1.709 . . . . 0.0 110.373 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.415 ' HG2' HG21 ' A' ' 58' ' ' ILE . 49.0 ttt180 -168.92 144.39 3.33 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 105.668 -1.975 . . . . 0.0 105.668 179.21 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 26.8 t30 -93.1 78.21 4.6 Favored 'General case' 0 C--N 1.35 0.621 0 N-CA-C 101.642 -3.466 . . . . 0.0 101.642 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.415 HG21 ' HG2' ' A' ' 56' ' ' ARG . 3.0 tt -110.3 110.12 30.98 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.338 1 O-C-N 130.01 4.569 . . . . 0.0 117.728 -179.549 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -63.02 135.11 57.09 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 103.89 -2.633 . . . . 0.0 103.89 177.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.525 HG13 ' CE2' ' A' ' 62' ' ' PHE . 10.1 t -107.41 92.37 2.06 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 -178.18 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.4 HG13 ' HB ' ' A' ' 48' ' ' THR 0.358 0.7 OUTLIER -90.81 135.24 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.151 0 O-C-N 118.681 -2.512 . . . . 0.0 111.951 -179.761 . . . . . . . . 4 4 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.525 ' CE2' HG13 ' A' ' 60' ' ' VAL . 24.4 p90 -166.05 97.25 0.62 Allowed 'General case' 0 C--N 1.314 -0.943 0 C-N-CA 118.151 -1.42 . . . . 0.0 110.296 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.404 ' HB2' HG12 ' A' ' 66' ' ' VAL . 1.0 OUTLIER -56.03 147.85 18.98 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 179.88 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.55 99.4 0.15 Allowed 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 179.73 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 98.7 34.46 5.23 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 119.321 2.489 . . . . 0.0 119.321 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.404 HG12 ' HB2' ' A' ' 63' ' ' GLU 0.433 34.8 m -114.3 77.67 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 N-CA-C 104.618 -2.364 . . . . 0.0 104.618 -179.924 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -35.16 103.21 0.03 OUTLIER 'General case' 0 CA--C 1.486 -1.481 0 O-C-N 126.803 2.564 . . . . 0.0 113.711 -179.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 28.9 p90 -116.52 174.97 5.78 Favored 'General case' 0 N--CA 1.423 -1.816 0 O-C-N 120.138 -1.601 . . . . 0.0 112.484 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -123.17 126.07 46.31 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 128.828 3.83 . . . . 0.0 105.488 179.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -121.56 -42.34 2.44 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-O 115.82 -2.038 . . . . 0.0 114.356 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.9 m 72.61 143.17 0.06 Allowed 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 105.95 -1.87 . . . . 0.0 105.95 -179.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.429 ' HG ' HD21 ' A' ' 78' ' ' LEU . 1.2 mp -95.95 -164.17 1.13 Allowed 'General case' 0 C--N 1.301 -1.509 0 CA-C-N 114.779 -1.101 . . . . 0.0 108.719 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -89.11 -48.75 7.19 Favored 'General case' 0 C--O 1.211 -0.964 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.117 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -129.01 12.94 6.22 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-O 115.557 -2.163 . . . . 0.0 109.633 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -107.29 -8.93 30.37 Favored Glycine 0 CA--C 1.546 1.998 0 CA-C-O 117.463 -1.743 . . . . 0.0 116.924 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . 0.377 0.1 OUTLIER 89.3 -164.08 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 114.696 -2.574 . . . . 0.0 113.97 179.946 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.441 ' CG ' HG23 ' A' ' 96' ' ' VAL . 0.5 OUTLIER -62.21 140.64 58.45 Favored 'General case' 0 C--N 1.318 -0.78 1 O-C-N 129.529 4.268 . . . . 0.0 114.891 179.914 . . . . . . . . 4 4 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.484 ' HG ' ' CD1' ' A' ' 93' ' ' PHE 0.399 11.1 tp -143.83 128.77 18.47 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 102.416 -3.179 . . . . 0.0 102.416 179.872 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 87.1 m -146.45 121.88 10.34 Favored 'General case' 0 CA--C 1.487 -1.461 0 N-CA-C 103.691 -2.707 . . . . 0.0 103.691 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -166.0 -146.49 4.84 Favored Glycine 0 C--N 1.297 -1.638 0 C-N-CA 114.576 -3.678 . . . . 0.0 110.949 -179.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 72.5 p -152.27 171.35 18.11 Favored 'General case' 0 CA--C 1.472 -2.048 0 O-C-N 125.632 1.431 . . . . 0.0 107.494 -179.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . 0.489 ' CE3' ' N ' ' A' ' 91' ' ' GLY . 24.2 m95 -125.03 139.72 53.55 Favored 'General case' 0 N--CA 1.429 -1.524 0 N-CA-C 103.703 -2.703 . . . . 0.0 103.703 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.438 HG21 ' CG1' ' A' ' 90' ' ' VAL . 10.1 t -147.32 149.44 32.83 Favored 'General case' 0 C--O 1.256 1.409 0 C-N-CA 119.051 -1.059 . . . . 0.0 111.445 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.8 130.04 34.93 Favored 'General case' 0 CA--C 1.494 -1.192 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 -179.715 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . 0.538 0.0 OUTLIER -110.41 60.26 0.61 Allowed 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 -179.854 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 73.07 -95.1 0.72 Allowed Glycine 0 N--CA 1.429 -1.817 0 CA-C-N 112.41 -2.177 . . . . 0.0 107.731 -179.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -94.66 12.33 28.07 Favored 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 115.151 1.537 . . . . 0.0 115.151 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . 0.404 4.2 mptt -140.28 175.7 9.38 Favored 'General case' 0 C--O 1.21 -1.013 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -125.13 141.88 51.83 Favored 'General case' 0 CA--C 1.548 0.898 0 N-CA-C 101.578 -3.49 . . . . 0.0 101.578 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.438 ' CG1' HG21 ' A' ' 83' ' ' THR . 7.6 p -133.82 119.73 33.9 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 O-C-N 125.505 1.753 . . . . 0.0 110.691 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.489 ' N ' ' CE3' ' A' ' 82' ' ' TRP . . . -93.31 103.07 2.99 Favored Glycine 0 N--CA 1.474 1.198 0 C-N-CA 127.532 2.492 . . . . 0.0 108.294 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -97.61 154.2 17.7 Favored 'General case' 0 CA--C 1.502 -0.895 0 N-CA-C 103.944 -2.613 . . . . 0.0 103.944 179.808 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.484 ' CD1' ' HG ' ' A' ' 78' ' ' LEU . 91.6 m-85 -151.54 118.47 5.84 Favored 'General case' 0 CA--C 1.502 -0.899 0 O-C-N 125.12 1.513 . . . . 0.0 111.253 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 25.0 mttm -93.76 152.29 19.03 Favored 'General case' 0 C--O 1.21 -0.986 0 CA-C-O 123.741 1.734 . . . . 0.0 107.669 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . 0.368 0.5 OUTLIER -115.62 121.8 43.69 Favored 'General case' 0 CA--C 1.488 -1.414 0 CA-C-N 114.983 -1.008 . . . . 0.0 108.953 179.914 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.441 HG23 ' CG ' ' A' ' 77' ' ' GLU . 23.4 m -62.52 -27.79 43.49 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 CA-C-O 125.264 2.459 . . . . 0.0 113.338 179.756 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . 0.31 2.4 m-20 -61.56 -10.17 7.48 Favored 'General case' 0 C--O 1.246 0.902 0 CA-C-N 113.55 -1.659 . . . . 0.0 113.34 179.715 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.479 ' ND2' ' N ' ' A' ' 98' ' ' ASN . 0.1 OUTLIER -169.89 15.28 0.02 OUTLIER 'General case' 0 N--CA 1.433 -1.287 0 N-CA-C 115.636 1.717 . . . . 0.0 115.636 179.929 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 55.13 21.22 24.29 Favored Glycine 0 CA--C 1.523 0.547 0 CA-C-O 123.635 1.686 . . . . 0.0 113.572 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp -78.25 -170.88 2.16 Favored 'General case' 0 C--O 1.199 -1.572 0 O-C-N 120.225 -1.75 . . . . 0.0 106.697 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -135.77 159.76 40.66 Favored 'General case' 0 CA--C 1.5 -0.971 0 O-C-N 127.808 3.193 . . . . 0.0 110.164 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.454 HD21 ' CD1' ' A' ' 78' ' ' LEU . 0.2 OUTLIER -146.22 149.58 34.19 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 131.648 3.979 . . . . 0.0 104.007 179.541 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.404 ' CD1' ' N ' ' A' ' 104' ' ' ALA . 0.0 OUTLIER -143.34 162.12 16.78 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.994 0 N-CA-C 106.657 -1.609 . . . . 0.0 106.657 -179.723 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.404 ' N ' ' CD1' ' A' ' 103' ' ' ILE . . . -149.67 143.57 25.58 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-O 114.965 -2.445 . . . . 0.0 106.567 179.52 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.9 p -126.24 105.52 14.53 Favored 'Isoleucine or valine' 0 C--O 1.257 1.466 0 CA-C-N 121.647 2.021 . . . . 0.0 108.15 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 63.6 mtt180 -67.79 90.29 0.28 Allowed 'General case' 0 CA--C 1.502 -0.883 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -83.69 78.57 9.67 Favored 'General case' 0 N--CA 1.433 -1.282 0 N-CA-C 116.639 2.089 . . . . 0.0 116.639 179.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.518 HG13 ' CE1' ' A' ' 2' ' ' PHE . 0.8 OUTLIER -68.52 101.33 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 C-N-CA 113.784 -3.167 . . . . 0.0 108.882 179.742 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.26 -29.78 69.5 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 114.199 -1.364 . . . . 0.0 107.536 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 154.01 -71.89 0.27 Allowed Glycine 0 C--O 1.243 0.715 1 C-N-CA 130.723 4.011 . . . . 0.0 111.583 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . 0.362 6.9 m120 -97.71 3.27 50.23 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 115.497 -2.192 . . . . 0.0 110.418 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -133.15 118.73 19.02 Favored 'General case' 0 CA--C 1.502 -0.867 0 O-C-N 128.005 3.315 . . . . 0.0 114.098 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.513 HD22 ' CE2' ' A' ' 128' ' ' PHE . 0.9 OUTLIER -97.29 94.22 6.97 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 103.214 -2.884 . . . . 0.0 103.214 179.821 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 77.2 mt -91.17 143.82 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.114 0 N-CA-C 103.419 -2.808 . . . . 0.0 103.419 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -132.8 108.17 8.81 Favored 'General case' 0 CA--C 1.49 -1.361 0 O-C-N 124.741 1.276 . . . . 0.0 109.136 -179.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 20.3 p -72.33 173.8 8.2 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 105.371 -2.085 . . . . 0.0 105.371 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -162.78 114.38 1.54 Allowed 'General case' 0 CA--C 1.477 -1.847 0 CA-C-O 117.192 -1.385 . . . . 0.0 113.734 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . 0.264 1.2 m -126.57 122.3 34.72 Favored 'General case' 0 N--CA 1.424 -1.766 0 O-C-N 127.267 2.854 . . . . 0.0 110.961 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.508 ' CG ' ' HE3' ' A' ' 20' ' ' LYS . 1.4 t80 -85.85 -25.2 26.37 Favored 'General case' 0 N--CA 1.476 0.831 0 O-C-N 126.49 2.369 . . . . 0.0 107.064 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -161.97 -75.14 0.05 Allowed 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 112.522 -2.126 . . . . 0.0 113.573 -179.767 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -139.74 25.57 2.69 Favored Glycine 0 CA--C 1.537 1.463 0 N-CA-C 120.408 2.923 . . . . 0.0 120.408 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 22.0 t -133.02 102.87 5.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 105.219 -2.141 . . . . 0.0 105.219 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -75.94 165.69 24.61 Favored 'General case' 0 C--O 1.206 -1.195 0 CA-C-O 124.344 2.021 . . . . 0.0 108.82 -179.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.447 ' HB3' ' CB ' ' A' ' 17' ' ' PHE . . . -161.02 101.18 1.26 Allowed 'General case' 0 N--CA 1.435 -1.209 0 CA-C-O 114.488 -2.673 . . . . 0.0 107.854 -179.822 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.414 ' N ' ' O ' ' A' ' 12' ' ' GLU 0.288 5.3 mptt -77.95 146.03 35.72 Favored 'General case' 0 N--CA 1.449 -0.513 0 O-C-N 127.228 2.83 . . . . 0.0 110.519 179.738 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.18 83.03 2.03 Favored 'General case' 0 C--O 1.212 -0.919 0 CA-C-O 114.955 -2.45 . . . . 0.0 106.845 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.4 ' HB ' ' HG2' ' A' ' 10' ' ' ARG . 1.9 mm -74.15 104.14 2.69 Favored 'Isoleucine or valine' 0 C--O 1.25 1.097 1 O-C-N 131.042 5.213 . . . . 0.0 117.381 179.808 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.516 ' CE1' ' HB ' ' A' ' 8' ' ' VAL . 0.7 OUTLIER -94.98 140.85 29.38 Favored 'General case' 0 CA--C 1.516 -0.361 0 O-C-N 124.565 1.166 . . . . 0.0 108.463 -179.813 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 27.7 mmtt -102.88 9.11 39.03 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-O 116.444 -1.741 . . . . 0.0 110.848 179.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.517 ' HD2' ' CH2' ' A' ' 6' ' ' TRP . 2.8 tttt 64.32 110.69 0.03 OUTLIER 'General case' 0 C--O 1.237 0.407 0 O-C-N 124.99 1.431 . . . . 0.0 113.67 -179.788 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . 0.746 1.9 mt-10 . . . . . 0 N--CA 1.438 -1.068 0 C-N-CA 118.422 -1.311 . . . . 0.0 114.066 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . 0.532 ' CZ ' HG23 ' A' ' 108' ' ' ILE . 0.8 OUTLIER . . . . . 0 N--CA 1.442 -0.872 0 N-CA-C 114.239 1.2 . . . . 0.0 114.239 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.409 ' HA ' HG23 ' A' ' 40' ' ' ILE . 26.0 t0 -158.91 90.54 0.99 Allowed 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 114.03 -1.441 . . . . 0.0 112.395 -179.562 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 142.0 174.72 14.86 Favored Glycine 0 N--CA 1.439 -1.155 0 C-N-CA 114.477 -3.725 . . . . 0.0 114.459 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . 0.705 3.3 t -58.3 151.86 18.67 Favored 'General case' 0 C--N 1.319 -0.734 0 O-C-N 127.169 2.335 . . . . 0.0 111.181 -179.664 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.524 ' CZ3' ' HB2' ' A' ' 130' ' ' LYS . 92.2 m95 -147.51 93.35 2.21 Favored 'General case' 0 N--CA 1.429 -1.515 0 O-C-N 127.945 3.278 . . . . 0.0 105.774 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 15.3 tttt -99.76 100.13 11.04 Favored 'General case' 0 CA--C 1.505 -0.785 0 CA-C-O 116.986 -1.483 . . . . 0.0 111.158 -179.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.427 HG13 HD21 ' A' ' 36' ' ' LEU 0.305 2.2 p -45.71 131.8 2.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 117.402 -1.285 . . . . 0.0 112.36 -179.745 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -133.64 -38.61 0.91 Allowed 'General case' 0 N--CA 1.445 -0.678 0 O-C-N 126.886 2.616 . . . . 0.0 111.476 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.458 ' CG ' ' HB ' ' A' ' 127' ' ' ILE . 0.2 OUTLIER -81.83 -69.71 0.6 Allowed 'General case' 0 N--CA 1.432 -1.329 0 C-N-CA 119.048 -1.061 . . . . 0.0 112.771 -179.587 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.445 ' HB3' ' CD2' ' A' ' 14' ' ' TYR . 7.5 t-20 71.56 146.92 0.07 Allowed 'General case' 0 C--O 1.245 0.826 0 O-C-N 125.817 1.948 . . . . 0.0 107.182 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.411 ' O ' ' N ' ' A' ' 125' ' ' LYS . 0.4 OUTLIER -156.65 147.36 21.7 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 115.807 -2.044 . . . . 0.0 107.901 -179.363 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.7 t30 46.07 27.08 0.48 Allowed 'General case' 0 N--CA 1.478 0.96 0 O-C-N 125.124 1.515 . . . . 0.0 113.065 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.479 ' CE1' ' HB2' ' A' ' 32' ' ' ALA . 10.7 p90 -81.52 -34.08 31.42 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 118.508 2.781 . . . . 0.0 118.508 -179.382 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -72.75 -39.93 66.44 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-N 120.445 1.475 . . . . 0.0 110.16 179.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.53 -34.84 76.57 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 125.17 2.414 . . . . 0.0 113.218 -179.757 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.529 ' CE2' ' CD2' ' A' ' 117' ' ' TYR . 0.2 OUTLIER -68.58 -28.05 66.6 Favored 'General case' 0 N--CA 1.431 -1.381 0 O-C-N 119.022 -2.298 . . . . 0.0 110.945 -179.981 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 1.5 mmt -77.3 -31.25 54.62 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 179.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -77.92 -20.71 52.35 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 126.484 3.04 . . . . 0.0 109.744 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 42.4 tptt -78.29 -39.92 38.41 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 112.686 -2.052 . . . . 0.0 108.93 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.459 ' HG3' ' CE1' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -73.18 -20.88 60.8 Favored 'General case' 0 CA--C 1.511 -0.556 0 O-C-N 119.552 -1.968 . . . . 0.0 108.273 179.92 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 97.96 46.73 2.2 Favored Glycine 0 N--CA 1.434 -1.488 0 CA-C-O 114.168 -3.573 . . . . 0.0 110.937 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.1 mm -93.6 176.8 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 O-C-N 129.269 3.57 . . . . 0.0 106.319 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -113.43 -178.61 3.42 Favored 'General case' 0 C--N 1.348 0.519 0 CA-C-O 115.156 -2.354 . . . . 0.0 110.849 -179.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . 0.347 0.6 OUTLIER -55.91 -49.23 76.31 Favored 'Isoleucine or valine' 0 C--N 1.352 0.716 0 O-C-N 128.606 3.691 . . . . 0.0 113.659 179.605 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.65 1.1 m -74.11 -41.89 51.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 O-C-N 127.056 2.722 . . . . 0.0 116.108 -179.702 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.6 mtmp? -66.2 -34.46 78.08 Favored 'General case' 0 CA--C 1.507 -0.695 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 -179.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.94 -27.56 39.81 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 125.361 2.505 . . . . 0.0 108.524 179.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.3 tmmm? -71.08 -52.92 16.65 Favored 'General case' 0 C--N 1.353 0.743 0 O-C-N 119.64 -1.912 . . . . 0.0 110.237 -179.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 34.5 mt -72.65 -28.93 63.03 Favored 'General case' 0 N--CA 1.445 -0.698 0 O-C-N 120.247 -1.533 . . . . 0.0 108.416 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -70.21 -31.29 69.07 Favored Glycine 0 CA--C 1.537 1.408 0 O-C-N 127.365 2.916 . . . . 0.0 110.169 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.479 ' HB2' ' CE1' ' A' ' 14' ' ' TYR . . . -72.65 -41.68 65.18 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 126.572 1.949 . . . . 0.0 113.586 -179.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -101.32 14.65 31.31 Favored 'General case' 0 N--CA 1.437 -1.107 0 O-C-N 126.845 2.591 . . . . 0.0 110.555 -179.589 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 14.6 p30 -41.17 -27.47 0.07 Allowed 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 120.009 3.337 . . . . 0.0 120.009 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . 0.274 20.7 m-80 74.35 35.32 0.73 Allowed 'General case' 0 C--O 1.235 0.337 0 O-C-N 123.938 0.774 . . . . 0.0 109.477 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.427 HD21 HG13 ' A' ' 8' ' ' VAL . 2.9 tt -59.44 137.93 57.84 Favored 'General case' 0 N--CA 1.479 0.986 0 O-C-N 125.22 1.575 . . . . 0.0 110.501 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 6.6 ttmt -134.41 87.77 2.39 Favored 'General case' 0 N--CA 1.435 -1.194 0 N-CA-C 106.176 -1.787 . . . . 0.0 106.176 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . 0.315 0.0 OUTLIER -72.15 135.87 46.32 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 103.087 -2.931 . . . . 0.0 103.087 179.809 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.437 ' HB ' ' HB3' ' A' ' 50' ' ' LYS . 3.7 m -102.44 -18.62 15.28 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 121.939 2.154 . . . . 0.0 110.272 -178.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.409 HG23 ' HA ' ' A' ' 3' ' ' ASP . 3.7 mm 40.97 116.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 CA-C-O 126.667 3.127 . . . . 0.0 114.536 179.491 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.432 ' HB ' HG22 ' A' ' 48' ' ' THR . 5.8 m -118.69 109.94 16.7 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 112.479 -2.146 . . . . 0.0 113.611 179.297 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.482 ' NE2' ' CE2' ' A' ' 47' ' ' PHE . 3.8 tp-100 -103.41 77.73 1.54 Allowed 'General case' 0 N--CA 1.444 -0.774 0 O-C-N 123.635 0.584 . . . . 0.0 109.734 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -65.44 -45.05 85.31 Favored 'General case' 0 N--CA 1.426 -1.663 0 CA-C-O 123.391 1.567 . . . . 0.0 110.296 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 163.6 82.1 0.04 OUTLIER Glycine 0 N--CA 1.44 -1.053 0 N-CA-C 105.839 -2.904 . . . . 0.0 105.839 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.354 75.2 m-20 90.77 -33.52 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.727 0 O-C-N 125.364 1.273 . . . . 0.0 108.495 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 18.7 tttt -93.28 128.58 39.34 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 119.256 -2.152 . . . . 0.0 106.74 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.482 ' CE2' ' NE2' ' A' ' 42' ' ' GLN . 3.0 m-85 -113.47 97.85 6.71 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 124.948 1.299 . . . . 0.0 107.601 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.432 HG22 ' HB ' ' A' ' 41' ' ' THR 0.375 5.1 t -93.68 102.36 14.52 Favored 'General case' 0 N--CA 1.432 -1.349 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 179.922 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.407 ' CG1' ' HB ' ' A' ' 60' ' ' VAL 0.622 0.8 OUTLIER -84.91 104.96 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.818 0 N-CA-C 118.089 2.626 . . . . 0.0 118.089 -179.433 . . . . . . . . 4 4 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.437 ' HB3' ' HB ' ' A' ' 39' ' ' THR . 0.0 OUTLIER -64.19 158.43 23.1 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 100.974 -3.713 . . . . 0.0 100.974 178.638 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.408 ' O ' ' N ' ' A' ' 53' ' ' SER 0.3 68.8 tt0 -144.16 53.93 1.28 Allowed 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 103.857 -2.646 . . . . 0.0 103.857 179.993 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -70.9 81.43 0.64 Allowed 'General case' 0 N--CA 1.425 -1.709 0 C-N-CA 118.41 -1.316 . . . . 0.0 109.004 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.408 ' N ' ' O ' ' A' ' 51' ' ' GLU . 1.2 m -111.67 -141.72 0.38 Allowed 'General case' 0 CA--C 1.505 -0.778 0 O-C-N 126.612 2.445 . . . . 0.0 110.428 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -94.27 -7.48 41.87 Favored 'General case' 0 C--O 1.211 -0.924 0 CA-C-N 120.865 1.666 . . . . 0.0 108.066 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.448 ' C ' ' HG2' ' A' ' 56' ' ' ARG . 46.1 m-85 -97.82 -71.66 0.68 Allowed 'General case' 0 N--CA 1.437 -1.087 0 CA-C-O 116.247 -1.835 . . . . 0.0 113.958 -179.758 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.448 ' HG2' ' C ' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -153.02 144.45 23.3 Favored 'General case' 0 C--O 1.254 1.327 0 CA-C-N 123.883 3.038 . . . . 0.0 109.712 -179.195 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -93.69 74.96 4.33 Favored 'General case' 0 C--O 1.219 -0.543 0 N-CA-C 102.269 -3.234 . . . . 0.0 102.269 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -99.61 114.3 37.41 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 O-C-N 127.733 3.146 . . . . 0.0 114.483 179.811 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -62.19 117.71 6.42 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 104.793 -2.299 . . . . 0.0 104.793 179.354 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.524 HG11 ' CE2' ' A' ' 62' ' ' PHE . 92.4 t -99.36 77.04 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.59 1.181 . . . . 0.0 109.003 -178.73 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.409 ' HA ' ' HA ' ' A' ' 48' ' ' THR 0.339 1.2 m -71.18 138.45 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.333 0 O-C-N 117.852 -3.03 . . . . 0.0 115.858 179.92 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.524 ' CE2' HG11 ' A' ' 60' ' ' VAL . 0.2 OUTLIER -156.36 92.2 1.31 Allowed 'General case' 0 N--CA 1.444 -0.772 0 O-C-N 118.991 -2.318 . . . . 0.0 109.717 -179.976 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -57.82 142.38 45.92 Favored 'General case' 0 C--O 1.244 0.775 0 N-CA-C 106.58 -1.637 . . . . 0.0 106.58 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.1 mt -65.08 122.69 17.62 Favored 'General case' 0 N--CA 1.443 -0.822 0 C-N-CA 118.063 -1.455 . . . . 0.0 111.056 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 75.02 9.89 83.98 Favored Glycine 0 N--CA 1.47 0.933 0 N-CA-C 119.863 2.705 . . . . 0.0 119.863 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.424 HG11 ' N ' ' A' ' 67' ' ' ASP 0.425 7.2 t -80.88 -97.69 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.213 0 O-C-N 121.416 -1.049 . . . . 0.0 110.396 -179.97 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.424 ' N ' HG11 ' A' ' 66' ' ' VAL 0.259 21.2 t70 157.82 145.86 0.01 OUTLIER 'General case' 0 CA--C 1.497 -1.088 0 CA-C-O 117.533 -1.222 . . . . 0.0 109.927 179.831 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.473 ' CZ ' ' HB3' ' A' ' 62' ' ' PHE . 0.2 OUTLIER -164.87 164.95 20.81 Favored 'General case' 0 N--CA 1.423 -1.798 0 C-N-CA 119.237 -0.985 . . . . 0.0 110.186 179.98 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -113.75 122.76 48.08 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -123.7 118.34 27.0 Favored 'General case' 0 N--CA 1.439 -0.975 0 O-C-N 121.383 -0.823 . . . . 0.0 110.835 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 2.5 p -81.41 126.29 31.45 Favored 'General case' 0 CA--C 1.496 -1.124 0 CA-C-N 120.047 1.294 . . . . 0.0 108.936 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -78.69 -171.37 2.5 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 104.251 -2.5 . . . . 0.0 104.251 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -114.1 25.38 11.18 Favored 'General case' 0 N--CA 1.436 -1.138 0 CA-C-O 124.117 1.913 . . . . 0.0 112.995 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -153.34 -35.17 0.11 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 119.664 -1.898 . . . . 0.0 112.969 -179.844 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -126.66 -12.89 3.2 Favored Glycine 0 CA--C 1.543 1.786 0 C-N-CA 125.375 1.464 . . . . 0.0 113.215 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.401 HG21 ' N ' ' A' ' 77' ' ' GLU 0.328 0.4 OUTLIER 69.13 171.07 0.3 Allowed 'General case' 0 CA--C 1.492 -1.27 0 C-N-CA 115.987 -2.285 . . . . 0.0 115.436 -179.734 . . . . . . . . 4 4 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.435 ' CB ' HG23 ' A' ' 96' ' ' VAL . 10.9 mt-10 26.21 109.6 0.0 OUTLIER 'General case' 0 N--CA 1.436 -1.129 1 O-C-N 129.423 4.202 . . . . 0.0 116.956 179.547 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.51 HD22 ' CD1' ' A' ' 93' ' ' PHE 0.363 0.4 OUTLIER -146.46 121.11 9.81 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 101.988 -3.338 . . . . 0.0 101.988 -179.889 . . . . . . . . 4 4 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 55.1 m -129.41 154.67 46.71 Favored 'General case' 0 C--O 1.198 -1.625 0 N-CA-C 106.002 -1.851 . . . . 0.0 106.002 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 169.97 -159.08 31.53 Favored Glycine 0 N--CA 1.439 -1.125 0 CA-C-O 118.076 -1.402 . . . . 0.0 110.715 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -148.04 167.69 24.28 Favored 'General case' 0 CA--C 1.492 -1.278 0 C-N-CA 117.252 -1.779 . . . . 0.0 109.992 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . 0.486 ' CE3' ' CA ' ' A' ' 91' ' ' GLY 0.271 63.1 m95 -121.66 138.12 54.47 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 101.693 -3.447 . . . . 0.0 101.693 179.934 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.407 HG21 HG23 ' A' ' 90' ' ' VAL . 12.4 t -140.97 140.85 34.44 Favored 'General case' 0 N--CA 1.426 -1.64 0 CA-C-O 123.516 1.627 . . . . 0.0 107.885 -179.747 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' MET . . . . . 0.404 ' HA ' HD22 ' A' ' 89' ' ' LEU . 3.6 ttm -85.21 133.91 34.17 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 104.616 -2.364 . . . . 0.0 104.616 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . 0.649 1.5 mm-40 -105.51 18.55 22.04 Favored 'General case' 0 N--CA 1.428 -1.574 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 93.69 -64.03 1.85 Allowed Glycine 0 N--CA 1.427 -1.911 0 N-CA-C 105.85 -2.9 . . . . 0.0 105.85 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -101.57 -7.67 22.55 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 117.683 2.475 . . . . 0.0 117.683 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . 0.358 6.6 mtmt -162.32 132.07 4.55 Favored 'General case' 0 CA--C 1.489 -1.398 0 O-C-N 127.096 2.747 . . . . 0.0 109.284 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.404 HD22 ' HA ' ' A' ' 84' ' ' MET . 0.0 OUTLIER -75.73 121.9 23.22 Favored 'General case' 0 C--N 1.309 -1.188 0 O-C-N 126.639 2.462 . . . . 0.0 104.988 179.766 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.407 HG23 HG21 ' A' ' 83' ' ' THR . 18.1 m -116.54 135.95 55.17 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 N-CA-C 105.698 -1.964 . . . . 0.0 105.698 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.486 ' CA ' ' CE3' ' A' ' 82' ' ' TRP . . . -115.44 118.45 4.28 Favored Glycine 0 CA--C 1.537 1.427 0 C-N-CA 126.525 2.012 . . . . 0.0 109.005 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 3.4 mtmm -112.3 147.34 36.52 Favored 'General case' 0 N--CA 1.432 -1.327 0 N-CA-C 103.569 -2.752 . . . . 0.0 103.569 179.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.51 ' CD1' HD22 ' A' ' 78' ' ' LEU . 55.2 m-85 -146.18 116.5 7.48 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 114.654 -1.157 . . . . 0.0 112.667 179.702 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 44.2 mtpt -88.53 -171.11 3.2 Favored 'General case' 0 N--CA 1.433 -1.295 0 C-N-CA 127.298 2.239 . . . . 0.0 108.146 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . 0.359 1.3 ttt180 -149.12 134.7 18.63 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 106.138 -1.801 . . . . 0.0 106.138 -179.712 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.435 HG23 ' CB ' ' A' ' 77' ' ' GLU . 17.0 m -57.73 -38.31 64.35 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 CA-C-O 123.809 1.766 . . . . 0.0 113.321 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . 0.366 96.3 m-20 -76.09 7.08 4.45 Favored 'General case' 0 C--O 1.253 1.277 0 CA-C-N 112.531 -2.122 . . . . 0.0 116.191 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 38.1 p30 -161.33 -17.92 0.05 OUTLIER 'General case' 0 N--CA 1.421 -1.898 0 N-CA-C 116.957 2.206 . . . . 0.0 116.957 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 58.24 19.21 38.48 Favored Glycine 0 C--O 1.228 -0.274 0 CA-C-O 124.737 2.298 . . . . 0.0 114.476 -179.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 9.7 mmtm -78.0 -103.59 0.02 OUTLIER 'General case' 0 C--O 1.199 -1.597 0 O-C-N 120.037 -1.86 . . . . 0.0 111.322 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 167.65 167.94 0.03 OUTLIER 'General case' 0 N--CA 1.438 -1.043 0 C-N-CA 130.058 3.343 . . . . 0.0 110.603 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.402 HD21 ' HB2' ' A' ' 93' ' ' PHE . 9.4 tt -153.91 154.27 33.56 Favored 'General case' 0 C--O 1.242 0.676 0 C-N-CA 131.693 3.997 . . . . 0.0 104.55 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.488 ' CG2' ' HB ' ' A' ' 118' ' ' THR . 13.4 tt -141.85 160.18 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.328 0 C-N-CA 116.469 -2.092 . . . . 0.0 110.277 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.422 ' N ' ' CG1' ' A' ' 103' ' ' ILE . . . -149.53 111.84 4.69 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 179.797 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.4 p -102.65 105.88 18.96 Favored 'Isoleucine or valine' 0 C--O 1.244 0.782 0 CA-C-O 124.824 2.249 . . . . 0.0 112.068 -179.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.435 ' CG ' ' HG2' ' A' ' 115' ' ' GLN 0.26 78.4 mtt180 -79.23 93.08 5.18 Favored 'General case' 0 N--CA 1.428 -1.573 0 CA-C-N 112.181 -2.281 . . . . 0.0 106.127 -179.848 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.424 ' HG3' ' HB ' ' A' ' 114' ' ' ILE . 21.2 pt-20 -101.5 82.73 2.34 Favored 'General case' 0 N--CA 1.425 -1.677 0 O-C-N 127.581 3.051 . . . . 0.0 110.339 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.532 HG23 ' CZ ' ' A' ' 2' ' ' PHE 0.391 4.4 tt -60.89 129.2 23.28 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.984 0 C-N-CA 114.485 -2.886 . . . . 0.0 114.999 -179.827 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.2 t -125.76 76.04 1.54 Allowed 'General case' 0 C--O 1.215 -0.733 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 179.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 80.55 -89.94 1.33 Allowed Glycine 0 CA--C 1.501 -0.822 0 C-N-CA 126.134 1.826 . . . . 0.0 112.636 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . 0.374 0.4 OUTLIER -116.32 22.79 12.59 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 115.785 -2.055 . . . . 0.0 110.456 -179.793 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.411 ' HB2' HD13 ' A' ' 114' ' ' ILE . 1.2 pt-20 -132.54 119.86 21.09 Favored 'General case' 0 C--O 1.211 -0.935 0 O-C-N 128.4 3.562 . . . . 0.0 110.933 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.46 ' HB2' ' CH2' ' A' ' 6' ' ' TRP . 0.9 OUTLIER -95.55 59.71 2.14 Favored 'General case' 0 CA--C 1.501 -0.933 0 O-C-N 128.725 3.766 . . . . 0.0 107.969 -179.647 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.517 ' CG1' ' CD1' ' A' ' 127' ' ' ILE 0.262 1.4 mp -51.81 127.0 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.762 0 O-C-N 125.508 1.755 . . . . 0.0 108.335 -179.621 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . 0.435 ' HG2' ' CG ' ' A' ' 106' ' ' ARG . 28.0 mt-30 -124.72 134.29 52.89 Favored 'General case' 0 C--O 1.246 0.904 0 N-CA-C 103.14 -2.911 . . . . 0.0 103.14 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 29.5 p -97.46 178.74 5.1 Favored 'General case' 0 N--CA 1.433 -1.279 0 O-C-N 128.304 3.503 . . . . 0.0 108.192 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . 0.529 ' CD2' ' CE2' ' A' ' 17' ' ' PHE . 19.1 m-85 -146.77 97.92 2.98 Favored 'General case' 0 CA--C 1.497 -1.086 0 CA-C-O 114.481 -2.676 . . . . 0.0 112.06 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.488 ' HB ' ' CG2' ' A' ' 103' ' ' ILE . 0.3 OUTLIER -116.2 94.75 4.78 Favored 'General case' 0 C--O 1.254 1.325 1 O-C-N 129.386 4.179 . . . . 0.0 112.868 179.76 . . . . . . . . 4 4 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 59.8 t80 -72.42 -14.09 61.61 Favored 'General case' 0 C--N 1.346 0.446 0 CA-C-O 122.472 1.13 . . . . 0.0 108.557 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -179.63 -81.29 0.0 OUTLIER 'General case' 0 C--N 1.292 -1.915 0 CA-C-N 113.747 -1.57 . . . . 0.0 113.379 -179.705 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -128.07 28.15 4.41 Favored Glycine 0 C--N 1.366 2.207 0 C-N-CA 126.579 2.037 . . . . 0.0 116.745 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 5.2 t -140.89 92.79 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -64.82 178.86 0.73 Allowed 'General case' 0 N--CA 1.428 -1.573 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.432 ' HB1' ' CB ' ' A' ' 17' ' ' PHE . . . -171.54 101.57 0.19 Allowed 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 103.778 -2.675 . . . . 0.0 103.778 179.79 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.411 ' N ' ' O ' ' A' ' 12' ' ' GLU . 0.0 OUTLIER -80.02 147.52 31.49 Favored 'General case' 0 C--O 1.244 0.811 0 O-C-N 126.802 2.563 . . . . 0.0 109.76 -179.882 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -137.7 78.64 1.7 Allowed 'General case' 0 C--O 1.214 -0.786 0 O-C-N 126.726 2.516 . . . . 0.0 104.863 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.517 ' CD1' ' CG1' ' A' ' 114' ' ' ILE . 5.5 mm -67.45 107.42 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.755 1 O-C-N 129.558 4.286 . . . . 0.0 113.526 -179.758 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.404 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 0.3 OUTLIER -99.74 151.03 21.7 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 179.348 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . 0.276 3.5 mmtt -115.83 44.28 1.94 Allowed 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.524 ' HB2' ' CZ3' ' A' ' 6' ' ' TRP . 23.9 tttm 32.32 86.85 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 126.686 1.994 . . . . 0.0 115.205 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . 0.733 0.5 OUTLIER . . . . . 0 N--CA 1.435 -1.224 0 CA-C-O 116.683 -1.627 . . . . 0.0 114.85 -179.679 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 . . . . . 0 N--CA 1.447 -0.617 0 CA-C-O 122.309 1.052 . . . . 0.0 112.94 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -154.6 100.72 2.27 Favored 'General case' 0 CA--C 1.491 -1.289 0 CA-C-O 127.465 3.507 . . . . 0.0 112.185 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 159.11 -168.1 35.05 Favored Glycine 0 CA--C 1.499 -0.952 0 C-N-CA 116.506 -2.759 . . . . 0.0 110.905 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.46 ' HG1' ' N ' ' A' ' 6' ' ' TRP 0.506 0.4 OUTLIER -97.28 164.88 12.29 Favored 'General case' 0 CA--C 1.493 -1.227 0 CA-C-N 117.062 0.431 . . . . 0.0 111.755 -179.891 . . . . . . . . 4 4 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.534 ' CZ3' ' HB2' ' A' ' 130' ' ' LYS 0.274 90.8 m95 -152.25 121.26 6.63 Favored 'General case' 0 N--CA 1.426 -1.639 0 O-C-N 127.027 2.704 . . . . 0.0 107.922 179.765 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 13.6 ttpt -124.82 97.87 5.46 Favored 'General case' 0 C--O 1.205 -1.274 0 CA-C-O 115.275 -2.297 . . . . 0.0 105.815 179.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.417 ' CG1' ' HB3' ' A' ' 36' ' ' LEU . 0.4 OUTLIER -38.65 138.64 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 O-C-N 126.309 2.256 . . . . 0.0 111.043 -179.987 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -137.34 16.42 2.97 Favored 'General case' 0 C--O 1.209 -1.067 0 O-C-N 126.109 2.13 . . . . 0.0 108.231 -179.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 171.13 135.39 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.439 0 CA-C-O 121.391 0.615 . . . . 0.0 110.159 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -118.86 -169.11 1.67 Allowed 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 116.928 -1.511 . . . . 0.0 107.869 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -145.83 -45.91 0.21 Allowed 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 120.786 1.63 . . . . 0.0 109.285 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 38.4 t30 -123.3 7.97 9.08 Favored 'General case' 0 N--CA 1.476 0.841 0 O-C-N 125.842 1.964 . . . . 0.0 114.535 179.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.525 ' CD2' ' HD3' ' A' ' 126' ' ' ARG . 32.4 t80 -57.03 -28.52 62.58 Favored 'General case' 0 N--CA 1.434 -1.244 0 CA-C-N 112.666 -2.061 . . . . 0.0 114.854 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -71.47 -38.19 71.26 Favored 'General case' 0 C--O 1.212 -0.92 0 CA-C-O 123.062 1.411 . . . . 0.0 109.721 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 3.0 ttmm -76.66 -26.84 55.28 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-O 123.203 1.477 . . . . 0.0 112.217 179.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.499 ' CB ' ' HB3' ' A' ' 124' ' ' ALA . 2.4 t80 -73.37 -23.06 60.15 Favored 'General case' 0 C--O 1.241 0.611 0 O-C-N 119.09 -2.256 . . . . 0.0 111.779 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 1.1 mmt -75.87 -30.28 58.82 Favored 'General case' 0 C--N 1.317 -0.829 1 O-C-N 116.299 -4.001 . . . . 0.0 107.154 179.656 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -68.3 -33.6 74.62 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 119.747 -1.846 . . . . 0.0 112.41 -179.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 5.1 tptt -75.41 -31.86 60.54 Favored 'General case' 0 C--O 1.215 -0.748 0 CA-C-N 114.786 -1.097 . . . . 0.0 110.297 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.413 ' HE3' ' NH1' ' A' ' 95' ' ' ARG . 0.5 OUTLIER -78.47 -20.3 51.22 Favored 'General case' 0 C--O 1.214 -0.804 0 O-C-N 125.543 1.777 . . . . 0.0 108.039 179.776 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 94.36 65.59 1.02 Allowed Glycine 0 C--N 1.302 -1.308 0 CA-C-O 116.865 -2.075 . . . . 0.0 109.598 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.507 ' CD1' ' HB3' ' A' ' 74' ' ' ASP . 2.1 mm -120.25 157.49 22.8 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 O-C-N 125.021 1.071 . . . . 0.0 109.432 -179.586 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -113.18 165.77 12.08 Favored 'General case' 0 C--O 1.246 0.92 0 O-C-N 124.846 1.341 . . . . 0.0 112.077 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . 0.375 0.0 OUTLIER -23.01 -61.02 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.501 -0.923 0 N-CA-C 120.833 3.642 . . . . 0.0 120.833 179.925 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.615 57.8 t -78.45 -38.55 22.76 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.751 0 CA-C-O 122.629 1.204 . . . . 0.0 112.796 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.42 ' HB3' HG21 ' A' ' 23' ' ' ILE . 0.1 OUTLIER -64.35 -37.28 86.97 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-N 113.523 -1.671 . . . . 0.0 113.798 -179.819 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.409 ' N ' HG23 ' A' ' 23' ' ' ILE . 15.9 ptt85 -77.94 -22.67 49.21 Favored 'General case' 0 C--O 1.22 -0.47 0 O-C-N 119.486 -2.008 . . . . 0.0 109.639 179.715 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 16.7 tttp -74.16 -37.29 64.03 Favored 'General case' 0 C--N 1.35 0.61 0 CA-C-N 113.543 -1.662 . . . . 0.0 113.707 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.5 mt -69.8 -34.48 73.77 Favored 'General case' 0 N--CA 1.436 -1.139 0 C-N-CA 125.757 1.623 . . . . 0.0 111.305 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -77.32 -25.2 64.09 Favored Glycine 0 C--N 1.339 0.715 0 O-C-N 126.344 2.277 . . . . 0.0 111.31 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -75.11 -40.39 59.95 Favored 'General case' 0 C--O 1.22 -0.449 0 O-C-N 120.894 -1.357 . . . . 0.0 111.829 -179.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -98.27 9.74 42.3 Favored 'General case' 0 CA--C 1.51 -0.581 0 O-C-N 128.958 3.911 . . . . 0.0 110.821 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 36.5 p30 -47.6 -29.33 2.83 Favored 'General case' 0 CA--C 1.505 -0.782 0 N-CA-C 120.679 3.585 . . . . 0.0 120.679 179.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . 0.288 2.1 m120 73.98 30.56 1.27 Allowed 'General case' 0 C--O 1.243 0.753 0 CA-C-N 120.77 1.623 . . . . 0.0 110.72 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.449 HD22 ' CE2' ' A' ' 128' ' ' PHE . 9.6 tp -49.86 109.76 0.32 Allowed 'General case' 0 C--N 1.354 0.777 0 C-N-CA 126.435 1.894 . . . . 0.0 108.578 -179.811 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 7.7 ttmm -108.86 102.79 11.78 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 104.664 -2.347 . . . . 0.0 104.664 179.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.424 ' HG ' ' CG2' ' A' ' 49' ' ' VAL 0.26 0.1 OUTLIER -88.57 109.44 20.08 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.907 . . . . . . . . 4 4 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.465 ' HB ' ' CB ' ' A' ' 50' ' ' LYS . 13.6 m -95.16 93.99 7.66 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 104.505 -2.405 . . . . 0.0 104.505 -179.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 21.0 mt -75.99 120.02 25.12 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.213 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 179.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.4 HG23 HG22 ' A' ' 48' ' ' THR . 2.6 m -124.97 100.85 6.78 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 111.78 -2.464 . . . . 0.0 109.655 179.625 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -74.05 162.91 28.53 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-O 116.488 -1.72 . . . . 0.0 111.017 -179.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -151.09 -133.79 0.06 Allowed 'General case' 0 N--CA 1.424 -1.745 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -86.47 70.93 2.88 Favored Glycine 0 C--N 1.302 -1.315 0 N-CA-C 104.729 -3.348 . . . . 0.0 104.729 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 81.24 -8.38 1.4 Allowed 'General case' 0 C--O 1.216 -0.659 0 O-C-N 124.777 0.928 . . . . 0.0 111.756 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.4 tttt -98.31 125.77 43.55 Favored 'General case' 0 C--O 1.25 1.093 0 C-N-CA 118.456 -1.298 . . . . 0.0 108.915 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . 0.261 0.7 OUTLIER -103.92 107.37 18.22 Favored 'General case' 0 N--CA 1.446 -0.654 0 O-C-N 125.983 2.052 . . . . 0.0 111.451 -179.955 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.483 ' HB ' ' CG1' ' A' ' 61' ' ' VAL 0.425 0.1 OUTLIER -94.68 131.04 40.91 Favored 'General case' 0 CA--C 1.493 -1.243 0 O-C-N 125.589 1.805 . . . . 0.0 108.332 179.891 . . . . . . . . 4 4 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.424 ' CG2' ' HG ' ' A' ' 38' ' ' LEU 0.644 0.3 OUTLIER -111.43 98.31 6.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 CA-C-N 113.353 -1.749 . . . . 0.0 112.233 -179.762 . . . . . . . . 4 4 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.465 ' CB ' ' HB ' ' A' ' 39' ' ' THR . 0.6 OUTLIER -65.8 119.67 11.65 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 102.47 -3.159 . . . . 0.0 102.47 -179.941 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -113.94 85.91 2.31 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 124.475 2.083 . . . . 0.0 106.527 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 43.0 m -88.79 63.0 6.67 Favored 'General case' 0 N--CA 1.419 -2.004 0 CA-C-N 113.221 -1.809 . . . . 0.0 106.801 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -77.39 170.32 16.75 Favored 'General case' 0 C--O 1.216 -0.692 0 C-N-CA 115.933 -2.307 . . . . 0.0 111.219 -179.747 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -58.61 -20.85 50.91 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 117.838 -1.545 . . . . 0.0 108.333 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -85.48 -60.73 1.94 Allowed 'General case' 0 N--CA 1.44 -0.944 0 CA-C-O 114.007 -2.901 . . . . 0.0 110.391 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.549 ' CB ' HG21 ' A' ' 58' ' ' ILE . 66.6 mtp85 -133.95 176.87 8.19 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 124.416 3.28 . . . . 0.0 110.46 -179.643 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 10.7 m-80 -138.76 59.02 1.64 Allowed 'General case' 0 C--O 1.215 -0.728 2 C-N-CA 132.002 4.121 . . . . 0.0 100.081 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.549 HG21 ' CB ' ' A' ' 56' ' ' ARG . 1.5 tt -84.18 -44.18 17.87 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 1 C-N-CA 132.688 4.395 . . . . 0.0 119.772 -178.695 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . 0.277 34.2 t0 78.55 140.33 0.07 Allowed 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 104.073 -2.565 . . . . 0.0 104.073 -176.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 58.0 t -112.39 -53.59 5.22 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.152 0 C-N-CA 118.527 -1.269 . . . . 0.0 112.627 -178.245 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.483 ' CG1' ' HB ' ' A' ' 48' ' ' THR 0.398 0.9 OUTLIER 66.97 131.52 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 CA-C-O 126.272 2.939 . . . . 0.0 109.016 -178.907 . . . . . . . . 4 4 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.556 ' CD2' ' CD1' ' A' ' 82' ' ' TRP . 12.5 p90 -164.03 93.76 0.72 Allowed 'General case' 0 N--CA 1.443 -0.817 0 O-C-N 117.05 -3.531 . . . . 0.0 110.334 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -65.59 136.63 56.6 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 105.644 -1.984 . . . . 0.0 105.644 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -50.88 121.86 6.59 Favored 'General case' 0 N--CA 1.437 -1.091 0 O-C-N 125.505 1.753 . . . . 0.0 110.691 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 79.98 3.59 89.43 Favored Glycine 0 C--N 1.35 1.336 0 CA-C-N 112.424 -2.171 . . . . 0.0 117.805 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . 0.378 79.4 t -106.03 97.48 5.67 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 N-CA-C 104.612 -2.366 . . . . 0.0 104.612 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -63.0 177.12 0.61 Allowed 'General case' 0 CA--C 1.484 -1.578 0 C-N-CA 117.584 -1.646 . . . . 0.0 114.605 -179.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.488 ' CD1' ' N ' ' A' ' 68' ' ' PHE . 1.1 p90 -155.98 172.21 18.77 Favored 'General case' 0 N--CA 1.433 -1.304 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.627 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -115.3 140.91 48.7 Favored 'General case' 0 C--N 1.322 -0.609 0 O-C-N 126.858 2.599 . . . . 0.0 105.851 179.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 13.4 t80 -152.65 112.13 3.89 Favored 'General case' 0 C--O 1.206 -1.19 0 CA-C-N 120.525 1.511 . . . . 0.0 114.024 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.5 p -81.79 144.41 31.09 Favored 'General case' 0 C--N 1.315 -0.909 0 O-C-N 119.147 -2.221 . . . . 0.0 105.448 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 10.5 mp -102.28 -175.17 2.75 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 124.592 1.183 . . . . 0.0 108.465 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -90.94 -13.39 33.56 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.135 0.974 . . . . 0.0 111.94 -179.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.507 ' HB3' ' CD1' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -79.63 -11.15 59.88 Favored 'General case' 0 N--CA 1.439 -0.998 0 C-N-CA 119.308 -0.957 . . . . 0.0 110.751 -179.549 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 102.93 22.83 9.03 Favored Glycine 0 C--O 1.204 -1.777 0 O-C-N 125.528 1.768 . . . . 0.0 111.733 -179.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -129.24 155.15 46.01 Favored 'General case' 0 CA--C 1.491 -1.309 0 C-N-CA 117.782 -1.567 . . . . 0.0 112.786 -179.788 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.463 ' CB ' ' HB ' ' A' ' 96' ' ' VAL . 32.1 mp0 -92.41 155.92 17.55 Favored 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 127.572 2.349 . . . . 0.0 112.646 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.53 HD12 ' CG ' ' A' ' 93' ' ' PHE 0.429 0.6 OUTLIER -156.41 153.43 28.87 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 105.264 -2.125 . . . . 0.0 105.264 -179.912 . . . . . . . . 4 4 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.404 ' O ' ' N ' ' A' ' 94' ' ' LYS . 64.2 m -157.67 139.21 13.81 Favored 'General case' 0 C--O 1.197 -1.669 0 N-CA-C 102.884 -3.006 . . . . 0.0 102.884 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 174.81 -172.15 45.2 Favored Glycine 0 C--N 1.293 -1.839 0 C-N-CA 114.116 -3.897 . . . . 0.0 114.759 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 76.3 p -132.88 169.09 17.27 Favored 'General case' 0 C--O 1.187 -2.19 0 CA-C-N 120.563 2.182 . . . . 0.0 109.252 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . 0.556 ' CD1' ' CD2' ' A' ' 62' ' ' PHE . 69.7 m95 -127.1 140.15 52.48 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 102.37 -3.196 . . . . 0.0 102.37 179.693 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.428 HG21 HG21 ' A' ' 90' ' ' VAL . 8.8 t -146.45 142.93 28.62 Favored 'General case' 0 C--O 1.255 1.366 0 CA-C-O 123.803 1.764 . . . . 0.0 109.994 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' MET . . . . . 0.4 ' HA ' HD21 ' A' ' 89' ' ' LEU . 2.0 ttm -81.24 99.67 8.72 Favored 'General case' 0 N--CA 1.425 -1.72 0 CA-C-N 111.111 -2.768 . . . . 0.0 109.584 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . 0.601 29.0 mm-40 -65.61 -104.19 0.0 OUTLIER 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 119.666 1.121 . . . . 0.0 113.248 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -137.39 93.92 0.22 Allowed Glycine 0 N--CA 1.436 -1.337 1 N-CA-C 102.932 -4.067 . . . . 0.0 102.932 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 58.34 21.17 8.01 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 113.191 0.811 . . . . 0.0 113.191 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . 0.33 7.1 mtmt -149.93 112.66 4.78 Favored 'General case' 0 CA--C 1.492 -1.267 0 O-C-N 126.395 2.309 . . . . 0.0 112.326 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.4 HD21 ' HA ' ' A' ' 84' ' ' MET . 0.0 OUTLIER -75.98 130.63 38.73 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 102.478 -3.156 . . . . 0.0 102.478 179.908 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.428 HG21 HG21 ' A' ' 83' ' ' THR . 5.4 m -129.03 136.3 60.02 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.932 0 CA-C-O 116.86 -1.543 . . . . 0.0 108.78 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -112.39 106.75 1.94 Allowed Glycine 0 CA--C 1.539 1.578 0 O-C-N 126.958 2.662 . . . . 0.0 112.86 179.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.411 ' HG2' HD11 ' A' ' 103' ' ' ILE . 8.0 mtpt -93.46 113.08 25.13 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 102.734 -3.061 . . . . 0.0 102.734 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.53 ' CG ' HD12 ' A' ' 78' ' ' LEU . 19.1 m-85 -104.46 96.93 6.94 Favored 'General case' 0 CA--C 1.502 -0.902 0 O-C-N 125.906 2.004 . . . . 0.0 114.492 -179.747 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.404 ' N ' ' O ' ' A' ' 79' ' ' THR . 39.1 mttt -80.04 127.48 32.34 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 126.541 1.936 . . . . 0.0 108.923 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.413 ' NH1' ' HE3' ' A' ' 21' ' ' MET 0.336 0.0 OUTLIER -72.71 144.32 47.71 Favored 'General case' 0 CA--C 1.502 -0.872 0 N-CA-C 104.434 -2.432 . . . . 0.0 104.434 -179.833 . . . . . . . . 4 4 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.463 ' HB ' ' CB ' ' A' ' 77' ' ' GLU . 17.4 t -77.09 -33.66 20.67 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 C-N-CA 125.895 1.678 . . . . 0.0 112.248 -179.782 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . 0.262 0.0 OUTLIER -95.73 -27.88 15.05 Favored 'General case' 0 C--O 1.254 1.294 0 N-CA-C 115.05 1.5 . . . . 0.0 115.05 -179.867 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.401 ' ND2' ' OH ' ' A' ' 119' ' ' TYR . 50.8 t30 -89.7 -25.07 21.39 Favored 'General case' 0 N--CA 1.419 -2.013 0 CA-C-N 114.623 -1.171 . . . . 0.0 113.702 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 64.97 10.24 45.11 Favored Glycine 0 CA--C 1.536 1.363 0 O-C-N 127.149 2.781 . . . . 0.0 113.826 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 73.1 mttt -103.26 159.01 15.93 Favored 'General case' 0 C--O 1.197 -1.662 0 N-CA-C 107.629 -1.248 . . . . 0.0 107.629 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.41 ' HG2' ' N ' ' A' ' 102' ' ' LEU . 2.3 tm-20 -95.27 158.91 15.25 Favored 'General case' 0 N--CA 1.431 -1.382 0 O-C-N 126.442 2.339 . . . . 0.0 116.001 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.513 ' CB ' ' HA ' ' A' ' 119' ' ' TYR . 5.0 tt -138.57 145.71 40.94 Favored 'General case' 0 C--N 1.326 -0.418 1 O-C-N 129.826 4.454 . . . . 0.0 104.477 179.569 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.463 ' CG2' ' HB ' ' A' ' 118' ' ' THR . 3.5 tp -127.39 152.85 35.93 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.071 0 N-CA-C 104.379 -2.452 . . . . 0.0 104.379 -179.435 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -134.76 132.79 39.17 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 114.119 -2.848 . . . . 0.0 106.26 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 10.7 p -120.19 103.65 14.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 O-C-N 125.612 1.82 . . . . 0.0 113.77 -179.383 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . 0.269 36.2 mtt85 -74.6 89.16 2.2 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 104.483 -2.414 . . . . 0.0 104.483 179.561 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -92.08 77.57 5.32 Favored 'General case' 0 N--CA 1.428 -1.571 0 O-C-N 127.041 2.713 . . . . 0.0 114.907 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.524 HD13 ' CH2' ' A' ' 6' ' ' TRP 0.326 0.0 OUTLIER -56.68 101.81 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 CA-C-O 123.274 1.511 . . . . 0.0 112.094 179.961 . . . . . . . . 4 4 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 61.4 m -88.19 71.06 9.26 Favored 'General case' 0 CA--C 1.502 -0.902 0 N-CA-C 104.569 -2.382 . . . . 0.0 104.569 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 66.59 -82.8 0.11 Allowed Glycine 0 C--N 1.344 1.02 0 C-N-CA 128.585 2.993 . . . . 0.0 111.743 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . 0.319 0.1 OUTLIER -98.73 -19.68 17.34 Favored 'General case' 0 C--O 1.221 -0.417 0 CA-C-O 117.651 -1.166 . . . . 0.0 111.911 -179.605 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 45.6 mp0 -105.86 127.93 53.43 Favored 'General case' 0 CA--C 1.498 -1.027 0 O-C-N 124.622 1.201 . . . . 0.0 112.175 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.403 ' HB3' ' CE3' ' A' ' 6' ' ' TRP . 2.0 tt -93.67 139.5 30.73 Favored 'General case' 0 C--O 1.211 -0.925 0 N-CA-C 100.208 -3.997 . . . . 0.0 100.208 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.413 HD12 HD13 ' A' ' 127' ' ' ILE . 68.5 mt -131.53 145.7 34.73 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 O-C-N 128.991 3.932 . . . . 0.0 103.776 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 9.1 mt-30 -134.52 129.9 35.81 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 24.3 p -101.65 -176.53 3.16 Favored 'General case' 0 C--O 1.249 1.035 0 O-C-N 126.703 2.502 . . . . 0.0 104.933 179.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . 0.437 ' HB2' ' HB1' ' A' ' 124' ' ' ALA . 68.4 m-85 -160.56 87.07 0.74 Allowed 'General case' 0 CA--C 1.475 -1.939 0 CA-C-O 115.789 -2.053 . . . . 0.0 109.69 179.661 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.463 ' HB ' ' CG2' ' A' ' 103' ' ' ILE . 95.4 m -94.47 101.29 13.2 Favored 'General case' 0 N--CA 1.433 -1.294 0 O-C-N 128.247 3.467 . . . . 0.0 110.107 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.513 ' HA ' ' CB ' ' A' ' 102' ' ' LEU . 5.8 t80 -77.97 -77.65 0.15 Allowed 'General case' 0 CA--C 1.499 -0.983 0 O-C-N 125.816 1.948 . . . . 0.0 107.523 -179.742 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.447 ' HG3' ' CE2' ' A' ' 119' ' ' TYR . 1.5 mm-40 -108.44 -75.7 0.63 Allowed 'General case' 0 C--N 1.298 -1.642 0 CA-C-O 117.522 -1.228 . . . . 0.0 108.462 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -133.71 32.94 2.62 Favored Glycine 0 CA--C 1.528 0.863 0 O-C-N 127.776 3.172 . . . . 0.0 114.74 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.411 HG13 ' HA ' ' A' ' 17' ' ' PHE . 0.3 OUTLIER -139.59 122.35 17.4 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.68 0 O-C-N 119.789 -2.006 . . . . 0.0 110.477 -179.883 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -95.82 177.65 5.7 Favored 'General case' 0 N--CA 1.431 -1.402 0 O-C-N 120.522 -1.361 . . . . 0.0 107.825 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.499 ' HB3' ' CB ' ' A' ' 17' ' ' PHE . . . -169.76 77.16 0.09 Allowed 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 115.709 -2.396 . . . . 0.0 109.193 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 12.1 mptt -64.3 141.27 58.83 Favored 'General case' 0 C--O 1.251 1.142 0 CA-C-N 118.488 0.586 . . . . 0.0 109.541 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.525 ' HD3' ' CD2' ' A' ' 14' ' ' TYR . 14.3 mtm180 -137.58 83.1 1.96 Allowed 'General case' 0 CA--C 1.509 -0.623 0 O-C-N 127.315 2.884 . . . . 0.0 108.535 179.78 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.421 HD11 ' N ' ' A' ' 127' ' ' ILE . 0.8 OUTLIER -74.84 119.31 22.15 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.788 1 O-C-N 129.79 4.432 . . . . 0.0 110.757 179.894 . . . . . . . . 4 4 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.449 ' CE2' HD22 ' A' ' 36' ' ' LEU . 0.1 OUTLIER -102.99 169.9 8.29 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 112.336 -2.211 . . . . 0.0 108.247 -180.0 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.12 0.49 11.26 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 105.693 -1.965 . . . . 0.0 105.693 179.786 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.534 ' HB2' ' CZ3' ' A' ' 6' ' ' TRP . 34.7 tttt 73.6 95.91 0.07 Allowed 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 120.684 1.583 . . . . 0.0 112.436 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . 0.854 3.8 mt-10 . . . . . 0 N--CA 1.435 -1.178 0 N-CA-C 117.523 2.416 . . . . 0.0 117.523 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . 0.523 ' CE1' HG12 ' A' ' 108' ' ' ILE . 97.3 m-85 . . . . . 0 CA--C 1.499 -0.983 0 N-CA-C 116.084 1.883 . . . . 0.0 116.084 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -166.39 86.59 0.32 Allowed 'General case' 0 CA--C 1.494 -1.204 0 C-N-CA 117.985 -1.486 . . . . 0.0 112.686 -179.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 150.47 -130.02 3.11 Favored Glycine 0 C--N 1.31 -0.915 0 C-N-CA 116.503 -2.761 . . . . 0.0 112.114 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . 0.625 0.8 OUTLIER -123.11 161.2 24.86 Favored 'General case' 0 N--CA 1.432 -1.339 0 CA-C-O 124.158 1.932 . . . . 0.0 112.014 -179.933 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.508 ' CD1' HG13 ' A' ' 40' ' ' ILE 0.264 86.7 m95 -153.77 114.7 4.07 Favored 'General case' 0 N--CA 1.431 -1.393 0 CA-C-N 111.872 -2.422 . . . . 0.0 110.856 179.896 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 30.4 ttmt -109.56 108.45 18.91 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-O 115.174 -2.346 . . . . 0.0 107.057 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.42 ' HB ' ' CE2' ' A' ' 128' ' ' PHE 0.411 8.2 p -48.51 147.0 0.76 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.846 0 CA-C-N 121.202 1.819 . . . . 0.0 109.222 -179.964 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.425 ' HB3' ' HG3' ' A' ' 129' ' ' LYS . 0.0 OUTLIER -157.28 14.09 0.25 Allowed 'General case' 0 CA--C 1.499 -0.996 0 C-N-CA 117.464 -1.695 . . . . 0.0 111.455 -179.126 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.27 -57.65 0.65 Allowed 'General case' 0 CA--C 1.487 -1.465 0 O-C-N 116.679 -3.763 . . . . 0.0 109.965 -179.684 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 59.74 170.91 0.08 Allowed 'General case' 0 C--O 1.244 0.778 0 O-C-N 127.529 3.018 . . . . 0.0 108.928 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.452 ' O ' ' N ' ' A' ' 125' ' ' LYS . 6.0 tt0 -170.43 134.51 1.14 Allowed 'General case' 0 C--N 1.3 -1.583 0 O-C-N 117.792 -3.068 . . . . 0.0 107.534 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.564 ' ND2' ' CD1' ' A' ' 17' ' ' PHE . 1.0 OUTLIER 62.67 29.78 16.87 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-N 122.563 2.438 . . . . 0.0 113.857 179.844 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . 0.348 9.3 t80 -98.11 -64.5 1.03 Allowed 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 121.201 3.778 . . . . 0.0 121.201 -178.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.09 -38.74 77.0 Favored 'General case' 0 CA--C 1.498 -1.049 0 CA-C-N 124.49 3.313 . . . . 0.0 113.792 -179.061 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.539 ' HB3' ' CD1' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -67.27 -43.23 82.35 Favored 'General case' 0 N--CA 1.422 -1.829 0 C-N-CA 127.643 2.377 . . . . 0.0 113.578 179.584 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.564 ' CD1' ' ND2' ' A' ' 13' ' ' ASN 0.266 64.8 m-85 -80.03 -20.1 46.11 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 111.188 -2.733 . . . . 0.0 113.557 -178.057 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.499 ' CB ' HG13 ' A' ' 23' ' ' ILE . 0.5 OUTLIER -72.21 -23.11 61.2 Favored 'General case' 0 N--CA 1.435 -1.22 0 O-C-N 117.035 -3.541 . . . . 0.0 105.983 176.591 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -74.24 -24.89 59.37 Favored 'General case' 0 C--N 1.348 0.528 0 O-C-N 120.378 -1.451 . . . . 0.0 109.849 179.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.497 ' CD ' HG13 ' A' ' 122' ' ' VAL . 11.3 tttp -79.1 -32.58 44.64 Favored 'General case' 0 N--CA 1.432 -1.367 0 CA-C-O 116.196 -1.859 . . . . 0.0 110.589 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.24 -23.5 57.54 Favored 'General case' 0 C--O 1.214 -0.814 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 179.312 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 104.25 40.89 2.17 Favored Glycine 0 N--CA 1.445 -0.714 0 CA-C-O 115.747 -2.696 . . . . 0.0 109.935 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.499 HG13 ' CB ' ' A' ' 18' ' ' MET . 2.2 mm -86.99 83.44 2.19 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 CA-C-N 120.49 2.145 . . . . 0.0 106.994 -179.682 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -42.09 112.91 0.38 Allowed 'General case' 0 C--O 1.248 1.009 0 O-C-N 124.91 1.381 . . . . 0.0 114.357 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . 0.364 84.7 t 18.52 -66.73 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.502 -0.893 0 N-CA-C 121.066 3.728 . . . . 0.0 121.066 -179.784 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.538 1.3 m -71.52 -24.49 23.63 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.122 0 N-CA-C 117.448 2.388 . . . . 0.0 117.448 -179.531 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.456 ' HD2' ' CB ' ' A' ' 74' ' ' ASP . 1.5 mtmp? -72.04 -29.22 63.94 Favored 'General case' 0 C--N 1.318 -0.775 0 C-N-CA 119.072 -1.051 . . . . 0.0 112.993 179.759 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.446 ' N ' ' CG2' ' A' ' 23' ' ' ILE . 2.6 ptt-85 -78.49 -21.51 48.87 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 116.777 -1.969 . . . . 0.0 109.363 179.83 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 12.0 tttt -77.78 -43.21 31.38 Favored 'General case' 0 CA--C 1.502 -0.869 0 CA-C-N 113.553 -1.658 . . . . 0.0 109.924 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -79.02 -23.07 44.58 Favored 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 -179.729 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -76.68 -34.88 42.4 Favored Glycine 0 CA--C 1.527 0.793 0 O-C-N 125.613 1.821 . . . . 0.0 112.476 179.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -72.9 -38.61 66.87 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 6.5 m-70 -98.92 20.33 13.4 Favored 'General case' 0 N--CA 1.439 -0.99 0 O-C-N 127.377 2.923 . . . . 0.0 112.604 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 23.6 p30 -47.75 -31.52 4.91 Favored 'General case' 0 CA--C 1.497 -1.096 0 N-CA-C 119.347 3.091 . . . . 0.0 119.347 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . 0.309 0.6 OUTLIER 76.59 15.85 2.06 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 119.291 0.951 . . . . 0.0 109.264 -179.809 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.455 ' CD2' ' NH2' ' A' ' 126' ' ' ARG . 30.5 tp -42.1 114.84 0.6 Allowed 'General case' 0 CA--C 1.5 -0.946 0 C-N-CA 128.636 2.775 . . . . 0.0 110.249 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -116.76 94.64 4.68 Favored 'General case' 0 C--O 1.211 -0.967 0 N-CA-C 105.246 -2.131 . . . . 0.0 105.246 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.422 HD13 HD12 ' A' ' 36' ' ' LEU 0.256 0.1 OUTLIER -79.8 105.28 10.97 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 179.73 . . . . . . . . 4 4 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.49 ' HB ' ' CB ' ' A' ' 50' ' ' LYS . 99.3 m -94.98 80.4 3.65 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 104.268 -2.493 . . . . 0.0 104.268 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.508 HG13 ' CD1' ' A' ' 6' ' ' TRP . 0.9 OUTLIER -60.23 134.99 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.371 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.331 179.977 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.3 m -128.45 108.19 10.35 Favored 'General case' 0 N--CA 1.475 0.81 0 O-C-N 128.043 3.34 . . . . 0.0 108.437 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -99.07 105.72 17.86 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 117.802 -1.094 . . . . 0.0 113.806 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -108.77 68.02 0.67 Allowed 'General case' 0 N--CA 1.424 -1.767 0 CA-C-O 126.756 3.17 . . . . 0.0 108.019 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 77.79 -108.55 2.63 Favored Glycine 0 C--N 1.293 -1.853 0 N-CA-C 106.956 -2.457 . . . . 0.0 106.956 179.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -102.38 48.3 0.87 Allowed 'General case' 0 N--CA 1.444 -0.735 0 CA-C-O 123.04 1.4 . . . . 0.0 110.456 179.688 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 3.1 ttmt -149.06 129.28 13.67 Favored 'General case' 0 C--N 1.312 -1.056 0 C-N-CA 116.479 -2.088 . . . . 0.0 107.657 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -114.53 88.12 2.79 Favored 'General case' 0 CA--C 1.511 -0.557 0 CA-C-O 121.958 0.885 . . . . 0.0 110.117 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . 0.349 14.8 t -95.19 85.92 4.43 Favored 'General case' 0 N--CA 1.428 -1.543 0 CA-C-O 125.799 2.714 . . . . 0.0 108.789 -179.742 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.431 HG13 HD11 ' A' ' 40' ' ' ILE 0.654 1.0 OUTLIER -70.39 108.67 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.768 0 N-CA-C 117.758 2.503 . . . . 0.0 117.758 -179.948 . . . . . . . . 4 4 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.49 ' CB ' ' HB ' ' A' ' 39' ' ' THR . 15.9 tttp -69.55 117.46 11.18 Favored 'General case' 0 C--N 1.303 -1.416 1 N-CA-C 99.508 -4.256 . . . . 0.0 99.508 179.218 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.434 ' HG3' ' CD1' ' A' ' 36' ' ' LEU . 1.1 tt0 -112.67 104.96 13.03 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 -179.334 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -103.45 51.63 0.79 Allowed 'General case' 0 C--N 1.289 -2.049 0 N-CA-C 105.317 -2.105 . . . . 0.0 105.317 179.562 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 4.3 t -73.05 21.37 0.07 Allowed 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 113.175 -1.83 . . . . 0.0 115.474 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 73.79 -51.42 0.69 Allowed 'General case' 0 CA--C 1.498 -1.032 0 CA-C-N 122.245 2.293 . . . . 0.0 109.787 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -67.1 -44.33 80.25 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-O 115.119 -2.372 . . . . 0.0 110.209 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.478 ' HG3' ' CG2' ' A' ' 58' ' ' ILE . 9.3 ptp180 -149.56 126.17 10.99 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 123.633 2.924 . . . . 0.0 106.795 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -99.71 74.42 1.85 Allowed 'General case' 0 N--CA 1.465 0.291 1 N-CA-C 100.197 -4.001 . . . . 0.0 100.197 179.784 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.478 ' CG2' ' HG3' ' A' ' 56' ' ' ARG . 3.3 tp -115.94 117.83 56.8 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.82 1 C-N-CA 132.417 4.287 . . . . 0.0 118.9 -179.104 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.95 125.58 26.77 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 103.607 -2.738 . . . . 0.0 103.607 178.163 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 1.4 t -107.85 103.96 16.32 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 O-C-N 124.515 1.135 . . . . 0.0 113.217 -178.064 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . 0.395 1.7 m -88.49 141.97 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.159 0 CA-C-O 125.091 2.377 . . . . 0.0 113.888 179.593 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.528 ' HB3' ' CE1' ' A' ' 68' ' ' PHE . 0.1 OUTLIER -160.75 95.64 1.1 Allowed 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 113.128 -1.851 . . . . 0.0 108.772 -179.833 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -54.49 144.57 20.8 Favored 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 104.772 -2.307 . . . . 0.0 104.772 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.9 mp -68.89 115.7 8.51 Favored 'General case' 0 N--CA 1.432 -1.345 0 O-C-N 119.475 -2.015 . . . . 0.0 107.238 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 81.87 26.62 48.93 Favored Glycine 0 N--CA 1.471 0.971 0 C-N-CA 126.713 2.102 . . . . 0.0 118.172 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . 0.387 41.2 t -114.8 81.39 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 N-CA-C 104.662 -2.347 . . . . 0.0 104.662 179.849 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -38.43 114.08 0.34 Allowed 'General case' 0 C--N 1.307 -1.262 0 O-C-N 125.689 1.868 . . . . 0.0 114.437 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.528 ' CE1' ' HB3' ' A' ' 62' ' ' PHE . 37.6 p90 -119.95 164.86 15.44 Favored 'General case' 0 N--CA 1.427 -1.598 0 O-C-N 125.18 1.55 . . . . 0.0 107.977 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -108.93 138.1 45.8 Favored 'General case' 0 C--N 1.319 -0.74 0 O-C-N 126.171 2.169 . . . . 0.0 106.997 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.482 ' HB3' ' CD2' ' A' ' 78' ' ' LEU . 35.9 t80 -133.73 95.57 3.5 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 119.787 1.176 . . . . 0.0 111.248 -179.596 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.47 ' HA ' HD23 ' A' ' 72' ' ' LEU . 1.9 p -72.26 79.22 0.99 Allowed 'General case' 0 N--CA 1.432 -1.36 0 CA-C-O 117.529 -1.224 . . . . 0.0 112.386 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.698 ' N ' ' CD2' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -40.06 175.75 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.813 1 O-C-N 130.355 4.785 . . . . 0.0 110.028 174.955 . . . . . . . . 4 4 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.52 -45.38 13.64 Favored 'General case' 0 C--N 1.351 0.671 0 O-C-N 120.522 -1.361 . . . . 0.0 113.613 -178.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.456 ' CB ' ' HD2' ' A' ' 27' ' ' LYS . 0.4 OUTLIER -148.96 25.74 0.91 Allowed 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 179.956 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.43 ' C ' ' HG ' ' A' ' 72' ' ' LEU . . . -95.03 -32.23 7.22 Favored Glycine 0 CA--C 1.544 1.874 0 CA-C-N 112.69 -2.05 . . . . 0.0 113.312 179.803 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.525 ' N ' ' HG ' ' A' ' 72' ' ' LEU 0.376 0.3 OUTLIER 84.76 117.82 0.04 OUTLIER 'General case' 0 C--N 1.305 -1.364 0 CA-C-O 114.465 -2.683 . . . . 0.0 107.175 -177.878 . . . . . . . . 4 4 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.461 ' CB ' HG23 ' A' ' 96' ' ' VAL . 0.6 OUTLIER -3.9 120.29 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.63 1 O-C-N 130.134 4.646 . . . . 0.0 114.405 -179.412 . . . . . . . . 4 4 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.51 ' HG ' ' CD1' ' A' ' 93' ' ' PHE 0.518 0.5 OUTLIER -133.22 122.12 23.49 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 102.022 -3.325 . . . . 0.0 102.022 179.772 . . . . . . . . 4 4 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 10.7 t -137.59 123.35 19.96 Favored 'General case' 0 C--O 1.198 -1.637 0 N-CA-C 101.765 -3.421 . . . . 0.0 101.765 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.408 ' HA3' ' HA ' ' A' ' 93' ' ' PHE . . . -156.89 -149.31 5.36 Favored Glycine 0 C--N 1.308 -1.02 0 C-N-CA 116.921 -2.562 . . . . 0.0 110.419 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 22.1 p -155.32 165.79 35.57 Favored 'General case' 0 C--O 1.198 -1.607 0 CA-C-O 123.838 1.78 . . . . 0.0 109.037 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . 0.542 ' CZ2' ' CZ ' ' A' ' 106' ' ' ARG 0.322 12.2 m95 -112.71 129.46 56.4 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 100.772 -3.788 . . . . 0.0 100.772 -179.879 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.404 HG21 HG22 ' A' ' 90' ' ' VAL . 1.7 t -144.17 100.81 3.62 Favored 'General case' 0 C--O 1.262 1.716 0 O-C-N 121.218 -0.926 . . . . 0.0 110.254 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 6.4 ttp -52.58 112.93 0.91 Allowed 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 105.471 -2.048 . . . . 0.0 105.471 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . 0.622 3.8 mm-40 -77.8 -56.34 4.59 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 124.806 1.316 . . . . 0.0 110.07 -179.731 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 160.24 124.8 0.75 Allowed Glycine 0 C--O 1.22 -0.725 0 N-CA-C 103.402 -3.879 . . . . 0.0 103.402 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . 0.26 0.1 OUTLIER 55.97 15.64 1.82 Allowed 'General case' 0 C--O 1.245 0.832 0 CA-C-O 116.572 -1.68 . . . . 0.0 113.638 -179.986 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . 0.418 3.1 mppt? -174.12 150.26 1.53 Allowed 'General case' 0 CA--C 1.496 -1.101 0 O-C-N 125.772 1.92 . . . . 0.0 106.812 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.413 ' HB3' ' HB2' ' A' ' 106' ' ' ARG . 0.7 OUTLIER -113.4 137.88 50.88 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 102.331 -3.211 . . . . 0.0 102.331 -179.879 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.404 HG22 HG21 ' A' ' 83' ' ' THR . 18.5 m -118.24 134.37 62.08 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.028 0 N-CA-C 105.547 -2.02 . . . . 0.0 105.547 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -113.65 95.09 0.73 Allowed Glycine 0 C--N 1.344 0.981 0 C-N-CA 128.164 2.792 . . . . 0.0 108.755 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -90.83 168.64 11.57 Favored 'General case' 0 N--CA 1.436 -1.135 0 N-CA-C 104.323 -2.473 . . . . 0.0 104.323 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.51 ' CD1' ' HG ' ' A' ' 78' ' ' LEU . 23.5 m-85 -157.71 97.33 1.57 Allowed 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 118.454 -1.299 . . . . 0.0 108.063 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 14.5 mtmt -74.39 161.2 30.07 Favored 'General case' 0 N--CA 1.446 -0.653 0 O-C-N 125.125 1.516 . . . . 0.0 108.47 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.408 ' HD2' ' N ' ' A' ' 95' ' ' ARG 0.457 0.9 OUTLIER -119.47 139.98 51.2 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 179.69 . . . . . . . . 4 4 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.461 HG23 ' CB ' ' A' ' 77' ' ' GLU . 3.1 m -83.0 -13.38 12.04 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 179.792 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . 0.333 14.3 p-10 -79.13 3.93 16.16 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 113.504 -1.68 . . . . 0.0 112.361 179.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . 0.256 0.2 OUTLIER -174.93 -29.28 0.01 OUTLIER 'General case' 0 N--CA 1.426 -1.635 0 C-N-CA 117.698 -1.601 . . . . 0.0 114.069 -179.735 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 97.56 20.07 23.31 Favored Glycine 0 N--CA 1.445 -0.701 0 N-CA-C 115.21 0.844 . . . . 0.0 115.21 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 39.3 mttt -82.95 -159.79 0.36 Allowed 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 116.159 -2.216 . . . . 0.0 106.344 -179.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -143.0 148.67 37.17 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-O 117.23 -1.367 . . . . 0.0 109.889 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.501 ' HB2' ' HA ' ' A' ' 119' ' ' TYR . 0.3 OUTLIER -133.09 110.1 9.96 Favored 'General case' 0 CA--C 1.543 0.708 1 O-C-N 131.552 5.533 . . . . 0.0 103.217 179.212 . . . . . . . . 4 4 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -92.03 161.18 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.174 0 CA-C-N 114.181 -1.372 . . . . 0.0 111.003 -179.238 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -150.15 106.38 3.47 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 116.152 -1.88 . . . . 0.0 107.376 -179.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 9.2 p -87.8 103.65 13.71 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.519 0 CA-C-N 120.877 1.672 . . . . 0.0 113.587 -179.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.542 ' CZ ' ' CZ2' ' A' ' 82' ' ' TRP . 19.2 mtt-85 -74.48 82.2 1.96 Allowed 'General case' 0 CA--C 1.507 -0.679 0 CA-C-O 124.872 2.273 . . . . 0.0 106.074 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.41 ' O ' ' N ' ' A' ' 109' ' ' SER . 0.2 OUTLIER -86.61 81.37 8.27 Favored 'General case' 0 N--CA 1.417 -2.078 0 CA-C-N 111.118 -2.765 . . . . 0.0 117.292 -179.989 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.523 HG12 ' CE1' ' A' ' 2' ' ' PHE . 1.9 mm -63.61 98.41 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 C-N-CA 116.106 -2.238 . . . . 0.0 107.287 179.081 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.41 ' N ' ' O ' ' A' ' 107' ' ' GLU . 2.1 p -62.9 -29.69 70.97 Favored 'General case' 0 C--N 1.319 -0.754 0 O-C-N 121.342 -0.849 . . . . 0.0 109.116 -179.272 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 145.77 -87.97 0.16 Allowed Glycine 0 CA--C 1.526 0.727 1 C-N-CA 131.965 4.602 . . . . 0.0 110.566 -179.304 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . 0.3 0.2 OUTLIER -81.76 -0.93 45.32 Favored 'General case' 0 C--O 1.212 -0.895 0 CA-C-O 113.794 -3.003 . . . . 0.0 110.137 179.235 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -136.61 118.69 15.4 Favored 'General case' 0 C--O 1.205 -1.245 1 O-C-N 129.751 4.407 . . . . 0.0 112.49 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.438 ' HG ' HG12 ' A' ' 108' ' ' ILE . 5.0 tt -91.66 141.1 29.06 Favored 'General case' 0 C--O 1.212 -0.898 0 N-CA-C 100.763 -3.791 . . . . 0.0 100.763 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.465 ' CD1' HD11 ' A' ' 127' ' ' ILE 0.309 14.3 mm -123.1 135.97 61.37 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 N-CA-C 102.55 -3.13 . . . . 0.0 102.55 179.666 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . 0.416 ' HG3' ' CD2' ' A' ' 113' ' ' LEU . 13.5 mt-30 -131.94 95.25 3.65 Favored 'General case' 0 C--O 1.245 0.828 0 CA-C-O 115.425 -2.226 . . . . 0.0 105.385 -179.79 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 61.0 p -70.28 -171.51 0.47 Allowed 'General case' 0 C--N 1.318 -0.772 0 O-C-N 127.017 2.698 . . . . 0.0 106.425 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . 0.466 ' N ' ' O ' ' A' ' 123' ' ' GLU . 12.3 m-85 -159.8 62.26 0.36 Allowed 'General case' 0 CA--C 1.494 -1.181 0 CA-C-O 115.735 -2.079 . . . . 0.0 106.781 179.785 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.47 ' CA ' ' HA ' ' A' ' 123' ' ' GLU . 0.3 OUTLIER -70.44 108.32 4.22 Favored 'General case' 0 C--O 1.254 1.295 0 O-C-N 126.885 2.616 . . . . 0.0 107.016 -179.171 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.501 ' HA ' ' HB2' ' A' ' 102' ' ' LEU . 76.3 t80 -72.82 -35.77 67.37 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 103.827 -2.657 . . . . 0.0 103.827 -179.425 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -151.77 -66.88 0.17 Allowed 'General case' 0 C--N 1.291 -1.938 1 O-C-N 129.751 4.407 . . . . 0.0 108.074 179.866 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -145.14 27.58 1.86 Allowed Glycine 0 CA--C 1.544 1.892 0 C-N-CA 128.196 2.808 . . . . 0.0 112.881 178.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.557 ' HA ' ' CD2' ' A' ' 17' ' ' PHE . 1.7 m -106.77 6.86 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 CA-C-N 112.766 -1.717 . . . . 0.0 110.755 -178.237 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.47 ' HA ' ' CA ' ' A' ' 118' ' ' THR . 26.4 tt0 12.71 -75.0 0.0 OUTLIER 'General case' 0 C--N 1.307 -1.275 0 O-C-N 129.007 3.942 . . . . 0.0 112.028 -179.639 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 70.5 84.33 0.14 Allowed 'General case' 0 C--O 1.206 -1.21 0 O-C-N 116.669 -3.769 . . . . 0.0 109.08 178.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.452 ' N ' ' O ' ' A' ' 12' ' ' GLU . 6.0 mptt -79.7 136.76 36.86 Favored 'General case' 0 C--O 1.254 1.333 1 O-C-N 129.601 4.313 . . . . 0.0 110.027 179.97 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.455 ' NH2' ' CD2' ' A' ' 36' ' ' LEU . 3.2 mtm180 -126.49 77.81 1.73 Allowed 'General case' 0 N--CA 1.437 -1.096 0 O-C-N 125.574 1.796 . . . . 0.0 112.155 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.465 HD11 ' CD1' ' A' ' 114' ' ' ILE . 0.4 OUTLIER -73.96 108.37 5.39 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.922 0 O-C-N 126.362 2.289 . . . . 0.0 115.179 179.42 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.42 ' CE2' ' HB ' ' A' ' 8' ' ' VAL . 28.7 m-85 -89.06 147.07 24.44 Favored 'General case' 0 N--CA 1.438 -1.064 0 C-N-CA 128.158 2.583 . . . . 0.0 111.215 179.812 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.425 ' HG3' ' HB3' ' A' ' 9' ' ' ASP 0.347 14.3 mtmt -100.15 8.45 43.86 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 117.733 -1.127 . . . . 0.0 110.392 -179.972 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.462 ' HA ' ' CE3' ' A' ' 6' ' ' TRP . 9.7 tttm 69.53 153.68 0.11 Allowed 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . 0.835 61.1 tt0 . . . . . 0 CA--C 1.505 -0.785 0 N-CA-C 119.246 3.054 . . . . 0.0 119.246 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.098 0 CA-C-O 124.076 1.893 . . . . 0.0 114.08 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -119.16 99.61 6.82 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 113.54 -1.664 . . . . 0.0 110.874 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . 0.412 ' O ' ' N ' ' A' ' 40' ' ' ILE . . . 157.9 -148.6 18.22 Favored Glycine 0 C--O 1.208 -1.472 0 CA-C-N 112.748 -2.023 . . . . 0.0 110.437 179.658 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.44 HG22 ' HA ' ' A' ' 131' ' ' GLU 0.566 6.3 t -102.03 159.29 15.5 Favored 'General case' 0 N--CA 1.432 -1.334 0 CA-C-N 113.794 -1.203 . . . . 0.0 112.294 -179.84 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.541 ' CZ3' ' CG ' ' A' ' 130' ' ' LYS . 96.0 m95 -146.5 112.26 5.65 Favored 'General case' 0 N--CA 1.441 -0.902 0 O-C-N 127.685 3.116 . . . . 0.0 111.161 179.806 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 11.8 ttmt -109.15 116.47 32.0 Favored 'General case' 0 C--O 1.207 -1.17 0 CA-C-N 121.548 1.976 . . . . 0.0 108.065 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.492 ' HB ' ' CD1' ' A' ' 128' ' ' PHE 0.289 1.5 p -57.62 128.47 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 O-C-N 119.04 -2.288 . . . . 0.0 114.897 179.986 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -107.93 -21.63 12.75 Favored 'General case' 0 C--O 1.213 -0.826 0 CA-C-O 126.201 2.905 . . . . 0.0 108.883 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.407 ' O ' ' N ' ' A' ' 127' ' ' ILE . 29.9 ptt-85 -163.79 146.56 9.69 Favored 'General case' 0 CA--C 1.478 -1.795 0 O-C-N 117.93 -2.982 . . . . 0.0 113.107 179.766 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . 0.413 0.8 OUTLIER -119.19 -176.13 3.07 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 112.919 -1.946 . . . . 0.0 107.018 179.927 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -145.79 -70.94 0.26 Allowed 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 122.194 2.27 . . . . 0.0 108.062 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.535 ' ND2' ' CG ' ' A' ' 17' ' ' PHE . 2.4 t30 -92.87 39.19 1.03 Allowed 'General case' 0 N--CA 1.476 0.827 0 O-C-N 127.555 3.035 . . . . 0.0 111.91 179.542 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . 0.313 34.5 t80 -97.81 -57.98 2.1 Favored 'General case' 0 N--CA 1.439 -1.01 0 N-CA-C 121.267 3.802 . . . . 0.0 121.267 -179.379 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . 0.252 6.1 pm0 -56.5 -55.02 38.94 Favored 'General case' 0 CA--C 1.505 -0.757 0 CA-C-N 124.227 3.194 . . . . 0.0 114.186 -179.066 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.594 ' HB3' ' CD2' ' A' ' 17' ' ' PHE . 8.5 ttmt -55.04 -42.05 72.17 Favored 'General case' 0 N--CA 1.421 -1.923 0 C-N-CA 127.537 2.335 . . . . 0.0 115.616 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.594 ' CD2' ' HB3' ' A' ' 16' ' ' LYS 0.293 45.1 m-85 -77.58 -19.91 54.87 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 111.282 -2.69 . . . . 0.0 114.044 -177.28 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.438 ' O ' HG12 ' A' ' 23' ' ' ILE . 4.4 mmt -70.43 -20.04 62.94 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 118.812 -2.43 . . . . 0.0 105.88 175.738 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.71 -32.59 63.98 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-O 127.904 3.716 . . . . 0.0 109.837 179.775 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.481 ' HD3' ' CG1' ' A' ' 122' ' ' VAL . 0.5 OUTLIER -72.51 -30.11 64.2 Favored 'General case' 0 N--CA 1.454 -0.256 0 O-C-N 118.113 -2.867 . . . . 0.0 110.371 179.97 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.415 ' CE ' ' HG ' ' A' ' 72' ' ' LEU . 1.5 mmm -78.06 -28.04 48.77 Favored 'General case' 0 C--O 1.201 -1.481 0 C-N-CA 127.472 2.309 . . . . 0.0 107.768 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.62 22.0 6.57 Favored Glycine 0 C--N 1.299 -1.48 0 CA-C-O 114.598 -3.334 . . . . 0.0 111.678 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.438 HG12 ' O ' ' A' ' 18' ' ' MET . 23.9 mm -78.78 139.76 17.94 Favored 'Isoleucine or valine' 0 C--N 1.352 0.709 0 O-C-N 126.765 2.097 . . . . 0.0 106.507 -179.288 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -102.29 143.12 32.46 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-O 116.559 -1.686 . . . . 0.0 113.119 -179.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . 0.437 0.2 OUTLIER 3.35 -73.81 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.508 -0.658 0 N-CA-C 119.957 3.318 . . . . 0.0 119.957 179.962 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.646 1.8 t -65.84 -30.33 49.7 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.972 0 O-C-N 126.936 2.648 . . . . 0.0 116.634 -179.764 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 30.5 mtmt -73.37 -31.22 63.8 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 114.222 -1.354 . . . . 0.0 111.236 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.92 -25.86 40.38 Favored 'General case' 0 N--CA 1.473 0.715 0 O-C-N 120.46 -1.4 . . . . 0.0 107.998 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 15.8 ttpt -78.57 -43.23 27.06 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.893 -1.049 . . . . 0.0 111.456 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.4 mt -77.73 -30.86 51.87 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 118.959 -1.096 . . . . 0.0 110.382 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -71.74 -30.95 65.47 Favored Glycine 0 C--O 1.217 -0.931 0 O-C-N 125.329 1.643 . . . . 0.0 111.998 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -75.81 -25.74 56.62 Favored 'General case' 0 N--CA 1.439 -0.981 0 O-C-N 120.996 -1.296 . . . . 0.0 112.959 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -121.3 28.3 7.87 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 127.605 2.362 . . . . 0.0 115.001 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -66.84 -13.88 62.08 Favored 'General case' 0 C--O 1.218 -0.591 0 N-CA-C 117.406 2.372 . . . . 0.0 117.406 -179.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . 0.302 0.5 OUTLIER 70.25 26.86 4.25 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 121.063 1.756 . . . . 0.0 110.004 179.741 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.427 ' HB3' ' CG1' ' A' ' 8' ' ' VAL . 0.9 OUTLIER -45.34 114.1 0.69 Allowed 'General case' 0 CA--C 1.495 -1.148 0 O-C-N 127.405 2.941 . . . . 0.0 108.76 -179.739 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 27.7 tttp -110.98 98.82 7.83 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 104.911 -2.255 . . . . 0.0 104.911 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.468 ' HG ' ' CG2' ' A' ' 49' ' ' VAL . 1.9 tp -79.87 139.92 36.96 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.5 ' HB ' ' CB ' ' A' ' 50' ' ' LYS . 47.3 m -131.16 82.45 2.04 Favored 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 103.189 -2.893 . . . . 0.0 103.189 179.741 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.412 ' N ' ' O ' ' A' ' 4' ' ' GLY . 2.4 mm -65.54 132.06 31.27 Favored 'Isoleucine or valine' 0 C--O 1.255 1.35 0 CA-C-N 112.482 -2.145 . . . . 0.0 111.116 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 13.3 m -139.76 92.29 2.55 Favored 'General case' 0 CA--C 1.501 -0.918 0 O-C-N 125.851 1.97 . . . . 0.0 112.108 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 54.8 tt0 -85.87 118.17 25.19 Favored 'General case' 0 C--O 1.243 0.745 0 CA-C-O 117.186 -1.388 . . . . 0.0 111.519 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -101.54 -109.39 0.22 Allowed 'General case' 0 CA--C 1.495 -1.166 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -112.22 76.33 0.23 Allowed Glycine 0 C--N 1.307 -1.038 0 N-CA-C 105.548 -3.021 . . . . 0.0 105.548 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.313 0.5 OUTLIER 89.62 -18.74 0.19 Allowed 'General case' 0 C--N 1.32 -0.678 0 O-C-N 128.345 3.026 . . . . 0.0 113.751 179.827 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.427 ' HA ' ' HA ' ' A' ' 63' ' ' GLU . 1.9 ttpm? -91.93 146.48 23.71 Favored 'General case' 0 N--CA 1.435 -1.199 0 C-N-CA 117.604 -1.638 . . . . 0.0 107.301 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . 0.28 4.4 m-85 -129.32 93.85 3.66 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-O 123.01 1.386 . . . . 0.0 108.94 179.803 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.475 ' HB ' ' CG1' ' A' ' 61' ' ' VAL 0.479 2.0 t -78.36 146.1 34.85 Favored 'General case' 0 CA--C 1.496 -1.101 0 CA-C-O 125.23 2.443 . . . . 0.0 107.949 179.739 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.468 ' CG2' ' HG ' ' A' ' 38' ' ' LEU 0.693 0.3 OUTLIER -120.68 95.75 3.78 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 CA-C-N 109.969 -3.287 . . . . 0.0 111.948 -179.981 . . . . . . . . 4 4 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.5 ' CB ' ' HB ' ' A' ' 39' ' ' THR . 0.9 OUTLIER -72.22 130.34 40.58 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 100.305 -3.961 . . . . 0.0 100.305 179.685 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -123.52 66.99 1.01 Allowed 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 105.947 -1.871 . . . . 0.0 105.947 -179.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 12.6 m -71.82 74.89 0.87 Allowed 'General case' 0 C--N 1.287 -2.11 0 CA-C-O 117.861 -1.066 . . . . 0.0 108.153 -179.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -103.6 -165.73 1.19 Allowed 'General case' 0 CA--C 1.506 -0.743 0 O-C-N 125.543 1.777 . . . . 0.0 112.777 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 62.5 t30 -70.77 -20.66 62.58 Favored 'General case' 0 N--CA 1.441 -0.882 0 O-C-N 123.979 0.799 . . . . 0.0 112.325 -179.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -87.26 -55.74 3.67 Favored 'General case' 0 C--O 1.22 -0.474 0 CA-C-O 115.071 -2.395 . . . . 0.0 112.258 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.75 176.61 12.15 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 124.496 3.316 . . . . 0.0 107.725 179.738 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -119.17 88.04 2.85 Favored 'General case' 0 C--O 1.216 -0.702 0 C-N-CA 131.466 3.906 . . . . 0.0 100.872 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -117.73 98.91 7.14 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.992 0 C-N-CA 129.041 2.936 . . . . 0.0 118.676 -179.511 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 19.3 p-10 -62.54 120.5 11.24 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 103.712 -2.699 . . . . 0.0 103.712 177.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.512 ' HB ' ' CZ ' ' A' ' 62' ' ' PHE . 2.8 t -83.91 -55.17 7.52 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 CA-C-O 125.42 2.533 . . . . 0.0 112.133 -177.466 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.475 ' CG1' ' HB ' ' A' ' 48' ' ' THR 0.349 0.7 OUTLIER 67.13 133.36 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.434 -1.252 0 O-C-N 120.046 -1.659 . . . . 0.0 114.034 -179.54 . . . . . . . . 4 4 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.604 ' CD2' ' CZ ' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -166.72 100.91 0.57 Allowed 'General case' 0 N--CA 1.428 -1.555 0 CA-C-O 116.989 -1.482 . . . . 0.0 111.427 179.493 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.427 ' HA ' ' HA ' ' A' ' 46' ' ' LYS . 30.1 mm-40 -54.35 142.48 26.55 Favored 'General case' 0 N--CA 1.429 -1.503 0 O-C-N 126.782 2.551 . . . . 0.0 105.726 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.1 mp -59.54 115.79 3.55 Favored 'General case' 0 N--CA 1.431 -1.389 0 CA-C-N 120.844 1.656 . . . . 0.0 111.43 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 83.08 33.76 22.75 Favored Glycine 0 C--N 1.34 0.782 0 O-C-N 128.433 3.583 . . . . 0.0 116.897 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . 0.426 2.2 t -117.1 92.42 2.12 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . 0.269 0.2 OUTLIER -44.3 134.73 4.88 Favored 'General case' 0 CA--C 1.494 -1.194 0 O-C-N 124.898 1.374 . . . . 0.0 113.203 -179.948 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.604 ' CZ ' ' CD2' ' A' ' 62' ' ' PHE . 11.7 p90 -132.46 170.18 15.49 Favored 'General case' 0 N--CA 1.439 -0.992 0 O-C-N 124.961 1.413 . . . . 0.0 108.14 -179.655 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -125.79 109.58 12.71 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 116.038 -1.934 . . . . 0.0 107.851 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 21.3 t80 -127.83 111.57 13.78 Favored 'General case' 0 C--N 1.319 -0.739 0 O-C-N 125.471 1.732 . . . . 0.0 112.876 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 8.2 t -79.95 156.32 27.29 Favored 'General case' 0 CA--C 1.487 -1.449 0 CA-C-N 119.239 0.927 . . . . 0.0 109.713 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.415 ' HG ' ' CE ' ' A' ' 21' ' ' MET . 4.0 mm? -81.22 -166.28 1.12 Allowed 'General case' 0 CA--C 1.503 -0.834 0 N-CA-C 103.874 -2.639 . . . . 0.0 103.874 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -87.85 -18.78 28.5 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 124.805 1.315 . . . . 0.0 112.491 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -84.57 -13.17 52.51 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 115.972 -2.291 . . . . 0.0 108.99 179.775 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 108.17 8.36 29.44 Favored Glycine 0 CA--C 1.542 1.768 0 CA-C-O 117.431 -1.761 . . . . 0.0 114.359 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . 0.278 7.5 m -89.83 125.57 35.37 Favored 'General case' 0 N--CA 1.433 -1.289 0 CA-C-N 119.397 1.599 . . . . 0.0 109.926 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.424 ' CB ' ' HB ' ' A' ' 96' ' ' VAL . 0.0 OUTLIER -66.64 169.48 7.72 Favored 'General case' 0 C--O 1.22 -0.466 0 O-C-N 128.013 3.321 . . . . 0.0 112.327 -179.989 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.516 HD22 ' CD1' ' A' ' 93' ' ' PHE 0.28 1.5 tt -153.08 142.44 21.64 Favored 'General case' 0 CA--C 1.503 -0.834 0 N-CA-C 102.512 -3.144 . . . . 0.0 102.512 179.777 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 19.0 p -144.94 111.79 5.86 Favored 'General case' 0 CA--C 1.491 -1.315 0 N-CA-C 102.729 -3.063 . . . . 0.0 102.729 -179.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -174.48 -167.45 33.93 Favored Glycine 0 C--N 1.301 -1.414 1 C-N-CA 113.058 -4.401 . . . . 0.0 114.414 -179.772 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -144.89 176.32 9.56 Favored 'General case' 0 C--O 1.187 -2.229 0 CA-C-N 119.821 1.811 . . . . 0.0 111.725 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . 0.421 ' CZ2' ' CE1' ' A' ' 62' ' ' PHE 0.311 13.7 m0 -116.85 154.32 30.96 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 106.244 -1.761 . . . . 0.0 106.244 -179.995 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.449 HG21 ' CG2' ' A' ' 90' ' ' VAL . 10.8 t -162.35 139.39 8.09 Favored 'General case' 0 C--N 1.297 -1.698 0 CA-C-O 124.499 2.095 . . . . 0.0 111.811 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 5.1 ttt -81.37 102.72 10.64 Favored 'General case' 0 C--O 1.211 -0.964 0 CA-C-N 112.018 -2.355 . . . . 0.0 106.881 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . 0.632 6.8 mt-10 -77.02 -121.12 0.01 OUTLIER 'General case' 0 N--CA 1.428 -1.526 0 CA-C-O 124.483 2.087 . . . . 0.0 111.383 -179.848 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -105.88 95.22 1.04 Allowed Glycine 0 N--CA 1.443 -0.86 0 N-CA-C 106.243 -2.743 . . . . 0.0 106.243 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 4.4 m120 61.81 12.84 4.99 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 116.347 1.98 . . . . 0.0 116.347 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . 0.348 9.0 mtmm -149.89 139.55 21.68 Favored 'General case' 0 C--O 1.215 -0.732 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 179.785 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -84.77 130.15 34.72 Favored 'General case' 0 C--N 1.317 -0.833 1 O-C-N 129.213 4.071 . . . . 0.0 102.046 179.849 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.449 ' CG2' HG21 ' A' ' 83' ' ' THR . 16.1 m -120.85 164.76 17.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.435 ' O ' ' N ' ' A' ' 104' ' ' ALA . . . -141.4 101.12 0.28 Allowed Glycine 0 C--O 1.216 -1.02 0 C-N-CA 127.932 2.682 . . . . 0.0 109.252 -179.833 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.98 123.79 37.56 Favored 'General case' 0 N--CA 1.436 -1.172 0 N-CA-C 104.583 -2.377 . . . . 0.0 104.583 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.516 ' CD1' HD22 ' A' ' 78' ' ' LEU . 21.2 m-30 -122.16 113.02 18.91 Favored 'General case' 0 CA--C 1.506 -0.716 0 O-C-N 125.417 1.698 . . . . 0.0 114.255 -179.543 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.408 ' HA ' ' HA ' ' A' ' 101' ' ' GLU . 12.3 mttm -92.12 173.18 7.97 Favored 'General case' 0 N--CA 1.427 -1.592 0 C-N-CA 126.586 1.955 . . . . 0.0 106.621 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . 0.37 3.3 mtp180 -119.72 145.53 46.45 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.424 ' HB ' ' CB ' ' A' ' 77' ' ' GLU . 5.2 t -69.71 -47.78 68.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 112.89 -1.959 . . . . 0.0 113.597 -179.817 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . 0.324 1.5 p-10 -102.51 35.13 2.54 Favored 'General case' 0 C--O 1.258 1.512 0 CA-C-O 122.798 1.285 . . . . 0.0 113.408 -179.817 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -144.17 -41.61 0.27 Allowed 'General case' 0 CA--C 1.491 -1.292 0 CA-C-N 114.131 -1.395 . . . . 0.0 113.723 -179.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 81.62 2.39 90.5 Favored Glycine 0 CA--C 1.543 1.788 0 C-N-CA 125.53 1.538 . . . . 0.0 112.395 -179.658 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 47.3 mttm -85.22 -171.32 3.57 Favored 'General case' 0 C--O 1.205 -1.251 0 CA-C-N 114.291 -0.954 . . . . 0.0 110.818 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.419 ' CG ' ' N ' ' A' ' 102' ' ' LEU . 23.0 tt0 -130.81 168.8 16.65 Favored 'General case' 0 N--CA 1.439 -1.009 0 C-N-CA 129.669 3.187 . . . . 0.0 111.066 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.551 ' CG ' ' HA ' ' A' ' 119' ' ' TYR . 5.0 tt -154.57 -179.05 7.61 Favored 'General case' 0 C--N 1.319 -0.756 2 C-N-CA 136.19 5.796 . . . . 0.0 104.361 179.827 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.422 HG13 ' N ' ' A' ' 104' ' ' ALA . 0.9 OUTLIER -157.38 155.33 5.08 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.406 0 N-CA-C 104.116 -2.55 . . . . 0.0 104.116 179.783 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.435 ' N ' ' O ' ' A' ' 91' ' ' GLY . . . -143.15 94.86 2.68 Favored 'General case' 0 N--CA 1.436 -1.158 0 C-N-CA 125.551 1.54 . . . . 0.0 108.284 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -89.39 116.55 31.06 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 CA-C-O 125.222 2.439 . . . . 0.0 110.588 179.713 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.426 ' NH1' ' HG3' ' A' ' 106' ' ' ARG . 38.3 mtt85 -88.42 90.84 8.56 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 105.915 -1.883 . . . . 0.0 105.915 179.672 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -89.38 80.05 6.87 Favored 'General case' 0 N--CA 1.423 -1.781 0 O-C-N 127.356 2.91 . . . . 0.0 117.287 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.534 HD12 ' CH2' ' A' ' 6' ' ' TRP 0.312 0.6 OUTLIER -54.24 96.79 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 C-N-CA 118.523 -1.271 . . . . 0.0 113.368 179.718 . . . . . . . . 4 4 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 8.6 t -92.11 73.73 5.48 Favored 'General case' 0 CA--C 1.508 -0.635 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 -179.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 42.6 87.33 0.01 OUTLIER Glycine 0 C--N 1.334 0.452 0 O-C-N 125.586 1.804 . . . . 0.0 114.834 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . 0.315 3.7 m-20 84.32 -11.9 0.8 Allowed 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 113.961 -2.923 . . . . 0.0 111.212 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -124.93 108.45 11.9 Favored 'General case' 0 CA--C 1.497 -1.076 0 O-C-N 125.369 1.668 . . . . 0.0 111.669 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 6.1 tt -85.74 117.48 24.65 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 102.475 -3.157 . . . . 0.0 102.475 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.481 ' CD1' HD13 ' A' ' 127' ' ' ILE . 73.0 mt -113.97 142.42 26.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 N-CA-C 103.314 -2.847 . . . . 0.0 103.314 179.876 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -121.07 119.91 33.81 Favored 'General case' 0 CA--C 1.503 -0.855 0 CA-C-O 115.812 -2.042 . . . . 0.0 108.599 -179.03 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.5 p -96.96 111.94 23.93 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 104.256 -2.498 . . . . 0.0 104.256 178.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -97.26 106.05 18.31 Favored 'General case' 0 CA--C 1.477 -1.847 0 O-C-N 125.578 1.799 . . . . 0.0 113.39 -179.375 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 1.7 m -109.56 95.75 5.82 Favored 'General case' 0 N--CA 1.423 -1.797 0 O-C-N 125.775 1.922 . . . . 0.0 115.464 -179.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.551 ' HA ' ' CG ' ' A' ' 102' ' ' LEU . 60.9 t80 -52.1 -51.07 60.08 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 104.5 -2.407 . . . . 0.0 104.5 179.111 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -148.31 -64.9 0.25 Allowed 'General case' 0 C--N 1.3 -1.55 0 CA-C-N 112.596 -2.093 . . . . 0.0 111.575 179.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -144.07 27.95 2.0 Allowed Glycine 0 CA--C 1.543 1.824 0 C-N-CA 128.745 3.069 . . . . 0.0 112.091 179.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.489 ' HB ' ' HB3' ' A' ' 17' ' ' PHE . 21.1 m -133.23 80.08 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 105.067 -2.198 . . . . 0.0 105.067 -178.572 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.403 ' O ' ' CB ' ' A' ' 124' ' ' ALA 0.301 3.0 tt0 -58.03 -169.36 0.01 OUTLIER 'General case' 0 N--CA 1.426 -1.665 0 C-N-CA 127.534 2.334 . . . . 0.0 111.985 179.937 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.403 ' CB ' ' O ' ' A' ' 123' ' ' GLU . . . 177.72 76.48 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 121.206 1.821 . . . . 0.0 109.022 179.193 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . 0.331 0.0 OUTLIER -70.08 142.34 52.65 Favored 'General case' 0 N--CA 1.446 -0.629 0 O-C-N 126.811 2.569 . . . . 0.0 107.092 179.587 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 10.8 mtm180 -144.31 78.51 1.58 Allowed 'General case' 0 C--O 1.218 -0.562 0 O-C-N 127.624 3.078 . . . . 0.0 104.894 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.481 HD13 ' CD1' ' A' ' 114' ' ' ILE . 2.4 mm -57.9 115.45 0.94 Allowed 'Isoleucine or valine' 0 C--O 1.247 0.948 0 O-C-N 128.215 3.447 . . . . 0.0 116.569 -179.776 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.492 ' CD1' ' HB ' ' A' ' 8' ' ' VAL . 22.8 m-85 -100.62 132.74 45.86 Favored 'General case' 0 N--CA 1.435 -1.223 0 C-N-CA 124.807 1.243 . . . . 0.0 108.144 179.492 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . 0.271 17.4 mtpt -95.69 6.16 49.63 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 117.229 -1.367 . . . . 0.0 110.737 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.541 ' CG ' ' CZ3' ' A' ' 6' ' ' TRP . 0.0 OUTLIER 72.27 157.0 0.17 Allowed 'General case' 0 C--O 1.238 0.478 0 CA-C-N 119.411 1.005 . . . . 0.0 111.572 179.972 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.44 ' HA ' HG22 ' A' ' 5' ' ' THR 0.845 7.3 tt0 . . . . . 0 N--CA 1.44 -0.974 0 N-CA-C 118.675 2.843 . . . . 0.0 118.675 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.448 -0.561 0 CA-C-O 121.624 0.725 . . . . 0.0 112.188 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -138.18 96.57 3.22 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 115.669 1.729 . . . . 0.0 115.669 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 149.23 -141.93 9.37 Favored Glycine 0 C--O 1.214 -1.139 0 C-N-CA 116.971 -2.537 . . . . 0.0 109.147 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . 0.517 6.6 t -118.39 161.24 20.29 Favored 'General case' 0 CA--C 1.497 -1.08 0 O-C-N 127.023 2.249 . . . . 0.0 113.549 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.545 ' HB3' ' CD2' ' A' ' 128' ' ' PHE . 92.3 m95 -148.07 145.03 28.27 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 126.486 2.366 . . . . 0.0 107.133 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.425 ' HE3' ' HB2' ' A' ' 37' ' ' LYS . 0.5 OUTLIER -132.85 102.95 5.84 Favored 'General case' 0 N--CA 1.439 -1.02 0 C-N-CA 123.655 0.782 . . . . 0.0 109.071 179.902 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.416 ' O ' ' ND2' ' A' ' 35' ' ' ASN 0.368 11.4 p -57.17 115.72 0.91 Allowed 'Isoleucine or valine' 0 C--O 1.246 0.875 0 O-C-N 120.573 -1.33 . . . . 0.0 109.076 179.964 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -99.71 -29.12 12.83 Favored 'General case' 0 C--O 1.209 -1.041 0 O-C-N 126.591 2.432 . . . . 0.0 112.038 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 2.2 ptm180 -162.38 95.8 0.94 Allowed 'General case' 0 CA--C 1.478 -1.797 0 C-N-CA 113.789 -3.164 . . . . 0.0 112.997 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -64.69 177.36 0.94 Allowed 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 113.147 -1.842 . . . . 0.0 108.124 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -131.17 -79.29 0.53 Allowed 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 115.395 -2.24 . . . . 0.0 108.778 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -92.25 21.04 5.45 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 126.693 2.496 . . . . 0.0 115.013 179.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.556 ' CD2' ' HG2' ' A' ' 126' ' ' ARG 0.348 0.1 OUTLIER -65.35 -33.29 75.62 Favored 'General case' 0 C--N 1.309 -1.193 0 O-C-N 128.186 3.429 . . . . 0.0 114.5 -179.982 . . . . . . . . 4 4 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -67.68 -23.78 65.34 Favored 'General case' 0 C--O 1.21 -1.015 0 O-C-N 117.108 -3.495 . . . . 0.0 110.694 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.439 ' HB3' HG13 ' A' ' 122' ' ' VAL . 0.9 OUTLIER -79.94 -44.94 19.43 Favored 'General case' 0 C--O 1.247 0.973 0 CA-C-N 112.485 -2.143 . . . . 0.0 113.022 179.918 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.515 ' CZ ' ' HE3' ' A' ' 21' ' ' MET . 0.4 OUTLIER -60.56 -26.47 66.94 Favored 'General case' 0 N--CA 1.435 -1.218 0 CA-C-O 125.664 2.649 . . . . 0.0 112.264 179.988 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.4 ' HB3' ' HB ' ' A' ' 23' ' ' ILE . 7.6 mtt -73.68 -29.6 62.39 Favored 'General case' 0 N--CA 1.443 -0.802 0 O-C-N 116.301 -3.999 . . . . 0.0 106.629 179.36 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -70.0 -44.2 69.86 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-O 124.014 1.864 . . . . 0.0 112.213 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.411 ' HD3' ' CG2' ' A' ' 122' ' ' VAL . 16.2 tptt -61.06 -30.63 70.45 Favored 'General case' 0 C--O 1.209 -1.045 0 O-C-N 120.124 -1.61 . . . . 0.0 114.226 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.515 ' HE3' ' CZ ' ' A' ' 17' ' ' PHE . 0.4 OUTLIER -79.45 -20.83 46.49 Favored 'General case' 0 N--CA 1.436 -1.154 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 -179.926 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 115.53 20.5 5.42 Favored Glycine 0 C--O 1.224 -0.502 0 N-CA-C 110.192 -1.163 . . . . 0.0 110.192 179.579 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.4 ' HB ' ' HB3' ' A' ' 18' ' ' MET . 0.5 OUTLIER -104.79 101.88 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.291 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 -179.373 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 8.7 p-10 -130.94 24.75 4.97 Favored 'General case' 0 C--O 1.24 0.582 0 N-CA-C 114.666 1.358 . . . . 0.0 114.666 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . 0.546 17.4 m -136.17 -123.62 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.504 -0.822 0 N-CA-C 117.629 2.455 . . . . 0.0 117.629 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.65 0.0 OUTLIER -76.78 -22.67 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 N-CA-C 117.637 2.458 . . . . 0.0 117.637 179.816 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -73.64 -25.91 60.52 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 114.463 -1.244 . . . . 0.0 113.985 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.66 -27.99 40.81 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 121.124 1.784 . . . . 0.0 107.301 -179.725 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -67.93 -41.29 82.82 Favored 'General case' 0 CA--C 1.508 -0.654 0 CA-C-O 123.249 1.5 . . . . 0.0 111.889 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 16.3 mt -73.7 -34.52 64.89 Favored 'General case' 0 N--CA 1.438 -1.034 0 O-C-N 120.5 -1.375 . . . . 0.0 107.439 179.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -76.51 -29.68 57.64 Favored Glycine 0 C--N 1.338 0.647 0 O-C-N 128.574 3.671 . . . . 0.0 114.995 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -71.91 -33.96 68.73 Favored 'General case' 0 C--O 1.243 0.732 0 O-C-N 119.425 -2.221 . . . . 0.0 110.24 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 7.2 t-80 -85.25 0.34 52.2 Favored 'General case' 0 N--CA 1.441 -0.916 0 O-C-N 127.384 2.927 . . . . 0.0 110.652 179.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.28 101.09 2.26 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-O 114.83 -2.51 . . . . 0.0 111.803 179.67 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.416 ' ND2' ' O ' ' A' ' 8' ' ' VAL . 1.5 t-20 -74.09 60.61 0.79 Allowed 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 121.447 1.931 . . . . 0.0 110.9 -179.373 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.449 HD12 HD21 ' A' ' 38' ' ' LEU . 0.2 OUTLIER -41.89 119.06 1.22 Allowed 'General case' 0 CA--C 1.496 -1.101 0 CA-C-O 125.492 2.568 . . . . 0.0 111.178 -179.627 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.425 ' HB2' ' HE3' ' A' ' 7' ' ' LYS . 44.9 tttm -107.78 111.24 23.3 Favored 'General case' 0 CA--C 1.516 -0.352 0 N-CA-C 102.076 -3.305 . . . . 0.0 102.076 179.793 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.449 HD21 HD12 ' A' ' 36' ' ' LEU . 0.1 OUTLIER -93.05 145.63 24.24 Favored 'General case' 0 C--N 1.31 -1.132 0 C-N-CA 114.941 -2.704 . . . . 0.0 105.149 -179.902 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.8 m -134.1 85.29 2.18 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 103.432 -2.803 . . . . 0.0 103.432 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.464 HG22 ' CD2' ' A' ' 47' ' ' PHE . 42.7 mt -79.86 117.76 26.23 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.122 0 O-C-N 124.731 1.27 . . . . 0.0 110.287 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -112.25 110.15 20.22 Favored 'General case' 0 CA--C 1.511 -0.529 1 O-C-N 129.868 4.48 . . . . 0.0 112.614 -179.86 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -85.68 95.8 9.49 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -110.23 86.19 2.26 Favored 'General case' 0 N--CA 1.426 -1.638 0 N-CA-C 104.698 -2.334 . . . . 0.0 104.698 179.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 75.18 -89.9 0.8 Allowed Glycine 0 C--N 1.305 -1.185 0 N-CA-C 106.764 -2.535 . . . . 0.0 106.764 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -129.06 -42.31 1.38 Allowed 'General case' 0 N--CA 1.443 -0.783 0 O-C-N 127.723 2.661 . . . . 0.0 111.394 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.42 129.23 41.05 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-O 123.49 1.614 . . . . 0.0 108.87 179.837 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.464 ' CD2' HG22 ' A' ' 40' ' ' ILE 0.289 1.7 m-85 -108.5 99.41 8.8 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 -179.804 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.51 ' CG2' HG12 ' A' ' 61' ' ' VAL 0.388 28.3 p -70.76 85.44 0.66 Allowed 'General case' 0 N--CA 1.432 -1.361 0 C-N-CA 117.646 -1.622 . . . . 0.0 110.034 -179.954 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.454 HG13 ' CZ ' ' A' ' 62' ' ' PHE 0.657 10.0 p -67.2 87.24 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.494 -1.179 0 O-C-N 126.051 2.094 . . . . 0.0 109.717 -179.864 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 9.8 ttpp -73.28 119.92 18.19 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 105.281 -2.118 . . . . 0.0 105.281 -179.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.401 ' O ' ' N ' ' A' ' 53' ' ' SER 0.335 71.9 tt0 -108.12 65.97 0.64 Allowed 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 103.783 -2.673 . . . . 0.0 103.783 -179.983 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.3 m -68.62 72.37 0.22 Allowed 'General case' 0 N--CA 1.418 -2.073 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 179.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.401 ' N ' ' O ' ' A' ' 51' ' ' GLU . 60.2 p -102.82 -177.43 3.38 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-O 116.51 -1.709 . . . . 0.0 111.698 -179.782 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -62.28 -30.12 70.91 Favored 'General case' 0 C--O 1.218 -0.599 0 CA-C-N 119.53 1.059 . . . . 0.0 108.178 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -67.38 -68.19 0.4 Allowed 'General case' 0 C--O 1.21 -0.99 0 CA-C-O 115.73 -2.081 . . . . 0.0 109.068 179.739 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.482 ' HB2' ' CG2' ' A' ' 58' ' ' ILE 0.272 13.5 mmt180 -136.36 -175.46 4.01 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 122.231 2.287 . . . . 0.0 111.198 -179.92 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -134.1 55.32 1.9 Allowed 'General case' 0 C--O 1.218 -0.567 2 N-CA-C 100.143 -4.021 . . . . 0.0 100.143 179.551 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.482 ' CG2' ' HB2' ' A' ' 56' ' ' ARG . 3.4 tt -99.31 106.11 18.46 Favored 'Isoleucine or valine' 0 C--N 1.346 0.419 1 C-N-CA 132.294 4.238 . . . . 0.0 117.398 -179.332 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -62.82 136.41 57.84 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 105.327 -2.101 . . . . 0.0 105.327 179.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.5 t -116.97 41.65 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 -179.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.51 HG12 ' CG2' ' A' ' 48' ' ' THR 0.354 0.1 OUTLIER -36.46 144.9 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 CA-C-O 125.707 2.67 . . . . 0.0 114.48 -179.941 . . . . . . . . 4 4 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.573 ' HB3' ' CE1' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -156.0 100.93 2.07 Favored 'General case' 0 N--CA 1.423 -1.796 0 O-C-N 119.732 -1.855 . . . . 0.0 109.608 178.435 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.419 ' O ' ' C ' ' A' ' 64' ' ' LEU . 0.0 OUTLIER -68.55 93.28 0.49 Allowed 'General case' 0 CA--C 1.533 0.309 1 N-CA-C 99.942 -4.096 . . . . 0.0 99.942 178.054 . . . . . . . . 4 4 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.655 ' CB ' ' CE2' ' A' ' 82' ' ' TRP . 0.0 OUTLIER -14.59 88.68 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.181 0 O-C-N 128.027 3.329 . . . . 0.0 110.523 -178.196 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.567 ' N ' ' CD1' ' A' ' 82' ' ' TRP . . . 90.67 44.13 4.64 Favored Glycine 0 C--N 1.353 1.478 0 CA-C-N 109.985 -3.279 . . . . 0.0 118.918 179.42 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . 0.484 0.6 OUTLIER -105.3 -8.8 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.236 0 CA-C-N 111.968 -2.116 . . . . 0.0 107.547 -179.846 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.417 ' HA ' HG23 ' A' ' 81' ' ' THR . 1.8 m-20 69.63 143.81 0.05 OUTLIER 'General case' 0 CA--C 1.491 -1.297 0 CA-C-O 122.154 0.978 . . . . 0.0 109.858 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.573 ' CE1' ' HB3' ' A' ' 62' ' ' PHE . 1.0 OUTLIER -163.81 119.29 1.61 Allowed 'General case' 0 N--CA 1.438 -1.045 0 C-N-CA 117.363 -1.735 . . . . 0.0 111.066 179.989 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -77.46 102.67 6.98 Favored 'General case' 0 C--O 1.245 0.841 0 N-CA-C 103.74 -2.689 . . . . 0.0 103.74 179.171 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.422 ' HB3' HD21 ' A' ' 78' ' ' LEU . 31.1 t80 -107.2 87.8 2.59 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-O 116.139 -1.886 . . . . 0.0 113.821 -178.275 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.434 ' HB2' HG21 ' A' ' 76' ' ' THR . 36.7 p -55.51 128.33 33.95 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 104.998 -2.223 . . . . 0.0 104.998 179.6 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.464 ' CD2' HD11 ' A' ' 78' ' ' LEU . 26.0 mt -71.57 -160.37 0.05 Allowed 'General case' 0 CA--C 1.495 -1.148 0 N-CA-C 106.133 -1.802 . . . . 0.0 106.133 -179.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -88.14 -30.4 19.85 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-O 124.97 2.319 . . . . 0.0 112.476 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.401 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 1.2 m-20 -124.77 -55.33 1.62 Allowed 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 113.045 -1.889 . . . . 0.0 111.211 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.0 -32.87 81.82 Favored Glycine 0 C--O 1.204 -1.755 0 CA-C-O 118.315 -1.269 . . . . 0.0 113.923 179.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.434 HG21 ' HB2' ' A' ' 71' ' ' SER 0.256 0.0 OUTLIER 70.24 169.89 0.31 Allowed 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 123.268 3.534 . . . . 0.0 114.738 179.821 . . . . . . . . 4 4 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 7.8 103.68 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.835 1 O-C-N 131.532 5.52 . . . . 0.0 113.704 -179.682 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.464 HD11 ' CD2' ' A' ' 72' ' ' LEU 0.414 0.4 OUTLIER -140.29 101.19 4.07 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 102.233 -3.247 . . . . 0.0 102.233 179.933 . . . . . . . . 4 4 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 48.6 m -108.05 135.07 50.02 Favored 'General case' 0 C--O 1.202 -1.438 0 O-C-N 126.459 2.35 . . . . 0.0 106.059 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.432 ' HA3' ' HA ' ' A' ' 93' ' ' PHE . . . 173.62 -144.34 7.62 Favored Glycine 0 C--N 1.3 -1.437 0 C-N-CA 117.209 -2.424 . . . . 0.0 109.821 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.534 ' HA ' ' CZ ' ' A' ' 68' ' ' PHE . 44.0 p -166.28 168.77 14.84 Favored 'General case' 0 C--O 1.19 -2.049 0 CA-C-O 123.48 1.609 . . . . 0.0 109.902 -179.637 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . 0.705 ' CG ' ' N ' ' A' ' 83' ' ' THR 0.406 1.9 p-90 -76.31 -169.64 1.24 Allowed 'General case' 0 C--N 1.316 -0.886 1 N-CA-C 99.807 -4.145 . . . . 0.0 99.807 175.419 . . . . . . . . 4 3 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.705 ' N ' ' CG ' ' A' ' 82' ' ' TRP 0.292 0.5 OUTLIER 177.19 128.26 0.04 OUTLIER 'General case' 0 N--CA 1.437 -1.122 0 CA-C-O 124.676 2.179 . . . . 0.0 112.897 174.94 . . . . . . . . 4 4 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' MET . . . . . 0.563 ' CB ' ' CH2' ' A' ' 82' ' ' TRP . 3.0 ttt -96.96 102.27 14.01 Favored 'General case' 0 N--CA 1.426 -1.633 0 N-CA-C 106.056 -1.831 . . . . 0.0 106.056 179.09 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.451 ' CG ' HG23 ' A' ' 90' ' ' VAL 0.67 0.0 OUTLIER -79.67 62.66 4.01 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 120.462 1.483 . . . . 0.0 108.655 179.691 . . . . . . . . 4 4 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 76.94 -64.3 3.08 Favored Glycine 0 C--O 1.219 -0.785 0 N-CA-C 107.261 -2.336 . . . . 0.0 107.261 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 28.9 p-10 -129.78 -16.29 3.77 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 120.866 2.333 . . . . 0.0 116.681 -179.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . 0.365 0.3 OUTLIER -113.89 111.35 21.56 Favored 'General case' 0 CA--C 1.496 -1.13 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 179.924 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.0 tt -66.24 153.8 41.55 Favored 'General case' 0 C--N 1.32 -0.715 0 O-C-N 125.186 1.554 . . . . 0.0 107.277 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.451 HG23 ' CG ' ' A' ' 85' ' ' GLU . 0.0 OUTLIER -144.19 179.97 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.021 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 179.986 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -140.53 99.17 0.24 Allowed Glycine 0 C--N 1.352 1.445 0 C-N-CA 129.034 3.206 . . . . 0.0 107.637 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.417 ' O ' ' CD1' ' A' ' 93' ' ' PHE . 5.9 mtpm? -98.25 138.11 36.0 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 102.365 -3.198 . . . . 0.0 102.365 -179.532 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.454 ' HB3' ' HG ' ' A' ' 78' ' ' LEU . 62.8 m-85 -150.06 127.77 11.67 Favored 'General case' 0 CA--C 1.5 -0.955 0 O-C-N 126.262 2.227 . . . . 0.0 113.702 -179.811 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 18.1 mttt -105.65 150.11 25.74 Favored 'General case' 0 N--CA 1.432 -1.374 0 CA-C-N 112.303 -2.226 . . . . 0.0 111.539 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . 0.401 1.0 OUTLIER -96.05 143.12 27.48 Favored 'General case' 0 N--CA 1.433 -1.322 0 CA-C-O 116.623 -1.656 . . . . 0.0 106.681 -179.713 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.4 m -83.53 -29.05 7.65 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.213 0 O-C-N 124.48 1.112 . . . . 0.0 113.941 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . 0.356 6.2 p-10 -90.17 11.63 20.41 Favored 'General case' 0 C--O 1.251 1.169 0 CA-C-N 112.454 -2.157 . . . . 0.0 111.281 179.569 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -138.57 -43.08 0.49 Allowed 'General case' 0 N--CA 1.439 -1.019 0 CA-C-N 112.562 -2.108 . . . . 0.0 116.604 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 86.7 -10.7 66.55 Favored Glycine 0 CA--C 1.535 1.301 0 CA-C-O 124.379 2.099 . . . . 0.0 113.469 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 47.4 mttt -70.77 -167.12 0.17 Allowed 'General case' 0 C--O 1.203 -1.367 0 O-C-N 120.299 -1.707 . . . . 0.0 109.783 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -135.2 154.07 51.73 Favored 'General case' 0 N--CA 1.441 -0.919 0 C-N-CA 128.612 2.765 . . . . 0.0 111.267 -179.818 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.458 ' HG ' ' HA ' ' A' ' 119' ' ' TYR . 7.2 tt -132.73 137.29 46.83 Favored 'General case' 0 C--O 1.247 0.938 1 C-N-CA 133.816 4.846 . . . . 0.0 105.412 -179.609 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.484 HG22 ' CB ' ' A' ' 117' ' ' TYR . 11.1 tt -132.0 160.17 42.62 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.158 0 N-CA-C 105.428 -2.064 . . . . 0.0 105.428 179.26 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.428 ' HA ' ' HB2' ' A' ' 117' ' ' TYR . . . -152.65 135.15 15.2 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-O 114.523 -2.656 . . . . 0.0 106.497 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.529 HG13 ' CZ ' ' A' ' 117' ' ' TYR . 7.1 p -119.99 114.71 45.03 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.799 0 CA-C-N 122.172 2.26 . . . . 0.0 114.454 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 3.5 mtm180 -82.8 94.43 7.65 Favored 'General case' 0 C--O 1.223 -0.323 0 N-CA-C 103.788 -2.671 . . . . 0.0 103.788 178.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . 0.329 4.7 tt0 -72.0 -38.01 69.73 Favored 'General case' 0 C--O 1.21 -0.993 0 CA-C-N 110.934 -2.848 . . . . 0.0 116.129 -177.272 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.505 HD12 ' CZ2' ' A' ' 6' ' ' TRP 0.395 2.7 mm 60.05 75.96 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 C-N-CA 111.782 -3.967 . . . . 0.0 113.904 -179.686 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 6.8 t -65.54 -102.76 0.0 OUTLIER 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 120.46 1.482 . . . . 0.0 109.533 -179.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -133.85 89.32 0.25 Allowed Glycine 0 CA--C 1.521 0.416 1 C-N-CA 130.958 4.123 . . . . 0.0 110.685 179.572 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . 0.326 31.8 m-20 90.52 -25.43 0.06 Allowed 'General case' 0 C--N 1.309 -1.185 0 CA-C-O 114.54 -2.648 . . . . 0.0 110.071 -179.13 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -113.1 137.52 51.31 Favored 'General case' 0 CA--C 1.489 -1.381 1 O-C-N 129.332 4.145 . . . . 0.0 113.873 -179.362 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.512 ' HB2' ' CH2' ' A' ' 6' ' ' TRP . 8.6 tt -102.98 147.04 27.43 Favored 'General case' 0 C--O 1.21 -1.003 0 N-CA-C 100.781 -3.785 . . . . 0.0 100.781 -179.807 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . 0.265 13.4 mt -150.44 125.49 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 N-CA-C 103.625 -2.731 . . . . 0.0 103.625 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . 0.449 ' HB2' ' HD2' ' A' ' 126' ' ' ARG . 8.4 mt-30 -101.14 139.69 36.48 Favored 'General case' 0 N--CA 1.441 -0.915 0 N-CA-C 103.121 -2.918 . . . . 0.0 103.121 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.509 ' O ' ' CG ' ' A' ' 117' ' ' TYR . 0.2 OUTLIER -156.68 144.58 19.38 Favored 'General case' 0 N--CA 1.415 -2.186 0 CA-C-N 113.496 -1.683 . . . . 0.0 112.664 179.986 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . 0.529 ' CZ ' HG13 ' A' ' 105' ' ' VAL 0.382 21.4 m-30 145.88 -136.29 0.0 OUTLIER 'General case' 0 CA--C 1.481 -1.684 0 O-C-N 128.088 3.367 . . . . 0.0 113.152 176.277 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.465 ' O ' ' N ' ' A' ' 103' ' ' ILE . 10.5 t -159.3 -157.97 0.63 Allowed 'General case' 0 C--N 1.311 -1.068 0 O-C-N 127.67 3.106 . . . . 0.0 116.567 -174.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.458 ' HA ' ' HG ' ' A' ' 102' ' ' LEU 0.302 6.8 t80 -120.6 -4.89 9.77 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 111.865 -2.425 . . . . 0.0 110.695 178.309 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -176.98 -68.92 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.511 0 O-C-N 120.506 -1.371 . . . . 0.0 112.025 -179.629 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -151.75 17.49 0.85 Allowed Glycine 0 CA--C 1.541 1.695 0 N-CA-C 119.692 2.637 . . . . 0.0 119.692 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.439 HG13 ' HB3' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -122.22 94.31 2.87 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 N-CA-C 104.314 -2.476 . . . . 0.0 104.314 -179.698 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.429 ' HA ' ' HB ' ' A' ' 118' ' ' THR . 0.8 OUTLIER -59.15 177.92 0.15 Allowed 'General case' 0 C--O 1.216 -0.659 0 CA-C-O 122.118 0.961 . . . . 0.0 112.377 -178.233 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -172.65 91.81 0.11 Allowed 'General case' 0 N--CA 1.437 -1.12 0 O-C-N 118.505 -2.622 . . . . 0.0 109.664 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.422 ' HD2' ' HB ' ' A' ' 116' ' ' THR . 1.7 mptm? -69.62 164.38 23.47 Favored 'General case' 0 CA--C 1.508 -0.671 0 CA-C-N 121.54 1.973 . . . . 0.0 110.997 179.734 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.556 ' HG2' ' CD2' ' A' ' 14' ' ' TYR . 36.7 mtt180 -145.82 72.77 1.32 Allowed 'General case' 0 C--O 1.208 -1.1 0 CA-C-N 110.466 -3.061 . . . . 0.0 110.481 -179.675 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 17.5 mm -66.3 117.8 7.98 Favored 'Isoleucine or valine' 0 C--O 1.254 1.325 1 O-C-N 129.102 4.001 . . . . 0.0 112.346 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.545 ' CD2' ' HB3' ' A' ' 6' ' ' TRP . 12.5 m-85 -103.91 167.77 9.56 Favored 'General case' 0 N--CA 1.442 -0.872 0 O-C-N 127.186 2.804 . . . . 0.0 107.552 179.175 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 2.4 mmmt -122.23 1.56 9.7 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 116.621 -1.657 . . . . 0.0 109.373 179.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.466 ' HD2' ' CH2' ' A' ' 6' ' ' TRP . 0.9 OUTLIER 68.81 97.14 0.06 Allowed 'General case' 0 C--O 1.238 0.487 0 CA-C-N 120.794 1.634 . . . . 0.0 113.218 -179.954 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . 0.823 21.5 tt0 . . . . . 0 N--CA 1.431 -1.419 0 CA-C-N 121.492 1.951 . . . . 0.0 115.084 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 . . . . . 0 N--CA 1.447 -0.604 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.407 ' N ' ' OD1' ' A' ' 3' ' ' ASP . 17.8 p-10 -55.98 85.97 0.01 OUTLIER 'General case' 0 CA--C 1.5 -0.974 0 N-CA-C 115.318 1.599 . . . . 0.0 115.318 -179.77 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -179.54 -151.5 9.88 Favored Glycine 0 N--CA 1.436 -1.33 0 C-N-CA 116.144 -2.932 . . . . 0.0 110.687 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.409 ' O ' ' N ' ' A' ' 131' ' ' GLU 0.441 0.1 OUTLIER -124.74 150.83 45.82 Favored 'General case' 0 N--CA 1.427 -1.589 0 N-CA-C 116.312 1.967 . . . . 0.0 116.312 -179.855 . . . . . . . . 4 4 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.567 ' CH2' ' CD1' ' A' ' 108' ' ' ILE . 21.0 m95 -137.16 -166.77 1.98 Allowed 'General case' 0 CA--C 1.498 -1.029 0 CA-C-O 114.37 -2.728 . . . . 0.0 106.509 178.623 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.638 ' N ' ' CE2' ' A' ' 128' ' ' PHE . 6.7 ttpt 177.28 27.57 0.0 OUTLIER 'General case' 0 N--CA 1.432 -1.339 0 CA-C-O 112.804 -3.474 . . . . 0.0 112.498 -177.083 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.564 ' N ' ' CD1' ' A' ' 128' ' ' PHE 0.404 1.7 m 15.24 108.95 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 CA-C-N 121.939 2.154 . . . . 0.0 116.745 -179.754 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -128.47 -69.36 0.72 Allowed 'General case' 0 CA--C 1.498 -1.022 0 O-C-N 120.48 -1.388 . . . . 0.0 113.118 -178.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.5 ptp180 -84.32 95.1 8.62 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 118.168 -1.413 . . . . 0.0 111.437 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.41 ' HA ' ' HA ' ' A' ' 126' ' ' ARG . 0.0 OUTLIER -93.33 -172.82 3.05 Favored 'General case' 0 N--CA 1.441 -0.903 0 O-C-N 127.092 2.745 . . . . 0.0 108.937 -179.697 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -143.6 -67.07 0.35 Allowed 'General case' 0 C--N 1.306 -1.288 0 CA-C-O 115.994 -1.955 . . . . 0.0 108.622 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -95.58 15.4 19.95 Favored 'General case' 0 C--O 1.219 -0.545 0 O-C-N 127.502 3.001 . . . . 0.0 113.617 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.514 ' CD1' ' HB2' ' A' ' 124' ' ' ALA 0.381 0.1 OUTLIER -76.38 -26.22 55.4 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 117.876 2.547 . . . . 0.0 117.876 179.852 . . . . . . . . 4 4 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -74.83 -37.35 62.3 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-O 122.615 1.198 . . . . 0.0 111.894 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 4.7 ttmt -78.15 -24.52 47.29 Favored 'General case' 0 C--O 1.246 0.894 0 CA-C-O 126.046 2.831 . . . . 0.0 113.826 -179.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.516 ' CD2' ' HB1' ' A' ' 124' ' ' ALA . 10.1 t80 -66.63 -31.0 71.4 Favored 'General case' 0 N--CA 1.438 -1.041 0 CA-C-O 125.834 2.73 . . . . 0.0 113.374 -179.681 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 29.3 mtt -73.63 -24.69 60.05 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 125.851 2.738 . . . . 0.0 106.859 179.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -73.27 -22.23 60.43 Favored 'General case' 0 N--CA 1.474 0.765 0 O-C-N 119.003 -2.311 . . . . 0.0 109.396 179.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 6.0 tptp -75.25 -38.73 60.4 Favored 'General case' 0 C--N 1.313 -0.993 0 O-C-N 118.996 -2.315 . . . . 0.0 113.244 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 7.3 mtm -76.37 -38.17 56.17 Favored 'General case' 0 C--O 1.214 -0.796 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 125.96 43.47 0.28 Allowed Glycine 0 C--N 1.304 -1.205 0 CA-C-O 116.797 -2.113 . . . . 0.0 111.87 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.404 HG22 HD11 ' A' ' 23' ' ' ILE . 0.2 OUTLIER -119.62 107.09 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 CA-C-O 115.758 -2.067 . . . . 0.0 107.212 -179.579 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -132.42 14.42 4.54 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 115.162 1.542 . . . . 0.0 115.162 -179.671 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . 0.412 33.2 m -119.66 -136.55 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.499 -0.99 0 O-C-N 126.992 2.683 . . . . 0.0 115.436 179.871 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.484 2.4 m -70.99 -24.09 24.2 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.934 0 CA-C-N 121.719 2.054 . . . . 0.0 114.027 179.823 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 13.2 mtmm -66.29 -34.68 78.54 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 115.002 1.482 . . . . 0.0 115.002 -179.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 7.4 ptt180 -78.87 -24.23 44.4 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 123.561 1.648 . . . . 0.0 108.221 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.2 tttt -78.99 -32.03 45.05 Favored 'General case' 0 C--O 1.213 -0.84 0 CA-C-N 113.96 -1.473 . . . . 0.0 110.921 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 8.7 tp -77.64 -35.97 51.99 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 114.645 -1.161 . . . . 0.0 111.903 179.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.74 -25.52 73.76 Favored Glycine 0 C--O 1.213 -1.169 0 C-N-CA 123.933 0.778 . . . . 0.0 112.636 -179.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -76.94 -32.44 57.34 Favored 'General case' 0 C--N 1.315 -0.93 0 C-N-CA 125.89 1.676 . . . . 0.0 109.237 179.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 65.4 m80 -123.31 28.55 7.03 Favored 'General case' 0 C--O 1.236 0.373 0 O-C-N 126.979 2.674 . . . . 0.0 114.189 179.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -67.36 -19.42 65.43 Favored 'General case' 0 C--O 1.216 -0.683 0 N-CA-C 114.545 1.313 . . . . 0.0 114.545 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . 0.254 1.4 m-20 76.72 62.06 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 116.914 -1.914 . . . . 0.0 108.812 179.564 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.561 ' HG ' ' CD1' ' A' ' 38' ' ' LEU . 16.9 tp -80.02 73.04 6.83 Favored 'General case' 0 N--CA 1.469 0.525 0 O-C-N 126.752 2.533 . . . . 0.0 108.309 -179.617 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.427 ' HA ' ' HA ' ' A' ' 7' ' ' LYS . 5.6 ttpp -68.9 112.08 5.35 Favored 'General case' 0 C--N 1.305 -1.349 1 N-CA-C 100.138 -4.023 . . . . 0.0 100.138 -179.508 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.561 ' CD1' ' HG ' ' A' ' 36' ' ' LEU 0.377 1.3 mp -104.8 103.13 12.68 Favored 'General case' 0 C--N 1.288 -2.079 0 N-CA-C 105.458 -2.053 . . . . 0.0 105.458 -178.316 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.485 ' HB ' ' CB ' ' A' ' 50' ' ' LYS . 1.9 m -94.85 86.39 4.68 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 117.276 -3.39 . . . . 0.0 103.902 179.793 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 12.0 mm -61.46 146.53 11.82 Favored 'Isoleucine or valine' 0 C--O 1.243 0.729 0 N-CA-C 105.973 -1.862 . . . . 0.0 105.973 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.469 ' CG2' HG22 ' A' ' 48' ' ' THR . 4.6 t -150.34 35.0 0.64 Allowed 'General case' 0 CA--C 1.506 -0.731 0 O-C-N 126.956 2.66 . . . . 0.0 114.493 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 24.7 tt0 -33.41 111.63 0.11 Allowed 'General case' 0 C--N 1.311 -1.106 0 O-C-N 126.981 2.676 . . . . 0.0 111.59 -179.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -81.08 -0.72 41.2 Favored 'General case' 0 N--CA 1.42 -1.947 0 CA-C-O 124.642 2.163 . . . . 0.0 111.935 -179.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 135.65 -55.66 0.72 Allowed Glycine 0 C--N 1.292 -1.87 0 N-CA-C 104.479 -3.448 . . . . 0.0 104.479 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.301 0.3 OUTLIER -127.4 -37.4 2.02 Favored 'General case' 0 C--N 1.316 -0.886 0 O-C-N 126.812 2.125 . . . . 0.0 112.587 -179.736 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 28.1 ttmt -91.12 139.2 30.98 Favored 'General case' 0 C--N 1.318 -0.792 0 O-C-N 117.906 -2.996 . . . . 0.0 107.601 -179.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . 0.251 21.0 m-85 -118.52 110.06 16.94 Favored 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 124.448 1.099 . . . . 0.0 110.956 -179.619 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.469 HG22 ' CG2' ' A' ' 41' ' ' THR 0.401 0.1 OUTLIER -98.4 78.14 2.41 Favored 'General case' 0 N--CA 1.44 -0.965 0 O-C-N 125.078 1.486 . . . . 0.0 107.096 179.951 . . . . . . . . 4 4 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.481 ' CG1' ' HB ' ' A' ' 60' ' ' VAL 0.625 11.3 p -52.3 97.62 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 CA-C-N 109.497 -3.501 . . . . 0.0 113.073 179.737 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.485 ' CB ' ' HB ' ' A' ' 39' ' ' THR . 0.0 OUTLIER -62.23 139.27 58.5 Favored 'General case' 0 C--N 1.304 -1.384 1 N-CA-C 100.102 -4.036 . . . . 0.0 100.102 -179.633 . . . . . . . . 4 4 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.464 ' CG ' HD13 ' A' ' 36' ' ' LEU 0.253 3.4 tt0 -138.67 91.11 2.51 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 -179.229 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -93.3 55.15 2.22 Favored 'General case' 0 C--N 1.286 -2.164 0 N-CA-C 105.634 -1.987 . . . . 0.0 105.634 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 89.5 p -69.39 158.9 34.21 Favored 'General case' 0 C--N 1.349 0.561 0 CA-C-O 114.912 -2.47 . . . . 0.0 109.21 -179.587 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -52.74 -29.31 26.32 Favored 'General case' 0 C--O 1.212 -0.904 0 O-C-N 125.846 1.966 . . . . 0.0 106.946 179.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -73.27 -55.76 5.99 Favored 'General case' 0 C--N 1.35 0.627 0 CA-C-O 114.707 -2.568 . . . . 0.0 111.211 179.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . 0.313 0.0 OUTLIER -142.83 174.79 10.34 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 124.42 3.282 . . . . 0.0 111.287 -179.88 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -121.97 71.73 1.0 Allowed 'General case' 0 C--O 1.221 -0.409 1 N-CA-C 99.873 -4.121 . . . . 0.0 99.873 179.382 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 1.9 tt -105.67 103.18 14.97 Favored 'Isoleucine or valine' 0 C--O 1.243 0.724 0 O-C-N 127.635 3.085 . . . . 0.0 118.997 -179.189 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -65.91 125.0 24.02 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 103.623 -2.732 . . . . 0.0 103.623 178.409 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.481 ' HB ' ' CG1' ' A' ' 49' ' ' VAL . 24.5 t -100.76 97.14 5.38 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 -178.177 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.434 ' CG1' ' HB ' ' A' ' 48' ' ' THR 0.427 0.6 OUTLIER -79.66 135.25 25.95 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 CA-C-N 121.543 1.974 . . . . 0.0 108.986 179.748 . . . . . . . . 4 4 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.486 ' CE2' ' CG ' ' A' ' 82' ' ' TRP . 12.4 p90 -160.45 90.59 0.88 Allowed 'General case' 0 N--CA 1.432 -1.339 0 CA-C-O 123.832 1.777 . . . . 0.0 109.978 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.418 ' HB2' ' HB ' ' A' ' 66' ' ' VAL . 1.6 mt-10 -59.33 149.36 29.18 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 104.805 -2.294 . . . . 0.0 104.805 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.0 mt -66.16 110.9 3.17 Favored 'General case' 0 N--CA 1.427 -1.61 0 C-N-CA 117.982 -1.487 . . . . 0.0 108.58 -179.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.411 ' HA2' ' HB ' ' A' ' 81' ' ' THR . . . 72.78 46.45 30.16 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 128.199 2.809 . . . . 0.0 119.165 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.418 ' HB ' ' HB2' ' A' ' 63' ' ' GLU 0.442 3.8 t -111.92 7.92 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 CA-C-O 115.435 -2.222 . . . . 0.0 107.889 -179.818 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 46.71 101.7 0.0 OUTLIER 'General case' 0 CA--C 1.482 -1.661 0 CA-C-O 124.822 2.249 . . . . 0.0 115.525 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.485 ' CE1' ' HB2' ' A' ' 62' ' ' PHE . 8.8 p90 -117.67 157.62 26.13 Favored 'General case' 0 N--CA 1.435 -1.199 0 O-C-N 118.899 -2.376 . . . . 0.0 107.213 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -107.43 142.83 36.66 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 179.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -147.77 107.99 4.07 Favored 'General case' 0 C--O 1.205 -1.279 0 C-N-CA 118.196 -1.402 . . . . 0.0 114.265 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -75.15 138.38 41.98 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 122.954 2.616 . . . . 0.0 105.323 179.813 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.421 HD13 ' HB2' ' A' ' 78' ' ' LEU . 0.7 OUTLIER -82.52 -170.07 2.77 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 104.413 -2.44 . . . . 0.0 104.413 179.815 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.2 -45.62 14.84 Favored 'General case' 0 CA--C 1.547 0.842 0 CA-C-O 123.7 1.714 . . . . 0.0 111.254 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -139.92 26.62 2.25 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 112.952 -1.931 . . . . 0.0 110.858 179.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -120.36 -9.29 7.97 Favored Glycine 0 CA--C 1.548 2.152 0 O-C-N 127.105 2.753 . . . . 0.0 112.514 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.409 ' HG1' ' NH2' ' A' ' 95' ' ' ARG 0.259 0.1 OUTLIER 75.13 -178.36 0.16 Allowed 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 117.393 -1.723 . . . . 0.0 114.706 -179.775 . . . . . . . . 4 4 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.479 ' CB ' ' HB ' ' A' ' 96' ' ' VAL . 13.8 mt-10 -40.65 141.09 0.6 Allowed 'General case' 0 N--CA 1.442 -0.848 0 CA-C-O 125.785 2.707 . . . . 0.0 112.293 179.825 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.46 ' CD1' ' HB3' ' A' ' 93' ' ' PHE 0.419 11.7 tp -166.09 120.38 1.16 Allowed 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 104.271 -2.492 . . . . 0.0 104.271 179.877 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.5 t -143.32 121.44 12.17 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 105.636 -1.986 . . . . 0.0 105.636 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -156.51 -144.65 3.98 Favored Glycine 0 CA--C 1.538 1.5 0 CA-C-O 116.537 -2.257 . . . . 0.0 110.022 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.411 ' HB ' ' HA2' ' A' ' 65' ' ' GLY . 11.5 p -148.84 161.06 42.6 Favored 'General case' 0 CA--C 1.476 -1.872 0 O-C-N 126.68 2.047 . . . . 0.0 110.215 -179.737 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . 0.486 ' CG ' ' CE2' ' A' ' 62' ' ' PHE . 16.1 m95 -117.05 151.26 37.16 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 101.155 -3.646 . . . . 0.0 101.155 -179.735 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.456 ' CG2' HG21 ' A' ' 90' ' ' VAL . 9.9 t -153.68 144.97 23.01 Favored 'General case' 0 C--O 1.255 1.364 0 CA-C-O 122.992 1.377 . . . . 0.0 111.558 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' MET . . . . . 0.415 ' HA ' HD21 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -80.22 105.82 11.77 Favored 'General case' 0 N--CA 1.436 -1.141 0 C-N-CA 117.162 -1.815 . . . . 0.0 109.662 -179.952 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.453 ' CG ' HG12 ' A' ' 90' ' ' VAL 0.574 12.4 mm-40 -76.47 178.31 6.7 Favored 'General case' 0 N--CA 1.428 -1.561 0 O-C-N 120.979 -1.075 . . . . 0.0 108.999 179.778 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -67.21 95.52 0.29 Allowed Glycine 0 C--N 1.346 1.095 0 N-CA-C 105.145 -3.182 . . . . 0.0 105.145 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 79.18 16.57 0.93 Allowed 'General case' 0 C--O 1.242 0.703 0 CA-C-O 115.487 -2.197 . . . . 0.0 115.886 179.837 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . 0.418 0.0 OUTLIER -156.29 177.93 10.89 Favored 'General case' 0 CA--C 1.492 -1.256 0 O-C-N 125.936 2.022 . . . . 0.0 107.587 -179.895 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.427 ' HB3' ' HB2' ' A' ' 106' ' ' ARG . 0.1 OUTLIER -120.53 147.79 44.69 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 103.508 -2.775 . . . . 0.0 103.508 -179.861 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.468 ' HB ' ' CG2' ' A' ' 105' ' ' VAL . 0.6 OUTLIER -140.85 164.31 21.1 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.867 0 N-CA-C 104.844 -2.28 . . . . 0.0 104.844 179.917 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.429 ' HA2' ' HA ' ' A' ' 82' ' ' TRP . . . -143.87 109.35 0.54 Allowed Glycine 0 C--N 1.34 0.789 0 O-C-N 128.306 3.504 . . . . 0.0 111.445 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.498 ' C ' ' CD1' ' A' ' 93' ' ' PHE . 23.0 mtmt -103.3 164.6 11.54 Favored 'General case' 0 N--CA 1.432 -1.33 0 N-CA-C 102.87 -3.011 . . . . 0.0 102.87 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.498 ' CD1' ' C ' ' A' ' 92' ' ' LYS 0.282 95.9 m-85 -161.85 116.07 1.91 Allowed 'General case' 0 N--CA 1.441 -0.879 0 C-N-CA 119.698 -0.801 . . . . 0.0 109.662 -179.751 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 4.2 mttp -92.02 142.84 27.09 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.409 ' NH2' ' HG1' ' A' ' 76' ' ' THR 0.273 2.4 ttt-85 -88.57 130.68 35.2 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 113.856 -1.52 . . . . 0.0 109.542 179.859 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.479 ' HB ' ' CB ' ' A' ' 77' ' ' GLU . 68.9 t -70.88 -33.51 52.45 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 O-C-N 121.278 -0.889 . . . . 0.0 112.949 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . 0.364 31.1 t70 -95.96 -8.5 33.61 Favored 'General case' 0 C--O 1.261 1.673 0 N-CA-C 114.043 1.127 . . . . 0.0 114.043 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.41 ' ND2' ' OH ' ' A' ' 119' ' ' TYR . 19.7 t30 -118.88 -28.54 5.54 Favored 'General case' 0 CA--C 1.498 -1.022 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 -179.632 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 76.13 11.5 84.81 Favored Glycine 0 CA--C 1.536 1.345 0 N-CA-C 117.455 1.742 . . . . 0.0 117.455 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 9.4 mttt -105.61 152.01 23.63 Favored 'General case' 0 C--O 1.208 -1.079 0 CA-C-O 121.95 0.881 . . . . 0.0 109.852 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -94.9 118.72 32.25 Favored 'General case' 0 N--CA 1.435 -1.199 0 C-N-CA 127.653 2.381 . . . . 0.0 114.473 -179.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.552 ' CB ' ' HA ' ' A' ' 119' ' ' TYR . 7.8 tt -97.28 118.56 34.01 Favored 'General case' 0 C--N 1.317 -0.816 0 O-C-N 128.798 3.811 . . . . 0.0 103.369 179.57 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.468 ' N ' ' O ' ' A' ' 118' ' ' THR . 15.2 tt -110.48 161.12 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.41 0 C-N-CA 116.35 -2.14 . . . . 0.0 107.327 -179.569 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.434 ' N ' HG12 ' A' ' 103' ' ' ILE . . . -150.93 151.14 31.73 Favored 'General case' 0 N--CA 1.437 -1.106 0 O-C-N 118.105 -2.872 . . . . 0.0 107.376 -179.424 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.562 ' CG2' ' CE2' ' A' ' 117' ' ' TYR . 1.3 t -149.33 117.81 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 121.577 1.989 . . . . 0.0 111.54 -179.756 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.427 ' HB2' ' HB3' ' A' ' 89' ' ' LEU 0.3 79.5 mtt180 -84.49 91.53 7.87 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 105.195 -2.15 . . . . 0.0 105.195 -179.922 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 61.0 tt0 -81.61 80.8 7.87 Favored 'General case' 0 N--CA 1.436 -1.147 0 CA-C-O 126.974 3.273 . . . . 0.0 114.525 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.567 ' CD1' ' CH2' ' A' ' 6' ' ' TRP 0.331 0.6 OUTLIER -61.61 99.45 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.735 0 C-N-CA 116.601 -2.04 . . . . 0.0 114.6 179.85 . . . . . . . . 4 4 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -98.64 90.03 4.58 Favored 'General case' 0 C--O 1.219 -0.514 0 N-CA-C 102.839 -3.023 . . . . 0.0 102.839 -179.81 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 56.94 -125.86 40.14 Favored Glycine 0 CA--C 1.524 0.608 0 O-C-N 127.858 3.224 . . . . 0.0 111.731 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . 0.385 1.2 m-20 -65.12 -21.33 66.78 Favored 'General case' 0 C--O 1.215 -0.715 0 CA-C-O 115.515 -2.183 . . . . 0.0 112.938 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -95.27 141.91 28.3 Favored 'General case' 0 N--CA 1.432 -1.328 0 O-C-N 128.064 3.353 . . . . 0.0 115.777 179.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.553 ' HB3' ' CE3' ' A' ' 6' ' ' TRP . 0.3 OUTLIER -103.39 149.5 24.72 Favored 'General case' 0 N--CA 1.475 0.799 1 N-CA-C 100.121 -4.029 . . . . 0.0 100.121 179.557 . . . . . . . . 4 4 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.42 HG12 HD11 ' A' ' 127' ' ' ILE 0.252 78.3 mt -147.01 100.65 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 N-CA-C 103.686 -2.709 . . . . 0.0 103.686 179.876 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . 0.508 ' HG2' ' CD2' ' A' ' 113' ' ' LEU . 0.8 OUTLIER -74.95 154.14 38.26 Favored 'General case' 0 CA--C 1.506 -0.732 1 O-C-N 129.318 4.136 . . . . 0.0 102.125 -179.823 . . . . . . . . 4 4 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.48 ' O ' ' N ' ' A' ' 105' ' ' VAL . 2.5 t 178.63 157.71 0.49 Allowed 'General case' 0 N--CA 1.415 -2.221 0 O-C-N 124.626 1.203 . . . . 0.0 109.945 -178.557 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . 0.562 ' CE2' ' CG2' ' A' ' 105' ' ' VAL 0.384 5.0 m-30 127.13 -157.27 0.0 OUTLIER 'General case' 0 CA--C 1.479 -1.785 1 O-C-N 129.639 4.337 . . . . 0.0 113.215 177.682 . . . . . . . . 4 3 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.468 ' O ' ' N ' ' A' ' 103' ' ' ILE . 5.3 t -135.31 -162.77 1.3 Allowed 'General case' 0 C--N 1.312 -1.027 0 CA-C-O 127.304 3.43 . . . . 0.0 117.464 -174.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.552 ' HA ' ' CB ' ' A' ' 102' ' ' LEU 0.282 0.9 OUTLIER -113.7 -53.21 2.7 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 112.187 -2.279 . . . . 0.0 106.759 179.143 . . . . . . . . 4 4 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -124.68 -59.66 1.43 Allowed 'General case' 0 N--CA 1.426 -1.664 0 CA-C-N 113.479 -1.692 . . . . 0.0 113.266 179.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -161.78 15.78 0.15 Allowed Glycine 0 C--N 1.358 1.798 0 N-CA-C 120.747 3.059 . . . . 0.0 120.747 -179.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 75.6 t -128.61 102.9 8.77 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 N-CA-C 103.383 -2.821 . . . . 0.0 103.383 179.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.444 ' HA ' ' O ' ' A' ' 117' ' ' TYR . 0.0 OUTLIER -68.95 -173.84 0.53 Allowed 'General case' 0 C--O 1.215 -0.721 0 CA-C-O 124.107 1.908 . . . . 0.0 112.207 -178.181 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.516 ' HB1' ' CD2' ' A' ' 17' ' ' PHE . . . -166.44 95.29 0.54 Allowed 'General case' 0 N--CA 1.438 -1.026 0 CA-C-O 114.663 -2.589 . . . . 0.0 109.997 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.44 ' HG3' ' HB ' ' A' ' 116' ' ' THR 0.362 0.9 OUTLIER -77.38 143.06 38.96 Favored 'General case' 0 C--O 1.245 0.855 0 O-C-N 126.822 2.576 . . . . 0.0 111.956 179.518 . . . . . . . . 4 4 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.496 ' NH2' HE22 ' A' ' 115' ' ' GLN . 0.2 OUTLIER -129.92 84.15 2.19 Favored 'General case' 0 C--O 1.207 -1.163 0 C-N-CA 128.394 2.678 . . . . 0.0 104.591 177.323 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.42 HD11 HG12 ' A' ' 114' ' ' ILE . 14.1 mm -70.77 93.15 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.009 1 O-C-N 129.369 4.168 . . . . 0.0 108.07 179.837 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.638 ' CE2' ' N ' ' A' ' 7' ' ' LYS 0.334 14.8 t80 -88.95 148.38 23.83 Favored 'General case' 0 N--CA 1.426 -1.664 0 CA-C-O 125.036 2.35 . . . . 0.0 113.507 -178.786 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.51 ' N ' ' CG ' ' A' ' 128' ' ' PHE 0.316 0.0 OUTLIER -99.67 25.13 7.45 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-N 110.851 -2.886 . . . . 0.0 114.11 -176.89 . . . . . . . . 4 4 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.556 ' HB2' ' CZ3' ' A' ' 6' ' ' TRP . 8.4 tttt 43.92 96.82 0.01 OUTLIER 'General case' 0 CA--C 1.507 -0.704 0 CA-C-N 122.526 2.421 . . . . 0.0 116.456 178.423 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.409 ' N ' ' O ' ' A' ' 5' ' ' THR 0.769 3.1 tt0 . . . . . 0 N--CA 1.447 -0.58 0 O-C-N 117.353 -3.342 . . . . 0.0 113.822 179.801 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 34.5 p90 . . . . . 0 N--CA 1.438 -1.042 0 N-CA-C 117.215 2.302 . . . . 0.0 117.215 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -63.15 98.86 0.15 Allowed 'General case' 0 CA--C 1.491 -1.29 0 CA-C-O 123.33 1.538 . . . . 0.0 112.683 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . 0.403 ' O ' ' N ' ' A' ' 40' ' ' ILE . . . 157.15 -159.77 29.94 Favored Glycine 0 CA--C 1.498 -0.99 0 C-N-CA 117.596 -2.24 . . . . 0.0 109.767 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . 0.53 9.2 t -91.53 159.35 15.97 Favored 'General case' 0 N--CA 1.447 -0.612 0 O-C-N 126.342 1.848 . . . . 0.0 113.167 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.545 ' CZ2' ' CD1' ' A' ' 108' ' ' ILE . 90.1 m95 -148.23 145.75 28.38 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 110.715 -2.948 . . . . 0.0 105.103 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 44.7 tttt -143.34 93.75 2.53 Favored 'General case' 0 C--O 1.209 -1.049 0 O-C-N 126.308 2.255 . . . . 0.0 109.961 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . 0.26 4.1 p -46.57 125.69 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 O-C-N 126.585 2.428 . . . . 0.0 109.222 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -119.34 -32.24 4.43 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-N 114.327 -1.306 . . . . 0.0 110.253 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.21 131.35 30.15 Favored 'General case' 0 CA--C 1.496 -1.105 0 CA-C-O 123.148 1.451 . . . . 0.0 108.205 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . 0.287 38.3 m-80 -101.35 -178.53 3.76 Favored 'General case' 0 CA--C 1.504 -0.795 0 CA-C-N 113.214 -1.812 . . . . 0.0 108.496 179.709 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.416 ' CB ' ' HB2' ' A' ' 125' ' ' LYS . 0.3 OUTLIER -163.85 62.54 0.16 Allowed 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 121.106 1.775 . . . . 0.0 107.27 -179.913 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . 0.298 4.2 t30 115.5 18.7 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 128.097 2.559 . . . . 0.0 114.239 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.469 ' CD2' ' CG ' ' A' ' 126' ' ' ARG 0.327 0.1 OUTLIER -80.69 -24.0 39.16 Favored 'General case' 0 C--N 1.314 -0.957 0 O-C-N 127.481 2.988 . . . . 0.0 117.58 -179.984 . . . . . . . . 4 4 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -73.21 -47.04 46.77 Favored 'General case' 0 C--O 1.208 -1.1 0 O-C-N 118.306 -2.746 . . . . 0.0 108.938 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 29.5 tttm -78.3 -21.08 50.21 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 125.823 1.952 . . . . 0.0 114.722 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.43 ' HB3' ' HB3' ' A' ' 124' ' ' ALA . 2.9 t80 -73.53 -23.86 60.05 Favored 'General case' 0 N--CA 1.419 -1.986 0 C-N-CA 116.835 -1.946 . . . . 0.0 111.77 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -73.25 -21.05 60.7 Favored 'General case' 0 C--N 1.307 -1.256 0 O-C-N 118.765 -2.459 . . . . 0.0 109.045 179.867 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 55.1 tt0 -64.17 -31.38 72.55 Favored 'General case' 0 C--N 1.347 0.48 0 CA-C-O 125.235 2.445 . . . . 0.0 112.401 179.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 32.6 tptt -74.26 -30.26 62.04 Favored 'General case' 0 C--O 1.215 -0.742 0 CA-C-N 112.922 -1.944 . . . . 0.0 110.375 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . 0.254 11.0 mtt -77.6 -40.17 43.01 Favored 'General case' 0 C--N 1.353 0.736 0 CA-C-O 124.107 1.908 . . . . 0.0 106.059 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 143.37 15.38 0.28 Allowed Glycine 0 N--CA 1.438 -1.232 0 CA-C-O 115.345 -2.92 . . . . 0.0 115.056 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.488 HD13 ' CB ' ' A' ' 74' ' ' ASP . 1.7 mp -75.49 134.09 29.97 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 CA-C-N 120.489 2.144 . . . . 0.0 105.844 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 67.8 m-80 -93.31 -45.74 7.69 Favored 'General case' 0 C--O 1.243 0.727 0 CA-C-O 114.2 -2.81 . . . . 0.0 116.521 -178.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.405 HG13 HG11 ' A' ' 26' ' ' VAL 0.402 1.2 t -160.2 -59.66 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.499 -0.987 0 N-CA-C 119.217 3.043 . . . . 0.0 119.217 -179.764 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.405 HG11 HG13 ' A' ' 25' ' ' VAL 0.668 1.9 m -78.19 -26.22 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -179.897 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 12.3 mttm -75.16 -28.19 60.01 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-O 118.311 -0.852 . . . . 0.0 110.866 -179.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.434 ' HG3' ' NH1' ' A' ' 28' ' ' ARG . 4.9 ptt85 -79.95 -23.8 41.43 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 116.61 -2.036 . . . . 0.0 109.081 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.94 -43.9 64.48 Favored 'General case' 0 CA--C 1.507 -0.702 0 CA-C-O 122.512 1.149 . . . . 0.0 109.78 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.43 HD22 ' CZ ' ' A' ' 55' ' ' PHE . 9.2 tp -75.45 -31.7 60.39 Favored 'General case' 0 C--O 1.212 -0.894 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 -179.813 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -73.77 -34.08 56.87 Favored Glycine 0 C--N 1.348 1.238 0 O-C-N 128.299 3.5 . . . . 0.0 112.425 179.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -74.99 -40.64 60.57 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 125.741 1.616 . . . . 0.0 109.708 179.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 3.4 m80 -107.95 57.89 0.62 Allowed 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 113.46 -1.7 . . . . 0.0 110.908 179.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -85.37 -26.34 26.53 Favored 'General case' 0 C--O 1.212 -0.872 0 N-CA-C 117.522 2.415 . . . . 0.0 117.522 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.3 m120 78.74 24.61 0.56 Allowed 'General case' 0 CA--C 1.539 0.531 0 O-C-N 124.472 1.108 . . . . 0.0 109.206 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.9 tp -46.2 97.78 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.499 0 O-C-N 125.893 1.995 . . . . 0.0 109.449 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.45 ' HB3' ' CB ' ' A' ' 52' ' ' SER . 16.3 ttpt -98.03 96.12 7.93 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 101.754 -3.425 . . . . 0.0 101.754 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . 0.313 1.3 tp -86.27 147.16 26.21 Favored 'General case' 0 C--N 1.313 -0.991 0 C-N-CA 115.414 -2.515 . . . . 0.0 106.45 -179.68 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.473 ' HB ' ' CB ' ' A' ' 50' ' ' LYS . 90.4 m -131.36 83.63 2.12 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 103.802 -2.666 . . . . 0.0 103.802 179.573 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.418 HG13 ' CD1' ' A' ' 6' ' ' TRP . 0.8 OUTLIER -63.15 108.73 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.01 0 O-C-N 124.51 1.131 . . . . 0.0 109.747 -179.914 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.9 m -117.58 84.78 2.22 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-O 122.475 1.131 . . . . 0.0 110.147 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -77.89 142.6 38.34 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 120.599 -1.313 . . . . 0.0 110.779 -179.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -139.82 -129.08 0.11 Allowed 'General case' 0 CA--C 1.492 -1.284 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -81.65 78.36 1.95 Allowed Glycine 0 C--N 1.294 -1.763 0 O-C-N 119.4 -2.063 . . . . 0.0 109.853 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.323 1.3 m-20 80.44 -10.56 1.25 Allowed 'General case' 0 C--N 1.315 -0.931 0 O-C-N 126.11 1.711 . . . . 0.0 113.014 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.433 ' HG2' HG13 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -88.63 -178.07 5.72 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 117.374 -1.731 . . . . 0.0 107.491 179.943 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.467 ' CE1' HD23 ' A' ' 64' ' ' LEU . 2.1 m-85 -157.34 82.14 0.91 Allowed 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 106.061 -1.829 . . . . 0.0 106.061 -179.653 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.64 ' CA ' HG11 ' A' ' 61' ' ' VAL 0.484 6.4 m -67.17 136.61 55.32 Favored 'General case' 0 CA--C 1.5 -0.952 0 C-N-CA 114.747 -2.781 . . . . 0.0 106.449 -179.733 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.49 HG13 ' CH2' ' A' ' 82' ' ' TRP 0.595 0.9 OUTLIER -121.12 93.53 2.55 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 CA-C-N 112.632 -2.076 . . . . 0.0 114.047 -179.154 . . . . . . . . 4 4 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.473 ' CB ' ' HB ' ' A' ' 39' ' ' THR . 0.4 OUTLIER -67.74 150.44 48.68 Favored 'General case' 0 C--N 1.315 -0.891 1 N-CA-C 99.895 -4.113 . . . . 0.0 99.895 179.563 . . . . . . . . 4 4 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -141.26 73.95 1.44 Allowed 'General case' 0 C--O 1.216 -0.685 0 N-CA-C 103.252 -2.87 . . . . 0.0 103.252 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.45 ' CB ' ' HB3' ' A' ' 37' ' ' LYS . 0.1 OUTLIER -76.05 77.81 2.91 Favored 'General case' 0 C--N 1.289 -2.043 0 O-C-N 119.571 -1.955 . . . . 0.0 105.764 -179.939 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 84.0 p -101.13 159.62 15.08 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-O 114.387 -2.72 . . . . 0.0 108.404 -179.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -53.9 -26.85 27.02 Favored 'General case' 0 CA--C 1.51 -0.559 0 O-C-N 125.259 1.599 . . . . 0.0 109.317 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.43 ' CZ ' HD22 ' A' ' 30' ' ' LEU . 61.0 m-85 -71.45 -57.04 4.8 Favored 'General case' 0 C--O 1.215 -0.725 0 CA-C-O 114.489 -2.672 . . . . 0.0 109.582 179.799 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . 0.26 0.4 OUTLIER -169.81 152.57 4.55 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 123.226 2.739 . . . . 0.0 110.287 179.646 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 5.6 p-10 -84.81 86.7 7.32 Favored 'General case' 0 C--O 1.217 -0.631 0 C-N-CA 131.308 3.843 . . . . 0.0 101.441 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 2.7 tt -114.48 86.47 0.91 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.792 0 N-CA-C 119.604 3.186 . . . . 0.0 119.604 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -60.83 105.61 0.48 Allowed 'General case' 0 C--O 1.214 -0.778 0 N-CA-C 104.585 -2.376 . . . . 0.0 104.585 178.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.472 ' CG1' ' N ' ' A' ' 61' ' ' VAL . 1.0 OUTLIER -68.15 -55.27 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 C-N-CA 125.346 1.458 . . . . 0.0 113.893 -178.044 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.64 HG11 ' CA ' ' A' ' 48' ' ' THR 0.478 0.1 OUTLIER 60.69 135.6 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 CA-C-O 126.38 2.991 . . . . 0.0 112.094 -177.211 . . . . . . . . 4 4 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.63 ' CD1' ' CD1' ' A' ' 68' ' ' PHE . 9.8 t80 -163.8 109.13 1.05 Allowed 'General case' 0 N--CA 1.432 -1.361 0 CA-C-N 112.321 -2.218 . . . . 0.0 110.255 179.654 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.467 ' CB ' HG22 ' A' ' 66' ' ' VAL . 0.4 OUTLIER -58.04 129.35 41.54 Favored 'General case' 0 C--O 1.251 1.133 0 N-CA-C 102.722 -3.066 . . . . 0.0 102.722 179.037 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.467 HD23 ' CE1' ' A' ' 47' ' ' PHE . 0.4 OUTLIER -50.05 130.96 22.96 Favored 'General case' 0 C--O 1.247 0.971 0 CA-C-O 123.252 1.501 . . . . 0.0 111.999 -179.702 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.41 ' HA2' ' HB ' ' A' ' 81' ' ' THR . . . 60.72 14.74 37.93 Favored Glycine 0 C--N 1.341 0.824 0 CA-C-N 112.368 -2.196 . . . . 0.0 115.203 -179.827 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.467 HG22 ' CB ' ' A' ' 63' ' ' GLU 0.412 16.1 t -72.27 -88.29 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 179.94 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 154.82 117.49 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.175 0 C-N-CA 125.627 1.571 . . . . 0.0 115.224 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.63 ' CD1' ' CD1' ' A' ' 62' ' ' PHE . 0.4 OUTLIER -133.31 147.94 51.89 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-N 118.91 0.777 . . . . 0.0 110.047 -179.961 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -104.15 150.4 24.38 Favored 'General case' 0 C--O 1.243 0.714 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -151.72 107.28 3.34 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-O 116.289 -1.815 . . . . 0.0 113.904 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -78.9 127.62 32.25 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 122.279 2.309 . . . . 0.0 105.137 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -65.98 -177.67 0.52 Allowed 'General case' 0 C--N 1.3 -1.576 0 O-C-N 125.054 1.471 . . . . 0.0 107.363 -179.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -103.05 9.73 38.4 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-O 124.883 2.278 . . . . 0.0 110.909 179.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.488 ' CB ' HD13 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -97.17 -28.52 14.06 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 112.675 -2.057 . . . . 0.0 112.316 -179.813 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 133.79 8.96 2.07 Favored Glycine 0 CA--C 1.547 2.046 0 CA-C-O 117.651 -1.638 . . . . 0.0 111.596 -178.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . 0.376 0.4 OUTLIER -131.44 169.65 15.76 Favored 'General case' 0 C--N 1.309 -1.154 0 C-N-CA 115.724 -2.39 . . . . 0.0 115.521 -179.757 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.472 ' HG2' ' CG2' ' A' ' 96' ' ' VAL . 0.1 OUTLIER -90.26 168.1 12.17 Favored 'General case' 0 N--CA 1.443 -0.807 1 O-C-N 130.764 5.04 . . . . 0.0 113.842 179.752 . . . . . . . . 4 4 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . 0.399 10.0 tp -167.33 148.39 5.59 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-N 114.123 -1.399 . . . . 0.0 107.642 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 7.4 m -159.27 116.2 2.67 Favored 'General case' 0 C--O 1.203 -1.362 0 N-CA-C 105.394 -2.076 . . . . 0.0 105.394 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.422 ' HA3' ' HA ' ' A' ' 93' ' ' PHE . . . -156.62 -151.73 6.06 Favored Glycine 0 C--N 1.296 -1.642 0 C-N-CA 116.92 -2.562 . . . . 0.0 114.564 -179.801 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.442 ' HA ' ' CZ ' ' A' ' 62' ' ' PHE . 1.3 p -152.39 168.3 25.9 Favored 'General case' 0 C--O 1.199 -1.599 0 C-N-CA 116.807 -1.957 . . . . 0.0 109.607 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . 0.622 ' CD1' ' CE2' ' A' ' 62' ' ' PHE 0.3 3.7 m0 -122.79 145.51 48.35 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 102.803 -3.036 . . . . 0.0 102.803 -179.81 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.508 ' CG2' ' CG2' ' A' ' 90' ' ' VAL . 10.3 t -143.28 124.64 14.68 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-O 124.924 2.297 . . . . 0.0 108.543 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 9.4 ttt -80.6 114.54 19.57 Favored 'General case' 0 N--CA 1.422 -1.872 0 CA-C-N 114.088 -1.415 . . . . 0.0 110.76 -179.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . 0.588 7.1 mm-40 -91.91 6.58 45.68 Favored 'General case' 0 N--CA 1.419 -2.002 0 CA-C-O 123.834 1.778 . . . . 0.0 112.746 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 91.3 -74.94 1.57 Allowed Glycine 0 C--N 1.345 1.05 0 N-CA-C 103.991 -3.643 . . . . 0.0 103.991 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 17.6 p30 -76.04 1.61 15.0 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 116.238 -1.839 . . . . 0.0 114.995 -179.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . 0.446 19.1 mttp -162.41 159.89 25.74 Favored 'General case' 0 C--O 1.218 -0.58 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.42 121.39 38.42 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 101.997 -3.334 . . . . 0.0 101.997 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.508 ' CG2' ' CG2' ' A' ' 83' ' ' THR . 1.2 m -102.53 161.95 3.88 Favored 'Isoleucine or valine' 0 C--O 1.244 0.774 0 N-CA-C 105.644 -1.984 . . . . 0.0 105.644 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -142.9 94.75 0.18 Allowed Glycine 0 C--N 1.35 1.306 0 C-N-CA 130.627 3.965 . . . . 0.0 110.407 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.455 ' HA ' ' HA ' ' A' ' 103' ' ' ILE . 1.4 mtpm? -103.62 156.47 17.76 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 104.379 -2.452 . . . . 0.0 104.379 179.511 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.422 ' HA ' ' HA3' ' A' ' 80' ' ' GLY . 64.6 m-85 -151.73 128.95 11.19 Favored 'General case' 0 CA--C 1.5 -0.967 0 O-C-N 125.464 1.728 . . . . 0.0 111.11 -179.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 36.3 mtpt -107.91 129.17 55.11 Favored 'General case' 0 C--O 1.212 -0.87 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.454 -179.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . 0.342 0.5 OUTLIER -68.72 168.27 13.6 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 120.679 -1.263 . . . . 0.0 109.008 -179.911 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.472 ' CG2' ' HG2' ' A' ' 77' ' ' GLU . 24.4 t -100.45 -34.85 4.21 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 O-C-N 126.262 2.226 . . . . 0.0 108.508 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . 0.315 0.4 OUTLIER -65.94 -23.2 66.56 Favored 'General case' 0 CA--C 1.505 -0.756 0 N-CA-C 115.897 1.814 . . . . 0.0 115.897 -179.794 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -160.93 23.22 0.14 Allowed 'General case' 0 CA--C 1.491 -1.296 0 N-CA-C 117.748 2.499 . . . . 0.0 117.748 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 56.15 19.13 22.62 Favored Glycine 0 CA--C 1.536 1.354 0 N-CA-C 117.744 1.858 . . . . 0.0 117.744 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 15.4 mmtp -74.52 -172.21 1.43 Allowed 'General case' 0 C--O 1.198 -1.618 0 CA-C-N 119.812 1.806 . . . . 0.0 108.034 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -129.55 150.22 50.98 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 127.516 2.326 . . . . 0.0 113.389 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.455 ' CD1' ' C ' ' A' ' 102' ' ' LEU . 0.0 OUTLIER -140.13 141.08 36.12 Favored 'General case' 0 C--O 1.246 0.878 0 O-C-N 128.345 3.528 . . . . 0.0 106.87 -179.516 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.548 HG12 ' CD2' ' A' ' 117' ' ' TYR . 11.3 tt -132.11 179.77 4.08 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.213 0 C-N-CA 117.342 -1.743 . . . . 0.0 109.777 179.568 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.455 ' H ' ' CG1' ' A' ' 103' ' ' ILE . . . -163.59 113.45 1.3 Allowed 'General case' 0 N--CA 1.427 -1.579 0 CA-C-O 114.2 -2.81 . . . . 0.0 107.493 -176.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -100.71 103.09 14.34 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.682 0 CA-C-N 121.079 1.763 . . . . 0.0 113.511 -179.058 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.408 ' NH1' ' CG ' ' A' ' 106' ' ' ARG . 1.4 mtt-85 -77.08 93.85 3.94 Favored 'General case' 0 CA--C 1.504 -0.821 0 CA-C-O 123.423 1.583 . . . . 0.0 109.337 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -94.59 79.09 3.79 Favored 'General case' 0 N--CA 1.423 -1.824 0 CA-C-N 113.24 -1.8 . . . . 0.0 114.415 -179.799 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.545 ' CD1' ' CZ2' ' A' ' 6' ' ' TRP 0.322 1.4 tt -58.27 107.6 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.251 0 C-N-CA 117.26 -1.776 . . . . 0.0 114.681 179.951 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -92.74 79.84 4.74 Favored 'General case' 0 N--CA 1.436 -1.132 0 O-C-N 120.141 -1.6 . . . . 0.0 107.105 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 56.6 -58.52 0.01 OUTLIER Glycine 0 C--O 1.245 0.784 0 C-N-CA 128.907 3.146 . . . . 0.0 113.973 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . 0.302 18.8 m120 -127.47 -1.07 6.24 Favored 'General case' 0 C--O 1.213 -0.828 0 CA-C-O 117.434 -1.269 . . . . 0.0 112.366 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -123.59 121.93 36.86 Favored 'General case' 0 C--O 1.209 -1.066 0 CA-C-O 115.443 -2.217 . . . . 0.0 111.121 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.435 ' HB3' ' HB2' ' A' ' 128' ' ' PHE . 0.8 OUTLIER -88.47 137.39 32.37 Favored 'General case' 0 C--O 1.209 -1.048 0 N-CA-C 102.004 -3.332 . . . . 0.0 102.004 -179.655 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.474 ' CG2' HG23 ' A' ' 116' ' ' THR . 72.4 mt -138.67 109.4 4.89 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 O-C-N 126.305 2.253 . . . . 0.0 109.377 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . 0.434 ' C ' ' CG2' ' A' ' 116' ' ' THR . 19.9 mt-30 -79.32 147.29 32.51 Favored 'General case' 0 CA--C 1.498 -1.046 0 N-CA-C 102.211 -3.255 . . . . 0.0 102.211 179.727 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.525 ' HB ' ' CD ' ' A' ' 125' ' ' LYS . 0.1 OUTLIER -163.24 111.89 1.27 Allowed 'General case' 0 N--CA 1.427 -1.599 0 C-N-CA 117.263 -1.775 . . . . 0.0 109.71 -179.168 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . 0.548 ' CD2' HG12 ' A' ' 103' ' ' ILE 0.273 0.1 OUTLIER 176.17 -162.57 0.03 OUTLIER 'General case' 0 CA--C 1.469 -2.159 0 C-N-CA 116.512 -2.075 . . . . 0.0 114.208 178.122 . . . . . . . . 4 4 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.445 ' O ' ' N ' ' A' ' 103' ' ' ILE . 8.0 t -128.46 -164.86 1.43 Allowed 'General case' 0 N--CA 1.425 -1.683 0 CA-C-O 127.407 3.479 . . . . 0.0 117.51 -174.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.44 ' HA ' ' HB2' ' A' ' 102' ' ' LEU 0.298 68.9 t80 -128.97 5.95 5.43 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 112.305 -2.225 . . . . 0.0 108.1 178.075 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 168.64 -60.65 0.01 OUTLIER 'General case' 0 C--N 1.289 -2.035 0 C-N-CA 125.68 1.592 . . . . 0.0 112.472 -178.185 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -157.34 22.52 0.43 Allowed Glycine 0 C--N 1.366 2.225 0 N-CA-C 121.434 3.334 . . . . 0.0 121.434 -179.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.416 HG13 ' HB2' ' A' ' 17' ' ' PHE . 75.7 t -135.42 118.71 23.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 O-C-N 117.857 -3.143 . . . . 0.0 105.123 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 37.5 mp0 -85.72 175.74 8.54 Favored 'General case' 0 C--O 1.21 -1.005 0 CA-C-O 123.882 1.801 . . . . 0.0 112.868 -179.457 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.43 ' HB3' ' HB3' ' A' ' 17' ' ' PHE . . . -165.53 115.05 1.03 Allowed 'General case' 0 N--CA 1.435 -1.19 0 CA-C-O 113.905 -2.95 . . . . 0.0 108.211 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.525 ' CD ' ' HB ' ' A' ' 116' ' ' THR . 0.1 OUTLIER -90.74 140.33 29.88 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 127.764 3.165 . . . . 0.0 109.535 179.942 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.469 ' CG ' ' CD2' ' A' ' 14' ' ' TYR . 0.1 OUTLIER -127.68 82.43 2.09 Favored 'General case' 0 N--CA 1.428 -1.543 0 CA-C-O 114.242 -2.79 . . . . 0.0 111.123 179.958 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 5.1 mm -74.46 102.22 2.07 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.832 1 O-C-N 130.894 5.121 . . . . 0.0 115.572 179.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.435 ' HB2' ' HB3' ' A' ' 113' ' ' LEU . 22.0 m-85 -94.27 128.94 41.05 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 128.887 2.875 . . . . 0.0 107.868 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . 0.308 10.4 mttt -93.19 3.14 56.18 Favored 'General case' 0 CA--C 1.507 -0.693 0 CA-C-O 116.768 -1.586 . . . . 0.0 112.083 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.529 ' HB2' ' CZ3' ' A' ' 6' ' ' TRP . 0.1 OUTLIER 69.79 99.9 0.06 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 122.146 2.248 . . . . 0.0 114.127 179.972 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . 0.833 9.4 tt0 . . . . . 0 CA--C 1.499 -0.987 0 C-N-CA 115.592 -2.443 . . . . 0.0 115.666 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.51 -0.593 0 CA-C-O 119.598 -0.239 . . . . 0.0 110.644 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.494 ' CD1' ' N ' ' A' ' 2' ' ' PHE . 2.2 m-30 73.42 -51.44 0.7 Allowed 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 117.866 2.543 . . . . 0.0 117.866 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -36.74 91.18 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 124.489 2.09 . . . . 0.0 115.749 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 164.13 -176.35 40.12 Favored Glycine 0 C--O 1.209 -1.433 0 C-N-CA 117.668 -2.206 . . . . 0.0 111.147 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.444 HG21 ' CG2' ' A' ' 39' ' ' THR 0.56 0.1 OUTLIER -91.35 155.33 18.58 Favored 'General case' 0 N--CA 1.443 -0.802 0 O-C-N 127.146 2.321 . . . . 0.0 110.63 -179.787 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.483 ' CH2' ' HE2' ' A' ' 130' ' ' LYS . 69.7 m95 -141.67 149.78 41.04 Favored 'General case' 0 N--CA 1.436 -1.147 0 O-C-N 127.874 3.234 . . . . 0.0 106.405 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 10.0 tmtt? -152.46 93.31 1.78 Allowed 'General case' 0 CA--C 1.5 -0.977 0 O-C-N 126.913 2.633 . . . . 0.0 107.14 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.475 ' HB ' ' CD1' ' A' ' 128' ' ' PHE 0.305 0.4 OUTLIER -42.56 137.0 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.0 0 CA-C-O 117.124 -1.417 . . . . 0.0 113.115 -179.998 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -118.27 -60.68 1.76 Allowed 'General case' 0 C--O 1.214 -0.807 0 O-C-N 126.405 2.316 . . . . 0.0 108.827 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -118.98 155.04 32.07 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . 0.363 0.1 OUTLIER -121.1 -165.76 1.26 Allowed 'General case' 0 C--N 1.324 -0.524 0 O-C-N 126.011 2.07 . . . . 0.0 107.459 -179.78 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.405 ' HB3' ' HB2' ' A' ' 125' ' ' LYS . 3.7 tp10 -176.35 89.3 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.523 0 C-N-CA 117.604 -1.638 . . . . 0.0 107.197 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 97.95 -3.6 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 126.143 1.777 . . . . 0.0 114.132 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.472 ' HA ' ' CB ' ' A' ' 124' ' ' ALA 0.27 76.9 t80 -62.07 -28.08 69.35 Favored 'General case' 0 C--O 1.241 0.618 0 O-C-N 127.908 3.255 . . . . 0.0 114.307 -179.834 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -68.18 -40.37 82.28 Favored 'General case' 0 CA--C 1.5 -0.949 0 O-C-N 124.672 1.232 . . . . 0.0 113.442 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.3 -26.03 55.42 Favored 'General case' 0 N--CA 1.441 -0.921 0 O-C-N 125.053 1.47 . . . . 0.0 111.216 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.477 ' CB ' ' HB3' ' A' ' 124' ' ' ALA . 4.7 t80 -68.59 -25.28 64.8 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 123.467 1.603 . . . . 0.0 112.773 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.416 ' HB3' ' HB ' ' A' ' 23' ' ' ILE . 0.6 OUTLIER -77.74 -24.91 48.95 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-O 124.018 1.866 . . . . 0.0 107.698 -179.91 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.7 tt0 -74.45 -20.28 60.08 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 125.297 2.475 . . . . 0.0 110.07 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.414 ' CE ' ' HB2' ' A' ' 120' ' ' GLU . 2.8 tmtm? -77.67 -48.3 17.11 Favored 'General case' 0 C--O 1.209 -1.032 0 CA-C-N 111.998 -2.364 . . . . 0.0 110.152 179.461 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 3.1 mtt -65.48 -20.25 66.27 Favored 'General case' 0 C--O 1.208 -1.12 0 C-N-CA 127.519 2.328 . . . . 0.0 107.507 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.13 31.35 5.96 Favored Glycine 0 C--N 1.298 -1.563 0 C-N-CA 125.221 1.391 . . . . 0.0 111.812 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.445 ' CG2' ' HB2' ' A' ' 27' ' ' LYS . 0.5 OUTLIER -91.56 132.75 35.2 Favored 'Isoleucine or valine' 0 C--N 1.351 0.643 0 CA-C-O 116.154 -1.879 . . . . 0.0 105.99 -179.863 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -90.76 -85.67 0.22 Allowed 'General case' 0 CA--C 1.508 -0.672 0 N-CA-C 116.365 1.987 . . . . 0.0 116.365 -179.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . 0.354 3.5 p -117.4 -72.41 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.495 -1.17 0 N-CA-C 120.022 3.341 . . . . 0.0 120.022 -179.508 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.579 2.2 m -63.43 -28.51 45.16 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.871 0 N-CA-C 118.619 2.822 . . . . 0.0 118.619 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.445 ' HB2' ' CG2' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -74.3 -42.66 59.15 Favored 'General case' 0 CA--C 1.508 -0.653 0 O-C-N 127.789 3.18 . . . . 0.0 114.146 -179.839 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 38.1 ptt180 -78.38 -23.43 46.83 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 123.41 1.576 . . . . 0.0 108.793 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 31.1 tttp -74.86 -39.55 61.49 Favored 'General case' 0 CA--C 1.509 -0.63 0 CA-C-N 114.15 -1.386 . . . . 0.0 111.029 179.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -74.65 -21.81 59.23 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 114.039 -1.437 . . . . 0.0 110.712 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -79.45 -30.71 44.04 Favored Glycine 0 CA--C 1.524 0.596 0 O-C-N 128.23 3.456 . . . . 0.0 110.929 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -77.09 -57.58 3.76 Favored 'General case' 0 N--CA 1.436 -1.167 0 C-N-CA 127.182 2.193 . . . . 0.0 112.1 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 22.4 m80 -75.18 -1.99 25.79 Favored 'General case' 0 N--CA 1.438 -1.054 0 CA-C-O 117.112 -1.423 . . . . 0.0 113.606 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.419 ' HA ' ' HB2' ' A' ' 54' ' ' ASN . 35.6 p-10 -38.6 -36.67 0.27 Allowed 'General case' 0 CA--C 1.495 -1.171 0 N-CA-C 119.888 3.292 . . . . 0.0 119.888 179.604 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . 0.263 13.4 m120 79.96 21.3 0.54 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 120.108 1.322 . . . . 0.0 113.422 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.419 HD22 ' CZ ' ' A' ' 128' ' ' PHE . 27.0 tp -37.08 93.47 0.01 OUTLIER 'General case' 0 C--N 1.351 0.643 0 O-C-N 126.993 2.683 . . . . 0.0 110.313 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.412 ' HB3' ' HB3' ' A' ' 52' ' ' SER . 2.4 ttmp? -92.82 105.47 17.59 Favored 'General case' 0 C--O 1.218 -0.602 0 N-CA-C 101.92 -3.363 . . . . 0.0 101.92 179.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . 0.252 1.3 tp -95.3 127.11 41.08 Favored 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 116.212 -2.195 . . . . 0.0 108.735 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.444 ' CG2' HG21 ' A' ' 5' ' ' THR . 89.0 m -109.97 83.14 1.71 Allowed 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 104.226 -2.509 . . . . 0.0 104.226 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 24.0 mm -63.91 132.93 29.85 Favored 'Isoleucine or valine' 0 C--O 1.247 0.94 0 CA-C-N 112.983 -1.917 . . . . 0.0 108.952 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 30.5 m -143.62 96.84 2.97 Favored 'General case' 0 CA--C 1.502 -0.874 0 CA-C-N 111.419 -2.628 . . . . 0.0 113.582 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 59.8 tt0 -89.5 131.94 35.29 Favored 'General case' 0 N--CA 1.447 -0.613 0 O-C-N 124.794 1.309 . . . . 0.0 110.272 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 46.3 tt0 -101.98 -52.33 3.19 Favored 'General case' 0 CA--C 1.49 -1.349 0 CA-C-O 125.172 2.415 . . . . 0.0 110.156 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -165.74 -69.19 0.03 OUTLIER Glycine 0 N--CA 1.433 -1.551 0 N-CA-C 105.422 -3.071 . . . . 0.0 105.422 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.364 0.0 OUTLIER -106.53 -22.7 12.69 Favored 'General case' 0 C--O 1.218 -0.602 0 CA-C-N 113.095 -1.552 . . . . 0.0 111.168 179.906 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.445 ' CD ' ' HG3' ' A' ' 63' ' ' GLU . 0.0 OUTLIER -98.32 156.23 16.82 Favored 'General case' 0 N--CA 1.435 -1.203 0 C-N-CA 120.318 -0.553 . . . . 0.0 111.931 -179.879 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -129.79 92.72 3.37 Favored 'General case' 0 N--CA 1.441 -0.893 0 C-N-CA 123.465 0.706 . . . . 0.0 109.436 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.441 ' CA ' HG11 ' A' ' 61' ' ' VAL 0.455 1.3 p -67.18 141.51 57.31 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 116.8 -1.96 . . . . 0.0 111.45 -179.903 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.549 ' CG1' ' CZ ' ' A' ' 62' ' ' PHE 0.695 0.4 OUTLIER -120.91 83.82 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.424 -1.726 0 CA-C-N 111.877 -2.42 . . . . 0.0 111.167 179.916 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.411 ' CB ' ' HB ' ' A' ' 39' ' ' THR . 2.1 ttpp -62.84 142.89 58.05 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 101.229 -3.619 . . . . 0.0 101.229 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -138.55 93.92 2.79 Favored 'General case' 0 C--O 1.217 -0.632 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.412 ' HB3' ' HB3' ' A' ' 37' ' ' LYS 0.287 3.9 t -91.64 60.8 4.1 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 106.722 -1.584 . . . . 0.0 106.722 179.81 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.409 ' HB2' ' HB2' ' A' ' 34' ' ' ASP . 1.7 p -89.59 -178.46 5.56 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 125.897 1.998 . . . . 0.0 112.447 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.419 ' HB2' ' HA ' ' A' ' 34' ' ' ASP . 0.1 OUTLIER -61.44 -28.59 69.38 Favored 'General case' 0 C--O 1.212 -0.878 0 CA-C-O 115.525 -2.178 . . . . 0.0 109.932 179.789 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.453 ' CD2' ' CB ' ' A' ' 73' ' ' ALA . 95.8 m-85 -70.93 -51.08 28.09 Favored 'General case' 0 C--O 1.221 -0.398 0 C-N-CA 117.285 -1.766 . . . . 0.0 114.13 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 6.3 ttm180 179.72 153.7 0.49 Allowed 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 120.702 1.592 . . . . 0.0 108.256 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 42.8 t-20 -88.89 85.98 6.85 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 102.336 -3.209 . . . . 0.0 102.336 -179.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 6.3 tp -117.57 107.31 21.83 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.866 1 C-N-CA 133.19 4.596 . . . . 0.0 118.477 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -66.2 134.07 51.95 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 104.606 -2.368 . . . . 0.0 104.606 178.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 22.3 t -86.16 -68.8 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 CA-C-O 125.517 2.58 . . . . 0.0 110.874 -179.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.441 HG11 ' CA ' ' A' ' 48' ' ' THR 0.497 0.0 OUTLIER 74.57 128.02 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.14 0 CA-C-N 113.825 -1.534 . . . . 0.0 113.347 179.995 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.549 ' CZ ' ' CG1' ' A' ' 49' ' ' VAL . 0.0 OUTLIER -160.11 99.95 1.37 Allowed 'General case' 0 C--N 1.313 -1.002 0 CA-C-O 117.756 -1.116 . . . . 0.0 111.141 -179.781 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.445 ' HG3' ' CD ' ' A' ' 46' ' ' LYS . 3.7 tt0 -49.59 137.61 15.16 Favored 'General case' 0 N--CA 1.439 -0.999 0 O-C-N 126.592 2.433 . . . . 0.0 104.564 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -60.33 129.69 42.9 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 123.395 1.569 . . . . 0.0 108.469 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 63.38 26.95 70.02 Favored Glycine 0 C--N 1.343 0.948 0 CA-C-N 111.437 -2.62 . . . . 0.0 118.849 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.428 HG22 ' HB3' ' A' ' 63' ' ' GLU 0.423 3.0 t -102.63 101.61 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 -179.962 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -58.03 126.45 27.52 Favored 'General case' 0 CA--C 1.49 -1.332 0 CA-C-O 116.816 -1.564 . . . . 0.0 111.391 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.549 ' CZ ' ' CB ' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -131.91 -174.24 3.37 Favored 'General case' 0 N--CA 1.437 -1.097 0 CA-C-N 119.289 0.949 . . . . 0.0 110.968 -179.84 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -125.81 118.38 25.38 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 -179.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 16.2 t80 -126.63 115.39 19.4 Favored 'General case' 0 C--O 1.209 -1.028 0 CA-C-N 120.503 1.501 . . . . 0.0 111.711 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 10.6 t -80.93 142.62 33.34 Favored 'General case' 0 CA--C 1.491 -1.327 0 O-C-N 120.352 -1.468 . . . . 0.0 109.434 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -97.83 -174.2 2.82 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 106.043 -1.836 . . . . 0.0 106.043 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.453 ' CB ' ' CD2' ' A' ' 55' ' ' PHE . . . -84.33 -49.28 8.88 Favored 'General case' 0 C--O 1.211 -0.973 0 O-C-N 125.355 1.659 . . . . 0.0 110.717 179.409 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.464 ' CB ' ' CG ' ' A' ' 132' ' ' PLM . 4.9 t70 -121.7 -10.06 8.8 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.079 -1.419 . . . . 0.0 109.72 179.182 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -89.19 -17.59 55.36 Favored Glycine 0 CA--C 1.546 1.982 0 CA-C-N 118.66 0.664 . . . . 0.0 112.763 179.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . 0.355 0.0 OUTLIER 71.96 -169.03 0.14 Allowed 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 116.495 -2.082 . . . . 0.0 113.302 179.922 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.431 ' HB3' HG12 ' A' ' 96' ' ' VAL . 4.0 mp0 -46.22 140.71 3.82 Favored 'General case' 0 C--N 1.319 -0.729 0 O-C-N 128.253 3.471 . . . . 0.0 112.039 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.462 ' HG ' ' CG ' ' A' ' 93' ' ' PHE 0.42 0.4 OUTLIER -156.83 100.67 1.92 Allowed 'General case' 0 C--O 1.243 0.734 0 N-CA-C 102.798 -3.038 . . . . 0.0 102.798 179.963 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 27.6 m -109.13 135.37 50.38 Favored 'General case' 0 CA--C 1.481 -1.686 0 O-C-N 125.009 1.443 . . . . 0.0 108.238 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 173.6 -168.0 40.78 Favored Glycine 0 C--N 1.303 -1.276 1 C-N-CA 113.805 -4.045 . . . . 0.0 108.775 -179.682 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.7 p -137.69 177.14 8.1 Favored 'General case' 0 CA--C 1.493 -1.218 0 CA-C-N 119.129 1.465 . . . . 0.0 110.981 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . 0.546 ' CE3' ' CA ' ' A' ' 91' ' ' GLY . 83.5 m95 -128.12 141.45 51.49 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 102.078 -3.304 . . . . 0.0 102.078 179.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 5.4 t -142.86 138.67 30.44 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-O 122.033 0.921 . . . . 0.0 109.312 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 13.6 ttt -83.44 105.24 14.22 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . 0.603 4.7 mt-10 -56.8 -28.74 61.89 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-O 124.986 2.327 . . . . 0.0 112.661 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 140.49 -46.71 0.91 Allowed Glycine 0 C--N 1.347 1.146 0 N-CA-C 104.081 -3.608 . . . . 0.0 104.081 179.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 17.3 t30 -113.28 -19.23 11.85 Favored 'General case' 0 N--CA 1.44 -0.937 0 O-C-N 127.109 2.299 . . . . 0.0 114.109 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . 0.385 20.3 mttt -136.93 151.41 49.01 Favored 'General case' 0 N--CA 1.44 -0.958 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 179.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.47 HD21 ' CD ' ' A' ' 106' ' ' ARG . 1.0 OUTLIER -98.74 129.56 45.18 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 101.313 -3.588 . . . . 0.0 101.313 179.634 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -120.26 114.75 44.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 C-N-CA 118.363 -1.335 . . . . 0.0 108.14 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.546 ' CA ' ' CE3' ' A' ' 82' ' ' TRP . . . -84.16 91.52 1.65 Allowed Glycine 0 C--N 1.354 1.582 0 C-N-CA 129.652 3.501 . . . . 0.0 107.819 -179.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -92.39 124.33 36.37 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 102.509 -3.145 . . . . 0.0 102.509 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.462 ' CG ' ' HG ' ' A' ' 78' ' ' LEU . 2.4 m-85 -136.23 108.99 7.53 Favored 'General case' 0 CA--C 1.502 -0.865 0 O-C-N 125.902 2.001 . . . . 0.0 111.941 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.04 -173.22 3.98 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . 0.42 0.6 OUTLIER -131.56 151.83 51.27 Favored 'General case' 0 CA--C 1.487 -1.459 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.859 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.431 HG12 ' HB3' ' A' ' 77' ' ' GLU . 17.4 m -82.03 -33.62 11.86 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 N-CA-C 114.176 1.176 . . . . 0.0 114.176 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . 0.436 0.5 OUTLIER -74.13 10.32 1.27 Allowed 'General case' 0 C--O 1.247 0.957 0 N-CA-C 116.226 1.936 . . . . 0.0 116.226 179.844 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -168.54 -33.99 0.02 OUTLIER 'General case' 0 CA--C 1.497 -1.084 0 N-CA-C 114.812 1.412 . . . . 0.0 114.812 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 76.7 41.63 23.52 Favored Glycine 0 C--N 1.339 0.733 0 N-CA-C 116.423 1.329 . . . . 0.0 116.423 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 69.4 mttt -81.97 -112.01 0.03 OUTLIER 'General case' 0 C--O 1.198 -1.647 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 166.17 142.4 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.391 0 C-N-CA 125.212 1.405 . . . . 0.0 109.897 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.425 ' HA ' ' HA ' ' A' ' 119' ' ' TYR . 0.8 OUTLIER -131.25 151.68 51.25 Favored 'General case' 0 C--O 1.247 0.94 0 O-C-N 128.289 3.493 . . . . 0.0 104.761 -179.723 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.432 ' CG2' ' HB ' ' A' ' 118' ' ' THR . 9.2 tt -132.23 174.69 12.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 CA-C-N 120.405 1.457 . . . . 0.0 107.891 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.418 ' N ' ' CG1' ' A' ' 103' ' ' ILE . . . -155.98 111.19 2.95 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 116.351 -1.785 . . . . 0.0 106.269 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -95.95 111.72 26.79 Favored 'Isoleucine or valine' 0 C--O 1.245 0.852 0 CA-C-N 121.44 1.927 . . . . 0.0 113.199 -179.416 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.47 ' CD ' HD21 ' A' ' 89' ' ' LEU . 37.3 mtt180 -91.24 94.1 9.39 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 106.327 -1.731 . . . . 0.0 106.327 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -94.03 74.96 4.11 Favored 'General case' 0 N--CA 1.42 -1.948 0 N-CA-C 116.915 2.191 . . . . 0.0 116.915 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.42 HD12 ' CH2' ' A' ' 6' ' ' TRP . 0.3 OUTLIER -61.07 128.73 22.83 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 C-N-CA 115.292 -2.563 . . . . 0.0 111.763 179.872 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 3.9 t -87.42 -65.71 0.99 Allowed 'General case' 0 C--O 1.218 -0.581 0 N-CA-C 104.575 -2.38 . . . . 0.0 104.575 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -167.39 -62.36 0.03 OUTLIER Glycine 0 C--N 1.348 1.213 0 C-N-CA 129.985 3.66 . . . . 0.0 112.683 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . 0.309 0.8 OUTLIER -101.96 -9.33 20.75 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-O 116.448 -1.739 . . . . 0.0 110.737 179.844 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -126.94 131.77 51.01 Favored 'General case' 0 CA--C 1.495 -1.159 0 O-C-N 128.078 3.361 . . . . 0.0 116.888 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.467 HD23 ' CE2' ' A' ' 128' ' ' PHE . 10.4 tt -105.32 117.0 32.9 Favored 'General case' 0 C--N 1.321 -0.669 0 O-C-N 127.739 3.149 . . . . 0.0 105.912 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.474 HG13 ' CD1' ' A' ' 127' ' ' ILE 0.281 1.2 mp -108.32 128.34 63.92 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 CA-C-O 116.212 -1.852 . . . . 0.0 107.574 -179.747 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.412 ' HG2' ' HG2' ' A' ' 106' ' ' ARG . 37.4 mt-30 -114.32 105.89 13.68 Favored 'General case' 0 N--CA 1.441 -0.897 0 O-C-N 126.543 2.402 . . . . 0.0 107.783 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 12.3 p -75.64 -179.0 4.43 Favored 'General case' 0 N--CA 1.429 -1.518 0 O-C-N 127.595 3.06 . . . . 0.0 105.409 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -165.96 112.1 0.88 Allowed 'General case' 0 C--O 1.198 -1.623 0 CA-C-O 116.605 -1.664 . . . . 0.0 113.19 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.432 ' HB ' ' CG2' ' A' ' 103' ' ' ILE . 54.0 m -122.73 129.33 51.65 Favored 'General case' 0 N--CA 1.425 -1.68 1 O-C-N 131.289 5.368 . . . . 0.0 113.661 179.77 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.425 ' HA ' ' HA ' ' A' ' 102' ' ' LEU . 2.1 t80 -109.14 12.85 24.82 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.414 ' HB2' ' CE ' ' A' ' 20' ' ' LYS . 0.7 OUTLIER 163.52 -84.95 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.566 0 O-C-N 127.818 3.199 . . . . 0.0 111.357 -179.796 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -128.59 24.27 4.95 Favored Glycine 0 CA--C 1.539 1.547 0 N-CA-C 119.892 2.717 . . . . 0.0 119.892 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 62.1 t -133.0 104.07 6.55 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.628 0 O-C-N 119.122 -2.399 . . . . 0.0 107.371 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -81.14 171.54 14.78 Favored 'General case' 0 N--CA 1.426 -1.647 0 CA-C-O 124.203 1.954 . . . . 0.0 108.623 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.477 ' HB3' ' CB ' ' A' ' 17' ' ' PHE . . . -162.72 97.08 0.95 Allowed 'General case' 0 C--O 1.211 -0.94 0 C-N-CA 117.746 -1.582 . . . . 0.0 107.194 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.405 ' HB2' ' HB3' ' A' ' 12' ' ' GLU 0.32 1.8 mptm? -83.88 132.91 34.75 Favored 'General case' 0 CA--C 1.506 -0.729 0 CA-C-O 122.331 1.063 . . . . 0.0 110.121 -179.903 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 4.6 mtm180 -119.94 81.47 1.74 Allowed 'General case' 0 C--O 1.209 -1.042 0 C-N-CA 127.158 2.183 . . . . 0.0 107.867 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.474 ' CD1' HG13 ' A' ' 114' ' ' ILE . 10.4 mm -63.97 126.32 22.41 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.861 0 O-C-N 128.522 3.639 . . . . 0.0 111.649 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.475 ' CD1' ' HB ' ' A' ' 8' ' ' VAL . 5.6 m-30 -112.66 139.47 48.23 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 113.25 -1.795 . . . . 0.0 107.681 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . 0.263 3.0 mmtp -104.11 13.73 31.87 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 116.947 -1.502 . . . . 0.0 111.206 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.483 ' HE2' ' CH2' ' A' ' 6' ' ' TRP . 0.1 OUTLIER 55.83 97.53 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 115.394 -2.241 . . . . 0.0 113.176 179.716 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . 0.88 2.4 tt0 . . . . . 0 N--CA 1.443 -0.814 0 C-N-CA 115.407 -2.517 . . . . 0.0 115.683 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' PLM . . . . . 0.464 ' CG ' ' CB ' ' A' ' 74' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.511 -0.554 0 CA-C-O 120.903 0.382 . . . . 0.0 110.383 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.445 ' CD1' ' N ' ' A' ' 2' ' ' PHE . 10.6 m-85 -88.17 72.74 9.06 Favored 'General case' 0 CA--C 1.511 -0.529 0 C-N-CA 119.397 -0.921 . . . . 0.0 111.908 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -145.53 100.9 3.51 Favored 'General case' 0 CA--C 1.495 -1.172 0 C-N-CA 119.528 -0.869 . . . . 0.0 111.629 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 143.65 -171.79 25.19 Favored Glycine 0 CA--C 1.503 -0.718 0 O-C-N 126.512 2.382 . . . . 0.0 111.603 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.416 ' C ' ' CG ' ' A' ' 6' ' ' TRP 0.587 0.5 OUTLIER -81.45 164.27 22.16 Favored 'General case' 0 N--CA 1.439 -1.006 0 CA-C-O 123.026 1.393 . . . . 0.0 111.523 179.931 . . . . . . . . 4 4 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.581 ' CH2' ' CD1' ' A' ' 108' ' ' ILE . 63.2 m95 -157.03 117.01 3.48 Favored 'General case' 0 N--CA 1.428 -1.563 0 CA-C-O 114.276 -2.773 . . . . 0.0 106.419 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 5.1 tttt -122.47 95.71 4.75 Favored 'General case' 0 N--CA 1.441 -0.902 0 O-C-N 126.062 2.101 . . . . 0.0 108.908 -179.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.422 HG13 ' HB3' ' A' ' 36' ' ' LEU 0.267 14.1 p -34.76 119.19 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.216 0 O-C-N 125.391 1.682 . . . . 0.0 114.561 -179.951 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -114.38 -46.99 2.94 Favored 'General case' 0 C--O 1.204 -1.296 0 O-C-N 125.484 1.74 . . . . 0.0 110.24 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.462 ' HG3' ' CG2' ' A' ' 127' ' ' ILE 0.27 0.0 OUTLIER -106.78 170.72 7.77 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-O 118.663 -0.684 . . . . 0.0 109.866 179.861 . . . . . . . . 4 4 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.645 ' CB ' ' CZ ' ' A' ' 14' ' ' TYR 0.391 20.0 m120 -169.62 179.39 3.78 Favored 'General case' 0 N--CA 1.437 -1.083 0 O-C-N 128.06 3.35 . . . . 0.0 109.962 -178.201 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.418 ' HB3' ' HD3' ' A' ' 125' ' ' LYS . 0.0 OUTLIER -150.38 -90.07 0.07 Allowed 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 121.839 2.109 . . . . 0.0 112.083 -179.782 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 17.2 t30 -85.04 4.91 31.71 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-N 122.449 2.386 . . . . 0.0 112.182 179.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.645 ' CZ ' ' CB ' ' A' ' 11' ' ' ASN . 0.4 OUTLIER -59.55 -21.82 60.82 Favored 'General case' 0 C--N 1.308 -1.238 0 C-N-CA 127.274 2.23 . . . . 0.0 113.301 -178.628 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -73.92 -26.63 60.61 Favored 'General case' 0 C--O 1.21 -0.983 0 CA-C-N 120.51 1.504 . . . . 0.0 111.424 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 37.2 tttm -79.97 -31.92 39.84 Favored 'General case' 0 N--CA 1.432 -1.339 0 CA-C-O 125.448 2.546 . . . . 0.0 110.665 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.538 ' CB ' ' HB1' ' A' ' 124' ' ' ALA . 0.0 OUTLIER -60.78 -33.89 73.66 Favored 'General case' 0 N--CA 1.428 -1.564 0 O-C-N 118.397 -2.689 . . . . 0.0 113.264 -179.755 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 19.2 mtt -72.88 -23.77 60.77 Favored 'General case' 0 N--CA 1.438 -1.073 0 O-C-N 119.229 -2.17 . . . . 0.0 108.465 179.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -76.13 -32.28 59.06 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 125.027 2.346 . . . . 0.0 111.379 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -64.72 -41.2 96.15 Favored 'General case' 0 N--CA 1.436 -1.171 0 O-C-N 117.55 -3.219 . . . . 0.0 112.379 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -73.66 -21.88 60.13 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 86.73 61.64 1.59 Allowed Glycine 0 C--N 1.314 -0.666 0 CA-C-O 115.263 -2.965 . . . . 0.0 109.998 179.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.483 HG21 ' CB ' ' A' ' 27' ' ' LYS . 7.2 mm -90.77 -7.21 10.77 Favored 'Isoleucine or valine' 0 C--N 1.358 0.943 0 CA-C-N 119.537 1.668 . . . . 0.0 108.408 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.1 m120 76.11 -106.01 0.02 OUTLIER 'General case' 0 N--CA 1.441 -0.882 0 CA-C-O 116.006 -1.95 . . . . 0.0 114.384 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . 0.343 69.2 t -133.74 -55.26 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.499 -0.995 0 N-CA-C 118.001 2.593 . . . . 0.0 118.001 -179.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.568 34.5 m -69.23 -35.21 66.81 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.079 0 N-CA-C 118.975 2.954 . . . . 0.0 118.975 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.483 ' CB ' HG21 ' A' ' 23' ' ' ILE . 27.7 mttt -74.72 -26.56 59.89 Favored 'General case' 0 C--N 1.32 -0.7 0 O-C-N 126.08 2.113 . . . . 0.0 113.326 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.401 ' N ' HG23 ' A' ' 23' ' ' ILE . 21.3 ptt180 -79.4 -23.75 43.05 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 120.347 1.43 . . . . 0.0 108.794 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 15.1 tttp -78.19 -44.0 26.99 Favored 'General case' 0 C--O 1.211 -0.959 0 CA-C-O 122.809 1.29 . . . . 0.0 110.599 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 76.1 mt -73.83 -23.42 59.64 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 114.498 -1.228 . . . . 0.0 109.149 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -66.97 -51.28 40.79 Favored Glycine 0 C--O 1.212 -1.268 0 CA-C-O 123.816 1.787 . . . . 0.0 112.96 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.505 ' CB ' ' CE2' ' A' ' 14' ' ' TYR . . . -55.2 -35.27 64.67 Favored 'General case' 0 N--CA 1.436 -1.174 0 C-N-CA 128.574 2.749 . . . . 0.0 115.707 179.116 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.427 ' C ' ' CD2' ' A' ' 33' ' ' HIS . 12.0 t-160 -130.63 60.55 1.63 Allowed 'General case' 0 CA--C 1.506 -0.732 0 CA-C-N 112.028 -2.351 . . . . 0.0 111.996 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -96.37 -15.45 21.83 Favored 'General case' 0 C--O 1.216 -0.696 0 N-CA-C 117.281 2.326 . . . . 0.0 117.281 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 97.07 29.13 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.842 0 O-C-N 125.9 2.0 . . . . 0.0 111.921 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.422 ' HB3' HG13 ' A' ' 8' ' ' VAL . 12.2 tp -65.94 81.8 0.08 Allowed 'General case' 0 CA--C 1.503 -0.84 0 CA-C-O 124.471 2.081 . . . . 0.0 110.396 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -90.24 88.97 7.44 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 101.873 -3.38 . . . . 0.0 101.873 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.43 ' N ' ' O ' ' A' ' 6' ' ' TRP . 1.0 OUTLIER -67.78 95.35 0.5 Allowed 'General case' 0 C--N 1.292 -1.932 0 C-N-CA 118.518 -1.273 . . . . 0.0 111.011 -179.18 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 39.6 m -81.4 104.83 12.12 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 101.781 -3.415 . . . . 0.0 101.781 179.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.409 HG21 ' N ' ' A' ' 41' ' ' THR . 83.7 mt -91.45 147.34 5.33 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 O-C-N 120.613 -1.304 . . . . 0.0 111.635 -179.457 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.409 ' N ' HG21 ' A' ' 40' ' ' ILE . 4.3 m -145.43 101.87 3.64 Favored 'General case' 0 C--O 1.22 -0.494 0 O-C-N 127.062 2.726 . . . . 0.0 112.609 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 15.1 tp60 -82.97 98.64 9.35 Favored 'General case' 0 N--CA 1.443 -0.804 0 O-C-N 125.557 1.785 . . . . 0.0 110.678 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 49.2 tt0 -107.34 84.36 1.96 Allowed 'General case' 0 N--CA 1.438 -1.04 0 CA-C-O 125.657 2.646 . . . . 0.0 105.066 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 70.43 -87.62 0.34 Allowed Glycine 0 C--N 1.296 -1.646 0 CA-C-O 115.814 -2.659 . . . . 0.0 106.582 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.331 0.1 OUTLIER -124.39 -11.99 7.34 Favored 'General case' 0 C--N 1.32 -0.679 0 O-C-N 127.332 2.43 . . . . 0.0 112.535 179.917 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.62 138.61 31.43 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 119.854 -1.779 . . . . 0.0 106.732 179.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.482 ' O ' ' N ' ' A' ' 49' ' ' VAL 0.342 3.8 m-85 -115.12 95.64 5.3 Favored 'General case' 0 N--CA 1.433 -1.285 0 C-N-CA 126.222 1.809 . . . . 0.0 107.633 179.777 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.471 HG21 ' CG1' ' A' ' 61' ' ' VAL 0.451 0.1 OUTLIER -67.38 79.53 0.16 Allowed 'General case' 0 N--CA 1.441 -0.875 0 CA-C-O 124.337 2.018 . . . . 0.0 110.594 179.477 . . . . . . . . 4 4 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.482 ' N ' ' O ' ' A' ' 47' ' ' PHE 0.753 0.8 OUTLIER -59.57 75.83 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 CA-C-N 109.845 -3.343 . . . . 0.0 115.332 179.794 . . . . . . . . 4 4 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.432 ' HA ' ' HA ' ' A' ' 59' ' ' ASP . 8.9 tttt -61.09 138.56 58.2 Favored 'General case' 0 C--N 1.317 -0.811 1 N-CA-C 99.964 -4.087 . . . . 0.0 99.964 179.742 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -133.71 105.16 6.67 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 102.431 -3.174 . . . . 0.0 102.431 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 54.1 p -104.1 44.85 0.99 Allowed 'General case' 0 C--N 1.288 -2.101 0 N-CA-C 105.95 -1.87 . . . . 0.0 105.95 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.7 t -67.89 149.03 50.35 Favored 'General case' 0 N--CA 1.466 0.335 0 O-C-N 127.322 2.889 . . . . 0.0 107.745 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -50.38 -21.78 1.58 Allowed 'General case' 0 C--O 1.221 -0.424 0 CA-C-N 120.656 1.571 . . . . 0.0 110.129 -179.425 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.487 ' CE2' ' HG1' ' A' ' 132' ' ' PLM . 19.8 m-85 -72.23 -49.96 31.07 Favored 'General case' 0 C--O 1.219 -0.529 0 C-N-CA 115.431 -2.507 . . . . 0.0 110.469 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.42 ' HB2' HG21 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -159.37 141.31 13.41 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 123.779 2.99 . . . . 0.0 110.522 -179.984 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 7.9 m-80 -97.56 78.4 2.65 Favored 'General case' 0 C--N 1.353 0.724 0 N-CA-C 100.36 -3.941 . . . . 0.0 100.36 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.42 HG21 ' HB2' ' A' ' 56' ' ' ARG . 2.6 tp -118.53 113.34 41.55 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.017 0 C-N-CA 131.155 3.782 . . . . 0.0 117.792 -179.243 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.432 ' HA ' ' HA ' ' A' ' 50' ' ' LYS . 3.9 p30 -59.18 149.39 28.41 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 104.357 -2.461 . . . . 0.0 104.357 178.619 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.466 ' HB ' ' CG1' ' A' ' 49' ' ' VAL . 3.2 t -101.89 -60.98 2.58 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 CA-C-O 124.696 2.189 . . . . 0.0 107.683 -177.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.471 ' CG1' HG21 ' A' ' 48' ' ' THR 0.458 0.0 OUTLIER 66.14 109.11 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.433 -1.319 0 CA-C-N 113.014 -1.903 . . . . 0.0 108.992 -179.519 . . . . . . . . 4 4 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.478 ' CZ ' ' HA ' ' A' ' 81' ' ' THR . 2.3 t80 -145.53 114.76 7.07 Favored 'General case' 0 C--N 1.312 -1.06 0 C-N-CA 115.694 -2.402 . . . . 0.0 106.651 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -68.28 141.83 55.75 Favored 'General case' 0 C--O 1.247 0.95 0 N-CA-C 102.49 -3.152 . . . . 0.0 102.49 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.82 137.23 55.15 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 120.266 1.393 . . . . 0.0 107.944 -179.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 57.98 25.0 55.84 Favored Glycine 0 CA--C 1.531 1.056 0 N-CA-C 117.925 1.93 . . . . 0.0 117.925 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . 0.296 37.2 t -111.37 84.6 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 104.851 -2.277 . . . . 0.0 104.851 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -39.36 113.43 0.32 Allowed 'General case' 0 C--O 1.202 -1.424 0 O-C-N 126.41 2.319 . . . . 0.0 114.648 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.449 ' CD1' ' C ' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -106.8 -166.26 1.15 Allowed 'General case' 0 N--CA 1.422 -1.839 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 -179.599 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -131.53 137.09 48.36 Favored 'General case' 0 CA--C 1.51 -0.583 0 CA-C-O 116.872 -1.537 . . . . 0.0 107.025 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -146.94 113.04 5.82 Favored 'General case' 0 C--O 1.216 -0.672 0 C-N-CA 117.966 -1.493 . . . . 0.0 113.808 -179.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 47.1 t -91.18 151.34 20.99 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.6 mp -96.58 -169.93 1.98 Allowed 'General case' 0 CA--C 1.498 -1.049 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.404 ' CB ' ' CD1' ' A' ' 55' ' ' PHE . . . -89.45 -6.19 56.71 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-O 124.774 2.226 . . . . 0.0 111.691 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -153.79 -44.75 0.09 Allowed 'General case' 0 N--CA 1.433 -1.29 0 CA-C-N 112.787 -2.006 . . . . 0.0 112.133 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -64.85 -8.0 32.17 Favored Glycine 0 C--O 1.205 -1.692 0 O-C-N 124.769 1.293 . . . . 0.0 114.839 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . 0.372 0.1 OUTLIER 71.46 172.3 0.31 Allowed 'General case' 0 C--N 1.308 -1.219 0 O-C-N 118.197 -2.943 . . . . 0.0 114.947 -179.982 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.417 ' HB3' HG22 ' A' ' 96' ' ' VAL . 5.8 mm-40 -35.77 151.99 0.01 OUTLIER 'General case' 0 N--CA 1.434 -1.245 1 O-C-N 130.051 4.594 . . . . 0.0 116.407 179.856 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . 0.388 8.8 tp -153.63 165.25 36.51 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-N 112.715 -2.039 . . . . 0.0 105.782 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -167.05 120.04 0.97 Allowed 'General case' 0 CA--C 1.503 -0.834 0 N-CA-C 105.201 -2.148 . . . . 0.0 105.201 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.415 ' HA3' ' HA ' ' A' ' 93' ' ' PHE . . . -168.65 -157.15 11.08 Favored Glycine 0 C--N 1.296 -1.669 0 C-N-CA 116.684 -2.674 . . . . 0.0 109.765 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.478 ' HA ' ' CZ ' ' A' ' 62' ' ' PHE . 2.8 p -144.98 159.91 42.18 Favored 'General case' 0 C--O 1.191 -2.026 0 O-C-N 126.553 1.973 . . . . 0.0 112.63 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . 0.478 ' CZ3' ' HG3' ' A' ' 106' ' ' ARG . 39.8 m95 -117.97 113.93 22.41 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 103.136 -2.913 . . . . 0.0 103.136 -179.725 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 4.0 t -122.85 139.09 54.4 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-O 122.199 1.0 . . . . 0.0 111.093 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 1.9 ttt -92.94 105.08 17.24 Favored 'General case' 0 N--CA 1.426 -1.674 0 CA-C-N 113.442 -1.708 . . . . 0.0 112.494 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . 0.532 0.6 OUTLIER -72.66 -143.98 0.01 OUTLIER 'General case' 0 N--CA 1.425 -1.719 0 O-C-N 125.008 1.443 . . . . 0.0 108.162 179.808 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -82.59 66.94 3.81 Favored Glycine 0 N--CA 1.45 -0.369 0 N-CA-C 105.447 -3.061 . . . . 0.0 105.447 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 96.74 -13.79 0.08 Allowed 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 117.293 2.331 . . . . 0.0 117.293 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . 0.409 0.0 OUTLIER -111.65 141.89 44.66 Favored 'General case' 0 C--O 1.215 -0.756 0 O-C-N 125.204 1.565 . . . . 0.0 107.714 179.869 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.456 ' CB ' ' HB2' ' A' ' 106' ' ' ARG . 1.0 OUTLIER -96.48 145.56 25.57 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 101.503 -3.517 . . . . 0.0 101.503 179.965 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.8 m -132.6 120.27 41.48 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 O-C-N 125.043 1.464 . . . . 0.0 109.596 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -100.27 87.08 0.69 Allowed Glycine 0 C--N 1.338 0.686 0 C-N-CA 128.358 2.885 . . . . 0.0 114.109 -179.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -90.67 148.11 22.83 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 102.388 -3.19 . . . . 0.0 102.388 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.494 ' CD2' HD22 ' A' ' 102' ' ' LEU . 15.7 m-85 -152.64 117.98 5.25 Favored 'General case' 0 CA--C 1.501 -0.906 0 C-N-CA 117.678 -1.609 . . . . 0.0 113.45 -179.654 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -88.36 -163.46 0.97 Allowed 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 -179.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . 0.334 0.2 OUTLIER -138.25 164.73 28.48 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 106.085 -1.82 . . . . 0.0 106.085 179.824 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.417 HG22 ' HB3' ' A' ' 77' ' ' GLU . 37.0 t -94.3 -40.01 11.0 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 C-N-CA 124.63 1.172 . . . . 0.0 108.537 -179.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . 0.287 0.2 OUTLIER -55.19 -30.66 60.38 Favored 'General case' 0 C--O 1.25 1.126 0 N-CA-C 114.681 1.363 . . . . 0.0 114.681 179.786 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -160.02 6.08 0.09 Allowed 'General case' 0 N--CA 1.44 -0.94 0 CA-C-O 115.809 -2.044 . . . . 0.0 116.428 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 54.02 85.01 0.03 OUTLIER Glycine 0 CA--C 1.524 0.612 0 N-CA-C 118.675 2.23 . . . . 0.0 118.675 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.0 mmtp -113.28 -111.37 0.34 Allowed 'General case' 0 C--O 1.213 -0.862 0 O-C-N 120.951 -1.323 . . . . 0.0 111.392 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 54.3 tt0 -177.75 162.24 1.72 Allowed 'General case' 0 C--O 1.211 -0.965 0 C-N-CA 127.954 2.502 . . . . 0.0 109.069 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.494 HD22 ' CD2' ' A' ' 93' ' ' PHE . 1.9 tp -158.29 109.16 2.15 Favored 'General case' 0 C--N 1.316 -0.887 0 C-N-CA 131.255 3.822 . . . . 0.0 102.653 -179.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.433 ' N ' ' O ' ' A' ' 118' ' ' THR . 0.8 OUTLIER -98.83 152.56 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.091 0 C-N-CA 115.093 -2.643 . . . . 0.0 105.532 -179.439 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.475 ' HA ' ' O ' ' A' ' 116' ' ' THR . . . -160.93 147.25 14.89 Favored 'General case' 0 C--N 1.309 -1.165 0 C-N-CA 124.733 1.213 . . . . 0.0 109.123 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.451 ' HB ' ' CE2' ' A' ' 117' ' ' TYR . 0.9 OUTLIER -137.11 102.46 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 116.033 -2.267 . . . . 0.0 111.461 -179.028 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.478 ' HG3' ' CZ3' ' A' ' 82' ' ' TRP 0.277 48.9 mtt180 -68.18 85.16 0.25 Allowed 'General case' 0 C--N 1.312 -1.029 0 O-C-N 126.562 2.414 . . . . 0.0 104.838 179.696 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.416 ' N ' ' O ' ' A' ' 105' ' ' VAL . 4.9 tt0 -79.52 76.38 6.13 Favored 'General case' 0 N--CA 1.424 -1.738 0 O-C-N 127.163 2.789 . . . . 0.0 117.765 -179.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.581 ' CD1' ' CH2' ' A' ' 6' ' ' TRP 0.426 0.9 OUTLIER -61.91 123.07 13.99 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 C-N-CA 116.112 -2.235 . . . . 0.0 108.41 179.65 . . . . . . . . 4 4 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 7.0 m -102.63 10.67 38.56 Favored 'General case' 0 C--O 1.219 -0.54 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 119.78 -60.21 0.52 Allowed Glycine 0 N--CA 1.444 -0.8 1 C-N-CA 132.266 4.746 . . . . 0.0 112.713 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -115.3 22.05 13.6 Favored 'General case' 0 C--N 1.314 -0.936 0 O-C-N 127.121 2.307 . . . . 0.0 111.681 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -149.42 99.62 2.93 Favored 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 120.299 -0.56 . . . . 0.0 111.33 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.411 ' HA ' ' CG1' ' A' ' 108' ' ' ILE . 7.0 tt -84.02 101.61 11.88 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 100.878 -3.749 . . . . 0.0 100.878 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.498 HG12 ' CG2' ' A' ' 127' ' ' ILE 0.295 3.7 mt -107.2 118.67 55.41 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.09 0 O-C-N 126.013 2.07 . . . . 0.0 111.145 -179.416 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.509 ' O ' ' N ' ' A' ' 126' ' ' ARG 0.316 76.1 mt-30 -89.83 149.67 22.57 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 100.433 -3.914 . . . . 0.0 100.433 177.487 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.623 ' OG1' ' CE2' ' A' ' 117' ' ' TYR . 79.9 p -160.65 179.09 8.85 Favored 'General case' 0 N--CA 1.422 -1.867 1 O-C-N 130.784 5.052 . . . . 0.0 106.615 -179.865 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . 0.623 ' CE2' ' OG1' ' A' ' 116' ' ' THR 0.297 33.2 m-85 96.6 -142.76 0.0 OUTLIER 'General case' 0 CA--C 1.442 -3.205 0 N-CA-C 120.314 3.45 . . . . 0.0 120.314 174.922 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.433 ' O ' ' N ' ' A' ' 103' ' ' ILE . 11.2 t -133.87 -174.11 3.44 Favored 'General case' 0 N--CA 1.417 -2.101 0 N-CA-C 120.342 3.46 . . . . 0.0 120.342 -174.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.488 ' CA ' HD11 ' A' ' 102' ' ' LEU 0.339 7.0 t80 -117.98 0.76 11.94 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 111.528 -2.578 . . . . 0.0 106.663 178.092 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -174.74 -84.03 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.274 0 O-C-N 119.537 -1.977 . . . . 0.0 111.256 179.456 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -138.87 32.99 2.24 Favored Glycine 0 CA--C 1.537 1.454 0 C-N-CA 127.432 2.444 . . . . 0.0 116.576 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 78.7 t -141.49 101.15 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 N-CA-C 105.73 -1.952 . . . . 0.0 105.73 -179.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.404 ' HA ' ' C ' ' A' ' 117' ' ' TYR . 1.8 mp0 -59.13 -179.67 0.08 Allowed 'General case' 0 C--O 1.207 -1.172 0 CA-C-O 123.785 1.755 . . . . 0.0 111.797 -179.464 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.568 ' N ' ' O ' ' A' ' 117' ' ' TYR . . . -168.08 76.21 0.13 Allowed 'General case' 0 CA--C 1.503 -0.847 0 C-N-CA 113.602 -3.239 . . . . 0.0 110.877 -178.043 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.539 ' HA ' ' CB ' ' A' ' 116' ' ' THR . 1.4 mptp? -57.58 144.69 36.35 Favored 'General case' 0 CA--C 1.508 -0.654 0 CA-C-N 123.897 3.044 . . . . 0.0 112.258 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.509 ' N ' ' O ' ' A' ' 115' ' ' GLN . 11.1 mtp180 -144.83 77.03 1.52 Allowed 'General case' 0 C--O 1.21 -0.978 0 C-N-CA 127.259 2.224 . . . . 0.0 105.565 178.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.498 ' CG2' HG12 ' A' ' 114' ' ' ILE . 0.8 OUTLIER -78.62 128.59 38.32 Favored 'Isoleucine or valine' 0 C--O 1.253 1.289 0 O-C-N 127.767 3.167 . . . . 0.0 116.794 179.77 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.42 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 0.1 OUTLIER -109.8 145.38 36.81 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 128.499 2.72 . . . . 0.0 107.122 179.917 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . 0.254 0.3 OUTLIER -112.67 29.13 8.2 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 117.051 -1.452 . . . . 0.0 112.286 -179.79 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.555 ' HB2' ' CZ3' ' A' ' 6' ' ' TRP . 3.3 tttp 50.37 89.26 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 127.397 2.279 . . . . 0.0 108.641 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . 0.773 64.0 mt-10 . . . . . 0 N--CA 1.426 -1.639 0 O-C-N 125.846 1.966 . . . . 0.0 113.6 -179.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' PLM . . . . . 0.487 ' HG1' ' CE2' ' A' ' 55' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.217 -0.619 0 CA-C-O 118.587 -0.721 . . . . 0.0 109.071 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -99.47 -42.24 7.03 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 116.067 1.877 . . . . 0.0 116.067 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -43.85 93.74 0.01 OUTLIER 'General case' 0 CA--C 1.496 -1.126 0 O-C-N 126.141 2.15 . . . . 0.0 111.691 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 176.3 -178.28 47.71 Favored Glycine 0 C--N 1.31 -0.886 0 C-N-CA 117.343 -2.36 . . . . 0.0 111.527 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.434 ' C ' ' CD1' ' A' ' 6' ' ' TRP 0.377 1.2 p -94.02 155.12 17.29 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 128.641 3.201 . . . . 0.0 111.951 -179.735 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.61 ' CE3' ' CB ' ' A' ' 113' ' ' LEU . 49.2 m95 -159.75 -158.98 0.69 Allowed 'General case' 0 N--CA 1.426 -1.667 0 CA-C-O 114.63 -2.605 . . . . 0.0 106.393 177.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.733 ' HB3' ' CZ ' ' A' ' 128' ' ' PHE . 6.9 ttmt 178.91 -99.64 0.0 OUTLIER 'General case' 0 C--O 1.209 -1.073 0 O-C-N 129.007 3.942 . . . . 0.0 105.17 179.387 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.594 ' CG1' ' HB3' ' A' ' 36' ' ' LEU 0.263 0.3 OUTLIER 159.3 120.13 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 O-C-N 126.329 2.268 . . . . 0.0 109.348 179.514 . . . . . . . . 4 4 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 61.5 t0 -125.55 -76.48 0.59 Allowed 'General case' 0 CA--C 1.506 -0.746 0 CA-C-O 125.965 2.793 . . . . 0.0 108.043 -179.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -83.83 122.97 29.41 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 118.626 -2.547 . . . . 0.0 108.269 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . 0.319 0.0 OUTLIER -114.76 -171.12 1.87 Allowed 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 107.151 -1.425 . . . . 0.0 107.151 179.685 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -170.53 109.89 0.36 Allowed 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 115.723 -2.391 . . . . 0.0 106.75 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.407 ' ND2' ' O ' ' A' ' 123' ' ' GLU 0.259 0.2 OUTLIER 87.65 -8.08 0.59 Allowed 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 -179.852 . . . . . . . . 4 4 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.532 ' CD1' ' HB2' ' A' ' 124' ' ' ALA 0.407 0.3 OUTLIER -68.09 -33.81 75.23 Favored 'General case' 0 C--N 1.321 -0.645 0 O-C-N 126.939 2.65 . . . . 0.0 115.6 179.882 . . . . . . . . 4 4 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -71.97 -20.51 61.72 Favored 'General case' 0 C--O 1.213 -0.832 0 O-C-N 119.072 -2.268 . . . . 0.0 110.556 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 24.5 mttt -78.61 -40.88 33.23 Favored 'General case' 0 N--CA 1.443 -0.777 0 O-C-N 126.765 2.541 . . . . 0.0 112.494 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.519 ' CE1' ' HG2' ' A' ' 21' ' ' MET . 0.6 OUTLIER -68.41 -31.79 71.38 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-O 126.076 2.846 . . . . 0.0 110.681 179.702 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 28.4 mtm -69.23 -23.64 63.9 Favored 'General case' 0 C--O 1.22 -0.459 1 O-C-N 114.918 -4.864 . . . . 0.0 108.793 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -79.33 -32.97 43.45 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-O 127.603 3.573 . . . . 0.0 110.647 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 16.6 tptt -74.16 -25.4 59.7 Favored 'General case' 0 N--CA 1.433 -1.302 0 O-C-N 118.257 -2.777 . . . . 0.0 112.728 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.519 ' HG2' ' CE1' ' A' ' 17' ' ' PHE 0.257 13.6 mmm -75.73 -29.1 58.78 Favored 'General case' 0 C--O 1.202 -1.415 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 -179.933 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 103.95 29.12 5.63 Favored Glycine 0 CA--C 1.504 -0.619 0 CA-C-O 115.94 -2.589 . . . . 0.0 109.583 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.2 mm -69.42 141.78 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.956 0 CA-C-N 118.857 1.328 . . . . 0.0 109.863 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 24.9 t30 -80.65 131.99 35.54 Favored 'General case' 0 C--N 1.345 0.399 0 CA-C-O 113.742 -3.028 . . . . 0.0 108.503 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . 0.454 99.1 t -11.01 -51.54 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.503 -0.86 0 O-C-N 128.513 3.633 . . . . 0.0 119.262 -179.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.614 13.7 t -72.84 -40.1 59.96 Favored 'Isoleucine or valine' 0 C--O 1.249 1.044 0 N-CA-C 116.637 2.088 . . . . 0.0 116.637 -179.467 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 11.3 mttm -67.09 -32.35 73.45 Favored 'General case' 0 C--O 1.213 -0.853 0 O-C-N 125.632 1.832 . . . . 0.0 113.369 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.401 ' HG3' ' N ' ' A' ' 29' ' ' LYS . 16.4 ptt180 -78.96 -29.28 43.86 Favored 'General case' 0 CA--C 1.514 -0.432 0 O-C-N 120.337 -1.477 . . . . 0.0 109.449 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.401 ' N ' ' HG3' ' A' ' 28' ' ' ARG . 0.2 OUTLIER -72.66 -40.85 66.01 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-O 122.626 1.203 . . . . 0.0 110.67 179.955 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.0 tp -73.2 -28.61 62.29 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 113.484 -1.689 . . . . 0.0 108.625 -179.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -74.57 -28.98 62.32 Favored Glycine 0 C--N 1.348 1.219 0 CA-C-N 113.897 -1.501 . . . . 0.0 113.969 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -71.63 -37.97 70.82 Favored 'General case' 0 C--O 1.241 0.655 0 C-N-CA 126.89 2.076 . . . . 0.0 111.563 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 6.6 m80 -111.28 30.27 7.07 Favored 'General case' 0 N--CA 1.447 -0.594 0 O-C-N 126.786 2.554 . . . . 0.0 110.186 179.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -49.68 -36.63 25.69 Favored 'General case' 0 CA--C 1.501 -0.912 0 N-CA-C 116.813 2.153 . . . . 0.0 116.813 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . 0.261 22.3 m120 70.42 54.22 0.3 Allowed 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 116.114 -2.234 . . . . 0.0 107.122 -179.196 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.594 ' HB3' ' CG1' ' A' ' 8' ' ' VAL 0.293 1.7 tp -85.8 107.45 17.65 Favored 'General case' 0 N--CA 1.479 0.992 0 O-C-N 128.7 3.75 . . . . 0.0 103.747 179.911 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.458 ' HA ' ' CB ' ' A' ' 7' ' ' LYS . 24.4 tttm -92.77 127.98 38.46 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 100.473 -3.899 . . . . 0.0 100.473 179.614 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.472 HD13 ' CD1' ' A' ' 36' ' ' LEU 0.377 0.5 OUTLIER -112.05 121.4 44.87 Favored 'General case' 0 C--N 1.288 -2.09 0 C-N-CA 116.011 -2.275 . . . . 0.0 107.004 -178.5 . . . . . . . . 4 4 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.48 ' HB ' ' CB ' ' A' ' 50' ' ' LYS . 28.0 m -116.12 90.86 3.43 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 117.287 -3.383 . . . . 0.0 104.588 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.547 HG22 ' CE2' ' A' ' 47' ' ' PHE . 26.5 mt -70.36 130.16 34.6 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 11.6 m -126.75 105.91 9.0 Favored 'General case' 0 N--CA 1.477 0.886 0 O-C-N 127.801 3.188 . . . . 0.0 109.734 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.521 ' HG2' ' CE1' ' A' ' 47' ' ' PHE . 1.0 OUTLIER -84.69 109.1 17.77 Favored 'General case' 0 C--O 1.24 0.6 0 N-CA-C 114.368 1.247 . . . . 0.0 114.368 -179.906 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -96.66 31.08 2.4 Favored 'General case' 0 N--CA 1.419 -1.991 0 O-C-N 121.214 -0.929 . . . . 0.0 109.857 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 97.41 -13.12 64.69 Favored Glycine 0 C--N 1.29 -1.99 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.376 0.0 OUTLIER -175.6 -50.59 0.01 OUTLIER 'General case' 0 C--O 1.213 -0.823 0 CA-C-O 126.132 2.872 . . . . 0.0 109.168 179.901 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 28.1 ttmt -64.89 115.9 5.81 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 113.048 -1.887 . . . . 0.0 110.504 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.547 ' CE2' HG22 ' A' ' 40' ' ' ILE . 0.9 OUTLIER -100.71 93.85 5.78 Favored 'General case' 0 CA--C 1.499 -0.995 0 CA-C-O 123.312 1.529 . . . . 0.0 107.271 179.803 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . 0.388 3.1 t -89.72 87.39 6.98 Favored 'General case' 0 N--CA 1.432 -1.347 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 179.623 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.468 HG13 ' CG1' ' A' ' 60' ' ' VAL 0.596 0.5 OUTLIER -70.09 107.93 2.03 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.12 0 O-C-N 125.884 1.99 . . . . 0.0 110.334 179.981 . . . . . . . . 4 4 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.48 ' CB ' ' HB ' ' A' ' 39' ' ' THR . 26.0 tttm -68.9 115.97 8.83 Favored 'General case' 0 C--N 1.302 -1.46 1 N-CA-C 100.192 -4.003 . . . . 0.0 100.192 -179.731 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.276 69.9 tt0 -107.29 96.32 6.33 Favored 'General case' 0 C--N 1.322 -0.63 0 O-C-N 126.659 2.474 . . . . 0.0 108.484 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.424 ' HA ' ' HA ' ' A' ' 57' ' ' ASN 0.261 0.1 OUTLIER -96.48 52.37 1.23 Allowed 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 105.201 -2.148 . . . . 0.0 105.201 179.378 . . . . . . . . 4 4 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.418 ' HA ' ' HA ' ' A' ' 36' ' ' LEU . 0.1 OUTLIER -77.97 160.23 28.32 Favored 'General case' 0 C--O 1.214 -0.781 0 O-C-N 127.552 3.032 . . . . 0.0 109.882 -179.537 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -53.65 -28.26 32.07 Favored 'General case' 0 C--O 1.215 -0.724 0 O-C-N 126.477 2.361 . . . . 0.0 108.633 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -62.27 -58.8 6.39 Favored 'General case' 0 C--N 1.351 0.639 0 CA-C-O 115.201 -2.333 . . . . 0.0 109.612 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.485 ' HB2' ' CG2' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -156.85 155.91 32.27 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-N 123.399 2.818 . . . . 0.0 106.102 179.414 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.424 ' HA ' ' HA ' ' A' ' 52' ' ' SER 0.262 21.2 t30 -101.07 70.94 1.37 Allowed 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 100.364 -3.939 . . . . 0.0 100.364 179.67 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.485 ' CG2' ' HB2' ' A' ' 56' ' ' ARG . 8.4 tp -120.03 122.98 69.88 Favored 'Isoleucine or valine' 0 C--O 1.243 0.728 0 C-N-CA 130.146 3.378 . . . . 0.0 118.697 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -72.58 135.66 45.6 Favored 'General case' 0 N--CA 1.468 0.441 0 O-C-N 118.694 -2.504 . . . . 0.0 105.466 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.468 ' CG1' HG13 ' A' ' 49' ' ' VAL . 4.4 p -109.96 101.13 12.13 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-O 126.177 2.894 . . . . 0.0 111.407 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . 0.311 2.0 m -88.56 131.2 36.62 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 O-C-N 116.684 -3.76 . . . . 0.0 113.061 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 22.1 p90 -151.58 89.02 1.45 Allowed 'General case' 0 N--CA 1.442 -0.827 0 C-N-CA 116.579 -2.049 . . . . 0.0 107.128 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -56.08 134.64 52.79 Favored 'General case' 0 N--CA 1.432 -1.362 0 N-CA-C 104.438 -2.43 . . . . 0.0 104.438 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -49.63 102.81 0.04 OUTLIER 'General case' 0 N--CA 1.428 -1.565 0 O-C-N 126.407 2.317 . . . . 0.0 110.515 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 89.73 32.19 10.4 Favored Glycine 0 C--N 1.346 1.115 0 C-N-CA 128.289 2.852 . . . . 0.0 119.924 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . 0.364 0.4 OUTLIER -111.42 99.16 8.1 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 N-CA-C 104.902 -2.258 . . . . 0.0 104.902 179.91 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -51.47 136.93 25.01 Favored 'General case' 0 CA--C 1.487 -1.45 0 O-C-N 126.079 2.112 . . . . 0.0 114.153 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 9.9 p90 -145.62 175.08 10.63 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -129.46 146.77 51.26 Favored 'General case' 0 CA--C 1.501 -0.924 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.454 ' HB3' ' CD2' ' A' ' 78' ' ' LEU . 16.5 t80 -129.96 -39.78 1.38 Allowed 'General case' 0 C--O 1.213 -0.863 0 CA-C-O 116.118 -1.896 . . . . 0.0 111.806 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.499 ' CB ' HD12 ' A' ' 72' ' ' LEU . 0.7 OUTLIER 64.39 158.44 0.09 Allowed 'General case' 0 C--N 1.308 -1.2 0 O-C-N 125.366 1.666 . . . . 0.0 112.056 -179.904 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.552 ' CD1' ' N ' ' A' ' 72' ' ' LEU . 0.0 OUTLIER 41.55 -158.7 0.01 OUTLIER 'General case' 0 C--N 1.293 -1.873 0 O-C-N 128.351 3.532 . . . . 0.0 110.424 178.369 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.404 ' O ' ' CB ' ' A' ' 74' ' ' ASP . . . 53.97 35.93 23.16 Favored 'General case' 0 C--O 1.208 -1.094 0 CA-C-N 114.237 -1.347 . . . . 0.0 111.444 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.404 ' CB ' ' O ' ' A' ' 73' ' ' ALA . 0.3 OUTLIER 102.34 19.84 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.365 0 O-C-N 126.565 2.415 . . . . 0.0 113.89 179.22 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.493 ' HA3' ' CD1' ' A' ' 78' ' ' LEU . . . -136.87 -38.63 0.15 Allowed Glycine 0 CA--C 1.549 2.174 0 N-CA-C 118.434 2.134 . . . . 0.0 118.434 179.025 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . 0.308 0.0 OUTLIER 59.28 65.95 1.1 Allowed 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 119.662 1.731 . . . . 0.0 107.897 -179.026 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.445 ' HB3' ' CG2' ' A' ' 96' ' ' VAL . 31.0 mt-10 71.81 76.39 0.17 Allowed 'General case' 0 C--O 1.218 -0.594 0 O-C-N 126.518 2.386 . . . . 0.0 108.529 -178.212 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.493 ' CD1' ' HA3' ' A' ' 75' ' ' GLY 0.436 0.7 OUTLIER -97.63 135.11 39.92 Favored 'General case' 0 CA--C 1.5 -0.978 0 O-C-N 127.764 3.165 . . . . 0.0 104.38 -178.162 . . . . . . . . 4 4 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 20.2 m -158.13 124.72 4.82 Favored 'General case' 0 CA--C 1.481 -1.696 0 N-CA-C 103.919 -2.623 . . . . 0.0 103.919 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -168.61 -155.49 9.66 Favored Glycine 0 C--N 1.302 -1.313 0 O-C-N 119.748 -1.845 . . . . 0.0 109.316 -179.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 4.2 p -145.17 -179.97 6.98 Favored 'General case' 0 C--O 1.196 -1.73 0 C-N-CA 117.23 -1.788 . . . . 0.0 106.965 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . 0.469 ' CZ3' ' NE ' ' A' ' 106' ' ' ARG . 19.7 m95 -132.27 142.88 49.55 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 101.689 -3.449 . . . . 0.0 101.689 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 14.4 t -143.77 160.96 39.82 Favored 'General case' 0 N--CA 1.417 -2.078 0 CA-C-O 124.948 2.309 . . . . 0.0 113.195 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -94.91 126.97 40.6 Favored 'General case' 0 C--N 1.354 0.8 0 CA-C-N 110.774 -2.921 . . . . 0.0 105.775 -179.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . 0.685 0.5 OUTLIER -107.24 33.72 3.85 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.88 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 95.26 -93.43 1.6 Allowed Glycine 0 N--CA 1.427 -1.953 0 N-CA-C 103.986 -3.646 . . . . 0.0 103.986 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -88.96 -5.84 57.68 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 120.154 3.39 . . . . 0.0 120.154 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . 0.265 0.2 OUTLIER -129.91 152.53 49.28 Favored 'General case' 0 CA--C 1.49 -1.354 0 O-C-N 125.163 1.54 . . . . 0.0 107.182 179.678 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.536 HD13 ' CE2' ' A' ' 47' ' ' PHE . 0.3 OUTLIER -106.21 134.15 49.79 Favored 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 105.039 -2.208 . . . . 0.0 105.039 -179.864 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -121.76 154.1 25.94 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.941 0 N-CA-C 105.276 -2.12 . . . . 0.0 105.276 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.435 ' HA3' ' CE2' ' A' ' 82' ' ' TRP . . . -134.96 111.61 0.94 Allowed Glycine 0 CA--C 1.531 1.04 1 C-N-CA 131.06 4.171 . . . . 0.0 109.509 179.898 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 24.8 mtmt -109.16 158.53 17.71 Favored 'General case' 0 N--CA 1.426 -1.651 0 N-CA-C 104.374 -2.454 . . . . 0.0 104.374 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -148.36 112.95 5.34 Favored 'General case' 0 CA--C 1.508 -0.635 0 CA-C-O 123.378 1.561 . . . . 0.0 108.079 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 57.0 mttm -93.39 138.91 31.27 Favored 'General case' 0 N--CA 1.437 -1.104 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . 0.302 0.3 OUTLIER -92.15 136.61 33.04 Favored 'General case' 0 CA--C 1.491 -1.293 0 CA-C-N 113.55 -1.659 . . . . 0.0 109.106 179.75 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.445 ' CG2' ' HB3' ' A' ' 77' ' ' GLU . 38.4 t -71.98 -38.13 63.12 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 C-N-CA 125.277 1.431 . . . . 0.0 111.166 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . 0.319 0.8 OUTLIER -83.24 2.64 34.85 Favored 'General case' 0 C--O 1.261 1.665 0 N-CA-C 118.103 2.631 . . . . 0.0 118.103 -179.959 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -144.28 -29.22 0.49 Allowed 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 116.197 -2.201 . . . . 0.0 114.843 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 92.48 -0.16 70.72 Favored Glycine 0 CA--C 1.532 1.129 0 N-CA-C 118.956 2.343 . . . . 0.0 118.956 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 6.4 mmtt -77.61 -155.1 0.07 Allowed 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 119.299 1.55 . . . . 0.0 111.331 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.55 118.58 4.7 Favored 'General case' 0 CA--C 1.489 -1.375 0 C-N-CA 128.983 2.913 . . . . 0.0 114.541 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.57 ' CB ' ' HA ' ' A' ' 119' ' ' TYR . 0.7 OUTLIER -92.23 135.87 33.65 Favored 'General case' 0 C--N 1.317 -0.812 1 C-N-CA 132.484 4.314 . . . . 0.0 102.741 179.073 . . . . . . . . 4 4 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.497 ' N ' ' O ' ' A' ' 118' ' ' THR . 14.0 tt -129.34 163.72 33.76 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.003 0 C-N-CA 116.524 -2.07 . . . . 0.0 109.395 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -150.39 146.77 26.9 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-O 115.658 -2.115 . . . . 0.0 107.808 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.561 ' HB ' ' CE2' ' A' ' 117' ' ' TYR . 8.8 p -136.53 120.8 24.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 122.915 2.598 . . . . 0.0 110.466 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.469 ' NE ' ' CZ3' ' A' ' 82' ' ' TRP . 1.2 mtt-85 -76.95 86.65 3.48 Favored 'General case' 0 CA--C 1.496 -1.105 0 O-C-N 126.66 2.475 . . . . 0.0 106.689 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 10.7 tt0 -81.65 78.67 8.37 Favored 'General case' 0 N--CA 1.424 -1.742 0 CA-C-O 123.104 1.431 . . . . 0.0 113.031 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.525 ' CD1' ' CZ2' ' A' ' 6' ' ' TRP . 2.3 mm -69.01 98.06 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 C-N-CA 115.537 -2.465 . . . . 0.0 110.296 179.693 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -100.1 101.43 12.49 Favored 'General case' 0 C--O 1.215 -0.742 0 N-CA-C 103.254 -2.869 . . . . 0.0 103.254 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 65.41 -88.8 0.1 Allowed Glycine 0 C--N 1.339 0.695 0 O-C-N 126.061 2.101 . . . . 0.0 112.138 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . 0.368 0.4 OUTLIER -117.82 -13.57 10.12 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-O 113.313 -3.232 . . . . 0.0 111.158 179.562 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . 0.251 2.2 mp0 -93.6 133.42 36.95 Favored 'General case' 0 C--O 1.212 -0.879 0 O-C-N 128.905 3.878 . . . . 0.0 110.89 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.61 ' CB ' ' CE3' ' A' ' 6' ' ' TRP 0.284 0.4 OUTLIER -103.06 141.74 35.3 Favored 'General case' 0 C--O 1.21 -1.011 0 N-CA-C 101.321 -3.585 . . . . 0.0 101.321 179.721 . . . . . . . . 4 4 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.493 HG13 ' CD1' ' A' ' 127' ' ' ILE 0.297 1.4 mp -129.95 139.0 52.64 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 N-CA-C 101.706 -3.442 . . . . 0.0 101.706 179.385 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.511 ' HB2' ' CD ' ' A' ' 126' ' ' ARG . 3.4 mt-30 -119.24 104.91 10.83 Favored 'General case' 0 C--N 1.316 -0.851 1 O-C-N 129.621 4.325 . . . . 0.0 101.492 179.699 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.445 ' O ' ' N ' ' A' ' 105' ' ' VAL . 3.4 t -140.68 157.68 45.09 Favored 'General case' 0 N--CA 1.412 -2.371 0 C-N-CA 116.924 -1.91 . . . . 0.0 112.357 -178.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . 0.561 ' CE2' ' HB ' ' A' ' 105' ' ' VAL 0.372 22.2 m-30 137.93 -138.36 0.0 OUTLIER 'General case' 0 CA--C 1.484 -1.584 1 O-C-N 129.408 4.193 . . . . 0.0 113.171 176.246 . . . . . . . . 4 3 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.497 ' O ' ' N ' ' A' ' 103' ' ' ILE . 10.2 t -158.67 -154.33 0.42 Allowed 'General case' 0 C--N 1.308 -1.229 0 O-C-N 127.674 3.109 . . . . 0.0 115.756 -174.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.57 ' HA ' ' CB ' ' A' ' 102' ' ' LEU . 1.7 t80 -114.9 -55.94 2.43 Favored 'General case' 0 C--N 1.346 0.417 0 N-CA-C 105.126 -2.176 . . . . 0.0 105.126 178.305 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.88 -83.37 0.65 Allowed 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 111.59 -2.55 . . . . 0.0 112.396 179.203 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -143.55 25.29 2.15 Favored Glycine 0 C--N 1.366 2.238 0 N-CA-C 121.359 3.303 . . . . 0.0 121.359 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 15.0 t -123.34 97.35 4.63 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 N-CA-C 103.011 -2.959 . . . . 0.0 103.011 179.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.414 ' HA ' ' HB ' ' A' ' 118' ' ' THR . 13.6 mt-10 -56.86 179.77 0.04 OUTLIER 'General case' 0 C--O 1.205 -1.289 0 CA-C-O 126.554 3.073 . . . . 0.0 113.093 -177.418 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.532 ' HB2' ' CD1' ' A' ' 14' ' ' TYR . . . -169.17 94.5 0.31 Allowed 'General case' 0 C--O 1.211 -0.961 0 O-C-N 118.821 -2.424 . . . . 0.0 107.987 -179.661 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.426 ' HG3' ' HB ' ' A' ' 116' ' ' THR 0.391 0.1 OUTLIER -84.92 153.72 22.67 Favored 'General case' 0 N--CA 1.444 -0.727 0 O-C-N 125.923 2.014 . . . . 0.0 112.529 -179.572 . . . . . . . . 4 4 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.511 ' CD ' ' HB2' ' A' ' 115' ' ' GLN . 1.0 OUTLIER -137.81 77.83 1.65 Allowed 'General case' 0 N--CA 1.427 -1.598 0 O-C-N 127.57 3.044 . . . . 0.0 105.297 177.114 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.493 ' CD1' HG13 ' A' ' 114' ' ' ILE . 50.8 mm -66.99 82.79 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.259 1.557 0 O-C-N 128.051 3.344 . . . . 0.0 111.202 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.733 ' CZ ' ' HB3' ' A' ' 7' ' ' LYS 0.368 5.7 t80 -84.44 144.39 28.79 Favored 'General case' 0 N--CA 1.419 -2.001 0 CA-C-O 125.256 2.455 . . . . 0.0 113.753 -179.641 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.407 ' N ' ' CG ' ' A' ' 128' ' ' PHE 0.391 8.7 mmtt -95.28 10.53 35.82 Favored 'General case' 0 N--CA 1.436 -1.147 0 CA-C-N 110.996 -2.82 . . . . 0.0 113.996 -177.666 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.489 ' HB2' ' CZ3' ' A' ' 6' ' ' TRP . 18.4 tttt 61.53 111.7 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 122.555 2.434 . . . . 0.0 113.666 -178.39 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . 0.857 2.3 tm-20 . . . . . 0 C--O 1.217 -0.612 0 O-C-N 117.167 -3.458 . . . . 0.0 114.508 -179.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' PLM . . . . . 0.467 ' O1 ' ' NH2' ' A' ' 106' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.384 0 CA-C-O 122.48 1.133 . . . . 0.0 109.489 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -61.98 -54.19 45.12 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 116.353 1.983 . . . . 0.0 116.353 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -39.78 91.39 0.0 OUTLIER 'General case' 0 CA--C 1.499 -0.984 0 O-C-N 126.678 2.486 . . . . 0.0 111.34 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.4 ' O ' ' N ' ' A' ' 40' ' ' ILE . . . 158.69 -174.71 35.78 Favored Glycine 0 C--O 1.214 -1.114 0 CA-C-N 113.824 -1.534 . . . . 0.0 110.91 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . 0.549 0.5 OUTLIER -81.93 156.88 24.52 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-O 124.426 2.06 . . . . 0.0 115.774 -179.697 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.505 ' CZ3' ' HB2' ' A' ' 130' ' ' LYS . 73.1 m95 -149.8 157.3 43.07 Favored 'General case' 0 N--CA 1.435 -1.182 0 CA-C-N 110.647 -2.979 . . . . 0.0 106.858 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -160.27 102.54 1.41 Allowed 'General case' 0 C--O 1.214 -0.79 1 O-C-N 129.59 4.306 . . . . 0.0 107.081 179.922 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.541 ' HB ' ' CD1' ' A' ' 128' ' ' PHE 0.38 9.3 p -47.12 139.35 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.289 0 CA-C-N 121.593 1.997 . . . . 0.0 113.131 179.992 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -131.61 0.98 4.03 Favored 'General case' 0 CA--C 1.496 -1.099 0 C-N-CA 119.785 -0.766 . . . . 0.0 112.55 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 16.6 ptp180 -160.79 -39.06 0.05 OUTLIER 'General case' 0 CA--C 1.474 -1.967 0 O-C-N 116.946 -3.596 . . . . 0.0 113.301 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . 0.278 0.6 OUTLIER 62.09 178.79 0.13 Allowed 'General case' 0 C--O 1.243 0.742 0 C-N-CA 125.293 1.437 . . . . 0.0 108.193 179.613 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -132.34 -80.2 0.5 Allowed 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 122.478 2.399 . . . . 0.0 109.635 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.404 ' HB3' ' HA ' ' A' ' 124' ' ' ALA . 16.5 t30 -96.05 15.46 20.62 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 124.799 1.312 . . . . 0.0 113.576 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.559 ' CE2' ' HG2' ' A' ' 126' ' ' ARG 0.26 0.1 OUTLIER -58.0 -26.87 62.94 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 117.978 2.584 . . . . 0.0 117.978 -179.952 . . . . . . . . 4 4 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -72.12 -41.32 67.37 Favored 'General case' 0 C--O 1.207 -1.168 0 O-C-N 120.822 -1.174 . . . . 0.0 110.794 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 17.8 tttm -79.72 -26.37 40.83 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-O 123.175 1.464 . . . . 0.0 114.161 -179.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.428 ' HB3' ' HB3' ' A' ' 124' ' ' ALA . 7.8 t80 -67.05 -35.67 80.37 Favored 'General case' 0 N--CA 1.422 -1.838 0 C-N-CA 118.509 -1.276 . . . . 0.0 113.752 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.448 ' CB ' HG13 ' A' ' 23' ' ' ILE . 24.2 mtt -72.51 -23.7 61.05 Favored 'General case' 0 N--CA 1.425 -1.714 0 CA-C-O 124.561 2.124 . . . . 0.0 107.81 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -76.85 -22.94 52.78 Favored 'General case' 0 CA--C 1.507 -0.689 0 C-N-CA 116.54 -2.064 . . . . 0.0 112.777 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 18.9 tptp -68.0 -39.69 83.17 Favored 'General case' 0 C--N 1.314 -0.936 0 O-C-N 118.827 -2.42 . . . . 0.0 114.889 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.53 ' HG3' ' CD2' ' A' ' 119' ' ' TYR . 3.2 mpp? -76.03 -37.57 58.23 Favored 'General case' 0 C--O 1.207 -1.132 0 C-N-CA 124.527 1.131 . . . . 0.0 109.429 179.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 118.73 47.91 0.39 Allowed Glycine 0 C--N 1.308 -1.016 0 CA-C-N 113.05 -1.886 . . . . 0.0 110.01 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.448 HG13 ' CB ' ' A' ' 18' ' ' MET . 5.4 mm -73.15 106.56 3.22 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.784 0 CA-C-N 121.735 2.768 . . . . 0.0 110.565 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -44.82 111.21 0.29 Allowed 'General case' 0 N--CA 1.44 -0.94 0 CA-C-O 114.136 -2.84 . . . . 0.0 113.019 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . 0.421 0.2 OUTLIER 3.76 -61.78 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.497 -1.076 1 O-C-N 129.463 4.227 . . . . 0.0 119.309 179.89 . . . . . . . . 4 3 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.579 13.3 m -72.59 -22.24 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.906 0 N-CA-C 117.53 2.419 . . . . 0.0 117.53 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.42 ' HB2' ' CG2' ' A' ' 23' ' ' ILE . 26.5 mttp -77.0 -25.97 53.31 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-O 118.406 -0.807 . . . . 0.0 110.918 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -79.98 -24.44 40.91 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 117.934 -1.506 . . . . 0.0 107.495 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.8 ttpt -74.84 -49.76 19.45 Favored 'General case' 0 C--O 1.212 -0.893 0 CA-C-O 123.819 1.771 . . . . 0.0 108.711 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 7.3 tp -73.25 -28.85 62.37 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 114.56 -1.2 . . . . 0.0 108.348 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -67.55 -32.64 79.23 Favored Glycine 0 CA--C 1.538 1.474 0 O-C-N 124.843 1.34 . . . . 0.0 112.219 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -78.05 -24.35 47.8 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -112.81 2.41 15.96 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-O 115.903 -1.999 . . . . 0.0 112.363 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 21.5 p-10 -33.46 -32.51 0.01 OUTLIER 'General case' 0 CA--C 1.505 -0.766 0 N-CA-C 117.922 2.564 . . . . 0.0 117.922 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . 0.259 4.5 t-20 75.42 31.03 0.79 Allowed 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 121.386 1.903 . . . . 0.0 109.561 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.468 ' HA ' ' CB ' ' A' ' 53' ' ' SER . 1.2 tp -60.97 87.83 0.02 OUTLIER 'General case' 0 C--O 1.213 -0.863 0 O-C-N 126.925 2.641 . . . . 0.0 109.602 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.82 104.15 16.63 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 102.122 -3.288 . . . . 0.0 102.122 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.402 ' N ' ' O ' ' A' ' 6' ' ' TRP 0.265 0.6 OUTLIER -90.47 104.13 16.74 Favored 'General case' 0 C--N 1.288 -2.089 0 O-C-N 125.921 2.013 . . . . 0.0 109.384 -179.901 . . . . . . . . 4 4 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.428 ' HB ' ' CB ' ' A' ' 50' ' ' LYS . 6.9 m -87.18 85.62 7.22 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 102.021 -3.326 . . . . 0.0 102.021 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.588 ' CG2' ' CE1' ' A' ' 47' ' ' PHE . 6.4 mm -60.0 131.44 24.66 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 CA-C-O 124.191 1.948 . . . . 0.0 110.68 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.0 m -150.34 103.4 3.15 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 112.915 -1.948 . . . . 0.0 114.575 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.436 ' HG2' ' CE1' ' A' ' 47' ' ' PHE . 1.6 mm-40 -49.21 117.73 2.31 Favored 'General case' 0 CA--C 1.547 0.847 0 O-C-N 126.479 2.362 . . . . 0.0 107.992 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.427 ' HB2' HG21 ' A' ' 48' ' ' THR 0.252 1.2 tp10 -90.86 45.65 1.27 Allowed 'General case' 0 CA--C 1.484 -1.562 0 O-C-N 124.816 1.322 . . . . 0.0 107.494 -179.46 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.02 -55.82 5.05 Favored Glycine 0 C--N 1.292 -1.912 0 N-CA-C 105.657 -2.977 . . . . 0.0 105.657 -179.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.455 ' HB2' ' CG ' ' A' ' 63' ' ' GLU 0.318 4.5 m-20 -108.13 -76.9 0.6 Allowed 'General case' 0 CA--C 1.504 -0.805 0 N-CA-C 115.158 1.54 . . . . 0.0 115.158 -179.449 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.632 ' HG3' ' N ' ' A' ' 47' ' ' PHE . 26.1 tptt -83.64 -76.85 0.27 Allowed 'General case' 0 N--CA 1.417 -2.093 0 C-N-CA 114.594 -2.842 . . . . 0.0 115.112 -178.346 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.632 ' N ' ' HG3' ' A' ' 46' ' ' LYS 0.422 0.1 OUTLIER 162.77 108.78 0.0 OUTLIER 'General case' 0 CA--C 1.496 -1.127 0 O-C-N 128.398 3.561 . . . . 0.0 109.423 -174.761 . . . . . . . . 4 4 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.474 ' HB ' ' CB ' ' A' ' 61' ' ' VAL 0.407 9.0 t -81.63 112.33 18.73 Favored 'General case' 0 C--O 1.248 0.992 0 O-C-N 119.458 -2.026 . . . . 0.0 106.118 178.316 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.414 HG23 ' HB ' ' A' ' 60' ' ' VAL 0.615 1.0 OUTLIER -90.47 105.04 15.9 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 N-CA-C 116.117 1.895 . . . . 0.0 116.117 -179.606 . . . . . . . . 4 4 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.428 ' CB ' ' HB ' ' A' ' 39' ' ' THR . 0.4 OUTLIER -67.4 111.3 3.98 Favored 'General case' 0 C--N 1.302 -1.487 1 N-CA-C 99.836 -4.135 . . . . 0.0 99.836 179.351 . . . . . . . . 4 4 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -96.82 67.9 2.33 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 104.173 -2.528 . . . . 0.0 104.173 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.7 m -78.67 68.4 4.64 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 105.417 -2.068 . . . . 0.0 105.417 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.468 ' CB ' ' HA ' ' A' ' 36' ' ' LEU . 1.1 p -109.66 -167.51 1.21 Allowed 'General case' 0 N--CA 1.438 -1.033 0 CA-C-N 114.76 -1.109 . . . . 0.0 110.057 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -75.58 -24.22 56.59 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 117.867 -1.533 . . . . 0.0 111.457 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.467 ' CZ ' ' HE2' ' A' ' 132' ' ' PLM . 31.8 m-85 -69.29 -50.55 45.71 Favored 'General case' 0 C--O 1.221 -0.423 0 C-N-CA 115.47 -2.492 . . . . 0.0 111.042 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 168.6 151.82 0.03 OUTLIER 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 123.916 3.053 . . . . 0.0 110.351 179.208 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -84.34 116.36 22.98 Favored 'General case' 0 C--N 1.348 0.535 1 N-CA-C 99.892 -4.114 . . . . 0.0 99.892 179.056 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . 0.299 0.0 OUTLIER -136.52 -28.02 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 O-C-N 128.524 3.64 . . . . 0.0 116.622 -178.223 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 67.46 79.05 0.23 Allowed 'General case' 0 C--N 1.352 0.701 0 N-CA-C 104.096 -2.557 . . . . 0.0 104.096 -178.57 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.583 ' CG1' ' CE2' ' A' ' 62' ' ' PHE . 94.2 t -86.72 77.61 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.408 0 CA-C-N 114.3 -1.318 . . . . 0.0 114.257 -177.254 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.511 ' O ' ' CD1' ' A' ' 62' ' ' PHE . 0.4 OUTLIER -69.6 143.03 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.378 0 O-C-N 118.749 -2.469 . . . . 0.0 106.923 177.334 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.656 ' CE1' ' CB ' ' A' ' 68' ' ' PHE . 1.6 m-30 -144.31 57.88 1.32 Allowed 'General case' 0 N--CA 1.44 -0.945 0 C-N-CA 114.392 -2.923 . . . . 0.0 111.839 178.235 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.611 ' HA ' ' CB ' ' A' ' 46' ' ' LYS . 1.2 mt-10 -19.61 119.66 0.02 OUTLIER 'General case' 0 C--N 1.311 -1.071 0 O-C-N 128.601 3.688 . . . . 0.0 108.682 -178.115 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.536 ' N ' ' HB2' ' A' ' 46' ' ' LYS . 0.4 OUTLIER -48.11 101.83 0.03 OUTLIER 'General case' 0 N--CA 1.438 -1.032 0 CA-C-O 122.761 1.267 . . . . 0.0 110.979 -177.387 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 93.38 22.25 27.4 Favored Glycine 0 C--N 1.351 1.415 0 CA-C-N 110.793 -2.912 . . . . 0.0 114.0 -179.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.411 ' N ' ' O ' ' A' ' 63' ' ' GLU 0.364 0.9 OUTLIER -102.7 77.79 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 N-CA-C 104.015 -2.587 . . . . 0.0 104.015 179.796 . . . . . . . . 4 4 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -39.17 111.71 0.2 Allowed 'General case' 0 CA--C 1.485 -1.55 0 O-C-N 126.895 2.622 . . . . 0.0 115.929 -179.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.656 ' CB ' ' CE1' ' A' ' 62' ' ' PHE . 17.1 p90 -106.7 -179.68 4.01 Favored 'General case' 0 N--CA 1.433 -1.306 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.533 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -144.69 148.3 34.05 Favored 'General case' 0 CA--C 1.521 -0.161 0 O-C-N 126.702 2.501 . . . . 0.0 109.183 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -146.31 118.94 8.55 Favored 'General case' 0 C--O 1.216 -0.679 0 O-C-N 125.274 1.609 . . . . 0.0 107.28 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.452 ' C ' ' CD1' ' A' ' 72' ' ' LEU . 0.7 OUTLIER -99.84 37.68 1.58 Allowed 'General case' 0 CA--C 1.489 -1.37 0 CA-C-N 121.366 1.893 . . . . 0.0 112.133 -179.255 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.46 ' CD1' ' N ' ' A' ' 72' ' ' LEU . 0.0 OUTLIER 173.61 -167.59 0.03 OUTLIER 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 125.14 1.376 . . . . 0.0 109.199 -179.094 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.465 ' O ' ' CB ' ' A' ' 74' ' ' ASP . . . 69.74 24.82 5.28 Favored 'General case' 0 C--O 1.208 -1.101 0 O-C-N 124.711 1.257 . . . . 0.0 110.352 -179.307 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.465 ' CB ' ' O ' ' A' ' 73' ' ' ALA . 27.8 t0 106.89 41.26 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.403 0 O-C-N 126.726 2.516 . . . . 0.0 113.692 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -155.53 -40.31 0.02 OUTLIER Glycine 0 CA--C 1.543 1.8 0 N-CA-C 118.301 2.08 . . . . 0.0 118.301 179.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . 0.257 0.1 OUTLIER 61.91 25.62 15.41 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-O 115.188 -2.339 . . . . 0.0 108.097 -179.554 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.484 ' CB ' ' HB ' ' A' ' 96' ' ' VAL . 3.9 mm-40 112.74 113.14 0.0 OUTLIER 'General case' 0 C--N 1.313 -1.02 1 O-C-N 133.923 7.014 . . . . 0.0 109.45 -177.659 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.44 ' HG ' ' HB3' ' A' ' 93' ' ' PHE 0.451 7.4 tt -139.53 119.68 13.66 Favored 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 102.662 -3.088 . . . . 0.0 102.662 -178.272 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 21.8 m -141.63 120.66 12.86 Favored 'General case' 0 C--O 1.197 -1.687 0 N-CA-C 103.38 -2.822 . . . . 0.0 103.38 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.422 ' HA3' ' HA ' ' A' ' 93' ' ' PHE . . . -160.9 -163.25 13.64 Favored Glycine 0 C--O 1.215 -1.051 0 C-N-CA 116.972 -2.537 . . . . 0.0 114.057 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 13.9 p -141.95 165.71 26.72 Favored 'General case' 0 C--O 1.188 -2.175 0 O-C-N 127.296 2.41 . . . . 0.0 110.616 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 93.9 m95 -107.36 147.46 30.31 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 103.76 -2.682 . . . . 0.0 103.76 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 5.0 t -147.15 127.53 13.99 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 125.093 1.495 . . . . 0.0 109.612 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -79.48 117.54 20.53 Favored 'General case' 0 N--CA 1.427 -1.606 0 CA-C-N 112.536 -2.12 . . . . 0.0 108.597 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . 0.608 3.4 mm-40 -78.03 -20.09 53.09 Favored 'General case' 0 N--CA 1.426 -1.662 0 O-C-N 123.766 0.666 . . . . 0.0 109.267 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 126.64 -53.2 0.8 Allowed Glycine 0 N--CA 1.436 -1.339 0 N-CA-C 104.921 -3.272 . . . . 0.0 104.921 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -112.54 -3.41 14.39 Favored 'General case' 0 C--O 1.245 0.834 0 CA-C-O 116.7 -1.619 . . . . 0.0 114.183 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . 0.379 10.2 mtpt -154.75 120.64 5.19 Favored 'General case' 0 CA--C 1.503 -0.837 0 O-C-N 125.574 1.796 . . . . 0.0 110.468 179.767 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.8 tp -76.56 144.55 39.61 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 103.512 -2.773 . . . . 0.0 103.512 179.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.449 HG11 ' CG2' ' A' ' 105' ' ' VAL . 2.7 m -141.56 153.35 19.5 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.052 0 N-CA-C 105.235 -2.135 . . . . 0.0 105.235 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -123.38 104.51 0.86 Allowed Glycine 0 CA--C 1.534 1.227 1 C-N-CA 130.794 4.045 . . . . 0.0 108.132 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -105.95 95.57 5.88 Favored 'General case' 0 N--CA 1.428 -1.565 0 C-N-CA 119.521 -0.872 . . . . 0.0 109.841 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.44 ' HB3' ' HG ' ' A' ' 78' ' ' LEU . 2.3 m-85 -92.96 123.32 36.13 Favored 'General case' 0 N--CA 1.435 -1.185 0 O-C-N 125.4 1.688 . . . . 0.0 114.092 179.672 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 24.7 mttt -91.5 146.77 23.53 Favored 'General case' 0 N--CA 1.429 -1.503 0 O-C-N 126.0 2.062 . . . . 0.0 110.059 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . 0.355 9.0 ttt180 -103.73 142.24 34.7 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-N 114.04 -1.436 . . . . 0.0 107.376 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.484 ' HB ' ' CB ' ' A' ' 77' ' ' GLU . 69.0 t -81.66 -36.04 14.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-O 124.793 2.235 . . . . 0.0 109.618 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . 0.32 1.3 t70 -72.82 -12.96 61.19 Favored 'General case' 0 C--O 1.256 1.405 0 N-CA-C 118.354 2.724 . . . . 0.0 118.354 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -141.36 -27.51 0.68 Allowed 'General case' 0 CA--C 1.502 -0.876 0 C-N-CA 116.854 -1.938 . . . . 0.0 115.671 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 94.77 9.98 58.14 Favored Glycine 0 C--N 1.337 0.625 0 O-C-N 125.555 1.784 . . . . 0.0 117.041 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 5.4 mmtm -106.04 172.29 6.89 Favored 'General case' 0 C--O 1.2 -1.544 0 CA-C-N 119.072 1.436 . . . . 0.0 109.278 179.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.96 126.14 50.15 Favored 'General case' 0 N--CA 1.436 -1.142 0 O-C-N 125.955 2.034 . . . . 0.0 114.841 -179.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.597 ' CB ' ' HA ' ' A' ' 119' ' ' TYR . 0.2 OUTLIER -79.38 116.44 19.62 Favored 'General case' 0 C--O 1.246 0.894 0 C-N-CA 130.456 3.502 . . . . 0.0 102.686 179.43 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.43 HG21 ' CB ' ' A' ' 117' ' ' TYR . 4.3 tt -97.8 150.15 4.83 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.116 0 C-N-CA 114.616 -2.833 . . . . 0.0 104.732 -179.245 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -143.29 145.03 32.37 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 116.533 -1.698 . . . . 0.0 109.312 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.54 ' CG1' ' CE2' ' A' ' 117' ' ' TYR . 7.6 p -134.5 113.83 17.49 Favored 'Isoleucine or valine' 0 C--O 1.248 1.012 0 CA-C-N 123.604 2.911 . . . . 0.0 113.528 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.464 ' CB ' HD23 ' A' ' 113' ' ' LEU . 63.0 mtt180 -81.37 95.67 7.1 Favored 'General case' 0 C--O 1.216 -0.667 0 N-CA-C 104.948 -2.242 . . . . 0.0 104.948 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 64.4 tt0 -102.31 81.97 2.13 Favored 'General case' 0 N--CA 1.419 -2.007 0 CA-C-N 111.49 -2.596 . . . . 0.0 114.727 -179.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.407 HG13 ' HA ' ' A' ' 113' ' ' LEU 0.29 0.3 OUTLIER -58.51 110.98 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 C-N-CA 117.448 -1.701 . . . . 0.0 107.853 179.516 . . . . . . . . 4 4 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 2.9 m -75.36 -17.93 60.1 Favored 'General case' 0 C--O 1.214 -0.776 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 -179.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 150.63 -109.35 0.42 Allowed Glycine 0 C--O 1.238 0.37 1 C-N-CA 132.087 4.661 . . . . 0.0 111.75 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 38.0 m-20 -59.77 -17.4 35.21 Favored 'General case' 0 C--O 1.213 -0.858 0 C-N-CA 116.778 -1.969 . . . . 0.0 111.61 179.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -110.64 135.23 51.58 Favored 'General case' 0 CA--C 1.496 -1.126 0 O-C-N 127.02 2.7 . . . . 0.0 117.476 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.505 HD12 ' CE2' ' A' ' 128' ' ' PHE . 0.1 OUTLIER -101.96 113.06 25.95 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 102.793 -3.04 . . . . 0.0 102.793 -179.938 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.466 ' CD1' HD13 ' A' ' 127' ' ' ILE . 78.0 mt -113.94 106.45 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.026 0 O-C-N 125.663 1.852 . . . . 0.0 110.309 -179.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.485 ' HB2' ' CG ' ' A' ' 126' ' ' ARG . 30.1 mt-30 -74.16 169.92 16.58 Favored 'General case' 0 C--O 1.244 0.791 0 N-CA-C 101.505 -3.517 . . . . 0.0 101.505 178.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.495 ' O ' ' N ' ' A' ' 105' ' ' VAL . 0.2 OUTLIER 173.75 155.04 0.11 Allowed 'General case' 0 N--CA 1.414 -2.254 0 C-N-CA 118.037 -1.465 . . . . 0.0 111.508 179.992 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . 0.54 ' CE2' ' CG1' ' A' ' 105' ' ' VAL 0.393 23.4 m-30 125.38 -141.91 0.0 OUTLIER 'General case' 0 CA--C 1.475 -1.934 1 O-C-N 130.475 4.859 . . . . 0.0 113.875 175.93 . . . . . . . . 4 3 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.428 ' O ' ' N ' ' A' ' 103' ' ' ILE . 0.0 OUTLIER -138.53 -165.18 1.77 Allowed 'General case' 0 N--CA 1.431 -1.38 0 CA-C-O 126.831 3.205 . . . . 0.0 117.656 -174.911 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.597 ' HA ' ' CB ' ' A' ' 102' ' ' LEU 0.259 0.0 OUTLIER -109.19 -55.42 2.41 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 111.463 -2.608 . . . . 0.0 105.287 177.872 . . . . . . . . 4 4 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.515 ' HB2' ' CD2' ' A' ' 119' ' ' TYR . 0.6 OUTLIER -129.12 -53.96 1.2 Allowed 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 111.516 -2.584 . . . . 0.0 112.744 179.526 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -162.01 15.91 0.15 Allowed Glycine 0 C--N 1.362 2.011 0 N-CA-C 118.928 2.331 . . . . 0.0 118.928 -179.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 82.9 t -120.7 112.58 36.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 N-CA-C 104.172 -2.529 . . . . 0.0 104.172 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.429 ' HA ' ' O ' ' A' ' 117' ' ' TYR . 1.2 mt-10 -71.42 177.51 3.93 Favored 'General case' 0 C--O 1.208 -1.116 0 C-N-CA 118.359 -1.337 . . . . 0.0 112.298 -178.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.438 ' CB ' ' HA ' ' A' ' 14' ' ' TYR . . . 179.71 97.83 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 116.525 -1.702 . . . . 0.0 110.284 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.426 ' HA ' ' HB ' ' A' ' 116' ' ' THR 0.327 0.0 OUTLIER -71.02 165.08 24.25 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 120.803 1.638 . . . . 0.0 111.192 179.656 . . . . . . . . 4 4 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.559 ' HG2' ' CE2' ' A' ' 14' ' ' TYR . 0.1 OUTLIER -140.56 77.09 1.59 Allowed 'General case' 0 N--CA 1.436 -1.128 1 O-C-N 129.661 4.351 . . . . 0.0 108.664 179.476 . . . . . . . . 4 4 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.466 HD13 ' CD1' ' A' ' 114' ' ' ILE . 0.6 OUTLIER -70.03 112.82 5.18 Favored 'Isoleucine or valine' 0 C--O 1.254 1.298 0 O-C-N 128.341 3.525 . . . . 0.0 112.824 179.752 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.541 ' CD1' ' HB ' ' A' ' 8' ' ' VAL . 1.8 m-30 -98.2 138.74 35.02 Favored 'General case' 0 C--O 1.221 -0.427 0 C-N-CA 127.298 2.239 . . . . 0.0 109.34 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . 0.266 26.6 mmtt -103.73 34.67 2.9 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 117.139 -1.41 . . . . 0.0 112.311 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.505 ' HB2' ' CZ3' ' A' ' 6' ' ' TRP . 10.0 tttp 29.83 100.78 0.0 OUTLIER 'General case' 0 CA--C 1.508 -0.65 0 N-CA-C 116.695 2.109 . . . . 0.0 116.695 179.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . 0.852 5.6 tt0 . . . . . 0 N--CA 1.439 -1.013 0 N-CA-C 119.502 3.149 . . . . 0.0 119.502 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' PLM . . . . . 0.467 ' HE2' ' CZ ' ' A' ' 55' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.326 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -124.29 -42.02 2.15 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 114.816 1.413 . . . . 0.0 114.816 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.38 101.08 0.07 Allowed 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 118.63 -1.228 . . . . 0.0 112.401 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 166.12 -155.32 26.49 Favored Glycine 0 C--O 1.217 -0.941 0 C-N-CA 115.809 -3.091 . . . . 0.0 113.267 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . 0.543 1.2 p -105.48 150.92 24.88 Favored 'General case' 0 CA--C 1.504 -0.823 0 CA-C-N 112.657 -1.772 . . . . 0.0 114.494 -179.728 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.51 ' CZ3' ' HB2' ' A' ' 130' ' ' LYS . 85.5 m95 -150.54 152.69 34.54 Favored 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 125.513 1.758 . . . . 0.0 108.576 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 5.6 tttp -153.13 103.01 2.68 Favored 'General case' 0 C--O 1.205 -1.268 0 CA-C-O 116.678 -1.629 . . . . 0.0 109.103 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.479 ' CG1' ' HB3' ' A' ' 36' ' ' LEU 0.396 13.9 p -48.98 124.39 2.26 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.066 0 O-C-N 126.464 2.353 . . . . 0.0 111.722 179.819 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 51.4 t0 -123.81 1.26 8.73 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 125.218 2.437 . . . . 0.0 108.717 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.9 ttt180 -169.28 133.51 1.4 Allowed 'General case' 0 C--N 1.294 -1.811 0 O-C-N 118.184 -2.822 . . . . 0.0 107.398 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . 0.299 0.0 OUTLIER -116.22 -171.89 2.08 Favored 'General case' 0 CA--C 1.501 -0.941 0 CA-C-N 114.394 -1.276 . . . . 0.0 108.513 179.894 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.432 ' CB ' ' HB2' ' A' ' 125' ' ' LYS . 0.5 OUTLIER -167.51 94.82 0.44 Allowed 'General case' 0 C--N 1.3 -1.579 0 CA-C-N 122.2 2.273 . . . . 0.0 107.917 179.907 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . 0.259 0.1 OUTLIER 97.68 -5.87 0.05 Allowed 'General case' 0 N--CA 1.486 1.359 0 O-C-N 126.984 2.678 . . . . 0.0 111.63 -179.636 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.519 ' CD2' ' HG2' ' A' ' 126' ' ' ARG . 0.4 OUTLIER -71.87 -16.36 62.14 Favored 'General case' 0 N--CA 1.432 -1.349 0 O-C-N 126.188 2.18 . . . . 0.0 116.103 -179.852 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -76.98 -37.68 54.71 Favored 'General case' 0 C--O 1.206 -1.201 0 CA-C-N 121.74 2.064 . . . . 0.0 109.25 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.42 -34.57 63.29 Favored 'General case' 0 N--CA 1.427 -1.617 0 CA-C-N 112.846 -1.979 . . . . 0.0 113.178 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.44 ' CA ' HG13 ' A' ' 122' ' ' VAL . 43.4 t80 -65.85 -24.79 66.96 Favored 'General case' 0 N--CA 1.421 -1.916 0 CA-C-O 123.213 1.482 . . . . 0.0 112.607 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.424 ' CB ' HG13 ' A' ' 23' ' ' ILE . 29.6 mtt -74.33 -28.56 61.2 Favored 'General case' 0 N--CA 1.443 -0.806 0 O-C-N 118.511 -2.618 . . . . 0.0 107.449 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -70.12 -32.62 70.72 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 125.665 2.65 . . . . 0.0 113.31 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 7.9 tttm -77.82 -43.9 29.03 Favored 'General case' 0 C--N 1.313 -0.984 0 O-C-N 119.855 -1.778 . . . . 0.0 112.086 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 11.1 mmm -62.29 -26.7 68.55 Favored 'General case' 0 C--O 1.205 -1.247 0 C-N-CA 126.098 1.759 . . . . 0.0 109.782 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 105.34 62.38 0.64 Allowed Glycine 0 N--CA 1.433 -1.521 0 CA-C-N 114.792 -1.095 . . . . 0.0 112.89 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.427 HG22 ' HB3' ' A' ' 27' ' ' LYS . 2.2 mm -118.31 134.9 60.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -79.35 157.35 27.67 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-O 113.872 -2.966 . . . . 0.0 112.391 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . 0.343 2.1 m -33.73 -39.1 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.21 -0.978 0 O-C-N 126.809 2.568 . . . . 0.0 114.318 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.488 2.5 m -78.18 -50.48 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.106 0 O-C-N 126.959 2.662 . . . . 0.0 115.129 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.427 ' HB3' HG22 ' A' ' 23' ' ' ILE . 13.7 mttm -64.25 -23.54 67.34 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.149 -0.932 . . . . 0.0 112.67 -179.635 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 6.9 ptt-85 -79.51 -26.19 41.6 Favored 'General case' 0 CA--C 1.532 0.27 0 O-C-N 119.826 -1.796 . . . . 0.0 107.753 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 7.0 ttmm -74.91 -38.45 61.81 Favored 'General case' 0 C--O 1.212 -0.905 0 O-C-N 125.086 1.492 . . . . 0.0 112.248 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.0 mp -78.08 -24.97 47.41 Favored 'General case' 0 N--CA 1.431 -1.404 0 C-N-CA 124.101 0.96 . . . . 0.0 110.579 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -79.42 -27.46 54.93 Favored Glycine 0 C--O 1.213 -1.165 0 O-C-N 125.238 1.586 . . . . 0.0 111.251 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -75.38 -41.8 55.49 Favored 'General case' 0 CA--C 1.514 -0.409 0 C-N-CA 125.912 1.685 . . . . 0.0 111.371 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 6.7 m-70 -101.03 14.32 32.35 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-O 116.152 -1.88 . . . . 0.0 115.408 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 14.9 p30 -40.34 -26.25 0.03 OUTLIER 'General case' 0 CA--C 1.499 -1.002 0 O-C-N 127.391 2.932 . . . . 0.0 118.763 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 6.9 p30 72.95 12.12 5.16 Favored 'General case' 0 C--N 1.311 -1.089 0 O-C-N 125.264 1.602 . . . . 0.0 109.155 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.479 ' HB3' ' CG1' ' A' ' 8' ' ' VAL . 2.6 tp -30.23 92.83 0.01 OUTLIER 'General case' 0 CA--C 1.503 -0.839 0 C-N-CA 129.298 3.039 . . . . 0.0 110.34 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 5.9 ttpm? -94.15 115.61 27.92 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 102.336 -3.209 . . . . 0.0 102.336 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.511 HD11 ' CE2' ' A' ' 128' ' ' PHE 0.26 0.1 OUTLIER -104.02 116.76 32.81 Favored 'General case' 0 C--N 1.291 -1.974 0 C-N-CA 116.923 -1.911 . . . . 0.0 110.01 -179.819 . . . . . . . . 4 4 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.422 ' HB ' ' HB2' ' A' ' 50' ' ' LYS . 10.5 m -106.3 99.11 8.71 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 124.748 2.213 . . . . 0.0 105.158 179.68 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 1.2 mt -88.17 128.42 40.52 Favored 'Isoleucine or valine' 0 C--O 1.251 1.184 0 CA-C-N 113.233 -1.803 . . . . 0.0 110.814 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 4.5 m -115.44 70.78 0.75 Allowed 'General case' 0 C--N 1.346 0.448 0 O-C-N 127.306 2.879 . . . . 0.0 107.567 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -65.69 112.96 3.93 Favored 'General case' 0 C--N 1.316 -0.854 0 C-N-CA 123.948 0.899 . . . . 0.0 109.716 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.408 ' HG2' ' N ' ' A' ' 44' ' ' GLY . 10.7 tt0 -99.16 -103.19 0.22 Allowed 'General case' 0 N--CA 1.423 -1.822 0 N-CA-C 105.312 -2.107 . . . . 0.0 105.312 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.408 ' N ' ' HG2' ' A' ' 43' ' ' GLU . . . -113.48 -48.41 0.6 Allowed Glycine 0 C--N 1.295 -1.743 0 N-CA-C 109.092 -1.603 . . . . 0.0 109.092 -179.702 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.532 ' ND2' ' N ' ' A' ' 45' ' ' ASN . 0.0 OUTLIER -127.58 -20.4 3.98 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 -179.942 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -90.14 161.23 15.86 Favored 'General case' 0 C--N 1.308 -1.217 0 C-N-CA 116.723 -1.991 . . . . 0.0 113.098 179.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -135.24 69.44 1.44 Allowed 'General case' 0 CA--C 1.512 -0.49 0 CA-C-O 124.273 1.987 . . . . 0.0 109.698 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.419 ' HB ' HG13 ' A' ' 61' ' ' VAL . 14.0 t -74.74 122.88 23.96 Favored 'General case' 0 N--CA 1.432 -1.362 0 O-C-N 119.562 -1.961 . . . . 0.0 106.753 179.345 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.475 HG21 ' CG1' ' A' ' 60' ' ' VAL 0.685 0.9 OUTLIER -116.44 120.9 66.33 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.727 0 N-CA-C 117.551 2.426 . . . . 0.0 117.551 -179.058 . . . . . . . . 4 4 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.422 ' HB2' ' HB ' ' A' ' 39' ' ' THR . 0.9 OUTLIER -64.87 145.15 56.69 Favored 'General case' 0 C--N 1.308 -1.235 1 N-CA-C 99.101 -4.407 . . . . 0.0 99.101 177.749 . . . . . . . . 4 4 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.472 ' O ' ' N ' ' A' ' 53' ' ' SER . 5.3 tt0 -133.87 51.69 2.12 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 104.279 -2.489 . . . . 0.0 104.279 -178.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . 0.26 4.6 m -61.95 86.6 0.02 OUTLIER 'General case' 0 C--N 1.289 -2.06 0 N-CA-C 104.736 -2.32 . . . . 0.0 104.736 179.348 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.472 ' N ' ' O ' ' A' ' 51' ' ' GLU . 1.3 m -122.48 44.34 2.65 Favored 'General case' 0 N--CA 1.443 -0.816 0 O-C-N 126.1 2.125 . . . . 0.0 114.607 -179.121 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 65.66 -54.04 0.36 Allowed 'General case' 0 N--CA 1.44 -0.957 0 O-C-N 126.717 2.51 . . . . 0.0 108.996 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.522 ' CE1' ' HB3' ' A' ' 73' ' ' ALA . 7.4 m-85 -62.81 -56.99 12.48 Favored 'General case' 0 C--O 1.217 -0.654 0 CA-C-O 114.699 -2.572 . . . . 0.0 109.186 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.459 ' HB3' ' CG2' ' A' ' 58' ' ' ILE . 23.1 ttt-85 -148.98 144.48 26.8 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 123.709 2.959 . . . . 0.0 112.054 179.665 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -97.66 81.84 2.98 Favored 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 100.623 -3.843 . . . . 0.0 100.623 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.459 ' CG2' ' HB3' ' A' ' 56' ' ' ARG . 1.5 tt -120.65 100.6 9.38 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.77 1 O-C-N 129.26 4.1 . . . . 0.0 118.927 -179.213 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -63.02 117.98 7.21 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 103.492 -2.781 . . . . 0.0 103.492 178.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.475 ' CG1' HG21 ' A' ' 49' ' ' VAL . 2.4 p -101.43 102.32 13.33 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 C-N-CA 119.672 -0.811 . . . . 0.0 111.103 -177.283 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.419 HG13 ' HB ' ' A' ' 48' ' ' THR 0.36 0.8 OUTLIER -87.12 138.06 19.76 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 CA-C-O 125.966 2.794 . . . . 0.0 113.58 -179.807 . . . . . . . . 4 4 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 23.7 p90 -153.49 100.62 2.43 Favored 'General case' 0 N--CA 1.437 -1.103 0 O-C-N 120.204 -1.56 . . . . 0.0 110.719 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.49 130.44 46.88 Favored 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 102.862 -3.014 . . . . 0.0 102.862 179.683 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 7.2 mt -52.31 118.09 3.29 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-O 122.886 1.327 . . . . 0.0 110.492 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 86.38 13.41 68.16 Favored Glycine 0 C--N 1.347 1.191 0 CA-C-N 111.627 -2.533 . . . . 0.0 117.39 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . 0.419 0.5 OUTLIER -101.1 129.5 51.98 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 N-CA-C 105.547 -2.02 . . . . 0.0 105.547 179.963 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -86.61 115.31 23.99 Favored 'General case' 0 CA--C 1.483 -1.625 0 N-CA-C 115.146 1.536 . . . . 0.0 115.146 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -111.7 155.04 24.08 Favored 'General case' 0 N--CA 1.427 -1.609 0 CA-C-O 116.276 -1.821 . . . . 0.0 106.798 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -109.51 130.07 55.53 Favored 'General case' 0 CA--C 1.51 -0.591 0 O-C-N 126.138 2.149 . . . . 0.0 106.783 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -130.87 101.16 5.52 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-O 116.67 -1.634 . . . . 0.0 113.903 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 26.8 m -67.18 119.41 12.04 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 105.78 -1.933 . . . . 0.0 105.78 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.467 ' CD2' ' HA1' ' A' ' 132' ' ' PLM . 16.7 mt -65.61 -175.81 0.3 Allowed 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 114.265 -1.334 . . . . 0.0 109.136 -179.676 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.522 ' HB3' ' CE1' ' A' ' 55' ' ' PHE . . . -75.42 -35.76 60.92 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-O 124.773 2.225 . . . . 0.0 111.814 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -153.11 23.91 0.55 Allowed 'General case' 0 C--O 1.239 0.514 0 CA-C-N 112.662 -2.063 . . . . 0.0 108.4 179.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -120.18 -10.0 7.67 Favored Glycine 0 C--O 1.213 -1.19 0 C-N-CA 125.052 1.31 . . . . 0.0 114.786 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER 74.51 -175.57 0.14 Allowed 'General case' 0 C--N 1.317 -0.811 0 C-N-CA 117.699 -1.601 . . . . 0.0 112.933 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -44.87 123.88 4.05 Favored 'General case' 0 N--CA 1.446 -0.64 0 O-C-N 127.467 2.979 . . . . 0.0 111.195 179.669 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.437 ' HG ' ' HB3' ' A' ' 93' ' ' PHE 0.423 0.6 OUTLIER -144.38 90.14 2.07 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 102.414 -3.18 . . . . 0.0 102.414 -179.819 . . . . . . . . 4 4 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 95.6 m -103.55 135.86 44.35 Favored 'General case' 0 CA--C 1.481 -1.678 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -170.78 -159.66 17.35 Favored Glycine 0 C--N 1.291 -1.917 0 C-N-CA 116.568 -2.729 . . . . 0.0 110.596 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -147.54 175.46 10.83 Favored 'General case' 0 C--O 1.197 -1.699 0 CA-C-O 122.554 1.169 . . . . 0.0 108.453 179.726 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . 0.505 ' CZ3' ' N ' ' A' ' 91' ' ' GLY . 54.6 m95 -130.02 135.43 48.27 Favored 'General case' 0 N--CA 1.427 -1.577 0 N-CA-C 104.078 -2.564 . . . . 0.0 104.078 179.506 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.471 ' CG2' HG21 ' A' ' 90' ' ' VAL . 8.8 t -135.87 134.76 39.13 Favored 'General case' 0 N--CA 1.425 -1.693 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.885 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.414 ' CA ' HD13 ' A' ' 89' ' ' LEU . 5.4 ttt -83.96 121.46 27.41 Favored 'General case' 0 N--CA 1.429 -1.523 0 O-C-N 125.793 1.933 . . . . 0.0 106.103 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . 0.539 0.5 OUTLIER -79.87 -24.24 41.36 Favored 'General case' 0 N--CA 1.426 -1.652 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 179.788 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 154.64 -85.43 0.14 Allowed Glycine 0 N--CA 1.447 -0.568 0 N-CA-C 105.047 -3.221 . . . . 0.0 105.047 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 13.2 m-80 -91.32 -0.72 57.71 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-O 116.385 -1.769 . . . . 0.0 115.264 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . 0.382 0.3 OUTLIER -141.55 146.91 36.9 Favored 'General case' 0 CA--C 1.489 -1.39 0 O-C-N 127.095 2.747 . . . . 0.0 106.973 -179.854 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.439 HD21 ' HD3' ' A' ' 106' ' ' ARG . 0.7 OUTLIER -109.88 141.88 41.97 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 104.934 -2.247 . . . . 0.0 104.934 -179.864 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.471 HG21 ' CG2' ' A' ' 83' ' ' THR . 0.3 OUTLIER -123.21 124.75 70.7 Favored 'Isoleucine or valine' 0 C--O 1.244 0.771 0 N-CA-C 105.007 -2.219 . . . . 0.0 105.007 -179.582 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.505 ' N ' ' CZ3' ' A' ' 82' ' ' TRP . . . -103.36 109.06 3.37 Favored Glycine 0 C--N 1.349 1.268 0 N-CA-C 108.892 -1.683 . . . . 0.0 108.892 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.472 ' C ' ' CD1' ' A' ' 93' ' ' PHE . 24.2 mtpp -102.71 152.77 20.83 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 105.175 -2.158 . . . . 0.0 105.175 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.472 ' CD1' ' C ' ' A' ' 92' ' ' LYS . 64.6 m-85 -148.73 111.61 4.84 Favored 'General case' 0 CA--C 1.508 -0.658 0 CA-C-O 122.931 1.348 . . . . 0.0 110.873 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 12.8 mttm -92.86 130.53 38.43 Favored 'General case' 0 N--CA 1.44 -0.942 0 C-N-CA 126.456 1.902 . . . . 0.0 107.626 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.414 ' HB3' ' ND2' ' A' ' 98' ' ' ASN 0.381 0.0 OUTLIER -95.62 143.4 26.93 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 104.917 -2.253 . . . . 0.0 104.917 -179.923 . . . . . . . . 4 4 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 29.6 m -70.24 -37.76 72.38 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 O-C-N 123.935 0.772 . . . . 0.0 111.081 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . 0.345 0.5 OUTLIER -56.82 -12.29 1.85 Allowed 'General case' 0 C--O 1.254 1.333 0 N-CA-C 114.825 1.417 . . . . 0.0 114.825 179.896 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.414 ' ND2' ' HB3' ' A' ' 95' ' ' ARG . 0.1 OUTLIER -159.52 5.91 0.09 Allowed 'General case' 0 N--CA 1.426 -1.647 0 N-CA-C 116.646 2.091 . . . . 0.0 116.646 179.93 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 44.65 25.39 0.86 Allowed Glycine 0 C--O 1.243 0.692 0 CA-C-O 124.0 1.889 . . . . 0.0 114.357 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 6.7 mmmt -70.91 -97.96 0.01 OUTLIER 'General case' 0 CA--C 1.554 1.129 0 O-C-N 119.185 -2.362 . . . . 0.0 109.611 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.454 ' CG ' ' N ' ' A' ' 102' ' ' LEU . 36.8 tt0 152.26 168.77 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 128.719 2.808 . . . . 0.0 109.345 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.6 ' CB ' ' HA ' ' A' ' 119' ' ' TYR . 0.9 OUTLIER -151.07 134.66 16.34 Favored 'General case' 0 C--O 1.246 0.909 1 C-N-CA 132.613 4.365 . . . . 0.0 103.986 -179.669 . . . . . . . . 4 4 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.562 ' N ' ' O ' ' A' ' 118' ' ' THR . 1.3 tp -118.17 159.9 18.22 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.09 0 N-CA-C 106.314 -1.736 . . . . 0.0 106.314 -179.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.447 ' N ' HG13 ' A' ' 103' ' ' ILE . . . -154.31 150.59 28.15 Favored 'General case' 0 C--O 1.242 0.708 0 CA-C-O 115.995 -1.955 . . . . 0.0 107.454 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.511 HG13 ' CE2' ' A' ' 117' ' ' TYR . 8.4 p -137.01 109.68 7.57 Favored 'Isoleucine or valine' 0 C--O 1.248 0.979 0 C-N-CA 116.439 -2.105 . . . . 0.0 114.301 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.439 ' HD3' HD21 ' A' ' 89' ' ' LEU 0.253 50.7 mtt180 -71.08 96.85 1.39 Allowed 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 104.347 -2.464 . . . . 0.0 104.347 179.498 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -94.75 73.89 3.63 Favored 'General case' 0 N--CA 1.422 -1.858 0 O-C-N 126.438 2.336 . . . . 0.0 112.082 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.427 HD12 ' CH2' ' A' ' 6' ' ' TRP 0.355 1.9 tt -59.55 97.65 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 C-N-CA 114.425 -2.91 . . . . 0.0 113.701 179.891 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 39.4 t -84.23 71.99 10.57 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 105.475 -2.046 . . . . 0.0 105.475 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 72.61 -89.59 0.54 Allowed Glycine 0 C--O 1.241 0.544 0 O-C-N 128.722 3.764 . . . . 0.0 113.26 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . 0.329 1.0 OUTLIER -95.01 -14.76 24.05 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 116.358 -1.782 . . . . 0.0 113.172 -179.891 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -108.9 134.64 51.3 Favored 'General case' 0 N--CA 1.431 -1.411 0 O-C-N 127.553 3.033 . . . . 0.0 112.897 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.439 ' HB2' ' CZ3' ' A' ' 6' ' ' TRP . 0.7 OUTLIER -99.29 141.83 31.56 Favored 'General case' 0 C--O 1.209 -1.064 0 N-CA-C 101.836 -3.394 . . . . 0.0 101.836 -179.647 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.419 HG12 HG22 ' A' ' 127' ' ' ILE . 63.6 mt -142.18 134.79 27.56 Favored 'Isoleucine or valine' 0 C--O 1.246 0.901 0 N-CA-C 103.729 -2.693 . . . . 0.0 103.729 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.485 ' HB2' ' CD ' ' A' ' 126' ' ' ARG . 24.2 mt-30 -117.23 118.48 32.43 Favored 'General case' 0 CA--C 1.497 -1.083 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.442 ' O ' ' N ' ' A' ' 105' ' ' VAL . 0.7 OUTLIER -137.53 156.86 47.64 Favored 'General case' 0 N--CA 1.413 -2.281 0 CA-C-N 114.247 -1.342 . . . . 0.0 112.397 -179.643 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . 0.511 ' CE2' HG13 ' A' ' 105' ' ' VAL 0.384 24.3 m-85 134.73 -141.5 0.0 OUTLIER 'General case' 0 CA--C 1.48 -1.736 1 O-C-N 130.708 5.005 . . . . 0.0 113.485 176.249 . . . . . . . . 4 3 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.562 ' O ' ' N ' ' A' ' 103' ' ' ILE . 4.4 t -156.04 -156.07 0.6 Allowed 'General case' 0 C--N 1.311 -1.072 0 O-C-N 127.268 2.855 . . . . 0.0 116.389 -174.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.6 ' HA ' ' CB ' ' A' ' 102' ' ' LEU . 0.0 OUTLIER -105.16 -62.86 1.29 Allowed 'General case' 0 C--N 1.347 0.485 0 N-CA-C 102.69 -3.078 . . . . 0.0 102.69 176.573 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.415 ' N ' HG22 ' A' ' 118' ' ' THR . 0.0 OUTLIER -120.56 -71.53 0.73 Allowed 'General case' 0 N--CA 1.426 -1.635 0 CA-C-N 111.857 -2.429 . . . . 0.0 116.039 179.488 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -140.7 10.78 2.91 Favored Glycine 0 C--N 1.355 1.633 0 N-CA-C 120.083 2.793 . . . . 0.0 120.083 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.44 HG13 ' CA ' ' A' ' 17' ' ' PHE . 72.3 t -114.12 94.69 3.28 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 O-C-N 117.39 -3.418 . . . . 0.0 103.163 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -58.02 177.36 0.12 Allowed 'General case' 0 C--O 1.213 -0.857 0 C-N-CA 118.36 -1.336 . . . . 0.0 112.637 -178.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.511 ' HB2' ' CD1' ' A' ' 14' ' ' TYR . . . -173.87 103.44 0.11 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 115.914 -1.993 . . . . 0.0 109.221 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.432 ' HB2' ' CB ' ' A' ' 12' ' ' GLU 0.343 1.5 mptt -79.49 162.15 25.6 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 121.661 2.028 . . . . 0.0 112.665 -179.91 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.519 ' HG2' ' CD2' ' A' ' 14' ' ' TYR . 0.2 OUTLIER -145.07 78.97 1.58 Allowed 'General case' 0 C--O 1.208 -1.104 0 CA-C-O 115.236 -2.316 . . . . 0.0 106.015 179.623 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.419 HG22 HG12 ' A' ' 114' ' ' ILE . 4.4 mm -77.32 111.05 13.68 Favored 'Isoleucine or valine' 0 C--O 1.246 0.888 1 O-C-N 131.973 5.796 . . . . 0.0 110.996 179.703 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.511 ' CE2' HD11 ' A' ' 38' ' ' LEU . 15.0 m-85 -92.52 169.21 10.72 Favored 'General case' 0 C--N 1.318 -0.783 0 O-C-N 127.255 2.847 . . . . 0.0 108.417 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . 0.305 19.8 mmtt -124.07 -6.21 7.82 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 115.406 -2.235 . . . . 0.0 110.634 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.51 ' HB2' ' CZ3' ' A' ' 6' ' ' TRP . 0.0 OUTLIER 71.82 102.04 0.07 Allowed 'General case' 0 N--CA 1.472 0.631 0 O-C-N 126.811 2.569 . . . . 0.0 109.597 179.823 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . 0.923 7.6 mt-10 . . . . . 0 N--CA 1.434 -1.232 0 N-CA-C 116.223 1.934 . . . . 0.0 116.223 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' PLM . . . . . 0.467 ' HA1' ' CD2' ' A' ' 72' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.284 0 CA-C-O 120.442 0.163 . . . . 0.0 111.412 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.499 ' CD1' ' N ' ' A' ' 2' ' ' PHE . 13.5 m-85 -122.11 69.66 0.95 Allowed 'General case' 0 C--N 1.313 -1.011 0 O-C-N 125.481 1.738 . . . . 0.0 112.438 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -144.05 98.27 3.19 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.521 -1.218 . . . . 0.0 110.594 179.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 161.12 -130.03 2.26 Favored Glycine 0 C--O 1.222 -0.623 0 C-N-CA 115.331 -3.318 . . . . 0.0 110.296 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . 0.609 0.1 OUTLIER -134.1 157.94 44.87 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 119.154 -1.018 . . . . 0.0 112.637 -179.812 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.523 ' CD1' HD13 ' A' ' 40' ' ' ILE 0.254 95.1 m95 -142.19 146.63 35.46 Favored 'General case' 0 C--O 1.212 -0.875 0 O-C-N 127.98 3.3 . . . . 0.0 106.253 -179.87 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -139.97 92.9 2.59 Favored 'General case' 0 C--O 1.21 -0.994 0 O-C-N 127.069 2.731 . . . . 0.0 106.452 -179.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.444 ' CG1' ' HB3' ' A' ' 36' ' ' LEU 0.396 2.1 p -43.77 125.84 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 CA-C-O 116.744 -1.598 . . . . 0.0 112.966 179.836 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -115.4 -31.96 5.76 Favored 'General case' 0 N--CA 1.439 -0.984 0 O-C-N 126.306 2.254 . . . . 0.0 108.846 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.1 149.22 32.6 Favored 'General case' 0 CA--C 1.482 -1.672 0 C-N-CA 116.526 -2.07 . . . . 0.0 108.6 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . 0.386 3.4 m-80 -120.32 -175.45 3.0 Favored 'General case' 0 N--CA 1.454 -0.227 0 O-C-N 126.909 2.631 . . . . 0.0 108.619 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -141.89 -78.42 0.26 Allowed 'General case' 0 N--CA 1.432 -1.326 0 C-N-CA 116.651 -2.02 . . . . 0.0 111.055 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -88.79 17.75 5.33 Favored 'General case' 0 N--CA 1.475 0.803 0 O-C-N 125.613 1.821 . . . . 0.0 114.291 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.461 ' CE2' ' HE1' ' A' ' 18' ' ' MET . 9.0 t80 -63.93 -39.08 93.34 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 119.084 2.994 . . . . 0.0 119.084 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.46 -35.29 78.85 Favored 'General case' 0 C--O 1.212 -0.918 0 CA-C-N 121.846 2.112 . . . . 0.0 112.171 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.93 -31.66 45.29 Favored 'General case' 0 N--CA 1.435 -1.185 0 O-C-N 126.492 2.37 . . . . 0.0 113.578 179.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.412 ' CD2' ' CB ' ' A' ' 124' ' ' ALA . 0.0 OUTLIER -70.59 -30.35 67.01 Favored 'General case' 0 N--CA 1.423 -1.788 0 CA-C-O 125.873 2.749 . . . . 0.0 114.185 -179.405 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.461 ' HE1' ' CE2' ' A' ' 14' ' ' TYR . 19.5 mmt -76.58 -22.75 53.83 Favored 'General case' 0 N--CA 1.431 -1.379 0 O-C-N 116.303 -3.998 . . . . 0.0 107.541 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -68.53 -25.29 64.85 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 119.384 -2.073 . . . . 0.0 112.004 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.479 ' CE ' ' CB ' ' A' ' 120' ' ' GLU . 2.2 tttp -79.06 -31.94 44.63 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-O 117.469 -1.253 . . . . 0.0 113.15 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 29.1 mtp -75.64 -23.2 56.31 Favored 'General case' 0 N--CA 1.437 -1.105 0 O-C-N 126.076 2.11 . . . . 0.0 109.006 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 105.26 31.02 4.5 Favored Glycine 0 C--O 1.225 -0.461 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 179.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.497 ' CG2' ' N ' ' A' ' 28' ' ' ARG . 2.7 mm -77.49 141.95 14.88 Favored 'Isoleucine or valine' 0 C--N 1.352 0.699 0 C-N-CA 124.97 1.308 . . . . 0.0 108.911 -179.664 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -101.69 154.34 18.97 Favored 'General case' 0 C--O 1.245 0.839 0 CA-C-O 115.944 -1.979 . . . . 0.0 110.171 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . 0.429 4.2 p -28.92 -40.95 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.518 -0.276 0 O-C-N 128.414 3.571 . . . . 0.0 119.231 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.65 2.5 t -79.83 -40.95 21.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 123.034 1.397 . . . . 0.0 112.572 179.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.0 ttmt -68.67 -43.64 75.72 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 110.469 -3.06 . . . . 0.0 114.548 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.497 ' N ' ' CG2' ' A' ' 23' ' ' ILE . 31.6 ptt85 -76.5 -20.82 56.55 Favored 'General case' 0 C--N 1.321 -0.659 0 O-C-N 119.625 -1.922 . . . . 0.0 108.653 -179.562 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.1 ttmt -76.21 -38.3 56.65 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-N 114.381 -1.282 . . . . 0.0 108.334 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -72.38 -35.76 68.55 Favored 'General case' 0 C--O 1.214 -0.766 0 CA-C-N 114.621 -1.172 . . . . 0.0 108.442 -179.729 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -73.67 -26.87 68.46 Favored Glycine 0 CA--C 1.532 1.118 0 O-C-N 126.239 2.212 . . . . 0.0 111.955 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -75.7 -39.26 57.72 Favored 'General case' 0 N--CA 1.434 -1.23 0 C-N-CA 125.681 1.592 . . . . 0.0 110.774 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -90.58 29.98 1.22 Allowed 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 124.237 1.015 . . . . 0.0 112.538 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 31.2 p-10 -81.02 98.63 8.05 Favored 'General case' 0 CA--C 1.508 -0.655 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -76.93 61.84 2.01 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 120.058 1.299 . . . . 0.0 109.27 179.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.521 HD22 ' CZ ' ' A' ' 128' ' ' PHE . 0.1 OUTLIER -61.87 124.92 22.08 Favored 'General case' 0 CA--C 1.492 -1.262 0 C-N-CA 126.836 2.054 . . . . 0.0 108.695 -179.519 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 21.8 ttmt -108.71 106.14 16.04 Favored 'General case' 0 N--CA 1.431 -1.398 0 N-CA-C 104.482 -2.414 . . . . 0.0 104.482 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.476 ' CD1' HD12 ' A' ' 36' ' ' LEU . 1.3 tp -91.82 111.14 22.55 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 120.844 1.656 . . . . 0.0 108.964 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.2 m -96.69 91.36 5.68 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 101.732 -3.432 . . . . 0.0 101.732 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.523 HD13 ' CD1' ' A' ' 6' ' ' TRP . 58.5 mt -72.05 120.58 20.67 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 -179.368 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -115.01 113.3 23.92 Favored 'General case' 0 CA--C 1.5 -0.976 0 O-C-N 128.221 3.451 . . . . 0.0 114.666 179.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.451 ' HG2' ' CE1' ' A' ' 47' ' ' PHE . 1.6 mm-40 -92.91 96.0 9.84 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-O 117.507 -1.235 . . . . 0.0 108.289 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -76.34 -13.47 60.14 Favored 'General case' 0 N--CA 1.42 -1.953 0 CA-C-N 120.505 1.502 . . . . 0.0 110.699 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 150.74 -30.28 1.02 Allowed Glycine 0 C--N 1.294 -1.767 0 N-CA-C 106.048 -2.821 . . . . 0.0 106.048 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -150.83 -52.82 0.14 Allowed 'General case' 0 N--CA 1.441 -0.896 0 O-C-N 127.045 2.262 . . . . 0.0 110.21 -179.677 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.36 148.69 49.82 Favored 'General case' 0 N--CA 1.436 -1.161 0 CA-C-N 113.765 -1.561 . . . . 0.0 109.023 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.451 ' CE1' ' HG2' ' A' ' 42' ' ' GLN . 0.9 OUTLIER -113.77 81.79 1.58 Allowed 'General case' 0 C--O 1.218 -0.574 0 N-CA-C 105.871 -1.9 . . . . 0.0 105.871 179.861 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.469 HG23 ' CG1' ' A' ' 61' ' ' VAL 0.441 0.9 OUTLIER -63.48 90.25 0.05 OUTLIER 'General case' 0 CA--C 1.503 -0.85 0 C-N-CA 115.477 -2.489 . . . . 0.0 111.591 -179.639 . . . . . . . . 4 4 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.488 ' HB ' ' CE1' ' A' ' 62' ' ' PHE 0.652 0.7 OUTLIER -78.05 86.36 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.58 0 CA-C-O 117.929 -1.034 . . . . 0.0 111.411 -179.874 . . . . . . . . 4 4 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 3.2 tttp -62.44 113.45 2.95 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 102.076 -3.305 . . . . 0.0 102.076 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.401 ' HG3' HD11 ' A' ' 36' ' ' LEU 0.271 2.4 tt0 -103.73 94.73 5.59 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 120.23 1.377 . . . . 0.0 107.834 -179.983 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 7.6 t -93.2 55.01 2.22 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 105.216 -2.142 . . . . 0.0 105.216 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 87.3 p -67.66 167.49 13.04 Favored 'General case' 0 C--N 1.348 0.541 0 O-C-N 125.633 1.833 . . . . 0.0 111.384 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -58.28 -27.12 63.75 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 119.363 0.983 . . . . 0.0 109.191 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.461 ' CE2' ' HB2' ' A' ' 73' ' ' ALA . 0.2 OUTLIER -69.13 -62.94 1.17 Allowed 'General case' 0 C--O 1.21 -1.026 0 CA-C-O 114.301 -2.761 . . . . 0.0 108.418 179.971 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.25 174.1 15.96 Favored 'General case' 0 C--O 1.244 0.813 0 CA-C-N 121.691 2.041 . . . . 0.0 109.947 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -104.43 85.14 2.3 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 103.453 -2.795 . . . . 0.0 103.453 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -114.21 106.81 21.39 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.323 0 C-N-CA 128.675 2.79 . . . . 0.0 115.806 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -59.84 135.44 57.69 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 104.465 -2.42 . . . . 0.0 104.465 179.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.441 HG22 HG13 ' A' ' 49' ' ' VAL . 36.5 t -96.17 -67.71 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.066 0 CA-C-O 126.066 2.841 . . . . 0.0 112.082 -178.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.469 ' CG1' HG23 ' A' ' 48' ' ' THR 0.442 0.1 OUTLIER 69.98 140.07 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 CA-C-N 113.512 -1.676 . . . . 0.0 113.601 -179.947 . . . . . . . . 4 4 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.512 ' HB3' ' CZ ' ' A' ' 68' ' ' PHE . 1.8 p90 -170.22 98.76 0.27 Allowed 'General case' 0 C--N 1.317 -0.814 0 C-N-CA 115.624 -2.43 . . . . 0.0 107.534 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -57.99 131.17 49.63 Favored 'General case' 0 C--O 1.246 0.897 0 N-CA-C 102.737 -3.06 . . . . 0.0 102.737 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -51.98 121.22 6.34 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 114.944 -1.025 . . . . 0.0 110.985 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 68.44 8.14 54.84 Favored Glycine 0 CA--C 1.531 1.061 0 N-CA-C 119.137 2.415 . . . . 0.0 119.137 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . 0.382 15.1 t -80.79 -108.28 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 N-CA-C 104.189 -2.523 . . . . 0.0 104.189 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 170.07 149.61 0.04 OUTLIER 'General case' 0 C--O 1.205 -1.243 0 O-C-N 124.509 1.13 . . . . 0.0 112.108 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.512 ' CZ ' ' HB3' ' A' ' 62' ' ' PHE . 2.1 p90 -161.69 135.46 6.6 Favored 'General case' 0 N--CA 1.431 -1.397 0 O-C-N 124.787 1.305 . . . . 0.0 109.907 -179.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.13 100.76 13.2 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 105.495 -2.039 . . . . 0.0 105.495 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -106.75 92.69 4.2 Favored 'General case' 0 C--O 1.216 -0.68 0 O-C-N 125.006 1.441 . . . . 0.0 114.179 -179.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 27.6 m -63.12 139.23 58.75 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 120.849 1.659 . . . . 0.0 107.083 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 5.3 mp -80.72 -157.85 0.17 Allowed 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 104.808 -2.293 . . . . 0.0 104.808 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.461 ' HB2' ' CE2' ' A' ' 55' ' ' PHE . . . -106.56 -8.92 16.79 Favored 'General case' 0 N--CA 1.439 -1.009 0 CA-C-O 122.499 1.143 . . . . 0.0 113.839 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.424 ' HB2' ' HG3' ' A' ' 132' ' ' PLM . 3.9 t70 -140.0 -39.53 0.45 Allowed 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 114.996 -1.002 . . . . 0.0 111.479 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -86.66 -16.53 61.63 Favored Glycine 0 CA--C 1.534 1.245 0 O-C-N 120.466 -1.396 . . . . 0.0 114.145 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . 0.342 0.1 OUTLIER 72.82 164.23 0.28 Allowed 'General case' 0 N--CA 1.432 -1.338 0 O-C-N 118.49 -2.77 . . . . 0.0 115.794 179.908 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -2.14 120.51 0.0 OUTLIER 'General case' 0 N--CA 1.439 -0.981 0 O-C-N 127.77 3.169 . . . . 0.0 117.505 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . 0.409 7.1 tp -134.97 134.95 41.06 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 103.049 -2.945 . . . . 0.0 103.049 179.721 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 6.1 m -145.52 121.2 10.49 Favored 'General case' 0 CA--C 1.485 -1.544 0 O-C-N 125.33 1.644 . . . . 0.0 106.782 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.411 ' HA3' ' HA ' ' A' ' 93' ' ' PHE . . . -175.99 -145.07 5.38 Favored Glycine 0 C--N 1.295 -1.72 0 O-C-N 118.871 -2.393 . . . . 0.0 110.24 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -154.24 177.45 11.11 Favored 'General case' 0 C--O 1.188 -2.157 0 CA-C-N 119.695 1.747 . . . . 0.0 110.976 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . 0.437 ' HA ' ' HA2' ' A' ' 91' ' ' GLY . 12.1 m95 -127.18 142.12 51.57 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 100.568 -3.864 . . . . 0.0 100.568 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 8.9 t -146.91 144.31 29.15 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 125.532 1.77 . . . . 0.0 111.744 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.4 ' HA ' HD21 ' A' ' 89' ' ' LEU . 20.7 ttt -83.76 101.36 11.53 Favored 'General case' 0 N--CA 1.436 -1.15 0 CA-C-N 110.996 -2.82 . . . . 0.0 107.854 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.449 ' CG ' HG12 ' A' ' 90' ' ' VAL 0.712 0.0 OUTLIER -90.17 70.07 7.24 Favored 'General case' 0 N--CA 1.427 -1.58 0 C-N-CA 122.8 0.44 . . . . 0.0 112.051 179.952 . . . . . . . . 4 4 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 54.52 -97.57 0.04 OUTLIER Glycine 0 C--N 1.349 1.298 0 N-CA-C 107.635 -2.186 . . . . 0.0 107.635 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -74.56 3.49 7.62 Favored 'General case' 0 CA--C 1.52 -0.178 0 N-CA-C 118.036 2.606 . . . . 0.0 118.036 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . 0.402 0.0 OUTLIER -156.0 166.62 32.92 Favored 'General case' 0 C--O 1.215 -0.745 0 CA-C-N 120.698 1.59 . . . . 0.0 110.682 -179.699 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.422 HD13 ' CE2' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -115.59 116.42 28.1 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 101.6 -3.481 . . . . 0.0 101.6 179.75 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.451 HG11 HG21 ' A' ' 105' ' ' VAL . 11.1 m -117.36 155.3 19.04 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 O-C-N 125.465 1.728 . . . . 0.0 106.632 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.437 ' HA2' ' HA ' ' A' ' 82' ' ' TRP . . . -126.88 110.67 1.25 Allowed Glycine 0 CA--C 1.53 0.989 0 O-C-N 128.352 3.532 . . . . 0.0 108.789 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.43 145.67 38.55 Favored 'General case' 0 N--CA 1.429 -1.517 0 N-CA-C 103.815 -2.661 . . . . 0.0 103.815 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.523 ' CE1' ' H42' ' A' ' 132' ' ' PLM . 15.3 m-85 -148.82 130.1 14.65 Favored 'General case' 0 CA--C 1.504 -0.818 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 13.8 mttp -99.18 159.02 15.29 Favored 'General case' 0 C--N 1.313 -1.004 0 O-C-N 125.59 1.806 . . . . 0.0 106.496 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . 0.325 0.1 OUTLIER -107.97 142.86 37.45 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 120.944 -1.097 . . . . 0.0 108.192 179.715 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 25.2 t -82.22 -32.55 10.83 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 C-N-CA 125.829 1.651 . . . . 0.0 108.318 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . 0.364 34.9 p-10 -99.5 6.47 45.87 Favored 'General case' 0 C--O 1.25 1.107 0 CA-C-O 124.399 2.047 . . . . 0.0 115.502 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -133.45 -44.2 0.83 Allowed 'General case' 0 N--CA 1.439 -1.008 0 O-C-N 120.792 -1.193 . . . . 0.0 112.465 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 77.45 12.03 84.93 Favored Glycine 0 C--N 1.347 1.185 0 O-C-N 124.526 1.141 . . . . 0.0 114.313 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 6.1 mttt -81.59 -116.1 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 176.65 158.83 0.32 Allowed 'General case' 0 CA--C 1.5 -0.943 0 C-N-CA 128.068 2.547 . . . . 0.0 111.091 -179.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.475 ' CD1' ' HB2' ' A' ' 119' ' ' TYR . 3.1 tp -142.52 141.33 32.07 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 128.297 3.498 . . . . 0.0 106.952 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.503 ' CG2' ' HB ' ' A' ' 118' ' ' THR . 4.1 tt -127.17 165.07 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.766 0 N-CA-C 104.971 -2.233 . . . . 0.0 104.971 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.457 ' N ' ' CG1' ' A' ' 103' ' ' ILE . . . -151.15 157.39 42.63 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-O 116.798 -1.573 . . . . 0.0 109.533 179.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.451 HG21 HG11 ' A' ' 90' ' ' VAL . 1.2 t -147.77 96.15 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-O 125.561 2.6 . . . . 0.0 110.63 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.42 ' HB2' ' HB3' ' A' ' 89' ' ' LEU . 16.8 mtt180 -71.81 90.52 1.1 Allowed 'General case' 0 C--O 1.236 0.368 0 N-CA-C 104.941 -2.244 . . . . 0.0 104.941 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -97.73 89.52 4.65 Favored 'General case' 0 N--CA 1.425 -1.725 0 C-N-CA 119.425 -0.91 . . . . 0.0 110.991 179.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.483 HD12 ' CH2' ' A' ' 6' ' ' TRP 0.439 0.0 OUTLIER -58.41 91.93 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 C-N-CA 117.117 -1.833 . . . . 0.0 114.171 -179.74 . . . . . . . . 4 4 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -78.28 76.86 4.78 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 102.56 -3.126 . . . . 0.0 102.56 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 60.93 -123.79 33.67 Favored Glycine 0 C--O 1.245 0.801 0 O-C-N 128.473 3.608 . . . . 0.0 110.705 -179.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . 0.31 28.5 m-80 -71.88 0.96 7.87 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-O 112.381 -3.676 . . . . 0.0 113.76 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.416 ' HG3' ' HA ' ' A' ' 129' ' ' LYS . 4.5 mp0 -118.18 117.75 29.99 Favored 'General case' 0 CA--C 1.511 -0.527 0 O-C-N 128.042 3.339 . . . . 0.0 110.615 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.431 ' HA ' ' HA ' ' A' ' 108' ' ' ILE . 0.5 OUTLIER -87.83 124.27 33.47 Favored 'General case' 0 C--O 1.216 -0.672 0 O-C-N 127.102 2.751 . . . . 0.0 103.969 179.761 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.473 ' CD1' HG22 ' A' ' 127' ' ' ILE 0.296 1.8 mm -114.55 133.43 60.7 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.33 0 N-CA-C 103.854 -2.647 . . . . 0.0 103.854 -179.68 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 10.7 mt-30 -115.4 97.36 6.13 Favored 'General case' 0 CA--C 1.489 -1.387 0 O-C-N 125.385 1.678 . . . . 0.0 109.461 -179.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 19.2 p -75.09 174.33 9.54 Favored 'General case' 0 C--O 1.247 0.929 0 N-CA-C 105.004 -2.221 . . . . 0.0 105.004 179.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 16.9 m-85 -162.5 115.31 1.68 Allowed 'General case' 0 CA--C 1.483 -1.631 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.503 ' HB ' ' CG2' ' A' ' 103' ' ' ILE . 88.4 m -113.68 88.84 2.94 Favored 'General case' 0 N--CA 1.42 -1.945 0 N-CA-C 116.95 2.204 . . . . 0.0 116.95 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.475 ' HB2' ' CD1' ' A' ' 102' ' ' LEU . 3.2 t80 -83.68 130.01 34.96 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 103.884 -2.635 . . . . 0.0 103.884 178.037 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.479 ' CB ' ' CE ' ' A' ' 20' ' ' LYS . 3.0 mm-40 61.89 -62.9 0.09 Allowed 'General case' 0 C--N 1.289 -2.037 0 O-C-N 125.293 1.621 . . . . 0.0 112.191 -179.088 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 179.64 33.34 0.06 OUTLIER Glycine 0 CA--C 1.542 1.78 0 C-N-CA 128.853 3.121 . . . . 0.0 116.173 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.401 HG22 ' HD2' ' A' ' 20' ' ' LYS . 10.7 t -125.68 97.85 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.65 0 O-C-N 120.744 -1.445 . . . . 0.0 107.637 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . 0.257 10.0 mt-10 -62.69 -175.56 0.09 Allowed 'General case' 0 N--CA 1.438 -1.067 0 CA-C-O 117.381 -1.295 . . . . 0.0 111.784 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.412 ' CB ' ' CD2' ' A' ' 17' ' ' PHE . . . -176.75 88.07 0.03 OUTLIER 'General case' 0 N--CA 1.436 -1.131 0 CA-C-O 114.911 -2.471 . . . . 0.0 107.076 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.424 ' N ' ' HE2' ' A' ' 125' ' ' LYS . 0.0 OUTLIER -68.43 139.99 55.76 Favored 'General case' 0 CA--C 1.487 -1.469 0 O-C-N 125.788 1.93 . . . . 0.0 110.546 179.989 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.42 ' NH2' HD21 ' A' ' 36' ' ' LEU . 5.0 mmm-85 -133.56 85.12 2.18 Favored 'General case' 0 N--CA 1.429 -1.504 0 O-C-N 126.34 2.275 . . . . 0.0 106.581 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.473 HG22 ' CD1' ' A' ' 114' ' ' ILE . 13.2 mt -83.79 112.47 21.27 Favored 'Isoleucine or valine' 0 C--O 1.249 1.067 0 O-C-N 127.86 3.225 . . . . 0.0 117.305 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.521 ' CZ ' HD22 ' A' ' 36' ' ' LEU . 0.0 OUTLIER -102.39 137.29 40.83 Favored 'General case' 0 N--CA 1.441 -0.9 0 O-C-N 126.642 2.464 . . . . 0.0 108.136 179.414 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.416 ' HA ' ' HG3' ' A' ' 112' ' ' GLU 0.284 12.2 mmtm -92.64 5.58 50.47 Favored 'General case' 0 C--O 1.244 0.78 0 CA-C-O 116.626 -1.655 . . . . 0.0 111.748 179.884 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.508 ' HA ' ' CE3' ' A' ' 6' ' ' TRP . 0.1 OUTLIER 76.59 138.95 0.07 Allowed 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 121.125 1.784 . . . . 0.0 108.424 179.79 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . 0.763 61.4 tt0 . . . . . 0 N--CA 1.443 -0.776 0 C-N-CA 116.563 -2.055 . . . . 0.0 113.789 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' PLM . . . . . 0.523 ' H42' ' CE1' ' A' ' 93' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.353 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.492 ' CD2' HD13 ' A' ' 113' ' ' LEU . 62.1 m-85 -105.66 81.06 1.63 Allowed 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 124.523 2.106 . . . . 0.0 113.776 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -156.73 96.33 1.62 Allowed 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 113.563 -1.653 . . . . 0.0 115.014 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 148.29 -152.44 24.51 Favored Glycine 0 C--N 1.313 -0.738 0 C-N-CA 116.778 -2.629 . . . . 0.0 112.942 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . 0.547 0.0 OUTLIER -111.48 158.12 19.52 Favored 'General case' 0 C--N 1.314 -0.968 0 O-C-N 127.53 2.547 . . . . 0.0 113.096 -179.782 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.56 ' CH2' ' CD1' ' A' ' 108' ' ' ILE . 85.1 m95 -149.37 113.02 5.05 Favored 'General case' 0 N--CA 1.433 -1.304 0 CA-C-N 112.618 -2.083 . . . . 0.0 110.173 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.9 101.83 11.39 Favored 'General case' 0 C--O 1.211 -0.961 0 CA-C-N 120.886 1.676 . . . . 0.0 107.365 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.484 ' CG1' ' HB3' ' A' ' 36' ' ' LEU . 0.3 OUTLIER -47.43 135.8 3.67 Favored 'Isoleucine or valine' 0 C--O 1.246 0.877 0 CA-C-N 120.76 1.618 . . . . 0.0 110.205 179.913 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -145.05 -11.45 0.56 Allowed 'General case' 0 N--CA 1.433 -1.29 0 C-N-CA 118.676 -1.209 . . . . 0.0 112.997 -179.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.426 ' HB3' ' HB ' ' A' ' 127' ' ' ILE . 5.6 tpp180 -111.05 -56.07 2.41 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-N 121.326 1.876 . . . . 0.0 113.245 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.507 ' ND2' ' CD2' ' A' ' 14' ' ' TYR . 1.2 m-20 62.7 165.84 0.11 Allowed 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 124.244 1.018 . . . . 0.0 110.454 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.406 ' N ' ' O ' ' A' ' 125' ' ' LYS . 2.4 mm-40 -171.26 103.05 0.21 Allowed 'General case' 0 C--N 1.314 -0.952 0 O-C-N 117.3 -3.375 . . . . 0.0 107.201 -179.6 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.411 ' HB3' ' HA ' ' A' ' 124' ' ' ALA . 0.3 OUTLIER 97.5 -27.28 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.18 0 O-C-N 125.447 1.717 . . . . 0.0 111.923 -179.238 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.507 ' CD2' ' ND2' ' A' ' 11' ' ' ASN . 2.4 p90 -29.96 -36.39 0.01 OUTLIER 'General case' 0 N--CA 1.435 -1.186 0 O-C-N 127.619 3.074 . . . . 0.0 118.03 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -75.77 -34.21 60.23 Favored 'General case' 0 CA--C 1.498 -1.024 0 C-N-CA 120.58 -0.448 . . . . 0.0 110.793 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -73.04 -28.7 62.49 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-O 124.304 2.002 . . . . 0.0 113.138 179.685 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.455 ' CB ' ' HB1' ' A' ' 124' ' ' ALA . 0.0 OUTLIER -71.45 -29.29 64.7 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-O 125.658 2.646 . . . . 0.0 110.393 179.908 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.409 ' HB3' HG13 ' A' ' 23' ' ' ILE . 29.6 mtm -79.88 -20.38 45.99 Favored 'General case' 0 C--N 1.318 -0.77 0 O-C-N 116.654 -3.779 . . . . 0.0 106.445 179.503 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.04 -31.13 39.51 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 123.103 1.43 . . . . 0.0 112.655 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.502 ' CE ' ' HB3' ' A' ' 119' ' ' TYR . 0.5 OUTLIER -73.49 -21.18 60.49 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 115.754 1.761 . . . . 0.0 115.754 -178.144 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 3.4 mtp -79.03 -47.6 15.91 Favored 'General case' 0 C--O 1.206 -1.192 0 N-CA-C 103.592 -2.744 . . . . 0.0 103.592 179.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 124.08 43.64 0.32 Allowed Glycine 0 N--CA 1.433 -1.537 0 CA-C-N 113.902 -1.499 . . . . 0.0 111.234 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.409 HG13 ' HB3' ' A' ' 18' ' ' MET . 1.9 mm -75.09 126.24 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.967 0 CA-C-O 115.813 -2.041 . . . . 0.0 112.173 -179.645 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -52.57 145.02 12.47 Favored 'General case' 0 C--N 1.348 0.527 0 CA-C-O 115.233 -2.318 . . . . 0.0 111.573 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . 0.445 26.9 m -36.39 -47.99 0.25 Allowed 'Isoleucine or valine' 0 C--O 1.216 -0.707 0 N-CA-C 119.162 3.023 . . . . 0.0 119.162 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.537 5.4 m -79.84 -28.38 12.62 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.995 0 N-CA-C 115.217 1.562 . . . . 0.0 115.217 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.9 ttmm -71.41 -31.58 67.42 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 112.147 -2.297 . . . . 0.0 114.904 179.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 7.5 ptt180 -79.35 -21.28 46.03 Favored 'General case' 0 C--O 1.219 -0.543 0 C-N-CA 117.721 -1.592 . . . . 0.0 109.303 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 9.3 tttm -72.13 -46.22 57.47 Favored 'General case' 0 CA--C 1.5 -0.959 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.64 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.3 tp -76.38 -28.61 56.82 Favored 'General case' 0 CA--C 1.505 -0.755 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -74.43 -20.99 79.45 Favored Glycine 0 C--N 1.345 1.055 0 CA-C-O 124.017 1.898 . . . . 0.0 111.981 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.452 ' HB3' ' CE2' ' A' ' 14' ' ' TYR . . . -75.25 -48.96 20.9 Favored 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 127.484 2.314 . . . . 0.0 111.02 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 8.5 m170 -96.35 7.66 45.92 Favored 'General case' 0 N--CA 1.429 -1.509 0 O-C-N 127.152 2.782 . . . . 0.0 110.672 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 29.8 p30 -33.6 -27.22 0.01 OUTLIER 'General case' 0 CA--C 1.507 -0.702 0 N-CA-C 116.774 2.139 . . . . 0.0 116.774 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.2 t30 77.1 26.7 0.72 Allowed 'General case' 0 C--O 1.244 0.778 0 CA-C-N 120.641 1.564 . . . . 0.0 112.351 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.484 ' HB3' ' CG1' ' A' ' 8' ' ' VAL . 1.3 tp -52.22 116.52 2.26 Favored 'General case' 0 CA--C 1.5 -0.962 0 CA-C-O 123.981 1.848 . . . . 0.0 109.341 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 6.3 ttmm -111.43 95.6 5.61 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 101.865 -3.383 . . . . 0.0 101.865 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.501 HD13 ' CZ ' ' A' ' 128' ' ' PHE 0.284 2.4 mt -78.58 141.52 38.02 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 119.041 -2.287 . . . . 0.0 108.292 -179.928 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.474 ' HB ' ' CB ' ' A' ' 50' ' ' LYS . 9.3 m -128.51 76.82 1.73 Allowed 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 102.213 -3.254 . . . . 0.0 102.213 179.23 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.486 ' CD1' HD12 ' A' ' 113' ' ' LEU . 6.0 mt -65.81 134.94 29.19 Favored 'Isoleucine or valine' 0 C--O 1.251 1.142 0 CA-C-N 112.401 -2.182 . . . . 0.0 106.359 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -145.91 113.81 6.48 Favored 'General case' 0 CA--C 1.504 -0.792 0 O-C-N 126.849 2.593 . . . . 0.0 110.648 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -90.09 134.35 34.31 Favored 'General case' 0 C--O 1.22 -0.465 0 CA-C-N 114.259 -1.337 . . . . 0.0 113.765 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 33.9 tp10 -135.55 91.01 2.67 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 105.578 -2.008 . . . . 0.0 105.578 179.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 67.13 -97.67 0.39 Allowed Glycine 0 C--N 1.292 -1.871 0 CA-C-O 116.367 -2.352 . . . . 0.0 109.313 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.335 0.0 OUTLIER -117.8 -1.93 11.46 Favored 'General case' 0 C--N 1.315 -0.917 0 O-C-N 129.712 3.83 . . . . 0.0 113.377 -179.895 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -99.62 136.66 39.23 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 106.997 -1.482 . . . . 0.0 106.997 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . 0.313 0.1 OUTLIER -121.48 108.27 13.44 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 105.616 -1.994 . . . . 0.0 105.616 -179.929 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.48 ' HB ' ' CG1' ' A' ' 61' ' ' VAL 0.386 0.1 OUTLIER -99.94 89.94 4.24 Favored 'General case' 0 N--CA 1.423 -1.789 0 O-C-N 124.804 1.315 . . . . 0.0 108.445 -179.68 . . . . . . . . 4 4 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.418 HG23 ' HB ' ' A' ' 60' ' ' VAL 0.714 1.0 OUTLIER -65.7 94.59 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.503 -0.858 0 O-C-N 127.246 2.841 . . . . 0.0 108.596 178.792 . . . . . . . . 4 4 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.474 ' CB ' ' HB ' ' A' ' 39' ' ' THR . 0.0 OUTLIER -63.35 140.46 58.87 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 102.448 -3.168 . . . . 0.0 102.448 -179.439 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.422 ' HB2' ' CG2' ' A' ' 60' ' ' VAL . 11.8 tt0 -130.04 73.0 1.5 Allowed 'General case' 0 CA--C 1.51 -0.559 0 N-CA-C 105.998 -1.853 . . . . 0.0 105.998 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.99 69.36 5.13 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 105.957 -1.868 . . . . 0.0 105.957 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.32 175.77 6.98 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.984 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.403 ' O ' ' ND2' ' A' ' 54' ' ' ASN . 2.7 t-20 -62.19 -26.58 68.43 Favored 'General case' 0 C--O 1.216 -0.674 0 O-C-N 125.441 1.713 . . . . 0.0 107.831 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.511 ' CZ ' ' HB2' ' A' ' 73' ' ' ALA . 0.3 OUTLIER -69.1 -64.38 0.88 Allowed 'General case' 0 C--O 1.222 -0.385 0 CA-C-O 114.473 -2.679 . . . . 0.0 108.659 179.821 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -173.05 172.52 3.91 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 122.8 2.545 . . . . 0.0 110.844 179.537 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -90.76 65.94 5.96 Favored 'General case' 0 CA--C 1.498 -1.02 0 O-C-N 128.46 3.6 . . . . 0.0 105.067 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -87.48 -41.11 14.32 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 O-C-N 127.353 2.908 . . . . 0.0 115.746 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 50.6 t0 79.58 141.66 0.07 Allowed 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 104.649 -2.352 . . . . 0.0 104.649 -179.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.422 ' CG2' ' HB2' ' A' ' 51' ' ' GLU . 1.5 t -129.38 84.77 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 N-CA-C 105.464 -2.05 . . . . 0.0 105.464 -179.543 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.48 ' CG1' ' HB ' ' A' ' 48' ' ' THR 0.314 1.5 m -90.18 136.56 23.55 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.519 0 N-CA-C 116.889 2.181 . . . . 0.0 116.889 -178.188 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.642 ' HB3' ' CZ ' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -137.25 95.0 3.01 Favored 'General case' 0 N--CA 1.422 -1.83 0 CA-C-O 114.18 -2.819 . . . . 0.0 110.8 177.263 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.492 ' O ' ' N ' ' A' ' 65' ' ' GLY . 24.0 tt0 -54.58 117.73 3.59 Favored 'General case' 0 C--N 1.32 -0.698 1 N-CA-C 98.813 -4.514 . . . . 0.0 98.813 175.998 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.724 ' HB3' ' CD2' ' A' ' 82' ' ' TRP . 0.0 OUTLIER -47.76 93.48 0.01 OUTLIER 'General case' 0 N--CA 1.429 -1.511 0 O-C-N 125.686 1.866 . . . . 0.0 107.69 -175.68 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.685 ' N ' ' NE1' ' A' ' 82' ' ' TRP . . . 94.71 50.33 2.16 Favored Glycine 0 C--N 1.353 1.517 0 N-CA-C 121.592 3.397 . . . . 0.0 121.592 178.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . 0.305 7.3 p -103.94 -19.91 6.03 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 CA-C-O 115.237 -2.316 . . . . 0.0 109.826 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.403 ' HA ' HG23 ' A' ' 81' ' ' THR . 64.8 t0 65.19 105.04 0.04 OUTLIER 'General case' 0 C--O 1.204 -1.305 0 CA-C-O 123.074 1.416 . . . . 0.0 107.409 -178.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.642 ' CZ ' ' HB3' ' A' ' 62' ' ' PHE . 0.1 OUTLIER -131.64 161.26 33.15 Favored 'General case' 0 C--N 1.307 -1.245 0 C-N-CA 125.876 1.67 . . . . 0.0 111.619 -176.876 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -110.75 130.07 55.67 Favored 'General case' 0 C--O 1.245 0.843 0 O-C-N 127.031 2.707 . . . . 0.0 105.122 179.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 83.9 t80 -132.6 96.5 3.84 Favored 'General case' 0 C--O 1.208 -1.104 0 O-C-N 125.353 1.658 . . . . 0.0 114.41 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 25.1 t -66.97 140.84 57.75 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 105.372 -2.084 . . . . 0.0 105.372 179.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -77.39 -174.68 3.41 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 103.257 -2.868 . . . . 0.0 103.257 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.511 ' HB2' ' CZ ' ' A' ' 55' ' ' PHE . . . -80.48 -19.71 45.34 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-O 124.836 2.255 . . . . 0.0 111.3 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.452 ' HB3' ' CG ' ' A' ' 132' ' ' PLM . 1.2 t70 -153.86 -37.61 0.1 Allowed 'General case' 0 C--O 1.222 -0.375 0 CA-C-N 112.669 -2.06 . . . . 0.0 111.129 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -69.72 -0.91 28.09 Favored Glycine 0 CA--C 1.533 1.207 0 N-CA-C 118.512 2.165 . . . . 0.0 118.512 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . 0.386 0.3 OUTLIER 77.27 164.44 0.24 Allowed 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 120.376 2.088 . . . . 0.0 114.857 -179.908 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.564 ' CB ' ' HB ' ' A' ' 96' ' ' VAL . 0.3 OUTLIER -30.31 145.21 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 111.763 -2.471 . . . . 0.0 116.567 -179.805 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.402 ' HG ' ' HB3' ' A' ' 93' ' ' PHE 0.386 0.6 OUTLIER -160.62 101.74 1.34 Allowed 'General case' 0 C--O 1.24 0.602 0 CA-C-N 109.924 -3.307 . . . . 0.0 107.142 179.982 . . . . . . . . 4 4 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.409 HG21 ' N ' ' A' ' 80' ' ' GLY . 91.6 m -105.82 -172.78 2.15 Favored 'General case' 0 CA--C 1.498 -1.037 0 N-CA-C 101.772 -3.418 . . . . 0.0 101.772 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.419 ' HA3' ' HA ' ' A' ' 93' ' ' PHE . . . 118.8 -148.07 18.4 Favored Glycine 0 C--N 1.292 -1.872 0 CA-C-O 116.571 -2.238 . . . . 0.0 113.191 179.629 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.403 HG23 ' HA ' ' A' ' 67' ' ' ASP . 60.3 p -165.46 166.73 18.2 Favored 'General case' 0 C--O 1.188 -2.155 0 CA-C-O 124.232 1.967 . . . . 0.0 110.712 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . 0.777 ' CG ' ' N ' ' A' ' 83' ' ' THR 0.399 4.0 p-90 -73.03 -162.39 0.11 Allowed 'General case' 0 N--CA 1.438 -1.063 0 N-CA-C 100.244 -3.984 . . . . 0.0 100.244 175.43 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.777 ' N ' ' CG ' ' A' ' 82' ' ' TRP . 4.7 t 159.43 129.51 0.0 OUTLIER 'General case' 0 N--CA 1.415 -2.219 0 CA-C-O 125.733 2.682 . . . . 0.0 112.657 174.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.54 ' N ' ' CZ3' ' A' ' 82' ' ' TRP . 0.0 OUTLIER -88.53 121.93 31.45 Favored 'General case' 0 N--CA 1.422 -1.836 0 CA-C-N 110.566 -3.015 . . . . 0.0 105.524 179.047 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.426 ' HG3' ' CG2' ' A' ' 90' ' ' VAL 0.622 2.5 pp20? -111.59 44.48 1.35 Allowed 'General case' 0 N--CA 1.421 -1.912 0 CA-C-O 123.574 1.654 . . . . 0.0 114.394 179.735 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 71.61 110.94 0.05 OUTLIER Glycine 0 N--CA 1.443 -0.854 0 N-CA-C 107.595 -2.202 . . . . 0.0 107.595 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 50.9 t30 66.67 -22.05 0.1 Allowed 'General case' 0 N--CA 1.44 -0.942 0 CA-C-O 114.948 -2.453 . . . . 0.0 116.347 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.403 ' HG3' ' HA ' ' A' ' 107' ' ' GLU 0.33 0.1 OUTLIER -129.1 142.76 50.79 Favored 'General case' 0 CA--C 1.491 -1.311 0 CA-C-N 120.903 1.683 . . . . 0.0 107.465 -179.97 . . . . . . . . 4 4 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.465 HD23 ' CE3' ' A' ' 82' ' ' TRP . 0.2 OUTLIER -94.85 152.55 18.3 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 101.715 -3.439 . . . . 0.0 101.715 -179.821 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.427 ' HB ' HG21 ' A' ' 83' ' ' THR . 1.4 t -136.75 164.65 30.17 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 N-CA-C 105.507 -2.035 . . . . 0.0 105.507 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -133.79 99.06 0.34 Allowed Glycine 0 C--N 1.363 2.079 0 C-N-CA 128.554 2.978 . . . . 0.0 108.865 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -98.45 127.93 44.6 Favored 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 103.343 -2.836 . . . . 0.0 103.343 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.52 ' CE1' ' H41' ' A' ' 132' ' ' PLM . 19.4 m-85 -140.5 130.49 24.69 Favored 'General case' 0 N--CA 1.442 -0.869 0 O-C-N 124.429 1.081 . . . . 0.0 113.279 179.484 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -115.27 124.2 50.73 Favored 'General case' 0 N--CA 1.422 -1.832 0 C-N-CA 130.159 3.384 . . . . 0.0 105.54 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.653 ' HE ' ' N ' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -54.74 -168.02 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.721 0 O-C-N 128.339 3.525 . . . . 0.0 110.573 178.647 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.564 ' HB ' ' CB ' ' A' ' 77' ' ' GLU . 20.5 t -124.56 -50.11 2.1 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 O-C-N 119.754 -1.841 . . . . 0.0 106.489 176.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . 0.293 0.3 OUTLIER -110.0 9.7 24.27 Favored 'General case' 0 C--O 1.255 1.348 0 CA-C-N 113.102 -1.863 . . . . 0.0 113.465 -179.939 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.422 ' HB3' ' HG2' ' A' ' 95' ' ' ARG 0.268 27.4 t30 -101.46 -23.91 14.25 Favored 'General case' 0 CA--C 1.494 -1.195 0 CA-C-O 116.281 -1.819 . . . . 0.0 111.322 -179.962 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.541 ' HA2' ' CZ ' ' A' ' 95' ' ' ARG . . . 71.87 11.1 73.55 Favored Glycine 0 CA--C 1.542 1.767 0 N-CA-C 118.38 2.112 . . . . 0.0 118.38 179.181 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.653 ' N ' ' HE ' ' A' ' 95' ' ' ARG . 3.8 mtpp -110.73 -148.04 0.42 Allowed 'General case' 0 C--N 1.3 -1.578 0 O-C-N 125.801 1.53 . . . . 0.0 111.004 -177.45 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 57.2 tt0 -160.65 161.91 32.53 Favored 'General case' 0 N--CA 1.433 -1.295 0 C-N-CA 131.385 3.874 . . . . 0.0 109.687 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.493 HD11 ' CG ' ' A' ' 119' ' ' TYR . 9.3 tp -142.33 157.75 44.47 Favored 'General case' 0 N--CA 1.438 -1.045 1 C-N-CA 132.014 4.125 . . . . 0.0 106.527 -179.243 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.576 ' CG2' ' HB ' ' A' ' 118' ' ' THR . 4.1 tt -150.25 154.63 8.67 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.993 0 N-CA-C 103.941 -2.615 . . . . 0.0 103.941 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -131.5 -172.0 2.74 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.452 HG11 ' CG2' ' A' ' 116' ' ' THR . 0.5 OUTLIER -169.72 77.02 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 CA-C-O 127.544 3.545 . . . . 0.0 107.539 179.647 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.409 ' HD3' HD22 ' A' ' 113' ' ' LEU . 0.1 OUTLIER -65.84 91.71 0.15 Allowed 'General case' 0 C--O 1.217 -0.617 0 N-CA-C 104.668 -2.345 . . . . 0.0 104.668 179.571 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.437 ' N ' ' O ' ' A' ' 105' ' ' VAL . 25.8 tt0 -72.75 -35.42 67.48 Favored 'General case' 0 C--O 1.202 -1.414 0 CA-C-N 110.994 -2.821 . . . . 0.0 115.044 -179.581 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.56 ' CD1' ' CH2' ' A' ' 6' ' ' TRP 0.428 3.2 tp 52.55 43.38 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 C-N-CA 112.927 -3.509 . . . . 0.0 113.236 179.956 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -66.73 103.19 1.05 Allowed 'General case' 0 CA--C 1.505 -0.782 0 O-C-N 120.494 -1.379 . . . . 0.0 108.193 -179.487 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 56.85 -73.29 0.01 OUTLIER Glycine 0 C--N 1.342 0.893 0 C-N-CA 127.206 2.336 . . . . 0.0 111.848 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . 0.351 0.0 OUTLIER -136.97 36.8 2.58 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 117.494 -1.241 . . . . 0.0 110.32 179.671 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -146.43 97.62 2.95 Favored 'General case' 0 C--N 1.363 1.162 0 O-C-N 126.521 2.388 . . . . 0.0 110.388 -179.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.492 HD13 ' CD2' ' A' ' 2' ' ' PHE . 0.4 OUTLIER -75.27 68.33 1.99 Allowed 'General case' 0 C--O 1.209 -1.068 1 O-C-N 129.353 4.158 . . . . 0.0 107.479 -179.51 . . . . . . . . 4 4 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.492 HG12 ' CD1' ' A' ' 127' ' ' ILE . 54.6 mt -72.07 128.27 34.86 Favored 'Isoleucine or valine' 0 C--O 1.25 1.114 0 N-CA-C 105.006 -2.22 . . . . 0.0 105.006 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -113.17 108.14 16.89 Favored 'General case' 0 CA--C 1.493 -1.232 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 -179.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.452 ' CG2' HG11 ' A' ' 105' ' ' VAL . 66.8 p -76.28 169.06 18.94 Favored 'General case' 0 C--O 1.245 0.846 0 C-N-CA 115.912 -2.315 . . . . 0.0 105.443 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -148.85 93.82 2.17 Favored 'General case' 0 CA--C 1.491 -1.298 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.576 ' HB ' ' CG2' ' A' ' 103' ' ' ILE . 0.2 OUTLIER -96.84 81.68 3.16 Favored 'General case' 0 N--CA 1.424 -1.762 0 O-C-N 126.702 2.501 . . . . 0.0 116.322 -179.781 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.502 ' HB3' ' CE ' ' A' ' 20' ' ' LYS . 0.2 OUTLIER -85.8 101.57 12.92 Favored 'General case' 0 N--CA 1.479 0.975 0 N-CA-C 103.278 -2.86 . . . . 0.0 103.278 178.625 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 65.25 -82.15 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.412 0 CA-C-N 113.88 -1.509 . . . . 0.0 114.178 -179.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -132.8 24.09 3.89 Favored Glycine 0 CA--C 1.54 1.623 0 N-CA-C 117.401 1.72 . . . . 0.0 117.401 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.461 ' HB ' ' HD3' ' A' ' 20' ' ' LYS . 3.3 t -133.14 87.36 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -68.62 129.97 41.49 Favored 'General case' 0 N--CA 1.436 -1.144 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.455 ' HB1' ' CB ' ' A' ' 17' ' ' PHE . . . -115.54 115.6 26.74 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-O 116.307 -1.806 . . . . 0.0 108.4 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.406 ' O ' ' N ' ' A' ' 12' ' ' GLU . 0.1 OUTLIER -92.7 129.94 38.48 Favored 'General case' 0 C--O 1.252 1.202 0 C-N-CA 116.991 -1.883 . . . . 0.0 109.932 -179.998 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 7.4 mtm180 -119.89 86.77 2.62 Favored 'General case' 0 N--CA 1.437 -1.122 0 CA-C-N 112.082 -2.326 . . . . 0.0 106.028 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.492 ' CD1' HG12 ' A' ' 114' ' ' ILE . 0.8 OUTLIER -84.28 125.9 40.23 Favored 'Isoleucine or valine' 0 C--O 1.252 1.23 0 CA-C-N 114.306 -1.316 . . . . 0.0 112.893 179.983 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.501 ' CZ ' HD13 ' A' ' 38' ' ' LEU . 0.2 OUTLIER -106.39 155.71 19.27 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-O 123.722 1.725 . . . . 0.0 107.926 179.709 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . 0.268 15.9 mtpp -117.3 16.99 14.79 Favored 'General case' 0 C--O 1.244 0.797 0 O-C-N 118.594 -2.566 . . . . 0.0 110.704 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.528 ' HG3' ' CH2' ' A' ' 6' ' ' TRP . 1.4 tttt 57.26 113.25 0.01 OUTLIER 'General case' 0 C--O 1.219 -0.527 0 N-CA-C 115.991 1.849 . . . . 0.0 115.991 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . 0.836 15.0 tt0 . . . . . 0 N--CA 1.429 -1.519 0 O-C-N 118.422 -2.674 . . . . 0.0 116.023 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' PLM . . . . . 0.533 ' H21' ' CE2' ' A' ' 62' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.445 ' O ' ' N ' ' A' ' 3' ' ' ASP . . . . . . . . 0 N--CA 1.447 -0.586 0 CA-C-O 116.353 -1.784 . . . . 0.0 112.899 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 19.2 p90 -35.48 79.59 0.0 OUTLIER 'General case' 0 N--CA 1.429 -1.513 0 N-CA-C 118.541 2.793 . . . . 0.0 118.541 179.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.445 ' N ' ' O ' ' A' ' 1' ' ' ALA . 23.2 t70 -167.45 96.92 0.48 Allowed 'General case' 0 N--CA 1.435 -1.191 0 O-C-N 119.605 -1.934 . . . . 0.0 112.091 -179.639 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 142.91 -152.48 23.99 Favored Glycine 0 C--O 1.212 -1.229 0 C-N-CA 118.587 -1.768 . . . . 0.0 109.435 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.4 ' C ' ' CG ' ' A' ' 6' ' ' TRP 0.567 13.2 p -89.69 155.08 19.46 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 123.358 0.663 . . . . 0.0 111.417 179.946 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.524 ' CZ3' ' HB2' ' A' ' 130' ' ' LYS . 91.9 m95 -152.69 105.17 2.95 Favored 'General case' 0 C--N 1.319 -0.747 0 O-C-N 127.652 3.095 . . . . 0.0 106.848 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 13.1 ttpt -106.04 101.85 11.31 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-O 114.991 -2.433 . . . . 0.0 108.313 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . 0.284 2.8 p -45.89 144.27 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 120.441 1.473 . . . . 0.0 111.015 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -146.55 -30.25 0.37 Allowed 'General case' 0 N--CA 1.438 -1.053 0 O-C-N 127.82 3.2 . . . . 0.0 112.371 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.41 ' HB2' ' HB ' ' A' ' 127' ' ' ILE . 17.9 mmt180 -82.84 -80.76 0.17 Allowed 'General case' 0 C--N 1.297 -1.684 0 O-C-N 119.022 -2.299 . . . . 0.0 114.286 -179.652 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.42 ' HA ' ' HA ' ' A' ' 126' ' ' ARG 0.284 8.2 m120 77.13 147.19 0.09 Allowed 'General case' 0 C--O 1.247 0.964 1 O-C-N 129.592 4.307 . . . . 0.0 106.275 -177.206 . . . . . . . . 4 3 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.408 ' N ' ' O ' ' A' ' 125' ' ' LYS . 2.8 tp10 -125.9 -69.54 0.77 Allowed 'General case' 0 C--N 1.296 -1.724 0 CA-C-N 122.398 2.363 . . . . 0.0 108.113 -179.595 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.402 ' HB3' ' HA ' ' A' ' 124' ' ' ALA . 5.2 t30 -112.17 29.37 7.95 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 127.325 2.891 . . . . 0.0 113.157 179.7 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.528 ' CE1' ' HG2' ' A' ' 126' ' ' ARG 0.376 1.1 m-85 -73.18 -27.68 61.78 Favored 'General case' 0 N--CA 1.44 -0.974 0 O-C-N 127.282 2.863 . . . . 0.0 117.488 179.708 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -74.36 -36.48 63.58 Favored 'General case' 0 C--O 1.209 -1.032 0 CA-C-N 120.479 1.49 . . . . 0.0 111.391 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 12.4 tptp -71.77 -32.14 67.35 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 111.537 -2.574 . . . . 0.0 115.216 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -70.76 -24.27 62.57 Favored 'General case' 0 N--CA 1.441 -0.88 0 O-C-N 124.868 1.355 . . . . 0.0 111.472 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 7.7 mmt -77.21 -34.65 56.04 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-O 123.841 1.781 . . . . 0.0 106.422 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -65.54 -31.14 72.04 Favored 'General case' 0 N--CA 1.473 0.709 0 O-C-N 118.199 -2.813 . . . . 0.0 112.529 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.437 ' HA ' ' HD2' ' A' ' 20' ' ' LYS . 11.6 tptm -77.04 -30.91 55.9 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 112.836 -1.984 . . . . 0.0 110.581 179.352 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.84 -21.08 55.55 Favored 'General case' 0 N--CA 1.435 -1.221 0 O-C-N 125.148 1.53 . . . . 0.0 107.792 179.373 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 123.01 1.64 9.49 Favored Glycine 0 C--N 1.301 -1.387 0 CA-C-O 117.674 -1.625 . . . . 0.0 113.258 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.404 HG21 ' HB2' ' A' ' 27' ' ' LYS . 0.6 OUTLIER -77.75 107.33 9.35 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.313 0 CA-C-O 117.73 -1.129 . . . . 0.0 108.605 179.913 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -118.67 1.49 11.64 Favored 'General case' 0 C--N 1.352 0.68 0 CA-C-O 116.001 -1.952 . . . . 0.0 114.154 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . 0.393 0.6 OUTLIER -112.72 -140.14 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.358 0.969 0 O-C-N 128.974 3.921 . . . . 0.0 116.34 -179.981 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.561 0.0 OUTLIER -72.76 -21.08 19.45 Favored 'Isoleucine or valine' 0 C--O 1.243 0.722 0 CA-C-N 120.689 1.586 . . . . 0.0 114.792 -179.926 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.404 ' HB2' HG21 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -62.14 -30.78 71.28 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 114.29 1.219 . . . . 0.0 114.29 179.89 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . 0.268 0.1 OUTLIER -78.97 -20.95 47.87 Favored 'General case' 0 N--CA 1.454 -0.247 0 O-C-N 119.502 -1.998 . . . . 0.0 108.31 180.0 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.6 tttm -78.9 -46.66 17.99 Favored 'General case' 0 C--O 1.215 -0.716 0 CA-C-N 113.318 -1.764 . . . . 0.0 108.768 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 11.0 mp -73.46 -22.69 60.12 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 113.746 -1.57 . . . . 0.0 110.248 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -68.79 -34.0 76.73 Favored Glycine 0 C--N 1.344 1.018 0 C-N-CA 123.638 0.637 . . . . 0.0 112.559 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -79.85 -34.86 38.97 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 127.625 2.37 . . . . 0.0 109.107 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 10.6 m170 -118.4 42.03 2.82 Favored 'General case' 0 C--O 1.24 0.573 0 C-N-CA 126.617 1.967 . . . . 0.0 114.338 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.8 p30 -71.29 -23.59 61.99 Favored 'General case' 0 C--O 1.215 -0.754 0 N-CA-C 119.17 3.026 . . . . 0.0 119.17 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 78.13 9.1 2.25 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 -179.635 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.479 HD13 ' CG ' ' A' ' 51' ' ' GLU . 0.9 OUTLIER -41.77 116.32 0.77 Allowed 'General case' 0 CA--C 1.51 -0.591 0 O-C-N 126.962 2.664 . . . . 0.0 110.873 -179.791 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 11.4 ttmm -113.86 92.11 3.87 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 105.166 -2.161 . . . . 0.0 105.166 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.423 ' HG ' ' CG2' ' A' ' 49' ' ' VAL 0.276 0.8 OUTLIER -75.17 114.08 13.25 Favored 'General case' 0 C--N 1.292 -1.91 0 C-N-CA 117.497 -1.681 . . . . 0.0 109.115 -179.983 . . . . . . . . 4 4 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.46 ' HB ' ' CB ' ' A' ' 50' ' ' LYS . 91.8 m -94.87 84.47 4.18 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 102.012 -3.329 . . . . 0.0 102.012 179.44 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.42 HD13 ' CD1' ' A' ' 6' ' ' TRP . 96.0 mt -71.73 116.14 13.04 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 CA-C-O 123.69 1.71 . . . . 0.0 110.81 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.3 m -110.38 118.01 35.14 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 110.324 -3.125 . . . . 0.0 109.348 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 2.7 tp60 -94.46 125.62 39.22 Favored 'General case' 0 C--N 1.311 -1.082 0 O-C-N 126.074 2.108 . . . . 0.0 107.794 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -135.08 68.31 1.47 Allowed 'General case' 0 N--CA 1.433 -1.31 0 CA-C-O 125.257 2.456 . . . . 0.0 105.684 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.17 -76.59 2.22 Favored Glycine 0 C--N 1.298 -1.559 0 N-CA-C 104.44 -3.464 . . . . 0.0 104.44 179.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.348 0.0 OUTLIER -130.51 -36.58 1.44 Allowed 'General case' 0 C--N 1.326 -0.449 0 O-C-N 126.608 2.005 . . . . 0.0 113.976 179.947 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.4 ttmt -57.38 109.26 0.65 Allowed 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 114.102 -1.408 . . . . 0.0 113.56 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.44 ' HB2' ' CD1' ' A' ' 62' ' ' PHE 0.254 3.2 m-30 -100.4 78.23 2.01 Favored 'General case' 0 CA--C 1.507 -0.684 0 CA-C-O 125.578 2.608 . . . . 0.0 106.942 179.639 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . 0.417 9.8 t -76.48 80.13 3.19 Favored 'General case' 0 N--CA 1.435 -1.216 0 O-C-N 118.832 -2.417 . . . . 0.0 113.439 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.423 ' CG2' ' HG ' ' A' ' 38' ' ' LEU 0.596 2.0 m -56.78 96.99 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.428 -1.532 0 CA-C-N 114.189 -1.369 . . . . 0.0 114.466 179.652 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.46 ' CB ' ' HB ' ' A' ' 39' ' ' THR . 1.1 ttmt -67.51 116.26 8.04 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 101.59 -3.485 . . . . 0.0 101.59 179.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.479 ' CG ' HD13 ' A' ' 36' ' ' LEU 0.263 1.9 tt0 -107.44 107.0 17.67 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 103.753 -2.684 . . . . 0.0 103.753 -179.997 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.402 ' HA ' ' HA ' ' A' ' 57' ' ' ASN . 3.0 m -106.56 48.79 0.82 Allowed 'General case' 0 C--N 1.285 -2.196 0 N-CA-C 105.004 -2.221 . . . . 0.0 105.004 179.722 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.3 m -76.36 162.54 27.8 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-O 115.431 -2.223 . . . . 0.0 109.106 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -48.57 -37.12 17.08 Favored 'General case' 0 C--O 1.211 -0.958 0 O-C-N 125.238 1.586 . . . . 0.0 107.531 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -52.88 -65.35 0.57 Allowed 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 116.459 -1.734 . . . . 0.0 109.54 179.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.408 ' HG3' ' N ' ' A' ' 57' ' ' ASN . 1.2 ttm-85 -173.08 148.02 1.67 Allowed 'General case' 0 CA--C 1.498 -1.028 0 CA-C-N 120.525 1.511 . . . . 0.0 110.462 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.408 ' N ' ' HG3' ' A' ' 56' ' ' ARG . 3.3 m-20 -78.4 86.64 4.45 Favored 'General case' 0 CA--C 1.499 -1.011 0 N-CA-C 102.338 -3.208 . . . . 0.0 102.338 -179.652 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -122.95 115.42 45.74 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.188 0 N-CA-C 117.864 2.542 . . . . 0.0 117.864 -179.475 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.404 ' OD1' ' N ' ' A' ' 59' ' ' ASP . 0.1 OUTLIER -64.69 147.6 52.71 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 104.024 -2.584 . . . . 0.0 104.024 178.909 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.461 ' CG2' ' HB2' ' A' ' 51' ' ' GLU . 1.8 t -124.71 46.43 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.019 0 CA-C-O 123.847 1.784 . . . . 0.0 106.523 -179.496 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . 0.304 0.5 OUTLIER -43.9 144.88 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.568 0 N-CA-C 116.414 2.005 . . . . 0.0 116.414 -179.309 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.552 ' HB3' ' CE1' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -154.51 92.79 1.52 Allowed 'General case' 0 N--CA 1.419 -2.022 0 CA-C-O 115.958 -1.972 . . . . 0.0 109.258 175.911 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . 0.263 1.2 mt-10 -66.45 94.77 0.29 Allowed 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 100.538 -3.875 . . . . 0.0 100.538 178.541 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.662 ' CB ' ' CE2' ' A' ' 82' ' ' TRP . 0.0 OUTLIER -12.22 89.08 0.01 OUTLIER 'General case' 0 N--CA 1.426 -1.664 0 O-C-N 128.006 3.316 . . . . 0.0 112.135 -178.566 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.565 ' N ' ' CD1' ' A' ' 82' ' ' TRP . . . 96.16 36.65 5.13 Favored Glycine 0 C--N 1.351 1.368 0 N-CA-C 121.586 3.395 . . . . 0.0 121.586 179.2 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . 0.409 38.1 t -121.48 77.99 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 N-CA-C 105.039 -2.208 . . . . 0.0 105.039 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -14.38 127.8 0.01 OUTLIER 'General case' 0 CA--C 1.48 -1.733 0 O-C-N 128.077 3.361 . . . . 0.0 116.513 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.552 ' CE1' ' HB3' ' A' ' 62' ' ' PHE . 8.9 p90 -147.93 164.05 34.95 Favored 'General case' 0 N--CA 1.441 -0.899 0 O-C-N 119.072 -2.267 . . . . 0.0 112.544 -178.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -116.11 148.41 40.31 Favored 'General case' 0 C--O 1.243 0.729 0 O-C-N 126.47 2.356 . . . . 0.0 105.445 179.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -116.65 -47.6 2.71 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-O 116.637 -1.649 . . . . 0.0 114.2 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.43 ' HA ' ' N ' ' A' ' 77' ' ' GLU . 2.5 t 70.01 104.43 0.06 Allowed 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 -179.507 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.41 ' HB3' ' HE2' ' A' ' 132' ' ' PLM . 6.1 mt -69.53 -175.81 0.9 Allowed 'General case' 0 C--N 1.302 -1.476 0 O-C-N 128.441 3.588 . . . . 0.0 109.172 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -105.97 -2.92 22.31 Favored 'General case' 0 N--CA 1.443 -0.817 0 O-C-N 128.089 3.368 . . . . 0.0 114.276 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -121.74 -47.15 2.21 Favored 'General case' 0 N--CA 1.435 -1.175 0 O-C-N 121.677 -0.639 . . . . 0.0 110.848 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -110.15 -10.11 22.87 Favored Glycine 0 CA--C 1.537 1.443 0 O-C-N 124.455 1.097 . . . . 0.0 115.774 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.482 ' CG2' ' N ' ' A' ' 77' ' ' GLU 0.349 0.7 OUTLIER 72.28 172.47 0.31 Allowed 'General case' 0 CA--C 1.501 -0.915 0 C-N-CA 115.793 -2.363 . . . . 0.0 110.27 -179.838 . . . . . . . . 4 4 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.482 ' N ' ' CG2' ' A' ' 76' ' ' THR . 0.2 OUTLIER 47.01 -171.28 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.818 1 O-C-N 129.391 4.182 . . . . 0.0 110.309 179.947 . . . . . . . . 4 4 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.432 ' HG ' ' HB3' ' A' ' 93' ' ' PHE 0.339 4.8 tt 130.9 141.62 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.808 0 O-C-N 128.423 3.577 . . . . 0.0 102.247 180.0 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 17.3 m -163.48 128.74 3.03 Favored 'General case' 0 C--O 1.199 -1.56 0 N-CA-C 103.17 -2.9 . . . . 0.0 103.17 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 179.56 -135.25 2.46 Favored Glycine 0 C--N 1.31 -0.905 0 C-N-CA 118.583 -1.77 . . . . 0.0 110.315 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.552 ' HA ' ' CZ ' ' A' ' 68' ' ' PHE . 33.6 p -164.59 164.27 21.64 Favored 'General case' 0 C--O 1.188 -2.132 0 C-N-CA 117.214 -1.794 . . . . 0.0 111.779 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . 0.688 ' CG ' ' N ' ' A' ' 83' ' ' THR 0.408 1.4 p-90 -74.67 -171.59 1.31 Allowed 'General case' 0 C--N 1.31 -1.112 1 N-CA-C 100.025 -4.065 . . . . 0.0 100.025 175.735 . . . . . . . . 4 3 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.688 ' N ' ' CG ' ' A' ' 82' ' ' TRP . 0.3 OUTLIER 172.4 118.17 0.02 OUTLIER 'General case' 0 N--CA 1.432 -1.331 0 CA-C-O 124.404 2.05 . . . . 0.0 113.316 174.913 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.529 ' HB2' ' CZ3' ' A' ' 82' ' ' TRP . 2.8 ttp -84.86 101.23 12.13 Favored 'General case' 0 N--CA 1.433 -1.275 0 O-C-N 120.852 -1.155 . . . . 0.0 108.076 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.429 ' CG ' ' CG2' ' A' ' 90' ' ' VAL 0.673 0.8 OUTLIER -54.82 -87.1 0.0 OUTLIER 'General case' 0 N--CA 1.432 -1.368 0 CA-C-O 125.918 2.77 . . . . 0.0 111.076 179.982 . . . . . . . . 4 4 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -138.65 -80.04 0.08 OUTLIER Glycine 0 N--CA 1.443 -0.852 0 N-CA-C 104.238 -3.545 . . . . 0.0 104.238 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -95.1 5.34 52.13 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 116.404 -1.76 . . . . 0.0 115.054 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . 0.371 0.6 OUTLIER -147.55 162.89 38.18 Favored 'General case' 0 CA--C 1.493 -1.215 0 O-C-N 126.281 2.238 . . . . 0.0 110.892 -179.967 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.416 ' HA ' ' HA ' ' A' ' 84' ' ' MET . 5.5 tt -104.76 150.6 24.63 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 103.322 -2.844 . . . . 0.0 103.322 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.47 HG11 ' CB ' ' A' ' 105' ' ' VAL . 0.0 OUTLIER -136.61 165.42 28.62 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.913 0 CA-C-O 123.849 1.785 . . . . 0.0 106.247 -179.808 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -128.83 97.4 0.43 Allowed Glycine 0 C--N 1.345 1.051 0 C-N-CA 128.636 3.017 . . . . 0.0 109.718 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 16.7 mtpt -95.29 139.74 31.17 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 102.375 -3.194 . . . . 0.0 102.375 179.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.497 ' CE1' ' H41' ' A' ' 132' ' ' PLM . 75.6 m-85 -149.84 121.4 7.99 Favored 'General case' 0 CA--C 1.501 -0.936 0 CA-C-O 124.284 1.992 . . . . 0.0 111.724 -179.717 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.409 ' HA ' ' HA ' ' A' ' 101' ' ' GLU . 31.0 mttt -91.15 -175.61 4.34 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-N 113.885 -1.507 . . . . 0.0 110.129 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . 0.366 1.4 mmt85 -128.63 128.32 43.94 Favored 'General case' 0 CA--C 1.489 -1.398 0 O-C-N 124.817 1.323 . . . . 0.0 107.879 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -33.11 -63.26 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 C-N-CA 126.841 2.056 . . . . 0.0 113.938 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . 0.368 0.0 OUTLIER -101.44 -22.24 14.6 Favored 'General case' 0 C--O 1.258 1.535 0 O-C-N 119.892 -1.755 . . . . 0.0 115.293 -179.811 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 46.5 t30 -77.45 -26.39 51.46 Favored 'General case' 0 N--CA 1.422 -1.827 0 CA-C-N 113.576 -1.647 . . . . 0.0 113.678 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 48.18 22.96 2.53 Favored Glycine 0 CA--C 1.531 1.05 0 O-C-N 127.287 2.867 . . . . 0.0 118.05 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 15.5 mmtp -75.36 -108.72 0.01 OUTLIER 'General case' 0 C--O 1.199 -1.592 0 O-C-N 119.842 -1.976 . . . . 0.0 108.17 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.421 ' HG2' ' N ' ' A' ' 102' ' ' LEU . 1.0 OUTLIER 173.22 179.18 0.09 Allowed 'General case' 0 C--N 1.316 -0.861 0 C-N-CA 129.286 3.034 . . . . 0.0 109.425 179.993 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.557 ' CB ' ' HA ' ' A' ' 119' ' ' TYR . 3.5 tt -166.15 139.94 4.26 Favored 'General case' 0 C--O 1.245 0.859 1 O-C-N 129.139 4.024 . . . . 0.0 106.231 179.34 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.506 ' N ' ' O ' ' A' ' 118' ' ' THR . 4.2 tp -128.16 156.07 40.09 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.068 0 N-CA-C 105.039 -2.208 . . . . 0.0 105.039 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.406 ' N ' HG13 ' A' ' 103' ' ' ILE . . . -153.25 145.2 23.64 Favored 'General case' 0 C--N 1.313 -0.998 0 O-C-N 119.213 -2.179 . . . . 0.0 106.714 -179.599 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.525 ' HB ' ' CE2' ' A' ' 117' ' ' TYR . 8.4 p -124.8 113.09 34.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 121.642 2.019 . . . . 0.0 111.709 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.473 ' CB ' HD13 ' A' ' 113' ' ' LEU . 0.2 OUTLIER -82.0 83.89 7.13 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 105.296 -2.113 . . . . 0.0 105.296 179.99 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 69.7 tt0 -90.66 77.5 6.35 Favored 'General case' 0 N--CA 1.418 -2.052 0 O-C-N 128.071 3.357 . . . . 0.0 112.357 -179.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.429 HG13 ' HA ' ' A' ' 113' ' ' LEU 0.406 2.1 tt -57.13 118.55 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 C-N-CA 115.652 -2.419 . . . . 0.0 112.313 179.736 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 36.6 m -109.6 60.74 0.6 Allowed 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 117.695 -1.145 . . . . 0.0 108.397 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 83.53 -108.33 3.03 Favored Glycine 0 C--N 1.347 1.193 0 O-C-N 126.701 2.501 . . . . 0.0 111.391 -179.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.435 ' ND2' ' N ' ' A' ' 111' ' ' ASN 0.323 0.0 OUTLIER -89.05 13.38 13.13 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 115.78 -2.057 . . . . 0.0 111.38 -179.823 . . . . . . . . 4 4 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -136.52 115.93 12.73 Favored 'General case' 0 C--O 1.208 -1.124 0 O-C-N 127.968 3.292 . . . . 0.0 113.515 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.473 HD13 ' CB ' ' A' ' 106' ' ' ARG . 0.1 OUTLIER -88.85 143.34 26.95 Favored 'General case' 0 C--O 1.213 -0.83 0 N-CA-C 100.725 -3.806 . . . . 0.0 100.725 179.719 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.422 HG23 HG23 ' A' ' 116' ' ' THR . 71.3 mt -138.77 118.85 14.85 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.973 0 O-C-N 127.661 3.1 . . . . 0.0 105.269 179.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 12.4 mt-30 -100.97 122.28 43.24 Favored 'General case' 0 CA--C 1.505 -0.759 0 O-C-N 126.036 2.085 . . . . 0.0 105.812 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.481 ' HB ' ' CG ' ' A' ' 125' ' ' LYS . 0.6 OUTLIER -140.55 152.16 45.31 Favored 'General case' 0 N--CA 1.419 -2.013 0 O-C-N 121.098 -1.001 . . . . 0.0 112.328 -179.644 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . 0.525 ' CE2' ' HB ' ' A' ' 105' ' ' VAL 0.377 22.4 m-85 135.69 -140.97 0.0 OUTLIER 'General case' 0 CA--C 1.478 -1.795 0 O-C-N 128.852 3.845 . . . . 0.0 113.493 176.58 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.506 ' O ' ' N ' ' A' ' 103' ' ' ILE . 4.8 t -151.71 -155.76 0.65 Allowed 'General case' 0 C--N 1.312 -1.055 0 O-C-N 127.278 2.861 . . . . 0.0 116.044 -174.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.557 ' HA ' ' CB ' ' A' ' 102' ' ' LEU 0.282 2.6 t80 -109.53 -57.46 2.17 Favored 'General case' 0 C--O 1.217 -0.636 0 CA-C-O 125.434 2.54 . . . . 0.0 104.82 177.721 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.522 ' HG3' ' CE2' ' A' ' 119' ' ' TYR . 3.7 mt-10 -123.38 -80.7 0.63 Allowed 'General case' 0 N--CA 1.436 -1.126 0 CA-C-N 112.591 -2.095 . . . . 0.0 111.981 179.416 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -137.03 36.07 2.01 Favored Glycine 0 C--N 1.36 1.872 0 N-CA-C 119.259 2.464 . . . . 0.0 119.259 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 65.3 t -137.02 91.26 0.83 Allowed 'Isoleucine or valine' 0 C--O 1.215 -0.739 0 N-CA-C 103.535 -2.765 . . . . 0.0 103.535 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.429 ' HA ' ' HB ' ' A' ' 118' ' ' THR . 1.5 mp0 -63.02 178.61 0.46 Allowed 'General case' 0 C--N 1.311 -1.102 0 CA-C-O 125.525 2.584 . . . . 0.0 113.955 -178.223 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.402 ' HA ' ' HB3' ' A' ' 13' ' ' ASN . . . -163.67 177.21 8.9 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 112.572 -3.585 . . . . 0.0 106.799 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.481 ' CG ' ' HB ' ' A' ' 116' ' ' THR 0.337 0.0 OUTLIER -161.92 131.44 4.58 Favored 'General case' 0 C--O 1.249 1.047 1 O-C-N 129.454 4.221 . . . . 0.0 107.423 -179.906 . . . . . . . . 5 4 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.528 ' HG2' ' CE1' ' A' ' 14' ' ' TYR . 7.7 ptm180 -132.02 85.78 2.28 Favored 'General case' 0 N--CA 1.426 -1.634 0 CA-C-O 114.556 -2.64 . . . . 0.0 111.653 -179.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.438 ' N ' HD12 ' A' ' 127' ' ' ILE . 1.0 OUTLIER -64.82 105.21 0.52 Allowed 'Isoleucine or valine' 0 C--O 1.25 1.121 1 O-C-N 132.138 5.899 . . . . 0.0 113.75 178.827 . . . . . . . . 4 4 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.472 ' CD2' ' HB3' ' A' ' 6' ' ' TRP . 0.0 OUTLIER -87.74 131.96 34.31 Favored 'General case' 0 N--CA 1.432 -1.352 0 CA-C-N 111.71 -2.495 . . . . 0.0 107.029 179.957 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 3.1 mmmp? -100.09 47.68 0.94 Allowed 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 114.394 -2.717 . . . . 0.0 110.059 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.524 ' HB2' ' CZ3' ' A' ' 6' ' ' TRP . 2.0 ttpm? 26.09 98.49 0.0 OUTLIER 'General case' 0 CA--C 1.518 -0.283 0 O-C-N 126.441 2.338 . . . . 0.0 115.401 179.378 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . 0.914 25.5 tt0 . . . . . 0 N--CA 1.446 -0.629 0 CA-C-N 120.327 1.422 . . . . 0.0 113.327 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' PLM . . . . . 0.524 ' H31' ' CE2' ' A' ' 62' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.494 ' C ' ' CD1' ' A' ' 2' ' ' PHE . . . . . . . . 0 C--O 1.216 -0.705 0 CA-C-O 117.639 -1.172 . . . . 0.0 109.832 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.494 ' CD1' ' C ' ' A' ' 1' ' ' ALA . 2.2 p90 38.09 56.33 1.66 Allowed 'General case' 0 C--N 1.309 -1.195 0 O-C-N 127.462 2.976 . . . . 0.0 116.645 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -143.56 99.83 3.49 Favored 'General case' 0 CA--C 1.501 -0.942 0 CA-C-N 114.621 -1.172 . . . . 0.0 110.96 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 151.12 -107.5 0.34 Allowed Glycine 0 C--O 1.213 -1.161 0 CA-C-O 117.844 -1.531 . . . . 0.0 113.0 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.406 ' OG1' ' N ' ' A' ' 6' ' ' TRP 0.482 1.1 t -137.01 173.55 11.58 Favored 'General case' 0 C--N 1.309 -1.157 0 O-C-N 127.397 2.469 . . . . 0.0 110.011 179.797 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.532 ' CZ3' ' HG3' ' A' ' 130' ' ' LYS . 91.6 m95 -161.56 150.19 15.7 Favored 'General case' 0 N--CA 1.427 -1.584 0 O-C-N 126.247 2.217 . . . . 0.0 108.287 -179.751 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 12.9 tttt -151.89 102.65 2.85 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-O 115.014 -2.422 . . . . 0.0 107.066 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.418 ' HA ' ' HA ' ' A' ' 128' ' ' PHE 0.323 5.7 p -46.84 138.94 1.82 Allowed 'Isoleucine or valine' 0 C--O 1.249 1.038 0 CA-C-N 121.024 1.738 . . . . 0.0 112.685 179.816 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -153.44 21.05 0.55 Allowed 'General case' 0 CA--C 1.498 -1.044 0 CA-C-O 123.427 1.584 . . . . 0.0 112.425 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.4 ' CG ' ' HB ' ' A' ' 127' ' ' ILE 0.259 1.2 ptp85 -155.63 -49.48 0.08 Allowed 'General case' 0 C--N 1.301 -1.52 0 O-C-N 117.285 -3.384 . . . . 0.0 110.468 179.727 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . 0.373 0.5 OUTLIER 51.11 -176.09 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.67 0 O-C-N 126.411 2.319 . . . . 0.0 110.719 179.8 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -146.88 -85.42 0.11 Allowed 'General case' 0 C--N 1.301 -1.542 0 O-C-N 119.36 -2.087 . . . . 0.0 107.773 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -89.74 18.04 5.96 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 120.111 1.323 . . . . 0.0 114.207 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 79.4 t80 -59.45 -32.54 70.32 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 118.898 2.925 . . . . 0.0 118.898 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -76.13 -29.3 57.77 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 121.816 2.098 . . . . 0.0 111.436 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 16.2 mttp -75.52 -24.64 56.82 Favored 'General case' 0 N--CA 1.425 -1.68 0 O-C-N 126.801 2.563 . . . . 0.0 113.398 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.435 ' CB ' ' HB3' ' A' ' 124' ' ' ALA . 11.6 t80 -79.17 -20.39 48.58 Favored 'General case' 0 N--CA 1.428 -1.538 0 O-C-N 121.763 -0.586 . . . . 0.0 110.944 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.426 ' HA ' HG13 ' A' ' 23' ' ' ILE . 0.4 OUTLIER -74.48 -35.07 63.25 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-O 122.902 1.334 . . . . 0.0 107.881 179.99 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . 0.267 7.1 tt0 -72.87 -25.67 61.18 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 126.232 2.92 . . . . 0.0 112.232 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 27.2 tptt -79.9 -29.73 39.96 Favored 'General case' 0 C--N 1.319 -0.753 0 O-C-N 119.423 -2.048 . . . . 0.0 111.361 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 1.1 mmm -75.73 -28.91 58.73 Favored 'General case' 0 C--O 1.217 -0.651 0 CA-C-O 124.552 2.12 . . . . 0.0 108.885 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 109.01 43.42 1.2 Allowed Glycine 0 N--CA 1.443 -0.896 0 CA-C-O 116.171 -2.46 . . . . 0.0 109.928 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.426 HG13 ' HA ' ' A' ' 18' ' ' MET . 3.5 mm -90.76 134.47 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 CA-C-N 119.551 1.676 . . . . 0.0 108.689 -179.443 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -78.47 132.64 37.34 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-O 114.387 -2.721 . . . . 0.0 113.614 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . 0.375 60.5 t -8.68 -53.59 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 O-C-N 128.889 3.868 . . . . 0.0 117.605 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.608 0.3 OUTLIER -79.75 -40.17 20.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 115.154 1.538 . . . . 0.0 115.154 -179.728 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 8.5 ttmm -60.67 -24.1 65.33 Favored 'General case' 0 N--CA 1.443 -0.783 0 O-C-N 127.237 2.836 . . . . 0.0 113.233 179.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 5.4 ptt85 -76.95 -30.88 56.23 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 15.0 ttmt -75.65 -29.01 58.98 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-O 123.47 1.605 . . . . 0.0 110.327 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.416 ' N ' HD21 ' A' ' 30' ' ' LEU . 1.4 mm? -76.1 -34.46 59.51 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 116.086 -1.912 . . . . 0.0 110.018 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -70.99 -25.06 76.46 Favored Glycine 0 C--O 1.21 -1.401 0 O-C-N 125.032 1.457 . . . . 0.0 112.255 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -77.52 -34.51 53.97 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 116.457 -1.735 . . . . 0.0 111.322 179.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 5.3 t-160 -103.63 21.63 15.81 Favored 'General case' 0 N--CA 1.445 -0.676 0 O-C-N 126.958 2.661 . . . . 0.0 113.918 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.78 -29.79 67.19 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 114.709 1.374 . . . . 0.0 114.709 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . 0.283 18.7 m120 76.55 27.86 0.77 Allowed 'General case' 0 C--O 1.245 0.821 0 O-C-N 118.63 -2.544 . . . . 0.0 109.542 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.2 tt -44.73 91.6 0.0 OUTLIER 'General case' 0 C--O 1.212 -0.876 0 O-C-N 126.156 2.16 . . . . 0.0 111.033 -179.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 8.7 tttt -97.33 103.22 15.13 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 101.682 -3.451 . . . . 0.0 101.682 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.475 ' HG ' ' CG2' ' A' ' 49' ' ' VAL 0.292 0.1 OUTLIER -91.29 147.32 23.13 Favored 'General case' 0 C--N 1.289 -2.03 0 CA-C-O 123.932 1.825 . . . . 0.0 106.591 -179.58 . . . . . . . . 4 4 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.424 ' HB ' ' HB3' ' A' ' 50' ' ' LYS . 2.4 m -129.19 103.15 6.79 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 102.498 -3.149 . . . . 0.0 102.498 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 59.3 mt -92.5 119.18 39.62 Favored 'Isoleucine or valine' 0 C--O 1.253 1.254 0 CA-C-O 124.13 1.919 . . . . 0.0 111.883 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 74.5 m -119.91 95.39 4.74 Favored 'General case' 0 C--N 1.348 0.542 0 CA-C-N 110.733 -2.939 . . . . 0.0 110.087 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.59 125.71 29.74 Favored 'General case' 0 C--N 1.313 -1.017 0 O-C-N 127.153 2.783 . . . . 0.0 108.705 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -158.1 112.7 2.59 Favored 'General case' 0 N--CA 1.417 -2.097 0 O-C-N 119.26 -2.15 . . . . 0.0 111.954 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 54.03 42.08 70.27 Favored Glycine 0 N--CA 1.428 -1.889 0 CA-C-N 114.386 -1.279 . . . . 0.0 109.934 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.311 4.4 m-20 83.26 -25.36 0.14 Allowed 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 112.556 -1.822 . . . . 0.0 112.224 179.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 5.7 ttmt -76.37 144.16 40.27 Favored 'General case' 0 C--N 1.307 -1.271 0 C-N-CA 115.639 -2.424 . . . . 0.0 108.681 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -119.59 87.85 2.82 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 118.164 -0.922 . . . . 0.0 111.534 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.486 ' CG2' HG12 ' A' ' 61' ' ' VAL 0.427 0.1 OUTLIER -61.04 118.54 6.89 Favored 'General case' 0 C--O 1.244 0.812 0 C-N-CA 115.206 -2.598 . . . . 0.0 109.502 -179.721 . . . . . . . . 4 4 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.489 ' CG1' ' HB ' ' A' ' 60' ' ' VAL 0.713 8.4 p -101.27 85.94 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 O-C-N 125.173 1.546 . . . . 0.0 108.592 179.557 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.424 ' HB3' ' HB ' ' A' ' 39' ' ' THR . 2.5 tttp -77.41 103.68 7.48 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 105.383 -2.08 . . . . 0.0 105.383 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -95.36 89.48 5.47 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 127.2 2.2 . . . . 0.0 105.413 -179.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -88.27 57.51 4.3 Favored 'General case' 0 C--N 1.289 -2.061 0 O-C-N 119.91 -1.744 . . . . 0.0 106.975 -179.66 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 80.7 p -83.11 160.17 21.94 Favored 'General case' 0 C--O 1.209 -1.065 0 CA-C-O 116.529 -1.701 . . . . 0.0 108.466 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 56.6 t30 -50.54 -32.64 18.98 Favored 'General case' 0 N--CA 1.435 -1.182 0 O-C-N 125.287 1.617 . . . . 0.0 109.498 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -62.66 -50.75 69.94 Favored 'General case' 0 C--N 1.352 0.71 0 C-N-CA 116.223 -2.191 . . . . 0.0 111.193 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.417 ' HG2' ' HB ' ' A' ' 58' ' ' ILE . 29.8 ttm-85 -176.11 148.8 0.83 Allowed 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 121.663 2.029 . . . . 0.0 106.959 178.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -95.3 83.35 3.84 Favored 'General case' 0 C--O 1.22 -0.467 0 N-CA-C 100.441 -3.911 . . . . 0.0 100.441 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.417 ' HB ' ' HG2' ' A' ' 56' ' ' ARG . 3.5 tp -105.58 101.42 12.37 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.238 0 O-C-N 128.015 3.322 . . . . 0.0 116.527 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 29.2 t0 -58.21 137.21 57.23 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 103.229 -2.878 . . . . 0.0 103.229 177.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.489 ' HB ' ' CG1' ' A' ' 49' ' ' VAL . 2.2 t -101.33 -67.75 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 N-CA-C 106.506 -1.664 . . . . 0.0 106.506 -176.419 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.486 HG12 ' CG2' ' A' ' 48' ' ' THR 0.506 0.0 OUTLIER 75.44 134.04 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 CA-C-O 124.065 1.888 . . . . 0.0 112.582 179.557 . . . . . . . . 4 4 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.64 ' CE2' ' CD1' ' A' ' 82' ' ' TRP . 3.9 p90 -168.98 110.71 0.5 Allowed 'General case' 0 N--CA 1.436 -1.17 0 CA-C-N 112.332 -2.213 . . . . 0.0 111.911 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -62.04 125.64 24.57 Favored 'General case' 0 N--CA 1.441 -0.914 0 N-CA-C 102.462 -3.162 . . . . 0.0 102.462 179.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -48.21 125.59 9.59 Favored 'General case' 0 N--CA 1.428 -1.559 0 O-C-N 124.466 1.104 . . . . 0.0 111.503 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' 82' ' ' TRP . . . 73.61 12.36 80.47 Favored Glycine 0 C--N 1.344 1.006 0 O-C-N 126.73 2.519 . . . . 0.0 117.036 -179.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . 0.419 44.0 t -81.18 -99.91 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.431 -1.389 0 CA-C-O 118.373 -0.822 . . . . 0.0 109.053 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.9 t70 165.37 130.08 0.01 OUTLIER 'General case' 0 CA--C 1.49 -1.346 0 CA-C-N 119.285 0.948 . . . . 0.0 110.567 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -135.48 174.75 10.27 Favored 'General case' 0 N--CA 1.428 -1.545 0 CA-C-N 120.156 1.344 . . . . 0.0 109.281 179.683 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -132.65 127.45 34.91 Favored 'General case' 0 C--O 1.244 0.801 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -157.19 125.23 5.5 Favored 'General case' 0 N--CA 1.443 -0.784 0 C-N-CA 118.632 -1.227 . . . . 0.0 113.563 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 18.3 t -57.67 156.92 7.78 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 105.124 -2.176 . . . . 0.0 105.124 179.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.482 ' CD1' HD13 ' A' ' 78' ' ' LEU . 8.4 mt -101.77 9.7 40.63 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-O 118.148 -0.93 . . . . 0.0 109.873 -179.35 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . 79.61 -4.24 2.0 Favored 'General case' 0 N--CA 1.438 -1.071 0 O-C-N 126.802 2.564 . . . . 0.0 113.174 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.459 ' CB ' ' CG ' ' A' ' 132' ' ' PLM . 28.9 t70 -165.96 -51.06 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 123.825 1.774 . . . . 0.0 110.259 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -67.8 -6.65 44.98 Favored Glycine 0 C--N 1.347 1.192 0 CA-C-N 113.704 -1.589 . . . . 0.0 112.98 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . 0.274 0.2 OUTLIER 78.62 163.31 0.21 Allowed 'General case' 0 N--CA 1.435 -1.204 0 CA-C-N 119.699 1.75 . . . . 0.0 115.298 179.678 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.443 ' HB3' ' HB ' ' A' ' 96' ' ' VAL . 1.1 mt-10 -36.61 98.43 0.01 OUTLIER 'General case' 0 N--CA 1.44 -0.945 0 O-C-N 128.392 3.558 . . . . 0.0 113.091 179.63 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.482 HD13 ' CD1' ' A' ' 72' ' ' LEU 0.472 5.5 tt -97.04 158.19 15.55 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 101.929 -3.36 . . . . 0.0 101.929 179.621 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 14.5 m -157.82 124.14 4.8 Favored 'General case' 0 CA--C 1.498 -1.054 0 N-CA-C 102.047 -3.316 . . . . 0.0 102.047 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -162.97 -175.83 34.4 Favored Glycine 0 C--N 1.292 -1.89 0 C-N-CA 115.746 -3.121 . . . . 0.0 111.959 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 15.7 p -137.87 159.82 40.97 Favored 'General case' 0 C--O 1.192 -1.965 0 C-N-CA 119.313 -0.955 . . . . 0.0 110.116 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . 0.64 ' CD1' ' CE2' ' A' ' 62' ' ' PHE . 72.2 m95 -118.74 137.75 53.14 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 100.624 -3.843 . . . . 0.0 100.624 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 13.5 t -147.74 143.15 27.36 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 123.597 1.665 . . . . 0.0 109.497 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.98 139.02 41.31 Favored 'General case' 0 N--CA 1.44 -0.965 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . 0.72 5.2 mt-10 -127.81 30.57 5.27 Favored 'General case' 0 C--N 1.307 -1.254 0 C-N-CA 116.687 -2.005 . . . . 0.0 109.686 179.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 71.5 97.68 0.06 OUTLIER Glycine 0 N--CA 1.436 -1.358 0 N-CA-C 106.147 -2.781 . . . . 0.0 106.147 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . 0.28 61.2 m-80 79.06 -7.53 1.75 Allowed 'General case' 0 C--O 1.236 0.387 0 N-CA-C 117.893 2.553 . . . . 0.0 117.893 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . 0.341 0.4 OUTLIER -143.73 133.13 23.33 Favored 'General case' 0 CA--C 1.498 -1.043 0 O-C-N 125.713 1.883 . . . . 0.0 106.575 179.988 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.418 ' HB3' ' HD2' ' A' ' 106' ' ' ARG . 0.2 OUTLIER -97.21 107.28 19.76 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 102.516 -3.142 . . . . 0.0 102.516 179.839 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.464 HG11 ' CG2' ' A' ' 105' ' ' VAL . 1.0 OUTLIER -98.55 156.42 3.72 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.939 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 179.888 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -134.55 104.95 0.53 Allowed Glycine 0 C--N 1.347 1.162 0 C-N-CA 129.969 3.652 . . . . 0.0 110.45 179.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 18.1 mtmt -102.92 117.09 33.83 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 104.541 -2.392 . . . . 0.0 104.541 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.438 ' CD2' HD12 ' A' ' 78' ' ' LEU . 16.0 m-30 -107.58 118.19 36.08 Favored 'General case' 0 C--N 1.328 -0.327 0 O-C-N 125.288 1.617 . . . . 0.0 111.839 -179.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 4.6 mtmt -102.03 161.56 13.59 Favored 'General case' 0 C--O 1.21 -0.981 0 CA-C-N 114.215 -1.357 . . . . 0.0 110.372 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . 0.377 0.0 OUTLIER -107.48 144.98 33.67 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-O 116.849 -1.548 . . . . 0.0 107.672 179.936 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.443 ' HB ' ' HB3' ' A' ' 77' ' ' GLU . 57.0 t -82.24 -30.55 9.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 C-N-CA 126.641 1.976 . . . . 0.0 114.094 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . 0.343 0.1 OUTLIER -110.0 -3.96 16.18 Favored 'General case' 0 C--O 1.259 1.568 0 N-CA-C 115.413 1.634 . . . . 0.0 115.413 179.925 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 44.1 t30 -112.46 -22.49 10.81 Favored 'General case' 0 N--CA 1.422 -1.857 0 N-CA-C 115.258 1.577 . . . . 0.0 115.258 -179.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 60.22 26.97 64.53 Favored Glycine 0 CA--C 1.53 0.985 0 N-CA-C 117.489 1.756 . . . . 0.0 117.489 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 15.2 mmtm -90.91 -113.33 0.08 Allowed 'General case' 0 CA--C 1.553 1.072 0 O-C-N 120.237 -1.743 . . . . 0.0 112.015 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 151.79 144.04 0.0 OUTLIER 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 129.882 3.273 . . . . 0.0 108.778 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.496 HD13 ' CD1' ' A' ' 119' ' ' TYR . 2.4 tt -127.87 176.34 7.65 Favored 'General case' 0 CA--C 1.511 -0.551 2 O-C-N 129.787 4.429 . . . . 0.0 106.835 -179.808 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.446 HG13 ' N ' ' A' ' 104' ' ' ALA . 0.1 OUTLIER -149.14 173.21 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.502 -0.869 0 C-N-CA 117.93 -1.508 . . . . 0.0 109.491 -179.725 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.463 ' HB3' ' CD1' ' A' ' 117' ' ' TYR . . . -154.46 133.36 12.3 Favored 'General case' 0 C--N 1.313 -1.013 0 O-C-N 117.709 -3.119 . . . . 0.0 107.418 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.464 ' CG2' HG11 ' A' ' 90' ' ' VAL . 0.9 OUTLIER -121.1 99.18 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 CA-C-N 122.113 2.233 . . . . 0.0 108.615 179.97 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.464 ' HG3' ' CZ3' ' A' ' 82' ' ' TRP 0.259 75.3 mtt180 -71.62 91.83 1.11 Allowed 'General case' 0 CA--C 1.503 -0.834 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 179.944 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.432 ' O ' ' N ' ' A' ' 109' ' ' SER . 0.1 OUTLIER -89.85 83.53 6.18 Favored 'General case' 0 N--CA 1.432 -1.359 0 CA-C-N 112.316 -2.22 . . . . 0.0 114.758 -179.638 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . 0.276 8.5 mm -62.17 93.81 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 C-N-CA 116.926 -1.909 . . . . 0.0 106.865 179.435 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.432 ' N ' ' O ' ' A' ' 107' ' ' GLU . 6.1 m -65.8 -20.85 66.4 Favored 'General case' 0 N--CA 1.439 -0.992 0 C-N-CA 125.426 1.491 . . . . 0.0 109.605 -179.462 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 123.01 97.8 1.35 Allowed Glycine 0 C--O 1.218 -0.845 0 C-N-CA 129.907 3.622 . . . . 0.0 110.387 -179.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . 0.326 0.8 OUTLIER 90.49 -27.27 0.05 OUTLIER 'General case' 0 C--N 1.308 -1.199 0 O-C-N 128.235 2.962 . . . . 0.0 109.944 -179.068 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -115.51 124.15 50.35 Favored 'General case' 0 C--N 1.361 1.072 0 CA-C-O 117.014 -1.469 . . . . 0.0 110.986 179.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 30.2 tp -96.82 116.85 29.87 Favored 'General case' 0 C--O 1.217 -0.627 0 N-CA-C 104.593 -2.373 . . . . 0.0 104.593 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.489 ' CD1' HG22 ' A' ' 127' ' ' ILE 0.27 2.9 mm -102.58 128.44 55.34 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 O-C-N 128.047 3.342 . . . . 0.0 104.417 -179.929 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -111.31 79.77 1.24 Allowed 'General case' 0 CA--C 1.494 -1.174 0 CA-C-O 124.041 1.877 . . . . 0.0 106.027 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -73.13 115.0 11.93 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 104.633 -2.358 . . . . 0.0 104.633 179.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . 0.463 ' CD1' ' HB3' ' A' ' 104' ' ' ALA 0.262 78.5 m-85 -106.53 145.71 31.52 Favored 'General case' 0 C--O 1.207 -1.168 0 O-C-N 126.818 2.574 . . . . 0.0 113.269 -179.562 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . 0.289 0.8 OUTLIER -141.2 126.48 18.59 Favored 'General case' 0 N--CA 1.446 -0.633 1 O-C-N 130.594 4.934 . . . . 0.0 108.439 179.577 . . . . . . . . 4 3 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.496 ' CD1' HD13 ' A' ' 102' ' ' LEU 0.277 22.4 t80 -101.07 -0.13 36.87 Favored 'General case' 0 C--O 1.245 0.851 0 CA-C-N 119.818 1.19 . . . . 0.0 107.835 -179.71 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 171.98 -79.95 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.543 0 O-C-N 126.211 2.194 . . . . 0.0 115.863 -179.527 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -130.47 30.47 3.44 Favored Glycine 0 C--N 1.353 1.513 0 N-CA-C 118.838 2.295 . . . . 0.0 118.838 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 54.9 t -145.65 113.88 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 103.972 -2.603 . . . . 0.0 103.972 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -83.51 -178.89 7.2 Favored 'General case' 0 C--O 1.21 -0.985 0 CA-C-O 124.727 2.203 . . . . 0.0 112.533 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.435 ' HB3' ' CB ' ' A' ' 17' ' ' PHE . . . -167.34 85.48 0.24 Allowed 'General case' 0 C--O 1.216 -0.687 0 CA-C-O 114.223 -2.799 . . . . 0.0 108.501 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.01 128.27 36.1 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 121.256 1.844 . . . . 0.0 109.631 -179.647 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.21 82.2 1.83 Allowed 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 125.959 1.704 . . . . 0.0 107.232 -179.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.489 HG22 ' CD1' ' A' ' 114' ' ' ILE . 2.1 mt -78.9 117.68 24.9 Favored 'Isoleucine or valine' 0 C--O 1.245 0.837 0 O-C-N 127.426 2.954 . . . . 0.0 116.448 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.461 ' CD2' ' HB3' ' A' ' 6' ' ' TRP . 1.3 m-30 -94.55 166.42 12.04 Favored 'General case' 0 N--CA 1.432 -1.347 0 O-C-N 128.102 3.376 . . . . 0.0 107.926 -179.725 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . 0.258 8.5 mmtt -119.44 -4.17 10.4 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 119.573 -0.251 . . . . 0.0 111.235 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.532 ' HG3' ' CZ3' ' A' ' 6' ' ' TRP . 4.2 tttp 73.28 116.18 0.05 Allowed 'General case' 0 C--O 1.215 -0.72 0 CA-C-O 115.765 -2.064 . . . . 0.0 108.024 -179.533 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . 0.797 3.4 mm-40 . . . . . 0 N--CA 1.424 -1.758 0 O-C-N 126.83 2.581 . . . . 0.0 115.126 -179.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' PLM . . . . . 0.475 ' C1 ' HG13 ' A' ' 49' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.508 -0.649 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -98.03 78.76 2.55 Favored 'General case' 0 N--CA 1.435 -1.207 0 C-N-CA 118.463 -1.295 . . . . 0.0 112.743 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -160.0 88.16 0.82 Allowed 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 112.513 -2.131 . . . . 0.0 111.878 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 153.07 -163.25 30.47 Favored Glycine 0 CA--C 1.495 -1.158 0 C-N-CA 115.635 -3.174 . . . . 0.0 109.168 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . 0.49 22.0 m -97.18 161.42 13.82 Favored 'General case' 0 C--N 1.314 -0.954 0 O-C-N 126.281 1.812 . . . . 0.0 110.503 -179.658 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.447 ' CH2' ' HD2' ' A' ' 130' ' ' LYS . 87.9 m95 -139.75 156.67 46.65 Favored 'General case' 0 N--CA 1.434 -1.249 0 CA-C-N 112.665 -2.062 . . . . 0.0 106.72 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 24.0 tttt -159.92 90.97 0.94 Allowed 'General case' 0 C--O 1.203 -1.346 0 O-C-N 126.283 2.239 . . . . 0.0 107.217 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.497 ' HB ' ' CD1' ' A' ' 128' ' ' PHE 0.315 0.1 OUTLIER -37.65 127.4 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 O-C-N 126.634 2.458 . . . . 0.0 112.063 179.957 . . . . . . . . 4 4 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.433 ' HB2' ' CG ' ' A' ' 129' ' ' LYS . 40.1 t0 -100.0 -32.38 10.98 Favored 'General case' 0 C--O 1.208 -1.092 0 O-C-N 126.793 2.558 . . . . 0.0 105.293 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 5.7 ptp180 -170.73 153.69 4.14 Favored 'General case' 0 C--N 1.296 -1.748 0 C-N-CA 115.846 -2.342 . . . . 0.0 109.189 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . 0.293 0.0 OUTLIER -106.77 -171.38 1.88 Allowed 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 111.297 -2.683 . . . . 0.0 107.675 179.514 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.471 ' CB ' ' HB2' ' A' ' 125' ' ' LYS . 4.1 tm-20 -131.67 -71.68 0.55 Allowed 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 117.468 -1.693 . . . . 0.0 108.293 179.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 23.5 t30 -113.43 28.41 8.8 Favored 'General case' 0 N--CA 1.474 0.774 0 O-C-N 125.246 1.591 . . . . 0.0 113.197 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.443 ' CA ' ' HB2' ' A' ' 124' ' ' ALA 0.347 0.2 OUTLIER -72.49 -19.79 61.48 Favored 'General case' 0 C--N 1.312 -1.037 0 O-C-N 128.416 3.572 . . . . 0.0 115.421 179.994 . . . . . . . . 4 4 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -76.85 -30.7 56.4 Favored 'General case' 0 C--O 1.218 -0.588 0 CA-C-N 120.984 1.72 . . . . 0.0 108.683 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -79.83 -32.32 40.59 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 111.529 -2.578 . . . . 0.0 114.286 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.553 ' CE2' ' HA ' ' A' ' 118' ' ' THR . 0.0 OUTLIER -70.78 -37.63 73.35 Favored 'General case' 0 C--O 1.217 -0.625 0 CA-C-O 123.889 1.804 . . . . 0.0 108.466 179.87 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 3.3 mtm -75.21 -22.47 57.92 Favored 'General case' 0 N--CA 1.432 -1.334 0 CA-C-O 123.263 1.506 . . . . 0.0 109.617 -179.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.26 -31.58 58.39 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 126.229 2.919 . . . . 0.0 111.143 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 5.4 tptp -67.83 -29.59 68.78 Favored 'General case' 0 C--O 1.209 -1.065 0 O-C-N 119.431 -2.043 . . . . 0.0 112.846 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.424 ' HA ' ' CE2' ' A' ' 119' ' ' TYR . 56.7 mtp -79.38 -30.41 42.52 Favored 'General case' 0 C--N 1.346 0.452 0 N-CA-C 105.325 -2.102 . . . . 0.0 105.325 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 101.89 34.23 4.4 Favored Glycine 0 C--N 1.31 -0.871 0 CA-C-O 117.948 -1.474 . . . . 0.0 110.211 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.415 ' CG2' ' HB2' ' A' ' 27' ' ' LYS . 1.5 mm -67.73 135.74 27.92 Favored 'Isoleucine or valine' 0 C--N 1.361 1.102 0 CA-C-O 116.426 -1.749 . . . . 0.0 108.313 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 38.0 m-20 -74.95 147.82 40.55 Favored 'General case' 0 C--O 1.244 0.788 0 CA-C-O 115.255 -2.307 . . . . 0.0 113.555 179.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . 0.372 1.5 t -20.87 -57.3 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.508 -0.645 0 O-C-N 127.365 2.915 . . . . 0.0 117.819 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.547 1.9 m -73.67 -36.95 48.27 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.814 0 O-C-N 125.233 1.583 . . . . 0.0 112.073 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.415 ' HB2' ' CG2' ' A' ' 23' ' ' ILE . 6.7 mttm -63.69 -42.69 97.96 Favored 'General case' 0 CA--C 1.51 -0.57 0 O-C-N 125.057 1.473 . . . . 0.0 114.487 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.402 ' N ' HG21 ' A' ' 23' ' ' ILE . 23.3 ptt85 -78.93 -23.68 44.52 Favored 'General case' 0 C--O 1.217 -0.638 0 CA-C-N 121.413 1.915 . . . . 0.0 108.464 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.9 ttpm? -76.09 -37.96 57.55 Favored 'General case' 0 N--CA 1.437 -1.096 0 CA-C-N 114.23 -1.35 . . . . 0.0 112.666 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.519 HD23 ' CE1' ' A' ' 33' ' ' HIS . 0.2 OUTLIER -77.05 -31.57 56.3 Favored 'General case' 0 N--CA 1.432 -1.327 0 CA-C-O 114.31 -2.757 . . . . 0.0 107.101 179.756 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -75.23 -21.53 77.75 Favored Glycine 0 CA--C 1.534 1.225 0 O-C-N 128.129 3.393 . . . . 0.0 114.425 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -78.37 -32.11 48.82 Favored 'General case' 0 C--N 1.314 -0.935 0 O-C-N 127.28 2.4 . . . . 0.0 110.898 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.519 ' CE1' HD23 ' A' ' 30' ' ' LEU . 6.7 p-80 -120.38 1.47 10.72 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 114.665 -1.152 . . . . 0.0 113.596 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 18.0 p30 -42.01 -19.92 0.01 OUTLIER 'General case' 0 CA--C 1.495 -1.156 0 N-CA-C 116.035 1.865 . . . . 0.0 116.035 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . 0.286 70.3 m-80 75.07 31.32 0.84 Allowed 'General case' 0 C--N 1.311 -1.092 0 CA-C-O 115.635 -2.126 . . . . 0.0 109.198 179.668 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.475 ' CG ' HD11 ' A' ' 38' ' ' LEU . 0.3 OUTLIER -45.64 103.48 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.964 0 O-C-N 127.559 3.037 . . . . 0.0 107.179 179.971 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 30.9 tttp -96.79 112.13 24.01 Favored 'General case' 0 C--O 1.219 -0.517 0 N-CA-C 102.067 -3.309 . . . . 0.0 102.067 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.528 HD21 ' CE2' ' A' ' 128' ' ' PHE 0.279 1.0 OUTLIER -103.6 112.12 24.89 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 121.399 1.909 . . . . 0.0 110.577 -179.947 . . . . . . . . 4 4 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.46 ' HB ' ' CB ' ' A' ' 50' ' ' LYS . 38.6 m -89.85 92.25 8.95 Favored 'General case' 0 N--CA 1.448 -0.557 0 O-C-N 118.003 -2.936 . . . . 0.0 106.675 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 5.3 mt -75.58 125.09 34.81 Favored 'Isoleucine or valine' 0 C--O 1.253 1.264 0 O-C-N 124.318 1.011 . . . . 0.0 111.016 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 53.2 m -128.3 95.16 4.08 Favored 'General case' 0 C--O 1.221 -0.445 0 O-C-N 127.037 2.711 . . . . 0.0 108.866 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -85.61 128.41 34.76 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-O 116.741 -1.599 . . . . 0.0 112.392 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -139.33 91.89 2.54 Favored 'General case' 0 N--CA 1.426 -1.671 0 CA-C-N 120.919 1.69 . . . . 0.0 110.589 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 50.0 68.07 1.56 Allowed Glycine 0 C--N 1.292 -1.881 0 O-C-N 126.013 2.071 . . . . 0.0 110.383 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.315 0.4 OUTLIER 83.4 -26.42 0.12 Allowed 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 114.258 1.207 . . . . 0.0 114.258 179.8 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 21.5 ttpt -87.25 143.03 27.47 Favored 'General case' 0 C--N 1.312 -1.05 0 C-N-CA 117.014 -1.875 . . . . 0.0 108.411 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -124.02 101.2 7.11 Favored 'General case' 0 C--N 1.34 0.18 0 O-C-N 124.844 1.34 . . . . 0.0 111.077 179.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.475 ' HB ' ' CG1' ' A' ' 61' ' ' VAL 0.432 0.1 OUTLIER -83.19 82.93 8.05 Favored 'General case' 0 N--CA 1.441 -0.899 0 O-C-N 125.774 1.921 . . . . 0.0 110.281 179.909 . . . . . . . . 4 4 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.505 HG13 ' CH2' ' A' ' 82' ' ' TRP 0.692 0.3 OUTLIER -62.96 89.12 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.493 -1.231 0 CA-C-N 110.687 -2.96 . . . . 0.0 115.788 179.971 . . . . . . . . 4 4 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.46 ' CB ' ' HB ' ' A' ' 39' ' ' THR . 1.7 tttm -63.83 146.29 54.23 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 100.672 -3.825 . . . . 0.0 100.672 179.468 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -144.15 75.0 1.44 Allowed 'General case' 0 C--O 1.215 -0.739 0 CA-C-N 120.582 1.537 . . . . 0.0 109.378 -179.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 51.4 m -77.4 73.2 3.97 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 105.454 -2.054 . . . . 0.0 105.454 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.403 ' HA ' ' HA ' ' A' ' 36' ' ' LEU . 5.8 p -93.19 39.5 1.05 Allowed 'General case' 0 CA--C 1.505 -0.77 0 C-N-CA 117.809 -1.556 . . . . 0.0 111.868 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.403 ' OD1' ' N ' ' A' ' 55' ' ' PHE . 0.1 OUTLIER 72.16 -52.43 0.7 Allowed 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 115.242 -2.313 . . . . 0.0 108.509 -179.915 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.411 ' CB ' ' HD2' ' A' ' 56' ' ' ARG . 81.5 m-85 -57.5 -73.89 0.06 Allowed 'General case' 0 C--O 1.22 -0.492 0 CA-C-N 122.311 2.323 . . . . 0.0 109.403 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.411 ' HD2' ' CB ' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -136.59 146.19 45.8 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 120.472 1.487 . . . . 0.0 110.631 179.847 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -95.57 80.58 3.46 Favored 'General case' 0 C--N 1.352 0.697 0 N-CA-C 101.214 -3.625 . . . . 0.0 101.214 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.0 tp -110.71 117.67 55.46 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 O-C-N 127.827 3.205 . . . . 0.0 118.826 -179.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.75 119.6 12.73 Favored 'General case' 0 C--O 1.217 -0.643 0 N-CA-C 104.211 -2.514 . . . . 0.0 104.211 178.305 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.58 ' CG1' ' CE2' ' A' ' 62' ' ' PHE . 42.8 t -97.27 69.49 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 CA-C-O 122.163 0.982 . . . . 0.0 110.828 -178.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.475 ' CG1' ' HB ' ' A' ' 48' ' ' THR 0.404 0.7 OUTLIER -64.02 111.86 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 C-N-CA 118.028 -1.469 . . . . 0.0 113.138 -179.795 . . . . . . . . 4 4 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.606 ' CE2' ' CE2' ' A' ' 68' ' ' PHE . 11.5 m-30 -136.99 97.25 3.46 Favored 'General case' 0 N--CA 1.431 -1.386 0 O-C-N 119.122 -2.236 . . . . 0.0 108.665 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -63.57 138.79 58.64 Favored 'General case' 0 C--O 1.246 0.886 0 N-CA-C 105.003 -2.221 . . . . 0.0 105.003 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -60.54 134.92 57.55 Favored 'General case' 0 C--O 1.252 1.2 0 N-CA-C 105.354 -2.091 . . . . 0.0 105.354 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 75.19 2.96 68.19 Favored Glycine 0 C--N 1.341 0.832 0 C-N-CA 127.892 2.663 . . . . 0.0 114.896 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . 0.39 2.1 t -89.64 83.63 2.18 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 N-CA-C 105.189 -2.152 . . . . 0.0 105.189 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -52.77 95.81 0.01 OUTLIER 'General case' 0 CA--C 1.479 -1.756 0 N-CA-C 115.579 1.696 . . . . 0.0 115.579 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.606 ' CE2' ' CE2' ' A' ' 62' ' ' PHE . 13.2 p90 -89.94 178.07 6.31 Favored 'General case' 0 C--N 1.309 -1.153 0 O-C-N 120.438 -1.414 . . . . 0.0 110.109 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -123.95 136.27 54.21 Favored 'General case' 0 C--O 1.244 0.777 0 O-C-N 127.269 2.856 . . . . 0.0 105.441 179.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -156.04 113.87 3.31 Favored 'General case' 0 C--O 1.21 -0.98 0 C-N-CA 118.002 -1.479 . . . . 0.0 114.37 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 9.0 p -67.0 176.5 2.08 Favored 'General case' 0 C--N 1.314 -0.97 0 O-C-N 119.617 -1.927 . . . . 0.0 107.183 179.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.46 ' CD2' HD21 ' A' ' 78' ' ' LEU . 2.9 mt -119.04 -154.5 0.57 Allowed 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 116.345 -1.788 . . . . 0.0 109.339 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -118.5 12.07 13.12 Favored 'General case' 0 N--CA 1.436 -1.165 0 O-C-N 125.627 1.829 . . . . 0.0 113.224 179.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -143.68 -49.41 0.3 Allowed 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 120.541 -0.464 . . . . 0.0 112.178 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -107.96 -9.81 27.49 Favored Glycine 0 CA--C 1.541 1.662 0 N-CA-C 117.192 1.637 . . . . 0.0 117.192 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . 0.412 0.0 OUTLIER 71.58 153.46 0.13 Allowed 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 122.004 2.902 . . . . 0.0 115.257 179.684 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.484 ' HB3' ' CG2' ' A' ' 96' ' ' VAL . 30.9 mt-10 48.76 154.5 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.676 1 O-C-N 129.885 4.491 . . . . 0.0 117.145 179.536 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.46 HD21 ' CD2' ' A' ' 72' ' ' LEU 0.401 11.9 tp 177.15 152.47 0.21 Allowed 'General case' 0 CA--C 1.51 -0.584 0 CA-C-N 110.949 -2.841 . . . . 0.0 107.016 -179.819 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 10.9 m -161.56 119.04 2.25 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 103.297 -2.853 . . . . 0.0 103.297 -179.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.408 ' HA3' ' HA ' ' A' ' 93' ' ' PHE . . . -165.13 -162.59 16.55 Favored Glycine 0 C--N 1.303 -1.256 0 C-N-CA 116.932 -2.556 . . . . 0.0 111.193 -179.647 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 17.4 p -145.21 164.36 31.58 Favored 'General case' 0 C--O 1.193 -1.915 0 C-N-CA 119.112 -1.035 . . . . 0.0 111.531 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . 0.505 ' CH2' HG13 ' A' ' 49' ' ' VAL 0.302 11.8 m0 -106.46 151.72 24.58 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 100.68 -3.822 . . . . 0.0 100.68 179.924 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.401 HG21 HG22 ' A' ' 90' ' ' VAL . 2.4 t -150.96 141.11 22.19 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-O 122.587 1.184 . . . . 0.0 111.766 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 6.9 ttp -91.41 110.36 21.66 Favored 'General case' 0 N--CA 1.429 -1.519 0 CA-C-N 113.037 -1.892 . . . . 0.0 109.705 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . 0.634 10.2 mt-10 -87.58 -133.43 0.08 Allowed 'General case' 0 N--CA 1.434 -1.265 0 O-C-N 124.315 1.009 . . . . 0.0 110.391 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -87.34 92.71 1.83 Allowed Glycine 0 C--N 1.336 0.531 0 N-CA-C 103.207 -3.957 . . . . 0.0 103.207 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 53.68 10.46 0.24 Allowed 'General case' 0 C--O 1.24 0.602 0 N-CA-C 118.059 2.614 . . . . 0.0 118.059 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . 0.335 0.0 OUTLIER -133.58 135.13 44.09 Favored 'General case' 0 CA--C 1.501 -0.933 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 -179.975 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -88.31 134.6 33.77 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 103.953 -2.61 . . . . 0.0 103.953 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.401 HG22 HG21 ' A' ' 83' ' ' THR . 0.0 OUTLIER -113.54 -172.77 0.54 Allowed 'Isoleucine or valine' 0 C--O 1.246 0.88 0 C-N-CA 119.218 -0.993 . . . . 0.0 108.5 179.924 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -164.69 109.11 0.35 Allowed Glycine 0 C--N 1.35 1.335 0 C-N-CA 126.767 2.127 . . . . 0.0 111.696 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 4.7 mmmt -112.33 135.79 52.59 Favored 'General case' 0 N--CA 1.426 -1.636 0 N-CA-C 106.511 -1.662 . . . . 0.0 106.511 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.443 ' HB3' ' HG ' ' A' ' 78' ' ' LEU . 39.2 m-85 -137.57 115.9 11.87 Favored 'General case' 0 CA--C 1.504 -0.806 0 O-C-N 126.306 2.254 . . . . 0.0 113.034 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.4 mtmt -99.58 138.89 36.04 Favored 'General case' 0 N--CA 1.436 -1.157 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . 0.369 0.0 OUTLIER -74.29 174.51 8.7 Favored 'General case' 0 N--CA 1.428 -1.526 0 N-CA-C 105.647 -1.983 . . . . 0.0 105.647 179.819 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.484 ' CG2' ' HB3' ' A' ' 77' ' ' GLU 0.258 2.7 t -86.35 -61.69 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 O-C-N 126.702 2.501 . . . . 0.0 110.862 179.606 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . 0.398 0.6 OUTLIER -57.88 -29.17 64.82 Favored 'General case' 0 C--O 1.26 1.609 0 N-CA-C 118.46 2.763 . . . . 0.0 118.46 -179.926 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -131.24 -4.92 3.85 Favored 'General case' 0 N--CA 1.425 -1.712 0 N-CA-C 116.435 2.013 . . . . 0.0 116.435 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 49.56 42.73 35.71 Favored Glycine 0 C--N 1.348 1.198 0 C-N-CA 118.953 -1.594 . . . . 0.0 114.658 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 26.1 mmtm -71.41 -103.25 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.339 0 CA-C-O 115.835 -2.031 . . . . 0.0 111.226 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 158.92 136.11 0.0 OUTLIER 'General case' 0 N--CA 1.433 -1.308 0 C-N-CA 131.197 3.799 . . . . 0.0 110.191 179.692 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.467 ' HG ' ' HA ' ' A' ' 119' ' ' TYR . 7.2 tt -125.13 111.19 15.03 Favored 'General case' 0 C--N 1.316 -0.868 1 C-N-CA 133.764 4.826 . . . . 0.0 102.744 178.947 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.488 ' N ' ' O ' ' A' ' 118' ' ' THR . 0.1 OUTLIER -101.31 160.72 3.79 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.185 0 C-N-CA 115.472 -2.491 . . . . 0.0 106.975 -179.222 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.405 ' N ' HG13 ' A' ' 103' ' ' ILE . . . -157.8 131.95 8.17 Favored 'General case' 0 C--N 1.322 -0.604 0 O-C-N 118.729 -2.482 . . . . 0.0 112.471 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.549 ' HB ' ' CE2' ' A' ' 117' ' ' TYR . 5.6 p -120.56 118.33 56.2 Favored 'Isoleucine or valine' 0 C--O 1.252 1.226 0 CA-C-N 122.452 2.387 . . . . 0.0 108.915 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.431 ' NH2' ' O1 ' ' A' ' 132' ' ' PLM . 9.6 mtt85 -86.34 88.12 7.56 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 105.301 -2.111 . . . . 0.0 105.301 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -91.36 85.6 5.85 Favored 'General case' 0 N--CA 1.429 -1.513 0 CA-C-N 113.023 -1.899 . . . . 0.0 114.458 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.438 HG13 ' CA ' ' A' ' 113' ' ' LEU 0.388 4.9 tt -65.27 92.12 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 C-N-CA 113.95 -3.1 . . . . 0.0 115.191 -179.927 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 38.9 t -76.54 77.53 3.23 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 102.929 -2.989 . . . . 0.0 102.929 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 62.4 -98.02 0.19 Allowed Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 127.162 2.315 . . . . 0.0 114.715 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . 0.325 7.0 m-20 -86.42 -0.9 56.96 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 114.726 -2.559 . . . . 0.0 110.717 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 6.3 mp0 -124.42 123.49 40.27 Favored 'General case' 0 C--O 1.205 -1.253 0 O-C-N 126.285 2.241 . . . . 0.0 112.451 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.454 HD23 ' CD2' ' A' ' 128' ' ' PHE . 10.0 tt -93.02 133.29 36.32 Favored 'General case' 0 C--O 1.222 -0.375 0 N-CA-C 101.286 -3.598 . . . . 0.0 101.286 -179.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.453 ' CG2' HG23 ' A' ' 116' ' ' THR 0.285 47.5 mt -138.03 120.85 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.301 0 O-C-N 125.976 2.048 . . . . 0.0 108.976 -179.79 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.481 ' HB2' ' CD ' ' A' ' 126' ' ' ARG . 72.6 mt-30 -91.74 150.04 21.31 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 101.772 -3.418 . . . . 0.0 101.772 -179.511 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.453 HG23 ' CG2' ' A' ' 114' ' ' ILE . 0.1 OUTLIER -166.15 148.68 7.1 Favored 'General case' 0 N--CA 1.414 -2.244 0 O-C-N 128.389 3.556 . . . . 0.0 111.181 -179.236 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . 0.549 ' CE2' ' HB ' ' A' ' 105' ' ' VAL 0.382 23.3 m-85 132.1 -142.86 0.0 OUTLIER 'General case' 0 CA--C 1.478 -1.793 0 O-C-N 128.682 3.739 . . . . 0.0 113.312 177.31 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.553 ' HA ' ' CE2' ' A' ' 17' ' ' PHE . 13.4 t -136.62 -173.66 3.49 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-O 127.165 3.364 . . . . 0.0 117.218 -174.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.467 ' HA ' ' HG ' ' A' ' 102' ' ' LEU 0.276 2.2 t80 -112.16 -15.99 13.11 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 112.56 -2.109 . . . . 0.0 109.055 177.644 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.452 ' HB2' ' CD2' ' A' ' 119' ' ' TYR . 0.4 OUTLIER -153.71 -71.17 0.14 Allowed 'General case' 0 C--N 1.298 -1.641 0 O-C-N 119.64 -1.912 . . . . 0.0 109.492 -179.916 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -160.51 34.1 0.42 Allowed Glycine 0 C--N 1.363 2.049 0 N-CA-C 120.59 2.996 . . . . 0.0 120.59 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 90.2 t -139.57 103.54 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.193 0 N-CA-C 103.476 -2.786 . . . . 0.0 103.476 179.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 6.6 mp0 -68.47 177.63 2.33 Favored 'General case' 0 CA--C 1.503 -0.852 0 CA-C-O 123.778 1.751 . . . . 0.0 113.264 -178.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.443 ' HB2' ' CA ' ' A' ' 14' ' ' TYR . . . -167.77 176.74 6.15 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-O 114.379 -2.724 . . . . 0.0 104.906 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.471 ' HB2' ' CB ' ' A' ' 12' ' ' GLU 0.328 2.8 mptp? -145.3 156.17 43.65 Favored 'General case' 0 CA--C 1.506 -0.732 0 O-C-N 127.55 3.031 . . . . 0.0 107.818 -179.68 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.481 ' CD ' ' HB2' ' A' ' 115' ' ' GLN . 0.0 OUTLIER -142.13 76.15 1.52 Allowed 'General case' 0 N--CA 1.432 -1.361 0 CA-C-N 112.556 -2.111 . . . . 0.0 110.411 179.753 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 6.7 mm -63.8 116.33 3.34 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 O-C-N 126.313 2.258 . . . . 0.0 115.209 179.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.528 ' CE2' HD21 ' A' ' 38' ' ' LEU . 2.7 m-30 -109.24 125.93 52.78 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 126.011 1.724 . . . . 0.0 107.57 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.433 ' CG ' ' HB2' ' A' ' 9' ' ' ASP 0.279 14.8 mmmt -91.16 3.22 55.35 Favored 'General case' 0 N--CA 1.441 -0.897 0 O-C-N 119.961 -1.712 . . . . 0.0 112.213 -179.649 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.447 ' HD2' ' CH2' ' A' ' 6' ' ' TRP . 4.3 tttp 74.14 143.26 0.07 Allowed 'General case' 0 C--N 1.349 0.561 0 O-C-N 124.501 1.126 . . . . 0.0 108.763 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . 0.835 1.0 OUTLIER . . . . . 0 N--CA 1.431 -1.419 0 N-CA-C 115.401 1.63 . . . . 0.0 115.401 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' PLM . . . . . 0.431 ' O1 ' ' NH2' ' A' ' 106' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.258 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -134.11 83.3 2.03 Favored 'General case' 0 N--CA 1.428 -1.534 0 O-C-N 121.079 -1.013 . . . . 0.0 113.363 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -156.94 88.41 1.03 Allowed 'General case' 0 N--CA 1.44 -0.94 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.904 179.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.4 ' O ' ' N ' ' A' ' 40' ' ' ILE . . . 160.09 -130.72 2.48 Favored Glycine 0 CA--C 1.5 -0.86 0 C-N-CA 117.017 -2.516 . . . . 0.0 109.373 -179.789 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.403 HG22 ' HA ' ' A' ' 131' ' ' GLU 0.499 5.3 t -117.73 171.11 8.26 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 123.197 1.475 . . . . 0.0 114.123 -179.958 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.527 ' CZ3' ' HB2' ' A' ' 130' ' ' LYS . 80.3 m95 -152.13 147.61 26.65 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-N 110.227 -3.17 . . . . 0.0 105.816 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 4.8 ttmm -139.61 122.19 16.27 Favored 'General case' 0 C--O 1.205 -1.246 0 O-C-N 127.767 3.167 . . . . 0.0 105.514 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.517 ' HB ' ' CD1' ' A' ' 128' ' ' PHE 0.379 8.0 p -69.02 139.21 20.85 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.022 0 CA-C-N 121.143 1.792 . . . . 0.0 110.773 179.996 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -129.39 -46.82 1.19 Allowed 'General case' 0 C--O 1.212 -0.91 0 O-C-N 127.387 2.929 . . . . 0.0 106.373 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.421 ' O ' ' N ' ' A' ' 127' ' ' ILE . 9.2 ttt180 -129.21 144.85 51.37 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 106.962 -1.495 . . . . 0.0 106.962 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.409 ' N ' ' HG3' ' A' ' 10' ' ' ARG 0.385 97.7 m-20 -131.59 -171.12 2.53 Favored 'General case' 0 CA--C 1.501 -0.936 0 O-C-N 128.604 3.69 . . . . 0.0 107.886 179.956 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -146.43 -85.69 0.11 Allowed 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 122.595 2.452 . . . . 0.0 110.897 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.424 ' HB3' ' HA ' ' A' ' 124' ' ' ALA . 2.8 t30 -90.64 16.74 8.55 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-N 121.342 1.883 . . . . 0.0 114.154 179.445 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.517 ' CD2' ' HG2' ' A' ' 126' ' ' ARG 0.283 0.2 OUTLIER -63.98 -20.98 66.29 Favored 'General case' 0 C--O 1.242 0.665 0 O-C-N 127.595 3.06 . . . . 0.0 115.11 179.858 . . . . . . . . 4 4 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -76.19 -36.91 58.43 Favored 'General case' 0 C--O 1.205 -1.261 0 O-C-N 118.909 -2.369 . . . . 0.0 108.186 179.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.408 ' HB3' ' ND2' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -77.3 -33.76 55.62 Favored 'General case' 0 N--CA 1.435 -1.189 0 CA-C-N 112.855 -1.975 . . . . 0.0 113.194 179.981 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -70.27 -21.44 62.97 Favored 'General case' 0 N--CA 1.438 -1.046 0 O-C-N 118.798 -2.439 . . . . 0.0 109.666 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.433 ' CB ' HG13 ' A' ' 23' ' ' ILE . 4.8 mtt -76.86 -35.19 57.65 Favored 'General case' 0 CA--C 1.503 -0.852 0 CA-C-O 125.868 2.747 . . . . 0.0 107.268 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -70.79 -29.62 65.87 Favored 'General case' 0 C--O 1.244 0.771 0 CA-C-O 127.295 3.426 . . . . 0.0 112.007 179.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 42.3 tptt -80.07 -27.78 39.28 Favored 'General case' 0 N--CA 1.437 -1.118 0 O-C-N 119.252 -2.155 . . . . 0.0 110.383 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 17.8 mtp -71.5 -30.88 66.47 Favored 'General case' 0 C--O 1.202 -1.436 0 O-C-N 119.554 -1.966 . . . . 0.0 106.669 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.31 32.52 2.75 Favored Glycine 0 C--N 1.306 -1.129 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.479 HG21 ' CB ' ' A' ' 27' ' ' LYS . 6.0 mm -78.33 -71.38 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.362 1.124 0 CA-C-O 115.561 -2.161 . . . . 0.0 106.901 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 66.53 152.17 0.07 Allowed 'General case' 0 N--CA 1.445 -0.716 0 O-C-N 126.777 2.548 . . . . 0.0 114.755 179.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . 0.4 2.6 t 50.18 -122.94 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.355 0.835 0 N-CA-C 120.268 3.432 . . . . 0.0 120.268 179.679 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.542 3.4 m -65.43 -36.86 78.68 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.037 0 N-CA-C 118.379 2.733 . . . . 0.0 118.379 -179.776 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.479 ' CB ' HG21 ' A' ' 23' ' ' ILE . 62.8 mttm -60.93 -25.89 67.1 Favored 'General case' 0 N--CA 1.438 -1.067 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 4.7 mtm-85 -78.08 -31.26 50.04 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 117.435 -1.706 . . . . 0.0 108.178 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 8.1 tptm -71.36 -45.85 61.89 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 114.02 -1.446 . . . . 0.0 111.798 179.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 12.2 mt -78.02 -29.2 49.36 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 -179.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.16 -36.07 60.43 Favored Glycine 0 C--N 1.338 0.641 0 CA-C-O 123.089 1.383 . . . . 0.0 111.681 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -75.63 -22.84 56.45 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-O 116.738 -1.601 . . . . 0.0 112.946 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 18.0 t60 -120.78 46.2 2.07 Favored 'General case' 0 N--CA 1.447 -0.615 0 O-C-N 128.829 3.831 . . . . 0.0 114.125 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -72.05 -19.19 61.87 Favored 'General case' 0 C--O 1.21 -0.991 0 O-C-N 128.544 3.653 . . . . 0.0 117.703 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . 0.255 2.0 t-20 65.93 38.99 4.73 Favored 'General case' 0 C--N 1.312 -1.037 0 C-N-CA 118.593 -1.243 . . . . 0.0 109.454 -179.314 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.435 HD22 ' N ' ' A' ' 38' ' ' LEU . 3.0 tt -61.2 137.29 58.24 Favored 'General case' 0 C--O 1.216 -0.698 0 O-C-N 125.632 1.833 . . . . 0.0 112.847 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.3 ttpt -139.2 100.83 4.11 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 101.55 -3.5 . . . . 0.0 101.55 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.435 ' N ' HD22 ' A' ' 36' ' ' LEU 0.277 0.4 OUTLIER -93.08 117.19 29.78 Favored 'General case' 0 C--N 1.293 -1.88 0 O-C-N 119.349 -2.095 . . . . 0.0 107.008 -179.578 . . . . . . . . 4 4 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.461 ' HB ' ' CB ' ' A' ' 50' ' ' LYS . 85.2 m -104.44 100.47 10.16 Favored 'General case' 0 N--CA 1.436 -1.135 0 N-CA-C 104.192 -2.522 . . . . 0.0 104.192 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.4 ' N ' ' O ' ' A' ' 4' ' ' GLY . 7.9 mt -71.29 149.86 9.56 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 179.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 89.3 m -142.71 63.44 1.39 Allowed 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 113.68 -1.6 . . . . 0.0 112.519 -179.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -62.35 119.85 9.88 Favored 'General case' 0 C--O 1.222 -0.362 0 O-C-N 125.228 1.58 . . . . 0.0 109.723 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -153.48 108.68 3.19 Favored 'General case' 0 CA--C 1.489 -1.392 0 CA-C-O 122.951 1.358 . . . . 0.0 110.079 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 61.35 31.73 78.32 Favored Glycine 0 C--N 1.306 -1.108 0 N-CA-C 108.888 -1.685 . . . . 0.0 108.888 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.31 0.2 OUTLIER 87.63 -14.05 0.44 Allowed 'General case' 0 C--O 1.225 -0.189 0 CA-C-N 112.978 -1.611 . . . . 0.0 110.856 179.728 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -80.09 121.1 25.12 Favored 'General case' 0 N--CA 1.428 -1.542 0 C-N-CA 116.333 -2.147 . . . . 0.0 110.094 -179.557 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.538 ' CD2' HD21 ' A' ' 64' ' ' LEU 0.311 0.4 OUTLIER -101.77 104.93 15.74 Favored 'General case' 0 C--O 1.217 -0.634 0 N-CA-C 105.985 -1.857 . . . . 0.0 105.985 179.963 . . . . . . . . 4 4 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . 0.432 1.6 t -105.29 73.2 1.02 Allowed 'General case' 0 C--N 1.313 -1.002 0 CA-C-O 125.542 2.591 . . . . 0.0 111.979 -179.596 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . 0.626 0.5 OUTLIER -52.37 94.47 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.425 -1.703 0 CA-C-N 108.704 -3.862 . . . . 0.0 112.636 -179.866 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.461 ' CB ' ' HB ' ' A' ' 39' ' ' THR . 5.1 ttmt -64.6 153.88 37.98 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 100.631 -3.84 . . . . 0.0 100.631 179.381 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -149.42 92.92 1.99 Allowed 'General case' 0 C--O 1.215 -0.733 0 N-CA-C 103.774 -2.676 . . . . 0.0 103.774 -179.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -88.06 77.88 8.29 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-O 125.025 2.345 . . . . 0.0 106.696 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -95.11 -176.51 3.84 Favored 'General case' 0 N--CA 1.439 -1.003 0 O-C-N 119.883 -1.761 . . . . 0.0 112.411 -179.401 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -65.21 -19.41 65.96 Favored 'General case' 0 N--CA 1.444 -0.772 0 O-C-N 126.681 2.488 . . . . 0.0 108.612 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.4 ' CD1' ' N ' ' A' ' 55' ' ' PHE . 6.1 m-85 -90.04 -56.52 3.19 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-O 115.22 -2.324 . . . . 0.0 115.165 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -155.62 168.58 26.69 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 123.833 3.015 . . . . 0.0 107.947 179.418 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -106.29 63.16 0.65 Allowed 'General case' 0 C--O 1.216 -0.696 2 N-CA-C 100.007 -4.071 . . . . 0.0 100.007 179.645 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 12.1 tt -91.95 97.8 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 O-C-N 127.99 3.306 . . . . 0.0 114.509 -179.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . 0.273 0.0 OUTLIER -62.88 125.9 25.54 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 104.935 -2.246 . . . . 0.0 104.935 179.136 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.52 HG13 ' CE2' ' A' ' 62' ' ' PHE . 2.5 t -105.2 85.38 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 C-N-CA 119.035 -1.066 . . . . 0.0 109.735 -178.641 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . 0.399 2.0 m -74.44 150.84 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.37 0 CA-C-O 125.865 2.745 . . . . 0.0 115.163 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.626 ' CZ ' ' CZ2' ' A' ' 82' ' ' TRP . 0.0 OUTLIER -168.21 95.65 0.4 Allowed 'General case' 0 N--CA 1.43 -1.473 0 CA-C-N 112.673 -2.058 . . . . 0.0 111.639 179.7 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.74 99.91 0.06 Allowed 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 102.477 -3.157 . . . . 0.0 102.477 179.572 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.538 HD21 ' CD2' ' A' ' 47' ' ' PHE . 0.2 OUTLIER -33.86 100.02 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 127.052 2.72 . . . . 0.0 112.683 -179.865 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 102.46 23.44 8.92 Favored Glycine 0 CA--C 1.528 0.881 0 O-C-N 128.453 3.596 . . . . 0.0 116.842 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.435 ' O ' ' CE2' ' A' ' 68' ' ' PHE 0.269 2.4 t -113.88 79.4 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.505 0 CA-C-O 115.184 -2.341 . . . . 0.0 105.301 -179.99 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . 0.278 23.5 m-20 -27.92 118.5 0.1 Allowed 'General case' 0 CA--C 1.498 -1.035 0 N-CA-C 115.682 1.734 . . . . 0.0 115.682 -179.806 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.571 ' CZ ' ' CB ' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -129.0 -173.57 3.02 Favored 'General case' 0 N--CA 1.442 -0.837 0 O-C-N 118.602 -2.561 . . . . 0.0 107.72 -179.922 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -128.84 138.15 51.88 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -138.85 95.17 2.92 Favored 'General case' 0 C--O 1.215 -0.727 0 C-N-CA 119.26 -0.976 . . . . 0.0 113.026 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -74.36 115.71 14.2 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 105.103 -2.184 . . . . 0.0 105.103 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 46.8 mt -71.16 -169.1 0.35 Allowed 'General case' 0 C--N 1.298 -1.637 0 CA-C-O 117.795 -1.098 . . . . 0.0 109.745 -179.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -85.26 -35.95 21.22 Favored 'General case' 0 C--O 1.214 -0.784 0 O-C-N 128.666 3.729 . . . . 0.0 113.332 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.424 ' HB2' ' CG ' ' A' ' 132' ' ' PLM . 11.7 t0 -143.17 21.88 1.9 Allowed 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 113.982 -1.463 . . . . 0.0 108.555 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -130.92 -15.42 1.72 Allowed Glycine 0 CA--C 1.544 1.851 0 CA-C-O 117.797 -1.557 . . . . 0.0 116.829 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER 64.7 -177.65 0.17 Allowed 'General case' 0 N--CA 1.433 -1.306 0 CA-C-N 119.994 1.897 . . . . 0.0 114.204 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.488 ' CB ' ' HB ' ' A' ' 96' ' ' VAL . 4.7 mp0 -26.94 119.71 0.09 Allowed 'General case' 0 CA--C 1.5 -0.958 1 O-C-N 129.626 4.329 . . . . 0.0 115.608 179.923 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.434 ' HG ' ' CD1' ' A' ' 93' ' ' PHE 0.433 0.9 OUTLIER -142.67 78.01 1.6 Allowed 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 101.9 -3.37 . . . . 0.0 101.9 179.997 . . . . . . . . 4 4 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 3.7 m -82.74 165.88 19.55 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 101.804 -3.406 . . . . 0.0 101.804 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 144.31 -170.65 25.99 Favored Glycine 0 CA--C 1.538 1.519 0 C-N-CA 119.345 -1.407 . . . . 0.0 112.336 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -146.38 171.32 15.19 Favored 'General case' 0 C--O 1.203 -1.364 0 C-N-CA 117.668 -1.613 . . . . 0.0 111.386 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . 0.626 ' CZ2' ' CZ ' ' A' ' 62' ' ' PHE 0.335 13.3 m0 -114.46 141.52 47.58 Favored 'General case' 0 N--CA 1.424 -1.771 0 N-CA-C 101.388 -3.56 . . . . 0.0 101.388 179.63 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.403 HG22 HG21 ' A' ' 90' ' ' VAL . 9.9 t -146.85 141.4 26.57 Favored 'General case' 0 N--CA 1.427 -1.581 0 O-C-N 124.261 0.975 . . . . 0.0 109.797 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 12.4 ttm -81.64 129.62 34.76 Favored 'General case' 0 CA--C 1.496 -1.133 0 C-N-CA 121.2 -0.2 . . . . 0.0 110.897 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . 0.597 3.7 pt-20 -122.51 54.75 1.19 Allowed 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 96.6 -127.82 9.32 Favored Glycine 0 N--CA 1.439 -1.111 0 O-C-N 126.008 2.067 . . . . 0.0 108.503 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -80.65 9.47 6.11 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 115.502 1.668 . . . . 0.0 115.502 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . 0.275 0.1 OUTLIER -132.49 172.8 12.02 Favored 'General case' 0 CA--C 1.503 -0.836 0 O-C-N 125.712 1.882 . . . . 0.0 106.667 179.623 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.487 HD22 ' CE2' ' A' ' 47' ' ' PHE . 2.6 tp -127.74 159.11 35.77 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 105.339 -2.097 . . . . 0.0 105.339 179.76 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.436 HG13 HG21 ' A' ' 105' ' ' VAL . 17.4 m -142.83 122.61 9.52 Favored 'Isoleucine or valine' 0 C--O 1.245 0.864 0 C-N-CA 116.09 -2.244 . . . . 0.0 110.107 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -92.64 97.49 2.27 Favored Glycine 0 C--N 1.35 1.338 0 N-CA-C 108.031 -2.028 . . . . 0.0 108.031 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.489 ' CG ' ' CD1' ' A' ' 103' ' ' ILE . 2.0 mttt -92.62 126.88 37.9 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 102.78 -3.045 . . . . 0.0 102.78 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.434 ' CD1' ' HG ' ' A' ' 78' ' ' LEU . 53.2 m-85 -127.96 110.74 12.83 Favored 'General case' 0 N--CA 1.444 -0.758 0 O-C-N 126.201 2.188 . . . . 0.0 112.621 -179.82 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -103.65 126.82 51.04 Favored 'General case' 0 N--CA 1.435 -1.203 0 N-CA-C 105.407 -2.071 . . . . 0.0 105.407 179.854 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . 0.433 3.3 mmm180 -81.64 156.49 25.08 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 127.227 2.829 . . . . 0.0 109.69 -179.778 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.488 ' HB ' ' CB ' ' A' ' 77' ' ' GLU . 3.3 t -78.4 -54.54 11.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 C-N-CA 124.552 1.141 . . . . 0.0 113.152 -179.682 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . 0.452 14.9 m-20 -68.53 -9.44 49.29 Favored 'General case' 0 C--O 1.254 1.311 0 N-CA-C 117.952 2.575 . . . . 0.0 117.952 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.401 ' ND2' ' HG3' ' A' ' 100' ' ' LYS . 19.5 p-10 -145.04 6.48 1.16 Allowed 'General case' 0 N--CA 1.438 -1.071 0 CA-C-O 115.328 -2.272 . . . . 0.0 114.069 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 39.98 40.64 1.76 Allowed Glycine 0 CA--C 1.542 1.773 0 O-C-N 125.285 1.616 . . . . 0.0 114.485 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.401 ' HG3' ' ND2' ' A' ' 98' ' ' ASN . 32.2 mmtm -78.18 -127.32 0.01 OUTLIER 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 114.14 -1.03 . . . . 0.0 109.293 -179.56 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 171.36 97.59 0.01 OUTLIER 'General case' 0 N--CA 1.433 -1.276 0 C-N-CA 130.019 3.327 . . . . 0.0 115.125 -179.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.562 ' CG ' ' HA ' ' A' ' 119' ' ' TYR . 0.3 OUTLIER -89.52 121.67 31.96 Favored 'General case' 0 N--CA 1.442 -0.875 2 C-N-CA 132.566 4.347 . . . . 0.0 103.871 178.863 . . . . . . . . 4 4 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.508 ' N ' ' O ' ' A' ' 118' ' ' THR . 4.6 tp -120.21 157.53 22.71 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.742 0 C-N-CA 115.844 -2.343 . . . . 0.0 105.864 179.276 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.451 ' HA ' ' HB2' ' A' ' 117' ' ' TYR . . . -141.33 136.69 31.77 Favored 'General case' 0 C--N 1.313 -1.001 0 O-C-N 118.557 -2.589 . . . . 0.0 108.16 -179.152 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.615 ' HB ' ' CD2' ' A' ' 117' ' ' TYR . 0.5 OUTLIER -125.63 104.56 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 CA-C-N 122.856 2.571 . . . . 0.0 112.837 -179.709 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.518 ' NH2' ' CZ2' ' A' ' 82' ' ' TRP . 4.9 mtt-85 -74.06 94.24 2.37 Favored 'General case' 0 C--N 1.307 -1.275 0 O-C-N 119.729 -1.857 . . . . 0.0 106.831 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -98.53 84.87 3.25 Favored 'General case' 0 N--CA 1.419 -2.002 0 O-C-N 126.058 2.099 . . . . 0.0 114.394 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.438 ' HA ' ' HA ' ' A' ' 113' ' ' LEU 0.38 0.1 OUTLIER -60.89 101.09 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 C-N-CA 116.403 -2.119 . . . . 0.0 108.503 179.897 . . . . . . . . 4 4 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 10.4 p -87.85 70.09 9.52 Favored 'General case' 0 CA--C 1.504 -0.79 0 N-CA-C 104.511 -2.404 . . . . 0.0 104.511 -179.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 76.99 -115.05 4.22 Favored Glycine 0 C--N 1.339 0.734 0 O-C-N 127.601 3.063 . . . . 0.0 111.677 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 48.8 m-20 -69.13 -25.24 64.29 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 120.014 1.907 . . . . 0.0 112.264 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.22 143.77 29.1 Favored 'General case' 0 CA--C 1.494 -1.19 0 CA-C-O 116.295 -1.812 . . . . 0.0 115.523 -179.592 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.491 ' HB2' ' CZ3' ' A' ' 6' ' ' TRP . 0.3 OUTLIER -104.79 146.12 29.42 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 100.741 -3.8 . . . . 0.0 100.741 179.979 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.474 ' CG2' HD11 ' A' ' 127' ' ' ILE 0.284 81.7 mt -149.26 110.74 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.171 0 CA-C-O 117.164 -1.398 . . . . 0.0 109.163 -179.904 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.515 ' HB2' ' HD2' ' A' ' 126' ' ' ARG . 55.3 mt-30 -86.2 167.0 15.28 Favored 'General case' 0 C--N 1.345 0.378 0 N-CA-C 104.035 -2.58 . . . . 0.0 104.035 179.857 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.475 ' CG2' ' C ' ' A' ' 115' ' ' GLN . 5.0 p -159.75 -152.33 0.3 Allowed 'General case' 0 CA--C 1.494 -1.184 1 O-C-N 130.516 4.885 . . . . 0.0 106.501 -177.198 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . 0.615 ' CD2' ' HB ' ' A' ' 105' ' ' VAL . 8.7 m-30 76.88 -165.74 0.05 Allowed 'General case' 0 CA--C 1.46 -2.488 1 O-C-N 129.379 4.175 . . . . 0.0 114.309 175.144 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.508 ' O ' ' N ' ' A' ' 103' ' ' ILE . 6.9 t -138.87 -162.37 1.31 Allowed 'General case' 0 N--CA 1.437 -1.11 0 CA-C-O 127.384 3.469 . . . . 0.0 117.116 -174.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.562 ' HA ' ' CG ' ' A' ' 102' ' ' LEU . 1.6 t80 -111.57 -25.79 9.38 Favored 'General case' 0 C--N 1.348 0.525 0 CA-C-N 111.769 -2.469 . . . . 0.0 109.773 178.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.503 ' HB2' ' CD2' ' A' ' 119' ' ' TYR . 0.2 OUTLIER -153.23 -59.83 0.14 Allowed 'General case' 0 C--N 1.29 -2.004 0 C-N-CA 126.498 1.919 . . . . 0.0 110.017 -179.876 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -153.76 1.56 0.23 Allowed Glycine 0 C--N 1.362 1.988 0 N-CA-C 121.178 3.231 . . . . 0.0 121.178 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 37.0 t -110.39 98.91 7.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 O-C-N 117.49 -3.359 . . . . 0.0 104.915 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -64.87 -175.54 0.2 Allowed 'General case' 0 C--O 1.21 -0.984 0 O-C-N 120.001 -1.687 . . . . 0.0 112.435 -179.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.424 ' HA ' ' HB3' ' A' ' 13' ' ' ASN . . . -170.19 -167.83 0.67 Allowed 'General case' 0 C--O 1.21 -0.992 0 CA-C-O 113.872 -2.966 . . . . 0.0 106.991 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . 0.29 0.0 OUTLIER -157.88 143.84 17.32 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 122.775 2.534 . . . . 0.0 111.867 179.901 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.517 ' HG2' ' CD2' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -137.39 78.22 1.68 Allowed 'General case' 0 C--O 1.209 -1.052 0 O-C-N 128.058 3.349 . . . . 0.0 110.573 179.752 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.474 HD11 ' CG2' ' A' ' 114' ' ' ILE . 1.7 mm -66.44 96.18 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 O-C-N 125.311 1.632 . . . . 0.0 114.422 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.517 ' CD1' ' HB ' ' A' ' 8' ' ' VAL . 26.5 m-85 -84.49 137.69 33.21 Favored 'General case' 0 C--O 1.219 -0.503 0 C-N-CA 126.524 1.93 . . . . 0.0 106.709 179.775 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 10.0 mmtt -101.12 41.24 1.2 Allowed 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 115.455 -2.212 . . . . 0.0 112.465 -179.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.527 ' HB2' ' CZ3' ' A' ' 6' ' ' TRP . 3.2 tttm 27.36 98.22 0.0 OUTLIER 'General case' 0 C--O 1.238 0.491 0 C-N-CA 127.462 2.305 . . . . 0.0 116.401 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.403 ' HA ' HG22 ' A' ' 5' ' ' THR 0.858 2.6 tm-20 . . . . . 0 N--CA 1.439 -1.022 0 O-C-N 117.912 -2.992 . . . . 0.0 116.892 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' PLM . . . . . 0.426 ' HE1' ' HE3' ' A' ' 18' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.516 -0.34 0 CA-C-O 117.061 -1.447 . . . . 0.0 112.617 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.528 ' CZ ' HG13 ' A' ' 108' ' ' ILE . 96.6 m-85 57.33 38.02 28.34 Favored 'General case' 0 CA--C 1.508 -0.659 0 C-N-CA 116.393 -2.123 . . . . 0.0 116.128 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -156.27 90.72 1.21 Allowed 'General case' 0 N--CA 1.436 -1.132 0 CA-C-N 113.66 -1.609 . . . . 0.0 113.205 179.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 155.98 -148.19 17.91 Favored Glycine 0 N--CA 1.432 -1.589 0 C-N-CA 114.992 -3.48 . . . . 0.0 114.395 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . 0.576 32.9 p -103.76 150.35 24.16 Favored 'General case' 0 C--N 1.311 -1.088 0 O-C-N 126.935 2.197 . . . . 0.0 114.182 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.531 ' CZ2' HD12 ' A' ' 108' ' ' ILE . 93.7 m95 -148.11 141.21 24.97 Favored 'General case' 0 N--CA 1.431 -1.405 0 O-C-N 126.346 2.279 . . . . 0.0 106.087 179.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 18.3 tttt -141.47 93.54 2.58 Favored 'General case' 0 C--O 1.204 -1.32 0 CA-C-O 116.778 -1.582 . . . . 0.0 107.257 179.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.484 ' CG1' ' HB3' ' A' ' 36' ' ' LEU 0.32 1.5 p -43.78 136.9 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-O 117.127 -1.416 . . . . 0.0 113.341 -179.96 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.419 ' N ' HG21 ' A' ' 8' ' ' VAL . 14.6 t70 -126.15 -18.45 4.99 Favored 'General case' 0 CA--C 1.503 -0.853 0 O-C-N 124.671 1.232 . . . . 0.0 111.321 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.02 145.65 15.4 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 119.753 -1.842 . . . . 0.0 106.496 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . 0.298 0.2 OUTLIER -109.09 -169.83 1.55 Allowed 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 112.452 -2.158 . . . . 0.0 109.54 179.715 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -176.87 90.35 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 100.7 -7.39 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 125.132 1.373 . . . . 0.0 112.229 -179.575 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.566 ' CD2' ' CG ' ' A' ' 126' ' ' ARG 0.252 0.2 OUTLIER -69.96 -38.67 76.17 Favored 'General case' 0 C--O 1.222 -0.386 0 O-C-N 128.314 3.509 . . . . 0.0 114.185 179.584 . . . . . . . . 4 4 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.52 -29.24 68.98 Favored 'General case' 0 CA--C 1.509 -0.602 0 CA-C-N 121.539 1.972 . . . . 0.0 113.043 179.696 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.9 -37.42 34.77 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 113.504 -1.68 . . . . 0.0 110.391 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.545 ' CD2' ' CE1' ' A' ' 14' ' ' TYR . 0.9 OUTLIER -70.73 -28.62 64.86 Favored 'General case' 0 C--O 1.244 0.765 0 CA-C-O 124.765 2.222 . . . . 0.0 111.747 -179.981 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 32.1 mtt -72.15 -26.04 61.95 Favored 'General case' 0 C--N 1.324 -0.521 1 O-C-N 115.36 -4.588 . . . . 0.0 108.466 -179.686 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -79.68 -24.16 41.96 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 116.138 -2.225 . . . . 0.0 111.937 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 12.4 tptp -79.19 -30.53 43.43 Favored 'General case' 0 C--N 1.31 -1.145 0 O-C-N 120.68 -1.262 . . . . 0.0 109.379 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.545 ' CE ' ' CD1' ' A' ' 119' ' ' TYR 0.304 0.7 OUTLIER -78.41 -23.49 46.68 Favored 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 179.783 . . . . . . . . 4 4 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 88.33 56.87 1.96 Allowed Glycine 0 C--N 1.307 -1.049 0 CA-C-O 116.301 -2.389 . . . . 0.0 108.793 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.409 HG22 ' HA ' ' A' ' 28' ' ' ARG . 1.6 mm -81.26 -34.17 13.22 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 CA-C-O 115.081 -2.39 . . . . 0.0 111.719 -179.68 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 89.61 98.64 0.02 OUTLIER 'General case' 0 C--N 1.346 0.426 0 O-C-N 125.877 1.985 . . . . 0.0 113.431 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . 0.475 4.1 p 12.86 -62.08 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.349 0.577 0 N-CA-C 119.292 3.071 . . . . 0.0 119.292 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.605 0.0 OUTLIER -72.07 -42.08 67.7 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.876 0 N-CA-C 118.212 2.671 . . . . 0.0 118.212 -179.465 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.4 mtpp -64.4 -24.59 67.69 Favored 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 114.787 1.403 . . . . 0.0 114.787 -179.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.409 ' HA ' HG22 ' A' ' 23' ' ' ILE . 5.0 ptt85 -79.8 -25.68 40.8 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 119.207 -2.183 . . . . 0.0 108.239 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 8.8 tttt -73.99 -46.39 44.08 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.609 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.1 mp -72.81 -31.96 65.19 Favored 'General case' 0 N--CA 1.438 -1.058 0 O-C-N 124.872 1.358 . . . . 0.0 107.387 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -74.95 -34.49 52.65 Favored Glycine 0 C--N 1.346 1.102 0 O-C-N 124.576 1.172 . . . . 0.0 111.779 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -73.35 -26.71 61.13 Favored 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 114.476 1.288 . . . . 0.0 114.476 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -124.8 57.83 1.26 Allowed 'General case' 0 C--N 1.348 0.502 0 O-C-N 127.343 2.902 . . . . 0.0 111.175 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -90.78 -17.82 25.99 Favored 'General case' 0 C--O 1.211 -0.948 0 N-CA-C 118.511 2.782 . . . . 0.0 118.511 -179.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 10.3 t30 75.32 27.12 1.11 Allowed 'General case' 0 C--O 1.24 0.6 0 C-N-CA 117.992 -1.483 . . . . 0.0 110.092 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.484 ' HB3' ' CG1' ' A' ' 8' ' ' VAL . 13.8 tp -52.77 106.54 0.16 Allowed 'General case' 0 C--O 1.216 -0.682 0 C-N-CA 126.542 1.937 . . . . 0.0 107.587 179.676 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 6.1 ttpt -104.58 103.91 13.65 Favored 'General case' 0 C--N 1.309 -1.183 0 O-C-N 127.086 2.741 . . . . 0.0 104.156 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . 0.271 1.0 OUTLIER -88.2 117.11 26.87 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 179.434 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.478 ' HB ' ' CB ' ' A' ' 50' ' ' LYS . 31.3 m -108.81 98.46 7.95 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 104.118 -2.549 . . . . 0.0 104.118 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.466 ' CG1' ' CG2' ' A' ' 49' ' ' VAL . 29.0 mt -81.38 142.33 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.38 0 O-C-N 126.143 2.152 . . . . 0.0 109.213 -179.717 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 20.9 m -145.33 83.14 1.66 Allowed 'General case' 0 CA--C 1.508 -0.639 0 O-C-N 128.091 3.369 . . . . 0.0 109.247 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.479 ' NE2' ' CE2' ' A' ' 47' ' ' PHE . 4.1 tt0 -82.85 132.18 35.17 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 114.375 -1.284 . . . . 0.0 108.312 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -117.67 67.53 0.75 Allowed 'General case' 0 CA--C 1.485 -1.527 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.91 -86.38 1.52 Allowed Glycine 0 N--CA 1.429 -1.82 0 N-CA-C 106.417 -2.673 . . . . 0.0 106.417 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.288 0.0 OUTLIER -111.08 -40.32 4.51 Favored 'General case' 0 N--CA 1.451 -0.417 0 O-C-N 125.541 1.377 . . . . 0.0 113.167 -179.912 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.408 ' HG3' ' HG3' ' A' ' 63' ' ' GLU . 5.3 ttmm -62.2 148.87 43.3 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.524 ' HB3' ' CE1' ' A' ' 62' ' ' PHE 0.306 1.7 m-85 -137.08 105.56 5.79 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 114.98 -1.009 . . . . 0.0 109.196 179.962 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.412 ' HB ' ' CG1' ' A' ' 61' ' ' VAL 0.423 9.5 t -99.38 126.05 45.18 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 105.712 -1.959 . . . . 0.0 105.712 179.43 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.466 ' CG2' ' CG1' ' A' ' 40' ' ' ILE 0.671 0.6 OUTLIER -107.23 115.89 49.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 O-C-N 126.801 2.563 . . . . 0.0 113.303 -179.84 . . . . . . . . 4 4 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.478 ' CB ' ' HB ' ' A' ' 39' ' ' THR . 7.3 tttt -78.63 100.37 6.97 Favored 'General case' 0 C--N 1.307 -1.267 1 N-CA-C 100.182 -4.006 . . . . 0.0 100.182 179.909 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 55.4 tt0 -95.64 63.75 2.47 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 102.446 -3.168 . . . . 0.0 102.446 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 11.0 m -74.92 60.27 0.96 Allowed 'General case' 0 C--N 1.289 -2.025 0 O-C-N 125.763 1.914 . . . . 0.0 106.725 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -82.13 179.36 7.84 Favored 'General case' 0 C--O 1.209 -1.073 0 C-N-CA 117.215 -1.794 . . . . 0.0 109.778 179.696 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -63.39 -30.43 71.56 Favored 'General case' 0 C--O 1.214 -0.789 0 O-C-N 125.329 1.643 . . . . 0.0 107.867 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.499 ' CD2' ' HB2' ' A' ' 73' ' ' ALA . 33.9 m-85 -68.16 -65.26 0.72 Allowed 'General case' 0 C--O 1.218 -0.6 0 C-N-CA 115.064 -2.654 . . . . 0.0 109.245 179.591 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.486 ' HB2' ' CG2' ' A' ' 58' ' ' ILE . 7.9 mtm-85 -139.81 170.88 15.07 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 123.98 3.082 . . . . 0.0 110.733 179.45 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -116.87 70.71 0.78 Allowed 'General case' 0 C--O 1.217 -0.636 1 N-CA-C 100.083 -4.043 . . . . 0.0 100.083 179.573 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.486 ' CG2' ' HB2' ' A' ' 56' ' ' ARG . 0.5 OUTLIER -107.05 91.41 1.76 Allowed 'Isoleucine or valine' 0 CA--C 1.561 1.382 0 C-N-CA 130.312 3.445 . . . . 0.0 117.432 -179.336 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -60.95 116.53 4.55 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 104.768 -2.308 . . . . 0.0 104.768 179.052 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.403 HG12 ' H21' ' A' ' 132' ' ' PLM . 13.3 p -104.0 105.75 19.02 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 O-C-N 124.64 1.212 . . . . 0.0 112.73 -178.132 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.412 ' CG1' ' HB ' ' A' ' 48' ' ' THR 0.412 0.6 OUTLIER -82.44 152.3 4.05 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 O-C-N 118.676 -2.515 . . . . 0.0 109.317 179.797 . . . . . . . . 4 4 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.641 ' CE1' ' CZ2' ' A' ' 82' ' ' TRP . 16.4 p90 -162.45 95.39 0.92 Allowed 'General case' 0 N--CA 1.445 -0.722 0 O-C-N 120.55 -1.344 . . . . 0.0 108.991 179.694 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.422 ' HB2' ' HB ' ' A' ' 66' ' ' VAL . 1.8 mt-10 -65.96 128.95 38.08 Favored 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 104.053 -2.573 . . . . 0.0 104.053 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.67 121.02 11.77 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-O 122.984 1.373 . . . . 0.0 110.857 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 71.09 25.55 75.47 Favored Glycine 0 N--CA 1.471 0.981 0 N-CA-C 117.525 1.77 . . . . 0.0 117.525 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.422 ' HB ' ' HB2' ' A' ' 63' ' ' GLU 0.409 78.3 t -102.99 -21.0 5.4 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 CA-C-O 116.958 -1.496 . . . . 0.0 108.049 179.712 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . 0.253 1.4 m-20 77.41 145.02 0.08 Allowed 'General case' 0 C--N 1.307 -1.279 0 O-C-N 126.081 2.113 . . . . 0.0 113.044 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.481 ' CE2' ' HB3' ' A' ' 62' ' ' PHE . 0.1 OUTLIER -167.25 177.0 6.37 Favored 'General case' 0 N--CA 1.419 -2.02 0 CA-C-N 119.691 1.132 . . . . 0.0 108.189 179.874 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -128.79 132.04 47.84 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 117.41 -1.281 . . . . 0.0 109.717 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 16.2 t80 -125.77 111.52 14.98 Favored 'General case' 0 N--CA 1.435 -1.206 0 O-C-N 125.46 1.725 . . . . 0.0 114.231 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.1 m -73.74 145.13 45.36 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 123.089 2.677 . . . . 0.0 106.699 179.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.1 mt -107.43 -171.48 1.88 Allowed 'General case' 0 CA--C 1.495 -1.155 0 N-CA-C 106.072 -1.825 . . . . 0.0 106.072 -179.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.499 ' HB2' ' CD2' ' A' ' 55' ' ' PHE . . . -109.31 11.97 25.01 Favored 'General case' 0 C--O 1.235 0.336 0 O-C-N 126.64 2.463 . . . . 0.0 114.822 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -132.12 -38.59 1.09 Allowed 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 113.499 0.926 . . . . 0.0 113.499 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -130.11 -4.7 4.51 Favored Glycine 0 CA--C 1.538 1.518 0 N-CA-C 117.252 1.661 . . . . 0.0 117.252 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . 0.363 0.0 OUTLIER 67.5 171.24 0.27 Allowed 'General case' 0 N--CA 1.441 -0.879 0 C-N-CA 116.793 -1.963 . . . . 0.0 113.35 179.953 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 12.02 111.37 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.891 1 O-C-N 130.192 4.682 . . . . 0.0 115.085 179.626 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.42 ' HG ' ' HB3' ' A' ' 93' ' ' PHE 0.406 0.7 OUTLIER -145.7 104.81 3.91 Favored 'General case' 0 C--O 1.219 -0.547 0 N-CA-C 101.863 -3.384 . . . . 0.0 101.863 179.939 . . . . . . . . 4 4 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 24.1 m -106.27 170.79 7.71 Favored 'General case' 0 CA--C 1.483 -1.597 0 CA-C-N 113.658 -1.61 . . . . 0.0 106.691 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 154.27 -171.45 32.82 Favored Glycine 0 N--CA 1.441 -0.98 0 C-N-CA 117.03 -2.509 . . . . 0.0 111.837 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 44.1 p -144.1 160.89 40.13 Favored 'General case' 0 C--O 1.199 -1.584 0 C-N-CA 117.701 -1.6 . . . . 0.0 109.899 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . 0.641 ' CZ2' ' CE1' ' A' ' 62' ' ' PHE . 10.5 m0 -101.94 156.51 17.49 Favored 'General case' 0 N--CA 1.426 -1.648 0 N-CA-C 102.055 -3.313 . . . . 0.0 102.055 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 3.2 t -150.42 124.18 9.19 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 117.751 -1.58 . . . . 0.0 106.932 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -84.32 111.68 19.63 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 112.714 -2.039 . . . . 0.0 111.733 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.426 ' HG3' ' CG2' ' A' ' 90' ' ' VAL 0.573 5.0 mt-10 -67.95 -49.69 60.29 Favored 'General case' 0 N--CA 1.421 -1.905 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -179.755 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 161.55 -61.2 0.29 Allowed Glycine 0 C--O 1.216 -1.028 0 N-CA-C 103.283 -3.927 . . . . 0.0 103.283 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -110.04 8.04 23.85 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 125.66 1.447 . . . . 0.0 113.675 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . 0.317 0.0 OUTLIER -156.87 126.73 6.29 Favored 'General case' 0 CA--C 1.503 -0.864 0 O-C-N 126.551 2.407 . . . . 0.0 107.571 179.953 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.2 mt -83.6 147.8 27.52 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 111.329 -2.669 . . . . 0.0 103.953 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.426 ' CG2' ' HG3' ' A' ' 85' ' ' GLU . 0.2 OUTLIER -137.35 133.54 46.6 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.889 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 -179.994 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -111.56 103.6 1.57 Allowed Glycine 0 CA--C 1.528 0.9 0 C-N-CA 125.649 1.595 . . . . 0.0 113.35 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 37.8 mtpt -98.65 118.57 35.66 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 102.935 -2.987 . . . . 0.0 102.935 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.496 ' CZ ' ' H52' ' A' ' 132' ' ' PLM . 15.6 m-85 -122.9 115.23 21.59 Favored 'General case' 0 CA--C 1.501 -0.916 0 O-C-N 126.416 2.322 . . . . 0.0 111.521 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 19.9 mttp -98.47 140.45 32.7 Favored 'General case' 0 CA--C 1.505 -0.762 0 CA-C-O 125.192 2.425 . . . . 0.0 108.434 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . 0.407 15.3 ttt180 -97.15 129.74 44.49 Favored 'General case' 0 CA--C 1.487 -1.475 0 CA-C-O 124.031 1.872 . . . . 0.0 106.102 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.476 ' CG2' ' N ' ' A' ' 97' ' ' ASP . 14.7 m -69.77 -34.73 62.04 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.934 0 CA-C-O 125.551 2.596 . . . . 0.0 114.675 -179.766 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.476 ' N ' ' CG2' ' A' ' 96' ' ' VAL 0.401 0.9 OUTLIER -63.75 -8.36 10.3 Favored 'General case' 0 C--O 1.255 1.39 0 CA-C-N 113.936 -1.484 . . . . 0.0 114.377 179.814 . . . . . . . . 4 4 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.407 ' ND2' ' OH ' ' A' ' 119' ' ' TYR . 13.3 p-10 -150.54 1.77 0.45 Allowed 'General case' 0 N--CA 1.433 -1.302 0 C-N-CA 116.196 -2.202 . . . . 0.0 116.732 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 65.83 21.94 69.79 Favored Glycine 0 CA--C 1.542 1.774 0 N-CA-C 115.673 1.029 . . . . 0.0 115.673 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 49.0 mmtt -89.68 -178.82 5.63 Favored 'General case' 0 C--O 1.202 -1.417 0 C-N-CA 119.823 -0.751 . . . . 0.0 112.802 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -143.48 119.42 10.63 Favored 'General case' 0 C--O 1.212 -0.885 0 C-N-CA 128.264 2.626 . . . . 0.0 113.866 179.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.532 ' CB ' ' HA ' ' A' ' 119' ' ' TYR . 5.5 tt -98.37 133.76 42.32 Favored 'General case' 0 N--CA 1.44 -0.972 1 C-N-CA 135.337 5.455 . . . . 0.0 106.211 -179.679 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.528 ' N ' ' O ' ' A' ' 118' ' ' THR . 7.1 tt -122.55 159.29 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.702 0 C-N-CA 115.855 -2.338 . . . . 0.0 104.726 179.489 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -156.39 145.54 20.49 Favored 'General case' 0 C--N 1.315 -0.902 0 O-C-N 118.844 -2.41 . . . . 0.0 107.542 -179.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.51 ' HB ' ' CE2' ' A' ' 117' ' ' TYR . 6.4 p -131.66 115.12 26.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-O 126.078 2.847 . . . . 0.0 110.287 -179.527 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.586 ' CZ ' ' CH2' ' A' ' 82' ' ' TRP . 2.3 mtt-85 -76.44 90.48 3.26 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 112.299 -2.228 . . . . 0.0 105.462 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.47 ' CG ' HG11 ' A' ' 105' ' ' VAL . 1.2 mt-10 -86.66 77.62 9.31 Favored 'General case' 0 N--CA 1.419 -2.015 0 CA-C-N 109.985 -3.28 . . . . 0.0 114.928 -179.682 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.531 HD12 ' CZ2' ' A' ' 6' ' ' TRP 0.257 0.6 OUTLIER -54.94 90.75 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 CA-C-O 122.931 1.348 . . . . 0.0 111.417 179.264 . . . . . . . . 4 4 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.459 ' N ' ' O ' ' A' ' 107' ' ' GLU . 23.9 m -80.97 66.99 6.71 Favored 'General case' 0 N--CA 1.432 -1.339 0 N-CA-C 103.822 -2.659 . . . . 0.0 103.822 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 52.7 -90.97 0.01 OUTLIER Glycine 0 N--CA 1.463 0.493 1 O-C-N 129.191 4.057 . . . . 0.0 111.113 -179.817 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . 0.322 4.5 m120 -82.29 -25.89 33.6 Favored 'General case' 0 C--N 1.309 -1.196 0 CA-C-O 115.935 -1.983 . . . . 0.0 110.675 179.805 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -110.28 125.63 53.33 Favored 'General case' 0 C--O 1.205 -1.256 0 N-CA-C 115.878 1.807 . . . . 0.0 115.878 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.413 HD21 ' N ' ' A' ' 114' ' ' ILE . 0.0 OUTLIER -87.04 143.6 27.26 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 100.633 -3.84 . . . . 0.0 100.633 179.983 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.462 ' CG2' HD12 ' A' ' 127' ' ' ILE 0.312 0.6 OUTLIER -142.13 136.57 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.585 0 N-CA-C 105.067 -2.197 . . . . 0.0 105.067 179.989 . . . . . . . . 4 4 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -109.54 123.24 49.08 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 100.926 -3.731 . . . . 0.0 100.926 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.463 ' O ' ' CG ' ' A' ' 117' ' ' TYR . 0.1 OUTLIER -135.39 147.73 49.12 Favored 'General case' 0 N--CA 1.417 -2.11 0 C-N-CA 118.091 -1.443 . . . . 0.0 111.829 -179.12 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . 0.51 ' CE2' ' HB ' ' A' ' 105' ' ' VAL 0.352 18.5 m-85 127.81 -144.95 0.0 OUTLIER 'General case' 0 CA--C 1.471 -2.08 1 O-C-N 131.892 5.745 . . . . 0.0 113.945 177.656 . . . . . . . . 4 3 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.528 ' O ' ' N ' ' A' ' 103' ' ' ILE . 7.9 t -150.13 -159.84 1.09 Allowed 'General case' 0 N--CA 1.437 -1.086 0 CA-C-O 125.825 2.726 . . . . 0.0 116.789 -174.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.545 ' CD1' ' CE ' ' A' ' 21' ' ' MET 0.25 38.1 t80 -108.5 -31.55 7.75 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 112.436 -2.165 . . . . 0.0 108.791 177.428 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.444 ' N ' HG22 ' A' ' 118' ' ' THR . 0.5 OUTLIER -148.16 -70.91 0.22 Allowed 'General case' 0 C--N 1.291 -1.955 0 C-N-CA 126.862 2.065 . . . . 0.0 109.605 179.112 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -147.3 18.55 1.52 Allowed Glycine 0 C--N 1.351 1.388 0 N-CA-C 120.887 3.115 . . . . 0.0 120.887 -179.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 50.7 t -117.24 93.08 2.35 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 N-CA-C 103.547 -2.76 . . . . 0.0 103.547 179.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.408 ' HA ' ' HB ' ' A' ' 118' ' ' THR . 6.6 mt-10 -57.99 178.82 0.08 Allowed 'General case' 0 CA--C 1.513 -0.467 0 CA-C-O 124.021 1.867 . . . . 0.0 112.368 -178.191 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.462 ' HB2' ' CG ' ' A' ' 14' ' ' TYR . . . -172.58 104.26 0.15 Allowed 'General case' 0 N--CA 1.436 -1.138 0 O-C-N 116.535 -3.853 . . . . 0.0 109.453 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.27 141.33 33.03 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 119.804 1.184 . . . . 0.0 108.997 179.49 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.566 ' CG ' ' CD2' ' A' ' 14' ' ' TYR . 3.8 mtp180 -129.13 79.21 1.9 Allowed 'General case' 0 C--O 1.214 -0.798 0 CA-C-O 116.126 -1.892 . . . . 0.0 110.509 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.462 HD12 ' CG2' ' A' ' 114' ' ' ILE . 3.8 mm -65.29 118.23 7.38 Favored 'Isoleucine or valine' 0 C--O 1.256 1.429 1 O-C-N 130.35 4.781 . . . . 0.0 115.201 179.64 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -104.67 137.46 42.46 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 126.362 1.865 . . . . 0.0 108.072 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . 0.363 0.6 OUTLIER -108.93 42.57 1.39 Allowed 'General case' 0 N--CA 1.439 -1.025 0 CA-C-O 116.475 -1.726 . . . . 0.0 111.47 -179.964 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.525 ' HB2' ' CZ3' ' A' ' 6' ' ' TRP . 0.0 OUTLIER 21.63 101.16 0.0 OUTLIER 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 128.404 2.682 . . . . 0.0 116.472 -179.904 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . 0.934 16.5 tt0 . . . . . 0 C--N 1.32 -0.697 0 N-CA-C 115.882 1.808 . . . . 0.0 115.882 179.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' PLM . . . . . 0.496 ' H52' ' CZ ' ' A' ' 93' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.419 ' HB2' ' CD2' ' A' ' 2' ' ' PHE . . . . . . . . 0 C--O 1.214 -0.773 0 CA-C-O 118.26 -0.876 . . . . 0.0 110.214 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.518 ' CE1' HG13 ' A' ' 108' ' ' ILE . 2.5 m-85 69.24 -74.46 0.08 Allowed 'General case' 0 N--CA 1.434 -1.255 0 C-N-CA 117.629 -1.628 . . . . 0.0 113.247 179.833 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -49.53 95.11 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.362 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 155.33 178.98 30.12 Favored Glycine 0 N--CA 1.441 -0.982 0 C-N-CA 118.024 -2.036 . . . . 0.0 112.324 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . 0.531 1.3 p -86.1 147.93 25.93 Favored 'General case' 0 C--N 1.312 -1.041 0 C-N-CA 124.82 1.248 . . . . 0.0 108.46 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.517 ' CH2' ' HD2' ' A' ' 130' ' ' LYS . 74.9 m95 -143.29 140.24 30.52 Favored 'General case' 0 CA--C 1.504 -0.804 0 CA-C-O 115.202 -2.332 . . . . 0.0 105.961 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 18.5 tttt -144.34 92.77 2.35 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 114.398 -2.715 . . . . 0.0 105.838 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.516 ' HB ' ' CE1' ' A' ' 128' ' ' PHE 0.258 7.4 p -34.38 128.13 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.16 0 CA-C-O 116.426 -1.749 . . . . 0.0 113.054 -179.998 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -126.35 -22.8 3.94 Favored 'General case' 0 N--CA 1.451 -0.406 0 O-C-N 125.922 2.014 . . . . 0.0 111.335 -179.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.4 ' HG2' ' HB ' ' A' ' 127' ' ' ILE . 0.0 OUTLIER -141.36 63.7 1.43 Allowed 'General case' 0 CA--C 1.49 -1.362 0 C-N-CA 118.758 -1.177 . . . . 0.0 113.409 -179.78 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . 0.473 16.4 m-20 -48.23 156.27 0.41 Allowed 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 124.023 0.929 . . . . 0.0 108.733 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.414 ' O ' ' N ' ' A' ' 125' ' ' LYS . 11.6 mt-10 -143.76 136.94 27.71 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-O 115.77 -2.062 . . . . 0.0 107.294 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.428 ' HB3' ' HA ' ' A' ' 124' ' ' ALA . 1.0 OUTLIER 53.76 20.7 2.36 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 122.127 2.239 . . . . 0.0 113.238 -179.691 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.402 ' HA ' ' HB2' ' A' ' 124' ' ' ALA 0.261 4.3 t80 -79.81 -35.81 37.88 Favored 'General case' 0 N--CA 1.442 -0.873 0 O-C-N 126.592 2.433 . . . . 0.0 114.858 179.529 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -77.37 -24.14 50.67 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 116.849 -1.548 . . . . 0.0 108.886 -179.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 8.3 ttmm -78.52 -29.41 46.51 Favored 'General case' 0 N--CA 1.431 -1.387 0 O-C-N 126.012 2.07 . . . . 0.0 111.669 179.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.447 ' CB ' ' HB3' ' A' ' 124' ' ' ALA . 0.2 OUTLIER -69.25 -34.98 75.64 Favored 'General case' 0 N--CA 1.429 -1.516 0 O-C-N 120.384 -1.448 . . . . 0.0 112.065 179.914 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 10.8 mtt -75.76 -26.49 57.44 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-O 124.903 2.287 . . . . 0.0 109.232 -179.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -79.61 -25.34 41.51 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 124.682 2.182 . . . . 0.0 112.347 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.508 ' HE3' ' CG ' ' A' ' 119' ' ' TYR . 3.5 tmtm? -70.61 -30.52 67.2 Favored 'General case' 0 C--O 1.209 -1.063 0 O-C-N 118.23 -2.794 . . . . 0.0 112.864 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -79.95 -33.86 39.28 Favored 'General case' 0 C--O 1.215 -0.745 0 O-C-N 126.132 2.145 . . . . 0.0 108.86 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 108.07 37.53 2.15 Favored Glycine 0 C--N 1.306 -1.1 0 CA-C-O 116.051 -2.527 . . . . 0.0 111.862 -179.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.5 mm -70.31 84.68 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.909 0 CA-C-O 113.253 -3.26 . . . . 0.0 105.033 179.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 10.9 m-20 -3.29 -90.07 0.0 OUTLIER 'General case' 0 C--O 1.247 0.933 0 O-C-N 128.484 3.615 . . . . 0.0 115.24 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . 0.359 20.3 m -155.86 -49.98 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.221 -0.419 0 N-CA-C 117.416 2.376 . . . . 0.0 117.416 179.716 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.569 14.4 m -76.4 -23.01 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.277 0 N-CA-C 116.837 2.162 . . . . 0.0 116.837 179.633 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.9 mtpt -74.98 -25.55 58.93 Favored 'General case' 0 N--CA 1.437 -1.1 0 O-C-N 127.253 2.845 . . . . 0.0 113.175 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.37 -22.22 44.69 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 118.317 -1.353 . . . . 0.0 108.784 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.7 ttpt -65.27 -50.35 66.1 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 122.251 1.024 . . . . 0.0 112.551 -179.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -76.01 -24.45 55.26 Favored 'General case' 0 C--O 1.214 -0.775 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 179.745 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -76.32 -31.56 54.38 Favored Glycine 0 N--CA 1.441 -1.021 0 O-C-N 128.643 3.714 . . . . 0.0 109.832 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -76.94 -38.99 52.27 Favored 'General case' 0 C--O 1.242 0.692 0 O-C-N 125.379 1.281 . . . . 0.0 111.026 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -108.07 47.54 0.89 Allowed 'General case' 0 N--CA 1.433 -1.277 0 CA-C-O 116.646 -1.645 . . . . 0.0 111.077 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -70.12 -37.23 75.27 Favored 'General case' 0 CA--C 1.495 -1.162 0 N-CA-C 118.63 2.826 . . . . 0.0 118.63 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . 0.262 0.1 OUTLIER 81.86 28.77 0.15 Allowed 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 117.709 -1.138 . . . . 0.0 110.629 -179.999 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -48.41 94.74 0.01 OUTLIER 'General case' 0 CA--C 1.507 -0.693 0 C-N-CA 125.05 1.34 . . . . 0.0 108.51 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 10.3 tttt -96.92 101.94 13.63 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 102.555 -3.128 . . . . 0.0 102.555 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.408 ' CB ' ' HB2' ' A' ' 6' ' ' TRP 0.322 2.1 tp -87.33 130.56 34.58 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 119.86 1.209 . . . . 0.0 110.157 -179.915 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.462 ' HB ' ' CB ' ' A' ' 50' ' ' LYS . 69.3 m -119.25 98.66 6.27 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 102.451 -3.166 . . . . 0.0 102.451 179.607 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.464 HG13 ' CD1' ' A' ' 6' ' ' TRP . 1.1 mt -91.42 141.01 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.368 0 CA-C-O 123.661 1.696 . . . . 0.0 111.121 179.595 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.2 m -133.46 93.02 3.07 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 111.04 -2.8 . . . . 0.0 108.45 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -80.31 100.99 8.66 Favored 'General case' 0 C--O 1.218 -0.588 0 O-C-N 125.723 1.89 . . . . 0.0 110.635 179.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -103.48 67.2 0.9 Allowed 'General case' 0 N--CA 1.436 -1.159 0 CA-C-O 125.635 2.636 . . . . 0.0 108.559 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 90.01 -101.03 2.73 Favored Glycine 0 C--N 1.302 -1.353 0 N-CA-C 108.107 -1.997 . . . . 0.0 108.107 179.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.314 83.5 m-20 -111.52 -13.04 13.89 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 128.321 3.012 . . . . 0.0 111.041 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.403 ' HA ' ' HA ' ' A' ' 63' ' ' GLU . 10.8 tttt -82.27 143.91 31.0 Favored 'General case' 0 C--N 1.31 -1.123 0 O-C-N 118.363 -2.711 . . . . 0.0 108.071 179.714 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -122.52 86.59 2.61 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 113.845 -1.525 . . . . 0.0 110.982 179.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.4 ' HB ' HG13 ' A' ' 61' ' ' VAL 0.336 9.5 t -91.76 104.28 16.75 Favored 'General case' 0 C--N 1.316 -0.882 0 O-C-N 126.796 2.56 . . . . 0.0 106.321 179.914 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.435 HG13 HG22 ' A' ' 40' ' ' ILE 0.702 0.7 OUTLIER -100.62 116.76 44.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 126.965 2.665 . . . . 0.0 116.401 -179.685 . . . . . . . . 4 4 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.462 ' CB ' ' HB ' ' A' ' 39' ' ' THR . 26.7 tttp -62.81 149.57 43.81 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 101.018 -3.697 . . . . 0.0 101.018 179.279 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.41 ' O ' ' N ' ' A' ' 53' ' ' SER . 49.4 tt0 -137.21 64.26 1.54 Allowed 'General case' 0 CA--C 1.511 -0.531 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 -179.487 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . 0.256 5.6 m -74.88 73.97 2.13 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 105.16 -2.163 . . . . 0.0 105.16 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.41 ' N ' ' O ' ' A' ' 51' ' ' GLU . 33.1 t -102.82 25.35 9.38 Favored 'General case' 0 CA--C 1.506 -0.715 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 -179.782 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.513 ' ND2' ' N ' ' A' ' 55' ' ' PHE . 0.0 OUTLIER 78.31 -48.23 0.46 Allowed 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 115.272 -2.299 . . . . 0.0 108.988 179.857 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.537 ' CZ ' ' HF2' ' A' ' 132' ' ' PLM . 96.9 m-85 -58.86 -45.1 90.94 Favored 'General case' 0 C--O 1.213 -0.849 0 C-N-CA 117.428 -1.709 . . . . 0.0 110.373 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.415 ' HG2' HG21 ' A' ' 58' ' ' ILE . 49.0 ttt180 -168.92 144.39 3.33 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 105.668 -1.975 . . . . 0.0 105.668 179.21 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 26.8 t30 -93.1 78.21 4.6 Favored 'General case' 0 C--N 1.35 0.621 0 N-CA-C 101.642 -3.466 . . . . 0.0 101.642 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.415 HG21 ' HG2' ' A' ' 56' ' ' ARG . 3.0 tt -110.3 110.12 30.98 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.338 1 O-C-N 130.01 4.569 . . . . 0.0 117.728 -179.549 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -63.02 135.11 57.09 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 103.89 -2.633 . . . . 0.0 103.89 177.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.525 HG13 ' CE2' ' A' ' 62' ' ' PHE . 10.1 t -107.41 92.37 2.06 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 -178.18 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.4 HG13 ' HB ' ' A' ' 48' ' ' THR 0.358 0.7 OUTLIER -90.81 135.24 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.151 0 O-C-N 118.681 -2.512 . . . . 0.0 111.951 -179.761 . . . . . . . . 4 4 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.525 ' CE2' HG13 ' A' ' 60' ' ' VAL . 24.4 p90 -166.05 97.25 0.62 Allowed 'General case' 0 C--N 1.314 -0.943 0 C-N-CA 118.151 -1.42 . . . . 0.0 110.296 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.404 ' HB2' HG12 ' A' ' 66' ' ' VAL . 1.0 OUTLIER -56.03 147.85 18.98 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 179.88 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.55 99.4 0.15 Allowed 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 179.73 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 98.7 34.46 5.23 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 119.321 2.489 . . . . 0.0 119.321 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.404 HG12 ' HB2' ' A' ' 63' ' ' GLU 0.433 34.8 m -114.3 77.67 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 N-CA-C 104.618 -2.364 . . . . 0.0 104.618 -179.924 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -35.16 103.21 0.03 OUTLIER 'General case' 0 CA--C 1.486 -1.481 0 O-C-N 126.803 2.564 . . . . 0.0 113.711 -179.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 28.9 p90 -116.52 174.97 5.78 Favored 'General case' 0 N--CA 1.423 -1.816 0 O-C-N 120.138 -1.601 . . . . 0.0 112.484 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -123.17 126.07 46.31 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 128.828 3.83 . . . . 0.0 105.488 179.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -121.56 -42.34 2.44 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-O 115.82 -2.038 . . . . 0.0 114.356 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.9 m 72.61 143.17 0.06 Allowed 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 105.95 -1.87 . . . . 0.0 105.95 -179.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.445 ' CD2' ' HC1' ' A' ' 132' ' ' PLM . 1.2 mp -95.95 -164.17 1.13 Allowed 'General case' 0 C--N 1.301 -1.509 0 CA-C-N 114.779 -1.101 . . . . 0.0 108.719 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -89.11 -48.75 7.19 Favored 'General case' 0 C--O 1.211 -0.964 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.117 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.431 ' HB2' ' CG ' ' A' ' 132' ' ' PLM . 0.2 OUTLIER -129.01 12.94 6.22 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-O 115.557 -2.163 . . . . 0.0 109.633 179.994 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -107.29 -8.93 30.37 Favored Glycine 0 CA--C 1.546 1.998 0 CA-C-O 117.463 -1.743 . . . . 0.0 116.924 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . 0.377 0.1 OUTLIER 89.3 -164.08 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 114.696 -2.574 . . . . 0.0 113.97 179.946 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.441 ' CG ' HG23 ' A' ' 96' ' ' VAL . 0.5 OUTLIER -62.21 140.64 58.45 Favored 'General case' 0 C--N 1.318 -0.78 1 O-C-N 129.529 4.268 . . . . 0.0 114.891 179.914 . . . . . . . . 4 4 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.484 ' HG ' ' CD1' ' A' ' 93' ' ' PHE 0.399 11.1 tp -143.83 128.77 18.47 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 102.416 -3.179 . . . . 0.0 102.416 179.872 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 87.1 m -146.45 121.88 10.34 Favored 'General case' 0 CA--C 1.487 -1.461 0 N-CA-C 103.691 -2.707 . . . . 0.0 103.691 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -166.0 -146.49 4.84 Favored Glycine 0 C--N 1.297 -1.638 0 C-N-CA 114.576 -3.678 . . . . 0.0 110.949 -179.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 72.5 p -152.27 171.35 18.11 Favored 'General case' 0 CA--C 1.472 -2.048 0 O-C-N 125.632 1.431 . . . . 0.0 107.494 -179.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . 0.489 ' CE3' ' N ' ' A' ' 91' ' ' GLY . 24.2 m95 -125.03 139.72 53.55 Favored 'General case' 0 N--CA 1.429 -1.524 0 N-CA-C 103.703 -2.703 . . . . 0.0 103.703 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.438 HG21 ' CG1' ' A' ' 90' ' ' VAL . 10.1 t -147.32 149.44 32.83 Favored 'General case' 0 C--O 1.256 1.409 0 C-N-CA 119.051 -1.059 . . . . 0.0 111.445 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.8 130.04 34.93 Favored 'General case' 0 CA--C 1.494 -1.192 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 -179.715 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . 0.538 0.0 OUTLIER -110.41 60.26 0.61 Allowed 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 -179.854 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 73.07 -95.1 0.72 Allowed Glycine 0 N--CA 1.429 -1.817 0 CA-C-N 112.41 -2.177 . . . . 0.0 107.731 -179.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -94.66 12.33 28.07 Favored 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 115.151 1.537 . . . . 0.0 115.151 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . 0.404 4.2 mptt -140.28 175.7 9.38 Favored 'General case' 0 C--O 1.21 -1.013 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -125.13 141.88 51.83 Favored 'General case' 0 CA--C 1.548 0.898 0 N-CA-C 101.578 -3.49 . . . . 0.0 101.578 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.438 ' CG1' HG21 ' A' ' 83' ' ' THR . 7.6 p -133.82 119.73 33.9 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 O-C-N 125.505 1.753 . . . . 0.0 110.691 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.489 ' N ' ' CE3' ' A' ' 82' ' ' TRP . . . -93.31 103.07 2.99 Favored Glycine 0 N--CA 1.474 1.198 0 C-N-CA 127.532 2.492 . . . . 0.0 108.294 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -97.61 154.2 17.7 Favored 'General case' 0 CA--C 1.502 -0.895 0 N-CA-C 103.944 -2.613 . . . . 0.0 103.944 179.808 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.484 ' CD1' ' HG ' ' A' ' 78' ' ' LEU . 91.6 m-85 -151.54 118.47 5.84 Favored 'General case' 0 CA--C 1.502 -0.899 0 O-C-N 125.12 1.513 . . . . 0.0 111.253 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 25.0 mttm -93.76 152.29 19.03 Favored 'General case' 0 C--O 1.21 -0.986 0 CA-C-O 123.741 1.734 . . . . 0.0 107.669 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . 0.368 0.5 OUTLIER -115.62 121.8 43.69 Favored 'General case' 0 CA--C 1.488 -1.414 0 CA-C-N 114.983 -1.008 . . . . 0.0 108.953 179.914 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.441 HG23 ' CG ' ' A' ' 77' ' ' GLU . 23.4 m -62.52 -27.79 43.49 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 CA-C-O 125.264 2.459 . . . . 0.0 113.338 179.756 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . 0.31 2.4 m-20 -61.56 -10.17 7.48 Favored 'General case' 0 C--O 1.246 0.902 0 CA-C-N 113.55 -1.659 . . . . 0.0 113.34 179.715 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.479 ' ND2' ' N ' ' A' ' 98' ' ' ASN . 0.1 OUTLIER -169.89 15.28 0.02 OUTLIER 'General case' 0 N--CA 1.433 -1.287 0 N-CA-C 115.636 1.717 . . . . 0.0 115.636 179.929 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 55.13 21.22 24.29 Favored Glycine 0 CA--C 1.523 0.547 0 CA-C-O 123.635 1.686 . . . . 0.0 113.572 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp -78.25 -170.88 2.16 Favored 'General case' 0 C--O 1.199 -1.572 0 O-C-N 120.225 -1.75 . . . . 0.0 106.697 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -135.77 159.76 40.66 Favored 'General case' 0 CA--C 1.5 -0.971 0 O-C-N 127.808 3.193 . . . . 0.0 110.164 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.454 HD21 ' CD1' ' A' ' 78' ' ' LEU . 0.2 OUTLIER -146.22 149.58 34.19 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 131.648 3.979 . . . . 0.0 104.007 179.541 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.404 ' CD1' ' N ' ' A' ' 104' ' ' ALA . 0.0 OUTLIER -143.34 162.12 16.78 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.994 0 N-CA-C 106.657 -1.609 . . . . 0.0 106.657 -179.723 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.404 ' N ' ' CD1' ' A' ' 103' ' ' ILE . . . -149.67 143.57 25.58 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-O 114.965 -2.445 . . . . 0.0 106.567 179.52 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.9 p -126.24 105.52 14.53 Favored 'Isoleucine or valine' 0 C--O 1.257 1.466 0 CA-C-N 121.647 2.021 . . . . 0.0 108.15 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 63.6 mtt180 -67.79 90.29 0.28 Allowed 'General case' 0 CA--C 1.502 -0.883 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -83.69 78.57 9.67 Favored 'General case' 0 N--CA 1.433 -1.282 0 N-CA-C 116.639 2.089 . . . . 0.0 116.639 179.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.518 HG13 ' CE1' ' A' ' 2' ' ' PHE . 0.8 OUTLIER -68.52 101.33 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 C-N-CA 113.784 -3.167 . . . . 0.0 108.882 179.742 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.26 -29.78 69.5 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 114.199 -1.364 . . . . 0.0 107.536 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 154.01 -71.89 0.27 Allowed Glycine 0 C--O 1.243 0.715 1 C-N-CA 130.723 4.011 . . . . 0.0 111.583 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . 0.362 6.9 m120 -97.71 3.27 50.23 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 115.497 -2.192 . . . . 0.0 110.418 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -133.15 118.73 19.02 Favored 'General case' 0 CA--C 1.502 -0.867 0 O-C-N 128.005 3.315 . . . . 0.0 114.098 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.513 HD22 ' CE2' ' A' ' 128' ' ' PHE . 0.9 OUTLIER -97.29 94.22 6.97 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 103.214 -2.884 . . . . 0.0 103.214 179.821 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 77.2 mt -91.17 143.82 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.114 0 N-CA-C 103.419 -2.808 . . . . 0.0 103.419 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -132.8 108.17 8.81 Favored 'General case' 0 CA--C 1.49 -1.361 0 O-C-N 124.741 1.276 . . . . 0.0 109.136 -179.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 20.3 p -72.33 173.8 8.2 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 105.371 -2.085 . . . . 0.0 105.371 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -162.78 114.38 1.54 Allowed 'General case' 0 CA--C 1.477 -1.847 0 CA-C-O 117.192 -1.385 . . . . 0.0 113.734 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . 0.264 1.2 m -126.57 122.3 34.72 Favored 'General case' 0 N--CA 1.424 -1.766 0 O-C-N 127.267 2.854 . . . . 0.0 110.961 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.508 ' CG ' ' HE3' ' A' ' 20' ' ' LYS . 1.4 t80 -85.85 -25.2 26.37 Favored 'General case' 0 N--CA 1.476 0.831 0 O-C-N 126.49 2.369 . . . . 0.0 107.064 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -161.97 -75.14 0.05 Allowed 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 112.522 -2.126 . . . . 0.0 113.573 -179.767 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -139.74 25.57 2.69 Favored Glycine 0 CA--C 1.537 1.463 0 N-CA-C 120.408 2.923 . . . . 0.0 120.408 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 22.0 t -133.02 102.87 5.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 105.219 -2.141 . . . . 0.0 105.219 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -75.94 165.69 24.61 Favored 'General case' 0 C--O 1.206 -1.195 0 CA-C-O 124.344 2.021 . . . . 0.0 108.82 -179.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.447 ' HB3' ' CB ' ' A' ' 17' ' ' PHE . . . -161.02 101.18 1.26 Allowed 'General case' 0 N--CA 1.435 -1.209 0 CA-C-O 114.488 -2.673 . . . . 0.0 107.854 -179.822 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.414 ' N ' ' O ' ' A' ' 12' ' ' GLU 0.288 5.3 mptt -77.95 146.03 35.72 Favored 'General case' 0 N--CA 1.449 -0.513 0 O-C-N 127.228 2.83 . . . . 0.0 110.519 179.738 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.18 83.03 2.03 Favored 'General case' 0 C--O 1.212 -0.919 0 CA-C-O 114.955 -2.45 . . . . 0.0 106.845 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.4 ' HB ' ' HG2' ' A' ' 10' ' ' ARG . 1.9 mm -74.15 104.14 2.69 Favored 'Isoleucine or valine' 0 C--O 1.25 1.097 1 O-C-N 131.042 5.213 . . . . 0.0 117.381 179.808 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.516 ' CE1' ' HB ' ' A' ' 8' ' ' VAL . 0.7 OUTLIER -94.98 140.85 29.38 Favored 'General case' 0 CA--C 1.516 -0.361 0 O-C-N 124.565 1.166 . . . . 0.0 108.463 -179.813 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 27.7 mmtt -102.88 9.11 39.03 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-O 116.444 -1.741 . . . . 0.0 110.848 179.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.517 ' HD2' ' CH2' ' A' ' 6' ' ' TRP . 2.8 tttt 64.32 110.69 0.03 OUTLIER 'General case' 0 C--O 1.237 0.407 0 O-C-N 124.99 1.431 . . . . 0.0 113.67 -179.788 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . 0.746 1.9 mt-10 . . . . . 0 N--CA 1.438 -1.068 0 C-N-CA 118.422 -1.311 . . . . 0.0 114.066 -179.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' PLM . . . . . 0.537 ' HF2' ' CZ ' ' A' ' 55' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.214 -0.806 0 CA-C-O 119.311 -0.376 . . . . 0.0 111.953 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.532 ' CZ ' HG23 ' A' ' 108' ' ' ILE . 0.8 OUTLIER 49.1 54.22 11.29 Favored 'General case' 0 N--CA 1.442 -0.872 0 N-CA-C 114.239 1.2 . . . . 0.0 114.239 -179.787 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.409 ' HA ' HG23 ' A' ' 40' ' ' ILE . 26.0 t0 -158.91 90.54 0.99 Allowed 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 114.03 -1.441 . . . . 0.0 112.395 -179.562 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 142.0 174.72 14.86 Favored Glycine 0 N--CA 1.439 -1.155 0 C-N-CA 114.477 -3.725 . . . . 0.0 114.459 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . 0.705 3.3 t -58.3 151.86 18.67 Favored 'General case' 0 C--N 1.319 -0.734 0 O-C-N 127.169 2.335 . . . . 0.0 111.181 -179.664 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.524 ' CZ3' ' HB2' ' A' ' 130' ' ' LYS . 92.2 m95 -147.51 93.35 2.21 Favored 'General case' 0 N--CA 1.429 -1.515 0 O-C-N 127.945 3.278 . . . . 0.0 105.774 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 15.3 tttt -99.76 100.13 11.04 Favored 'General case' 0 CA--C 1.505 -0.785 0 CA-C-O 116.986 -1.483 . . . . 0.0 111.158 -179.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.427 HG13 HD21 ' A' ' 36' ' ' LEU 0.305 2.2 p -45.71 131.8 2.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 117.402 -1.285 . . . . 0.0 112.36 -179.745 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -133.64 -38.61 0.91 Allowed 'General case' 0 N--CA 1.445 -0.678 0 O-C-N 126.886 2.616 . . . . 0.0 111.476 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.458 ' CG ' ' HB ' ' A' ' 127' ' ' ILE . 0.2 OUTLIER -81.83 -69.71 0.6 Allowed 'General case' 0 N--CA 1.432 -1.329 0 C-N-CA 119.048 -1.061 . . . . 0.0 112.771 -179.587 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.445 ' HB3' ' CD2' ' A' ' 14' ' ' TYR . 7.5 t-20 71.56 146.92 0.07 Allowed 'General case' 0 C--O 1.245 0.826 0 O-C-N 125.817 1.948 . . . . 0.0 107.182 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.411 ' O ' ' N ' ' A' ' 125' ' ' LYS . 0.4 OUTLIER -156.65 147.36 21.7 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 115.807 -2.044 . . . . 0.0 107.901 -179.363 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.7 t30 46.07 27.08 0.48 Allowed 'General case' 0 N--CA 1.478 0.96 0 O-C-N 125.124 1.515 . . . . 0.0 113.065 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.479 ' CE1' ' HB2' ' A' ' 32' ' ' ALA . 10.7 p90 -81.52 -34.08 31.42 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 118.508 2.781 . . . . 0.0 118.508 -179.382 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -72.75 -39.93 66.44 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-N 120.445 1.475 . . . . 0.0 110.16 179.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.53 -34.84 76.57 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 125.17 2.414 . . . . 0.0 113.218 -179.757 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.529 ' CE2' ' CD2' ' A' ' 117' ' ' TYR . 0.2 OUTLIER -68.58 -28.05 66.6 Favored 'General case' 0 N--CA 1.431 -1.381 0 O-C-N 119.022 -2.298 . . . . 0.0 110.945 -179.981 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 1.5 mmt -77.3 -31.25 54.62 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 179.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -77.92 -20.71 52.35 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 126.484 3.04 . . . . 0.0 109.744 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 42.4 tptt -78.29 -39.92 38.41 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 112.686 -2.052 . . . . 0.0 108.93 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.459 ' HG3' ' CE1' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -73.18 -20.88 60.8 Favored 'General case' 0 CA--C 1.511 -0.556 0 O-C-N 119.552 -1.968 . . . . 0.0 108.273 179.92 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 97.96 46.73 2.2 Favored Glycine 0 N--CA 1.434 -1.488 0 CA-C-O 114.168 -3.573 . . . . 0.0 110.937 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.479 ' CD1' ' HG1' ' A' ' 132' ' ' PLM . 2.1 mm -93.6 176.8 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 O-C-N 129.269 3.57 . . . . 0.0 106.319 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -113.43 -178.61 3.42 Favored 'General case' 0 C--N 1.348 0.519 0 CA-C-O 115.156 -2.354 . . . . 0.0 110.849 -179.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . 0.347 0.6 OUTLIER -55.91 -49.23 76.31 Favored 'Isoleucine or valine' 0 C--N 1.352 0.716 0 O-C-N 128.606 3.691 . . . . 0.0 113.659 179.605 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.65 1.1 m -74.11 -41.89 51.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 O-C-N 127.056 2.722 . . . . 0.0 116.108 -179.702 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.6 mtmp? -66.2 -34.46 78.08 Favored 'General case' 0 CA--C 1.507 -0.695 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 -179.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.94 -27.56 39.81 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 125.361 2.505 . . . . 0.0 108.524 179.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.3 tmmm? -71.08 -52.92 16.65 Favored 'General case' 0 C--N 1.353 0.743 0 O-C-N 119.64 -1.912 . . . . 0.0 110.237 -179.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 34.5 mt -72.65 -28.93 63.03 Favored 'General case' 0 N--CA 1.445 -0.698 0 O-C-N 120.247 -1.533 . . . . 0.0 108.416 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -70.21 -31.29 69.07 Favored Glycine 0 CA--C 1.537 1.408 0 O-C-N 127.365 2.916 . . . . 0.0 110.169 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.479 ' HB2' ' CE1' ' A' ' 14' ' ' TYR . . . -72.65 -41.68 65.18 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 126.572 1.949 . . . . 0.0 113.586 -179.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -101.32 14.65 31.31 Favored 'General case' 0 N--CA 1.437 -1.107 0 O-C-N 126.845 2.591 . . . . 0.0 110.555 -179.589 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 14.6 p30 -41.17 -27.47 0.07 Allowed 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 120.009 3.337 . . . . 0.0 120.009 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . 0.274 20.7 m-80 74.35 35.32 0.73 Allowed 'General case' 0 C--O 1.235 0.337 0 O-C-N 123.938 0.774 . . . . 0.0 109.477 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.427 HD21 HG13 ' A' ' 8' ' ' VAL . 2.9 tt -59.44 137.93 57.84 Favored 'General case' 0 N--CA 1.479 0.986 0 O-C-N 125.22 1.575 . . . . 0.0 110.501 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 6.6 ttmt -134.41 87.77 2.39 Favored 'General case' 0 N--CA 1.435 -1.194 0 N-CA-C 106.176 -1.787 . . . . 0.0 106.176 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . 0.315 0.0 OUTLIER -72.15 135.87 46.32 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 103.087 -2.931 . . . . 0.0 103.087 179.809 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.437 ' HB ' ' HB3' ' A' ' 50' ' ' LYS . 3.7 m -102.44 -18.62 15.28 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 121.939 2.154 . . . . 0.0 110.272 -178.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.409 HG23 ' HA ' ' A' ' 3' ' ' ASP . 3.7 mm 40.97 116.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 CA-C-O 126.667 3.127 . . . . 0.0 114.536 179.491 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.432 ' HB ' HG22 ' A' ' 48' ' ' THR . 5.8 m -118.69 109.94 16.7 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 112.479 -2.146 . . . . 0.0 113.611 179.297 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.482 ' NE2' ' CE2' ' A' ' 47' ' ' PHE . 3.8 tp-100 -103.41 77.73 1.54 Allowed 'General case' 0 N--CA 1.444 -0.774 0 O-C-N 123.635 0.584 . . . . 0.0 109.734 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -65.44 -45.05 85.31 Favored 'General case' 0 N--CA 1.426 -1.663 0 CA-C-O 123.391 1.567 . . . . 0.0 110.296 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 163.6 82.1 0.04 OUTLIER Glycine 0 N--CA 1.44 -1.053 0 N-CA-C 105.839 -2.904 . . . . 0.0 105.839 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.354 75.2 m-20 90.77 -33.52 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.727 0 O-C-N 125.364 1.273 . . . . 0.0 108.495 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 18.7 tttt -93.28 128.58 39.34 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 119.256 -2.152 . . . . 0.0 106.74 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.482 ' CE2' ' NE2' ' A' ' 42' ' ' GLN . 3.0 m-85 -113.47 97.85 6.71 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 124.948 1.299 . . . . 0.0 107.601 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.432 HG22 ' HB ' ' A' ' 41' ' ' THR 0.375 5.1 t -93.68 102.36 14.52 Favored 'General case' 0 N--CA 1.432 -1.349 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 179.922 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.407 ' CG1' ' HB ' ' A' ' 60' ' ' VAL 0.622 0.8 OUTLIER -84.91 104.96 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.818 0 N-CA-C 118.089 2.626 . . . . 0.0 118.089 -179.433 . . . . . . . . 4 4 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.437 ' HB3' ' HB ' ' A' ' 39' ' ' THR . 0.0 OUTLIER -64.19 158.43 23.1 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 100.974 -3.713 . . . . 0.0 100.974 178.638 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.408 ' O ' ' N ' ' A' ' 53' ' ' SER 0.3 68.8 tt0 -144.16 53.93 1.28 Allowed 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 103.857 -2.646 . . . . 0.0 103.857 179.993 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -70.9 81.43 0.64 Allowed 'General case' 0 N--CA 1.425 -1.709 0 C-N-CA 118.41 -1.316 . . . . 0.0 109.004 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.408 ' N ' ' O ' ' A' ' 51' ' ' GLU . 1.2 m -111.67 -141.72 0.38 Allowed 'General case' 0 CA--C 1.505 -0.778 0 O-C-N 126.612 2.445 . . . . 0.0 110.428 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -94.27 -7.48 41.87 Favored 'General case' 0 C--O 1.211 -0.924 0 CA-C-N 120.865 1.666 . . . . 0.0 108.066 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.529 ' CZ ' ' HF2' ' A' ' 132' ' ' PLM . 46.1 m-85 -97.82 -71.66 0.68 Allowed 'General case' 0 N--CA 1.437 -1.087 0 CA-C-O 116.247 -1.835 . . . . 0.0 113.958 -179.758 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.448 ' HG2' ' C ' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -153.02 144.45 23.3 Favored 'General case' 0 C--O 1.254 1.327 0 CA-C-N 123.883 3.038 . . . . 0.0 109.712 -179.195 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -93.69 74.96 4.33 Favored 'General case' 0 C--O 1.219 -0.543 0 N-CA-C 102.269 -3.234 . . . . 0.0 102.269 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -99.61 114.3 37.41 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 O-C-N 127.733 3.146 . . . . 0.0 114.483 179.811 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -62.19 117.71 6.42 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 104.793 -2.299 . . . . 0.0 104.793 179.354 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.524 HG11 ' CE2' ' A' ' 62' ' ' PHE . 92.4 t -99.36 77.04 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.59 1.181 . . . . 0.0 109.003 -178.73 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.409 ' HA ' ' HA ' ' A' ' 48' ' ' THR 0.339 1.2 m -71.18 138.45 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.333 0 O-C-N 117.852 -3.03 . . . . 0.0 115.858 179.92 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.524 ' CE2' HG11 ' A' ' 60' ' ' VAL . 0.2 OUTLIER -156.36 92.2 1.31 Allowed 'General case' 0 N--CA 1.444 -0.772 0 O-C-N 118.991 -2.318 . . . . 0.0 109.717 -179.976 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -57.82 142.38 45.92 Favored 'General case' 0 C--O 1.244 0.775 0 N-CA-C 106.58 -1.637 . . . . 0.0 106.58 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.1 mt -65.08 122.69 17.62 Favored 'General case' 0 N--CA 1.443 -0.822 0 C-N-CA 118.063 -1.455 . . . . 0.0 111.056 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 75.02 9.89 83.98 Favored Glycine 0 N--CA 1.47 0.933 0 N-CA-C 119.863 2.705 . . . . 0.0 119.863 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.424 HG11 ' N ' ' A' ' 67' ' ' ASP 0.425 7.2 t -80.88 -97.69 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.213 0 O-C-N 121.416 -1.049 . . . . 0.0 110.396 -179.97 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.424 ' N ' HG11 ' A' ' 66' ' ' VAL 0.259 21.2 t70 157.82 145.86 0.01 OUTLIER 'General case' 0 CA--C 1.497 -1.088 0 CA-C-O 117.533 -1.222 . . . . 0.0 109.927 179.831 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.473 ' CZ ' ' HB3' ' A' ' 62' ' ' PHE . 0.2 OUTLIER -164.87 164.95 20.81 Favored 'General case' 0 N--CA 1.423 -1.798 0 C-N-CA 119.237 -0.985 . . . . 0.0 110.186 179.98 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -113.75 122.76 48.08 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -123.7 118.34 27.0 Favored 'General case' 0 N--CA 1.439 -0.975 0 O-C-N 121.383 -0.823 . . . . 0.0 110.835 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 2.5 p -81.41 126.29 31.45 Favored 'General case' 0 CA--C 1.496 -1.124 0 CA-C-N 120.047 1.294 . . . . 0.0 108.936 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -78.69 -171.37 2.5 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 104.251 -2.5 . . . . 0.0 104.251 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -114.1 25.38 11.18 Favored 'General case' 0 N--CA 1.436 -1.138 0 CA-C-O 124.117 1.913 . . . . 0.0 112.995 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.453 ' HB3' ' CG ' ' A' ' 132' ' ' PLM . 0.2 OUTLIER -153.34 -35.17 0.11 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 119.664 -1.898 . . . . 0.0 112.969 -179.844 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -126.66 -12.89 3.2 Favored Glycine 0 CA--C 1.543 1.786 0 C-N-CA 125.375 1.464 . . . . 0.0 113.215 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.401 HG21 ' N ' ' A' ' 77' ' ' GLU 0.328 0.4 OUTLIER 69.13 171.07 0.3 Allowed 'General case' 0 CA--C 1.492 -1.27 0 C-N-CA 115.987 -2.285 . . . . 0.0 115.436 -179.734 . . . . . . . . 4 4 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.435 ' CB ' HG23 ' A' ' 96' ' ' VAL . 10.9 mt-10 26.21 109.6 0.0 OUTLIER 'General case' 0 N--CA 1.436 -1.129 1 O-C-N 129.423 4.202 . . . . 0.0 116.956 179.547 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.51 HD22 ' CD1' ' A' ' 93' ' ' PHE 0.363 0.4 OUTLIER -146.46 121.11 9.81 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 101.988 -3.338 . . . . 0.0 101.988 -179.889 . . . . . . . . 4 4 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 55.1 m -129.41 154.67 46.71 Favored 'General case' 0 C--O 1.198 -1.625 0 N-CA-C 106.002 -1.851 . . . . 0.0 106.002 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 169.97 -159.08 31.53 Favored Glycine 0 N--CA 1.439 -1.125 0 CA-C-O 118.076 -1.402 . . . . 0.0 110.715 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -148.04 167.69 24.28 Favored 'General case' 0 CA--C 1.492 -1.278 0 C-N-CA 117.252 -1.779 . . . . 0.0 109.992 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . 0.486 ' CE3' ' CA ' ' A' ' 91' ' ' GLY 0.271 63.1 m95 -121.66 138.12 54.47 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 101.693 -3.447 . . . . 0.0 101.693 179.934 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.407 HG21 HG23 ' A' ' 90' ' ' VAL . 12.4 t -140.97 140.85 34.44 Favored 'General case' 0 N--CA 1.426 -1.64 0 CA-C-O 123.516 1.627 . . . . 0.0 107.885 -179.747 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.404 ' HA ' HD22 ' A' ' 89' ' ' LEU . 3.6 ttm -85.21 133.91 34.17 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 104.616 -2.364 . . . . 0.0 104.616 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . 0.649 1.5 mm-40 -105.51 18.55 22.04 Favored 'General case' 0 N--CA 1.428 -1.574 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 93.69 -64.03 1.85 Allowed Glycine 0 N--CA 1.427 -1.911 0 N-CA-C 105.85 -2.9 . . . . 0.0 105.85 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -101.57 -7.67 22.55 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 117.683 2.475 . . . . 0.0 117.683 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . 0.358 6.6 mtmt -162.32 132.07 4.55 Favored 'General case' 0 CA--C 1.489 -1.398 0 O-C-N 127.096 2.747 . . . . 0.0 109.284 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.404 HD22 ' HA ' ' A' ' 84' ' ' MET . 0.0 OUTLIER -75.73 121.9 23.22 Favored 'General case' 0 C--N 1.309 -1.188 0 O-C-N 126.639 2.462 . . . . 0.0 104.988 179.766 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.407 HG23 HG21 ' A' ' 83' ' ' THR . 18.1 m -116.54 135.95 55.17 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 N-CA-C 105.698 -1.964 . . . . 0.0 105.698 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.486 ' CA ' ' CE3' ' A' ' 82' ' ' TRP . . . -115.44 118.45 4.28 Favored Glycine 0 CA--C 1.537 1.427 0 C-N-CA 126.525 2.012 . . . . 0.0 109.005 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 3.4 mtmm -112.3 147.34 36.52 Favored 'General case' 0 N--CA 1.432 -1.327 0 N-CA-C 103.569 -2.752 . . . . 0.0 103.569 179.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.51 ' CD1' HD22 ' A' ' 78' ' ' LEU . 55.2 m-85 -146.18 116.5 7.48 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 114.654 -1.157 . . . . 0.0 112.667 179.702 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 44.2 mtpt -88.53 -171.11 3.2 Favored 'General case' 0 N--CA 1.433 -1.295 0 C-N-CA 127.298 2.239 . . . . 0.0 108.146 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . 0.359 1.3 ttt180 -149.12 134.7 18.63 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 106.138 -1.801 . . . . 0.0 106.138 -179.712 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.435 HG23 ' CB ' ' A' ' 77' ' ' GLU . 17.0 m -57.73 -38.31 64.35 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 CA-C-O 123.809 1.766 . . . . 0.0 113.321 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . 0.366 96.3 m-20 -76.09 7.08 4.45 Favored 'General case' 0 C--O 1.253 1.277 0 CA-C-N 112.531 -2.122 . . . . 0.0 116.191 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 38.1 p30 -161.33 -17.92 0.05 OUTLIER 'General case' 0 N--CA 1.421 -1.898 0 N-CA-C 116.957 2.206 . . . . 0.0 116.957 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 58.24 19.21 38.48 Favored Glycine 0 C--O 1.228 -0.274 0 CA-C-O 124.737 2.298 . . . . 0.0 114.476 -179.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 9.7 mmtm -78.0 -103.59 0.02 OUTLIER 'General case' 0 C--O 1.199 -1.597 0 O-C-N 120.037 -1.86 . . . . 0.0 111.322 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 167.65 167.94 0.03 OUTLIER 'General case' 0 N--CA 1.438 -1.043 0 C-N-CA 130.058 3.343 . . . . 0.0 110.603 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.402 HD21 ' HB2' ' A' ' 93' ' ' PHE . 9.4 tt -153.91 154.27 33.56 Favored 'General case' 0 C--O 1.242 0.676 0 C-N-CA 131.693 3.997 . . . . 0.0 104.55 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.488 ' CG2' ' HB ' ' A' ' 118' ' ' THR . 13.4 tt -141.85 160.18 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.328 0 C-N-CA 116.469 -2.092 . . . . 0.0 110.277 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.422 ' N ' ' CG1' ' A' ' 103' ' ' ILE . . . -149.53 111.84 4.69 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 179.797 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.4 p -102.65 105.88 18.96 Favored 'Isoleucine or valine' 0 C--O 1.244 0.782 0 CA-C-O 124.824 2.249 . . . . 0.0 112.068 -179.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.435 ' CG ' ' HG2' ' A' ' 115' ' ' GLN 0.26 78.4 mtt180 -79.23 93.08 5.18 Favored 'General case' 0 N--CA 1.428 -1.573 0 CA-C-N 112.181 -2.281 . . . . 0.0 106.127 -179.848 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.424 ' HG3' ' HB ' ' A' ' 114' ' ' ILE . 21.2 pt-20 -101.5 82.73 2.34 Favored 'General case' 0 N--CA 1.425 -1.677 0 O-C-N 127.581 3.051 . . . . 0.0 110.339 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.532 HG23 ' CZ ' ' A' ' 2' ' ' PHE 0.391 4.4 tt -60.89 129.2 23.28 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.984 0 C-N-CA 114.485 -2.886 . . . . 0.0 114.999 -179.827 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.2 t -125.76 76.04 1.54 Allowed 'General case' 0 C--O 1.215 -0.733 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 179.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 80.55 -89.94 1.33 Allowed Glycine 0 CA--C 1.501 -0.822 0 C-N-CA 126.134 1.826 . . . . 0.0 112.636 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . 0.374 0.4 OUTLIER -116.32 22.79 12.59 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 115.785 -2.055 . . . . 0.0 110.456 -179.793 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.411 ' HB2' HD13 ' A' ' 114' ' ' ILE . 1.2 pt-20 -132.54 119.86 21.09 Favored 'General case' 0 C--O 1.211 -0.935 0 O-C-N 128.4 3.562 . . . . 0.0 110.933 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.46 ' HB2' ' CH2' ' A' ' 6' ' ' TRP . 0.9 OUTLIER -95.55 59.71 2.14 Favored 'General case' 0 CA--C 1.501 -0.933 0 O-C-N 128.725 3.766 . . . . 0.0 107.969 -179.647 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.517 ' CG1' ' CD1' ' A' ' 127' ' ' ILE 0.262 1.4 mp -51.81 127.0 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.762 0 O-C-N 125.508 1.755 . . . . 0.0 108.335 -179.621 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.435 ' HG2' ' CG ' ' A' ' 106' ' ' ARG . 28.0 mt-30 -124.72 134.29 52.89 Favored 'General case' 0 C--O 1.246 0.904 0 N-CA-C 103.14 -2.911 . . . . 0.0 103.14 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 29.5 p -97.46 178.74 5.1 Favored 'General case' 0 N--CA 1.433 -1.279 0 O-C-N 128.304 3.503 . . . . 0.0 108.192 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . 0.529 ' CD2' ' CE2' ' A' ' 17' ' ' PHE . 19.1 m-85 -146.77 97.92 2.98 Favored 'General case' 0 CA--C 1.497 -1.086 0 CA-C-O 114.481 -2.676 . . . . 0.0 112.06 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.488 ' HB ' ' CG2' ' A' ' 103' ' ' ILE . 0.3 OUTLIER -116.2 94.75 4.78 Favored 'General case' 0 C--O 1.254 1.325 1 O-C-N 129.386 4.179 . . . . 0.0 112.868 179.76 . . . . . . . . 4 4 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 59.8 t80 -72.42 -14.09 61.61 Favored 'General case' 0 C--N 1.346 0.446 0 CA-C-O 122.472 1.13 . . . . 0.0 108.557 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -179.63 -81.29 0.0 OUTLIER 'General case' 0 C--N 1.292 -1.915 0 CA-C-N 113.747 -1.57 . . . . 0.0 113.379 -179.705 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -128.07 28.15 4.41 Favored Glycine 0 C--N 1.366 2.207 0 C-N-CA 126.579 2.037 . . . . 0.0 116.745 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 5.2 t -140.89 92.79 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -64.82 178.86 0.73 Allowed 'General case' 0 N--CA 1.428 -1.573 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.432 ' HB1' ' CB ' ' A' ' 17' ' ' PHE . . . -171.54 101.57 0.19 Allowed 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 103.778 -2.675 . . . . 0.0 103.778 179.79 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.411 ' N ' ' O ' ' A' ' 12' ' ' GLU . 0.0 OUTLIER -80.02 147.52 31.49 Favored 'General case' 0 C--O 1.244 0.811 0 O-C-N 126.802 2.563 . . . . 0.0 109.76 -179.882 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -137.7 78.64 1.7 Allowed 'General case' 0 C--O 1.214 -0.786 0 O-C-N 126.726 2.516 . . . . 0.0 104.863 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.517 ' CD1' ' CG1' ' A' ' 114' ' ' ILE . 5.5 mm -67.45 107.42 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.755 1 O-C-N 129.558 4.286 . . . . 0.0 113.526 -179.758 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.404 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 0.3 OUTLIER -99.74 151.03 21.7 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 179.348 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . 0.276 3.5 mmtt -115.83 44.28 1.94 Allowed 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.524 ' HB2' ' CZ3' ' A' ' 6' ' ' TRP . 23.9 tttm 32.32 86.85 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 126.686 1.994 . . . . 0.0 115.205 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . 0.733 0.5 OUTLIER . . . . . 0 N--CA 1.435 -1.224 0 CA-C-O 116.683 -1.627 . . . . 0.0 114.85 -179.679 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' PLM . . . . . 0.529 ' HF2' ' CZ ' ' A' ' 55' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.514 -0.42 0 CA-C-O 122.47 1.128 . . . . 0.0 110.122 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -83.37 70.94 10.27 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 116.376 -2.13 . . . . 0.0 112.94 179.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -154.6 100.72 2.27 Favored 'General case' 0 CA--C 1.491 -1.289 0 CA-C-O 127.465 3.507 . . . . 0.0 112.185 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 159.11 -168.1 35.05 Favored Glycine 0 CA--C 1.499 -0.952 0 C-N-CA 116.506 -2.759 . . . . 0.0 110.905 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.46 ' HG1' ' N ' ' A' ' 6' ' ' TRP 0.506 0.4 OUTLIER -97.28 164.88 12.29 Favored 'General case' 0 CA--C 1.493 -1.227 0 CA-C-N 117.062 0.431 . . . . 0.0 111.755 -179.891 . . . . . . . . 4 4 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.534 ' CZ3' ' HB2' ' A' ' 130' ' ' LYS 0.274 90.8 m95 -152.25 121.26 6.63 Favored 'General case' 0 N--CA 1.426 -1.639 0 O-C-N 127.027 2.704 . . . . 0.0 107.922 179.765 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 13.6 ttpt -124.82 97.87 5.46 Favored 'General case' 0 C--O 1.205 -1.274 0 CA-C-O 115.275 -2.297 . . . . 0.0 105.815 179.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.417 ' CG1' ' HB3' ' A' ' 36' ' ' LEU . 0.4 OUTLIER -38.65 138.64 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 O-C-N 126.309 2.256 . . . . 0.0 111.043 -179.987 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -137.34 16.42 2.97 Favored 'General case' 0 C--O 1.209 -1.067 0 O-C-N 126.109 2.13 . . . . 0.0 108.231 -179.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 171.13 135.39 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.439 0 CA-C-O 121.391 0.615 . . . . 0.0 110.159 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -118.86 -169.11 1.67 Allowed 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 116.928 -1.511 . . . . 0.0 107.869 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -145.83 -45.91 0.21 Allowed 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 120.786 1.63 . . . . 0.0 109.285 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 38.4 t30 -123.3 7.97 9.08 Favored 'General case' 0 N--CA 1.476 0.841 0 O-C-N 125.842 1.964 . . . . 0.0 114.535 179.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.525 ' CD2' ' HD3' ' A' ' 126' ' ' ARG . 32.4 t80 -57.03 -28.52 62.58 Favored 'General case' 0 N--CA 1.434 -1.244 0 CA-C-N 112.666 -2.061 . . . . 0.0 114.854 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -71.47 -38.19 71.26 Favored 'General case' 0 C--O 1.212 -0.92 0 CA-C-O 123.062 1.411 . . . . 0.0 109.721 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 3.0 ttmm -76.66 -26.84 55.28 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-O 123.203 1.477 . . . . 0.0 112.217 179.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.499 ' CB ' ' HB3' ' A' ' 124' ' ' ALA . 2.4 t80 -73.37 -23.06 60.15 Favored 'General case' 0 C--O 1.241 0.611 0 O-C-N 119.09 -2.256 . . . . 0.0 111.779 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 1.1 mmt -75.87 -30.28 58.82 Favored 'General case' 0 C--N 1.317 -0.829 1 O-C-N 116.299 -4.001 . . . . 0.0 107.154 179.656 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -68.3 -33.6 74.62 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 119.747 -1.846 . . . . 0.0 112.41 -179.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 5.1 tptt -75.41 -31.86 60.54 Favored 'General case' 0 C--O 1.215 -0.748 0 CA-C-N 114.786 -1.097 . . . . 0.0 110.297 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.413 ' HE3' ' NH1' ' A' ' 95' ' ' ARG . 0.5 OUTLIER -78.47 -20.3 51.22 Favored 'General case' 0 C--O 1.214 -0.804 0 O-C-N 125.543 1.777 . . . . 0.0 108.039 179.776 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 94.36 65.59 1.02 Allowed Glycine 0 C--N 1.302 -1.308 0 CA-C-O 116.865 -2.075 . . . . 0.0 109.598 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.507 ' CD1' ' HB3' ' A' ' 74' ' ' ASP . 2.1 mm -120.25 157.49 22.8 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 O-C-N 125.021 1.071 . . . . 0.0 109.432 -179.586 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -113.18 165.77 12.08 Favored 'General case' 0 C--O 1.246 0.92 0 O-C-N 124.846 1.341 . . . . 0.0 112.077 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . 0.375 0.0 OUTLIER -23.01 -61.02 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.501 -0.923 0 N-CA-C 120.833 3.642 . . . . 0.0 120.833 179.925 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.615 57.8 t -78.45 -38.55 22.76 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.751 0 CA-C-O 122.629 1.204 . . . . 0.0 112.796 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.42 ' HB3' HG21 ' A' ' 23' ' ' ILE . 0.1 OUTLIER -64.35 -37.28 86.97 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-N 113.523 -1.671 . . . . 0.0 113.798 -179.819 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.409 ' N ' HG23 ' A' ' 23' ' ' ILE . 15.9 ptt85 -77.94 -22.67 49.21 Favored 'General case' 0 C--O 1.22 -0.47 0 O-C-N 119.486 -2.008 . . . . 0.0 109.639 179.715 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 16.7 tttp -74.16 -37.29 64.03 Favored 'General case' 0 C--N 1.35 0.61 0 CA-C-N 113.543 -1.662 . . . . 0.0 113.707 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.5 mt -69.8 -34.48 73.77 Favored 'General case' 0 N--CA 1.436 -1.139 0 C-N-CA 125.757 1.623 . . . . 0.0 111.305 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -77.32 -25.2 64.09 Favored Glycine 0 C--N 1.339 0.715 0 O-C-N 126.344 2.277 . . . . 0.0 111.31 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -75.11 -40.39 59.95 Favored 'General case' 0 C--O 1.22 -0.449 0 O-C-N 120.894 -1.357 . . . . 0.0 111.829 -179.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -98.27 9.74 42.3 Favored 'General case' 0 CA--C 1.51 -0.581 0 O-C-N 128.958 3.911 . . . . 0.0 110.821 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 36.5 p30 -47.6 -29.33 2.83 Favored 'General case' 0 CA--C 1.505 -0.782 0 N-CA-C 120.679 3.585 . . . . 0.0 120.679 179.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . 0.288 2.1 m120 73.98 30.56 1.27 Allowed 'General case' 0 C--O 1.243 0.753 0 CA-C-N 120.77 1.623 . . . . 0.0 110.72 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.449 HD22 ' CE2' ' A' ' 128' ' ' PHE . 9.6 tp -49.86 109.76 0.32 Allowed 'General case' 0 C--N 1.354 0.777 0 C-N-CA 126.435 1.894 . . . . 0.0 108.578 -179.811 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 7.7 ttmm -108.86 102.79 11.78 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 104.664 -2.347 . . . . 0.0 104.664 179.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.424 ' HG ' ' CG2' ' A' ' 49' ' ' VAL 0.26 0.1 OUTLIER -88.57 109.44 20.08 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.907 . . . . . . . . 4 4 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.465 ' HB ' ' CB ' ' A' ' 50' ' ' LYS . 13.6 m -95.16 93.99 7.66 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 104.505 -2.405 . . . . 0.0 104.505 -179.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 21.0 mt -75.99 120.02 25.12 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.213 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 179.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.4 HG23 HG22 ' A' ' 48' ' ' THR . 2.6 m -124.97 100.85 6.78 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 111.78 -2.464 . . . . 0.0 109.655 179.625 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -74.05 162.91 28.53 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-O 116.488 -1.72 . . . . 0.0 111.017 -179.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -151.09 -133.79 0.06 Allowed 'General case' 0 N--CA 1.424 -1.745 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -86.47 70.93 2.88 Favored Glycine 0 C--N 1.302 -1.315 0 N-CA-C 104.729 -3.348 . . . . 0.0 104.729 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 81.24 -8.38 1.4 Allowed 'General case' 0 C--O 1.216 -0.659 0 O-C-N 124.777 0.928 . . . . 0.0 111.756 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.4 tttt -98.31 125.77 43.55 Favored 'General case' 0 C--O 1.25 1.093 0 C-N-CA 118.456 -1.298 . . . . 0.0 108.915 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . 0.261 0.7 OUTLIER -103.92 107.37 18.22 Favored 'General case' 0 N--CA 1.446 -0.654 0 O-C-N 125.983 2.052 . . . . 0.0 111.451 -179.955 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.483 ' HB ' ' CG1' ' A' ' 61' ' ' VAL 0.425 0.1 OUTLIER -94.68 131.04 40.91 Favored 'General case' 0 CA--C 1.493 -1.243 0 O-C-N 125.589 1.805 . . . . 0.0 108.332 179.891 . . . . . . . . 4 4 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.424 ' CG2' ' HG ' ' A' ' 38' ' ' LEU 0.644 0.3 OUTLIER -111.43 98.31 6.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 CA-C-N 113.353 -1.749 . . . . 0.0 112.233 -179.762 . . . . . . . . 4 4 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.465 ' CB ' ' HB ' ' A' ' 39' ' ' THR . 0.6 OUTLIER -65.8 119.67 11.65 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 102.47 -3.159 . . . . 0.0 102.47 -179.941 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -113.94 85.91 2.31 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 124.475 2.083 . . . . 0.0 106.527 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 43.0 m -88.79 63.0 6.67 Favored 'General case' 0 N--CA 1.419 -2.004 0 CA-C-N 113.221 -1.809 . . . . 0.0 106.801 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -77.39 170.32 16.75 Favored 'General case' 0 C--O 1.216 -0.692 0 C-N-CA 115.933 -2.307 . . . . 0.0 111.219 -179.747 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -58.61 -20.85 50.91 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 117.838 -1.545 . . . . 0.0 108.333 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.529 ' CE1' ' HE2' ' A' ' 132' ' ' PLM . 11.1 m-85 -85.48 -60.73 1.94 Allowed 'General case' 0 N--CA 1.44 -0.944 0 CA-C-O 114.007 -2.901 . . . . 0.0 110.391 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.549 ' CB ' HG21 ' A' ' 58' ' ' ILE . 66.6 mtp85 -133.95 176.87 8.19 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 124.416 3.28 . . . . 0.0 110.46 -179.643 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 10.7 m-80 -138.76 59.02 1.64 Allowed 'General case' 0 C--O 1.215 -0.728 2 C-N-CA 132.002 4.121 . . . . 0.0 100.081 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.549 HG21 ' CB ' ' A' ' 56' ' ' ARG . 1.5 tt -84.18 -44.18 17.87 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 1 C-N-CA 132.688 4.395 . . . . 0.0 119.772 -178.695 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . 0.277 34.2 t0 78.55 140.33 0.07 Allowed 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 104.073 -2.565 . . . . 0.0 104.073 -176.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 58.0 t -112.39 -53.59 5.22 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.152 0 C-N-CA 118.527 -1.269 . . . . 0.0 112.627 -178.245 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.483 ' CG1' ' HB ' ' A' ' 48' ' ' THR 0.398 0.9 OUTLIER 66.97 131.52 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 CA-C-O 126.272 2.939 . . . . 0.0 109.016 -178.907 . . . . . . . . 4 4 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.556 ' CD2' ' CD1' ' A' ' 82' ' ' TRP . 12.5 p90 -164.03 93.76 0.72 Allowed 'General case' 0 N--CA 1.443 -0.817 0 O-C-N 117.05 -3.531 . . . . 0.0 110.334 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -65.59 136.63 56.6 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 105.644 -1.984 . . . . 0.0 105.644 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -50.88 121.86 6.59 Favored 'General case' 0 N--CA 1.437 -1.091 0 O-C-N 125.505 1.753 . . . . 0.0 110.691 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 79.98 3.59 89.43 Favored Glycine 0 C--N 1.35 1.336 0 CA-C-N 112.424 -2.171 . . . . 0.0 117.805 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . 0.378 79.4 t -106.03 97.48 5.67 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 N-CA-C 104.612 -2.366 . . . . 0.0 104.612 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -63.0 177.12 0.61 Allowed 'General case' 0 CA--C 1.484 -1.578 0 C-N-CA 117.584 -1.646 . . . . 0.0 114.605 -179.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.488 ' CD1' ' N ' ' A' ' 68' ' ' PHE . 1.1 p90 -155.98 172.21 18.77 Favored 'General case' 0 N--CA 1.433 -1.304 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.627 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -115.3 140.91 48.7 Favored 'General case' 0 C--N 1.322 -0.609 0 O-C-N 126.858 2.599 . . . . 0.0 105.851 179.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 13.4 t80 -152.65 112.13 3.89 Favored 'General case' 0 C--O 1.206 -1.19 0 CA-C-N 120.525 1.511 . . . . 0.0 114.024 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.5 p -81.79 144.41 31.09 Favored 'General case' 0 C--N 1.315 -0.909 0 O-C-N 119.147 -2.221 . . . . 0.0 105.448 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 10.5 mp -102.28 -175.17 2.75 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 124.592 1.183 . . . . 0.0 108.465 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -90.94 -13.39 33.56 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.135 0.974 . . . . 0.0 111.94 -179.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.507 ' HB3' ' CD1' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -79.63 -11.15 59.88 Favored 'General case' 0 N--CA 1.439 -0.998 0 C-N-CA 119.308 -0.957 . . . . 0.0 110.751 -179.549 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 102.93 22.83 9.03 Favored Glycine 0 C--O 1.204 -1.777 0 O-C-N 125.528 1.768 . . . . 0.0 111.733 -179.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -129.24 155.15 46.01 Favored 'General case' 0 CA--C 1.491 -1.309 0 C-N-CA 117.782 -1.567 . . . . 0.0 112.786 -179.788 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.463 ' CB ' ' HB ' ' A' ' 96' ' ' VAL . 32.1 mp0 -92.41 155.92 17.55 Favored 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 127.572 2.349 . . . . 0.0 112.646 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.53 HD12 ' CG ' ' A' ' 93' ' ' PHE 0.429 0.6 OUTLIER -156.41 153.43 28.87 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 105.264 -2.125 . . . . 0.0 105.264 -179.912 . . . . . . . . 4 4 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.404 ' O ' ' N ' ' A' ' 94' ' ' LYS . 64.2 m -157.67 139.21 13.81 Favored 'General case' 0 C--O 1.197 -1.669 0 N-CA-C 102.884 -3.006 . . . . 0.0 102.884 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 174.81 -172.15 45.2 Favored Glycine 0 C--N 1.293 -1.839 0 C-N-CA 114.116 -3.897 . . . . 0.0 114.759 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 76.3 p -132.88 169.09 17.27 Favored 'General case' 0 C--O 1.187 -2.19 0 CA-C-N 120.563 2.182 . . . . 0.0 109.252 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . 0.556 ' CD1' ' CD2' ' A' ' 62' ' ' PHE . 69.7 m95 -127.1 140.15 52.48 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 102.37 -3.196 . . . . 0.0 102.37 179.693 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.428 HG21 HG21 ' A' ' 90' ' ' VAL . 8.8 t -146.45 142.93 28.62 Favored 'General case' 0 C--O 1.255 1.366 0 CA-C-O 123.803 1.764 . . . . 0.0 109.994 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.4 ' HA ' HD21 ' A' ' 89' ' ' LEU . 2.0 ttm -81.24 99.67 8.72 Favored 'General case' 0 N--CA 1.425 -1.72 0 CA-C-N 111.111 -2.768 . . . . 0.0 109.584 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . 0.601 29.0 mm-40 -65.61 -104.19 0.0 OUTLIER 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 119.666 1.121 . . . . 0.0 113.248 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -137.39 93.92 0.22 Allowed Glycine 0 N--CA 1.436 -1.337 1 N-CA-C 102.932 -4.067 . . . . 0.0 102.932 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 58.34 21.17 8.01 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 113.191 0.811 . . . . 0.0 113.191 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . 0.33 7.1 mtmt -149.93 112.66 4.78 Favored 'General case' 0 CA--C 1.492 -1.267 0 O-C-N 126.395 2.309 . . . . 0.0 112.326 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.4 HD21 ' HA ' ' A' ' 84' ' ' MET . 0.0 OUTLIER -75.98 130.63 38.73 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 102.478 -3.156 . . . . 0.0 102.478 179.908 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.428 HG21 HG21 ' A' ' 83' ' ' THR . 5.4 m -129.03 136.3 60.02 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.932 0 CA-C-O 116.86 -1.543 . . . . 0.0 108.78 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -112.39 106.75 1.94 Allowed Glycine 0 CA--C 1.539 1.578 0 O-C-N 126.958 2.662 . . . . 0.0 112.86 179.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.411 ' HG2' HD11 ' A' ' 103' ' ' ILE . 8.0 mtpt -93.46 113.08 25.13 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 102.734 -3.061 . . . . 0.0 102.734 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.53 ' CG ' HD12 ' A' ' 78' ' ' LEU . 19.1 m-85 -104.46 96.93 6.94 Favored 'General case' 0 CA--C 1.502 -0.902 0 O-C-N 125.906 2.004 . . . . 0.0 114.492 -179.747 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.404 ' N ' ' O ' ' A' ' 79' ' ' THR . 39.1 mttt -80.04 127.48 32.34 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 126.541 1.936 . . . . 0.0 108.923 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.413 ' NH1' ' HE3' ' A' ' 21' ' ' MET 0.336 0.0 OUTLIER -72.71 144.32 47.71 Favored 'General case' 0 CA--C 1.502 -0.872 0 N-CA-C 104.434 -2.432 . . . . 0.0 104.434 -179.833 . . . . . . . . 4 4 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.463 ' HB ' ' CB ' ' A' ' 77' ' ' GLU . 17.4 t -77.09 -33.66 20.67 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 C-N-CA 125.895 1.678 . . . . 0.0 112.248 -179.782 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . 0.262 0.0 OUTLIER -95.73 -27.88 15.05 Favored 'General case' 0 C--O 1.254 1.294 0 N-CA-C 115.05 1.5 . . . . 0.0 115.05 -179.867 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.401 ' ND2' ' OH ' ' A' ' 119' ' ' TYR . 50.8 t30 -89.7 -25.07 21.39 Favored 'General case' 0 N--CA 1.419 -2.013 0 CA-C-N 114.623 -1.171 . . . . 0.0 113.702 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 64.97 10.24 45.11 Favored Glycine 0 CA--C 1.536 1.363 0 O-C-N 127.149 2.781 . . . . 0.0 113.826 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 73.1 mttt -103.26 159.01 15.93 Favored 'General case' 0 C--O 1.197 -1.662 0 N-CA-C 107.629 -1.248 . . . . 0.0 107.629 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.41 ' HG2' ' N ' ' A' ' 102' ' ' LEU . 2.3 tm-20 -95.27 158.91 15.25 Favored 'General case' 0 N--CA 1.431 -1.382 0 O-C-N 126.442 2.339 . . . . 0.0 116.001 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.513 ' CB ' ' HA ' ' A' ' 119' ' ' TYR . 5.0 tt -138.57 145.71 40.94 Favored 'General case' 0 C--N 1.326 -0.418 1 O-C-N 129.826 4.454 . . . . 0.0 104.477 179.569 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.463 ' CG2' ' HB ' ' A' ' 118' ' ' THR . 3.5 tp -127.39 152.85 35.93 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.071 0 N-CA-C 104.379 -2.452 . . . . 0.0 104.379 -179.435 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -134.76 132.79 39.17 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 114.119 -2.848 . . . . 0.0 106.26 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 10.7 p -120.19 103.65 14.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 O-C-N 125.612 1.82 . . . . 0.0 113.77 -179.383 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . 0.269 36.2 mtt85 -74.6 89.16 2.2 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 104.483 -2.414 . . . . 0.0 104.483 179.561 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -92.08 77.57 5.32 Favored 'General case' 0 N--CA 1.428 -1.571 0 O-C-N 127.041 2.713 . . . . 0.0 114.907 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.524 HD13 ' CH2' ' A' ' 6' ' ' TRP 0.326 0.0 OUTLIER -56.68 101.81 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 CA-C-O 123.274 1.511 . . . . 0.0 112.094 179.961 . . . . . . . . 4 4 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 61.4 m -88.19 71.06 9.26 Favored 'General case' 0 CA--C 1.502 -0.902 0 N-CA-C 104.569 -2.382 . . . . 0.0 104.569 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 66.59 -82.8 0.11 Allowed Glycine 0 C--N 1.344 1.02 0 C-N-CA 128.585 2.993 . . . . 0.0 111.743 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . 0.319 0.1 OUTLIER -98.73 -19.68 17.34 Favored 'General case' 0 C--O 1.221 -0.417 0 CA-C-O 117.651 -1.166 . . . . 0.0 111.911 -179.605 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 45.6 mp0 -105.86 127.93 53.43 Favored 'General case' 0 CA--C 1.498 -1.027 0 O-C-N 124.622 1.201 . . . . 0.0 112.175 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.403 ' HB3' ' CE3' ' A' ' 6' ' ' TRP . 2.0 tt -93.67 139.5 30.73 Favored 'General case' 0 C--O 1.211 -0.925 0 N-CA-C 100.208 -3.997 . . . . 0.0 100.208 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.413 HD12 HD13 ' A' ' 127' ' ' ILE . 68.5 mt -131.53 145.7 34.73 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 O-C-N 128.991 3.932 . . . . 0.0 103.776 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 9.1 mt-30 -134.52 129.9 35.81 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 24.3 p -101.65 -176.53 3.16 Favored 'General case' 0 C--O 1.249 1.035 0 O-C-N 126.703 2.502 . . . . 0.0 104.933 179.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . 0.437 ' HB2' ' HB1' ' A' ' 124' ' ' ALA . 68.4 m-85 -160.56 87.07 0.74 Allowed 'General case' 0 CA--C 1.475 -1.939 0 CA-C-O 115.789 -2.053 . . . . 0.0 109.69 179.661 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.463 ' HB ' ' CG2' ' A' ' 103' ' ' ILE . 95.4 m -94.47 101.29 13.2 Favored 'General case' 0 N--CA 1.433 -1.294 0 O-C-N 128.247 3.467 . . . . 0.0 110.107 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.513 ' HA ' ' CB ' ' A' ' 102' ' ' LEU . 5.8 t80 -77.97 -77.65 0.15 Allowed 'General case' 0 CA--C 1.499 -0.983 0 O-C-N 125.816 1.948 . . . . 0.0 107.523 -179.742 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.447 ' HG3' ' CE2' ' A' ' 119' ' ' TYR . 1.5 mm-40 -108.44 -75.7 0.63 Allowed 'General case' 0 C--N 1.298 -1.642 0 CA-C-O 117.522 -1.228 . . . . 0.0 108.462 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -133.71 32.94 2.62 Favored Glycine 0 CA--C 1.528 0.863 0 O-C-N 127.776 3.172 . . . . 0.0 114.74 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.411 HG13 ' HA ' ' A' ' 17' ' ' PHE . 0.3 OUTLIER -139.59 122.35 17.4 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.68 0 O-C-N 119.789 -2.006 . . . . 0.0 110.477 -179.883 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -95.82 177.65 5.7 Favored 'General case' 0 N--CA 1.431 -1.402 0 O-C-N 120.522 -1.361 . . . . 0.0 107.825 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.499 ' HB3' ' CB ' ' A' ' 17' ' ' PHE . . . -169.76 77.16 0.09 Allowed 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 115.709 -2.396 . . . . 0.0 109.193 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 12.1 mptt -64.3 141.27 58.83 Favored 'General case' 0 C--O 1.251 1.142 0 CA-C-N 118.488 0.586 . . . . 0.0 109.541 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.525 ' HD3' ' CD2' ' A' ' 14' ' ' TYR . 14.3 mtm180 -137.58 83.1 1.96 Allowed 'General case' 0 CA--C 1.509 -0.623 0 O-C-N 127.315 2.884 . . . . 0.0 108.535 179.78 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.421 HD11 ' N ' ' A' ' 127' ' ' ILE . 0.8 OUTLIER -74.84 119.31 22.15 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.788 1 O-C-N 129.79 4.432 . . . . 0.0 110.757 179.894 . . . . . . . . 4 4 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.449 ' CE2' HD22 ' A' ' 36' ' ' LEU . 0.1 OUTLIER -102.99 169.9 8.29 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 112.336 -2.211 . . . . 0.0 108.247 -180.0 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.12 0.49 11.26 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 105.693 -1.965 . . . . 0.0 105.693 179.786 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.534 ' HB2' ' CZ3' ' A' ' 6' ' ' TRP . 34.7 tttt 73.6 95.91 0.07 Allowed 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 120.684 1.583 . . . . 0.0 112.436 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . 0.854 3.8 mt-10 . . . . . 0 N--CA 1.435 -1.178 0 N-CA-C 117.523 2.416 . . . . 0.0 117.523 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' PLM . . . . . 0.529 ' HE2' ' CE1' ' A' ' 55' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 0.229 0 CA-C-O 116.888 -1.529 . . . . 0.0 110.122 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.523 ' CE1' HG12 ' A' ' 108' ' ' ILE . 97.3 m-85 -43.28 89.91 0.0 OUTLIER 'General case' 0 C--N 1.312 -1.062 0 O-C-N 126.082 2.114 . . . . 0.0 116.084 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -166.39 86.59 0.32 Allowed 'General case' 0 CA--C 1.494 -1.204 0 C-N-CA 117.985 -1.486 . . . . 0.0 112.686 -179.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 150.47 -130.02 3.11 Favored Glycine 0 C--N 1.31 -0.915 0 C-N-CA 116.503 -2.761 . . . . 0.0 112.114 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . 0.625 0.8 OUTLIER -123.11 161.2 24.86 Favored 'General case' 0 N--CA 1.432 -1.339 0 CA-C-O 124.158 1.932 . . . . 0.0 112.014 -179.933 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.508 ' CD1' HG13 ' A' ' 40' ' ' ILE 0.264 86.7 m95 -153.77 114.7 4.07 Favored 'General case' 0 N--CA 1.431 -1.393 0 CA-C-N 111.872 -2.422 . . . . 0.0 110.856 179.896 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 30.4 ttmt -109.56 108.45 18.91 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-O 115.174 -2.346 . . . . 0.0 107.057 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.42 ' HB ' ' CE2' ' A' ' 128' ' ' PHE 0.411 8.2 p -48.51 147.0 0.76 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.846 0 CA-C-N 121.202 1.819 . . . . 0.0 109.222 -179.964 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.425 ' HB3' ' HG3' ' A' ' 129' ' ' LYS . 0.0 OUTLIER -157.28 14.09 0.25 Allowed 'General case' 0 CA--C 1.499 -0.996 0 C-N-CA 117.464 -1.695 . . . . 0.0 111.455 -179.126 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.27 -57.65 0.65 Allowed 'General case' 0 CA--C 1.487 -1.465 0 O-C-N 116.679 -3.763 . . . . 0.0 109.965 -179.684 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 59.74 170.91 0.08 Allowed 'General case' 0 C--O 1.244 0.778 0 O-C-N 127.529 3.018 . . . . 0.0 108.928 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.452 ' O ' ' N ' ' A' ' 125' ' ' LYS . 6.0 tt0 -170.43 134.51 1.14 Allowed 'General case' 0 C--N 1.3 -1.583 0 O-C-N 117.792 -3.068 . . . . 0.0 107.534 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.564 ' ND2' ' CD1' ' A' ' 17' ' ' PHE . 1.0 OUTLIER 62.67 29.78 16.87 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-N 122.563 2.438 . . . . 0.0 113.857 179.844 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . 0.348 9.3 t80 -98.11 -64.5 1.03 Allowed 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 121.201 3.778 . . . . 0.0 121.201 -178.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.09 -38.74 77.0 Favored 'General case' 0 CA--C 1.498 -1.049 0 CA-C-N 124.49 3.313 . . . . 0.0 113.792 -179.061 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.539 ' HB3' ' CD1' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -67.27 -43.23 82.35 Favored 'General case' 0 N--CA 1.422 -1.829 0 C-N-CA 127.643 2.377 . . . . 0.0 113.578 179.584 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.564 ' CD1' ' ND2' ' A' ' 13' ' ' ASN 0.266 64.8 m-85 -80.03 -20.1 46.11 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 111.188 -2.733 . . . . 0.0 113.557 -178.057 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.499 ' CB ' HG13 ' A' ' 23' ' ' ILE . 0.5 OUTLIER -72.21 -23.11 61.2 Favored 'General case' 0 N--CA 1.435 -1.22 0 O-C-N 117.035 -3.541 . . . . 0.0 105.983 176.591 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -74.24 -24.89 59.37 Favored 'General case' 0 C--N 1.348 0.528 0 O-C-N 120.378 -1.451 . . . . 0.0 109.849 179.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.497 ' CD ' HG13 ' A' ' 122' ' ' VAL . 11.3 tttp -79.1 -32.58 44.64 Favored 'General case' 0 N--CA 1.432 -1.367 0 CA-C-O 116.196 -1.859 . . . . 0.0 110.589 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.24 -23.5 57.54 Favored 'General case' 0 C--O 1.214 -0.814 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 179.312 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 104.25 40.89 2.17 Favored Glycine 0 N--CA 1.445 -0.714 0 CA-C-O 115.747 -2.696 . . . . 0.0 109.935 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.499 HG13 ' CB ' ' A' ' 18' ' ' MET . 2.2 mm -86.99 83.44 2.19 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 CA-C-N 120.49 2.145 . . . . 0.0 106.994 -179.682 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -42.09 112.91 0.38 Allowed 'General case' 0 C--O 1.248 1.009 0 O-C-N 124.91 1.381 . . . . 0.0 114.357 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . 0.364 84.7 t 18.52 -66.73 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.502 -0.893 0 N-CA-C 121.066 3.728 . . . . 0.0 121.066 -179.784 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.538 1.3 m -71.52 -24.49 23.63 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.122 0 N-CA-C 117.448 2.388 . . . . 0.0 117.448 -179.531 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.456 ' HD2' ' CB ' ' A' ' 74' ' ' ASP . 1.5 mtmp? -72.04 -29.22 63.94 Favored 'General case' 0 C--N 1.318 -0.775 0 C-N-CA 119.072 -1.051 . . . . 0.0 112.993 179.759 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.446 ' N ' ' CG2' ' A' ' 23' ' ' ILE . 2.6 ptt-85 -78.49 -21.51 48.87 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 116.777 -1.969 . . . . 0.0 109.363 179.83 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 12.0 tttt -77.78 -43.21 31.38 Favored 'General case' 0 CA--C 1.502 -0.869 0 CA-C-N 113.553 -1.658 . . . . 0.0 109.924 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -79.02 -23.07 44.58 Favored 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 -179.729 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -76.68 -34.88 42.4 Favored Glycine 0 CA--C 1.527 0.793 0 O-C-N 125.613 1.821 . . . . 0.0 112.476 179.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -72.9 -38.61 66.87 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 6.5 m-70 -98.92 20.33 13.4 Favored 'General case' 0 N--CA 1.439 -0.99 0 O-C-N 127.377 2.923 . . . . 0.0 112.604 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 23.6 p30 -47.75 -31.52 4.91 Favored 'General case' 0 CA--C 1.497 -1.096 0 N-CA-C 119.347 3.091 . . . . 0.0 119.347 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . 0.309 0.6 OUTLIER 76.59 15.85 2.06 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 119.291 0.951 . . . . 0.0 109.264 -179.809 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.455 ' CD2' ' NH2' ' A' ' 126' ' ' ARG . 30.5 tp -42.1 114.84 0.6 Allowed 'General case' 0 CA--C 1.5 -0.946 0 C-N-CA 128.636 2.775 . . . . 0.0 110.249 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -116.76 94.64 4.68 Favored 'General case' 0 C--O 1.211 -0.967 0 N-CA-C 105.246 -2.131 . . . . 0.0 105.246 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.422 HD13 HD12 ' A' ' 36' ' ' LEU 0.256 0.1 OUTLIER -79.8 105.28 10.97 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 179.73 . . . . . . . . 4 4 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.49 ' HB ' ' CB ' ' A' ' 50' ' ' LYS . 99.3 m -94.98 80.4 3.65 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 104.268 -2.493 . . . . 0.0 104.268 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.508 HG13 ' CD1' ' A' ' 6' ' ' TRP . 0.9 OUTLIER -60.23 134.99 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.371 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.331 179.977 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.3 m -128.45 108.19 10.35 Favored 'General case' 0 N--CA 1.475 0.81 0 O-C-N 128.043 3.34 . . . . 0.0 108.437 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -99.07 105.72 17.86 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 117.802 -1.094 . . . . 0.0 113.806 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -108.77 68.02 0.67 Allowed 'General case' 0 N--CA 1.424 -1.767 0 CA-C-O 126.756 3.17 . . . . 0.0 108.019 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 77.79 -108.55 2.63 Favored Glycine 0 C--N 1.293 -1.853 0 N-CA-C 106.956 -2.457 . . . . 0.0 106.956 179.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -102.38 48.3 0.87 Allowed 'General case' 0 N--CA 1.444 -0.735 0 CA-C-O 123.04 1.4 . . . . 0.0 110.456 179.688 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 3.1 ttmt -149.06 129.28 13.67 Favored 'General case' 0 C--N 1.312 -1.056 0 C-N-CA 116.479 -2.088 . . . . 0.0 107.657 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -114.53 88.12 2.79 Favored 'General case' 0 CA--C 1.511 -0.557 0 CA-C-O 121.958 0.885 . . . . 0.0 110.117 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . 0.349 14.8 t -95.19 85.92 4.43 Favored 'General case' 0 N--CA 1.428 -1.543 0 CA-C-O 125.799 2.714 . . . . 0.0 108.789 -179.742 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.431 HG13 HD11 ' A' ' 40' ' ' ILE 0.654 1.0 OUTLIER -70.39 108.67 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.768 0 N-CA-C 117.758 2.503 . . . . 0.0 117.758 -179.948 . . . . . . . . 4 4 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.49 ' CB ' ' HB ' ' A' ' 39' ' ' THR . 15.9 tttp -69.55 117.46 11.18 Favored 'General case' 0 C--N 1.303 -1.416 1 N-CA-C 99.508 -4.256 . . . . 0.0 99.508 179.218 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.434 ' HG3' ' CD1' ' A' ' 36' ' ' LEU . 1.1 tt0 -112.67 104.96 13.03 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 -179.334 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -103.45 51.63 0.79 Allowed 'General case' 0 C--N 1.289 -2.049 0 N-CA-C 105.317 -2.105 . . . . 0.0 105.317 179.562 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 4.3 t -73.05 21.37 0.07 Allowed 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 113.175 -1.83 . . . . 0.0 115.474 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 73.79 -51.42 0.69 Allowed 'General case' 0 CA--C 1.498 -1.032 0 CA-C-N 122.245 2.293 . . . . 0.0 109.787 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -67.1 -44.33 80.25 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-O 115.119 -2.372 . . . . 0.0 110.209 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.478 ' HG3' ' CG2' ' A' ' 58' ' ' ILE . 9.3 ptp180 -149.56 126.17 10.99 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 123.633 2.924 . . . . 0.0 106.795 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -99.71 74.42 1.85 Allowed 'General case' 0 N--CA 1.465 0.291 1 N-CA-C 100.197 -4.001 . . . . 0.0 100.197 179.784 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.478 ' CG2' ' HG3' ' A' ' 56' ' ' ARG . 3.3 tp -115.94 117.83 56.8 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.82 1 C-N-CA 132.417 4.287 . . . . 0.0 118.9 -179.104 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.95 125.58 26.77 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 103.607 -2.738 . . . . 0.0 103.607 178.163 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 1.4 t -107.85 103.96 16.32 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 O-C-N 124.515 1.135 . . . . 0.0 113.217 -178.064 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . 0.395 1.7 m -88.49 141.97 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.159 0 CA-C-O 125.091 2.377 . . . . 0.0 113.888 179.593 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.528 ' HB3' ' CE1' ' A' ' 68' ' ' PHE . 0.1 OUTLIER -160.75 95.64 1.1 Allowed 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 113.128 -1.851 . . . . 0.0 108.772 -179.833 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -54.49 144.57 20.8 Favored 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 104.772 -2.307 . . . . 0.0 104.772 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.9 mp -68.89 115.7 8.51 Favored 'General case' 0 N--CA 1.432 -1.345 0 O-C-N 119.475 -2.015 . . . . 0.0 107.238 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 81.87 26.62 48.93 Favored Glycine 0 N--CA 1.471 0.971 0 C-N-CA 126.713 2.102 . . . . 0.0 118.172 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . 0.387 41.2 t -114.8 81.39 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 N-CA-C 104.662 -2.347 . . . . 0.0 104.662 179.849 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -38.43 114.08 0.34 Allowed 'General case' 0 C--N 1.307 -1.262 0 O-C-N 125.689 1.868 . . . . 0.0 114.437 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.528 ' CE1' ' HB3' ' A' ' 62' ' ' PHE . 37.6 p90 -119.95 164.86 15.44 Favored 'General case' 0 N--CA 1.427 -1.598 0 O-C-N 125.18 1.55 . . . . 0.0 107.977 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -108.93 138.1 45.8 Favored 'General case' 0 C--N 1.319 -0.74 0 O-C-N 126.171 2.169 . . . . 0.0 106.997 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.482 ' HB3' ' CD2' ' A' ' 78' ' ' LEU . 35.9 t80 -133.73 95.57 3.5 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 119.787 1.176 . . . . 0.0 111.248 -179.596 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.47 ' HA ' HD23 ' A' ' 72' ' ' LEU . 1.9 p -72.26 79.22 0.99 Allowed 'General case' 0 N--CA 1.432 -1.36 0 CA-C-O 117.529 -1.224 . . . . 0.0 112.386 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.698 ' N ' ' CD2' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -40.06 175.75 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.813 1 O-C-N 130.355 4.785 . . . . 0.0 110.028 174.955 . . . . . . . . 4 4 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.52 -45.38 13.64 Favored 'General case' 0 C--N 1.351 0.671 0 O-C-N 120.522 -1.361 . . . . 0.0 113.613 -178.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.456 ' CB ' ' HD2' ' A' ' 27' ' ' LYS . 0.4 OUTLIER -148.96 25.74 0.91 Allowed 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 179.956 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.43 ' C ' ' HG ' ' A' ' 72' ' ' LEU . . . -95.03 -32.23 7.22 Favored Glycine 0 CA--C 1.544 1.874 0 CA-C-N 112.69 -2.05 . . . . 0.0 113.312 179.803 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.525 ' N ' ' HG ' ' A' ' 72' ' ' LEU 0.376 0.3 OUTLIER 84.76 117.82 0.04 OUTLIER 'General case' 0 C--N 1.305 -1.364 0 CA-C-O 114.465 -2.683 . . . . 0.0 107.175 -177.878 . . . . . . . . 4 4 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.461 ' CB ' HG23 ' A' ' 96' ' ' VAL . 0.6 OUTLIER -3.9 120.29 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.63 1 O-C-N 130.134 4.646 . . . . 0.0 114.405 -179.412 . . . . . . . . 4 4 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.51 ' HG ' ' CD1' ' A' ' 93' ' ' PHE 0.518 0.5 OUTLIER -133.22 122.12 23.49 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 102.022 -3.325 . . . . 0.0 102.022 179.772 . . . . . . . . 4 4 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 10.7 t -137.59 123.35 19.96 Favored 'General case' 0 C--O 1.198 -1.637 0 N-CA-C 101.765 -3.421 . . . . 0.0 101.765 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.408 ' HA3' ' HA ' ' A' ' 93' ' ' PHE . . . -156.89 -149.31 5.36 Favored Glycine 0 C--N 1.308 -1.02 0 C-N-CA 116.921 -2.562 . . . . 0.0 110.419 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 22.1 p -155.32 165.79 35.57 Favored 'General case' 0 C--O 1.198 -1.607 0 CA-C-O 123.838 1.78 . . . . 0.0 109.037 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . 0.542 ' CZ2' ' CZ ' ' A' ' 106' ' ' ARG 0.322 12.2 m95 -112.71 129.46 56.4 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 100.772 -3.788 . . . . 0.0 100.772 -179.879 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.404 HG21 HG22 ' A' ' 90' ' ' VAL . 1.7 t -144.17 100.81 3.62 Favored 'General case' 0 C--O 1.262 1.716 0 O-C-N 121.218 -0.926 . . . . 0.0 110.254 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 6.4 ttp -52.58 112.93 0.91 Allowed 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 105.471 -2.048 . . . . 0.0 105.471 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . 0.622 3.8 mm-40 -77.8 -56.34 4.59 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 124.806 1.316 . . . . 0.0 110.07 -179.731 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 160.24 124.8 0.75 Allowed Glycine 0 C--O 1.22 -0.725 0 N-CA-C 103.402 -3.879 . . . . 0.0 103.402 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . 0.26 0.1 OUTLIER 55.97 15.64 1.82 Allowed 'General case' 0 C--O 1.245 0.832 0 CA-C-O 116.572 -1.68 . . . . 0.0 113.638 -179.986 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . 0.418 3.1 mppt? -174.12 150.26 1.53 Allowed 'General case' 0 CA--C 1.496 -1.101 0 O-C-N 125.772 1.92 . . . . 0.0 106.812 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.413 ' HB3' ' HB2' ' A' ' 106' ' ' ARG . 0.7 OUTLIER -113.4 137.88 50.88 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 102.331 -3.211 . . . . 0.0 102.331 -179.879 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.404 HG22 HG21 ' A' ' 83' ' ' THR . 18.5 m -118.24 134.37 62.08 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.028 0 N-CA-C 105.547 -2.02 . . . . 0.0 105.547 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -113.65 95.09 0.73 Allowed Glycine 0 C--N 1.344 0.981 0 C-N-CA 128.164 2.792 . . . . 0.0 108.755 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -90.83 168.64 11.57 Favored 'General case' 0 N--CA 1.436 -1.135 0 N-CA-C 104.323 -2.473 . . . . 0.0 104.323 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.51 ' CD1' ' HG ' ' A' ' 78' ' ' LEU . 23.5 m-85 -157.71 97.33 1.57 Allowed 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 118.454 -1.299 . . . . 0.0 108.063 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 14.5 mtmt -74.39 161.2 30.07 Favored 'General case' 0 N--CA 1.446 -0.653 0 O-C-N 125.125 1.516 . . . . 0.0 108.47 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.408 ' HD2' ' N ' ' A' ' 95' ' ' ARG 0.457 0.9 OUTLIER -119.47 139.98 51.2 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 179.69 . . . . . . . . 4 4 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.461 HG23 ' CB ' ' A' ' 77' ' ' GLU . 3.1 m -83.0 -13.38 12.04 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 179.792 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . 0.333 14.3 p-10 -79.13 3.93 16.16 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 113.504 -1.68 . . . . 0.0 112.361 179.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . 0.256 0.2 OUTLIER -174.93 -29.28 0.01 OUTLIER 'General case' 0 N--CA 1.426 -1.635 0 C-N-CA 117.698 -1.601 . . . . 0.0 114.069 -179.735 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 97.56 20.07 23.31 Favored Glycine 0 N--CA 1.445 -0.701 0 N-CA-C 115.21 0.844 . . . . 0.0 115.21 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 39.3 mttt -82.95 -159.79 0.36 Allowed 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 116.159 -2.216 . . . . 0.0 106.344 -179.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -143.0 148.67 37.17 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-O 117.23 -1.367 . . . . 0.0 109.889 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.501 ' HB2' ' HA ' ' A' ' 119' ' ' TYR . 0.3 OUTLIER -133.09 110.1 9.96 Favored 'General case' 0 CA--C 1.543 0.708 1 O-C-N 131.552 5.533 . . . . 0.0 103.217 179.212 . . . . . . . . 4 4 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -92.03 161.18 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.174 0 CA-C-N 114.181 -1.372 . . . . 0.0 111.003 -179.238 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -150.15 106.38 3.47 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 116.152 -1.88 . . . . 0.0 107.376 -179.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 9.2 p -87.8 103.65 13.71 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.519 0 CA-C-N 120.877 1.672 . . . . 0.0 113.587 -179.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.542 ' CZ ' ' CZ2' ' A' ' 82' ' ' TRP . 19.2 mtt-85 -74.48 82.2 1.96 Allowed 'General case' 0 CA--C 1.507 -0.679 0 CA-C-O 124.872 2.273 . . . . 0.0 106.074 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.41 ' O ' ' N ' ' A' ' 109' ' ' SER . 0.2 OUTLIER -86.61 81.37 8.27 Favored 'General case' 0 N--CA 1.417 -2.078 0 CA-C-N 111.118 -2.765 . . . . 0.0 117.292 -179.989 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.523 HG12 ' CE1' ' A' ' 2' ' ' PHE . 1.9 mm -63.61 98.41 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 C-N-CA 116.106 -2.238 . . . . 0.0 107.287 179.081 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.41 ' N ' ' O ' ' A' ' 107' ' ' GLU . 2.1 p -62.9 -29.69 70.97 Favored 'General case' 0 C--N 1.319 -0.754 0 O-C-N 121.342 -0.849 . . . . 0.0 109.116 -179.272 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 145.77 -87.97 0.16 Allowed Glycine 0 CA--C 1.526 0.727 1 C-N-CA 131.965 4.602 . . . . 0.0 110.566 -179.304 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . 0.3 0.2 OUTLIER -81.76 -0.93 45.32 Favored 'General case' 0 C--O 1.212 -0.895 0 CA-C-O 113.794 -3.003 . . . . 0.0 110.137 179.235 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -136.61 118.69 15.4 Favored 'General case' 0 C--O 1.205 -1.245 1 O-C-N 129.751 4.407 . . . . 0.0 112.49 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.438 ' HG ' HG12 ' A' ' 108' ' ' ILE . 5.0 tt -91.66 141.1 29.06 Favored 'General case' 0 C--O 1.212 -0.898 0 N-CA-C 100.763 -3.791 . . . . 0.0 100.763 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.465 ' CD1' HD11 ' A' ' 127' ' ' ILE 0.309 14.3 mm -123.1 135.97 61.37 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 N-CA-C 102.55 -3.13 . . . . 0.0 102.55 179.666 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.416 ' HG3' ' CD2' ' A' ' 113' ' ' LEU . 13.5 mt-30 -131.94 95.25 3.65 Favored 'General case' 0 C--O 1.245 0.828 0 CA-C-O 115.425 -2.226 . . . . 0.0 105.385 -179.79 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 61.0 p -70.28 -171.51 0.47 Allowed 'General case' 0 C--N 1.318 -0.772 0 O-C-N 127.017 2.698 . . . . 0.0 106.425 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . 0.466 ' N ' ' O ' ' A' ' 123' ' ' GLU . 12.3 m-85 -159.8 62.26 0.36 Allowed 'General case' 0 CA--C 1.494 -1.181 0 CA-C-O 115.735 -2.079 . . . . 0.0 106.781 179.785 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.47 ' CA ' ' HA ' ' A' ' 123' ' ' GLU . 0.3 OUTLIER -70.44 108.32 4.22 Favored 'General case' 0 C--O 1.254 1.295 0 O-C-N 126.885 2.616 . . . . 0.0 107.016 -179.171 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.501 ' HA ' ' HB2' ' A' ' 102' ' ' LEU . 76.3 t80 -72.82 -35.77 67.37 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 103.827 -2.657 . . . . 0.0 103.827 -179.425 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -151.77 -66.88 0.17 Allowed 'General case' 0 C--N 1.291 -1.938 1 O-C-N 129.751 4.407 . . . . 0.0 108.074 179.866 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -145.14 27.58 1.86 Allowed Glycine 0 CA--C 1.544 1.892 0 C-N-CA 128.196 2.808 . . . . 0.0 112.881 178.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.557 ' HA ' ' CD2' ' A' ' 17' ' ' PHE . 1.7 m -106.77 6.86 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 CA-C-N 112.766 -1.717 . . . . 0.0 110.755 -178.237 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.47 ' HA ' ' CA ' ' A' ' 118' ' ' THR . 26.4 tt0 12.71 -75.0 0.0 OUTLIER 'General case' 0 C--N 1.307 -1.275 0 O-C-N 129.007 3.942 . . . . 0.0 112.028 -179.639 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 70.5 84.33 0.14 Allowed 'General case' 0 C--O 1.206 -1.21 0 O-C-N 116.669 -3.769 . . . . 0.0 109.08 178.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.452 ' N ' ' O ' ' A' ' 12' ' ' GLU . 6.0 mptt -79.7 136.76 36.86 Favored 'General case' 0 C--O 1.254 1.333 1 O-C-N 129.601 4.313 . . . . 0.0 110.027 179.97 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.455 ' NH2' ' CD2' ' A' ' 36' ' ' LEU . 3.2 mtm180 -126.49 77.81 1.73 Allowed 'General case' 0 N--CA 1.437 -1.096 0 O-C-N 125.574 1.796 . . . . 0.0 112.155 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.465 HD11 ' CD1' ' A' ' 114' ' ' ILE . 0.4 OUTLIER -73.96 108.37 5.39 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.922 0 O-C-N 126.362 2.289 . . . . 0.0 115.179 179.42 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.42 ' CE2' ' HB ' ' A' ' 8' ' ' VAL . 28.7 m-85 -89.06 147.07 24.44 Favored 'General case' 0 N--CA 1.438 -1.064 0 C-N-CA 128.158 2.583 . . . . 0.0 111.215 179.812 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.425 ' HG3' ' HB3' ' A' ' 9' ' ' ASP 0.347 14.3 mtmt -100.15 8.45 43.86 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 117.733 -1.127 . . . . 0.0 110.392 -179.972 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.462 ' HA ' ' CE3' ' A' ' 6' ' ' TRP . 9.7 tttm 69.53 153.68 0.11 Allowed 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . 0.835 61.1 tt0 . . . . . 0 CA--C 1.505 -0.785 0 N-CA-C 119.246 3.054 . . . . 0.0 119.246 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' PLM . . . . . 0.436 ' C6 ' ' CE2' ' A' ' 70' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.267 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -140.33 31.71 1.92 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 124.076 1.893 . . . . 0.0 114.08 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -119.16 99.61 6.82 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 113.54 -1.664 . . . . 0.0 110.874 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.412 ' O ' ' N ' ' A' ' 40' ' ' ILE . . . 157.9 -148.6 18.22 Favored Glycine 0 C--O 1.208 -1.472 0 CA-C-N 112.748 -2.023 . . . . 0.0 110.437 179.658 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.44 HG22 ' HA ' ' A' ' 131' ' ' GLU 0.566 6.3 t -102.03 159.29 15.5 Favored 'General case' 0 N--CA 1.432 -1.334 0 CA-C-N 113.794 -1.203 . . . . 0.0 112.294 -179.84 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.541 ' CZ3' ' CG ' ' A' ' 130' ' ' LYS . 96.0 m95 -146.5 112.26 5.65 Favored 'General case' 0 N--CA 1.441 -0.902 0 O-C-N 127.685 3.116 . . . . 0.0 111.161 179.806 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 11.8 ttmt -109.15 116.47 32.0 Favored 'General case' 0 C--O 1.207 -1.17 0 CA-C-N 121.548 1.976 . . . . 0.0 108.065 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.492 ' HB ' ' CD1' ' A' ' 128' ' ' PHE 0.289 1.5 p -57.62 128.47 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 O-C-N 119.04 -2.288 . . . . 0.0 114.897 179.986 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -107.93 -21.63 12.75 Favored 'General case' 0 C--O 1.213 -0.826 0 CA-C-O 126.201 2.905 . . . . 0.0 108.883 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.407 ' O ' ' N ' ' A' ' 127' ' ' ILE . 29.9 ptt-85 -163.79 146.56 9.69 Favored 'General case' 0 CA--C 1.478 -1.795 0 O-C-N 117.93 -2.982 . . . . 0.0 113.107 179.766 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . 0.413 0.8 OUTLIER -119.19 -176.13 3.07 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 112.919 -1.946 . . . . 0.0 107.018 179.927 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -145.79 -70.94 0.26 Allowed 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 122.194 2.27 . . . . 0.0 108.062 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.535 ' ND2' ' CG ' ' A' ' 17' ' ' PHE . 2.4 t30 -92.87 39.19 1.03 Allowed 'General case' 0 N--CA 1.476 0.827 0 O-C-N 127.555 3.035 . . . . 0.0 111.91 179.542 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . 0.313 34.5 t80 -97.81 -57.98 2.1 Favored 'General case' 0 N--CA 1.439 -1.01 0 N-CA-C 121.267 3.802 . . . . 0.0 121.267 -179.379 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . 0.252 6.1 pm0 -56.5 -55.02 38.94 Favored 'General case' 0 CA--C 1.505 -0.757 0 CA-C-N 124.227 3.194 . . . . 0.0 114.186 -179.066 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.594 ' HB3' ' CD2' ' A' ' 17' ' ' PHE . 8.5 ttmt -55.04 -42.05 72.17 Favored 'General case' 0 N--CA 1.421 -1.923 0 C-N-CA 127.537 2.335 . . . . 0.0 115.616 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.594 ' CD2' ' HB3' ' A' ' 16' ' ' LYS 0.293 45.1 m-85 -77.58 -19.91 54.87 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 111.282 -2.69 . . . . 0.0 114.044 -177.28 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.438 ' O ' HG12 ' A' ' 23' ' ' ILE . 4.4 mmt -70.43 -20.04 62.94 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 118.812 -2.43 . . . . 0.0 105.88 175.738 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.71 -32.59 63.98 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-O 127.904 3.716 . . . . 0.0 109.837 179.775 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.481 ' HD3' ' CG1' ' A' ' 122' ' ' VAL . 0.5 OUTLIER -72.51 -30.11 64.2 Favored 'General case' 0 N--CA 1.454 -0.256 0 O-C-N 118.113 -2.867 . . . . 0.0 110.371 179.97 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.415 ' CE ' ' HG ' ' A' ' 72' ' ' LEU . 1.5 mmm -78.06 -28.04 48.77 Favored 'General case' 0 C--O 1.201 -1.481 0 C-N-CA 127.472 2.309 . . . . 0.0 107.768 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.62 22.0 6.57 Favored Glycine 0 C--N 1.299 -1.48 0 CA-C-O 114.598 -3.334 . . . . 0.0 111.678 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.438 HG12 ' O ' ' A' ' 18' ' ' MET . 23.9 mm -78.78 139.76 17.94 Favored 'Isoleucine or valine' 0 C--N 1.352 0.709 0 O-C-N 126.765 2.097 . . . . 0.0 106.507 -179.288 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -102.29 143.12 32.46 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-O 116.559 -1.686 . . . . 0.0 113.119 -179.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . 0.437 0.2 OUTLIER 3.35 -73.81 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.508 -0.658 0 N-CA-C 119.957 3.318 . . . . 0.0 119.957 179.962 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.646 1.8 t -65.84 -30.33 49.7 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.972 0 O-C-N 126.936 2.648 . . . . 0.0 116.634 -179.764 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 30.5 mtmt -73.37 -31.22 63.8 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 114.222 -1.354 . . . . 0.0 111.236 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.92 -25.86 40.38 Favored 'General case' 0 N--CA 1.473 0.715 0 O-C-N 120.46 -1.4 . . . . 0.0 107.998 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 15.8 ttpt -78.57 -43.23 27.06 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.893 -1.049 . . . . 0.0 111.456 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.4 mt -77.73 -30.86 51.87 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 118.959 -1.096 . . . . 0.0 110.382 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -71.74 -30.95 65.47 Favored Glycine 0 C--O 1.217 -0.931 0 O-C-N 125.329 1.643 . . . . 0.0 111.998 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -75.81 -25.74 56.62 Favored 'General case' 0 N--CA 1.439 -0.981 0 O-C-N 120.996 -1.296 . . . . 0.0 112.959 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -121.3 28.3 7.87 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 127.605 2.362 . . . . 0.0 115.001 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -66.84 -13.88 62.08 Favored 'General case' 0 C--O 1.218 -0.591 0 N-CA-C 117.406 2.372 . . . . 0.0 117.406 -179.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . 0.302 0.5 OUTLIER 70.25 26.86 4.25 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 121.063 1.756 . . . . 0.0 110.004 179.741 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.427 ' HB3' ' CG1' ' A' ' 8' ' ' VAL . 0.9 OUTLIER -45.34 114.1 0.69 Allowed 'General case' 0 CA--C 1.495 -1.148 0 O-C-N 127.405 2.941 . . . . 0.0 108.76 -179.739 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 27.7 tttp -110.98 98.82 7.83 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 104.911 -2.255 . . . . 0.0 104.911 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.468 ' HG ' ' CG2' ' A' ' 49' ' ' VAL . 1.9 tp -79.87 139.92 36.96 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.5 ' HB ' ' CB ' ' A' ' 50' ' ' LYS . 47.3 m -131.16 82.45 2.04 Favored 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 103.189 -2.893 . . . . 0.0 103.189 179.741 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.412 ' N ' ' O ' ' A' ' 4' ' ' GLY . 2.4 mm -65.54 132.06 31.27 Favored 'Isoleucine or valine' 0 C--O 1.255 1.35 0 CA-C-N 112.482 -2.145 . . . . 0.0 111.116 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 13.3 m -139.76 92.29 2.55 Favored 'General case' 0 CA--C 1.501 -0.918 0 O-C-N 125.851 1.97 . . . . 0.0 112.108 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 54.8 tt0 -85.87 118.17 25.19 Favored 'General case' 0 C--O 1.243 0.745 0 CA-C-O 117.186 -1.388 . . . . 0.0 111.519 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -101.54 -109.39 0.22 Allowed 'General case' 0 CA--C 1.495 -1.166 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -112.22 76.33 0.23 Allowed Glycine 0 C--N 1.307 -1.038 0 N-CA-C 105.548 -3.021 . . . . 0.0 105.548 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.313 0.5 OUTLIER 89.62 -18.74 0.19 Allowed 'General case' 0 C--N 1.32 -0.678 0 O-C-N 128.345 3.026 . . . . 0.0 113.751 179.827 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.427 ' HA ' ' HA ' ' A' ' 63' ' ' GLU . 1.9 ttpm? -91.93 146.48 23.71 Favored 'General case' 0 N--CA 1.435 -1.199 0 C-N-CA 117.604 -1.638 . . . . 0.0 107.301 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . 0.28 4.4 m-85 -129.32 93.85 3.66 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-O 123.01 1.386 . . . . 0.0 108.94 179.803 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.475 ' HB ' ' CG1' ' A' ' 61' ' ' VAL 0.479 2.0 t -78.36 146.1 34.85 Favored 'General case' 0 CA--C 1.496 -1.101 0 CA-C-O 125.23 2.443 . . . . 0.0 107.949 179.739 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.468 ' CG2' ' HG ' ' A' ' 38' ' ' LEU 0.693 0.3 OUTLIER -120.68 95.75 3.78 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 CA-C-N 109.969 -3.287 . . . . 0.0 111.948 -179.981 . . . . . . . . 4 4 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.5 ' CB ' ' HB ' ' A' ' 39' ' ' THR . 0.9 OUTLIER -72.22 130.34 40.58 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 100.305 -3.961 . . . . 0.0 100.305 179.685 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -123.52 66.99 1.01 Allowed 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 105.947 -1.871 . . . . 0.0 105.947 -179.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 12.6 m -71.82 74.89 0.87 Allowed 'General case' 0 C--N 1.287 -2.11 0 CA-C-O 117.861 -1.066 . . . . 0.0 108.153 -179.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -103.6 -165.73 1.19 Allowed 'General case' 0 CA--C 1.506 -0.743 0 O-C-N 125.543 1.777 . . . . 0.0 112.777 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 62.5 t30 -70.77 -20.66 62.58 Favored 'General case' 0 N--CA 1.441 -0.882 0 O-C-N 123.979 0.799 . . . . 0.0 112.325 -179.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -87.26 -55.74 3.67 Favored 'General case' 0 C--O 1.22 -0.474 0 CA-C-O 115.071 -2.395 . . . . 0.0 112.258 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.75 176.61 12.15 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 124.496 3.316 . . . . 0.0 107.725 179.738 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -119.17 88.04 2.85 Favored 'General case' 0 C--O 1.216 -0.702 0 C-N-CA 131.466 3.906 . . . . 0.0 100.872 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -117.73 98.91 7.14 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.992 0 C-N-CA 129.041 2.936 . . . . 0.0 118.676 -179.511 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 19.3 p-10 -62.54 120.5 11.24 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 103.712 -2.699 . . . . 0.0 103.712 177.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.512 ' HB ' ' CZ ' ' A' ' 62' ' ' PHE . 2.8 t -83.91 -55.17 7.52 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 CA-C-O 125.42 2.533 . . . . 0.0 112.133 -177.466 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.475 ' CG1' ' HB ' ' A' ' 48' ' ' THR 0.349 0.7 OUTLIER 67.13 133.36 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.434 -1.252 0 O-C-N 120.046 -1.659 . . . . 0.0 114.034 -179.54 . . . . . . . . 4 4 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.604 ' CD2' ' CZ ' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -166.72 100.91 0.57 Allowed 'General case' 0 N--CA 1.428 -1.555 0 CA-C-O 116.989 -1.482 . . . . 0.0 111.427 179.493 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.427 ' HA ' ' HA ' ' A' ' 46' ' ' LYS . 30.1 mm-40 -54.35 142.48 26.55 Favored 'General case' 0 N--CA 1.429 -1.503 0 O-C-N 126.782 2.551 . . . . 0.0 105.726 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.1 mp -59.54 115.79 3.55 Favored 'General case' 0 N--CA 1.431 -1.389 0 CA-C-N 120.844 1.656 . . . . 0.0 111.43 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 83.08 33.76 22.75 Favored Glycine 0 C--N 1.34 0.782 0 O-C-N 128.433 3.583 . . . . 0.0 116.897 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . 0.426 2.2 t -117.1 92.42 2.12 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . 0.269 0.2 OUTLIER -44.3 134.73 4.88 Favored 'General case' 0 CA--C 1.494 -1.194 0 O-C-N 124.898 1.374 . . . . 0.0 113.203 -179.948 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.604 ' CZ ' ' CD2' ' A' ' 62' ' ' PHE . 11.7 p90 -132.46 170.18 15.49 Favored 'General case' 0 N--CA 1.439 -0.992 0 O-C-N 124.961 1.413 . . . . 0.0 108.14 -179.655 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -125.79 109.58 12.71 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 116.038 -1.934 . . . . 0.0 107.851 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 21.3 t80 -127.83 111.57 13.78 Favored 'General case' 0 C--N 1.319 -0.739 0 O-C-N 125.471 1.732 . . . . 0.0 112.876 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 8.2 t -79.95 156.32 27.29 Favored 'General case' 0 CA--C 1.487 -1.449 0 CA-C-N 119.239 0.927 . . . . 0.0 109.713 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.415 ' HG ' ' CE ' ' A' ' 21' ' ' MET . 4.0 mm? -81.22 -166.28 1.12 Allowed 'General case' 0 CA--C 1.503 -0.834 0 N-CA-C 103.874 -2.639 . . . . 0.0 103.874 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -87.85 -18.78 28.5 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 124.805 1.315 . . . . 0.0 112.491 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -84.57 -13.17 52.51 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 115.972 -2.291 . . . . 0.0 108.99 179.775 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 108.17 8.36 29.44 Favored Glycine 0 CA--C 1.542 1.768 0 CA-C-O 117.431 -1.761 . . . . 0.0 114.359 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . 0.278 7.5 m -89.83 125.57 35.37 Favored 'General case' 0 N--CA 1.433 -1.289 0 CA-C-N 119.397 1.599 . . . . 0.0 109.926 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.424 ' CB ' ' HB ' ' A' ' 96' ' ' VAL . 0.0 OUTLIER -66.64 169.48 7.72 Favored 'General case' 0 C--O 1.22 -0.466 0 O-C-N 128.013 3.321 . . . . 0.0 112.327 -179.989 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.516 HD22 ' CD1' ' A' ' 93' ' ' PHE 0.28 1.5 tt -153.08 142.44 21.64 Favored 'General case' 0 CA--C 1.503 -0.834 0 N-CA-C 102.512 -3.144 . . . . 0.0 102.512 179.777 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 19.0 p -144.94 111.79 5.86 Favored 'General case' 0 CA--C 1.491 -1.315 0 N-CA-C 102.729 -3.063 . . . . 0.0 102.729 -179.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -174.48 -167.45 33.93 Favored Glycine 0 C--N 1.301 -1.414 1 C-N-CA 113.058 -4.401 . . . . 0.0 114.414 -179.772 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -144.89 176.32 9.56 Favored 'General case' 0 C--O 1.187 -2.229 0 CA-C-N 119.821 1.811 . . . . 0.0 111.725 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . 0.421 ' CZ2' ' CE1' ' A' ' 62' ' ' PHE 0.311 13.7 m0 -116.85 154.32 30.96 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 106.244 -1.761 . . . . 0.0 106.244 -179.995 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.449 HG21 ' CG2' ' A' ' 90' ' ' VAL . 10.8 t -162.35 139.39 8.09 Favored 'General case' 0 C--N 1.297 -1.698 0 CA-C-O 124.499 2.095 . . . . 0.0 111.811 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 5.1 ttt -81.37 102.72 10.64 Favored 'General case' 0 C--O 1.211 -0.964 0 CA-C-N 112.018 -2.355 . . . . 0.0 106.881 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . 0.632 6.8 mt-10 -77.02 -121.12 0.01 OUTLIER 'General case' 0 N--CA 1.428 -1.526 0 CA-C-O 124.483 2.087 . . . . 0.0 111.383 -179.848 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -105.88 95.22 1.04 Allowed Glycine 0 N--CA 1.443 -0.86 0 N-CA-C 106.243 -2.743 . . . . 0.0 106.243 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 4.4 m120 61.81 12.84 4.99 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 116.347 1.98 . . . . 0.0 116.347 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . 0.348 9.0 mtmm -149.89 139.55 21.68 Favored 'General case' 0 C--O 1.215 -0.732 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 179.785 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -84.77 130.15 34.72 Favored 'General case' 0 C--N 1.317 -0.833 1 O-C-N 129.213 4.071 . . . . 0.0 102.046 179.849 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.449 ' CG2' HG21 ' A' ' 83' ' ' THR . 16.1 m -120.85 164.76 17.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.435 ' O ' ' N ' ' A' ' 104' ' ' ALA . . . -141.4 101.12 0.28 Allowed Glycine 0 C--O 1.216 -1.02 0 C-N-CA 127.932 2.682 . . . . 0.0 109.252 -179.833 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.98 123.79 37.56 Favored 'General case' 0 N--CA 1.436 -1.172 0 N-CA-C 104.583 -2.377 . . . . 0.0 104.583 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.516 ' CD1' HD22 ' A' ' 78' ' ' LEU . 21.2 m-30 -122.16 113.02 18.91 Favored 'General case' 0 CA--C 1.506 -0.716 0 O-C-N 125.417 1.698 . . . . 0.0 114.255 -179.543 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.408 ' HA ' ' HA ' ' A' ' 101' ' ' GLU . 12.3 mttm -92.12 173.18 7.97 Favored 'General case' 0 N--CA 1.427 -1.592 0 C-N-CA 126.586 1.955 . . . . 0.0 106.621 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . 0.37 3.3 mtp180 -119.72 145.53 46.45 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.424 ' HB ' ' CB ' ' A' ' 77' ' ' GLU . 5.2 t -69.71 -47.78 68.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 112.89 -1.959 . . . . 0.0 113.597 -179.817 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . 0.324 1.5 p-10 -102.51 35.13 2.54 Favored 'General case' 0 C--O 1.258 1.512 0 CA-C-O 122.798 1.285 . . . . 0.0 113.408 -179.817 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -144.17 -41.61 0.27 Allowed 'General case' 0 CA--C 1.491 -1.292 0 CA-C-N 114.131 -1.395 . . . . 0.0 113.723 -179.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 81.62 2.39 90.5 Favored Glycine 0 CA--C 1.543 1.788 0 C-N-CA 125.53 1.538 . . . . 0.0 112.395 -179.658 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 47.3 mttm -85.22 -171.32 3.57 Favored 'General case' 0 C--O 1.205 -1.251 0 CA-C-N 114.291 -0.954 . . . . 0.0 110.818 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.419 ' CG ' ' N ' ' A' ' 102' ' ' LEU . 23.0 tt0 -130.81 168.8 16.65 Favored 'General case' 0 N--CA 1.439 -1.009 0 C-N-CA 129.669 3.187 . . . . 0.0 111.066 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.551 ' CG ' ' HA ' ' A' ' 119' ' ' TYR . 5.0 tt -154.57 -179.05 7.61 Favored 'General case' 0 C--N 1.319 -0.756 2 C-N-CA 136.19 5.796 . . . . 0.0 104.361 179.827 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.422 HG13 ' N ' ' A' ' 104' ' ' ALA . 0.9 OUTLIER -157.38 155.33 5.08 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.406 0 N-CA-C 104.116 -2.55 . . . . 0.0 104.116 179.783 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.435 ' N ' ' O ' ' A' ' 91' ' ' GLY . . . -143.15 94.86 2.68 Favored 'General case' 0 N--CA 1.436 -1.158 0 C-N-CA 125.551 1.54 . . . . 0.0 108.284 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -89.39 116.55 31.06 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 CA-C-O 125.222 2.439 . . . . 0.0 110.588 179.713 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.426 ' NH1' ' HG3' ' A' ' 106' ' ' ARG . 38.3 mtt85 -88.42 90.84 8.56 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 105.915 -1.883 . . . . 0.0 105.915 179.672 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -89.38 80.05 6.87 Favored 'General case' 0 N--CA 1.423 -1.781 0 O-C-N 127.356 2.91 . . . . 0.0 117.287 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.534 HD12 ' CH2' ' A' ' 6' ' ' TRP 0.312 0.6 OUTLIER -54.24 96.79 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 C-N-CA 118.523 -1.271 . . . . 0.0 113.368 179.718 . . . . . . . . 4 4 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 8.6 t -92.11 73.73 5.48 Favored 'General case' 0 CA--C 1.508 -0.635 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 -179.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 42.6 87.33 0.01 OUTLIER Glycine 0 C--N 1.334 0.452 0 O-C-N 125.586 1.804 . . . . 0.0 114.834 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . 0.315 3.7 m-20 84.32 -11.9 0.8 Allowed 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 113.961 -2.923 . . . . 0.0 111.212 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -124.93 108.45 11.9 Favored 'General case' 0 CA--C 1.497 -1.076 0 O-C-N 125.369 1.668 . . . . 0.0 111.669 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 6.1 tt -85.74 117.48 24.65 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 102.475 -3.157 . . . . 0.0 102.475 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.481 ' CD1' HD13 ' A' ' 127' ' ' ILE . 73.0 mt -113.97 142.42 26.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 N-CA-C 103.314 -2.847 . . . . 0.0 103.314 179.876 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -121.07 119.91 33.81 Favored 'General case' 0 CA--C 1.503 -0.855 0 CA-C-O 115.812 -2.042 . . . . 0.0 108.599 -179.03 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.5 p -96.96 111.94 23.93 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 104.256 -2.498 . . . . 0.0 104.256 178.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -97.26 106.05 18.31 Favored 'General case' 0 CA--C 1.477 -1.847 0 O-C-N 125.578 1.799 . . . . 0.0 113.39 -179.375 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 1.7 m -109.56 95.75 5.82 Favored 'General case' 0 N--CA 1.423 -1.797 0 O-C-N 125.775 1.922 . . . . 0.0 115.464 -179.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.551 ' HA ' ' CG ' ' A' ' 102' ' ' LEU . 60.9 t80 -52.1 -51.07 60.08 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 104.5 -2.407 . . . . 0.0 104.5 179.111 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -148.31 -64.9 0.25 Allowed 'General case' 0 C--N 1.3 -1.55 0 CA-C-N 112.596 -2.093 . . . . 0.0 111.575 179.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -144.07 27.95 2.0 Allowed Glycine 0 CA--C 1.543 1.824 0 C-N-CA 128.745 3.069 . . . . 0.0 112.091 179.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.489 ' HB ' ' HB3' ' A' ' 17' ' ' PHE . 21.1 m -133.23 80.08 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 105.067 -2.198 . . . . 0.0 105.067 -178.572 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.403 ' O ' ' CB ' ' A' ' 124' ' ' ALA 0.301 3.0 tt0 -58.03 -169.36 0.01 OUTLIER 'General case' 0 N--CA 1.426 -1.665 0 C-N-CA 127.534 2.334 . . . . 0.0 111.985 179.937 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.403 ' CB ' ' O ' ' A' ' 123' ' ' GLU . . . 177.72 76.48 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 121.206 1.821 . . . . 0.0 109.022 179.193 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . 0.331 0.0 OUTLIER -70.08 142.34 52.65 Favored 'General case' 0 N--CA 1.446 -0.629 0 O-C-N 126.811 2.569 . . . . 0.0 107.092 179.587 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 10.8 mtm180 -144.31 78.51 1.58 Allowed 'General case' 0 C--O 1.218 -0.562 0 O-C-N 127.624 3.078 . . . . 0.0 104.894 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.481 HD13 ' CD1' ' A' ' 114' ' ' ILE . 2.4 mm -57.9 115.45 0.94 Allowed 'Isoleucine or valine' 0 C--O 1.247 0.948 0 O-C-N 128.215 3.447 . . . . 0.0 116.569 -179.776 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.492 ' CD1' ' HB ' ' A' ' 8' ' ' VAL . 22.8 m-85 -100.62 132.74 45.86 Favored 'General case' 0 N--CA 1.435 -1.223 0 C-N-CA 124.807 1.243 . . . . 0.0 108.144 179.492 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . 0.271 17.4 mtpt -95.69 6.16 49.63 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 117.229 -1.367 . . . . 0.0 110.737 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.541 ' CG ' ' CZ3' ' A' ' 6' ' ' TRP . 0.0 OUTLIER 72.27 157.0 0.17 Allowed 'General case' 0 C--O 1.238 0.478 0 CA-C-N 119.411 1.005 . . . . 0.0 111.572 179.972 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.44 ' HA ' HG22 ' A' ' 5' ' ' THR 0.845 7.3 tt0 . . . . . 0 N--CA 1.44 -0.974 0 N-CA-C 118.675 2.843 . . . . 0.0 118.675 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' PLM . . . . . 0.434 ' H21' HG13 ' A' ' 49' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.417 ' C ' ' CG ' ' A' ' 2' ' ' PHE . . . . . . . . 0 CA--C 1.51 -0.587 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.417 ' CG ' ' C ' ' A' ' 1' ' ' ALA . 0.1 OUTLIER 62.02 49.46 4.57 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 118.63 -1.228 . . . . 0.0 112.188 179.752 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -138.18 96.57 3.22 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 115.669 1.729 . . . . 0.0 115.669 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 149.23 -141.93 9.37 Favored Glycine 0 C--O 1.214 -1.139 0 C-N-CA 116.971 -2.537 . . . . 0.0 109.147 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . 0.517 6.6 t -118.39 161.24 20.29 Favored 'General case' 0 CA--C 1.497 -1.08 0 O-C-N 127.023 2.249 . . . . 0.0 113.549 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.545 ' HB3' ' CD2' ' A' ' 128' ' ' PHE . 92.3 m95 -148.07 145.03 28.27 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 126.486 2.366 . . . . 0.0 107.133 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.425 ' HE3' ' HB2' ' A' ' 37' ' ' LYS . 0.5 OUTLIER -132.85 102.95 5.84 Favored 'General case' 0 N--CA 1.439 -1.02 0 C-N-CA 123.655 0.782 . . . . 0.0 109.071 179.902 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.416 ' O ' ' ND2' ' A' ' 35' ' ' ASN 0.368 11.4 p -57.17 115.72 0.91 Allowed 'Isoleucine or valine' 0 C--O 1.246 0.875 0 O-C-N 120.573 -1.33 . . . . 0.0 109.076 179.964 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -99.71 -29.12 12.83 Favored 'General case' 0 C--O 1.209 -1.041 0 O-C-N 126.591 2.432 . . . . 0.0 112.038 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 2.2 ptm180 -162.38 95.8 0.94 Allowed 'General case' 0 CA--C 1.478 -1.797 0 C-N-CA 113.789 -3.164 . . . . 0.0 112.997 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -64.69 177.36 0.94 Allowed 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 113.147 -1.842 . . . . 0.0 108.124 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -131.17 -79.29 0.53 Allowed 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 115.395 -2.24 . . . . 0.0 108.778 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -92.25 21.04 5.45 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 126.693 2.496 . . . . 0.0 115.013 179.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.556 ' CD2' ' HG2' ' A' ' 126' ' ' ARG 0.348 0.1 OUTLIER -65.35 -33.29 75.62 Favored 'General case' 0 C--N 1.309 -1.193 0 O-C-N 128.186 3.429 . . . . 0.0 114.5 -179.982 . . . . . . . . 4 4 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -67.68 -23.78 65.34 Favored 'General case' 0 C--O 1.21 -1.015 0 O-C-N 117.108 -3.495 . . . . 0.0 110.694 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.439 ' HB3' HG13 ' A' ' 122' ' ' VAL . 0.9 OUTLIER -79.94 -44.94 19.43 Favored 'General case' 0 C--O 1.247 0.973 0 CA-C-N 112.485 -2.143 . . . . 0.0 113.022 179.918 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.515 ' CZ ' ' HE3' ' A' ' 21' ' ' MET . 0.4 OUTLIER -60.56 -26.47 66.94 Favored 'General case' 0 N--CA 1.435 -1.218 0 CA-C-O 125.664 2.649 . . . . 0.0 112.264 179.988 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.4 ' HB3' ' HB ' ' A' ' 23' ' ' ILE . 7.6 mtt -73.68 -29.6 62.39 Favored 'General case' 0 N--CA 1.443 -0.802 0 O-C-N 116.301 -3.999 . . . . 0.0 106.629 179.36 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -70.0 -44.2 69.86 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-O 124.014 1.864 . . . . 0.0 112.213 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.411 ' HD3' ' CG2' ' A' ' 122' ' ' VAL . 16.2 tptt -61.06 -30.63 70.45 Favored 'General case' 0 C--O 1.209 -1.045 0 O-C-N 120.124 -1.61 . . . . 0.0 114.226 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.515 ' HE3' ' CZ ' ' A' ' 17' ' ' PHE . 0.4 OUTLIER -79.45 -20.83 46.49 Favored 'General case' 0 N--CA 1.436 -1.154 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 -179.926 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 115.53 20.5 5.42 Favored Glycine 0 C--O 1.224 -0.502 0 N-CA-C 110.192 -1.163 . . . . 0.0 110.192 179.579 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.475 ' CD1' ' HG3' ' A' ' 132' ' ' PLM . 0.5 OUTLIER -104.79 101.88 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.291 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 -179.373 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 8.7 p-10 -130.94 24.75 4.97 Favored 'General case' 0 C--O 1.24 0.582 0 N-CA-C 114.666 1.358 . . . . 0.0 114.666 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . 0.546 17.4 m -136.17 -123.62 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.504 -0.822 0 N-CA-C 117.629 2.455 . . . . 0.0 117.629 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.65 0.0 OUTLIER -76.78 -22.67 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 N-CA-C 117.637 2.458 . . . . 0.0 117.637 179.816 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -73.64 -25.91 60.52 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 114.463 -1.244 . . . . 0.0 113.985 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.66 -27.99 40.81 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 121.124 1.784 . . . . 0.0 107.301 -179.725 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -67.93 -41.29 82.82 Favored 'General case' 0 CA--C 1.508 -0.654 0 CA-C-O 123.249 1.5 . . . . 0.0 111.889 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 16.3 mt -73.7 -34.52 64.89 Favored 'General case' 0 N--CA 1.438 -1.034 0 O-C-N 120.5 -1.375 . . . . 0.0 107.439 179.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -76.51 -29.68 57.64 Favored Glycine 0 C--N 1.338 0.647 0 O-C-N 128.574 3.671 . . . . 0.0 114.995 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -71.91 -33.96 68.73 Favored 'General case' 0 C--O 1.243 0.732 0 O-C-N 119.425 -2.221 . . . . 0.0 110.24 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 7.2 t-80 -85.25 0.34 52.2 Favored 'General case' 0 N--CA 1.441 -0.916 0 O-C-N 127.384 2.927 . . . . 0.0 110.652 179.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.28 101.09 2.26 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-O 114.83 -2.51 . . . . 0.0 111.803 179.67 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.416 ' ND2' ' O ' ' A' ' 8' ' ' VAL . 1.5 t-20 -74.09 60.61 0.79 Allowed 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 121.447 1.931 . . . . 0.0 110.9 -179.373 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.449 HD12 HD21 ' A' ' 38' ' ' LEU . 0.2 OUTLIER -41.89 119.06 1.22 Allowed 'General case' 0 CA--C 1.496 -1.101 0 CA-C-O 125.492 2.568 . . . . 0.0 111.178 -179.627 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.425 ' HB2' ' HE3' ' A' ' 7' ' ' LYS . 44.9 tttm -107.78 111.24 23.3 Favored 'General case' 0 CA--C 1.516 -0.352 0 N-CA-C 102.076 -3.305 . . . . 0.0 102.076 179.793 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.449 HD21 HD12 ' A' ' 36' ' ' LEU . 0.1 OUTLIER -93.05 145.63 24.24 Favored 'General case' 0 C--N 1.31 -1.132 0 C-N-CA 114.941 -2.704 . . . . 0.0 105.149 -179.902 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.8 m -134.1 85.29 2.18 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 103.432 -2.803 . . . . 0.0 103.432 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.464 HG22 ' CD2' ' A' ' 47' ' ' PHE . 42.7 mt -79.86 117.76 26.23 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.122 0 O-C-N 124.731 1.27 . . . . 0.0 110.287 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -112.25 110.15 20.22 Favored 'General case' 0 CA--C 1.511 -0.529 1 O-C-N 129.868 4.48 . . . . 0.0 112.614 -179.86 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -85.68 95.8 9.49 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -110.23 86.19 2.26 Favored 'General case' 0 N--CA 1.426 -1.638 0 N-CA-C 104.698 -2.334 . . . . 0.0 104.698 179.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 75.18 -89.9 0.8 Allowed Glycine 0 C--N 1.305 -1.185 0 N-CA-C 106.764 -2.535 . . . . 0.0 106.764 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -129.06 -42.31 1.38 Allowed 'General case' 0 N--CA 1.443 -0.783 0 O-C-N 127.723 2.661 . . . . 0.0 111.394 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.42 129.23 41.05 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-O 123.49 1.614 . . . . 0.0 108.87 179.837 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.464 ' CD2' HG22 ' A' ' 40' ' ' ILE 0.289 1.7 m-85 -108.5 99.41 8.8 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 -179.804 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.51 ' CG2' HG12 ' A' ' 61' ' ' VAL 0.388 28.3 p -70.76 85.44 0.66 Allowed 'General case' 0 N--CA 1.432 -1.361 0 C-N-CA 117.646 -1.622 . . . . 0.0 110.034 -179.954 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.454 HG13 ' CZ ' ' A' ' 62' ' ' PHE 0.657 10.0 p -67.2 87.24 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.494 -1.179 0 O-C-N 126.051 2.094 . . . . 0.0 109.717 -179.864 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 9.8 ttpp -73.28 119.92 18.19 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 105.281 -2.118 . . . . 0.0 105.281 -179.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.401 ' O ' ' N ' ' A' ' 53' ' ' SER 0.335 71.9 tt0 -108.12 65.97 0.64 Allowed 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 103.783 -2.673 . . . . 0.0 103.783 -179.983 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.3 m -68.62 72.37 0.22 Allowed 'General case' 0 N--CA 1.418 -2.073 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 179.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.401 ' N ' ' O ' ' A' ' 51' ' ' GLU . 60.2 p -102.82 -177.43 3.38 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-O 116.51 -1.709 . . . . 0.0 111.698 -179.782 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -62.28 -30.12 70.91 Favored 'General case' 0 C--O 1.218 -0.599 0 CA-C-N 119.53 1.059 . . . . 0.0 108.178 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -67.38 -68.19 0.4 Allowed 'General case' 0 C--O 1.21 -0.99 0 CA-C-O 115.73 -2.081 . . . . 0.0 109.068 179.739 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.482 ' HB2' ' CG2' ' A' ' 58' ' ' ILE 0.272 13.5 mmt180 -136.36 -175.46 4.01 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 122.231 2.287 . . . . 0.0 111.198 -179.92 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -134.1 55.32 1.9 Allowed 'General case' 0 C--O 1.218 -0.567 2 N-CA-C 100.143 -4.021 . . . . 0.0 100.143 179.551 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.482 ' CG2' ' HB2' ' A' ' 56' ' ' ARG . 3.4 tt -99.31 106.11 18.46 Favored 'Isoleucine or valine' 0 C--N 1.346 0.419 1 C-N-CA 132.294 4.238 . . . . 0.0 117.398 -179.332 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -62.82 136.41 57.84 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 105.327 -2.101 . . . . 0.0 105.327 179.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.5 t -116.97 41.65 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 -179.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.51 HG12 ' CG2' ' A' ' 48' ' ' THR 0.354 0.1 OUTLIER -36.46 144.9 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 CA-C-O 125.707 2.67 . . . . 0.0 114.48 -179.941 . . . . . . . . 4 4 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.573 ' HB3' ' CE1' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -156.0 100.93 2.07 Favored 'General case' 0 N--CA 1.423 -1.796 0 O-C-N 119.732 -1.855 . . . . 0.0 109.608 178.435 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.419 ' O ' ' C ' ' A' ' 64' ' ' LEU . 0.0 OUTLIER -68.55 93.28 0.49 Allowed 'General case' 0 CA--C 1.533 0.309 1 N-CA-C 99.942 -4.096 . . . . 0.0 99.942 178.054 . . . . . . . . 4 4 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.655 ' CB ' ' CE2' ' A' ' 82' ' ' TRP . 0.0 OUTLIER -14.59 88.68 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.181 0 O-C-N 128.027 3.329 . . . . 0.0 110.523 -178.196 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.567 ' N ' ' CD1' ' A' ' 82' ' ' TRP . . . 90.67 44.13 4.64 Favored Glycine 0 C--N 1.353 1.478 0 CA-C-N 109.985 -3.279 . . . . 0.0 118.918 179.42 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . 0.484 0.6 OUTLIER -105.3 -8.8 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.236 0 CA-C-N 111.968 -2.116 . . . . 0.0 107.547 -179.846 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.417 ' HA ' HG23 ' A' ' 81' ' ' THR . 1.8 m-20 69.63 143.81 0.05 OUTLIER 'General case' 0 CA--C 1.491 -1.297 0 CA-C-O 122.154 0.978 . . . . 0.0 109.858 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.573 ' CE1' ' HB3' ' A' ' 62' ' ' PHE . 1.0 OUTLIER -163.81 119.29 1.61 Allowed 'General case' 0 N--CA 1.438 -1.045 0 C-N-CA 117.363 -1.735 . . . . 0.0 111.066 179.989 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -77.46 102.67 6.98 Favored 'General case' 0 C--O 1.245 0.841 0 N-CA-C 103.74 -2.689 . . . . 0.0 103.74 179.171 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.422 ' HB3' HD21 ' A' ' 78' ' ' LEU . 31.1 t80 -107.2 87.8 2.59 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-O 116.139 -1.886 . . . . 0.0 113.821 -178.275 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.434 ' HB2' HG21 ' A' ' 76' ' ' THR . 36.7 p -55.51 128.33 33.95 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 104.998 -2.223 . . . . 0.0 104.998 179.6 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.464 ' CD2' HD11 ' A' ' 78' ' ' LEU . 26.0 mt -71.57 -160.37 0.05 Allowed 'General case' 0 CA--C 1.495 -1.148 0 N-CA-C 106.133 -1.802 . . . . 0.0 106.133 -179.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -88.14 -30.4 19.85 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-O 124.97 2.319 . . . . 0.0 112.476 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.401 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 1.2 m-20 -124.77 -55.33 1.62 Allowed 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 113.045 -1.889 . . . . 0.0 111.211 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.0 -32.87 81.82 Favored Glycine 0 C--O 1.204 -1.755 0 CA-C-O 118.315 -1.269 . . . . 0.0 113.923 179.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.434 HG21 ' HB2' ' A' ' 71' ' ' SER 0.256 0.0 OUTLIER 70.24 169.89 0.31 Allowed 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 123.268 3.534 . . . . 0.0 114.738 179.821 . . . . . . . . 4 4 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 7.8 103.68 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.835 1 O-C-N 131.532 5.52 . . . . 0.0 113.704 -179.682 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.464 HD11 ' CD2' ' A' ' 72' ' ' LEU 0.414 0.4 OUTLIER -140.29 101.19 4.07 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 102.233 -3.247 . . . . 0.0 102.233 179.933 . . . . . . . . 4 4 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 48.6 m -108.05 135.07 50.02 Favored 'General case' 0 C--O 1.202 -1.438 0 O-C-N 126.459 2.35 . . . . 0.0 106.059 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.432 ' HA3' ' HA ' ' A' ' 93' ' ' PHE . . . 173.62 -144.34 7.62 Favored Glycine 0 C--N 1.3 -1.437 0 C-N-CA 117.209 -2.424 . . . . 0.0 109.821 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.534 ' HA ' ' CZ ' ' A' ' 68' ' ' PHE . 44.0 p -166.28 168.77 14.84 Favored 'General case' 0 C--O 1.19 -2.049 0 CA-C-O 123.48 1.609 . . . . 0.0 109.902 -179.637 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . 0.705 ' CG ' ' N ' ' A' ' 83' ' ' THR 0.406 1.9 p-90 -76.31 -169.64 1.24 Allowed 'General case' 0 C--N 1.316 -0.886 1 N-CA-C 99.807 -4.145 . . . . 0.0 99.807 175.419 . . . . . . . . 4 3 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.705 ' N ' ' CG ' ' A' ' 82' ' ' TRP 0.292 0.5 OUTLIER 177.19 128.26 0.04 OUTLIER 'General case' 0 N--CA 1.437 -1.122 0 CA-C-O 124.676 2.179 . . . . 0.0 112.897 174.94 . . . . . . . . 4 4 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.563 ' CB ' ' CH2' ' A' ' 82' ' ' TRP . 3.0 ttt -96.96 102.27 14.01 Favored 'General case' 0 N--CA 1.426 -1.633 0 N-CA-C 106.056 -1.831 . . . . 0.0 106.056 179.09 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.451 ' CG ' HG23 ' A' ' 90' ' ' VAL 0.67 0.0 OUTLIER -79.67 62.66 4.01 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 120.462 1.483 . . . . 0.0 108.655 179.691 . . . . . . . . 4 4 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 76.94 -64.3 3.08 Favored Glycine 0 C--O 1.219 -0.785 0 N-CA-C 107.261 -2.336 . . . . 0.0 107.261 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 28.9 p-10 -129.78 -16.29 3.77 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 120.866 2.333 . . . . 0.0 116.681 -179.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . 0.365 0.3 OUTLIER -113.89 111.35 21.56 Favored 'General case' 0 CA--C 1.496 -1.13 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 179.924 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.0 tt -66.24 153.8 41.55 Favored 'General case' 0 C--N 1.32 -0.715 0 O-C-N 125.186 1.554 . . . . 0.0 107.277 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.451 HG23 ' CG ' ' A' ' 85' ' ' GLU . 0.0 OUTLIER -144.19 179.97 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.021 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 179.986 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -140.53 99.17 0.24 Allowed Glycine 0 C--N 1.352 1.445 0 C-N-CA 129.034 3.206 . . . . 0.0 107.637 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.417 ' O ' ' CD1' ' A' ' 93' ' ' PHE . 5.9 mtpm? -98.25 138.11 36.0 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 102.365 -3.198 . . . . 0.0 102.365 -179.532 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.542 ' CZ ' ' H42' ' A' ' 132' ' ' PLM . 62.8 m-85 -150.06 127.77 11.67 Favored 'General case' 0 CA--C 1.5 -0.955 0 O-C-N 126.262 2.227 . . . . 0.0 113.702 -179.811 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 18.1 mttt -105.65 150.11 25.74 Favored 'General case' 0 N--CA 1.432 -1.374 0 CA-C-N 112.303 -2.226 . . . . 0.0 111.539 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . 0.401 1.0 OUTLIER -96.05 143.12 27.48 Favored 'General case' 0 N--CA 1.433 -1.322 0 CA-C-O 116.623 -1.656 . . . . 0.0 106.681 -179.713 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.4 m -83.53 -29.05 7.65 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.213 0 O-C-N 124.48 1.112 . . . . 0.0 113.941 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . 0.356 6.2 p-10 -90.17 11.63 20.41 Favored 'General case' 0 C--O 1.251 1.169 0 CA-C-N 112.454 -2.157 . . . . 0.0 111.281 179.569 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -138.57 -43.08 0.49 Allowed 'General case' 0 N--CA 1.439 -1.019 0 CA-C-N 112.562 -2.108 . . . . 0.0 116.604 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 86.7 -10.7 66.55 Favored Glycine 0 CA--C 1.535 1.301 0 CA-C-O 124.379 2.099 . . . . 0.0 113.469 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 47.4 mttt -70.77 -167.12 0.17 Allowed 'General case' 0 C--O 1.203 -1.367 0 O-C-N 120.299 -1.707 . . . . 0.0 109.783 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -135.2 154.07 51.73 Favored 'General case' 0 N--CA 1.441 -0.919 0 C-N-CA 128.612 2.765 . . . . 0.0 111.267 -179.818 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.458 ' HG ' ' HA ' ' A' ' 119' ' ' TYR . 7.2 tt -132.73 137.29 46.83 Favored 'General case' 0 C--O 1.247 0.938 1 C-N-CA 133.816 4.846 . . . . 0.0 105.412 -179.609 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.484 HG22 ' CB ' ' A' ' 117' ' ' TYR . 11.1 tt -132.0 160.17 42.62 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.158 0 N-CA-C 105.428 -2.064 . . . . 0.0 105.428 179.26 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.428 ' HA ' ' HB2' ' A' ' 117' ' ' TYR . . . -152.65 135.15 15.2 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-O 114.523 -2.656 . . . . 0.0 106.497 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.529 HG13 ' CZ ' ' A' ' 117' ' ' TYR . 7.1 p -119.99 114.71 45.03 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.799 0 CA-C-N 122.172 2.26 . . . . 0.0 114.454 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.43 ' NH1' ' O1 ' ' A' ' 132' ' ' PLM . 3.5 mtm180 -82.8 94.43 7.65 Favored 'General case' 0 C--O 1.223 -0.323 0 N-CA-C 103.788 -2.671 . . . . 0.0 103.788 178.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . 0.329 4.7 tt0 -72.0 -38.01 69.73 Favored 'General case' 0 C--O 1.21 -0.993 0 CA-C-N 110.934 -2.848 . . . . 0.0 116.129 -177.272 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.505 HD12 ' CZ2' ' A' ' 6' ' ' TRP 0.395 2.7 mm 60.05 75.96 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 C-N-CA 111.782 -3.967 . . . . 0.0 113.904 -179.686 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 6.8 t -65.54 -102.76 0.0 OUTLIER 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 120.46 1.482 . . . . 0.0 109.533 -179.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -133.85 89.32 0.25 Allowed Glycine 0 CA--C 1.521 0.416 1 C-N-CA 130.958 4.123 . . . . 0.0 110.685 179.572 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . 0.326 31.8 m-20 90.52 -25.43 0.06 Allowed 'General case' 0 C--N 1.309 -1.185 0 CA-C-O 114.54 -2.648 . . . . 0.0 110.071 -179.13 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -113.1 137.52 51.31 Favored 'General case' 0 CA--C 1.489 -1.381 1 O-C-N 129.332 4.145 . . . . 0.0 113.873 -179.362 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.512 ' HB2' ' CH2' ' A' ' 6' ' ' TRP . 8.6 tt -102.98 147.04 27.43 Favored 'General case' 0 C--O 1.21 -1.003 0 N-CA-C 100.781 -3.785 . . . . 0.0 100.781 -179.807 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . 0.265 13.4 mt -150.44 125.49 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 N-CA-C 103.625 -2.731 . . . . 0.0 103.625 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.449 ' HB2' ' HD2' ' A' ' 126' ' ' ARG . 8.4 mt-30 -101.14 139.69 36.48 Favored 'General case' 0 N--CA 1.441 -0.915 0 N-CA-C 103.121 -2.918 . . . . 0.0 103.121 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.509 ' O ' ' CG ' ' A' ' 117' ' ' TYR . 0.2 OUTLIER -156.68 144.58 19.38 Favored 'General case' 0 N--CA 1.415 -2.186 0 CA-C-N 113.496 -1.683 . . . . 0.0 112.664 179.986 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . 0.529 ' CZ ' HG13 ' A' ' 105' ' ' VAL 0.382 21.4 m-30 145.88 -136.29 0.0 OUTLIER 'General case' 0 CA--C 1.481 -1.684 0 O-C-N 128.088 3.367 . . . . 0.0 113.152 176.277 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.465 ' O ' ' N ' ' A' ' 103' ' ' ILE . 10.5 t -159.3 -157.97 0.63 Allowed 'General case' 0 C--N 1.311 -1.068 0 O-C-N 127.67 3.106 . . . . 0.0 116.567 -174.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.458 ' HA ' ' HG ' ' A' ' 102' ' ' LEU 0.302 6.8 t80 -120.6 -4.89 9.77 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 111.865 -2.425 . . . . 0.0 110.695 178.309 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -176.98 -68.92 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.511 0 O-C-N 120.506 -1.371 . . . . 0.0 112.025 -179.629 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -151.75 17.49 0.85 Allowed Glycine 0 CA--C 1.541 1.695 0 N-CA-C 119.692 2.637 . . . . 0.0 119.692 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.439 HG13 ' HB3' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -122.22 94.31 2.87 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 N-CA-C 104.314 -2.476 . . . . 0.0 104.314 -179.698 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.429 ' HA ' ' HB ' ' A' ' 118' ' ' THR . 0.8 OUTLIER -59.15 177.92 0.15 Allowed 'General case' 0 C--O 1.216 -0.659 0 CA-C-O 122.118 0.961 . . . . 0.0 112.377 -178.233 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -172.65 91.81 0.11 Allowed 'General case' 0 N--CA 1.437 -1.12 0 O-C-N 118.505 -2.622 . . . . 0.0 109.664 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.422 ' HD2' ' HB ' ' A' ' 116' ' ' THR . 1.7 mptm? -69.62 164.38 23.47 Favored 'General case' 0 CA--C 1.508 -0.671 0 CA-C-N 121.54 1.973 . . . . 0.0 110.997 179.734 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.556 ' HG2' ' CD2' ' A' ' 14' ' ' TYR . 36.7 mtt180 -145.82 72.77 1.32 Allowed 'General case' 0 C--O 1.208 -1.1 0 CA-C-N 110.466 -3.061 . . . . 0.0 110.481 -179.675 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 17.5 mm -66.3 117.8 7.98 Favored 'Isoleucine or valine' 0 C--O 1.254 1.325 1 O-C-N 129.102 4.001 . . . . 0.0 112.346 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.545 ' CD2' ' HB3' ' A' ' 6' ' ' TRP . 12.5 m-85 -103.91 167.77 9.56 Favored 'General case' 0 N--CA 1.442 -0.872 0 O-C-N 127.186 2.804 . . . . 0.0 107.552 179.175 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 2.4 mmmt -122.23 1.56 9.7 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 116.621 -1.657 . . . . 0.0 109.373 179.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.466 ' HD2' ' CH2' ' A' ' 6' ' ' TRP . 0.9 OUTLIER 68.81 97.14 0.06 Allowed 'General case' 0 C--O 1.238 0.487 0 CA-C-N 120.794 1.634 . . . . 0.0 113.218 -179.954 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . 0.823 21.5 tt0 . . . . . 0 N--CA 1.431 -1.419 0 CA-C-N 121.492 1.951 . . . . 0.0 115.084 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' PLM . . . . . 0.542 ' H42' ' CZ ' ' A' ' 93' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.218 -0.582 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -83.06 0.66 43.89 Favored 'General case' 0 C--N 1.31 -1.124 0 O-C-N 120.302 -1.499 . . . . 0.0 112.577 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.407 ' N ' ' OD1' ' A' ' 3' ' ' ASP . 17.8 p-10 -55.98 85.97 0.01 OUTLIER 'General case' 0 CA--C 1.5 -0.974 0 N-CA-C 115.318 1.599 . . . . 0.0 115.318 -179.77 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -179.54 -151.5 9.88 Favored Glycine 0 N--CA 1.436 -1.33 0 C-N-CA 116.144 -2.932 . . . . 0.0 110.687 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.409 ' O ' ' N ' ' A' ' 131' ' ' GLU 0.441 0.1 OUTLIER -124.74 150.83 45.82 Favored 'General case' 0 N--CA 1.427 -1.589 0 N-CA-C 116.312 1.967 . . . . 0.0 116.312 -179.855 . . . . . . . . 4 4 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.567 ' CH2' ' CD1' ' A' ' 108' ' ' ILE . 21.0 m95 -137.16 -166.77 1.98 Allowed 'General case' 0 CA--C 1.498 -1.029 0 CA-C-O 114.37 -2.728 . . . . 0.0 106.509 178.623 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.638 ' N ' ' CE2' ' A' ' 128' ' ' PHE . 6.7 ttpt 177.28 27.57 0.0 OUTLIER 'General case' 0 N--CA 1.432 -1.339 0 CA-C-O 112.804 -3.474 . . . . 0.0 112.498 -177.083 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.564 ' N ' ' CD1' ' A' ' 128' ' ' PHE 0.404 1.7 m 15.24 108.95 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 CA-C-N 121.939 2.154 . . . . 0.0 116.745 -179.754 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -128.47 -69.36 0.72 Allowed 'General case' 0 CA--C 1.498 -1.022 0 O-C-N 120.48 -1.388 . . . . 0.0 113.118 -178.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.5 ptp180 -84.32 95.1 8.62 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 118.168 -1.413 . . . . 0.0 111.437 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.41 ' HA ' ' HA ' ' A' ' 126' ' ' ARG . 0.0 OUTLIER -93.33 -172.82 3.05 Favored 'General case' 0 N--CA 1.441 -0.903 0 O-C-N 127.092 2.745 . . . . 0.0 108.937 -179.697 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -143.6 -67.07 0.35 Allowed 'General case' 0 C--N 1.306 -1.288 0 CA-C-O 115.994 -1.955 . . . . 0.0 108.622 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -95.58 15.4 19.95 Favored 'General case' 0 C--O 1.219 -0.545 0 O-C-N 127.502 3.001 . . . . 0.0 113.617 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.514 ' CD1' ' HB2' ' A' ' 124' ' ' ALA 0.381 0.1 OUTLIER -76.38 -26.22 55.4 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 117.876 2.547 . . . . 0.0 117.876 179.852 . . . . . . . . 4 4 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -74.83 -37.35 62.3 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-O 122.615 1.198 . . . . 0.0 111.894 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 4.7 ttmt -78.15 -24.52 47.29 Favored 'General case' 0 C--O 1.246 0.894 0 CA-C-O 126.046 2.831 . . . . 0.0 113.826 -179.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.516 ' CD2' ' HB1' ' A' ' 124' ' ' ALA . 10.1 t80 -66.63 -31.0 71.4 Favored 'General case' 0 N--CA 1.438 -1.041 0 CA-C-O 125.834 2.73 . . . . 0.0 113.374 -179.681 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 29.3 mtt -73.63 -24.69 60.05 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 125.851 2.738 . . . . 0.0 106.859 179.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -73.27 -22.23 60.43 Favored 'General case' 0 N--CA 1.474 0.765 0 O-C-N 119.003 -2.311 . . . . 0.0 109.396 179.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 6.0 tptp -75.25 -38.73 60.4 Favored 'General case' 0 C--N 1.313 -0.993 0 O-C-N 118.996 -2.315 . . . . 0.0 113.244 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 7.3 mtm -76.37 -38.17 56.17 Favored 'General case' 0 C--O 1.214 -0.796 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 125.96 43.47 0.28 Allowed Glycine 0 C--N 1.304 -1.205 0 CA-C-O 116.797 -2.113 . . . . 0.0 111.87 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.475 ' CD1' ' HG3' ' A' ' 132' ' ' PLM . 0.2 OUTLIER -119.62 107.09 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 CA-C-O 115.758 -2.067 . . . . 0.0 107.212 -179.579 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -132.42 14.42 4.54 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 115.162 1.542 . . . . 0.0 115.162 -179.671 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . 0.412 33.2 m -119.66 -136.55 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.499 -0.99 0 O-C-N 126.992 2.683 . . . . 0.0 115.436 179.871 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.484 2.4 m -70.99 -24.09 24.2 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.934 0 CA-C-N 121.719 2.054 . . . . 0.0 114.027 179.823 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.423 ' HB3' ' HF1' ' A' ' 132' ' ' PLM . 13.2 mtmm -66.29 -34.68 78.54 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 115.002 1.482 . . . . 0.0 115.002 -179.819 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 7.4 ptt180 -78.87 -24.23 44.4 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 123.561 1.648 . . . . 0.0 108.221 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.2 tttt -78.99 -32.03 45.05 Favored 'General case' 0 C--O 1.213 -0.84 0 CA-C-N 113.96 -1.473 . . . . 0.0 110.921 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 8.7 tp -77.64 -35.97 51.99 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 114.645 -1.161 . . . . 0.0 111.903 179.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.74 -25.52 73.76 Favored Glycine 0 C--O 1.213 -1.169 0 C-N-CA 123.933 0.778 . . . . 0.0 112.636 -179.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -76.94 -32.44 57.34 Favored 'General case' 0 C--N 1.315 -0.93 0 C-N-CA 125.89 1.676 . . . . 0.0 109.237 179.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 65.4 m80 -123.31 28.55 7.03 Favored 'General case' 0 C--O 1.236 0.373 0 O-C-N 126.979 2.674 . . . . 0.0 114.189 179.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -67.36 -19.42 65.43 Favored 'General case' 0 C--O 1.216 -0.683 0 N-CA-C 114.545 1.313 . . . . 0.0 114.545 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . 0.254 1.4 m-20 76.72 62.06 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 116.914 -1.914 . . . . 0.0 108.812 179.564 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.561 ' HG ' ' CD1' ' A' ' 38' ' ' LEU . 16.9 tp -80.02 73.04 6.83 Favored 'General case' 0 N--CA 1.469 0.525 0 O-C-N 126.752 2.533 . . . . 0.0 108.309 -179.617 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.427 ' HA ' ' HA ' ' A' ' 7' ' ' LYS . 5.6 ttpp -68.9 112.08 5.35 Favored 'General case' 0 C--N 1.305 -1.349 1 N-CA-C 100.138 -4.023 . . . . 0.0 100.138 -179.508 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.561 ' CD1' ' HG ' ' A' ' 36' ' ' LEU 0.377 1.3 mp -104.8 103.13 12.68 Favored 'General case' 0 C--N 1.288 -2.079 0 N-CA-C 105.458 -2.053 . . . . 0.0 105.458 -178.316 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.485 ' HB ' ' CB ' ' A' ' 50' ' ' LYS . 1.9 m -94.85 86.39 4.68 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 117.276 -3.39 . . . . 0.0 103.902 179.793 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 12.0 mm -61.46 146.53 11.82 Favored 'Isoleucine or valine' 0 C--O 1.243 0.729 0 N-CA-C 105.973 -1.862 . . . . 0.0 105.973 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.469 ' CG2' HG22 ' A' ' 48' ' ' THR . 4.6 t -150.34 35.0 0.64 Allowed 'General case' 0 CA--C 1.506 -0.731 0 O-C-N 126.956 2.66 . . . . 0.0 114.493 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 24.7 tt0 -33.41 111.63 0.11 Allowed 'General case' 0 C--N 1.311 -1.106 0 O-C-N 126.981 2.676 . . . . 0.0 111.59 -179.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -81.08 -0.72 41.2 Favored 'General case' 0 N--CA 1.42 -1.947 0 CA-C-O 124.642 2.163 . . . . 0.0 111.935 -179.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 135.65 -55.66 0.72 Allowed Glycine 0 C--N 1.292 -1.87 0 N-CA-C 104.479 -3.448 . . . . 0.0 104.479 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.301 0.3 OUTLIER -127.4 -37.4 2.02 Favored 'General case' 0 C--N 1.316 -0.886 0 O-C-N 126.812 2.125 . . . . 0.0 112.587 -179.736 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 28.1 ttmt -91.12 139.2 30.98 Favored 'General case' 0 C--N 1.318 -0.792 0 O-C-N 117.906 -2.996 . . . . 0.0 107.601 -179.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . 0.251 21.0 m-85 -118.52 110.06 16.94 Favored 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 124.448 1.099 . . . . 0.0 110.956 -179.619 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.469 HG22 ' CG2' ' A' ' 41' ' ' THR 0.401 0.1 OUTLIER -98.4 78.14 2.41 Favored 'General case' 0 N--CA 1.44 -0.965 0 O-C-N 125.078 1.486 . . . . 0.0 107.096 179.951 . . . . . . . . 4 4 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.481 ' CG1' ' HB ' ' A' ' 60' ' ' VAL 0.625 11.3 p -52.3 97.62 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 CA-C-N 109.497 -3.501 . . . . 0.0 113.073 179.737 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.485 ' CB ' ' HB ' ' A' ' 39' ' ' THR . 0.0 OUTLIER -62.23 139.27 58.5 Favored 'General case' 0 C--N 1.304 -1.384 1 N-CA-C 100.102 -4.036 . . . . 0.0 100.102 -179.633 . . . . . . . . 4 4 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.464 ' CG ' HD13 ' A' ' 36' ' ' LEU 0.253 3.4 tt0 -138.67 91.11 2.51 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 -179.229 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -93.3 55.15 2.22 Favored 'General case' 0 C--N 1.286 -2.164 0 N-CA-C 105.634 -1.987 . . . . 0.0 105.634 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 89.5 p -69.39 158.9 34.21 Favored 'General case' 0 C--N 1.349 0.561 0 CA-C-O 114.912 -2.47 . . . . 0.0 109.21 -179.587 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -52.74 -29.31 26.32 Favored 'General case' 0 C--O 1.212 -0.904 0 O-C-N 125.846 1.966 . . . . 0.0 106.946 179.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.418 ' CZ ' ' HE2' ' A' ' 132' ' ' PLM . 11.1 m-85 -73.27 -55.76 5.99 Favored 'General case' 0 C--N 1.35 0.627 0 CA-C-O 114.707 -2.568 . . . . 0.0 111.211 179.341 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . 0.313 0.0 OUTLIER -142.83 174.79 10.34 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 124.42 3.282 . . . . 0.0 111.287 -179.88 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -121.97 71.73 1.0 Allowed 'General case' 0 C--O 1.221 -0.409 1 N-CA-C 99.873 -4.121 . . . . 0.0 99.873 179.382 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 1.9 tt -105.67 103.18 14.97 Favored 'Isoleucine or valine' 0 C--O 1.243 0.724 0 O-C-N 127.635 3.085 . . . . 0.0 118.997 -179.189 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -65.91 125.0 24.02 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 103.623 -2.732 . . . . 0.0 103.623 178.409 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.481 ' HB ' ' CG1' ' A' ' 49' ' ' VAL . 24.5 t -100.76 97.14 5.38 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 -178.177 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.434 ' CG1' ' HB ' ' A' ' 48' ' ' THR 0.427 0.6 OUTLIER -79.66 135.25 25.95 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 CA-C-N 121.543 1.974 . . . . 0.0 108.986 179.748 . . . . . . . . 4 4 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.486 ' CE2' ' CG ' ' A' ' 82' ' ' TRP . 12.4 p90 -160.45 90.59 0.88 Allowed 'General case' 0 N--CA 1.432 -1.339 0 CA-C-O 123.832 1.777 . . . . 0.0 109.978 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.418 ' HB2' ' HB ' ' A' ' 66' ' ' VAL . 1.6 mt-10 -59.33 149.36 29.18 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 104.805 -2.294 . . . . 0.0 104.805 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.0 mt -66.16 110.9 3.17 Favored 'General case' 0 N--CA 1.427 -1.61 0 C-N-CA 117.982 -1.487 . . . . 0.0 108.58 -179.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.411 ' HA2' ' HB ' ' A' ' 81' ' ' THR . . . 72.78 46.45 30.16 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 128.199 2.809 . . . . 0.0 119.165 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.418 ' HB ' ' HB2' ' A' ' 63' ' ' GLU 0.442 3.8 t -111.92 7.92 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 CA-C-O 115.435 -2.222 . . . . 0.0 107.889 -179.818 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 46.71 101.7 0.0 OUTLIER 'General case' 0 CA--C 1.482 -1.661 0 CA-C-O 124.822 2.249 . . . . 0.0 115.525 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.485 ' CE1' ' HB2' ' A' ' 62' ' ' PHE . 8.8 p90 -117.67 157.62 26.13 Favored 'General case' 0 N--CA 1.435 -1.199 0 O-C-N 118.899 -2.376 . . . . 0.0 107.213 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -107.43 142.83 36.66 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 179.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -147.77 107.99 4.07 Favored 'General case' 0 C--O 1.205 -1.279 0 C-N-CA 118.196 -1.402 . . . . 0.0 114.265 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -75.15 138.38 41.98 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 122.954 2.616 . . . . 0.0 105.323 179.813 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.421 HD13 ' HB2' ' A' ' 78' ' ' LEU . 0.7 OUTLIER -82.52 -170.07 2.77 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 104.413 -2.44 . . . . 0.0 104.413 179.815 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.2 -45.62 14.84 Favored 'General case' 0 CA--C 1.547 0.842 0 CA-C-O 123.7 1.714 . . . . 0.0 111.254 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -139.92 26.62 2.25 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 112.952 -1.931 . . . . 0.0 110.858 179.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -120.36 -9.29 7.97 Favored Glycine 0 CA--C 1.548 2.152 0 O-C-N 127.105 2.753 . . . . 0.0 112.514 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.409 ' HG1' ' NH2' ' A' ' 95' ' ' ARG 0.259 0.1 OUTLIER 75.13 -178.36 0.16 Allowed 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 117.393 -1.723 . . . . 0.0 114.706 -179.775 . . . . . . . . 4 4 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.479 ' CB ' ' HB ' ' A' ' 96' ' ' VAL . 13.8 mt-10 -40.65 141.09 0.6 Allowed 'General case' 0 N--CA 1.442 -0.848 0 CA-C-O 125.785 2.707 . . . . 0.0 112.293 179.825 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.46 ' CD1' ' HB3' ' A' ' 93' ' ' PHE 0.419 11.7 tp -166.09 120.38 1.16 Allowed 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 104.271 -2.492 . . . . 0.0 104.271 179.877 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.5 t -143.32 121.44 12.17 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 105.636 -1.986 . . . . 0.0 105.636 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -156.51 -144.65 3.98 Favored Glycine 0 CA--C 1.538 1.5 0 CA-C-O 116.537 -2.257 . . . . 0.0 110.022 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.411 ' HB ' ' HA2' ' A' ' 65' ' ' GLY . 11.5 p -148.84 161.06 42.6 Favored 'General case' 0 CA--C 1.476 -1.872 0 O-C-N 126.68 2.047 . . . . 0.0 110.215 -179.737 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . 0.486 ' CG ' ' CE2' ' A' ' 62' ' ' PHE . 16.1 m95 -117.05 151.26 37.16 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 101.155 -3.646 . . . . 0.0 101.155 -179.735 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.456 ' CG2' HG21 ' A' ' 90' ' ' VAL . 9.9 t -153.68 144.97 23.01 Favored 'General case' 0 C--O 1.255 1.364 0 CA-C-O 122.992 1.377 . . . . 0.0 111.558 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.415 ' HA ' HD21 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -80.22 105.82 11.77 Favored 'General case' 0 N--CA 1.436 -1.141 0 C-N-CA 117.162 -1.815 . . . . 0.0 109.662 -179.952 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.453 ' CG ' HG12 ' A' ' 90' ' ' VAL 0.574 12.4 mm-40 -76.47 178.31 6.7 Favored 'General case' 0 N--CA 1.428 -1.561 0 O-C-N 120.979 -1.075 . . . . 0.0 108.999 179.778 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -67.21 95.52 0.29 Allowed Glycine 0 C--N 1.346 1.095 0 N-CA-C 105.145 -3.182 . . . . 0.0 105.145 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 79.18 16.57 0.93 Allowed 'General case' 0 C--O 1.242 0.703 0 CA-C-O 115.487 -2.197 . . . . 0.0 115.886 179.837 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . 0.418 0.0 OUTLIER -156.29 177.93 10.89 Favored 'General case' 0 CA--C 1.492 -1.256 0 O-C-N 125.936 2.022 . . . . 0.0 107.587 -179.895 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.427 ' HB3' ' HB2' ' A' ' 106' ' ' ARG . 0.1 OUTLIER -120.53 147.79 44.69 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 103.508 -2.775 . . . . 0.0 103.508 -179.861 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.468 ' HB ' ' CG2' ' A' ' 105' ' ' VAL . 0.6 OUTLIER -140.85 164.31 21.1 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.867 0 N-CA-C 104.844 -2.28 . . . . 0.0 104.844 179.917 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.429 ' HA2' ' HA ' ' A' ' 82' ' ' TRP . . . -143.87 109.35 0.54 Allowed Glycine 0 C--N 1.34 0.789 0 O-C-N 128.306 3.504 . . . . 0.0 111.445 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.498 ' C ' ' CD1' ' A' ' 93' ' ' PHE . 23.0 mtmt -103.3 164.6 11.54 Favored 'General case' 0 N--CA 1.432 -1.33 0 N-CA-C 102.87 -3.011 . . . . 0.0 102.87 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.498 ' CD1' ' C ' ' A' ' 92' ' ' LYS 0.282 95.9 m-85 -161.85 116.07 1.91 Allowed 'General case' 0 N--CA 1.441 -0.879 0 C-N-CA 119.698 -0.801 . . . . 0.0 109.662 -179.751 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 4.2 mttp -92.02 142.84 27.09 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.409 ' NH2' ' HG1' ' A' ' 76' ' ' THR 0.273 2.4 ttt-85 -88.57 130.68 35.2 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 113.856 -1.52 . . . . 0.0 109.542 179.859 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.479 ' HB ' ' CB ' ' A' ' 77' ' ' GLU . 68.9 t -70.88 -33.51 52.45 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 O-C-N 121.278 -0.889 . . . . 0.0 112.949 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . 0.364 31.1 t70 -95.96 -8.5 33.61 Favored 'General case' 0 C--O 1.261 1.673 0 N-CA-C 114.043 1.127 . . . . 0.0 114.043 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.41 ' ND2' ' OH ' ' A' ' 119' ' ' TYR . 19.7 t30 -118.88 -28.54 5.54 Favored 'General case' 0 CA--C 1.498 -1.022 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 -179.632 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 76.13 11.5 84.81 Favored Glycine 0 CA--C 1.536 1.345 0 N-CA-C 117.455 1.742 . . . . 0.0 117.455 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 9.4 mttt -105.61 152.01 23.63 Favored 'General case' 0 C--O 1.208 -1.079 0 CA-C-O 121.95 0.881 . . . . 0.0 109.852 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -94.9 118.72 32.25 Favored 'General case' 0 N--CA 1.435 -1.199 0 C-N-CA 127.653 2.381 . . . . 0.0 114.473 -179.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.552 ' CB ' ' HA ' ' A' ' 119' ' ' TYR . 7.8 tt -97.28 118.56 34.01 Favored 'General case' 0 C--N 1.317 -0.816 0 O-C-N 128.798 3.811 . . . . 0.0 103.369 179.57 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.468 ' N ' ' O ' ' A' ' 118' ' ' THR . 15.2 tt -110.48 161.12 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.41 0 C-N-CA 116.35 -2.14 . . . . 0.0 107.327 -179.569 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.434 ' N ' HG12 ' A' ' 103' ' ' ILE . . . -150.93 151.14 31.73 Favored 'General case' 0 N--CA 1.437 -1.106 0 O-C-N 118.105 -2.872 . . . . 0.0 107.376 -179.424 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.562 ' CG2' ' CE2' ' A' ' 117' ' ' TYR . 1.3 t -149.33 117.81 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 121.577 1.989 . . . . 0.0 111.54 -179.756 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.427 ' HB2' ' HB3' ' A' ' 89' ' ' LEU 0.3 79.5 mtt180 -84.49 91.53 7.87 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 105.195 -2.15 . . . . 0.0 105.195 -179.922 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 61.0 tt0 -81.61 80.8 7.87 Favored 'General case' 0 N--CA 1.436 -1.147 0 CA-C-O 126.974 3.273 . . . . 0.0 114.525 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.567 ' CD1' ' CH2' ' A' ' 6' ' ' TRP 0.331 0.6 OUTLIER -61.61 99.45 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.735 0 C-N-CA 116.601 -2.04 . . . . 0.0 114.6 179.85 . . . . . . . . 4 4 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -98.64 90.03 4.58 Favored 'General case' 0 C--O 1.219 -0.514 0 N-CA-C 102.839 -3.023 . . . . 0.0 102.839 -179.81 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 56.94 -125.86 40.14 Favored Glycine 0 CA--C 1.524 0.608 0 O-C-N 127.858 3.224 . . . . 0.0 111.731 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . 0.385 1.2 m-20 -65.12 -21.33 66.78 Favored 'General case' 0 C--O 1.215 -0.715 0 CA-C-O 115.515 -2.183 . . . . 0.0 112.938 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -95.27 141.91 28.3 Favored 'General case' 0 N--CA 1.432 -1.328 0 O-C-N 128.064 3.353 . . . . 0.0 115.777 179.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.553 ' HB3' ' CE3' ' A' ' 6' ' ' TRP . 0.3 OUTLIER -103.39 149.5 24.72 Favored 'General case' 0 N--CA 1.475 0.799 1 N-CA-C 100.121 -4.029 . . . . 0.0 100.121 179.557 . . . . . . . . 4 4 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.42 HG12 HD11 ' A' ' 127' ' ' ILE 0.252 78.3 mt -147.01 100.65 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 N-CA-C 103.686 -2.709 . . . . 0.0 103.686 179.876 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.508 ' HG2' ' CD2' ' A' ' 113' ' ' LEU . 0.8 OUTLIER -74.95 154.14 38.26 Favored 'General case' 0 CA--C 1.506 -0.732 1 O-C-N 129.318 4.136 . . . . 0.0 102.125 -179.823 . . . . . . . . 4 4 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.48 ' O ' ' N ' ' A' ' 105' ' ' VAL . 2.5 t 178.63 157.71 0.49 Allowed 'General case' 0 N--CA 1.415 -2.221 0 O-C-N 124.626 1.203 . . . . 0.0 109.945 -178.557 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . 0.562 ' CE2' ' CG2' ' A' ' 105' ' ' VAL 0.384 5.0 m-30 127.13 -157.27 0.0 OUTLIER 'General case' 0 CA--C 1.479 -1.785 1 O-C-N 129.639 4.337 . . . . 0.0 113.215 177.682 . . . . . . . . 4 3 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.468 ' O ' ' N ' ' A' ' 103' ' ' ILE . 5.3 t -135.31 -162.77 1.3 Allowed 'General case' 0 C--N 1.312 -1.027 0 CA-C-O 127.304 3.43 . . . . 0.0 117.464 -174.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.552 ' HA ' ' CB ' ' A' ' 102' ' ' LEU 0.282 0.9 OUTLIER -113.7 -53.21 2.7 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 112.187 -2.279 . . . . 0.0 106.759 179.143 . . . . . . . . 4 4 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -124.68 -59.66 1.43 Allowed 'General case' 0 N--CA 1.426 -1.664 0 CA-C-N 113.479 -1.692 . . . . 0.0 113.266 179.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -161.78 15.78 0.15 Allowed Glycine 0 C--N 1.358 1.798 0 N-CA-C 120.747 3.059 . . . . 0.0 120.747 -179.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 75.6 t -128.61 102.9 8.77 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 N-CA-C 103.383 -2.821 . . . . 0.0 103.383 179.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.444 ' HA ' ' O ' ' A' ' 117' ' ' TYR . 0.0 OUTLIER -68.95 -173.84 0.53 Allowed 'General case' 0 C--O 1.215 -0.721 0 CA-C-O 124.107 1.908 . . . . 0.0 112.207 -178.181 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.516 ' HB1' ' CD2' ' A' ' 17' ' ' PHE . . . -166.44 95.29 0.54 Allowed 'General case' 0 N--CA 1.438 -1.026 0 CA-C-O 114.663 -2.589 . . . . 0.0 109.997 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.44 ' HG3' ' HB ' ' A' ' 116' ' ' THR 0.362 0.9 OUTLIER -77.38 143.06 38.96 Favored 'General case' 0 C--O 1.245 0.855 0 O-C-N 126.822 2.576 . . . . 0.0 111.956 179.518 . . . . . . . . 4 4 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.496 ' NH2' HE22 ' A' ' 115' ' ' GLN . 0.2 OUTLIER -129.92 84.15 2.19 Favored 'General case' 0 C--O 1.207 -1.163 0 C-N-CA 128.394 2.678 . . . . 0.0 104.591 177.323 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.42 HD11 HG12 ' A' ' 114' ' ' ILE . 14.1 mm -70.77 93.15 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.009 1 O-C-N 129.369 4.168 . . . . 0.0 108.07 179.837 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.638 ' CE2' ' N ' ' A' ' 7' ' ' LYS 0.334 14.8 t80 -88.95 148.38 23.83 Favored 'General case' 0 N--CA 1.426 -1.664 0 CA-C-O 125.036 2.35 . . . . 0.0 113.507 -178.786 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.51 ' N ' ' CG ' ' A' ' 128' ' ' PHE 0.316 0.0 OUTLIER -99.67 25.13 7.45 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-N 110.851 -2.886 . . . . 0.0 114.11 -176.89 . . . . . . . . 4 4 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.556 ' HB2' ' CZ3' ' A' ' 6' ' ' TRP . 8.4 tttt 43.92 96.82 0.01 OUTLIER 'General case' 0 CA--C 1.507 -0.704 0 CA-C-N 122.526 2.421 . . . . 0.0 116.456 178.423 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.409 ' N ' ' O ' ' A' ' 5' ' ' THR 0.769 3.1 tt0 . . . . . 0 N--CA 1.447 -0.58 0 O-C-N 117.353 -3.342 . . . . 0.0 113.822 179.801 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' PLM . . . . . 0.475 ' HG3' ' CD1' ' A' ' 23' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.216 -0.69 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 34.5 p90 -55.33 -25.92 37.61 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 117.215 2.302 . . . . 0.0 117.215 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -63.15 98.86 0.15 Allowed 'General case' 0 CA--C 1.491 -1.29 0 CA-C-O 123.33 1.538 . . . . 0.0 112.683 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.403 ' O ' ' N ' ' A' ' 40' ' ' ILE . . . 157.15 -159.77 29.94 Favored Glycine 0 CA--C 1.498 -0.99 0 C-N-CA 117.596 -2.24 . . . . 0.0 109.767 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . 0.53 9.2 t -91.53 159.35 15.97 Favored 'General case' 0 N--CA 1.447 -0.612 0 O-C-N 126.342 1.848 . . . . 0.0 113.167 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.545 ' CZ2' ' CD1' ' A' ' 108' ' ' ILE . 90.1 m95 -148.23 145.75 28.38 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 110.715 -2.948 . . . . 0.0 105.103 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 44.7 tttt -143.34 93.75 2.53 Favored 'General case' 0 C--O 1.209 -1.049 0 O-C-N 126.308 2.255 . . . . 0.0 109.961 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . 0.26 4.1 p -46.57 125.69 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 O-C-N 126.585 2.428 . . . . 0.0 109.222 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -119.34 -32.24 4.43 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-N 114.327 -1.306 . . . . 0.0 110.253 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.21 131.35 30.15 Favored 'General case' 0 CA--C 1.496 -1.105 0 CA-C-O 123.148 1.451 . . . . 0.0 108.205 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . 0.287 38.3 m-80 -101.35 -178.53 3.76 Favored 'General case' 0 CA--C 1.504 -0.795 0 CA-C-N 113.214 -1.812 . . . . 0.0 108.496 179.709 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.416 ' CB ' ' HB2' ' A' ' 125' ' ' LYS . 0.3 OUTLIER -163.85 62.54 0.16 Allowed 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 121.106 1.775 . . . . 0.0 107.27 -179.913 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . 0.298 4.2 t30 115.5 18.7 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 128.097 2.559 . . . . 0.0 114.239 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.469 ' CD2' ' CG ' ' A' ' 126' ' ' ARG 0.327 0.1 OUTLIER -80.69 -24.0 39.16 Favored 'General case' 0 C--N 1.314 -0.957 0 O-C-N 127.481 2.988 . . . . 0.0 117.58 -179.984 . . . . . . . . 4 4 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -73.21 -47.04 46.77 Favored 'General case' 0 C--O 1.208 -1.1 0 O-C-N 118.306 -2.746 . . . . 0.0 108.938 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 29.5 tttm -78.3 -21.08 50.21 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 125.823 1.952 . . . . 0.0 114.722 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.43 ' HB3' ' HB3' ' A' ' 124' ' ' ALA . 2.9 t80 -73.53 -23.86 60.05 Favored 'General case' 0 N--CA 1.419 -1.986 0 C-N-CA 116.835 -1.946 . . . . 0.0 111.77 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -73.25 -21.05 60.7 Favored 'General case' 0 C--N 1.307 -1.256 0 O-C-N 118.765 -2.459 . . . . 0.0 109.045 179.867 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 55.1 tt0 -64.17 -31.38 72.55 Favored 'General case' 0 C--N 1.347 0.48 0 CA-C-O 125.235 2.445 . . . . 0.0 112.401 179.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 32.6 tptt -74.26 -30.26 62.04 Favored 'General case' 0 C--O 1.215 -0.742 0 CA-C-N 112.922 -1.944 . . . . 0.0 110.375 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . 0.254 11.0 mtt -77.6 -40.17 43.01 Favored 'General case' 0 C--N 1.353 0.736 0 CA-C-O 124.107 1.908 . . . . 0.0 106.059 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 143.37 15.38 0.28 Allowed Glycine 0 N--CA 1.438 -1.232 0 CA-C-O 115.345 -2.92 . . . . 0.0 115.056 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.488 HD13 ' CB ' ' A' ' 74' ' ' ASP . 1.7 mp -75.49 134.09 29.97 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 CA-C-N 120.489 2.144 . . . . 0.0 105.844 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 67.8 m-80 -93.31 -45.74 7.69 Favored 'General case' 0 C--O 1.243 0.727 0 CA-C-O 114.2 -2.81 . . . . 0.0 116.521 -178.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.405 HG13 HG11 ' A' ' 26' ' ' VAL 0.402 1.2 t -160.2 -59.66 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.499 -0.987 0 N-CA-C 119.217 3.043 . . . . 0.0 119.217 -179.764 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.405 HG11 HG13 ' A' ' 25' ' ' VAL 0.668 1.9 m -78.19 -26.22 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -179.897 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.407 ' HB3' ' HG3' ' A' ' 132' ' ' PLM . 12.3 mttm -75.16 -28.19 60.01 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-O 118.311 -0.852 . . . . 0.0 110.866 -179.799 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.434 ' HG3' ' NH1' ' A' ' 28' ' ' ARG . 4.9 ptt85 -79.95 -23.8 41.43 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 116.61 -2.036 . . . . 0.0 109.081 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.94 -43.9 64.48 Favored 'General case' 0 CA--C 1.507 -0.702 0 CA-C-O 122.512 1.149 . . . . 0.0 109.78 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.43 HD22 ' CZ ' ' A' ' 55' ' ' PHE . 9.2 tp -75.45 -31.7 60.39 Favored 'General case' 0 C--O 1.212 -0.894 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 -179.813 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -73.77 -34.08 56.87 Favored Glycine 0 C--N 1.348 1.238 0 O-C-N 128.299 3.5 . . . . 0.0 112.425 179.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -74.99 -40.64 60.57 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 125.741 1.616 . . . . 0.0 109.708 179.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 3.4 m80 -107.95 57.89 0.62 Allowed 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 113.46 -1.7 . . . . 0.0 110.908 179.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -85.37 -26.34 26.53 Favored 'General case' 0 C--O 1.212 -0.872 0 N-CA-C 117.522 2.415 . . . . 0.0 117.522 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.3 m120 78.74 24.61 0.56 Allowed 'General case' 0 CA--C 1.539 0.531 0 O-C-N 124.472 1.108 . . . . 0.0 109.206 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.9 tp -46.2 97.78 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.499 0 O-C-N 125.893 1.995 . . . . 0.0 109.449 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.45 ' HB3' ' CB ' ' A' ' 52' ' ' SER . 16.3 ttpt -98.03 96.12 7.93 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 101.754 -3.425 . . . . 0.0 101.754 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . 0.313 1.3 tp -86.27 147.16 26.21 Favored 'General case' 0 C--N 1.313 -0.991 0 C-N-CA 115.414 -2.515 . . . . 0.0 106.45 -179.68 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.473 ' HB ' ' CB ' ' A' ' 50' ' ' LYS . 90.4 m -131.36 83.63 2.12 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 103.802 -2.666 . . . . 0.0 103.802 179.573 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.418 HG13 ' CD1' ' A' ' 6' ' ' TRP . 0.8 OUTLIER -63.15 108.73 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.01 0 O-C-N 124.51 1.131 . . . . 0.0 109.747 -179.914 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.9 m -117.58 84.78 2.22 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-O 122.475 1.131 . . . . 0.0 110.147 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -77.89 142.6 38.34 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 120.599 -1.313 . . . . 0.0 110.779 -179.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -139.82 -129.08 0.11 Allowed 'General case' 0 CA--C 1.492 -1.284 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -81.65 78.36 1.95 Allowed Glycine 0 C--N 1.294 -1.763 0 O-C-N 119.4 -2.063 . . . . 0.0 109.853 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.323 1.3 m-20 80.44 -10.56 1.25 Allowed 'General case' 0 C--N 1.315 -0.931 0 O-C-N 126.11 1.711 . . . . 0.0 113.014 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.433 ' HG2' HG13 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -88.63 -178.07 5.72 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 117.374 -1.731 . . . . 0.0 107.491 179.943 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.467 ' CE1' HD23 ' A' ' 64' ' ' LEU . 2.1 m-85 -157.34 82.14 0.91 Allowed 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 106.061 -1.829 . . . . 0.0 106.061 -179.653 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.64 ' CA ' HG11 ' A' ' 61' ' ' VAL 0.484 6.4 m -67.17 136.61 55.32 Favored 'General case' 0 CA--C 1.5 -0.952 0 C-N-CA 114.747 -2.781 . . . . 0.0 106.449 -179.733 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.49 HG13 ' CH2' ' A' ' 82' ' ' TRP 0.595 0.9 OUTLIER -121.12 93.53 2.55 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 CA-C-N 112.632 -2.076 . . . . 0.0 114.047 -179.154 . . . . . . . . 4 4 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.473 ' CB ' ' HB ' ' A' ' 39' ' ' THR . 0.4 OUTLIER -67.74 150.44 48.68 Favored 'General case' 0 C--N 1.315 -0.891 1 N-CA-C 99.895 -4.113 . . . . 0.0 99.895 179.563 . . . . . . . . 4 4 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -141.26 73.95 1.44 Allowed 'General case' 0 C--O 1.216 -0.685 0 N-CA-C 103.252 -2.87 . . . . 0.0 103.252 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.45 ' CB ' ' HB3' ' A' ' 37' ' ' LYS . 0.1 OUTLIER -76.05 77.81 2.91 Favored 'General case' 0 C--N 1.289 -2.043 0 O-C-N 119.571 -1.955 . . . . 0.0 105.764 -179.939 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 84.0 p -101.13 159.62 15.08 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-O 114.387 -2.72 . . . . 0.0 108.404 -179.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -53.9 -26.85 27.02 Favored 'General case' 0 CA--C 1.51 -0.559 0 O-C-N 125.259 1.599 . . . . 0.0 109.317 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.43 ' CZ ' HD22 ' A' ' 30' ' ' LEU . 61.0 m-85 -71.45 -57.04 4.8 Favored 'General case' 0 C--O 1.215 -0.725 0 CA-C-O 114.489 -2.672 . . . . 0.0 109.582 179.799 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . 0.26 0.4 OUTLIER -169.81 152.57 4.55 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 123.226 2.739 . . . . 0.0 110.287 179.646 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 5.6 p-10 -84.81 86.7 7.32 Favored 'General case' 0 C--O 1.217 -0.631 0 C-N-CA 131.308 3.843 . . . . 0.0 101.441 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 2.7 tt -114.48 86.47 0.91 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.792 0 N-CA-C 119.604 3.186 . . . . 0.0 119.604 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -60.83 105.61 0.48 Allowed 'General case' 0 C--O 1.214 -0.778 0 N-CA-C 104.585 -2.376 . . . . 0.0 104.585 178.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.472 ' CG1' ' N ' ' A' ' 61' ' ' VAL . 1.0 OUTLIER -68.15 -55.27 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 C-N-CA 125.346 1.458 . . . . 0.0 113.893 -178.044 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.64 HG11 ' CA ' ' A' ' 48' ' ' THR 0.478 0.1 OUTLIER 60.69 135.6 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 CA-C-O 126.38 2.991 . . . . 0.0 112.094 -177.211 . . . . . . . . 4 4 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.63 ' CD1' ' CD1' ' A' ' 68' ' ' PHE . 9.8 t80 -163.8 109.13 1.05 Allowed 'General case' 0 N--CA 1.432 -1.361 0 CA-C-N 112.321 -2.218 . . . . 0.0 110.255 179.654 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.467 ' CB ' HG22 ' A' ' 66' ' ' VAL . 0.4 OUTLIER -58.04 129.35 41.54 Favored 'General case' 0 C--O 1.251 1.133 0 N-CA-C 102.722 -3.066 . . . . 0.0 102.722 179.037 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.467 HD23 ' CE1' ' A' ' 47' ' ' PHE . 0.4 OUTLIER -50.05 130.96 22.96 Favored 'General case' 0 C--O 1.247 0.971 0 CA-C-O 123.252 1.501 . . . . 0.0 111.999 -179.702 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.41 ' HA2' ' HB ' ' A' ' 81' ' ' THR . . . 60.72 14.74 37.93 Favored Glycine 0 C--N 1.341 0.824 0 CA-C-N 112.368 -2.196 . . . . 0.0 115.203 -179.827 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.467 HG22 ' CB ' ' A' ' 63' ' ' GLU 0.412 16.1 t -72.27 -88.29 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 179.94 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 154.82 117.49 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.175 0 C-N-CA 125.627 1.571 . . . . 0.0 115.224 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.63 ' CD1' ' CD1' ' A' ' 62' ' ' PHE . 0.4 OUTLIER -133.31 147.94 51.89 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-N 118.91 0.777 . . . . 0.0 110.047 -179.961 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -104.15 150.4 24.38 Favored 'General case' 0 C--O 1.243 0.714 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.489 ' CD2' ' H71' ' A' ' 132' ' ' PLM . 9.7 t80 -151.72 107.28 3.34 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-O 116.289 -1.815 . . . . 0.0 113.904 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -78.9 127.62 32.25 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 122.279 2.309 . . . . 0.0 105.137 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.403 ' CD1' ' C8 ' ' A' ' 132' ' ' PLM . 4.2 mm? -65.98 -177.67 0.52 Allowed 'General case' 0 C--N 1.3 -1.576 0 O-C-N 125.054 1.471 . . . . 0.0 107.363 -179.653 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -103.05 9.73 38.4 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-O 124.883 2.278 . . . . 0.0 110.909 179.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.488 ' CB ' HD13 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -97.17 -28.52 14.06 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 112.675 -2.057 . . . . 0.0 112.316 -179.813 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 133.79 8.96 2.07 Favored Glycine 0 CA--C 1.547 2.046 0 CA-C-O 117.651 -1.638 . . . . 0.0 111.596 -178.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . 0.376 0.4 OUTLIER -131.44 169.65 15.76 Favored 'General case' 0 C--N 1.309 -1.154 0 C-N-CA 115.724 -2.39 . . . . 0.0 115.521 -179.757 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.472 ' HG2' ' CG2' ' A' ' 96' ' ' VAL . 0.1 OUTLIER -90.26 168.1 12.17 Favored 'General case' 0 N--CA 1.443 -0.807 1 O-C-N 130.764 5.04 . . . . 0.0 113.842 179.752 . . . . . . . . 4 4 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . 0.399 10.0 tp -167.33 148.39 5.59 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-N 114.123 -1.399 . . . . 0.0 107.642 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 7.4 m -159.27 116.2 2.67 Favored 'General case' 0 C--O 1.203 -1.362 0 N-CA-C 105.394 -2.076 . . . . 0.0 105.394 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.422 ' HA3' ' HA ' ' A' ' 93' ' ' PHE . . . -156.62 -151.73 6.06 Favored Glycine 0 C--N 1.296 -1.642 0 C-N-CA 116.92 -2.562 . . . . 0.0 114.564 -179.801 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.442 ' HA ' ' CZ ' ' A' ' 62' ' ' PHE . 1.3 p -152.39 168.3 25.9 Favored 'General case' 0 C--O 1.199 -1.599 0 C-N-CA 116.807 -1.957 . . . . 0.0 109.607 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . 0.622 ' CD1' ' CE2' ' A' ' 62' ' ' PHE 0.3 3.7 m0 -122.79 145.51 48.35 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 102.803 -3.036 . . . . 0.0 102.803 -179.81 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.508 ' CG2' ' CG2' ' A' ' 90' ' ' VAL . 10.3 t -143.28 124.64 14.68 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-O 124.924 2.297 . . . . 0.0 108.543 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 9.4 ttt -80.6 114.54 19.57 Favored 'General case' 0 N--CA 1.422 -1.872 0 CA-C-N 114.088 -1.415 . . . . 0.0 110.76 -179.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . 0.588 7.1 mm-40 -91.91 6.58 45.68 Favored 'General case' 0 N--CA 1.419 -2.002 0 CA-C-O 123.834 1.778 . . . . 0.0 112.746 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 91.3 -74.94 1.57 Allowed Glycine 0 C--N 1.345 1.05 0 N-CA-C 103.991 -3.643 . . . . 0.0 103.991 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 17.6 p30 -76.04 1.61 15.0 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 116.238 -1.839 . . . . 0.0 114.995 -179.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . 0.446 19.1 mttp -162.41 159.89 25.74 Favored 'General case' 0 C--O 1.218 -0.58 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.42 121.39 38.42 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 101.997 -3.334 . . . . 0.0 101.997 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.508 ' CG2' ' CG2' ' A' ' 83' ' ' THR . 1.2 m -102.53 161.95 3.88 Favored 'Isoleucine or valine' 0 C--O 1.244 0.774 0 N-CA-C 105.644 -1.984 . . . . 0.0 105.644 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -142.9 94.75 0.18 Allowed Glycine 0 C--N 1.35 1.306 0 C-N-CA 130.627 3.965 . . . . 0.0 110.407 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.455 ' HA ' ' HA ' ' A' ' 103' ' ' ILE . 1.4 mtpm? -103.62 156.47 17.76 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 104.379 -2.452 . . . . 0.0 104.379 179.511 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.422 ' HA ' ' HA3' ' A' ' 80' ' ' GLY . 64.6 m-85 -151.73 128.95 11.19 Favored 'General case' 0 CA--C 1.5 -0.967 0 O-C-N 125.464 1.728 . . . . 0.0 111.11 -179.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 36.3 mtpt -107.91 129.17 55.11 Favored 'General case' 0 C--O 1.212 -0.87 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.454 -179.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . 0.342 0.5 OUTLIER -68.72 168.27 13.6 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 120.679 -1.263 . . . . 0.0 109.008 -179.911 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.472 ' CG2' ' HG2' ' A' ' 77' ' ' GLU . 24.4 t -100.45 -34.85 4.21 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 O-C-N 126.262 2.226 . . . . 0.0 108.508 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . 0.315 0.4 OUTLIER -65.94 -23.2 66.56 Favored 'General case' 0 CA--C 1.505 -0.756 0 N-CA-C 115.897 1.814 . . . . 0.0 115.897 -179.794 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -160.93 23.22 0.14 Allowed 'General case' 0 CA--C 1.491 -1.296 0 N-CA-C 117.748 2.499 . . . . 0.0 117.748 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 56.15 19.13 22.62 Favored Glycine 0 CA--C 1.536 1.354 0 N-CA-C 117.744 1.858 . . . . 0.0 117.744 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 15.4 mmtp -74.52 -172.21 1.43 Allowed 'General case' 0 C--O 1.198 -1.618 0 CA-C-N 119.812 1.806 . . . . 0.0 108.034 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -129.55 150.22 50.98 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 127.516 2.326 . . . . 0.0 113.389 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.455 ' CD1' ' C ' ' A' ' 102' ' ' LEU . 0.0 OUTLIER -140.13 141.08 36.12 Favored 'General case' 0 C--O 1.246 0.878 0 O-C-N 128.345 3.528 . . . . 0.0 106.87 -179.516 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.548 HG12 ' CD2' ' A' ' 117' ' ' TYR . 11.3 tt -132.11 179.77 4.08 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.213 0 C-N-CA 117.342 -1.743 . . . . 0.0 109.777 179.568 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.455 ' H ' ' CG1' ' A' ' 103' ' ' ILE . . . -163.59 113.45 1.3 Allowed 'General case' 0 N--CA 1.427 -1.579 0 CA-C-O 114.2 -2.81 . . . . 0.0 107.493 -176.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -100.71 103.09 14.34 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.682 0 CA-C-N 121.079 1.763 . . . . 0.0 113.511 -179.058 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.408 ' NH1' ' CG ' ' A' ' 106' ' ' ARG . 1.4 mtt-85 -77.08 93.85 3.94 Favored 'General case' 0 CA--C 1.504 -0.821 0 CA-C-O 123.423 1.583 . . . . 0.0 109.337 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -94.59 79.09 3.79 Favored 'General case' 0 N--CA 1.423 -1.824 0 CA-C-N 113.24 -1.8 . . . . 0.0 114.415 -179.799 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.545 ' CD1' ' CZ2' ' A' ' 6' ' ' TRP 0.322 1.4 tt -58.27 107.6 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.251 0 C-N-CA 117.26 -1.776 . . . . 0.0 114.681 179.951 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -92.74 79.84 4.74 Favored 'General case' 0 N--CA 1.436 -1.132 0 O-C-N 120.141 -1.6 . . . . 0.0 107.105 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 56.6 -58.52 0.01 OUTLIER Glycine 0 C--O 1.245 0.784 0 C-N-CA 128.907 3.146 . . . . 0.0 113.973 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . 0.302 18.8 m120 -127.47 -1.07 6.24 Favored 'General case' 0 C--O 1.213 -0.828 0 CA-C-O 117.434 -1.269 . . . . 0.0 112.366 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -123.59 121.93 36.86 Favored 'General case' 0 C--O 1.209 -1.066 0 CA-C-O 115.443 -2.217 . . . . 0.0 111.121 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.435 ' HB3' ' HB2' ' A' ' 128' ' ' PHE . 0.8 OUTLIER -88.47 137.39 32.37 Favored 'General case' 0 C--O 1.209 -1.048 0 N-CA-C 102.004 -3.332 . . . . 0.0 102.004 -179.655 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.474 ' CG2' HG23 ' A' ' 116' ' ' THR . 72.4 mt -138.67 109.4 4.89 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 O-C-N 126.305 2.253 . . . . 0.0 109.377 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.434 ' C ' ' CG2' ' A' ' 116' ' ' THR . 19.9 mt-30 -79.32 147.29 32.51 Favored 'General case' 0 CA--C 1.498 -1.046 0 N-CA-C 102.211 -3.255 . . . . 0.0 102.211 179.727 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.525 ' HB ' ' CD ' ' A' ' 125' ' ' LYS . 0.1 OUTLIER -163.24 111.89 1.27 Allowed 'General case' 0 N--CA 1.427 -1.599 0 C-N-CA 117.263 -1.775 . . . . 0.0 109.71 -179.168 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . 0.548 ' CD2' HG12 ' A' ' 103' ' ' ILE 0.273 0.1 OUTLIER 176.17 -162.57 0.03 OUTLIER 'General case' 0 CA--C 1.469 -2.159 0 C-N-CA 116.512 -2.075 . . . . 0.0 114.208 178.122 . . . . . . . . 4 4 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.445 ' O ' ' N ' ' A' ' 103' ' ' ILE . 8.0 t -128.46 -164.86 1.43 Allowed 'General case' 0 N--CA 1.425 -1.683 0 CA-C-O 127.407 3.479 . . . . 0.0 117.51 -174.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.44 ' HA ' ' HB2' ' A' ' 102' ' ' LEU 0.298 68.9 t80 -128.97 5.95 5.43 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 112.305 -2.225 . . . . 0.0 108.1 178.075 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 168.64 -60.65 0.01 OUTLIER 'General case' 0 C--N 1.289 -2.035 0 C-N-CA 125.68 1.592 . . . . 0.0 112.472 -178.185 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -157.34 22.52 0.43 Allowed Glycine 0 C--N 1.366 2.225 0 N-CA-C 121.434 3.334 . . . . 0.0 121.434 -179.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.416 HG13 ' HB2' ' A' ' 17' ' ' PHE . 75.7 t -135.42 118.71 23.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 O-C-N 117.857 -3.143 . . . . 0.0 105.123 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 37.5 mp0 -85.72 175.74 8.54 Favored 'General case' 0 C--O 1.21 -1.005 0 CA-C-O 123.882 1.801 . . . . 0.0 112.868 -179.457 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.43 ' HB3' ' HB3' ' A' ' 17' ' ' PHE . . . -165.53 115.05 1.03 Allowed 'General case' 0 N--CA 1.435 -1.19 0 CA-C-O 113.905 -2.95 . . . . 0.0 108.211 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.525 ' CD ' ' HB ' ' A' ' 116' ' ' THR . 0.1 OUTLIER -90.74 140.33 29.88 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 127.764 3.165 . . . . 0.0 109.535 179.942 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.469 ' CG ' ' CD2' ' A' ' 14' ' ' TYR . 0.1 OUTLIER -127.68 82.43 2.09 Favored 'General case' 0 N--CA 1.428 -1.543 0 CA-C-O 114.242 -2.79 . . . . 0.0 111.123 179.958 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 5.1 mm -74.46 102.22 2.07 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.832 1 O-C-N 130.894 5.121 . . . . 0.0 115.572 179.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.435 ' HB2' ' HB3' ' A' ' 113' ' ' LEU . 22.0 m-85 -94.27 128.94 41.05 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 128.887 2.875 . . . . 0.0 107.868 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . 0.308 10.4 mttt -93.19 3.14 56.18 Favored 'General case' 0 CA--C 1.507 -0.693 0 CA-C-O 116.768 -1.586 . . . . 0.0 112.083 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.529 ' HB2' ' CZ3' ' A' ' 6' ' ' TRP . 0.1 OUTLIER 69.79 99.9 0.06 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 122.146 2.248 . . . . 0.0 114.127 179.972 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . 0.833 9.4 tt0 . . . . . 0 CA--C 1.499 -0.987 0 C-N-CA 115.592 -2.443 . . . . 0.0 115.666 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' PLM . . . . . 0.489 ' H71' ' CD2' ' A' ' 70' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 2' ' ' PHE . . . . . 0.61 ' CE2' HD13 ' A' ' 89' ' ' LEU . 2.2 m-30 . . . . . 0 N--CA 1.444 -0.765 0 N-CA-C 117.866 2.543 . . . . 0.0 117.866 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -36.74 91.18 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 124.489 2.09 . . . . 0.0 115.749 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 164.13 -176.35 40.12 Favored Glycine 0 C--O 1.209 -1.433 0 C-N-CA 117.668 -2.206 . . . . 0.0 111.147 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.77 HG22 HG23 ' A' ' 39' ' ' THR 0.56 0.1 OUTLIER -91.35 155.33 18.58 Favored 'General case' 0 N--CA 1.443 -0.802 0 O-C-N 127.146 2.321 . . . . 0.0 110.63 -179.787 . . . . . . . . 4 4 . 1 . 001 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.838 ' CH2' HD11 ' A' ' 108' ' ' ILE . 69.7 m95 -141.67 149.78 41.04 Favored 'General case' 0 N--CA 1.436 -1.147 0 O-C-N 127.874 3.234 . . . . 0.0 106.405 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 10.0 tmtt? -152.46 93.31 1.78 Allowed 'General case' 0 CA--C 1.5 -0.977 0 O-C-N 126.913 2.633 . . . . 0.0 107.14 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.564 ' HB ' ' CD1' ' A' ' 128' ' ' PHE 0.305 0.4 OUTLIER -42.56 137.0 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.0 0 CA-C-O 117.124 -1.417 . . . . 0.0 113.115 -179.998 . . . . . . . . 4 4 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -118.27 -60.68 1.76 Allowed 'General case' 0 C--O 1.214 -0.807 0 O-C-N 126.405 2.316 . . . . 0.0 108.827 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.407 ' O ' ' HB ' ' A' ' 127' ' ' ILE . 0.4 OUTLIER -118.98 155.04 32.07 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 179.939 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . 0.363 0.1 OUTLIER -121.1 -165.76 1.26 Allowed 'General case' 0 C--N 1.324 -0.524 0 O-C-N 126.011 2.07 . . . . 0.0 107.459 -179.78 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.473 ' HB3' ' HB2' ' A' ' 125' ' ' LYS . 3.7 tp10 -176.35 89.3 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.523 0 C-N-CA 117.604 -1.638 . . . . 0.0 107.197 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 97.95 -3.6 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 126.143 1.777 . . . . 0.0 114.132 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.801 ' HA ' ' HB1' ' A' ' 124' ' ' ALA 0.27 76.9 t80 -62.07 -28.08 69.35 Favored 'General case' 0 C--O 1.241 0.618 0 O-C-N 127.908 3.255 . . . . 0.0 114.307 -179.834 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -68.18 -40.37 82.28 Favored 'General case' 0 CA--C 1.5 -0.949 0 O-C-N 124.672 1.232 . . . . 0.0 113.442 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.3 -26.03 55.42 Favored 'General case' 0 N--CA 1.441 -0.921 0 O-C-N 125.053 1.47 . . . . 0.0 111.216 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.612 ' HB2' ' HB2' ' A' ' 124' ' ' ALA . 4.7 t80 -68.59 -25.28 64.8 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 123.467 1.603 . . . . 0.0 112.773 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -77.74 -24.91 48.95 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-O 124.018 1.866 . . . . 0.0 107.698 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.7 tt0 -74.45 -20.28 60.08 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 125.297 2.475 . . . . 0.0 110.07 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.422 ' CE ' ' HB2' ' A' ' 120' ' ' GLU . 2.8 tmtm? -77.67 -48.3 17.11 Favored 'General case' 0 C--O 1.209 -1.032 0 CA-C-N 111.998 -2.364 . . . . 0.0 110.152 179.461 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 3.1 mtt -65.48 -20.25 66.27 Favored 'General case' 0 C--O 1.208 -1.12 0 C-N-CA 127.519 2.328 . . . . 0.0 107.507 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.13 31.35 5.96 Favored Glycine 0 C--N 1.298 -1.563 0 C-N-CA 125.221 1.391 . . . . 0.0 111.812 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.486 ' CG2' ' HB2' ' A' ' 27' ' ' LYS . 0.5 OUTLIER -91.56 132.75 35.2 Favored 'Isoleucine or valine' 0 C--N 1.351 0.643 0 CA-C-O 116.154 -1.879 . . . . 0.0 105.99 -179.863 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 41.6 m-20 -90.76 -85.67 0.22 Allowed 'General case' 0 CA--C 1.508 -0.672 0 N-CA-C 116.365 1.987 . . . . 0.0 116.365 -179.358 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . 0.354 3.5 p -117.4 -72.41 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.495 -1.17 0 N-CA-C 120.022 3.341 . . . . 0.0 120.022 -179.508 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.579 2.2 m -63.43 -28.51 45.16 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.871 0 N-CA-C 118.619 2.822 . . . . 0.0 118.619 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.486 ' HB2' ' CG2' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -74.3 -42.66 59.15 Favored 'General case' 0 CA--C 1.508 -0.653 0 O-C-N 127.789 3.18 . . . . 0.0 114.146 -179.839 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 38.1 ptt180 -78.38 -23.43 46.83 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 123.41 1.576 . . . . 0.0 108.793 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 31.1 tttp -74.86 -39.55 61.49 Favored 'General case' 0 CA--C 1.509 -0.63 0 CA-C-N 114.15 -1.386 . . . . 0.0 111.029 179.442 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.425 ' HA ' HD22 ' A' ' 30' ' ' LEU . 0.8 OUTLIER -74.65 -21.81 59.23 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 114.039 -1.437 . . . . 0.0 110.712 -179.913 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -79.45 -30.71 44.04 Favored Glycine 0 CA--C 1.524 0.596 0 O-C-N 128.23 3.456 . . . . 0.0 110.929 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -77.09 -57.58 3.76 Favored 'General case' 0 N--CA 1.436 -1.167 0 C-N-CA 127.182 2.193 . . . . 0.0 112.1 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 22.4 m80 -75.18 -1.99 25.79 Favored 'General case' 0 N--CA 1.438 -1.054 0 CA-C-O 117.112 -1.423 . . . . 0.0 113.606 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.43 ' HB2' ' HB2' ' A' ' 53' ' ' SER . 35.6 p-10 -38.6 -36.67 0.27 Allowed 'General case' 0 CA--C 1.495 -1.171 0 N-CA-C 119.888 3.292 . . . . 0.0 119.888 179.604 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . 0.263 13.4 m120 79.96 21.3 0.54 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 120.108 1.322 . . . . 0.0 113.422 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.627 HD21 HD13 ' A' ' 38' ' ' LEU . 27.0 tp -37.08 93.47 0.01 OUTLIER 'General case' 0 C--N 1.351 0.643 0 O-C-N 126.993 2.683 . . . . 0.0 110.313 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.423 ' HB3' ' HB3' ' A' ' 52' ' ' SER . 2.4 ttmp? -92.82 105.47 17.59 Favored 'General case' 0 C--O 1.218 -0.602 0 N-CA-C 101.92 -3.363 . . . . 0.0 101.92 179.75 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.627 HD13 HD21 ' A' ' 36' ' ' LEU 0.252 1.3 tp -95.3 127.11 41.08 Favored 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 116.212 -2.195 . . . . 0.0 108.735 179.729 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.77 HG23 HG22 ' A' ' 5' ' ' THR . 89.0 m -109.97 83.14 1.71 Allowed 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 104.226 -2.509 . . . . 0.0 104.226 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.447 HD11 HD23 ' A' ' 38' ' ' LEU . 24.0 mm -63.91 132.93 29.85 Favored 'Isoleucine or valine' 0 C--O 1.247 0.94 0 CA-C-N 112.983 -1.917 . . . . 0.0 108.952 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 30.5 m -143.62 96.84 2.97 Favored 'General case' 0 CA--C 1.502 -0.874 0 CA-C-N 111.419 -2.628 . . . . 0.0 113.582 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 59.8 tt0 -89.5 131.94 35.29 Favored 'General case' 0 N--CA 1.447 -0.613 0 O-C-N 124.794 1.309 . . . . 0.0 110.272 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 46.3 tt0 -101.98 -52.33 3.19 Favored 'General case' 0 CA--C 1.49 -1.349 0 CA-C-O 125.172 2.415 . . . . 0.0 110.156 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -165.74 -69.19 0.03 OUTLIER Glycine 0 N--CA 1.433 -1.551 0 N-CA-C 105.422 -3.071 . . . . 0.0 105.422 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.364 0.0 OUTLIER -106.53 -22.7 12.69 Favored 'General case' 0 C--O 1.218 -0.602 0 CA-C-N 113.095 -1.552 . . . . 0.0 111.168 179.906 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.409 ' CD ' ' HG3' ' A' ' 63' ' ' GLU . 0.0 OUTLIER -98.32 156.23 16.82 Favored 'General case' 0 N--CA 1.435 -1.203 0 C-N-CA 120.318 -0.553 . . . . 0.0 111.931 -179.879 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.407 ' HE2' HD21 ' A' ' 64' ' ' LEU . 2.1 m-85 -129.79 92.72 3.37 Favored 'General case' 0 N--CA 1.441 -0.893 0 C-N-CA 123.465 0.706 . . . . 0.0 109.436 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.84 HG22 ' CG1' ' A' ' 61' ' ' VAL 0.455 1.3 p -67.18 141.51 57.31 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 116.8 -1.96 . . . . 0.0 111.45 -179.903 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.874 HG11 ' CZ ' ' A' ' 62' ' ' PHE 0.695 0.4 OUTLIER -120.91 83.82 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.424 -1.726 0 CA-C-N 111.877 -2.42 . . . . 0.0 111.167 179.916 . . . . . . . . 4 4 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.458 ' CB ' ' HB ' ' A' ' 39' ' ' THR . 2.1 ttpp -62.84 142.89 58.05 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 101.229 -3.619 . . . . 0.0 101.229 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.572 ' OE2' HD13 ' A' ' 36' ' ' LEU . 4.3 tt0 -138.55 93.92 2.79 Favored 'General case' 0 C--O 1.217 -0.632 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.423 ' HB3' ' HB3' ' A' ' 37' ' ' LYS 0.287 3.9 t -91.64 60.8 4.1 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 106.722 -1.584 . . . . 0.0 106.722 179.81 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.43 ' HB2' ' HB2' ' A' ' 34' ' ' ASP . 1.7 p -89.59 -178.46 5.56 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 125.897 1.998 . . . . 0.0 112.447 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.44 -28.59 69.38 Favored 'General case' 0 C--O 1.212 -0.878 0 CA-C-O 115.525 -2.178 . . . . 0.0 109.932 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.453 ' CD2' ' CB ' ' A' ' 73' ' ' ALA . 95.8 m-85 -70.93 -51.08 28.09 Favored 'General case' 0 C--O 1.221 -0.398 0 C-N-CA 117.285 -1.766 . . . . 0.0 114.13 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.443 ' O ' HG22 ' A' ' 58' ' ' ILE . 6.3 ttm180 179.72 153.7 0.49 Allowed 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 120.702 1.592 . . . . 0.0 108.256 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 42.8 t-20 -88.89 85.98 6.85 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 102.336 -3.209 . . . . 0.0 102.336 -179.516 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.443 HG22 ' O ' ' A' ' 56' ' ' ARG . 6.3 tp -117.57 107.31 21.83 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.866 1 C-N-CA 133.19 4.596 . . . . 0.0 118.477 -179.827 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -66.2 134.07 51.95 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 104.606 -2.368 . . . . 0.0 104.606 178.846 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.402 ' O ' HG23 ' A' ' 61' ' ' VAL . 22.3 t -86.16 -68.8 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 CA-C-O 125.517 2.58 . . . . 0.0 110.874 -179.299 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.84 ' CG1' HG22 ' A' ' 48' ' ' THR 0.497 0.0 OUTLIER 74.57 128.02 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.14 0 CA-C-N 113.825 -1.534 . . . . 0.0 113.347 179.995 . . . . . . . . 4 4 . 1 . 001 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.874 ' CZ ' HG11 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -160.11 99.95 1.37 Allowed 'General case' 0 C--N 1.313 -1.002 0 CA-C-O 117.756 -1.116 . . . . 0.0 111.141 -179.781 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.409 ' HG3' ' CD ' ' A' ' 46' ' ' LYS . 3.7 tt0 -49.59 137.61 15.16 Favored 'General case' 0 N--CA 1.439 -0.999 0 O-C-N 126.592 2.433 . . . . 0.0 104.564 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.407 HD21 ' HE2' ' A' ' 47' ' ' PHE . 0.8 OUTLIER -60.33 129.69 42.9 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 123.395 1.569 . . . . 0.0 108.469 -179.74 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 63.38 26.95 70.02 Favored Glycine 0 C--N 1.343 0.948 0 CA-C-N 111.437 -2.62 . . . . 0.0 118.849 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . 0.423 3.0 t -102.63 101.61 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.732 ' HA ' HG22 ' A' ' 81' ' ' THR . 25.5 t0 -58.03 126.45 27.52 Favored 'General case' 0 CA--C 1.49 -1.332 0 CA-C-O 116.816 -1.564 . . . . 0.0 111.391 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.581 ' CZ ' ' HB2' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -131.91 -174.24 3.37 Favored 'General case' 0 N--CA 1.437 -1.097 0 CA-C-N 119.289 0.949 . . . . 0.0 110.968 -179.84 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -125.81 118.38 25.38 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 -179.651 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 16.2 t80 -126.63 115.39 19.4 Favored 'General case' 0 C--O 1.209 -1.028 0 CA-C-N 120.503 1.501 . . . . 0.0 111.711 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 10.6 t -80.93 142.62 33.34 Favored 'General case' 0 CA--C 1.491 -1.327 0 O-C-N 120.352 -1.468 . . . . 0.0 109.434 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.6 HD21 HD22 ' A' ' 78' ' ' LEU . 0.1 OUTLIER -97.83 -174.2 2.82 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 106.043 -1.836 . . . . 0.0 106.043 179.901 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.453 ' CB ' ' CD2' ' A' ' 55' ' ' PHE . . . -84.33 -49.28 8.88 Favored 'General case' 0 C--O 1.211 -0.973 0 O-C-N 125.355 1.659 . . . . 0.0 110.717 179.409 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.425 ' HB2' ' HD3' ' A' ' 27' ' ' LYS . 4.9 t70 -121.7 -10.06 8.8 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.079 -1.419 . . . . 0.0 109.72 179.182 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -89.19 -17.59 55.36 Favored Glycine 0 CA--C 1.546 1.982 0 CA-C-N 118.66 0.664 . . . . 0.0 112.763 179.676 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.489 HG22 ' H ' ' A' ' 77' ' ' GLU 0.355 0.0 OUTLIER 71.96 -169.03 0.14 Allowed 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 116.495 -2.082 . . . . 0.0 113.302 179.922 . . . . . . . . 4 4 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.504 ' HB2' HG22 ' A' ' 96' ' ' VAL . 4.0 mp0 -46.22 140.71 3.82 Favored 'General case' 0 C--N 1.319 -0.729 0 O-C-N 128.253 3.471 . . . . 0.0 112.039 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.6 HD22 HD21 ' A' ' 72' ' ' LEU 0.42 0.4 OUTLIER -156.83 100.67 1.92 Allowed 'General case' 0 C--O 1.243 0.734 0 N-CA-C 102.798 -3.038 . . . . 0.0 102.798 179.963 . . . . . . . . 4 4 . 1 . 001 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.535 ' HB ' ' O ' ' A' ' 68' ' ' PHE . 27.6 m -109.13 135.37 50.38 Favored 'General case' 0 CA--C 1.481 -1.686 0 O-C-N 125.009 1.443 . . . . 0.0 108.238 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 173.6 -168.0 40.78 Favored Glycine 0 C--N 1.303 -1.276 1 C-N-CA 113.805 -4.045 . . . . 0.0 108.775 -179.682 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.732 HG22 ' HA ' ' A' ' 67' ' ' ASP . 2.7 p -137.69 177.14 8.1 Favored 'General case' 0 CA--C 1.493 -1.218 0 CA-C-N 119.129 1.465 . . . . 0.0 110.981 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' TRP . . . . . 0.546 ' CE3' ' CA ' ' A' ' 91' ' ' GLY . 83.5 m95 -128.12 141.45 51.49 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 102.078 -3.304 . . . . 0.0 102.078 179.776 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.513 HG23 HG23 ' A' ' 90' ' ' VAL . 5.4 t -142.86 138.67 30.44 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-O 122.033 0.921 . . . . 0.0 109.312 -179.753 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 13.6 ttt -83.44 105.24 14.22 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . 0.603 4.7 mt-10 -56.8 -28.74 61.89 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-O 124.986 2.327 . . . . 0.0 112.661 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 140.49 -46.71 0.91 Allowed Glycine 0 C--N 1.347 1.146 0 N-CA-C 104.081 -3.608 . . . . 0.0 104.081 179.741 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 17.3 t30 -113.28 -19.23 11.85 Favored 'General case' 0 N--CA 1.44 -0.937 0 O-C-N 127.109 2.299 . . . . 0.0 114.109 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . 0.385 20.3 mttt -136.93 151.41 49.01 Favored 'General case' 0 N--CA 1.44 -0.958 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 179.736 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.952 HD23 HH11 ' A' ' 106' ' ' ARG . 1.0 OUTLIER -98.74 129.56 45.18 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 101.313 -3.588 . . . . 0.0 101.313 179.634 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.513 HG23 HG23 ' A' ' 83' ' ' THR . 0.0 OUTLIER -120.26 114.75 44.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 C-N-CA 118.363 -1.335 . . . . 0.0 108.14 -179.844 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.546 ' CA ' ' CE3' ' A' ' 82' ' ' TRP . . . -84.16 91.52 1.65 Allowed Glycine 0 C--N 1.354 1.582 0 C-N-CA 129.652 3.501 . . . . 0.0 107.819 -179.763 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -92.39 124.33 36.37 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 102.509 -3.145 . . . . 0.0 102.509 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.463 ' CG ' ' HG ' ' A' ' 78' ' ' LEU . 2.4 m-85 -136.23 108.99 7.53 Favored 'General case' 0 CA--C 1.502 -0.865 0 O-C-N 125.902 2.001 . . . . 0.0 111.941 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.432 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 0.1 OUTLIER -89.04 -173.22 3.98 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 179.937 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . 0.42 0.6 OUTLIER -131.56 151.83 51.27 Favored 'General case' 0 CA--C 1.487 -1.459 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.859 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.504 HG22 ' HB2' ' A' ' 77' ' ' GLU . 17.4 m -82.03 -33.62 11.86 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 N-CA-C 114.176 1.176 . . . . 0.0 114.176 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.412 ' N ' HG23 ' A' ' 96' ' ' VAL 0.436 0.5 OUTLIER -74.13 10.32 1.27 Allowed 'General case' 0 C--O 1.247 0.957 0 N-CA-C 116.226 1.936 . . . . 0.0 116.226 179.844 . . . . . . . . 4 4 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -168.54 -33.99 0.02 OUTLIER 'General case' 0 CA--C 1.497 -1.084 0 N-CA-C 114.812 1.412 . . . . 0.0 114.812 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 76.7 41.63 23.52 Favored Glycine 0 C--N 1.339 0.733 0 N-CA-C 116.423 1.329 . . . . 0.0 116.423 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 69.4 mttt -81.97 -112.01 0.03 OUTLIER 'General case' 0 C--O 1.198 -1.647 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.428 ' HG3' ' N ' ' A' ' 102' ' ' LEU . 0.1 OUTLIER 166.17 142.4 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.391 0 C-N-CA 125.212 1.405 . . . . 0.0 109.897 -179.913 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.553 ' HG ' ' HA ' ' A' ' 119' ' ' TYR . 0.8 OUTLIER -131.25 151.68 51.25 Favored 'General case' 0 C--O 1.247 0.94 0 O-C-N 128.289 3.493 . . . . 0.0 104.761 -179.723 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.453 ' CG2' ' HB ' ' A' ' 118' ' ' THR . 9.2 tt -132.23 174.69 12.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 CA-C-N 120.405 1.457 . . . . 0.0 107.891 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.418 ' N ' ' CG1' ' A' ' 103' ' ' ILE . . . -155.98 111.19 2.95 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 116.351 -1.785 . . . . 0.0 106.269 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.466 HG12 HG23 ' A' ' 116' ' ' THR . 0.9 OUTLIER -95.95 111.72 26.79 Favored 'Isoleucine or valine' 0 C--O 1.245 0.852 0 CA-C-N 121.44 1.927 . . . . 0.0 113.199 -179.416 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.952 HH11 HD23 ' A' ' 89' ' ' LEU . 37.3 mtt180 -91.24 94.1 9.39 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 106.327 -1.731 . . . . 0.0 106.327 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -94.03 74.96 4.11 Favored 'General case' 0 N--CA 1.42 -1.948 0 N-CA-C 116.915 2.191 . . . . 0.0 116.915 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.838 HD11 ' CH2' ' A' ' 6' ' ' TRP . 0.3 OUTLIER -61.07 128.73 22.83 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 C-N-CA 115.292 -2.563 . . . . 0.0 111.763 179.872 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 3.9 t -87.42 -65.71 0.99 Allowed 'General case' 0 C--O 1.218 -0.581 0 N-CA-C 104.575 -2.38 . . . . 0.0 104.575 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -167.39 -62.36 0.03 OUTLIER Glycine 0 C--N 1.348 1.213 0 C-N-CA 129.985 3.66 . . . . 0.0 112.683 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . 0.309 0.8 OUTLIER -101.96 -9.33 20.75 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-O 116.448 -1.739 . . . . 0.0 110.737 179.844 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.53 ' O ' HD13 ' A' ' 108' ' ' ILE . 1.3 mt-10 -126.94 131.77 51.01 Favored 'General case' 0 CA--C 1.495 -1.159 0 O-C-N 128.078 3.361 . . . . 0.0 116.888 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.684 HD22 ' CD2' ' A' ' 128' ' ' PHE . 10.4 tt -105.32 117.0 32.9 Favored 'General case' 0 C--N 1.321 -0.669 0 O-C-N 127.739 3.149 . . . . 0.0 105.912 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.735 HG13 HD13 ' A' ' 127' ' ' ILE 0.281 1.2 mp -108.32 128.34 63.92 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 CA-C-O 116.212 -1.852 . . . . 0.0 107.574 -179.747 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 115' ' ' GLN . . . . . 0.605 HE21 ' HZ ' ' A' ' 128' ' ' PHE . 37.4 mt-30 -114.32 105.89 13.68 Favored 'General case' 0 N--CA 1.441 -0.897 0 O-C-N 126.543 2.402 . . . . 0.0 107.783 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.466 HG23 HG12 ' A' ' 105' ' ' VAL . 12.3 p -75.64 -179.0 4.43 Favored 'General case' 0 N--CA 1.429 -1.518 0 O-C-N 127.595 3.06 . . . . 0.0 105.409 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.428 ' HB2' ' HB3' ' A' ' 124' ' ' ALA . 97.4 m-85 -165.96 112.1 0.88 Allowed 'General case' 0 C--O 1.198 -1.623 0 CA-C-O 116.605 -1.664 . . . . 0.0 113.19 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.522 HG22 ' H ' ' A' ' 120' ' ' GLU . 54.0 m -122.73 129.33 51.65 Favored 'General case' 0 N--CA 1.425 -1.68 1 O-C-N 131.289 5.368 . . . . 0.0 113.661 179.77 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.553 ' HA ' ' HG ' ' A' ' 102' ' ' LEU . 2.1 t80 -109.14 12.85 24.82 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.522 ' H ' HG22 ' A' ' 118' ' ' THR . 0.7 OUTLIER 163.52 -84.95 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.566 0 O-C-N 127.818 3.199 . . . . 0.0 111.357 -179.796 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -128.59 24.27 4.95 Favored Glycine 0 CA--C 1.539 1.547 0 N-CA-C 119.892 2.717 . . . . 0.0 119.892 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 62.1 t -133.0 104.07 6.55 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.628 0 O-C-N 119.122 -2.399 . . . . 0.0 107.371 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -81.14 171.54 14.78 Favored 'General case' 0 N--CA 1.426 -1.647 0 CA-C-O 124.203 1.954 . . . . 0.0 108.623 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.801 ' HB1' ' HA ' ' A' ' 14' ' ' TYR . . . -162.72 97.08 0.95 Allowed 'General case' 0 C--O 1.211 -0.94 0 C-N-CA 117.746 -1.582 . . . . 0.0 107.194 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.473 ' HB2' ' HB3' ' A' ' 12' ' ' GLU 0.32 1.8 mptm? -83.88 132.91 34.75 Favored 'General case' 0 CA--C 1.506 -0.729 0 CA-C-O 122.331 1.063 . . . . 0.0 110.121 -179.903 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.513 HH12 HD22 ' A' ' 36' ' ' LEU . 4.6 mtm180 -119.94 81.47 1.74 Allowed 'General case' 0 C--O 1.209 -1.042 0 C-N-CA 127.158 2.183 . . . . 0.0 107.867 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.735 HD13 HG13 ' A' ' 114' ' ' ILE . 10.4 mm -63.97 126.32 22.41 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.861 0 O-C-N 128.522 3.639 . . . . 0.0 111.649 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.684 ' CD2' HD22 ' A' ' 113' ' ' LEU . 5.6 m-30 -112.66 139.47 48.23 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 113.25 -1.795 . . . . 0.0 107.681 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . 0.263 3.0 mmtp -104.11 13.73 31.87 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 116.947 -1.502 . . . . 0.0 111.206 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.519 ' HB2' ' CZ3' ' A' ' 6' ' ' TRP . 0.1 OUTLIER 55.83 97.53 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 115.394 -2.241 . . . . 0.0 113.176 179.716 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . 0.88 2.4 tt0 . . . . . 0 N--CA 1.443 -0.814 0 C-N-CA 115.407 -2.517 . . . . 0.0 115.683 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' PHE . . . . . 0.445 ' N ' ' CD1' ' A' ' 2' ' ' PHE . 10.6 m-85 . . . . . 0 CA--C 1.511 -0.529 0 CA-C-O 121.074 0.464 . . . . 0.0 111.908 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -145.53 100.9 3.51 Favored 'General case' 0 CA--C 1.495 -1.172 0 C-N-CA 119.528 -0.869 . . . . 0.0 111.629 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 143.65 -171.79 25.19 Favored Glycine 0 CA--C 1.503 -0.718 0 O-C-N 126.512 2.382 . . . . 0.0 111.603 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.416 ' C ' ' CG ' ' A' ' 6' ' ' TRP 0.587 0.5 OUTLIER -81.45 164.27 22.16 Favored 'General case' 0 N--CA 1.439 -1.006 0 CA-C-O 123.026 1.393 . . . . 0.0 111.523 179.931 . . . . . . . . 4 4 . 1 . 002 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.755 ' CH2' HD11 ' A' ' 108' ' ' ILE . 63.2 m95 -157.03 117.01 3.48 Favored 'General case' 0 N--CA 1.428 -1.563 0 CA-C-O 114.276 -2.773 . . . . 0.0 106.419 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 5.1 tttt -122.47 95.71 4.75 Favored 'General case' 0 N--CA 1.441 -0.902 0 O-C-N 126.062 2.101 . . . . 0.0 108.908 -179.677 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.583 ' HA ' ' HA ' ' A' ' 128' ' ' PHE 0.267 14.1 p -34.76 119.19 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.216 0 O-C-N 125.391 1.682 . . . . 0.0 114.561 -179.951 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -114.38 -46.99 2.94 Favored 'General case' 0 C--O 1.204 -1.296 0 O-C-N 125.484 1.74 . . . . 0.0 110.24 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.602 ' HG3' HG21 ' A' ' 127' ' ' ILE 0.27 0.0 OUTLIER -106.78 170.72 7.77 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-O 118.663 -0.684 . . . . 0.0 109.866 179.861 . . . . . . . . 4 4 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.738 ' HB3' ' CD1' ' A' ' 14' ' ' TYR 0.391 42.8 m-80 -169.62 179.39 3.78 Favored 'General case' 0 N--CA 1.437 -1.083 0 O-C-N 128.06 3.35 . . . . 0.0 109.962 -178.201 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -150.38 -90.07 0.07 Allowed 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 121.839 2.109 . . . . 0.0 112.083 -179.782 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -85.04 4.91 31.71 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-N 122.449 2.386 . . . . 0.0 112.182 179.328 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.738 ' CD1' ' HB3' ' A' ' 11' ' ' ASN . 0.4 OUTLIER -59.55 -21.82 60.82 Favored 'General case' 0 C--N 1.308 -1.238 0 C-N-CA 127.274 2.23 . . . . 0.0 113.301 -178.628 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -73.92 -26.63 60.61 Favored 'General case' 0 C--O 1.21 -0.983 0 CA-C-N 120.51 1.504 . . . . 0.0 111.424 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 37.2 tttm -79.97 -31.92 39.84 Favored 'General case' 0 N--CA 1.432 -1.339 0 CA-C-O 125.448 2.546 . . . . 0.0 110.665 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.658 ' CB ' ' HB2' ' A' ' 124' ' ' ALA . 0.0 OUTLIER -60.78 -33.89 73.66 Favored 'General case' 0 N--CA 1.428 -1.564 0 O-C-N 118.397 -2.689 . . . . 0.0 113.264 -179.755 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 19.2 mtt -72.88 -23.77 60.77 Favored 'General case' 0 N--CA 1.438 -1.073 0 O-C-N 119.229 -2.17 . . . . 0.0 108.465 179.558 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -76.13 -32.28 59.06 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 125.027 2.346 . . . . 0.0 111.379 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.411 ' HE3' ' HB3' ' A' ' 120' ' ' GLU . 0.6 OUTLIER -64.72 -41.2 96.15 Favored 'General case' 0 N--CA 1.436 -1.171 0 O-C-N 117.55 -3.219 . . . . 0.0 112.379 179.76 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -73.66 -21.88 60.13 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 86.73 61.64 1.59 Allowed Glycine 0 C--N 1.314 -0.666 0 CA-C-O 115.263 -2.965 . . . . 0.0 109.998 179.566 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.468 HG23 ' CB ' ' A' ' 27' ' ' LYS . 7.2 mm -90.77 -7.21 10.77 Favored 'Isoleucine or valine' 0 C--N 1.358 0.943 0 CA-C-N 119.537 1.668 . . . . 0.0 108.408 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 76.11 -106.01 0.02 OUTLIER 'General case' 0 N--CA 1.441 -0.882 0 CA-C-O 116.006 -1.95 . . . . 0.0 114.384 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . 0.343 69.2 t -133.74 -55.26 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.499 -0.995 0 N-CA-C 118.001 2.593 . . . . 0.0 118.001 -179.641 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.568 34.5 m -69.23 -35.21 66.81 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.079 0 N-CA-C 118.975 2.954 . . . . 0.0 118.975 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.468 ' CB ' HG23 ' A' ' 23' ' ' ILE . 27.7 mttt -74.72 -26.56 59.89 Favored 'General case' 0 C--N 1.32 -0.7 0 O-C-N 126.08 2.113 . . . . 0.0 113.326 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 21.3 ptt180 -79.4 -23.75 43.05 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 120.347 1.43 . . . . 0.0 108.794 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 15.1 tttp -78.19 -44.0 26.99 Favored 'General case' 0 C--O 1.211 -0.959 0 CA-C-O 122.809 1.29 . . . . 0.0 110.599 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 76.1 mt -73.83 -23.42 59.64 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 114.498 -1.228 . . . . 0.0 109.149 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -66.97 -51.28 40.79 Favored Glycine 0 C--O 1.212 -1.268 0 CA-C-O 123.816 1.787 . . . . 0.0 112.96 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.556 ' HB1' ' CE2' ' A' ' 14' ' ' TYR . . . -55.2 -35.27 64.67 Favored 'General case' 0 N--CA 1.436 -1.174 0 C-N-CA 128.574 2.749 . . . . 0.0 115.707 179.116 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -130.63 60.55 1.63 Allowed 'General case' 0 CA--C 1.506 -0.732 0 CA-C-N 112.028 -2.351 . . . . 0.0 111.996 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -96.37 -15.45 21.83 Favored 'General case' 0 C--O 1.216 -0.696 0 N-CA-C 117.281 2.326 . . . . 0.0 117.281 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 97.07 29.13 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.842 0 O-C-N 125.9 2.0 . . . . 0.0 111.921 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.416 HD23 ' HZ ' ' A' ' 128' ' ' PHE . 12.2 tp -65.94 81.8 0.08 Allowed 'General case' 0 CA--C 1.503 -0.84 0 CA-C-O 124.471 2.081 . . . . 0.0 110.396 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -90.24 88.97 7.44 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 101.873 -3.38 . . . . 0.0 101.873 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.447 ' HG ' HG23 ' A' ' 49' ' ' VAL . 1.0 OUTLIER -67.78 95.35 0.5 Allowed 'General case' 0 C--N 1.292 -1.932 0 C-N-CA 118.518 -1.273 . . . . 0.0 111.011 -179.18 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.414 ' HB ' ' CB ' ' A' ' 50' ' ' LYS . 39.6 m -81.4 104.83 12.12 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 101.781 -3.415 . . . . 0.0 101.781 179.355 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.648 HD12 ' CD1' ' A' ' 6' ' ' TRP . 83.7 mt -91.45 147.34 5.33 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 O-C-N 120.613 -1.304 . . . . 0.0 111.635 -179.457 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 4.3 m -145.43 101.87 3.64 Favored 'General case' 0 C--O 1.22 -0.494 0 O-C-N 127.062 2.726 . . . . 0.0 112.609 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 15.1 tp60 -82.97 98.64 9.35 Favored 'General case' 0 N--CA 1.443 -0.804 0 O-C-N 125.557 1.785 . . . . 0.0 110.678 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 49.2 tt0 -107.34 84.36 1.96 Allowed 'General case' 0 N--CA 1.438 -1.04 0 CA-C-O 125.657 2.646 . . . . 0.0 105.066 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 70.43 -87.62 0.34 Allowed Glycine 0 C--N 1.296 -1.646 0 CA-C-O 115.814 -2.659 . . . . 0.0 106.582 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.331 0.1 OUTLIER -124.39 -11.99 7.34 Favored 'General case' 0 C--N 1.32 -0.679 0 O-C-N 127.332 2.43 . . . . 0.0 112.535 179.917 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.42 ' HD2' ' CG ' ' A' ' 63' ' ' GLU . 0.0 OUTLIER -90.62 138.61 31.43 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 119.854 -1.779 . . . . 0.0 106.732 179.741 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.482 ' O ' ' N ' ' A' ' 49' ' ' VAL 0.342 3.8 m-85 -115.12 95.64 5.3 Favored 'General case' 0 N--CA 1.433 -1.285 0 C-N-CA 126.222 1.809 . . . . 0.0 107.633 179.777 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.768 ' CB ' HG13 ' A' ' 61' ' ' VAL 0.451 0.1 OUTLIER -67.38 79.53 0.16 Allowed 'General case' 0 N--CA 1.441 -0.875 0 CA-C-O 124.337 2.018 . . . . 0.0 110.594 179.477 . . . . . . . . 4 4 . 1 . 002 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.859 HG13 ' HB ' ' A' ' 60' ' ' VAL 0.753 0.8 OUTLIER -59.57 75.83 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 CA-C-N 109.845 -3.343 . . . . 0.0 115.332 179.794 . . . . . . . . 4 4 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.444 ' HA ' ' HA ' ' A' ' 59' ' ' ASP . 8.9 tttt -61.09 138.56 58.2 Favored 'General case' 0 C--N 1.317 -0.811 1 N-CA-C 99.964 -4.087 . . . . 0.0 99.964 179.742 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -133.71 105.16 6.67 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 102.431 -3.174 . . . . 0.0 102.431 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 54.1 p -104.1 44.85 0.99 Allowed 'General case' 0 C--N 1.288 -2.101 0 N-CA-C 105.95 -1.87 . . . . 0.0 105.95 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.7 t -67.89 149.03 50.35 Favored 'General case' 0 N--CA 1.466 0.335 0 O-C-N 127.322 2.889 . . . . 0.0 107.745 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -50.38 -21.78 1.58 Allowed 'General case' 0 C--O 1.221 -0.424 0 CA-C-N 120.656 1.571 . . . . 0.0 110.129 -179.425 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.404 ' CD1' ' CB ' ' A' ' 73' ' ' ALA . 19.8 m-85 -72.23 -49.96 31.07 Favored 'General case' 0 C--O 1.219 -0.529 0 C-N-CA 115.431 -2.507 . . . . 0.0 110.469 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.664 ' HB2' HG22 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -159.37 141.31 13.41 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 123.779 2.99 . . . . 0.0 110.522 -179.984 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 7.9 m-80 -97.56 78.4 2.65 Favored 'General case' 0 C--N 1.353 0.724 0 N-CA-C 100.36 -3.941 . . . . 0.0 100.36 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.664 HG22 ' HB2' ' A' ' 56' ' ' ARG . 2.6 tp -118.53 113.34 41.55 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.017 0 C-N-CA 131.155 3.782 . . . . 0.0 117.792 -179.243 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.444 ' HA ' ' HA ' ' A' ' 50' ' ' LYS . 3.9 p30 -59.18 149.39 28.41 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 104.357 -2.461 . . . . 0.0 104.357 178.619 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.859 ' HB ' HG13 ' A' ' 49' ' ' VAL . 3.2 t -101.89 -60.98 2.58 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 CA-C-O 124.696 2.189 . . . . 0.0 107.683 -177.933 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.768 HG13 ' CB ' ' A' ' 48' ' ' THR 0.458 0.0 OUTLIER 66.14 109.11 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.433 -1.319 0 CA-C-N 113.014 -1.903 . . . . 0.0 108.992 -179.519 . . . . . . . . 4 4 . 1 . 002 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.441 ' CZ ' ' HA ' ' A' ' 81' ' ' THR . 2.3 t80 -145.53 114.76 7.07 Favored 'General case' 0 C--N 1.312 -1.06 0 C-N-CA 115.694 -2.402 . . . . 0.0 106.651 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.51 ' OE1' HG21 ' A' ' 66' ' ' VAL . 25.9 mt-10 -68.28 141.83 55.75 Favored 'General case' 0 C--O 1.247 0.95 0 N-CA-C 102.49 -3.152 . . . . 0.0 102.49 179.739 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.82 137.23 55.15 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 120.266 1.393 . . . . 0.0 107.944 -179.687 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 57.98 25.0 55.84 Favored Glycine 0 CA--C 1.531 1.056 0 N-CA-C 117.925 1.93 . . . . 0.0 117.925 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.51 HG21 ' OE1' ' A' ' 63' ' ' GLU 0.296 37.2 t -111.37 84.6 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 104.851 -2.277 . . . . 0.0 104.851 179.94 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -39.36 113.43 0.32 Allowed 'General case' 0 C--O 1.202 -1.424 0 O-C-N 126.41 2.319 . . . . 0.0 114.648 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.449 ' CD1' ' C ' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -106.8 -166.26 1.15 Allowed 'General case' 0 N--CA 1.422 -1.839 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 -179.599 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -131.53 137.09 48.36 Favored 'General case' 0 CA--C 1.51 -0.583 0 CA-C-O 116.872 -1.537 . . . . 0.0 107.025 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -146.94 113.04 5.82 Favored 'General case' 0 C--O 1.216 -0.672 0 C-N-CA 117.966 -1.493 . . . . 0.0 113.808 -179.794 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 47.1 t -91.18 151.34 20.99 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.6 mp -96.58 -169.93 1.98 Allowed 'General case' 0 CA--C 1.498 -1.049 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.404 ' CB ' ' CD1' ' A' ' 55' ' ' PHE . . . -89.45 -6.19 56.71 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-O 124.774 2.226 . . . . 0.0 111.691 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -153.79 -44.75 0.09 Allowed 'General case' 0 N--CA 1.433 -1.29 0 CA-C-N 112.787 -2.006 . . . . 0.0 112.133 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -64.85 -8.0 32.17 Favored Glycine 0 C--O 1.205 -1.692 0 O-C-N 124.769 1.293 . . . . 0.0 114.839 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . 0.372 0.1 OUTLIER 71.46 172.3 0.31 Allowed 'General case' 0 C--N 1.308 -1.219 0 O-C-N 118.197 -2.943 . . . . 0.0 114.947 -179.982 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -35.77 151.99 0.01 OUTLIER 'General case' 0 N--CA 1.434 -1.245 1 O-C-N 130.051 4.594 . . . . 0.0 116.407 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.429 HD11 HD22 ' A' ' 102' ' ' LEU 0.388 8.8 tp -153.63 165.25 36.51 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-N 112.715 -2.039 . . . . 0.0 105.782 -179.958 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -167.05 120.04 0.97 Allowed 'General case' 0 CA--C 1.503 -0.834 0 N-CA-C 105.201 -2.148 . . . . 0.0 105.201 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.442 ' HA3' ' HA ' ' A' ' 93' ' ' PHE . . . -168.65 -157.15 11.08 Favored Glycine 0 C--N 1.296 -1.669 0 C-N-CA 116.684 -2.674 . . . . 0.0 109.765 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.441 ' HA ' ' CZ ' ' A' ' 62' ' ' PHE . 2.8 p -144.98 159.91 42.18 Favored 'General case' 0 C--O 1.191 -2.026 0 O-C-N 126.553 1.973 . . . . 0.0 112.63 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' TRP . . . . . 0.461 ' CZ3' ' HG3' ' A' ' 106' ' ' ARG . 39.8 m95 -117.97 113.93 22.41 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 103.136 -2.913 . . . . 0.0 103.136 -179.725 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 4.0 t -122.85 139.09 54.4 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-O 122.199 1.0 . . . . 0.0 111.093 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 1.9 ttt -92.94 105.08 17.24 Favored 'General case' 0 N--CA 1.426 -1.674 0 CA-C-N 113.442 -1.708 . . . . 0.0 112.494 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . 0.532 0.6 OUTLIER -72.66 -143.98 0.01 OUTLIER 'General case' 0 N--CA 1.425 -1.719 0 O-C-N 125.008 1.443 . . . . 0.0 108.162 179.808 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -82.59 66.94 3.81 Favored Glycine 0 N--CA 1.45 -0.369 0 N-CA-C 105.447 -3.061 . . . . 0.0 105.447 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 96.74 -13.79 0.08 Allowed 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 117.293 2.331 . . . . 0.0 117.293 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . 0.409 0.0 OUTLIER -111.65 141.89 44.66 Favored 'General case' 0 C--O 1.215 -0.756 0 O-C-N 125.204 1.565 . . . . 0.0 107.714 179.869 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.499 HD13 ' CD ' ' A' ' 106' ' ' ARG . 1.0 OUTLIER -96.48 145.56 25.57 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 101.503 -3.517 . . . . 0.0 101.503 179.965 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.8 m -132.6 120.27 41.48 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 O-C-N 125.043 1.464 . . . . 0.0 109.596 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -100.27 87.08 0.69 Allowed Glycine 0 C--N 1.338 0.686 0 C-N-CA 128.358 2.885 . . . . 0.0 114.109 -179.474 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -90.67 148.11 22.83 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 102.388 -3.19 . . . . 0.0 102.388 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.744 ' HB2' HD23 ' A' ' 102' ' ' LEU . 15.7 m-85 -152.64 117.98 5.25 Favored 'General case' 0 CA--C 1.501 -0.906 0 C-N-CA 117.678 -1.609 . . . . 0.0 113.45 -179.654 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -88.36 -163.46 0.97 Allowed 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 -179.614 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . 0.334 0.2 OUTLIER -138.25 164.73 28.48 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 106.085 -1.82 . . . . 0.0 106.085 179.824 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 37.0 t -94.3 -40.01 11.0 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 C-N-CA 124.63 1.172 . . . . 0.0 108.537 -179.696 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . 0.287 0.2 OUTLIER -55.19 -30.66 60.38 Favored 'General case' 0 C--O 1.25 1.126 0 N-CA-C 114.681 1.363 . . . . 0.0 114.681 179.786 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -160.02 6.08 0.09 Allowed 'General case' 0 N--CA 1.44 -0.94 0 CA-C-O 115.809 -2.044 . . . . 0.0 116.428 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 54.02 85.01 0.03 OUTLIER Glycine 0 CA--C 1.524 0.612 0 N-CA-C 118.675 2.23 . . . . 0.0 118.675 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.0 mmtp -113.28 -111.37 0.34 Allowed 'General case' 0 C--O 1.213 -0.862 0 O-C-N 120.951 -1.323 . . . . 0.0 111.392 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 54.3 tt0 -177.75 162.24 1.72 Allowed 'General case' 0 C--O 1.211 -0.965 0 C-N-CA 127.954 2.502 . . . . 0.0 109.069 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.744 HD23 ' HB2' ' A' ' 93' ' ' PHE . 1.9 tp -158.29 109.16 2.15 Favored 'General case' 0 C--N 1.316 -0.887 0 C-N-CA 131.255 3.822 . . . . 0.0 102.653 -179.755 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.433 ' N ' ' O ' ' A' ' 118' ' ' THR . 0.8 OUTLIER -98.83 152.56 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.091 0 C-N-CA 115.093 -2.643 . . . . 0.0 105.532 -179.439 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.604 ' HA ' ' O ' ' A' ' 116' ' ' THR . . . -160.93 147.25 14.89 Favored 'General case' 0 C--N 1.309 -1.165 0 C-N-CA 124.733 1.213 . . . . 0.0 109.123 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.469 ' O ' HG12 ' A' ' 105' ' ' VAL . 0.9 OUTLIER -137.11 102.46 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 116.033 -2.267 . . . . 0.0 111.461 -179.028 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.499 ' CD ' HD13 ' A' ' 89' ' ' LEU 0.277 48.9 mtt180 -68.18 85.16 0.25 Allowed 'General case' 0 C--N 1.312 -1.029 0 O-C-N 126.562 2.414 . . . . 0.0 104.838 179.696 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.416 ' N ' ' O ' ' A' ' 105' ' ' VAL . 4.9 tt0 -79.52 76.38 6.13 Favored 'General case' 0 N--CA 1.424 -1.738 0 O-C-N 127.163 2.789 . . . . 0.0 117.765 -179.819 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.755 HD11 ' CH2' ' A' ' 6' ' ' TRP 0.426 0.9 OUTLIER -61.91 123.07 13.99 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 C-N-CA 116.112 -2.235 . . . . 0.0 108.41 179.65 . . . . . . . . 4 4 . 1 . 002 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 7.0 m -102.63 10.67 38.56 Favored 'General case' 0 C--O 1.219 -0.54 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.564 ' H ' HG23 ' A' ' 108' ' ' ILE . . . 119.78 -60.21 0.52 Allowed Glycine 0 N--CA 1.444 -0.8 1 C-N-CA 132.266 4.746 . . . . 0.0 112.713 179.752 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -115.3 22.05 13.6 Favored 'General case' 0 C--N 1.314 -0.936 0 O-C-N 127.121 2.307 . . . . 0.0 111.681 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -149.42 99.62 2.93 Favored 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 120.299 -0.56 . . . . 0.0 111.33 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.459 ' O ' HD23 ' A' ' 113' ' ' LEU . 7.0 tt -84.02 101.61 11.88 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 100.878 -3.749 . . . . 0.0 100.878 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.911 HG12 HG23 ' A' ' 127' ' ' ILE 0.295 3.7 mt -107.2 118.67 55.41 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.09 0 O-C-N 126.013 2.07 . . . . 0.0 111.145 -179.416 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 115' ' ' GLN . . . . . 0.509 ' O ' ' N ' ' A' ' 126' ' ' ARG 0.316 76.1 mt-30 -89.83 149.67 22.57 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 100.433 -3.914 . . . . 0.0 100.433 177.487 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.828 ' CG2' HG22 ' A' ' 114' ' ' ILE . 79.9 p -160.65 179.09 8.85 Favored 'General case' 0 N--CA 1.422 -1.867 1 O-C-N 130.784 5.052 . . . . 0.0 106.615 -179.865 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.621 ' CE2' ' OG1' ' A' ' 116' ' ' THR 0.297 33.2 m-85 96.6 -142.76 0.0 OUTLIER 'General case' 0 CA--C 1.442 -3.205 0 N-CA-C 120.314 3.45 . . . . 0.0 120.314 174.922 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.603 ' O ' HD12 ' A' ' 102' ' ' LEU . 11.2 t -133.87 -174.11 3.44 Favored 'General case' 0 N--CA 1.417 -2.101 0 N-CA-C 120.342 3.46 . . . . 0.0 120.342 -174.648 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.717 ' HA ' ' HA ' ' A' ' 102' ' ' LEU 0.339 7.0 t80 -117.98 0.76 11.94 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 111.528 -2.578 . . . . 0.0 106.663 178.092 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.411 ' HB3' ' HE3' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -174.74 -84.03 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.274 0 O-C-N 119.537 -1.977 . . . . 0.0 111.256 179.456 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -138.87 32.99 2.24 Favored Glycine 0 CA--C 1.537 1.454 0 C-N-CA 127.432 2.444 . . . . 0.0 116.576 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 78.7 t -141.49 101.15 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 N-CA-C 105.73 -1.952 . . . . 0.0 105.73 -179.735 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.402 ' HA ' ' C ' ' A' ' 117' ' ' TYR . 1.8 mp0 -59.13 -179.67 0.08 Allowed 'General case' 0 C--O 1.207 -1.172 0 CA-C-O 123.785 1.755 . . . . 0.0 111.797 -179.464 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.658 ' HB2' ' CB ' ' A' ' 17' ' ' PHE . . . -168.08 76.21 0.13 Allowed 'General case' 0 CA--C 1.503 -0.847 0 C-N-CA 113.602 -3.239 . . . . 0.0 110.877 -178.043 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.568 ' HA ' ' CB ' ' A' ' 116' ' ' THR . 1.4 mptp? -57.58 144.69 36.35 Favored 'General case' 0 CA--C 1.508 -0.654 0 CA-C-N 123.897 3.044 . . . . 0.0 112.258 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.509 ' N ' ' O ' ' A' ' 115' ' ' GLN . 11.1 mtp180 -144.83 77.03 1.52 Allowed 'General case' 0 C--O 1.21 -0.978 0 C-N-CA 127.259 2.224 . . . . 0.0 105.565 178.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.911 HG23 HG12 ' A' ' 114' ' ' ILE . 0.8 OUTLIER -78.62 128.59 38.32 Favored 'Isoleucine or valine' 0 C--O 1.253 1.289 0 O-C-N 127.767 3.167 . . . . 0.0 116.794 179.77 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.583 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 0.1 OUTLIER -109.8 145.38 36.81 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 128.499 2.72 . . . . 0.0 107.122 179.917 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . 0.254 0.3 OUTLIER -112.67 29.13 8.2 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 117.051 -1.452 . . . . 0.0 112.286 -179.79 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.594 ' HB2' ' CZ3' ' A' ' 6' ' ' TRP . 3.3 tttp 50.37 89.26 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 127.397 2.279 . . . . 0.0 108.641 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . 0.773 64.0 mt-10 . . . . . 0 N--CA 1.426 -1.639 0 O-C-N 125.846 1.966 . . . . 0.0 113.6 -179.557 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.445 -0.716 0 N-CA-C 116.067 1.877 . . . . 0.0 116.067 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -43.85 93.74 0.01 OUTLIER 'General case' 0 CA--C 1.496 -1.126 0 O-C-N 126.141 2.15 . . . . 0.0 111.691 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 176.3 -178.28 47.71 Favored Glycine 0 C--N 1.31 -0.886 0 C-N-CA 117.343 -2.36 . . . . 0.0 111.527 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.569 HG23 HG23 ' A' ' 39' ' ' THR 0.377 1.2 p -94.02 155.12 17.29 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 128.641 3.201 . . . . 0.0 111.951 -179.735 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.71 ' NE1' HD12 ' A' ' 40' ' ' ILE . 49.2 m95 -159.75 -158.98 0.69 Allowed 'General case' 0 N--CA 1.426 -1.667 0 CA-C-O 114.63 -2.605 . . . . 0.0 106.393 177.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.757 ' HB3' ' CZ ' ' A' ' 128' ' ' PHE . 6.9 ttmt 178.91 -99.64 0.0 OUTLIER 'General case' 0 C--O 1.209 -1.073 0 O-C-N 129.007 3.942 . . . . 0.0 105.17 179.387 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.755 HG12 ' O ' ' A' ' 7' ' ' LYS 0.263 0.3 OUTLIER 159.3 120.13 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 O-C-N 126.329 2.268 . . . . 0.0 109.348 179.514 . . . . . . . . 4 4 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 61.5 t0 -125.55 -76.48 0.59 Allowed 'General case' 0 CA--C 1.506 -0.746 0 CA-C-O 125.965 2.793 . . . . 0.0 108.043 -179.666 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -83.83 122.97 29.41 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 118.626 -2.547 . . . . 0.0 108.269 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . 0.319 0.0 OUTLIER -114.76 -171.12 1.87 Allowed 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 107.151 -1.425 . . . . 0.0 107.151 179.685 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.401 ' HB3' ' HD3' ' A' ' 125' ' ' LYS . 4.6 tt0 -170.53 109.89 0.36 Allowed 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 115.723 -2.391 . . . . 0.0 106.75 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.407 ' ND2' HG12 ' A' ' 122' ' ' VAL 0.259 0.2 OUTLIER 87.65 -8.08 0.59 Allowed 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 -179.852 . . . . . . . . 4 4 . 1 . 003 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.703 ' CD1' ' HB1' ' A' ' 124' ' ' ALA 0.407 0.3 OUTLIER -68.09 -33.81 75.23 Favored 'General case' 0 C--N 1.321 -0.645 0 O-C-N 126.939 2.65 . . . . 0.0 115.6 179.882 . . . . . . . . 4 4 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -71.97 -20.51 61.72 Favored 'General case' 0 C--O 1.213 -0.832 0 O-C-N 119.072 -2.268 . . . . 0.0 110.556 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 24.5 mttt -78.61 -40.88 33.23 Favored 'General case' 0 N--CA 1.443 -0.777 0 O-C-N 126.765 2.541 . . . . 0.0 112.494 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.544 ' CE1' ' HG2' ' A' ' 21' ' ' MET . 0.6 OUTLIER -68.41 -31.79 71.38 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-O 126.076 2.846 . . . . 0.0 110.681 179.702 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 28.4 mtm -69.23 -23.64 63.9 Favored 'General case' 0 C--O 1.22 -0.459 1 O-C-N 114.918 -4.864 . . . . 0.0 108.793 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -79.33 -32.97 43.45 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-O 127.603 3.573 . . . . 0.0 110.647 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.415 ' HD3' HG21 ' A' ' 122' ' ' VAL . 16.6 tptt -74.16 -25.4 59.7 Favored 'General case' 0 N--CA 1.433 -1.302 0 O-C-N 118.257 -2.777 . . . . 0.0 112.728 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.544 ' HG2' ' CE1' ' A' ' 17' ' ' PHE 0.257 13.6 mmm -75.73 -29.1 58.78 Favored 'General case' 0 C--O 1.202 -1.415 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 -179.933 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 103.95 29.12 5.63 Favored Glycine 0 CA--C 1.504 -0.619 0 CA-C-O 115.94 -2.589 . . . . 0.0 109.583 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.2 mm -69.42 141.78 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.956 0 CA-C-N 118.857 1.328 . . . . 0.0 109.863 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 24.9 t30 -80.65 131.99 35.54 Favored 'General case' 0 C--N 1.345 0.399 0 CA-C-O 113.742 -3.028 . . . . 0.0 108.503 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . 0.454 99.1 t -11.01 -51.54 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.503 -0.86 0 O-C-N 128.513 3.633 . . . . 0.0 119.262 -179.788 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.614 13.7 t -72.84 -40.1 59.96 Favored 'Isoleucine or valine' 0 C--O 1.249 1.044 0 N-CA-C 116.637 2.088 . . . . 0.0 116.637 -179.467 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 11.3 mttm -67.09 -32.35 73.45 Favored 'General case' 0 C--O 1.213 -0.853 0 O-C-N 125.632 1.832 . . . . 0.0 113.369 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.467 ' HG3' ' N ' ' A' ' 29' ' ' LYS . 16.4 ptt180 -78.96 -29.28 43.86 Favored 'General case' 0 CA--C 1.514 -0.432 0 O-C-N 120.337 -1.477 . . . . 0.0 109.449 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.467 ' N ' ' HG3' ' A' ' 28' ' ' ARG . 0.2 OUTLIER -72.66 -40.85 66.01 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-O 122.626 1.203 . . . . 0.0 110.67 179.955 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.0 tp -73.2 -28.61 62.29 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 113.484 -1.689 . . . . 0.0 108.625 -179.684 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -74.57 -28.98 62.32 Favored Glycine 0 C--N 1.348 1.219 0 CA-C-N 113.897 -1.501 . . . . 0.0 113.969 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -71.63 -37.97 70.82 Favored 'General case' 0 C--O 1.241 0.655 0 C-N-CA 126.89 2.076 . . . . 0.0 111.563 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 6.6 m80 -111.28 30.27 7.07 Favored 'General case' 0 N--CA 1.447 -0.594 0 O-C-N 126.786 2.554 . . . . 0.0 110.186 179.346 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -49.68 -36.63 25.69 Favored 'General case' 0 CA--C 1.501 -0.912 0 N-CA-C 116.813 2.153 . . . . 0.0 116.813 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . 0.261 92.9 m-20 70.42 54.22 0.3 Allowed 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 116.114 -2.234 . . . . 0.0 107.122 -179.196 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.778 HD11 HD12 ' A' ' 38' ' ' LEU 0.293 1.7 tp -85.8 107.45 17.65 Favored 'General case' 0 N--CA 1.479 0.992 0 O-C-N 128.7 3.75 . . . . 0.0 103.747 179.911 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.43 ' HA ' ' CB ' ' A' ' 7' ' ' LYS . 24.4 tttm -92.77 127.98 38.46 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 100.473 -3.899 . . . . 0.0 100.473 179.614 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.778 HD12 HD11 ' A' ' 36' ' ' LEU 0.377 0.5 OUTLIER -112.05 121.4 44.87 Favored 'General case' 0 C--N 1.288 -2.09 0 C-N-CA 116.011 -2.275 . . . . 0.0 107.004 -178.5 . . . . . . . . 4 4 . 1 . 003 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.569 HG23 HG23 ' A' ' 5' ' ' THR . 28.0 m -116.12 90.86 3.43 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 117.287 -3.383 . . . . 0.0 104.588 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.71 HD12 ' NE1' ' A' ' 6' ' ' TRP . 26.5 mt -70.36 130.16 34.6 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.467 ' HB ' HG23 ' A' ' 48' ' ' THR . 11.6 m -126.75 105.91 9.0 Favored 'General case' 0 N--CA 1.477 0.886 0 O-C-N 127.801 3.188 . . . . 0.0 109.734 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.578 ' HG2' ' CE1' ' A' ' 47' ' ' PHE . 1.0 OUTLIER -84.69 109.1 17.77 Favored 'General case' 0 C--O 1.24 0.6 0 N-CA-C 114.368 1.247 . . . . 0.0 114.368 -179.906 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -96.66 31.08 2.4 Favored 'General case' 0 N--CA 1.419 -1.991 0 O-C-N 121.214 -0.929 . . . . 0.0 109.857 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 97.41 -13.12 64.69 Favored Glycine 0 C--N 1.29 -1.99 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.376 0.0 OUTLIER -175.6 -50.59 0.01 OUTLIER 'General case' 0 C--O 1.213 -0.823 0 CA-C-O 126.132 2.872 . . . . 0.0 109.168 179.901 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 28.1 ttmt -64.89 115.9 5.81 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 113.048 -1.887 . . . . 0.0 110.504 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.578 ' CE1' ' HG2' ' A' ' 42' ' ' GLN . 0.9 OUTLIER -100.71 93.85 5.78 Favored 'General case' 0 CA--C 1.499 -0.995 0 CA-C-O 123.312 1.529 . . . . 0.0 107.271 179.803 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.526 ' HA ' ' HA ' ' A' ' 61' ' ' VAL 0.388 3.1 t -89.72 87.39 6.98 Favored 'General case' 0 N--CA 1.432 -1.347 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 179.623 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.794 HG12 ' CG1' ' A' ' 60' ' ' VAL 0.596 0.5 OUTLIER -70.09 107.93 2.03 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.12 0 O-C-N 125.884 1.99 . . . . 0.0 110.334 179.981 . . . . . . . . 4 4 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.55 ' CB ' ' HB ' ' A' ' 39' ' ' THR . 26.0 tttm -68.9 115.97 8.83 Favored 'General case' 0 C--N 1.302 -1.46 1 N-CA-C 100.192 -4.003 . . . . 0.0 100.192 -179.731 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.476 ' HG3' HD13 ' A' ' 36' ' ' LEU 0.276 69.9 tt0 -107.29 96.32 6.33 Favored 'General case' 0 C--N 1.322 -0.63 0 O-C-N 126.659 2.474 . . . . 0.0 108.484 179.906 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.427 ' HA ' ' HA ' ' A' ' 57' ' ' ASN 0.261 0.1 OUTLIER -96.48 52.37 1.23 Allowed 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 105.201 -2.148 . . . . 0.0 105.201 179.378 . . . . . . . . 4 4 . 1 . 003 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.538 ' HA ' ' HA ' ' A' ' 36' ' ' LEU . 0.1 OUTLIER -77.97 160.23 28.32 Favored 'General case' 0 C--O 1.214 -0.781 0 O-C-N 127.552 3.032 . . . . 0.0 109.882 -179.537 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -53.65 -28.26 32.07 Favored 'General case' 0 C--O 1.215 -0.724 0 O-C-N 126.477 2.361 . . . . 0.0 108.633 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.413 ' C ' ' HG2' ' A' ' 56' ' ' ARG . 8.0 m-85 -62.27 -58.8 6.39 Favored 'General case' 0 C--N 1.351 0.639 0 CA-C-O 115.201 -2.333 . . . . 0.0 109.612 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.658 ' HB2' HG22 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -156.85 155.91 32.27 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-N 123.399 2.818 . . . . 0.0 106.102 179.414 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.427 ' HA ' ' HA ' ' A' ' 52' ' ' SER 0.262 21.2 t30 -101.07 70.94 1.37 Allowed 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 100.364 -3.939 . . . . 0.0 100.364 179.67 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.658 HG22 ' HB2' ' A' ' 56' ' ' ARG . 8.4 tp -120.03 122.98 69.88 Favored 'Isoleucine or valine' 0 C--O 1.243 0.728 0 C-N-CA 130.146 3.378 . . . . 0.0 118.697 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.436 ' HA ' ' HA ' ' A' ' 50' ' ' LYS . 0.0 OUTLIER -72.58 135.66 45.6 Favored 'General case' 0 N--CA 1.468 0.441 0 O-C-N 118.694 -2.504 . . . . 0.0 105.466 179.856 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.794 ' CG1' HG12 ' A' ' 49' ' ' VAL . 4.4 p -109.96 101.13 12.13 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-O 126.177 2.894 . . . . 0.0 111.407 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.526 ' HA ' ' HA ' ' A' ' 48' ' ' THR 0.311 2.0 m -88.56 131.2 36.62 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 O-C-N 116.684 -3.76 . . . . 0.0 113.061 179.858 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.443 ' HE1' HG13 ' A' ' 60' ' ' VAL . 22.1 p90 -151.58 89.02 1.45 Allowed 'General case' 0 N--CA 1.442 -0.827 0 C-N-CA 116.579 -2.049 . . . . 0.0 107.128 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -56.08 134.64 52.79 Favored 'General case' 0 N--CA 1.432 -1.362 0 N-CA-C 104.438 -2.43 . . . . 0.0 104.438 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -49.63 102.81 0.04 OUTLIER 'General case' 0 N--CA 1.428 -1.565 0 O-C-N 126.407 2.317 . . . . 0.0 110.515 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 89.73 32.19 10.4 Favored Glycine 0 C--N 1.346 1.115 0 C-N-CA 128.289 2.852 . . . . 0.0 119.924 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . 0.364 0.4 OUTLIER -111.42 99.16 8.1 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 N-CA-C 104.902 -2.258 . . . . 0.0 104.902 179.91 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.42 ' HA ' HG22 ' A' ' 81' ' ' THR . 0.1 OUTLIER -51.47 136.93 25.01 Favored 'General case' 0 CA--C 1.487 -1.45 0 O-C-N 126.079 2.112 . . . . 0.0 114.153 179.971 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 9.9 p90 -145.62 175.08 10.63 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -129.46 146.77 51.26 Favored 'General case' 0 CA--C 1.501 -0.924 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.51 ' HB3' HD23 ' A' ' 78' ' ' LEU . 16.5 t80 -129.96 -39.78 1.38 Allowed 'General case' 0 C--O 1.213 -0.863 0 CA-C-O 116.118 -1.896 . . . . 0.0 111.806 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.545 ' C ' HD22 ' A' ' 72' ' ' LEU . 0.7 OUTLIER 64.39 158.44 0.09 Allowed 'General case' 0 C--N 1.308 -1.2 0 O-C-N 125.366 1.666 . . . . 0.0 112.056 -179.904 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.797 ' N ' HD13 ' A' ' 72' ' ' LEU . 0.0 OUTLIER 41.55 -158.7 0.01 OUTLIER 'General case' 0 C--N 1.293 -1.873 0 O-C-N 128.351 3.532 . . . . 0.0 110.424 178.369 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.404 ' O ' ' CB ' ' A' ' 74' ' ' ASP . . . 53.97 35.93 23.16 Favored 'General case' 0 C--O 1.208 -1.094 0 CA-C-N 114.237 -1.347 . . . . 0.0 111.444 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.404 ' CB ' ' O ' ' A' ' 73' ' ' ALA . 0.3 OUTLIER 102.34 19.84 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.365 0 O-C-N 126.565 2.415 . . . . 0.0 113.89 179.22 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.571 ' HA3' ' CD1' ' A' ' 78' ' ' LEU . . . -136.87 -38.63 0.15 Allowed Glycine 0 CA--C 1.549 2.174 0 N-CA-C 118.434 2.134 . . . . 0.0 118.434 179.025 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . 0.308 0.0 OUTLIER 59.28 65.95 1.1 Allowed 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 119.662 1.731 . . . . 0.0 107.897 -179.026 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.569 ' HB3' ' HB ' ' A' ' 96' ' ' VAL . 31.0 mt-10 71.81 76.39 0.17 Allowed 'General case' 0 C--O 1.218 -0.594 0 O-C-N 126.518 2.386 . . . . 0.0 108.529 -178.212 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.571 ' CD1' ' HA3' ' A' ' 75' ' ' GLY 0.436 0.7 OUTLIER -97.63 135.11 39.92 Favored 'General case' 0 CA--C 1.5 -0.978 0 O-C-N 127.764 3.165 . . . . 0.0 104.38 -178.162 . . . . . . . . 4 4 . 1 . 003 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 20.2 m -158.13 124.72 4.82 Favored 'General case' 0 CA--C 1.481 -1.696 0 N-CA-C 103.919 -2.623 . . . . 0.0 103.919 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -168.61 -155.49 9.66 Favored Glycine 0 C--N 1.302 -1.313 0 O-C-N 119.748 -1.845 . . . . 0.0 109.316 -179.618 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.42 HG22 ' HA ' ' A' ' 67' ' ' ASP . 4.2 p -145.17 -179.97 6.98 Favored 'General case' 0 C--O 1.196 -1.73 0 C-N-CA 117.23 -1.788 . . . . 0.0 106.965 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' TRP . . . . . 0.472 ' CE2' ' HA3' ' A' ' 91' ' ' GLY . 19.7 m95 -132.27 142.88 49.55 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 101.689 -3.449 . . . . 0.0 101.689 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 14.4 t -143.77 160.96 39.82 Favored 'General case' 0 N--CA 1.417 -2.078 0 CA-C-O 124.948 2.309 . . . . 0.0 113.195 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -94.91 126.97 40.6 Favored 'General case' 0 C--N 1.354 0.8 0 CA-C-N 110.774 -2.921 . . . . 0.0 105.775 -179.728 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . 0.685 0.5 OUTLIER -107.24 33.72 3.85 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.88 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 95.26 -93.43 1.6 Allowed Glycine 0 N--CA 1.427 -1.953 0 N-CA-C 103.986 -3.646 . . . . 0.0 103.986 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -88.96 -5.84 57.68 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 120.154 3.39 . . . . 0.0 120.154 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.4 ' HE2' HG21 ' A' ' 105' ' ' VAL 0.265 0.2 OUTLIER -129.91 152.53 49.28 Favored 'General case' 0 CA--C 1.49 -1.354 0 O-C-N 125.163 1.54 . . . . 0.0 107.182 179.678 . . . . . . . . 4 4 . 1 . 003 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.43 ' HB3' ' HB2' ' A' ' 106' ' ' ARG . 0.3 OUTLIER -106.21 134.15 49.79 Favored 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 105.039 -2.208 . . . . 0.0 105.039 -179.864 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -121.76 154.1 25.94 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.941 0 N-CA-C 105.276 -2.12 . . . . 0.0 105.276 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.472 ' HA3' ' CE2' ' A' ' 82' ' ' TRP . . . -134.96 111.61 0.94 Allowed Glycine 0 CA--C 1.531 1.04 1 C-N-CA 131.06 4.171 . . . . 0.0 109.509 179.898 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 24.8 mtmt -109.16 158.53 17.71 Favored 'General case' 0 N--CA 1.426 -1.651 0 N-CA-C 104.374 -2.454 . . . . 0.0 104.374 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.548 ' HB2' HD22 ' A' ' 102' ' ' LEU . 30.5 m-85 -148.36 112.95 5.34 Favored 'General case' 0 CA--C 1.508 -0.635 0 CA-C-O 123.378 1.561 . . . . 0.0 108.079 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 57.0 mttm -93.39 138.91 31.27 Favored 'General case' 0 N--CA 1.437 -1.104 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . 0.302 0.3 OUTLIER -92.15 136.61 33.04 Favored 'General case' 0 CA--C 1.491 -1.293 0 CA-C-N 113.55 -1.659 . . . . 0.0 109.106 179.75 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.569 ' HB ' ' HB3' ' A' ' 77' ' ' GLU . 38.4 t -71.98 -38.13 63.12 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 C-N-CA 125.277 1.431 . . . . 0.0 111.166 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . 0.319 0.8 OUTLIER -83.24 2.64 34.85 Favored 'General case' 0 C--O 1.261 1.665 0 N-CA-C 118.103 2.631 . . . . 0.0 118.103 -179.959 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -144.28 -29.22 0.49 Allowed 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 116.197 -2.201 . . . . 0.0 114.843 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 92.48 -0.16 70.72 Favored Glycine 0 CA--C 1.532 1.129 0 N-CA-C 118.956 2.343 . . . . 0.0 118.956 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 6.4 mmtt -77.61 -155.1 0.07 Allowed 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 119.299 1.55 . . . . 0.0 111.331 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.55 118.58 4.7 Favored 'General case' 0 CA--C 1.489 -1.375 0 C-N-CA 128.983 2.913 . . . . 0.0 114.541 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.627 ' HA ' ' HA ' ' A' ' 119' ' ' TYR . 0.7 OUTLIER -92.23 135.87 33.65 Favored 'General case' 0 C--N 1.317 -0.812 1 C-N-CA 132.484 4.314 . . . . 0.0 102.741 179.073 . . . . . . . . 4 4 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.85 HG23 ' HB3' ' A' ' 117' ' ' TYR . 14.0 tt -129.34 163.72 33.76 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.003 0 C-N-CA 116.524 -2.07 . . . . 0.0 109.395 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -150.39 146.77 26.9 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-O 115.658 -2.115 . . . . 0.0 107.808 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.593 ' HB ' ' CE2' ' A' ' 117' ' ' TYR . 8.8 p -136.53 120.8 24.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 122.915 2.598 . . . . 0.0 110.466 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.789 ' HG2' HH11 ' A' ' 106' ' ' ARG . 1.2 mtt-85 -76.95 86.65 3.48 Favored 'General case' 0 CA--C 1.496 -1.105 0 O-C-N 126.66 2.475 . . . . 0.0 106.689 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 10.7 tt0 -81.65 78.67 8.37 Favored 'General case' 0 N--CA 1.424 -1.742 0 CA-C-O 123.104 1.431 . . . . 0.0 113.031 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.525 ' CD1' ' CZ2' ' A' ' 6' ' ' TRP . 2.3 mm -69.01 98.06 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 C-N-CA 115.537 -2.465 . . . . 0.0 110.296 179.693 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -100.1 101.43 12.49 Favored 'General case' 0 C--O 1.215 -0.742 0 N-CA-C 103.254 -2.869 . . . . 0.0 103.254 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 65.41 -88.8 0.1 Allowed Glycine 0 C--N 1.339 0.695 0 O-C-N 126.061 2.101 . . . . 0.0 112.138 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . 0.368 0.4 OUTLIER -117.82 -13.57 10.12 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-O 113.313 -3.232 . . . . 0.0 111.158 179.562 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . 0.251 2.2 mp0 -93.6 133.42 36.95 Favored 'General case' 0 C--O 1.212 -0.879 0 O-C-N 128.905 3.878 . . . . 0.0 110.89 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.909 HD21 ' HG2' ' A' ' 115' ' ' GLN 0.284 0.4 OUTLIER -103.06 141.74 35.3 Favored 'General case' 0 C--O 1.21 -1.011 0 N-CA-C 101.321 -3.585 . . . . 0.0 101.321 179.721 . . . . . . . . 4 4 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.762 HG13 HD13 ' A' ' 127' ' ' ILE 0.297 1.4 mp -129.95 139.0 52.64 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 N-CA-C 101.706 -3.442 . . . . 0.0 101.706 179.385 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 115' ' ' GLN . . . . . 0.909 ' HG2' HD21 ' A' ' 113' ' ' LEU . 3.4 mt-30 -119.24 104.91 10.83 Favored 'General case' 0 C--N 1.316 -0.851 1 O-C-N 129.621 4.325 . . . . 0.0 101.492 179.699 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.53 ' HB ' ' HG3' ' A' ' 125' ' ' LYS . 3.4 t -140.68 157.68 45.09 Favored 'General case' 0 N--CA 1.412 -2.371 0 C-N-CA 116.924 -1.91 . . . . 0.0 112.357 -178.879 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.85 ' HB3' HG23 ' A' ' 103' ' ' ILE 0.372 22.2 m-30 137.93 -138.36 0.0 OUTLIER 'General case' 0 CA--C 1.484 -1.584 1 O-C-N 129.408 4.193 . . . . 0.0 113.171 176.246 . . . . . . . . 4 3 . 1 . 003 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.502 ' HB ' ' HA ' ' A' ' 123' ' ' GLU . 10.2 t -158.67 -154.33 0.42 Allowed 'General case' 0 C--N 1.308 -1.229 0 O-C-N 127.674 3.109 . . . . 0.0 115.756 -174.99 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.627 ' HA ' ' HA ' ' A' ' 102' ' ' LEU . 1.7 t80 -114.9 -55.94 2.43 Favored 'General case' 0 C--N 1.346 0.417 0 N-CA-C 105.126 -2.176 . . . . 0.0 105.126 178.305 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.88 -83.37 0.65 Allowed 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 111.59 -2.55 . . . . 0.0 112.396 179.203 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -143.55 25.29 2.15 Favored Glycine 0 C--N 1.366 2.238 0 N-CA-C 121.359 3.303 . . . . 0.0 121.359 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.415 HG21 ' HD3' ' A' ' 20' ' ' LYS . 15.0 t -123.34 97.35 4.63 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 N-CA-C 103.011 -2.959 . . . . 0.0 103.011 179.253 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.502 ' HA ' ' HB ' ' A' ' 118' ' ' THR . 13.6 mt-10 -56.86 179.77 0.04 OUTLIER 'General case' 0 C--O 1.205 -1.289 0 CA-C-O 126.554 3.073 . . . . 0.0 113.093 -177.418 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.703 ' HB1' ' CD1' ' A' ' 14' ' ' TYR . . . -169.17 94.5 0.31 Allowed 'General case' 0 C--O 1.211 -0.961 0 O-C-N 118.821 -2.424 . . . . 0.0 107.987 -179.661 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.53 ' HG3' ' HB ' ' A' ' 116' ' ' THR 0.391 0.1 OUTLIER -84.92 153.72 22.67 Favored 'General case' 0 N--CA 1.444 -0.727 0 O-C-N 125.923 2.014 . . . . 0.0 112.529 -179.572 . . . . . . . . 4 4 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.549 ' CD ' ' HB2' ' A' ' 115' ' ' GLN . 1.0 OUTLIER -137.81 77.83 1.65 Allowed 'General case' 0 N--CA 1.427 -1.598 0 O-C-N 127.57 3.044 . . . . 0.0 105.297 177.114 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.762 HD13 HG13 ' A' ' 114' ' ' ILE . 50.8 mm -66.99 82.79 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.259 1.557 0 O-C-N 128.051 3.344 . . . . 0.0 111.202 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.757 ' CZ ' ' HB3' ' A' ' 7' ' ' LYS 0.368 5.7 t80 -84.44 144.39 28.79 Favored 'General case' 0 N--CA 1.419 -2.001 0 CA-C-O 125.256 2.455 . . . . 0.0 113.753 -179.641 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.407 ' N ' ' CG ' ' A' ' 128' ' ' PHE 0.391 8.7 mmtt -95.28 10.53 35.82 Favored 'General case' 0 N--CA 1.436 -1.147 0 CA-C-N 110.996 -2.82 . . . . 0.0 113.996 -177.666 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.509 ' HA ' ' CE3' ' A' ' 6' ' ' TRP . 18.4 tttt 61.53 111.7 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 122.555 2.434 . . . . 0.0 113.666 -178.39 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . 0.857 2.3 tm-20 . . . . . 0 C--O 1.217 -0.612 0 O-C-N 117.167 -3.458 . . . . 0.0 114.508 -179.666 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' PHE . . . . . 0.684 ' CE1' HD12 ' A' ' 108' ' ' ILE . 65.4 m-85 . . . . . 0 N--CA 1.451 -0.406 0 N-CA-C 116.353 1.983 . . . . 0.0 116.353 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -39.78 91.39 0.0 OUTLIER 'General case' 0 CA--C 1.499 -0.984 0 O-C-N 126.678 2.486 . . . . 0.0 111.34 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' GLY . . . . . 0.43 ' O ' ' HB ' ' A' ' 40' ' ' ILE . . . 158.69 -174.71 35.78 Favored Glycine 0 C--O 1.214 -1.114 0 CA-C-N 113.824 -1.534 . . . . 0.0 110.91 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.582 ' HA ' ' HA ' ' A' ' 39' ' ' THR 0.549 0.5 OUTLIER -81.93 156.88 24.52 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-O 124.426 2.06 . . . . 0.0 115.774 -179.697 . . . . . . . . 4 4 . 1 . 004 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.54 ' CH2' HD11 ' A' ' 108' ' ' ILE . 73.1 m95 -149.8 157.3 43.07 Favored 'General case' 0 N--CA 1.435 -1.182 0 CA-C-N 110.647 -2.979 . . . . 0.0 106.858 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -160.27 102.54 1.41 Allowed 'General case' 0 C--O 1.214 -0.79 1 O-C-N 129.59 4.306 . . . . 0.0 107.081 179.922 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.527 ' HB ' ' CD1' ' A' ' 128' ' ' PHE 0.38 9.3 p -47.12 139.35 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.289 0 CA-C-N 121.593 1.997 . . . . 0.0 113.131 179.992 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -131.61 0.98 4.03 Favored 'General case' 0 CA--C 1.496 -1.099 0 C-N-CA 119.785 -0.766 . . . . 0.0 112.55 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 16.6 ptp180 -160.79 -39.06 0.05 OUTLIER 'General case' 0 CA--C 1.474 -1.967 0 O-C-N 116.946 -3.596 . . . . 0.0 113.301 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . 0.278 0.6 OUTLIER 62.09 178.79 0.13 Allowed 'General case' 0 C--O 1.243 0.742 0 C-N-CA 125.293 1.437 . . . . 0.0 108.193 179.613 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -132.34 -80.2 0.5 Allowed 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 122.478 2.399 . . . . 0.0 109.635 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 16.5 t30 -96.05 15.46 20.62 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 124.799 1.312 . . . . 0.0 113.576 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.876 ' HA ' ' HB1' ' A' ' 124' ' ' ALA 0.26 0.1 OUTLIER -58.0 -26.87 62.94 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 117.978 2.584 . . . . 0.0 117.978 -179.952 . . . . . . . . 4 4 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -72.12 -41.32 67.37 Favored 'General case' 0 C--O 1.207 -1.168 0 O-C-N 120.822 -1.174 . . . . 0.0 110.794 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 17.8 tttm -79.72 -26.37 40.83 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-O 123.175 1.464 . . . . 0.0 114.161 -179.679 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.676 ' CB ' ' HB2' ' A' ' 124' ' ' ALA . 7.8 t80 -67.05 -35.67 80.37 Favored 'General case' 0 N--CA 1.422 -1.838 0 C-N-CA 118.509 -1.276 . . . . 0.0 113.752 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.451 ' CB ' HG13 ' A' ' 23' ' ' ILE . 24.2 mtt -72.51 -23.7 61.05 Favored 'General case' 0 N--CA 1.425 -1.714 0 CA-C-O 124.561 2.124 . . . . 0.0 107.81 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -76.85 -22.94 52.78 Favored 'General case' 0 CA--C 1.507 -0.689 0 C-N-CA 116.54 -2.064 . . . . 0.0 112.777 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 18.9 tptp -68.0 -39.69 83.17 Favored 'General case' 0 C--N 1.314 -0.936 0 O-C-N 118.827 -2.42 . . . . 0.0 114.889 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.514 ' HG3' ' CD2' ' A' ' 119' ' ' TYR . 3.2 mpp? -76.03 -37.57 58.23 Favored 'General case' 0 C--O 1.207 -1.132 0 C-N-CA 124.527 1.131 . . . . 0.0 109.429 179.802 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 118.73 47.91 0.39 Allowed Glycine 0 C--N 1.308 -1.016 0 CA-C-N 113.05 -1.886 . . . . 0.0 110.01 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.571 HG22 ' HG2' ' A' ' 28' ' ' ARG . 5.4 mm -73.15 106.56 3.22 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.784 0 CA-C-N 121.735 2.768 . . . . 0.0 110.565 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -44.82 111.21 0.29 Allowed 'General case' 0 N--CA 1.44 -0.94 0 CA-C-O 114.136 -2.84 . . . . 0.0 113.019 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . 0.421 0.2 OUTLIER 3.76 -61.78 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.497 -1.076 1 O-C-N 129.463 4.227 . . . . 0.0 119.309 179.89 . . . . . . . . 4 3 . 1 . 004 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.579 13.3 m -72.59 -22.24 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.906 0 N-CA-C 117.53 2.419 . . . . 0.0 117.53 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.43 ' HB2' ' CG2' ' A' ' 23' ' ' ILE . 26.5 mttp -77.0 -25.97 53.31 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-O 118.406 -0.807 . . . . 0.0 110.918 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.571 ' HG2' HG22 ' A' ' 23' ' ' ILE . 0.1 OUTLIER -79.98 -24.44 40.91 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 117.934 -1.506 . . . . 0.0 107.495 179.882 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.8 ttpt -74.84 -49.76 19.45 Favored 'General case' 0 C--O 1.212 -0.893 0 CA-C-O 123.819 1.771 . . . . 0.0 108.711 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.428 ' HA ' HD12 ' A' ' 30' ' ' LEU . 7.3 tp -73.25 -28.85 62.37 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 114.56 -1.2 . . . . 0.0 108.348 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -67.55 -32.64 79.23 Favored Glycine 0 CA--C 1.538 1.474 0 O-C-N 124.843 1.34 . . . . 0.0 112.219 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -78.05 -24.35 47.8 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -112.81 2.41 15.96 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-O 115.903 -1.999 . . . . 0.0 112.363 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 21.5 p-10 -33.46 -32.51 0.01 OUTLIER 'General case' 0 CA--C 1.505 -0.766 0 N-CA-C 117.922 2.564 . . . . 0.0 117.922 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . 0.259 4.5 t-20 75.42 31.03 0.79 Allowed 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 121.386 1.903 . . . . 0.0 109.561 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.584 ' CG ' HD13 ' A' ' 38' ' ' LEU . 1.2 tp -60.97 87.83 0.02 OUTLIER 'General case' 0 C--O 1.213 -0.863 0 O-C-N 126.925 2.641 . . . . 0.0 109.602 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.82 104.15 16.63 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 102.122 -3.288 . . . . 0.0 102.122 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.584 HD13 ' CG ' ' A' ' 36' ' ' LEU 0.265 0.6 OUTLIER -90.47 104.13 16.74 Favored 'General case' 0 C--N 1.288 -2.089 0 O-C-N 125.921 2.013 . . . . 0.0 109.384 -179.901 . . . . . . . . 4 4 . 1 . 004 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.582 ' HA ' ' HA ' ' A' ' 5' ' ' THR . 6.9 m -87.18 85.62 7.22 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 102.021 -3.326 . . . . 0.0 102.021 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.656 HD13 HG12 ' A' ' 49' ' ' VAL . 6.4 mm -60.0 131.44 24.66 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 CA-C-O 124.191 1.948 . . . . 0.0 110.68 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.428 HG22 ' O ' ' A' ' 41' ' ' THR . 3.0 m -150.34 103.4 3.15 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 112.915 -1.948 . . . . 0.0 114.575 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.44 ' HG2' ' CE1' ' A' ' 47' ' ' PHE . 1.6 mm-40 -49.21 117.73 2.31 Favored 'General case' 0 CA--C 1.547 0.847 0 O-C-N 126.479 2.362 . . . . 0.0 107.992 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.477 ' HB2' HG22 ' A' ' 48' ' ' THR 0.252 1.2 tp10 -90.86 45.65 1.27 Allowed 'General case' 0 CA--C 1.484 -1.562 0 O-C-N 124.816 1.322 . . . . 0.0 107.494 -179.46 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.02 -55.82 5.05 Favored Glycine 0 C--N 1.292 -1.912 0 N-CA-C 105.657 -2.977 . . . . 0.0 105.657 -179.68 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.503 ' HB2' ' CG ' ' A' ' 63' ' ' GLU 0.318 1.7 m120 -108.13 -76.9 0.6 Allowed 'General case' 0 CA--C 1.504 -0.805 0 N-CA-C 115.158 1.54 . . . . 0.0 115.158 -179.449 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.712 ' HG3' ' N ' ' A' ' 47' ' ' PHE . 26.1 tptt -83.64 -76.85 0.27 Allowed 'General case' 0 N--CA 1.417 -2.093 0 C-N-CA 114.594 -2.842 . . . . 0.0 115.112 -178.346 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.712 ' N ' ' HG3' ' A' ' 46' ' ' LYS 0.422 0.1 OUTLIER 162.77 108.78 0.0 OUTLIER 'General case' 0 CA--C 1.496 -1.127 0 O-C-N 128.398 3.561 . . . . 0.0 109.423 -174.761 . . . . . . . . 4 4 . 1 . 004 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.875 ' HA ' ' HA ' ' A' ' 61' ' ' VAL 0.407 9.0 t -81.63 112.33 18.73 Favored 'General case' 0 C--O 1.248 0.992 0 O-C-N 119.458 -2.026 . . . . 0.0 106.118 178.316 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.656 HG12 HD13 ' A' ' 40' ' ' ILE 0.615 1.0 OUTLIER -90.47 105.04 15.9 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 N-CA-C 116.117 1.895 . . . . 0.0 116.117 -179.606 . . . . . . . . 4 4 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.458 ' CB ' ' HB ' ' A' ' 39' ' ' THR . 0.4 OUTLIER -67.4 111.3 3.98 Favored 'General case' 0 C--N 1.302 -1.487 1 N-CA-C 99.836 -4.135 . . . . 0.0 99.836 179.351 . . . . . . . . 4 4 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -96.82 67.9 2.33 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 104.173 -2.528 . . . . 0.0 104.173 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.7 m -78.67 68.4 4.64 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 105.417 -2.068 . . . . 0.0 105.417 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.553 ' CB ' ' HA ' ' A' ' 36' ' ' LEU . 1.1 p -109.66 -167.51 1.21 Allowed 'General case' 0 N--CA 1.438 -1.033 0 CA-C-N 114.76 -1.109 . . . . 0.0 110.057 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -75.58 -24.22 56.59 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 117.867 -1.533 . . . . 0.0 111.457 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.52 ' CE2' ' HA ' ' A' ' 73' ' ' ALA . 31.8 m-85 -69.29 -50.55 45.71 Favored 'General case' 0 C--O 1.221 -0.423 0 C-N-CA 115.47 -2.492 . . . . 0.0 111.042 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.405 ' O ' HG22 ' A' ' 58' ' ' ILE . 0.0 OUTLIER 168.6 151.82 0.03 OUTLIER 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 123.916 3.053 . . . . 0.0 110.351 179.208 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 31.2 t30 -84.34 116.36 22.98 Favored 'General case' 0 C--N 1.348 0.535 1 N-CA-C 99.892 -4.114 . . . . 0.0 99.892 179.056 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.405 HG22 ' O ' ' A' ' 56' ' ' ARG 0.299 0.0 OUTLIER -136.52 -28.02 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 O-C-N 128.524 3.64 . . . . 0.0 116.622 -178.223 . . . . . . . . 4 4 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 67.46 79.05 0.23 Allowed 'General case' 0 C--N 1.352 0.701 0 N-CA-C 104.096 -2.557 . . . . 0.0 104.096 -178.57 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.583 ' CG1' ' CE2' ' A' ' 62' ' ' PHE . 94.2 t -86.72 77.61 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.408 0 CA-C-N 114.3 -1.318 . . . . 0.0 114.257 -177.254 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.875 ' HA ' ' HA ' ' A' ' 48' ' ' THR . 0.4 OUTLIER -69.6 143.03 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.378 0 O-C-N 118.749 -2.469 . . . . 0.0 106.923 177.334 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.656 ' CE1' ' CB ' ' A' ' 68' ' ' PHE . 1.6 m-30 -144.31 57.88 1.32 Allowed 'General case' 0 N--CA 1.44 -0.945 0 C-N-CA 114.392 -2.923 . . . . 0.0 111.839 178.235 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.672 ' CA ' ' HB2' ' A' ' 46' ' ' LYS . 1.2 mt-10 -19.61 119.66 0.02 OUTLIER 'General case' 0 C--N 1.311 -1.071 0 O-C-N 128.601 3.688 . . . . 0.0 108.682 -178.115 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.546 ' N ' ' HB2' ' A' ' 46' ' ' LYS . 0.4 OUTLIER -48.11 101.83 0.03 OUTLIER 'General case' 0 N--CA 1.438 -1.032 0 CA-C-O 122.761 1.267 . . . . 0.0 110.979 -177.387 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 93.38 22.25 27.4 Favored Glycine 0 C--N 1.351 1.415 0 CA-C-N 110.793 -2.912 . . . . 0.0 114.0 -179.464 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.411 ' N ' ' O ' ' A' ' 63' ' ' GLU 0.364 0.9 OUTLIER -102.7 77.79 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 N-CA-C 104.015 -2.587 . . . . 0.0 104.015 179.796 . . . . . . . . 4 4 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -39.17 111.71 0.2 Allowed 'General case' 0 CA--C 1.485 -1.55 0 O-C-N 126.895 2.622 . . . . 0.0 115.929 -179.525 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.656 ' CB ' ' CE1' ' A' ' 62' ' ' PHE . 17.1 p90 -106.7 -179.68 4.01 Favored 'General case' 0 N--CA 1.433 -1.306 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.533 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -144.69 148.3 34.05 Favored 'General case' 0 CA--C 1.521 -0.161 0 O-C-N 126.702 2.501 . . . . 0.0 109.183 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.456 ' CB ' HD22 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -146.31 118.94 8.55 Favored 'General case' 0 C--O 1.216 -0.679 0 O-C-N 125.274 1.609 . . . . 0.0 107.28 -179.997 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.452 ' C ' ' CD1' ' A' ' 72' ' ' LEU . 0.7 OUTLIER -99.84 37.68 1.58 Allowed 'General case' 0 CA--C 1.489 -1.37 0 CA-C-N 121.366 1.893 . . . . 0.0 112.133 -179.255 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.575 ' N ' HD13 ' A' ' 72' ' ' LEU . 0.0 OUTLIER 173.61 -167.59 0.03 OUTLIER 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 125.14 1.376 . . . . 0.0 109.199 -179.094 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.52 ' HA ' ' CE2' ' A' ' 55' ' ' PHE . . . 69.74 24.82 5.28 Favored 'General case' 0 C--O 1.208 -1.101 0 O-C-N 124.711 1.257 . . . . 0.0 110.352 -179.307 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.465 ' CB ' ' O ' ' A' ' 73' ' ' ALA . 27.8 t0 106.89 41.26 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.403 0 O-C-N 126.726 2.516 . . . . 0.0 113.692 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -155.53 -40.31 0.02 OUTLIER Glycine 0 CA--C 1.543 1.8 0 N-CA-C 118.301 2.08 . . . . 0.0 118.301 179.556 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.472 ' O ' ' HB2' ' A' ' 77' ' ' GLU 0.257 0.1 OUTLIER 61.91 25.62 15.41 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-O 115.188 -2.339 . . . . 0.0 108.097 -179.554 . . . . . . . . 4 4 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.499 ' HB3' ' HB ' ' A' ' 96' ' ' VAL . 3.9 mm-40 112.74 113.14 0.0 OUTLIER 'General case' 0 C--N 1.313 -1.02 1 O-C-N 133.923 7.014 . . . . 0.0 109.45 -177.659 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.5 ' HG ' ' HB3' ' A' ' 93' ' ' PHE 0.451 7.4 tt -139.53 119.68 13.66 Favored 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 102.662 -3.088 . . . . 0.0 102.662 -178.272 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 21.8 m -141.63 120.66 12.86 Favored 'General case' 0 C--O 1.197 -1.687 0 N-CA-C 103.38 -2.822 . . . . 0.0 103.38 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.517 ' HA3' ' HA ' ' A' ' 93' ' ' PHE . . . -160.9 -163.25 13.64 Favored Glycine 0 C--O 1.215 -1.051 0 C-N-CA 116.972 -2.537 . . . . 0.0 114.057 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 13.9 p -141.95 165.71 26.72 Favored 'General case' 0 C--O 1.188 -2.175 0 O-C-N 127.296 2.41 . . . . 0.0 110.616 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 93.9 m95 -107.36 147.46 30.31 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 103.76 -2.682 . . . . 0.0 103.76 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 5.0 t -147.15 127.53 13.99 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 125.093 1.495 . . . . 0.0 109.612 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -79.48 117.54 20.53 Favored 'General case' 0 N--CA 1.427 -1.606 0 CA-C-N 112.536 -2.12 . . . . 0.0 108.597 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.408 ' HA ' ' OE1' ' A' ' 85' ' ' GLU 0.608 3.4 mm-40 -78.03 -20.09 53.09 Favored 'General case' 0 N--CA 1.426 -1.662 0 O-C-N 123.766 0.666 . . . . 0.0 109.267 179.975 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 126.64 -53.2 0.8 Allowed Glycine 0 N--CA 1.436 -1.339 0 N-CA-C 104.921 -3.272 . . . . 0.0 104.921 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -112.54 -3.41 14.39 Favored 'General case' 0 C--O 1.245 0.834 0 CA-C-O 116.7 -1.619 . . . . 0.0 114.183 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . 0.379 10.2 mtpt -154.75 120.64 5.19 Favored 'General case' 0 CA--C 1.503 -0.837 0 O-C-N 125.574 1.796 . . . . 0.0 110.468 179.767 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.842 HD23 ' HD2' ' A' ' 106' ' ' ARG . 3.8 tp -76.56 144.55 39.61 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 103.512 -2.773 . . . . 0.0 103.512 179.775 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.555 ' CG1' HG23 ' A' ' 105' ' ' VAL . 2.7 m -141.56 153.35 19.5 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.052 0 N-CA-C 105.235 -2.135 . . . . 0.0 105.235 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -123.38 104.51 0.86 Allowed Glycine 0 CA--C 1.534 1.227 1 C-N-CA 130.794 4.045 . . . . 0.0 108.132 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -105.95 95.57 5.88 Favored 'General case' 0 N--CA 1.428 -1.565 0 C-N-CA 119.521 -0.872 . . . . 0.0 109.841 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.517 ' HA ' ' HA3' ' A' ' 80' ' ' GLY . 2.3 m-85 -92.96 123.32 36.13 Favored 'General case' 0 N--CA 1.435 -1.185 0 O-C-N 125.4 1.688 . . . . 0.0 114.092 179.672 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 24.7 mttt -91.5 146.77 23.53 Favored 'General case' 0 N--CA 1.429 -1.503 0 O-C-N 126.0 2.062 . . . . 0.0 110.059 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . 0.355 9.0 ttt180 -103.73 142.24 34.7 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-N 114.04 -1.436 . . . . 0.0 107.376 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.499 ' HB ' ' HB3' ' A' ' 77' ' ' GLU . 69.0 t -81.66 -36.04 14.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-O 124.793 2.235 . . . . 0.0 109.618 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . 0.32 1.3 t70 -72.82 -12.96 61.19 Favored 'General case' 0 C--O 1.256 1.405 0 N-CA-C 118.354 2.724 . . . . 0.0 118.354 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -141.36 -27.51 0.68 Allowed 'General case' 0 CA--C 1.502 -0.876 0 C-N-CA 116.854 -1.938 . . . . 0.0 115.671 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 94.77 9.98 58.14 Favored Glycine 0 C--N 1.337 0.625 0 O-C-N 125.555 1.784 . . . . 0.0 117.041 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 5.4 mmtm -106.04 172.29 6.89 Favored 'General case' 0 C--O 1.2 -1.544 0 CA-C-N 119.072 1.436 . . . . 0.0 109.278 179.525 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.96 126.14 50.15 Favored 'General case' 0 N--CA 1.436 -1.142 0 O-C-N 125.955 2.034 . . . . 0.0 114.841 -179.724 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.778 HD22 ' HD1' ' A' ' 119' ' ' TYR . 0.2 OUTLIER -79.38 116.44 19.62 Favored 'General case' 0 C--O 1.246 0.894 0 C-N-CA 130.456 3.502 . . . . 0.0 102.686 179.43 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.709 HG23 ' HB3' ' A' ' 117' ' ' TYR . 4.3 tt -97.8 150.15 4.83 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.116 0 C-N-CA 114.616 -2.833 . . . . 0.0 104.732 -179.245 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -143.29 145.03 32.37 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 116.533 -1.698 . . . . 0.0 109.312 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.747 HG12 HG23 ' A' ' 116' ' ' THR . 7.6 p -134.5 113.83 17.49 Favored 'Isoleucine or valine' 0 C--O 1.248 1.012 0 CA-C-N 123.604 2.911 . . . . 0.0 113.528 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.842 ' HD2' HD23 ' A' ' 89' ' ' LEU . 63.0 mtt180 -81.37 95.67 7.1 Favored 'General case' 0 C--O 1.216 -0.667 0 N-CA-C 104.948 -2.242 . . . . 0.0 104.948 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 64.4 tt0 -102.31 81.97 2.13 Favored 'General case' 0 N--CA 1.419 -2.007 0 CA-C-N 111.49 -2.596 . . . . 0.0 114.727 -179.558 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.684 HD12 ' CE1' ' A' ' 2' ' ' PHE 0.29 0.3 OUTLIER -58.51 110.98 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 C-N-CA 117.448 -1.701 . . . . 0.0 107.853 179.516 . . . . . . . . 4 4 . 1 . 004 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 2.9 m -75.36 -17.93 60.1 Favored 'General case' 0 C--O 1.214 -0.776 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 -179.618 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 150.63 -109.35 0.42 Allowed Glycine 0 C--O 1.238 0.37 1 C-N-CA 132.087 4.661 . . . . 0.0 111.75 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 38.0 m-20 -59.77 -17.4 35.21 Favored 'General case' 0 C--O 1.213 -0.858 0 C-N-CA 116.778 -1.969 . . . . 0.0 111.61 179.571 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -110.64 135.23 51.58 Favored 'General case' 0 CA--C 1.496 -1.126 0 O-C-N 127.02 2.7 . . . . 0.0 117.476 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.648 HD13 ' CE2' ' A' ' 128' ' ' PHE . 0.1 OUTLIER -101.96 113.06 25.95 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 102.793 -3.04 . . . . 0.0 102.793 -179.938 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.737 HG23 HD12 ' A' ' 127' ' ' ILE . 78.0 mt -113.94 106.45 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.026 0 O-C-N 125.663 1.852 . . . . 0.0 110.309 -179.8 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' GLN . . . . . 0.571 ' HB2' ' CG ' ' A' ' 126' ' ' ARG . 24.4 mt-30 -74.16 169.92 16.58 Favored 'General case' 0 C--O 1.244 0.791 0 N-CA-C 101.505 -3.517 . . . . 0.0 101.505 178.939 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.747 HG23 HG12 ' A' ' 105' ' ' VAL . 0.2 OUTLIER 173.75 155.04 0.11 Allowed 'General case' 0 N--CA 1.414 -2.254 0 C-N-CA 118.037 -1.465 . . . . 0.0 111.508 179.992 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.709 ' HB3' HG23 ' A' ' 103' ' ' ILE 0.393 23.4 m-30 125.38 -141.91 0.0 OUTLIER 'General case' 0 CA--C 1.475 -1.934 1 O-C-N 130.475 4.859 . . . . 0.0 113.875 175.93 . . . . . . . . 4 3 . 1 . 004 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.508 HG22 ' HG3' ' A' ' 123' ' ' GLU . 0.0 OUTLIER -138.53 -165.18 1.77 Allowed 'General case' 0 N--CA 1.431 -1.38 0 CA-C-O 126.831 3.205 . . . . 0.0 117.656 -174.911 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.778 ' HD1' HD22 ' A' ' 102' ' ' LEU 0.259 0.0 OUTLIER -109.19 -55.42 2.41 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 111.463 -2.608 . . . . 0.0 105.287 177.872 . . . . . . . . 4 4 . 1 . 004 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.534 ' HB2' ' CD2' ' A' ' 119' ' ' TYR . 0.6 OUTLIER -129.12 -53.96 1.2 Allowed 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 111.516 -2.584 . . . . 0.0 112.744 179.526 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -162.01 15.91 0.15 Allowed Glycine 0 C--N 1.362 2.011 0 N-CA-C 118.928 2.331 . . . . 0.0 118.928 -179.538 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.401 ' O ' ' HB ' ' A' ' 118' ' ' THR . 82.9 t -120.7 112.58 36.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 N-CA-C 104.172 -2.529 . . . . 0.0 104.172 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.508 ' HG3' HG22 ' A' ' 118' ' ' THR . 1.2 mt-10 -71.42 177.51 3.93 Favored 'General case' 0 C--O 1.208 -1.116 0 C-N-CA 118.359 -1.337 . . . . 0.0 112.298 -178.869 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.876 ' HB1' ' HA ' ' A' ' 14' ' ' TYR . . . 179.71 97.83 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 116.525 -1.702 . . . . 0.0 110.284 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.531 ' HA ' ' HB ' ' A' ' 116' ' ' THR 0.327 0.0 OUTLIER -71.02 165.08 24.25 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 120.803 1.638 . . . . 0.0 111.192 179.656 . . . . . . . . 4 4 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.604 ' HG2' ' CE2' ' A' ' 14' ' ' TYR . 0.1 OUTLIER -140.56 77.09 1.59 Allowed 'General case' 0 N--CA 1.436 -1.128 1 O-C-N 129.661 4.351 . . . . 0.0 108.664 179.476 . . . . . . . . 4 4 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.737 HD12 HG23 ' A' ' 114' ' ' ILE . 0.6 OUTLIER -70.03 112.82 5.18 Favored 'Isoleucine or valine' 0 C--O 1.254 1.298 0 O-C-N 128.341 3.525 . . . . 0.0 112.824 179.752 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.648 ' CE2' HD13 ' A' ' 113' ' ' LEU . 1.8 m-30 -98.2 138.74 35.02 Favored 'General case' 0 C--O 1.221 -0.427 0 C-N-CA 127.298 2.239 . . . . 0.0 109.34 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . 0.266 26.6 mmtt -103.73 34.67 2.9 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 117.139 -1.41 . . . . 0.0 112.311 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.487 ' HA ' ' HA ' ' A' ' 6' ' ' TRP . 10.0 tttp 29.83 100.78 0.0 OUTLIER 'General case' 0 CA--C 1.508 -0.65 0 N-CA-C 116.695 2.109 . . . . 0.0 116.695 179.725 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.41 ' HA ' ' OG1' ' A' ' 5' ' ' THR 0.852 5.6 tt0 . . . . . 0 N--CA 1.439 -1.013 0 N-CA-C 119.502 3.149 . . . . 0.0 119.502 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 . . . . . 0 N--CA 1.449 -0.481 0 N-CA-C 114.816 1.413 . . . . 0.0 114.816 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.38 101.08 0.07 Allowed 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 118.63 -1.228 . . . . 0.0 112.401 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 166.12 -155.32 26.49 Favored Glycine 0 C--O 1.217 -0.941 0 C-N-CA 115.809 -3.091 . . . . 0.0 113.267 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . 0.543 1.2 p -105.48 150.92 24.88 Favored 'General case' 0 CA--C 1.504 -0.823 0 CA-C-N 112.657 -1.772 . . . . 0.0 114.494 -179.728 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.654 ' CH2' HD11 ' A' ' 108' ' ' ILE . 85.5 m95 -150.54 152.69 34.54 Favored 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 125.513 1.758 . . . . 0.0 108.576 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 5.6 tttp -153.13 103.01 2.68 Favored 'General case' 0 C--O 1.205 -1.268 0 CA-C-O 116.678 -1.629 . . . . 0.0 109.103 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.718 HG12 ' HB3' ' A' ' 36' ' ' LEU 0.396 13.9 p -48.98 124.39 2.26 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.066 0 O-C-N 126.464 2.353 . . . . 0.0 111.722 179.819 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 51.4 t0 -123.81 1.26 8.73 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 125.218 2.437 . . . . 0.0 108.717 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.429 ' O ' ' HB ' ' A' ' 127' ' ' ILE . 1.9 ttt180 -169.28 133.51 1.4 Allowed 'General case' 0 C--N 1.294 -1.811 0 O-C-N 118.184 -2.822 . . . . 0.0 107.398 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . 0.299 0.0 OUTLIER -116.22 -171.89 2.08 Favored 'General case' 0 CA--C 1.501 -0.941 0 CA-C-N 114.394 -1.276 . . . . 0.0 108.513 179.894 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.462 ' CB ' ' HB2' ' A' ' 125' ' ' LYS . 0.5 OUTLIER -167.51 94.82 0.44 Allowed 'General case' 0 C--N 1.3 -1.579 0 CA-C-N 122.2 2.273 . . . . 0.0 107.917 179.907 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . 0.259 0.1 OUTLIER 97.68 -5.87 0.05 Allowed 'General case' 0 N--CA 1.486 1.359 0 O-C-N 126.984 2.678 . . . . 0.0 111.63 -179.636 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.715 ' HA ' ' HB1' ' A' ' 124' ' ' ALA . 0.4 OUTLIER -71.87 -16.36 62.14 Favored 'General case' 0 N--CA 1.432 -1.349 0 O-C-N 126.188 2.18 . . . . 0.0 116.103 -179.852 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -76.98 -37.68 54.71 Favored 'General case' 0 C--O 1.206 -1.201 0 CA-C-N 121.74 2.064 . . . . 0.0 109.25 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.42 -34.57 63.29 Favored 'General case' 0 N--CA 1.427 -1.617 0 CA-C-N 112.846 -1.979 . . . . 0.0 113.178 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.43 ' CB ' ' HB2' ' A' ' 124' ' ' ALA . 43.4 t80 -65.85 -24.79 66.96 Favored 'General case' 0 N--CA 1.421 -1.916 0 CA-C-O 123.213 1.482 . . . . 0.0 112.607 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 29.6 mtt -74.33 -28.56 61.2 Favored 'General case' 0 N--CA 1.443 -0.806 0 O-C-N 118.511 -2.618 . . . . 0.0 107.449 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -70.12 -32.62 70.72 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 125.665 2.65 . . . . 0.0 113.31 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 7.9 tttm -77.82 -43.9 29.03 Favored 'General case' 0 C--N 1.313 -0.984 0 O-C-N 119.855 -1.778 . . . . 0.0 112.086 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 11.1 mmm -62.29 -26.7 68.55 Favored 'General case' 0 C--O 1.205 -1.247 0 C-N-CA 126.098 1.759 . . . . 0.0 109.782 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 105.34 62.38 0.64 Allowed Glycine 0 N--CA 1.433 -1.521 0 CA-C-N 114.792 -1.095 . . . . 0.0 112.89 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.423 HG23 ' HB3' ' A' ' 27' ' ' LYS . 2.2 mm -118.31 134.9 60.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -79.35 157.35 27.67 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-O 113.872 -2.966 . . . . 0.0 112.391 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . 0.343 2.1 m -33.73 -39.1 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.21 -0.978 0 O-C-N 126.809 2.568 . . . . 0.0 114.318 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.488 2.5 m -78.18 -50.48 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.106 0 O-C-N 126.959 2.662 . . . . 0.0 115.129 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.423 ' HB3' HG23 ' A' ' 23' ' ' ILE . 13.7 mttm -64.25 -23.54 67.34 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.149 -0.932 . . . . 0.0 112.67 -179.635 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 6.9 ptt-85 -79.51 -26.19 41.6 Favored 'General case' 0 CA--C 1.532 0.27 0 O-C-N 119.826 -1.796 . . . . 0.0 107.753 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 7.0 ttmm -74.91 -38.45 61.81 Favored 'General case' 0 C--O 1.212 -0.905 0 O-C-N 125.086 1.492 . . . . 0.0 112.248 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.0 mp -78.08 -24.97 47.41 Favored 'General case' 0 N--CA 1.431 -1.404 0 C-N-CA 124.101 0.96 . . . . 0.0 110.579 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -79.42 -27.46 54.93 Favored Glycine 0 C--O 1.213 -1.165 0 O-C-N 125.238 1.586 . . . . 0.0 111.251 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -75.38 -41.8 55.49 Favored 'General case' 0 CA--C 1.514 -0.409 0 C-N-CA 125.912 1.685 . . . . 0.0 111.371 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 6.7 m-70 -101.03 14.32 32.35 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-O 116.152 -1.88 . . . . 0.0 115.408 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 14.9 p30 -40.34 -26.25 0.03 OUTLIER 'General case' 0 CA--C 1.499 -1.002 0 O-C-N 127.391 2.932 . . . . 0.0 118.763 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 72.95 12.12 5.16 Favored 'General case' 0 C--N 1.311 -1.089 0 O-C-N 125.264 1.602 . . . . 0.0 109.155 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.718 ' HB3' HG12 ' A' ' 8' ' ' VAL . 2.6 tp -30.23 92.83 0.01 OUTLIER 'General case' 0 CA--C 1.503 -0.839 0 C-N-CA 129.298 3.039 . . . . 0.0 110.34 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 5.9 ttpm? -94.15 115.61 27.92 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 102.336 -3.209 . . . . 0.0 102.336 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.784 ' CD2' HG21 ' A' ' 49' ' ' VAL 0.26 0.1 OUTLIER -104.02 116.76 32.81 Favored 'General case' 0 C--N 1.291 -1.974 0 C-N-CA 116.923 -1.911 . . . . 0.0 110.01 -179.819 . . . . . . . . 4 4 . 1 . 005 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.404 ' HB ' ' HB2' ' A' ' 50' ' ' LYS . 10.5 m -106.3 99.11 8.71 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 124.748 2.213 . . . . 0.0 105.158 179.68 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.472 HG23 HG12 ' A' ' 49' ' ' VAL . 1.2 mt -88.17 128.42 40.52 Favored 'Isoleucine or valine' 0 C--O 1.251 1.184 0 CA-C-N 113.233 -1.803 . . . . 0.0 110.814 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.535 HG22 ' O ' ' A' ' 41' ' ' THR . 4.5 m -115.44 70.78 0.75 Allowed 'General case' 0 C--N 1.346 0.448 0 O-C-N 127.306 2.879 . . . . 0.0 107.567 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -65.69 112.96 3.93 Favored 'General case' 0 C--N 1.316 -0.854 0 C-N-CA 123.948 0.899 . . . . 0.0 109.716 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.7 tt0 -99.16 -103.19 0.22 Allowed 'General case' 0 N--CA 1.423 -1.822 0 N-CA-C 105.312 -2.107 . . . . 0.0 105.312 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -113.48 -48.41 0.6 Allowed Glycine 0 C--N 1.295 -1.743 0 N-CA-C 109.092 -1.603 . . . . 0.0 109.092 -179.702 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -127.58 -20.4 3.98 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -90.14 161.23 15.86 Favored 'General case' 0 C--N 1.308 -1.217 0 C-N-CA 116.723 -1.991 . . . . 0.0 113.098 179.801 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -135.24 69.44 1.44 Allowed 'General case' 0 CA--C 1.512 -0.49 0 CA-C-O 124.273 1.987 . . . . 0.0 109.698 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.847 ' OG1' HG12 ' A' ' 61' ' ' VAL . 14.0 t -74.74 122.88 23.96 Favored 'General case' 0 N--CA 1.432 -1.362 0 O-C-N 119.562 -1.961 . . . . 0.0 106.753 179.345 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.784 HG21 ' CD2' ' A' ' 38' ' ' LEU 0.685 0.9 OUTLIER -116.44 120.9 66.33 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.727 0 N-CA-C 117.551 2.426 . . . . 0.0 117.551 -179.058 . . . . . . . . 4 4 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.404 ' HB2' ' HB ' ' A' ' 39' ' ' THR . 0.9 OUTLIER -64.87 145.15 56.69 Favored 'General case' 0 C--N 1.308 -1.235 1 N-CA-C 99.101 -4.407 . . . . 0.0 99.101 177.749 . . . . . . . . 4 4 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.472 ' O ' ' N ' ' A' ' 53' ' ' SER . 5.3 tt0 -133.87 51.69 2.12 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 104.279 -2.489 . . . . 0.0 104.279 -178.881 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . 0.26 4.6 m -61.95 86.6 0.02 OUTLIER 'General case' 0 C--N 1.289 -2.06 0 N-CA-C 104.736 -2.32 . . . . 0.0 104.736 179.348 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.671 ' OG ' HD13 ' A' ' 36' ' ' LEU . 1.3 m -122.48 44.34 2.65 Favored 'General case' 0 N--CA 1.443 -0.816 0 O-C-N 126.1 2.125 . . . . 0.0 114.607 -179.121 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 65.66 -54.04 0.36 Allowed 'General case' 0 N--CA 1.44 -0.957 0 O-C-N 126.717 2.51 . . . . 0.0 108.996 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.505 ' CE1' ' HB1' ' A' ' 73' ' ' ALA . 7.4 m-85 -62.81 -56.99 12.48 Favored 'General case' 0 C--O 1.217 -0.654 0 CA-C-O 114.699 -2.572 . . . . 0.0 109.186 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.657 ' HB3' HG22 ' A' ' 58' ' ' ILE . 23.1 ttt-85 -148.98 144.48 26.8 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 123.709 2.959 . . . . 0.0 112.054 179.665 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 44.7 t-20 -97.66 81.84 2.98 Favored 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 100.623 -3.843 . . . . 0.0 100.623 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.657 HG22 ' HB3' ' A' ' 56' ' ' ARG . 1.5 tt -120.65 100.6 9.38 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.77 1 O-C-N 129.26 4.1 . . . . 0.0 118.927 -179.213 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -63.02 117.98 7.21 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 103.492 -2.781 . . . . 0.0 103.492 178.059 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.535 ' CG1' HG22 ' A' ' 49' ' ' VAL . 2.4 p -101.43 102.32 13.33 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 C-N-CA 119.672 -0.811 . . . . 0.0 111.103 -177.283 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.847 HG12 ' OG1' ' A' ' 48' ' ' THR 0.36 0.8 OUTLIER -87.12 138.06 19.76 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 CA-C-O 125.966 2.794 . . . . 0.0 113.58 -179.807 . . . . . . . . 4 4 . 1 . 005 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.633 ' HZ ' HH22 ' A' ' 106' ' ' ARG . 23.7 p90 -153.49 100.62 2.43 Favored 'General case' 0 N--CA 1.437 -1.103 0 O-C-N 120.204 -1.56 . . . . 0.0 110.719 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.49 130.44 46.88 Favored 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 102.862 -3.014 . . . . 0.0 102.862 179.683 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 7.2 mt -52.31 118.09 3.29 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-O 122.886 1.327 . . . . 0.0 110.492 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 86.38 13.41 68.16 Favored Glycine 0 C--N 1.347 1.191 0 CA-C-N 111.627 -2.533 . . . . 0.0 117.39 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . 0.419 0.5 OUTLIER -101.1 129.5 51.98 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 N-CA-C 105.547 -2.02 . . . . 0.0 105.547 179.963 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -86.61 115.31 23.99 Favored 'General case' 0 CA--C 1.483 -1.625 0 N-CA-C 115.146 1.536 . . . . 0.0 115.146 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.411 ' CE1' ' HB3' ' A' ' 62' ' ' PHE . 0.3 OUTLIER -111.7 155.04 24.08 Favored 'General case' 0 N--CA 1.427 -1.609 0 CA-C-O 116.276 -1.821 . . . . 0.0 106.798 -179.979 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -109.51 130.07 55.53 Favored 'General case' 0 CA--C 1.51 -0.591 0 O-C-N 126.138 2.149 . . . . 0.0 106.783 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -130.87 101.16 5.52 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-O 116.67 -1.634 . . . . 0.0 113.903 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 26.8 m -67.18 119.41 12.04 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 105.78 -1.933 . . . . 0.0 105.78 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.533 HD11 HD13 ' A' ' 78' ' ' LEU . 16.7 mt -65.61 -175.81 0.3 Allowed 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 114.265 -1.334 . . . . 0.0 109.136 -179.676 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.505 ' HB1' ' CE1' ' A' ' 55' ' ' PHE . . . -75.42 -35.76 60.92 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-O 124.773 2.225 . . . . 0.0 111.814 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -153.11 23.91 0.55 Allowed 'General case' 0 C--O 1.239 0.514 0 CA-C-N 112.662 -2.063 . . . . 0.0 108.4 179.718 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.56 ' C ' HG23 ' A' ' 76' ' ' THR . . . -120.18 -10.0 7.67 Favored Glycine 0 C--O 1.213 -1.19 0 C-N-CA 125.052 1.31 . . . . 0.0 114.786 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.56 HG23 ' C ' ' A' ' 75' ' ' GLY . 0.1 OUTLIER 74.51 -175.57 0.14 Allowed 'General case' 0 C--N 1.317 -0.811 0 C-N-CA 117.699 -1.601 . . . . 0.0 112.933 179.926 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -44.87 123.88 4.05 Favored 'General case' 0 N--CA 1.446 -0.64 0 O-C-N 127.467 2.979 . . . . 0.0 111.195 179.669 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.56 ' HG ' ' HB3' ' A' ' 93' ' ' PHE 0.423 0.6 OUTLIER -144.38 90.14 2.07 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 102.414 -3.18 . . . . 0.0 102.414 -179.819 . . . . . . . . 4 4 . 1 . 005 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 95.6 m -103.55 135.86 44.35 Favored 'General case' 0 CA--C 1.481 -1.678 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -170.78 -159.66 17.35 Favored Glycine 0 C--N 1.291 -1.917 0 C-N-CA 116.568 -2.729 . . . . 0.0 110.596 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -147.54 175.46 10.83 Favored 'General case' 0 C--O 1.197 -1.699 0 CA-C-O 122.554 1.169 . . . . 0.0 108.453 179.726 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' TRP . . . . . 0.505 ' CZ3' ' N ' ' A' ' 91' ' ' GLY . 54.6 m95 -130.02 135.43 48.27 Favored 'General case' 0 N--CA 1.427 -1.577 0 N-CA-C 104.078 -2.564 . . . . 0.0 104.078 179.506 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.474 ' CG2' HG23 ' A' ' 90' ' ' VAL . 8.8 t -135.87 134.76 39.13 Favored 'General case' 0 N--CA 1.425 -1.693 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.885 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.468 ' CA ' HD12 ' A' ' 89' ' ' LEU . 5.4 ttt -83.96 121.46 27.41 Favored 'General case' 0 N--CA 1.429 -1.523 0 O-C-N 125.793 1.933 . . . . 0.0 106.103 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . 0.539 0.5 OUTLIER -79.87 -24.24 41.36 Favored 'General case' 0 N--CA 1.426 -1.652 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 179.788 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 154.64 -85.43 0.14 Allowed Glycine 0 N--CA 1.447 -0.568 0 N-CA-C 105.047 -3.221 . . . . 0.0 105.047 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 13.2 m-80 -91.32 -0.72 57.71 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-O 116.385 -1.769 . . . . 0.0 115.264 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . 0.382 0.3 OUTLIER -141.55 146.91 36.9 Favored 'General case' 0 CA--C 1.489 -1.39 0 O-C-N 127.095 2.747 . . . . 0.0 106.973 -179.854 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.488 HD23 ' CD ' ' A' ' 106' ' ' ARG . 0.7 OUTLIER -109.88 141.88 41.97 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 104.934 -2.247 . . . . 0.0 104.934 -179.864 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.474 HG23 ' CG2' ' A' ' 83' ' ' THR . 0.3 OUTLIER -123.21 124.75 70.7 Favored 'Isoleucine or valine' 0 C--O 1.244 0.771 0 N-CA-C 105.007 -2.219 . . . . 0.0 105.007 -179.582 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.505 ' N ' ' CZ3' ' A' ' 82' ' ' TRP . . . -103.36 109.06 3.37 Favored Glycine 0 C--N 1.349 1.268 0 N-CA-C 108.892 -1.683 . . . . 0.0 108.892 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.472 ' C ' ' CD1' ' A' ' 93' ' ' PHE . 24.2 mtpp -102.71 152.77 20.83 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 105.175 -2.158 . . . . 0.0 105.175 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.56 ' HB3' ' HG ' ' A' ' 78' ' ' LEU . 64.6 m-85 -148.73 111.61 4.84 Favored 'General case' 0 CA--C 1.508 -0.658 0 CA-C-O 122.931 1.348 . . . . 0.0 110.873 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 12.8 mttm -92.86 130.53 38.43 Favored 'General case' 0 N--CA 1.44 -0.942 0 C-N-CA 126.456 1.902 . . . . 0.0 107.626 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . 0.381 0.0 OUTLIER -95.62 143.4 26.93 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 104.917 -2.253 . . . . 0.0 104.917 -179.923 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 29.6 m -70.24 -37.76 72.38 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 O-C-N 123.935 0.772 . . . . 0.0 111.081 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . 0.345 0.5 OUTLIER -56.82 -12.29 1.85 Allowed 'General case' 0 C--O 1.254 1.333 0 N-CA-C 114.825 1.417 . . . . 0.0 114.825 179.896 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 15.8 p30 -159.52 5.91 0.09 Allowed 'General case' 0 N--CA 1.426 -1.647 0 N-CA-C 116.646 2.091 . . . . 0.0 116.646 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 44.65 25.39 0.86 Allowed Glycine 0 C--O 1.243 0.692 0 CA-C-O 124.0 1.889 . . . . 0.0 114.357 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 6.7 mmmt -70.91 -97.96 0.01 OUTLIER 'General case' 0 CA--C 1.554 1.129 0 O-C-N 119.185 -2.362 . . . . 0.0 109.611 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.454 ' CG ' ' N ' ' A' ' 102' ' ' LEU . 36.8 tt0 152.26 168.77 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 128.719 2.808 . . . . 0.0 109.345 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.625 ' CB ' ' HA ' ' A' ' 119' ' ' TYR . 0.9 OUTLIER -151.07 134.66 16.34 Favored 'General case' 0 C--O 1.246 0.909 1 C-N-CA 132.613 4.365 . . . . 0.0 103.986 -179.669 . . . . . . . . 4 4 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.562 ' N ' ' O ' ' A' ' 118' ' ' THR . 1.3 tp -118.17 159.9 18.22 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.09 0 N-CA-C 106.314 -1.736 . . . . 0.0 106.314 -179.687 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.469 ' N ' HG13 ' A' ' 103' ' ' ILE . . . -154.31 150.59 28.15 Favored 'General case' 0 C--O 1.242 0.708 0 CA-C-O 115.995 -1.955 . . . . 0.0 107.454 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.649 HG12 HG23 ' A' ' 116' ' ' THR . 8.4 p -137.01 109.68 7.57 Favored 'Isoleucine or valine' 0 C--O 1.248 0.979 0 C-N-CA 116.439 -2.105 . . . . 0.0 114.301 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.633 HH22 ' HZ ' ' A' ' 62' ' ' PHE 0.253 50.7 mtt180 -71.08 96.85 1.39 Allowed 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 104.347 -2.464 . . . . 0.0 104.347 179.498 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -94.75 73.89 3.63 Favored 'General case' 0 N--CA 1.422 -1.858 0 O-C-N 126.438 2.336 . . . . 0.0 112.082 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.654 HD11 ' CH2' ' A' ' 6' ' ' TRP 0.355 1.9 tt -59.55 97.65 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 C-N-CA 114.425 -2.91 . . . . 0.0 113.701 179.891 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 39.4 t -84.23 71.99 10.57 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 105.475 -2.046 . . . . 0.0 105.475 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 72.61 -89.59 0.54 Allowed Glycine 0 C--O 1.241 0.544 0 O-C-N 128.722 3.764 . . . . 0.0 113.26 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . 0.329 1.0 OUTLIER -95.01 -14.76 24.05 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 116.358 -1.782 . . . . 0.0 113.172 -179.891 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -108.9 134.64 51.3 Favored 'General case' 0 N--CA 1.431 -1.411 0 O-C-N 127.553 3.033 . . . . 0.0 112.897 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.467 ' HB2' ' CZ3' ' A' ' 6' ' ' TRP . 0.7 OUTLIER -99.29 141.83 31.56 Favored 'General case' 0 C--O 1.209 -1.064 0 N-CA-C 101.836 -3.394 . . . . 0.0 101.836 -179.647 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.768 HG23 HD13 ' A' ' 127' ' ' ILE . 63.6 mt -142.18 134.79 27.56 Favored 'Isoleucine or valine' 0 C--O 1.246 0.901 0 N-CA-C 103.729 -2.693 . . . . 0.0 103.729 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' GLN . . . . . 0.526 ' HB2' ' CD ' ' A' ' 126' ' ' ARG . 24.2 mt-30 -117.23 118.48 32.43 Favored 'General case' 0 CA--C 1.497 -1.083 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.649 HG23 HG12 ' A' ' 105' ' ' VAL . 0.7 OUTLIER -137.53 156.86 47.64 Favored 'General case' 0 N--CA 1.413 -2.281 0 CA-C-N 114.247 -1.342 . . . . 0.0 112.397 -179.643 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.467 ' CE2' ' HB ' ' A' ' 105' ' ' VAL 0.384 24.3 m-85 134.73 -141.5 0.0 OUTLIER 'General case' 0 CA--C 1.48 -1.736 1 O-C-N 130.708 5.005 . . . . 0.0 113.485 176.249 . . . . . . . . 4 3 . 1 . 005 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.616 HG23 ' N ' ' A' ' 119' ' ' TYR . 4.4 t -156.04 -156.07 0.6 Allowed 'General case' 0 C--N 1.311 -1.072 0 O-C-N 127.268 2.855 . . . . 0.0 116.389 -174.854 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.625 ' HA ' ' CB ' ' A' ' 102' ' ' LEU . 0.0 OUTLIER -105.16 -62.86 1.29 Allowed 'General case' 0 C--N 1.347 0.485 0 N-CA-C 102.69 -3.078 . . . . 0.0 102.69 176.573 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.56 -71.53 0.73 Allowed 'General case' 0 N--CA 1.426 -1.635 0 CA-C-N 111.857 -2.429 . . . . 0.0 116.039 179.488 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -140.7 10.78 2.91 Favored Glycine 0 C--N 1.355 1.633 0 N-CA-C 120.083 2.793 . . . . 0.0 120.083 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 72.3 t -114.12 94.69 3.28 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 O-C-N 117.39 -3.418 . . . . 0.0 103.163 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.458 ' HA ' ' HB ' ' A' ' 118' ' ' THR . 5.6 mt-10 -58.02 177.36 0.12 Allowed 'General case' 0 C--O 1.213 -0.857 0 C-N-CA 118.36 -1.336 . . . . 0.0 112.637 -178.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.715 ' HB1' ' HA ' ' A' ' 14' ' ' TYR . . . -173.87 103.44 0.11 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 115.914 -1.993 . . . . 0.0 109.221 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.505 ' HG3' ' HB ' ' A' ' 116' ' ' THR 0.343 1.5 mptt -79.49 162.15 25.6 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 121.661 2.028 . . . . 0.0 112.665 -179.91 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.599 ' HG2' ' CD2' ' A' ' 14' ' ' TYR . 0.2 OUTLIER -145.07 78.97 1.58 Allowed 'General case' 0 C--O 1.208 -1.104 0 CA-C-O 115.236 -2.316 . . . . 0.0 106.015 179.623 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.768 HD13 HG23 ' A' ' 114' ' ' ILE . 4.4 mm -77.32 111.05 13.68 Favored 'Isoleucine or valine' 0 C--O 1.246 0.888 1 O-C-N 131.973 5.796 . . . . 0.0 110.996 179.703 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.61 ' CZ ' HD12 ' A' ' 38' ' ' LEU . 15.0 m-85 -92.52 169.21 10.72 Favored 'General case' 0 C--N 1.318 -0.783 0 O-C-N 127.255 2.847 . . . . 0.0 108.417 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . 0.305 19.8 mmtt -124.07 -6.21 7.82 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 115.406 -2.235 . . . . 0.0 110.634 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.535 ' HB2' ' CZ3' ' A' ' 6' ' ' TRP . 0.0 OUTLIER 71.82 102.04 0.07 Allowed 'General case' 0 N--CA 1.472 0.631 0 O-C-N 126.811 2.569 . . . . 0.0 109.597 179.823 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . 0.923 7.6 mt-10 . . . . . 0 N--CA 1.434 -1.232 0 N-CA-C 116.223 1.934 . . . . 0.0 116.223 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' PHE . . . . . 0.499 ' N ' ' CD1' ' A' ' 2' ' ' PHE . 13.5 m-85 . . . . . 0 N--CA 1.443 -0.797 0 CA-C-O 122.587 1.184 . . . . 0.0 112.438 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -144.05 98.27 3.19 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.521 -1.218 . . . . 0.0 110.594 179.52 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 161.12 -130.03 2.26 Favored Glycine 0 C--O 1.222 -0.623 0 C-N-CA 115.331 -3.318 . . . . 0.0 110.296 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.589 ' HB ' ' HA ' ' A' ' 39' ' ' THR 0.609 0.1 OUTLIER -134.1 157.94 44.87 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 119.154 -1.018 . . . . 0.0 112.637 -179.812 . . . . . . . . 4 4 . 1 . 006 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.758 ' NE1' HD12 ' A' ' 40' ' ' ILE 0.254 95.1 m95 -142.19 146.63 35.46 Favored 'General case' 0 C--O 1.212 -0.875 0 O-C-N 127.98 3.3 . . . . 0.0 106.253 -179.87 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -139.97 92.9 2.59 Favored 'General case' 0 C--O 1.21 -0.994 0 O-C-N 127.069 2.731 . . . . 0.0 106.452 -179.681 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.636 HG21 ' HD2' ' A' ' 126' ' ' ARG 0.396 2.1 p -43.77 125.84 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 CA-C-O 116.744 -1.598 . . . . 0.0 112.966 179.836 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -115.4 -31.96 5.76 Favored 'General case' 0 N--CA 1.439 -0.984 0 O-C-N 126.306 2.254 . . . . 0.0 108.846 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.1 149.22 32.6 Favored 'General case' 0 CA--C 1.482 -1.672 0 C-N-CA 116.526 -2.07 . . . . 0.0 108.6 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . 0.386 3.4 m-80 -120.32 -175.45 3.0 Favored 'General case' 0 N--CA 1.454 -0.227 0 O-C-N 126.909 2.631 . . . . 0.0 108.619 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.421 ' HB2' ' HB2' ' A' ' 125' ' ' LYS . 3.6 tt0 -141.89 -78.42 0.26 Allowed 'General case' 0 N--CA 1.432 -1.326 0 C-N-CA 116.651 -2.02 . . . . 0.0 111.055 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -88.79 17.75 5.33 Favored 'General case' 0 N--CA 1.475 0.803 0 O-C-N 125.613 1.821 . . . . 0.0 114.291 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.499 ' CE2' ' HE2' ' A' ' 18' ' ' MET . 9.0 t80 -63.93 -39.08 93.34 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 119.084 2.994 . . . . 0.0 119.084 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.46 -35.29 78.85 Favored 'General case' 0 C--O 1.212 -0.918 0 CA-C-N 121.846 2.112 . . . . 0.0 112.171 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.93 -31.66 45.29 Favored 'General case' 0 N--CA 1.435 -1.185 0 O-C-N 126.492 2.37 . . . . 0.0 113.578 179.717 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.513 ' CB ' ' HB2' ' A' ' 124' ' ' ALA . 0.0 OUTLIER -70.59 -30.35 67.01 Favored 'General case' 0 N--CA 1.423 -1.788 0 CA-C-O 125.873 2.749 . . . . 0.0 114.185 -179.405 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.499 ' HE2' ' CE2' ' A' ' 14' ' ' TYR . 19.5 mmt -76.58 -22.75 53.83 Favored 'General case' 0 N--CA 1.431 -1.379 0 O-C-N 116.303 -3.998 . . . . 0.0 107.541 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -68.53 -25.29 64.85 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 119.384 -2.073 . . . . 0.0 112.004 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.495 ' HE3' ' CB ' ' A' ' 120' ' ' GLU . 2.2 tttp -79.06 -31.94 44.63 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-O 117.469 -1.253 . . . . 0.0 113.15 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.412 ' HE1' HH22 ' A' ' 95' ' ' ARG . 29.1 mtp -75.64 -23.2 56.31 Favored 'General case' 0 N--CA 1.437 -1.105 0 O-C-N 126.076 2.11 . . . . 0.0 109.006 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 105.26 31.02 4.5 Favored Glycine 0 C--O 1.225 -0.461 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 179.74 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.531 HG21 ' CA ' ' A' ' 28' ' ' ARG . 2.7 mm -77.49 141.95 14.88 Favored 'Isoleucine or valine' 0 C--N 1.352 0.699 0 C-N-CA 124.97 1.308 . . . . 0.0 108.911 -179.664 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -101.69 154.34 18.97 Favored 'General case' 0 C--O 1.245 0.839 0 CA-C-O 115.944 -1.979 . . . . 0.0 110.171 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . 0.429 4.2 p -28.92 -40.95 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.518 -0.276 0 O-C-N 128.414 3.571 . . . . 0.0 119.231 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.65 2.5 t -79.83 -40.95 21.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 123.034 1.397 . . . . 0.0 112.572 179.71 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.0 ttmt -68.67 -43.64 75.72 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 110.469 -3.06 . . . . 0.0 114.548 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.531 ' CA ' HG21 ' A' ' 23' ' ' ILE . 31.6 ptt85 -76.5 -20.82 56.55 Favored 'General case' 0 C--N 1.321 -0.659 0 O-C-N 119.625 -1.922 . . . . 0.0 108.653 -179.562 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.1 ttmt -76.21 -38.3 56.65 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-N 114.381 -1.282 . . . . 0.0 108.334 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -72.38 -35.76 68.55 Favored 'General case' 0 C--O 1.214 -0.766 0 CA-C-N 114.621 -1.172 . . . . 0.0 108.442 -179.729 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -73.67 -26.87 68.46 Favored Glycine 0 CA--C 1.532 1.118 0 O-C-N 126.239 2.212 . . . . 0.0 111.955 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -75.7 -39.26 57.72 Favored 'General case' 0 N--CA 1.434 -1.23 0 C-N-CA 125.681 1.592 . . . . 0.0 110.774 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -90.58 29.98 1.22 Allowed 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 124.237 1.015 . . . . 0.0 112.538 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 31.2 p-10 -81.02 98.63 8.05 Favored 'General case' 0 CA--C 1.508 -0.655 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -76.93 61.84 2.01 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 120.058 1.299 . . . . 0.0 109.27 179.48 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.859 HD11 ' CD1' ' A' ' 38' ' ' LEU . 0.1 OUTLIER -61.87 124.92 22.08 Favored 'General case' 0 CA--C 1.492 -1.262 0 C-N-CA 126.836 2.054 . . . . 0.0 108.695 -179.519 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.492 ' HB3' ' HB3' ' A' ' 52' ' ' SER . 21.8 ttmt -108.71 106.14 16.04 Favored 'General case' 0 N--CA 1.431 -1.398 0 N-CA-C 104.482 -2.414 . . . . 0.0 104.482 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.859 ' CD1' HD11 ' A' ' 36' ' ' LEU . 1.3 tp -91.82 111.14 22.55 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 120.844 1.656 . . . . 0.0 108.964 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.589 ' HA ' ' HB ' ' A' ' 5' ' ' THR . 2.2 m -96.69 91.36 5.68 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 101.732 -3.432 . . . . 0.0 101.732 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.758 HD12 ' NE1' ' A' ' 6' ' ' TRP . 58.5 mt -72.05 120.58 20.67 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 -179.368 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -115.01 113.3 23.92 Favored 'General case' 0 CA--C 1.5 -0.976 0 O-C-N 128.221 3.451 . . . . 0.0 114.666 179.694 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.493 ' HG2' ' CE1' ' A' ' 47' ' ' PHE . 1.6 mm-40 -92.91 96.0 9.84 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-O 117.507 -1.235 . . . . 0.0 108.289 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -76.34 -13.47 60.14 Favored 'General case' 0 N--CA 1.42 -1.953 0 CA-C-N 120.505 1.502 . . . . 0.0 110.699 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 150.74 -30.28 1.02 Allowed Glycine 0 C--N 1.294 -1.767 0 N-CA-C 106.048 -2.821 . . . . 0.0 106.048 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -150.83 -52.82 0.14 Allowed 'General case' 0 N--CA 1.441 -0.896 0 O-C-N 127.045 2.262 . . . . 0.0 110.21 -179.677 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.36 148.69 49.82 Favored 'General case' 0 N--CA 1.436 -1.161 0 CA-C-N 113.765 -1.561 . . . . 0.0 109.023 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.493 ' CE1' ' HG2' ' A' ' 42' ' ' GLN . 0.9 OUTLIER -113.77 81.79 1.58 Allowed 'General case' 0 C--O 1.218 -0.574 0 N-CA-C 105.871 -1.9 . . . . 0.0 105.871 179.861 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.877 HG22 ' CG1' ' A' ' 61' ' ' VAL 0.441 0.9 OUTLIER -63.48 90.25 0.05 OUTLIER 'General case' 0 CA--C 1.503 -0.85 0 C-N-CA 115.477 -2.489 . . . . 0.0 111.591 -179.639 . . . . . . . . 4 4 . 1 . 006 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.586 ' HB ' ' CE1' ' A' ' 62' ' ' PHE 0.652 0.7 OUTLIER -78.05 86.36 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.58 0 CA-C-O 117.929 -1.034 . . . . 0.0 111.411 -179.874 . . . . . . . . 4 4 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.437 ' HB3' ' HB ' ' A' ' 39' ' ' THR . 3.2 tttp -62.44 113.45 2.95 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 102.076 -3.305 . . . . 0.0 102.076 -179.794 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.271 2.4 tt0 -103.73 94.73 5.59 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 120.23 1.377 . . . . 0.0 107.834 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.492 ' HB3' ' HB3' ' A' ' 37' ' ' LYS . 7.6 t -93.2 55.01 2.22 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 105.216 -2.142 . . . . 0.0 105.216 179.673 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.432 ' HA ' ' HA ' ' A' ' 36' ' ' LEU . 87.3 p -67.66 167.49 13.04 Favored 'General case' 0 C--N 1.348 0.541 0 O-C-N 125.633 1.833 . . . . 0.0 111.384 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -58.28 -27.12 63.75 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 119.363 0.983 . . . . 0.0 109.191 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -69.13 -62.94 1.17 Allowed 'General case' 0 C--O 1.21 -1.026 0 CA-C-O 114.301 -2.761 . . . . 0.0 108.418 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.481 ' HG3' HG22 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -157.25 174.1 15.96 Favored 'General case' 0 C--O 1.244 0.813 0 CA-C-N 121.691 2.041 . . . . 0.0 109.947 179.847 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 -104.43 85.14 2.3 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 103.453 -2.795 . . . . 0.0 103.453 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.481 HG22 ' HG3' ' A' ' 56' ' ' ARG . 0.6 OUTLIER -114.21 106.81 21.39 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.323 0 C-N-CA 128.675 2.79 . . . . 0.0 115.806 -179.759 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -59.84 135.44 57.69 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 104.465 -2.42 . . . . 0.0 104.465 179.23 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.585 HG23 ' O ' ' A' ' 49' ' ' VAL . 36.5 t -96.17 -67.71 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.066 0 CA-C-O 126.066 2.841 . . . . 0.0 112.082 -178.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.877 ' CG1' HG22 ' A' ' 48' ' ' THR 0.442 0.1 OUTLIER 69.98 140.07 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 CA-C-N 113.512 -1.676 . . . . 0.0 113.601 -179.947 . . . . . . . . 4 4 . 1 . 006 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.589 ' HZ ' HH22 ' A' ' 106' ' ' ARG . 1.8 p90 -170.22 98.76 0.27 Allowed 'General case' 0 C--N 1.317 -0.814 0 C-N-CA 115.624 -2.43 . . . . 0.0 107.534 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -57.99 131.17 49.63 Favored 'General case' 0 C--O 1.246 0.897 0 N-CA-C 102.737 -3.06 . . . . 0.0 102.737 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -51.98 121.22 6.34 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 114.944 -1.025 . . . . 0.0 110.985 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 68.44 8.14 54.84 Favored Glycine 0 CA--C 1.531 1.061 0 N-CA-C 119.137 2.415 . . . . 0.0 119.137 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.403 HG12 ' H ' ' A' ' 67' ' ' ASP 0.382 15.1 t -80.79 -108.28 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 N-CA-C 104.189 -2.523 . . . . 0.0 104.189 179.823 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.403 ' H ' HG12 ' A' ' 66' ' ' VAL . 7.3 p-10 170.07 149.61 0.04 OUTLIER 'General case' 0 C--O 1.205 -1.243 0 O-C-N 124.509 1.13 . . . . 0.0 112.108 179.715 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.492 ' CZ ' ' HB3' ' A' ' 62' ' ' PHE . 2.1 p90 -161.69 135.46 6.6 Favored 'General case' 0 N--CA 1.431 -1.397 0 O-C-N 124.787 1.305 . . . . 0.0 109.907 -179.742 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.13 100.76 13.2 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 105.495 -2.039 . . . . 0.0 105.495 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -106.75 92.69 4.2 Favored 'General case' 0 C--O 1.216 -0.68 0 O-C-N 125.006 1.441 . . . . 0.0 114.179 -179.671 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 27.6 m -63.12 139.23 58.75 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 120.849 1.659 . . . . 0.0 107.083 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.568 HD11 HD22 ' A' ' 78' ' ' LEU . 5.3 mp -80.72 -157.85 0.17 Allowed 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 104.808 -2.293 . . . . 0.0 104.808 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -106.56 -8.92 16.79 Favored 'General case' 0 N--CA 1.439 -1.009 0 CA-C-O 122.499 1.143 . . . . 0.0 113.839 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -140.0 -39.53 0.45 Allowed 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 114.996 -1.002 . . . . 0.0 111.479 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -86.66 -16.53 61.63 Favored Glycine 0 CA--C 1.534 1.245 0 O-C-N 120.466 -1.396 . . . . 0.0 114.145 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . 0.342 0.1 OUTLIER 72.82 164.23 0.28 Allowed 'General case' 0 N--CA 1.432 -1.338 0 O-C-N 118.49 -2.77 . . . . 0.0 115.794 179.908 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -2.14 120.51 0.0 OUTLIER 'General case' 0 N--CA 1.439 -0.981 0 O-C-N 127.77 3.169 . . . . 0.0 117.505 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.697 HD13 HH21 ' A' ' 95' ' ' ARG 0.409 7.1 tp -134.97 134.95 41.06 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 103.049 -2.945 . . . . 0.0 103.049 179.721 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 6.1 m -145.52 121.2 10.49 Favored 'General case' 0 CA--C 1.485 -1.544 0 O-C-N 125.33 1.644 . . . . 0.0 106.782 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.458 ' HA3' ' HA ' ' A' ' 93' ' ' PHE . . . -175.99 -145.07 5.38 Favored Glycine 0 C--N 1.295 -1.72 0 O-C-N 118.871 -2.393 . . . . 0.0 110.24 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -154.24 177.45 11.11 Favored 'General case' 0 C--O 1.188 -2.157 0 CA-C-N 119.695 1.747 . . . . 0.0 110.976 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' TRP . . . . . 0.433 ' HA ' ' HA2' ' A' ' 91' ' ' GLY . 12.1 m95 -127.18 142.12 51.57 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 100.568 -3.864 . . . . 0.0 100.568 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 8.9 t -146.91 144.31 29.15 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 125.532 1.77 . . . . 0.0 111.744 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.405 ' HA ' HD23 ' A' ' 89' ' ' LEU . 20.7 ttt -83.76 101.36 11.53 Favored 'General case' 0 N--CA 1.436 -1.15 0 CA-C-N 110.996 -2.82 . . . . 0.0 107.854 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . 0.712 0.0 OUTLIER -90.17 70.07 7.24 Favored 'General case' 0 N--CA 1.427 -1.58 0 C-N-CA 122.8 0.44 . . . . 0.0 112.051 179.952 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 54.52 -97.57 0.04 OUTLIER Glycine 0 C--N 1.349 1.298 0 N-CA-C 107.635 -2.186 . . . . 0.0 107.635 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -74.56 3.49 7.62 Favored 'General case' 0 CA--C 1.52 -0.178 0 N-CA-C 118.036 2.606 . . . . 0.0 118.036 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . 0.402 0.0 OUTLIER -156.0 166.62 32.92 Favored 'General case' 0 C--O 1.215 -0.745 0 CA-C-N 120.698 1.59 . . . . 0.0 110.682 -179.699 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.557 HD13 HH11 ' A' ' 106' ' ' ARG . 0.0 OUTLIER -115.59 116.42 28.1 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 101.6 -3.481 . . . . 0.0 101.6 179.75 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.827 HG12 ' CG2' ' A' ' 105' ' ' VAL . 11.1 m -117.36 155.3 19.04 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 O-C-N 125.465 1.728 . . . . 0.0 106.632 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.433 ' HA2' ' HA ' ' A' ' 82' ' ' TRP . . . -126.88 110.67 1.25 Allowed Glycine 0 CA--C 1.53 0.989 0 O-C-N 128.352 3.532 . . . . 0.0 108.789 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.43 145.67 38.55 Favored 'General case' 0 N--CA 1.429 -1.517 0 N-CA-C 103.815 -2.661 . . . . 0.0 103.815 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.522 ' HB3' ' HG ' ' A' ' 78' ' ' LEU . 15.3 m-85 -148.82 130.1 14.65 Favored 'General case' 0 CA--C 1.504 -0.818 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 13.8 mttp -99.18 159.02 15.29 Favored 'General case' 0 C--N 1.313 -1.004 0 O-C-N 125.59 1.806 . . . . 0.0 106.496 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.697 HH21 HD13 ' A' ' 78' ' ' LEU 0.325 0.1 OUTLIER -107.97 142.86 37.45 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 120.944 -1.097 . . . . 0.0 108.192 179.715 . . . . . . . . 4 4 . 1 . 006 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 25.2 t -82.22 -32.55 10.83 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 C-N-CA 125.829 1.651 . . . . 0.0 108.318 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . 0.364 34.9 p-10 -99.5 6.47 45.87 Favored 'General case' 0 C--O 1.25 1.107 0 CA-C-O 124.399 2.047 . . . . 0.0 115.502 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -133.45 -44.2 0.83 Allowed 'General case' 0 N--CA 1.439 -1.008 0 O-C-N 120.792 -1.193 . . . . 0.0 112.465 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 77.45 12.03 84.93 Favored Glycine 0 C--N 1.347 1.185 0 O-C-N 124.526 1.141 . . . . 0.0 114.313 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 6.1 mttt -81.59 -116.1 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 176.65 158.83 0.32 Allowed 'General case' 0 CA--C 1.5 -0.943 0 C-N-CA 128.068 2.547 . . . . 0.0 111.091 -179.58 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.494 ' CD1' ' HB2' ' A' ' 119' ' ' TYR . 3.1 tp -142.52 141.33 32.07 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 128.297 3.498 . . . . 0.0 106.952 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.512 ' CG2' ' HB ' ' A' ' 118' ' ' THR . 4.1 tt -127.17 165.07 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.766 0 N-CA-C 104.971 -2.233 . . . . 0.0 104.971 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.457 ' N ' ' CG1' ' A' ' 103' ' ' ILE . . . -151.15 157.39 42.63 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-O 116.798 -1.573 . . . . 0.0 109.533 179.772 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.827 ' CG2' HG12 ' A' ' 90' ' ' VAL . 1.2 t -147.77 96.15 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-O 125.561 2.6 . . . . 0.0 110.63 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.589 HH22 ' HZ ' ' A' ' 62' ' ' PHE . 16.8 mtt180 -71.81 90.52 1.1 Allowed 'General case' 0 C--O 1.236 0.368 0 N-CA-C 104.941 -2.244 . . . . 0.0 104.941 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -97.73 89.52 4.65 Favored 'General case' 0 N--CA 1.425 -1.725 0 C-N-CA 119.425 -0.91 . . . . 0.0 110.991 179.626 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.493 ' HA ' ' HA ' ' A' ' 113' ' ' LEU 0.439 0.0 OUTLIER -58.41 91.93 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 C-N-CA 117.117 -1.833 . . . . 0.0 114.171 -179.74 . . . . . . . . 4 4 . 1 . 006 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -78.28 76.86 4.78 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 102.56 -3.126 . . . . 0.0 102.56 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 60.93 -123.79 33.67 Favored Glycine 0 C--O 1.245 0.801 0 O-C-N 128.473 3.608 . . . . 0.0 110.705 -179.587 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . 0.31 28.5 m-80 -71.88 0.96 7.87 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-O 112.381 -3.676 . . . . 0.0 113.76 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.501 ' HG3' ' HA ' ' A' ' 129' ' ' LYS . 4.5 mp0 -118.18 117.75 29.99 Favored 'General case' 0 CA--C 1.511 -0.527 0 O-C-N 128.042 3.339 . . . . 0.0 110.615 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.493 ' HA ' ' HA ' ' A' ' 108' ' ' ILE . 0.5 OUTLIER -87.83 124.27 33.47 Favored 'General case' 0 C--O 1.216 -0.672 0 O-C-N 127.102 2.751 . . . . 0.0 103.969 179.761 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.774 HD13 HG23 ' A' ' 127' ' ' ILE 0.296 1.8 mm -114.55 133.43 60.7 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.33 0 N-CA-C 103.854 -2.647 . . . . 0.0 103.854 -179.68 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 10.7 mt-30 -115.4 97.36 6.13 Favored 'General case' 0 CA--C 1.489 -1.387 0 O-C-N 125.385 1.678 . . . . 0.0 109.461 -179.469 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.465 HG22 ' HG3' ' A' ' 125' ' ' LYS . 19.2 p -75.09 174.33 9.54 Favored 'General case' 0 C--O 1.247 0.929 0 N-CA-C 105.004 -2.221 . . . . 0.0 105.004 179.63 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 16.9 m-85 -162.5 115.31 1.68 Allowed 'General case' 0 CA--C 1.483 -1.631 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.512 ' HB ' ' CG2' ' A' ' 103' ' ' ILE . 88.4 m -113.68 88.84 2.94 Favored 'General case' 0 N--CA 1.42 -1.945 0 N-CA-C 116.95 2.204 . . . . 0.0 116.95 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.494 ' HB2' ' CD1' ' A' ' 102' ' ' LEU . 3.2 t80 -83.68 130.01 34.96 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 103.884 -2.635 . . . . 0.0 103.884 178.037 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.495 ' CB ' ' HE3' ' A' ' 20' ' ' LYS . 3.0 mm-40 61.89 -62.9 0.09 Allowed 'General case' 0 C--N 1.289 -2.037 0 O-C-N 125.293 1.621 . . . . 0.0 112.191 -179.088 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 179.64 33.34 0.06 OUTLIER Glycine 0 CA--C 1.542 1.78 0 C-N-CA 128.853 3.121 . . . . 0.0 116.173 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 10.7 t -125.68 97.85 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.65 0 O-C-N 120.744 -1.445 . . . . 0.0 107.637 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.496 ' O ' ' HB2' ' A' ' 124' ' ' ALA 0.257 10.0 mt-10 -62.69 -175.56 0.09 Allowed 'General case' 0 N--CA 1.438 -1.067 0 CA-C-O 117.381 -1.295 . . . . 0.0 111.784 179.983 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.513 ' HB2' ' CB ' ' A' ' 17' ' ' PHE . . . -176.75 88.07 0.03 OUTLIER 'General case' 0 N--CA 1.436 -1.131 0 CA-C-O 114.911 -2.471 . . . . 0.0 107.076 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.465 ' HG3' HG22 ' A' ' 116' ' ' THR . 0.0 OUTLIER -68.43 139.99 55.76 Favored 'General case' 0 CA--C 1.487 -1.469 0 O-C-N 125.788 1.93 . . . . 0.0 110.546 179.989 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.636 ' HD2' HG21 ' A' ' 8' ' ' VAL . 5.0 mmm-85 -133.56 85.12 2.18 Favored 'General case' 0 N--CA 1.429 -1.504 0 O-C-N 126.34 2.275 . . . . 0.0 106.581 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.774 HG23 HD13 ' A' ' 114' ' ' ILE . 13.2 mt -83.79 112.47 21.27 Favored 'Isoleucine or valine' 0 C--O 1.249 1.067 0 O-C-N 127.86 3.225 . . . . 0.0 117.305 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.528 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 0.0 OUTLIER -102.39 137.29 40.83 Favored 'General case' 0 N--CA 1.441 -0.9 0 O-C-N 126.642 2.464 . . . . 0.0 108.136 179.414 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.501 ' HA ' ' HG3' ' A' ' 112' ' ' GLU 0.284 12.2 mmtm -92.64 5.58 50.47 Favored 'General case' 0 C--O 1.244 0.78 0 CA-C-O 116.626 -1.655 . . . . 0.0 111.748 179.884 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.623 ' HA ' ' CE3' ' A' ' 6' ' ' TRP . 0.1 OUTLIER 76.59 138.95 0.07 Allowed 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 121.125 1.784 . . . . 0.0 108.424 179.79 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . 0.763 61.4 tt0 . . . . . 0 N--CA 1.443 -0.776 0 C-N-CA 116.563 -2.055 . . . . 0.0 113.789 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' PHE . . . . . 0.575 ' CZ ' HG21 ' A' ' 108' ' ' ILE . 62.1 m-85 . . . . . 0 N--CA 1.448 -0.568 0 CA-C-O 124.523 2.106 . . . . 0.0 113.776 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -156.73 96.33 1.62 Allowed 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 113.563 -1.653 . . . . 0.0 115.014 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 148.29 -152.44 24.51 Favored Glycine 0 C--N 1.313 -0.738 0 C-N-CA 116.778 -2.629 . . . . 0.0 112.942 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . 0.547 0.0 OUTLIER -111.48 158.12 19.52 Favored 'General case' 0 C--N 1.314 -0.968 0 O-C-N 127.53 2.547 . . . . 0.0 113.096 -179.782 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.647 ' CD1' HD12 ' A' ' 40' ' ' ILE . 85.1 m95 -149.37 113.02 5.05 Favored 'General case' 0 N--CA 1.433 -1.304 0 CA-C-N 112.618 -2.083 . . . . 0.0 110.173 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.9 101.83 11.39 Favored 'General case' 0 C--O 1.211 -0.961 0 CA-C-N 120.886 1.676 . . . . 0.0 107.365 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.505 ' CG1' ' HB3' ' A' ' 36' ' ' LEU . 0.3 OUTLIER -47.43 135.8 3.67 Favored 'Isoleucine or valine' 0 C--O 1.246 0.877 0 CA-C-N 120.76 1.618 . . . . 0.0 110.205 179.913 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -145.05 -11.45 0.56 Allowed 'General case' 0 N--CA 1.433 -1.29 0 C-N-CA 118.676 -1.209 . . . . 0.0 112.997 -179.584 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.422 ' HB3' ' HB ' ' A' ' 127' ' ' ILE . 5.6 tpp180 -111.05 -56.07 2.41 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-N 121.326 1.876 . . . . 0.0 113.245 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.528 ' HB3' ' CD1' ' A' ' 14' ' ' TYR . 1.2 m-20 62.7 165.84 0.11 Allowed 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 124.244 1.018 . . . . 0.0 110.454 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.406 ' N ' ' O ' ' A' ' 125' ' ' LYS . 2.4 mm-40 -171.26 103.05 0.21 Allowed 'General case' 0 C--N 1.314 -0.952 0 O-C-N 117.3 -3.375 . . . . 0.0 107.201 -179.6 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.433 ' HB3' ' HA ' ' A' ' 124' ' ' ALA . 5.6 t-20 97.5 -27.28 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.18 0 O-C-N 125.447 1.717 . . . . 0.0 111.923 -179.238 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.757 ' CE2' ' HB1' ' A' ' 32' ' ' ALA . 2.4 p90 -29.96 -36.39 0.01 OUTLIER 'General case' 0 N--CA 1.435 -1.186 0 O-C-N 127.619 3.074 . . . . 0.0 118.03 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -75.77 -34.21 60.23 Favored 'General case' 0 CA--C 1.498 -1.024 0 C-N-CA 120.58 -0.448 . . . . 0.0 110.793 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -73.04 -28.7 62.49 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-O 124.304 2.002 . . . . 0.0 113.138 179.685 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.79 ' CB ' ' HB2' ' A' ' 124' ' ' ALA . 0.0 OUTLIER -71.45 -29.29 64.7 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-O 125.658 2.646 . . . . 0.0 110.393 179.908 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 29.6 mtm -79.88 -20.38 45.99 Favored 'General case' 0 C--N 1.318 -0.77 0 O-C-N 116.654 -3.779 . . . . 0.0 106.445 179.503 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.04 -31.13 39.51 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 123.103 1.43 . . . . 0.0 112.655 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.602 ' CE ' ' HB3' ' A' ' 119' ' ' TYR . 0.5 OUTLIER -73.49 -21.18 60.49 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 115.754 1.761 . . . . 0.0 115.754 -178.144 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 3.4 mtp -79.03 -47.6 15.91 Favored 'General case' 0 C--O 1.206 -1.192 0 N-CA-C 103.592 -2.744 . . . . 0.0 103.592 179.301 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 124.08 43.64 0.32 Allowed Glycine 0 N--CA 1.433 -1.537 0 CA-C-N 113.902 -1.499 . . . . 0.0 111.234 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.9 mm -75.09 126.24 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.967 0 CA-C-O 115.813 -2.041 . . . . 0.0 112.173 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -52.57 145.02 12.47 Favored 'General case' 0 C--N 1.348 0.527 0 CA-C-O 115.233 -2.318 . . . . 0.0 111.573 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . 0.445 26.9 m -36.39 -47.99 0.25 Allowed 'Isoleucine or valine' 0 C--O 1.216 -0.707 0 N-CA-C 119.162 3.023 . . . . 0.0 119.162 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.537 5.4 m -79.84 -28.38 12.62 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.995 0 N-CA-C 115.217 1.562 . . . . 0.0 115.217 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.9 ttmm -71.41 -31.58 67.42 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 112.147 -2.297 . . . . 0.0 114.904 179.648 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 7.5 ptt180 -79.35 -21.28 46.03 Favored 'General case' 0 C--O 1.219 -0.543 0 C-N-CA 117.721 -1.592 . . . . 0.0 109.303 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 9.3 tttm -72.13 -46.22 57.47 Favored 'General case' 0 CA--C 1.5 -0.959 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.64 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.3 tp -76.38 -28.61 56.82 Favored 'General case' 0 CA--C 1.505 -0.755 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -74.43 -20.99 79.45 Favored Glycine 0 C--N 1.345 1.055 0 CA-C-O 124.017 1.898 . . . . 0.0 111.981 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.757 ' HB1' ' CE2' ' A' ' 14' ' ' TYR . . . -75.25 -48.96 20.9 Favored 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 127.484 2.314 . . . . 0.0 111.02 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 8.5 m170 -96.35 7.66 45.92 Favored 'General case' 0 N--CA 1.429 -1.509 0 O-C-N 127.152 2.782 . . . . 0.0 110.672 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 29.8 p30 -33.6 -27.22 0.01 OUTLIER 'General case' 0 CA--C 1.507 -0.702 0 N-CA-C 116.774 2.139 . . . . 0.0 116.774 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.2 t30 77.1 26.7 0.72 Allowed 'General case' 0 C--O 1.244 0.778 0 CA-C-N 120.641 1.564 . . . . 0.0 112.351 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.522 HD11 ' HG ' ' A' ' 38' ' ' LEU . 1.3 tp -52.22 116.52 2.26 Favored 'General case' 0 CA--C 1.5 -0.962 0 CA-C-O 123.981 1.848 . . . . 0.0 109.341 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.508 ' N ' HD12 ' A' ' 36' ' ' LEU . 6.3 ttmm -111.43 95.6 5.61 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 101.865 -3.383 . . . . 0.0 101.865 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.611 HD12 ' CE2' ' A' ' 128' ' ' PHE 0.284 2.4 mt -78.58 141.52 38.02 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 119.041 -2.287 . . . . 0.0 108.292 -179.928 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.505 ' HB ' ' CB ' ' A' ' 50' ' ' LYS . 9.3 m -128.51 76.82 1.73 Allowed 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 102.213 -3.254 . . . . 0.0 102.213 179.23 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.647 HD12 ' CD1' ' A' ' 6' ' ' TRP . 6.0 mt -65.81 134.94 29.19 Favored 'Isoleucine or valine' 0 C--O 1.251 1.142 0 CA-C-N 112.401 -2.182 . . . . 0.0 106.359 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.411 HG22 ' O ' ' A' ' 41' ' ' THR . 0.8 OUTLIER -145.91 113.81 6.48 Favored 'General case' 0 CA--C 1.504 -0.792 0 O-C-N 126.849 2.593 . . . . 0.0 110.648 -179.949 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -90.09 134.35 34.31 Favored 'General case' 0 C--O 1.22 -0.465 0 CA-C-N 114.259 -1.337 . . . . 0.0 113.765 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 33.9 tp10 -135.55 91.01 2.67 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 105.578 -2.008 . . . . 0.0 105.578 179.758 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 67.13 -97.67 0.39 Allowed Glycine 0 C--N 1.292 -1.871 0 CA-C-O 116.367 -2.352 . . . . 0.0 109.313 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.335 0.0 OUTLIER -117.8 -1.93 11.46 Favored 'General case' 0 C--N 1.315 -0.917 0 O-C-N 129.712 3.83 . . . . 0.0 113.377 -179.895 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.42 ' HA ' ' HA ' ' A' ' 63' ' ' GLU . 0.6 OUTLIER -99.62 136.66 39.23 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 106.997 -1.482 . . . . 0.0 106.997 -179.952 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.497 ' HE2' HD11 ' A' ' 89' ' ' LEU 0.313 0.1 OUTLIER -121.48 108.27 13.44 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 105.616 -1.994 . . . . 0.0 105.616 -179.929 . . . . . . . . 4 4 . 1 . 007 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.692 ' HB ' HG12 ' A' ' 61' ' ' VAL 0.386 0.1 OUTLIER -99.94 89.94 4.24 Favored 'General case' 0 N--CA 1.423 -1.789 0 O-C-N 124.804 1.315 . . . . 0.0 108.445 -179.68 . . . . . . . . 4 4 . 1 . 007 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.636 HG22 ' HB ' ' A' ' 60' ' ' VAL 0.714 1.0 OUTLIER -65.7 94.59 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.503 -0.858 0 O-C-N 127.246 2.841 . . . . 0.0 108.596 178.792 . . . . . . . . 4 4 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.505 ' CB ' ' HB ' ' A' ' 39' ' ' THR . 0.0 OUTLIER -63.35 140.46 58.87 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 102.448 -3.168 . . . . 0.0 102.448 -179.439 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.471 ' HB2' HG23 ' A' ' 60' ' ' VAL . 11.8 tt0 -130.04 73.0 1.5 Allowed 'General case' 0 CA--C 1.51 -0.559 0 N-CA-C 105.998 -1.853 . . . . 0.0 105.998 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.99 69.36 5.13 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 105.957 -1.868 . . . . 0.0 105.957 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.32 175.77 6.98 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.984 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -62.19 -26.58 68.43 Favored 'General case' 0 C--O 1.216 -0.674 0 O-C-N 125.441 1.713 . . . . 0.0 107.831 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.645 ' CE1' ' HB1' ' A' ' 73' ' ' ALA . 0.3 OUTLIER -69.1 -64.38 0.88 Allowed 'General case' 0 C--O 1.222 -0.385 0 CA-C-O 114.473 -2.679 . . . . 0.0 108.659 179.821 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -173.05 172.52 3.91 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 122.8 2.545 . . . . 0.0 110.844 179.537 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -90.76 65.94 5.96 Favored 'General case' 0 CA--C 1.498 -1.02 0 O-C-N 128.46 3.6 . . . . 0.0 105.067 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -87.48 -41.11 14.32 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 O-C-N 127.353 2.908 . . . . 0.0 115.746 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 50.6 t0 79.58 141.66 0.07 Allowed 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 104.649 -2.352 . . . . 0.0 104.649 -179.009 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.636 ' HB ' HG22 ' A' ' 49' ' ' VAL . 1.5 t -129.38 84.77 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 N-CA-C 105.464 -2.05 . . . . 0.0 105.464 -179.543 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.692 HG12 ' HB ' ' A' ' 48' ' ' THR 0.314 1.5 m -90.18 136.56 23.55 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.519 0 N-CA-C 116.889 2.181 . . . . 0.0 116.889 -178.188 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.539 ' HB3' ' CZ ' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -137.25 95.0 3.01 Favored 'General case' 0 N--CA 1.422 -1.83 0 CA-C-O 114.18 -2.819 . . . . 0.0 110.8 177.263 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.492 ' O ' ' N ' ' A' ' 65' ' ' GLY . 24.0 tt0 -54.58 117.73 3.59 Favored 'General case' 0 C--N 1.32 -0.698 1 N-CA-C 98.813 -4.514 . . . . 0.0 98.813 175.998 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.776 ' HB3' ' CD2' ' A' ' 82' ' ' TRP . 0.0 OUTLIER -47.76 93.48 0.01 OUTLIER 'General case' 0 N--CA 1.429 -1.511 0 O-C-N 125.686 1.866 . . . . 0.0 107.69 -175.68 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.685 ' N ' ' NE1' ' A' ' 82' ' ' TRP . . . 94.71 50.33 2.16 Favored Glycine 0 C--N 1.353 1.517 0 N-CA-C 121.592 3.397 . . . . 0.0 121.592 178.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.41 ' HB ' ' HB3' ' A' ' 63' ' ' GLU 0.305 7.3 p -103.94 -19.91 6.03 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 CA-C-O 115.237 -2.316 . . . . 0.0 109.826 -179.985 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.548 ' HA ' HG22 ' A' ' 81' ' ' THR . 64.8 t0 65.19 105.04 0.04 OUTLIER 'General case' 0 C--O 1.204 -1.305 0 CA-C-O 123.074 1.416 . . . . 0.0 107.409 -178.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.608 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 0.1 OUTLIER -131.64 161.26 33.15 Favored 'General case' 0 C--N 1.307 -1.245 0 C-N-CA 125.876 1.67 . . . . 0.0 111.619 -176.876 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -110.75 130.07 55.67 Favored 'General case' 0 C--O 1.245 0.843 0 O-C-N 127.031 2.707 . . . . 0.0 105.122 179.537 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 83.9 t80 -132.6 96.5 3.84 Favored 'General case' 0 C--O 1.208 -1.104 0 O-C-N 125.353 1.658 . . . . 0.0 114.41 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 25.1 t -66.97 140.84 57.75 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 105.372 -2.084 . . . . 0.0 105.372 179.527 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -77.39 -174.68 3.41 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 103.257 -2.868 . . . . 0.0 103.257 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.645 ' HB1' ' CE1' ' A' ' 55' ' ' PHE . . . -80.48 -19.71 45.34 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-O 124.836 2.255 . . . . 0.0 111.3 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -153.86 -37.61 0.1 Allowed 'General case' 0 C--O 1.222 -0.375 0 CA-C-N 112.669 -2.06 . . . . 0.0 111.129 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.567 ' O ' HG22 ' A' ' 76' ' ' THR . . . -69.72 -0.91 28.09 Favored Glycine 0 CA--C 1.533 1.207 0 N-CA-C 118.512 2.165 . . . . 0.0 118.512 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.567 HG22 ' O ' ' A' ' 75' ' ' GLY 0.386 0.3 OUTLIER 77.27 164.44 0.24 Allowed 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 120.376 2.088 . . . . 0.0 114.857 -179.908 . . . . . . . . 4 4 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.575 ' HG2' HG21 ' A' ' 96' ' ' VAL . 0.3 OUTLIER -30.31 145.21 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 111.763 -2.471 . . . . 0.0 116.567 -179.805 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.499 ' HG ' ' HB3' ' A' ' 93' ' ' PHE 0.386 0.6 OUTLIER -160.62 101.74 1.34 Allowed 'General case' 0 C--O 1.24 0.602 0 CA-C-N 109.924 -3.307 . . . . 0.0 107.142 179.982 . . . . . . . . 4 4 . 1 . 007 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.658 HG22 ' O ' ' A' ' 94' ' ' LYS . 91.6 m -105.82 -172.78 2.15 Favored 'General case' 0 CA--C 1.498 -1.037 0 N-CA-C 101.772 -3.418 . . . . 0.0 101.772 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.446 ' HA3' ' HA ' ' A' ' 93' ' ' PHE . . . 118.8 -148.07 18.4 Favored Glycine 0 C--N 1.292 -1.872 0 CA-C-O 116.571 -2.238 . . . . 0.0 113.191 179.629 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.548 HG22 ' HA ' ' A' ' 67' ' ' ASP . 60.3 p -165.46 166.73 18.2 Favored 'General case' 0 C--O 1.188 -2.155 0 CA-C-O 124.232 1.967 . . . . 0.0 110.712 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' TRP . . . . . 0.777 ' CG ' ' N ' ' A' ' 83' ' ' THR 0.399 4.0 p-90 -73.03 -162.39 0.11 Allowed 'General case' 0 N--CA 1.438 -1.063 0 N-CA-C 100.244 -3.984 . . . . 0.0 100.244 175.43 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.777 ' N ' ' CG ' ' A' ' 82' ' ' TRP . 4.7 t 159.43 129.51 0.0 OUTLIER 'General case' 0 N--CA 1.415 -2.219 0 CA-C-O 125.733 2.682 . . . . 0.0 112.657 174.929 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.584 ' HB2' ' CZ3' ' A' ' 82' ' ' TRP . 0.0 OUTLIER -88.53 121.93 31.45 Favored 'General case' 0 N--CA 1.422 -1.836 0 CA-C-N 110.566 -3.015 . . . . 0.0 105.524 179.047 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.669 ' HG2' HG21 ' A' ' 90' ' ' VAL 0.622 2.5 pp20? -111.59 44.48 1.35 Allowed 'General case' 0 N--CA 1.421 -1.912 0 CA-C-O 123.574 1.654 . . . . 0.0 114.394 179.735 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 71.61 110.94 0.05 OUTLIER Glycine 0 N--CA 1.443 -0.854 0 N-CA-C 107.595 -2.202 . . . . 0.0 107.595 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 50.9 t30 66.67 -22.05 0.1 Allowed 'General case' 0 N--CA 1.44 -0.942 0 CA-C-O 114.948 -2.453 . . . . 0.0 116.347 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.451 ' HG3' ' HA ' ' A' ' 107' ' ' GLU 0.33 0.1 OUTLIER -129.1 142.76 50.79 Favored 'General case' 0 CA--C 1.491 -1.311 0 CA-C-N 120.903 1.683 . . . . 0.0 107.465 -179.97 . . . . . . . . 4 4 . 1 . 007 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.508 HD23 ' HA ' ' A' ' 89' ' ' LEU . 0.2 OUTLIER -94.85 152.55 18.3 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 101.715 -3.439 . . . . 0.0 101.715 -179.821 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.669 HG21 ' HG2' ' A' ' 85' ' ' GLU . 1.4 t -136.75 164.65 30.17 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 N-CA-C 105.507 -2.035 . . . . 0.0 105.507 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -133.79 99.06 0.34 Allowed Glycine 0 C--N 1.363 2.079 0 C-N-CA 128.554 2.978 . . . . 0.0 108.865 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -98.45 127.93 44.6 Favored 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 103.343 -2.836 . . . . 0.0 103.343 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.538 ' HB2' ' HB3' ' A' ' 102' ' ' LEU . 19.4 m-85 -140.5 130.49 24.69 Favored 'General case' 0 N--CA 1.442 -0.869 0 O-C-N 124.429 1.081 . . . . 0.0 113.279 179.484 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.658 ' O ' HG22 ' A' ' 79' ' ' THR . 0.5 OUTLIER -115.27 124.2 50.73 Favored 'General case' 0 N--CA 1.422 -1.832 0 C-N-CA 130.159 3.384 . . . . 0.0 105.54 -179.987 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.713 ' HE ' ' N ' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -54.74 -168.02 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.721 0 O-C-N 128.339 3.525 . . . . 0.0 110.573 178.647 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.575 HG21 ' HG2' ' A' ' 77' ' ' GLU . 20.5 t -124.56 -50.11 2.1 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 O-C-N 119.754 -1.841 . . . . 0.0 106.489 176.666 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . 0.293 0.3 OUTLIER -110.0 9.7 24.27 Favored 'General case' 0 C--O 1.255 1.348 0 CA-C-N 113.102 -1.863 . . . . 0.0 113.465 -179.939 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.432 ' HB3' ' CB ' ' A' ' 95' ' ' ARG 0.268 8.0 t-20 -101.46 -23.91 14.25 Favored 'General case' 0 CA--C 1.494 -1.195 0 CA-C-O 116.281 -1.819 . . . . 0.0 111.322 -179.962 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.658 ' HA2' ' CZ ' ' A' ' 95' ' ' ARG . . . 71.87 11.1 73.55 Favored Glycine 0 CA--C 1.542 1.767 0 N-CA-C 118.38 2.112 . . . . 0.0 118.38 179.181 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.713 ' N ' ' HE ' ' A' ' 95' ' ' ARG . 3.8 mtpp -110.73 -148.04 0.42 Allowed 'General case' 0 C--N 1.3 -1.578 0 O-C-N 125.801 1.53 . . . . 0.0 111.004 -177.45 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 57.2 tt0 -160.65 161.91 32.53 Favored 'General case' 0 N--CA 1.433 -1.295 0 C-N-CA 131.385 3.874 . . . . 0.0 109.687 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.538 ' HB3' ' HB2' ' A' ' 93' ' ' PHE . 9.3 tp -142.33 157.75 44.47 Favored 'General case' 0 N--CA 1.438 -1.045 1 C-N-CA 132.014 4.125 . . . . 0.0 106.527 -179.243 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.643 ' CG2' ' HB ' ' A' ' 118' ' ' THR . 4.1 tt -150.25 154.63 8.67 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.993 0 N-CA-C 103.941 -2.615 . . . . 0.0 103.941 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -131.5 -172.0 2.74 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.569 HG12 HG23 ' A' ' 116' ' ' THR . 0.5 OUTLIER -169.72 77.02 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 CA-C-O 127.544 3.545 . . . . 0.0 107.539 179.647 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.463 HH12 ' HE2' ' A' ' 62' ' ' PHE . 0.1 OUTLIER -65.84 91.71 0.15 Allowed 'General case' 0 C--O 1.217 -0.617 0 N-CA-C 104.668 -2.345 . . . . 0.0 104.668 179.571 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.451 ' HA ' ' HG3' ' A' ' 88' ' ' LYS . 25.8 tt0 -72.75 -35.42 67.48 Favored 'General case' 0 C--O 1.202 -1.414 0 CA-C-N 110.994 -2.821 . . . . 0.0 115.044 -179.581 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.83 HD13 HD12 ' A' ' 113' ' ' LEU 0.428 3.2 tp 52.55 43.38 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 C-N-CA 112.927 -3.509 . . . . 0.0 113.236 179.956 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -66.73 103.19 1.05 Allowed 'General case' 0 CA--C 1.505 -0.782 0 O-C-N 120.494 -1.379 . . . . 0.0 108.193 -179.487 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 56.85 -73.29 0.01 OUTLIER Glycine 0 C--N 1.342 0.893 0 C-N-CA 127.206 2.336 . . . . 0.0 111.848 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . 0.351 0.0 OUTLIER -136.97 36.8 2.58 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 117.494 -1.241 . . . . 0.0 110.32 179.671 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -146.43 97.62 2.95 Favored 'General case' 0 C--N 1.363 1.162 0 O-C-N 126.521 2.388 . . . . 0.0 110.388 -179.651 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.83 HD12 HD13 ' A' ' 108' ' ' ILE . 0.4 OUTLIER -75.27 68.33 1.99 Allowed 'General case' 0 C--O 1.209 -1.068 1 O-C-N 129.353 4.158 . . . . 0.0 107.479 -179.51 . . . . . . . . 4 4 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.866 HG12 HD13 ' A' ' 127' ' ' ILE . 54.6 mt -72.07 128.27 34.86 Favored 'Isoleucine or valine' 0 C--O 1.25 1.114 0 N-CA-C 105.006 -2.22 . . . . 0.0 105.006 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -113.17 108.14 16.89 Favored 'General case' 0 CA--C 1.493 -1.232 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 -179.656 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.569 HG23 HG12 ' A' ' 105' ' ' VAL . 66.8 p -76.28 169.06 18.94 Favored 'General case' 0 C--O 1.245 0.846 0 C-N-CA 115.912 -2.315 . . . . 0.0 105.443 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.707 ' HB2' ' HB3' ' A' ' 124' ' ' ALA . 0.8 OUTLIER -148.85 93.82 2.17 Favored 'General case' 0 CA--C 1.491 -1.298 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 -179.986 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.643 ' HB ' ' CG2' ' A' ' 103' ' ' ILE . 0.2 OUTLIER -96.84 81.68 3.16 Favored 'General case' 0 N--CA 1.424 -1.762 0 O-C-N 126.702 2.501 . . . . 0.0 116.322 -179.781 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.602 ' HB3' ' CE ' ' A' ' 20' ' ' LYS . 0.2 OUTLIER -85.8 101.57 12.92 Favored 'General case' 0 N--CA 1.479 0.975 0 N-CA-C 103.278 -2.86 . . . . 0.0 103.278 178.625 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 65.25 -82.15 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.412 0 CA-C-N 113.88 -1.509 . . . . 0.0 114.178 -179.228 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -132.8 24.09 3.89 Favored Glycine 0 CA--C 1.54 1.623 0 N-CA-C 117.401 1.72 . . . . 0.0 117.401 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.534 ' HB ' ' HD3' ' A' ' 20' ' ' LYS . 3.3 t -133.14 87.36 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -68.62 129.97 41.49 Favored 'General case' 0 N--CA 1.436 -1.144 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.79 ' HB2' ' CB ' ' A' ' 17' ' ' PHE . . . -115.54 115.6 26.74 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-O 116.307 -1.806 . . . . 0.0 108.4 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.406 ' O ' ' N ' ' A' ' 12' ' ' GLU . 0.1 OUTLIER -92.7 129.94 38.48 Favored 'General case' 0 C--O 1.252 1.202 0 C-N-CA 116.991 -1.883 . . . . 0.0 109.932 -179.998 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 7.4 mtm180 -119.89 86.77 2.62 Favored 'General case' 0 N--CA 1.437 -1.122 0 CA-C-N 112.082 -2.326 . . . . 0.0 106.028 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.866 HD13 HG12 ' A' ' 114' ' ' ILE . 0.8 OUTLIER -84.28 125.9 40.23 Favored 'Isoleucine or valine' 0 C--O 1.252 1.23 0 CA-C-N 114.306 -1.316 . . . . 0.0 112.893 179.983 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.611 ' CE2' HD12 ' A' ' 38' ' ' LEU . 0.2 OUTLIER -106.39 155.71 19.27 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-O 123.722 1.725 . . . . 0.0 107.926 179.709 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . 0.268 15.9 mtpp -117.3 16.99 14.79 Favored 'General case' 0 C--O 1.244 0.797 0 O-C-N 118.594 -2.566 . . . . 0.0 110.704 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.554 ' HG3' ' CH2' ' A' ' 6' ' ' TRP . 1.4 tttt 57.26 113.25 0.01 OUTLIER 'General case' 0 C--O 1.219 -0.527 0 N-CA-C 115.991 1.849 . . . . 0.0 115.991 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . 0.836 15.0 tt0 . . . . . 0 N--CA 1.429 -1.519 0 O-C-N 118.422 -2.674 . . . . 0.0 116.023 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 19.2 p90 . . . . . 0 N--CA 1.429 -1.513 0 N-CA-C 118.541 2.793 . . . . 0.0 118.541 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -167.45 96.92 0.48 Allowed 'General case' 0 N--CA 1.435 -1.191 0 O-C-N 119.605 -1.934 . . . . 0.0 112.091 -179.639 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 142.91 -152.48 23.99 Favored Glycine 0 C--O 1.212 -1.229 0 C-N-CA 118.587 -1.768 . . . . 0.0 109.435 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.486 HG22 ' HG2' ' A' ' 37' ' ' LYS 0.567 13.2 p -89.69 155.08 19.46 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 123.358 0.663 . . . . 0.0 111.417 179.946 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.573 ' CH2' HD11 ' A' ' 108' ' ' ILE . 91.9 m95 -152.69 105.17 2.95 Favored 'General case' 0 C--N 1.319 -0.747 0 O-C-N 127.652 3.095 . . . . 0.0 106.848 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 13.1 ttpt -106.04 101.85 11.31 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-O 114.991 -2.433 . . . . 0.0 108.313 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.481 ' HA ' ' HA ' ' A' ' 128' ' ' PHE 0.284 2.8 p -45.89 144.27 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 120.441 1.473 . . . . 0.0 111.015 179.804 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -146.55 -30.25 0.37 Allowed 'General case' 0 N--CA 1.438 -1.053 0 O-C-N 127.82 3.2 . . . . 0.0 112.371 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.608 ' HB2' ' HB ' ' A' ' 127' ' ' ILE . 17.9 mmt180 -82.84 -80.76 0.17 Allowed 'General case' 0 C--N 1.297 -1.684 0 O-C-N 119.022 -2.299 . . . . 0.0 114.286 -179.652 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.526 ' HA ' ' HA ' ' A' ' 126' ' ' ARG 0.284 8.2 m120 77.13 147.19 0.09 Allowed 'General case' 0 C--O 1.247 0.964 1 O-C-N 129.592 4.307 . . . . 0.0 106.275 -177.206 . . . . . . . . 4 3 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.41 ' N ' ' O ' ' A' ' 125' ' ' LYS . 2.8 tp10 -125.9 -69.54 0.77 Allowed 'General case' 0 C--N 1.296 -1.724 0 CA-C-N 122.398 2.363 . . . . 0.0 108.113 -179.595 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.496 ' HB3' ' HA ' ' A' ' 124' ' ' ALA . 5.2 t30 -112.17 29.37 7.95 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 127.325 2.891 . . . . 0.0 113.157 179.7 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.676 ' CD1' ' HB1' ' A' ' 124' ' ' ALA 0.376 1.1 m-85 -73.18 -27.68 61.78 Favored 'General case' 0 N--CA 1.44 -0.974 0 O-C-N 127.282 2.863 . . . . 0.0 117.488 179.708 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -74.36 -36.48 63.58 Favored 'General case' 0 C--O 1.209 -1.032 0 CA-C-N 120.479 1.49 . . . . 0.0 111.391 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.4 ' HB3' ' ND2' ' A' ' 13' ' ' ASN . 12.4 tptp -71.77 -32.14 67.35 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 111.537 -2.574 . . . . 0.0 115.216 179.772 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -70.76 -24.27 62.57 Favored 'General case' 0 N--CA 1.441 -0.88 0 O-C-N 124.868 1.355 . . . . 0.0 111.472 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 7.7 mmt -77.21 -34.65 56.04 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-O 123.841 1.781 . . . . 0.0 106.422 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -65.54 -31.14 72.04 Favored 'General case' 0 N--CA 1.473 0.709 0 O-C-N 118.199 -2.813 . . . . 0.0 112.529 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.414 ' HA ' ' HD2' ' A' ' 20' ' ' LYS . 11.6 tptm -77.04 -30.91 55.9 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 112.836 -1.984 . . . . 0.0 110.581 179.352 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.84 -21.08 55.55 Favored 'General case' 0 N--CA 1.435 -1.221 0 O-C-N 125.148 1.53 . . . . 0.0 107.792 179.373 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 123.01 1.64 9.49 Favored Glycine 0 C--N 1.301 -1.387 0 CA-C-O 117.674 -1.625 . . . . 0.0 113.258 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.415 HG23 ' HB2' ' A' ' 27' ' ' LYS . 0.6 OUTLIER -77.75 107.33 9.35 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.313 0 CA-C-O 117.73 -1.129 . . . . 0.0 108.605 179.913 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -118.67 1.49 11.64 Favored 'General case' 0 C--N 1.352 0.68 0 CA-C-O 116.001 -1.952 . . . . 0.0 114.154 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . 0.393 0.6 OUTLIER -112.72 -140.14 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.358 0.969 0 O-C-N 128.974 3.921 . . . . 0.0 116.34 -179.981 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.561 0.0 OUTLIER -72.76 -21.08 19.45 Favored 'Isoleucine or valine' 0 C--O 1.243 0.722 0 CA-C-N 120.689 1.586 . . . . 0.0 114.792 -179.926 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.415 ' HB2' HG23 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -62.14 -30.78 71.28 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 114.29 1.219 . . . . 0.0 114.29 179.89 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . 0.268 0.1 OUTLIER -78.97 -20.95 47.87 Favored 'General case' 0 N--CA 1.454 -0.247 0 O-C-N 119.502 -1.998 . . . . 0.0 108.31 180.0 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.6 tttm -78.9 -46.66 17.99 Favored 'General case' 0 C--O 1.215 -0.716 0 CA-C-N 113.318 -1.764 . . . . 0.0 108.768 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 11.0 mp -73.46 -22.69 60.12 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 113.746 -1.57 . . . . 0.0 110.248 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -68.79 -34.0 76.73 Favored Glycine 0 C--N 1.344 1.018 0 C-N-CA 123.638 0.637 . . . . 0.0 112.559 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -79.85 -34.86 38.97 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 127.625 2.37 . . . . 0.0 109.107 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 1.4 m80 -118.4 42.03 2.82 Favored 'General case' 0 C--O 1.24 0.573 0 C-N-CA 126.617 1.967 . . . . 0.0 114.338 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.8 p30 -71.29 -23.59 61.99 Favored 'General case' 0 C--O 1.215 -0.754 0 N-CA-C 119.17 3.026 . . . . 0.0 119.17 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 78.13 9.1 2.25 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 -179.635 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.769 HD22 HH21 ' A' ' 126' ' ' ARG . 0.9 OUTLIER -41.77 116.32 0.77 Allowed 'General case' 0 CA--C 1.51 -0.591 0 O-C-N 126.962 2.664 . . . . 0.0 110.873 -179.791 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.486 ' HG2' HG22 ' A' ' 5' ' ' THR . 11.4 ttmm -113.86 92.11 3.87 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 105.166 -2.161 . . . . 0.0 105.166 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.713 HD13 HD21 ' A' ' 36' ' ' LEU 0.276 0.8 OUTLIER -75.17 114.08 13.25 Favored 'General case' 0 C--N 1.292 -1.91 0 C-N-CA 117.497 -1.681 . . . . 0.0 109.115 -179.983 . . . . . . . . 4 4 . 1 . 008 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.524 ' HB ' ' CB ' ' A' ' 50' ' ' LYS . 91.8 m -94.87 84.47 4.18 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 102.012 -3.329 . . . . 0.0 102.012 179.44 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.57 HD12 ' CD1' ' A' ' 6' ' ' TRP . 96.0 mt -71.73 116.14 13.04 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 CA-C-O 123.69 1.71 . . . . 0.0 110.81 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.3 m -110.38 118.01 35.14 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 110.324 -3.125 . . . . 0.0 109.348 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 2.7 tp60 -94.46 125.62 39.22 Favored 'General case' 0 C--N 1.311 -1.082 0 O-C-N 126.074 2.108 . . . . 0.0 107.794 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -135.08 68.31 1.47 Allowed 'General case' 0 N--CA 1.433 -1.31 0 CA-C-O 125.257 2.456 . . . . 0.0 105.684 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.17 -76.59 2.22 Favored Glycine 0 C--N 1.298 -1.559 0 N-CA-C 104.44 -3.464 . . . . 0.0 104.44 179.785 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.348 0.0 OUTLIER -130.51 -36.58 1.44 Allowed 'General case' 0 C--N 1.326 -0.449 0 O-C-N 126.608 2.005 . . . . 0.0 113.976 179.947 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.481 ' HA ' ' HA ' ' A' ' 63' ' ' GLU . 7.4 ttmt -57.38 109.26 0.65 Allowed 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 114.102 -1.408 . . . . 0.0 113.56 -179.77 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . 0.254 3.2 m-30 -100.4 78.23 2.01 Favored 'General case' 0 CA--C 1.507 -0.684 0 CA-C-O 125.578 2.608 . . . . 0.0 106.942 179.639 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.619 ' HB ' ' HB ' ' A' ' 61' ' ' VAL 0.417 9.8 t -76.48 80.13 3.19 Favored 'General case' 0 N--CA 1.435 -1.216 0 O-C-N 118.832 -2.417 . . . . 0.0 113.439 -179.873 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.48 ' CG2' ' HG ' ' A' ' 38' ' ' LEU 0.596 2.0 m -56.78 96.99 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.428 -1.532 0 CA-C-N 114.189 -1.369 . . . . 0.0 114.466 179.652 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.524 ' CB ' ' HB ' ' A' ' 39' ' ' THR . 1.1 ttmt -67.51 116.26 8.04 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 101.59 -3.485 . . . . 0.0 101.59 179.719 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.508 ' HB2' ' CG2' ' A' ' 60' ' ' VAL 0.263 1.9 tt0 -107.44 107.0 17.67 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 103.753 -2.684 . . . . 0.0 103.753 -179.997 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.0 m -106.56 48.79 0.82 Allowed 'General case' 0 C--N 1.285 -2.196 0 N-CA-C 105.004 -2.221 . . . . 0.0 105.004 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.3 m -76.36 162.54 27.8 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-O 115.431 -2.223 . . . . 0.0 109.106 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -48.57 -37.12 17.08 Favored 'General case' 0 C--O 1.211 -0.958 0 O-C-N 125.238 1.586 . . . . 0.0 107.531 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -52.88 -65.35 0.57 Allowed 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 116.459 -1.734 . . . . 0.0 109.54 179.297 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.446 ' HG3' ' N ' ' A' ' 57' ' ' ASN . 1.2 ttm-85 -173.08 148.02 1.67 Allowed 'General case' 0 CA--C 1.498 -1.028 0 CA-C-N 120.525 1.511 . . . . 0.0 110.462 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.446 ' N ' ' HG3' ' A' ' 56' ' ' ARG . 3.3 m-20 -78.4 86.64 4.45 Favored 'General case' 0 CA--C 1.499 -1.011 0 N-CA-C 102.338 -3.208 . . . . 0.0 102.338 -179.652 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -122.95 115.42 45.74 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.188 0 N-CA-C 117.864 2.542 . . . . 0.0 117.864 -179.475 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.404 ' OD1' ' N ' ' A' ' 59' ' ' ASP . 0.1 OUTLIER -64.69 147.6 52.71 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 104.024 -2.584 . . . . 0.0 104.024 178.909 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.508 ' CG2' ' HB2' ' A' ' 51' ' ' GLU . 1.8 t -124.71 46.43 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.019 0 CA-C-O 123.847 1.784 . . . . 0.0 106.523 -179.496 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.619 ' HB ' ' HB ' ' A' ' 48' ' ' THR 0.304 0.5 OUTLIER -43.9 144.88 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.568 0 N-CA-C 116.414 2.005 . . . . 0.0 116.414 -179.309 . . . . . . . . 4 4 . 1 . 008 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.466 ' O ' ' N ' ' A' ' 64' ' ' LEU . 0.0 OUTLIER -154.51 92.79 1.52 Allowed 'General case' 0 N--CA 1.419 -2.022 0 CA-C-O 115.958 -1.972 . . . . 0.0 109.258 175.911 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.481 ' HA ' ' HA ' ' A' ' 46' ' ' LYS 0.263 1.2 mt-10 -66.45 94.77 0.29 Allowed 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 100.538 -3.875 . . . . 0.0 100.538 178.541 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.674 ' HB3' ' CE2' ' A' ' 82' ' ' TRP . 0.0 OUTLIER -12.22 89.08 0.01 OUTLIER 'General case' 0 N--CA 1.426 -1.664 0 O-C-N 128.006 3.316 . . . . 0.0 112.135 -178.566 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.565 ' N ' ' CD1' ' A' ' 82' ' ' TRP . . . 96.16 36.65 5.13 Favored Glycine 0 C--N 1.351 1.368 0 N-CA-C 121.586 3.395 . . . . 0.0 121.586 179.2 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . 0.409 38.1 t -121.48 77.99 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 N-CA-C 105.039 -2.208 . . . . 0.0 105.039 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -14.38 127.8 0.01 OUTLIER 'General case' 0 CA--C 1.48 -1.733 0 O-C-N 128.077 3.361 . . . . 0.0 116.513 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.576 ' CZ ' ' HA ' ' A' ' 81' ' ' THR . 8.9 p90 -147.93 164.05 34.95 Favored 'General case' 0 N--CA 1.441 -0.899 0 O-C-N 119.072 -2.267 . . . . 0.0 112.544 -178.75 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -116.11 148.41 40.31 Favored 'General case' 0 C--O 1.243 0.729 0 O-C-N 126.47 2.356 . . . . 0.0 105.445 179.351 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.907 ' HB3' HD22 ' A' ' 78' ' ' LEU . 2.9 t80 -116.65 -47.6 2.71 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-O 116.637 -1.649 . . . . 0.0 114.2 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.468 ' HA ' ' N ' ' A' ' 77' ' ' GLU . 2.5 t 70.01 104.43 0.06 Allowed 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 -179.507 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 6.1 mt -69.53 -175.81 0.9 Allowed 'General case' 0 C--N 1.302 -1.476 0 O-C-N 128.441 3.588 . . . . 0.0 109.172 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -105.97 -2.92 22.31 Favored 'General case' 0 N--CA 1.443 -0.817 0 O-C-N 128.089 3.368 . . . . 0.0 114.276 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -121.74 -47.15 2.21 Favored 'General case' 0 N--CA 1.435 -1.175 0 O-C-N 121.677 -0.639 . . . . 0.0 110.848 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -110.15 -10.11 22.87 Favored Glycine 0 CA--C 1.537 1.443 0 O-C-N 124.455 1.097 . . . . 0.0 115.774 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.673 HG23 ' N ' ' A' ' 77' ' ' GLU 0.349 0.7 OUTLIER 72.28 172.47 0.31 Allowed 'General case' 0 CA--C 1.501 -0.915 0 C-N-CA 115.793 -2.363 . . . . 0.0 110.27 -179.838 . . . . . . . . 4 4 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.673 ' N ' HG23 ' A' ' 76' ' ' THR . 0.2 OUTLIER 47.01 -171.28 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.818 1 O-C-N 129.391 4.182 . . . . 0.0 110.309 179.947 . . . . . . . . 4 4 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.907 HD22 ' HB3' ' A' ' 70' ' ' TYR 0.339 4.8 tt 130.9 141.62 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.808 0 O-C-N 128.423 3.577 . . . . 0.0 102.247 180.0 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.414 ' N ' HD23 ' A' ' 78' ' ' LEU . 17.3 m -163.48 128.74 3.03 Favored 'General case' 0 C--O 1.199 -1.56 0 N-CA-C 103.17 -2.9 . . . . 0.0 103.17 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.405 ' HA3' ' HA ' ' A' ' 93' ' ' PHE . . . 179.56 -135.25 2.46 Favored Glycine 0 C--N 1.31 -0.905 0 C-N-CA 118.583 -1.77 . . . . 0.0 110.315 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.576 ' HA ' ' CZ ' ' A' ' 68' ' ' PHE . 33.6 p -164.59 164.27 21.64 Favored 'General case' 0 C--O 1.188 -2.132 0 C-N-CA 117.214 -1.794 . . . . 0.0 111.779 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' TRP . . . . . 0.688 ' CG ' ' N ' ' A' ' 83' ' ' THR 0.408 1.4 p-90 -74.67 -171.59 1.31 Allowed 'General case' 0 C--N 1.31 -1.112 1 N-CA-C 100.025 -4.065 . . . . 0.0 100.025 175.735 . . . . . . . . 4 3 . 1 . 008 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.688 ' N ' ' CG ' ' A' ' 82' ' ' TRP . 0.3 OUTLIER 172.4 118.17 0.02 OUTLIER 'General case' 0 N--CA 1.432 -1.331 0 CA-C-O 124.404 2.05 . . . . 0.0 113.316 174.913 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.591 ' HB2' ' CZ3' ' A' ' 82' ' ' TRP . 2.8 ttp -84.86 101.23 12.13 Favored 'General case' 0 N--CA 1.433 -1.275 0 O-C-N 120.852 -1.155 . . . . 0.0 108.076 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.429 ' CG ' ' CG2' ' A' ' 90' ' ' VAL 0.673 0.8 OUTLIER -54.82 -87.1 0.0 OUTLIER 'General case' 0 N--CA 1.432 -1.368 0 CA-C-O 125.918 2.77 . . . . 0.0 111.076 179.982 . . . . . . . . 4 4 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -138.65 -80.04 0.08 OUTLIER Glycine 0 N--CA 1.443 -0.852 0 N-CA-C 104.238 -3.545 . . . . 0.0 104.238 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -95.1 5.34 52.13 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 116.404 -1.76 . . . . 0.0 115.054 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.46 ' HE2' HG21 ' A' ' 105' ' ' VAL 0.371 0.6 OUTLIER -147.55 162.89 38.18 Favored 'General case' 0 CA--C 1.493 -1.215 0 O-C-N 126.281 2.238 . . . . 0.0 110.892 -179.967 . . . . . . . . 4 4 . 1 . 008 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.803 HD22 ' HD2' ' A' ' 106' ' ' ARG . 5.5 tt -104.76 150.6 24.63 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 103.322 -2.844 . . . . 0.0 103.322 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.663 HG12 ' O ' ' A' ' 104' ' ' ALA . 0.0 OUTLIER -136.61 165.42 28.62 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.913 0 CA-C-O 123.849 1.785 . . . . 0.0 106.247 -179.808 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -128.83 97.4 0.43 Allowed Glycine 0 C--N 1.345 1.051 0 C-N-CA 128.636 3.017 . . . . 0.0 109.718 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 16.7 mtpt -95.29 139.74 31.17 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 102.375 -3.194 . . . . 0.0 102.375 179.614 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.648 ' HD2' HD22 ' A' ' 102' ' ' LEU . 75.6 m-85 -149.84 121.4 7.99 Favored 'General case' 0 CA--C 1.501 -0.936 0 CA-C-O 124.284 1.992 . . . . 0.0 111.724 -179.717 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 31.0 mttt -91.15 -175.61 4.34 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-N 113.885 -1.507 . . . . 0.0 110.129 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.411 ' CB ' ' HB3' ' A' ' 98' ' ' ASN 0.366 1.4 mmt85 -128.63 128.32 43.94 Favored 'General case' 0 CA--C 1.489 -1.398 0 O-C-N 124.817 1.323 . . . . 0.0 107.879 -179.98 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.582 HG23 ' H ' ' A' ' 97' ' ' ASP . 0.8 OUTLIER -33.11 -63.26 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 C-N-CA 126.841 2.056 . . . . 0.0 113.938 -179.881 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.582 ' H ' HG23 ' A' ' 96' ' ' VAL 0.368 0.0 OUTLIER -101.44 -22.24 14.6 Favored 'General case' 0 C--O 1.258 1.535 0 O-C-N 119.892 -1.755 . . . . 0.0 115.293 -179.811 . . . . . . . . 4 4 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.411 ' HB3' ' CB ' ' A' ' 95' ' ' ARG . 46.5 t30 -77.45 -26.39 51.46 Favored 'General case' 0 N--CA 1.422 -1.827 0 CA-C-N 113.576 -1.647 . . . . 0.0 113.678 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 48.18 22.96 2.53 Favored Glycine 0 CA--C 1.531 1.05 0 O-C-N 127.287 2.867 . . . . 0.0 118.05 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 15.5 mmtp -75.36 -108.72 0.01 OUTLIER 'General case' 0 C--O 1.199 -1.592 0 O-C-N 119.842 -1.976 . . . . 0.0 108.17 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.483 ' HG2' ' N ' ' A' ' 102' ' ' LEU . 1.0 OUTLIER 173.22 179.18 0.09 Allowed 'General case' 0 C--N 1.316 -0.861 0 C-N-CA 129.286 3.034 . . . . 0.0 109.425 179.993 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.67 ' HG ' ' HA ' ' A' ' 119' ' ' TYR . 3.5 tt -166.15 139.94 4.26 Favored 'General case' 0 C--O 1.245 0.859 1 O-C-N 129.139 4.024 . . . . 0.0 106.231 179.34 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.524 HG23 ' HB3' ' A' ' 117' ' ' TYR . 4.2 tp -128.16 156.07 40.09 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.068 0 N-CA-C 105.039 -2.208 . . . . 0.0 105.039 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.663 ' O ' HG12 ' A' ' 90' ' ' VAL . . . -153.25 145.2 23.64 Favored 'General case' 0 C--N 1.313 -0.998 0 O-C-N 119.213 -2.179 . . . . 0.0 106.714 -179.599 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.605 ' HB ' ' CE2' ' A' ' 117' ' ' TYR . 8.4 p -124.8 113.09 34.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 121.642 2.019 . . . . 0.0 111.709 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.803 ' HD2' HD22 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -82.0 83.89 7.13 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 105.296 -2.113 . . . . 0.0 105.296 179.99 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 69.7 tt0 -90.66 77.5 6.35 Favored 'General case' 0 N--CA 1.418 -2.052 0 O-C-N 128.071 3.357 . . . . 0.0 112.357 -179.324 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.573 HD11 ' CH2' ' A' ' 6' ' ' TRP 0.406 2.1 tt -57.13 118.55 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 C-N-CA 115.652 -2.419 . . . . 0.0 112.313 179.736 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 36.6 m -109.6 60.74 0.6 Allowed 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 117.695 -1.145 . . . . 0.0 108.397 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 83.53 -108.33 3.03 Favored Glycine 0 C--N 1.347 1.193 0 O-C-N 126.701 2.501 . . . . 0.0 111.391 -179.629 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . 0.323 0.0 OUTLIER -89.05 13.38 13.13 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 115.78 -2.057 . . . . 0.0 111.38 -179.823 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -136.52 115.93 12.73 Favored 'General case' 0 C--O 1.208 -1.124 0 O-C-N 127.968 3.292 . . . . 0.0 113.515 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.535 ' HA ' HG13 ' A' ' 108' ' ' ILE . 0.1 OUTLIER -88.85 143.34 26.95 Favored 'General case' 0 C--O 1.213 -0.83 0 N-CA-C 100.725 -3.806 . . . . 0.0 100.725 179.719 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.636 HG12 HG23 ' A' ' 127' ' ' ILE . 71.3 mt -138.77 118.85 14.85 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.973 0 O-C-N 127.661 3.1 . . . . 0.0 105.269 179.714 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' GLN . . . . . 0.43 ' O ' ' HG2' ' A' ' 126' ' ' ARG . 12.4 mt-30 -100.97 122.28 43.24 Favored 'General case' 0 CA--C 1.505 -0.759 0 O-C-N 126.036 2.085 . . . . 0.0 105.812 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.549 ' HB ' ' HA ' ' A' ' 125' ' ' LYS . 0.6 OUTLIER -140.55 152.16 45.31 Favored 'General case' 0 N--CA 1.419 -2.013 0 O-C-N 121.098 -1.001 . . . . 0.0 112.328 -179.644 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.605 ' CE2' ' HB ' ' A' ' 105' ' ' VAL 0.377 22.4 m-85 135.69 -140.97 0.0 OUTLIER 'General case' 0 CA--C 1.478 -1.795 0 O-C-N 128.852 3.845 . . . . 0.0 113.493 176.58 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.514 HG23 ' N ' ' A' ' 119' ' ' TYR . 4.8 t -151.71 -155.76 0.65 Allowed 'General case' 0 C--N 1.312 -1.055 0 O-C-N 127.278 2.861 . . . . 0.0 116.044 -174.898 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.67 ' HA ' ' HG ' ' A' ' 102' ' ' LEU 0.282 2.6 t80 -109.53 -57.46 2.17 Favored 'General case' 0 C--O 1.217 -0.636 0 CA-C-O 125.434 2.54 . . . . 0.0 104.82 177.721 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.501 ' HG3' ' CE2' ' A' ' 119' ' ' TYR . 3.7 mt-10 -123.38 -80.7 0.63 Allowed 'General case' 0 N--CA 1.436 -1.126 0 CA-C-N 112.591 -2.095 . . . . 0.0 111.981 179.416 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -137.03 36.07 2.01 Favored Glycine 0 C--N 1.36 1.872 0 N-CA-C 119.259 2.464 . . . . 0.0 119.259 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 65.3 t -137.02 91.26 0.83 Allowed 'Isoleucine or valine' 0 C--O 1.215 -0.739 0 N-CA-C 103.535 -2.765 . . . . 0.0 103.535 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.506 ' HA ' ' HB ' ' A' ' 118' ' ' THR . 1.5 mp0 -63.02 178.61 0.46 Allowed 'General case' 0 C--N 1.311 -1.102 0 CA-C-O 125.525 2.584 . . . . 0.0 113.955 -178.223 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.676 ' HB1' ' CD1' ' A' ' 14' ' ' TYR . . . -163.67 177.21 8.9 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 112.572 -3.585 . . . . 0.0 106.799 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.549 ' HA ' ' HB ' ' A' ' 116' ' ' THR 0.337 0.0 OUTLIER -161.92 131.44 4.58 Favored 'General case' 0 C--O 1.249 1.047 1 O-C-N 129.454 4.221 . . . . 0.0 107.423 -179.906 . . . . . . . . 5 4 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.769 HH21 HD22 ' A' ' 36' ' ' LEU . 7.7 ptm180 -132.02 85.78 2.28 Favored 'General case' 0 N--CA 1.426 -1.634 0 CA-C-O 114.556 -2.64 . . . . 0.0 111.653 -179.688 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.636 HG23 HG12 ' A' ' 114' ' ' ILE . 1.0 OUTLIER -64.82 105.21 0.52 Allowed 'Isoleucine or valine' 0 C--O 1.25 1.121 1 O-C-N 132.138 5.899 . . . . 0.0 113.75 178.827 . . . . . . . . 4 4 . 1 . 008 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.635 ' HE2' HD21 ' A' ' 36' ' ' LEU . 0.0 OUTLIER -87.74 131.96 34.31 Favored 'General case' 0 N--CA 1.432 -1.352 0 CA-C-N 111.71 -2.495 . . . . 0.0 107.029 179.957 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 3.1 mmmp? -100.09 47.68 0.94 Allowed 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 114.394 -2.717 . . . . 0.0 110.059 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.511 ' HA ' ' HA ' ' A' ' 6' ' ' TRP . 2.0 ttpm? 26.09 98.49 0.0 OUTLIER 'General case' 0 CA--C 1.518 -0.283 0 O-C-N 126.441 2.338 . . . . 0.0 115.401 179.378 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . 0.914 25.5 tt0 . . . . . 0 N--CA 1.446 -0.629 0 CA-C-N 120.327 1.422 . . . . 0.0 113.327 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' PHE . . . . . 0.476 ' N ' ' CD1' ' A' ' 2' ' ' PHE . 2.2 p90 . . . . . 0 N--CA 1.448 -0.564 0 N-CA-C 116.645 2.091 . . . . 0.0 116.645 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -143.56 99.83 3.49 Favored 'General case' 0 CA--C 1.501 -0.942 0 CA-C-N 114.621 -1.172 . . . . 0.0 110.96 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 151.12 -107.5 0.34 Allowed Glycine 0 C--O 1.213 -1.161 0 CA-C-O 117.844 -1.531 . . . . 0.0 113.0 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.533 ' HA ' ' HA ' ' A' ' 39' ' ' THR 0.482 1.1 t -137.01 173.55 11.58 Favored 'General case' 0 C--N 1.309 -1.157 0 O-C-N 127.397 2.469 . . . . 0.0 110.011 179.797 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.557 ' CZ3' ' HG3' ' A' ' 130' ' ' LYS . 91.6 m95 -161.56 150.19 15.7 Favored 'General case' 0 N--CA 1.427 -1.584 0 O-C-N 126.247 2.217 . . . . 0.0 108.287 -179.751 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 12.9 tttt -151.89 102.65 2.85 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-O 115.014 -2.422 . . . . 0.0 107.066 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.571 HG12 ' HB3' ' A' ' 36' ' ' LEU 0.323 5.7 p -46.84 138.94 1.82 Allowed 'Isoleucine or valine' 0 C--O 1.249 1.038 0 CA-C-N 121.024 1.738 . . . . 0.0 112.685 179.816 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -153.44 21.05 0.55 Allowed 'General case' 0 CA--C 1.498 -1.044 0 CA-C-O 123.427 1.584 . . . . 0.0 112.425 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.446 ' CG ' ' HB ' ' A' ' 127' ' ' ILE 0.259 1.2 ptp85 -155.63 -49.48 0.08 Allowed 'General case' 0 C--N 1.301 -1.52 0 O-C-N 117.285 -3.384 . . . . 0.0 110.468 179.727 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.414 ' N ' ' HG3' ' A' ' 10' ' ' ARG 0.373 0.5 OUTLIER 51.11 -176.09 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.67 0 O-C-N 126.411 2.319 . . . . 0.0 110.719 179.8 . . . . . . . . 4 4 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -146.88 -85.42 0.11 Allowed 'General case' 0 C--N 1.301 -1.542 0 O-C-N 119.36 -2.087 . . . . 0.0 107.773 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -89.74 18.04 5.96 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 120.111 1.323 . . . . 0.0 114.207 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.631 ' HA ' ' HB1' ' A' ' 124' ' ' ALA . 79.4 t80 -59.45 -32.54 70.32 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 118.898 2.925 . . . . 0.0 118.898 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -76.13 -29.3 57.77 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 121.816 2.098 . . . . 0.0 111.436 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 16.2 mttp -75.52 -24.64 56.82 Favored 'General case' 0 N--CA 1.425 -1.68 0 O-C-N 126.801 2.563 . . . . 0.0 113.398 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.742 ' CB ' ' HB2' ' A' ' 124' ' ' ALA . 11.6 t80 -79.17 -20.39 48.58 Favored 'General case' 0 N--CA 1.428 -1.538 0 O-C-N 121.763 -0.586 . . . . 0.0 110.944 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.451 ' HB3' HG13 ' A' ' 23' ' ' ILE . 0.4 OUTLIER -74.48 -35.07 63.25 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-O 122.902 1.334 . . . . 0.0 107.881 179.99 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . 0.267 7.1 tt0 -72.87 -25.67 61.18 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 126.232 2.92 . . . . 0.0 112.232 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 27.2 tptt -79.9 -29.73 39.96 Favored 'General case' 0 C--N 1.319 -0.753 0 O-C-N 119.423 -2.048 . . . . 0.0 111.361 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.518 ' CE ' HD13 ' A' ' 72' ' ' LEU . 1.1 mmm -75.73 -28.91 58.73 Favored 'General case' 0 C--O 1.217 -0.651 0 CA-C-O 124.552 2.12 . . . . 0.0 108.885 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 109.01 43.42 1.2 Allowed Glycine 0 N--CA 1.443 -0.896 0 CA-C-O 116.171 -2.46 . . . . 0.0 109.928 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.603 HG21 ' HA ' ' A' ' 28' ' ' ARG . 3.5 mm -90.76 134.47 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 CA-C-N 119.551 1.676 . . . . 0.0 108.689 -179.443 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -78.47 132.64 37.34 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-O 114.387 -2.721 . . . . 0.0 113.614 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . 0.375 60.5 t -8.68 -53.59 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 O-C-N 128.889 3.868 . . . . 0.0 117.605 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.608 0.3 OUTLIER -79.75 -40.17 20.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 115.154 1.538 . . . . 0.0 115.154 -179.728 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.436 ' HD3' ' HB2' ' A' ' 74' ' ' ASP . 8.5 ttmm -60.67 -24.1 65.33 Favored 'General case' 0 N--CA 1.443 -0.783 0 O-C-N 127.237 2.836 . . . . 0.0 113.233 179.481 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.603 ' HA ' HG21 ' A' ' 23' ' ' ILE . 5.4 ptt85 -76.95 -30.88 56.23 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 15.0 ttmt -75.65 -29.01 58.98 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-O 123.47 1.605 . . . . 0.0 110.327 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -76.1 -34.46 59.51 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 116.086 -1.912 . . . . 0.0 110.018 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -70.99 -25.06 76.46 Favored Glycine 0 C--O 1.21 -1.401 0 O-C-N 125.032 1.457 . . . . 0.0 112.255 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -77.52 -34.51 53.97 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 116.457 -1.735 . . . . 0.0 111.322 179.483 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -103.63 21.63 15.81 Favored 'General case' 0 N--CA 1.445 -0.676 0 O-C-N 126.958 2.661 . . . . 0.0 113.918 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.406 ' HB3' ' HB2' ' A' ' 53' ' ' SER . 0.8 OUTLIER -69.78 -29.79 67.19 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 114.709 1.374 . . . . 0.0 114.709 -179.761 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . 0.283 77.0 m-20 76.55 27.86 0.77 Allowed 'General case' 0 C--O 1.245 0.821 0 O-C-N 118.63 -2.544 . . . . 0.0 109.542 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.681 HD21 HD13 ' A' ' 38' ' ' LEU . 1.2 tt -44.73 91.6 0.0 OUTLIER 'General case' 0 C--O 1.212 -0.876 0 O-C-N 126.156 2.16 . . . . 0.0 111.033 -179.414 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 8.7 tttt -97.33 103.22 15.13 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 101.682 -3.451 . . . . 0.0 101.682 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.681 HD13 HD21 ' A' ' 36' ' ' LEU 0.292 0.1 OUTLIER -91.29 147.32 23.13 Favored 'General case' 0 C--N 1.289 -2.03 0 CA-C-O 123.932 1.825 . . . . 0.0 106.591 -179.58 . . . . . . . . 4 4 . 1 . 009 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.55 ' HB ' ' HB3' ' A' ' 50' ' ' LYS . 2.4 m -129.19 103.15 6.79 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 102.498 -3.149 . . . . 0.0 102.498 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 59.3 mt -92.5 119.18 39.62 Favored 'Isoleucine or valine' 0 C--O 1.253 1.254 0 CA-C-O 124.13 1.919 . . . . 0.0 111.883 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 74.5 m -119.91 95.39 4.74 Favored 'General case' 0 C--N 1.348 0.542 0 CA-C-N 110.733 -2.939 . . . . 0.0 110.087 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.59 125.71 29.74 Favored 'General case' 0 C--N 1.313 -1.017 0 O-C-N 127.153 2.783 . . . . 0.0 108.705 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -158.1 112.7 2.59 Favored 'General case' 0 N--CA 1.417 -2.097 0 O-C-N 119.26 -2.15 . . . . 0.0 111.954 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 54.03 42.08 70.27 Favored Glycine 0 N--CA 1.428 -1.889 0 CA-C-N 114.386 -1.279 . . . . 0.0 109.934 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.311 4.4 m-20 83.26 -25.36 0.14 Allowed 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 112.556 -1.822 . . . . 0.0 112.224 179.78 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 5.7 ttmt -76.37 144.16 40.27 Favored 'General case' 0 C--N 1.307 -1.271 0 C-N-CA 115.639 -2.424 . . . . 0.0 108.681 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.593 ' CZ ' HD21 ' A' ' 64' ' ' LEU . 2.8 m-85 -119.59 87.85 2.82 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 118.164 -0.922 . . . . 0.0 111.534 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.983 ' HA ' HG13 ' A' ' 61' ' ' VAL 0.427 0.1 OUTLIER -61.04 118.54 6.89 Favored 'General case' 0 C--O 1.244 0.812 0 C-N-CA 115.206 -2.598 . . . . 0.0 109.502 -179.721 . . . . . . . . 4 4 . 1 . 009 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.549 ' CG2' ' HG ' ' A' ' 38' ' ' LEU 0.713 8.4 p -101.27 85.94 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 O-C-N 125.173 1.546 . . . . 0.0 108.592 179.557 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.55 ' HB3' ' HB ' ' A' ' 39' ' ' THR . 2.5 tttp -77.41 103.68 7.48 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 105.383 -2.08 . . . . 0.0 105.383 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -95.36 89.48 5.47 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 127.2 2.2 . . . . 0.0 105.413 -179.58 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -88.27 57.51 4.3 Favored 'General case' 0 C--N 1.289 -2.061 0 O-C-N 119.91 -1.744 . . . . 0.0 106.975 -179.66 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.406 ' HB2' ' HB3' ' A' ' 34' ' ' ASP . 80.7 p -83.11 160.17 21.94 Favored 'General case' 0 C--O 1.209 -1.065 0 CA-C-O 116.529 -1.701 . . . . 0.0 108.466 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 56.6 t30 -50.54 -32.64 18.98 Favored 'General case' 0 N--CA 1.435 -1.182 0 O-C-N 125.287 1.617 . . . . 0.0 109.498 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -62.66 -50.75 69.94 Favored 'General case' 0 C--N 1.352 0.71 0 C-N-CA 116.223 -2.191 . . . . 0.0 111.193 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 29.8 ttm-85 -176.11 148.8 0.83 Allowed 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 121.663 2.029 . . . . 0.0 106.959 178.737 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -95.3 83.35 3.84 Favored 'General case' 0 C--O 1.22 -0.467 0 N-CA-C 100.441 -3.911 . . . . 0.0 100.441 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.5 tp -105.58 101.42 12.37 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.238 0 O-C-N 128.015 3.322 . . . . 0.0 116.527 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.457 ' OD1' HG22 ' A' ' 61' ' ' VAL . 29.2 t0 -58.21 137.21 57.23 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 103.229 -2.878 . . . . 0.0 103.229 177.593 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.6 HG12 ' N ' ' A' ' 61' ' ' VAL . 2.2 t -101.33 -67.75 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 N-CA-C 106.506 -1.664 . . . . 0.0 106.506 -176.419 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.983 HG13 ' HA ' ' A' ' 48' ' ' THR 0.506 0.0 OUTLIER 75.44 134.04 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 CA-C-O 124.065 1.888 . . . . 0.0 112.582 179.557 . . . . . . . . 4 4 . 1 . 009 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.64 ' CE2' ' CD1' ' A' ' 82' ' ' TRP . 3.9 p90 -168.98 110.71 0.5 Allowed 'General case' 0 N--CA 1.436 -1.17 0 CA-C-N 112.332 -2.213 . . . . 0.0 111.911 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -62.04 125.64 24.57 Favored 'General case' 0 N--CA 1.441 -0.914 0 N-CA-C 102.462 -3.162 . . . . 0.0 102.462 179.691 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.593 HD21 ' CZ ' ' A' ' 47' ' ' PHE . 0.6 OUTLIER -48.21 125.59 9.59 Favored 'General case' 0 N--CA 1.428 -1.559 0 O-C-N 124.466 1.104 . . . . 0.0 111.503 -179.728 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' 82' ' ' TRP . . . 73.61 12.36 80.47 Favored Glycine 0 C--N 1.344 1.006 0 O-C-N 126.73 2.519 . . . . 0.0 117.036 -179.826 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . 0.419 44.0 t -81.18 -99.91 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.431 -1.389 0 CA-C-O 118.373 -0.822 . . . . 0.0 109.053 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.9 t70 165.37 130.08 0.01 OUTLIER 'General case' 0 CA--C 1.49 -1.346 0 CA-C-N 119.285 0.948 . . . . 0.0 110.567 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -135.48 174.75 10.27 Favored 'General case' 0 N--CA 1.428 -1.545 0 CA-C-N 120.156 1.344 . . . . 0.0 109.281 179.683 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -132.65 127.45 34.91 Favored 'General case' 0 C--O 1.244 0.801 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -157.19 125.23 5.5 Favored 'General case' 0 N--CA 1.443 -0.784 0 C-N-CA 118.632 -1.227 . . . . 0.0 113.563 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 18.3 t -57.67 156.92 7.78 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 105.124 -2.176 . . . . 0.0 105.124 179.559 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.808 HD11 HD12 ' A' ' 78' ' ' LEU . 8.4 mt -101.77 9.7 40.63 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-O 118.148 -0.93 . . . . 0.0 109.873 -179.35 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.423 ' HB3' ' O ' ' A' ' 72' ' ' LEU . . . 79.61 -4.24 2.0 Favored 'General case' 0 N--CA 1.438 -1.071 0 O-C-N 126.802 2.564 . . . . 0.0 113.174 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.456 ' OD2' HD13 ' A' ' 23' ' ' ILE . 28.9 t70 -165.96 -51.06 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 123.825 1.774 . . . . 0.0 110.259 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -67.8 -6.65 44.98 Favored Glycine 0 C--N 1.347 1.192 0 CA-C-N 113.704 -1.589 . . . . 0.0 112.98 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.548 HG22 ' H ' ' A' ' 77' ' ' GLU 0.274 0.2 OUTLIER 78.62 163.31 0.21 Allowed 'General case' 0 N--CA 1.435 -1.204 0 CA-C-N 119.699 1.75 . . . . 0.0 115.298 179.678 . . . . . . . . 4 4 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.548 ' H ' HG22 ' A' ' 76' ' ' THR . 1.1 mt-10 -36.61 98.43 0.01 OUTLIER 'General case' 0 N--CA 1.44 -0.945 0 O-C-N 128.392 3.558 . . . . 0.0 113.091 179.63 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.808 HD12 HD11 ' A' ' 72' ' ' LEU 0.472 5.5 tt -97.04 158.19 15.55 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 101.929 -3.36 . . . . 0.0 101.929 179.621 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 14.5 m -157.82 124.14 4.8 Favored 'General case' 0 CA--C 1.498 -1.054 0 N-CA-C 102.047 -3.316 . . . . 0.0 102.047 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -162.97 -175.83 34.4 Favored Glycine 0 C--N 1.292 -1.89 0 C-N-CA 115.746 -3.121 . . . . 0.0 111.959 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 15.7 p -137.87 159.82 40.97 Favored 'General case' 0 C--O 1.192 -1.965 0 C-N-CA 119.313 -0.955 . . . . 0.0 110.116 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' TRP . . . . . 0.64 ' CD1' ' CE2' ' A' ' 62' ' ' PHE . 72.2 m95 -118.74 137.75 53.14 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 100.624 -3.843 . . . . 0.0 100.624 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 13.5 t -147.74 143.15 27.36 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 123.597 1.665 . . . . 0.0 109.497 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.98 139.02 41.31 Favored 'General case' 0 N--CA 1.44 -0.965 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . 0.72 5.2 mt-10 -127.81 30.57 5.27 Favored 'General case' 0 C--N 1.307 -1.254 0 C-N-CA 116.687 -2.005 . . . . 0.0 109.686 179.733 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 71.5 97.68 0.06 OUTLIER Glycine 0 N--CA 1.436 -1.358 0 N-CA-C 106.147 -2.781 . . . . 0.0 106.147 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . 0.28 61.2 m-80 79.06 -7.53 1.75 Allowed 'General case' 0 C--O 1.236 0.387 0 N-CA-C 117.893 2.553 . . . . 0.0 117.893 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . 0.341 0.4 OUTLIER -143.73 133.13 23.33 Favored 'General case' 0 CA--C 1.498 -1.043 0 O-C-N 125.713 1.883 . . . . 0.0 106.575 179.988 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.78 HD13 HH11 ' A' ' 106' ' ' ARG . 0.2 OUTLIER -97.21 107.28 19.76 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 102.516 -3.142 . . . . 0.0 102.516 179.839 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.546 HG12 ' CG2' ' A' ' 105' ' ' VAL . 1.0 OUTLIER -98.55 156.42 3.72 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.939 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 179.888 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -134.55 104.95 0.53 Allowed Glycine 0 C--N 1.347 1.162 0 C-N-CA 129.969 3.652 . . . . 0.0 110.45 179.7 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.413 ' HA ' ' HA ' ' A' ' 103' ' ' ILE . 18.1 mtmt -102.92 117.09 33.83 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 104.541 -2.392 . . . . 0.0 104.541 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.411 ' CD2' HD11 ' A' ' 78' ' ' LEU . 16.0 m-30 -107.58 118.19 36.08 Favored 'General case' 0 C--N 1.328 -0.327 0 O-C-N 125.288 1.617 . . . . 0.0 111.839 -179.741 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.409 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 4.6 mtmt -102.03 161.56 13.59 Favored 'General case' 0 C--O 1.21 -0.981 0 CA-C-N 114.215 -1.357 . . . . 0.0 110.372 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . 0.377 0.0 OUTLIER -107.48 144.98 33.67 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-O 116.849 -1.548 . . . . 0.0 107.672 179.936 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.411 ' HB ' ' HB3' ' A' ' 77' ' ' GLU . 57.0 t -82.24 -30.55 9.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 C-N-CA 126.641 1.976 . . . . 0.0 114.094 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . 0.343 0.1 OUTLIER -110.0 -3.96 16.18 Favored 'General case' 0 C--O 1.259 1.568 0 N-CA-C 115.413 1.634 . . . . 0.0 115.413 179.925 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 44.1 t30 -112.46 -22.49 10.81 Favored 'General case' 0 N--CA 1.422 -1.857 0 N-CA-C 115.258 1.577 . . . . 0.0 115.258 -179.599 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 60.22 26.97 64.53 Favored Glycine 0 CA--C 1.53 0.985 0 N-CA-C 117.489 1.756 . . . . 0.0 117.489 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 15.2 mmtm -90.91 -113.33 0.08 Allowed 'General case' 0 CA--C 1.553 1.072 0 O-C-N 120.237 -1.743 . . . . 0.0 112.015 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 151.79 144.04 0.0 OUTLIER 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 129.882 3.273 . . . . 0.0 108.778 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.71 HD12 ' CD1' ' A' ' 119' ' ' TYR . 2.4 tt -127.87 176.34 7.65 Favored 'General case' 0 CA--C 1.511 -0.551 2 O-C-N 129.787 4.429 . . . . 0.0 106.835 -179.808 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.513 HG13 ' N ' ' A' ' 104' ' ' ALA . 0.1 OUTLIER -149.14 173.21 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.502 -0.869 0 C-N-CA 117.93 -1.508 . . . . 0.0 109.491 -179.725 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.513 ' N ' HG13 ' A' ' 103' ' ' ILE . . . -154.46 133.36 12.3 Favored 'General case' 0 C--N 1.313 -1.013 0 O-C-N 117.709 -3.119 . . . . 0.0 107.418 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.546 ' CG2' HG12 ' A' ' 90' ' ' VAL . 0.9 OUTLIER -121.1 99.18 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 CA-C-N 122.113 2.233 . . . . 0.0 108.615 179.97 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.78 HH11 HD13 ' A' ' 89' ' ' LEU 0.259 75.3 mtt180 -71.62 91.83 1.11 Allowed 'General case' 0 CA--C 1.503 -0.834 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 179.944 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.432 ' O ' ' N ' ' A' ' 109' ' ' SER . 0.1 OUTLIER -89.85 83.53 6.18 Favored 'General case' 0 N--CA 1.432 -1.359 0 CA-C-N 112.316 -2.22 . . . . 0.0 114.758 -179.638 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.409 HD13 ' HA ' ' A' ' 108' ' ' ILE 0.276 8.5 mm -62.17 93.81 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 C-N-CA 116.926 -1.909 . . . . 0.0 106.865 179.435 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.432 ' N ' ' O ' ' A' ' 107' ' ' GLU . 6.1 m -65.8 -20.85 66.4 Favored 'General case' 0 N--CA 1.439 -0.992 0 C-N-CA 125.426 1.491 . . . . 0.0 109.605 -179.462 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 123.01 97.8 1.35 Allowed Glycine 0 C--O 1.218 -0.845 0 C-N-CA 129.907 3.622 . . . . 0.0 110.387 -179.267 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . 0.326 0.8 OUTLIER 90.49 -27.27 0.05 OUTLIER 'General case' 0 C--N 1.308 -1.199 0 O-C-N 128.235 2.962 . . . . 0.0 109.944 -179.068 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.464 ' HG2' ' HA ' ' A' ' 129' ' ' LYS . 88.6 mt-10 -115.51 124.15 50.35 Favored 'General case' 0 C--N 1.361 1.072 0 CA-C-O 117.014 -1.469 . . . . 0.0 110.986 179.593 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 30.2 tp -96.82 116.85 29.87 Favored 'General case' 0 C--O 1.217 -0.627 0 N-CA-C 104.593 -2.373 . . . . 0.0 104.593 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.85 HG23 HG12 ' A' ' 127' ' ' ILE 0.27 2.9 mm -102.58 128.44 55.34 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 O-C-N 128.047 3.342 . . . . 0.0 104.417 -179.929 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -111.31 79.77 1.24 Allowed 'General case' 0 CA--C 1.494 -1.174 0 CA-C-O 124.041 1.877 . . . . 0.0 106.027 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.406 ' HA ' ' HA ' ' A' ' 125' ' ' LYS . 0.3 OUTLIER -73.13 115.0 11.93 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 104.633 -2.358 . . . . 0.0 104.633 179.668 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . 0.262 78.5 m-85 -106.53 145.71 31.52 Favored 'General case' 0 C--O 1.207 -1.168 0 O-C-N 126.818 2.574 . . . . 0.0 113.269 -179.562 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.499 HG23 ' H ' ' A' ' 120' ' ' GLU 0.289 0.8 OUTLIER -141.2 126.48 18.59 Favored 'General case' 0 N--CA 1.446 -0.633 1 O-C-N 130.594 4.934 . . . . 0.0 108.439 179.577 . . . . . . . . 5 4 . 1 . 009 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.71 ' CD1' HD12 ' A' ' 102' ' ' LEU 0.277 22.4 t80 -101.07 -0.13 36.87 Favored 'General case' 0 C--O 1.245 0.851 0 CA-C-N 119.818 1.19 . . . . 0.0 107.835 -179.71 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.499 ' H ' HG23 ' A' ' 118' ' ' THR . 0.0 OUTLIER 171.98 -79.95 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.543 0 O-C-N 126.211 2.194 . . . . 0.0 115.863 -179.527 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -130.47 30.47 3.44 Favored Glycine 0 C--N 1.353 1.513 0 N-CA-C 118.838 2.295 . . . . 0.0 118.838 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 54.9 t -145.65 113.88 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 103.972 -2.603 . . . . 0.0 103.972 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -83.51 -178.89 7.2 Favored 'General case' 0 C--O 1.21 -0.985 0 CA-C-O 124.727 2.203 . . . . 0.0 112.533 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.742 ' HB2' ' CB ' ' A' ' 17' ' ' PHE . . . -167.34 85.48 0.24 Allowed 'General case' 0 C--O 1.216 -0.687 0 CA-C-O 114.223 -2.799 . . . . 0.0 108.501 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.406 ' HA ' ' HA ' ' A' ' 116' ' ' THR . 0.1 OUTLIER -69.01 128.27 36.1 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 121.256 1.844 . . . . 0.0 109.631 -179.647 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.414 ' NH2' HD13 ' A' ' 36' ' ' LEU . 0.0 OUTLIER -119.21 82.2 1.83 Allowed 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 125.959 1.704 . . . . 0.0 107.232 -179.8 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.85 HG12 HG23 ' A' ' 114' ' ' ILE . 2.1 mt -78.9 117.68 24.9 Favored 'Isoleucine or valine' 0 C--O 1.245 0.837 0 O-C-N 127.426 2.954 . . . . 0.0 116.448 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.501 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 1.3 m-30 -94.55 166.42 12.04 Favored 'General case' 0 N--CA 1.432 -1.347 0 O-C-N 128.102 3.376 . . . . 0.0 107.926 -179.725 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.464 ' HA ' ' HG2' ' A' ' 112' ' ' GLU 0.258 8.5 mmtt -119.44 -4.17 10.4 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 119.573 -0.251 . . . . 0.0 111.235 -179.885 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.557 ' HG3' ' CZ3' ' A' ' 6' ' ' TRP . 4.2 tttp 73.28 116.18 0.05 Allowed 'General case' 0 C--O 1.215 -0.72 0 CA-C-O 115.765 -2.064 . . . . 0.0 108.024 -179.533 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . 0.797 3.4 mm-40 . . . . . 0 N--CA 1.424 -1.758 0 O-C-N 126.83 2.581 . . . . 0.0 115.126 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.435 -1.207 0 CA-C-O 121.493 0.663 . . . . 0.0 112.743 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -160.0 88.16 0.82 Allowed 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 112.513 -2.131 . . . . 0.0 111.878 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 153.07 -163.25 30.47 Favored Glycine 0 CA--C 1.495 -1.158 0 C-N-CA 115.635 -3.174 . . . . 0.0 109.168 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.423 ' HA ' ' HA ' ' A' ' 39' ' ' THR 0.49 22.0 m -97.18 161.42 13.82 Favored 'General case' 0 C--N 1.314 -0.954 0 O-C-N 126.281 1.812 . . . . 0.0 110.503 -179.658 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.774 ' CH2' HD11 ' A' ' 108' ' ' ILE . 87.9 m95 -139.75 156.67 46.65 Favored 'General case' 0 N--CA 1.434 -1.249 0 CA-C-N 112.665 -2.062 . . . . 0.0 106.72 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 24.0 tttt -159.92 90.97 0.94 Allowed 'General case' 0 C--O 1.203 -1.346 0 O-C-N 126.283 2.239 . . . . 0.0 107.217 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.599 ' HB ' ' CD1' ' A' ' 128' ' ' PHE 0.315 0.1 OUTLIER -37.65 127.4 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 O-C-N 126.634 2.458 . . . . 0.0 112.063 179.957 . . . . . . . . 4 4 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.446 ' HB2' ' CG ' ' A' ' 129' ' ' LYS . 40.1 t0 -100.0 -32.38 10.98 Favored 'General case' 0 C--O 1.208 -1.092 0 O-C-N 126.793 2.558 . . . . 0.0 105.293 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 5.7 ptp180 -170.73 153.69 4.14 Favored 'General case' 0 C--N 1.296 -1.748 0 C-N-CA 115.846 -2.342 . . . . 0.0 109.189 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . 0.293 0.0 OUTLIER -106.77 -171.38 1.88 Allowed 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 111.297 -2.683 . . . . 0.0 107.675 179.514 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.506 ' CB ' ' HB2' ' A' ' 125' ' ' LYS . 4.1 tm-20 -131.67 -71.68 0.55 Allowed 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 117.468 -1.693 . . . . 0.0 108.293 179.695 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.455 ' HB3' ' HA ' ' A' ' 124' ' ' ALA . 23.5 t30 -113.43 28.41 8.8 Favored 'General case' 0 N--CA 1.474 0.774 0 O-C-N 125.246 1.591 . . . . 0.0 113.197 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.529 ' CA ' ' HB1' ' A' ' 124' ' ' ALA 0.347 0.2 OUTLIER -72.49 -19.79 61.48 Favored 'General case' 0 C--N 1.312 -1.037 0 O-C-N 128.416 3.572 . . . . 0.0 115.421 179.994 . . . . . . . . 4 4 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -76.85 -30.7 56.4 Favored 'General case' 0 C--O 1.218 -0.588 0 CA-C-N 120.984 1.72 . . . . 0.0 108.683 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -79.83 -32.32 40.59 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 111.529 -2.578 . . . . 0.0 114.286 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.603 ' CE2' ' HA ' ' A' ' 118' ' ' THR . 0.0 OUTLIER -70.78 -37.63 73.35 Favored 'General case' 0 C--O 1.217 -0.625 0 CA-C-O 123.889 1.804 . . . . 0.0 108.466 179.87 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 3.3 mtm -75.21 -22.47 57.92 Favored 'General case' 0 N--CA 1.432 -1.334 0 CA-C-O 123.263 1.506 . . . . 0.0 109.617 -179.028 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.26 -31.58 58.39 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 126.229 2.919 . . . . 0.0 111.143 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 5.4 tptp -67.83 -29.59 68.78 Favored 'General case' 0 C--O 1.209 -1.065 0 O-C-N 119.431 -2.043 . . . . 0.0 112.846 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.462 ' HG2' ' CD1' ' A' ' 119' ' ' TYR . 56.7 mtp -79.38 -30.41 42.52 Favored 'General case' 0 C--N 1.346 0.452 0 N-CA-C 105.325 -2.102 . . . . 0.0 105.325 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 101.89 34.23 4.4 Favored Glycine 0 C--N 1.31 -0.871 0 CA-C-O 117.948 -1.474 . . . . 0.0 110.211 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.429 ' CG2' ' HB2' ' A' ' 27' ' ' LYS . 1.5 mm -67.73 135.74 27.92 Favored 'Isoleucine or valine' 0 C--N 1.361 1.102 0 CA-C-O 116.426 -1.749 . . . . 0.0 108.313 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 38.0 m-20 -74.95 147.82 40.55 Favored 'General case' 0 C--O 1.244 0.788 0 CA-C-O 115.255 -2.307 . . . . 0.0 113.555 179.762 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . 0.372 1.5 t -20.87 -57.3 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.508 -0.645 0 O-C-N 127.365 2.915 . . . . 0.0 117.819 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.547 1.9 m -73.67 -36.95 48.27 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.814 0 O-C-N 125.233 1.583 . . . . 0.0 112.073 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.429 ' HB2' ' CG2' ' A' ' 23' ' ' ILE . 6.7 mttm -63.69 -42.69 97.96 Favored 'General case' 0 CA--C 1.51 -0.57 0 O-C-N 125.057 1.473 . . . . 0.0 114.487 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 23.3 ptt85 -78.93 -23.68 44.52 Favored 'General case' 0 C--O 1.217 -0.638 0 CA-C-N 121.413 1.915 . . . . 0.0 108.464 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.9 ttpm? -76.09 -37.96 57.55 Favored 'General case' 0 N--CA 1.437 -1.096 0 CA-C-N 114.23 -1.35 . . . . 0.0 112.666 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.423 HD22 ' HA ' ' A' ' 30' ' ' LEU . 0.2 OUTLIER -77.05 -31.57 56.3 Favored 'General case' 0 N--CA 1.432 -1.327 0 CA-C-O 114.31 -2.757 . . . . 0.0 107.101 179.756 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -75.23 -21.53 77.75 Favored Glycine 0 CA--C 1.534 1.225 0 O-C-N 128.129 3.393 . . . . 0.0 114.425 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -78.37 -32.11 48.82 Favored 'General case' 0 C--N 1.314 -0.935 0 O-C-N 127.28 2.4 . . . . 0.0 110.898 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.413 ' NE2' HD22 ' A' ' 30' ' ' LEU . 5.6 p80 -120.38 1.47 10.72 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 114.665 -1.152 . . . . 0.0 113.596 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 18.0 p30 -42.01 -19.92 0.01 OUTLIER 'General case' 0 CA--C 1.495 -1.156 0 N-CA-C 116.035 1.865 . . . . 0.0 116.035 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . 0.286 70.3 m-80 75.07 31.32 0.84 Allowed 'General case' 0 C--N 1.311 -1.092 0 CA-C-O 115.635 -2.126 . . . . 0.0 109.198 179.668 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.584 HD21 HD13 ' A' ' 38' ' ' LEU . 0.3 OUTLIER -45.64 103.48 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.964 0 O-C-N 127.559 3.037 . . . . 0.0 107.179 179.971 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.406 ' HE3' HG21 ' A' ' 5' ' ' THR . 30.9 tttp -96.79 112.13 24.01 Favored 'General case' 0 C--O 1.219 -0.517 0 N-CA-C 102.067 -3.309 . . . . 0.0 102.067 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.584 HD13 HD21 ' A' ' 36' ' ' LEU 0.279 1.0 OUTLIER -103.6 112.12 24.89 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 121.399 1.909 . . . . 0.0 110.577 -179.947 . . . . . . . . 4 4 . 1 . 010 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.527 ' HB ' ' CB ' ' A' ' 50' ' ' LYS . 38.6 m -89.85 92.25 8.95 Favored 'General case' 0 N--CA 1.448 -0.557 0 O-C-N 118.003 -2.936 . . . . 0.0 106.675 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 5.3 mt -75.58 125.09 34.81 Favored 'Isoleucine or valine' 0 C--O 1.253 1.264 0 O-C-N 124.318 1.011 . . . . 0.0 111.016 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 53.2 m -128.3 95.16 4.08 Favored 'General case' 0 C--O 1.221 -0.445 0 O-C-N 127.037 2.711 . . . . 0.0 108.866 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -85.61 128.41 34.76 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-O 116.741 -1.599 . . . . 0.0 112.392 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -139.33 91.89 2.54 Favored 'General case' 0 N--CA 1.426 -1.671 0 CA-C-N 120.919 1.69 . . . . 0.0 110.589 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 50.0 68.07 1.56 Allowed Glycine 0 C--N 1.292 -1.881 0 O-C-N 126.013 2.071 . . . . 0.0 110.383 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.315 0.4 OUTLIER 83.4 -26.42 0.12 Allowed 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 114.258 1.207 . . . . 0.0 114.258 179.8 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 21.5 ttpt -87.25 143.03 27.47 Favored 'General case' 0 C--N 1.312 -1.05 0 C-N-CA 117.014 -1.875 . . . . 0.0 108.411 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.447 ' HE2' HD21 ' A' ' 64' ' ' LEU . 22.9 m-85 -124.02 101.2 7.11 Favored 'General case' 0 C--N 1.34 0.18 0 O-C-N 124.844 1.34 . . . . 0.0 111.077 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.958 ' HB ' HG12 ' A' ' 61' ' ' VAL 0.432 0.1 OUTLIER -83.19 82.93 8.05 Favored 'General case' 0 N--CA 1.441 -0.899 0 O-C-N 125.774 1.921 . . . . 0.0 110.281 179.909 . . . . . . . . 4 4 . 1 . 010 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.616 HG22 ' HB ' ' A' ' 60' ' ' VAL 0.692 0.3 OUTLIER -62.96 89.12 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.493 -1.231 0 CA-C-N 110.687 -2.96 . . . . 0.0 115.788 179.971 . . . . . . . . 4 4 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.527 ' CB ' ' HB ' ' A' ' 39' ' ' THR . 1.7 tttm -63.83 146.29 54.23 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 100.672 -3.825 . . . . 0.0 100.672 179.468 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -144.15 75.0 1.44 Allowed 'General case' 0 C--O 1.215 -0.739 0 CA-C-N 120.582 1.537 . . . . 0.0 109.378 -179.52 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 51.4 m -77.4 73.2 3.97 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 105.454 -2.054 . . . . 0.0 105.454 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.8 p -93.19 39.5 1.05 Allowed 'General case' 0 CA--C 1.505 -0.77 0 C-N-CA 117.809 -1.556 . . . . 0.0 111.868 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.403 ' OD1' ' N ' ' A' ' 55' ' ' PHE . 0.1 OUTLIER 72.16 -52.43 0.7 Allowed 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 115.242 -2.313 . . . . 0.0 108.509 -179.915 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.445 ' HB3' ' HD2' ' A' ' 56' ' ' ARG . 81.5 m-85 -57.5 -73.89 0.06 Allowed 'General case' 0 C--O 1.22 -0.492 0 CA-C-N 122.311 2.323 . . . . 0.0 109.403 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.445 ' HD2' ' HB3' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -136.59 146.19 45.8 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 120.472 1.487 . . . . 0.0 110.631 179.847 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -95.57 80.58 3.46 Favored 'General case' 0 C--N 1.352 0.697 0 N-CA-C 101.214 -3.625 . . . . 0.0 101.214 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.0 tp -110.71 117.67 55.46 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 O-C-N 127.827 3.205 . . . . 0.0 118.826 -179.407 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.75 119.6 12.73 Favored 'General case' 0 C--O 1.217 -0.643 0 N-CA-C 104.211 -2.514 . . . . 0.0 104.211 178.305 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.616 ' HB ' HG22 ' A' ' 49' ' ' VAL . 42.8 t -97.27 69.49 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 CA-C-O 122.163 0.982 . . . . 0.0 110.828 -178.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.958 HG12 ' HB ' ' A' ' 48' ' ' THR 0.404 0.7 OUTLIER -64.02 111.86 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 C-N-CA 118.028 -1.469 . . . . 0.0 113.138 -179.795 . . . . . . . . 4 4 . 1 . 010 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.606 ' CE2' ' CE2' ' A' ' 68' ' ' PHE . 11.5 m-30 -136.99 97.25 3.46 Favored 'General case' 0 N--CA 1.431 -1.386 0 O-C-N 119.122 -2.236 . . . . 0.0 108.665 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -63.57 138.79 58.64 Favored 'General case' 0 C--O 1.246 0.886 0 N-CA-C 105.003 -2.221 . . . . 0.0 105.003 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.447 HD21 ' HE2' ' A' ' 47' ' ' PHE . 0.4 OUTLIER -60.54 134.92 57.55 Favored 'General case' 0 C--O 1.252 1.2 0 N-CA-C 105.354 -2.091 . . . . 0.0 105.354 -179.996 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 75.19 2.96 68.19 Favored Glycine 0 C--N 1.341 0.832 0 C-N-CA 127.892 2.663 . . . . 0.0 114.896 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . 0.39 2.1 t -89.64 83.63 2.18 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 N-CA-C 105.189 -2.152 . . . . 0.0 105.189 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -52.77 95.81 0.01 OUTLIER 'General case' 0 CA--C 1.479 -1.756 0 N-CA-C 115.579 1.696 . . . . 0.0 115.579 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.606 ' CE2' ' CE2' ' A' ' 62' ' ' PHE . 13.2 p90 -89.94 178.07 6.31 Favored 'General case' 0 C--N 1.309 -1.153 0 O-C-N 120.438 -1.414 . . . . 0.0 110.109 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -123.95 136.27 54.21 Favored 'General case' 0 C--O 1.244 0.777 0 O-C-N 127.269 2.856 . . . . 0.0 105.441 179.546 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -156.04 113.87 3.31 Favored 'General case' 0 C--O 1.21 -0.98 0 C-N-CA 118.002 -1.479 . . . . 0.0 114.37 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 9.0 p -67.0 176.5 2.08 Favored 'General case' 0 C--N 1.314 -0.97 0 O-C-N 119.617 -1.927 . . . . 0.0 107.183 179.452 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.493 ' CD2' HD22 ' A' ' 78' ' ' LEU . 2.9 mt -119.04 -154.5 0.57 Allowed 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 116.345 -1.788 . . . . 0.0 109.339 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -118.5 12.07 13.12 Favored 'General case' 0 N--CA 1.436 -1.165 0 O-C-N 125.627 1.829 . . . . 0.0 113.224 179.623 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -143.68 -49.41 0.3 Allowed 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 120.541 -0.464 . . . . 0.0 112.178 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -107.96 -9.81 27.49 Favored Glycine 0 CA--C 1.541 1.662 0 N-CA-C 117.192 1.637 . . . . 0.0 117.192 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . 0.412 0.0 OUTLIER 71.58 153.46 0.13 Allowed 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 122.004 2.902 . . . . 0.0 115.257 179.684 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.507 ' HB3' ' CG2' ' A' ' 96' ' ' VAL . 30.9 mt-10 48.76 154.5 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.676 1 O-C-N 129.885 4.491 . . . . 0.0 117.145 179.536 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.545 ' HG ' ' HB3' ' A' ' 93' ' ' PHE 0.401 11.9 tp 177.15 152.47 0.21 Allowed 'General case' 0 CA--C 1.51 -0.584 0 CA-C-N 110.949 -2.841 . . . . 0.0 107.016 -179.819 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 10.9 m -161.56 119.04 2.25 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 103.297 -2.853 . . . . 0.0 103.297 -179.671 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -165.13 -162.59 16.55 Favored Glycine 0 C--N 1.303 -1.256 0 C-N-CA 116.932 -2.556 . . . . 0.0 111.193 -179.647 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 17.4 p -145.21 164.36 31.58 Favored 'General case' 0 C--O 1.193 -1.915 0 C-N-CA 119.112 -1.035 . . . . 0.0 111.531 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' TRP . . . . . 0.508 ' CZ2' HG11 ' A' ' 49' ' ' VAL 0.302 11.8 m0 -106.46 151.72 24.58 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 100.68 -3.822 . . . . 0.0 100.68 179.924 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 2.4 t -150.96 141.11 22.19 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-O 122.587 1.184 . . . . 0.0 111.766 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 6.9 ttp -91.41 110.36 21.66 Favored 'General case' 0 N--CA 1.429 -1.519 0 CA-C-N 113.037 -1.892 . . . . 0.0 109.705 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . 0.634 10.2 mt-10 -87.58 -133.43 0.08 Allowed 'General case' 0 N--CA 1.434 -1.265 0 O-C-N 124.315 1.009 . . . . 0.0 110.391 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -87.34 92.71 1.83 Allowed Glycine 0 C--N 1.336 0.531 0 N-CA-C 103.207 -3.957 . . . . 0.0 103.207 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 53.68 10.46 0.24 Allowed 'General case' 0 C--O 1.24 0.602 0 N-CA-C 118.059 2.614 . . . . 0.0 118.059 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . 0.335 0.0 OUTLIER -133.58 135.13 44.09 Favored 'General case' 0 CA--C 1.501 -0.933 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 -179.975 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -88.31 134.6 33.77 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 103.953 -2.61 . . . . 0.0 103.953 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -113.54 -172.77 0.54 Allowed 'Isoleucine or valine' 0 C--O 1.246 0.88 0 C-N-CA 119.218 -0.993 . . . . 0.0 108.5 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -164.69 109.11 0.35 Allowed Glycine 0 C--N 1.35 1.335 0 C-N-CA 126.767 2.127 . . . . 0.0 111.696 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 4.7 mmmt -112.33 135.79 52.59 Favored 'General case' 0 N--CA 1.426 -1.636 0 N-CA-C 106.511 -1.662 . . . . 0.0 106.511 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.66 ' HD2' HD22 ' A' ' 102' ' ' LEU . 39.2 m-85 -137.57 115.9 11.87 Favored 'General case' 0 CA--C 1.504 -0.806 0 O-C-N 126.306 2.254 . . . . 0.0 113.034 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.4 mtmt -99.58 138.89 36.04 Favored 'General case' 0 N--CA 1.436 -1.157 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . 0.369 0.0 OUTLIER -74.29 174.51 8.7 Favored 'General case' 0 N--CA 1.428 -1.526 0 N-CA-C 105.647 -1.983 . . . . 0.0 105.647 179.819 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.507 ' CG2' ' HB3' ' A' ' 77' ' ' GLU 0.258 2.7 t -86.35 -61.69 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 O-C-N 126.702 2.501 . . . . 0.0 110.862 179.606 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . 0.398 0.6 OUTLIER -57.88 -29.17 64.82 Favored 'General case' 0 C--O 1.26 1.609 0 N-CA-C 118.46 2.763 . . . . 0.0 118.46 -179.926 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -131.24 -4.92 3.85 Favored 'General case' 0 N--CA 1.425 -1.712 0 N-CA-C 116.435 2.013 . . . . 0.0 116.435 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 49.56 42.73 35.71 Favored Glycine 0 C--N 1.348 1.198 0 C-N-CA 118.953 -1.594 . . . . 0.0 114.658 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 26.1 mmtm -71.41 -103.25 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.339 0 CA-C-O 115.835 -2.031 . . . . 0.0 111.226 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 158.92 136.11 0.0 OUTLIER 'General case' 0 N--CA 1.433 -1.308 0 C-N-CA 131.197 3.799 . . . . 0.0 110.191 179.692 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.678 ' HG ' ' HA ' ' A' ' 119' ' ' TYR . 7.2 tt -125.13 111.19 15.03 Favored 'General case' 0 C--N 1.316 -0.868 1 C-N-CA 133.764 4.826 . . . . 0.0 102.744 178.947 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.614 HD12 ' H ' ' A' ' 104' ' ' ALA . 0.1 OUTLIER -101.31 160.72 3.79 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.185 0 C-N-CA 115.472 -2.491 . . . . 0.0 106.975 -179.222 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.614 ' H ' HD12 ' A' ' 103' ' ' ILE . . . -157.8 131.95 8.17 Favored 'General case' 0 C--N 1.322 -0.604 0 O-C-N 118.729 -2.482 . . . . 0.0 112.471 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.624 ' HB ' ' CE2' ' A' ' 117' ' ' TYR . 5.6 p -120.56 118.33 56.2 Favored 'Isoleucine or valine' 0 C--O 1.252 1.226 0 CA-C-N 122.452 2.387 . . . . 0.0 108.915 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.493 HH11 ' HG3' ' A' ' 106' ' ' ARG . 9.6 mtt85 -86.34 88.12 7.56 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 105.301 -2.111 . . . . 0.0 105.301 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -91.36 85.6 5.85 Favored 'General case' 0 N--CA 1.429 -1.513 0 CA-C-N 113.023 -1.899 . . . . 0.0 114.458 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.774 HD11 ' CH2' ' A' ' 6' ' ' TRP 0.388 4.9 tt -65.27 92.12 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 C-N-CA 113.95 -3.1 . . . . 0.0 115.191 -179.927 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 38.9 t -76.54 77.53 3.23 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 102.929 -2.989 . . . . 0.0 102.929 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 62.4 -98.02 0.19 Allowed Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 127.162 2.315 . . . . 0.0 114.715 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . 0.325 7.0 m-20 -86.42 -0.9 56.96 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 114.726 -2.559 . . . . 0.0 110.717 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.439 ' HG2' ' HD2' ' A' ' 129' ' ' LYS . 6.3 mp0 -124.42 123.49 40.27 Favored 'General case' 0 C--O 1.205 -1.253 0 O-C-N 126.285 2.241 . . . . 0.0 112.451 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.654 HD22 ' CD2' ' A' ' 128' ' ' PHE . 10.0 tt -93.02 133.29 36.32 Favored 'General case' 0 C--O 1.222 -0.375 0 N-CA-C 101.286 -3.598 . . . . 0.0 101.286 -179.685 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.859 HG22 HG22 ' A' ' 116' ' ' THR 0.285 47.5 mt -138.03 120.85 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.301 0 O-C-N 125.976 2.048 . . . . 0.0 108.976 -179.79 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 115' ' ' GLN . . . . . 0.534 ' HB2' ' CD ' ' A' ' 126' ' ' ARG . 72.6 mt-30 -91.74 150.04 21.31 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 101.772 -3.418 . . . . 0.0 101.772 -179.511 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.859 HG22 HG22 ' A' ' 114' ' ' ILE . 0.1 OUTLIER -166.15 148.68 7.1 Favored 'General case' 0 N--CA 1.414 -2.244 0 O-C-N 128.389 3.556 . . . . 0.0 111.181 -179.236 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.624 ' CE2' ' HB ' ' A' ' 105' ' ' VAL 0.382 23.3 m-85 132.1 -142.86 0.0 OUTLIER 'General case' 0 CA--C 1.478 -1.793 0 O-C-N 128.682 3.739 . . . . 0.0 113.312 177.31 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.603 ' HA ' ' CE2' ' A' ' 17' ' ' PHE . 13.4 t -136.62 -173.66 3.49 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-O 127.165 3.364 . . . . 0.0 117.218 -174.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.678 ' HA ' ' HG ' ' A' ' 102' ' ' LEU 0.276 2.2 t80 -112.16 -15.99 13.11 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 112.56 -2.109 . . . . 0.0 109.055 177.644 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.448 ' HB2' ' CD2' ' A' ' 119' ' ' TYR . 0.4 OUTLIER -153.71 -71.17 0.14 Allowed 'General case' 0 C--N 1.298 -1.641 0 O-C-N 119.64 -1.912 . . . . 0.0 109.492 -179.916 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -160.51 34.1 0.42 Allowed Glycine 0 C--N 1.363 2.049 0 N-CA-C 120.59 2.996 . . . . 0.0 120.59 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 90.2 t -139.57 103.54 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.193 0 N-CA-C 103.476 -2.786 . . . . 0.0 103.476 179.359 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.447 ' HA ' ' O ' ' A' ' 117' ' ' TYR . 6.6 mp0 -68.47 177.63 2.33 Favored 'General case' 0 CA--C 1.503 -0.852 0 CA-C-O 123.778 1.751 . . . . 0.0 113.264 -178.843 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.529 ' HB1' ' CA ' ' A' ' 14' ' ' TYR . . . -167.77 176.74 6.15 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-O 114.379 -2.724 . . . . 0.0 104.906 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.506 ' HB2' ' CB ' ' A' ' 12' ' ' GLU 0.328 2.8 mptp? -145.3 156.17 43.65 Favored 'General case' 0 CA--C 1.506 -0.732 0 O-C-N 127.55 3.031 . . . . 0.0 107.818 -179.68 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.534 ' CD ' ' HB2' ' A' ' 115' ' ' GLN . 0.0 OUTLIER -142.13 76.15 1.52 Allowed 'General case' 0 N--CA 1.432 -1.361 0 CA-C-N 112.556 -2.111 . . . . 0.0 110.411 179.753 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.469 HD13 HG23 ' A' ' 114' ' ' ILE . 6.7 mm -63.8 116.33 3.34 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 O-C-N 126.313 2.258 . . . . 0.0 115.209 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.654 ' CD2' HD22 ' A' ' 113' ' ' LEU . 2.7 m-30 -109.24 125.93 52.78 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 126.011 1.724 . . . . 0.0 107.57 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.446 ' CG ' ' HB2' ' A' ' 9' ' ' ASP 0.279 14.8 mmmt -91.16 3.22 55.35 Favored 'General case' 0 N--CA 1.441 -0.897 0 O-C-N 119.961 -1.712 . . . . 0.0 112.213 -179.649 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.485 ' HD2' ' CH2' ' A' ' 6' ' ' TRP . 4.3 tttp 74.14 143.26 0.07 Allowed 'General case' 0 C--N 1.349 0.561 0 O-C-N 124.501 1.126 . . . . 0.0 108.763 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . 0.835 1.0 OUTLIER . . . . . 0 N--CA 1.431 -1.419 0 N-CA-C 115.401 1.63 . . . . 0.0 115.401 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.428 -1.534 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -156.94 88.41 1.03 Allowed 'General case' 0 N--CA 1.44 -0.94 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.904 179.74 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' GLY . . . . . 0.4 ' O ' ' N ' ' A' ' 40' ' ' ILE . . . 160.09 -130.72 2.48 Favored Glycine 0 CA--C 1.5 -0.86 0 C-N-CA 117.017 -2.516 . . . . 0.0 109.373 -179.789 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.621 ' HA ' ' HA ' ' A' ' 39' ' ' THR 0.499 5.3 t -117.73 171.11 8.26 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 123.197 1.475 . . . . 0.0 114.123 -179.958 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.803 ' CH2' HD11 ' A' ' 108' ' ' ILE . 80.3 m95 -152.13 147.61 26.65 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-N 110.227 -3.17 . . . . 0.0 105.816 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 4.8 ttmm -139.61 122.19 16.27 Favored 'General case' 0 C--O 1.205 -1.246 0 O-C-N 127.767 3.167 . . . . 0.0 105.514 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.721 HG12 ' HB3' ' A' ' 36' ' ' LEU 0.379 8.0 p -69.02 139.21 20.85 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.022 0 CA-C-N 121.143 1.792 . . . . 0.0 110.773 179.996 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -129.39 -46.82 1.19 Allowed 'General case' 0 C--O 1.212 -0.91 0 O-C-N 127.387 2.929 . . . . 0.0 106.373 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.452 ' HG3' ' N ' ' A' ' 11' ' ' ASN . 9.2 ttt180 -129.21 144.85 51.37 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 106.962 -1.495 . . . . 0.0 106.962 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.484 ' OD1' HG21 ' A' ' 8' ' ' VAL 0.385 97.7 m-20 -131.59 -171.12 2.53 Favored 'General case' 0 CA--C 1.501 -0.936 0 O-C-N 128.604 3.69 . . . . 0.0 107.886 179.956 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.527 ' HB2' ' HB2' ' A' ' 125' ' ' LYS . 0.9 OUTLIER -146.43 -85.69 0.11 Allowed 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 122.595 2.452 . . . . 0.0 110.897 179.942 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.538 ' HB3' ' HA ' ' A' ' 124' ' ' ALA . 2.2 t-20 -90.64 16.74 8.55 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-N 121.342 1.883 . . . . 0.0 114.154 179.445 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.514 ' CD2' ' HG2' ' A' ' 126' ' ' ARG 0.283 0.2 OUTLIER -63.98 -20.98 66.29 Favored 'General case' 0 C--O 1.242 0.665 0 O-C-N 127.595 3.06 . . . . 0.0 115.11 179.858 . . . . . . . . 4 4 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -76.19 -36.91 58.43 Favored 'General case' 0 C--O 1.205 -1.261 0 O-C-N 118.909 -2.369 . . . . 0.0 108.186 179.742 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.3 -33.76 55.62 Favored 'General case' 0 N--CA 1.435 -1.189 0 CA-C-N 112.855 -1.975 . . . . 0.0 113.194 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -70.27 -21.44 62.97 Favored 'General case' 0 N--CA 1.438 -1.046 0 O-C-N 118.798 -2.439 . . . . 0.0 109.666 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.434 ' CB ' HG13 ' A' ' 23' ' ' ILE . 4.8 mtt -76.86 -35.19 57.65 Favored 'General case' 0 CA--C 1.503 -0.852 0 CA-C-O 125.868 2.747 . . . . 0.0 107.268 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -70.79 -29.62 65.87 Favored 'General case' 0 C--O 1.244 0.771 0 CA-C-O 127.295 3.426 . . . . 0.0 112.007 179.524 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 42.3 tptt -80.07 -27.78 39.28 Favored 'General case' 0 N--CA 1.437 -1.118 0 O-C-N 119.252 -2.155 . . . . 0.0 110.383 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 17.8 mtp -71.5 -30.88 66.47 Favored 'General case' 0 C--O 1.202 -1.436 0 O-C-N 119.554 -1.966 . . . . 0.0 106.669 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.31 32.52 2.75 Favored Glycine 0 C--N 1.306 -1.129 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.449 HG23 ' HB3' ' A' ' 27' ' ' LYS . 6.0 mm -78.33 -71.38 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.362 1.124 0 CA-C-O 115.561 -2.161 . . . . 0.0 106.901 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 66.53 152.17 0.07 Allowed 'General case' 0 N--CA 1.445 -0.716 0 O-C-N 126.777 2.548 . . . . 0.0 114.755 179.572 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.442 HG12 ' N ' ' A' ' 26' ' ' VAL 0.4 2.6 t 50.18 -122.94 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.355 0.835 0 N-CA-C 120.268 3.432 . . . . 0.0 120.268 179.679 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.442 ' N ' HG12 ' A' ' 25' ' ' VAL 0.542 3.4 m -65.43 -36.86 78.68 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.037 0 N-CA-C 118.379 2.733 . . . . 0.0 118.379 -179.776 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.449 ' HB3' HG23 ' A' ' 23' ' ' ILE . 62.8 mttm -60.93 -25.89 67.1 Favored 'General case' 0 N--CA 1.438 -1.067 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 4.7 mtm-85 -78.08 -31.26 50.04 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 117.435 -1.706 . . . . 0.0 108.178 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 8.1 tptm -71.36 -45.85 61.89 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 114.02 -1.446 . . . . 0.0 111.798 179.655 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 12.2 mt -78.02 -29.2 49.36 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 -179.786 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.16 -36.07 60.43 Favored Glycine 0 C--N 1.338 0.641 0 CA-C-O 123.089 1.383 . . . . 0.0 111.681 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -75.63 -22.84 56.45 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-O 116.738 -1.601 . . . . 0.0 112.946 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 18.0 t60 -120.78 46.2 2.07 Favored 'General case' 0 N--CA 1.447 -0.615 0 O-C-N 128.829 3.831 . . . . 0.0 114.125 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -72.05 -19.19 61.87 Favored 'General case' 0 C--O 1.21 -0.991 0 O-C-N 128.544 3.653 . . . . 0.0 117.703 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . 0.255 0.6 OUTLIER 65.93 38.99 4.73 Favored 'General case' 0 C--N 1.312 -1.037 0 C-N-CA 118.593 -1.243 . . . . 0.0 109.454 -179.314 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.92 HD21 HD13 ' A' ' 38' ' ' LEU . 3.0 tt -61.2 137.29 58.24 Favored 'General case' 0 C--O 1.216 -0.698 0 O-C-N 125.632 1.833 . . . . 0.0 112.847 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.3 ttpt -139.2 100.83 4.11 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 101.55 -3.5 . . . . 0.0 101.55 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.92 HD13 HD21 ' A' ' 36' ' ' LEU 0.277 0.4 OUTLIER -93.08 117.19 29.78 Favored 'General case' 0 C--N 1.293 -1.88 0 O-C-N 119.349 -2.095 . . . . 0.0 107.008 -179.578 . . . . . . . . 4 4 . 1 . 011 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.621 ' HA ' ' HA ' ' A' ' 5' ' ' THR . 85.2 m -104.44 100.47 10.16 Favored 'General case' 0 N--CA 1.436 -1.135 0 N-CA-C 104.192 -2.522 . . . . 0.0 104.192 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.439 HG12 HG23 ' A' ' 49' ' ' VAL . 7.9 mt -71.29 149.86 9.56 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 179.821 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.695 ' HB ' HG23 ' A' ' 48' ' ' THR . 89.3 m -142.71 63.44 1.39 Allowed 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 113.68 -1.6 . . . . 0.0 112.519 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.408 ' HG3' ' CE1' ' A' ' 47' ' ' PHE . 0.4 OUTLIER -62.35 119.85 9.88 Favored 'General case' 0 C--O 1.222 -0.362 0 O-C-N 125.228 1.58 . . . . 0.0 109.723 179.86 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -153.48 108.68 3.19 Favored 'General case' 0 CA--C 1.489 -1.392 0 CA-C-O 122.951 1.358 . . . . 0.0 110.079 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 61.35 31.73 78.32 Favored Glycine 0 C--N 1.306 -1.108 0 N-CA-C 108.888 -1.685 . . . . 0.0 108.888 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.31 0.2 OUTLIER 87.63 -14.05 0.44 Allowed 'General case' 0 C--O 1.225 -0.189 0 CA-C-N 112.978 -1.611 . . . . 0.0 110.856 179.728 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -80.09 121.1 25.12 Favored 'General case' 0 N--CA 1.428 -1.542 0 C-N-CA 116.333 -2.147 . . . . 0.0 110.094 -179.557 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.859 ' CE2' HD21 ' A' ' 89' ' ' LEU 0.311 0.4 OUTLIER -101.77 104.93 15.74 Favored 'General case' 0 C--O 1.217 -0.634 0 N-CA-C 105.985 -1.857 . . . . 0.0 105.985 179.963 . . . . . . . . 4 4 . 1 . 011 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.695 HG23 ' HB ' ' A' ' 41' ' ' THR 0.432 1.6 t -105.29 73.2 1.02 Allowed 'General case' 0 C--N 1.313 -1.002 0 CA-C-O 125.542 2.591 . . . . 0.0 111.979 -179.596 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.439 HG23 HG12 ' A' ' 40' ' ' ILE 0.626 0.5 OUTLIER -52.37 94.47 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.425 -1.703 0 CA-C-N 108.704 -3.862 . . . . 0.0 112.636 -179.866 . . . . . . . . 4 4 . 1 . 011 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.606 ' HB3' ' HB ' ' A' ' 39' ' ' THR . 5.1 ttmt -64.6 153.88 37.98 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 100.631 -3.84 . . . . 0.0 100.631 179.381 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.562 ' OE2' HD11 ' A' ' 36' ' ' LEU . 1.3 tp10 -149.42 92.92 1.99 Allowed 'General case' 0 C--O 1.215 -0.733 0 N-CA-C 103.774 -2.676 . . . . 0.0 103.774 -179.743 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -88.06 77.88 8.29 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-O 125.025 2.345 . . . . 0.0 106.696 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -95.11 -176.51 3.84 Favored 'General case' 0 N--CA 1.439 -1.003 0 O-C-N 119.883 -1.761 . . . . 0.0 112.411 -179.401 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -65.21 -19.41 65.96 Favored 'General case' 0 N--CA 1.444 -0.772 0 O-C-N 126.681 2.488 . . . . 0.0 108.612 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.417 ' CE2' ' HB1' ' A' ' 73' ' ' ALA . 6.1 m-85 -90.04 -56.52 3.19 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-O 115.22 -2.324 . . . . 0.0 115.165 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.686 HH21 HD12 ' A' ' 58' ' ' ILE . 0.1 OUTLIER -155.62 168.58 26.69 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 123.833 3.015 . . . . 0.0 107.947 179.418 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -106.29 63.16 0.65 Allowed 'General case' 0 C--O 1.216 -0.696 2 N-CA-C 100.007 -4.071 . . . . 0.0 100.007 179.645 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.686 HD12 HH21 ' A' ' 56' ' ' ARG . 12.1 tt -91.95 97.8 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 O-C-N 127.99 3.306 . . . . 0.0 114.509 -179.385 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.442 ' HA ' ' HA ' ' A' ' 50' ' ' LYS 0.273 0.0 OUTLIER -62.88 125.9 25.54 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 104.935 -2.246 . . . . 0.0 104.935 179.136 . . . . . . . . 4 4 . 1 . 011 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.5 t -105.2 85.38 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 C-N-CA 119.035 -1.066 . . . . 0.0 109.735 -178.641 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.582 HG12 ' HB ' ' A' ' 48' ' ' THR 0.399 2.0 m -74.44 150.84 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.37 0 CA-C-O 125.865 2.745 . . . . 0.0 115.163 -179.882 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.626 ' CZ ' ' CZ2' ' A' ' 82' ' ' TRP . 0.0 OUTLIER -168.21 95.65 0.4 Allowed 'General case' 0 N--CA 1.43 -1.473 0 CA-C-N 112.673 -2.058 . . . . 0.0 111.639 179.7 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.74 99.91 0.06 Allowed 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 102.477 -3.157 . . . . 0.0 102.477 179.572 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.461 HD23 ' CD2' ' A' ' 47' ' ' PHE . 0.2 OUTLIER -33.86 100.02 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 127.052 2.72 . . . . 0.0 112.683 -179.865 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 102.46 23.44 8.92 Favored Glycine 0 CA--C 1.528 0.881 0 O-C-N 128.453 3.596 . . . . 0.0 116.842 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.435 ' O ' ' CE2' ' A' ' 68' ' ' PHE 0.269 2.4 t -113.88 79.4 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.505 0 CA-C-O 115.184 -2.341 . . . . 0.0 105.301 -179.99 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . 0.278 23.5 m-20 -27.92 118.5 0.1 Allowed 'General case' 0 CA--C 1.498 -1.035 0 N-CA-C 115.682 1.734 . . . . 0.0 115.682 -179.806 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.571 ' CZ ' ' CB ' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -129.0 -173.57 3.02 Favored 'General case' 0 N--CA 1.442 -0.837 0 O-C-N 118.602 -2.561 . . . . 0.0 107.72 -179.922 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -128.84 138.15 51.88 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.439 ' HB3' HD23 ' A' ' 78' ' ' LEU . 1.7 t80 -138.85 95.17 2.92 Favored 'General case' 0 C--O 1.215 -0.727 0 C-N-CA 119.26 -0.976 . . . . 0.0 113.026 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -74.36 115.71 14.2 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 105.103 -2.184 . . . . 0.0 105.103 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.864 HD11 HD13 ' A' ' 78' ' ' LEU . 46.8 mt -71.16 -169.1 0.35 Allowed 'General case' 0 C--N 1.298 -1.637 0 CA-C-O 117.795 -1.098 . . . . 0.0 109.745 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.417 ' HB1' ' CE2' ' A' ' 55' ' ' PHE . . . -85.26 -35.95 21.22 Favored 'General case' 0 C--O 1.214 -0.784 0 O-C-N 128.666 3.729 . . . . 0.0 113.332 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -143.17 21.88 1.9 Allowed 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 113.982 -1.463 . . . . 0.0 108.555 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -130.92 -15.42 1.72 Allowed Glycine 0 CA--C 1.544 1.851 0 CA-C-O 117.797 -1.557 . . . . 0.0 116.829 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER 64.7 -177.65 0.17 Allowed 'General case' 0 N--CA 1.433 -1.306 0 CA-C-N 119.994 1.897 . . . . 0.0 114.204 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.491 ' CB ' ' HB ' ' A' ' 96' ' ' VAL . 4.7 mp0 -26.94 119.71 0.09 Allowed 'General case' 0 CA--C 1.5 -0.958 1 O-C-N 129.626 4.329 . . . . 0.0 115.608 179.923 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.864 HD13 HD11 ' A' ' 72' ' ' LEU 0.433 0.9 OUTLIER -142.67 78.01 1.6 Allowed 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 101.9 -3.37 . . . . 0.0 101.9 179.997 . . . . . . . . 4 4 . 1 . 011 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 3.7 m -82.74 165.88 19.55 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 101.804 -3.406 . . . . 0.0 101.804 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 144.31 -170.65 25.99 Favored Glycine 0 CA--C 1.538 1.519 0 C-N-CA 119.345 -1.407 . . . . 0.0 112.336 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -146.38 171.32 15.19 Favored 'General case' 0 C--O 1.203 -1.364 0 C-N-CA 117.668 -1.613 . . . . 0.0 111.386 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' TRP . . . . . 0.626 ' CZ2' ' CZ ' ' A' ' 62' ' ' PHE 0.335 13.3 m0 -114.46 141.52 47.58 Favored 'General case' 0 N--CA 1.424 -1.771 0 N-CA-C 101.388 -3.56 . . . . 0.0 101.388 179.63 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.471 HG23 HG22 ' A' ' 90' ' ' VAL . 9.9 t -146.85 141.4 26.57 Favored 'General case' 0 N--CA 1.427 -1.581 0 O-C-N 124.261 0.975 . . . . 0.0 109.797 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 12.4 ttm -81.64 129.62 34.76 Favored 'General case' 0 CA--C 1.496 -1.133 0 C-N-CA 121.2 -0.2 . . . . 0.0 110.897 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . 0.597 3.7 pt-20 -122.51 54.75 1.19 Allowed 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 96.6 -127.82 9.32 Favored Glycine 0 N--CA 1.439 -1.111 0 O-C-N 126.008 2.067 . . . . 0.0 108.503 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -80.65 9.47 6.11 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 115.502 1.668 . . . . 0.0 115.502 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . 0.275 0.1 OUTLIER -132.49 172.8 12.02 Favored 'General case' 0 CA--C 1.503 -0.836 0 O-C-N 125.712 1.882 . . . . 0.0 106.667 179.623 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.859 HD21 ' CE2' ' A' ' 47' ' ' PHE . 2.6 tp -127.74 159.11 35.77 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 105.339 -2.097 . . . . 0.0 105.339 179.76 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.471 HG22 HG23 ' A' ' 83' ' ' THR . 17.4 m -142.83 122.61 9.52 Favored 'Isoleucine or valine' 0 C--O 1.245 0.864 0 C-N-CA 116.09 -2.244 . . . . 0.0 110.107 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -92.64 97.49 2.27 Favored Glycine 0 C--N 1.35 1.338 0 N-CA-C 108.031 -2.028 . . . . 0.0 108.031 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.637 ' HA ' HD12 ' A' ' 103' ' ' ILE . 2.0 mttt -92.62 126.88 37.9 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 102.78 -3.045 . . . . 0.0 102.78 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.456 ' HB3' ' HG ' ' A' ' 78' ' ' LEU . 53.2 m-85 -127.96 110.74 12.83 Favored 'General case' 0 N--CA 1.444 -0.758 0 O-C-N 126.201 2.188 . . . . 0.0 112.621 -179.82 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -103.65 126.82 51.04 Favored 'General case' 0 N--CA 1.435 -1.203 0 N-CA-C 105.407 -2.071 . . . . 0.0 105.407 179.854 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . 0.433 3.3 mmm180 -81.64 156.49 25.08 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 127.227 2.829 . . . . 0.0 109.69 -179.778 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.491 ' HB ' ' CB ' ' A' ' 77' ' ' GLU . 3.3 t -78.4 -54.54 11.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 C-N-CA 124.552 1.141 . . . . 0.0 113.152 -179.682 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . 0.452 14.9 m-20 -68.53 -9.44 49.29 Favored 'General case' 0 C--O 1.254 1.311 0 N-CA-C 117.952 2.575 . . . . 0.0 117.952 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.417 ' ND2' ' HG3' ' A' ' 100' ' ' LYS . 19.5 p-10 -145.04 6.48 1.16 Allowed 'General case' 0 N--CA 1.438 -1.071 0 CA-C-O 115.328 -2.272 . . . . 0.0 114.069 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 39.98 40.64 1.76 Allowed Glycine 0 CA--C 1.542 1.773 0 O-C-N 125.285 1.616 . . . . 0.0 114.485 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.417 ' HG3' ' ND2' ' A' ' 98' ' ' ASN . 32.2 mmtm -78.18 -127.32 0.01 OUTLIER 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 114.14 -1.03 . . . . 0.0 109.293 -179.56 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 171.36 97.59 0.01 OUTLIER 'General case' 0 N--CA 1.433 -1.276 0 C-N-CA 130.019 3.327 . . . . 0.0 115.125 -179.641 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.698 HD13 HD12 ' A' ' 78' ' ' LEU . 0.3 OUTLIER -89.52 121.67 31.96 Favored 'General case' 0 N--CA 1.442 -0.875 2 C-N-CA 132.566 4.347 . . . . 0.0 103.871 178.863 . . . . . . . . 4 4 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.885 HG23 ' HB3' ' A' ' 117' ' ' TYR . 4.6 tp -120.21 157.53 22.71 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.742 0 C-N-CA 115.844 -2.343 . . . . 0.0 105.864 179.276 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.536 ' HA ' ' HB2' ' A' ' 117' ' ' TYR . . . -141.33 136.69 31.77 Favored 'General case' 0 C--N 1.313 -1.001 0 O-C-N 118.557 -2.589 . . . . 0.0 108.16 -179.152 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.663 ' HB ' ' CD2' ' A' ' 117' ' ' TYR . 0.5 OUTLIER -125.63 104.56 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 CA-C-N 122.856 2.571 . . . . 0.0 112.837 -179.709 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.641 ' HG2' HH11 ' A' ' 106' ' ' ARG . 4.9 mtt-85 -74.06 94.24 2.37 Favored 'General case' 0 C--N 1.307 -1.275 0 O-C-N 119.729 -1.857 . . . . 0.0 106.831 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -98.53 84.87 3.25 Favored 'General case' 0 N--CA 1.419 -2.002 0 O-C-N 126.058 2.099 . . . . 0.0 114.394 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.803 HD11 ' CH2' ' A' ' 6' ' ' TRP 0.38 0.1 OUTLIER -60.89 101.09 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 C-N-CA 116.403 -2.119 . . . . 0.0 108.503 179.897 . . . . . . . . 4 4 . 1 . 011 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 10.4 p -87.85 70.09 9.52 Favored 'General case' 0 CA--C 1.504 -0.79 0 N-CA-C 104.511 -2.404 . . . . 0.0 104.511 -179.795 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 76.99 -115.05 4.22 Favored Glycine 0 C--N 1.339 0.734 0 O-C-N 127.601 3.063 . . . . 0.0 111.677 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 48.8 m-20 -69.13 -25.24 64.29 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 120.014 1.907 . . . . 0.0 112.264 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.22 143.77 29.1 Favored 'General case' 0 CA--C 1.494 -1.19 0 CA-C-O 116.295 -1.812 . . . . 0.0 115.523 -179.592 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.543 HD23 ' N ' ' A' ' 114' ' ' ILE . 0.3 OUTLIER -104.79 146.12 29.42 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 100.741 -3.8 . . . . 0.0 100.741 179.979 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.607 HD13 HD12 ' A' ' 127' ' ' ILE 0.284 81.7 mt -149.26 110.74 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.171 0 CA-C-O 117.164 -1.398 . . . . 0.0 109.163 -179.904 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 115' ' ' GLN . . . . . 0.658 ' HB2' ' HD2' ' A' ' 126' ' ' ARG . 55.3 mt-30 -86.2 167.0 15.28 Favored 'General case' 0 C--N 1.345 0.378 0 N-CA-C 104.035 -2.58 . . . . 0.0 104.035 179.857 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.475 ' CG2' ' C ' ' A' ' 115' ' ' GLN . 5.0 p -159.75 -152.33 0.3 Allowed 'General case' 0 CA--C 1.494 -1.184 1 O-C-N 130.516 4.885 . . . . 0.0 106.501 -177.198 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.885 ' HB3' HG23 ' A' ' 103' ' ' ILE . 8.7 m-30 76.88 -165.74 0.05 Allowed 'General case' 0 CA--C 1.46 -2.488 1 O-C-N 129.379 4.175 . . . . 0.0 114.309 175.144 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.508 ' O ' ' N ' ' A' ' 103' ' ' ILE . 6.9 t -138.87 -162.37 1.31 Allowed 'General case' 0 N--CA 1.437 -1.11 0 CA-C-O 127.384 3.469 . . . . 0.0 117.116 -174.942 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.598 ' HA ' ' HG ' ' A' ' 102' ' ' LEU . 1.6 t80 -111.57 -25.79 9.38 Favored 'General case' 0 C--N 1.348 0.525 0 CA-C-N 111.769 -2.469 . . . . 0.0 109.773 178.863 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.519 ' HB2' ' CD2' ' A' ' 119' ' ' TYR . 0.2 OUTLIER -153.23 -59.83 0.14 Allowed 'General case' 0 C--N 1.29 -2.004 0 C-N-CA 126.498 1.919 . . . . 0.0 110.017 -179.876 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -153.76 1.56 0.23 Allowed Glycine 0 C--N 1.362 1.988 0 N-CA-C 121.178 3.231 . . . . 0.0 121.178 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 37.0 t -110.39 98.91 7.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 O-C-N 117.49 -3.359 . . . . 0.0 104.915 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.413 ' HA ' ' HB ' ' A' ' 118' ' ' THR . 4.8 mp0 -64.87 -175.54 0.2 Allowed 'General case' 0 C--O 1.21 -0.984 0 O-C-N 120.001 -1.687 . . . . 0.0 112.435 -179.641 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.538 ' HA ' ' HB3' ' A' ' 13' ' ' ASN . . . -170.19 -167.83 0.67 Allowed 'General case' 0 C--O 1.21 -0.992 0 CA-C-O 113.872 -2.966 . . . . 0.0 106.991 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.527 ' HB2' ' HB2' ' A' ' 12' ' ' GLU 0.29 0.0 OUTLIER -157.88 143.84 17.32 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 122.775 2.534 . . . . 0.0 111.867 179.901 . . . . . . . . 4 4 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.658 ' HD2' ' HB2' ' A' ' 115' ' ' GLN . 0.0 OUTLIER -137.39 78.22 1.68 Allowed 'General case' 0 C--O 1.209 -1.052 0 O-C-N 128.058 3.349 . . . . 0.0 110.573 179.752 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.607 HD12 HD13 ' A' ' 114' ' ' ILE . 1.7 mm -66.44 96.18 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 O-C-N 125.311 1.632 . . . . 0.0 114.422 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.776 ' CE1' HD22 ' A' ' 36' ' ' LEU . 26.5 m-85 -84.49 137.69 33.21 Favored 'General case' 0 C--O 1.219 -0.503 0 C-N-CA 126.524 1.93 . . . . 0.0 106.709 179.775 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 10.0 mmtt -101.12 41.24 1.2 Allowed 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 115.455 -2.212 . . . . 0.0 112.465 -179.714 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.533 ' HA ' ' HA ' ' A' ' 6' ' ' TRP . 3.2 tttm 27.36 98.22 0.0 OUTLIER 'General case' 0 C--O 1.238 0.491 0 C-N-CA 127.462 2.305 . . . . 0.0 116.401 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.435 ' HA ' HG23 ' A' ' 5' ' ' THR 0.858 2.6 tm-20 . . . . . 0 N--CA 1.439 -1.022 0 O-C-N 117.912 -2.992 . . . . 0.0 116.892 -179.763 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 2' ' ' PHE . . . . . 0.583 ' CZ ' HG13 ' A' ' 108' ' ' ILE . 96.6 m-85 . . . . . 0 CA--C 1.508 -0.659 0 CA-C-O 124.147 1.927 . . . . 0.0 116.128 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -156.27 90.72 1.21 Allowed 'General case' 0 N--CA 1.436 -1.132 0 CA-C-N 113.66 -1.609 . . . . 0.0 113.205 179.764 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 155.98 -148.19 17.91 Favored Glycine 0 N--CA 1.432 -1.589 0 C-N-CA 114.992 -3.48 . . . . 0.0 114.395 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.598 HG23 HG23 ' A' ' 39' ' ' THR 0.576 32.9 p -103.76 150.35 24.16 Favored 'General case' 0 C--N 1.311 -1.088 0 O-C-N 126.935 2.197 . . . . 0.0 114.182 179.967 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.578 ' CZ2' HD11 ' A' ' 108' ' ' ILE . 93.7 m95 -148.11 141.21 24.97 Favored 'General case' 0 N--CA 1.431 -1.405 0 O-C-N 126.346 2.279 . . . . 0.0 106.087 179.83 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 18.3 tttt -141.47 93.54 2.58 Favored 'General case' 0 C--O 1.204 -1.32 0 CA-C-O 116.778 -1.582 . . . . 0.0 107.257 179.633 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.482 ' CG1' ' HB3' ' A' ' 36' ' ' LEU 0.32 1.5 p -43.78 136.9 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-O 117.127 -1.416 . . . . 0.0 113.341 -179.96 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -126.15 -18.45 4.99 Favored 'General case' 0 CA--C 1.503 -0.853 0 O-C-N 124.671 1.232 . . . . 0.0 111.321 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.02 145.65 15.4 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 119.753 -1.842 . . . . 0.0 106.496 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . 0.298 0.2 OUTLIER -109.09 -169.83 1.55 Allowed 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 112.452 -2.158 . . . . 0.0 109.54 179.715 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -176.87 90.35 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.464 ' HB3' ' HA ' ' A' ' 124' ' ' ALA . 0.2 OUTLIER 100.7 -7.39 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 125.132 1.373 . . . . 0.0 112.229 -179.575 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.566 ' CD2' ' CG ' ' A' ' 126' ' ' ARG 0.252 0.2 OUTLIER -69.96 -38.67 76.17 Favored 'General case' 0 C--O 1.222 -0.386 0 O-C-N 128.314 3.509 . . . . 0.0 114.185 179.584 . . . . . . . . 4 4 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.52 -29.24 68.98 Favored 'General case' 0 CA--C 1.509 -0.602 0 CA-C-N 121.539 1.972 . . . . 0.0 113.043 179.696 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.9 -37.42 34.77 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 113.504 -1.68 . . . . 0.0 110.391 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.545 ' CD2' ' CE1' ' A' ' 14' ' ' TYR . 0.9 OUTLIER -70.73 -28.62 64.86 Favored 'General case' 0 C--O 1.244 0.765 0 CA-C-O 124.765 2.222 . . . . 0.0 111.747 -179.981 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.409 ' CB ' HG13 ' A' ' 23' ' ' ILE . 32.1 mtt -72.15 -26.04 61.95 Favored 'General case' 0 C--N 1.324 -0.521 1 O-C-N 115.36 -4.588 . . . . 0.0 108.466 -179.686 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -79.68 -24.16 41.96 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 116.138 -2.225 . . . . 0.0 111.937 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 12.4 tptp -79.19 -30.53 43.43 Favored 'General case' 0 C--N 1.31 -1.145 0 O-C-N 120.68 -1.262 . . . . 0.0 109.379 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.545 ' CE ' ' CD1' ' A' ' 119' ' ' TYR 0.304 0.7 OUTLIER -78.41 -23.49 46.68 Favored 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 179.783 . . . . . . . . 4 4 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 88.33 56.87 1.96 Allowed Glycine 0 C--N 1.307 -1.049 0 CA-C-O 116.301 -2.389 . . . . 0.0 108.793 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.475 HG21 ' HA ' ' A' ' 28' ' ' ARG . 1.6 mm -81.26 -34.17 13.22 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 CA-C-O 115.081 -2.39 . . . . 0.0 111.719 -179.68 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 89.61 98.64 0.02 OUTLIER 'General case' 0 C--N 1.346 0.426 0 O-C-N 125.877 1.985 . . . . 0.0 113.431 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.471 HG13 HG22 ' A' ' 26' ' ' VAL 0.475 4.1 p 12.86 -62.08 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.349 0.577 0 N-CA-C 119.292 3.071 . . . . 0.0 119.292 179.974 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.471 HG22 HG13 ' A' ' 25' ' ' VAL 0.605 0.0 OUTLIER -72.07 -42.08 67.7 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.876 0 N-CA-C 118.212 2.671 . . . . 0.0 118.212 -179.465 . . . . . . . . 4 4 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.4 mtpp -64.4 -24.59 67.69 Favored 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 114.787 1.403 . . . . 0.0 114.787 -179.424 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.475 ' HA ' HG21 ' A' ' 23' ' ' ILE . 5.0 ptt85 -79.8 -25.68 40.8 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 119.207 -2.183 . . . . 0.0 108.239 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 8.8 tttt -73.99 -46.39 44.08 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.609 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.1 mp -72.81 -31.96 65.19 Favored 'General case' 0 N--CA 1.438 -1.058 0 O-C-N 124.872 1.358 . . . . 0.0 107.387 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -74.95 -34.49 52.65 Favored Glycine 0 C--N 1.346 1.102 0 O-C-N 124.576 1.172 . . . . 0.0 111.779 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -73.35 -26.71 61.13 Favored 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 114.476 1.288 . . . . 0.0 114.476 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -124.8 57.83 1.26 Allowed 'General case' 0 C--N 1.348 0.502 0 O-C-N 127.343 2.902 . . . . 0.0 111.175 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -90.78 -17.82 25.99 Favored 'General case' 0 C--O 1.211 -0.948 0 N-CA-C 118.511 2.782 . . . . 0.0 118.511 -179.824 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 10.3 t30 75.32 27.12 1.11 Allowed 'General case' 0 C--O 1.24 0.6 0 C-N-CA 117.992 -1.483 . . . . 0.0 110.092 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.522 HD11 ' CD1' ' A' ' 38' ' ' LEU . 13.8 tp -52.77 106.54 0.16 Allowed 'General case' 0 C--O 1.216 -0.682 0 C-N-CA 126.542 1.937 . . . . 0.0 107.587 179.676 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 6.1 ttpt -104.58 103.91 13.65 Favored 'General case' 0 C--N 1.309 -1.183 0 O-C-N 127.086 2.741 . . . . 0.0 104.156 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.522 ' CD1' HD11 ' A' ' 36' ' ' LEU 0.271 1.0 OUTLIER -88.2 117.11 26.87 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 179.434 . . . . . . . . 4 4 . 1 . 012 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.598 HG23 HG23 ' A' ' 5' ' ' THR . 31.3 m -108.81 98.46 7.95 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 104.118 -2.549 . . . . 0.0 104.118 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.478 HG13 ' CG2' ' A' ' 49' ' ' VAL . 29.0 mt -81.38 142.33 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.38 0 O-C-N 126.143 2.152 . . . . 0.0 109.213 -179.717 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.448 HG22 ' O ' ' A' ' 41' ' ' THR . 20.9 m -145.33 83.14 1.66 Allowed 'General case' 0 CA--C 1.508 -0.639 0 O-C-N 128.091 3.369 . . . . 0.0 109.247 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.479 ' NE2' ' CE2' ' A' ' 47' ' ' PHE . 4.1 tt0 -82.85 132.18 35.17 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 114.375 -1.284 . . . . 0.0 108.312 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -117.67 67.53 0.75 Allowed 'General case' 0 CA--C 1.485 -1.527 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.91 -86.38 1.52 Allowed Glycine 0 N--CA 1.429 -1.82 0 N-CA-C 106.417 -2.673 . . . . 0.0 106.417 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.288 0.0 OUTLIER -111.08 -40.32 4.51 Favored 'General case' 0 N--CA 1.451 -0.417 0 O-C-N 125.541 1.377 . . . . 0.0 113.167 -179.912 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.45 ' HG3' ' HG3' ' A' ' 63' ' ' GLU . 5.3 ttmm -62.2 148.87 43.3 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.596 ' HB3' ' CE1' ' A' ' 62' ' ' PHE 0.306 1.7 m-85 -137.08 105.56 5.79 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 114.98 -1.009 . . . . 0.0 109.196 179.962 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.812 ' HB ' HG12 ' A' ' 61' ' ' VAL 0.423 9.5 t -99.38 126.05 45.18 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 105.712 -1.959 . . . . 0.0 105.712 179.43 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.498 ' HB ' ' CE2' ' A' ' 62' ' ' PHE 0.671 0.6 OUTLIER -107.23 115.89 49.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 O-C-N 126.801 2.563 . . . . 0.0 113.303 -179.84 . . . . . . . . 4 4 . 1 . 012 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.546 ' CB ' ' HB ' ' A' ' 39' ' ' THR . 7.3 tttt -78.63 100.37 6.97 Favored 'General case' 0 C--N 1.307 -1.267 1 N-CA-C 100.182 -4.006 . . . . 0.0 100.182 179.909 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 55.4 tt0 -95.64 63.75 2.47 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 102.446 -3.168 . . . . 0.0 102.446 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 11.0 m -74.92 60.27 0.96 Allowed 'General case' 0 C--N 1.289 -2.025 0 O-C-N 125.763 1.914 . . . . 0.0 106.725 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -82.13 179.36 7.84 Favored 'General case' 0 C--O 1.209 -1.073 0 C-N-CA 117.215 -1.794 . . . . 0.0 109.778 179.696 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -63.39 -30.43 71.56 Favored 'General case' 0 C--O 1.214 -0.789 0 O-C-N 125.329 1.643 . . . . 0.0 107.867 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 -68.16 -65.26 0.72 Allowed 'General case' 0 C--O 1.218 -0.6 0 C-N-CA 115.064 -2.654 . . . . 0.0 109.245 179.591 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.903 ' HB2' HG22 ' A' ' 58' ' ' ILE . 7.9 mtm-85 -139.81 170.88 15.07 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 123.98 3.082 . . . . 0.0 110.733 179.45 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -116.87 70.71 0.78 Allowed 'General case' 0 C--O 1.217 -0.636 1 N-CA-C 100.083 -4.043 . . . . 0.0 100.083 179.573 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.903 HG22 ' HB2' ' A' ' 56' ' ' ARG . 0.5 OUTLIER -107.05 91.41 1.76 Allowed 'Isoleucine or valine' 0 CA--C 1.561 1.382 0 C-N-CA 130.312 3.445 . . . . 0.0 117.432 -179.336 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -60.95 116.53 4.55 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 104.768 -2.308 . . . . 0.0 104.768 179.052 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.522 HG13 ' O ' ' A' ' 60' ' ' VAL . 13.3 p -104.0 105.75 19.02 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 O-C-N 124.64 1.212 . . . . 0.0 112.73 -178.132 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.812 HG12 ' HB ' ' A' ' 48' ' ' THR 0.412 0.6 OUTLIER -82.44 152.3 4.05 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 O-C-N 118.676 -2.515 . . . . 0.0 109.317 179.797 . . . . . . . . 4 4 . 1 . 012 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.641 ' CE1' ' CZ2' ' A' ' 82' ' ' TRP . 16.4 p90 -162.45 95.39 0.92 Allowed 'General case' 0 N--CA 1.445 -0.722 0 O-C-N 120.55 -1.344 . . . . 0.0 108.991 179.694 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.52 ' OE1' HG11 ' A' ' 66' ' ' VAL . 1.8 mt-10 -65.96 128.95 38.08 Favored 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 104.053 -2.573 . . . . 0.0 104.053 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.449 HD21 ' CE2' ' A' ' 47' ' ' PHE . 0.4 OUTLIER -61.67 121.02 11.77 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-O 122.984 1.373 . . . . 0.0 110.857 -179.898 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 71.09 25.55 75.47 Favored Glycine 0 N--CA 1.471 0.981 0 N-CA-C 117.525 1.77 . . . . 0.0 117.525 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.52 HG11 ' OE1' ' A' ' 63' ' ' GLU 0.409 78.3 t -102.99 -21.0 5.4 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 CA-C-O 116.958 -1.496 . . . . 0.0 108.049 179.712 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.69 ' HA ' HG22 ' A' ' 81' ' ' THR 0.253 1.4 m-20 77.41 145.02 0.08 Allowed 'General case' 0 C--N 1.307 -1.279 0 O-C-N 126.081 2.113 . . . . 0.0 113.044 179.896 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.525 ' CZ ' ' HB3' ' A' ' 62' ' ' PHE . 0.1 OUTLIER -167.25 177.0 6.37 Favored 'General case' 0 N--CA 1.419 -2.02 0 CA-C-N 119.691 1.132 . . . . 0.0 108.189 179.874 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -128.79 132.04 47.84 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 117.41 -1.281 . . . . 0.0 109.717 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 16.2 t80 -125.77 111.52 14.98 Favored 'General case' 0 N--CA 1.435 -1.206 0 O-C-N 125.46 1.725 . . . . 0.0 114.231 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.1 m -73.74 145.13 45.36 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 123.089 2.677 . . . . 0.0 106.699 179.753 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.688 HD21 HD13 ' A' ' 78' ' ' LEU . 1.1 mt -107.43 -171.48 1.88 Allowed 'General case' 0 CA--C 1.495 -1.155 0 N-CA-C 106.072 -1.825 . . . . 0.0 106.072 -179.768 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -109.31 11.97 25.01 Favored 'General case' 0 C--O 1.235 0.336 0 O-C-N 126.64 2.463 . . . . 0.0 114.822 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -132.12 -38.59 1.09 Allowed 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 113.499 0.926 . . . . 0.0 113.499 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -130.11 -4.7 4.51 Favored Glycine 0 CA--C 1.538 1.518 0 N-CA-C 117.252 1.661 . . . . 0.0 117.252 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . 0.363 0.0 OUTLIER 67.5 171.24 0.27 Allowed 'General case' 0 N--CA 1.441 -0.879 0 C-N-CA 116.793 -1.963 . . . . 0.0 113.35 179.953 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.446 ' HB2' HG22 ' A' ' 96' ' ' VAL . 9.7 mt-10 12.02 111.37 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.891 1 O-C-N 130.192 4.682 . . . . 0.0 115.085 179.626 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.688 HD13 HD21 ' A' ' 72' ' ' LEU 0.406 0.7 OUTLIER -145.7 104.81 3.91 Favored 'General case' 0 C--O 1.219 -0.547 0 N-CA-C 101.863 -3.384 . . . . 0.0 101.863 179.939 . . . . . . . . 4 4 . 1 . 012 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 24.1 m -106.27 170.79 7.71 Favored 'General case' 0 CA--C 1.483 -1.597 0 CA-C-N 113.658 -1.61 . . . . 0.0 106.691 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 154.27 -171.45 32.82 Favored Glycine 0 N--CA 1.441 -0.98 0 C-N-CA 117.03 -2.509 . . . . 0.0 111.837 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.69 HG22 ' HA ' ' A' ' 67' ' ' ASP . 44.1 p -144.1 160.89 40.13 Favored 'General case' 0 C--O 1.199 -1.584 0 C-N-CA 117.701 -1.6 . . . . 0.0 109.899 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' TRP . . . . . 0.641 ' CZ2' ' CE1' ' A' ' 62' ' ' PHE . 10.5 m0 -101.94 156.51 17.49 Favored 'General case' 0 N--CA 1.426 -1.648 0 N-CA-C 102.055 -3.313 . . . . 0.0 102.055 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 3.2 t -150.42 124.18 9.19 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 117.751 -1.58 . . . . 0.0 106.932 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.472 ' HA ' HD23 ' A' ' 89' ' ' LEU . 0.3 OUTLIER -84.32 111.68 19.63 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 112.714 -2.039 . . . . 0.0 111.733 -179.911 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.478 ' HG3' ' CG2' ' A' ' 90' ' ' VAL 0.573 5.0 mt-10 -67.95 -49.69 60.29 Favored 'General case' 0 N--CA 1.421 -1.905 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -179.755 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 161.55 -61.2 0.29 Allowed Glycine 0 C--O 1.216 -1.028 0 N-CA-C 103.283 -3.927 . . . . 0.0 103.283 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -110.04 8.04 23.85 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 125.66 1.447 . . . . 0.0 113.675 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . 0.317 0.0 OUTLIER -156.87 126.73 6.29 Favored 'General case' 0 CA--C 1.503 -0.864 0 O-C-N 126.551 2.407 . . . . 0.0 107.571 179.953 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.513 HD13 ' CE3' ' A' ' 82' ' ' TRP . 1.2 mt -83.6 147.8 27.52 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 111.329 -2.669 . . . . 0.0 103.953 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.478 ' CG2' ' HG3' ' A' ' 85' ' ' GLU . 0.2 OUTLIER -137.35 133.54 46.6 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.889 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 -179.994 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -111.56 103.6 1.57 Allowed Glycine 0 CA--C 1.528 0.9 0 C-N-CA 125.649 1.595 . . . . 0.0 113.35 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 37.8 mtpt -98.65 118.57 35.66 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 102.935 -2.987 . . . . 0.0 102.935 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.456 ' HB3' ' HG ' ' A' ' 78' ' ' LEU . 15.6 m-85 -122.9 115.23 21.59 Favored 'General case' 0 CA--C 1.501 -0.916 0 O-C-N 126.416 2.322 . . . . 0.0 111.521 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 19.9 mttp -98.47 140.45 32.7 Favored 'General case' 0 CA--C 1.505 -0.762 0 CA-C-O 125.192 2.425 . . . . 0.0 108.434 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . 0.407 15.3 ttt180 -97.15 129.74 44.49 Favored 'General case' 0 CA--C 1.487 -1.475 0 CA-C-O 124.031 1.872 . . . . 0.0 106.102 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.501 HG23 ' N ' ' A' ' 97' ' ' ASP . 14.7 m -69.77 -34.73 62.04 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.934 0 CA-C-O 125.551 2.596 . . . . 0.0 114.675 -179.766 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.501 ' N ' HG23 ' A' ' 96' ' ' VAL 0.401 0.9 OUTLIER -63.75 -8.36 10.3 Favored 'General case' 0 C--O 1.255 1.39 0 CA-C-N 113.936 -1.484 . . . . 0.0 114.377 179.814 . . . . . . . . 4 4 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.468 ' ND2' ' HG2' ' A' ' 100' ' ' LYS . 13.3 p-10 -150.54 1.77 0.45 Allowed 'General case' 0 N--CA 1.433 -1.302 0 C-N-CA 116.196 -2.202 . . . . 0.0 116.732 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 65.83 21.94 69.79 Favored Glycine 0 CA--C 1.542 1.774 0 N-CA-C 115.673 1.029 . . . . 0.0 115.673 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.468 ' HG2' ' ND2' ' A' ' 98' ' ' ASN . 49.0 mmtt -89.68 -178.82 5.63 Favored 'General case' 0 C--O 1.202 -1.417 0 C-N-CA 119.823 -0.751 . . . . 0.0 112.802 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -143.48 119.42 10.63 Favored 'General case' 0 C--O 1.212 -0.885 0 C-N-CA 128.264 2.626 . . . . 0.0 113.866 179.761 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.64 ' HG ' ' HA ' ' A' ' 119' ' ' TYR . 5.5 tt -98.37 133.76 42.32 Favored 'General case' 0 N--CA 1.44 -0.972 1 C-N-CA 135.337 5.455 . . . . 0.0 106.211 -179.679 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.618 HG23 ' HB3' ' A' ' 117' ' ' TYR . 7.1 tt -122.55 159.29 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.702 0 C-N-CA 115.855 -2.338 . . . . 0.0 104.726 179.489 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -156.39 145.54 20.49 Favored 'General case' 0 C--N 1.315 -0.902 0 O-C-N 118.844 -2.41 . . . . 0.0 107.542 -179.706 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.684 HG13 ' HG2' ' A' ' 107' ' ' GLU . 6.4 p -131.66 115.12 26.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-O 126.078 2.847 . . . . 0.0 110.287 -179.527 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.586 ' CZ ' ' CH2' ' A' ' 82' ' ' TRP . 2.3 mtt-85 -76.44 90.48 3.26 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 112.299 -2.228 . . . . 0.0 105.462 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.684 ' HG2' HG13 ' A' ' 105' ' ' VAL . 1.2 mt-10 -86.66 77.62 9.31 Favored 'General case' 0 N--CA 1.419 -2.015 0 CA-C-N 109.985 -3.28 . . . . 0.0 114.928 -179.682 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.583 HG13 ' CZ ' ' A' ' 2' ' ' PHE 0.257 0.6 OUTLIER -54.94 90.75 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 CA-C-O 122.931 1.348 . . . . 0.0 111.417 179.264 . . . . . . . . 4 4 . 1 . 012 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.459 ' N ' ' O ' ' A' ' 107' ' ' GLU . 23.9 m -80.97 66.99 6.71 Favored 'General case' 0 N--CA 1.432 -1.339 0 N-CA-C 103.822 -2.659 . . . . 0.0 103.822 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 52.7 -90.97 0.01 OUTLIER Glycine 0 N--CA 1.463 0.493 1 O-C-N 129.191 4.057 . . . . 0.0 111.113 -179.817 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . 0.322 4.5 m120 -82.29 -25.89 33.6 Favored 'General case' 0 C--N 1.309 -1.196 0 CA-C-O 115.935 -1.983 . . . . 0.0 110.675 179.805 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -110.28 125.63 53.33 Favored 'General case' 0 C--O 1.205 -1.256 0 N-CA-C 115.878 1.807 . . . . 0.0 115.878 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.456 HD21 ' HB3' ' A' ' 106' ' ' ARG . 0.0 OUTLIER -87.04 143.6 27.26 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 100.633 -3.84 . . . . 0.0 100.633 179.983 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.8 HG23 HD13 ' A' ' 127' ' ' ILE 0.312 0.6 OUTLIER -142.13 136.57 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.585 0 N-CA-C 105.067 -2.197 . . . . 0.0 105.067 179.989 . . . . . . . . 4 4 . 1 . 012 nuclear build core ' A' A ' 115' ' ' GLN . . . . . 0.439 HE21 ' HE1' ' A' ' 128' ' ' PHE . 49.6 mt-30 -109.54 123.24 49.08 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 100.926 -3.731 . . . . 0.0 100.926 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.52 HG23 ' HG3' ' A' ' 107' ' ' GLU . 0.1 OUTLIER -135.39 147.73 49.12 Favored 'General case' 0 N--CA 1.417 -2.11 0 C-N-CA 118.091 -1.443 . . . . 0.0 111.829 -179.12 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.618 ' HB3' HG23 ' A' ' 103' ' ' ILE 0.352 18.5 m-85 127.81 -144.95 0.0 OUTLIER 'General case' 0 CA--C 1.471 -2.08 1 O-C-N 131.892 5.745 . . . . 0.0 113.945 177.656 . . . . . . . . 4 3 . 1 . 012 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.528 ' O ' ' N ' ' A' ' 103' ' ' ILE . 7.9 t -150.13 -159.84 1.09 Allowed 'General case' 0 N--CA 1.437 -1.086 0 CA-C-O 125.825 2.726 . . . . 0.0 116.789 -174.908 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.64 ' HA ' ' HG ' ' A' ' 102' ' ' LEU 0.25 38.1 t80 -108.5 -31.55 7.75 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 112.436 -2.165 . . . . 0.0 108.791 177.428 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -148.16 -70.91 0.22 Allowed 'General case' 0 C--N 1.291 -1.955 0 C-N-CA 126.862 2.065 . . . . 0.0 109.605 179.112 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -147.3 18.55 1.52 Allowed Glycine 0 C--N 1.351 1.388 0 N-CA-C 120.887 3.115 . . . . 0.0 120.887 -179.756 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 50.7 t -117.24 93.08 2.35 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 N-CA-C 103.547 -2.76 . . . . 0.0 103.547 179.667 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.456 ' HA ' ' O ' ' A' ' 117' ' ' TYR . 6.6 mt-10 -57.99 178.82 0.08 Allowed 'General case' 0 CA--C 1.513 -0.467 0 CA-C-O 124.021 1.867 . . . . 0.0 112.368 -178.191 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.536 ' HB1' ' HA ' ' A' ' 14' ' ' TYR . . . -172.58 104.26 0.15 Allowed 'General case' 0 N--CA 1.436 -1.138 0 O-C-N 116.535 -3.853 . . . . 0.0 109.453 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.27 141.33 33.03 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 119.804 1.184 . . . . 0.0 108.997 179.49 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.566 ' CG ' ' CD2' ' A' ' 14' ' ' TYR . 3.8 mtp180 -129.13 79.21 1.9 Allowed 'General case' 0 C--O 1.214 -0.798 0 CA-C-O 116.126 -1.892 . . . . 0.0 110.509 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.8 HD13 HG23 ' A' ' 114' ' ' ILE . 3.8 mm -65.29 118.23 7.38 Favored 'Isoleucine or valine' 0 C--O 1.256 1.429 1 O-C-N 130.35 4.781 . . . . 0.0 115.201 179.64 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.479 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 80.6 m-85 -104.67 137.46 42.46 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 126.362 1.865 . . . . 0.0 108.072 -179.616 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . 0.363 0.6 OUTLIER -108.93 42.57 1.39 Allowed 'General case' 0 N--CA 1.439 -1.025 0 CA-C-O 116.475 -1.726 . . . . 0.0 111.47 -179.964 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.514 ' HA ' ' CE3' ' A' ' 6' ' ' TRP . 0.0 OUTLIER 21.63 101.16 0.0 OUTLIER 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 128.404 2.682 . . . . 0.0 116.472 -179.904 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . 0.934 16.5 tt0 . . . . . 0 C--N 1.32 -0.697 0 N-CA-C 115.882 1.808 . . . . 0.0 115.882 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 2' ' ' PHE . . . . . 0.554 ' CE1' HG13 ' A' ' 108' ' ' ILE . 2.5 m-85 . . . . . 0 N--CA 1.434 -1.255 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -49.53 95.11 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.362 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 155.33 178.98 30.12 Favored Glycine 0 N--CA 1.441 -0.982 0 C-N-CA 118.024 -2.036 . . . . 0.0 112.324 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . 0.531 1.3 p -86.1 147.93 25.93 Favored 'General case' 0 C--N 1.312 -1.041 0 C-N-CA 124.82 1.248 . . . . 0.0 108.46 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.524 ' CH2' ' HD2' ' A' ' 130' ' ' LYS . 74.9 m95 -143.29 140.24 30.52 Favored 'General case' 0 CA--C 1.504 -0.804 0 CA-C-O 115.202 -2.332 . . . . 0.0 105.961 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 18.5 tttt -144.34 92.77 2.35 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 114.398 -2.715 . . . . 0.0 105.838 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.532 ' HB ' ' CD1' ' A' ' 128' ' ' PHE 0.258 7.4 p -34.38 128.13 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.16 0 CA-C-O 116.426 -1.749 . . . . 0.0 113.054 -179.998 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -126.35 -22.8 3.94 Favored 'General case' 0 N--CA 1.451 -0.406 0 O-C-N 125.922 2.014 . . . . 0.0 111.335 -179.693 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.427 ' HD2' ' HE3' ' A' ' 129' ' ' LYS . 0.0 OUTLIER -141.36 63.7 1.43 Allowed 'General case' 0 CA--C 1.49 -1.362 0 C-N-CA 118.758 -1.177 . . . . 0.0 113.409 -179.78 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . 0.473 16.4 m-20 -48.23 156.27 0.41 Allowed 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 124.023 0.929 . . . . 0.0 108.733 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.44 ' HB2' ' HB2' ' A' ' 125' ' ' LYS . 11.6 mt-10 -143.76 136.94 27.71 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-O 115.77 -2.062 . . . . 0.0 107.294 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.418 ' HB3' ' HA ' ' A' ' 124' ' ' ALA . 1.0 OUTLIER 53.76 20.7 2.36 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 122.127 2.239 . . . . 0.0 113.238 -179.691 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.547 ' HA ' ' HB1' ' A' ' 124' ' ' ALA 0.261 4.3 t80 -79.81 -35.81 37.88 Favored 'General case' 0 N--CA 1.442 -0.873 0 O-C-N 126.592 2.433 . . . . 0.0 114.858 179.529 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -77.37 -24.14 50.67 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 116.849 -1.548 . . . . 0.0 108.886 -179.523 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 8.3 ttmm -78.52 -29.41 46.51 Favored 'General case' 0 N--CA 1.431 -1.387 0 O-C-N 126.012 2.07 . . . . 0.0 111.669 179.727 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.491 ' CB ' ' HB2' ' A' ' 124' ' ' ALA . 0.2 OUTLIER -69.25 -34.98 75.64 Favored 'General case' 0 N--CA 1.429 -1.516 0 O-C-N 120.384 -1.448 . . . . 0.0 112.065 179.914 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 10.8 mtt -75.76 -26.49 57.44 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-O 124.903 2.287 . . . . 0.0 109.232 -179.605 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -79.61 -25.34 41.51 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 124.682 2.182 . . . . 0.0 112.347 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.555 ' HE3' ' CG ' ' A' ' 119' ' ' TYR . 3.5 tmtm? -70.61 -30.52 67.2 Favored 'General case' 0 C--O 1.209 -1.063 0 O-C-N 118.23 -2.794 . . . . 0.0 112.864 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -79.95 -33.86 39.28 Favored 'General case' 0 C--O 1.215 -0.745 0 O-C-N 126.132 2.145 . . . . 0.0 108.86 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 108.07 37.53 2.15 Favored Glycine 0 C--N 1.306 -1.1 0 CA-C-O 116.051 -2.527 . . . . 0.0 111.862 -179.661 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.5 mm -70.31 84.68 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.909 0 CA-C-O 113.253 -3.26 . . . . 0.0 105.033 179.732 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 10.9 m-20 -3.29 -90.07 0.0 OUTLIER 'General case' 0 C--O 1.247 0.933 0 O-C-N 128.484 3.615 . . . . 0.0 115.24 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . 0.359 20.3 m -155.86 -49.98 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.221 -0.419 0 N-CA-C 117.416 2.376 . . . . 0.0 117.416 179.716 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.569 14.4 m -76.4 -23.01 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.277 0 N-CA-C 116.837 2.162 . . . . 0.0 116.837 179.633 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.9 mtpt -74.98 -25.55 58.93 Favored 'General case' 0 N--CA 1.437 -1.1 0 O-C-N 127.253 2.845 . . . . 0.0 113.175 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.37 -22.22 44.69 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 118.317 -1.353 . . . . 0.0 108.784 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.7 ttpt -65.27 -50.35 66.1 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 122.251 1.024 . . . . 0.0 112.551 -179.466 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.453 ' HA ' HD12 ' A' ' 30' ' ' LEU . 0.7 OUTLIER -76.01 -24.45 55.26 Favored 'General case' 0 C--O 1.214 -0.775 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 179.745 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -76.32 -31.56 54.38 Favored Glycine 0 N--CA 1.441 -1.021 0 O-C-N 128.643 3.714 . . . . 0.0 109.832 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -76.94 -38.99 52.27 Favored 'General case' 0 C--O 1.242 0.692 0 O-C-N 125.379 1.281 . . . . 0.0 111.026 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -108.07 47.54 0.89 Allowed 'General case' 0 N--CA 1.433 -1.277 0 CA-C-O 116.646 -1.645 . . . . 0.0 111.077 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -70.12 -37.23 75.27 Favored 'General case' 0 CA--C 1.495 -1.162 0 N-CA-C 118.63 2.826 . . . . 0.0 118.63 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . 0.262 0.1 OUTLIER 81.86 28.77 0.15 Allowed 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 117.709 -1.138 . . . . 0.0 110.629 -179.999 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 1.018 HD21 HD13 ' A' ' 38' ' ' LEU . 0.5 OUTLIER -48.41 94.74 0.01 OUTLIER 'General case' 0 CA--C 1.507 -0.693 0 C-N-CA 125.05 1.34 . . . . 0.0 108.51 -179.866 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 10.3 tttt -96.92 101.94 13.63 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 102.555 -3.128 . . . . 0.0 102.555 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 1.018 HD13 HD21 ' A' ' 36' ' ' LEU 0.322 2.1 tp -87.33 130.56 34.58 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 119.86 1.209 . . . . 0.0 110.157 -179.915 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.523 ' HB ' ' CB ' ' A' ' 50' ' ' LYS . 69.3 m -119.25 98.66 6.27 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 102.451 -3.166 . . . . 0.0 102.451 179.607 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 1.084 HG23 HG12 ' A' ' 49' ' ' VAL . 1.1 mt -91.42 141.01 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.368 0 CA-C-O 123.661 1.696 . . . . 0.0 111.121 179.595 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.507 HG22 ' O ' ' A' ' 41' ' ' THR . 3.2 m -133.46 93.02 3.07 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 111.04 -2.8 . . . . 0.0 108.45 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -80.31 100.99 8.66 Favored 'General case' 0 C--O 1.218 -0.588 0 O-C-N 125.723 1.89 . . . . 0.0 110.635 179.805 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -103.48 67.2 0.9 Allowed 'General case' 0 N--CA 1.436 -1.159 0 CA-C-O 125.635 2.636 . . . . 0.0 108.559 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 90.01 -101.03 2.73 Favored Glycine 0 C--N 1.302 -1.353 0 N-CA-C 108.107 -1.997 . . . . 0.0 108.107 179.758 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.314 83.5 m-20 -111.52 -13.04 13.89 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 128.321 3.012 . . . . 0.0 111.041 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.478 ' HA ' ' HA ' ' A' ' 63' ' ' GLU . 10.8 tttt -82.27 143.91 31.0 Favored 'General case' 0 C--N 1.31 -1.123 0 O-C-N 118.363 -2.711 . . . . 0.0 108.071 179.714 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.714 ' CE1' HD21 ' A' ' 64' ' ' LEU . 18.3 m-85 -122.52 86.59 2.61 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 113.845 -1.525 . . . . 0.0 110.982 179.693 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.761 ' OG1' HG12 ' A' ' 61' ' ' VAL 0.336 9.5 t -91.76 104.28 16.75 Favored 'General case' 0 C--N 1.316 -0.882 0 O-C-N 126.796 2.56 . . . . 0.0 106.321 179.914 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 1.084 HG12 HG23 ' A' ' 40' ' ' ILE 0.702 0.7 OUTLIER -100.62 116.76 44.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 126.965 2.665 . . . . 0.0 116.401 -179.685 . . . . . . . . 4 4 . 1 . 013 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.523 ' CB ' ' HB ' ' A' ' 39' ' ' THR . 26.7 tttp -62.81 149.57 43.81 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 101.018 -3.697 . . . . 0.0 101.018 179.279 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.41 ' O ' ' N ' ' A' ' 53' ' ' SER . 49.4 tt0 -137.21 64.26 1.54 Allowed 'General case' 0 CA--C 1.511 -0.531 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 -179.487 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . 0.256 5.6 m -74.88 73.97 2.13 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 105.16 -2.163 . . . . 0.0 105.16 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.545 ' HB2' HD12 ' A' ' 36' ' ' LEU . 33.1 t -102.82 25.35 9.38 Favored 'General case' 0 CA--C 1.506 -0.715 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 -179.782 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 78.31 -48.23 0.46 Allowed 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 115.272 -2.299 . . . . 0.0 108.988 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -58.86 -45.1 90.94 Favored 'General case' 0 C--O 1.213 -0.849 0 C-N-CA 117.428 -1.709 . . . . 0.0 110.373 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.415 ' NE ' ' HB ' ' A' ' 58' ' ' ILE . 49.0 ttt180 -168.92 144.39 3.33 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 105.668 -1.975 . . . . 0.0 105.668 179.21 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 26.8 t30 -93.1 78.21 4.6 Favored 'General case' 0 C--N 1.35 0.621 0 N-CA-C 101.642 -3.466 . . . . 0.0 101.642 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.415 ' HB ' ' NE ' ' A' ' 56' ' ' ARG . 3.0 tt -110.3 110.12 30.98 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.338 1 O-C-N 130.01 4.569 . . . . 0.0 117.728 -179.549 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -63.02 135.11 57.09 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 103.89 -2.633 . . . . 0.0 103.89 177.942 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.614 HG12 ' CD2' ' A' ' 62' ' ' PHE . 10.1 t -107.41 92.37 2.06 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 -178.18 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.761 HG12 ' OG1' ' A' ' 48' ' ' THR 0.358 0.7 OUTLIER -90.81 135.24 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.151 0 O-C-N 118.681 -2.512 . . . . 0.0 111.951 -179.761 . . . . . . . . 4 4 . 1 . 013 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.614 ' CD2' HG12 ' A' ' 60' ' ' VAL . 24.4 p90 -166.05 97.25 0.62 Allowed 'General case' 0 C--N 1.314 -0.943 0 C-N-CA 118.151 -1.42 . . . . 0.0 110.296 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.478 ' HA ' ' HA ' ' A' ' 46' ' ' LYS . 1.0 OUTLIER -56.03 147.85 18.98 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 179.88 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.714 HD21 ' CE1' ' A' ' 47' ' ' PHE . 0.3 OUTLIER -62.55 99.4 0.15 Allowed 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 179.73 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 98.7 34.46 5.23 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 119.321 2.489 . . . . 0.0 119.321 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . 0.433 34.8 m -114.3 77.67 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 N-CA-C 104.618 -2.364 . . . . 0.0 104.618 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -35.16 103.21 0.03 OUTLIER 'General case' 0 CA--C 1.486 -1.481 0 O-C-N 126.803 2.564 . . . . 0.0 113.711 -179.68 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 28.9 p90 -116.52 174.97 5.78 Favored 'General case' 0 N--CA 1.423 -1.816 0 O-C-N 120.138 -1.601 . . . . 0.0 112.484 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -123.17 126.07 46.31 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 128.828 3.83 . . . . 0.0 105.488 179.604 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -121.56 -42.34 2.44 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-O 115.82 -2.038 . . . . 0.0 114.356 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.9 m 72.61 143.17 0.06 Allowed 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 105.95 -1.87 . . . . 0.0 105.95 -179.499 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.573 HD11 HD13 ' A' ' 78' ' ' LEU . 1.2 mp -95.95 -164.17 1.13 Allowed 'General case' 0 C--N 1.301 -1.509 0 CA-C-N 114.779 -1.101 . . . . 0.0 108.719 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -89.11 -48.75 7.19 Favored 'General case' 0 C--O 1.211 -0.964 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.117 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -129.01 12.94 6.22 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-O 115.557 -2.163 . . . . 0.0 109.633 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.45 ' C ' HG23 ' A' ' 76' ' ' THR . . . -107.29 -8.93 30.37 Favored Glycine 0 CA--C 1.546 1.998 0 CA-C-O 117.463 -1.743 . . . . 0.0 116.924 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.554 ' O ' HD12 ' A' ' 72' ' ' LEU 0.377 0.1 OUTLIER 89.3 -164.08 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 114.696 -2.574 . . . . 0.0 113.97 179.946 . . . . . . . . 4 4 . 1 . 013 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.669 ' CB ' HG22 ' A' ' 96' ' ' VAL . 0.5 OUTLIER -62.21 140.64 58.45 Favored 'General case' 0 C--N 1.318 -0.78 1 O-C-N 129.529 4.268 . . . . 0.0 114.891 179.914 . . . . . . . . 4 4 . 1 . 013 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.573 HD13 HD11 ' A' ' 72' ' ' LEU 0.399 11.1 tp -143.83 128.77 18.47 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 102.416 -3.179 . . . . 0.0 102.416 179.872 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 87.1 m -146.45 121.88 10.34 Favored 'General case' 0 CA--C 1.487 -1.461 0 N-CA-C 103.691 -2.707 . . . . 0.0 103.691 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -166.0 -146.49 4.84 Favored Glycine 0 C--N 1.297 -1.638 0 C-N-CA 114.576 -3.678 . . . . 0.0 110.949 -179.615 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 72.5 p -152.27 171.35 18.11 Favored 'General case' 0 CA--C 1.472 -2.048 0 O-C-N 125.632 1.431 . . . . 0.0 107.494 -179.646 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' TRP . . . . . 0.489 ' CE3' ' N ' ' A' ' 91' ' ' GLY . 24.2 m95 -125.03 139.72 53.55 Favored 'General case' 0 N--CA 1.429 -1.524 0 N-CA-C 103.703 -2.703 . . . . 0.0 103.703 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 10.1 t -147.32 149.44 32.83 Favored 'General case' 0 C--O 1.256 1.409 0 C-N-CA 119.051 -1.059 . . . . 0.0 111.445 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.8 130.04 34.93 Favored 'General case' 0 CA--C 1.494 -1.192 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 -179.715 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . 0.538 0.0 OUTLIER -110.41 60.26 0.61 Allowed 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 -179.854 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 73.07 -95.1 0.72 Allowed Glycine 0 N--CA 1.429 -1.817 0 CA-C-N 112.41 -2.177 . . . . 0.0 107.731 -179.804 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -94.66 12.33 28.07 Favored 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 115.151 1.537 . . . . 0.0 115.151 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . 0.404 4.2 mptt -140.28 175.7 9.38 Favored 'General case' 0 C--O 1.21 -1.013 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.474 ' HA ' HD23 ' A' ' 89' ' ' LEU . 0.3 OUTLIER -125.13 141.88 51.83 Favored 'General case' 0 CA--C 1.548 0.898 0 N-CA-C 101.578 -3.49 . . . . 0.0 101.578 -180.0 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 104' ' ' ALA . 7.6 p -133.82 119.73 33.9 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 O-C-N 125.505 1.753 . . . . 0.0 110.691 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.489 ' N ' ' CE3' ' A' ' 82' ' ' TRP . . . -93.31 103.07 2.99 Favored Glycine 0 N--CA 1.474 1.198 0 C-N-CA 127.532 2.492 . . . . 0.0 108.294 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -97.61 154.2 17.7 Favored 'General case' 0 CA--C 1.502 -0.895 0 N-CA-C 103.944 -2.613 . . . . 0.0 103.944 179.808 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.503 ' HB2' HD23 ' A' ' 102' ' ' LEU . 91.6 m-85 -151.54 118.47 5.84 Favored 'General case' 0 CA--C 1.502 -0.899 0 O-C-N 125.12 1.513 . . . . 0.0 111.253 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 25.0 mttm -93.76 152.29 19.03 Favored 'General case' 0 C--O 1.21 -0.986 0 CA-C-O 123.741 1.734 . . . . 0.0 107.669 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . 0.368 0.5 OUTLIER -115.62 121.8 43.69 Favored 'General case' 0 CA--C 1.488 -1.414 0 CA-C-N 114.983 -1.008 . . . . 0.0 108.953 179.914 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.669 HG22 ' CB ' ' A' ' 77' ' ' GLU . 23.4 m -62.52 -27.79 43.49 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 CA-C-O 125.264 2.459 . . . . 0.0 113.338 179.756 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . 0.31 2.4 m-20 -61.56 -10.17 7.48 Favored 'General case' 0 C--O 1.246 0.902 0 CA-C-N 113.55 -1.659 . . . . 0.0 113.34 179.715 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -169.89 15.28 0.02 OUTLIER 'General case' 0 N--CA 1.433 -1.287 0 N-CA-C 115.636 1.717 . . . . 0.0 115.636 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 55.13 21.22 24.29 Favored Glycine 0 CA--C 1.523 0.547 0 CA-C-O 123.635 1.686 . . . . 0.0 113.572 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp -78.25 -170.88 2.16 Favored 'General case' 0 C--O 1.199 -1.572 0 O-C-N 120.225 -1.75 . . . . 0.0 106.697 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -135.77 159.76 40.66 Favored 'General case' 0 CA--C 1.5 -0.971 0 O-C-N 127.808 3.193 . . . . 0.0 110.164 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.664 HD11 ' HD1' ' A' ' 117' ' ' TYR . 0.2 OUTLIER -146.22 149.58 34.19 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 131.648 3.979 . . . . 0.0 104.007 179.541 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.754 HD13 ' N ' ' A' ' 104' ' ' ALA . 0.0 OUTLIER -143.34 162.12 16.78 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.994 0 N-CA-C 106.657 -1.609 . . . . 0.0 106.657 -179.723 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.754 ' N ' HD13 ' A' ' 103' ' ' ILE . . . -149.67 143.57 25.58 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-O 114.965 -2.445 . . . . 0.0 106.567 179.52 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.453 HG12 ' OG1' ' A' ' 116' ' ' THR . 2.9 p -126.24 105.52 14.53 Favored 'Isoleucine or valine' 0 C--O 1.257 1.466 0 CA-C-N 121.647 2.021 . . . . 0.0 108.15 -179.825 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.537 HH22 ' HZ ' ' A' ' 62' ' ' PHE . 63.6 mtt180 -67.79 90.29 0.28 Allowed 'General case' 0 CA--C 1.502 -0.883 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -83.69 78.57 9.67 Favored 'General case' 0 N--CA 1.433 -1.282 0 N-CA-C 116.639 2.089 . . . . 0.0 116.639 179.753 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.78 ' CG1' HD12 ' A' ' 113' ' ' LEU . 0.8 OUTLIER -68.52 101.33 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 C-N-CA 113.784 -3.167 . . . . 0.0 108.882 179.742 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.26 -29.78 69.5 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 114.199 -1.364 . . . . 0.0 107.536 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 154.01 -71.89 0.27 Allowed Glycine 0 C--O 1.243 0.715 1 C-N-CA 130.723 4.011 . . . . 0.0 111.583 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . 0.362 6.9 m120 -97.71 3.27 50.23 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 115.497 -2.192 . . . . 0.0 110.418 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -133.15 118.73 19.02 Favored 'General case' 0 CA--C 1.502 -0.867 0 O-C-N 128.005 3.315 . . . . 0.0 114.098 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.78 HD12 ' CG1' ' A' ' 108' ' ' ILE . 0.9 OUTLIER -97.29 94.22 6.97 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 103.214 -2.884 . . . . 0.0 103.214 179.821 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.501 HG12 HG23 ' A' ' 127' ' ' ILE . 77.2 mt -91.17 143.82 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.114 0 N-CA-C 103.419 -2.808 . . . . 0.0 103.419 179.655 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -132.8 108.17 8.81 Favored 'General case' 0 CA--C 1.49 -1.361 0 O-C-N 124.741 1.276 . . . . 0.0 109.136 -179.484 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.453 ' OG1' HG12 ' A' ' 105' ' ' VAL . 20.3 p -72.33 173.8 8.2 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 105.371 -2.085 . . . . 0.0 105.371 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.664 ' HD1' HD11 ' A' ' 102' ' ' LEU . 8.0 m-85 -162.78 114.38 1.54 Allowed 'General case' 0 CA--C 1.477 -1.847 0 CA-C-O 117.192 -1.385 . . . . 0.0 113.734 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . 0.264 1.2 m -126.57 122.3 34.72 Favored 'General case' 0 N--CA 1.424 -1.766 0 O-C-N 127.267 2.854 . . . . 0.0 110.961 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.555 ' CG ' ' HE3' ' A' ' 20' ' ' LYS . 1.4 t80 -85.85 -25.2 26.37 Favored 'General case' 0 N--CA 1.476 0.831 0 O-C-N 126.49 2.369 . . . . 0.0 107.064 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -161.97 -75.14 0.05 Allowed 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 112.522 -2.126 . . . . 0.0 113.573 -179.767 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -139.74 25.57 2.69 Favored Glycine 0 CA--C 1.537 1.463 0 N-CA-C 120.408 2.923 . . . . 0.0 120.408 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 22.0 t -133.02 102.87 5.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 105.219 -2.141 . . . . 0.0 105.219 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -75.94 165.69 24.61 Favored 'General case' 0 C--O 1.206 -1.195 0 CA-C-O 124.344 2.021 . . . . 0.0 108.82 -179.756 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.547 ' HB1' ' HA ' ' A' ' 14' ' ' TYR . . . -161.02 101.18 1.26 Allowed 'General case' 0 N--CA 1.435 -1.209 0 CA-C-O 114.488 -2.673 . . . . 0.0 107.854 -179.822 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.44 ' HB2' ' HB2' ' A' ' 12' ' ' GLU 0.288 5.3 mptt -77.95 146.03 35.72 Favored 'General case' 0 N--CA 1.449 -0.513 0 O-C-N 127.228 2.83 . . . . 0.0 110.519 179.738 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.45 ' NH2' HD13 ' A' ' 36' ' ' LEU . 0.0 OUTLIER -133.18 83.03 2.03 Favored 'General case' 0 C--O 1.212 -0.919 0 CA-C-O 114.955 -2.45 . . . . 0.0 106.845 179.823 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.501 HG23 HG12 ' A' ' 114' ' ' ILE . 1.9 mm -74.15 104.14 2.69 Favored 'Isoleucine or valine' 0 C--O 1.25 1.097 1 O-C-N 131.042 5.213 . . . . 0.0 117.381 179.808 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.712 ' CE2' HD22 ' A' ' 38' ' ' LEU . 0.7 OUTLIER -94.98 140.85 29.38 Favored 'General case' 0 CA--C 1.516 -0.361 0 O-C-N 124.565 1.166 . . . . 0.0 108.463 -179.813 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.427 ' HE3' ' HD2' ' A' ' 10' ' ' ARG . 27.7 mmtt -102.88 9.11 39.03 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-O 116.444 -1.741 . . . . 0.0 110.848 179.705 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.524 ' HD2' ' CH2' ' A' ' 6' ' ' TRP . 2.8 tttt 64.32 110.69 0.03 OUTLIER 'General case' 0 C--O 1.237 0.407 0 O-C-N 124.99 1.431 . . . . 0.0 113.67 -179.788 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . 0.746 1.9 mt-10 . . . . . 0 N--CA 1.438 -1.068 0 C-N-CA 118.422 -1.311 . . . . 0.0 114.066 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.442 -0.872 0 N-CA-C 114.239 1.2 . . . . 0.0 114.239 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -158.91 90.54 0.99 Allowed 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 114.03 -1.441 . . . . 0.0 112.395 -179.562 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 142.0 174.72 14.86 Favored Glycine 0 N--CA 1.439 -1.155 0 C-N-CA 114.477 -3.725 . . . . 0.0 114.459 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.601 ' HA ' ' HA ' ' A' ' 39' ' ' THR 0.705 3.3 t -58.3 151.86 18.67 Favored 'General case' 0 C--N 1.319 -0.734 0 O-C-N 127.169 2.335 . . . . 0.0 111.181 -179.664 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.714 ' HH2' HD11 ' A' ' 108' ' ' ILE . 92.2 m95 -147.51 93.35 2.21 Favored 'General case' 0 N--CA 1.429 -1.515 0 O-C-N 127.945 3.278 . . . . 0.0 105.774 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 15.3 tttt -99.76 100.13 11.04 Favored 'General case' 0 CA--C 1.505 -0.785 0 CA-C-O 116.986 -1.483 . . . . 0.0 111.158 -179.825 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.51 ' HA ' ' HA ' ' A' ' 128' ' ' PHE 0.305 2.2 p -45.71 131.8 2.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 117.402 -1.285 . . . . 0.0 112.36 -179.745 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -133.64 -38.61 0.91 Allowed 'General case' 0 N--CA 1.445 -0.678 0 O-C-N 126.886 2.616 . . . . 0.0 111.476 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.465 ' HB2' ' CG1' ' A' ' 127' ' ' ILE . 0.2 OUTLIER -81.83 -69.71 0.6 Allowed 'General case' 0 N--CA 1.432 -1.329 0 C-N-CA 119.048 -1.061 . . . . 0.0 112.771 -179.587 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 71.56 146.92 0.07 Allowed 'General case' 0 C--O 1.245 0.826 0 O-C-N 125.817 1.948 . . . . 0.0 107.182 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.411 ' O ' ' N ' ' A' ' 125' ' ' LYS . 0.4 OUTLIER -156.65 147.36 21.7 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 115.807 -2.044 . . . . 0.0 107.901 -179.363 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.7 t30 46.07 27.08 0.48 Allowed 'General case' 0 N--CA 1.478 0.96 0 O-C-N 125.124 1.515 . . . . 0.0 113.065 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.563 ' CE1' ' HB1' ' A' ' 32' ' ' ALA . 10.7 p90 -81.52 -34.08 31.42 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 118.508 2.781 . . . . 0.0 118.508 -179.382 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -72.75 -39.93 66.44 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-N 120.445 1.475 . . . . 0.0 110.16 179.563 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.53 -34.84 76.57 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 125.17 2.414 . . . . 0.0 113.218 -179.757 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.731 ' CB ' ' HB2' ' A' ' 124' ' ' ALA . 0.2 OUTLIER -68.58 -28.05 66.6 Favored 'General case' 0 N--CA 1.431 -1.381 0 O-C-N 119.022 -2.298 . . . . 0.0 110.945 -179.981 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 1.5 mmt -77.3 -31.25 54.62 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 179.703 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -77.92 -20.71 52.35 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 126.484 3.04 . . . . 0.0 109.744 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 42.4 tptt -78.29 -39.92 38.41 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 112.686 -2.052 . . . . 0.0 108.93 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.46 ' HG3' ' CE1' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -73.18 -20.88 60.8 Favored 'General case' 0 CA--C 1.511 -0.556 0 O-C-N 119.552 -1.968 . . . . 0.0 108.273 179.92 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 97.96 46.73 2.2 Favored Glycine 0 N--CA 1.434 -1.488 0 CA-C-O 114.168 -3.573 . . . . 0.0 110.937 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.472 HG22 ' N ' ' A' ' 24' ' ' ASN . 2.1 mm -93.6 176.8 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 O-C-N 129.269 3.57 . . . . 0.0 106.319 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.472 ' N ' HG22 ' A' ' 23' ' ' ILE . 2.8 m-80 -113.43 -178.61 3.42 Favored 'General case' 0 C--N 1.348 0.519 0 CA-C-O 115.156 -2.354 . . . . 0.0 110.849 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . 0.347 0.6 OUTLIER -55.91 -49.23 76.31 Favored 'Isoleucine or valine' 0 C--N 1.352 0.716 0 O-C-N 128.606 3.691 . . . . 0.0 113.659 179.605 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.65 1.1 m -74.11 -41.89 51.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 O-C-N 127.056 2.722 . . . . 0.0 116.108 -179.702 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.457 ' HB3' HG23 ' A' ' 23' ' ' ILE . 2.6 mtmp? -66.2 -34.46 78.08 Favored 'General case' 0 CA--C 1.507 -0.695 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 -179.706 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.426 ' CG ' HH11 ' A' ' 28' ' ' ARG . 0.0 OUTLIER -79.94 -27.56 39.81 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 125.361 2.505 . . . . 0.0 108.524 179.777 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.3 tmmm? -71.08 -52.92 16.65 Favored 'General case' 0 C--N 1.353 0.743 0 O-C-N 119.64 -1.912 . . . . 0.0 110.237 -179.538 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 34.5 mt -72.65 -28.93 63.03 Favored 'General case' 0 N--CA 1.445 -0.698 0 O-C-N 120.247 -1.533 . . . . 0.0 108.416 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -70.21 -31.29 69.07 Favored Glycine 0 CA--C 1.537 1.408 0 O-C-N 127.365 2.916 . . . . 0.0 110.169 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.563 ' HB1' ' CE1' ' A' ' 14' ' ' TYR . . . -72.65 -41.68 65.18 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 126.572 1.949 . . . . 0.0 113.586 -179.822 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -101.32 14.65 31.31 Favored 'General case' 0 N--CA 1.437 -1.107 0 O-C-N 126.845 2.591 . . . . 0.0 110.555 -179.589 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 14.6 p30 -41.17 -27.47 0.07 Allowed 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 120.009 3.337 . . . . 0.0 120.009 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . 0.274 20.7 m-80 74.35 35.32 0.73 Allowed 'General case' 0 C--O 1.235 0.337 0 O-C-N 123.938 0.774 . . . . 0.0 109.477 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.715 HD11 HD13 ' A' ' 38' ' ' LEU . 2.9 tt -59.44 137.93 57.84 Favored 'General case' 0 N--CA 1.479 0.986 0 O-C-N 125.22 1.575 . . . . 0.0 110.501 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 6.6 ttmt -134.41 87.77 2.39 Favored 'General case' 0 N--CA 1.435 -1.194 0 N-CA-C 106.176 -1.787 . . . . 0.0 106.176 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.715 HD13 HD11 ' A' ' 36' ' ' LEU 0.315 0.0 OUTLIER -72.15 135.87 46.32 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 103.087 -2.931 . . . . 0.0 103.087 179.809 . . . . . . . . 4 4 . 1 . 014 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.601 ' HA ' ' HA ' ' A' ' 5' ' ' THR . 3.7 m -102.44 -18.62 15.28 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 121.939 2.154 . . . . 0.0 110.272 -178.921 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.45 HG12 HG23 ' A' ' 49' ' ' VAL . 3.7 mm 40.97 116.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 CA-C-O 126.667 3.127 . . . . 0.0 114.536 179.491 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.611 ' HB ' HG23 ' A' ' 48' ' ' THR . 5.8 m -118.69 109.94 16.7 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 112.479 -2.146 . . . . 0.0 113.611 179.297 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.482 ' NE2' ' CE2' ' A' ' 47' ' ' PHE . 3.8 tp-100 -103.41 77.73 1.54 Allowed 'General case' 0 N--CA 1.444 -0.774 0 O-C-N 123.635 0.584 . . . . 0.0 109.734 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -65.44 -45.05 85.31 Favored 'General case' 0 N--CA 1.426 -1.663 0 CA-C-O 123.391 1.567 . . . . 0.0 110.296 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 163.6 82.1 0.04 OUTLIER Glycine 0 N--CA 1.44 -1.053 0 N-CA-C 105.839 -2.904 . . . . 0.0 105.839 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.354 75.2 m-20 90.77 -33.52 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.727 0 O-C-N 125.364 1.273 . . . . 0.0 108.495 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 18.7 tttt -93.28 128.58 39.34 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 119.256 -2.152 . . . . 0.0 106.74 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.482 ' CE2' ' NE2' ' A' ' 42' ' ' GLN . 3.0 m-85 -113.47 97.85 6.71 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 124.948 1.299 . . . . 0.0 107.601 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.611 HG23 ' HB ' ' A' ' 41' ' ' THR 0.375 5.1 t -93.68 102.36 14.52 Favored 'General case' 0 N--CA 1.432 -1.349 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 179.922 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.548 HG21 ' HG ' ' A' ' 38' ' ' LEU 0.622 0.8 OUTLIER -84.91 104.96 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.818 0 N-CA-C 118.089 2.626 . . . . 0.0 118.089 -179.433 . . . . . . . . 4 4 . 1 . 014 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.546 ' HB3' ' HB ' ' A' ' 39' ' ' THR . 0.0 OUTLIER -64.19 158.43 23.1 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 100.974 -3.713 . . . . 0.0 100.974 178.638 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.408 ' O ' ' N ' ' A' ' 53' ' ' SER 0.3 68.8 tt0 -144.16 53.93 1.28 Allowed 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 103.857 -2.646 . . . . 0.0 103.857 179.993 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -70.9 81.43 0.64 Allowed 'General case' 0 N--CA 1.425 -1.709 0 C-N-CA 118.41 -1.316 . . . . 0.0 109.004 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.408 ' N ' ' O ' ' A' ' 51' ' ' GLU . 1.2 m -111.67 -141.72 0.38 Allowed 'General case' 0 CA--C 1.505 -0.778 0 O-C-N 126.612 2.445 . . . . 0.0 110.428 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -94.27 -7.48 41.87 Favored 'General case' 0 C--O 1.211 -0.924 0 CA-C-N 120.865 1.666 . . . . 0.0 108.066 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.52 ' C ' ' HG2' ' A' ' 56' ' ' ARG . 46.1 m-85 -97.82 -71.66 0.68 Allowed 'General case' 0 N--CA 1.437 -1.087 0 CA-C-O 116.247 -1.835 . . . . 0.0 113.958 -179.758 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.52 ' HG2' ' C ' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -153.02 144.45 23.3 Favored 'General case' 0 C--O 1.254 1.327 0 CA-C-N 123.883 3.038 . . . . 0.0 109.712 -179.195 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -93.69 74.96 4.33 Favored 'General case' 0 C--O 1.219 -0.543 0 N-CA-C 102.269 -3.234 . . . . 0.0 102.269 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.465 ' O ' HG23 ' A' ' 60' ' ' VAL . 0.7 OUTLIER -99.61 114.3 37.41 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 O-C-N 127.733 3.146 . . . . 0.0 114.483 179.811 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -62.19 117.71 6.42 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 104.793 -2.299 . . . . 0.0 104.793 179.354 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.638 HG12 ' CE2' ' A' ' 62' ' ' PHE . 92.4 t -99.36 77.04 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.59 1.181 . . . . 0.0 109.003 -178.73 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.597 ' HA ' ' HA ' ' A' ' 48' ' ' THR 0.339 1.2 m -71.18 138.45 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.333 0 O-C-N 117.852 -3.03 . . . . 0.0 115.858 179.92 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.638 ' CE2' HG12 ' A' ' 60' ' ' VAL . 0.2 OUTLIER -156.36 92.2 1.31 Allowed 'General case' 0 N--CA 1.444 -0.772 0 O-C-N 118.991 -2.318 . . . . 0.0 109.717 -179.976 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -57.82 142.38 45.92 Favored 'General case' 0 C--O 1.244 0.775 0 N-CA-C 106.58 -1.637 . . . . 0.0 106.58 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.1 mt -65.08 122.69 17.62 Favored 'General case' 0 N--CA 1.443 -0.822 0 C-N-CA 118.063 -1.455 . . . . 0.0 111.056 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 75.02 9.89 83.98 Favored Glycine 0 N--CA 1.47 0.933 0 N-CA-C 119.863 2.705 . . . . 0.0 119.863 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.401 HG12 ' N ' ' A' ' 67' ' ' ASP 0.425 7.2 t -80.88 -97.69 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.213 0 O-C-N 121.416 -1.049 . . . . 0.0 110.396 -179.97 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.401 ' N ' HG12 ' A' ' 66' ' ' VAL 0.259 21.2 t70 157.82 145.86 0.01 OUTLIER 'General case' 0 CA--C 1.497 -1.088 0 CA-C-O 117.533 -1.222 . . . . 0.0 109.927 179.831 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.502 ' CZ ' ' HB3' ' A' ' 62' ' ' PHE . 0.2 OUTLIER -164.87 164.95 20.81 Favored 'General case' 0 N--CA 1.423 -1.798 0 C-N-CA 119.237 -0.985 . . . . 0.0 110.186 179.98 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -113.75 122.76 48.08 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -123.7 118.34 27.0 Favored 'General case' 0 N--CA 1.439 -0.975 0 O-C-N 121.383 -0.823 . . . . 0.0 110.835 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 2.5 p -81.41 126.29 31.45 Favored 'General case' 0 CA--C 1.496 -1.124 0 CA-C-N 120.047 1.294 . . . . 0.0 108.936 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -78.69 -171.37 2.5 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 104.251 -2.5 . . . . 0.0 104.251 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -114.1 25.38 11.18 Favored 'General case' 0 N--CA 1.436 -1.138 0 CA-C-O 124.117 1.913 . . . . 0.0 112.995 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -153.34 -35.17 0.11 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 119.664 -1.898 . . . . 0.0 112.969 -179.844 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.507 ' O ' HG22 ' A' ' 76' ' ' THR . . . -126.66 -12.89 3.2 Favored Glycine 0 CA--C 1.543 1.786 0 C-N-CA 125.375 1.464 . . . . 0.0 113.215 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.507 HG22 ' O ' ' A' ' 75' ' ' GLY 0.328 0.4 OUTLIER 69.13 171.07 0.3 Allowed 'General case' 0 CA--C 1.492 -1.27 0 C-N-CA 115.987 -2.285 . . . . 0.0 115.436 -179.734 . . . . . . . . 4 4 . 1 . 014 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 26.21 109.6 0.0 OUTLIER 'General case' 0 N--CA 1.436 -1.129 1 O-C-N 129.423 4.202 . . . . 0.0 116.956 179.547 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.56 HD21 ' CD1' ' A' ' 93' ' ' PHE 0.363 0.4 OUTLIER -146.46 121.11 9.81 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 101.988 -3.338 . . . . 0.0 101.988 -179.889 . . . . . . . . 4 4 . 1 . 014 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 55.1 m -129.41 154.67 46.71 Favored 'General case' 0 C--O 1.198 -1.625 0 N-CA-C 106.002 -1.851 . . . . 0.0 106.002 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 169.97 -159.08 31.53 Favored Glycine 0 N--CA 1.439 -1.125 0 CA-C-O 118.076 -1.402 . . . . 0.0 110.715 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -148.04 167.69 24.28 Favored 'General case' 0 CA--C 1.492 -1.278 0 C-N-CA 117.252 -1.779 . . . . 0.0 109.992 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' TRP . . . . . 0.486 ' CE3' ' CA ' ' A' ' 91' ' ' GLY 0.271 63.1 m95 -121.66 138.12 54.47 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 101.693 -3.447 . . . . 0.0 101.693 179.934 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 12.4 t -140.97 140.85 34.44 Favored 'General case' 0 N--CA 1.426 -1.64 0 CA-C-O 123.516 1.627 . . . . 0.0 107.885 -179.747 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.632 ' HA ' HD23 ' A' ' 89' ' ' LEU . 3.6 ttm -85.21 133.91 34.17 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 104.616 -2.364 . . . . 0.0 104.616 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . 0.649 1.5 mm-40 -105.51 18.55 22.04 Favored 'General case' 0 N--CA 1.428 -1.574 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 93.69 -64.03 1.85 Allowed Glycine 0 N--CA 1.427 -1.911 0 N-CA-C 105.85 -2.9 . . . . 0.0 105.85 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -101.57 -7.67 22.55 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 117.683 2.475 . . . . 0.0 117.683 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . 0.358 6.6 mtmt -162.32 132.07 4.55 Favored 'General case' 0 CA--C 1.489 -1.398 0 O-C-N 127.096 2.747 . . . . 0.0 109.284 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.632 HD23 ' HA ' ' A' ' 84' ' ' MET . 0.0 OUTLIER -75.73 121.9 23.22 Favored 'General case' 0 C--N 1.309 -1.188 0 O-C-N 126.639 2.462 . . . . 0.0 104.988 179.766 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.495 HG12 HG23 ' A' ' 105' ' ' VAL . 18.1 m -116.54 135.95 55.17 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 N-CA-C 105.698 -1.964 . . . . 0.0 105.698 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.486 ' CA ' ' CE3' ' A' ' 82' ' ' TRP . . . -115.44 118.45 4.28 Favored Glycine 0 CA--C 1.537 1.427 0 C-N-CA 126.525 2.012 . . . . 0.0 109.005 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 3.4 mtmm -112.3 147.34 36.52 Favored 'General case' 0 N--CA 1.432 -1.327 0 N-CA-C 103.569 -2.752 . . . . 0.0 103.569 179.693 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.56 ' CD1' HD21 ' A' ' 78' ' ' LEU . 55.2 m-85 -146.18 116.5 7.48 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 114.654 -1.157 . . . . 0.0 112.667 179.702 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.401 ' HE2' ' HB3' ' A' ' 94' ' ' LYS . 44.2 mtpt -88.53 -171.11 3.2 Favored 'General case' 0 N--CA 1.433 -1.295 0 C-N-CA 127.298 2.239 . . . . 0.0 108.146 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . 0.359 1.3 ttt180 -149.12 134.7 18.63 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 106.138 -1.801 . . . . 0.0 106.138 -179.712 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.492 HG23 ' N ' ' A' ' 97' ' ' ASP . 17.0 m -57.73 -38.31 64.35 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 CA-C-O 123.809 1.766 . . . . 0.0 113.321 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.492 ' N ' HG23 ' A' ' 96' ' ' VAL 0.366 96.3 m-20 -76.09 7.08 4.45 Favored 'General case' 0 C--O 1.253 1.277 0 CA-C-N 112.531 -2.122 . . . . 0.0 116.191 179.931 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 38.1 p30 -161.33 -17.92 0.05 OUTLIER 'General case' 0 N--CA 1.421 -1.898 0 N-CA-C 116.957 2.206 . . . . 0.0 116.957 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 58.24 19.21 38.48 Favored Glycine 0 C--O 1.228 -0.274 0 CA-C-O 124.737 2.298 . . . . 0.0 114.476 -179.753 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 9.7 mmtm -78.0 -103.59 0.02 OUTLIER 'General case' 0 C--O 1.199 -1.597 0 O-C-N 120.037 -1.86 . . . . 0.0 111.322 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 167.65 167.94 0.03 OUTLIER 'General case' 0 N--CA 1.438 -1.043 0 C-N-CA 130.058 3.343 . . . . 0.0 110.603 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.504 HD23 ' N ' ' A' ' 103' ' ' ILE . 9.4 tt -153.91 154.27 33.56 Favored 'General case' 0 C--O 1.242 0.676 0 C-N-CA 131.693 3.997 . . . . 0.0 104.55 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.549 ' CG2' ' HB ' ' A' ' 118' ' ' THR . 13.4 tt -141.85 160.18 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.328 0 C-N-CA 116.469 -2.092 . . . . 0.0 110.277 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.422 ' N ' ' CG1' ' A' ' 103' ' ' ILE . . . -149.53 111.84 4.69 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 179.797 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.495 HG23 HG12 ' A' ' 90' ' ' VAL . 2.4 p -102.65 105.88 18.96 Favored 'Isoleucine or valine' 0 C--O 1.244 0.782 0 CA-C-O 124.824 2.249 . . . . 0.0 112.068 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.423 ' CG ' ' HG2' ' A' ' 115' ' ' GLN 0.26 78.4 mtt180 -79.23 93.08 5.18 Favored 'General case' 0 N--CA 1.428 -1.573 0 CA-C-N 112.181 -2.281 . . . . 0.0 106.127 -179.848 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 21.2 pt-20 -101.5 82.73 2.34 Favored 'General case' 0 N--CA 1.425 -1.677 0 O-C-N 127.581 3.051 . . . . 0.0 110.339 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.714 HD11 ' HH2' ' A' ' 6' ' ' TRP 0.391 4.4 tt -60.89 129.2 23.28 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.984 0 C-N-CA 114.485 -2.886 . . . . 0.0 114.999 -179.827 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.2 t -125.76 76.04 1.54 Allowed 'General case' 0 C--O 1.215 -0.733 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 179.778 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 80.55 -89.94 1.33 Allowed Glycine 0 CA--C 1.501 -0.822 0 C-N-CA 126.134 1.826 . . . . 0.0 112.636 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . 0.374 0.4 OUTLIER -116.32 22.79 12.59 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 115.785 -2.055 . . . . 0.0 110.456 -179.793 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -132.54 119.86 21.09 Favored 'General case' 0 C--O 1.211 -0.935 0 O-C-N 128.4 3.562 . . . . 0.0 110.933 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.493 ' HB2' ' CH2' ' A' ' 6' ' ' TRP . 0.9 OUTLIER -95.55 59.71 2.14 Favored 'General case' 0 CA--C 1.501 -0.933 0 O-C-N 128.725 3.766 . . . . 0.0 107.969 -179.647 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.578 ' CG1' HD13 ' A' ' 127' ' ' ILE 0.262 1.4 mp -51.81 127.0 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.762 0 O-C-N 125.508 1.755 . . . . 0.0 108.335 -179.621 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 115' ' ' GLN . . . . . 0.614 HE21 ' HZ ' ' A' ' 128' ' ' PHE . 28.0 mt-30 -124.72 134.29 52.89 Favored 'General case' 0 C--O 1.246 0.904 0 N-CA-C 103.14 -2.911 . . . . 0.0 103.14 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.48 HG22 ' HE2' ' A' ' 125' ' ' LYS . 29.5 p -97.46 178.74 5.1 Favored 'General case' 0 N--CA 1.433 -1.279 0 O-C-N 128.304 3.503 . . . . 0.0 108.192 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.954 ' HB2' ' HB3' ' A' ' 124' ' ' ALA . 19.1 m-85 -146.77 97.92 2.98 Favored 'General case' 0 CA--C 1.497 -1.086 0 CA-C-O 114.481 -2.676 . . . . 0.0 112.06 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.549 ' HB ' ' CG2' ' A' ' 103' ' ' ILE . 0.3 OUTLIER -116.2 94.75 4.78 Favored 'General case' 0 C--O 1.254 1.325 1 O-C-N 129.386 4.179 . . . . 0.0 112.868 179.76 . . . . . . . . 4 4 . 1 . 014 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.493 ' HA ' ' HA ' ' A' ' 102' ' ' LEU . 59.8 t80 -72.42 -14.09 61.61 Favored 'General case' 0 C--N 1.346 0.446 0 CA-C-O 122.472 1.13 . . . . 0.0 108.557 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -179.63 -81.29 0.0 OUTLIER 'General case' 0 C--N 1.292 -1.915 0 CA-C-N 113.747 -1.57 . . . . 0.0 113.379 -179.705 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -128.07 28.15 4.41 Favored Glycine 0 C--N 1.366 2.207 0 C-N-CA 126.579 2.037 . . . . 0.0 116.745 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 5.2 t -140.89 92.79 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -64.82 178.86 0.73 Allowed 'General case' 0 N--CA 1.428 -1.573 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.954 ' HB3' ' HB2' ' A' ' 117' ' ' TYR . . . -171.54 101.57 0.19 Allowed 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 103.778 -2.675 . . . . 0.0 103.778 179.79 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.48 ' HE2' HG22 ' A' ' 116' ' ' THR . 0.0 OUTLIER -80.02 147.52 31.49 Favored 'General case' 0 C--O 1.244 0.811 0 O-C-N 126.802 2.563 . . . . 0.0 109.76 -179.882 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -137.7 78.64 1.7 Allowed 'General case' 0 C--O 1.214 -0.786 0 O-C-N 126.726 2.516 . . . . 0.0 104.863 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.578 HD13 ' CG1' ' A' ' 114' ' ' ILE . 5.5 mm -67.45 107.42 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.755 1 O-C-N 129.558 4.286 . . . . 0.0 113.526 -179.758 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.614 ' HZ ' HE21 ' A' ' 115' ' ' GLN . 0.3 OUTLIER -99.74 151.03 21.7 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 179.348 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . 0.276 3.5 mmtt -115.83 44.28 1.94 Allowed 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.542 ' HB2' ' CZ3' ' A' ' 6' ' ' TRP . 23.9 tttm 32.32 86.85 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 126.686 1.994 . . . . 0.0 115.205 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . 0.733 0.5 OUTLIER . . . . . 0 N--CA 1.435 -1.224 0 CA-C-O 116.683 -1.627 . . . . 0.0 114.85 -179.679 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 . . . . . 0 N--CA 1.447 -0.617 0 CA-C-O 122.309 1.052 . . . . 0.0 112.94 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -154.6 100.72 2.27 Favored 'General case' 0 CA--C 1.491 -1.289 0 CA-C-O 127.465 3.507 . . . . 0.0 112.185 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 159.11 -168.1 35.05 Favored Glycine 0 CA--C 1.499 -0.952 0 C-N-CA 116.506 -2.759 . . . . 0.0 110.905 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.435 ' HB ' ' HA ' ' A' ' 39' ' ' THR 0.506 0.4 OUTLIER -97.28 164.88 12.29 Favored 'General case' 0 CA--C 1.493 -1.227 0 CA-C-N 117.062 0.431 . . . . 0.0 111.755 -179.891 . . . . . . . . 4 4 . 1 . 015 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.63 ' CE3' ' HA ' ' A' ' 130' ' ' LYS 0.274 90.8 m95 -152.25 121.26 6.63 Favored 'General case' 0 N--CA 1.426 -1.639 0 O-C-N 127.027 2.704 . . . . 0.0 107.922 179.765 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 13.6 ttpt -124.82 97.87 5.46 Favored 'General case' 0 C--O 1.205 -1.274 0 CA-C-O 115.275 -2.297 . . . . 0.0 105.815 179.723 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.509 ' HA ' ' HA ' ' A' ' 128' ' ' PHE . 0.4 OUTLIER -38.65 138.64 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 O-C-N 126.309 2.256 . . . . 0.0 111.043 -179.987 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -137.34 16.42 2.97 Favored 'General case' 0 C--O 1.209 -1.067 0 O-C-N 126.109 2.13 . . . . 0.0 108.231 -179.659 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 171.13 135.39 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.439 0 CA-C-O 121.391 0.615 . . . . 0.0 110.159 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -118.86 -169.11 1.67 Allowed 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 116.928 -1.511 . . . . 0.0 107.869 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.414 ' HB3' ' HB2' ' A' ' 125' ' ' LYS . 2.3 tp10 -145.83 -45.91 0.21 Allowed 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 120.786 1.63 . . . . 0.0 109.285 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 38.4 t30 -123.3 7.97 9.08 Favored 'General case' 0 N--CA 1.476 0.841 0 O-C-N 125.842 1.964 . . . . 0.0 114.535 179.725 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.54 ' CD2' ' HD3' ' A' ' 126' ' ' ARG . 32.4 t80 -57.03 -28.52 62.58 Favored 'General case' 0 N--CA 1.434 -1.244 0 CA-C-N 112.666 -2.061 . . . . 0.0 114.854 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -71.47 -38.19 71.26 Favored 'General case' 0 C--O 1.212 -0.92 0 CA-C-O 123.062 1.411 . . . . 0.0 109.721 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 3.0 ttmm -76.66 -26.84 55.28 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-O 123.203 1.477 . . . . 0.0 112.217 179.625 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.588 ' HA ' HG11 ' A' ' 122' ' ' VAL . 2.4 t80 -73.37 -23.06 60.15 Favored 'General case' 0 C--O 1.241 0.611 0 O-C-N 119.09 -2.256 . . . . 0.0 111.779 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.411 ' HB3' HG13 ' A' ' 23' ' ' ILE . 1.1 mmt -75.87 -30.28 58.82 Favored 'General case' 0 C--N 1.317 -0.829 1 O-C-N 116.299 -4.001 . . . . 0.0 107.154 179.656 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -68.3 -33.6 74.62 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 119.747 -1.846 . . . . 0.0 112.41 -179.726 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 5.1 tptt -75.41 -31.86 60.54 Favored 'General case' 0 C--O 1.215 -0.748 0 CA-C-N 114.786 -1.097 . . . . 0.0 110.297 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.521 ' CE ' HH12 ' A' ' 95' ' ' ARG . 0.5 OUTLIER -78.47 -20.3 51.22 Favored 'General case' 0 C--O 1.214 -0.804 0 O-C-N 125.543 1.777 . . . . 0.0 108.039 179.776 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 94.36 65.59 1.02 Allowed Glycine 0 C--N 1.302 -1.308 0 CA-C-O 116.865 -2.075 . . . . 0.0 109.598 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.627 HG23 ' HG2' ' A' ' 27' ' ' LYS . 2.1 mm -120.25 157.49 22.8 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 O-C-N 125.021 1.071 . . . . 0.0 109.432 -179.586 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -113.18 165.77 12.08 Favored 'General case' 0 C--O 1.246 0.92 0 O-C-N 124.846 1.341 . . . . 0.0 112.077 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . 0.375 0.0 OUTLIER -23.01 -61.02 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.501 -0.923 0 N-CA-C 120.833 3.642 . . . . 0.0 120.833 179.925 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.615 57.8 t -78.45 -38.55 22.76 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.751 0 CA-C-O 122.629 1.204 . . . . 0.0 112.796 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.627 ' HG2' HG23 ' A' ' 23' ' ' ILE . 0.1 OUTLIER -64.35 -37.28 86.97 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-N 113.523 -1.671 . . . . 0.0 113.798 -179.819 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.492 ' HA ' HG21 ' A' ' 23' ' ' ILE . 15.9 ptt85 -77.94 -22.67 49.21 Favored 'General case' 0 C--O 1.22 -0.47 0 O-C-N 119.486 -2.008 . . . . 0.0 109.639 179.715 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 16.7 tttp -74.16 -37.29 64.03 Favored 'General case' 0 C--N 1.35 0.61 0 CA-C-N 113.543 -1.662 . . . . 0.0 113.707 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.5 mt -69.8 -34.48 73.77 Favored 'General case' 0 N--CA 1.436 -1.139 0 C-N-CA 125.757 1.623 . . . . 0.0 111.305 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -77.32 -25.2 64.09 Favored Glycine 0 C--N 1.339 0.715 0 O-C-N 126.344 2.277 . . . . 0.0 111.31 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -75.11 -40.39 59.95 Favored 'General case' 0 C--O 1.22 -0.449 0 O-C-N 120.894 -1.357 . . . . 0.0 111.829 -179.772 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -98.27 9.74 42.3 Favored 'General case' 0 CA--C 1.51 -0.581 0 O-C-N 128.958 3.911 . . . . 0.0 110.821 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 36.5 p30 -47.6 -29.33 2.83 Favored 'General case' 0 CA--C 1.505 -0.782 0 N-CA-C 120.679 3.585 . . . . 0.0 120.679 179.574 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . 0.288 11.2 m-20 73.98 30.56 1.27 Allowed 'General case' 0 C--O 1.243 0.753 0 CA-C-N 120.77 1.623 . . . . 0.0 110.72 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.634 HD11 HD13 ' A' ' 38' ' ' LEU . 9.6 tp -49.86 109.76 0.32 Allowed 'General case' 0 C--N 1.354 0.777 0 C-N-CA 126.435 1.894 . . . . 0.0 108.578 -179.811 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 7.7 ttmm -108.86 102.79 11.78 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 104.664 -2.347 . . . . 0.0 104.664 179.783 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.634 HD13 HD11 ' A' ' 36' ' ' LEU 0.26 0.1 OUTLIER -88.57 109.44 20.08 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.907 . . . . . . . . 4 4 . 1 . 015 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.483 ' HB ' ' CB ' ' A' ' 50' ' ' LYS . 13.6 m -95.16 93.99 7.66 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 104.505 -2.405 . . . . 0.0 104.505 -179.849 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 21.0 mt -75.99 120.02 25.12 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.213 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 179.579 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.421 ' O ' HG22 ' A' ' 41' ' ' THR . 2.6 m -124.97 100.85 6.78 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 111.78 -2.464 . . . . 0.0 109.655 179.625 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -74.05 162.91 28.53 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-O 116.488 -1.72 . . . . 0.0 111.017 -179.735 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -151.09 -133.79 0.06 Allowed 'General case' 0 N--CA 1.424 -1.745 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -86.47 70.93 2.88 Favored Glycine 0 C--N 1.302 -1.315 0 N-CA-C 104.729 -3.348 . . . . 0.0 104.729 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 81.24 -8.38 1.4 Allowed 'General case' 0 C--O 1.216 -0.659 0 O-C-N 124.777 0.928 . . . . 0.0 111.756 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.465 ' HE2' ' HB ' ' A' ' 61' ' ' VAL . 13.4 tttt -98.31 125.77 43.55 Favored 'General case' 0 C--O 1.25 1.093 0 C-N-CA 118.456 -1.298 . . . . 0.0 108.915 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . 0.261 0.7 OUTLIER -103.92 107.37 18.22 Favored 'General case' 0 N--CA 1.446 -0.654 0 O-C-N 125.983 2.052 . . . . 0.0 111.451 -179.955 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 48' ' ' THR . . . . . 1.039 ' HB ' HG12 ' A' ' 61' ' ' VAL 0.425 0.1 OUTLIER -94.68 131.04 40.91 Favored 'General case' 0 CA--C 1.493 -1.243 0 O-C-N 125.589 1.805 . . . . 0.0 108.332 179.891 . . . . . . . . 4 4 . 1 . 015 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.599 HG21 ' HG ' ' A' ' 38' ' ' LEU 0.644 0.3 OUTLIER -111.43 98.31 6.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 CA-C-N 113.353 -1.749 . . . . 0.0 112.233 -179.762 . . . . . . . . 4 4 . 1 . 015 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.483 ' CB ' ' HB ' ' A' ' 39' ' ' THR . 0.6 OUTLIER -65.8 119.67 11.65 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 102.47 -3.159 . . . . 0.0 102.47 -179.941 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -113.94 85.91 2.31 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 124.475 2.083 . . . . 0.0 106.527 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 43.0 m -88.79 63.0 6.67 Favored 'General case' 0 N--CA 1.419 -2.004 0 CA-C-N 113.221 -1.809 . . . . 0.0 106.801 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -77.39 170.32 16.75 Favored 'General case' 0 C--O 1.216 -0.692 0 C-N-CA 115.933 -2.307 . . . . 0.0 111.219 -179.747 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -58.61 -20.85 50.91 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 117.838 -1.545 . . . . 0.0 108.333 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -85.48 -60.73 1.94 Allowed 'General case' 0 N--CA 1.44 -0.944 0 CA-C-O 114.007 -2.901 . . . . 0.0 110.391 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.7 ' HB2' HG22 ' A' ' 58' ' ' ILE . 66.6 mtp85 -133.95 176.87 8.19 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 124.416 3.28 . . . . 0.0 110.46 -179.643 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -138.76 59.02 1.64 Allowed 'General case' 0 C--O 1.215 -0.728 2 C-N-CA 132.002 4.121 . . . . 0.0 100.081 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.7 HG22 ' HB2' ' A' ' 56' ' ' ARG . 1.5 tt -84.18 -44.18 17.87 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 1 C-N-CA 132.688 4.395 . . . . 0.0 119.772 -178.695 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . 0.277 34.2 t0 78.55 140.33 0.07 Allowed 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 104.073 -2.565 . . . . 0.0 104.073 -176.878 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 58.0 t -112.39 -53.59 5.22 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.152 0 C-N-CA 118.527 -1.269 . . . . 0.0 112.627 -178.245 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 1.039 HG12 ' HB ' ' A' ' 48' ' ' THR 0.398 0.9 OUTLIER 66.97 131.52 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 CA-C-O 126.272 2.939 . . . . 0.0 109.016 -178.907 . . . . . . . . 4 4 . 1 . 015 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.556 ' CD2' ' CD1' ' A' ' 82' ' ' TRP . 12.5 p90 -164.03 93.76 0.72 Allowed 'General case' 0 N--CA 1.443 -0.817 0 O-C-N 117.05 -3.531 . . . . 0.0 110.334 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.418 ' HA ' ' HA ' ' A' ' 46' ' ' LYS . 27.3 mt-10 -65.59 136.63 56.6 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 105.644 -1.984 . . . . 0.0 105.644 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -50.88 121.86 6.59 Favored 'General case' 0 N--CA 1.437 -1.091 0 O-C-N 125.505 1.753 . . . . 0.0 110.691 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 79.98 3.59 89.43 Favored Glycine 0 C--N 1.35 1.336 0 CA-C-N 112.424 -2.171 . . . . 0.0 117.805 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . 0.378 79.4 t -106.03 97.48 5.67 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 N-CA-C 104.612 -2.366 . . . . 0.0 104.612 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -63.0 177.12 0.61 Allowed 'General case' 0 CA--C 1.484 -1.578 0 C-N-CA 117.584 -1.646 . . . . 0.0 114.605 -179.466 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.488 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 1.1 p90 -155.98 172.21 18.77 Favored 'General case' 0 N--CA 1.433 -1.304 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.627 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -115.3 140.91 48.7 Favored 'General case' 0 C--N 1.322 -0.609 0 O-C-N 126.858 2.599 . . . . 0.0 105.851 179.7 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 13.4 t80 -152.65 112.13 3.89 Favored 'General case' 0 C--O 1.206 -1.19 0 CA-C-N 120.525 1.511 . . . . 0.0 114.024 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.5 p -81.79 144.41 31.09 Favored 'General case' 0 C--N 1.315 -0.909 0 O-C-N 119.147 -2.221 . . . . 0.0 105.448 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 10.5 mp -102.28 -175.17 2.75 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 124.592 1.183 . . . . 0.0 108.465 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -90.94 -13.39 33.56 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.135 0.974 . . . . 0.0 111.94 -179.762 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.568 ' HB3' ' CD1' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -79.63 -11.15 59.88 Favored 'General case' 0 N--CA 1.439 -0.998 0 C-N-CA 119.308 -0.957 . . . . 0.0 110.751 -179.549 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 102.93 22.83 9.03 Favored Glycine 0 C--O 1.204 -1.777 0 O-C-N 125.528 1.768 . . . . 0.0 111.733 -179.769 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -129.24 155.15 46.01 Favored 'General case' 0 CA--C 1.491 -1.309 0 C-N-CA 117.782 -1.567 . . . . 0.0 112.786 -179.788 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.471 ' CB ' ' HB ' ' A' ' 96' ' ' VAL . 32.1 mp0 -92.41 155.92 17.55 Favored 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 127.572 2.349 . . . . 0.0 112.646 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.572 HD11 ' CG ' ' A' ' 93' ' ' PHE 0.429 0.6 OUTLIER -156.41 153.43 28.87 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 105.264 -2.125 . . . . 0.0 105.264 -179.912 . . . . . . . . 4 4 . 1 . 015 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.404 ' O ' ' N ' ' A' ' 94' ' ' LYS . 64.2 m -157.67 139.21 13.81 Favored 'General case' 0 C--O 1.197 -1.669 0 N-CA-C 102.884 -3.006 . . . . 0.0 102.884 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 174.81 -172.15 45.2 Favored Glycine 0 C--N 1.293 -1.839 0 C-N-CA 114.116 -3.897 . . . . 0.0 114.759 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 76.3 p -132.88 169.09 17.27 Favored 'General case' 0 C--O 1.187 -2.19 0 CA-C-N 120.563 2.182 . . . . 0.0 109.252 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' TRP . . . . . 0.556 ' CD1' ' CD2' ' A' ' 62' ' ' PHE . 69.7 m95 -127.1 140.15 52.48 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 102.37 -3.196 . . . . 0.0 102.37 179.693 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 8.8 t -146.45 142.93 28.62 Favored 'General case' 0 C--O 1.255 1.366 0 CA-C-O 123.803 1.764 . . . . 0.0 109.994 179.79 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 2.0 ttm -81.24 99.67 8.72 Favored 'General case' 0 N--CA 1.425 -1.72 0 CA-C-N 111.111 -2.768 . . . . 0.0 109.584 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . 0.601 29.0 mm-40 -65.61 -104.19 0.0 OUTLIER 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 119.666 1.121 . . . . 0.0 113.248 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -137.39 93.92 0.22 Allowed Glycine 0 N--CA 1.436 -1.337 1 N-CA-C 102.932 -4.067 . . . . 0.0 102.932 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 58.34 21.17 8.01 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 113.191 0.811 . . . . 0.0 113.191 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . 0.33 7.1 mtmt -149.93 112.66 4.78 Favored 'General case' 0 CA--C 1.492 -1.267 0 O-C-N 126.395 2.309 . . . . 0.0 112.326 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.582 HD12 ' HD2' ' A' ' 106' ' ' ARG . 0.0 OUTLIER -75.98 130.63 38.73 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 102.478 -3.156 . . . . 0.0 102.478 179.908 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.51 ' HB ' HD11 ' A' ' 103' ' ' ILE . 5.4 m -129.03 136.3 60.02 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.932 0 CA-C-O 116.86 -1.543 . . . . 0.0 108.78 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -112.39 106.75 1.94 Allowed Glycine 0 CA--C 1.539 1.578 0 O-C-N 126.958 2.662 . . . . 0.0 112.86 179.524 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 8.0 mtpt -93.46 113.08 25.13 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 102.734 -3.061 . . . . 0.0 102.734 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.599 ' HD2' HD22 ' A' ' 102' ' ' LEU . 19.1 m-85 -104.46 96.93 6.94 Favored 'General case' 0 CA--C 1.502 -0.902 0 O-C-N 125.906 2.004 . . . . 0.0 114.492 -179.747 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.404 ' N ' ' O ' ' A' ' 79' ' ' THR . 39.1 mttt -80.04 127.48 32.34 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 126.541 1.936 . . . . 0.0 108.923 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.521 HH12 ' CE ' ' A' ' 21' ' ' MET 0.336 0.0 OUTLIER -72.71 144.32 47.71 Favored 'General case' 0 CA--C 1.502 -0.872 0 N-CA-C 104.434 -2.432 . . . . 0.0 104.434 -179.833 . . . . . . . . 4 4 . 1 . 015 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.471 ' HB ' ' CB ' ' A' ' 77' ' ' GLU . 17.4 t -77.09 -33.66 20.67 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 C-N-CA 125.895 1.678 . . . . 0.0 112.248 -179.782 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . 0.262 0.0 OUTLIER -95.73 -27.88 15.05 Favored 'General case' 0 C--O 1.254 1.294 0 N-CA-C 115.05 1.5 . . . . 0.0 115.05 -179.867 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -89.7 -25.07 21.39 Favored 'General case' 0 N--CA 1.419 -2.013 0 CA-C-N 114.623 -1.171 . . . . 0.0 113.702 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 64.97 10.24 45.11 Favored Glycine 0 CA--C 1.536 1.363 0 O-C-N 127.149 2.781 . . . . 0.0 113.826 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 73.1 mttt -103.26 159.01 15.93 Favored 'General case' 0 C--O 1.197 -1.662 0 N-CA-C 107.629 -1.248 . . . . 0.0 107.629 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -95.27 158.91 15.25 Favored 'General case' 0 N--CA 1.431 -1.382 0 O-C-N 126.442 2.339 . . . . 0.0 116.001 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.599 HD22 ' HD2' ' A' ' 93' ' ' PHE . 5.0 tt -138.57 145.71 40.94 Favored 'General case' 0 C--N 1.326 -0.418 1 O-C-N 129.826 4.454 . . . . 0.0 104.477 179.569 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.583 ' N ' HD23 ' A' ' 102' ' ' LEU . 3.5 tp -127.39 152.85 35.93 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.071 0 N-CA-C 104.379 -2.452 . . . . 0.0 104.379 -179.435 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -134.76 132.79 39.17 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 114.119 -2.848 . . . . 0.0 106.26 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.677 HG12 ' OG1' ' A' ' 116' ' ' THR . 10.7 p -120.19 103.65 14.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 O-C-N 125.612 1.82 . . . . 0.0 113.77 -179.383 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.582 ' HD2' HD12 ' A' ' 89' ' ' LEU 0.269 36.2 mtt85 -74.6 89.16 2.2 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 104.483 -2.414 . . . . 0.0 104.483 179.561 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -92.08 77.57 5.32 Favored 'General case' 0 N--CA 1.428 -1.571 0 O-C-N 127.041 2.713 . . . . 0.0 114.907 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.565 HD11 ' CH2' ' A' ' 6' ' ' TRP 0.326 0.0 OUTLIER -56.68 101.81 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 CA-C-O 123.274 1.511 . . . . 0.0 112.094 179.961 . . . . . . . . 4 4 . 1 . 015 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 61.4 m -88.19 71.06 9.26 Favored 'General case' 0 CA--C 1.502 -0.902 0 N-CA-C 104.569 -2.382 . . . . 0.0 104.569 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 66.59 -82.8 0.11 Allowed Glycine 0 C--N 1.344 1.02 0 C-N-CA 128.585 2.993 . . . . 0.0 111.743 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . 0.319 0.1 OUTLIER -98.73 -19.68 17.34 Favored 'General case' 0 C--O 1.221 -0.417 0 CA-C-O 117.651 -1.166 . . . . 0.0 111.911 -179.605 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.446 ' HG3' ' HA ' ' A' ' 129' ' ' LYS . 45.6 mp0 -105.86 127.93 53.43 Favored 'General case' 0 CA--C 1.498 -1.027 0 O-C-N 124.622 1.201 . . . . 0.0 112.175 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.479 HD23 ' CD1' ' A' ' 128' ' ' PHE . 2.0 tt -93.67 139.5 30.73 Favored 'General case' 0 C--O 1.211 -0.925 0 N-CA-C 100.208 -3.997 . . . . 0.0 100.208 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.527 HG23 HD12 ' A' ' 127' ' ' ILE . 68.5 mt -131.53 145.7 34.73 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 O-C-N 128.991 3.932 . . . . 0.0 103.776 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 9.1 mt-30 -134.52 129.9 35.81 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.677 ' OG1' HG12 ' A' ' 105' ' ' VAL . 24.3 p -101.65 -176.53 3.16 Favored 'General case' 0 C--O 1.249 1.035 0 O-C-N 126.703 2.502 . . . . 0.0 104.933 179.42 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.434 ' HB2' ' HB3' ' A' ' 124' ' ' ALA . 68.4 m-85 -160.56 87.07 0.74 Allowed 'General case' 0 CA--C 1.475 -1.939 0 CA-C-O 115.789 -2.053 . . . . 0.0 109.69 179.661 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.469 ' HB ' ' CG2' ' A' ' 103' ' ' ILE . 95.4 m -94.47 101.29 13.2 Favored 'General case' 0 N--CA 1.433 -1.294 0 O-C-N 128.247 3.467 . . . . 0.0 110.107 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.56 ' HA ' ' HA ' ' A' ' 102' ' ' LEU . 5.8 t80 -77.97 -77.65 0.15 Allowed 'General case' 0 CA--C 1.499 -0.983 0 O-C-N 125.816 1.948 . . . . 0.0 107.523 -179.742 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.457 ' HG3' ' CE2' ' A' ' 119' ' ' TYR . 1.5 mm-40 -108.44 -75.7 0.63 Allowed 'General case' 0 C--N 1.298 -1.642 0 CA-C-O 117.522 -1.228 . . . . 0.0 108.462 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -133.71 32.94 2.62 Favored Glycine 0 CA--C 1.528 0.863 0 O-C-N 127.776 3.172 . . . . 0.0 114.74 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.588 HG11 ' HA ' ' A' ' 17' ' ' PHE . 0.3 OUTLIER -139.59 122.35 17.4 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.68 0 O-C-N 119.789 -2.006 . . . . 0.0 110.477 -179.883 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -95.82 177.65 5.7 Favored 'General case' 0 N--CA 1.431 -1.402 0 O-C-N 120.522 -1.361 . . . . 0.0 107.825 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.521 ' HB2' ' CB ' ' A' ' 17' ' ' PHE . . . -169.76 77.16 0.09 Allowed 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 115.709 -2.396 . . . . 0.0 109.193 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.414 ' HB2' ' HB3' ' A' ' 12' ' ' GLU . 12.1 mptt -64.3 141.27 58.83 Favored 'General case' 0 C--O 1.251 1.142 0 CA-C-N 118.488 0.586 . . . . 0.0 109.541 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.54 ' HD3' ' CD2' ' A' ' 14' ' ' TYR . 14.3 mtm180 -137.58 83.1 1.96 Allowed 'General case' 0 CA--C 1.509 -0.623 0 O-C-N 127.315 2.884 . . . . 0.0 108.535 179.78 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.527 HD12 HG23 ' A' ' 114' ' ' ILE . 0.8 OUTLIER -74.84 119.31 22.15 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.788 1 O-C-N 129.79 4.432 . . . . 0.0 110.757 179.894 . . . . . . . . 4 4 . 1 . 015 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.509 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 0.1 OUTLIER -102.99 169.9 8.29 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 112.336 -2.211 . . . . 0.0 108.247 -180.0 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.446 ' HA ' ' HG3' ' A' ' 112' ' ' GLU . 0.0 OUTLIER -119.12 0.49 11.26 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 105.693 -1.965 . . . . 0.0 105.693 179.786 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.63 ' HA ' ' CE3' ' A' ' 6' ' ' TRP . 34.7 tttt 73.6 95.91 0.07 Allowed 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 120.684 1.583 . . . . 0.0 112.436 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . 0.854 3.8 mt-10 . . . . . 0 N--CA 1.435 -1.178 0 N-CA-C 117.523 2.416 . . . . 0.0 117.523 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 2' ' ' PHE . . . . . 0.518 ' CE1' HG12 ' A' ' 108' ' ' ILE . 97.3 m-85 . . . . . 0 CA--C 1.499 -0.983 0 N-CA-C 116.084 1.883 . . . . 0.0 116.084 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -166.39 86.59 0.32 Allowed 'General case' 0 CA--C 1.494 -1.204 0 C-N-CA 117.985 -1.486 . . . . 0.0 112.686 -179.435 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 150.47 -130.02 3.11 Favored Glycine 0 C--N 1.31 -0.915 0 C-N-CA 116.503 -2.761 . . . . 0.0 112.114 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.449 ' HA ' ' HA ' ' A' ' 39' ' ' THR 0.625 0.8 OUTLIER -123.11 161.2 24.86 Favored 'General case' 0 N--CA 1.432 -1.339 0 CA-C-O 124.158 1.932 . . . . 0.0 112.014 -179.933 . . . . . . . . 4 4 . 1 . 016 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.596 ' CE3' ' HA ' ' A' ' 130' ' ' LYS 0.264 86.7 m95 -153.77 114.7 4.07 Favored 'General case' 0 N--CA 1.431 -1.393 0 CA-C-N 111.872 -2.422 . . . . 0.0 110.856 179.896 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 30.4 ttmt -109.56 108.45 18.91 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-O 115.174 -2.346 . . . . 0.0 107.057 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.534 HG12 ' HB3' ' A' ' 36' ' ' LEU 0.411 8.2 p -48.51 147.0 0.76 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.846 0 CA-C-N 121.202 1.819 . . . . 0.0 109.222 -179.964 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -157.28 14.09 0.25 Allowed 'General case' 0 CA--C 1.499 -0.996 0 C-N-CA 117.464 -1.695 . . . . 0.0 111.455 -179.126 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.27 -57.65 0.65 Allowed 'General case' 0 CA--C 1.487 -1.465 0 O-C-N 116.679 -3.763 . . . . 0.0 109.965 -179.684 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 59.74 170.91 0.08 Allowed 'General case' 0 C--O 1.244 0.778 0 O-C-N 127.529 3.018 . . . . 0.0 108.928 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.452 ' O ' ' N ' ' A' ' 125' ' ' LYS . 6.0 tt0 -170.43 134.51 1.14 Allowed 'General case' 0 C--N 1.3 -1.583 0 O-C-N 117.792 -3.068 . . . . 0.0 107.534 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.417 ' HB3' ' H ' ' A' ' 124' ' ' ALA . 2.1 t-20 62.67 29.78 16.87 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-N 122.563 2.438 . . . . 0.0 113.857 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . 0.348 9.3 t80 -98.11 -64.5 1.03 Allowed 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 121.201 3.778 . . . . 0.0 121.201 -178.702 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.09 -38.74 77.0 Favored 'General case' 0 CA--C 1.498 -1.049 0 CA-C-N 124.49 3.313 . . . . 0.0 113.792 -179.061 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.479 ' HB3' ' CD1' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -67.27 -43.23 82.35 Favored 'General case' 0 N--CA 1.422 -1.829 0 C-N-CA 127.643 2.377 . . . . 0.0 113.578 179.584 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.645 ' HB3' ' HB ' ' A' ' 122' ' ' VAL 0.266 64.8 m-85 -80.03 -20.1 46.11 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 111.188 -2.733 . . . . 0.0 113.557 -178.057 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.525 ' CB ' HG13 ' A' ' 23' ' ' ILE . 0.5 OUTLIER -72.21 -23.11 61.2 Favored 'General case' 0 N--CA 1.435 -1.22 0 O-C-N 117.035 -3.541 . . . . 0.0 105.983 176.591 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -74.24 -24.89 59.37 Favored 'General case' 0 C--N 1.348 0.528 0 O-C-N 120.378 -1.451 . . . . 0.0 109.849 179.676 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.487 ' CE ' HG12 ' A' ' 122' ' ' VAL . 11.3 tttp -79.1 -32.58 44.64 Favored 'General case' 0 N--CA 1.432 -1.367 0 CA-C-O 116.196 -1.859 . . . . 0.0 110.589 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.24 -23.5 57.54 Favored 'General case' 0 C--O 1.214 -0.814 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 179.312 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 104.25 40.89 2.17 Favored Glycine 0 N--CA 1.445 -0.714 0 CA-C-O 115.747 -2.696 . . . . 0.0 109.935 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.589 HG23 ' HB3' ' A' ' 27' ' ' LYS . 2.2 mm -86.99 83.44 2.19 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 CA-C-N 120.49 2.145 . . . . 0.0 106.994 -179.682 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -42.09 112.91 0.38 Allowed 'General case' 0 C--O 1.248 1.009 0 O-C-N 124.91 1.381 . . . . 0.0 114.357 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . 0.364 84.7 t 18.52 -66.73 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.502 -0.893 0 N-CA-C 121.066 3.728 . . . . 0.0 121.066 -179.784 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.538 1.3 m -71.52 -24.49 23.63 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.122 0 N-CA-C 117.448 2.388 . . . . 0.0 117.448 -179.531 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.589 ' HB3' HG23 ' A' ' 23' ' ' ILE . 1.5 mtmp? -72.04 -29.22 63.94 Favored 'General case' 0 C--N 1.318 -0.775 0 C-N-CA 119.072 -1.051 . . . . 0.0 112.993 179.759 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.49 ' N ' HG22 ' A' ' 23' ' ' ILE . 2.6 ptt-85 -78.49 -21.51 48.87 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 116.777 -1.969 . . . . 0.0 109.363 179.83 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 12.0 tttt -77.78 -43.21 31.38 Favored 'General case' 0 CA--C 1.502 -0.869 0 CA-C-N 113.553 -1.658 . . . . 0.0 109.924 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -79.02 -23.07 44.58 Favored 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 -179.729 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -76.68 -34.88 42.4 Favored Glycine 0 CA--C 1.527 0.793 0 O-C-N 125.613 1.821 . . . . 0.0 112.476 179.754 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -72.9 -38.61 66.87 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 6.5 m-70 -98.92 20.33 13.4 Favored 'General case' 0 N--CA 1.439 -0.99 0 O-C-N 127.377 2.923 . . . . 0.0 112.604 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 23.6 p30 -47.75 -31.52 4.91 Favored 'General case' 0 CA--C 1.497 -1.096 0 N-CA-C 119.347 3.091 . . . . 0.0 119.347 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . 0.309 0.6 OUTLIER 76.59 15.85 2.06 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 119.291 0.951 . . . . 0.0 109.264 -179.809 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.583 HD11 HD12 ' A' ' 38' ' ' LEU . 30.5 tp -42.1 114.84 0.6 Allowed 'General case' 0 CA--C 1.5 -0.946 0 C-N-CA 128.636 2.775 . . . . 0.0 110.249 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -116.76 94.64 4.68 Favored 'General case' 0 C--O 1.211 -0.967 0 N-CA-C 105.246 -2.131 . . . . 0.0 105.246 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.646 HD13 ' CZ ' ' A' ' 128' ' ' PHE 0.256 0.1 OUTLIER -79.8 105.28 10.97 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 179.73 . . . . . . . . 4 4 . 1 . 016 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.555 ' HB ' ' HB3' ' A' ' 50' ' ' LYS . 99.3 m -94.98 80.4 3.65 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 104.268 -2.493 . . . . 0.0 104.268 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.55 HG13 ' CD1' ' A' ' 6' ' ' TRP . 0.9 OUTLIER -60.23 134.99 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.371 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.331 179.977 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.3 m -128.45 108.19 10.35 Favored 'General case' 0 N--CA 1.475 0.81 0 O-C-N 128.043 3.34 . . . . 0.0 108.437 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -99.07 105.72 17.86 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 117.802 -1.094 . . . . 0.0 113.806 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -108.77 68.02 0.67 Allowed 'General case' 0 N--CA 1.424 -1.767 0 CA-C-O 126.756 3.17 . . . . 0.0 108.019 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 77.79 -108.55 2.63 Favored Glycine 0 C--N 1.293 -1.853 0 N-CA-C 106.956 -2.457 . . . . 0.0 106.956 179.754 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -102.38 48.3 0.87 Allowed 'General case' 0 N--CA 1.444 -0.735 0 CA-C-O 123.04 1.4 . . . . 0.0 110.456 179.688 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 3.1 ttmt -149.06 129.28 13.67 Favored 'General case' 0 C--N 1.312 -1.056 0 C-N-CA 116.479 -2.088 . . . . 0.0 107.657 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.409 ' CE2' HD11 ' A' ' 89' ' ' LEU . 11.0 m-85 -114.53 88.12 2.79 Favored 'General case' 0 CA--C 1.511 -0.557 0 CA-C-O 121.958 0.885 . . . . 0.0 110.117 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.658 ' OG1' HG12 ' A' ' 61' ' ' VAL 0.349 14.8 t -95.19 85.92 4.43 Favored 'General case' 0 N--CA 1.428 -1.543 0 CA-C-O 125.799 2.714 . . . . 0.0 108.789 -179.742 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.454 HG13 ' HE1' ' A' ' 62' ' ' PHE 0.654 1.0 OUTLIER -70.39 108.67 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.768 0 N-CA-C 117.758 2.503 . . . . 0.0 117.758 -179.948 . . . . . . . . 4 4 . 1 . 016 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.555 ' HB3' ' HB ' ' A' ' 39' ' ' THR . 15.9 tttp -69.55 117.46 11.18 Favored 'General case' 0 C--N 1.303 -1.416 1 N-CA-C 99.508 -4.256 . . . . 0.0 99.508 179.218 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.438 ' HG3' ' CD1' ' A' ' 36' ' ' LEU . 1.1 tt0 -112.67 104.96 13.03 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 -179.334 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -103.45 51.63 0.79 Allowed 'General case' 0 C--N 1.289 -2.049 0 N-CA-C 105.317 -2.105 . . . . 0.0 105.317 179.562 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 4.3 t -73.05 21.37 0.07 Allowed 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 113.175 -1.83 . . . . 0.0 115.474 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 73.79 -51.42 0.69 Allowed 'General case' 0 CA--C 1.498 -1.032 0 CA-C-N 122.245 2.293 . . . . 0.0 109.787 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -67.1 -44.33 80.25 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-O 115.119 -2.372 . . . . 0.0 110.209 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.518 ' HB2' HG22 ' A' ' 58' ' ' ILE . 9.3 ptp180 -149.56 126.17 10.99 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 123.633 2.924 . . . . 0.0 106.795 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -99.71 74.42 1.85 Allowed 'General case' 0 N--CA 1.465 0.291 1 N-CA-C 100.197 -4.001 . . . . 0.0 100.197 179.784 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.518 HG22 ' HB2' ' A' ' 56' ' ' ARG . 3.3 tp -115.94 117.83 56.8 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.82 1 C-N-CA 132.417 4.287 . . . . 0.0 118.9 -179.104 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.95 125.58 26.77 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 103.607 -2.738 . . . . 0.0 103.607 178.163 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 1.4 t -107.85 103.96 16.32 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 O-C-N 124.515 1.135 . . . . 0.0 113.217 -178.064 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.658 HG12 ' OG1' ' A' ' 48' ' ' THR 0.395 1.7 m -88.49 141.97 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.159 0 CA-C-O 125.091 2.377 . . . . 0.0 113.888 179.593 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.597 ' HB3' ' CE1' ' A' ' 68' ' ' PHE . 0.1 OUTLIER -160.75 95.64 1.1 Allowed 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 113.128 -1.851 . . . . 0.0 108.772 -179.833 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -54.49 144.57 20.8 Favored 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 104.772 -2.307 . . . . 0.0 104.772 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.636 ' H ' HD12 ' A' ' 64' ' ' LEU . 2.9 mp -68.89 115.7 8.51 Favored 'General case' 0 N--CA 1.432 -1.345 0 O-C-N 119.475 -2.015 . . . . 0.0 107.238 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 81.87 26.62 48.93 Favored Glycine 0 N--CA 1.471 0.971 0 C-N-CA 126.713 2.102 . . . . 0.0 118.172 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . 0.387 41.2 t -114.8 81.39 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 N-CA-C 104.662 -2.347 . . . . 0.0 104.662 179.849 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.435 ' HA ' ' CG2' ' A' ' 81' ' ' THR . 0.7 OUTLIER -38.43 114.08 0.34 Allowed 'General case' 0 C--N 1.307 -1.262 0 O-C-N 125.689 1.868 . . . . 0.0 114.437 -179.917 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.597 ' CE1' ' HB3' ' A' ' 62' ' ' PHE . 37.6 p90 -119.95 164.86 15.44 Favored 'General case' 0 N--CA 1.427 -1.598 0 O-C-N 125.18 1.55 . . . . 0.0 107.977 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -108.93 138.1 45.8 Favored 'General case' 0 C--N 1.319 -0.74 0 O-C-N 126.171 2.169 . . . . 0.0 106.997 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.801 ' O ' HD13 ' A' ' 72' ' ' LEU . 35.9 t80 -133.73 95.57 3.5 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 119.787 1.176 . . . . 0.0 111.248 -179.596 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.514 ' C ' HD22 ' A' ' 72' ' ' LEU . 1.9 p -72.26 79.22 0.99 Allowed 'General case' 0 N--CA 1.432 -1.36 0 CA-C-O 117.529 -1.224 . . . . 0.0 112.386 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.955 HD22 ' N ' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -40.06 175.75 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.813 1 O-C-N 130.355 4.785 . . . . 0.0 110.028 174.955 . . . . . . . . 4 4 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.52 -45.38 13.64 Favored 'General case' 0 C--N 1.351 0.671 0 O-C-N 120.522 -1.361 . . . . 0.0 113.613 -178.808 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.551 ' CB ' ' HD2' ' A' ' 27' ' ' LYS . 0.4 OUTLIER -148.96 25.74 0.91 Allowed 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 179.956 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.473 ' C ' ' HG ' ' A' ' 72' ' ' LEU . . . -95.03 -32.23 7.22 Favored Glycine 0 CA--C 1.544 1.874 0 CA-C-N 112.69 -2.05 . . . . 0.0 113.312 179.803 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.633 ' N ' ' HG ' ' A' ' 72' ' ' LEU 0.376 0.3 OUTLIER 84.76 117.82 0.04 OUTLIER 'General case' 0 C--N 1.305 -1.364 0 CA-C-O 114.465 -2.683 . . . . 0.0 107.175 -177.878 . . . . . . . . 4 4 . 1 . 016 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.713 ' N ' HD21 ' A' ' 72' ' ' LEU . 0.6 OUTLIER -3.9 120.29 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.63 1 O-C-N 130.134 4.646 . . . . 0.0 114.405 -179.412 . . . . . . . . 4 4 . 1 . 016 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.691 HD12 HD23 ' A' ' 102' ' ' LEU 0.518 0.5 OUTLIER -133.22 122.12 23.49 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 102.022 -3.325 . . . . 0.0 102.022 179.772 . . . . . . . . 4 4 . 1 . 016 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 10.7 t -137.59 123.35 19.96 Favored 'General case' 0 C--O 1.198 -1.637 0 N-CA-C 101.765 -3.421 . . . . 0.0 101.765 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -156.89 -149.31 5.36 Favored Glycine 0 C--N 1.308 -1.02 0 C-N-CA 116.921 -2.562 . . . . 0.0 110.419 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.435 ' CG2' ' HA ' ' A' ' 67' ' ' ASP . 22.1 p -155.32 165.79 35.57 Favored 'General case' 0 C--O 1.198 -1.607 0 CA-C-O 123.838 1.78 . . . . 0.0 109.037 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' TRP . . . . . 0.542 ' CZ2' ' CZ ' ' A' ' 106' ' ' ARG 0.322 12.2 m95 -112.71 129.46 56.4 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 100.772 -3.788 . . . . 0.0 100.772 -179.879 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.7 t -144.17 100.81 3.62 Favored 'General case' 0 C--O 1.262 1.716 0 O-C-N 121.218 -0.926 . . . . 0.0 110.254 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.482 ' CA ' HD23 ' A' ' 89' ' ' LEU . 6.4 ttp -52.58 112.93 0.91 Allowed 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 105.471 -2.048 . . . . 0.0 105.471 179.807 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . 0.622 3.8 mm-40 -77.8 -56.34 4.59 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 124.806 1.316 . . . . 0.0 110.07 -179.731 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 160.24 124.8 0.75 Allowed Glycine 0 C--O 1.22 -0.725 0 N-CA-C 103.402 -3.879 . . . . 0.0 103.402 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . 0.26 0.1 OUTLIER 55.97 15.64 1.82 Allowed 'General case' 0 C--O 1.245 0.832 0 CA-C-O 116.572 -1.68 . . . . 0.0 113.638 -179.986 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . 0.418 3.1 mppt? -174.12 150.26 1.53 Allowed 'General case' 0 CA--C 1.496 -1.101 0 O-C-N 125.772 1.92 . . . . 0.0 106.812 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.482 HD23 ' CA ' ' A' ' 84' ' ' MET . 0.7 OUTLIER -113.4 137.88 50.88 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 102.331 -3.211 . . . . 0.0 102.331 -179.879 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 18.5 m -118.24 134.37 62.08 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.028 0 N-CA-C 105.547 -2.02 . . . . 0.0 105.547 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.486 ' O ' ' HB3' ' A' ' 104' ' ' ALA . . . -113.65 95.09 0.73 Allowed Glycine 0 C--N 1.344 0.981 0 C-N-CA 128.164 2.792 . . . . 0.0 108.755 -179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.402 ' HA ' ' HA ' ' A' ' 103' ' ' ILE . 0.6 OUTLIER -90.83 168.64 11.57 Favored 'General case' 0 N--CA 1.436 -1.135 0 N-CA-C 104.323 -2.473 . . . . 0.0 104.323 179.963 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.581 ' HB3' ' HG ' ' A' ' 78' ' ' LEU . 23.5 m-85 -157.71 97.33 1.57 Allowed 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 118.454 -1.299 . . . . 0.0 108.063 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 14.5 mtmt -74.39 161.2 30.07 Favored 'General case' 0 N--CA 1.446 -0.653 0 O-C-N 125.125 1.516 . . . . 0.0 108.47 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.457 ' HD2' ' N ' ' A' ' 95' ' ' ARG 0.457 0.9 OUTLIER -119.47 139.98 51.2 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 179.69 . . . . . . . . 4 4 . 1 . 016 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.603 HG11 ' HG2' ' A' ' 77' ' ' GLU . 3.1 m -83.0 -13.38 12.04 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 179.792 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . 0.333 14.3 p-10 -79.13 3.93 16.16 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 113.504 -1.68 . . . . 0.0 112.361 179.801 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . 0.256 0.8 OUTLIER -174.93 -29.28 0.01 OUTLIER 'General case' 0 N--CA 1.426 -1.635 0 C-N-CA 117.698 -1.601 . . . . 0.0 114.069 -179.735 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 97.56 20.07 23.31 Favored Glycine 0 N--CA 1.445 -0.701 0 N-CA-C 115.21 0.844 . . . . 0.0 115.21 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 39.3 mttt -82.95 -159.79 0.36 Allowed 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 116.159 -2.216 . . . . 0.0 106.344 -179.745 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -143.0 148.67 37.17 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-O 117.23 -1.367 . . . . 0.0 109.889 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.691 HD23 HD12 ' A' ' 78' ' ' LEU . 0.3 OUTLIER -133.09 110.1 9.96 Favored 'General case' 0 CA--C 1.543 0.708 1 O-C-N 131.552 5.533 . . . . 0.0 103.217 179.212 . . . . . . . . 4 4 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.697 HD13 ' N ' ' A' ' 104' ' ' ALA . 0.0 OUTLIER -92.03 161.18 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.174 0 CA-C-N 114.181 -1.372 . . . . 0.0 111.003 -179.238 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.697 ' N ' HD13 ' A' ' 103' ' ' ILE . . . -150.15 106.38 3.47 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 116.152 -1.88 . . . . 0.0 107.376 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 9.2 p -87.8 103.65 13.71 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.519 0 CA-C-N 120.877 1.672 . . . . 0.0 113.587 -179.768 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.542 ' CZ ' ' CZ2' ' A' ' 82' ' ' TRP . 19.2 mtt-85 -74.48 82.2 1.96 Allowed 'General case' 0 CA--C 1.507 -0.679 0 CA-C-O 124.872 2.273 . . . . 0.0 106.074 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.41 ' O ' ' N ' ' A' ' 109' ' ' SER . 0.2 OUTLIER -86.61 81.37 8.27 Favored 'General case' 0 N--CA 1.417 -2.078 0 CA-C-N 111.118 -2.765 . . . . 0.0 117.292 -179.989 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.518 HG12 ' CE1' ' A' ' 2' ' ' PHE . 1.9 mm -63.61 98.41 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 C-N-CA 116.106 -2.238 . . . . 0.0 107.287 179.081 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.41 ' N ' ' O ' ' A' ' 107' ' ' GLU . 2.1 p -62.9 -29.69 70.97 Favored 'General case' 0 C--N 1.319 -0.754 0 O-C-N 121.342 -0.849 . . . . 0.0 109.116 -179.272 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 145.77 -87.97 0.16 Allowed Glycine 0 CA--C 1.526 0.727 1 C-N-CA 131.965 4.602 . . . . 0.0 110.566 -179.304 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . 0.3 0.2 OUTLIER -81.76 -0.93 45.32 Favored 'General case' 0 C--O 1.212 -0.895 0 CA-C-O 113.794 -3.003 . . . . 0.0 110.137 179.235 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -136.61 118.69 15.4 Favored 'General case' 0 C--O 1.205 -1.245 1 O-C-N 129.751 4.407 . . . . 0.0 112.49 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.47 ' HG ' HG12 ' A' ' 108' ' ' ILE . 5.0 tt -91.66 141.1 29.06 Favored 'General case' 0 C--O 1.212 -0.898 0 N-CA-C 100.763 -3.791 . . . . 0.0 100.763 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 1.048 HD12 HD12 ' A' ' 127' ' ' ILE 0.309 14.3 mm -123.1 135.97 61.37 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 N-CA-C 102.55 -3.13 . . . . 0.0 102.55 179.666 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 115' ' ' GLN . . . . . 0.451 ' HG3' ' CD2' ' A' ' 113' ' ' LEU . 13.5 mt-30 -131.94 95.25 3.65 Favored 'General case' 0 C--O 1.245 0.828 0 CA-C-O 115.425 -2.226 . . . . 0.0 105.385 -179.79 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 61.0 p -70.28 -171.51 0.47 Allowed 'General case' 0 C--N 1.318 -0.772 0 O-C-N 127.017 2.698 . . . . 0.0 106.425 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.466 ' N ' ' O ' ' A' ' 123' ' ' GLU . 12.3 m-85 -159.8 62.26 0.36 Allowed 'General case' 0 CA--C 1.494 -1.181 0 CA-C-O 115.735 -2.079 . . . . 0.0 106.781 179.785 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.515 ' HB ' HG22 ' A' ' 103' ' ' ILE . 0.3 OUTLIER -70.44 108.32 4.22 Favored 'General case' 0 C--O 1.254 1.295 0 O-C-N 126.885 2.616 . . . . 0.0 107.016 -179.171 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.564 ' H ' HG22 ' A' ' 122' ' ' VAL . 76.3 t80 -72.82 -35.77 67.37 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 103.827 -2.657 . . . . 0.0 103.827 -179.425 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -151.77 -66.88 0.17 Allowed 'General case' 0 C--N 1.291 -1.938 1 O-C-N 129.751 4.407 . . . . 0.0 108.074 179.866 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -145.14 27.58 1.86 Allowed Glycine 0 CA--C 1.544 1.892 0 C-N-CA 128.196 2.808 . . . . 0.0 112.881 178.545 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.645 ' HB ' ' HB3' ' A' ' 17' ' ' PHE . 1.7 m -106.77 6.86 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 CA-C-N 112.766 -1.717 . . . . 0.0 110.755 -178.237 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.466 ' O ' ' N ' ' A' ' 117' ' ' TYR . 26.4 tt0 12.71 -75.0 0.0 OUTLIER 'General case' 0 C--N 1.307 -1.275 0 O-C-N 129.007 3.942 . . . . 0.0 112.028 -179.639 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.46 ' HB3' ' O ' ' A' ' 123' ' ' GLU . . . 70.5 84.33 0.14 Allowed 'General case' 0 C--O 1.206 -1.21 0 O-C-N 116.669 -3.769 . . . . 0.0 109.08 178.793 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.452 ' N ' ' O ' ' A' ' 12' ' ' GLU . 6.0 mptt -79.7 136.76 36.86 Favored 'General case' 0 C--O 1.254 1.333 1 O-C-N 129.601 4.313 . . . . 0.0 110.027 179.97 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.499 ' NH2' HD22 ' A' ' 36' ' ' LEU . 3.2 mtm180 -126.49 77.81 1.73 Allowed 'General case' 0 N--CA 1.437 -1.096 0 O-C-N 125.574 1.796 . . . . 0.0 112.155 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 1.048 HD12 HD12 ' A' ' 114' ' ' ILE . 0.4 OUTLIER -73.96 108.37 5.39 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.922 0 O-C-N 126.362 2.289 . . . . 0.0 115.179 179.42 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.646 ' CZ ' HD13 ' A' ' 38' ' ' LEU . 28.7 m-85 -89.06 147.07 24.44 Favored 'General case' 0 N--CA 1.438 -1.064 0 C-N-CA 128.158 2.583 . . . . 0.0 111.215 179.812 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . 0.347 14.3 mtmt -100.15 8.45 43.86 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 117.733 -1.127 . . . . 0.0 110.392 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.596 ' HA ' ' CE3' ' A' ' 6' ' ' TRP . 9.7 tttm 69.53 153.68 0.11 Allowed 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . 0.835 61.1 tt0 . . . . . 0 CA--C 1.505 -0.785 0 N-CA-C 119.246 3.054 . . . . 0.0 119.246 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 2' ' ' PHE . . . . . 0.462 ' O ' HG21 ' A' ' 40' ' ' ILE . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.098 0 CA-C-O 124.076 1.893 . . . . 0.0 114.08 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -119.16 99.61 6.82 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 113.54 -1.664 . . . . 0.0 110.874 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' GLY . . . . . 0.412 ' O ' ' N ' ' A' ' 40' ' ' ILE . . . 157.9 -148.6 18.22 Favored Glycine 0 C--O 1.208 -1.472 0 CA-C-N 112.748 -2.023 . . . . 0.0 110.437 179.658 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.429 HG23 ' HA ' ' A' ' 131' ' ' GLU 0.566 6.3 t -102.03 159.29 15.5 Favored 'General case' 0 N--CA 1.432 -1.334 0 CA-C-N 113.794 -1.203 . . . . 0.0 112.294 -179.84 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.701 ' CH2' HD11 ' A' ' 108' ' ' ILE . 96.0 m95 -146.5 112.26 5.65 Favored 'General case' 0 N--CA 1.441 -0.902 0 O-C-N 127.685 3.116 . . . . 0.0 111.161 179.806 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 11.8 ttmt -109.15 116.47 32.0 Favored 'General case' 0 C--O 1.207 -1.17 0 CA-C-N 121.548 1.976 . . . . 0.0 108.065 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.567 ' HB ' ' CD1' ' A' ' 128' ' ' PHE 0.289 1.5 p -57.62 128.47 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 O-C-N 119.04 -2.288 . . . . 0.0 114.897 179.986 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -107.93 -21.63 12.75 Favored 'General case' 0 C--O 1.213 -0.826 0 CA-C-O 126.201 2.905 . . . . 0.0 108.883 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.407 ' O ' ' N ' ' A' ' 127' ' ' ILE . 29.9 ptt-85 -163.79 146.56 9.69 Favored 'General case' 0 CA--C 1.478 -1.795 0 O-C-N 117.93 -2.982 . . . . 0.0 113.107 179.766 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . 0.413 0.8 OUTLIER -119.19 -176.13 3.07 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 112.919 -1.946 . . . . 0.0 107.018 179.927 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -145.79 -70.94 0.26 Allowed 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 122.194 2.27 . . . . 0.0 108.062 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.475 ' CG ' ' CE2' ' A' ' 17' ' ' PHE . 2.5 t-20 -92.87 39.19 1.03 Allowed 'General case' 0 N--CA 1.476 0.827 0 O-C-N 127.555 3.035 . . . . 0.0 111.91 179.542 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.467 ' HD1' ' HB1' ' A' ' 124' ' ' ALA 0.313 34.5 t80 -97.81 -57.98 2.1 Favored 'General case' 0 N--CA 1.439 -1.01 0 N-CA-C 121.267 3.802 . . . . 0.0 121.267 -179.379 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . 0.252 6.1 pm0 -56.5 -55.02 38.94 Favored 'General case' 0 CA--C 1.505 -0.757 0 CA-C-N 124.227 3.194 . . . . 0.0 114.186 -179.066 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.584 ' HB3' ' CE2' ' A' ' 17' ' ' PHE . 8.5 ttmt -55.04 -42.05 72.17 Favored 'General case' 0 N--CA 1.421 -1.923 0 C-N-CA 127.537 2.335 . . . . 0.0 115.616 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.589 ' HB3' ' HB ' ' A' ' 122' ' ' VAL 0.293 45.1 m-85 -77.58 -19.91 54.87 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 111.282 -2.69 . . . . 0.0 114.044 -177.28 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.529 ' O ' HG12 ' A' ' 23' ' ' ILE . 4.4 mmt -70.43 -20.04 62.94 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 118.812 -2.43 . . . . 0.0 105.88 175.738 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.71 -32.59 63.98 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-O 127.904 3.716 . . . . 0.0 109.837 179.775 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.885 ' HD3' HG11 ' A' ' 122' ' ' VAL . 0.5 OUTLIER -72.51 -30.11 64.2 Favored 'General case' 0 N--CA 1.454 -0.256 0 O-C-N 118.113 -2.867 . . . . 0.0 110.371 179.97 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.434 ' CE ' ' HG ' ' A' ' 72' ' ' LEU . 1.5 mmm -78.06 -28.04 48.77 Favored 'General case' 0 C--O 1.201 -1.481 0 C-N-CA 127.472 2.309 . . . . 0.0 107.768 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.62 22.0 6.57 Favored Glycine 0 C--N 1.299 -1.48 0 CA-C-O 114.598 -3.334 . . . . 0.0 111.678 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.529 HG12 ' O ' ' A' ' 18' ' ' MET . 23.9 mm -78.78 139.76 17.94 Favored 'Isoleucine or valine' 0 C--N 1.352 0.709 0 O-C-N 126.765 2.097 . . . . 0.0 106.507 -179.288 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -102.29 143.12 32.46 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-O 116.559 -1.686 . . . . 0.0 113.119 -179.64 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . 0.437 0.2 OUTLIER 3.35 -73.81 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.508 -0.658 0 N-CA-C 119.957 3.318 . . . . 0.0 119.957 179.962 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.646 1.8 t -65.84 -30.33 49.7 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.972 0 O-C-N 126.936 2.648 . . . . 0.0 116.634 -179.764 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.424 ' HB2' HG22 ' A' ' 23' ' ' ILE . 30.5 mtmt -73.37 -31.22 63.8 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 114.222 -1.354 . . . . 0.0 111.236 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.92 -25.86 40.38 Favored 'General case' 0 N--CA 1.473 0.715 0 O-C-N 120.46 -1.4 . . . . 0.0 107.998 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 15.8 ttpt -78.57 -43.23 27.06 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.893 -1.049 . . . . 0.0 111.456 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.4 mt -77.73 -30.86 51.87 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 118.959 -1.096 . . . . 0.0 110.382 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -71.74 -30.95 65.47 Favored Glycine 0 C--O 1.217 -0.931 0 O-C-N 125.329 1.643 . . . . 0.0 111.998 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -75.81 -25.74 56.62 Favored 'General case' 0 N--CA 1.439 -0.981 0 O-C-N 120.996 -1.296 . . . . 0.0 112.959 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -121.3 28.3 7.87 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 127.605 2.362 . . . . 0.0 115.001 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -66.84 -13.88 62.08 Favored 'General case' 0 C--O 1.218 -0.591 0 N-CA-C 117.406 2.372 . . . . 0.0 117.406 -179.809 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . 0.302 0.5 OUTLIER 70.25 26.86 4.25 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 121.063 1.756 . . . . 0.0 110.004 179.741 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.614 HD11 HD13 ' A' ' 38' ' ' LEU . 0.9 OUTLIER -45.34 114.1 0.69 Allowed 'General case' 0 CA--C 1.495 -1.148 0 O-C-N 127.405 2.941 . . . . 0.0 108.76 -179.739 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.554 ' N ' HD12 ' A' ' 36' ' ' LEU . 27.7 tttp -110.98 98.82 7.83 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 104.911 -2.255 . . . . 0.0 104.911 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.692 HD22 ' CE2' ' A' ' 128' ' ' PHE . 1.9 tp -79.87 139.92 36.96 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.564 ' HB ' ' CB ' ' A' ' 50' ' ' LYS . 47.3 m -131.16 82.45 2.04 Favored 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 103.189 -2.893 . . . . 0.0 103.189 179.741 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.693 HD13 HG23 ' A' ' 49' ' ' VAL . 2.4 mm -65.54 132.06 31.27 Favored 'Isoleucine or valine' 0 C--O 1.255 1.35 0 CA-C-N 112.482 -2.145 . . . . 0.0 111.116 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.485 HG22 ' O ' ' A' ' 41' ' ' THR . 13.3 m -139.76 92.29 2.55 Favored 'General case' 0 CA--C 1.501 -0.918 0 O-C-N 125.851 1.97 . . . . 0.0 112.108 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 54.8 tt0 -85.87 118.17 25.19 Favored 'General case' 0 C--O 1.243 0.745 0 CA-C-O 117.186 -1.388 . . . . 0.0 111.519 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -101.54 -109.39 0.22 Allowed 'General case' 0 CA--C 1.495 -1.166 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -112.22 76.33 0.23 Allowed Glycine 0 C--N 1.307 -1.038 0 N-CA-C 105.548 -3.021 . . . . 0.0 105.548 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.313 0.5 OUTLIER 89.62 -18.74 0.19 Allowed 'General case' 0 C--N 1.32 -0.678 0 O-C-N 128.345 3.026 . . . . 0.0 113.751 179.827 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.466 ' HA ' ' HA ' ' A' ' 63' ' ' GLU . 1.9 ttpm? -91.93 146.48 23.71 Favored 'General case' 0 N--CA 1.435 -1.199 0 C-N-CA 117.604 -1.638 . . . . 0.0 107.301 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . 0.28 4.4 m-85 -129.32 93.85 3.66 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-O 123.01 1.386 . . . . 0.0 108.94 179.803 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.982 ' HB ' HG12 ' A' ' 61' ' ' VAL 0.479 2.0 t -78.36 146.1 34.85 Favored 'General case' 0 CA--C 1.496 -1.101 0 CA-C-O 125.23 2.443 . . . . 0.0 107.949 179.739 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.693 HG23 HD13 ' A' ' 40' ' ' ILE 0.693 0.3 OUTLIER -120.68 95.75 3.78 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 CA-C-N 109.969 -3.287 . . . . 0.0 111.948 -179.981 . . . . . . . . 4 4 . 1 . 017 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.564 ' CB ' ' HB ' ' A' ' 39' ' ' THR . 0.9 OUTLIER -72.22 130.34 40.58 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 100.305 -3.961 . . . . 0.0 100.305 179.685 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.522 ' HG3' HD13 ' A' ' 36' ' ' LEU . 15.9 tt0 -123.52 66.99 1.01 Allowed 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 105.947 -1.871 . . . . 0.0 105.947 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 12.6 m -71.82 74.89 0.87 Allowed 'General case' 0 C--N 1.287 -2.11 0 CA-C-O 117.861 -1.066 . . . . 0.0 108.153 -179.816 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -103.6 -165.73 1.19 Allowed 'General case' 0 CA--C 1.506 -0.743 0 O-C-N 125.543 1.777 . . . . 0.0 112.777 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 62.5 t30 -70.77 -20.66 62.58 Favored 'General case' 0 N--CA 1.441 -0.882 0 O-C-N 123.979 0.799 . . . . 0.0 112.325 -179.703 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -87.26 -55.74 3.67 Favored 'General case' 0 C--O 1.22 -0.474 0 CA-C-O 115.071 -2.395 . . . . 0.0 112.258 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.75 176.61 12.15 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 124.496 3.316 . . . . 0.0 107.725 179.738 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -119.17 88.04 2.85 Favored 'General case' 0 C--O 1.216 -0.702 0 C-N-CA 131.466 3.906 . . . . 0.0 100.872 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -117.73 98.91 7.14 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.992 0 C-N-CA 129.041 2.936 . . . . 0.0 118.676 -179.511 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 19.3 p-10 -62.54 120.5 11.24 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 103.712 -2.699 . . . . 0.0 103.712 177.592 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.53 ' HB ' ' CZ ' ' A' ' 62' ' ' PHE . 2.8 t -83.91 -55.17 7.52 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 CA-C-O 125.42 2.533 . . . . 0.0 112.133 -177.466 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.982 HG12 ' HB ' ' A' ' 48' ' ' THR 0.349 0.7 OUTLIER 67.13 133.36 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.434 -1.252 0 O-C-N 120.046 -1.659 . . . . 0.0 114.034 -179.54 . . . . . . . . 4 4 . 1 . 017 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.604 ' CD2' ' CZ ' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -166.72 100.91 0.57 Allowed 'General case' 0 N--CA 1.428 -1.555 0 CA-C-O 116.989 -1.482 . . . . 0.0 111.427 179.493 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.466 ' HA ' ' HA ' ' A' ' 46' ' ' LYS . 30.1 mm-40 -54.35 142.48 26.55 Favored 'General case' 0 N--CA 1.429 -1.503 0 O-C-N 126.782 2.551 . . . . 0.0 105.726 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.1 mp -59.54 115.79 3.55 Favored 'General case' 0 N--CA 1.431 -1.389 0 CA-C-N 120.844 1.656 . . . . 0.0 111.43 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 83.08 33.76 22.75 Favored Glycine 0 C--N 1.34 0.782 0 O-C-N 128.433 3.583 . . . . 0.0 116.897 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . 0.426 2.2 t -117.1 92.42 2.12 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.53 ' HA ' HG22 ' A' ' 81' ' ' THR 0.269 0.2 OUTLIER -44.3 134.73 4.88 Favored 'General case' 0 CA--C 1.494 -1.194 0 O-C-N 124.898 1.374 . . . . 0.0 113.203 -179.948 . . . . . . . . 4 4 . 1 . 017 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.604 ' CZ ' ' CD2' ' A' ' 62' ' ' PHE . 11.7 p90 -132.46 170.18 15.49 Favored 'General case' 0 N--CA 1.439 -0.992 0 O-C-N 124.961 1.413 . . . . 0.0 108.14 -179.655 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -125.79 109.58 12.71 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 116.038 -1.934 . . . . 0.0 107.851 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 21.3 t80 -127.83 111.57 13.78 Favored 'General case' 0 C--N 1.319 -0.739 0 O-C-N 125.471 1.732 . . . . 0.0 112.876 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 8.2 t -79.95 156.32 27.29 Favored 'General case' 0 CA--C 1.487 -1.449 0 CA-C-N 119.239 0.927 . . . . 0.0 109.713 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.434 ' HG ' ' CE ' ' A' ' 21' ' ' MET . 4.0 mm? -81.22 -166.28 1.12 Allowed 'General case' 0 CA--C 1.503 -0.834 0 N-CA-C 103.874 -2.639 . . . . 0.0 103.874 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -87.85 -18.78 28.5 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 124.805 1.315 . . . . 0.0 112.491 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -84.57 -13.17 52.51 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 115.972 -2.291 . . . . 0.0 108.99 179.775 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 108.17 8.36 29.44 Favored Glycine 0 CA--C 1.542 1.768 0 CA-C-O 117.431 -1.761 . . . . 0.0 114.359 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . 0.278 7.5 m -89.83 125.57 35.37 Favored 'General case' 0 N--CA 1.433 -1.289 0 CA-C-N 119.397 1.599 . . . . 0.0 109.926 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.507 ' HG2' HG21 ' A' ' 96' ' ' VAL . 0.0 OUTLIER -66.64 169.48 7.72 Favored 'General case' 0 C--O 1.22 -0.466 0 O-C-N 128.013 3.321 . . . . 0.0 112.327 -179.989 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.486 ' HG ' ' HB3' ' A' ' 93' ' ' PHE 0.28 1.5 tt -153.08 142.44 21.64 Favored 'General case' 0 CA--C 1.503 -0.834 0 N-CA-C 102.512 -3.144 . . . . 0.0 102.512 179.777 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 19.0 p -144.94 111.79 5.86 Favored 'General case' 0 CA--C 1.491 -1.315 0 N-CA-C 102.729 -3.063 . . . . 0.0 102.729 -179.735 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -174.48 -167.45 33.93 Favored Glycine 0 C--N 1.301 -1.414 1 C-N-CA 113.058 -4.401 . . . . 0.0 114.414 -179.772 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.53 HG22 ' HA ' ' A' ' 67' ' ' ASP . 0.5 OUTLIER -144.89 176.32 9.56 Favored 'General case' 0 C--O 1.187 -2.229 0 CA-C-N 119.821 1.811 . . . . 0.0 111.725 -179.953 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 82' ' ' TRP . . . . . 0.421 ' CZ2' ' CE1' ' A' ' 62' ' ' PHE 0.311 13.7 m0 -116.85 154.32 30.96 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 106.244 -1.761 . . . . 0.0 106.244 -179.995 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.571 HG23 HG22 ' A' ' 90' ' ' VAL . 10.8 t -162.35 139.39 8.09 Favored 'General case' 0 C--N 1.297 -1.698 0 CA-C-O 124.499 2.095 . . . . 0.0 111.811 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.427 ' HA ' HD23 ' A' ' 89' ' ' LEU . 5.1 ttt -81.37 102.72 10.64 Favored 'General case' 0 C--O 1.211 -0.964 0 CA-C-N 112.018 -2.355 . . . . 0.0 106.881 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . 0.632 6.8 mt-10 -77.02 -121.12 0.01 OUTLIER 'General case' 0 N--CA 1.428 -1.526 0 CA-C-O 124.483 2.087 . . . . 0.0 111.383 -179.848 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -105.88 95.22 1.04 Allowed Glycine 0 N--CA 1.443 -0.86 0 N-CA-C 106.243 -2.743 . . . . 0.0 106.243 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 4.4 m120 61.81 12.84 4.99 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 116.347 1.98 . . . . 0.0 116.347 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . 0.348 9.0 mtmm -149.89 139.55 21.68 Favored 'General case' 0 C--O 1.215 -0.732 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 179.785 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.427 HD23 ' HA ' ' A' ' 84' ' ' MET . 0.0 OUTLIER -84.77 130.15 34.72 Favored 'General case' 0 C--N 1.317 -0.833 1 O-C-N 129.213 4.071 . . . . 0.0 102.046 179.849 . . . . . . . . 4 4 . 1 . 017 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.748 HG12 HG23 ' A' ' 105' ' ' VAL . 16.1 m -120.85 164.76 17.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.435 ' O ' ' N ' ' A' ' 104' ' ' ALA . . . -141.4 101.12 0.28 Allowed Glycine 0 C--O 1.216 -1.02 0 C-N-CA 127.932 2.682 . . . . 0.0 109.252 -179.833 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.98 123.79 37.56 Favored 'General case' 0 N--CA 1.436 -1.172 0 N-CA-C 104.583 -2.377 . . . . 0.0 104.583 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.486 ' HB3' ' HG ' ' A' ' 78' ' ' LEU . 21.2 m-30 -122.16 113.02 18.91 Favored 'General case' 0 CA--C 1.506 -0.716 0 O-C-N 125.417 1.698 . . . . 0.0 114.255 -179.543 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.491 ' HA ' ' HA ' ' A' ' 101' ' ' GLU . 12.3 mttm -92.12 173.18 7.97 Favored 'General case' 0 N--CA 1.427 -1.592 0 C-N-CA 126.586 1.955 . . . . 0.0 106.621 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . 0.37 3.3 mtp180 -119.72 145.53 46.45 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.507 HG21 ' HG2' ' A' ' 77' ' ' GLU . 5.2 t -69.71 -47.78 68.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 112.89 -1.959 . . . . 0.0 113.597 -179.817 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . 0.324 1.5 p-10 -102.51 35.13 2.54 Favored 'General case' 0 C--O 1.258 1.512 0 CA-C-O 122.798 1.285 . . . . 0.0 113.408 -179.817 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -144.17 -41.61 0.27 Allowed 'General case' 0 CA--C 1.491 -1.292 0 CA-C-N 114.131 -1.395 . . . . 0.0 113.723 -179.794 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 81.62 2.39 90.5 Favored Glycine 0 CA--C 1.543 1.788 0 C-N-CA 125.53 1.538 . . . . 0.0 112.395 -179.658 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 47.3 mttm -85.22 -171.32 3.57 Favored 'General case' 0 C--O 1.205 -1.251 0 CA-C-N 114.291 -0.954 . . . . 0.0 110.818 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.491 ' HA ' ' HA ' ' A' ' 94' ' ' LYS . 23.0 tt0 -130.81 168.8 16.65 Favored 'General case' 0 N--CA 1.439 -1.009 0 C-N-CA 129.669 3.187 . . . . 0.0 111.066 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.551 ' CG ' ' HA ' ' A' ' 119' ' ' TYR . 5.0 tt -154.57 -179.05 7.61 Favored 'General case' 0 C--N 1.319 -0.756 2 C-N-CA 136.19 5.796 . . . . 0.0 104.361 179.827 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.479 HG23 ' HB ' ' A' ' 118' ' ' THR . 0.9 OUTLIER -157.38 155.33 5.08 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.406 0 N-CA-C 104.116 -2.55 . . . . 0.0 104.116 179.783 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.471 ' N ' HG13 ' A' ' 103' ' ' ILE . . . -143.15 94.86 2.68 Favored 'General case' 0 N--CA 1.436 -1.158 0 C-N-CA 125.551 1.54 . . . . 0.0 108.284 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.748 HG23 HG12 ' A' ' 90' ' ' VAL . 0.5 OUTLIER -89.39 116.55 31.06 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 CA-C-O 125.222 2.439 . . . . 0.0 110.588 179.713 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.565 HH11 ' HG3' ' A' ' 106' ' ' ARG . 38.3 mtt85 -88.42 90.84 8.56 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 105.915 -1.883 . . . . 0.0 105.915 179.672 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -89.38 80.05 6.87 Favored 'General case' 0 N--CA 1.423 -1.781 0 O-C-N 127.356 2.91 . . . . 0.0 117.287 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.701 HD11 ' CH2' ' A' ' 6' ' ' TRP 0.312 0.6 OUTLIER -54.24 96.79 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 C-N-CA 118.523 -1.271 . . . . 0.0 113.368 179.718 . . . . . . . . 4 4 . 1 . 017 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 8.6 t -92.11 73.73 5.48 Favored 'General case' 0 CA--C 1.508 -0.635 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 -179.715 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 42.6 87.33 0.01 OUTLIER Glycine 0 C--N 1.334 0.452 0 O-C-N 125.586 1.804 . . . . 0.0 114.834 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . 0.315 3.7 m-20 84.32 -11.9 0.8 Allowed 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 113.961 -2.923 . . . . 0.0 111.212 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -124.93 108.45 11.9 Favored 'General case' 0 CA--C 1.497 -1.076 0 O-C-N 125.369 1.668 . . . . 0.0 111.669 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.497 HD21 ' HG2' ' A' ' 106' ' ' ARG . 6.1 tt -85.74 117.48 24.65 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 102.475 -3.157 . . . . 0.0 102.475 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.705 HG12 HG23 ' A' ' 127' ' ' ILE . 73.0 mt -113.97 142.42 26.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 N-CA-C 103.314 -2.847 . . . . 0.0 103.314 179.876 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' GLN . . . . . 0.443 ' HG2' ' HG2' ' A' ' 106' ' ' ARG . 35.2 mt-30 -121.07 119.91 33.81 Favored 'General case' 0 CA--C 1.503 -0.855 0 CA-C-O 115.812 -2.042 . . . . 0.0 108.599 -179.03 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.5 p -96.96 111.94 23.93 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 104.256 -2.498 . . . . 0.0 104.256 178.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.706 ' HB2' ' HB3' ' A' ' 124' ' ' ALA . 98.8 m-85 -97.26 106.05 18.31 Favored 'General case' 0 CA--C 1.477 -1.847 0 O-C-N 125.578 1.799 . . . . 0.0 113.39 -179.375 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.479 ' HB ' HG23 ' A' ' 103' ' ' ILE . 1.7 m -109.56 95.75 5.82 Favored 'General case' 0 N--CA 1.423 -1.797 0 O-C-N 125.775 1.922 . . . . 0.0 115.464 -179.766 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.551 ' HA ' ' CG ' ' A' ' 102' ' ' LEU . 60.9 t80 -52.1 -51.07 60.08 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 104.5 -2.407 . . . . 0.0 104.5 179.111 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -148.31 -64.9 0.25 Allowed 'General case' 0 C--N 1.3 -1.55 0 CA-C-N 112.596 -2.093 . . . . 0.0 111.575 179.735 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -144.07 27.95 2.0 Allowed Glycine 0 CA--C 1.543 1.824 0 C-N-CA 128.745 3.069 . . . . 0.0 112.091 179.559 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.885 HG11 ' HD3' ' A' ' 20' ' ' LYS . 21.1 m -133.23 80.08 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 105.067 -2.198 . . . . 0.0 105.067 -178.572 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.562 ' O ' ' HB2' ' A' ' 124' ' ' ALA 0.301 3.0 tt0 -58.03 -169.36 0.01 OUTLIER 'General case' 0 N--CA 1.426 -1.665 0 C-N-CA 127.534 2.334 . . . . 0.0 111.985 179.937 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.706 ' HB3' ' HB2' ' A' ' 117' ' ' TYR . . . 177.72 76.48 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 121.206 1.821 . . . . 0.0 109.022 179.193 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . 0.331 0.0 OUTLIER -70.08 142.34 52.65 Favored 'General case' 0 N--CA 1.446 -0.629 0 O-C-N 126.811 2.569 . . . . 0.0 107.092 179.587 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 10.8 mtm180 -144.31 78.51 1.58 Allowed 'General case' 0 C--O 1.218 -0.562 0 O-C-N 127.624 3.078 . . . . 0.0 104.894 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.705 HG23 HG12 ' A' ' 114' ' ' ILE . 2.4 mm -57.9 115.45 0.94 Allowed 'Isoleucine or valine' 0 C--O 1.247 0.948 0 O-C-N 128.215 3.447 . . . . 0.0 116.569 -179.776 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.692 ' CE2' HD22 ' A' ' 38' ' ' LEU . 22.8 m-85 -100.62 132.74 45.86 Favored 'General case' 0 N--CA 1.435 -1.223 0 C-N-CA 124.807 1.243 . . . . 0.0 108.144 179.492 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . 0.271 17.4 mtpt -95.69 6.16 49.63 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 117.229 -1.367 . . . . 0.0 110.737 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.558 ' HG3' ' CH2' ' A' ' 6' ' ' TRP . 0.0 OUTLIER 72.27 157.0 0.17 Allowed 'General case' 0 C--O 1.238 0.478 0 CA-C-N 119.411 1.005 . . . . 0.0 111.572 179.972 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.429 ' HA ' HG23 ' A' ' 5' ' ' THR 0.845 7.3 tt0 . . . . . 0 N--CA 1.44 -0.974 0 N-CA-C 118.675 2.843 . . . . 0.0 118.675 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.448 -0.561 0 CA-C-O 121.624 0.725 . . . . 0.0 112.188 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -138.18 96.57 3.22 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 115.669 1.729 . . . . 0.0 115.669 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 149.23 -141.93 9.37 Favored Glycine 0 C--O 1.214 -1.139 0 C-N-CA 116.971 -2.537 . . . . 0.0 109.147 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . 0.517 6.6 t -118.39 161.24 20.29 Favored 'General case' 0 CA--C 1.497 -1.08 0 O-C-N 127.023 2.249 . . . . 0.0 113.549 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.55 ' HB3' ' CD2' ' A' ' 128' ' ' PHE . 92.3 m95 -148.07 145.03 28.27 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 126.486 2.366 . . . . 0.0 107.133 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -132.85 102.95 5.84 Favored 'General case' 0 N--CA 1.439 -1.02 0 C-N-CA 123.655 0.782 . . . . 0.0 109.071 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.447 ' HA ' ' HA ' ' A' ' 128' ' ' PHE 0.368 11.4 p -57.17 115.72 0.91 Allowed 'Isoleucine or valine' 0 C--O 1.246 0.875 0 O-C-N 120.573 -1.33 . . . . 0.0 109.076 179.964 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -99.71 -29.12 12.83 Favored 'General case' 0 C--O 1.209 -1.041 0 O-C-N 126.591 2.432 . . . . 0.0 112.038 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 2.2 ptm180 -162.38 95.8 0.94 Allowed 'General case' 0 CA--C 1.478 -1.797 0 C-N-CA 113.789 -3.164 . . . . 0.0 112.997 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -64.69 177.36 0.94 Allowed 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 113.147 -1.842 . . . . 0.0 108.124 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -131.17 -79.29 0.53 Allowed 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 115.395 -2.24 . . . . 0.0 108.778 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -92.25 21.04 5.45 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 126.693 2.496 . . . . 0.0 115.013 179.679 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.766 ' HA ' ' HB1' ' A' ' 124' ' ' ALA 0.348 0.1 OUTLIER -65.35 -33.29 75.62 Favored 'General case' 0 C--N 1.309 -1.193 0 O-C-N 128.186 3.429 . . . . 0.0 114.5 -179.982 . . . . . . . . 4 4 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -67.68 -23.78 65.34 Favored 'General case' 0 C--O 1.21 -1.015 0 O-C-N 117.108 -3.495 . . . . 0.0 110.694 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -79.94 -44.94 19.43 Favored 'General case' 0 C--O 1.247 0.973 0 CA-C-N 112.485 -2.143 . . . . 0.0 113.022 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.5 ' HB3' ' HB2' ' A' ' 124' ' ' ALA . 0.4 OUTLIER -60.56 -26.47 66.94 Favored 'General case' 0 N--CA 1.435 -1.218 0 CA-C-O 125.664 2.649 . . . . 0.0 112.264 179.988 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.436 ' HB3' ' HB ' ' A' ' 23' ' ' ILE . 7.6 mtt -73.68 -29.6 62.39 Favored 'General case' 0 N--CA 1.443 -0.802 0 O-C-N 116.301 -3.999 . . . . 0.0 106.629 179.36 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -70.0 -44.2 69.86 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-O 124.014 1.864 . . . . 0.0 112.213 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.804 ' HB2' HG21 ' A' ' 122' ' ' VAL . 16.2 tptt -61.06 -30.63 70.45 Favored 'General case' 0 C--O 1.209 -1.045 0 O-C-N 120.124 -1.61 . . . . 0.0 114.226 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.481 ' HG3' ' CE1' ' A' ' 17' ' ' PHE . 0.4 OUTLIER -79.45 -20.83 46.49 Favored 'General case' 0 N--CA 1.436 -1.154 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 -179.926 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 115.53 20.5 5.42 Favored Glycine 0 C--O 1.224 -0.502 0 N-CA-C 110.192 -1.163 . . . . 0.0 110.192 179.579 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.497 HG23 ' HB2' ' A' ' 27' ' ' LYS . 0.5 OUTLIER -104.79 101.88 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.291 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 -179.373 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 8.7 p-10 -130.94 24.75 4.97 Favored 'General case' 0 C--O 1.24 0.582 0 N-CA-C 114.666 1.358 . . . . 0.0 114.666 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . 0.546 17.4 m -136.17 -123.62 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.504 -0.822 0 N-CA-C 117.629 2.455 . . . . 0.0 117.629 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.65 0.0 OUTLIER -76.78 -22.67 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 N-CA-C 117.637 2.458 . . . . 0.0 117.637 179.816 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.497 ' HB2' HG23 ' A' ' 23' ' ' ILE . 0.7 OUTLIER -73.64 -25.91 60.52 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 114.463 -1.244 . . . . 0.0 113.985 179.957 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.66 -27.99 40.81 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 121.124 1.784 . . . . 0.0 107.301 -179.725 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -67.93 -41.29 82.82 Favored 'General case' 0 CA--C 1.508 -0.654 0 CA-C-O 123.249 1.5 . . . . 0.0 111.889 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 16.3 mt -73.7 -34.52 64.89 Favored 'General case' 0 N--CA 1.438 -1.034 0 O-C-N 120.5 -1.375 . . . . 0.0 107.439 179.652 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -76.51 -29.68 57.64 Favored Glycine 0 C--N 1.338 0.647 0 O-C-N 128.574 3.671 . . . . 0.0 114.995 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -71.91 -33.96 68.73 Favored 'General case' 0 C--O 1.243 0.732 0 O-C-N 119.425 -2.221 . . . . 0.0 110.24 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 7.2 t-80 -85.25 0.34 52.2 Favored 'General case' 0 N--CA 1.441 -0.916 0 O-C-N 127.384 2.927 . . . . 0.0 110.652 179.74 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.28 101.09 2.26 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-O 114.83 -2.51 . . . . 0.0 111.803 179.67 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 44.3 t30 -74.09 60.61 0.79 Allowed 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 121.447 1.931 . . . . 0.0 110.9 -179.373 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.536 HD21 ' HZ ' ' A' ' 128' ' ' PHE . 0.2 OUTLIER -41.89 119.06 1.22 Allowed 'General case' 0 CA--C 1.496 -1.101 0 CA-C-O 125.492 2.568 . . . . 0.0 111.178 -179.627 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.489 ' N ' HD12 ' A' ' 36' ' ' LEU . 44.9 tttm -107.78 111.24 23.3 Favored 'General case' 0 CA--C 1.516 -0.352 0 N-CA-C 102.076 -3.305 . . . . 0.0 102.076 179.793 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.522 ' CD2' HG22 ' A' ' 49' ' ' VAL . 0.1 OUTLIER -93.05 145.63 24.24 Favored 'General case' 0 C--N 1.31 -1.132 0 C-N-CA 114.941 -2.704 . . . . 0.0 105.149 -179.902 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.8 m -134.1 85.29 2.18 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 103.432 -2.803 . . . . 0.0 103.432 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.495 HG12 HG23 ' A' ' 49' ' ' VAL . 42.7 mt -79.86 117.76 26.23 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.122 0 O-C-N 124.731 1.27 . . . . 0.0 110.287 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.482 HG22 ' O ' ' A' ' 41' ' ' THR . 0.9 OUTLIER -112.25 110.15 20.22 Favored 'General case' 0 CA--C 1.511 -0.529 1 O-C-N 129.868 4.48 . . . . 0.0 112.614 -179.86 . . . . . . . . 4 4 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -85.68 95.8 9.49 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -110.23 86.19 2.26 Favored 'General case' 0 N--CA 1.426 -1.638 0 N-CA-C 104.698 -2.334 . . . . 0.0 104.698 179.787 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 75.18 -89.9 0.8 Allowed Glycine 0 C--N 1.305 -1.185 0 N-CA-C 106.764 -2.535 . . . . 0.0 106.764 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -129.06 -42.31 1.38 Allowed 'General case' 0 N--CA 1.443 -0.783 0 O-C-N 127.723 2.661 . . . . 0.0 111.394 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.402 ' HA ' ' HA ' ' A' ' 63' ' ' GLU . 0.1 OUTLIER -58.42 129.23 41.05 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-O 123.49 1.614 . . . . 0.0 108.87 179.837 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.57 ' CE1' HD21 ' A' ' 64' ' ' LEU 0.289 1.7 m-85 -108.5 99.41 8.8 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 -179.804 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.719 ' HA ' HG13 ' A' ' 61' ' ' VAL 0.388 28.3 p -70.76 85.44 0.66 Allowed 'General case' 0 N--CA 1.432 -1.361 0 C-N-CA 117.646 -1.622 . . . . 0.0 110.034 -179.954 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.769 HG13 ' HB ' ' A' ' 60' ' ' VAL 0.657 10.0 p -67.2 87.24 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.494 -1.179 0 O-C-N 126.051 2.094 . . . . 0.0 109.717 -179.864 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 9.8 ttpp -73.28 119.92 18.19 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 105.281 -2.118 . . . . 0.0 105.281 -179.402 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.401 ' O ' ' N ' ' A' ' 53' ' ' SER 0.335 71.9 tt0 -108.12 65.97 0.64 Allowed 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 103.783 -2.673 . . . . 0.0 103.783 -179.983 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.3 m -68.62 72.37 0.22 Allowed 'General case' 0 N--CA 1.418 -2.073 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 179.653 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.401 ' N ' ' O ' ' A' ' 51' ' ' GLU . 60.2 p -102.82 -177.43 3.38 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-O 116.51 -1.709 . . . . 0.0 111.698 -179.782 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -62.28 -30.12 70.91 Favored 'General case' 0 C--O 1.218 -0.599 0 CA-C-N 119.53 1.059 . . . . 0.0 108.178 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -67.38 -68.19 0.4 Allowed 'General case' 0 C--O 1.21 -0.99 0 CA-C-O 115.73 -2.081 . . . . 0.0 109.068 179.739 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.818 ' HB2' HG22 ' A' ' 58' ' ' ILE 0.272 13.5 mmt180 -136.36 -175.46 4.01 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 122.231 2.287 . . . . 0.0 111.198 -179.92 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -134.1 55.32 1.9 Allowed 'General case' 0 C--O 1.218 -0.567 2 N-CA-C 100.143 -4.021 . . . . 0.0 100.143 179.551 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.818 HG22 ' HB2' ' A' ' 56' ' ' ARG . 3.4 tt -99.31 106.11 18.46 Favored 'Isoleucine or valine' 0 C--N 1.346 0.419 1 C-N-CA 132.294 4.238 . . . . 0.0 117.398 -179.332 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -62.82 136.41 57.84 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 105.327 -2.101 . . . . 0.0 105.327 179.549 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.769 ' HB ' HG13 ' A' ' 49' ' ' VAL . 2.5 t -116.97 41.65 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 -179.59 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.719 HG13 ' HA ' ' A' ' 48' ' ' THR 0.354 0.1 OUTLIER -36.46 144.9 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 CA-C-O 125.707 2.67 . . . . 0.0 114.48 -179.941 . . . . . . . . 4 4 . 1 . 018 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.457 ' HB3' ' CE1' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -156.0 100.93 2.07 Favored 'General case' 0 N--CA 1.423 -1.796 0 O-C-N 119.732 -1.855 . . . . 0.0 109.608 178.435 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.419 ' O ' ' C ' ' A' ' 64' ' ' LEU . 0.0 OUTLIER -68.55 93.28 0.49 Allowed 'General case' 0 CA--C 1.533 0.309 1 N-CA-C 99.942 -4.096 . . . . 0.0 99.942 178.054 . . . . . . . . 4 4 . 1 . 018 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.655 ' CB ' ' CE2' ' A' ' 82' ' ' TRP . 0.0 OUTLIER -14.59 88.68 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.181 0 O-C-N 128.027 3.329 . . . . 0.0 110.523 -178.196 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.567 ' N ' ' CD1' ' A' ' 82' ' ' TRP . . . 90.67 44.13 4.64 Favored Glycine 0 C--N 1.353 1.478 0 CA-C-N 109.985 -3.279 . . . . 0.0 118.918 179.42 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . 0.484 0.6 OUTLIER -105.3 -8.8 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.236 0 CA-C-N 111.968 -2.116 . . . . 0.0 107.547 -179.846 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.574 ' HA ' HG22 ' A' ' 81' ' ' THR . 1.8 m-20 69.63 143.81 0.05 OUTLIER 'General case' 0 CA--C 1.491 -1.297 0 CA-C-O 122.154 0.978 . . . . 0.0 109.858 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.574 ' CZ ' ' HA ' ' A' ' 81' ' ' THR . 1.0 OUTLIER -163.81 119.29 1.61 Allowed 'General case' 0 N--CA 1.438 -1.045 0 C-N-CA 117.363 -1.735 . . . . 0.0 111.066 179.989 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -77.46 102.67 6.98 Favored 'General case' 0 C--O 1.245 0.841 0 N-CA-C 103.74 -2.689 . . . . 0.0 103.74 179.171 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.515 ' HD2' HD22 ' A' ' 78' ' ' LEU . 31.1 t80 -107.2 87.8 2.59 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-O 116.139 -1.886 . . . . 0.0 113.821 -178.275 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 36.7 p -55.51 128.33 33.95 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 104.998 -2.223 . . . . 0.0 104.998 179.6 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.976 HD21 HD13 ' A' ' 78' ' ' LEU . 26.0 mt -71.57 -160.37 0.05 Allowed 'General case' 0 CA--C 1.495 -1.148 0 N-CA-C 106.133 -1.802 . . . . 0.0 106.133 -179.86 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -88.14 -30.4 19.85 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-O 124.97 2.319 . . . . 0.0 112.476 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.401 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 1.2 m-20 -124.77 -55.33 1.62 Allowed 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 113.045 -1.889 . . . . 0.0 111.211 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.0 -32.87 81.82 Favored Glycine 0 C--O 1.204 -1.755 0 CA-C-O 118.315 -1.269 . . . . 0.0 113.923 179.655 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.545 HG22 ' H ' ' A' ' 77' ' ' GLU 0.256 0.0 OUTLIER 70.24 169.89 0.31 Allowed 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 123.268 3.534 . . . . 0.0 114.738 179.821 . . . . . . . . 4 4 . 1 . 018 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.545 ' H ' HG22 ' A' ' 76' ' ' THR . 5.0 mt-10 7.8 103.68 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.835 1 O-C-N 131.532 5.52 . . . . 0.0 113.704 -179.682 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.976 HD13 HD21 ' A' ' 72' ' ' LEU 0.414 0.4 OUTLIER -140.29 101.19 4.07 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 102.233 -3.247 . . . . 0.0 102.233 179.933 . . . . . . . . 4 4 . 1 . 018 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 48.6 m -108.05 135.07 50.02 Favored 'General case' 0 C--O 1.202 -1.438 0 O-C-N 126.459 2.35 . . . . 0.0 106.059 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 173.62 -144.34 7.62 Favored Glycine 0 C--N 1.3 -1.437 0 C-N-CA 117.209 -2.424 . . . . 0.0 109.821 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.574 HG22 ' HA ' ' A' ' 67' ' ' ASP . 44.0 p -166.28 168.77 14.84 Favored 'General case' 0 C--O 1.19 -2.049 0 CA-C-O 123.48 1.609 . . . . 0.0 109.902 -179.637 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' TRP . . . . . 0.705 ' CG ' ' N ' ' A' ' 83' ' ' THR 0.406 1.9 p-90 -76.31 -169.64 1.24 Allowed 'General case' 0 C--N 1.316 -0.886 1 N-CA-C 99.807 -4.145 . . . . 0.0 99.807 175.419 . . . . . . . . 4 3 . 1 . 018 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.94 HG23 HG23 ' A' ' 90' ' ' VAL 0.292 0.5 OUTLIER 177.19 128.26 0.04 OUTLIER 'General case' 0 N--CA 1.437 -1.122 0 CA-C-O 124.676 2.179 . . . . 0.0 112.897 174.94 . . . . . . . . 4 4 . 1 . 018 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.563 ' CB ' ' CH2' ' A' ' 82' ' ' TRP . 3.0 ttt -96.96 102.27 14.01 Favored 'General case' 0 N--CA 1.426 -1.633 0 N-CA-C 106.056 -1.831 . . . . 0.0 106.056 179.09 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.434 ' CG ' ' CG2' ' A' ' 90' ' ' VAL 0.67 0.0 OUTLIER -79.67 62.66 4.01 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 120.462 1.483 . . . . 0.0 108.655 179.691 . . . . . . . . 4 4 . 1 . 018 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 76.94 -64.3 3.08 Favored Glycine 0 C--O 1.219 -0.785 0 N-CA-C 107.261 -2.336 . . . . 0.0 107.261 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 28.9 p-10 -129.78 -16.29 3.77 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 120.866 2.333 . . . . 0.0 116.681 -179.814 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . 0.365 0.3 OUTLIER -113.89 111.35 21.56 Favored 'General case' 0 CA--C 1.496 -1.13 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 179.924 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.598 HD22 ' HE ' ' A' ' 106' ' ' ARG . 2.0 tt -66.24 153.8 41.55 Favored 'General case' 0 C--N 1.32 -0.715 0 O-C-N 125.186 1.554 . . . . 0.0 107.277 179.856 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.94 HG23 HG23 ' A' ' 83' ' ' THR . 0.0 OUTLIER -144.19 179.97 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.021 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 179.986 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -140.53 99.17 0.24 Allowed Glycine 0 C--N 1.352 1.445 0 C-N-CA 129.034 3.206 . . . . 0.0 107.637 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.417 ' O ' ' CD1' ' A' ' 93' ' ' PHE . 5.9 mtpm? -98.25 138.11 36.0 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 102.365 -3.198 . . . . 0.0 102.365 -179.532 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.556 ' HB3' ' HG ' ' A' ' 78' ' ' LEU . 62.8 m-85 -150.06 127.77 11.67 Favored 'General case' 0 CA--C 1.5 -0.955 0 O-C-N 126.262 2.227 . . . . 0.0 113.702 -179.811 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 18.1 mttt -105.65 150.11 25.74 Favored 'General case' 0 N--CA 1.432 -1.374 0 CA-C-N 112.303 -2.226 . . . . 0.0 111.539 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.447 ' HG2' ' HB2' ' A' ' 98' ' ' ASN 0.401 1.0 OUTLIER -96.05 143.12 27.48 Favored 'General case' 0 N--CA 1.433 -1.322 0 CA-C-O 116.623 -1.656 . . . . 0.0 106.681 -179.713 . . . . . . . . 4 4 . 1 . 018 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.4 m -83.53 -29.05 7.65 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.213 0 O-C-N 124.48 1.112 . . . . 0.0 113.941 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . 0.356 6.2 p-10 -90.17 11.63 20.41 Favored 'General case' 0 C--O 1.251 1.169 0 CA-C-N 112.454 -2.157 . . . . 0.0 111.281 179.569 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.447 ' HB2' ' HG2' ' A' ' 95' ' ' ARG . 0.3 OUTLIER -138.57 -43.08 0.49 Allowed 'General case' 0 N--CA 1.439 -1.019 0 CA-C-N 112.562 -2.108 . . . . 0.0 116.604 -179.923 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 86.7 -10.7 66.55 Favored Glycine 0 CA--C 1.535 1.301 0 CA-C-O 124.379 2.099 . . . . 0.0 113.469 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 47.4 mttt -70.77 -167.12 0.17 Allowed 'General case' 0 C--O 1.203 -1.367 0 O-C-N 120.299 -1.707 . . . . 0.0 109.783 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -135.2 154.07 51.73 Favored 'General case' 0 N--CA 1.441 -0.919 0 C-N-CA 128.612 2.765 . . . . 0.0 111.267 -179.818 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.635 ' HG ' ' HA ' ' A' ' 119' ' ' TYR . 7.2 tt -132.73 137.29 46.83 Favored 'General case' 0 C--O 1.247 0.938 1 C-N-CA 133.816 4.846 . . . . 0.0 105.412 -179.609 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.732 HG23 ' HB3' ' A' ' 117' ' ' TYR . 11.1 tt -132.0 160.17 42.62 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.158 0 N-CA-C 105.428 -2.064 . . . . 0.0 105.428 179.26 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.464 ' O ' HG12 ' A' ' 90' ' ' VAL . . . -152.65 135.15 15.2 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-O 114.523 -2.656 . . . . 0.0 106.497 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.745 HG12 ' O ' ' A' ' 116' ' ' THR . 7.1 p -119.99 114.71 45.03 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.799 0 CA-C-N 122.172 2.26 . . . . 0.0 114.454 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.598 ' HE ' HD22 ' A' ' 89' ' ' LEU . 3.5 mtm180 -82.8 94.43 7.65 Favored 'General case' 0 C--O 1.223 -0.323 0 N-CA-C 103.788 -2.671 . . . . 0.0 103.788 178.918 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . 0.329 4.7 tt0 -72.0 -38.01 69.73 Favored 'General case' 0 C--O 1.21 -0.993 0 CA-C-N 110.934 -2.848 . . . . 0.0 116.129 -177.272 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.538 HD11 ' CZ2' ' A' ' 6' ' ' TRP 0.395 2.7 mm 60.05 75.96 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 C-N-CA 111.782 -3.967 . . . . 0.0 113.904 -179.686 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 6.8 t -65.54 -102.76 0.0 OUTLIER 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 120.46 1.482 . . . . 0.0 109.533 -179.538 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -133.85 89.32 0.25 Allowed Glycine 0 CA--C 1.521 0.416 1 C-N-CA 130.958 4.123 . . . . 0.0 110.685 179.572 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . 0.326 31.8 m-20 90.52 -25.43 0.06 Allowed 'General case' 0 C--N 1.309 -1.185 0 CA-C-O 114.54 -2.648 . . . . 0.0 110.071 -179.13 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -113.1 137.52 51.31 Favored 'General case' 0 CA--C 1.489 -1.381 1 O-C-N 129.332 4.145 . . . . 0.0 113.873 -179.362 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.53 ' HB2' ' CH2' ' A' ' 6' ' ' TRP . 8.6 tt -102.98 147.04 27.43 Favored 'General case' 0 C--O 1.21 -1.003 0 N-CA-C 100.781 -3.785 . . . . 0.0 100.781 -179.807 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.782 HG23 HD13 ' A' ' 127' ' ' ILE 0.265 13.4 mt -150.44 125.49 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 N-CA-C 103.625 -2.731 . . . . 0.0 103.625 179.961 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 115' ' ' GLN . . . . . 0.561 ' HB2' ' HD2' ' A' ' 126' ' ' ARG . 51.6 mt-30 -101.14 139.69 36.48 Favored 'General case' 0 N--CA 1.441 -0.915 0 N-CA-C 103.121 -2.918 . . . . 0.0 103.121 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.745 ' O ' HG12 ' A' ' 105' ' ' VAL . 0.2 OUTLIER -156.68 144.58 19.38 Favored 'General case' 0 N--CA 1.415 -2.186 0 CA-C-N 113.496 -1.683 . . . . 0.0 112.664 179.986 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.732 ' HB3' HG23 ' A' ' 103' ' ' ILE 0.382 21.4 m-30 145.88 -136.29 0.0 OUTLIER 'General case' 0 CA--C 1.481 -1.684 0 O-C-N 128.088 3.367 . . . . 0.0 113.152 176.277 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.505 HG23 ' H ' ' A' ' 120' ' ' GLU . 10.5 t -159.3 -157.97 0.63 Allowed 'General case' 0 C--N 1.311 -1.068 0 O-C-N 127.67 3.106 . . . . 0.0 116.567 -174.876 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.635 ' HA ' ' HG ' ' A' ' 102' ' ' LEU 0.302 6.8 t80 -120.6 -4.89 9.77 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 111.865 -2.425 . . . . 0.0 110.695 178.309 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.505 ' H ' HG23 ' A' ' 118' ' ' THR . 0.9 OUTLIER -176.98 -68.92 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.511 0 O-C-N 120.506 -1.371 . . . . 0.0 112.025 -179.629 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -151.75 17.49 0.85 Allowed Glycine 0 CA--C 1.541 1.695 0 N-CA-C 119.692 2.637 . . . . 0.0 119.692 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.804 HG21 ' HB2' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -122.22 94.31 2.87 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 N-CA-C 104.314 -2.476 . . . . 0.0 104.314 -179.698 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.477 ' HA ' ' HB ' ' A' ' 118' ' ' THR . 0.8 OUTLIER -59.15 177.92 0.15 Allowed 'General case' 0 C--O 1.216 -0.659 0 CA-C-O 122.118 0.961 . . . . 0.0 112.377 -178.233 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.766 ' HB1' ' HA ' ' A' ' 14' ' ' TYR . . . -172.65 91.81 0.11 Allowed 'General case' 0 N--CA 1.437 -1.12 0 O-C-N 118.505 -2.622 . . . . 0.0 109.664 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.543 ' HG3' ' HB ' ' A' ' 116' ' ' THR . 1.7 mptm? -69.62 164.38 23.47 Favored 'General case' 0 CA--C 1.508 -0.671 0 CA-C-N 121.54 1.973 . . . . 0.0 110.997 179.734 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.593 ' HG2' ' CD2' ' A' ' 14' ' ' TYR . 36.7 mtt180 -145.82 72.77 1.32 Allowed 'General case' 0 C--O 1.208 -1.1 0 CA-C-N 110.466 -3.061 . . . . 0.0 110.481 -179.675 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.782 HD13 HG23 ' A' ' 114' ' ' ILE . 17.5 mm -66.3 117.8 7.98 Favored 'Isoleucine or valine' 0 C--O 1.254 1.325 1 O-C-N 129.102 4.001 . . . . 0.0 112.346 -179.987 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.55 ' CD2' ' HB3' ' A' ' 6' ' ' TRP . 12.5 m-85 -103.91 167.77 9.56 Favored 'General case' 0 N--CA 1.442 -0.872 0 O-C-N 127.186 2.804 . . . . 0.0 107.552 179.175 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 2.4 mmmt -122.23 1.56 9.7 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 116.621 -1.657 . . . . 0.0 109.373 179.702 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.518 ' HD2' ' CH2' ' A' ' 6' ' ' TRP . 0.9 OUTLIER 68.81 97.14 0.06 Allowed 'General case' 0 C--O 1.238 0.487 0 CA-C-N 120.794 1.634 . . . . 0.0 113.218 -179.954 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . 0.823 21.5 tt0 . . . . . 0 N--CA 1.431 -1.419 0 CA-C-N 121.492 1.951 . . . . 0.0 115.084 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 . . . . . 0 N--CA 1.447 -0.604 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.407 ' N ' ' OD1' ' A' ' 3' ' ' ASP . 17.8 p-10 -55.98 85.97 0.01 OUTLIER 'General case' 0 CA--C 1.5 -0.974 0 N-CA-C 115.318 1.599 . . . . 0.0 115.318 -179.77 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -179.54 -151.5 9.88 Favored Glycine 0 N--CA 1.436 -1.33 0 C-N-CA 116.144 -2.932 . . . . 0.0 110.687 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.447 HG22 ' HA ' ' A' ' 39' ' ' THR 0.441 0.1 OUTLIER -124.74 150.83 45.82 Favored 'General case' 0 N--CA 1.427 -1.589 0 N-CA-C 116.312 1.967 . . . . 0.0 116.312 -179.855 . . . . . . . . 4 4 . 1 . 019 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.704 ' HA ' ' CE2' ' A' ' 128' ' ' PHE . 21.0 m95 -137.16 -166.77 1.98 Allowed 'General case' 0 CA--C 1.498 -1.029 0 CA-C-O 114.37 -2.728 . . . . 0.0 106.509 178.623 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.638 ' CB ' ' CZ ' ' A' ' 128' ' ' PHE . 6.7 ttpt 177.28 27.57 0.0 OUTLIER 'General case' 0 N--CA 1.432 -1.339 0 CA-C-O 112.804 -3.474 . . . . 0.0 112.498 -177.083 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.746 ' CG1' HD23 ' A' ' 36' ' ' LEU 0.404 1.7 m 15.24 108.95 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 CA-C-N 121.939 2.154 . . . . 0.0 116.745 -179.754 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -128.47 -69.36 0.72 Allowed 'General case' 0 CA--C 1.498 -1.022 0 O-C-N 120.48 -1.388 . . . . 0.0 113.118 -178.715 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.5 ptp180 -84.32 95.1 8.62 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 118.168 -1.413 . . . . 0.0 111.437 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -93.33 -172.82 3.05 Favored 'General case' 0 N--CA 1.441 -0.903 0 O-C-N 127.092 2.745 . . . . 0.0 108.937 -179.697 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -143.6 -67.07 0.35 Allowed 'General case' 0 C--N 1.306 -1.288 0 CA-C-O 115.994 -1.955 . . . . 0.0 108.622 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -95.58 15.4 19.95 Favored 'General case' 0 C--O 1.219 -0.545 0 O-C-N 127.502 3.001 . . . . 0.0 113.617 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.669 ' HA ' ' HB1' ' A' ' 124' ' ' ALA 0.381 0.1 OUTLIER -76.38 -26.22 55.4 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 117.876 2.547 . . . . 0.0 117.876 179.852 . . . . . . . . 4 4 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -74.83 -37.35 62.3 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-O 122.615 1.198 . . . . 0.0 111.894 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 4.7 ttmt -78.15 -24.52 47.29 Favored 'General case' 0 C--O 1.246 0.894 0 CA-C-O 126.046 2.831 . . . . 0.0 113.826 -179.679 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.581 ' CB ' ' HB2' ' A' ' 124' ' ' ALA . 10.1 t80 -66.63 -31.0 71.4 Favored 'General case' 0 N--CA 1.438 -1.041 0 CA-C-O 125.834 2.73 . . . . 0.0 113.374 -179.681 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.512 ' HB3' ' HB ' ' A' ' 23' ' ' ILE . 29.3 mtt -73.63 -24.69 60.05 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 125.851 2.738 . . . . 0.0 106.859 179.668 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -73.27 -22.23 60.43 Favored 'General case' 0 N--CA 1.474 0.765 0 O-C-N 119.003 -2.311 . . . . 0.0 109.396 179.705 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 6.0 tptp -75.25 -38.73 60.4 Favored 'General case' 0 C--N 1.313 -0.993 0 O-C-N 118.996 -2.315 . . . . 0.0 113.244 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 7.3 mtm -76.37 -38.17 56.17 Favored 'General case' 0 C--O 1.214 -0.796 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 125.96 43.47 0.28 Allowed Glycine 0 C--N 1.304 -1.205 0 CA-C-O 116.797 -2.113 . . . . 0.0 111.87 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.512 ' HB ' ' HB3' ' A' ' 18' ' ' MET . 0.2 OUTLIER -119.62 107.09 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 CA-C-O 115.758 -2.067 . . . . 0.0 107.212 -179.579 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -132.42 14.42 4.54 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 115.162 1.542 . . . . 0.0 115.162 -179.671 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . 0.412 33.2 m -119.66 -136.55 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.499 -0.99 0 O-C-N 126.992 2.683 . . . . 0.0 115.436 179.871 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.484 2.4 m -70.99 -24.09 24.2 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.934 0 CA-C-N 121.719 2.054 . . . . 0.0 114.027 179.823 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.41 ' HD2' ' CG ' ' A' ' 74' ' ' ASP . 13.2 mtmm -66.29 -34.68 78.54 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 115.002 1.482 . . . . 0.0 115.002 -179.819 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.405 ' N ' HG22 ' A' ' 23' ' ' ILE . 7.4 ptt180 -78.87 -24.23 44.4 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 123.561 1.648 . . . . 0.0 108.221 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.2 tttt -78.99 -32.03 45.05 Favored 'General case' 0 C--O 1.213 -0.84 0 CA-C-N 113.96 -1.473 . . . . 0.0 110.921 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.421 HD12 ' HA ' ' A' ' 30' ' ' LEU . 8.7 tp -77.64 -35.97 51.99 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 114.645 -1.161 . . . . 0.0 111.903 179.713 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.74 -25.52 73.76 Favored Glycine 0 C--O 1.213 -1.169 0 C-N-CA 123.933 0.778 . . . . 0.0 112.636 -179.771 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -76.94 -32.44 57.34 Favored 'General case' 0 C--N 1.315 -0.93 0 C-N-CA 125.89 1.676 . . . . 0.0 109.237 179.616 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 65.4 m80 -123.31 28.55 7.03 Favored 'General case' 0 C--O 1.236 0.373 0 O-C-N 126.979 2.674 . . . . 0.0 114.189 179.829 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -67.36 -19.42 65.43 Favored 'General case' 0 C--O 1.216 -0.683 0 N-CA-C 114.545 1.313 . . . . 0.0 114.545 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . 0.254 1.4 m-20 76.72 62.06 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 116.914 -1.914 . . . . 0.0 108.812 179.564 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.746 HD23 ' CG1' ' A' ' 8' ' ' VAL . 16.9 tp -80.02 73.04 6.83 Favored 'General case' 0 N--CA 1.469 0.525 0 O-C-N 126.752 2.533 . . . . 0.0 108.309 -179.617 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.447 ' HB3' ' HB2' ' A' ' 52' ' ' SER . 5.6 ttpp -68.9 112.08 5.35 Favored 'General case' 0 C--N 1.305 -1.349 1 N-CA-C 100.138 -4.023 . . . . 0.0 100.138 -179.508 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.547 ' CD1' ' HG ' ' A' ' 36' ' ' LEU 0.377 1.3 mp -104.8 103.13 12.68 Favored 'General case' 0 C--N 1.288 -2.079 0 N-CA-C 105.458 -2.053 . . . . 0.0 105.458 -178.316 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.504 ' HB ' ' CB ' ' A' ' 50' ' ' LYS . 1.9 m -94.85 86.39 4.68 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 117.276 -3.39 . . . . 0.0 103.902 179.793 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.585 HD13 HG23 ' A' ' 49' ' ' VAL . 12.0 mm -61.46 146.53 11.82 Favored 'Isoleucine or valine' 0 C--O 1.243 0.729 0 N-CA-C 105.973 -1.862 . . . . 0.0 105.973 -179.839 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.525 ' CG2' HG23 ' A' ' 48' ' ' THR . 4.6 t -150.34 35.0 0.64 Allowed 'General case' 0 CA--C 1.506 -0.731 0 O-C-N 126.956 2.66 . . . . 0.0 114.493 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -33.41 111.63 0.11 Allowed 'General case' 0 C--N 1.311 -1.106 0 O-C-N 126.981 2.676 . . . . 0.0 111.59 -179.831 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -81.08 -0.72 41.2 Favored 'General case' 0 N--CA 1.42 -1.947 0 CA-C-O 124.642 2.163 . . . . 0.0 111.935 -179.697 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 135.65 -55.66 0.72 Allowed Glycine 0 C--N 1.292 -1.87 0 N-CA-C 104.479 -3.448 . . . . 0.0 104.479 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.301 0.3 OUTLIER -127.4 -37.4 2.02 Favored 'General case' 0 C--N 1.316 -0.886 0 O-C-N 126.812 2.125 . . . . 0.0 112.587 -179.736 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 28.1 ttmt -91.12 139.2 30.98 Favored 'General case' 0 C--N 1.318 -0.792 0 O-C-N 117.906 -2.996 . . . . 0.0 107.601 -179.834 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . 0.251 21.0 m-85 -118.52 110.06 16.94 Favored 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 124.448 1.099 . . . . 0.0 110.956 -179.619 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.906 ' HB ' HG12 ' A' ' 61' ' ' VAL 0.401 0.1 OUTLIER -98.4 78.14 2.41 Favored 'General case' 0 N--CA 1.44 -0.965 0 O-C-N 125.078 1.486 . . . . 0.0 107.096 179.951 . . . . . . . . 4 4 . 1 . 019 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.725 HG13 ' HB ' ' A' ' 60' ' ' VAL 0.625 11.3 p -52.3 97.62 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 CA-C-N 109.497 -3.501 . . . . 0.0 113.073 179.737 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.504 ' CB ' ' HB ' ' A' ' 39' ' ' THR . 0.0 OUTLIER -62.23 139.27 58.5 Favored 'General case' 0 C--N 1.304 -1.384 1 N-CA-C 100.102 -4.036 . . . . 0.0 100.102 -179.633 . . . . . . . . 4 4 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.539 ' HB3' HG23 ' A' ' 58' ' ' ILE 0.253 3.4 tt0 -138.67 91.11 2.51 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 -179.229 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.447 ' HB2' ' HB3' ' A' ' 37' ' ' LYS . 1.0 OUTLIER -93.3 55.15 2.22 Favored 'General case' 0 C--N 1.286 -2.164 0 N-CA-C 105.634 -1.987 . . . . 0.0 105.634 -179.916 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 89.5 p -69.39 158.9 34.21 Favored 'General case' 0 C--N 1.349 0.561 0 CA-C-O 114.912 -2.47 . . . . 0.0 109.21 -179.587 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -52.74 -29.31 26.32 Favored 'General case' 0 C--O 1.212 -0.904 0 O-C-N 125.846 1.966 . . . . 0.0 106.946 179.786 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.523 ' CE2' ' HB1' ' A' ' 73' ' ' ALA . 11.1 m-85 -73.27 -55.76 5.99 Favored 'General case' 0 C--N 1.35 0.627 0 CA-C-O 114.707 -2.568 . . . . 0.0 111.211 179.341 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.852 ' HB3' HG22 ' A' ' 58' ' ' ILE 0.313 0.0 OUTLIER -142.83 174.79 10.34 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 124.42 3.282 . . . . 0.0 111.287 -179.88 . . . . . . . . 4 4 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -121.97 71.73 1.0 Allowed 'General case' 0 C--O 1.221 -0.409 1 N-CA-C 99.873 -4.121 . . . . 0.0 99.873 179.382 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.852 HG22 ' HB3' ' A' ' 56' ' ' ARG . 1.9 tt -105.67 103.18 14.97 Favored 'Isoleucine or valine' 0 C--O 1.243 0.724 0 O-C-N 127.635 3.085 . . . . 0.0 118.997 -179.189 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -65.91 125.0 24.02 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 103.623 -2.732 . . . . 0.0 103.623 178.409 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.725 ' HB ' HG13 ' A' ' 49' ' ' VAL . 24.5 t -100.76 97.14 5.38 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 -178.177 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.906 HG12 ' HB ' ' A' ' 48' ' ' THR 0.427 0.6 OUTLIER -79.66 135.25 25.95 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 CA-C-N 121.543 1.974 . . . . 0.0 108.986 179.748 . . . . . . . . 4 4 . 1 . 019 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.517 ' CE1' HG12 ' A' ' 49' ' ' VAL . 12.4 p90 -160.45 90.59 0.88 Allowed 'General case' 0 N--CA 1.432 -1.339 0 CA-C-O 123.832 1.777 . . . . 0.0 109.978 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -59.33 149.36 29.18 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 104.805 -2.294 . . . . 0.0 104.805 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.0 mt -66.16 110.9 3.17 Favored 'General case' 0 N--CA 1.427 -1.61 0 C-N-CA 117.982 -1.487 . . . . 0.0 108.58 -179.617 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.415 ' HA2' ' HB ' ' A' ' 81' ' ' THR . . . 72.78 46.45 30.16 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 128.199 2.809 . . . . 0.0 119.165 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . 0.442 3.8 t -111.92 7.92 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 CA-C-O 115.435 -2.222 . . . . 0.0 107.889 -179.818 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 46.71 101.7 0.0 OUTLIER 'General case' 0 CA--C 1.482 -1.661 0 CA-C-O 124.822 2.249 . . . . 0.0 115.525 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.5 ' CE1' ' HB2' ' A' ' 62' ' ' PHE . 8.8 p90 -117.67 157.62 26.13 Favored 'General case' 0 N--CA 1.435 -1.199 0 O-C-N 118.899 -2.376 . . . . 0.0 107.213 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -107.43 142.83 36.66 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 179.779 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -147.77 107.99 4.07 Favored 'General case' 0 C--O 1.205 -1.279 0 C-N-CA 118.196 -1.402 . . . . 0.0 114.265 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -75.15 138.38 41.98 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 122.954 2.616 . . . . 0.0 105.323 179.813 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.698 HD12 ' O ' ' A' ' 76' ' ' THR . 0.7 OUTLIER -82.52 -170.07 2.77 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 104.413 -2.44 . . . . 0.0 104.413 179.815 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.523 ' HB1' ' CE2' ' A' ' 55' ' ' PHE . . . -82.2 -45.62 14.84 Favored 'General case' 0 CA--C 1.547 0.842 0 CA-C-O 123.7 1.714 . . . . 0.0 111.254 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.41 ' CG ' ' HD2' ' A' ' 27' ' ' LYS . 12.2 t70 -139.92 26.62 2.25 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 112.952 -1.931 . . . . 0.0 110.858 179.716 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -120.36 -9.29 7.97 Favored Glycine 0 CA--C 1.548 2.152 0 O-C-N 127.105 2.753 . . . . 0.0 112.514 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.698 ' O ' HD12 ' A' ' 72' ' ' LEU 0.259 0.1 OUTLIER 75.13 -178.36 0.16 Allowed 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 117.393 -1.723 . . . . 0.0 114.706 -179.775 . . . . . . . . 4 4 . 1 . 019 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.441 ' CB ' ' HB ' ' A' ' 96' ' ' VAL . 13.8 mt-10 -40.65 141.09 0.6 Allowed 'General case' 0 N--CA 1.442 -0.848 0 CA-C-O 125.785 2.707 . . . . 0.0 112.293 179.825 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.691 ' HG ' ' HB3' ' A' ' 93' ' ' PHE 0.419 11.7 tp -166.09 120.38 1.16 Allowed 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 104.271 -2.492 . . . . 0.0 104.271 179.877 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.5 t -143.32 121.44 12.17 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 105.636 -1.986 . . . . 0.0 105.636 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.5 ' HA3' ' HA ' ' A' ' 93' ' ' PHE . . . -156.51 -144.65 3.98 Favored Glycine 0 CA--C 1.538 1.5 0 CA-C-O 116.537 -2.257 . . . . 0.0 110.022 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.415 ' HB ' ' HA2' ' A' ' 65' ' ' GLY . 11.5 p -148.84 161.06 42.6 Favored 'General case' 0 CA--C 1.476 -1.872 0 O-C-N 126.68 2.047 . . . . 0.0 110.215 -179.737 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' TRP . . . . . 0.486 ' CG ' ' CE2' ' A' ' 62' ' ' PHE . 16.1 m95 -117.05 151.26 37.16 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 101.155 -3.646 . . . . 0.0 101.155 -179.735 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.529 HG22 HG22 ' A' ' 90' ' ' VAL . 9.9 t -153.68 144.97 23.01 Favored 'General case' 0 C--O 1.255 1.364 0 CA-C-O 122.992 1.377 . . . . 0.0 111.558 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.22 105.82 11.77 Favored 'General case' 0 N--CA 1.436 -1.141 0 C-N-CA 117.162 -1.815 . . . . 0.0 109.662 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.443 ' HG3' HG11 ' A' ' 90' ' ' VAL 0.574 12.4 mm-40 -76.47 178.31 6.7 Favored 'General case' 0 N--CA 1.428 -1.561 0 O-C-N 120.979 -1.075 . . . . 0.0 108.999 179.778 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -67.21 95.52 0.29 Allowed Glycine 0 C--N 1.346 1.095 0 N-CA-C 105.145 -3.182 . . . . 0.0 105.145 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 79.18 16.57 0.93 Allowed 'General case' 0 C--O 1.242 0.703 0 CA-C-O 115.487 -2.197 . . . . 0.0 115.886 179.837 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . 0.418 0.0 OUTLIER -156.29 177.93 10.89 Favored 'General case' 0 CA--C 1.492 -1.256 0 O-C-N 125.936 2.022 . . . . 0.0 107.587 -179.895 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.524 HD12 ' HD2' ' A' ' 106' ' ' ARG . 0.1 OUTLIER -120.53 147.79 44.69 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 103.508 -2.775 . . . . 0.0 103.508 -179.861 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.601 ' HB ' HG23 ' A' ' 105' ' ' VAL . 0.6 OUTLIER -140.85 164.31 21.1 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.867 0 N-CA-C 104.844 -2.28 . . . . 0.0 104.844 179.917 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.48 ' HA2' ' HA ' ' A' ' 82' ' ' TRP . . . -143.87 109.35 0.54 Allowed Glycine 0 C--N 1.34 0.789 0 O-C-N 128.306 3.504 . . . . 0.0 111.445 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.498 ' C ' ' CD1' ' A' ' 93' ' ' PHE . 23.0 mtmt -103.3 164.6 11.54 Favored 'General case' 0 N--CA 1.432 -1.33 0 N-CA-C 102.87 -3.011 . . . . 0.0 102.87 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.691 ' HB3' ' HG ' ' A' ' 78' ' ' LEU 0.282 95.9 m-85 -161.85 116.07 1.91 Allowed 'General case' 0 N--CA 1.441 -0.879 0 C-N-CA 119.698 -0.801 . . . . 0.0 109.662 -179.751 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 4.2 mttp -92.02 142.84 27.09 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . 0.273 2.4 ttt-85 -88.57 130.68 35.2 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 113.856 -1.52 . . . . 0.0 109.542 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.441 ' HB ' ' CB ' ' A' ' 77' ' ' GLU . 68.9 t -70.88 -33.51 52.45 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 O-C-N 121.278 -0.889 . . . . 0.0 112.949 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . 0.364 31.1 t70 -95.96 -8.5 33.61 Favored 'General case' 0 C--O 1.261 1.673 0 N-CA-C 114.043 1.127 . . . . 0.0 114.043 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -118.88 -28.54 5.54 Favored 'General case' 0 CA--C 1.498 -1.022 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 -179.632 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 76.13 11.5 84.81 Favored Glycine 0 CA--C 1.536 1.345 0 N-CA-C 117.455 1.742 . . . . 0.0 117.455 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 9.4 mttt -105.61 152.01 23.63 Favored 'General case' 0 C--O 1.208 -1.079 0 CA-C-O 121.95 0.881 . . . . 0.0 109.852 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -94.9 118.72 32.25 Favored 'General case' 0 N--CA 1.435 -1.199 0 C-N-CA 127.653 2.381 . . . . 0.0 114.473 -179.742 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.666 ' HG ' ' HA ' ' A' ' 119' ' ' TYR . 7.8 tt -97.28 118.56 34.01 Favored 'General case' 0 C--N 1.317 -0.816 0 O-C-N 128.798 3.811 . . . . 0.0 103.369 179.57 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.71 HG23 ' HB3' ' A' ' 117' ' ' TYR . 15.2 tt -110.48 161.12 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.41 0 C-N-CA 116.35 -2.14 . . . . 0.0 107.327 -179.569 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.481 ' HA ' ' HB2' ' A' ' 117' ' ' TYR . . . -150.93 151.14 31.73 Favored 'General case' 0 N--CA 1.437 -1.106 0 O-C-N 118.105 -2.872 . . . . 0.0 107.376 -179.424 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.601 HG23 ' HB ' ' A' ' 90' ' ' VAL . 1.3 t -149.33 117.81 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 121.577 1.989 . . . . 0.0 111.54 -179.756 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.524 ' HD2' HD12 ' A' ' 89' ' ' LEU 0.3 79.5 mtt180 -84.49 91.53 7.87 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 105.195 -2.15 . . . . 0.0 105.195 -179.922 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 61.0 tt0 -81.61 80.8 7.87 Favored 'General case' 0 N--CA 1.436 -1.147 0 CA-C-O 126.974 3.273 . . . . 0.0 114.525 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.567 ' CD1' ' CH2' ' A' ' 6' ' ' TRP 0.331 0.6 OUTLIER -61.61 99.45 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.735 0 C-N-CA 116.601 -2.04 . . . . 0.0 114.6 179.85 . . . . . . . . 4 4 . 1 . 019 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -98.64 90.03 4.58 Favored 'General case' 0 C--O 1.219 -0.514 0 N-CA-C 102.839 -3.023 . . . . 0.0 102.839 -179.81 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 56.94 -125.86 40.14 Favored Glycine 0 CA--C 1.524 0.608 0 O-C-N 127.858 3.224 . . . . 0.0 111.731 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . 0.385 1.2 m-20 -65.12 -21.33 66.78 Favored 'General case' 0 C--O 1.215 -0.715 0 CA-C-O 115.515 -2.183 . . . . 0.0 112.938 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -95.27 141.91 28.3 Favored 'General case' 0 N--CA 1.432 -1.328 0 O-C-N 128.064 3.353 . . . . 0.0 115.777 179.656 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.931 HD21 ' HG2' ' A' ' 115' ' ' GLN . 0.3 OUTLIER -103.39 149.5 24.72 Favored 'General case' 0 N--CA 1.475 0.799 1 N-CA-C 100.121 -4.029 . . . . 0.0 100.121 179.557 . . . . . . . . 4 4 . 1 . 019 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.682 HG23 HD13 ' A' ' 127' ' ' ILE 0.252 78.3 mt -147.01 100.65 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 N-CA-C 103.686 -2.709 . . . . 0.0 103.686 179.876 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 115' ' ' GLN . . . . . 0.931 ' HG2' HD21 ' A' ' 113' ' ' LEU . 0.6 OUTLIER -74.95 154.14 38.26 Favored 'General case' 0 CA--C 1.506 -0.732 1 O-C-N 129.318 4.136 . . . . 0.0 102.125 -179.823 . . . . . . . . 4 4 . 1 . 019 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.58 ' HB ' ' HG3' ' A' ' 125' ' ' LYS . 2.5 t 178.63 157.71 0.49 Allowed 'General case' 0 N--CA 1.415 -2.221 0 O-C-N 124.626 1.203 . . . . 0.0 109.945 -178.557 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.71 ' HB3' HG23 ' A' ' 103' ' ' ILE 0.384 5.0 m-30 127.13 -157.27 0.0 OUTLIER 'General case' 0 CA--C 1.479 -1.785 1 O-C-N 129.639 4.337 . . . . 0.0 113.215 177.682 . . . . . . . . 4 3 . 1 . 019 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.468 ' O ' ' N ' ' A' ' 103' ' ' ILE . 5.3 t -135.31 -162.77 1.3 Allowed 'General case' 0 C--N 1.312 -1.027 0 CA-C-O 127.304 3.43 . . . . 0.0 117.464 -174.905 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.666 ' HA ' ' HG ' ' A' ' 102' ' ' LEU 0.282 0.9 OUTLIER -113.7 -53.21 2.7 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 112.187 -2.279 . . . . 0.0 106.759 179.143 . . . . . . . . 4 4 . 1 . 019 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -124.68 -59.66 1.43 Allowed 'General case' 0 N--CA 1.426 -1.664 0 CA-C-N 113.479 -1.692 . . . . 0.0 113.266 179.675 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -161.78 15.78 0.15 Allowed Glycine 0 C--N 1.358 1.798 0 N-CA-C 120.747 3.059 . . . . 0.0 120.747 -179.61 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 75.6 t -128.61 102.9 8.77 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 N-CA-C 103.383 -2.821 . . . . 0.0 103.383 179.458 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.462 ' HA ' ' O ' ' A' ' 117' ' ' TYR . 0.0 OUTLIER -68.95 -173.84 0.53 Allowed 'General case' 0 C--O 1.215 -0.721 0 CA-C-O 124.107 1.908 . . . . 0.0 112.207 -178.181 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.669 ' HB1' ' HA ' ' A' ' 14' ' ' TYR . . . -166.44 95.29 0.54 Allowed 'General case' 0 N--CA 1.438 -1.026 0 CA-C-O 114.663 -2.589 . . . . 0.0 109.997 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.58 ' HG3' ' HB ' ' A' ' 116' ' ' THR 0.362 0.9 OUTLIER -77.38 143.06 38.96 Favored 'General case' 0 C--O 1.245 0.855 0 O-C-N 126.822 2.576 . . . . 0.0 111.956 179.518 . . . . . . . . 4 4 . 1 . 019 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.58 ' HD3' ' HB2' ' A' ' 115' ' ' GLN . 0.2 OUTLIER -129.92 84.15 2.19 Favored 'General case' 0 C--O 1.207 -1.163 0 C-N-CA 128.394 2.678 . . . . 0.0 104.591 177.323 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.682 HD13 HG23 ' A' ' 114' ' ' ILE . 14.1 mm -70.77 93.15 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.009 1 O-C-N 129.369 4.168 . . . . 0.0 108.07 179.837 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.704 ' CE2' ' HA ' ' A' ' 6' ' ' TRP 0.334 14.8 t80 -88.95 148.38 23.83 Favored 'General case' 0 N--CA 1.426 -1.664 0 CA-C-O 125.036 2.35 . . . . 0.0 113.507 -178.786 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.51 ' N ' ' CG ' ' A' ' 128' ' ' PHE 0.316 0.0 OUTLIER -99.67 25.13 7.45 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-N 110.851 -2.886 . . . . 0.0 114.11 -176.89 . . . . . . . . 4 4 . 1 . 019 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.588 ' HB2' ' CZ3' ' A' ' 6' ' ' TRP . 8.4 tttt 43.92 96.82 0.01 OUTLIER 'General case' 0 CA--C 1.507 -0.704 0 CA-C-N 122.526 2.421 . . . . 0.0 116.456 178.423 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.409 ' N ' ' O ' ' A' ' 5' ' ' THR 0.769 3.1 tt0 . . . . . 0 N--CA 1.447 -0.58 0 O-C-N 117.353 -3.342 . . . . 0.0 113.822 179.801 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 34.5 p90 . . . . . 0 N--CA 1.438 -1.042 0 N-CA-C 117.215 2.302 . . . . 0.0 117.215 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -63.15 98.86 0.15 Allowed 'General case' 0 CA--C 1.491 -1.29 0 CA-C-O 123.33 1.538 . . . . 0.0 112.683 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' GLY . . . . . 0.403 ' O ' ' N ' ' A' ' 40' ' ' ILE . . . 157.15 -159.77 29.94 Favored Glycine 0 CA--C 1.498 -0.99 0 C-N-CA 117.596 -2.24 . . . . 0.0 109.767 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.594 ' HA ' ' HA ' ' A' ' 39' ' ' THR 0.53 9.2 t -91.53 159.35 15.97 Favored 'General case' 0 N--CA 1.447 -0.612 0 O-C-N 126.342 1.848 . . . . 0.0 113.167 179.978 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 1.021 ' CZ2' HD11 ' A' ' 108' ' ' ILE . 90.1 m95 -148.23 145.75 28.38 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 110.715 -2.948 . . . . 0.0 105.103 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 44.7 tttt -143.34 93.75 2.53 Favored 'General case' 0 C--O 1.209 -1.049 0 O-C-N 126.308 2.255 . . . . 0.0 109.961 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.429 HG12 ' HB3' ' A' ' 36' ' ' LEU 0.26 4.1 p -46.57 125.69 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 O-C-N 126.585 2.428 . . . . 0.0 109.222 -179.876 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -119.34 -32.24 4.43 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-N 114.327 -1.306 . . . . 0.0 110.253 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.411 ' O ' ' HB ' ' A' ' 127' ' ' ILE . 0.0 OUTLIER -138.21 131.35 30.15 Favored 'General case' 0 CA--C 1.496 -1.105 0 CA-C-O 123.148 1.451 . . . . 0.0 108.205 -179.923 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . 0.287 38.3 m-80 -101.35 -178.53 3.76 Favored 'General case' 0 CA--C 1.504 -0.795 0 CA-C-N 113.214 -1.812 . . . . 0.0 108.496 179.709 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.505 ' CB ' ' HB2' ' A' ' 125' ' ' LYS . 0.3 OUTLIER -163.85 62.54 0.16 Allowed 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 121.106 1.775 . . . . 0.0 107.27 -179.913 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . 0.298 4.2 t30 115.5 18.7 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 128.097 2.559 . . . . 0.0 114.239 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.471 ' CE2' ' HG2' ' A' ' 126' ' ' ARG 0.327 0.1 OUTLIER -80.69 -24.0 39.16 Favored 'General case' 0 C--N 1.314 -0.957 0 O-C-N 127.481 2.988 . . . . 0.0 117.58 -179.984 . . . . . . . . 4 4 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -73.21 -47.04 46.77 Favored 'General case' 0 C--O 1.208 -1.1 0 O-C-N 118.306 -2.746 . . . . 0.0 108.938 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 29.5 tttm -78.3 -21.08 50.21 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 125.823 1.952 . . . . 0.0 114.722 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.524 ' CB ' ' HB2' ' A' ' 124' ' ' ALA . 2.9 t80 -73.53 -23.86 60.05 Favored 'General case' 0 N--CA 1.419 -1.986 0 C-N-CA 116.835 -1.946 . . . . 0.0 111.77 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.44 ' HB3' HG12 ' A' ' 23' ' ' ILE . 0.2 OUTLIER -73.25 -21.05 60.7 Favored 'General case' 0 C--N 1.307 -1.256 0 O-C-N 118.765 -2.459 . . . . 0.0 109.045 179.867 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 55.1 tt0 -64.17 -31.38 72.55 Favored 'General case' 0 C--N 1.347 0.48 0 CA-C-O 125.235 2.445 . . . . 0.0 112.401 179.564 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 32.6 tptt -74.26 -30.26 62.04 Favored 'General case' 0 C--O 1.215 -0.742 0 CA-C-N 112.922 -1.944 . . . . 0.0 110.375 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . 0.254 11.0 mtt -77.6 -40.17 43.01 Favored 'General case' 0 C--N 1.353 0.736 0 CA-C-O 124.107 1.908 . . . . 0.0 106.059 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 143.37 15.38 0.28 Allowed Glycine 0 N--CA 1.438 -1.232 0 CA-C-O 115.345 -2.92 . . . . 0.0 115.056 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.537 HD11 ' CB ' ' A' ' 74' ' ' ASP . 1.7 mp -75.49 134.09 29.97 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 CA-C-N 120.489 2.144 . . . . 0.0 105.844 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 67.8 m-80 -93.31 -45.74 7.69 Favored 'General case' 0 C--O 1.243 0.727 0 CA-C-O 114.2 -2.81 . . . . 0.0 116.521 -178.877 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . 0.402 1.2 t -160.2 -59.66 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.499 -0.987 0 N-CA-C 119.217 3.043 . . . . 0.0 119.217 -179.764 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.668 1.9 m -78.19 -26.22 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 12.3 mttm -75.16 -28.19 60.01 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-O 118.311 -0.852 . . . . 0.0 110.866 -179.799 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.813 HH11 ' HG3' ' A' ' 28' ' ' ARG . 4.9 ptt85 -79.95 -23.8 41.43 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 116.61 -2.036 . . . . 0.0 109.081 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.94 -43.9 64.48 Favored 'General case' 0 CA--C 1.507 -0.702 0 CA-C-O 122.512 1.149 . . . . 0.0 109.78 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.411 HD23 ' CZ ' ' A' ' 55' ' ' PHE . 9.2 tp -75.45 -31.7 60.39 Favored 'General case' 0 C--O 1.212 -0.894 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 -179.813 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -73.77 -34.08 56.87 Favored Glycine 0 C--N 1.348 1.238 0 O-C-N 128.299 3.5 . . . . 0.0 112.425 179.824 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -74.99 -40.64 60.57 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 125.741 1.616 . . . . 0.0 109.708 179.77 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 3.4 m80 -107.95 57.89 0.62 Allowed 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 113.46 -1.7 . . . . 0.0 110.908 179.782 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -85.37 -26.34 26.53 Favored 'General case' 0 C--O 1.212 -0.872 0 N-CA-C 117.522 2.415 . . . . 0.0 117.522 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.3 m120 78.74 24.61 0.56 Allowed 'General case' 0 CA--C 1.539 0.531 0 O-C-N 124.472 1.108 . . . . 0.0 109.206 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.429 ' HB3' HG12 ' A' ' 8' ' ' VAL . 1.9 tp -46.2 97.78 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.499 0 O-C-N 125.893 1.995 . . . . 0.0 109.449 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.485 ' HB3' ' CB ' ' A' ' 52' ' ' SER . 16.3 ttpt -98.03 96.12 7.93 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 101.754 -3.425 . . . . 0.0 101.754 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . 0.313 1.3 tp -86.27 147.16 26.21 Favored 'General case' 0 C--N 1.313 -0.991 0 C-N-CA 115.414 -2.515 . . . . 0.0 106.45 -179.68 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.594 ' HA ' ' HA ' ' A' ' 5' ' ' THR . 90.4 m -131.36 83.63 2.12 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 103.802 -2.666 . . . . 0.0 103.802 179.573 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.443 HG13 ' CD1' ' A' ' 6' ' ' TRP . 0.8 OUTLIER -63.15 108.73 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.01 0 O-C-N 124.51 1.131 . . . . 0.0 109.747 -179.914 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.9 m -117.58 84.78 2.22 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-O 122.475 1.131 . . . . 0.0 110.147 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -77.89 142.6 38.34 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 120.599 -1.313 . . . . 0.0 110.779 -179.771 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -139.82 -129.08 0.11 Allowed 'General case' 0 CA--C 1.492 -1.284 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -81.65 78.36 1.95 Allowed Glycine 0 C--N 1.294 -1.763 0 O-C-N 119.4 -2.063 . . . . 0.0 109.853 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.323 1.3 m-20 80.44 -10.56 1.25 Allowed 'General case' 0 C--N 1.315 -0.931 0 O-C-N 126.11 1.711 . . . . 0.0 113.014 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.441 ' HA ' ' HA ' ' A' ' 63' ' ' GLU . 0.0 OUTLIER -88.63 -178.07 5.72 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 117.374 -1.731 . . . . 0.0 107.491 179.943 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.619 ' CE1' HD21 ' A' ' 64' ' ' LEU . 2.1 m-85 -157.34 82.14 0.91 Allowed 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 106.061 -1.829 . . . . 0.0 106.061 -179.653 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.931 HG23 HG22 ' A' ' 61' ' ' VAL 0.484 6.4 m -67.17 136.61 55.32 Favored 'General case' 0 CA--C 1.5 -0.952 0 C-N-CA 114.747 -2.781 . . . . 0.0 106.449 -179.733 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.554 HG11 ' CH2' ' A' ' 82' ' ' TRP 0.595 0.9 OUTLIER -121.12 93.53 2.55 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 CA-C-N 112.632 -2.076 . . . . 0.0 114.047 -179.154 . . . . . . . . 4 4 . 1 . 020 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.534 ' CB ' ' HB ' ' A' ' 39' ' ' THR . 0.4 OUTLIER -67.74 150.44 48.68 Favored 'General case' 0 C--N 1.315 -0.891 1 N-CA-C 99.895 -4.113 . . . . 0.0 99.895 179.563 . . . . . . . . 4 4 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.402 ' O ' ' N ' ' A' ' 53' ' ' SER . 0.5 OUTLIER -141.26 73.95 1.44 Allowed 'General case' 0 C--O 1.216 -0.685 0 N-CA-C 103.252 -2.87 . . . . 0.0 103.252 -179.914 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.485 ' CB ' ' HB3' ' A' ' 37' ' ' LYS . 0.1 OUTLIER -76.05 77.81 2.91 Favored 'General case' 0 C--N 1.289 -2.043 0 O-C-N 119.571 -1.955 . . . . 0.0 105.764 -179.939 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.402 ' N ' ' O ' ' A' ' 51' ' ' GLU . 84.0 p -101.13 159.62 15.08 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-O 114.387 -2.72 . . . . 0.0 108.404 -179.825 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -53.9 -26.85 27.02 Favored 'General case' 0 CA--C 1.51 -0.559 0 O-C-N 125.259 1.599 . . . . 0.0 109.317 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.411 ' CZ ' HD23 ' A' ' 30' ' ' LEU . 61.0 m-85 -71.45 -57.04 4.8 Favored 'General case' 0 C--O 1.215 -0.725 0 CA-C-O 114.489 -2.672 . . . . 0.0 109.582 179.799 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.42 ' O ' HG22 ' A' ' 58' ' ' ILE 0.26 0.4 OUTLIER -169.81 152.57 4.55 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 123.226 2.739 . . . . 0.0 110.287 179.646 . . . . . . . . 4 4 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 5.6 p-10 -84.81 86.7 7.32 Favored 'General case' 0 C--O 1.217 -0.631 0 C-N-CA 131.308 3.843 . . . . 0.0 101.441 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.42 HG22 ' O ' ' A' ' 56' ' ' ARG . 2.7 tt -114.48 86.47 0.91 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.792 0 N-CA-C 119.604 3.186 . . . . 0.0 119.604 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -60.83 105.61 0.48 Allowed 'General case' 0 C--O 1.214 -0.778 0 N-CA-C 104.585 -2.376 . . . . 0.0 104.585 178.929 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.561 HG12 ' N ' ' A' ' 61' ' ' VAL . 1.0 OUTLIER -68.15 -55.27 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 C-N-CA 125.346 1.458 . . . . 0.0 113.893 -178.044 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.931 HG22 HG23 ' A' ' 48' ' ' THR 0.478 0.1 OUTLIER 60.69 135.6 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 CA-C-O 126.38 2.991 . . . . 0.0 112.094 -177.211 . . . . . . . . 4 4 . 1 . 020 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.63 ' CD1' ' CD1' ' A' ' 68' ' ' PHE . 9.8 t80 -163.8 109.13 1.05 Allowed 'General case' 0 N--CA 1.432 -1.361 0 CA-C-N 112.321 -2.218 . . . . 0.0 110.255 179.654 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.441 ' HA ' ' HA ' ' A' ' 46' ' ' LYS . 0.4 OUTLIER -58.04 129.35 41.54 Favored 'General case' 0 C--O 1.251 1.133 0 N-CA-C 102.722 -3.066 . . . . 0.0 102.722 179.037 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.619 HD21 ' CE1' ' A' ' 47' ' ' PHE . 0.4 OUTLIER -50.05 130.96 22.96 Favored 'General case' 0 C--O 1.247 0.971 0 CA-C-O 123.252 1.501 . . . . 0.0 111.999 -179.702 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.442 ' HA2' ' HB ' ' A' ' 81' ' ' THR . . . 60.72 14.74 37.93 Favored Glycine 0 C--N 1.341 0.824 0 CA-C-N 112.368 -2.196 . . . . 0.0 115.203 -179.827 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . 0.412 16.1 t -72.27 -88.29 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 154.82 117.49 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.175 0 C-N-CA 125.627 1.571 . . . . 0.0 115.224 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.63 ' CD1' ' CD1' ' A' ' 62' ' ' PHE . 0.4 OUTLIER -133.31 147.94 51.89 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-N 118.91 0.777 . . . . 0.0 110.047 -179.961 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -104.15 150.4 24.38 Favored 'General case' 0 C--O 1.243 0.714 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -151.72 107.28 3.34 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-O 116.289 -1.815 . . . . 0.0 113.904 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -78.9 127.62 32.25 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 122.279 2.309 . . . . 0.0 105.137 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.433 HD21 HD13 ' A' ' 78' ' ' LEU . 4.2 mm? -65.98 -177.67 0.52 Allowed 'General case' 0 C--N 1.3 -1.576 0 O-C-N 125.054 1.471 . . . . 0.0 107.363 -179.653 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -103.05 9.73 38.4 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-O 124.883 2.278 . . . . 0.0 110.909 179.663 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.537 ' CB ' HD11 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -97.17 -28.52 14.06 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 112.675 -2.057 . . . . 0.0 112.316 -179.813 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 133.79 8.96 2.07 Favored Glycine 0 CA--C 1.547 2.046 0 CA-C-O 117.651 -1.638 . . . . 0.0 111.596 -178.904 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.458 HG23 ' O ' ' A' ' 77' ' ' GLU 0.376 0.4 OUTLIER -131.44 169.65 15.76 Favored 'General case' 0 C--N 1.309 -1.154 0 C-N-CA 115.724 -2.39 . . . . 0.0 115.521 -179.757 . . . . . . . . 4 4 . 1 . 020 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.631 ' HG2' HG21 ' A' ' 96' ' ' VAL . 0.1 OUTLIER -90.26 168.1 12.17 Favored 'General case' 0 N--CA 1.443 -0.807 1 O-C-N 130.764 5.04 . . . . 0.0 113.842 179.752 . . . . . . . . 4 4 . 1 . 020 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.474 ' HG ' ' HB3' ' A' ' 93' ' ' PHE 0.399 10.0 tp -167.33 148.39 5.59 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-N 114.123 -1.399 . . . . 0.0 107.642 179.915 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 7.4 m -159.27 116.2 2.67 Favored 'General case' 0 C--O 1.203 -1.362 0 N-CA-C 105.394 -2.076 . . . . 0.0 105.394 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.449 ' HA3' ' HA ' ' A' ' 93' ' ' PHE . . . -156.62 -151.73 6.06 Favored Glycine 0 C--N 1.296 -1.642 0 C-N-CA 116.92 -2.562 . . . . 0.0 114.564 -179.801 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.442 ' HB ' ' HA2' ' A' ' 65' ' ' GLY . 1.3 p -152.39 168.3 25.9 Favored 'General case' 0 C--O 1.199 -1.599 0 C-N-CA 116.807 -1.957 . . . . 0.0 109.607 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' TRP . . . . . 0.622 ' CD1' ' CE2' ' A' ' 62' ' ' PHE 0.3 3.7 m0 -122.79 145.51 48.35 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 102.803 -3.036 . . . . 0.0 102.803 -179.81 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.918 HG22 HG22 ' A' ' 90' ' ' VAL . 10.3 t -143.28 124.64 14.68 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-O 124.924 2.297 . . . . 0.0 108.543 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.542 ' HA ' HD23 ' A' ' 89' ' ' LEU . 9.4 ttt -80.6 114.54 19.57 Favored 'General case' 0 N--CA 1.422 -1.872 0 CA-C-N 114.088 -1.415 . . . . 0.0 110.76 -179.727 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.468 ' HA ' ' OE1' ' A' ' 85' ' ' GLU 0.588 7.1 mm-40 -91.91 6.58 45.68 Favored 'General case' 0 N--CA 1.419 -2.002 0 CA-C-O 123.834 1.778 . . . . 0.0 112.746 179.864 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 91.3 -74.94 1.57 Allowed Glycine 0 C--N 1.345 1.05 0 N-CA-C 103.991 -3.643 . . . . 0.0 103.991 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 17.6 p30 -76.04 1.61 15.0 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 116.238 -1.839 . . . . 0.0 114.995 -179.856 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . 0.446 19.1 mttp -162.41 159.89 25.74 Favored 'General case' 0 C--O 1.218 -0.58 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.542 HD23 ' HA ' ' A' ' 84' ' ' MET . 0.1 OUTLIER -120.42 121.39 38.42 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 101.997 -3.334 . . . . 0.0 101.997 -179.95 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.918 HG22 HG22 ' A' ' 83' ' ' THR . 1.2 m -102.53 161.95 3.88 Favored 'Isoleucine or valine' 0 C--O 1.244 0.774 0 N-CA-C 105.644 -1.984 . . . . 0.0 105.644 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -142.9 94.75 0.18 Allowed Glycine 0 C--N 1.35 1.306 0 C-N-CA 130.627 3.965 . . . . 0.0 110.407 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.436 ' HA ' ' HA ' ' A' ' 103' ' ' ILE . 1.4 mtpm? -103.62 156.47 17.76 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 104.379 -2.452 . . . . 0.0 104.379 179.511 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.489 ' HD2' HD12 ' A' ' 102' ' ' LEU . 64.6 m-85 -151.73 128.95 11.19 Favored 'General case' 0 CA--C 1.5 -0.967 0 O-C-N 125.464 1.728 . . . . 0.0 111.11 -179.871 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 36.3 mtpt -107.91 129.17 55.11 Favored 'General case' 0 C--O 1.212 -0.87 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.454 -179.666 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . 0.342 0.5 OUTLIER -68.72 168.27 13.6 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 120.679 -1.263 . . . . 0.0 109.008 -179.911 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.631 HG21 ' HG2' ' A' ' 77' ' ' GLU . 24.4 t -100.45 -34.85 4.21 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 O-C-N 126.262 2.226 . . . . 0.0 108.508 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . 0.315 0.4 OUTLIER -65.94 -23.2 66.56 Favored 'General case' 0 CA--C 1.505 -0.756 0 N-CA-C 115.897 1.814 . . . . 0.0 115.897 -179.794 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -160.93 23.22 0.14 Allowed 'General case' 0 CA--C 1.491 -1.296 0 N-CA-C 117.748 2.499 . . . . 0.0 117.748 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 56.15 19.13 22.62 Favored Glycine 0 CA--C 1.536 1.354 0 N-CA-C 117.744 1.858 . . . . 0.0 117.744 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 15.4 mmtp -74.52 -172.21 1.43 Allowed 'General case' 0 C--O 1.198 -1.618 0 CA-C-N 119.812 1.806 . . . . 0.0 108.034 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -129.55 150.22 50.98 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 127.516 2.326 . . . . 0.0 113.389 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.588 ' HA ' ' HA ' ' A' ' 119' ' ' TYR . 0.0 OUTLIER -140.13 141.08 36.12 Favored 'General case' 0 C--O 1.246 0.878 0 O-C-N 128.345 3.528 . . . . 0.0 106.87 -179.516 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.639 HG23 ' CG ' ' A' ' 117' ' ' TYR . 11.3 tt -132.11 179.77 4.08 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.213 0 C-N-CA 117.342 -1.743 . . . . 0.0 109.777 179.568 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.524 ' HA ' ' HB2' ' A' ' 117' ' ' TYR . . . -163.59 113.45 1.3 Allowed 'General case' 0 N--CA 1.427 -1.579 0 CA-C-O 114.2 -2.81 . . . . 0.0 107.493 -176.898 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -100.71 103.09 14.34 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.682 0 CA-C-N 121.079 1.763 . . . . 0.0 113.511 -179.058 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.469 HH11 ' CG ' ' A' ' 106' ' ' ARG . 1.4 mtt-85 -77.08 93.85 3.94 Favored 'General case' 0 CA--C 1.504 -0.821 0 CA-C-O 123.423 1.583 . . . . 0.0 109.337 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -94.59 79.09 3.79 Favored 'General case' 0 N--CA 1.423 -1.824 0 CA-C-N 113.24 -1.8 . . . . 0.0 114.415 -179.799 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 1.021 HD11 ' CZ2' ' A' ' 6' ' ' TRP 0.322 1.4 tt -58.27 107.6 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.251 0 C-N-CA 117.26 -1.776 . . . . 0.0 114.681 179.951 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -92.74 79.84 4.74 Favored 'General case' 0 N--CA 1.436 -1.132 0 O-C-N 120.141 -1.6 . . . . 0.0 107.105 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 56.6 -58.52 0.01 OUTLIER Glycine 0 C--O 1.245 0.784 0 C-N-CA 128.907 3.146 . . . . 0.0 113.973 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . 0.302 18.8 m120 -127.47 -1.07 6.24 Favored 'General case' 0 C--O 1.213 -0.828 0 CA-C-O 117.434 -1.269 . . . . 0.0 112.366 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -123.59 121.93 36.86 Favored 'General case' 0 C--O 1.209 -1.066 0 CA-C-O 115.443 -2.217 . . . . 0.0 111.121 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.552 HD23 ' CD1' ' A' ' 128' ' ' PHE . 0.8 OUTLIER -88.47 137.39 32.37 Favored 'General case' 0 C--O 1.209 -1.048 0 N-CA-C 102.004 -3.332 . . . . 0.0 102.004 -179.655 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.847 HG22 HG22 ' A' ' 116' ' ' THR . 72.4 mt -138.67 109.4 4.89 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 O-C-N 126.305 2.253 . . . . 0.0 109.377 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' GLN . . . . . 0.549 ' O ' HG22 ' A' ' 116' ' ' THR . 19.9 mt-30 -79.32 147.29 32.51 Favored 'General case' 0 CA--C 1.498 -1.046 0 N-CA-C 102.211 -3.255 . . . . 0.0 102.211 179.727 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.847 HG22 HG22 ' A' ' 114' ' ' ILE . 0.1 OUTLIER -163.24 111.89 1.27 Allowed 'General case' 0 N--CA 1.427 -1.599 0 C-N-CA 117.263 -1.775 . . . . 0.0 109.71 -179.168 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.639 ' CG ' HG23 ' A' ' 103' ' ' ILE 0.273 0.1 OUTLIER 176.17 -162.57 0.03 OUTLIER 'General case' 0 CA--C 1.469 -2.159 0 C-N-CA 116.512 -2.075 . . . . 0.0 114.208 178.122 . . . . . . . . 4 4 . 1 . 020 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.496 ' O ' HD22 ' A' ' 102' ' ' LEU . 8.0 t -128.46 -164.86 1.43 Allowed 'General case' 0 N--CA 1.425 -1.683 0 CA-C-O 127.407 3.479 . . . . 0.0 117.51 -174.923 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.588 ' HA ' ' HA ' ' A' ' 102' ' ' LEU 0.298 68.9 t80 -128.97 5.95 5.43 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 112.305 -2.225 . . . . 0.0 108.1 178.075 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.451 ' H ' HG23 ' A' ' 118' ' ' THR . 1.9 tt0 168.64 -60.65 0.01 OUTLIER 'General case' 0 C--N 1.289 -2.035 0 C-N-CA 125.68 1.592 . . . . 0.0 112.472 -178.185 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -157.34 22.52 0.43 Allowed Glycine 0 C--N 1.366 2.225 0 N-CA-C 121.434 3.334 . . . . 0.0 121.434 -179.636 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 75.7 t -135.42 118.71 23.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 O-C-N 117.857 -3.143 . . . . 0.0 105.123 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 37.5 mp0 -85.72 175.74 8.54 Favored 'General case' 0 C--O 1.21 -1.005 0 CA-C-O 123.882 1.801 . . . . 0.0 112.868 -179.457 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.524 ' HB2' ' CB ' ' A' ' 17' ' ' PHE . . . -165.53 115.05 1.03 Allowed 'General case' 0 N--CA 1.435 -1.19 0 CA-C-O 113.905 -2.95 . . . . 0.0 108.211 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.551 ' CD ' ' HB ' ' A' ' 116' ' ' THR . 0.1 OUTLIER -90.74 140.33 29.88 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 127.764 3.165 . . . . 0.0 109.535 179.942 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.471 ' HG2' ' CE2' ' A' ' 14' ' ' TYR . 0.1 OUTLIER -127.68 82.43 2.09 Favored 'General case' 0 N--CA 1.428 -1.543 0 CA-C-O 114.242 -2.79 . . . . 0.0 111.123 179.958 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.507 HD13 HG23 ' A' ' 114' ' ' ILE . 5.1 mm -74.46 102.22 2.07 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.832 1 O-C-N 130.894 5.121 . . . . 0.0 115.572 179.863 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.552 ' CD1' HD23 ' A' ' 113' ' ' LEU . 22.0 m-85 -94.27 128.94 41.05 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 128.887 2.875 . . . . 0.0 107.868 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . 0.308 10.4 mttt -93.19 3.14 56.18 Favored 'General case' 0 CA--C 1.507 -0.693 0 CA-C-O 116.768 -1.586 . . . . 0.0 112.083 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.576 ' HB2' ' CZ3' ' A' ' 6' ' ' TRP . 0.1 OUTLIER 69.79 99.9 0.06 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 122.146 2.248 . . . . 0.0 114.127 179.972 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . 0.833 9.4 tt0 . . . . . 0 CA--C 1.499 -0.987 0 C-N-CA 115.592 -2.443 . . . . 0.0 115.666 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.51 -0.593 0 CA-C-O 119.598 -0.239 . . . . 0.0 110.644 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.61 ' CE2' HD13 ' A' ' 89' ' ' LEU . 2.2 m-30 73.42 -51.44 0.7 Allowed 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 117.866 2.543 . . . . 0.0 117.866 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -36.74 91.18 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 124.489 2.09 . . . . 0.0 115.749 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 164.13 -176.35 40.12 Favored Glycine 0 C--O 1.209 -1.433 0 C-N-CA 117.668 -2.206 . . . . 0.0 111.147 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.77 HG22 HG23 ' A' ' 39' ' ' THR 0.56 0.1 OUTLIER -91.35 155.33 18.58 Favored 'General case' 0 N--CA 1.443 -0.802 0 O-C-N 127.146 2.321 . . . . 0.0 110.63 -179.787 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.838 ' CH2' HD11 ' A' ' 108' ' ' ILE . 69.7 m95 -141.67 149.78 41.04 Favored 'General case' 0 N--CA 1.436 -1.147 0 O-C-N 127.874 3.234 . . . . 0.0 106.405 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 10.0 tmtt? -152.46 93.31 1.78 Allowed 'General case' 0 CA--C 1.5 -0.977 0 O-C-N 126.913 2.633 . . . . 0.0 107.14 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.564 ' HB ' ' CD1' ' A' ' 128' ' ' PHE 0.305 0.4 OUTLIER -42.56 137.0 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.0 0 CA-C-O 117.124 -1.417 . . . . 0.0 113.115 -179.998 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -118.27 -60.68 1.76 Allowed 'General case' 0 C--O 1.214 -0.807 0 O-C-N 126.405 2.316 . . . . 0.0 108.827 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.407 ' O ' ' HB ' ' A' ' 127' ' ' ILE . 0.4 OUTLIER -118.98 155.04 32.07 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 179.939 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . 0.363 0.1 OUTLIER -121.1 -165.76 1.26 Allowed 'General case' 0 C--N 1.324 -0.524 0 O-C-N 126.011 2.07 . . . . 0.0 107.459 -179.78 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.473 ' HB3' ' HB2' ' A' ' 125' ' ' LYS . 3.7 tp10 -176.35 89.3 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.523 0 C-N-CA 117.604 -1.638 . . . . 0.0 107.197 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 97.95 -3.6 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 126.143 1.777 . . . . 0.0 114.132 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.801 ' HA ' ' HB1' ' A' ' 124' ' ' ALA 0.27 76.9 t80 -62.07 -28.08 69.35 Favored 'General case' 0 C--O 1.241 0.618 0 O-C-N 127.908 3.255 . . . . 0.0 114.307 -179.834 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -68.18 -40.37 82.28 Favored 'General case' 0 CA--C 1.5 -0.949 0 O-C-N 124.672 1.232 . . . . 0.0 113.442 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.3 -26.03 55.42 Favored 'General case' 0 N--CA 1.441 -0.921 0 O-C-N 125.053 1.47 . . . . 0.0 111.216 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.612 ' HB2' ' HB2' ' A' ' 124' ' ' ALA . 4.7 t80 -68.59 -25.28 64.8 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 123.467 1.603 . . . . 0.0 112.773 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -77.74 -24.91 48.95 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-O 124.018 1.866 . . . . 0.0 107.698 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.7 tt0 -74.45 -20.28 60.08 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 125.297 2.475 . . . . 0.0 110.07 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.422 ' CE ' ' HB2' ' A' ' 120' ' ' GLU . 2.8 tmtm? -77.67 -48.3 17.11 Favored 'General case' 0 C--O 1.209 -1.032 0 CA-C-N 111.998 -2.364 . . . . 0.0 110.152 179.461 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 3.1 mtt -65.48 -20.25 66.27 Favored 'General case' 0 C--O 1.208 -1.12 0 C-N-CA 127.519 2.328 . . . . 0.0 107.507 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.13 31.35 5.96 Favored Glycine 0 C--N 1.298 -1.563 0 C-N-CA 125.221 1.391 . . . . 0.0 111.812 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.486 ' CG2' ' HB2' ' A' ' 27' ' ' LYS . 0.5 OUTLIER -91.56 132.75 35.2 Favored 'Isoleucine or valine' 0 C--N 1.351 0.643 0 CA-C-O 116.154 -1.879 . . . . 0.0 105.99 -179.863 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 41.6 m-20 -90.76 -85.67 0.22 Allowed 'General case' 0 CA--C 1.508 -0.672 0 N-CA-C 116.365 1.987 . . . . 0.0 116.365 -179.358 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . 0.354 3.5 p -117.4 -72.41 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.495 -1.17 0 N-CA-C 120.022 3.341 . . . . 0.0 120.022 -179.508 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.579 2.2 m -63.43 -28.51 45.16 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.871 0 N-CA-C 118.619 2.822 . . . . 0.0 118.619 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.486 ' HB2' ' CG2' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -74.3 -42.66 59.15 Favored 'General case' 0 CA--C 1.508 -0.653 0 O-C-N 127.789 3.18 . . . . 0.0 114.146 -179.839 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 38.1 ptt180 -78.38 -23.43 46.83 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 123.41 1.576 . . . . 0.0 108.793 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 31.1 tttp -74.86 -39.55 61.49 Favored 'General case' 0 CA--C 1.509 -0.63 0 CA-C-N 114.15 -1.386 . . . . 0.0 111.029 179.442 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.425 ' HA ' HD22 ' A' ' 30' ' ' LEU . 0.8 OUTLIER -74.65 -21.81 59.23 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 114.039 -1.437 . . . . 0.0 110.712 -179.913 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -79.45 -30.71 44.04 Favored Glycine 0 CA--C 1.524 0.596 0 O-C-N 128.23 3.456 . . . . 0.0 110.929 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -77.09 -57.58 3.76 Favored 'General case' 0 N--CA 1.436 -1.167 0 C-N-CA 127.182 2.193 . . . . 0.0 112.1 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 22.4 m80 -75.18 -1.99 25.79 Favored 'General case' 0 N--CA 1.438 -1.054 0 CA-C-O 117.112 -1.423 . . . . 0.0 113.606 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.43 ' HB2' ' HB2' ' A' ' 53' ' ' SER . 35.6 p-10 -38.6 -36.67 0.27 Allowed 'General case' 0 CA--C 1.495 -1.171 0 N-CA-C 119.888 3.292 . . . . 0.0 119.888 179.604 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . 0.263 13.4 m120 79.96 21.3 0.54 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 120.108 1.322 . . . . 0.0 113.422 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.627 HD21 HD13 ' A' ' 38' ' ' LEU . 27.0 tp -37.08 93.47 0.01 OUTLIER 'General case' 0 C--N 1.351 0.643 0 O-C-N 126.993 2.683 . . . . 0.0 110.313 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.423 ' HB3' ' HB3' ' A' ' 52' ' ' SER . 2.4 ttmp? -92.82 105.47 17.59 Favored 'General case' 0 C--O 1.218 -0.602 0 N-CA-C 101.92 -3.363 . . . . 0.0 101.92 179.75 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.627 HD13 HD21 ' A' ' 36' ' ' LEU 0.252 1.3 tp -95.3 127.11 41.08 Favored 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 116.212 -2.195 . . . . 0.0 108.735 179.729 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.77 HG23 HG22 ' A' ' 5' ' ' THR . 89.0 m -109.97 83.14 1.71 Allowed 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 104.226 -2.509 . . . . 0.0 104.226 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.447 HD11 HD23 ' A' ' 38' ' ' LEU . 24.0 mm -63.91 132.93 29.85 Favored 'Isoleucine or valine' 0 C--O 1.247 0.94 0 CA-C-N 112.983 -1.917 . . . . 0.0 108.952 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 30.5 m -143.62 96.84 2.97 Favored 'General case' 0 CA--C 1.502 -0.874 0 CA-C-N 111.419 -2.628 . . . . 0.0 113.582 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 59.8 tt0 -89.5 131.94 35.29 Favored 'General case' 0 N--CA 1.447 -0.613 0 O-C-N 124.794 1.309 . . . . 0.0 110.272 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 46.3 tt0 -101.98 -52.33 3.19 Favored 'General case' 0 CA--C 1.49 -1.349 0 CA-C-O 125.172 2.415 . . . . 0.0 110.156 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -165.74 -69.19 0.03 OUTLIER Glycine 0 N--CA 1.433 -1.551 0 N-CA-C 105.422 -3.071 . . . . 0.0 105.422 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.364 0.0 OUTLIER -106.53 -22.7 12.69 Favored 'General case' 0 C--O 1.218 -0.602 0 CA-C-N 113.095 -1.552 . . . . 0.0 111.168 179.906 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.409 ' CD ' ' HG3' ' A' ' 63' ' ' GLU . 0.0 OUTLIER -98.32 156.23 16.82 Favored 'General case' 0 N--CA 1.435 -1.203 0 C-N-CA 120.318 -0.553 . . . . 0.0 111.931 -179.879 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.407 ' HE2' HD21 ' A' ' 64' ' ' LEU . 2.1 m-85 -129.79 92.72 3.37 Favored 'General case' 0 N--CA 1.441 -0.893 0 C-N-CA 123.465 0.706 . . . . 0.0 109.436 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.84 HG22 ' CG1' ' A' ' 61' ' ' VAL 0.455 1.3 p -67.18 141.51 57.31 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 116.8 -1.96 . . . . 0.0 111.45 -179.903 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.874 HG11 ' CZ ' ' A' ' 62' ' ' PHE 0.695 0.4 OUTLIER -120.91 83.82 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.424 -1.726 0 CA-C-N 111.877 -2.42 . . . . 0.0 111.167 179.916 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.458 ' CB ' ' HB ' ' A' ' 39' ' ' THR . 2.1 ttpp -62.84 142.89 58.05 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 101.229 -3.619 . . . . 0.0 101.229 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.572 ' OE2' HD13 ' A' ' 36' ' ' LEU . 4.3 tt0 -138.55 93.92 2.79 Favored 'General case' 0 C--O 1.217 -0.632 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.423 ' HB3' ' HB3' ' A' ' 37' ' ' LYS 0.287 3.9 t -91.64 60.8 4.1 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 106.722 -1.584 . . . . 0.0 106.722 179.81 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.43 ' HB2' ' HB2' ' A' ' 34' ' ' ASP . 1.7 p -89.59 -178.46 5.56 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 125.897 1.998 . . . . 0.0 112.447 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.44 -28.59 69.38 Favored 'General case' 0 C--O 1.212 -0.878 0 CA-C-O 115.525 -2.178 . . . . 0.0 109.932 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.453 ' CD2' ' CB ' ' A' ' 73' ' ' ALA . 95.8 m-85 -70.93 -51.08 28.09 Favored 'General case' 0 C--O 1.221 -0.398 0 C-N-CA 117.285 -1.766 . . . . 0.0 114.13 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.443 ' O ' HG22 ' A' ' 58' ' ' ILE . 6.3 ttm180 179.72 153.7 0.49 Allowed 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 120.702 1.592 . . . . 0.0 108.256 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 42.8 t-20 -88.89 85.98 6.85 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 102.336 -3.209 . . . . 0.0 102.336 -179.516 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.443 HG22 ' O ' ' A' ' 56' ' ' ARG . 6.3 tp -117.57 107.31 21.83 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.866 1 C-N-CA 133.19 4.596 . . . . 0.0 118.477 -179.827 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -66.2 134.07 51.95 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 104.606 -2.368 . . . . 0.0 104.606 178.846 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.402 ' O ' HG23 ' A' ' 61' ' ' VAL . 22.3 t -86.16 -68.8 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 CA-C-O 125.517 2.58 . . . . 0.0 110.874 -179.299 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.84 ' CG1' HG22 ' A' ' 48' ' ' THR 0.497 0.0 OUTLIER 74.57 128.02 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.14 0 CA-C-N 113.825 -1.534 . . . . 0.0 113.347 179.995 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.874 ' CZ ' HG11 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -160.11 99.95 1.37 Allowed 'General case' 0 C--N 1.313 -1.002 0 CA-C-O 117.756 -1.116 . . . . 0.0 111.141 -179.781 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.409 ' HG3' ' CD ' ' A' ' 46' ' ' LYS . 3.7 tt0 -49.59 137.61 15.16 Favored 'General case' 0 N--CA 1.439 -0.999 0 O-C-N 126.592 2.433 . . . . 0.0 104.564 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.407 HD21 ' HE2' ' A' ' 47' ' ' PHE . 0.8 OUTLIER -60.33 129.69 42.9 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 123.395 1.569 . . . . 0.0 108.469 -179.74 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 63.38 26.95 70.02 Favored Glycine 0 C--N 1.343 0.948 0 CA-C-N 111.437 -2.62 . . . . 0.0 118.849 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . 0.423 3.0 t -102.63 101.61 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.732 ' HA ' HG22 ' A' ' 81' ' ' THR . 25.5 t0 -58.03 126.45 27.52 Favored 'General case' 0 CA--C 1.49 -1.332 0 CA-C-O 116.816 -1.564 . . . . 0.0 111.391 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.581 ' CZ ' ' HB2' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -131.91 -174.24 3.37 Favored 'General case' 0 N--CA 1.437 -1.097 0 CA-C-N 119.289 0.949 . . . . 0.0 110.968 -179.84 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -125.81 118.38 25.38 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 -179.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 16.2 t80 -126.63 115.39 19.4 Favored 'General case' 0 C--O 1.209 -1.028 0 CA-C-N 120.503 1.501 . . . . 0.0 111.711 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 10.6 t -80.93 142.62 33.34 Favored 'General case' 0 CA--C 1.491 -1.327 0 O-C-N 120.352 -1.468 . . . . 0.0 109.434 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.6 HD21 HD22 ' A' ' 78' ' ' LEU . 0.1 OUTLIER -97.83 -174.2 2.82 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 106.043 -1.836 . . . . 0.0 106.043 179.901 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.453 ' CB ' ' CD2' ' A' ' 55' ' ' PHE . . . -84.33 -49.28 8.88 Favored 'General case' 0 C--O 1.211 -0.973 0 O-C-N 125.355 1.659 . . . . 0.0 110.717 179.409 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.543 ' HB3' ' CG ' ' A' ' 132' ' ' PLM . 4.9 t70 -121.7 -10.06 8.8 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.079 -1.419 . . . . 0.0 109.72 179.182 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -89.19 -17.59 55.36 Favored Glycine 0 CA--C 1.546 1.982 0 CA-C-N 118.66 0.664 . . . . 0.0 112.763 179.676 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.489 HG22 ' H ' ' A' ' 77' ' ' GLU 0.355 0.0 OUTLIER 71.96 -169.03 0.14 Allowed 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 116.495 -2.082 . . . . 0.0 113.302 179.922 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.504 ' HB2' HG22 ' A' ' 96' ' ' VAL . 4.0 mp0 -46.22 140.71 3.82 Favored 'General case' 0 C--N 1.319 -0.729 0 O-C-N 128.253 3.471 . . . . 0.0 112.039 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.6 HD22 HD21 ' A' ' 72' ' ' LEU 0.42 0.4 OUTLIER -156.83 100.67 1.92 Allowed 'General case' 0 C--O 1.243 0.734 0 N-CA-C 102.798 -3.038 . . . . 0.0 102.798 179.963 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.535 ' HB ' ' O ' ' A' ' 68' ' ' PHE . 27.6 m -109.13 135.37 50.38 Favored 'General case' 0 CA--C 1.481 -1.686 0 O-C-N 125.009 1.443 . . . . 0.0 108.238 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 173.6 -168.0 40.78 Favored Glycine 0 C--N 1.303 -1.276 1 C-N-CA 113.805 -4.045 . . . . 0.0 108.775 -179.682 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.732 HG22 ' HA ' ' A' ' 67' ' ' ASP . 2.7 p -137.69 177.14 8.1 Favored 'General case' 0 CA--C 1.493 -1.218 0 CA-C-N 119.129 1.465 . . . . 0.0 110.981 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' TRP . . . . . 0.546 ' CE3' ' CA ' ' A' ' 91' ' ' GLY . 83.5 m95 -128.12 141.45 51.49 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 102.078 -3.304 . . . . 0.0 102.078 179.776 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.513 HG23 HG23 ' A' ' 90' ' ' VAL . 5.4 t -142.86 138.67 30.44 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-O 122.033 0.921 . . . . 0.0 109.312 -179.753 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 13.6 ttt -83.44 105.24 14.22 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . 0.603 4.7 mt-10 -56.8 -28.74 61.89 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-O 124.986 2.327 . . . . 0.0 112.661 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 140.49 -46.71 0.91 Allowed Glycine 0 C--N 1.347 1.146 0 N-CA-C 104.081 -3.608 . . . . 0.0 104.081 179.741 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 17.3 t30 -113.28 -19.23 11.85 Favored 'General case' 0 N--CA 1.44 -0.937 0 O-C-N 127.109 2.299 . . . . 0.0 114.109 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . 0.385 20.3 mttt -136.93 151.41 49.01 Favored 'General case' 0 N--CA 1.44 -0.958 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 179.736 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.952 HD23 HH11 ' A' ' 106' ' ' ARG . 1.0 OUTLIER -98.74 129.56 45.18 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 101.313 -3.588 . . . . 0.0 101.313 179.634 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.513 HG23 HG23 ' A' ' 83' ' ' THR . 0.0 OUTLIER -120.26 114.75 44.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 C-N-CA 118.363 -1.335 . . . . 0.0 108.14 -179.844 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.546 ' CA ' ' CE3' ' A' ' 82' ' ' TRP . . . -84.16 91.52 1.65 Allowed Glycine 0 C--N 1.354 1.582 0 C-N-CA 129.652 3.501 . . . . 0.0 107.819 -179.763 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -92.39 124.33 36.37 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 102.509 -3.145 . . . . 0.0 102.509 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.463 ' CG ' ' HG ' ' A' ' 78' ' ' LEU . 2.4 m-85 -136.23 108.99 7.53 Favored 'General case' 0 CA--C 1.502 -0.865 0 O-C-N 125.902 2.001 . . . . 0.0 111.941 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.432 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 0.1 OUTLIER -89.04 -173.22 3.98 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 179.937 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . 0.42 0.6 OUTLIER -131.56 151.83 51.27 Favored 'General case' 0 CA--C 1.487 -1.459 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.859 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.504 HG22 ' HB2' ' A' ' 77' ' ' GLU . 17.4 m -82.03 -33.62 11.86 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 N-CA-C 114.176 1.176 . . . . 0.0 114.176 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.412 ' N ' HG23 ' A' ' 96' ' ' VAL 0.436 0.5 OUTLIER -74.13 10.32 1.27 Allowed 'General case' 0 C--O 1.247 0.957 0 N-CA-C 116.226 1.936 . . . . 0.0 116.226 179.844 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -168.54 -33.99 0.02 OUTLIER 'General case' 0 CA--C 1.497 -1.084 0 N-CA-C 114.812 1.412 . . . . 0.0 114.812 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 76.7 41.63 23.52 Favored Glycine 0 C--N 1.339 0.733 0 N-CA-C 116.423 1.329 . . . . 0.0 116.423 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 69.4 mttt -81.97 -112.01 0.03 OUTLIER 'General case' 0 C--O 1.198 -1.647 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.428 ' HG3' ' N ' ' A' ' 102' ' ' LEU . 0.1 OUTLIER 166.17 142.4 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.391 0 C-N-CA 125.212 1.405 . . . . 0.0 109.897 -179.913 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.553 ' HG ' ' HA ' ' A' ' 119' ' ' TYR . 0.8 OUTLIER -131.25 151.68 51.25 Favored 'General case' 0 C--O 1.247 0.94 0 O-C-N 128.289 3.493 . . . . 0.0 104.761 -179.723 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.453 ' CG2' ' HB ' ' A' ' 118' ' ' THR . 9.2 tt -132.23 174.69 12.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 CA-C-N 120.405 1.457 . . . . 0.0 107.891 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.418 ' N ' ' CG1' ' A' ' 103' ' ' ILE . . . -155.98 111.19 2.95 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 116.351 -1.785 . . . . 0.0 106.269 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.466 HG12 HG23 ' A' ' 116' ' ' THR . 0.9 OUTLIER -95.95 111.72 26.79 Favored 'Isoleucine or valine' 0 C--O 1.245 0.852 0 CA-C-N 121.44 1.927 . . . . 0.0 113.199 -179.416 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.952 HH11 HD23 ' A' ' 89' ' ' LEU . 37.3 mtt180 -91.24 94.1 9.39 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 106.327 -1.731 . . . . 0.0 106.327 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -94.03 74.96 4.11 Favored 'General case' 0 N--CA 1.42 -1.948 0 N-CA-C 116.915 2.191 . . . . 0.0 116.915 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.838 HD11 ' CH2' ' A' ' 6' ' ' TRP . 0.3 OUTLIER -61.07 128.73 22.83 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 C-N-CA 115.292 -2.563 . . . . 0.0 111.763 179.872 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 3.9 t -87.42 -65.71 0.99 Allowed 'General case' 0 C--O 1.218 -0.581 0 N-CA-C 104.575 -2.38 . . . . 0.0 104.575 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -167.39 -62.36 0.03 OUTLIER Glycine 0 C--N 1.348 1.213 0 C-N-CA 129.985 3.66 . . . . 0.0 112.683 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . 0.309 0.8 OUTLIER -101.96 -9.33 20.75 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-O 116.448 -1.739 . . . . 0.0 110.737 179.844 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.53 ' O ' HD13 ' A' ' 108' ' ' ILE . 1.3 mt-10 -126.94 131.77 51.01 Favored 'General case' 0 CA--C 1.495 -1.159 0 O-C-N 128.078 3.361 . . . . 0.0 116.888 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.684 HD22 ' CD2' ' A' ' 128' ' ' PHE . 10.4 tt -105.32 117.0 32.9 Favored 'General case' 0 C--N 1.321 -0.669 0 O-C-N 127.739 3.149 . . . . 0.0 105.912 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.735 HG13 HD13 ' A' ' 127' ' ' ILE 0.281 1.2 mp -108.32 128.34 63.92 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 CA-C-O 116.212 -1.852 . . . . 0.0 107.574 -179.747 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.605 HE21 ' HZ ' ' A' ' 128' ' ' PHE . 37.4 mt-30 -114.32 105.89 13.68 Favored 'General case' 0 N--CA 1.441 -0.897 0 O-C-N 126.543 2.402 . . . . 0.0 107.783 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.466 HG23 HG12 ' A' ' 105' ' ' VAL . 12.3 p -75.64 -179.0 4.43 Favored 'General case' 0 N--CA 1.429 -1.518 0 O-C-N 127.595 3.06 . . . . 0.0 105.409 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.428 ' HB2' ' HB3' ' A' ' 124' ' ' ALA . 97.4 m-85 -165.96 112.1 0.88 Allowed 'General case' 0 C--O 1.198 -1.623 0 CA-C-O 116.605 -1.664 . . . . 0.0 113.19 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.522 HG22 ' H ' ' A' ' 120' ' ' GLU . 54.0 m -122.73 129.33 51.65 Favored 'General case' 0 N--CA 1.425 -1.68 1 O-C-N 131.289 5.368 . . . . 0.0 113.661 179.77 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.553 ' HA ' ' HG ' ' A' ' 102' ' ' LEU . 2.1 t80 -109.14 12.85 24.82 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.522 ' H ' HG22 ' A' ' 118' ' ' THR . 0.7 OUTLIER 163.52 -84.95 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.566 0 O-C-N 127.818 3.199 . . . . 0.0 111.357 -179.796 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -128.59 24.27 4.95 Favored Glycine 0 CA--C 1.539 1.547 0 N-CA-C 119.892 2.717 . . . . 0.0 119.892 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 62.1 t -133.0 104.07 6.55 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.628 0 O-C-N 119.122 -2.399 . . . . 0.0 107.371 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -81.14 171.54 14.78 Favored 'General case' 0 N--CA 1.426 -1.647 0 CA-C-O 124.203 1.954 . . . . 0.0 108.623 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.801 ' HB1' ' HA ' ' A' ' 14' ' ' TYR . . . -162.72 97.08 0.95 Allowed 'General case' 0 C--O 1.211 -0.94 0 C-N-CA 117.746 -1.582 . . . . 0.0 107.194 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.473 ' HB2' ' HB3' ' A' ' 12' ' ' GLU 0.32 1.8 mptm? -83.88 132.91 34.75 Favored 'General case' 0 CA--C 1.506 -0.729 0 CA-C-O 122.331 1.063 . . . . 0.0 110.121 -179.903 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.513 HH12 HD22 ' A' ' 36' ' ' LEU . 4.6 mtm180 -119.94 81.47 1.74 Allowed 'General case' 0 C--O 1.209 -1.042 0 C-N-CA 127.158 2.183 . . . . 0.0 107.867 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.735 HD13 HG13 ' A' ' 114' ' ' ILE . 10.4 mm -63.97 126.32 22.41 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.861 0 O-C-N 128.522 3.639 . . . . 0.0 111.649 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.684 ' CD2' HD22 ' A' ' 113' ' ' LEU . 5.6 m-30 -112.66 139.47 48.23 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 113.25 -1.795 . . . . 0.0 107.681 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . 0.263 3.0 mmtp -104.11 13.73 31.87 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 116.947 -1.502 . . . . 0.0 111.206 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.519 ' HB2' ' CZ3' ' A' ' 6' ' ' TRP . 0.1 OUTLIER 55.83 97.53 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 115.394 -2.241 . . . . 0.0 113.176 179.716 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . 0.88 2.4 tt0 . . . . . 0 N--CA 1.443 -0.814 0 C-N-CA 115.407 -2.517 . . . . 0.0 115.683 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' PLM . . . . . 0.543 ' CG ' ' HB3' ' A' ' 74' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.511 -0.554 0 CA-C-O 120.903 0.382 . . . . 0.0 110.383 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.445 ' N ' ' CD1' ' A' ' 2' ' ' PHE . 10.6 m-85 -88.17 72.74 9.06 Favored 'General case' 0 CA--C 1.511 -0.529 0 C-N-CA 119.397 -0.921 . . . . 0.0 111.908 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -145.53 100.9 3.51 Favored 'General case' 0 CA--C 1.495 -1.172 0 C-N-CA 119.528 -0.869 . . . . 0.0 111.629 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 143.65 -171.79 25.19 Favored Glycine 0 CA--C 1.503 -0.718 0 O-C-N 126.512 2.382 . . . . 0.0 111.603 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.416 ' C ' ' CG ' ' A' ' 6' ' ' TRP 0.587 0.5 OUTLIER -81.45 164.27 22.16 Favored 'General case' 0 N--CA 1.439 -1.006 0 CA-C-O 123.026 1.393 . . . . 0.0 111.523 179.931 . . . . . . . . 4 4 . 1 . 002 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.755 ' CH2' HD11 ' A' ' 108' ' ' ILE . 63.2 m95 -157.03 117.01 3.48 Favored 'General case' 0 N--CA 1.428 -1.563 0 CA-C-O 114.276 -2.773 . . . . 0.0 106.419 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 5.1 tttt -122.47 95.71 4.75 Favored 'General case' 0 N--CA 1.441 -0.902 0 O-C-N 126.062 2.101 . . . . 0.0 108.908 -179.677 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.583 ' HA ' ' HA ' ' A' ' 128' ' ' PHE 0.267 14.1 p -34.76 119.19 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.216 0 O-C-N 125.391 1.682 . . . . 0.0 114.561 -179.951 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -114.38 -46.99 2.94 Favored 'General case' 0 C--O 1.204 -1.296 0 O-C-N 125.484 1.74 . . . . 0.0 110.24 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.602 ' HG3' HG21 ' A' ' 127' ' ' ILE 0.27 0.0 OUTLIER -106.78 170.72 7.77 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-O 118.663 -0.684 . . . . 0.0 109.866 179.861 . . . . . . . . 4 4 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.738 ' HB3' ' CD1' ' A' ' 14' ' ' TYR 0.391 42.8 m-80 -169.62 179.39 3.78 Favored 'General case' 0 N--CA 1.437 -1.083 0 O-C-N 128.06 3.35 . . . . 0.0 109.962 -178.201 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -150.38 -90.07 0.07 Allowed 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 121.839 2.109 . . . . 0.0 112.083 -179.782 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -85.04 4.91 31.71 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-N 122.449 2.386 . . . . 0.0 112.182 179.328 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.738 ' CD1' ' HB3' ' A' ' 11' ' ' ASN . 0.4 OUTLIER -59.55 -21.82 60.82 Favored 'General case' 0 C--N 1.308 -1.238 0 C-N-CA 127.274 2.23 . . . . 0.0 113.301 -178.628 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -73.92 -26.63 60.61 Favored 'General case' 0 C--O 1.21 -0.983 0 CA-C-N 120.51 1.504 . . . . 0.0 111.424 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 37.2 tttm -79.97 -31.92 39.84 Favored 'General case' 0 N--CA 1.432 -1.339 0 CA-C-O 125.448 2.546 . . . . 0.0 110.665 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.658 ' CB ' ' HB2' ' A' ' 124' ' ' ALA . 0.0 OUTLIER -60.78 -33.89 73.66 Favored 'General case' 0 N--CA 1.428 -1.564 0 O-C-N 118.397 -2.689 . . . . 0.0 113.264 -179.755 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 19.2 mtt -72.88 -23.77 60.77 Favored 'General case' 0 N--CA 1.438 -1.073 0 O-C-N 119.229 -2.17 . . . . 0.0 108.465 179.558 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -76.13 -32.28 59.06 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 125.027 2.346 . . . . 0.0 111.379 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.411 ' HE3' ' HB3' ' A' ' 120' ' ' GLU . 0.6 OUTLIER -64.72 -41.2 96.15 Favored 'General case' 0 N--CA 1.436 -1.171 0 O-C-N 117.55 -3.219 . . . . 0.0 112.379 179.76 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -73.66 -21.88 60.13 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 86.73 61.64 1.59 Allowed Glycine 0 C--N 1.314 -0.666 0 CA-C-O 115.263 -2.965 . . . . 0.0 109.998 179.566 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.468 HG23 ' CB ' ' A' ' 27' ' ' LYS . 7.2 mm -90.77 -7.21 10.77 Favored 'Isoleucine or valine' 0 C--N 1.358 0.943 0 CA-C-N 119.537 1.668 . . . . 0.0 108.408 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 76.11 -106.01 0.02 OUTLIER 'General case' 0 N--CA 1.441 -0.882 0 CA-C-O 116.006 -1.95 . . . . 0.0 114.384 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . 0.343 69.2 t -133.74 -55.26 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.499 -0.995 0 N-CA-C 118.001 2.593 . . . . 0.0 118.001 -179.641 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.568 34.5 m -69.23 -35.21 66.81 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.079 0 N-CA-C 118.975 2.954 . . . . 0.0 118.975 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.468 ' CB ' HG23 ' A' ' 23' ' ' ILE . 27.7 mttt -74.72 -26.56 59.89 Favored 'General case' 0 C--N 1.32 -0.7 0 O-C-N 126.08 2.113 . . . . 0.0 113.326 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 21.3 ptt180 -79.4 -23.75 43.05 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 120.347 1.43 . . . . 0.0 108.794 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 15.1 tttp -78.19 -44.0 26.99 Favored 'General case' 0 C--O 1.211 -0.959 0 CA-C-O 122.809 1.29 . . . . 0.0 110.599 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 76.1 mt -73.83 -23.42 59.64 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 114.498 -1.228 . . . . 0.0 109.149 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -66.97 -51.28 40.79 Favored Glycine 0 C--O 1.212 -1.268 0 CA-C-O 123.816 1.787 . . . . 0.0 112.96 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.556 ' HB1' ' CE2' ' A' ' 14' ' ' TYR . . . -55.2 -35.27 64.67 Favored 'General case' 0 N--CA 1.436 -1.174 0 C-N-CA 128.574 2.749 . . . . 0.0 115.707 179.116 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -130.63 60.55 1.63 Allowed 'General case' 0 CA--C 1.506 -0.732 0 CA-C-N 112.028 -2.351 . . . . 0.0 111.996 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -96.37 -15.45 21.83 Favored 'General case' 0 C--O 1.216 -0.696 0 N-CA-C 117.281 2.326 . . . . 0.0 117.281 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 97.07 29.13 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.842 0 O-C-N 125.9 2.0 . . . . 0.0 111.921 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.487 HD21 ' H61' ' A' ' 132' ' ' PLM . 12.2 tp -65.94 81.8 0.08 Allowed 'General case' 0 CA--C 1.503 -0.84 0 CA-C-O 124.471 2.081 . . . . 0.0 110.396 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -90.24 88.97 7.44 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 101.873 -3.38 . . . . 0.0 101.873 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.447 ' HG ' HG23 ' A' ' 49' ' ' VAL . 1.0 OUTLIER -67.78 95.35 0.5 Allowed 'General case' 0 C--N 1.292 -1.932 0 C-N-CA 118.518 -1.273 . . . . 0.0 111.011 -179.18 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.414 ' HB ' ' CB ' ' A' ' 50' ' ' LYS . 39.6 m -81.4 104.83 12.12 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 101.781 -3.415 . . . . 0.0 101.781 179.355 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.648 HD12 ' CD1' ' A' ' 6' ' ' TRP . 83.7 mt -91.45 147.34 5.33 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 O-C-N 120.613 -1.304 . . . . 0.0 111.635 -179.457 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 4.3 m -145.43 101.87 3.64 Favored 'General case' 0 C--O 1.22 -0.494 0 O-C-N 127.062 2.726 . . . . 0.0 112.609 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 15.1 tp60 -82.97 98.64 9.35 Favored 'General case' 0 N--CA 1.443 -0.804 0 O-C-N 125.557 1.785 . . . . 0.0 110.678 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 49.2 tt0 -107.34 84.36 1.96 Allowed 'General case' 0 N--CA 1.438 -1.04 0 CA-C-O 125.657 2.646 . . . . 0.0 105.066 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 70.43 -87.62 0.34 Allowed Glycine 0 C--N 1.296 -1.646 0 CA-C-O 115.814 -2.659 . . . . 0.0 106.582 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.331 0.1 OUTLIER -124.39 -11.99 7.34 Favored 'General case' 0 C--N 1.32 -0.679 0 O-C-N 127.332 2.43 . . . . 0.0 112.535 179.917 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.42 ' HD2' ' CG ' ' A' ' 63' ' ' GLU . 0.0 OUTLIER -90.62 138.61 31.43 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 119.854 -1.779 . . . . 0.0 106.732 179.741 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.482 ' O ' ' N ' ' A' ' 49' ' ' VAL 0.342 3.8 m-85 -115.12 95.64 5.3 Favored 'General case' 0 N--CA 1.433 -1.285 0 C-N-CA 126.222 1.809 . . . . 0.0 107.633 179.777 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.768 ' CB ' HG13 ' A' ' 61' ' ' VAL 0.451 0.1 OUTLIER -67.38 79.53 0.16 Allowed 'General case' 0 N--CA 1.441 -0.875 0 CA-C-O 124.337 2.018 . . . . 0.0 110.594 179.477 . . . . . . . . 4 4 . 1 . 002 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.859 HG13 ' HB ' ' A' ' 60' ' ' VAL 0.753 0.8 OUTLIER -59.57 75.83 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 CA-C-N 109.845 -3.343 . . . . 0.0 115.332 179.794 . . . . . . . . 4 4 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.444 ' HA ' ' HA ' ' A' ' 59' ' ' ASP . 8.9 tttt -61.09 138.56 58.2 Favored 'General case' 0 C--N 1.317 -0.811 1 N-CA-C 99.964 -4.087 . . . . 0.0 99.964 179.742 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -133.71 105.16 6.67 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 102.431 -3.174 . . . . 0.0 102.431 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 54.1 p -104.1 44.85 0.99 Allowed 'General case' 0 C--N 1.288 -2.101 0 N-CA-C 105.95 -1.87 . . . . 0.0 105.95 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.7 t -67.89 149.03 50.35 Favored 'General case' 0 N--CA 1.466 0.335 0 O-C-N 127.322 2.889 . . . . 0.0 107.745 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -50.38 -21.78 1.58 Allowed 'General case' 0 C--O 1.221 -0.424 0 CA-C-N 120.656 1.571 . . . . 0.0 110.129 -179.425 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.52 ' CE2' ' HG2' ' A' ' 132' ' ' PLM . 19.8 m-85 -72.23 -49.96 31.07 Favored 'General case' 0 C--O 1.219 -0.529 0 C-N-CA 115.431 -2.507 . . . . 0.0 110.469 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.664 ' HB2' HG22 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -159.37 141.31 13.41 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 123.779 2.99 . . . . 0.0 110.522 -179.984 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 7.9 m-80 -97.56 78.4 2.65 Favored 'General case' 0 C--N 1.353 0.724 0 N-CA-C 100.36 -3.941 . . . . 0.0 100.36 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.664 HG22 ' HB2' ' A' ' 56' ' ' ARG . 2.6 tp -118.53 113.34 41.55 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.017 0 C-N-CA 131.155 3.782 . . . . 0.0 117.792 -179.243 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.444 ' HA ' ' HA ' ' A' ' 50' ' ' LYS . 3.9 p30 -59.18 149.39 28.41 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 104.357 -2.461 . . . . 0.0 104.357 178.619 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.859 ' HB ' HG13 ' A' ' 49' ' ' VAL . 3.2 t -101.89 -60.98 2.58 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 CA-C-O 124.696 2.189 . . . . 0.0 107.683 -177.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.768 HG13 ' CB ' ' A' ' 48' ' ' THR 0.458 0.0 OUTLIER 66.14 109.11 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.433 -1.319 0 CA-C-N 113.014 -1.903 . . . . 0.0 108.992 -179.519 . . . . . . . . 4 4 . 1 . 002 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.441 ' CZ ' ' HA ' ' A' ' 81' ' ' THR . 2.3 t80 -145.53 114.76 7.07 Favored 'General case' 0 C--N 1.312 -1.06 0 C-N-CA 115.694 -2.402 . . . . 0.0 106.651 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.51 ' OE1' HG21 ' A' ' 66' ' ' VAL . 25.9 mt-10 -68.28 141.83 55.75 Favored 'General case' 0 C--O 1.247 0.95 0 N-CA-C 102.49 -3.152 . . . . 0.0 102.49 179.739 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.82 137.23 55.15 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 120.266 1.393 . . . . 0.0 107.944 -179.687 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 57.98 25.0 55.84 Favored Glycine 0 CA--C 1.531 1.056 0 N-CA-C 117.925 1.93 . . . . 0.0 117.925 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.51 HG21 ' OE1' ' A' ' 63' ' ' GLU 0.296 37.2 t -111.37 84.6 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 104.851 -2.277 . . . . 0.0 104.851 179.94 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -39.36 113.43 0.32 Allowed 'General case' 0 C--O 1.202 -1.424 0 O-C-N 126.41 2.319 . . . . 0.0 114.648 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.449 ' CD1' ' C ' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -106.8 -166.26 1.15 Allowed 'General case' 0 N--CA 1.422 -1.839 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 -179.599 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -131.53 137.09 48.36 Favored 'General case' 0 CA--C 1.51 -0.583 0 CA-C-O 116.872 -1.537 . . . . 0.0 107.025 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -146.94 113.04 5.82 Favored 'General case' 0 C--O 1.216 -0.672 0 C-N-CA 117.966 -1.493 . . . . 0.0 113.808 -179.794 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 47.1 t -91.18 151.34 20.99 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.6 mp -96.58 -169.93 1.98 Allowed 'General case' 0 CA--C 1.498 -1.049 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.404 ' CB ' ' CD1' ' A' ' 55' ' ' PHE . . . -89.45 -6.19 56.71 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-O 124.774 2.226 . . . . 0.0 111.691 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -153.79 -44.75 0.09 Allowed 'General case' 0 N--CA 1.433 -1.29 0 CA-C-N 112.787 -2.006 . . . . 0.0 112.133 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -64.85 -8.0 32.17 Favored Glycine 0 C--O 1.205 -1.692 0 O-C-N 124.769 1.293 . . . . 0.0 114.839 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . 0.372 0.1 OUTLIER 71.46 172.3 0.31 Allowed 'General case' 0 C--N 1.308 -1.219 0 O-C-N 118.197 -2.943 . . . . 0.0 114.947 -179.982 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -35.77 151.99 0.01 OUTLIER 'General case' 0 N--CA 1.434 -1.245 1 O-C-N 130.051 4.594 . . . . 0.0 116.407 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.429 HD11 HD22 ' A' ' 102' ' ' LEU 0.388 8.8 tp -153.63 165.25 36.51 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-N 112.715 -2.039 . . . . 0.0 105.782 -179.958 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -167.05 120.04 0.97 Allowed 'General case' 0 CA--C 1.503 -0.834 0 N-CA-C 105.201 -2.148 . . . . 0.0 105.201 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.442 ' HA3' ' HA ' ' A' ' 93' ' ' PHE . . . -168.65 -157.15 11.08 Favored Glycine 0 C--N 1.296 -1.669 0 C-N-CA 116.684 -2.674 . . . . 0.0 109.765 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.441 ' HA ' ' CZ ' ' A' ' 62' ' ' PHE . 2.8 p -144.98 159.91 42.18 Favored 'General case' 0 C--O 1.191 -2.026 0 O-C-N 126.553 1.973 . . . . 0.0 112.63 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' TRP . . . . . 0.461 ' CZ3' ' HG3' ' A' ' 106' ' ' ARG . 39.8 m95 -117.97 113.93 22.41 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 103.136 -2.913 . . . . 0.0 103.136 -179.725 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 4.0 t -122.85 139.09 54.4 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-O 122.199 1.0 . . . . 0.0 111.093 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 1.9 ttt -92.94 105.08 17.24 Favored 'General case' 0 N--CA 1.426 -1.674 0 CA-C-N 113.442 -1.708 . . . . 0.0 112.494 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . 0.532 0.6 OUTLIER -72.66 -143.98 0.01 OUTLIER 'General case' 0 N--CA 1.425 -1.719 0 O-C-N 125.008 1.443 . . . . 0.0 108.162 179.808 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -82.59 66.94 3.81 Favored Glycine 0 N--CA 1.45 -0.369 0 N-CA-C 105.447 -3.061 . . . . 0.0 105.447 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 96.74 -13.79 0.08 Allowed 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 117.293 2.331 . . . . 0.0 117.293 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . 0.409 0.0 OUTLIER -111.65 141.89 44.66 Favored 'General case' 0 C--O 1.215 -0.756 0 O-C-N 125.204 1.565 . . . . 0.0 107.714 179.869 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.499 HD13 ' CD ' ' A' ' 106' ' ' ARG . 1.0 OUTLIER -96.48 145.56 25.57 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 101.503 -3.517 . . . . 0.0 101.503 179.965 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.8 m -132.6 120.27 41.48 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 O-C-N 125.043 1.464 . . . . 0.0 109.596 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -100.27 87.08 0.69 Allowed Glycine 0 C--N 1.338 0.686 0 C-N-CA 128.358 2.885 . . . . 0.0 114.109 -179.474 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -90.67 148.11 22.83 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 102.388 -3.19 . . . . 0.0 102.388 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.744 ' HB2' HD23 ' A' ' 102' ' ' LEU . 15.7 m-85 -152.64 117.98 5.25 Favored 'General case' 0 CA--C 1.501 -0.906 0 C-N-CA 117.678 -1.609 . . . . 0.0 113.45 -179.654 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -88.36 -163.46 0.97 Allowed 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 -179.614 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . 0.334 0.2 OUTLIER -138.25 164.73 28.48 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 106.085 -1.82 . . . . 0.0 106.085 179.824 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 37.0 t -94.3 -40.01 11.0 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 C-N-CA 124.63 1.172 . . . . 0.0 108.537 -179.696 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . 0.287 0.2 OUTLIER -55.19 -30.66 60.38 Favored 'General case' 0 C--O 1.25 1.126 0 N-CA-C 114.681 1.363 . . . . 0.0 114.681 179.786 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -160.02 6.08 0.09 Allowed 'General case' 0 N--CA 1.44 -0.94 0 CA-C-O 115.809 -2.044 . . . . 0.0 116.428 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 54.02 85.01 0.03 OUTLIER Glycine 0 CA--C 1.524 0.612 0 N-CA-C 118.675 2.23 . . . . 0.0 118.675 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.0 mmtp -113.28 -111.37 0.34 Allowed 'General case' 0 C--O 1.213 -0.862 0 O-C-N 120.951 -1.323 . . . . 0.0 111.392 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 54.3 tt0 -177.75 162.24 1.72 Allowed 'General case' 0 C--O 1.211 -0.965 0 C-N-CA 127.954 2.502 . . . . 0.0 109.069 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.744 HD23 ' HB2' ' A' ' 93' ' ' PHE . 1.9 tp -158.29 109.16 2.15 Favored 'General case' 0 C--N 1.316 -0.887 0 C-N-CA 131.255 3.822 . . . . 0.0 102.653 -179.755 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.433 ' N ' ' O ' ' A' ' 118' ' ' THR . 0.8 OUTLIER -98.83 152.56 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.091 0 C-N-CA 115.093 -2.643 . . . . 0.0 105.532 -179.439 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.604 ' HA ' ' O ' ' A' ' 116' ' ' THR . . . -160.93 147.25 14.89 Favored 'General case' 0 C--N 1.309 -1.165 0 C-N-CA 124.733 1.213 . . . . 0.0 109.123 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.469 ' O ' HG12 ' A' ' 105' ' ' VAL . 0.9 OUTLIER -137.11 102.46 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 116.033 -2.267 . . . . 0.0 111.461 -179.028 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.499 ' CD ' HD13 ' A' ' 89' ' ' LEU 0.277 48.9 mtt180 -68.18 85.16 0.25 Allowed 'General case' 0 C--N 1.312 -1.029 0 O-C-N 126.562 2.414 . . . . 0.0 104.838 179.696 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.416 ' N ' ' O ' ' A' ' 105' ' ' VAL . 4.9 tt0 -79.52 76.38 6.13 Favored 'General case' 0 N--CA 1.424 -1.738 0 O-C-N 127.163 2.789 . . . . 0.0 117.765 -179.819 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.755 HD11 ' CH2' ' A' ' 6' ' ' TRP 0.426 0.9 OUTLIER -61.91 123.07 13.99 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 C-N-CA 116.112 -2.235 . . . . 0.0 108.41 179.65 . . . . . . . . 4 4 . 1 . 002 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 7.0 m -102.63 10.67 38.56 Favored 'General case' 0 C--O 1.219 -0.54 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.564 ' H ' HG23 ' A' ' 108' ' ' ILE . . . 119.78 -60.21 0.52 Allowed Glycine 0 N--CA 1.444 -0.8 1 C-N-CA 132.266 4.746 . . . . 0.0 112.713 179.752 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -115.3 22.05 13.6 Favored 'General case' 0 C--N 1.314 -0.936 0 O-C-N 127.121 2.307 . . . . 0.0 111.681 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -149.42 99.62 2.93 Favored 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 120.299 -0.56 . . . . 0.0 111.33 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.459 ' O ' HD23 ' A' ' 113' ' ' LEU . 7.0 tt -84.02 101.61 11.88 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 100.878 -3.749 . . . . 0.0 100.878 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.911 HG12 HG23 ' A' ' 127' ' ' ILE 0.295 3.7 mt -107.2 118.67 55.41 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.09 0 O-C-N 126.013 2.07 . . . . 0.0 111.145 -179.416 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.509 ' O ' ' N ' ' A' ' 126' ' ' ARG 0.316 76.1 mt-30 -89.83 149.67 22.57 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 100.433 -3.914 . . . . 0.0 100.433 177.487 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.828 ' CG2' HG22 ' A' ' 114' ' ' ILE . 79.9 p -160.65 179.09 8.85 Favored 'General case' 0 N--CA 1.422 -1.867 1 O-C-N 130.784 5.052 . . . . 0.0 106.615 -179.865 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.621 ' CE2' ' OG1' ' A' ' 116' ' ' THR 0.297 33.2 m-85 96.6 -142.76 0.0 OUTLIER 'General case' 0 CA--C 1.442 -3.205 0 N-CA-C 120.314 3.45 . . . . 0.0 120.314 174.922 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.603 ' O ' HD12 ' A' ' 102' ' ' LEU . 11.2 t -133.87 -174.11 3.44 Favored 'General case' 0 N--CA 1.417 -2.101 0 N-CA-C 120.342 3.46 . . . . 0.0 120.342 -174.648 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.717 ' HA ' ' HA ' ' A' ' 102' ' ' LEU 0.339 7.0 t80 -117.98 0.76 11.94 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 111.528 -2.578 . . . . 0.0 106.663 178.092 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.411 ' HB3' ' HE3' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -174.74 -84.03 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.274 0 O-C-N 119.537 -1.977 . . . . 0.0 111.256 179.456 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -138.87 32.99 2.24 Favored Glycine 0 CA--C 1.537 1.454 0 C-N-CA 127.432 2.444 . . . . 0.0 116.576 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 78.7 t -141.49 101.15 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 N-CA-C 105.73 -1.952 . . . . 0.0 105.73 -179.735 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.402 ' HA ' ' C ' ' A' ' 117' ' ' TYR . 1.8 mp0 -59.13 -179.67 0.08 Allowed 'General case' 0 C--O 1.207 -1.172 0 CA-C-O 123.785 1.755 . . . . 0.0 111.797 -179.464 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.658 ' HB2' ' CB ' ' A' ' 17' ' ' PHE . . . -168.08 76.21 0.13 Allowed 'General case' 0 CA--C 1.503 -0.847 0 C-N-CA 113.602 -3.239 . . . . 0.0 110.877 -178.043 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.568 ' HA ' ' CB ' ' A' ' 116' ' ' THR . 1.4 mptp? -57.58 144.69 36.35 Favored 'General case' 0 CA--C 1.508 -0.654 0 CA-C-N 123.897 3.044 . . . . 0.0 112.258 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.509 ' N ' ' O ' ' A' ' 115' ' ' GLN . 11.1 mtp180 -144.83 77.03 1.52 Allowed 'General case' 0 C--O 1.21 -0.978 0 C-N-CA 127.259 2.224 . . . . 0.0 105.565 178.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.911 HG23 HG12 ' A' ' 114' ' ' ILE . 0.8 OUTLIER -78.62 128.59 38.32 Favored 'Isoleucine or valine' 0 C--O 1.253 1.289 0 O-C-N 127.767 3.167 . . . . 0.0 116.794 179.77 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.583 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 0.1 OUTLIER -109.8 145.38 36.81 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 128.499 2.72 . . . . 0.0 107.122 179.917 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . 0.254 0.3 OUTLIER -112.67 29.13 8.2 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 117.051 -1.452 . . . . 0.0 112.286 -179.79 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.594 ' HB2' ' CZ3' ' A' ' 6' ' ' TRP . 3.3 tttp 50.37 89.26 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 127.397 2.279 . . . . 0.0 108.641 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . 0.773 64.0 mt-10 . . . . . 0 N--CA 1.426 -1.639 0 O-C-N 125.846 1.966 . . . . 0.0 113.6 -179.557 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' PLM . . . . . 0.52 ' HG2' ' CE2' ' A' ' 55' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.217 -0.619 0 CA-C-O 118.587 -0.721 . . . . 0.0 109.071 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -99.47 -42.24 7.03 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 116.067 1.877 . . . . 0.0 116.067 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -43.85 93.74 0.01 OUTLIER 'General case' 0 CA--C 1.496 -1.126 0 O-C-N 126.141 2.15 . . . . 0.0 111.691 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 176.3 -178.28 47.71 Favored Glycine 0 C--N 1.31 -0.886 0 C-N-CA 117.343 -2.36 . . . . 0.0 111.527 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.569 HG23 HG23 ' A' ' 39' ' ' THR 0.377 1.2 p -94.02 155.12 17.29 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 128.641 3.201 . . . . 0.0 111.951 -179.735 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.71 ' NE1' HD12 ' A' ' 40' ' ' ILE . 49.2 m95 -159.75 -158.98 0.69 Allowed 'General case' 0 N--CA 1.426 -1.667 0 CA-C-O 114.63 -2.605 . . . . 0.0 106.393 177.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.757 ' HB3' ' CZ ' ' A' ' 128' ' ' PHE . 6.9 ttmt 178.91 -99.64 0.0 OUTLIER 'General case' 0 C--O 1.209 -1.073 0 O-C-N 129.007 3.942 . . . . 0.0 105.17 179.387 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.755 HG12 ' O ' ' A' ' 7' ' ' LYS 0.263 0.3 OUTLIER 159.3 120.13 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 O-C-N 126.329 2.268 . . . . 0.0 109.348 179.514 . . . . . . . . 4 4 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 61.5 t0 -125.55 -76.48 0.59 Allowed 'General case' 0 CA--C 1.506 -0.746 0 CA-C-O 125.965 2.793 . . . . 0.0 108.043 -179.666 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -83.83 122.97 29.41 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 118.626 -2.547 . . . . 0.0 108.269 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . 0.319 0.0 OUTLIER -114.76 -171.12 1.87 Allowed 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 107.151 -1.425 . . . . 0.0 107.151 179.685 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.401 ' HB3' ' HD3' ' A' ' 125' ' ' LYS . 4.6 tt0 -170.53 109.89 0.36 Allowed 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 115.723 -2.391 . . . . 0.0 106.75 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.407 ' ND2' HG12 ' A' ' 122' ' ' VAL 0.259 0.2 OUTLIER 87.65 -8.08 0.59 Allowed 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 -179.852 . . . . . . . . 4 4 . 1 . 003 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.703 ' CD1' ' HB1' ' A' ' 124' ' ' ALA 0.407 0.3 OUTLIER -68.09 -33.81 75.23 Favored 'General case' 0 C--N 1.321 -0.645 0 O-C-N 126.939 2.65 . . . . 0.0 115.6 179.882 . . . . . . . . 4 4 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -71.97 -20.51 61.72 Favored 'General case' 0 C--O 1.213 -0.832 0 O-C-N 119.072 -2.268 . . . . 0.0 110.556 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 24.5 mttt -78.61 -40.88 33.23 Favored 'General case' 0 N--CA 1.443 -0.777 0 O-C-N 126.765 2.541 . . . . 0.0 112.494 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.544 ' CE1' ' HG2' ' A' ' 21' ' ' MET . 0.6 OUTLIER -68.41 -31.79 71.38 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-O 126.076 2.846 . . . . 0.0 110.681 179.702 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 28.4 mtm -69.23 -23.64 63.9 Favored 'General case' 0 C--O 1.22 -0.459 1 O-C-N 114.918 -4.864 . . . . 0.0 108.793 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -79.33 -32.97 43.45 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-O 127.603 3.573 . . . . 0.0 110.647 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.415 ' HD3' HG21 ' A' ' 122' ' ' VAL . 16.6 tptt -74.16 -25.4 59.7 Favored 'General case' 0 N--CA 1.433 -1.302 0 O-C-N 118.257 -2.777 . . . . 0.0 112.728 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.544 ' HG2' ' CE1' ' A' ' 17' ' ' PHE 0.257 13.6 mmm -75.73 -29.1 58.78 Favored 'General case' 0 C--O 1.202 -1.415 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 -179.933 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 103.95 29.12 5.63 Favored Glycine 0 CA--C 1.504 -0.619 0 CA-C-O 115.94 -2.589 . . . . 0.0 109.583 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.614 HD12 ' HG1' ' A' ' 132' ' ' PLM . 2.2 mm -69.42 141.78 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.956 0 CA-C-N 118.857 1.328 . . . . 0.0 109.863 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 24.9 t30 -80.65 131.99 35.54 Favored 'General case' 0 C--N 1.345 0.399 0 CA-C-O 113.742 -3.028 . . . . 0.0 108.503 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . 0.454 99.1 t -11.01 -51.54 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.503 -0.86 0 O-C-N 128.513 3.633 . . . . 0.0 119.262 -179.788 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.614 13.7 t -72.84 -40.1 59.96 Favored 'Isoleucine or valine' 0 C--O 1.249 1.044 0 N-CA-C 116.637 2.088 . . . . 0.0 116.637 -179.467 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 11.3 mttm -67.09 -32.35 73.45 Favored 'General case' 0 C--O 1.213 -0.853 0 O-C-N 125.632 1.832 . . . . 0.0 113.369 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.467 ' HG3' ' N ' ' A' ' 29' ' ' LYS . 16.4 ptt180 -78.96 -29.28 43.86 Favored 'General case' 0 CA--C 1.514 -0.432 0 O-C-N 120.337 -1.477 . . . . 0.0 109.449 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.467 ' N ' ' HG3' ' A' ' 28' ' ' ARG . 0.2 OUTLIER -72.66 -40.85 66.01 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-O 122.626 1.203 . . . . 0.0 110.67 179.955 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.0 tp -73.2 -28.61 62.29 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 113.484 -1.689 . . . . 0.0 108.625 -179.684 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -74.57 -28.98 62.32 Favored Glycine 0 C--N 1.348 1.219 0 CA-C-N 113.897 -1.501 . . . . 0.0 113.969 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -71.63 -37.97 70.82 Favored 'General case' 0 C--O 1.241 0.655 0 C-N-CA 126.89 2.076 . . . . 0.0 111.563 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 6.6 m80 -111.28 30.27 7.07 Favored 'General case' 0 N--CA 1.447 -0.594 0 O-C-N 126.786 2.554 . . . . 0.0 110.186 179.346 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -49.68 -36.63 25.69 Favored 'General case' 0 CA--C 1.501 -0.912 0 N-CA-C 116.813 2.153 . . . . 0.0 116.813 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . 0.261 92.9 m-20 70.42 54.22 0.3 Allowed 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 116.114 -2.234 . . . . 0.0 107.122 -179.196 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.778 HD11 HD12 ' A' ' 38' ' ' LEU 0.293 1.7 tp -85.8 107.45 17.65 Favored 'General case' 0 N--CA 1.479 0.992 0 O-C-N 128.7 3.75 . . . . 0.0 103.747 179.911 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.43 ' HA ' ' CB ' ' A' ' 7' ' ' LYS . 24.4 tttm -92.77 127.98 38.46 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 100.473 -3.899 . . . . 0.0 100.473 179.614 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.778 HD12 HD11 ' A' ' 36' ' ' LEU 0.377 0.5 OUTLIER -112.05 121.4 44.87 Favored 'General case' 0 C--N 1.288 -2.09 0 C-N-CA 116.011 -2.275 . . . . 0.0 107.004 -178.5 . . . . . . . . 4 4 . 1 . 003 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.569 HG23 HG23 ' A' ' 5' ' ' THR . 28.0 m -116.12 90.86 3.43 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 117.287 -3.383 . . . . 0.0 104.588 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.71 HD12 ' NE1' ' A' ' 6' ' ' TRP . 26.5 mt -70.36 130.16 34.6 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.467 ' HB ' HG23 ' A' ' 48' ' ' THR . 11.6 m -126.75 105.91 9.0 Favored 'General case' 0 N--CA 1.477 0.886 0 O-C-N 127.801 3.188 . . . . 0.0 109.734 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.578 ' HG2' ' CE1' ' A' ' 47' ' ' PHE . 1.0 OUTLIER -84.69 109.1 17.77 Favored 'General case' 0 C--O 1.24 0.6 0 N-CA-C 114.368 1.247 . . . . 0.0 114.368 -179.906 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -96.66 31.08 2.4 Favored 'General case' 0 N--CA 1.419 -1.991 0 O-C-N 121.214 -0.929 . . . . 0.0 109.857 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 97.41 -13.12 64.69 Favored Glycine 0 C--N 1.29 -1.99 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.376 0.0 OUTLIER -175.6 -50.59 0.01 OUTLIER 'General case' 0 C--O 1.213 -0.823 0 CA-C-O 126.132 2.872 . . . . 0.0 109.168 179.901 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 28.1 ttmt -64.89 115.9 5.81 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 113.048 -1.887 . . . . 0.0 110.504 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.578 ' CE1' ' HG2' ' A' ' 42' ' ' GLN . 0.9 OUTLIER -100.71 93.85 5.78 Favored 'General case' 0 CA--C 1.499 -0.995 0 CA-C-O 123.312 1.529 . . . . 0.0 107.271 179.803 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.526 ' HA ' ' HA ' ' A' ' 61' ' ' VAL 0.388 3.1 t -89.72 87.39 6.98 Favored 'General case' 0 N--CA 1.432 -1.347 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 179.623 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.794 HG12 ' CG1' ' A' ' 60' ' ' VAL 0.596 0.5 OUTLIER -70.09 107.93 2.03 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.12 0 O-C-N 125.884 1.99 . . . . 0.0 110.334 179.981 . . . . . . . . 4 4 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.55 ' CB ' ' HB ' ' A' ' 39' ' ' THR . 26.0 tttm -68.9 115.97 8.83 Favored 'General case' 0 C--N 1.302 -1.46 1 N-CA-C 100.192 -4.003 . . . . 0.0 100.192 -179.731 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.476 ' HG3' HD13 ' A' ' 36' ' ' LEU 0.276 69.9 tt0 -107.29 96.32 6.33 Favored 'General case' 0 C--N 1.322 -0.63 0 O-C-N 126.659 2.474 . . . . 0.0 108.484 179.906 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.427 ' HA ' ' HA ' ' A' ' 57' ' ' ASN 0.261 0.1 OUTLIER -96.48 52.37 1.23 Allowed 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 105.201 -2.148 . . . . 0.0 105.201 179.378 . . . . . . . . 4 4 . 1 . 003 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.538 ' HA ' ' HA ' ' A' ' 36' ' ' LEU . 0.1 OUTLIER -77.97 160.23 28.32 Favored 'General case' 0 C--O 1.214 -0.781 0 O-C-N 127.552 3.032 . . . . 0.0 109.882 -179.537 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -53.65 -28.26 32.07 Favored 'General case' 0 C--O 1.215 -0.724 0 O-C-N 126.477 2.361 . . . . 0.0 108.633 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.413 ' C ' ' HG2' ' A' ' 56' ' ' ARG . 8.0 m-85 -62.27 -58.8 6.39 Favored 'General case' 0 C--N 1.351 0.639 0 CA-C-O 115.201 -2.333 . . . . 0.0 109.612 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.658 ' HB2' HG22 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -156.85 155.91 32.27 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-N 123.399 2.818 . . . . 0.0 106.102 179.414 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.427 ' HA ' ' HA ' ' A' ' 52' ' ' SER 0.262 21.2 t30 -101.07 70.94 1.37 Allowed 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 100.364 -3.939 . . . . 0.0 100.364 179.67 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.658 HG22 ' HB2' ' A' ' 56' ' ' ARG . 8.4 tp -120.03 122.98 69.88 Favored 'Isoleucine or valine' 0 C--O 1.243 0.728 0 C-N-CA 130.146 3.378 . . . . 0.0 118.697 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.436 ' HA ' ' HA ' ' A' ' 50' ' ' LYS . 0.0 OUTLIER -72.58 135.66 45.6 Favored 'General case' 0 N--CA 1.468 0.441 0 O-C-N 118.694 -2.504 . . . . 0.0 105.466 179.856 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.794 ' CG1' HG12 ' A' ' 49' ' ' VAL . 4.4 p -109.96 101.13 12.13 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-O 126.177 2.894 . . . . 0.0 111.407 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.526 ' HA ' ' HA ' ' A' ' 48' ' ' THR 0.311 2.0 m -88.56 131.2 36.62 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 O-C-N 116.684 -3.76 . . . . 0.0 113.061 179.858 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.443 ' HE1' HG13 ' A' ' 60' ' ' VAL . 22.1 p90 -151.58 89.02 1.45 Allowed 'General case' 0 N--CA 1.442 -0.827 0 C-N-CA 116.579 -2.049 . . . . 0.0 107.128 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -56.08 134.64 52.79 Favored 'General case' 0 N--CA 1.432 -1.362 0 N-CA-C 104.438 -2.43 . . . . 0.0 104.438 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -49.63 102.81 0.04 OUTLIER 'General case' 0 N--CA 1.428 -1.565 0 O-C-N 126.407 2.317 . . . . 0.0 110.515 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 89.73 32.19 10.4 Favored Glycine 0 C--N 1.346 1.115 0 C-N-CA 128.289 2.852 . . . . 0.0 119.924 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . 0.364 0.4 OUTLIER -111.42 99.16 8.1 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 N-CA-C 104.902 -2.258 . . . . 0.0 104.902 179.91 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.42 ' HA ' HG22 ' A' ' 81' ' ' THR . 0.1 OUTLIER -51.47 136.93 25.01 Favored 'General case' 0 CA--C 1.487 -1.45 0 O-C-N 126.079 2.112 . . . . 0.0 114.153 179.971 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 9.9 p90 -145.62 175.08 10.63 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -129.46 146.77 51.26 Favored 'General case' 0 CA--C 1.501 -0.924 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.51 ' HB3' HD23 ' A' ' 78' ' ' LEU . 16.5 t80 -129.96 -39.78 1.38 Allowed 'General case' 0 C--O 1.213 -0.863 0 CA-C-O 116.118 -1.896 . . . . 0.0 111.806 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.545 ' C ' HD22 ' A' ' 72' ' ' LEU . 0.7 OUTLIER 64.39 158.44 0.09 Allowed 'General case' 0 C--N 1.308 -1.2 0 O-C-N 125.366 1.666 . . . . 0.0 112.056 -179.904 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.797 ' N ' HD13 ' A' ' 72' ' ' LEU . 0.0 OUTLIER 41.55 -158.7 0.01 OUTLIER 'General case' 0 C--N 1.293 -1.873 0 O-C-N 128.351 3.532 . . . . 0.0 110.424 178.369 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.584 ' HA ' ' HG3' ' A' ' 132' ' ' PLM . . . 53.97 35.93 23.16 Favored 'General case' 0 C--O 1.208 -1.094 0 CA-C-N 114.237 -1.347 . . . . 0.0 111.444 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.404 ' CB ' ' O ' ' A' ' 73' ' ' ALA . 0.3 OUTLIER 102.34 19.84 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.365 0 O-C-N 126.565 2.415 . . . . 0.0 113.89 179.22 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.571 ' HA3' ' CD1' ' A' ' 78' ' ' LEU . . . -136.87 -38.63 0.15 Allowed Glycine 0 CA--C 1.549 2.174 0 N-CA-C 118.434 2.134 . . . . 0.0 118.434 179.025 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . 0.308 0.0 OUTLIER 59.28 65.95 1.1 Allowed 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 119.662 1.731 . . . . 0.0 107.897 -179.026 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.569 ' HB3' ' HB ' ' A' ' 96' ' ' VAL . 31.0 mt-10 71.81 76.39 0.17 Allowed 'General case' 0 C--O 1.218 -0.594 0 O-C-N 126.518 2.386 . . . . 0.0 108.529 -178.212 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.571 ' CD1' ' HA3' ' A' ' 75' ' ' GLY 0.436 0.7 OUTLIER -97.63 135.11 39.92 Favored 'General case' 0 CA--C 1.5 -0.978 0 O-C-N 127.764 3.165 . . . . 0.0 104.38 -178.162 . . . . . . . . 4 4 . 1 . 003 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 20.2 m -158.13 124.72 4.82 Favored 'General case' 0 CA--C 1.481 -1.696 0 N-CA-C 103.919 -2.623 . . . . 0.0 103.919 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -168.61 -155.49 9.66 Favored Glycine 0 C--N 1.302 -1.313 0 O-C-N 119.748 -1.845 . . . . 0.0 109.316 -179.618 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.42 HG22 ' HA ' ' A' ' 67' ' ' ASP . 4.2 p -145.17 -179.97 6.98 Favored 'General case' 0 C--O 1.196 -1.73 0 C-N-CA 117.23 -1.788 . . . . 0.0 106.965 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' TRP . . . . . 0.472 ' CE2' ' HA3' ' A' ' 91' ' ' GLY . 19.7 m95 -132.27 142.88 49.55 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 101.689 -3.449 . . . . 0.0 101.689 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 14.4 t -143.77 160.96 39.82 Favored 'General case' 0 N--CA 1.417 -2.078 0 CA-C-O 124.948 2.309 . . . . 0.0 113.195 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -94.91 126.97 40.6 Favored 'General case' 0 C--N 1.354 0.8 0 CA-C-N 110.774 -2.921 . . . . 0.0 105.775 -179.728 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . 0.685 0.5 OUTLIER -107.24 33.72 3.85 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.88 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 95.26 -93.43 1.6 Allowed Glycine 0 N--CA 1.427 -1.953 0 N-CA-C 103.986 -3.646 . . . . 0.0 103.986 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -88.96 -5.84 57.68 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 120.154 3.39 . . . . 0.0 120.154 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.4 ' HE2' HG21 ' A' ' 105' ' ' VAL 0.265 0.2 OUTLIER -129.91 152.53 49.28 Favored 'General case' 0 CA--C 1.49 -1.354 0 O-C-N 125.163 1.54 . . . . 0.0 107.182 179.678 . . . . . . . . 4 4 . 1 . 003 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.43 ' HB3' ' HB2' ' A' ' 106' ' ' ARG . 0.3 OUTLIER -106.21 134.15 49.79 Favored 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 105.039 -2.208 . . . . 0.0 105.039 -179.864 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -121.76 154.1 25.94 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.941 0 N-CA-C 105.276 -2.12 . . . . 0.0 105.276 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.472 ' HA3' ' CE2' ' A' ' 82' ' ' TRP . . . -134.96 111.61 0.94 Allowed Glycine 0 CA--C 1.531 1.04 1 C-N-CA 131.06 4.171 . . . . 0.0 109.509 179.898 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 24.8 mtmt -109.16 158.53 17.71 Favored 'General case' 0 N--CA 1.426 -1.651 0 N-CA-C 104.374 -2.454 . . . . 0.0 104.374 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.548 ' HB2' HD22 ' A' ' 102' ' ' LEU . 30.5 m-85 -148.36 112.95 5.34 Favored 'General case' 0 CA--C 1.508 -0.635 0 CA-C-O 123.378 1.561 . . . . 0.0 108.079 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 57.0 mttm -93.39 138.91 31.27 Favored 'General case' 0 N--CA 1.437 -1.104 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . 0.302 0.3 OUTLIER -92.15 136.61 33.04 Favored 'General case' 0 CA--C 1.491 -1.293 0 CA-C-N 113.55 -1.659 . . . . 0.0 109.106 179.75 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.569 ' HB ' ' HB3' ' A' ' 77' ' ' GLU . 38.4 t -71.98 -38.13 63.12 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 C-N-CA 125.277 1.431 . . . . 0.0 111.166 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . 0.319 0.8 OUTLIER -83.24 2.64 34.85 Favored 'General case' 0 C--O 1.261 1.665 0 N-CA-C 118.103 2.631 . . . . 0.0 118.103 -179.959 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -144.28 -29.22 0.49 Allowed 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 116.197 -2.201 . . . . 0.0 114.843 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 92.48 -0.16 70.72 Favored Glycine 0 CA--C 1.532 1.129 0 N-CA-C 118.956 2.343 . . . . 0.0 118.956 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 6.4 mmtt -77.61 -155.1 0.07 Allowed 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 119.299 1.55 . . . . 0.0 111.331 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.55 118.58 4.7 Favored 'General case' 0 CA--C 1.489 -1.375 0 C-N-CA 128.983 2.913 . . . . 0.0 114.541 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.627 ' HA ' ' HA ' ' A' ' 119' ' ' TYR . 0.7 OUTLIER -92.23 135.87 33.65 Favored 'General case' 0 C--N 1.317 -0.812 1 C-N-CA 132.484 4.314 . . . . 0.0 102.741 179.073 . . . . . . . . 4 4 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.85 HG23 ' HB3' ' A' ' 117' ' ' TYR . 14.0 tt -129.34 163.72 33.76 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.003 0 C-N-CA 116.524 -2.07 . . . . 0.0 109.395 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -150.39 146.77 26.9 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-O 115.658 -2.115 . . . . 0.0 107.808 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.593 ' HB ' ' CE2' ' A' ' 117' ' ' TYR . 8.8 p -136.53 120.8 24.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 122.915 2.598 . . . . 0.0 110.466 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.789 ' HG2' HH11 ' A' ' 106' ' ' ARG . 1.2 mtt-85 -76.95 86.65 3.48 Favored 'General case' 0 CA--C 1.496 -1.105 0 O-C-N 126.66 2.475 . . . . 0.0 106.689 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 10.7 tt0 -81.65 78.67 8.37 Favored 'General case' 0 N--CA 1.424 -1.742 0 CA-C-O 123.104 1.431 . . . . 0.0 113.031 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.525 ' CD1' ' CZ2' ' A' ' 6' ' ' TRP . 2.3 mm -69.01 98.06 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 C-N-CA 115.537 -2.465 . . . . 0.0 110.296 179.693 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -100.1 101.43 12.49 Favored 'General case' 0 C--O 1.215 -0.742 0 N-CA-C 103.254 -2.869 . . . . 0.0 103.254 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 65.41 -88.8 0.1 Allowed Glycine 0 C--N 1.339 0.695 0 O-C-N 126.061 2.101 . . . . 0.0 112.138 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . 0.368 0.4 OUTLIER -117.82 -13.57 10.12 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-O 113.313 -3.232 . . . . 0.0 111.158 179.562 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . 0.251 2.2 mp0 -93.6 133.42 36.95 Favored 'General case' 0 C--O 1.212 -0.879 0 O-C-N 128.905 3.878 . . . . 0.0 110.89 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.909 HD21 ' HG2' ' A' ' 115' ' ' GLN 0.284 0.4 OUTLIER -103.06 141.74 35.3 Favored 'General case' 0 C--O 1.21 -1.011 0 N-CA-C 101.321 -3.585 . . . . 0.0 101.321 179.721 . . . . . . . . 4 4 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.762 HG13 HD13 ' A' ' 127' ' ' ILE 0.297 1.4 mp -129.95 139.0 52.64 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 N-CA-C 101.706 -3.442 . . . . 0.0 101.706 179.385 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.909 ' HG2' HD21 ' A' ' 113' ' ' LEU . 3.4 mt-30 -119.24 104.91 10.83 Favored 'General case' 0 C--N 1.316 -0.851 1 O-C-N 129.621 4.325 . . . . 0.0 101.492 179.699 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.53 ' HB ' ' HG3' ' A' ' 125' ' ' LYS . 3.4 t -140.68 157.68 45.09 Favored 'General case' 0 N--CA 1.412 -2.371 0 C-N-CA 116.924 -1.91 . . . . 0.0 112.357 -178.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.85 ' HB3' HG23 ' A' ' 103' ' ' ILE 0.372 22.2 m-30 137.93 -138.36 0.0 OUTLIER 'General case' 0 CA--C 1.484 -1.584 1 O-C-N 129.408 4.193 . . . . 0.0 113.171 176.246 . . . . . . . . 4 3 . 1 . 003 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.502 ' HB ' ' HA ' ' A' ' 123' ' ' GLU . 10.2 t -158.67 -154.33 0.42 Allowed 'General case' 0 C--N 1.308 -1.229 0 O-C-N 127.674 3.109 . . . . 0.0 115.756 -174.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.627 ' HA ' ' HA ' ' A' ' 102' ' ' LEU . 1.7 t80 -114.9 -55.94 2.43 Favored 'General case' 0 C--N 1.346 0.417 0 N-CA-C 105.126 -2.176 . . . . 0.0 105.126 178.305 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.88 -83.37 0.65 Allowed 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 111.59 -2.55 . . . . 0.0 112.396 179.203 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -143.55 25.29 2.15 Favored Glycine 0 C--N 1.366 2.238 0 N-CA-C 121.359 3.303 . . . . 0.0 121.359 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.415 HG21 ' HD3' ' A' ' 20' ' ' LYS . 15.0 t -123.34 97.35 4.63 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 N-CA-C 103.011 -2.959 . . . . 0.0 103.011 179.253 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.502 ' HA ' ' HB ' ' A' ' 118' ' ' THR . 13.6 mt-10 -56.86 179.77 0.04 OUTLIER 'General case' 0 C--O 1.205 -1.289 0 CA-C-O 126.554 3.073 . . . . 0.0 113.093 -177.418 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.703 ' HB1' ' CD1' ' A' ' 14' ' ' TYR . . . -169.17 94.5 0.31 Allowed 'General case' 0 C--O 1.211 -0.961 0 O-C-N 118.821 -2.424 . . . . 0.0 107.987 -179.661 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.53 ' HG3' ' HB ' ' A' ' 116' ' ' THR 0.391 0.1 OUTLIER -84.92 153.72 22.67 Favored 'General case' 0 N--CA 1.444 -0.727 0 O-C-N 125.923 2.014 . . . . 0.0 112.529 -179.572 . . . . . . . . 4 4 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.549 ' CD ' ' HB2' ' A' ' 115' ' ' GLN . 1.0 OUTLIER -137.81 77.83 1.65 Allowed 'General case' 0 N--CA 1.427 -1.598 0 O-C-N 127.57 3.044 . . . . 0.0 105.297 177.114 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.762 HD13 HG13 ' A' ' 114' ' ' ILE . 50.8 mm -66.99 82.79 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.259 1.557 0 O-C-N 128.051 3.344 . . . . 0.0 111.202 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.757 ' CZ ' ' HB3' ' A' ' 7' ' ' LYS 0.368 5.7 t80 -84.44 144.39 28.79 Favored 'General case' 0 N--CA 1.419 -2.001 0 CA-C-O 125.256 2.455 . . . . 0.0 113.753 -179.641 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.407 ' N ' ' CG ' ' A' ' 128' ' ' PHE 0.391 8.7 mmtt -95.28 10.53 35.82 Favored 'General case' 0 N--CA 1.436 -1.147 0 CA-C-N 110.996 -2.82 . . . . 0.0 113.996 -177.666 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.509 ' HA ' ' CE3' ' A' ' 6' ' ' TRP . 18.4 tttt 61.53 111.7 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 122.555 2.434 . . . . 0.0 113.666 -178.39 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . 0.857 2.3 tm-20 . . . . . 0 C--O 1.217 -0.612 0 O-C-N 117.167 -3.458 . . . . 0.0 114.508 -179.666 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' PLM . . . . . 0.712 ' H21' HG11 ' A' ' 60' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.384 0 CA-C-O 122.48 1.133 . . . . 0.0 109.489 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.684 ' CE1' HD12 ' A' ' 108' ' ' ILE . 65.4 m-85 -61.98 -54.19 45.12 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 116.353 1.983 . . . . 0.0 116.353 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -39.78 91.39 0.0 OUTLIER 'General case' 0 CA--C 1.499 -0.984 0 O-C-N 126.678 2.486 . . . . 0.0 111.34 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.43 ' O ' ' HB ' ' A' ' 40' ' ' ILE . . . 158.69 -174.71 35.78 Favored Glycine 0 C--O 1.214 -1.114 0 CA-C-N 113.824 -1.534 . . . . 0.0 110.91 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.582 ' HA ' ' HA ' ' A' ' 39' ' ' THR 0.549 0.5 OUTLIER -81.93 156.88 24.52 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-O 124.426 2.06 . . . . 0.0 115.774 -179.697 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.54 ' CH2' HD11 ' A' ' 108' ' ' ILE . 73.1 m95 -149.8 157.3 43.07 Favored 'General case' 0 N--CA 1.435 -1.182 0 CA-C-N 110.647 -2.979 . . . . 0.0 106.858 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -160.27 102.54 1.41 Allowed 'General case' 0 C--O 1.214 -0.79 1 O-C-N 129.59 4.306 . . . . 0.0 107.081 179.922 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.527 ' HB ' ' CD1' ' A' ' 128' ' ' PHE 0.38 9.3 p -47.12 139.35 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.289 0 CA-C-N 121.593 1.997 . . . . 0.0 113.131 179.992 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -131.61 0.98 4.03 Favored 'General case' 0 CA--C 1.496 -1.099 0 C-N-CA 119.785 -0.766 . . . . 0.0 112.55 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 16.6 ptp180 -160.79 -39.06 0.05 OUTLIER 'General case' 0 CA--C 1.474 -1.967 0 O-C-N 116.946 -3.596 . . . . 0.0 113.301 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . 0.278 0.6 OUTLIER 62.09 178.79 0.13 Allowed 'General case' 0 C--O 1.243 0.742 0 C-N-CA 125.293 1.437 . . . . 0.0 108.193 179.613 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -132.34 -80.2 0.5 Allowed 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 122.478 2.399 . . . . 0.0 109.635 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 16.5 t30 -96.05 15.46 20.62 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 124.799 1.312 . . . . 0.0 113.576 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.876 ' HA ' ' HB1' ' A' ' 124' ' ' ALA 0.26 0.1 OUTLIER -58.0 -26.87 62.94 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 117.978 2.584 . . . . 0.0 117.978 -179.952 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -72.12 -41.32 67.37 Favored 'General case' 0 C--O 1.207 -1.168 0 O-C-N 120.822 -1.174 . . . . 0.0 110.794 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 17.8 tttm -79.72 -26.37 40.83 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-O 123.175 1.464 . . . . 0.0 114.161 -179.679 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.676 ' CB ' ' HB2' ' A' ' 124' ' ' ALA . 7.8 t80 -67.05 -35.67 80.37 Favored 'General case' 0 N--CA 1.422 -1.838 0 C-N-CA 118.509 -1.276 . . . . 0.0 113.752 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.451 ' CB ' HG13 ' A' ' 23' ' ' ILE . 24.2 mtt -72.51 -23.7 61.05 Favored 'General case' 0 N--CA 1.425 -1.714 0 CA-C-O 124.561 2.124 . . . . 0.0 107.81 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -76.85 -22.94 52.78 Favored 'General case' 0 CA--C 1.507 -0.689 0 C-N-CA 116.54 -2.064 . . . . 0.0 112.777 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 18.9 tptp -68.0 -39.69 83.17 Favored 'General case' 0 C--N 1.314 -0.936 0 O-C-N 118.827 -2.42 . . . . 0.0 114.889 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.514 ' HG3' ' CD2' ' A' ' 119' ' ' TYR . 3.2 mpp? -76.03 -37.57 58.23 Favored 'General case' 0 C--O 1.207 -1.132 0 C-N-CA 124.527 1.131 . . . . 0.0 109.429 179.802 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 118.73 47.91 0.39 Allowed Glycine 0 C--N 1.308 -1.016 0 CA-C-N 113.05 -1.886 . . . . 0.0 110.01 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.571 HG22 ' HG2' ' A' ' 28' ' ' ARG . 5.4 mm -73.15 106.56 3.22 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.784 0 CA-C-N 121.735 2.768 . . . . 0.0 110.565 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -44.82 111.21 0.29 Allowed 'General case' 0 N--CA 1.44 -0.94 0 CA-C-O 114.136 -2.84 . . . . 0.0 113.019 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . 0.421 0.2 OUTLIER 3.76 -61.78 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.497 -1.076 1 O-C-N 129.463 4.227 . . . . 0.0 119.309 179.89 . . . . . . . . 4 3 . 1 . 004 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.579 13.3 m -72.59 -22.24 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.906 0 N-CA-C 117.53 2.419 . . . . 0.0 117.53 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.43 ' HB2' ' CG2' ' A' ' 23' ' ' ILE . 26.5 mttp -77.0 -25.97 53.31 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-O 118.406 -0.807 . . . . 0.0 110.918 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.571 ' HG2' HG22 ' A' ' 23' ' ' ILE . 0.1 OUTLIER -79.98 -24.44 40.91 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 117.934 -1.506 . . . . 0.0 107.495 179.882 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.8 ttpt -74.84 -49.76 19.45 Favored 'General case' 0 C--O 1.212 -0.893 0 CA-C-O 123.819 1.771 . . . . 0.0 108.711 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.428 ' HA ' HD12 ' A' ' 30' ' ' LEU . 7.3 tp -73.25 -28.85 62.37 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 114.56 -1.2 . . . . 0.0 108.348 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -67.55 -32.64 79.23 Favored Glycine 0 CA--C 1.538 1.474 0 O-C-N 124.843 1.34 . . . . 0.0 112.219 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -78.05 -24.35 47.8 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -112.81 2.41 15.96 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-O 115.903 -1.999 . . . . 0.0 112.363 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 21.5 p-10 -33.46 -32.51 0.01 OUTLIER 'General case' 0 CA--C 1.505 -0.766 0 N-CA-C 117.922 2.564 . . . . 0.0 117.922 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . 0.259 4.5 t-20 75.42 31.03 0.79 Allowed 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 121.386 1.903 . . . . 0.0 109.561 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.584 ' CG ' HD13 ' A' ' 38' ' ' LEU . 1.2 tp -60.97 87.83 0.02 OUTLIER 'General case' 0 C--O 1.213 -0.863 0 O-C-N 126.925 2.641 . . . . 0.0 109.602 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.82 104.15 16.63 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 102.122 -3.288 . . . . 0.0 102.122 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.584 HD13 ' CG ' ' A' ' 36' ' ' LEU 0.265 0.6 OUTLIER -90.47 104.13 16.74 Favored 'General case' 0 C--N 1.288 -2.089 0 O-C-N 125.921 2.013 . . . . 0.0 109.384 -179.901 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.582 ' HA ' ' HA ' ' A' ' 5' ' ' THR . 6.9 m -87.18 85.62 7.22 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 102.021 -3.326 . . . . 0.0 102.021 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.656 HD13 HG12 ' A' ' 49' ' ' VAL . 6.4 mm -60.0 131.44 24.66 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 CA-C-O 124.191 1.948 . . . . 0.0 110.68 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.428 HG22 ' O ' ' A' ' 41' ' ' THR . 3.0 m -150.34 103.4 3.15 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 112.915 -1.948 . . . . 0.0 114.575 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.44 ' HG2' ' CE1' ' A' ' 47' ' ' PHE . 1.6 mm-40 -49.21 117.73 2.31 Favored 'General case' 0 CA--C 1.547 0.847 0 O-C-N 126.479 2.362 . . . . 0.0 107.992 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.477 ' HB2' HG22 ' A' ' 48' ' ' THR 0.252 1.2 tp10 -90.86 45.65 1.27 Allowed 'General case' 0 CA--C 1.484 -1.562 0 O-C-N 124.816 1.322 . . . . 0.0 107.494 -179.46 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.02 -55.82 5.05 Favored Glycine 0 C--N 1.292 -1.912 0 N-CA-C 105.657 -2.977 . . . . 0.0 105.657 -179.68 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.503 ' HB2' ' CG ' ' A' ' 63' ' ' GLU 0.318 1.7 m120 -108.13 -76.9 0.6 Allowed 'General case' 0 CA--C 1.504 -0.805 0 N-CA-C 115.158 1.54 . . . . 0.0 115.158 -179.449 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.712 ' HG3' ' N ' ' A' ' 47' ' ' PHE . 26.1 tptt -83.64 -76.85 0.27 Allowed 'General case' 0 N--CA 1.417 -2.093 0 C-N-CA 114.594 -2.842 . . . . 0.0 115.112 -178.346 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.712 ' N ' ' HG3' ' A' ' 46' ' ' LYS 0.422 0.1 OUTLIER 162.77 108.78 0.0 OUTLIER 'General case' 0 CA--C 1.496 -1.127 0 O-C-N 128.398 3.561 . . . . 0.0 109.423 -174.761 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.875 ' HA ' ' HA ' ' A' ' 61' ' ' VAL 0.407 9.0 t -81.63 112.33 18.73 Favored 'General case' 0 C--O 1.248 0.992 0 O-C-N 119.458 -2.026 . . . . 0.0 106.118 178.316 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.656 HG12 HD13 ' A' ' 40' ' ' ILE 0.615 1.0 OUTLIER -90.47 105.04 15.9 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 N-CA-C 116.117 1.895 . . . . 0.0 116.117 -179.606 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.458 ' CB ' ' HB ' ' A' ' 39' ' ' THR . 0.4 OUTLIER -67.4 111.3 3.98 Favored 'General case' 0 C--N 1.302 -1.487 1 N-CA-C 99.836 -4.135 . . . . 0.0 99.836 179.351 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -96.82 67.9 2.33 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 104.173 -2.528 . . . . 0.0 104.173 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.7 m -78.67 68.4 4.64 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 105.417 -2.068 . . . . 0.0 105.417 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.553 ' CB ' ' HA ' ' A' ' 36' ' ' LEU . 1.1 p -109.66 -167.51 1.21 Allowed 'General case' 0 N--CA 1.438 -1.033 0 CA-C-N 114.76 -1.109 . . . . 0.0 110.057 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -75.58 -24.22 56.59 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 117.867 -1.533 . . . . 0.0 111.457 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.52 ' CE2' ' HA ' ' A' ' 73' ' ' ALA . 31.8 m-85 -69.29 -50.55 45.71 Favored 'General case' 0 C--O 1.221 -0.423 0 C-N-CA 115.47 -2.492 . . . . 0.0 111.042 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.405 ' O ' HG22 ' A' ' 58' ' ' ILE . 0.0 OUTLIER 168.6 151.82 0.03 OUTLIER 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 123.916 3.053 . . . . 0.0 110.351 179.208 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 31.2 t30 -84.34 116.36 22.98 Favored 'General case' 0 C--N 1.348 0.535 1 N-CA-C 99.892 -4.114 . . . . 0.0 99.892 179.056 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.405 HG22 ' O ' ' A' ' 56' ' ' ARG 0.299 0.0 OUTLIER -136.52 -28.02 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 O-C-N 128.524 3.64 . . . . 0.0 116.622 -178.223 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 67.46 79.05 0.23 Allowed 'General case' 0 C--N 1.352 0.701 0 N-CA-C 104.096 -2.557 . . . . 0.0 104.096 -178.57 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.583 ' CG1' ' CE2' ' A' ' 62' ' ' PHE . 94.2 t -86.72 77.61 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.408 0 CA-C-N 114.3 -1.318 . . . . 0.0 114.257 -177.254 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.875 ' HA ' ' HA ' ' A' ' 48' ' ' THR . 0.4 OUTLIER -69.6 143.03 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.378 0 O-C-N 118.749 -2.469 . . . . 0.0 106.923 177.334 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.656 ' CE1' ' CB ' ' A' ' 68' ' ' PHE . 1.6 m-30 -144.31 57.88 1.32 Allowed 'General case' 0 N--CA 1.44 -0.945 0 C-N-CA 114.392 -2.923 . . . . 0.0 111.839 178.235 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.672 ' CA ' ' HB2' ' A' ' 46' ' ' LYS . 1.2 mt-10 -19.61 119.66 0.02 OUTLIER 'General case' 0 C--N 1.311 -1.071 0 O-C-N 128.601 3.688 . . . . 0.0 108.682 -178.115 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.546 ' N ' ' HB2' ' A' ' 46' ' ' LYS . 0.4 OUTLIER -48.11 101.83 0.03 OUTLIER 'General case' 0 N--CA 1.438 -1.032 0 CA-C-O 122.761 1.267 . . . . 0.0 110.979 -177.387 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 93.38 22.25 27.4 Favored Glycine 0 C--N 1.351 1.415 0 CA-C-N 110.793 -2.912 . . . . 0.0 114.0 -179.464 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.411 ' N ' ' O ' ' A' ' 63' ' ' GLU 0.364 0.9 OUTLIER -102.7 77.79 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 N-CA-C 104.015 -2.587 . . . . 0.0 104.015 179.796 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -39.17 111.71 0.2 Allowed 'General case' 0 CA--C 1.485 -1.55 0 O-C-N 126.895 2.622 . . . . 0.0 115.929 -179.525 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.656 ' CB ' ' CE1' ' A' ' 62' ' ' PHE . 17.1 p90 -106.7 -179.68 4.01 Favored 'General case' 0 N--CA 1.433 -1.306 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.533 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -144.69 148.3 34.05 Favored 'General case' 0 CA--C 1.521 -0.161 0 O-C-N 126.702 2.501 . . . . 0.0 109.183 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.456 ' CB ' HD22 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -146.31 118.94 8.55 Favored 'General case' 0 C--O 1.216 -0.679 0 O-C-N 125.274 1.609 . . . . 0.0 107.28 -179.997 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.452 ' C ' ' CD1' ' A' ' 72' ' ' LEU . 0.7 OUTLIER -99.84 37.68 1.58 Allowed 'General case' 0 CA--C 1.489 -1.37 0 CA-C-N 121.366 1.893 . . . . 0.0 112.133 -179.255 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.575 ' N ' HD13 ' A' ' 72' ' ' LEU . 0.0 OUTLIER 173.61 -167.59 0.03 OUTLIER 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 125.14 1.376 . . . . 0.0 109.199 -179.094 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.52 ' HA ' ' CE2' ' A' ' 55' ' ' PHE . . . 69.74 24.82 5.28 Favored 'General case' 0 C--O 1.208 -1.101 0 O-C-N 124.711 1.257 . . . . 0.0 110.352 -179.307 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.77 ' N ' ' HG3' ' A' ' 132' ' ' PLM . 27.8 t0 106.89 41.26 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.403 0 O-C-N 126.726 2.516 . . . . 0.0 113.692 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -155.53 -40.31 0.02 OUTLIER Glycine 0 CA--C 1.543 1.8 0 N-CA-C 118.301 2.08 . . . . 0.0 118.301 179.556 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.472 ' O ' ' HB2' ' A' ' 77' ' ' GLU 0.257 0.1 OUTLIER 61.91 25.62 15.41 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-O 115.188 -2.339 . . . . 0.0 108.097 -179.554 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.499 ' HB3' ' HB ' ' A' ' 96' ' ' VAL . 3.9 mm-40 112.74 113.14 0.0 OUTLIER 'General case' 0 C--N 1.313 -1.02 1 O-C-N 133.923 7.014 . . . . 0.0 109.45 -177.659 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.5 ' HG ' ' HB3' ' A' ' 93' ' ' PHE 0.451 7.4 tt -139.53 119.68 13.66 Favored 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 102.662 -3.088 . . . . 0.0 102.662 -178.272 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 21.8 m -141.63 120.66 12.86 Favored 'General case' 0 C--O 1.197 -1.687 0 N-CA-C 103.38 -2.822 . . . . 0.0 103.38 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.517 ' HA3' ' HA ' ' A' ' 93' ' ' PHE . . . -160.9 -163.25 13.64 Favored Glycine 0 C--O 1.215 -1.051 0 C-N-CA 116.972 -2.537 . . . . 0.0 114.057 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 13.9 p -141.95 165.71 26.72 Favored 'General case' 0 C--O 1.188 -2.175 0 O-C-N 127.296 2.41 . . . . 0.0 110.616 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 93.9 m95 -107.36 147.46 30.31 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 103.76 -2.682 . . . . 0.0 103.76 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 5.0 t -147.15 127.53 13.99 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 125.093 1.495 . . . . 0.0 109.612 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -79.48 117.54 20.53 Favored 'General case' 0 N--CA 1.427 -1.606 0 CA-C-N 112.536 -2.12 . . . . 0.0 108.597 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.408 ' HA ' ' OE1' ' A' ' 85' ' ' GLU 0.608 3.4 mm-40 -78.03 -20.09 53.09 Favored 'General case' 0 N--CA 1.426 -1.662 0 O-C-N 123.766 0.666 . . . . 0.0 109.267 179.975 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 126.64 -53.2 0.8 Allowed Glycine 0 N--CA 1.436 -1.339 0 N-CA-C 104.921 -3.272 . . . . 0.0 104.921 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -112.54 -3.41 14.39 Favored 'General case' 0 C--O 1.245 0.834 0 CA-C-O 116.7 -1.619 . . . . 0.0 114.183 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . 0.379 10.2 mtpt -154.75 120.64 5.19 Favored 'General case' 0 CA--C 1.503 -0.837 0 O-C-N 125.574 1.796 . . . . 0.0 110.468 179.767 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.842 HD23 ' HD2' ' A' ' 106' ' ' ARG . 3.8 tp -76.56 144.55 39.61 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 103.512 -2.773 . . . . 0.0 103.512 179.775 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.555 ' CG1' HG23 ' A' ' 105' ' ' VAL . 2.7 m -141.56 153.35 19.5 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.052 0 N-CA-C 105.235 -2.135 . . . . 0.0 105.235 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -123.38 104.51 0.86 Allowed Glycine 0 CA--C 1.534 1.227 1 C-N-CA 130.794 4.045 . . . . 0.0 108.132 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -105.95 95.57 5.88 Favored 'General case' 0 N--CA 1.428 -1.565 0 C-N-CA 119.521 -0.872 . . . . 0.0 109.841 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.517 ' HA ' ' HA3' ' A' ' 80' ' ' GLY . 2.3 m-85 -92.96 123.32 36.13 Favored 'General case' 0 N--CA 1.435 -1.185 0 O-C-N 125.4 1.688 . . . . 0.0 114.092 179.672 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 24.7 mttt -91.5 146.77 23.53 Favored 'General case' 0 N--CA 1.429 -1.503 0 O-C-N 126.0 2.062 . . . . 0.0 110.059 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . 0.355 9.0 ttt180 -103.73 142.24 34.7 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-N 114.04 -1.436 . . . . 0.0 107.376 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.499 ' HB ' ' HB3' ' A' ' 77' ' ' GLU . 69.0 t -81.66 -36.04 14.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-O 124.793 2.235 . . . . 0.0 109.618 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . 0.32 1.3 t70 -72.82 -12.96 61.19 Favored 'General case' 0 C--O 1.256 1.405 0 N-CA-C 118.354 2.724 . . . . 0.0 118.354 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -141.36 -27.51 0.68 Allowed 'General case' 0 CA--C 1.502 -0.876 0 C-N-CA 116.854 -1.938 . . . . 0.0 115.671 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 94.77 9.98 58.14 Favored Glycine 0 C--N 1.337 0.625 0 O-C-N 125.555 1.784 . . . . 0.0 117.041 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 5.4 mmtm -106.04 172.29 6.89 Favored 'General case' 0 C--O 1.2 -1.544 0 CA-C-N 119.072 1.436 . . . . 0.0 109.278 179.525 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.96 126.14 50.15 Favored 'General case' 0 N--CA 1.436 -1.142 0 O-C-N 125.955 2.034 . . . . 0.0 114.841 -179.724 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.778 HD22 ' HD1' ' A' ' 119' ' ' TYR . 0.2 OUTLIER -79.38 116.44 19.62 Favored 'General case' 0 C--O 1.246 0.894 0 C-N-CA 130.456 3.502 . . . . 0.0 102.686 179.43 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.709 HG23 ' HB3' ' A' ' 117' ' ' TYR . 4.3 tt -97.8 150.15 4.83 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.116 0 C-N-CA 114.616 -2.833 . . . . 0.0 104.732 -179.245 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -143.29 145.03 32.37 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 116.533 -1.698 . . . . 0.0 109.312 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.747 HG12 HG23 ' A' ' 116' ' ' THR . 7.6 p -134.5 113.83 17.49 Favored 'Isoleucine or valine' 0 C--O 1.248 1.012 0 CA-C-N 123.604 2.911 . . . . 0.0 113.528 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.842 ' HD2' HD23 ' A' ' 89' ' ' LEU . 63.0 mtt180 -81.37 95.67 7.1 Favored 'General case' 0 C--O 1.216 -0.667 0 N-CA-C 104.948 -2.242 . . . . 0.0 104.948 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 64.4 tt0 -102.31 81.97 2.13 Favored 'General case' 0 N--CA 1.419 -2.007 0 CA-C-N 111.49 -2.596 . . . . 0.0 114.727 -179.558 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.684 HD12 ' CE1' ' A' ' 2' ' ' PHE 0.29 0.3 OUTLIER -58.51 110.98 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 C-N-CA 117.448 -1.701 . . . . 0.0 107.853 179.516 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 2.9 m -75.36 -17.93 60.1 Favored 'General case' 0 C--O 1.214 -0.776 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 -179.618 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 150.63 -109.35 0.42 Allowed Glycine 0 C--O 1.238 0.37 1 C-N-CA 132.087 4.661 . . . . 0.0 111.75 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 38.0 m-20 -59.77 -17.4 35.21 Favored 'General case' 0 C--O 1.213 -0.858 0 C-N-CA 116.778 -1.969 . . . . 0.0 111.61 179.571 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -110.64 135.23 51.58 Favored 'General case' 0 CA--C 1.496 -1.126 0 O-C-N 127.02 2.7 . . . . 0.0 117.476 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.648 HD13 ' CE2' ' A' ' 128' ' ' PHE . 0.1 OUTLIER -101.96 113.06 25.95 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 102.793 -3.04 . . . . 0.0 102.793 -179.938 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.737 HG23 HD12 ' A' ' 127' ' ' ILE . 78.0 mt -113.94 106.45 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.026 0 O-C-N 125.663 1.852 . . . . 0.0 110.309 -179.8 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.571 ' HB2' ' CG ' ' A' ' 126' ' ' ARG . 24.4 mt-30 -74.16 169.92 16.58 Favored 'General case' 0 C--O 1.244 0.791 0 N-CA-C 101.505 -3.517 . . . . 0.0 101.505 178.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.747 HG23 HG12 ' A' ' 105' ' ' VAL . 0.2 OUTLIER 173.75 155.04 0.11 Allowed 'General case' 0 N--CA 1.414 -2.254 0 C-N-CA 118.037 -1.465 . . . . 0.0 111.508 179.992 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.709 ' HB3' HG23 ' A' ' 103' ' ' ILE 0.393 23.4 m-30 125.38 -141.91 0.0 OUTLIER 'General case' 0 CA--C 1.475 -1.934 1 O-C-N 130.475 4.859 . . . . 0.0 113.875 175.93 . . . . . . . . 4 3 . 1 . 004 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.508 HG22 ' HG3' ' A' ' 123' ' ' GLU . 0.0 OUTLIER -138.53 -165.18 1.77 Allowed 'General case' 0 N--CA 1.431 -1.38 0 CA-C-O 126.831 3.205 . . . . 0.0 117.656 -174.911 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.778 ' HD1' HD22 ' A' ' 102' ' ' LEU 0.259 0.0 OUTLIER -109.19 -55.42 2.41 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 111.463 -2.608 . . . . 0.0 105.287 177.872 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.534 ' HB2' ' CD2' ' A' ' 119' ' ' TYR . 0.6 OUTLIER -129.12 -53.96 1.2 Allowed 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 111.516 -2.584 . . . . 0.0 112.744 179.526 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -162.01 15.91 0.15 Allowed Glycine 0 C--N 1.362 2.011 0 N-CA-C 118.928 2.331 . . . . 0.0 118.928 -179.538 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.401 ' O ' ' HB ' ' A' ' 118' ' ' THR . 82.9 t -120.7 112.58 36.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 N-CA-C 104.172 -2.529 . . . . 0.0 104.172 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.508 ' HG3' HG22 ' A' ' 118' ' ' THR . 1.2 mt-10 -71.42 177.51 3.93 Favored 'General case' 0 C--O 1.208 -1.116 0 C-N-CA 118.359 -1.337 . . . . 0.0 112.298 -178.869 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.876 ' HB1' ' HA ' ' A' ' 14' ' ' TYR . . . 179.71 97.83 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 116.525 -1.702 . . . . 0.0 110.284 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.531 ' HA ' ' HB ' ' A' ' 116' ' ' THR 0.327 0.0 OUTLIER -71.02 165.08 24.25 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 120.803 1.638 . . . . 0.0 111.192 179.656 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.604 ' HG2' ' CE2' ' A' ' 14' ' ' TYR . 0.1 OUTLIER -140.56 77.09 1.59 Allowed 'General case' 0 N--CA 1.436 -1.128 1 O-C-N 129.661 4.351 . . . . 0.0 108.664 179.476 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.737 HD12 HG23 ' A' ' 114' ' ' ILE . 0.6 OUTLIER -70.03 112.82 5.18 Favored 'Isoleucine or valine' 0 C--O 1.254 1.298 0 O-C-N 128.341 3.525 . . . . 0.0 112.824 179.752 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.648 ' CE2' HD13 ' A' ' 113' ' ' LEU . 1.8 m-30 -98.2 138.74 35.02 Favored 'General case' 0 C--O 1.221 -0.427 0 C-N-CA 127.298 2.239 . . . . 0.0 109.34 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . 0.266 26.6 mmtt -103.73 34.67 2.9 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 117.139 -1.41 . . . . 0.0 112.311 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.487 ' HA ' ' HA ' ' A' ' 6' ' ' TRP . 10.0 tttp 29.83 100.78 0.0 OUTLIER 'General case' 0 CA--C 1.508 -0.65 0 N-CA-C 116.695 2.109 . . . . 0.0 116.695 179.725 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.41 ' HA ' ' OG1' ' A' ' 5' ' ' THR 0.852 5.6 tt0 . . . . . 0 N--CA 1.439 -1.013 0 N-CA-C 119.502 3.149 . . . . 0.0 119.502 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' PLM . . . . . 0.77 ' HG3' ' N ' ' A' ' 74' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.326 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -124.29 -42.02 2.15 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 114.816 1.413 . . . . 0.0 114.816 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.38 101.08 0.07 Allowed 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 118.63 -1.228 . . . . 0.0 112.401 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 166.12 -155.32 26.49 Favored Glycine 0 C--O 1.217 -0.941 0 C-N-CA 115.809 -3.091 . . . . 0.0 113.267 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . 0.543 1.2 p -105.48 150.92 24.88 Favored 'General case' 0 CA--C 1.504 -0.823 0 CA-C-N 112.657 -1.772 . . . . 0.0 114.494 -179.728 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.654 ' CH2' HD11 ' A' ' 108' ' ' ILE . 85.5 m95 -150.54 152.69 34.54 Favored 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 125.513 1.758 . . . . 0.0 108.576 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 5.6 tttp -153.13 103.01 2.68 Favored 'General case' 0 C--O 1.205 -1.268 0 CA-C-O 116.678 -1.629 . . . . 0.0 109.103 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.718 HG12 ' HB3' ' A' ' 36' ' ' LEU 0.396 13.9 p -48.98 124.39 2.26 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.066 0 O-C-N 126.464 2.353 . . . . 0.0 111.722 179.819 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 51.4 t0 -123.81 1.26 8.73 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 125.218 2.437 . . . . 0.0 108.717 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.429 ' O ' ' HB ' ' A' ' 127' ' ' ILE . 1.9 ttt180 -169.28 133.51 1.4 Allowed 'General case' 0 C--N 1.294 -1.811 0 O-C-N 118.184 -2.822 . . . . 0.0 107.398 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . 0.299 0.0 OUTLIER -116.22 -171.89 2.08 Favored 'General case' 0 CA--C 1.501 -0.941 0 CA-C-N 114.394 -1.276 . . . . 0.0 108.513 179.894 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.462 ' CB ' ' HB2' ' A' ' 125' ' ' LYS . 0.5 OUTLIER -167.51 94.82 0.44 Allowed 'General case' 0 C--N 1.3 -1.579 0 CA-C-N 122.2 2.273 . . . . 0.0 107.917 179.907 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . 0.259 0.1 OUTLIER 97.68 -5.87 0.05 Allowed 'General case' 0 N--CA 1.486 1.359 0 O-C-N 126.984 2.678 . . . . 0.0 111.63 -179.636 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.715 ' HA ' ' HB1' ' A' ' 124' ' ' ALA . 0.4 OUTLIER -71.87 -16.36 62.14 Favored 'General case' 0 N--CA 1.432 -1.349 0 O-C-N 126.188 2.18 . . . . 0.0 116.103 -179.852 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -76.98 -37.68 54.71 Favored 'General case' 0 C--O 1.206 -1.201 0 CA-C-N 121.74 2.064 . . . . 0.0 109.25 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.42 -34.57 63.29 Favored 'General case' 0 N--CA 1.427 -1.617 0 CA-C-N 112.846 -1.979 . . . . 0.0 113.178 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.43 ' CB ' ' HB2' ' A' ' 124' ' ' ALA . 43.4 t80 -65.85 -24.79 66.96 Favored 'General case' 0 N--CA 1.421 -1.916 0 CA-C-O 123.213 1.482 . . . . 0.0 112.607 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 29.6 mtt -74.33 -28.56 61.2 Favored 'General case' 0 N--CA 1.443 -0.806 0 O-C-N 118.511 -2.618 . . . . 0.0 107.449 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -70.12 -32.62 70.72 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 125.665 2.65 . . . . 0.0 113.31 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 7.9 tttm -77.82 -43.9 29.03 Favored 'General case' 0 C--N 1.313 -0.984 0 O-C-N 119.855 -1.778 . . . . 0.0 112.086 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 11.1 mmm -62.29 -26.7 68.55 Favored 'General case' 0 C--O 1.205 -1.247 0 C-N-CA 126.098 1.759 . . . . 0.0 109.782 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 105.34 62.38 0.64 Allowed Glycine 0 N--CA 1.433 -1.521 0 CA-C-N 114.792 -1.095 . . . . 0.0 112.89 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.423 HG23 ' HB3' ' A' ' 27' ' ' LYS . 2.2 mm -118.31 134.9 60.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -79.35 157.35 27.67 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-O 113.872 -2.966 . . . . 0.0 112.391 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . 0.343 2.1 m -33.73 -39.1 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.21 -0.978 0 O-C-N 126.809 2.568 . . . . 0.0 114.318 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.488 2.5 m -78.18 -50.48 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.106 0 O-C-N 126.959 2.662 . . . . 0.0 115.129 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.423 ' HB3' HG23 ' A' ' 23' ' ' ILE . 13.7 mttm -64.25 -23.54 67.34 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.149 -0.932 . . . . 0.0 112.67 -179.635 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 6.9 ptt-85 -79.51 -26.19 41.6 Favored 'General case' 0 CA--C 1.532 0.27 0 O-C-N 119.826 -1.796 . . . . 0.0 107.753 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 7.0 ttmm -74.91 -38.45 61.81 Favored 'General case' 0 C--O 1.212 -0.905 0 O-C-N 125.086 1.492 . . . . 0.0 112.248 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.0 mp -78.08 -24.97 47.41 Favored 'General case' 0 N--CA 1.431 -1.404 0 C-N-CA 124.101 0.96 . . . . 0.0 110.579 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -79.42 -27.46 54.93 Favored Glycine 0 C--O 1.213 -1.165 0 O-C-N 125.238 1.586 . . . . 0.0 111.251 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -75.38 -41.8 55.49 Favored 'General case' 0 CA--C 1.514 -0.409 0 C-N-CA 125.912 1.685 . . . . 0.0 111.371 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 6.7 m-70 -101.03 14.32 32.35 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-O 116.152 -1.88 . . . . 0.0 115.408 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 14.9 p30 -40.34 -26.25 0.03 OUTLIER 'General case' 0 CA--C 1.499 -1.002 0 O-C-N 127.391 2.932 . . . . 0.0 118.763 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 72.95 12.12 5.16 Favored 'General case' 0 C--N 1.311 -1.089 0 O-C-N 125.264 1.602 . . . . 0.0 109.155 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.718 ' HB3' HG12 ' A' ' 8' ' ' VAL . 2.6 tp -30.23 92.83 0.01 OUTLIER 'General case' 0 CA--C 1.503 -0.839 0 C-N-CA 129.298 3.039 . . . . 0.0 110.34 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 5.9 ttpm? -94.15 115.61 27.92 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 102.336 -3.209 . . . . 0.0 102.336 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.784 ' CD2' HG21 ' A' ' 49' ' ' VAL 0.26 0.1 OUTLIER -104.02 116.76 32.81 Favored 'General case' 0 C--N 1.291 -1.974 0 C-N-CA 116.923 -1.911 . . . . 0.0 110.01 -179.819 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.404 ' HB ' ' HB2' ' A' ' 50' ' ' LYS . 10.5 m -106.3 99.11 8.71 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 124.748 2.213 . . . . 0.0 105.158 179.68 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.472 HG23 HG12 ' A' ' 49' ' ' VAL . 1.2 mt -88.17 128.42 40.52 Favored 'Isoleucine or valine' 0 C--O 1.251 1.184 0 CA-C-N 113.233 -1.803 . . . . 0.0 110.814 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.535 HG22 ' O ' ' A' ' 41' ' ' THR . 4.5 m -115.44 70.78 0.75 Allowed 'General case' 0 C--N 1.346 0.448 0 O-C-N 127.306 2.879 . . . . 0.0 107.567 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -65.69 112.96 3.93 Favored 'General case' 0 C--N 1.316 -0.854 0 C-N-CA 123.948 0.899 . . . . 0.0 109.716 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.7 tt0 -99.16 -103.19 0.22 Allowed 'General case' 0 N--CA 1.423 -1.822 0 N-CA-C 105.312 -2.107 . . . . 0.0 105.312 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -113.48 -48.41 0.6 Allowed Glycine 0 C--N 1.295 -1.743 0 N-CA-C 109.092 -1.603 . . . . 0.0 109.092 -179.702 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -127.58 -20.4 3.98 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -90.14 161.23 15.86 Favored 'General case' 0 C--N 1.308 -1.217 0 C-N-CA 116.723 -1.991 . . . . 0.0 113.098 179.801 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -135.24 69.44 1.44 Allowed 'General case' 0 CA--C 1.512 -0.49 0 CA-C-O 124.273 1.987 . . . . 0.0 109.698 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.847 ' OG1' HG12 ' A' ' 61' ' ' VAL . 14.0 t -74.74 122.88 23.96 Favored 'General case' 0 N--CA 1.432 -1.362 0 O-C-N 119.562 -1.961 . . . . 0.0 106.753 179.345 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.784 HG21 ' CD2' ' A' ' 38' ' ' LEU 0.685 0.9 OUTLIER -116.44 120.9 66.33 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.727 0 N-CA-C 117.551 2.426 . . . . 0.0 117.551 -179.058 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.404 ' HB2' ' HB ' ' A' ' 39' ' ' THR . 0.9 OUTLIER -64.87 145.15 56.69 Favored 'General case' 0 C--N 1.308 -1.235 1 N-CA-C 99.101 -4.407 . . . . 0.0 99.101 177.749 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.472 ' O ' ' N ' ' A' ' 53' ' ' SER . 5.3 tt0 -133.87 51.69 2.12 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 104.279 -2.489 . . . . 0.0 104.279 -178.881 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . 0.26 4.6 m -61.95 86.6 0.02 OUTLIER 'General case' 0 C--N 1.289 -2.06 0 N-CA-C 104.736 -2.32 . . . . 0.0 104.736 179.348 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.671 ' OG ' HD13 ' A' ' 36' ' ' LEU . 1.3 m -122.48 44.34 2.65 Favored 'General case' 0 N--CA 1.443 -0.816 0 O-C-N 126.1 2.125 . . . . 0.0 114.607 -179.121 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 65.66 -54.04 0.36 Allowed 'General case' 0 N--CA 1.44 -0.957 0 O-C-N 126.717 2.51 . . . . 0.0 108.996 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.505 ' CE1' ' HB1' ' A' ' 73' ' ' ALA . 7.4 m-85 -62.81 -56.99 12.48 Favored 'General case' 0 C--O 1.217 -0.654 0 CA-C-O 114.699 -2.572 . . . . 0.0 109.186 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.657 ' HB3' HG22 ' A' ' 58' ' ' ILE . 23.1 ttt-85 -148.98 144.48 26.8 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 123.709 2.959 . . . . 0.0 112.054 179.665 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 44.7 t-20 -97.66 81.84 2.98 Favored 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 100.623 -3.843 . . . . 0.0 100.623 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.657 HG22 ' HB3' ' A' ' 56' ' ' ARG . 1.5 tt -120.65 100.6 9.38 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.77 1 O-C-N 129.26 4.1 . . . . 0.0 118.927 -179.213 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -63.02 117.98 7.21 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 103.492 -2.781 . . . . 0.0 103.492 178.059 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.535 ' CG1' HG22 ' A' ' 49' ' ' VAL . 2.4 p -101.43 102.32 13.33 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 C-N-CA 119.672 -0.811 . . . . 0.0 111.103 -177.283 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.847 HG12 ' OG1' ' A' ' 48' ' ' THR 0.36 0.8 OUTLIER -87.12 138.06 19.76 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 CA-C-O 125.966 2.794 . . . . 0.0 113.58 -179.807 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.633 ' HZ ' HH22 ' A' ' 106' ' ' ARG . 23.7 p90 -153.49 100.62 2.43 Favored 'General case' 0 N--CA 1.437 -1.103 0 O-C-N 120.204 -1.56 . . . . 0.0 110.719 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.49 130.44 46.88 Favored 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 102.862 -3.014 . . . . 0.0 102.862 179.683 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 7.2 mt -52.31 118.09 3.29 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-O 122.886 1.327 . . . . 0.0 110.492 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 86.38 13.41 68.16 Favored Glycine 0 C--N 1.347 1.191 0 CA-C-N 111.627 -2.533 . . . . 0.0 117.39 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . 0.419 0.5 OUTLIER -101.1 129.5 51.98 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 N-CA-C 105.547 -2.02 . . . . 0.0 105.547 179.963 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -86.61 115.31 23.99 Favored 'General case' 0 CA--C 1.483 -1.625 0 N-CA-C 115.146 1.536 . . . . 0.0 115.146 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.411 ' CE1' ' HB3' ' A' ' 62' ' ' PHE . 0.3 OUTLIER -111.7 155.04 24.08 Favored 'General case' 0 N--CA 1.427 -1.609 0 CA-C-O 116.276 -1.821 . . . . 0.0 106.798 -179.979 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -109.51 130.07 55.53 Favored 'General case' 0 CA--C 1.51 -0.591 0 O-C-N 126.138 2.149 . . . . 0.0 106.783 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -130.87 101.16 5.52 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-O 116.67 -1.634 . . . . 0.0 113.903 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 26.8 m -67.18 119.41 12.04 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 105.78 -1.933 . . . . 0.0 105.78 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.533 HD11 HD13 ' A' ' 78' ' ' LEU . 16.7 mt -65.61 -175.81 0.3 Allowed 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 114.265 -1.334 . . . . 0.0 109.136 -179.676 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.505 ' HB1' ' CE1' ' A' ' 55' ' ' PHE . . . -75.42 -35.76 60.92 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-O 124.773 2.225 . . . . 0.0 111.814 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.693 ' HB2' ' HG1' ' A' ' 132' ' ' PLM . 0.3 OUTLIER -153.11 23.91 0.55 Allowed 'General case' 0 C--O 1.239 0.514 0 CA-C-N 112.662 -2.063 . . . . 0.0 108.4 179.718 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.56 ' C ' HG23 ' A' ' 76' ' ' THR . . . -120.18 -10.0 7.67 Favored Glycine 0 C--O 1.213 -1.19 0 C-N-CA 125.052 1.31 . . . . 0.0 114.786 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.56 HG23 ' C ' ' A' ' 75' ' ' GLY . 0.1 OUTLIER 74.51 -175.57 0.14 Allowed 'General case' 0 C--N 1.317 -0.811 0 C-N-CA 117.699 -1.601 . . . . 0.0 112.933 179.926 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -44.87 123.88 4.05 Favored 'General case' 0 N--CA 1.446 -0.64 0 O-C-N 127.467 2.979 . . . . 0.0 111.195 179.669 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.56 ' HG ' ' HB3' ' A' ' 93' ' ' PHE 0.423 0.6 OUTLIER -144.38 90.14 2.07 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 102.414 -3.18 . . . . 0.0 102.414 -179.819 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 95.6 m -103.55 135.86 44.35 Favored 'General case' 0 CA--C 1.481 -1.678 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -170.78 -159.66 17.35 Favored Glycine 0 C--N 1.291 -1.917 0 C-N-CA 116.568 -2.729 . . . . 0.0 110.596 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -147.54 175.46 10.83 Favored 'General case' 0 C--O 1.197 -1.699 0 CA-C-O 122.554 1.169 . . . . 0.0 108.453 179.726 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' TRP . . . . . 0.505 ' CZ3' ' N ' ' A' ' 91' ' ' GLY . 54.6 m95 -130.02 135.43 48.27 Favored 'General case' 0 N--CA 1.427 -1.577 0 N-CA-C 104.078 -2.564 . . . . 0.0 104.078 179.506 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.474 ' CG2' HG23 ' A' ' 90' ' ' VAL . 8.8 t -135.87 134.76 39.13 Favored 'General case' 0 N--CA 1.425 -1.693 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.885 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.468 ' CA ' HD12 ' A' ' 89' ' ' LEU . 5.4 ttt -83.96 121.46 27.41 Favored 'General case' 0 N--CA 1.429 -1.523 0 O-C-N 125.793 1.933 . . . . 0.0 106.103 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . 0.539 0.5 OUTLIER -79.87 -24.24 41.36 Favored 'General case' 0 N--CA 1.426 -1.652 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 179.788 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 154.64 -85.43 0.14 Allowed Glycine 0 N--CA 1.447 -0.568 0 N-CA-C 105.047 -3.221 . . . . 0.0 105.047 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 13.2 m-80 -91.32 -0.72 57.71 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-O 116.385 -1.769 . . . . 0.0 115.264 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . 0.382 0.3 OUTLIER -141.55 146.91 36.9 Favored 'General case' 0 CA--C 1.489 -1.39 0 O-C-N 127.095 2.747 . . . . 0.0 106.973 -179.854 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.488 HD23 ' CD ' ' A' ' 106' ' ' ARG . 0.7 OUTLIER -109.88 141.88 41.97 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 104.934 -2.247 . . . . 0.0 104.934 -179.864 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.474 HG23 ' CG2' ' A' ' 83' ' ' THR . 0.3 OUTLIER -123.21 124.75 70.7 Favored 'Isoleucine or valine' 0 C--O 1.244 0.771 0 N-CA-C 105.007 -2.219 . . . . 0.0 105.007 -179.582 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.505 ' N ' ' CZ3' ' A' ' 82' ' ' TRP . . . -103.36 109.06 3.37 Favored Glycine 0 C--N 1.349 1.268 0 N-CA-C 108.892 -1.683 . . . . 0.0 108.892 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.472 ' C ' ' CD1' ' A' ' 93' ' ' PHE . 24.2 mtpp -102.71 152.77 20.83 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 105.175 -2.158 . . . . 0.0 105.175 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.56 ' HB3' ' HG ' ' A' ' 78' ' ' LEU . 64.6 m-85 -148.73 111.61 4.84 Favored 'General case' 0 CA--C 1.508 -0.658 0 CA-C-O 122.931 1.348 . . . . 0.0 110.873 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 12.8 mttm -92.86 130.53 38.43 Favored 'General case' 0 N--CA 1.44 -0.942 0 C-N-CA 126.456 1.902 . . . . 0.0 107.626 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . 0.381 0.0 OUTLIER -95.62 143.4 26.93 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 104.917 -2.253 . . . . 0.0 104.917 -179.923 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 29.6 m -70.24 -37.76 72.38 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 O-C-N 123.935 0.772 . . . . 0.0 111.081 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . 0.345 0.5 OUTLIER -56.82 -12.29 1.85 Allowed 'General case' 0 C--O 1.254 1.333 0 N-CA-C 114.825 1.417 . . . . 0.0 114.825 179.896 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 15.8 p30 -159.52 5.91 0.09 Allowed 'General case' 0 N--CA 1.426 -1.647 0 N-CA-C 116.646 2.091 . . . . 0.0 116.646 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 44.65 25.39 0.86 Allowed Glycine 0 C--O 1.243 0.692 0 CA-C-O 124.0 1.889 . . . . 0.0 114.357 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 6.7 mmmt -70.91 -97.96 0.01 OUTLIER 'General case' 0 CA--C 1.554 1.129 0 O-C-N 119.185 -2.362 . . . . 0.0 109.611 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.454 ' CG ' ' N ' ' A' ' 102' ' ' LEU . 36.8 tt0 152.26 168.77 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 128.719 2.808 . . . . 0.0 109.345 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.625 ' CB ' ' HA ' ' A' ' 119' ' ' TYR . 0.9 OUTLIER -151.07 134.66 16.34 Favored 'General case' 0 C--O 1.246 0.909 1 C-N-CA 132.613 4.365 . . . . 0.0 103.986 -179.669 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.562 ' N ' ' O ' ' A' ' 118' ' ' THR . 1.3 tp -118.17 159.9 18.22 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.09 0 N-CA-C 106.314 -1.736 . . . . 0.0 106.314 -179.687 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.469 ' N ' HG13 ' A' ' 103' ' ' ILE . . . -154.31 150.59 28.15 Favored 'General case' 0 C--O 1.242 0.708 0 CA-C-O 115.995 -1.955 . . . . 0.0 107.454 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.649 HG12 HG23 ' A' ' 116' ' ' THR . 8.4 p -137.01 109.68 7.57 Favored 'Isoleucine or valine' 0 C--O 1.248 0.979 0 C-N-CA 116.439 -2.105 . . . . 0.0 114.301 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.633 HH22 ' HZ ' ' A' ' 62' ' ' PHE 0.253 50.7 mtt180 -71.08 96.85 1.39 Allowed 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 104.347 -2.464 . . . . 0.0 104.347 179.498 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -94.75 73.89 3.63 Favored 'General case' 0 N--CA 1.422 -1.858 0 O-C-N 126.438 2.336 . . . . 0.0 112.082 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.654 HD11 ' CH2' ' A' ' 6' ' ' TRP 0.355 1.9 tt -59.55 97.65 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 C-N-CA 114.425 -2.91 . . . . 0.0 113.701 179.891 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 39.4 t -84.23 71.99 10.57 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 105.475 -2.046 . . . . 0.0 105.475 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 72.61 -89.59 0.54 Allowed Glycine 0 C--O 1.241 0.544 0 O-C-N 128.722 3.764 . . . . 0.0 113.26 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . 0.329 1.0 OUTLIER -95.01 -14.76 24.05 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 116.358 -1.782 . . . . 0.0 113.172 -179.891 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -108.9 134.64 51.3 Favored 'General case' 0 N--CA 1.431 -1.411 0 O-C-N 127.553 3.033 . . . . 0.0 112.897 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.467 ' HB2' ' CZ3' ' A' ' 6' ' ' TRP . 0.7 OUTLIER -99.29 141.83 31.56 Favored 'General case' 0 C--O 1.209 -1.064 0 N-CA-C 101.836 -3.394 . . . . 0.0 101.836 -179.647 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.768 HG23 HD13 ' A' ' 127' ' ' ILE . 63.6 mt -142.18 134.79 27.56 Favored 'Isoleucine or valine' 0 C--O 1.246 0.901 0 N-CA-C 103.729 -2.693 . . . . 0.0 103.729 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.526 ' HB2' ' CD ' ' A' ' 126' ' ' ARG . 24.2 mt-30 -117.23 118.48 32.43 Favored 'General case' 0 CA--C 1.497 -1.083 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.649 HG23 HG12 ' A' ' 105' ' ' VAL . 0.7 OUTLIER -137.53 156.86 47.64 Favored 'General case' 0 N--CA 1.413 -2.281 0 CA-C-N 114.247 -1.342 . . . . 0.0 112.397 -179.643 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.467 ' CE2' ' HB ' ' A' ' 105' ' ' VAL 0.384 24.3 m-85 134.73 -141.5 0.0 OUTLIER 'General case' 0 CA--C 1.48 -1.736 1 O-C-N 130.708 5.005 . . . . 0.0 113.485 176.249 . . . . . . . . 4 3 . 1 . 005 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.616 HG23 ' N ' ' A' ' 119' ' ' TYR . 4.4 t -156.04 -156.07 0.6 Allowed 'General case' 0 C--N 1.311 -1.072 0 O-C-N 127.268 2.855 . . . . 0.0 116.389 -174.854 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.625 ' HA ' ' CB ' ' A' ' 102' ' ' LEU . 0.0 OUTLIER -105.16 -62.86 1.29 Allowed 'General case' 0 C--N 1.347 0.485 0 N-CA-C 102.69 -3.078 . . . . 0.0 102.69 176.573 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.56 -71.53 0.73 Allowed 'General case' 0 N--CA 1.426 -1.635 0 CA-C-N 111.857 -2.429 . . . . 0.0 116.039 179.488 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -140.7 10.78 2.91 Favored Glycine 0 C--N 1.355 1.633 0 N-CA-C 120.083 2.793 . . . . 0.0 120.083 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 72.3 t -114.12 94.69 3.28 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 O-C-N 117.39 -3.418 . . . . 0.0 103.163 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.458 ' HA ' ' HB ' ' A' ' 118' ' ' THR . 5.6 mt-10 -58.02 177.36 0.12 Allowed 'General case' 0 C--O 1.213 -0.857 0 C-N-CA 118.36 -1.336 . . . . 0.0 112.637 -178.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.715 ' HB1' ' HA ' ' A' ' 14' ' ' TYR . . . -173.87 103.44 0.11 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 115.914 -1.993 . . . . 0.0 109.221 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.505 ' HG3' ' HB ' ' A' ' 116' ' ' THR 0.343 1.5 mptt -79.49 162.15 25.6 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 121.661 2.028 . . . . 0.0 112.665 -179.91 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.599 ' HG2' ' CD2' ' A' ' 14' ' ' TYR . 0.2 OUTLIER -145.07 78.97 1.58 Allowed 'General case' 0 C--O 1.208 -1.104 0 CA-C-O 115.236 -2.316 . . . . 0.0 106.015 179.623 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.768 HD13 HG23 ' A' ' 114' ' ' ILE . 4.4 mm -77.32 111.05 13.68 Favored 'Isoleucine or valine' 0 C--O 1.246 0.888 1 O-C-N 131.973 5.796 . . . . 0.0 110.996 179.703 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.61 ' CZ ' HD12 ' A' ' 38' ' ' LEU . 15.0 m-85 -92.52 169.21 10.72 Favored 'General case' 0 C--N 1.318 -0.783 0 O-C-N 127.255 2.847 . . . . 0.0 108.417 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . 0.305 19.8 mmtt -124.07 -6.21 7.82 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 115.406 -2.235 . . . . 0.0 110.634 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.535 ' HB2' ' CZ3' ' A' ' 6' ' ' TRP . 0.0 OUTLIER 71.82 102.04 0.07 Allowed 'General case' 0 N--CA 1.472 0.631 0 O-C-N 126.811 2.569 . . . . 0.0 109.597 179.823 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . 0.923 7.6 mt-10 . . . . . 0 N--CA 1.434 -1.232 0 N-CA-C 116.223 1.934 . . . . 0.0 116.223 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' PLM . . . . . 0.693 ' HG1' ' HB2' ' A' ' 74' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.284 0 CA-C-O 120.442 0.163 . . . . 0.0 111.412 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.499 ' N ' ' CD1' ' A' ' 2' ' ' PHE . 13.5 m-85 -122.11 69.66 0.95 Allowed 'General case' 0 C--N 1.313 -1.011 0 O-C-N 125.481 1.738 . . . . 0.0 112.438 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -144.05 98.27 3.19 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.521 -1.218 . . . . 0.0 110.594 179.52 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 161.12 -130.03 2.26 Favored Glycine 0 C--O 1.222 -0.623 0 C-N-CA 115.331 -3.318 . . . . 0.0 110.296 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.589 ' HB ' ' HA ' ' A' ' 39' ' ' THR 0.609 0.1 OUTLIER -134.1 157.94 44.87 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 119.154 -1.018 . . . . 0.0 112.637 -179.812 . . . . . . . . 4 4 . 1 . 006 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.758 ' NE1' HD12 ' A' ' 40' ' ' ILE 0.254 95.1 m95 -142.19 146.63 35.46 Favored 'General case' 0 C--O 1.212 -0.875 0 O-C-N 127.98 3.3 . . . . 0.0 106.253 -179.87 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -139.97 92.9 2.59 Favored 'General case' 0 C--O 1.21 -0.994 0 O-C-N 127.069 2.731 . . . . 0.0 106.452 -179.681 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.636 HG21 ' HD2' ' A' ' 126' ' ' ARG 0.396 2.1 p -43.77 125.84 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 CA-C-O 116.744 -1.598 . . . . 0.0 112.966 179.836 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -115.4 -31.96 5.76 Favored 'General case' 0 N--CA 1.439 -0.984 0 O-C-N 126.306 2.254 . . . . 0.0 108.846 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.1 149.22 32.6 Favored 'General case' 0 CA--C 1.482 -1.672 0 C-N-CA 116.526 -2.07 . . . . 0.0 108.6 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . 0.386 3.4 m-80 -120.32 -175.45 3.0 Favored 'General case' 0 N--CA 1.454 -0.227 0 O-C-N 126.909 2.631 . . . . 0.0 108.619 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.421 ' HB2' ' HB2' ' A' ' 125' ' ' LYS . 3.6 tt0 -141.89 -78.42 0.26 Allowed 'General case' 0 N--CA 1.432 -1.326 0 C-N-CA 116.651 -2.02 . . . . 0.0 111.055 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -88.79 17.75 5.33 Favored 'General case' 0 N--CA 1.475 0.803 0 O-C-N 125.613 1.821 . . . . 0.0 114.291 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.492 ' CE2' ' HE2' ' A' ' 18' ' ' MET . 9.0 t80 -63.93 -39.08 93.34 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 119.084 2.994 . . . . 0.0 119.084 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.46 -35.29 78.85 Favored 'General case' 0 C--O 1.212 -0.918 0 CA-C-N 121.846 2.112 . . . . 0.0 112.171 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.93 -31.66 45.29 Favored 'General case' 0 N--CA 1.435 -1.185 0 O-C-N 126.492 2.37 . . . . 0.0 113.578 179.717 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.513 ' CB ' ' HB2' ' A' ' 124' ' ' ALA . 0.0 OUTLIER -70.59 -30.35 67.01 Favored 'General case' 0 N--CA 1.423 -1.788 0 CA-C-O 125.873 2.749 . . . . 0.0 114.185 -179.405 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.492 ' HE2' ' CE2' ' A' ' 14' ' ' TYR . 19.5 mmt -76.58 -22.75 53.83 Favored 'General case' 0 N--CA 1.431 -1.379 0 O-C-N 116.303 -3.998 . . . . 0.0 107.541 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -68.53 -25.29 64.85 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 119.384 -2.073 . . . . 0.0 112.004 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.495 ' HE3' ' CB ' ' A' ' 120' ' ' GLU . 2.2 tttp -79.06 -31.94 44.63 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-O 117.469 -1.253 . . . . 0.0 113.15 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.412 ' HE1' HH22 ' A' ' 95' ' ' ARG . 29.1 mtp -75.64 -23.2 56.31 Favored 'General case' 0 N--CA 1.437 -1.105 0 O-C-N 126.076 2.11 . . . . 0.0 109.006 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 105.26 31.02 4.5 Favored Glycine 0 C--O 1.225 -0.461 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 179.74 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.531 HG21 ' CA ' ' A' ' 28' ' ' ARG . 2.7 mm -77.49 141.95 14.88 Favored 'Isoleucine or valine' 0 C--N 1.352 0.699 0 C-N-CA 124.97 1.308 . . . . 0.0 108.911 -179.664 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -101.69 154.34 18.97 Favored 'General case' 0 C--O 1.245 0.839 0 CA-C-O 115.944 -1.979 . . . . 0.0 110.171 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . 0.429 4.2 p -28.92 -40.95 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.518 -0.276 0 O-C-N 128.414 3.571 . . . . 0.0 119.231 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.65 2.5 t -79.83 -40.95 21.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 123.034 1.397 . . . . 0.0 112.572 179.71 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.0 ttmt -68.67 -43.64 75.72 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 110.469 -3.06 . . . . 0.0 114.548 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.531 ' CA ' HG21 ' A' ' 23' ' ' ILE . 31.6 ptt85 -76.5 -20.82 56.55 Favored 'General case' 0 C--N 1.321 -0.659 0 O-C-N 119.625 -1.922 . . . . 0.0 108.653 -179.562 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.1 ttmt -76.21 -38.3 56.65 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-N 114.381 -1.282 . . . . 0.0 108.334 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -72.38 -35.76 68.55 Favored 'General case' 0 C--O 1.214 -0.766 0 CA-C-N 114.621 -1.172 . . . . 0.0 108.442 -179.729 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -73.67 -26.87 68.46 Favored Glycine 0 CA--C 1.532 1.118 0 O-C-N 126.239 2.212 . . . . 0.0 111.955 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -75.7 -39.26 57.72 Favored 'General case' 0 N--CA 1.434 -1.23 0 C-N-CA 125.681 1.592 . . . . 0.0 110.774 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -90.58 29.98 1.22 Allowed 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 124.237 1.015 . . . . 0.0 112.538 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 31.2 p-10 -81.02 98.63 8.05 Favored 'General case' 0 CA--C 1.508 -0.655 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -76.93 61.84 2.01 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 120.058 1.299 . . . . 0.0 109.27 179.48 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.859 HD11 ' CD1' ' A' ' 38' ' ' LEU . 0.1 OUTLIER -61.87 124.92 22.08 Favored 'General case' 0 CA--C 1.492 -1.262 0 C-N-CA 126.836 2.054 . . . . 0.0 108.695 -179.519 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.492 ' HB3' ' HB3' ' A' ' 52' ' ' SER . 21.8 ttmt -108.71 106.14 16.04 Favored 'General case' 0 N--CA 1.431 -1.398 0 N-CA-C 104.482 -2.414 . . . . 0.0 104.482 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.859 ' CD1' HD11 ' A' ' 36' ' ' LEU . 1.3 tp -91.82 111.14 22.55 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 120.844 1.656 . . . . 0.0 108.964 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.589 ' HA ' ' HB ' ' A' ' 5' ' ' THR . 2.2 m -96.69 91.36 5.68 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 101.732 -3.432 . . . . 0.0 101.732 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.758 HD12 ' NE1' ' A' ' 6' ' ' TRP . 58.5 mt -72.05 120.58 20.67 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 -179.368 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -115.01 113.3 23.92 Favored 'General case' 0 CA--C 1.5 -0.976 0 O-C-N 128.221 3.451 . . . . 0.0 114.666 179.694 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.493 ' HG2' ' CE1' ' A' ' 47' ' ' PHE . 1.6 mm-40 -92.91 96.0 9.84 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-O 117.507 -1.235 . . . . 0.0 108.289 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -76.34 -13.47 60.14 Favored 'General case' 0 N--CA 1.42 -1.953 0 CA-C-N 120.505 1.502 . . . . 0.0 110.699 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 150.74 -30.28 1.02 Allowed Glycine 0 C--N 1.294 -1.767 0 N-CA-C 106.048 -2.821 . . . . 0.0 106.048 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -150.83 -52.82 0.14 Allowed 'General case' 0 N--CA 1.441 -0.896 0 O-C-N 127.045 2.262 . . . . 0.0 110.21 -179.677 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.36 148.69 49.82 Favored 'General case' 0 N--CA 1.436 -1.161 0 CA-C-N 113.765 -1.561 . . . . 0.0 109.023 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.493 ' CE1' ' HG2' ' A' ' 42' ' ' GLN . 0.9 OUTLIER -113.77 81.79 1.58 Allowed 'General case' 0 C--O 1.218 -0.574 0 N-CA-C 105.871 -1.9 . . . . 0.0 105.871 179.861 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.877 HG22 ' CG1' ' A' ' 61' ' ' VAL 0.441 0.9 OUTLIER -63.48 90.25 0.05 OUTLIER 'General case' 0 CA--C 1.503 -0.85 0 C-N-CA 115.477 -2.489 . . . . 0.0 111.591 -179.639 . . . . . . . . 4 4 . 1 . 006 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.586 ' HB ' ' CE1' ' A' ' 62' ' ' PHE 0.652 0.7 OUTLIER -78.05 86.36 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.58 0 CA-C-O 117.929 -1.034 . . . . 0.0 111.411 -179.874 . . . . . . . . 4 4 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.437 ' HB3' ' HB ' ' A' ' 39' ' ' THR . 3.2 tttp -62.44 113.45 2.95 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 102.076 -3.305 . . . . 0.0 102.076 -179.794 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.271 2.4 tt0 -103.73 94.73 5.59 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 120.23 1.377 . . . . 0.0 107.834 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.492 ' HB3' ' HB3' ' A' ' 37' ' ' LYS . 7.6 t -93.2 55.01 2.22 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 105.216 -2.142 . . . . 0.0 105.216 179.673 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.432 ' HA ' ' HA ' ' A' ' 36' ' ' LEU . 87.3 p -67.66 167.49 13.04 Favored 'General case' 0 C--N 1.348 0.541 0 O-C-N 125.633 1.833 . . . . 0.0 111.384 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -58.28 -27.12 63.75 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 119.363 0.983 . . . . 0.0 109.191 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -69.13 -62.94 1.17 Allowed 'General case' 0 C--O 1.21 -1.026 0 CA-C-O 114.301 -2.761 . . . . 0.0 108.418 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.481 ' HG3' HG22 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -157.25 174.1 15.96 Favored 'General case' 0 C--O 1.244 0.813 0 CA-C-N 121.691 2.041 . . . . 0.0 109.947 179.847 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 -104.43 85.14 2.3 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 103.453 -2.795 . . . . 0.0 103.453 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.481 HG22 ' HG3' ' A' ' 56' ' ' ARG . 0.6 OUTLIER -114.21 106.81 21.39 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.323 0 C-N-CA 128.675 2.79 . . . . 0.0 115.806 -179.759 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -59.84 135.44 57.69 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 104.465 -2.42 . . . . 0.0 104.465 179.23 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.585 HG23 ' O ' ' A' ' 49' ' ' VAL . 36.5 t -96.17 -67.71 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.066 0 CA-C-O 126.066 2.841 . . . . 0.0 112.082 -178.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.877 ' CG1' HG22 ' A' ' 48' ' ' THR 0.442 0.1 OUTLIER 69.98 140.07 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 CA-C-N 113.512 -1.676 . . . . 0.0 113.601 -179.947 . . . . . . . . 4 4 . 1 . 006 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.589 ' HZ ' HH22 ' A' ' 106' ' ' ARG . 1.8 p90 -170.22 98.76 0.27 Allowed 'General case' 0 C--N 1.317 -0.814 0 C-N-CA 115.624 -2.43 . . . . 0.0 107.534 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -57.99 131.17 49.63 Favored 'General case' 0 C--O 1.246 0.897 0 N-CA-C 102.737 -3.06 . . . . 0.0 102.737 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -51.98 121.22 6.34 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 114.944 -1.025 . . . . 0.0 110.985 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 68.44 8.14 54.84 Favored Glycine 0 CA--C 1.531 1.061 0 N-CA-C 119.137 2.415 . . . . 0.0 119.137 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.403 HG12 ' H ' ' A' ' 67' ' ' ASP 0.382 15.1 t -80.79 -108.28 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 N-CA-C 104.189 -2.523 . . . . 0.0 104.189 179.823 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.403 ' H ' HG12 ' A' ' 66' ' ' VAL . 7.3 p-10 170.07 149.61 0.04 OUTLIER 'General case' 0 C--O 1.205 -1.243 0 O-C-N 124.509 1.13 . . . . 0.0 112.108 179.715 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.492 ' CZ ' ' HB3' ' A' ' 62' ' ' PHE . 2.1 p90 -161.69 135.46 6.6 Favored 'General case' 0 N--CA 1.431 -1.397 0 O-C-N 124.787 1.305 . . . . 0.0 109.907 -179.742 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.13 100.76 13.2 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 105.495 -2.039 . . . . 0.0 105.495 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -106.75 92.69 4.2 Favored 'General case' 0 C--O 1.216 -0.68 0 O-C-N 125.006 1.441 . . . . 0.0 114.179 -179.671 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 27.6 m -63.12 139.23 58.75 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 120.849 1.659 . . . . 0.0 107.083 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.658 HD23 ' HB2' ' A' ' 132' ' ' PLM . 5.3 mp -80.72 -157.85 0.17 Allowed 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 104.808 -2.293 . . . . 0.0 104.808 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -106.56 -8.92 16.79 Favored 'General case' 0 N--CA 1.439 -1.009 0 CA-C-O 122.499 1.143 . . . . 0.0 113.839 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.42 ' HB2' ' HG2' ' A' ' 132' ' ' PLM . 3.9 t70 -140.0 -39.53 0.45 Allowed 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 114.996 -1.002 . . . . 0.0 111.479 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -86.66 -16.53 61.63 Favored Glycine 0 CA--C 1.534 1.245 0 O-C-N 120.466 -1.396 . . . . 0.0 114.145 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . 0.342 0.1 OUTLIER 72.82 164.23 0.28 Allowed 'General case' 0 N--CA 1.432 -1.338 0 O-C-N 118.49 -2.77 . . . . 0.0 115.794 179.908 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -2.14 120.51 0.0 OUTLIER 'General case' 0 N--CA 1.439 -0.981 0 O-C-N 127.77 3.169 . . . . 0.0 117.505 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.697 HD13 HH21 ' A' ' 95' ' ' ARG 0.409 7.1 tp -134.97 134.95 41.06 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 103.049 -2.945 . . . . 0.0 103.049 179.721 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 6.1 m -145.52 121.2 10.49 Favored 'General case' 0 CA--C 1.485 -1.544 0 O-C-N 125.33 1.644 . . . . 0.0 106.782 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.458 ' HA3' ' HA ' ' A' ' 93' ' ' PHE . . . -175.99 -145.07 5.38 Favored Glycine 0 C--N 1.295 -1.72 0 O-C-N 118.871 -2.393 . . . . 0.0 110.24 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -154.24 177.45 11.11 Favored 'General case' 0 C--O 1.188 -2.157 0 CA-C-N 119.695 1.747 . . . . 0.0 110.976 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' TRP . . . . . 0.433 ' HA ' ' HA2' ' A' ' 91' ' ' GLY . 12.1 m95 -127.18 142.12 51.57 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 100.568 -3.864 . . . . 0.0 100.568 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 8.9 t -146.91 144.31 29.15 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 125.532 1.77 . . . . 0.0 111.744 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.405 ' HA ' HD23 ' A' ' 89' ' ' LEU . 20.7 ttt -83.76 101.36 11.53 Favored 'General case' 0 N--CA 1.436 -1.15 0 CA-C-N 110.996 -2.82 . . . . 0.0 107.854 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . 0.712 0.0 OUTLIER -90.17 70.07 7.24 Favored 'General case' 0 N--CA 1.427 -1.58 0 C-N-CA 122.8 0.44 . . . . 0.0 112.051 179.952 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 54.52 -97.57 0.04 OUTLIER Glycine 0 C--N 1.349 1.298 0 N-CA-C 107.635 -2.186 . . . . 0.0 107.635 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -74.56 3.49 7.62 Favored 'General case' 0 CA--C 1.52 -0.178 0 N-CA-C 118.036 2.606 . . . . 0.0 118.036 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . 0.402 0.0 OUTLIER -156.0 166.62 32.92 Favored 'General case' 0 C--O 1.215 -0.745 0 CA-C-N 120.698 1.59 . . . . 0.0 110.682 -179.699 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.557 HD13 HH11 ' A' ' 106' ' ' ARG . 0.0 OUTLIER -115.59 116.42 28.1 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 101.6 -3.481 . . . . 0.0 101.6 179.75 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.827 HG12 ' CG2' ' A' ' 105' ' ' VAL . 11.1 m -117.36 155.3 19.04 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 O-C-N 125.465 1.728 . . . . 0.0 106.632 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.433 ' HA2' ' HA ' ' A' ' 82' ' ' TRP . . . -126.88 110.67 1.25 Allowed Glycine 0 CA--C 1.53 0.989 0 O-C-N 128.352 3.532 . . . . 0.0 108.789 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.43 145.67 38.55 Favored 'General case' 0 N--CA 1.429 -1.517 0 N-CA-C 103.815 -2.661 . . . . 0.0 103.815 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.536 ' CE1' ' H41' ' A' ' 132' ' ' PLM . 15.3 m-85 -148.82 130.1 14.65 Favored 'General case' 0 CA--C 1.504 -0.818 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 13.8 mttp -99.18 159.02 15.29 Favored 'General case' 0 C--N 1.313 -1.004 0 O-C-N 125.59 1.806 . . . . 0.0 106.496 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.697 HH21 HD13 ' A' ' 78' ' ' LEU 0.325 0.1 OUTLIER -107.97 142.86 37.45 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 120.944 -1.097 . . . . 0.0 108.192 179.715 . . . . . . . . 4 4 . 1 . 006 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 25.2 t -82.22 -32.55 10.83 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 C-N-CA 125.829 1.651 . . . . 0.0 108.318 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . 0.364 34.9 p-10 -99.5 6.47 45.87 Favored 'General case' 0 C--O 1.25 1.107 0 CA-C-O 124.399 2.047 . . . . 0.0 115.502 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -133.45 -44.2 0.83 Allowed 'General case' 0 N--CA 1.439 -1.008 0 O-C-N 120.792 -1.193 . . . . 0.0 112.465 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 77.45 12.03 84.93 Favored Glycine 0 C--N 1.347 1.185 0 O-C-N 124.526 1.141 . . . . 0.0 114.313 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 6.1 mttt -81.59 -116.1 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 176.65 158.83 0.32 Allowed 'General case' 0 CA--C 1.5 -0.943 0 C-N-CA 128.068 2.547 . . . . 0.0 111.091 -179.58 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.494 ' CD1' ' HB2' ' A' ' 119' ' ' TYR . 3.1 tp -142.52 141.33 32.07 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 128.297 3.498 . . . . 0.0 106.952 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.512 ' CG2' ' HB ' ' A' ' 118' ' ' THR . 4.1 tt -127.17 165.07 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.766 0 N-CA-C 104.971 -2.233 . . . . 0.0 104.971 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.457 ' N ' ' CG1' ' A' ' 103' ' ' ILE . . . -151.15 157.39 42.63 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-O 116.798 -1.573 . . . . 0.0 109.533 179.772 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.827 ' CG2' HG12 ' A' ' 90' ' ' VAL . 1.2 t -147.77 96.15 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-O 125.561 2.6 . . . . 0.0 110.63 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.589 HH22 ' HZ ' ' A' ' 62' ' ' PHE . 16.8 mtt180 -71.81 90.52 1.1 Allowed 'General case' 0 C--O 1.236 0.368 0 N-CA-C 104.941 -2.244 . . . . 0.0 104.941 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -97.73 89.52 4.65 Favored 'General case' 0 N--CA 1.425 -1.725 0 C-N-CA 119.425 -0.91 . . . . 0.0 110.991 179.626 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.493 ' HA ' ' HA ' ' A' ' 113' ' ' LEU 0.439 0.0 OUTLIER -58.41 91.93 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 C-N-CA 117.117 -1.833 . . . . 0.0 114.171 -179.74 . . . . . . . . 4 4 . 1 . 006 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -78.28 76.86 4.78 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 102.56 -3.126 . . . . 0.0 102.56 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 60.93 -123.79 33.67 Favored Glycine 0 C--O 1.245 0.801 0 O-C-N 128.473 3.608 . . . . 0.0 110.705 -179.587 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . 0.31 28.5 m-80 -71.88 0.96 7.87 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-O 112.381 -3.676 . . . . 0.0 113.76 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.501 ' HG3' ' HA ' ' A' ' 129' ' ' LYS . 4.5 mp0 -118.18 117.75 29.99 Favored 'General case' 0 CA--C 1.511 -0.527 0 O-C-N 128.042 3.339 . . . . 0.0 110.615 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.493 ' HA ' ' HA ' ' A' ' 108' ' ' ILE . 0.5 OUTLIER -87.83 124.27 33.47 Favored 'General case' 0 C--O 1.216 -0.672 0 O-C-N 127.102 2.751 . . . . 0.0 103.969 179.761 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.774 HD13 HG23 ' A' ' 127' ' ' ILE 0.296 1.8 mm -114.55 133.43 60.7 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.33 0 N-CA-C 103.854 -2.647 . . . . 0.0 103.854 -179.68 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 10.7 mt-30 -115.4 97.36 6.13 Favored 'General case' 0 CA--C 1.489 -1.387 0 O-C-N 125.385 1.678 . . . . 0.0 109.461 -179.469 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.465 HG22 ' HG3' ' A' ' 125' ' ' LYS . 19.2 p -75.09 174.33 9.54 Favored 'General case' 0 C--O 1.247 0.929 0 N-CA-C 105.004 -2.221 . . . . 0.0 105.004 179.63 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 16.9 m-85 -162.5 115.31 1.68 Allowed 'General case' 0 CA--C 1.483 -1.631 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.512 ' HB ' ' CG2' ' A' ' 103' ' ' ILE . 88.4 m -113.68 88.84 2.94 Favored 'General case' 0 N--CA 1.42 -1.945 0 N-CA-C 116.95 2.204 . . . . 0.0 116.95 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.494 ' HB2' ' CD1' ' A' ' 102' ' ' LEU . 3.2 t80 -83.68 130.01 34.96 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 103.884 -2.635 . . . . 0.0 103.884 178.037 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.495 ' CB ' ' HE3' ' A' ' 20' ' ' LYS . 3.0 mm-40 61.89 -62.9 0.09 Allowed 'General case' 0 C--N 1.289 -2.037 0 O-C-N 125.293 1.621 . . . . 0.0 112.191 -179.088 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 179.64 33.34 0.06 OUTLIER Glycine 0 CA--C 1.542 1.78 0 C-N-CA 128.853 3.121 . . . . 0.0 116.173 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 10.7 t -125.68 97.85 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.65 0 O-C-N 120.744 -1.445 . . . . 0.0 107.637 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.496 ' O ' ' HB2' ' A' ' 124' ' ' ALA 0.257 10.0 mt-10 -62.69 -175.56 0.09 Allowed 'General case' 0 N--CA 1.438 -1.067 0 CA-C-O 117.381 -1.295 . . . . 0.0 111.784 179.983 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.513 ' HB2' ' CB ' ' A' ' 17' ' ' PHE . . . -176.75 88.07 0.03 OUTLIER 'General case' 0 N--CA 1.436 -1.131 0 CA-C-O 114.911 -2.471 . . . . 0.0 107.076 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.465 ' HG3' HG22 ' A' ' 116' ' ' THR . 0.0 OUTLIER -68.43 139.99 55.76 Favored 'General case' 0 CA--C 1.487 -1.469 0 O-C-N 125.788 1.93 . . . . 0.0 110.546 179.989 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.636 ' HD2' HG21 ' A' ' 8' ' ' VAL . 5.0 mmm-85 -133.56 85.12 2.18 Favored 'General case' 0 N--CA 1.429 -1.504 0 O-C-N 126.34 2.275 . . . . 0.0 106.581 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.774 HG23 HD13 ' A' ' 114' ' ' ILE . 13.2 mt -83.79 112.47 21.27 Favored 'Isoleucine or valine' 0 C--O 1.249 1.067 0 O-C-N 127.86 3.225 . . . . 0.0 117.305 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.528 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 0.0 OUTLIER -102.39 137.29 40.83 Favored 'General case' 0 N--CA 1.441 -0.9 0 O-C-N 126.642 2.464 . . . . 0.0 108.136 179.414 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.501 ' HA ' ' HG3' ' A' ' 112' ' ' GLU 0.284 12.2 mmtm -92.64 5.58 50.47 Favored 'General case' 0 C--O 1.244 0.78 0 CA-C-O 116.626 -1.655 . . . . 0.0 111.748 179.884 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.623 ' HA ' ' CE3' ' A' ' 6' ' ' TRP . 0.1 OUTLIER 76.59 138.95 0.07 Allowed 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 121.125 1.784 . . . . 0.0 108.424 179.79 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . 0.763 61.4 tt0 . . . . . 0 N--CA 1.443 -0.776 0 C-N-CA 116.563 -2.055 . . . . 0.0 113.789 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' PLM . . . . . 0.658 ' HB2' HD23 ' A' ' 72' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.353 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.575 ' CZ ' HG21 ' A' ' 108' ' ' ILE . 62.1 m-85 -105.66 81.06 1.63 Allowed 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 124.523 2.106 . . . . 0.0 113.776 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -156.73 96.33 1.62 Allowed 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 113.563 -1.653 . . . . 0.0 115.014 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 148.29 -152.44 24.51 Favored Glycine 0 C--N 1.313 -0.738 0 C-N-CA 116.778 -2.629 . . . . 0.0 112.942 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . 0.547 0.0 OUTLIER -111.48 158.12 19.52 Favored 'General case' 0 C--N 1.314 -0.968 0 O-C-N 127.53 2.547 . . . . 0.0 113.096 -179.782 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.647 ' CD1' HD12 ' A' ' 40' ' ' ILE . 85.1 m95 -149.37 113.02 5.05 Favored 'General case' 0 N--CA 1.433 -1.304 0 CA-C-N 112.618 -2.083 . . . . 0.0 110.173 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.9 101.83 11.39 Favored 'General case' 0 C--O 1.211 -0.961 0 CA-C-N 120.886 1.676 . . . . 0.0 107.365 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.505 ' CG1' ' HB3' ' A' ' 36' ' ' LEU . 0.3 OUTLIER -47.43 135.8 3.67 Favored 'Isoleucine or valine' 0 C--O 1.246 0.877 0 CA-C-N 120.76 1.618 . . . . 0.0 110.205 179.913 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -145.05 -11.45 0.56 Allowed 'General case' 0 N--CA 1.433 -1.29 0 C-N-CA 118.676 -1.209 . . . . 0.0 112.997 -179.584 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.422 ' HB3' ' HB ' ' A' ' 127' ' ' ILE . 5.6 tpp180 -111.05 -56.07 2.41 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-N 121.326 1.876 . . . . 0.0 113.245 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.528 ' HB3' ' CD1' ' A' ' 14' ' ' TYR . 1.2 m-20 62.7 165.84 0.11 Allowed 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 124.244 1.018 . . . . 0.0 110.454 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.406 ' N ' ' O ' ' A' ' 125' ' ' LYS . 2.4 mm-40 -171.26 103.05 0.21 Allowed 'General case' 0 C--N 1.314 -0.952 0 O-C-N 117.3 -3.375 . . . . 0.0 107.201 -179.6 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.433 ' HB3' ' HA ' ' A' ' 124' ' ' ALA . 5.6 t-20 97.5 -27.28 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.18 0 O-C-N 125.447 1.717 . . . . 0.0 111.923 -179.238 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.757 ' CE2' ' HB1' ' A' ' 32' ' ' ALA . 2.4 p90 -29.96 -36.39 0.01 OUTLIER 'General case' 0 N--CA 1.435 -1.186 0 O-C-N 127.619 3.074 . . . . 0.0 118.03 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -75.77 -34.21 60.23 Favored 'General case' 0 CA--C 1.498 -1.024 0 C-N-CA 120.58 -0.448 . . . . 0.0 110.793 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -73.04 -28.7 62.49 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-O 124.304 2.002 . . . . 0.0 113.138 179.685 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.79 ' CB ' ' HB2' ' A' ' 124' ' ' ALA . 0.0 OUTLIER -71.45 -29.29 64.7 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-O 125.658 2.646 . . . . 0.0 110.393 179.908 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 29.6 mtm -79.88 -20.38 45.99 Favored 'General case' 0 C--N 1.318 -0.77 0 O-C-N 116.654 -3.779 . . . . 0.0 106.445 179.503 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.04 -31.13 39.51 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 123.103 1.43 . . . . 0.0 112.655 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.602 ' CE ' ' HB3' ' A' ' 119' ' ' TYR . 0.5 OUTLIER -73.49 -21.18 60.49 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 115.754 1.761 . . . . 0.0 115.754 -178.144 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 3.4 mtp -79.03 -47.6 15.91 Favored 'General case' 0 C--O 1.206 -1.192 0 N-CA-C 103.592 -2.744 . . . . 0.0 103.592 179.301 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 124.08 43.64 0.32 Allowed Glycine 0 N--CA 1.433 -1.537 0 CA-C-N 113.902 -1.499 . . . . 0.0 111.234 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.499 ' CD1' ' HG3' ' A' ' 132' ' ' PLM . 1.9 mm -75.09 126.24 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.967 0 CA-C-O 115.813 -2.041 . . . . 0.0 112.173 -179.645 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -52.57 145.02 12.47 Favored 'General case' 0 C--N 1.348 0.527 0 CA-C-O 115.233 -2.318 . . . . 0.0 111.573 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . 0.445 26.9 m -36.39 -47.99 0.25 Allowed 'Isoleucine or valine' 0 C--O 1.216 -0.707 0 N-CA-C 119.162 3.023 . . . . 0.0 119.162 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.537 5.4 m -79.84 -28.38 12.62 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.995 0 N-CA-C 115.217 1.562 . . . . 0.0 115.217 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.9 ttmm -71.41 -31.58 67.42 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 112.147 -2.297 . . . . 0.0 114.904 179.648 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 7.5 ptt180 -79.35 -21.28 46.03 Favored 'General case' 0 C--O 1.219 -0.543 0 C-N-CA 117.721 -1.592 . . . . 0.0 109.303 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 9.3 tttm -72.13 -46.22 57.47 Favored 'General case' 0 CA--C 1.5 -0.959 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.64 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.3 tp -76.38 -28.61 56.82 Favored 'General case' 0 CA--C 1.505 -0.755 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -74.43 -20.99 79.45 Favored Glycine 0 C--N 1.345 1.055 0 CA-C-O 124.017 1.898 . . . . 0.0 111.981 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.757 ' HB1' ' CE2' ' A' ' 14' ' ' TYR . . . -75.25 -48.96 20.9 Favored 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 127.484 2.314 . . . . 0.0 111.02 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 8.5 m170 -96.35 7.66 45.92 Favored 'General case' 0 N--CA 1.429 -1.509 0 O-C-N 127.152 2.782 . . . . 0.0 110.672 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 29.8 p30 -33.6 -27.22 0.01 OUTLIER 'General case' 0 CA--C 1.507 -0.702 0 N-CA-C 116.774 2.139 . . . . 0.0 116.774 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.2 t30 77.1 26.7 0.72 Allowed 'General case' 0 C--O 1.244 0.778 0 CA-C-N 120.641 1.564 . . . . 0.0 112.351 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.522 HD11 ' HG ' ' A' ' 38' ' ' LEU . 1.3 tp -52.22 116.52 2.26 Favored 'General case' 0 CA--C 1.5 -0.962 0 CA-C-O 123.981 1.848 . . . . 0.0 109.341 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.508 ' N ' HD12 ' A' ' 36' ' ' LEU . 6.3 ttmm -111.43 95.6 5.61 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 101.865 -3.383 . . . . 0.0 101.865 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.611 HD12 ' CE2' ' A' ' 128' ' ' PHE 0.284 2.4 mt -78.58 141.52 38.02 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 119.041 -2.287 . . . . 0.0 108.292 -179.928 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.505 ' HB ' ' CB ' ' A' ' 50' ' ' LYS . 9.3 m -128.51 76.82 1.73 Allowed 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 102.213 -3.254 . . . . 0.0 102.213 179.23 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.647 HD12 ' CD1' ' A' ' 6' ' ' TRP . 6.0 mt -65.81 134.94 29.19 Favored 'Isoleucine or valine' 0 C--O 1.251 1.142 0 CA-C-N 112.401 -2.182 . . . . 0.0 106.359 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.411 HG22 ' O ' ' A' ' 41' ' ' THR . 0.8 OUTLIER -145.91 113.81 6.48 Favored 'General case' 0 CA--C 1.504 -0.792 0 O-C-N 126.849 2.593 . . . . 0.0 110.648 -179.949 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -90.09 134.35 34.31 Favored 'General case' 0 C--O 1.22 -0.465 0 CA-C-N 114.259 -1.337 . . . . 0.0 113.765 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 33.9 tp10 -135.55 91.01 2.67 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 105.578 -2.008 . . . . 0.0 105.578 179.758 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 67.13 -97.67 0.39 Allowed Glycine 0 C--N 1.292 -1.871 0 CA-C-O 116.367 -2.352 . . . . 0.0 109.313 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.335 0.0 OUTLIER -117.8 -1.93 11.46 Favored 'General case' 0 C--N 1.315 -0.917 0 O-C-N 129.712 3.83 . . . . 0.0 113.377 -179.895 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.42 ' HA ' ' HA ' ' A' ' 63' ' ' GLU . 0.6 OUTLIER -99.62 136.66 39.23 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 106.997 -1.482 . . . . 0.0 106.997 -179.952 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.497 ' HE2' HD11 ' A' ' 89' ' ' LEU 0.313 0.1 OUTLIER -121.48 108.27 13.44 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 105.616 -1.994 . . . . 0.0 105.616 -179.929 . . . . . . . . 4 4 . 1 . 007 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.692 ' HB ' HG12 ' A' ' 61' ' ' VAL 0.386 0.1 OUTLIER -99.94 89.94 4.24 Favored 'General case' 0 N--CA 1.423 -1.789 0 O-C-N 124.804 1.315 . . . . 0.0 108.445 -179.68 . . . . . . . . 4 4 . 1 . 007 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.636 HG22 ' HB ' ' A' ' 60' ' ' VAL 0.714 1.0 OUTLIER -65.7 94.59 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.503 -0.858 0 O-C-N 127.246 2.841 . . . . 0.0 108.596 178.792 . . . . . . . . 4 4 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.505 ' CB ' ' HB ' ' A' ' 39' ' ' THR . 0.0 OUTLIER -63.35 140.46 58.87 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 102.448 -3.168 . . . . 0.0 102.448 -179.439 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.471 ' HB2' HG23 ' A' ' 60' ' ' VAL . 11.8 tt0 -130.04 73.0 1.5 Allowed 'General case' 0 CA--C 1.51 -0.559 0 N-CA-C 105.998 -1.853 . . . . 0.0 105.998 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.99 69.36 5.13 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 105.957 -1.868 . . . . 0.0 105.957 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.32 175.77 6.98 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.984 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -62.19 -26.58 68.43 Favored 'General case' 0 C--O 1.216 -0.674 0 O-C-N 125.441 1.713 . . . . 0.0 107.831 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.645 ' CE1' ' HB1' ' A' ' 73' ' ' ALA . 0.3 OUTLIER -69.1 -64.38 0.88 Allowed 'General case' 0 C--O 1.222 -0.385 0 CA-C-O 114.473 -2.679 . . . . 0.0 108.659 179.821 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -173.05 172.52 3.91 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 122.8 2.545 . . . . 0.0 110.844 179.537 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -90.76 65.94 5.96 Favored 'General case' 0 CA--C 1.498 -1.02 0 O-C-N 128.46 3.6 . . . . 0.0 105.067 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -87.48 -41.11 14.32 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 O-C-N 127.353 2.908 . . . . 0.0 115.746 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 50.6 t0 79.58 141.66 0.07 Allowed 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 104.649 -2.352 . . . . 0.0 104.649 -179.009 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.636 ' HB ' HG22 ' A' ' 49' ' ' VAL . 1.5 t -129.38 84.77 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 N-CA-C 105.464 -2.05 . . . . 0.0 105.464 -179.543 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.692 HG12 ' HB ' ' A' ' 48' ' ' THR 0.314 1.5 m -90.18 136.56 23.55 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.519 0 N-CA-C 116.889 2.181 . . . . 0.0 116.889 -178.188 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.583 ' CE2' ' H22' ' A' ' 132' ' ' PLM . 0.0 OUTLIER -137.25 95.0 3.01 Favored 'General case' 0 N--CA 1.422 -1.83 0 CA-C-O 114.18 -2.819 . . . . 0.0 110.8 177.263 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.492 ' O ' ' N ' ' A' ' 65' ' ' GLY . 24.0 tt0 -54.58 117.73 3.59 Favored 'General case' 0 C--N 1.32 -0.698 1 N-CA-C 98.813 -4.514 . . . . 0.0 98.813 175.998 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.776 ' HB3' ' CD2' ' A' ' 82' ' ' TRP . 0.0 OUTLIER -47.76 93.48 0.01 OUTLIER 'General case' 0 N--CA 1.429 -1.511 0 O-C-N 125.686 1.866 . . . . 0.0 107.69 -175.68 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.685 ' N ' ' NE1' ' A' ' 82' ' ' TRP . . . 94.71 50.33 2.16 Favored Glycine 0 C--N 1.353 1.517 0 N-CA-C 121.592 3.397 . . . . 0.0 121.592 178.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.41 ' HB ' ' HB3' ' A' ' 63' ' ' GLU 0.305 7.3 p -103.94 -19.91 6.03 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 CA-C-O 115.237 -2.316 . . . . 0.0 109.826 -179.985 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.548 ' HA ' HG22 ' A' ' 81' ' ' THR . 64.8 t0 65.19 105.04 0.04 OUTLIER 'General case' 0 C--O 1.204 -1.305 0 CA-C-O 123.074 1.416 . . . . 0.0 107.409 -178.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.608 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 0.1 OUTLIER -131.64 161.26 33.15 Favored 'General case' 0 C--N 1.307 -1.245 0 C-N-CA 125.876 1.67 . . . . 0.0 111.619 -176.876 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -110.75 130.07 55.67 Favored 'General case' 0 C--O 1.245 0.843 0 O-C-N 127.031 2.707 . . . . 0.0 105.122 179.537 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 83.9 t80 -132.6 96.5 3.84 Favored 'General case' 0 C--O 1.208 -1.104 0 O-C-N 125.353 1.658 . . . . 0.0 114.41 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 25.1 t -66.97 140.84 57.75 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 105.372 -2.084 . . . . 0.0 105.372 179.527 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.411 HD11 ' H92' ' A' ' 132' ' ' PLM . 2.9 mm? -77.39 -174.68 3.41 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 103.257 -2.868 . . . . 0.0 103.257 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.645 ' HB1' ' CE1' ' A' ' 55' ' ' PHE . . . -80.48 -19.71 45.34 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-O 124.836 2.255 . . . . 0.0 111.3 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.466 ' HB3' ' CG ' ' A' ' 132' ' ' PLM . 1.2 t70 -153.86 -37.61 0.1 Allowed 'General case' 0 C--O 1.222 -0.375 0 CA-C-N 112.669 -2.06 . . . . 0.0 111.129 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.567 ' O ' HG22 ' A' ' 76' ' ' THR . . . -69.72 -0.91 28.09 Favored Glycine 0 CA--C 1.533 1.207 0 N-CA-C 118.512 2.165 . . . . 0.0 118.512 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.567 HG22 ' O ' ' A' ' 75' ' ' GLY 0.386 0.3 OUTLIER 77.27 164.44 0.24 Allowed 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 120.376 2.088 . . . . 0.0 114.857 -179.908 . . . . . . . . 4 4 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.575 ' HG2' HG21 ' A' ' 96' ' ' VAL . 0.3 OUTLIER -30.31 145.21 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 111.763 -2.471 . . . . 0.0 116.567 -179.805 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.499 ' HG ' ' HB3' ' A' ' 93' ' ' PHE 0.386 0.6 OUTLIER -160.62 101.74 1.34 Allowed 'General case' 0 C--O 1.24 0.602 0 CA-C-N 109.924 -3.307 . . . . 0.0 107.142 179.982 . . . . . . . . 4 4 . 1 . 007 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.658 HG22 ' O ' ' A' ' 94' ' ' LYS . 91.6 m -105.82 -172.78 2.15 Favored 'General case' 0 CA--C 1.498 -1.037 0 N-CA-C 101.772 -3.418 . . . . 0.0 101.772 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.446 ' HA3' ' HA ' ' A' ' 93' ' ' PHE . . . 118.8 -148.07 18.4 Favored Glycine 0 C--N 1.292 -1.872 0 CA-C-O 116.571 -2.238 . . . . 0.0 113.191 179.629 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.548 HG22 ' HA ' ' A' ' 67' ' ' ASP . 60.3 p -165.46 166.73 18.2 Favored 'General case' 0 C--O 1.188 -2.155 0 CA-C-O 124.232 1.967 . . . . 0.0 110.712 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' TRP . . . . . 0.777 ' CG ' ' N ' ' A' ' 83' ' ' THR 0.399 4.0 p-90 -73.03 -162.39 0.11 Allowed 'General case' 0 N--CA 1.438 -1.063 0 N-CA-C 100.244 -3.984 . . . . 0.0 100.244 175.43 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.777 ' N ' ' CG ' ' A' ' 82' ' ' TRP . 4.7 t 159.43 129.51 0.0 OUTLIER 'General case' 0 N--CA 1.415 -2.219 0 CA-C-O 125.733 2.682 . . . . 0.0 112.657 174.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.584 ' HB2' ' CZ3' ' A' ' 82' ' ' TRP . 0.0 OUTLIER -88.53 121.93 31.45 Favored 'General case' 0 N--CA 1.422 -1.836 0 CA-C-N 110.566 -3.015 . . . . 0.0 105.524 179.047 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.669 ' HG2' HG21 ' A' ' 90' ' ' VAL 0.622 2.5 pp20? -111.59 44.48 1.35 Allowed 'General case' 0 N--CA 1.421 -1.912 0 CA-C-O 123.574 1.654 . . . . 0.0 114.394 179.735 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 71.61 110.94 0.05 OUTLIER Glycine 0 N--CA 1.443 -0.854 0 N-CA-C 107.595 -2.202 . . . . 0.0 107.595 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 50.9 t30 66.67 -22.05 0.1 Allowed 'General case' 0 N--CA 1.44 -0.942 0 CA-C-O 114.948 -2.453 . . . . 0.0 116.347 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.451 ' HG3' ' HA ' ' A' ' 107' ' ' GLU 0.33 0.1 OUTLIER -129.1 142.76 50.79 Favored 'General case' 0 CA--C 1.491 -1.311 0 CA-C-N 120.903 1.683 . . . . 0.0 107.465 -179.97 . . . . . . . . 4 4 . 1 . 007 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.508 HD23 ' HA ' ' A' ' 89' ' ' LEU . 0.2 OUTLIER -94.85 152.55 18.3 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 101.715 -3.439 . . . . 0.0 101.715 -179.821 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.669 HG21 ' HG2' ' A' ' 85' ' ' GLU . 1.4 t -136.75 164.65 30.17 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 N-CA-C 105.507 -2.035 . . . . 0.0 105.507 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -133.79 99.06 0.34 Allowed Glycine 0 C--N 1.363 2.079 0 C-N-CA 128.554 2.978 . . . . 0.0 108.865 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -98.45 127.93 44.6 Favored 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 103.343 -2.836 . . . . 0.0 103.343 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.538 ' HB2' ' HB3' ' A' ' 102' ' ' LEU . 19.4 m-85 -140.5 130.49 24.69 Favored 'General case' 0 N--CA 1.442 -0.869 0 O-C-N 124.429 1.081 . . . . 0.0 113.279 179.484 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.658 ' O ' HG22 ' A' ' 79' ' ' THR . 0.5 OUTLIER -115.27 124.2 50.73 Favored 'General case' 0 N--CA 1.422 -1.832 0 C-N-CA 130.159 3.384 . . . . 0.0 105.54 -179.987 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.713 ' HE ' ' N ' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -54.74 -168.02 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.721 0 O-C-N 128.339 3.525 . . . . 0.0 110.573 178.647 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.575 HG21 ' HG2' ' A' ' 77' ' ' GLU . 20.5 t -124.56 -50.11 2.1 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 O-C-N 119.754 -1.841 . . . . 0.0 106.489 176.666 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . 0.293 0.3 OUTLIER -110.0 9.7 24.27 Favored 'General case' 0 C--O 1.255 1.348 0 CA-C-N 113.102 -1.863 . . . . 0.0 113.465 -179.939 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.432 ' HB3' ' CB ' ' A' ' 95' ' ' ARG 0.268 8.0 t-20 -101.46 -23.91 14.25 Favored 'General case' 0 CA--C 1.494 -1.195 0 CA-C-O 116.281 -1.819 . . . . 0.0 111.322 -179.962 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.658 ' HA2' ' CZ ' ' A' ' 95' ' ' ARG . . . 71.87 11.1 73.55 Favored Glycine 0 CA--C 1.542 1.767 0 N-CA-C 118.38 2.112 . . . . 0.0 118.38 179.181 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.713 ' N ' ' HE ' ' A' ' 95' ' ' ARG . 3.8 mtpp -110.73 -148.04 0.42 Allowed 'General case' 0 C--N 1.3 -1.578 0 O-C-N 125.801 1.53 . . . . 0.0 111.004 -177.45 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 57.2 tt0 -160.65 161.91 32.53 Favored 'General case' 0 N--CA 1.433 -1.295 0 C-N-CA 131.385 3.874 . . . . 0.0 109.687 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.538 ' HB3' ' HB2' ' A' ' 93' ' ' PHE . 9.3 tp -142.33 157.75 44.47 Favored 'General case' 0 N--CA 1.438 -1.045 1 C-N-CA 132.014 4.125 . . . . 0.0 106.527 -179.243 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.643 ' CG2' ' HB ' ' A' ' 118' ' ' THR . 4.1 tt -150.25 154.63 8.67 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.993 0 N-CA-C 103.941 -2.615 . . . . 0.0 103.941 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -131.5 -172.0 2.74 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.569 HG12 HG23 ' A' ' 116' ' ' THR . 0.5 OUTLIER -169.72 77.02 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 CA-C-O 127.544 3.545 . . . . 0.0 107.539 179.647 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.463 HH12 ' HE2' ' A' ' 62' ' ' PHE . 0.1 OUTLIER -65.84 91.71 0.15 Allowed 'General case' 0 C--O 1.217 -0.617 0 N-CA-C 104.668 -2.345 . . . . 0.0 104.668 179.571 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.451 ' HA ' ' HG3' ' A' ' 88' ' ' LYS . 25.8 tt0 -72.75 -35.42 67.48 Favored 'General case' 0 C--O 1.202 -1.414 0 CA-C-N 110.994 -2.821 . . . . 0.0 115.044 -179.581 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.83 HD13 HD12 ' A' ' 113' ' ' LEU 0.428 3.2 tp 52.55 43.38 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 C-N-CA 112.927 -3.509 . . . . 0.0 113.236 179.956 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -66.73 103.19 1.05 Allowed 'General case' 0 CA--C 1.505 -0.782 0 O-C-N 120.494 -1.379 . . . . 0.0 108.193 -179.487 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 56.85 -73.29 0.01 OUTLIER Glycine 0 C--N 1.342 0.893 0 C-N-CA 127.206 2.336 . . . . 0.0 111.848 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . 0.351 0.0 OUTLIER -136.97 36.8 2.58 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 117.494 -1.241 . . . . 0.0 110.32 179.671 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -146.43 97.62 2.95 Favored 'General case' 0 C--N 1.363 1.162 0 O-C-N 126.521 2.388 . . . . 0.0 110.388 -179.651 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.83 HD12 HD13 ' A' ' 108' ' ' ILE . 0.4 OUTLIER -75.27 68.33 1.99 Allowed 'General case' 0 C--O 1.209 -1.068 1 O-C-N 129.353 4.158 . . . . 0.0 107.479 -179.51 . . . . . . . . 4 4 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.866 HG12 HD13 ' A' ' 127' ' ' ILE . 54.6 mt -72.07 128.27 34.86 Favored 'Isoleucine or valine' 0 C--O 1.25 1.114 0 N-CA-C 105.006 -2.22 . . . . 0.0 105.006 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -113.17 108.14 16.89 Favored 'General case' 0 CA--C 1.493 -1.232 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 -179.656 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.569 HG23 HG12 ' A' ' 105' ' ' VAL . 66.8 p -76.28 169.06 18.94 Favored 'General case' 0 C--O 1.245 0.846 0 C-N-CA 115.912 -2.315 . . . . 0.0 105.443 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.707 ' HB2' ' HB3' ' A' ' 124' ' ' ALA . 0.8 OUTLIER -148.85 93.82 2.17 Favored 'General case' 0 CA--C 1.491 -1.298 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 -179.986 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.643 ' HB ' ' CG2' ' A' ' 103' ' ' ILE . 0.2 OUTLIER -96.84 81.68 3.16 Favored 'General case' 0 N--CA 1.424 -1.762 0 O-C-N 126.702 2.501 . . . . 0.0 116.322 -179.781 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.602 ' HB3' ' CE ' ' A' ' 20' ' ' LYS . 0.2 OUTLIER -85.8 101.57 12.92 Favored 'General case' 0 N--CA 1.479 0.975 0 N-CA-C 103.278 -2.86 . . . . 0.0 103.278 178.625 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 65.25 -82.15 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.412 0 CA-C-N 113.88 -1.509 . . . . 0.0 114.178 -179.228 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -132.8 24.09 3.89 Favored Glycine 0 CA--C 1.54 1.623 0 N-CA-C 117.401 1.72 . . . . 0.0 117.401 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.534 ' HB ' ' HD3' ' A' ' 20' ' ' LYS . 3.3 t -133.14 87.36 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -68.62 129.97 41.49 Favored 'General case' 0 N--CA 1.436 -1.144 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.79 ' HB2' ' CB ' ' A' ' 17' ' ' PHE . . . -115.54 115.6 26.74 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-O 116.307 -1.806 . . . . 0.0 108.4 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.406 ' O ' ' N ' ' A' ' 12' ' ' GLU . 0.1 OUTLIER -92.7 129.94 38.48 Favored 'General case' 0 C--O 1.252 1.202 0 C-N-CA 116.991 -1.883 . . . . 0.0 109.932 -179.998 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 7.4 mtm180 -119.89 86.77 2.62 Favored 'General case' 0 N--CA 1.437 -1.122 0 CA-C-N 112.082 -2.326 . . . . 0.0 106.028 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.866 HD13 HG12 ' A' ' 114' ' ' ILE . 0.8 OUTLIER -84.28 125.9 40.23 Favored 'Isoleucine or valine' 0 C--O 1.252 1.23 0 CA-C-N 114.306 -1.316 . . . . 0.0 112.893 179.983 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.611 ' CE2' HD12 ' A' ' 38' ' ' LEU . 0.2 OUTLIER -106.39 155.71 19.27 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-O 123.722 1.725 . . . . 0.0 107.926 179.709 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . 0.268 15.9 mtpp -117.3 16.99 14.79 Favored 'General case' 0 C--O 1.244 0.797 0 O-C-N 118.594 -2.566 . . . . 0.0 110.704 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.554 ' HG3' ' CH2' ' A' ' 6' ' ' TRP . 1.4 tttt 57.26 113.25 0.01 OUTLIER 'General case' 0 C--O 1.219 -0.527 0 N-CA-C 115.991 1.849 . . . . 0.0 115.991 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . 0.836 15.0 tt0 . . . . . 0 N--CA 1.429 -1.519 0 O-C-N 118.422 -2.674 . . . . 0.0 116.023 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' PLM . . . . . 0.583 ' H22' ' CE2' ' A' ' 62' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.445 ' O ' ' N ' ' A' ' 3' ' ' ASP . . . . . . . . 0 N--CA 1.447 -0.586 0 CA-C-O 116.353 -1.784 . . . . 0.0 112.899 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 19.2 p90 -35.48 79.59 0.0 OUTLIER 'General case' 0 N--CA 1.429 -1.513 0 N-CA-C 118.541 2.793 . . . . 0.0 118.541 179.769 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.445 ' N ' ' O ' ' A' ' 1' ' ' ALA . 23.2 t70 -167.45 96.92 0.48 Allowed 'General case' 0 N--CA 1.435 -1.191 0 O-C-N 119.605 -1.934 . . . . 0.0 112.091 -179.639 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 142.91 -152.48 23.99 Favored Glycine 0 C--O 1.212 -1.229 0 C-N-CA 118.587 -1.768 . . . . 0.0 109.435 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.486 HG22 ' HG2' ' A' ' 37' ' ' LYS 0.567 13.2 p -89.69 155.08 19.46 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 123.358 0.663 . . . . 0.0 111.417 179.946 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.573 ' CH2' HD11 ' A' ' 108' ' ' ILE . 91.9 m95 -152.69 105.17 2.95 Favored 'General case' 0 C--N 1.319 -0.747 0 O-C-N 127.652 3.095 . . . . 0.0 106.848 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 13.1 ttpt -106.04 101.85 11.31 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-O 114.991 -2.433 . . . . 0.0 108.313 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.481 ' HA ' ' HA ' ' A' ' 128' ' ' PHE 0.284 2.8 p -45.89 144.27 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 120.441 1.473 . . . . 0.0 111.015 179.804 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -146.55 -30.25 0.37 Allowed 'General case' 0 N--CA 1.438 -1.053 0 O-C-N 127.82 3.2 . . . . 0.0 112.371 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.608 ' HB2' ' HB ' ' A' ' 127' ' ' ILE . 17.9 mmt180 -82.84 -80.76 0.17 Allowed 'General case' 0 C--N 1.297 -1.684 0 O-C-N 119.022 -2.299 . . . . 0.0 114.286 -179.652 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.526 ' HA ' ' HA ' ' A' ' 126' ' ' ARG 0.284 8.2 m120 77.13 147.19 0.09 Allowed 'General case' 0 C--O 1.247 0.964 1 O-C-N 129.592 4.307 . . . . 0.0 106.275 -177.206 . . . . . . . . 4 3 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.41 ' N ' ' O ' ' A' ' 125' ' ' LYS . 2.8 tp10 -125.9 -69.54 0.77 Allowed 'General case' 0 C--N 1.296 -1.724 0 CA-C-N 122.398 2.363 . . . . 0.0 108.113 -179.595 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.496 ' HB3' ' HA ' ' A' ' 124' ' ' ALA . 5.2 t30 -112.17 29.37 7.95 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 127.325 2.891 . . . . 0.0 113.157 179.7 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.676 ' CD1' ' HB1' ' A' ' 124' ' ' ALA 0.376 1.1 m-85 -73.18 -27.68 61.78 Favored 'General case' 0 N--CA 1.44 -0.974 0 O-C-N 127.282 2.863 . . . . 0.0 117.488 179.708 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -74.36 -36.48 63.58 Favored 'General case' 0 C--O 1.209 -1.032 0 CA-C-N 120.479 1.49 . . . . 0.0 111.391 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.4 ' HB3' ' ND2' ' A' ' 13' ' ' ASN . 12.4 tptp -71.77 -32.14 67.35 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 111.537 -2.574 . . . . 0.0 115.216 179.772 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -70.76 -24.27 62.57 Favored 'General case' 0 N--CA 1.441 -0.88 0 O-C-N 124.868 1.355 . . . . 0.0 111.472 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 7.7 mmt -77.21 -34.65 56.04 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-O 123.841 1.781 . . . . 0.0 106.422 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -65.54 -31.14 72.04 Favored 'General case' 0 N--CA 1.473 0.709 0 O-C-N 118.199 -2.813 . . . . 0.0 112.529 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.414 ' HA ' ' HD2' ' A' ' 20' ' ' LYS . 11.6 tptm -77.04 -30.91 55.9 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 112.836 -1.984 . . . . 0.0 110.581 179.352 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.84 -21.08 55.55 Favored 'General case' 0 N--CA 1.435 -1.221 0 O-C-N 125.148 1.53 . . . . 0.0 107.792 179.373 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 123.01 1.64 9.49 Favored Glycine 0 C--N 1.301 -1.387 0 CA-C-O 117.674 -1.625 . . . . 0.0 113.258 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.415 HG23 ' HB2' ' A' ' 27' ' ' LYS . 0.6 OUTLIER -77.75 107.33 9.35 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.313 0 CA-C-O 117.73 -1.129 . . . . 0.0 108.605 179.913 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -118.67 1.49 11.64 Favored 'General case' 0 C--N 1.352 0.68 0 CA-C-O 116.001 -1.952 . . . . 0.0 114.154 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . 0.393 0.6 OUTLIER -112.72 -140.14 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.358 0.969 0 O-C-N 128.974 3.921 . . . . 0.0 116.34 -179.981 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.561 0.0 OUTLIER -72.76 -21.08 19.45 Favored 'Isoleucine or valine' 0 C--O 1.243 0.722 0 CA-C-N 120.689 1.586 . . . . 0.0 114.792 -179.926 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.415 ' HB2' HG23 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -62.14 -30.78 71.28 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 114.29 1.219 . . . . 0.0 114.29 179.89 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . 0.268 0.1 OUTLIER -78.97 -20.95 47.87 Favored 'General case' 0 N--CA 1.454 -0.247 0 O-C-N 119.502 -1.998 . . . . 0.0 108.31 180.0 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.6 tttm -78.9 -46.66 17.99 Favored 'General case' 0 C--O 1.215 -0.716 0 CA-C-N 113.318 -1.764 . . . . 0.0 108.768 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 11.0 mp -73.46 -22.69 60.12 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 113.746 -1.57 . . . . 0.0 110.248 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -68.79 -34.0 76.73 Favored Glycine 0 C--N 1.344 1.018 0 C-N-CA 123.638 0.637 . . . . 0.0 112.559 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -79.85 -34.86 38.97 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 127.625 2.37 . . . . 0.0 109.107 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 1.4 m80 -118.4 42.03 2.82 Favored 'General case' 0 C--O 1.24 0.573 0 C-N-CA 126.617 1.967 . . . . 0.0 114.338 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.8 p30 -71.29 -23.59 61.99 Favored 'General case' 0 C--O 1.215 -0.754 0 N-CA-C 119.17 3.026 . . . . 0.0 119.17 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 78.13 9.1 2.25 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 -179.635 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.769 HD22 HH21 ' A' ' 126' ' ' ARG . 0.9 OUTLIER -41.77 116.32 0.77 Allowed 'General case' 0 CA--C 1.51 -0.591 0 O-C-N 126.962 2.664 . . . . 0.0 110.873 -179.791 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.486 ' HG2' HG22 ' A' ' 5' ' ' THR . 11.4 ttmm -113.86 92.11 3.87 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 105.166 -2.161 . . . . 0.0 105.166 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.713 HD13 HD21 ' A' ' 36' ' ' LEU 0.276 0.8 OUTLIER -75.17 114.08 13.25 Favored 'General case' 0 C--N 1.292 -1.91 0 C-N-CA 117.497 -1.681 . . . . 0.0 109.115 -179.983 . . . . . . . . 4 4 . 1 . 008 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.524 ' HB ' ' CB ' ' A' ' 50' ' ' LYS . 91.8 m -94.87 84.47 4.18 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 102.012 -3.329 . . . . 0.0 102.012 179.44 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.57 HD12 ' CD1' ' A' ' 6' ' ' TRP . 96.0 mt -71.73 116.14 13.04 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 CA-C-O 123.69 1.71 . . . . 0.0 110.81 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.3 m -110.38 118.01 35.14 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 110.324 -3.125 . . . . 0.0 109.348 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 2.7 tp60 -94.46 125.62 39.22 Favored 'General case' 0 C--N 1.311 -1.082 0 O-C-N 126.074 2.108 . . . . 0.0 107.794 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -135.08 68.31 1.47 Allowed 'General case' 0 N--CA 1.433 -1.31 0 CA-C-O 125.257 2.456 . . . . 0.0 105.684 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.17 -76.59 2.22 Favored Glycine 0 C--N 1.298 -1.559 0 N-CA-C 104.44 -3.464 . . . . 0.0 104.44 179.785 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.348 0.0 OUTLIER -130.51 -36.58 1.44 Allowed 'General case' 0 C--N 1.326 -0.449 0 O-C-N 126.608 2.005 . . . . 0.0 113.976 179.947 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.481 ' HA ' ' HA ' ' A' ' 63' ' ' GLU . 7.4 ttmt -57.38 109.26 0.65 Allowed 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 114.102 -1.408 . . . . 0.0 113.56 -179.77 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . 0.254 3.2 m-30 -100.4 78.23 2.01 Favored 'General case' 0 CA--C 1.507 -0.684 0 CA-C-O 125.578 2.608 . . . . 0.0 106.942 179.639 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.619 ' HB ' ' HB ' ' A' ' 61' ' ' VAL 0.417 9.8 t -76.48 80.13 3.19 Favored 'General case' 0 N--CA 1.435 -1.216 0 O-C-N 118.832 -2.417 . . . . 0.0 113.439 -179.873 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.48 ' CG2' ' HG ' ' A' ' 38' ' ' LEU 0.596 2.0 m -56.78 96.99 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.428 -1.532 0 CA-C-N 114.189 -1.369 . . . . 0.0 114.466 179.652 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.524 ' CB ' ' HB ' ' A' ' 39' ' ' THR . 1.1 ttmt -67.51 116.26 8.04 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 101.59 -3.485 . . . . 0.0 101.59 179.719 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.508 ' HB2' ' CG2' ' A' ' 60' ' ' VAL 0.263 1.9 tt0 -107.44 107.0 17.67 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 103.753 -2.684 . . . . 0.0 103.753 -179.997 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.0 m -106.56 48.79 0.82 Allowed 'General case' 0 C--N 1.285 -2.196 0 N-CA-C 105.004 -2.221 . . . . 0.0 105.004 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.3 m -76.36 162.54 27.8 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-O 115.431 -2.223 . . . . 0.0 109.106 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -48.57 -37.12 17.08 Favored 'General case' 0 C--O 1.211 -0.958 0 O-C-N 125.238 1.586 . . . . 0.0 107.531 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -52.88 -65.35 0.57 Allowed 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 116.459 -1.734 . . . . 0.0 109.54 179.297 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.446 ' HG3' ' N ' ' A' ' 57' ' ' ASN . 1.2 ttm-85 -173.08 148.02 1.67 Allowed 'General case' 0 CA--C 1.498 -1.028 0 CA-C-N 120.525 1.511 . . . . 0.0 110.462 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.446 ' N ' ' HG3' ' A' ' 56' ' ' ARG . 3.3 m-20 -78.4 86.64 4.45 Favored 'General case' 0 CA--C 1.499 -1.011 0 N-CA-C 102.338 -3.208 . . . . 0.0 102.338 -179.652 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -122.95 115.42 45.74 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.188 0 N-CA-C 117.864 2.542 . . . . 0.0 117.864 -179.475 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.404 ' OD1' ' N ' ' A' ' 59' ' ' ASP . 0.1 OUTLIER -64.69 147.6 52.71 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 104.024 -2.584 . . . . 0.0 104.024 178.909 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.508 ' CG2' ' HB2' ' A' ' 51' ' ' GLU . 1.8 t -124.71 46.43 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.019 0 CA-C-O 123.847 1.784 . . . . 0.0 106.523 -179.496 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.619 ' HB ' ' HB ' ' A' ' 48' ' ' THR 0.304 0.5 OUTLIER -43.9 144.88 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.568 0 N-CA-C 116.414 2.005 . . . . 0.0 116.414 -179.309 . . . . . . . . 4 4 . 1 . 008 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.505 ' CE2' ' H32' ' A' ' 132' ' ' PLM . 0.0 OUTLIER -154.51 92.79 1.52 Allowed 'General case' 0 N--CA 1.419 -2.022 0 CA-C-O 115.958 -1.972 . . . . 0.0 109.258 175.911 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.481 ' HA ' ' HA ' ' A' ' 46' ' ' LYS 0.263 1.2 mt-10 -66.45 94.77 0.29 Allowed 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 100.538 -3.875 . . . . 0.0 100.538 178.541 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.674 ' HB3' ' CE2' ' A' ' 82' ' ' TRP . 0.0 OUTLIER -12.22 89.08 0.01 OUTLIER 'General case' 0 N--CA 1.426 -1.664 0 O-C-N 128.006 3.316 . . . . 0.0 112.135 -178.566 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.565 ' N ' ' CD1' ' A' ' 82' ' ' TRP . . . 96.16 36.65 5.13 Favored Glycine 0 C--N 1.351 1.368 0 N-CA-C 121.586 3.395 . . . . 0.0 121.586 179.2 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . 0.409 38.1 t -121.48 77.99 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 N-CA-C 105.039 -2.208 . . . . 0.0 105.039 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -14.38 127.8 0.01 OUTLIER 'General case' 0 CA--C 1.48 -1.733 0 O-C-N 128.077 3.361 . . . . 0.0 116.513 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.576 ' CZ ' ' HA ' ' A' ' 81' ' ' THR . 8.9 p90 -147.93 164.05 34.95 Favored 'General case' 0 N--CA 1.441 -0.899 0 O-C-N 119.072 -2.267 . . . . 0.0 112.544 -178.75 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -116.11 148.41 40.31 Favored 'General case' 0 C--O 1.243 0.729 0 O-C-N 126.47 2.356 . . . . 0.0 105.445 179.351 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.907 ' HB3' HD22 ' A' ' 78' ' ' LEU . 2.9 t80 -116.65 -47.6 2.71 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-O 116.637 -1.649 . . . . 0.0 114.2 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.468 ' HA ' ' N ' ' A' ' 77' ' ' GLU . 2.5 t 70.01 104.43 0.06 Allowed 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 -179.507 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.404 ' HB3' ' HE2' ' A' ' 132' ' ' PLM . 6.1 mt -69.53 -175.81 0.9 Allowed 'General case' 0 C--N 1.302 -1.476 0 O-C-N 128.441 3.588 . . . . 0.0 109.172 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -105.97 -2.92 22.31 Favored 'General case' 0 N--CA 1.443 -0.817 0 O-C-N 128.089 3.368 . . . . 0.0 114.276 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -121.74 -47.15 2.21 Favored 'General case' 0 N--CA 1.435 -1.175 0 O-C-N 121.677 -0.639 . . . . 0.0 110.848 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -110.15 -10.11 22.87 Favored Glycine 0 CA--C 1.537 1.443 0 O-C-N 124.455 1.097 . . . . 0.0 115.774 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.673 HG23 ' N ' ' A' ' 77' ' ' GLU 0.349 0.7 OUTLIER 72.28 172.47 0.31 Allowed 'General case' 0 CA--C 1.501 -0.915 0 C-N-CA 115.793 -2.363 . . . . 0.0 110.27 -179.838 . . . . . . . . 4 4 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.673 ' N ' HG23 ' A' ' 76' ' ' THR . 0.2 OUTLIER 47.01 -171.28 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.818 1 O-C-N 129.391 4.182 . . . . 0.0 110.309 179.947 . . . . . . . . 4 4 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.907 HD22 ' HB3' ' A' ' 70' ' ' TYR 0.339 4.8 tt 130.9 141.62 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.808 0 O-C-N 128.423 3.577 . . . . 0.0 102.247 180.0 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.414 ' N ' HD23 ' A' ' 78' ' ' LEU . 17.3 m -163.48 128.74 3.03 Favored 'General case' 0 C--O 1.199 -1.56 0 N-CA-C 103.17 -2.9 . . . . 0.0 103.17 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.405 ' HA3' ' HA ' ' A' ' 93' ' ' PHE . . . 179.56 -135.25 2.46 Favored Glycine 0 C--N 1.31 -0.905 0 C-N-CA 118.583 -1.77 . . . . 0.0 110.315 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.576 ' HA ' ' CZ ' ' A' ' 68' ' ' PHE . 33.6 p -164.59 164.27 21.64 Favored 'General case' 0 C--O 1.188 -2.132 0 C-N-CA 117.214 -1.794 . . . . 0.0 111.779 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' TRP . . . . . 0.688 ' CG ' ' N ' ' A' ' 83' ' ' THR 0.408 1.4 p-90 -74.67 -171.59 1.31 Allowed 'General case' 0 C--N 1.31 -1.112 1 N-CA-C 100.025 -4.065 . . . . 0.0 100.025 175.735 . . . . . . . . 4 3 . 1 . 008 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.688 ' N ' ' CG ' ' A' ' 82' ' ' TRP . 0.3 OUTLIER 172.4 118.17 0.02 OUTLIER 'General case' 0 N--CA 1.432 -1.331 0 CA-C-O 124.404 2.05 . . . . 0.0 113.316 174.913 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.591 ' HB2' ' CZ3' ' A' ' 82' ' ' TRP . 2.8 ttp -84.86 101.23 12.13 Favored 'General case' 0 N--CA 1.433 -1.275 0 O-C-N 120.852 -1.155 . . . . 0.0 108.076 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.429 ' CG ' ' CG2' ' A' ' 90' ' ' VAL 0.673 0.8 OUTLIER -54.82 -87.1 0.0 OUTLIER 'General case' 0 N--CA 1.432 -1.368 0 CA-C-O 125.918 2.77 . . . . 0.0 111.076 179.982 . . . . . . . . 4 4 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -138.65 -80.04 0.08 OUTLIER Glycine 0 N--CA 1.443 -0.852 0 N-CA-C 104.238 -3.545 . . . . 0.0 104.238 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -95.1 5.34 52.13 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 116.404 -1.76 . . . . 0.0 115.054 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.46 ' HE2' HG21 ' A' ' 105' ' ' VAL 0.371 0.6 OUTLIER -147.55 162.89 38.18 Favored 'General case' 0 CA--C 1.493 -1.215 0 O-C-N 126.281 2.238 . . . . 0.0 110.892 -179.967 . . . . . . . . 4 4 . 1 . 008 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.803 HD22 ' HD2' ' A' ' 106' ' ' ARG . 5.5 tt -104.76 150.6 24.63 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 103.322 -2.844 . . . . 0.0 103.322 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.663 HG12 ' O ' ' A' ' 104' ' ' ALA . 0.0 OUTLIER -136.61 165.42 28.62 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.913 0 CA-C-O 123.849 1.785 . . . . 0.0 106.247 -179.808 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -128.83 97.4 0.43 Allowed Glycine 0 C--N 1.345 1.051 0 C-N-CA 128.636 3.017 . . . . 0.0 109.718 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 16.7 mtpt -95.29 139.74 31.17 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 102.375 -3.194 . . . . 0.0 102.375 179.614 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.648 ' HD2' HD22 ' A' ' 102' ' ' LEU . 75.6 m-85 -149.84 121.4 7.99 Favored 'General case' 0 CA--C 1.501 -0.936 0 CA-C-O 124.284 1.992 . . . . 0.0 111.724 -179.717 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 31.0 mttt -91.15 -175.61 4.34 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-N 113.885 -1.507 . . . . 0.0 110.129 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.411 ' CB ' ' HB3' ' A' ' 98' ' ' ASN 0.366 1.4 mmt85 -128.63 128.32 43.94 Favored 'General case' 0 CA--C 1.489 -1.398 0 O-C-N 124.817 1.323 . . . . 0.0 107.879 -179.98 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.582 HG23 ' H ' ' A' ' 97' ' ' ASP . 0.8 OUTLIER -33.11 -63.26 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 C-N-CA 126.841 2.056 . . . . 0.0 113.938 -179.881 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.582 ' H ' HG23 ' A' ' 96' ' ' VAL 0.368 0.0 OUTLIER -101.44 -22.24 14.6 Favored 'General case' 0 C--O 1.258 1.535 0 O-C-N 119.892 -1.755 . . . . 0.0 115.293 -179.811 . . . . . . . . 4 4 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.411 ' HB3' ' CB ' ' A' ' 95' ' ' ARG . 46.5 t30 -77.45 -26.39 51.46 Favored 'General case' 0 N--CA 1.422 -1.827 0 CA-C-N 113.576 -1.647 . . . . 0.0 113.678 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 48.18 22.96 2.53 Favored Glycine 0 CA--C 1.531 1.05 0 O-C-N 127.287 2.867 . . . . 0.0 118.05 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 15.5 mmtp -75.36 -108.72 0.01 OUTLIER 'General case' 0 C--O 1.199 -1.592 0 O-C-N 119.842 -1.976 . . . . 0.0 108.17 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.483 ' HG2' ' N ' ' A' ' 102' ' ' LEU . 1.0 OUTLIER 173.22 179.18 0.09 Allowed 'General case' 0 C--N 1.316 -0.861 0 C-N-CA 129.286 3.034 . . . . 0.0 109.425 179.993 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.67 ' HG ' ' HA ' ' A' ' 119' ' ' TYR . 3.5 tt -166.15 139.94 4.26 Favored 'General case' 0 C--O 1.245 0.859 1 O-C-N 129.139 4.024 . . . . 0.0 106.231 179.34 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.524 HG23 ' HB3' ' A' ' 117' ' ' TYR . 4.2 tp -128.16 156.07 40.09 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.068 0 N-CA-C 105.039 -2.208 . . . . 0.0 105.039 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.663 ' O ' HG12 ' A' ' 90' ' ' VAL . . . -153.25 145.2 23.64 Favored 'General case' 0 C--N 1.313 -0.998 0 O-C-N 119.213 -2.179 . . . . 0.0 106.714 -179.599 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.605 ' HB ' ' CE2' ' A' ' 117' ' ' TYR . 8.4 p -124.8 113.09 34.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 121.642 2.019 . . . . 0.0 111.709 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.803 ' HD2' HD22 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -82.0 83.89 7.13 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 105.296 -2.113 . . . . 0.0 105.296 179.99 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 69.7 tt0 -90.66 77.5 6.35 Favored 'General case' 0 N--CA 1.418 -2.052 0 O-C-N 128.071 3.357 . . . . 0.0 112.357 -179.324 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.573 HD11 ' CH2' ' A' ' 6' ' ' TRP 0.406 2.1 tt -57.13 118.55 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 C-N-CA 115.652 -2.419 . . . . 0.0 112.313 179.736 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 36.6 m -109.6 60.74 0.6 Allowed 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 117.695 -1.145 . . . . 0.0 108.397 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 83.53 -108.33 3.03 Favored Glycine 0 C--N 1.347 1.193 0 O-C-N 126.701 2.501 . . . . 0.0 111.391 -179.629 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . 0.323 0.0 OUTLIER -89.05 13.38 13.13 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 115.78 -2.057 . . . . 0.0 111.38 -179.823 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -136.52 115.93 12.73 Favored 'General case' 0 C--O 1.208 -1.124 0 O-C-N 127.968 3.292 . . . . 0.0 113.515 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.535 ' HA ' HG13 ' A' ' 108' ' ' ILE . 0.1 OUTLIER -88.85 143.34 26.95 Favored 'General case' 0 C--O 1.213 -0.83 0 N-CA-C 100.725 -3.806 . . . . 0.0 100.725 179.719 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.636 HG12 HG23 ' A' ' 127' ' ' ILE . 71.3 mt -138.77 118.85 14.85 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.973 0 O-C-N 127.661 3.1 . . . . 0.0 105.269 179.714 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.43 ' O ' ' HG2' ' A' ' 126' ' ' ARG . 12.4 mt-30 -100.97 122.28 43.24 Favored 'General case' 0 CA--C 1.505 -0.759 0 O-C-N 126.036 2.085 . . . . 0.0 105.812 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.549 ' HB ' ' HA ' ' A' ' 125' ' ' LYS . 0.6 OUTLIER -140.55 152.16 45.31 Favored 'General case' 0 N--CA 1.419 -2.013 0 O-C-N 121.098 -1.001 . . . . 0.0 112.328 -179.644 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.605 ' CE2' ' HB ' ' A' ' 105' ' ' VAL 0.377 22.4 m-85 135.69 -140.97 0.0 OUTLIER 'General case' 0 CA--C 1.478 -1.795 0 O-C-N 128.852 3.845 . . . . 0.0 113.493 176.58 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.514 HG23 ' N ' ' A' ' 119' ' ' TYR . 4.8 t -151.71 -155.76 0.65 Allowed 'General case' 0 C--N 1.312 -1.055 0 O-C-N 127.278 2.861 . . . . 0.0 116.044 -174.898 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.67 ' HA ' ' HG ' ' A' ' 102' ' ' LEU 0.282 2.6 t80 -109.53 -57.46 2.17 Favored 'General case' 0 C--O 1.217 -0.636 0 CA-C-O 125.434 2.54 . . . . 0.0 104.82 177.721 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.501 ' HG3' ' CE2' ' A' ' 119' ' ' TYR . 3.7 mt-10 -123.38 -80.7 0.63 Allowed 'General case' 0 N--CA 1.436 -1.126 0 CA-C-N 112.591 -2.095 . . . . 0.0 111.981 179.416 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -137.03 36.07 2.01 Favored Glycine 0 C--N 1.36 1.872 0 N-CA-C 119.259 2.464 . . . . 0.0 119.259 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 65.3 t -137.02 91.26 0.83 Allowed 'Isoleucine or valine' 0 C--O 1.215 -0.739 0 N-CA-C 103.535 -2.765 . . . . 0.0 103.535 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.506 ' HA ' ' HB ' ' A' ' 118' ' ' THR . 1.5 mp0 -63.02 178.61 0.46 Allowed 'General case' 0 C--N 1.311 -1.102 0 CA-C-O 125.525 2.584 . . . . 0.0 113.955 -178.223 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.676 ' HB1' ' CD1' ' A' ' 14' ' ' TYR . . . -163.67 177.21 8.9 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 112.572 -3.585 . . . . 0.0 106.799 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.549 ' HA ' ' HB ' ' A' ' 116' ' ' THR 0.337 0.0 OUTLIER -161.92 131.44 4.58 Favored 'General case' 0 C--O 1.249 1.047 1 O-C-N 129.454 4.221 . . . . 0.0 107.423 -179.906 . . . . . . . . 5 4 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.769 HH21 HD22 ' A' ' 36' ' ' LEU . 7.7 ptm180 -132.02 85.78 2.28 Favored 'General case' 0 N--CA 1.426 -1.634 0 CA-C-O 114.556 -2.64 . . . . 0.0 111.653 -179.688 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.636 HG23 HG12 ' A' ' 114' ' ' ILE . 1.0 OUTLIER -64.82 105.21 0.52 Allowed 'Isoleucine or valine' 0 C--O 1.25 1.121 1 O-C-N 132.138 5.899 . . . . 0.0 113.75 178.827 . . . . . . . . 4 4 . 1 . 008 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.635 ' HE2' HD21 ' A' ' 36' ' ' LEU . 0.0 OUTLIER -87.74 131.96 34.31 Favored 'General case' 0 N--CA 1.432 -1.352 0 CA-C-N 111.71 -2.495 . . . . 0.0 107.029 179.957 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 3.1 mmmp? -100.09 47.68 0.94 Allowed 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 114.394 -2.717 . . . . 0.0 110.059 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.511 ' HA ' ' HA ' ' A' ' 6' ' ' TRP . 2.0 ttpm? 26.09 98.49 0.0 OUTLIER 'General case' 0 CA--C 1.518 -0.283 0 O-C-N 126.441 2.338 . . . . 0.0 115.401 179.378 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . 0.914 25.5 tt0 . . . . . 0 N--CA 1.446 -0.629 0 CA-C-N 120.327 1.422 . . . . 0.0 113.327 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' PLM . . . . . 0.515 ' H42' ' CE1' ' A' ' 93' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.494 ' C ' ' CD1' ' A' ' 2' ' ' PHE . . . . . . . . 0 C--O 1.216 -0.705 0 CA-C-O 117.639 -1.172 . . . . 0.0 109.832 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.494 ' CD1' ' C ' ' A' ' 1' ' ' ALA . 2.2 p90 38.09 56.33 1.66 Allowed 'General case' 0 C--N 1.309 -1.195 0 O-C-N 127.462 2.976 . . . . 0.0 116.645 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -143.56 99.83 3.49 Favored 'General case' 0 CA--C 1.501 -0.942 0 CA-C-N 114.621 -1.172 . . . . 0.0 110.96 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 151.12 -107.5 0.34 Allowed Glycine 0 C--O 1.213 -1.161 0 CA-C-O 117.844 -1.531 . . . . 0.0 113.0 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.533 ' HA ' ' HA ' ' A' ' 39' ' ' THR 0.482 1.1 t -137.01 173.55 11.58 Favored 'General case' 0 C--N 1.309 -1.157 0 O-C-N 127.397 2.469 . . . . 0.0 110.011 179.797 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.557 ' CZ3' ' HG3' ' A' ' 130' ' ' LYS . 91.6 m95 -161.56 150.19 15.7 Favored 'General case' 0 N--CA 1.427 -1.584 0 O-C-N 126.247 2.217 . . . . 0.0 108.287 -179.751 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 12.9 tttt -151.89 102.65 2.85 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-O 115.014 -2.422 . . . . 0.0 107.066 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.571 HG12 ' HB3' ' A' ' 36' ' ' LEU 0.323 5.7 p -46.84 138.94 1.82 Allowed 'Isoleucine or valine' 0 C--O 1.249 1.038 0 CA-C-N 121.024 1.738 . . . . 0.0 112.685 179.816 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -153.44 21.05 0.55 Allowed 'General case' 0 CA--C 1.498 -1.044 0 CA-C-O 123.427 1.584 . . . . 0.0 112.425 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.446 ' CG ' ' HB ' ' A' ' 127' ' ' ILE 0.259 1.2 ptp85 -155.63 -49.48 0.08 Allowed 'General case' 0 C--N 1.301 -1.52 0 O-C-N 117.285 -3.384 . . . . 0.0 110.468 179.727 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.414 ' N ' ' HG3' ' A' ' 10' ' ' ARG 0.373 0.5 OUTLIER 51.11 -176.09 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.67 0 O-C-N 126.411 2.319 . . . . 0.0 110.719 179.8 . . . . . . . . 4 4 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -146.88 -85.42 0.11 Allowed 'General case' 0 C--N 1.301 -1.542 0 O-C-N 119.36 -2.087 . . . . 0.0 107.773 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -89.74 18.04 5.96 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 120.111 1.323 . . . . 0.0 114.207 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.631 ' HA ' ' HB1' ' A' ' 124' ' ' ALA . 79.4 t80 -59.45 -32.54 70.32 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 118.898 2.925 . . . . 0.0 118.898 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -76.13 -29.3 57.77 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 121.816 2.098 . . . . 0.0 111.436 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 16.2 mttp -75.52 -24.64 56.82 Favored 'General case' 0 N--CA 1.425 -1.68 0 O-C-N 126.801 2.563 . . . . 0.0 113.398 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.742 ' CB ' ' HB2' ' A' ' 124' ' ' ALA . 11.6 t80 -79.17 -20.39 48.58 Favored 'General case' 0 N--CA 1.428 -1.538 0 O-C-N 121.763 -0.586 . . . . 0.0 110.944 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.451 ' HB3' HG13 ' A' ' 23' ' ' ILE . 0.4 OUTLIER -74.48 -35.07 63.25 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-O 122.902 1.334 . . . . 0.0 107.881 179.99 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . 0.267 7.1 tt0 -72.87 -25.67 61.18 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 126.232 2.92 . . . . 0.0 112.232 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 27.2 tptt -79.9 -29.73 39.96 Favored 'General case' 0 C--N 1.319 -0.753 0 O-C-N 119.423 -2.048 . . . . 0.0 111.361 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.518 ' CE ' HD13 ' A' ' 72' ' ' LEU . 1.1 mmm -75.73 -28.91 58.73 Favored 'General case' 0 C--O 1.217 -0.651 0 CA-C-O 124.552 2.12 . . . . 0.0 108.885 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 109.01 43.42 1.2 Allowed Glycine 0 N--CA 1.443 -0.896 0 CA-C-O 116.171 -2.46 . . . . 0.0 109.928 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.603 HG21 ' HA ' ' A' ' 28' ' ' ARG . 3.5 mm -90.76 134.47 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 CA-C-N 119.551 1.676 . . . . 0.0 108.689 -179.443 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -78.47 132.64 37.34 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-O 114.387 -2.721 . . . . 0.0 113.614 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . 0.375 60.5 t -8.68 -53.59 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 O-C-N 128.889 3.868 . . . . 0.0 117.605 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.608 0.3 OUTLIER -79.75 -40.17 20.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 115.154 1.538 . . . . 0.0 115.154 -179.728 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.562 ' HD3' ' HG1' ' A' ' 132' ' ' PLM . 8.5 ttmm -60.67 -24.1 65.33 Favored 'General case' 0 N--CA 1.443 -0.783 0 O-C-N 127.237 2.836 . . . . 0.0 113.233 179.481 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.603 ' HA ' HG21 ' A' ' 23' ' ' ILE . 5.4 ptt85 -76.95 -30.88 56.23 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 15.0 ttmt -75.65 -29.01 58.98 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-O 123.47 1.605 . . . . 0.0 110.327 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -76.1 -34.46 59.51 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 116.086 -1.912 . . . . 0.0 110.018 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -70.99 -25.06 76.46 Favored Glycine 0 C--O 1.21 -1.401 0 O-C-N 125.032 1.457 . . . . 0.0 112.255 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -77.52 -34.51 53.97 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 116.457 -1.735 . . . . 0.0 111.322 179.483 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -103.63 21.63 15.81 Favored 'General case' 0 N--CA 1.445 -0.676 0 O-C-N 126.958 2.661 . . . . 0.0 113.918 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.406 ' HB3' ' HB2' ' A' ' 53' ' ' SER . 0.8 OUTLIER -69.78 -29.79 67.19 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 114.709 1.374 . . . . 0.0 114.709 -179.761 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . 0.283 77.0 m-20 76.55 27.86 0.77 Allowed 'General case' 0 C--O 1.245 0.821 0 O-C-N 118.63 -2.544 . . . . 0.0 109.542 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.681 HD21 HD13 ' A' ' 38' ' ' LEU . 1.2 tt -44.73 91.6 0.0 OUTLIER 'General case' 0 C--O 1.212 -0.876 0 O-C-N 126.156 2.16 . . . . 0.0 111.033 -179.414 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 8.7 tttt -97.33 103.22 15.13 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 101.682 -3.451 . . . . 0.0 101.682 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.681 HD13 HD21 ' A' ' 36' ' ' LEU 0.292 0.1 OUTLIER -91.29 147.32 23.13 Favored 'General case' 0 C--N 1.289 -2.03 0 CA-C-O 123.932 1.825 . . . . 0.0 106.591 -179.58 . . . . . . . . 4 4 . 1 . 009 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.55 ' HB ' ' HB3' ' A' ' 50' ' ' LYS . 2.4 m -129.19 103.15 6.79 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 102.498 -3.149 . . . . 0.0 102.498 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 59.3 mt -92.5 119.18 39.62 Favored 'Isoleucine or valine' 0 C--O 1.253 1.254 0 CA-C-O 124.13 1.919 . . . . 0.0 111.883 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 74.5 m -119.91 95.39 4.74 Favored 'General case' 0 C--N 1.348 0.542 0 CA-C-N 110.733 -2.939 . . . . 0.0 110.087 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.59 125.71 29.74 Favored 'General case' 0 C--N 1.313 -1.017 0 O-C-N 127.153 2.783 . . . . 0.0 108.705 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -158.1 112.7 2.59 Favored 'General case' 0 N--CA 1.417 -2.097 0 O-C-N 119.26 -2.15 . . . . 0.0 111.954 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 54.03 42.08 70.27 Favored Glycine 0 N--CA 1.428 -1.889 0 CA-C-N 114.386 -1.279 . . . . 0.0 109.934 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.311 4.4 m-20 83.26 -25.36 0.14 Allowed 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 112.556 -1.822 . . . . 0.0 112.224 179.78 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 5.7 ttmt -76.37 144.16 40.27 Favored 'General case' 0 C--N 1.307 -1.271 0 C-N-CA 115.639 -2.424 . . . . 0.0 108.681 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.593 ' CZ ' HD21 ' A' ' 64' ' ' LEU . 2.8 m-85 -119.59 87.85 2.82 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 118.164 -0.922 . . . . 0.0 111.534 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.983 ' HA ' HG13 ' A' ' 61' ' ' VAL 0.427 0.1 OUTLIER -61.04 118.54 6.89 Favored 'General case' 0 C--O 1.244 0.812 0 C-N-CA 115.206 -2.598 . . . . 0.0 109.502 -179.721 . . . . . . . . 4 4 . 1 . 009 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.549 ' CG2' ' HG ' ' A' ' 38' ' ' LEU 0.713 8.4 p -101.27 85.94 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 O-C-N 125.173 1.546 . . . . 0.0 108.592 179.557 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.55 ' HB3' ' HB ' ' A' ' 39' ' ' THR . 2.5 tttp -77.41 103.68 7.48 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 105.383 -2.08 . . . . 0.0 105.383 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -95.36 89.48 5.47 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 127.2 2.2 . . . . 0.0 105.413 -179.58 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -88.27 57.51 4.3 Favored 'General case' 0 C--N 1.289 -2.061 0 O-C-N 119.91 -1.744 . . . . 0.0 106.975 -179.66 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.406 ' HB2' ' HB3' ' A' ' 34' ' ' ASP . 80.7 p -83.11 160.17 21.94 Favored 'General case' 0 C--O 1.209 -1.065 0 CA-C-O 116.529 -1.701 . . . . 0.0 108.466 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 56.6 t30 -50.54 -32.64 18.98 Favored 'General case' 0 N--CA 1.435 -1.182 0 O-C-N 125.287 1.617 . . . . 0.0 109.498 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -62.66 -50.75 69.94 Favored 'General case' 0 C--N 1.352 0.71 0 C-N-CA 116.223 -2.191 . . . . 0.0 111.193 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 29.8 ttm-85 -176.11 148.8 0.83 Allowed 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 121.663 2.029 . . . . 0.0 106.959 178.737 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -95.3 83.35 3.84 Favored 'General case' 0 C--O 1.22 -0.467 0 N-CA-C 100.441 -3.911 . . . . 0.0 100.441 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.5 tp -105.58 101.42 12.37 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.238 0 O-C-N 128.015 3.322 . . . . 0.0 116.527 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.457 ' OD1' HG22 ' A' ' 61' ' ' VAL . 29.2 t0 -58.21 137.21 57.23 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 103.229 -2.878 . . . . 0.0 103.229 177.593 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.6 HG12 ' N ' ' A' ' 61' ' ' VAL . 2.2 t -101.33 -67.75 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 N-CA-C 106.506 -1.664 . . . . 0.0 106.506 -176.419 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.983 HG13 ' HA ' ' A' ' 48' ' ' THR 0.506 0.0 OUTLIER 75.44 134.04 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 CA-C-O 124.065 1.888 . . . . 0.0 112.582 179.557 . . . . . . . . 4 4 . 1 . 009 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.64 ' CE2' ' CD1' ' A' ' 82' ' ' TRP . 3.9 p90 -168.98 110.71 0.5 Allowed 'General case' 0 N--CA 1.436 -1.17 0 CA-C-N 112.332 -2.213 . . . . 0.0 111.911 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -62.04 125.64 24.57 Favored 'General case' 0 N--CA 1.441 -0.914 0 N-CA-C 102.462 -3.162 . . . . 0.0 102.462 179.691 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.593 HD21 ' CZ ' ' A' ' 47' ' ' PHE . 0.6 OUTLIER -48.21 125.59 9.59 Favored 'General case' 0 N--CA 1.428 -1.559 0 O-C-N 124.466 1.104 . . . . 0.0 111.503 -179.728 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' 82' ' ' TRP . . . 73.61 12.36 80.47 Favored Glycine 0 C--N 1.344 1.006 0 O-C-N 126.73 2.519 . . . . 0.0 117.036 -179.826 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . 0.419 44.0 t -81.18 -99.91 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.431 -1.389 0 CA-C-O 118.373 -0.822 . . . . 0.0 109.053 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.9 t70 165.37 130.08 0.01 OUTLIER 'General case' 0 CA--C 1.49 -1.346 0 CA-C-N 119.285 0.948 . . . . 0.0 110.567 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -135.48 174.75 10.27 Favored 'General case' 0 N--CA 1.428 -1.545 0 CA-C-N 120.156 1.344 . . . . 0.0 109.281 179.683 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -132.65 127.45 34.91 Favored 'General case' 0 C--O 1.244 0.801 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -157.19 125.23 5.5 Favored 'General case' 0 N--CA 1.443 -0.784 0 C-N-CA 118.632 -1.227 . . . . 0.0 113.563 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 18.3 t -57.67 156.92 7.78 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 105.124 -2.176 . . . . 0.0 105.124 179.559 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.808 HD11 HD12 ' A' ' 78' ' ' LEU . 8.4 mt -101.77 9.7 40.63 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-O 118.148 -0.93 . . . . 0.0 109.873 -179.35 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.423 ' HB3' ' O ' ' A' ' 72' ' ' LEU . . . 79.61 -4.24 2.0 Favored 'General case' 0 N--CA 1.438 -1.071 0 O-C-N 126.802 2.564 . . . . 0.0 113.174 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.536 ' HB3' ' HG3' ' A' ' 132' ' ' PLM . 28.9 t70 -165.96 -51.06 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 123.825 1.774 . . . . 0.0 110.259 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -67.8 -6.65 44.98 Favored Glycine 0 C--N 1.347 1.192 0 CA-C-N 113.704 -1.589 . . . . 0.0 112.98 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.548 HG22 ' H ' ' A' ' 77' ' ' GLU 0.274 0.2 OUTLIER 78.62 163.31 0.21 Allowed 'General case' 0 N--CA 1.435 -1.204 0 CA-C-N 119.699 1.75 . . . . 0.0 115.298 179.678 . . . . . . . . 4 4 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.548 ' H ' HG22 ' A' ' 76' ' ' THR . 1.1 mt-10 -36.61 98.43 0.01 OUTLIER 'General case' 0 N--CA 1.44 -0.945 0 O-C-N 128.392 3.558 . . . . 0.0 113.091 179.63 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.808 HD12 HD11 ' A' ' 72' ' ' LEU 0.472 5.5 tt -97.04 158.19 15.55 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 101.929 -3.36 . . . . 0.0 101.929 179.621 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 14.5 m -157.82 124.14 4.8 Favored 'General case' 0 CA--C 1.498 -1.054 0 N-CA-C 102.047 -3.316 . . . . 0.0 102.047 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -162.97 -175.83 34.4 Favored Glycine 0 C--N 1.292 -1.89 0 C-N-CA 115.746 -3.121 . . . . 0.0 111.959 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 15.7 p -137.87 159.82 40.97 Favored 'General case' 0 C--O 1.192 -1.965 0 C-N-CA 119.313 -0.955 . . . . 0.0 110.116 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' TRP . . . . . 0.64 ' CD1' ' CE2' ' A' ' 62' ' ' PHE . 72.2 m95 -118.74 137.75 53.14 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 100.624 -3.843 . . . . 0.0 100.624 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 13.5 t -147.74 143.15 27.36 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 123.597 1.665 . . . . 0.0 109.497 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.98 139.02 41.31 Favored 'General case' 0 N--CA 1.44 -0.965 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . 0.72 5.2 mt-10 -127.81 30.57 5.27 Favored 'General case' 0 C--N 1.307 -1.254 0 C-N-CA 116.687 -2.005 . . . . 0.0 109.686 179.733 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 71.5 97.68 0.06 OUTLIER Glycine 0 N--CA 1.436 -1.358 0 N-CA-C 106.147 -2.781 . . . . 0.0 106.147 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . 0.28 61.2 m-80 79.06 -7.53 1.75 Allowed 'General case' 0 C--O 1.236 0.387 0 N-CA-C 117.893 2.553 . . . . 0.0 117.893 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . 0.341 0.4 OUTLIER -143.73 133.13 23.33 Favored 'General case' 0 CA--C 1.498 -1.043 0 O-C-N 125.713 1.883 . . . . 0.0 106.575 179.988 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.78 HD13 HH11 ' A' ' 106' ' ' ARG . 0.2 OUTLIER -97.21 107.28 19.76 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 102.516 -3.142 . . . . 0.0 102.516 179.839 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.546 HG12 ' CG2' ' A' ' 105' ' ' VAL . 1.0 OUTLIER -98.55 156.42 3.72 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.939 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 179.888 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -134.55 104.95 0.53 Allowed Glycine 0 C--N 1.347 1.162 0 C-N-CA 129.969 3.652 . . . . 0.0 110.45 179.7 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.413 ' HA ' ' HA ' ' A' ' 103' ' ' ILE . 18.1 mtmt -102.92 117.09 33.83 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 104.541 -2.392 . . . . 0.0 104.541 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.411 ' CD2' HD11 ' A' ' 78' ' ' LEU . 16.0 m-30 -107.58 118.19 36.08 Favored 'General case' 0 C--N 1.328 -0.327 0 O-C-N 125.288 1.617 . . . . 0.0 111.839 -179.741 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.409 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 4.6 mtmt -102.03 161.56 13.59 Favored 'General case' 0 C--O 1.21 -0.981 0 CA-C-N 114.215 -1.357 . . . . 0.0 110.372 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . 0.377 0.0 OUTLIER -107.48 144.98 33.67 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-O 116.849 -1.548 . . . . 0.0 107.672 179.936 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.411 ' HB ' ' HB3' ' A' ' 77' ' ' GLU . 57.0 t -82.24 -30.55 9.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 C-N-CA 126.641 1.976 . . . . 0.0 114.094 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . 0.343 0.1 OUTLIER -110.0 -3.96 16.18 Favored 'General case' 0 C--O 1.259 1.568 0 N-CA-C 115.413 1.634 . . . . 0.0 115.413 179.925 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 44.1 t30 -112.46 -22.49 10.81 Favored 'General case' 0 N--CA 1.422 -1.857 0 N-CA-C 115.258 1.577 . . . . 0.0 115.258 -179.599 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 60.22 26.97 64.53 Favored Glycine 0 CA--C 1.53 0.985 0 N-CA-C 117.489 1.756 . . . . 0.0 117.489 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 15.2 mmtm -90.91 -113.33 0.08 Allowed 'General case' 0 CA--C 1.553 1.072 0 O-C-N 120.237 -1.743 . . . . 0.0 112.015 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 151.79 144.04 0.0 OUTLIER 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 129.882 3.273 . . . . 0.0 108.778 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.71 HD12 ' CD1' ' A' ' 119' ' ' TYR . 2.4 tt -127.87 176.34 7.65 Favored 'General case' 0 CA--C 1.511 -0.551 2 O-C-N 129.787 4.429 . . . . 0.0 106.835 -179.808 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.513 HG13 ' N ' ' A' ' 104' ' ' ALA . 0.1 OUTLIER -149.14 173.21 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.502 -0.869 0 C-N-CA 117.93 -1.508 . . . . 0.0 109.491 -179.725 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.513 ' N ' HG13 ' A' ' 103' ' ' ILE . . . -154.46 133.36 12.3 Favored 'General case' 0 C--N 1.313 -1.013 0 O-C-N 117.709 -3.119 . . . . 0.0 107.418 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.546 ' CG2' HG12 ' A' ' 90' ' ' VAL . 0.9 OUTLIER -121.1 99.18 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 CA-C-N 122.113 2.233 . . . . 0.0 108.615 179.97 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.78 HH11 HD13 ' A' ' 89' ' ' LEU 0.259 75.3 mtt180 -71.62 91.83 1.11 Allowed 'General case' 0 CA--C 1.503 -0.834 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 179.944 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.432 ' O ' ' N ' ' A' ' 109' ' ' SER . 0.1 OUTLIER -89.85 83.53 6.18 Favored 'General case' 0 N--CA 1.432 -1.359 0 CA-C-N 112.316 -2.22 . . . . 0.0 114.758 -179.638 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.409 HD13 ' HA ' ' A' ' 108' ' ' ILE 0.276 8.5 mm -62.17 93.81 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 C-N-CA 116.926 -1.909 . . . . 0.0 106.865 179.435 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.432 ' N ' ' O ' ' A' ' 107' ' ' GLU . 6.1 m -65.8 -20.85 66.4 Favored 'General case' 0 N--CA 1.439 -0.992 0 C-N-CA 125.426 1.491 . . . . 0.0 109.605 -179.462 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 123.01 97.8 1.35 Allowed Glycine 0 C--O 1.218 -0.845 0 C-N-CA 129.907 3.622 . . . . 0.0 110.387 -179.267 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . 0.326 0.8 OUTLIER 90.49 -27.27 0.05 OUTLIER 'General case' 0 C--N 1.308 -1.199 0 O-C-N 128.235 2.962 . . . . 0.0 109.944 -179.068 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.464 ' HG2' ' HA ' ' A' ' 129' ' ' LYS . 88.6 mt-10 -115.51 124.15 50.35 Favored 'General case' 0 C--N 1.361 1.072 0 CA-C-O 117.014 -1.469 . . . . 0.0 110.986 179.593 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 30.2 tp -96.82 116.85 29.87 Favored 'General case' 0 C--O 1.217 -0.627 0 N-CA-C 104.593 -2.373 . . . . 0.0 104.593 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.85 HG23 HG12 ' A' ' 127' ' ' ILE 0.27 2.9 mm -102.58 128.44 55.34 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 O-C-N 128.047 3.342 . . . . 0.0 104.417 -179.929 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -111.31 79.77 1.24 Allowed 'General case' 0 CA--C 1.494 -1.174 0 CA-C-O 124.041 1.877 . . . . 0.0 106.027 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.406 ' HA ' ' HA ' ' A' ' 125' ' ' LYS . 0.3 OUTLIER -73.13 115.0 11.93 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 104.633 -2.358 . . . . 0.0 104.633 179.668 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . 0.262 78.5 m-85 -106.53 145.71 31.52 Favored 'General case' 0 C--O 1.207 -1.168 0 O-C-N 126.818 2.574 . . . . 0.0 113.269 -179.562 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.499 HG23 ' H ' ' A' ' 120' ' ' GLU 0.289 0.8 OUTLIER -141.2 126.48 18.59 Favored 'General case' 0 N--CA 1.446 -0.633 1 O-C-N 130.594 4.934 . . . . 0.0 108.439 179.577 . . . . . . . . 5 4 . 1 . 009 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.71 ' CD1' HD12 ' A' ' 102' ' ' LEU 0.277 22.4 t80 -101.07 -0.13 36.87 Favored 'General case' 0 C--O 1.245 0.851 0 CA-C-N 119.818 1.19 . . . . 0.0 107.835 -179.71 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.499 ' H ' HG23 ' A' ' 118' ' ' THR . 0.0 OUTLIER 171.98 -79.95 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.543 0 O-C-N 126.211 2.194 . . . . 0.0 115.863 -179.527 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -130.47 30.47 3.44 Favored Glycine 0 C--N 1.353 1.513 0 N-CA-C 118.838 2.295 . . . . 0.0 118.838 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 54.9 t -145.65 113.88 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 103.972 -2.603 . . . . 0.0 103.972 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -83.51 -178.89 7.2 Favored 'General case' 0 C--O 1.21 -0.985 0 CA-C-O 124.727 2.203 . . . . 0.0 112.533 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.742 ' HB2' ' CB ' ' A' ' 17' ' ' PHE . . . -167.34 85.48 0.24 Allowed 'General case' 0 C--O 1.216 -0.687 0 CA-C-O 114.223 -2.799 . . . . 0.0 108.501 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.406 ' HA ' ' HA ' ' A' ' 116' ' ' THR . 0.1 OUTLIER -69.01 128.27 36.1 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 121.256 1.844 . . . . 0.0 109.631 -179.647 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.414 ' NH2' HD13 ' A' ' 36' ' ' LEU . 0.0 OUTLIER -119.21 82.2 1.83 Allowed 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 125.959 1.704 . . . . 0.0 107.232 -179.8 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.85 HG12 HG23 ' A' ' 114' ' ' ILE . 2.1 mt -78.9 117.68 24.9 Favored 'Isoleucine or valine' 0 C--O 1.245 0.837 0 O-C-N 127.426 2.954 . . . . 0.0 116.448 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.501 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 1.3 m-30 -94.55 166.42 12.04 Favored 'General case' 0 N--CA 1.432 -1.347 0 O-C-N 128.102 3.376 . . . . 0.0 107.926 -179.725 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.464 ' HA ' ' HG2' ' A' ' 112' ' ' GLU 0.258 8.5 mmtt -119.44 -4.17 10.4 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 119.573 -0.251 . . . . 0.0 111.235 -179.885 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.557 ' HG3' ' CZ3' ' A' ' 6' ' ' TRP . 4.2 tttp 73.28 116.18 0.05 Allowed 'General case' 0 C--O 1.215 -0.72 0 CA-C-O 115.765 -2.064 . . . . 0.0 108.024 -179.533 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . 0.797 3.4 mm-40 . . . . . 0 N--CA 1.424 -1.758 0 O-C-N 126.83 2.581 . . . . 0.0 115.126 -179.683 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' PLM . . . . . 0.562 ' HG1' ' HD3' ' A' ' 27' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.508 -0.649 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -98.03 78.76 2.55 Favored 'General case' 0 N--CA 1.435 -1.207 0 C-N-CA 118.463 -1.295 . . . . 0.0 112.743 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -160.0 88.16 0.82 Allowed 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 112.513 -2.131 . . . . 0.0 111.878 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 153.07 -163.25 30.47 Favored Glycine 0 CA--C 1.495 -1.158 0 C-N-CA 115.635 -3.174 . . . . 0.0 109.168 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.423 ' HA ' ' HA ' ' A' ' 39' ' ' THR 0.49 22.0 m -97.18 161.42 13.82 Favored 'General case' 0 C--N 1.314 -0.954 0 O-C-N 126.281 1.812 . . . . 0.0 110.503 -179.658 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.774 ' CH2' HD11 ' A' ' 108' ' ' ILE . 87.9 m95 -139.75 156.67 46.65 Favored 'General case' 0 N--CA 1.434 -1.249 0 CA-C-N 112.665 -2.062 . . . . 0.0 106.72 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 24.0 tttt -159.92 90.97 0.94 Allowed 'General case' 0 C--O 1.203 -1.346 0 O-C-N 126.283 2.239 . . . . 0.0 107.217 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.599 ' HB ' ' CD1' ' A' ' 128' ' ' PHE 0.315 0.1 OUTLIER -37.65 127.4 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 O-C-N 126.634 2.458 . . . . 0.0 112.063 179.957 . . . . . . . . 4 4 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.446 ' HB2' ' CG ' ' A' ' 129' ' ' LYS . 40.1 t0 -100.0 -32.38 10.98 Favored 'General case' 0 C--O 1.208 -1.092 0 O-C-N 126.793 2.558 . . . . 0.0 105.293 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 5.7 ptp180 -170.73 153.69 4.14 Favored 'General case' 0 C--N 1.296 -1.748 0 C-N-CA 115.846 -2.342 . . . . 0.0 109.189 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . 0.293 0.0 OUTLIER -106.77 -171.38 1.88 Allowed 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 111.297 -2.683 . . . . 0.0 107.675 179.514 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.506 ' CB ' ' HB2' ' A' ' 125' ' ' LYS . 4.1 tm-20 -131.67 -71.68 0.55 Allowed 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 117.468 -1.693 . . . . 0.0 108.293 179.695 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.455 ' HB3' ' HA ' ' A' ' 124' ' ' ALA . 23.5 t30 -113.43 28.41 8.8 Favored 'General case' 0 N--CA 1.474 0.774 0 O-C-N 125.246 1.591 . . . . 0.0 113.197 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.529 ' CA ' ' HB1' ' A' ' 124' ' ' ALA 0.347 0.2 OUTLIER -72.49 -19.79 61.48 Favored 'General case' 0 C--N 1.312 -1.037 0 O-C-N 128.416 3.572 . . . . 0.0 115.421 179.994 . . . . . . . . 4 4 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -76.85 -30.7 56.4 Favored 'General case' 0 C--O 1.218 -0.588 0 CA-C-N 120.984 1.72 . . . . 0.0 108.683 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -79.83 -32.32 40.59 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 111.529 -2.578 . . . . 0.0 114.286 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.603 ' CE2' ' HA ' ' A' ' 118' ' ' THR . 0.0 OUTLIER -70.78 -37.63 73.35 Favored 'General case' 0 C--O 1.217 -0.625 0 CA-C-O 123.889 1.804 . . . . 0.0 108.466 179.87 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 3.3 mtm -75.21 -22.47 57.92 Favored 'General case' 0 N--CA 1.432 -1.334 0 CA-C-O 123.263 1.506 . . . . 0.0 109.617 -179.028 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.26 -31.58 58.39 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 126.229 2.919 . . . . 0.0 111.143 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 5.4 tptp -67.83 -29.59 68.78 Favored 'General case' 0 C--O 1.209 -1.065 0 O-C-N 119.431 -2.043 . . . . 0.0 112.846 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.462 ' HG2' ' CD1' ' A' ' 119' ' ' TYR . 56.7 mtp -79.38 -30.41 42.52 Favored 'General case' 0 C--N 1.346 0.452 0 N-CA-C 105.325 -2.102 . . . . 0.0 105.325 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 101.89 34.23 4.4 Favored Glycine 0 C--N 1.31 -0.871 0 CA-C-O 117.948 -1.474 . . . . 0.0 110.211 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.467 HD12 ' HG2' ' A' ' 132' ' ' PLM . 1.5 mm -67.73 135.74 27.92 Favored 'Isoleucine or valine' 0 C--N 1.361 1.102 0 CA-C-O 116.426 -1.749 . . . . 0.0 108.313 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 38.0 m-20 -74.95 147.82 40.55 Favored 'General case' 0 C--O 1.244 0.788 0 CA-C-O 115.255 -2.307 . . . . 0.0 113.555 179.762 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . 0.372 1.5 t -20.87 -57.3 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.508 -0.645 0 O-C-N 127.365 2.915 . . . . 0.0 117.819 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.547 1.9 m -73.67 -36.95 48.27 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.814 0 O-C-N 125.233 1.583 . . . . 0.0 112.073 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.429 ' HB2' ' CG2' ' A' ' 23' ' ' ILE . 6.7 mttm -63.69 -42.69 97.96 Favored 'General case' 0 CA--C 1.51 -0.57 0 O-C-N 125.057 1.473 . . . . 0.0 114.487 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 23.3 ptt85 -78.93 -23.68 44.52 Favored 'General case' 0 C--O 1.217 -0.638 0 CA-C-N 121.413 1.915 . . . . 0.0 108.464 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.9 ttpm? -76.09 -37.96 57.55 Favored 'General case' 0 N--CA 1.437 -1.096 0 CA-C-N 114.23 -1.35 . . . . 0.0 112.666 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.423 HD22 ' HA ' ' A' ' 30' ' ' LEU . 0.2 OUTLIER -77.05 -31.57 56.3 Favored 'General case' 0 N--CA 1.432 -1.327 0 CA-C-O 114.31 -2.757 . . . . 0.0 107.101 179.756 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -75.23 -21.53 77.75 Favored Glycine 0 CA--C 1.534 1.225 0 O-C-N 128.129 3.393 . . . . 0.0 114.425 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -78.37 -32.11 48.82 Favored 'General case' 0 C--N 1.314 -0.935 0 O-C-N 127.28 2.4 . . . . 0.0 110.898 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.413 ' NE2' HD22 ' A' ' 30' ' ' LEU . 5.6 p80 -120.38 1.47 10.72 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 114.665 -1.152 . . . . 0.0 113.596 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 18.0 p30 -42.01 -19.92 0.01 OUTLIER 'General case' 0 CA--C 1.495 -1.156 0 N-CA-C 116.035 1.865 . . . . 0.0 116.035 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . 0.286 70.3 m-80 75.07 31.32 0.84 Allowed 'General case' 0 C--N 1.311 -1.092 0 CA-C-O 115.635 -2.126 . . . . 0.0 109.198 179.668 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.584 HD21 HD13 ' A' ' 38' ' ' LEU . 0.3 OUTLIER -45.64 103.48 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.964 0 O-C-N 127.559 3.037 . . . . 0.0 107.179 179.971 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.406 ' HE3' HG21 ' A' ' 5' ' ' THR . 30.9 tttp -96.79 112.13 24.01 Favored 'General case' 0 C--O 1.219 -0.517 0 N-CA-C 102.067 -3.309 . . . . 0.0 102.067 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.584 HD13 HD21 ' A' ' 36' ' ' LEU 0.279 1.0 OUTLIER -103.6 112.12 24.89 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 121.399 1.909 . . . . 0.0 110.577 -179.947 . . . . . . . . 4 4 . 1 . 010 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.527 ' HB ' ' CB ' ' A' ' 50' ' ' LYS . 38.6 m -89.85 92.25 8.95 Favored 'General case' 0 N--CA 1.448 -0.557 0 O-C-N 118.003 -2.936 . . . . 0.0 106.675 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 5.3 mt -75.58 125.09 34.81 Favored 'Isoleucine or valine' 0 C--O 1.253 1.264 0 O-C-N 124.318 1.011 . . . . 0.0 111.016 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 53.2 m -128.3 95.16 4.08 Favored 'General case' 0 C--O 1.221 -0.445 0 O-C-N 127.037 2.711 . . . . 0.0 108.866 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -85.61 128.41 34.76 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-O 116.741 -1.599 . . . . 0.0 112.392 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -139.33 91.89 2.54 Favored 'General case' 0 N--CA 1.426 -1.671 0 CA-C-N 120.919 1.69 . . . . 0.0 110.589 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 50.0 68.07 1.56 Allowed Glycine 0 C--N 1.292 -1.881 0 O-C-N 126.013 2.071 . . . . 0.0 110.383 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.315 0.4 OUTLIER 83.4 -26.42 0.12 Allowed 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 114.258 1.207 . . . . 0.0 114.258 179.8 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 21.5 ttpt -87.25 143.03 27.47 Favored 'General case' 0 C--N 1.312 -1.05 0 C-N-CA 117.014 -1.875 . . . . 0.0 108.411 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.447 ' HE2' HD21 ' A' ' 64' ' ' LEU . 22.9 m-85 -124.02 101.2 7.11 Favored 'General case' 0 C--N 1.34 0.18 0 O-C-N 124.844 1.34 . . . . 0.0 111.077 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.958 ' HB ' HG12 ' A' ' 61' ' ' VAL 0.432 0.1 OUTLIER -83.19 82.93 8.05 Favored 'General case' 0 N--CA 1.441 -0.899 0 O-C-N 125.774 1.921 . . . . 0.0 110.281 179.909 . . . . . . . . 4 4 . 1 . 010 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.616 HG22 ' HB ' ' A' ' 60' ' ' VAL 0.692 0.3 OUTLIER -62.96 89.12 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.493 -1.231 0 CA-C-N 110.687 -2.96 . . . . 0.0 115.788 179.971 . . . . . . . . 4 4 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.527 ' CB ' ' HB ' ' A' ' 39' ' ' THR . 1.7 tttm -63.83 146.29 54.23 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 100.672 -3.825 . . . . 0.0 100.672 179.468 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -144.15 75.0 1.44 Allowed 'General case' 0 C--O 1.215 -0.739 0 CA-C-N 120.582 1.537 . . . . 0.0 109.378 -179.52 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 51.4 m -77.4 73.2 3.97 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 105.454 -2.054 . . . . 0.0 105.454 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.8 p -93.19 39.5 1.05 Allowed 'General case' 0 CA--C 1.505 -0.77 0 C-N-CA 117.809 -1.556 . . . . 0.0 111.868 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.403 ' OD1' ' N ' ' A' ' 55' ' ' PHE . 0.1 OUTLIER 72.16 -52.43 0.7 Allowed 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 115.242 -2.313 . . . . 0.0 108.509 -179.915 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.445 ' HB3' ' HD2' ' A' ' 56' ' ' ARG . 81.5 m-85 -57.5 -73.89 0.06 Allowed 'General case' 0 C--O 1.22 -0.492 0 CA-C-N 122.311 2.323 . . . . 0.0 109.403 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.445 ' HD2' ' HB3' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -136.59 146.19 45.8 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 120.472 1.487 . . . . 0.0 110.631 179.847 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -95.57 80.58 3.46 Favored 'General case' 0 C--N 1.352 0.697 0 N-CA-C 101.214 -3.625 . . . . 0.0 101.214 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.0 tp -110.71 117.67 55.46 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 O-C-N 127.827 3.205 . . . . 0.0 118.826 -179.407 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.75 119.6 12.73 Favored 'General case' 0 C--O 1.217 -0.643 0 N-CA-C 104.211 -2.514 . . . . 0.0 104.211 178.305 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.616 ' HB ' HG22 ' A' ' 49' ' ' VAL . 42.8 t -97.27 69.49 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 CA-C-O 122.163 0.982 . . . . 0.0 110.828 -178.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.958 HG12 ' HB ' ' A' ' 48' ' ' THR 0.404 0.7 OUTLIER -64.02 111.86 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 C-N-CA 118.028 -1.469 . . . . 0.0 113.138 -179.795 . . . . . . . . 4 4 . 1 . 010 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.606 ' CE2' ' CE2' ' A' ' 68' ' ' PHE . 11.5 m-30 -136.99 97.25 3.46 Favored 'General case' 0 N--CA 1.431 -1.386 0 O-C-N 119.122 -2.236 . . . . 0.0 108.665 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -63.57 138.79 58.64 Favored 'General case' 0 C--O 1.246 0.886 0 N-CA-C 105.003 -2.221 . . . . 0.0 105.003 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.447 HD21 ' HE2' ' A' ' 47' ' ' PHE . 0.4 OUTLIER -60.54 134.92 57.55 Favored 'General case' 0 C--O 1.252 1.2 0 N-CA-C 105.354 -2.091 . . . . 0.0 105.354 -179.996 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 75.19 2.96 68.19 Favored Glycine 0 C--N 1.341 0.832 0 C-N-CA 127.892 2.663 . . . . 0.0 114.896 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . 0.39 2.1 t -89.64 83.63 2.18 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 N-CA-C 105.189 -2.152 . . . . 0.0 105.189 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -52.77 95.81 0.01 OUTLIER 'General case' 0 CA--C 1.479 -1.756 0 N-CA-C 115.579 1.696 . . . . 0.0 115.579 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.606 ' CE2' ' CE2' ' A' ' 62' ' ' PHE . 13.2 p90 -89.94 178.07 6.31 Favored 'General case' 0 C--N 1.309 -1.153 0 O-C-N 120.438 -1.414 . . . . 0.0 110.109 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -123.95 136.27 54.21 Favored 'General case' 0 C--O 1.244 0.777 0 O-C-N 127.269 2.856 . . . . 0.0 105.441 179.546 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -156.04 113.87 3.31 Favored 'General case' 0 C--O 1.21 -0.98 0 C-N-CA 118.002 -1.479 . . . . 0.0 114.37 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 9.0 p -67.0 176.5 2.08 Favored 'General case' 0 C--N 1.314 -0.97 0 O-C-N 119.617 -1.927 . . . . 0.0 107.183 179.452 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.493 ' CD2' HD22 ' A' ' 78' ' ' LEU . 2.9 mt -119.04 -154.5 0.57 Allowed 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 116.345 -1.788 . . . . 0.0 109.339 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -118.5 12.07 13.12 Favored 'General case' 0 N--CA 1.436 -1.165 0 O-C-N 125.627 1.829 . . . . 0.0 113.224 179.623 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -143.68 -49.41 0.3 Allowed 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 120.541 -0.464 . . . . 0.0 112.178 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -107.96 -9.81 27.49 Favored Glycine 0 CA--C 1.541 1.662 0 N-CA-C 117.192 1.637 . . . . 0.0 117.192 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . 0.412 0.0 OUTLIER 71.58 153.46 0.13 Allowed 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 122.004 2.902 . . . . 0.0 115.257 179.684 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.507 ' HB3' ' CG2' ' A' ' 96' ' ' VAL . 30.9 mt-10 48.76 154.5 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.676 1 O-C-N 129.885 4.491 . . . . 0.0 117.145 179.536 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.545 ' HG ' ' HB3' ' A' ' 93' ' ' PHE 0.401 11.9 tp 177.15 152.47 0.21 Allowed 'General case' 0 CA--C 1.51 -0.584 0 CA-C-N 110.949 -2.841 . . . . 0.0 107.016 -179.819 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 10.9 m -161.56 119.04 2.25 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 103.297 -2.853 . . . . 0.0 103.297 -179.671 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -165.13 -162.59 16.55 Favored Glycine 0 C--N 1.303 -1.256 0 C-N-CA 116.932 -2.556 . . . . 0.0 111.193 -179.647 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 17.4 p -145.21 164.36 31.58 Favored 'General case' 0 C--O 1.193 -1.915 0 C-N-CA 119.112 -1.035 . . . . 0.0 111.531 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' TRP . . . . . 0.508 ' CZ2' HG11 ' A' ' 49' ' ' VAL 0.302 11.8 m0 -106.46 151.72 24.58 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 100.68 -3.822 . . . . 0.0 100.68 179.924 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 2.4 t -150.96 141.11 22.19 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-O 122.587 1.184 . . . . 0.0 111.766 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 6.9 ttp -91.41 110.36 21.66 Favored 'General case' 0 N--CA 1.429 -1.519 0 CA-C-N 113.037 -1.892 . . . . 0.0 109.705 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . 0.634 10.2 mt-10 -87.58 -133.43 0.08 Allowed 'General case' 0 N--CA 1.434 -1.265 0 O-C-N 124.315 1.009 . . . . 0.0 110.391 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -87.34 92.71 1.83 Allowed Glycine 0 C--N 1.336 0.531 0 N-CA-C 103.207 -3.957 . . . . 0.0 103.207 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 53.68 10.46 0.24 Allowed 'General case' 0 C--O 1.24 0.602 0 N-CA-C 118.059 2.614 . . . . 0.0 118.059 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . 0.335 0.0 OUTLIER -133.58 135.13 44.09 Favored 'General case' 0 CA--C 1.501 -0.933 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 -179.975 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -88.31 134.6 33.77 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 103.953 -2.61 . . . . 0.0 103.953 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -113.54 -172.77 0.54 Allowed 'Isoleucine or valine' 0 C--O 1.246 0.88 0 C-N-CA 119.218 -0.993 . . . . 0.0 108.5 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -164.69 109.11 0.35 Allowed Glycine 0 C--N 1.35 1.335 0 C-N-CA 126.767 2.127 . . . . 0.0 111.696 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 4.7 mmmt -112.33 135.79 52.59 Favored 'General case' 0 N--CA 1.426 -1.636 0 N-CA-C 106.511 -1.662 . . . . 0.0 106.511 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.66 ' HD2' HD22 ' A' ' 102' ' ' LEU . 39.2 m-85 -137.57 115.9 11.87 Favored 'General case' 0 CA--C 1.504 -0.806 0 O-C-N 126.306 2.254 . . . . 0.0 113.034 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.4 mtmt -99.58 138.89 36.04 Favored 'General case' 0 N--CA 1.436 -1.157 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . 0.369 0.0 OUTLIER -74.29 174.51 8.7 Favored 'General case' 0 N--CA 1.428 -1.526 0 N-CA-C 105.647 -1.983 . . . . 0.0 105.647 179.819 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.507 ' CG2' ' HB3' ' A' ' 77' ' ' GLU 0.258 2.7 t -86.35 -61.69 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 O-C-N 126.702 2.501 . . . . 0.0 110.862 179.606 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . 0.398 0.6 OUTLIER -57.88 -29.17 64.82 Favored 'General case' 0 C--O 1.26 1.609 0 N-CA-C 118.46 2.763 . . . . 0.0 118.46 -179.926 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -131.24 -4.92 3.85 Favored 'General case' 0 N--CA 1.425 -1.712 0 N-CA-C 116.435 2.013 . . . . 0.0 116.435 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 49.56 42.73 35.71 Favored Glycine 0 C--N 1.348 1.198 0 C-N-CA 118.953 -1.594 . . . . 0.0 114.658 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 26.1 mmtm -71.41 -103.25 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.339 0 CA-C-O 115.835 -2.031 . . . . 0.0 111.226 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 158.92 136.11 0.0 OUTLIER 'General case' 0 N--CA 1.433 -1.308 0 C-N-CA 131.197 3.799 . . . . 0.0 110.191 179.692 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.678 ' HG ' ' HA ' ' A' ' 119' ' ' TYR . 7.2 tt -125.13 111.19 15.03 Favored 'General case' 0 C--N 1.316 -0.868 1 C-N-CA 133.764 4.826 . . . . 0.0 102.744 178.947 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.614 HD12 ' H ' ' A' ' 104' ' ' ALA . 0.1 OUTLIER -101.31 160.72 3.79 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.185 0 C-N-CA 115.472 -2.491 . . . . 0.0 106.975 -179.222 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.614 ' H ' HD12 ' A' ' 103' ' ' ILE . . . -157.8 131.95 8.17 Favored 'General case' 0 C--N 1.322 -0.604 0 O-C-N 118.729 -2.482 . . . . 0.0 112.471 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.624 ' HB ' ' CE2' ' A' ' 117' ' ' TYR . 5.6 p -120.56 118.33 56.2 Favored 'Isoleucine or valine' 0 C--O 1.252 1.226 0 CA-C-N 122.452 2.387 . . . . 0.0 108.915 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.493 HH11 ' HG3' ' A' ' 106' ' ' ARG . 9.6 mtt85 -86.34 88.12 7.56 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 105.301 -2.111 . . . . 0.0 105.301 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -91.36 85.6 5.85 Favored 'General case' 0 N--CA 1.429 -1.513 0 CA-C-N 113.023 -1.899 . . . . 0.0 114.458 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.774 HD11 ' CH2' ' A' ' 6' ' ' TRP 0.388 4.9 tt -65.27 92.12 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 C-N-CA 113.95 -3.1 . . . . 0.0 115.191 -179.927 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 38.9 t -76.54 77.53 3.23 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 102.929 -2.989 . . . . 0.0 102.929 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 62.4 -98.02 0.19 Allowed Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 127.162 2.315 . . . . 0.0 114.715 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . 0.325 7.0 m-20 -86.42 -0.9 56.96 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 114.726 -2.559 . . . . 0.0 110.717 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.439 ' HG2' ' HD2' ' A' ' 129' ' ' LYS . 6.3 mp0 -124.42 123.49 40.27 Favored 'General case' 0 C--O 1.205 -1.253 0 O-C-N 126.285 2.241 . . . . 0.0 112.451 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.654 HD22 ' CD2' ' A' ' 128' ' ' PHE . 10.0 tt -93.02 133.29 36.32 Favored 'General case' 0 C--O 1.222 -0.375 0 N-CA-C 101.286 -3.598 . . . . 0.0 101.286 -179.685 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.859 HG22 HG22 ' A' ' 116' ' ' THR 0.285 47.5 mt -138.03 120.85 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.301 0 O-C-N 125.976 2.048 . . . . 0.0 108.976 -179.79 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.534 ' HB2' ' CD ' ' A' ' 126' ' ' ARG . 72.6 mt-30 -91.74 150.04 21.31 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 101.772 -3.418 . . . . 0.0 101.772 -179.511 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.859 HG22 HG22 ' A' ' 114' ' ' ILE . 0.1 OUTLIER -166.15 148.68 7.1 Favored 'General case' 0 N--CA 1.414 -2.244 0 O-C-N 128.389 3.556 . . . . 0.0 111.181 -179.236 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.624 ' CE2' ' HB ' ' A' ' 105' ' ' VAL 0.382 23.3 m-85 132.1 -142.86 0.0 OUTLIER 'General case' 0 CA--C 1.478 -1.793 0 O-C-N 128.682 3.739 . . . . 0.0 113.312 177.31 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.603 ' HA ' ' CE2' ' A' ' 17' ' ' PHE . 13.4 t -136.62 -173.66 3.49 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-O 127.165 3.364 . . . . 0.0 117.218 -174.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.678 ' HA ' ' HG ' ' A' ' 102' ' ' LEU 0.276 2.2 t80 -112.16 -15.99 13.11 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 112.56 -2.109 . . . . 0.0 109.055 177.644 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.448 ' HB2' ' CD2' ' A' ' 119' ' ' TYR . 0.4 OUTLIER -153.71 -71.17 0.14 Allowed 'General case' 0 C--N 1.298 -1.641 0 O-C-N 119.64 -1.912 . . . . 0.0 109.492 -179.916 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -160.51 34.1 0.42 Allowed Glycine 0 C--N 1.363 2.049 0 N-CA-C 120.59 2.996 . . . . 0.0 120.59 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 90.2 t -139.57 103.54 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.193 0 N-CA-C 103.476 -2.786 . . . . 0.0 103.476 179.359 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.447 ' HA ' ' O ' ' A' ' 117' ' ' TYR . 6.6 mp0 -68.47 177.63 2.33 Favored 'General case' 0 CA--C 1.503 -0.852 0 CA-C-O 123.778 1.751 . . . . 0.0 113.264 -178.843 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.529 ' HB1' ' CA ' ' A' ' 14' ' ' TYR . . . -167.77 176.74 6.15 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-O 114.379 -2.724 . . . . 0.0 104.906 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.506 ' HB2' ' CB ' ' A' ' 12' ' ' GLU 0.328 2.8 mptp? -145.3 156.17 43.65 Favored 'General case' 0 CA--C 1.506 -0.732 0 O-C-N 127.55 3.031 . . . . 0.0 107.818 -179.68 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.534 ' CD ' ' HB2' ' A' ' 115' ' ' GLN . 0.0 OUTLIER -142.13 76.15 1.52 Allowed 'General case' 0 N--CA 1.432 -1.361 0 CA-C-N 112.556 -2.111 . . . . 0.0 110.411 179.753 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.469 HD13 HG23 ' A' ' 114' ' ' ILE . 6.7 mm -63.8 116.33 3.34 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 O-C-N 126.313 2.258 . . . . 0.0 115.209 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.654 ' CD2' HD22 ' A' ' 113' ' ' LEU . 2.7 m-30 -109.24 125.93 52.78 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 126.011 1.724 . . . . 0.0 107.57 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.446 ' CG ' ' HB2' ' A' ' 9' ' ' ASP 0.279 14.8 mmmt -91.16 3.22 55.35 Favored 'General case' 0 N--CA 1.441 -0.897 0 O-C-N 119.961 -1.712 . . . . 0.0 112.213 -179.649 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.485 ' HD2' ' CH2' ' A' ' 6' ' ' TRP . 4.3 tttp 74.14 143.26 0.07 Allowed 'General case' 0 C--N 1.349 0.561 0 O-C-N 124.501 1.126 . . . . 0.0 108.763 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . 0.835 1.0 OUTLIER . . . . . 0 N--CA 1.431 -1.419 0 N-CA-C 115.401 1.63 . . . . 0.0 115.401 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' PLM . . . . . 0.467 ' HG2' HD12 ' A' ' 23' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.258 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -134.11 83.3 2.03 Favored 'General case' 0 N--CA 1.428 -1.534 0 O-C-N 121.079 -1.013 . . . . 0.0 113.363 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -156.94 88.41 1.03 Allowed 'General case' 0 N--CA 1.44 -0.94 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.904 179.74 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.4 ' O ' ' N ' ' A' ' 40' ' ' ILE . . . 160.09 -130.72 2.48 Favored Glycine 0 CA--C 1.5 -0.86 0 C-N-CA 117.017 -2.516 . . . . 0.0 109.373 -179.789 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.621 ' HA ' ' HA ' ' A' ' 39' ' ' THR 0.499 5.3 t -117.73 171.11 8.26 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 123.197 1.475 . . . . 0.0 114.123 -179.958 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.803 ' CH2' HD11 ' A' ' 108' ' ' ILE . 80.3 m95 -152.13 147.61 26.65 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-N 110.227 -3.17 . . . . 0.0 105.816 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 4.8 ttmm -139.61 122.19 16.27 Favored 'General case' 0 C--O 1.205 -1.246 0 O-C-N 127.767 3.167 . . . . 0.0 105.514 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.721 HG12 ' HB3' ' A' ' 36' ' ' LEU 0.379 8.0 p -69.02 139.21 20.85 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.022 0 CA-C-N 121.143 1.792 . . . . 0.0 110.773 179.996 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -129.39 -46.82 1.19 Allowed 'General case' 0 C--O 1.212 -0.91 0 O-C-N 127.387 2.929 . . . . 0.0 106.373 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.452 ' HG3' ' N ' ' A' ' 11' ' ' ASN . 9.2 ttt180 -129.21 144.85 51.37 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 106.962 -1.495 . . . . 0.0 106.962 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.484 ' OD1' HG21 ' A' ' 8' ' ' VAL 0.385 97.7 m-20 -131.59 -171.12 2.53 Favored 'General case' 0 CA--C 1.501 -0.936 0 O-C-N 128.604 3.69 . . . . 0.0 107.886 179.956 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.527 ' HB2' ' HB2' ' A' ' 125' ' ' LYS . 0.9 OUTLIER -146.43 -85.69 0.11 Allowed 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 122.595 2.452 . . . . 0.0 110.897 179.942 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.538 ' HB3' ' HA ' ' A' ' 124' ' ' ALA . 2.2 t-20 -90.64 16.74 8.55 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-N 121.342 1.883 . . . . 0.0 114.154 179.445 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.514 ' CD2' ' HG2' ' A' ' 126' ' ' ARG 0.283 0.2 OUTLIER -63.98 -20.98 66.29 Favored 'General case' 0 C--O 1.242 0.665 0 O-C-N 127.595 3.06 . . . . 0.0 115.11 179.858 . . . . . . . . 4 4 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -76.19 -36.91 58.43 Favored 'General case' 0 C--O 1.205 -1.261 0 O-C-N 118.909 -2.369 . . . . 0.0 108.186 179.742 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.3 -33.76 55.62 Favored 'General case' 0 N--CA 1.435 -1.189 0 CA-C-N 112.855 -1.975 . . . . 0.0 113.194 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -70.27 -21.44 62.97 Favored 'General case' 0 N--CA 1.438 -1.046 0 O-C-N 118.798 -2.439 . . . . 0.0 109.666 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.434 ' CB ' HG13 ' A' ' 23' ' ' ILE . 4.8 mtt -76.86 -35.19 57.65 Favored 'General case' 0 CA--C 1.503 -0.852 0 CA-C-O 125.868 2.747 . . . . 0.0 107.268 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -70.79 -29.62 65.87 Favored 'General case' 0 C--O 1.244 0.771 0 CA-C-O 127.295 3.426 . . . . 0.0 112.007 179.524 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 42.3 tptt -80.07 -27.78 39.28 Favored 'General case' 0 N--CA 1.437 -1.118 0 O-C-N 119.252 -2.155 . . . . 0.0 110.383 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 17.8 mtp -71.5 -30.88 66.47 Favored 'General case' 0 C--O 1.202 -1.436 0 O-C-N 119.554 -1.966 . . . . 0.0 106.669 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.31 32.52 2.75 Favored Glycine 0 C--N 1.306 -1.129 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.449 HG23 ' HB3' ' A' ' 27' ' ' LYS . 6.0 mm -78.33 -71.38 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.362 1.124 0 CA-C-O 115.561 -2.161 . . . . 0.0 106.901 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 66.53 152.17 0.07 Allowed 'General case' 0 N--CA 1.445 -0.716 0 O-C-N 126.777 2.548 . . . . 0.0 114.755 179.572 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.442 HG12 ' N ' ' A' ' 26' ' ' VAL 0.4 2.6 t 50.18 -122.94 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.355 0.835 0 N-CA-C 120.268 3.432 . . . . 0.0 120.268 179.679 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.442 ' N ' HG12 ' A' ' 25' ' ' VAL 0.542 3.4 m -65.43 -36.86 78.68 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.037 0 N-CA-C 118.379 2.733 . . . . 0.0 118.379 -179.776 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.449 ' HB3' HG23 ' A' ' 23' ' ' ILE . 62.8 mttm -60.93 -25.89 67.1 Favored 'General case' 0 N--CA 1.438 -1.067 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 4.7 mtm-85 -78.08 -31.26 50.04 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 117.435 -1.706 . . . . 0.0 108.178 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 8.1 tptm -71.36 -45.85 61.89 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 114.02 -1.446 . . . . 0.0 111.798 179.655 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 12.2 mt -78.02 -29.2 49.36 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 -179.786 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.16 -36.07 60.43 Favored Glycine 0 C--N 1.338 0.641 0 CA-C-O 123.089 1.383 . . . . 0.0 111.681 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -75.63 -22.84 56.45 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-O 116.738 -1.601 . . . . 0.0 112.946 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 18.0 t60 -120.78 46.2 2.07 Favored 'General case' 0 N--CA 1.447 -0.615 0 O-C-N 128.829 3.831 . . . . 0.0 114.125 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -72.05 -19.19 61.87 Favored 'General case' 0 C--O 1.21 -0.991 0 O-C-N 128.544 3.653 . . . . 0.0 117.703 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . 0.255 0.6 OUTLIER 65.93 38.99 4.73 Favored 'General case' 0 C--N 1.312 -1.037 0 C-N-CA 118.593 -1.243 . . . . 0.0 109.454 -179.314 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.92 HD21 HD13 ' A' ' 38' ' ' LEU . 3.0 tt -61.2 137.29 58.24 Favored 'General case' 0 C--O 1.216 -0.698 0 O-C-N 125.632 1.833 . . . . 0.0 112.847 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.3 ttpt -139.2 100.83 4.11 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 101.55 -3.5 . . . . 0.0 101.55 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.92 HD13 HD21 ' A' ' 36' ' ' LEU 0.277 0.4 OUTLIER -93.08 117.19 29.78 Favored 'General case' 0 C--N 1.293 -1.88 0 O-C-N 119.349 -2.095 . . . . 0.0 107.008 -179.578 . . . . . . . . 4 4 . 1 . 011 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.621 ' HA ' ' HA ' ' A' ' 5' ' ' THR . 85.2 m -104.44 100.47 10.16 Favored 'General case' 0 N--CA 1.436 -1.135 0 N-CA-C 104.192 -2.522 . . . . 0.0 104.192 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.439 HG12 HG23 ' A' ' 49' ' ' VAL . 7.9 mt -71.29 149.86 9.56 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 179.821 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.695 ' HB ' HG23 ' A' ' 48' ' ' THR . 89.3 m -142.71 63.44 1.39 Allowed 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 113.68 -1.6 . . . . 0.0 112.519 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.408 ' HG3' ' CE1' ' A' ' 47' ' ' PHE . 0.4 OUTLIER -62.35 119.85 9.88 Favored 'General case' 0 C--O 1.222 -0.362 0 O-C-N 125.228 1.58 . . . . 0.0 109.723 179.86 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -153.48 108.68 3.19 Favored 'General case' 0 CA--C 1.489 -1.392 0 CA-C-O 122.951 1.358 . . . . 0.0 110.079 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 61.35 31.73 78.32 Favored Glycine 0 C--N 1.306 -1.108 0 N-CA-C 108.888 -1.685 . . . . 0.0 108.888 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.31 0.2 OUTLIER 87.63 -14.05 0.44 Allowed 'General case' 0 C--O 1.225 -0.189 0 CA-C-N 112.978 -1.611 . . . . 0.0 110.856 179.728 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -80.09 121.1 25.12 Favored 'General case' 0 N--CA 1.428 -1.542 0 C-N-CA 116.333 -2.147 . . . . 0.0 110.094 -179.557 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.859 ' CE2' HD21 ' A' ' 89' ' ' LEU 0.311 0.4 OUTLIER -101.77 104.93 15.74 Favored 'General case' 0 C--O 1.217 -0.634 0 N-CA-C 105.985 -1.857 . . . . 0.0 105.985 179.963 . . . . . . . . 4 4 . 1 . 011 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.695 HG23 ' HB ' ' A' ' 41' ' ' THR 0.432 1.6 t -105.29 73.2 1.02 Allowed 'General case' 0 C--N 1.313 -1.002 0 CA-C-O 125.542 2.591 . . . . 0.0 111.979 -179.596 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.439 HG23 HG12 ' A' ' 40' ' ' ILE 0.626 0.5 OUTLIER -52.37 94.47 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.425 -1.703 0 CA-C-N 108.704 -3.862 . . . . 0.0 112.636 -179.866 . . . . . . . . 4 4 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.606 ' HB3' ' HB ' ' A' ' 39' ' ' THR . 5.1 ttmt -64.6 153.88 37.98 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 100.631 -3.84 . . . . 0.0 100.631 179.381 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.562 ' OE2' HD11 ' A' ' 36' ' ' LEU . 1.3 tp10 -149.42 92.92 1.99 Allowed 'General case' 0 C--O 1.215 -0.733 0 N-CA-C 103.774 -2.676 . . . . 0.0 103.774 -179.743 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -88.06 77.88 8.29 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-O 125.025 2.345 . . . . 0.0 106.696 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -95.11 -176.51 3.84 Favored 'General case' 0 N--CA 1.439 -1.003 0 O-C-N 119.883 -1.761 . . . . 0.0 112.411 -179.401 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -65.21 -19.41 65.96 Favored 'General case' 0 N--CA 1.444 -0.772 0 O-C-N 126.681 2.488 . . . . 0.0 108.612 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.417 ' CE2' ' HB1' ' A' ' 73' ' ' ALA . 6.1 m-85 -90.04 -56.52 3.19 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-O 115.22 -2.324 . . . . 0.0 115.165 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.686 HH21 HD12 ' A' ' 58' ' ' ILE . 0.1 OUTLIER -155.62 168.58 26.69 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 123.833 3.015 . . . . 0.0 107.947 179.418 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -106.29 63.16 0.65 Allowed 'General case' 0 C--O 1.216 -0.696 2 N-CA-C 100.007 -4.071 . . . . 0.0 100.007 179.645 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.686 HD12 HH21 ' A' ' 56' ' ' ARG . 12.1 tt -91.95 97.8 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 O-C-N 127.99 3.306 . . . . 0.0 114.509 -179.385 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.442 ' HA ' ' HA ' ' A' ' 50' ' ' LYS 0.273 0.0 OUTLIER -62.88 125.9 25.54 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 104.935 -2.246 . . . . 0.0 104.935 179.136 . . . . . . . . 4 4 . 1 . 011 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.5 t -105.2 85.38 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 C-N-CA 119.035 -1.066 . . . . 0.0 109.735 -178.641 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.582 HG12 ' HB ' ' A' ' 48' ' ' THR 0.399 2.0 m -74.44 150.84 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.37 0 CA-C-O 125.865 2.745 . . . . 0.0 115.163 -179.882 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.626 ' CZ ' ' CZ2' ' A' ' 82' ' ' TRP . 0.0 OUTLIER -168.21 95.65 0.4 Allowed 'General case' 0 N--CA 1.43 -1.473 0 CA-C-N 112.673 -2.058 . . . . 0.0 111.639 179.7 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.74 99.91 0.06 Allowed 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 102.477 -3.157 . . . . 0.0 102.477 179.572 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.461 HD23 ' CD2' ' A' ' 47' ' ' PHE . 0.2 OUTLIER -33.86 100.02 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 127.052 2.72 . . . . 0.0 112.683 -179.865 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 102.46 23.44 8.92 Favored Glycine 0 CA--C 1.528 0.881 0 O-C-N 128.453 3.596 . . . . 0.0 116.842 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.435 ' O ' ' CE2' ' A' ' 68' ' ' PHE 0.269 2.4 t -113.88 79.4 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.505 0 CA-C-O 115.184 -2.341 . . . . 0.0 105.301 -179.99 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . 0.278 23.5 m-20 -27.92 118.5 0.1 Allowed 'General case' 0 CA--C 1.498 -1.035 0 N-CA-C 115.682 1.734 . . . . 0.0 115.682 -179.806 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.571 ' CZ ' ' CB ' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -129.0 -173.57 3.02 Favored 'General case' 0 N--CA 1.442 -0.837 0 O-C-N 118.602 -2.561 . . . . 0.0 107.72 -179.922 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -128.84 138.15 51.88 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.439 ' HB3' HD23 ' A' ' 78' ' ' LEU . 1.7 t80 -138.85 95.17 2.92 Favored 'General case' 0 C--O 1.215 -0.727 0 C-N-CA 119.26 -0.976 . . . . 0.0 113.026 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -74.36 115.71 14.2 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 105.103 -2.184 . . . . 0.0 105.103 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.864 HD11 HD13 ' A' ' 78' ' ' LEU . 46.8 mt -71.16 -169.1 0.35 Allowed 'General case' 0 C--N 1.298 -1.637 0 CA-C-O 117.795 -1.098 . . . . 0.0 109.745 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.417 ' HB1' ' CE2' ' A' ' 55' ' ' PHE . . . -85.26 -35.95 21.22 Favored 'General case' 0 C--O 1.214 -0.784 0 O-C-N 128.666 3.729 . . . . 0.0 113.332 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.424 ' HB2' ' CG ' ' A' ' 132' ' ' PLM . 11.7 t0 -143.17 21.88 1.9 Allowed 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 113.982 -1.463 . . . . 0.0 108.555 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -130.92 -15.42 1.72 Allowed Glycine 0 CA--C 1.544 1.851 0 CA-C-O 117.797 -1.557 . . . . 0.0 116.829 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER 64.7 -177.65 0.17 Allowed 'General case' 0 N--CA 1.433 -1.306 0 CA-C-N 119.994 1.897 . . . . 0.0 114.204 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.491 ' CB ' ' HB ' ' A' ' 96' ' ' VAL . 4.7 mp0 -26.94 119.71 0.09 Allowed 'General case' 0 CA--C 1.5 -0.958 1 O-C-N 129.626 4.329 . . . . 0.0 115.608 179.923 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.864 HD13 HD11 ' A' ' 72' ' ' LEU 0.433 0.9 OUTLIER -142.67 78.01 1.6 Allowed 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 101.9 -3.37 . . . . 0.0 101.9 179.997 . . . . . . . . 4 4 . 1 . 011 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 3.7 m -82.74 165.88 19.55 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 101.804 -3.406 . . . . 0.0 101.804 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 144.31 -170.65 25.99 Favored Glycine 0 CA--C 1.538 1.519 0 C-N-CA 119.345 -1.407 . . . . 0.0 112.336 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -146.38 171.32 15.19 Favored 'General case' 0 C--O 1.203 -1.364 0 C-N-CA 117.668 -1.613 . . . . 0.0 111.386 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' TRP . . . . . 0.626 ' CZ2' ' CZ ' ' A' ' 62' ' ' PHE 0.335 13.3 m0 -114.46 141.52 47.58 Favored 'General case' 0 N--CA 1.424 -1.771 0 N-CA-C 101.388 -3.56 . . . . 0.0 101.388 179.63 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.471 HG23 HG22 ' A' ' 90' ' ' VAL . 9.9 t -146.85 141.4 26.57 Favored 'General case' 0 N--CA 1.427 -1.581 0 O-C-N 124.261 0.975 . . . . 0.0 109.797 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 12.4 ttm -81.64 129.62 34.76 Favored 'General case' 0 CA--C 1.496 -1.133 0 C-N-CA 121.2 -0.2 . . . . 0.0 110.897 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . 0.597 3.7 pt-20 -122.51 54.75 1.19 Allowed 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 96.6 -127.82 9.32 Favored Glycine 0 N--CA 1.439 -1.111 0 O-C-N 126.008 2.067 . . . . 0.0 108.503 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -80.65 9.47 6.11 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 115.502 1.668 . . . . 0.0 115.502 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . 0.275 0.1 OUTLIER -132.49 172.8 12.02 Favored 'General case' 0 CA--C 1.503 -0.836 0 O-C-N 125.712 1.882 . . . . 0.0 106.667 179.623 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.859 HD21 ' CE2' ' A' ' 47' ' ' PHE . 2.6 tp -127.74 159.11 35.77 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 105.339 -2.097 . . . . 0.0 105.339 179.76 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.471 HG22 HG23 ' A' ' 83' ' ' THR . 17.4 m -142.83 122.61 9.52 Favored 'Isoleucine or valine' 0 C--O 1.245 0.864 0 C-N-CA 116.09 -2.244 . . . . 0.0 110.107 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -92.64 97.49 2.27 Favored Glycine 0 C--N 1.35 1.338 0 N-CA-C 108.031 -2.028 . . . . 0.0 108.031 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.637 ' HA ' HD12 ' A' ' 103' ' ' ILE . 2.0 mttt -92.62 126.88 37.9 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 102.78 -3.045 . . . . 0.0 102.78 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.456 ' HB3' ' HG ' ' A' ' 78' ' ' LEU . 53.2 m-85 -127.96 110.74 12.83 Favored 'General case' 0 N--CA 1.444 -0.758 0 O-C-N 126.201 2.188 . . . . 0.0 112.621 -179.82 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -103.65 126.82 51.04 Favored 'General case' 0 N--CA 1.435 -1.203 0 N-CA-C 105.407 -2.071 . . . . 0.0 105.407 179.854 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . 0.433 3.3 mmm180 -81.64 156.49 25.08 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 127.227 2.829 . . . . 0.0 109.69 -179.778 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.491 ' HB ' ' CB ' ' A' ' 77' ' ' GLU . 3.3 t -78.4 -54.54 11.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 C-N-CA 124.552 1.141 . . . . 0.0 113.152 -179.682 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . 0.452 14.9 m-20 -68.53 -9.44 49.29 Favored 'General case' 0 C--O 1.254 1.311 0 N-CA-C 117.952 2.575 . . . . 0.0 117.952 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.417 ' ND2' ' HG3' ' A' ' 100' ' ' LYS . 19.5 p-10 -145.04 6.48 1.16 Allowed 'General case' 0 N--CA 1.438 -1.071 0 CA-C-O 115.328 -2.272 . . . . 0.0 114.069 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 39.98 40.64 1.76 Allowed Glycine 0 CA--C 1.542 1.773 0 O-C-N 125.285 1.616 . . . . 0.0 114.485 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.417 ' HG3' ' ND2' ' A' ' 98' ' ' ASN . 32.2 mmtm -78.18 -127.32 0.01 OUTLIER 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 114.14 -1.03 . . . . 0.0 109.293 -179.56 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 171.36 97.59 0.01 OUTLIER 'General case' 0 N--CA 1.433 -1.276 0 C-N-CA 130.019 3.327 . . . . 0.0 115.125 -179.641 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.698 HD13 HD12 ' A' ' 78' ' ' LEU . 0.3 OUTLIER -89.52 121.67 31.96 Favored 'General case' 0 N--CA 1.442 -0.875 2 C-N-CA 132.566 4.347 . . . . 0.0 103.871 178.863 . . . . . . . . 4 4 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.885 HG23 ' HB3' ' A' ' 117' ' ' TYR . 4.6 tp -120.21 157.53 22.71 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.742 0 C-N-CA 115.844 -2.343 . . . . 0.0 105.864 179.276 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.536 ' HA ' ' HB2' ' A' ' 117' ' ' TYR . . . -141.33 136.69 31.77 Favored 'General case' 0 C--N 1.313 -1.001 0 O-C-N 118.557 -2.589 . . . . 0.0 108.16 -179.152 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.663 ' HB ' ' CD2' ' A' ' 117' ' ' TYR . 0.5 OUTLIER -125.63 104.56 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 CA-C-N 122.856 2.571 . . . . 0.0 112.837 -179.709 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.641 ' HG2' HH11 ' A' ' 106' ' ' ARG . 4.9 mtt-85 -74.06 94.24 2.37 Favored 'General case' 0 C--N 1.307 -1.275 0 O-C-N 119.729 -1.857 . . . . 0.0 106.831 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -98.53 84.87 3.25 Favored 'General case' 0 N--CA 1.419 -2.002 0 O-C-N 126.058 2.099 . . . . 0.0 114.394 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.803 HD11 ' CH2' ' A' ' 6' ' ' TRP 0.38 0.1 OUTLIER -60.89 101.09 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 C-N-CA 116.403 -2.119 . . . . 0.0 108.503 179.897 . . . . . . . . 4 4 . 1 . 011 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 10.4 p -87.85 70.09 9.52 Favored 'General case' 0 CA--C 1.504 -0.79 0 N-CA-C 104.511 -2.404 . . . . 0.0 104.511 -179.795 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 76.99 -115.05 4.22 Favored Glycine 0 C--N 1.339 0.734 0 O-C-N 127.601 3.063 . . . . 0.0 111.677 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 48.8 m-20 -69.13 -25.24 64.29 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 120.014 1.907 . . . . 0.0 112.264 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.22 143.77 29.1 Favored 'General case' 0 CA--C 1.494 -1.19 0 CA-C-O 116.295 -1.812 . . . . 0.0 115.523 -179.592 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.543 HD23 ' N ' ' A' ' 114' ' ' ILE . 0.3 OUTLIER -104.79 146.12 29.42 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 100.741 -3.8 . . . . 0.0 100.741 179.979 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.607 HD13 HD12 ' A' ' 127' ' ' ILE 0.284 81.7 mt -149.26 110.74 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.171 0 CA-C-O 117.164 -1.398 . . . . 0.0 109.163 -179.904 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.658 ' HB2' ' HD2' ' A' ' 126' ' ' ARG . 55.3 mt-30 -86.2 167.0 15.28 Favored 'General case' 0 C--N 1.345 0.378 0 N-CA-C 104.035 -2.58 . . . . 0.0 104.035 179.857 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.475 ' CG2' ' C ' ' A' ' 115' ' ' GLN . 5.0 p -159.75 -152.33 0.3 Allowed 'General case' 0 CA--C 1.494 -1.184 1 O-C-N 130.516 4.885 . . . . 0.0 106.501 -177.198 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.885 ' HB3' HG23 ' A' ' 103' ' ' ILE . 8.7 m-30 76.88 -165.74 0.05 Allowed 'General case' 0 CA--C 1.46 -2.488 1 O-C-N 129.379 4.175 . . . . 0.0 114.309 175.144 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.508 ' O ' ' N ' ' A' ' 103' ' ' ILE . 6.9 t -138.87 -162.37 1.31 Allowed 'General case' 0 N--CA 1.437 -1.11 0 CA-C-O 127.384 3.469 . . . . 0.0 117.116 -174.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.598 ' HA ' ' HG ' ' A' ' 102' ' ' LEU . 1.6 t80 -111.57 -25.79 9.38 Favored 'General case' 0 C--N 1.348 0.525 0 CA-C-N 111.769 -2.469 . . . . 0.0 109.773 178.863 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.519 ' HB2' ' CD2' ' A' ' 119' ' ' TYR . 0.2 OUTLIER -153.23 -59.83 0.14 Allowed 'General case' 0 C--N 1.29 -2.004 0 C-N-CA 126.498 1.919 . . . . 0.0 110.017 -179.876 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -153.76 1.56 0.23 Allowed Glycine 0 C--N 1.362 1.988 0 N-CA-C 121.178 3.231 . . . . 0.0 121.178 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 37.0 t -110.39 98.91 7.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 O-C-N 117.49 -3.359 . . . . 0.0 104.915 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.413 ' HA ' ' HB ' ' A' ' 118' ' ' THR . 4.8 mp0 -64.87 -175.54 0.2 Allowed 'General case' 0 C--O 1.21 -0.984 0 O-C-N 120.001 -1.687 . . . . 0.0 112.435 -179.641 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.538 ' HA ' ' HB3' ' A' ' 13' ' ' ASN . . . -170.19 -167.83 0.67 Allowed 'General case' 0 C--O 1.21 -0.992 0 CA-C-O 113.872 -2.966 . . . . 0.0 106.991 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.527 ' HB2' ' HB2' ' A' ' 12' ' ' GLU 0.29 0.0 OUTLIER -157.88 143.84 17.32 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 122.775 2.534 . . . . 0.0 111.867 179.901 . . . . . . . . 4 4 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.658 ' HD2' ' HB2' ' A' ' 115' ' ' GLN . 0.0 OUTLIER -137.39 78.22 1.68 Allowed 'General case' 0 C--O 1.209 -1.052 0 O-C-N 128.058 3.349 . . . . 0.0 110.573 179.752 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.607 HD12 HD13 ' A' ' 114' ' ' ILE . 1.7 mm -66.44 96.18 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 O-C-N 125.311 1.632 . . . . 0.0 114.422 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.776 ' CE1' HD22 ' A' ' 36' ' ' LEU . 26.5 m-85 -84.49 137.69 33.21 Favored 'General case' 0 C--O 1.219 -0.503 0 C-N-CA 126.524 1.93 . . . . 0.0 106.709 179.775 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 10.0 mmtt -101.12 41.24 1.2 Allowed 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 115.455 -2.212 . . . . 0.0 112.465 -179.714 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.533 ' HA ' ' HA ' ' A' ' 6' ' ' TRP . 3.2 tttm 27.36 98.22 0.0 OUTLIER 'General case' 0 C--O 1.238 0.491 0 C-N-CA 127.462 2.305 . . . . 0.0 116.401 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.435 ' HA ' HG23 ' A' ' 5' ' ' THR 0.858 2.6 tm-20 . . . . . 0 N--CA 1.439 -1.022 0 O-C-N 117.912 -2.992 . . . . 0.0 116.892 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' PLM . . . . . 0.584 ' C9 ' HD22 ' A' ' 72' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.516 -0.34 0 CA-C-O 117.061 -1.447 . . . . 0.0 112.617 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.583 ' CZ ' HG13 ' A' ' 108' ' ' ILE . 96.6 m-85 57.33 38.02 28.34 Favored 'General case' 0 CA--C 1.508 -0.659 0 C-N-CA 116.393 -2.123 . . . . 0.0 116.128 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -156.27 90.72 1.21 Allowed 'General case' 0 N--CA 1.436 -1.132 0 CA-C-N 113.66 -1.609 . . . . 0.0 113.205 179.764 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 155.98 -148.19 17.91 Favored Glycine 0 N--CA 1.432 -1.589 0 C-N-CA 114.992 -3.48 . . . . 0.0 114.395 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.598 HG23 HG23 ' A' ' 39' ' ' THR 0.576 32.9 p -103.76 150.35 24.16 Favored 'General case' 0 C--N 1.311 -1.088 0 O-C-N 126.935 2.197 . . . . 0.0 114.182 179.967 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.578 ' CZ2' HD11 ' A' ' 108' ' ' ILE . 93.7 m95 -148.11 141.21 24.97 Favored 'General case' 0 N--CA 1.431 -1.405 0 O-C-N 126.346 2.279 . . . . 0.0 106.087 179.83 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 18.3 tttt -141.47 93.54 2.58 Favored 'General case' 0 C--O 1.204 -1.32 0 CA-C-O 116.778 -1.582 . . . . 0.0 107.257 179.633 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.482 ' CG1' ' HB3' ' A' ' 36' ' ' LEU 0.32 1.5 p -43.78 136.9 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-O 117.127 -1.416 . . . . 0.0 113.341 -179.96 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -126.15 -18.45 4.99 Favored 'General case' 0 CA--C 1.503 -0.853 0 O-C-N 124.671 1.232 . . . . 0.0 111.321 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.02 145.65 15.4 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 119.753 -1.842 . . . . 0.0 106.496 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . 0.298 0.2 OUTLIER -109.09 -169.83 1.55 Allowed 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 112.452 -2.158 . . . . 0.0 109.54 179.715 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -176.87 90.35 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.464 ' HB3' ' HA ' ' A' ' 124' ' ' ALA . 0.2 OUTLIER 100.7 -7.39 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 125.132 1.373 . . . . 0.0 112.229 -179.575 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.566 ' CD2' ' CG ' ' A' ' 126' ' ' ARG 0.252 0.2 OUTLIER -69.96 -38.67 76.17 Favored 'General case' 0 C--O 1.222 -0.386 0 O-C-N 128.314 3.509 . . . . 0.0 114.185 179.584 . . . . . . . . 4 4 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.52 -29.24 68.98 Favored 'General case' 0 CA--C 1.509 -0.602 0 CA-C-N 121.539 1.972 . . . . 0.0 113.043 179.696 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.9 -37.42 34.77 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 113.504 -1.68 . . . . 0.0 110.391 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.545 ' CD2' ' CE1' ' A' ' 14' ' ' TYR . 0.9 OUTLIER -70.73 -28.62 64.86 Favored 'General case' 0 C--O 1.244 0.765 0 CA-C-O 124.765 2.222 . . . . 0.0 111.747 -179.981 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.409 ' CB ' HG13 ' A' ' 23' ' ' ILE . 32.1 mtt -72.15 -26.04 61.95 Favored 'General case' 0 C--N 1.324 -0.521 1 O-C-N 115.36 -4.588 . . . . 0.0 108.466 -179.686 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -79.68 -24.16 41.96 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 116.138 -2.225 . . . . 0.0 111.937 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 12.4 tptp -79.19 -30.53 43.43 Favored 'General case' 0 C--N 1.31 -1.145 0 O-C-N 120.68 -1.262 . . . . 0.0 109.379 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.545 ' CE ' ' CD1' ' A' ' 119' ' ' TYR 0.304 0.7 OUTLIER -78.41 -23.49 46.68 Favored 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 179.783 . . . . . . . . 4 4 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 88.33 56.87 1.96 Allowed Glycine 0 C--N 1.307 -1.049 0 CA-C-O 116.301 -2.389 . . . . 0.0 108.793 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.475 HG21 ' HA ' ' A' ' 28' ' ' ARG . 1.6 mm -81.26 -34.17 13.22 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 CA-C-O 115.081 -2.39 . . . . 0.0 111.719 -179.68 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 89.61 98.64 0.02 OUTLIER 'General case' 0 C--N 1.346 0.426 0 O-C-N 125.877 1.985 . . . . 0.0 113.431 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.471 HG13 HG22 ' A' ' 26' ' ' VAL 0.475 4.1 p 12.86 -62.08 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.349 0.577 0 N-CA-C 119.292 3.071 . . . . 0.0 119.292 179.974 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.471 HG22 HG13 ' A' ' 25' ' ' VAL 0.605 0.0 OUTLIER -72.07 -42.08 67.7 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.876 0 N-CA-C 118.212 2.671 . . . . 0.0 118.212 -179.465 . . . . . . . . 4 4 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.4 mtpp -64.4 -24.59 67.69 Favored 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 114.787 1.403 . . . . 0.0 114.787 -179.424 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.475 ' HA ' HG21 ' A' ' 23' ' ' ILE . 5.0 ptt85 -79.8 -25.68 40.8 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 119.207 -2.183 . . . . 0.0 108.239 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 8.8 tttt -73.99 -46.39 44.08 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.609 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.1 mp -72.81 -31.96 65.19 Favored 'General case' 0 N--CA 1.438 -1.058 0 O-C-N 124.872 1.358 . . . . 0.0 107.387 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -74.95 -34.49 52.65 Favored Glycine 0 C--N 1.346 1.102 0 O-C-N 124.576 1.172 . . . . 0.0 111.779 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -73.35 -26.71 61.13 Favored 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 114.476 1.288 . . . . 0.0 114.476 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -124.8 57.83 1.26 Allowed 'General case' 0 C--N 1.348 0.502 0 O-C-N 127.343 2.902 . . . . 0.0 111.175 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -90.78 -17.82 25.99 Favored 'General case' 0 C--O 1.211 -0.948 0 N-CA-C 118.511 2.782 . . . . 0.0 118.511 -179.824 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 10.3 t30 75.32 27.12 1.11 Allowed 'General case' 0 C--O 1.24 0.6 0 C-N-CA 117.992 -1.483 . . . . 0.0 110.092 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.522 HD11 ' CD1' ' A' ' 38' ' ' LEU . 13.8 tp -52.77 106.54 0.16 Allowed 'General case' 0 C--O 1.216 -0.682 0 C-N-CA 126.542 1.937 . . . . 0.0 107.587 179.676 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 6.1 ttpt -104.58 103.91 13.65 Favored 'General case' 0 C--N 1.309 -1.183 0 O-C-N 127.086 2.741 . . . . 0.0 104.156 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.522 ' CD1' HD11 ' A' ' 36' ' ' LEU 0.271 1.0 OUTLIER -88.2 117.11 26.87 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 179.434 . . . . . . . . 4 4 . 1 . 012 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.598 HG23 HG23 ' A' ' 5' ' ' THR . 31.3 m -108.81 98.46 7.95 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 104.118 -2.549 . . . . 0.0 104.118 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.478 HG13 ' CG2' ' A' ' 49' ' ' VAL . 29.0 mt -81.38 142.33 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.38 0 O-C-N 126.143 2.152 . . . . 0.0 109.213 -179.717 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.448 HG22 ' O ' ' A' ' 41' ' ' THR . 20.9 m -145.33 83.14 1.66 Allowed 'General case' 0 CA--C 1.508 -0.639 0 O-C-N 128.091 3.369 . . . . 0.0 109.247 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.479 ' NE2' ' CE2' ' A' ' 47' ' ' PHE . 4.1 tt0 -82.85 132.18 35.17 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 114.375 -1.284 . . . . 0.0 108.312 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -117.67 67.53 0.75 Allowed 'General case' 0 CA--C 1.485 -1.527 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.91 -86.38 1.52 Allowed Glycine 0 N--CA 1.429 -1.82 0 N-CA-C 106.417 -2.673 . . . . 0.0 106.417 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.288 0.0 OUTLIER -111.08 -40.32 4.51 Favored 'General case' 0 N--CA 1.451 -0.417 0 O-C-N 125.541 1.377 . . . . 0.0 113.167 -179.912 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.45 ' HG3' ' HG3' ' A' ' 63' ' ' GLU . 5.3 ttmm -62.2 148.87 43.3 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.596 ' HB3' ' CE1' ' A' ' 62' ' ' PHE 0.306 1.7 m-85 -137.08 105.56 5.79 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 114.98 -1.009 . . . . 0.0 109.196 179.962 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.812 ' HB ' HG12 ' A' ' 61' ' ' VAL 0.423 9.5 t -99.38 126.05 45.18 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 105.712 -1.959 . . . . 0.0 105.712 179.43 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.498 ' HB ' ' CE2' ' A' ' 62' ' ' PHE 0.671 0.6 OUTLIER -107.23 115.89 49.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 O-C-N 126.801 2.563 . . . . 0.0 113.303 -179.84 . . . . . . . . 4 4 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.546 ' CB ' ' HB ' ' A' ' 39' ' ' THR . 7.3 tttt -78.63 100.37 6.97 Favored 'General case' 0 C--N 1.307 -1.267 1 N-CA-C 100.182 -4.006 . . . . 0.0 100.182 179.909 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 55.4 tt0 -95.64 63.75 2.47 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 102.446 -3.168 . . . . 0.0 102.446 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 11.0 m -74.92 60.27 0.96 Allowed 'General case' 0 C--N 1.289 -2.025 0 O-C-N 125.763 1.914 . . . . 0.0 106.725 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -82.13 179.36 7.84 Favored 'General case' 0 C--O 1.209 -1.073 0 C-N-CA 117.215 -1.794 . . . . 0.0 109.778 179.696 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -63.39 -30.43 71.56 Favored 'General case' 0 C--O 1.214 -0.789 0 O-C-N 125.329 1.643 . . . . 0.0 107.867 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 -68.16 -65.26 0.72 Allowed 'General case' 0 C--O 1.218 -0.6 0 C-N-CA 115.064 -2.654 . . . . 0.0 109.245 179.591 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.903 ' HB2' HG22 ' A' ' 58' ' ' ILE . 7.9 mtm-85 -139.81 170.88 15.07 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 123.98 3.082 . . . . 0.0 110.733 179.45 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -116.87 70.71 0.78 Allowed 'General case' 0 C--O 1.217 -0.636 1 N-CA-C 100.083 -4.043 . . . . 0.0 100.083 179.573 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.903 HG22 ' HB2' ' A' ' 56' ' ' ARG . 0.5 OUTLIER -107.05 91.41 1.76 Allowed 'Isoleucine or valine' 0 CA--C 1.561 1.382 0 C-N-CA 130.312 3.445 . . . . 0.0 117.432 -179.336 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -60.95 116.53 4.55 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 104.768 -2.308 . . . . 0.0 104.768 179.052 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.522 HG13 ' O ' ' A' ' 60' ' ' VAL . 13.3 p -104.0 105.75 19.02 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 O-C-N 124.64 1.212 . . . . 0.0 112.73 -178.132 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.812 HG12 ' HB ' ' A' ' 48' ' ' THR 0.412 0.6 OUTLIER -82.44 152.3 4.05 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 O-C-N 118.676 -2.515 . . . . 0.0 109.317 179.797 . . . . . . . . 4 4 . 1 . 012 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.641 ' CE1' ' CZ2' ' A' ' 82' ' ' TRP . 16.4 p90 -162.45 95.39 0.92 Allowed 'General case' 0 N--CA 1.445 -0.722 0 O-C-N 120.55 -1.344 . . . . 0.0 108.991 179.694 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.52 ' OE1' HG11 ' A' ' 66' ' ' VAL . 1.8 mt-10 -65.96 128.95 38.08 Favored 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 104.053 -2.573 . . . . 0.0 104.053 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.449 HD21 ' CE2' ' A' ' 47' ' ' PHE . 0.4 OUTLIER -61.67 121.02 11.77 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-O 122.984 1.373 . . . . 0.0 110.857 -179.898 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 71.09 25.55 75.47 Favored Glycine 0 N--CA 1.471 0.981 0 N-CA-C 117.525 1.77 . . . . 0.0 117.525 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.52 HG11 ' OE1' ' A' ' 63' ' ' GLU 0.409 78.3 t -102.99 -21.0 5.4 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 CA-C-O 116.958 -1.496 . . . . 0.0 108.049 179.712 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.69 ' HA ' HG22 ' A' ' 81' ' ' THR 0.253 1.4 m-20 77.41 145.02 0.08 Allowed 'General case' 0 C--N 1.307 -1.279 0 O-C-N 126.081 2.113 . . . . 0.0 113.044 179.896 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.525 ' CZ ' ' HB3' ' A' ' 62' ' ' PHE . 0.1 OUTLIER -167.25 177.0 6.37 Favored 'General case' 0 N--CA 1.419 -2.02 0 CA-C-N 119.691 1.132 . . . . 0.0 108.189 179.874 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -128.79 132.04 47.84 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 117.41 -1.281 . . . . 0.0 109.717 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 16.2 t80 -125.77 111.52 14.98 Favored 'General case' 0 N--CA 1.435 -1.206 0 O-C-N 125.46 1.725 . . . . 0.0 114.231 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.1 m -73.74 145.13 45.36 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 123.089 2.677 . . . . 0.0 106.699 179.753 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.688 HD21 HD13 ' A' ' 78' ' ' LEU . 1.1 mt -107.43 -171.48 1.88 Allowed 'General case' 0 CA--C 1.495 -1.155 0 N-CA-C 106.072 -1.825 . . . . 0.0 106.072 -179.768 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -109.31 11.97 25.01 Favored 'General case' 0 C--O 1.235 0.336 0 O-C-N 126.64 2.463 . . . . 0.0 114.822 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.507 ' OD2' ' HG3' ' A' ' 132' ' ' PLM . 3.5 p30 -132.12 -38.59 1.09 Allowed 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 113.499 0.926 . . . . 0.0 113.499 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -130.11 -4.7 4.51 Favored Glycine 0 CA--C 1.538 1.518 0 N-CA-C 117.252 1.661 . . . . 0.0 117.252 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . 0.363 0.0 OUTLIER 67.5 171.24 0.27 Allowed 'General case' 0 N--CA 1.441 -0.879 0 C-N-CA 116.793 -1.963 . . . . 0.0 113.35 179.953 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.446 ' HB2' HG22 ' A' ' 96' ' ' VAL . 9.7 mt-10 12.02 111.37 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.891 1 O-C-N 130.192 4.682 . . . . 0.0 115.085 179.626 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.688 HD13 HD21 ' A' ' 72' ' ' LEU 0.406 0.7 OUTLIER -145.7 104.81 3.91 Favored 'General case' 0 C--O 1.219 -0.547 0 N-CA-C 101.863 -3.384 . . . . 0.0 101.863 179.939 . . . . . . . . 4 4 . 1 . 012 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 24.1 m -106.27 170.79 7.71 Favored 'General case' 0 CA--C 1.483 -1.597 0 CA-C-N 113.658 -1.61 . . . . 0.0 106.691 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 154.27 -171.45 32.82 Favored Glycine 0 N--CA 1.441 -0.98 0 C-N-CA 117.03 -2.509 . . . . 0.0 111.837 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.69 HG22 ' HA ' ' A' ' 67' ' ' ASP . 44.1 p -144.1 160.89 40.13 Favored 'General case' 0 C--O 1.199 -1.584 0 C-N-CA 117.701 -1.6 . . . . 0.0 109.899 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' TRP . . . . . 0.641 ' CZ2' ' CE1' ' A' ' 62' ' ' PHE . 10.5 m0 -101.94 156.51 17.49 Favored 'General case' 0 N--CA 1.426 -1.648 0 N-CA-C 102.055 -3.313 . . . . 0.0 102.055 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 3.2 t -150.42 124.18 9.19 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 117.751 -1.58 . . . . 0.0 106.932 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.472 ' HA ' HD23 ' A' ' 89' ' ' LEU . 0.3 OUTLIER -84.32 111.68 19.63 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 112.714 -2.039 . . . . 0.0 111.733 -179.911 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.478 ' HG3' ' CG2' ' A' ' 90' ' ' VAL 0.573 5.0 mt-10 -67.95 -49.69 60.29 Favored 'General case' 0 N--CA 1.421 -1.905 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -179.755 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 161.55 -61.2 0.29 Allowed Glycine 0 C--O 1.216 -1.028 0 N-CA-C 103.283 -3.927 . . . . 0.0 103.283 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -110.04 8.04 23.85 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 125.66 1.447 . . . . 0.0 113.675 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . 0.317 0.0 OUTLIER -156.87 126.73 6.29 Favored 'General case' 0 CA--C 1.503 -0.864 0 O-C-N 126.551 2.407 . . . . 0.0 107.571 179.953 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.513 HD13 ' CE3' ' A' ' 82' ' ' TRP . 1.2 mt -83.6 147.8 27.52 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 111.329 -2.669 . . . . 0.0 103.953 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.478 ' CG2' ' HG3' ' A' ' 85' ' ' GLU . 0.2 OUTLIER -137.35 133.54 46.6 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.889 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 -179.994 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -111.56 103.6 1.57 Allowed Glycine 0 CA--C 1.528 0.9 0 C-N-CA 125.649 1.595 . . . . 0.0 113.35 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 37.8 mtpt -98.65 118.57 35.66 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 102.935 -2.987 . . . . 0.0 102.935 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.483 ' CZ ' ' H52' ' A' ' 132' ' ' PLM . 15.6 m-85 -122.9 115.23 21.59 Favored 'General case' 0 CA--C 1.501 -0.916 0 O-C-N 126.416 2.322 . . . . 0.0 111.521 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 19.9 mttp -98.47 140.45 32.7 Favored 'General case' 0 CA--C 1.505 -0.762 0 CA-C-O 125.192 2.425 . . . . 0.0 108.434 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . 0.407 15.3 ttt180 -97.15 129.74 44.49 Favored 'General case' 0 CA--C 1.487 -1.475 0 CA-C-O 124.031 1.872 . . . . 0.0 106.102 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.501 HG23 ' N ' ' A' ' 97' ' ' ASP . 14.7 m -69.77 -34.73 62.04 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.934 0 CA-C-O 125.551 2.596 . . . . 0.0 114.675 -179.766 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.501 ' N ' HG23 ' A' ' 96' ' ' VAL 0.401 0.9 OUTLIER -63.75 -8.36 10.3 Favored 'General case' 0 C--O 1.255 1.39 0 CA-C-N 113.936 -1.484 . . . . 0.0 114.377 179.814 . . . . . . . . 4 4 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.468 ' ND2' ' HG2' ' A' ' 100' ' ' LYS . 13.3 p-10 -150.54 1.77 0.45 Allowed 'General case' 0 N--CA 1.433 -1.302 0 C-N-CA 116.196 -2.202 . . . . 0.0 116.732 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 65.83 21.94 69.79 Favored Glycine 0 CA--C 1.542 1.774 0 N-CA-C 115.673 1.029 . . . . 0.0 115.673 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.468 ' HG2' ' ND2' ' A' ' 98' ' ' ASN . 49.0 mmtt -89.68 -178.82 5.63 Favored 'General case' 0 C--O 1.202 -1.417 0 C-N-CA 119.823 -0.751 . . . . 0.0 112.802 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -143.48 119.42 10.63 Favored 'General case' 0 C--O 1.212 -0.885 0 C-N-CA 128.264 2.626 . . . . 0.0 113.866 179.761 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.64 ' HG ' ' HA ' ' A' ' 119' ' ' TYR . 5.5 tt -98.37 133.76 42.32 Favored 'General case' 0 N--CA 1.44 -0.972 1 C-N-CA 135.337 5.455 . . . . 0.0 106.211 -179.679 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.618 HG23 ' HB3' ' A' ' 117' ' ' TYR . 7.1 tt -122.55 159.29 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.702 0 C-N-CA 115.855 -2.338 . . . . 0.0 104.726 179.489 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -156.39 145.54 20.49 Favored 'General case' 0 C--N 1.315 -0.902 0 O-C-N 118.844 -2.41 . . . . 0.0 107.542 -179.706 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.684 HG13 ' HG2' ' A' ' 107' ' ' GLU . 6.4 p -131.66 115.12 26.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-O 126.078 2.847 . . . . 0.0 110.287 -179.527 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.586 ' CZ ' ' CH2' ' A' ' 82' ' ' TRP . 2.3 mtt-85 -76.44 90.48 3.26 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 112.299 -2.228 . . . . 0.0 105.462 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.684 ' HG2' HG13 ' A' ' 105' ' ' VAL . 1.2 mt-10 -86.66 77.62 9.31 Favored 'General case' 0 N--CA 1.419 -2.015 0 CA-C-N 109.985 -3.28 . . . . 0.0 114.928 -179.682 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.583 HG13 ' CZ ' ' A' ' 2' ' ' PHE 0.257 0.6 OUTLIER -54.94 90.75 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 CA-C-O 122.931 1.348 . . . . 0.0 111.417 179.264 . . . . . . . . 4 4 . 1 . 012 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.459 ' N ' ' O ' ' A' ' 107' ' ' GLU . 23.9 m -80.97 66.99 6.71 Favored 'General case' 0 N--CA 1.432 -1.339 0 N-CA-C 103.822 -2.659 . . . . 0.0 103.822 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 52.7 -90.97 0.01 OUTLIER Glycine 0 N--CA 1.463 0.493 1 O-C-N 129.191 4.057 . . . . 0.0 111.113 -179.817 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . 0.322 4.5 m120 -82.29 -25.89 33.6 Favored 'General case' 0 C--N 1.309 -1.196 0 CA-C-O 115.935 -1.983 . . . . 0.0 110.675 179.805 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -110.28 125.63 53.33 Favored 'General case' 0 C--O 1.205 -1.256 0 N-CA-C 115.878 1.807 . . . . 0.0 115.878 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.456 HD21 ' HB3' ' A' ' 106' ' ' ARG . 0.0 OUTLIER -87.04 143.6 27.26 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 100.633 -3.84 . . . . 0.0 100.633 179.983 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.8 HG23 HD13 ' A' ' 127' ' ' ILE 0.312 0.6 OUTLIER -142.13 136.57 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.585 0 N-CA-C 105.067 -2.197 . . . . 0.0 105.067 179.989 . . . . . . . . 4 4 . 1 . 012 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.439 HE21 ' HE1' ' A' ' 128' ' ' PHE . 49.6 mt-30 -109.54 123.24 49.08 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 100.926 -3.731 . . . . 0.0 100.926 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.52 HG23 ' HG3' ' A' ' 107' ' ' GLU . 0.1 OUTLIER -135.39 147.73 49.12 Favored 'General case' 0 N--CA 1.417 -2.11 0 C-N-CA 118.091 -1.443 . . . . 0.0 111.829 -179.12 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.618 ' HB3' HG23 ' A' ' 103' ' ' ILE 0.352 18.5 m-85 127.81 -144.95 0.0 OUTLIER 'General case' 0 CA--C 1.471 -2.08 1 O-C-N 131.892 5.745 . . . . 0.0 113.945 177.656 . . . . . . . . 4 3 . 1 . 012 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.528 ' O ' ' N ' ' A' ' 103' ' ' ILE . 7.9 t -150.13 -159.84 1.09 Allowed 'General case' 0 N--CA 1.437 -1.086 0 CA-C-O 125.825 2.726 . . . . 0.0 116.789 -174.908 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.64 ' HA ' ' HG ' ' A' ' 102' ' ' LEU 0.25 38.1 t80 -108.5 -31.55 7.75 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 112.436 -2.165 . . . . 0.0 108.791 177.428 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -148.16 -70.91 0.22 Allowed 'General case' 0 C--N 1.291 -1.955 0 C-N-CA 126.862 2.065 . . . . 0.0 109.605 179.112 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -147.3 18.55 1.52 Allowed Glycine 0 C--N 1.351 1.388 0 N-CA-C 120.887 3.115 . . . . 0.0 120.887 -179.756 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 50.7 t -117.24 93.08 2.35 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 N-CA-C 103.547 -2.76 . . . . 0.0 103.547 179.667 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.456 ' HA ' ' O ' ' A' ' 117' ' ' TYR . 6.6 mt-10 -57.99 178.82 0.08 Allowed 'General case' 0 CA--C 1.513 -0.467 0 CA-C-O 124.021 1.867 . . . . 0.0 112.368 -178.191 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.536 ' HB1' ' HA ' ' A' ' 14' ' ' TYR . . . -172.58 104.26 0.15 Allowed 'General case' 0 N--CA 1.436 -1.138 0 O-C-N 116.535 -3.853 . . . . 0.0 109.453 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.27 141.33 33.03 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 119.804 1.184 . . . . 0.0 108.997 179.49 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.566 ' CG ' ' CD2' ' A' ' 14' ' ' TYR . 3.8 mtp180 -129.13 79.21 1.9 Allowed 'General case' 0 C--O 1.214 -0.798 0 CA-C-O 116.126 -1.892 . . . . 0.0 110.509 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.8 HD13 HG23 ' A' ' 114' ' ' ILE . 3.8 mm -65.29 118.23 7.38 Favored 'Isoleucine or valine' 0 C--O 1.256 1.429 1 O-C-N 130.35 4.781 . . . . 0.0 115.201 179.64 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.479 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 80.6 m-85 -104.67 137.46 42.46 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 126.362 1.865 . . . . 0.0 108.072 -179.616 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . 0.363 0.6 OUTLIER -108.93 42.57 1.39 Allowed 'General case' 0 N--CA 1.439 -1.025 0 CA-C-O 116.475 -1.726 . . . . 0.0 111.47 -179.964 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.514 ' HA ' ' CE3' ' A' ' 6' ' ' TRP . 0.0 OUTLIER 21.63 101.16 0.0 OUTLIER 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 128.404 2.682 . . . . 0.0 116.472 -179.904 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . 0.934 16.5 tt0 . . . . . 0 C--N 1.32 -0.697 0 N-CA-C 115.882 1.808 . . . . 0.0 115.882 179.743 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' PLM . . . . . 0.507 ' HG3' ' OD2' ' A' ' 74' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.214 -0.773 0 CA-C-O 118.26 -0.876 . . . . 0.0 110.214 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.554 ' CE1' HG13 ' A' ' 108' ' ' ILE . 2.5 m-85 69.24 -74.46 0.08 Allowed 'General case' 0 N--CA 1.434 -1.255 0 C-N-CA 117.629 -1.628 . . . . 0.0 113.247 179.833 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -49.53 95.11 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.362 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 155.33 178.98 30.12 Favored Glycine 0 N--CA 1.441 -0.982 0 C-N-CA 118.024 -2.036 . . . . 0.0 112.324 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . 0.531 1.3 p -86.1 147.93 25.93 Favored 'General case' 0 C--N 1.312 -1.041 0 C-N-CA 124.82 1.248 . . . . 0.0 108.46 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.524 ' CH2' ' HD2' ' A' ' 130' ' ' LYS . 74.9 m95 -143.29 140.24 30.52 Favored 'General case' 0 CA--C 1.504 -0.804 0 CA-C-O 115.202 -2.332 . . . . 0.0 105.961 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 18.5 tttt -144.34 92.77 2.35 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 114.398 -2.715 . . . . 0.0 105.838 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.532 ' HB ' ' CD1' ' A' ' 128' ' ' PHE 0.258 7.4 p -34.38 128.13 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.16 0 CA-C-O 116.426 -1.749 . . . . 0.0 113.054 -179.998 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -126.35 -22.8 3.94 Favored 'General case' 0 N--CA 1.451 -0.406 0 O-C-N 125.922 2.014 . . . . 0.0 111.335 -179.693 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.427 ' HD2' ' HE3' ' A' ' 129' ' ' LYS . 0.0 OUTLIER -141.36 63.7 1.43 Allowed 'General case' 0 CA--C 1.49 -1.362 0 C-N-CA 118.758 -1.177 . . . . 0.0 113.409 -179.78 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . 0.473 16.4 m-20 -48.23 156.27 0.41 Allowed 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 124.023 0.929 . . . . 0.0 108.733 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.44 ' HB2' ' HB2' ' A' ' 125' ' ' LYS . 11.6 mt-10 -143.76 136.94 27.71 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-O 115.77 -2.062 . . . . 0.0 107.294 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.418 ' HB3' ' HA ' ' A' ' 124' ' ' ALA . 1.0 OUTLIER 53.76 20.7 2.36 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 122.127 2.239 . . . . 0.0 113.238 -179.691 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.547 ' HA ' ' HB1' ' A' ' 124' ' ' ALA 0.261 4.3 t80 -79.81 -35.81 37.88 Favored 'General case' 0 N--CA 1.442 -0.873 0 O-C-N 126.592 2.433 . . . . 0.0 114.858 179.529 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -77.37 -24.14 50.67 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 116.849 -1.548 . . . . 0.0 108.886 -179.523 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 8.3 ttmm -78.52 -29.41 46.51 Favored 'General case' 0 N--CA 1.431 -1.387 0 O-C-N 126.012 2.07 . . . . 0.0 111.669 179.727 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.491 ' CB ' ' HB2' ' A' ' 124' ' ' ALA . 0.2 OUTLIER -69.25 -34.98 75.64 Favored 'General case' 0 N--CA 1.429 -1.516 0 O-C-N 120.384 -1.448 . . . . 0.0 112.065 179.914 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 10.8 mtt -75.76 -26.49 57.44 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-O 124.903 2.287 . . . . 0.0 109.232 -179.605 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -79.61 -25.34 41.51 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 124.682 2.182 . . . . 0.0 112.347 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.555 ' HE3' ' CG ' ' A' ' 119' ' ' TYR . 3.5 tmtm? -70.61 -30.52 67.2 Favored 'General case' 0 C--O 1.209 -1.063 0 O-C-N 118.23 -2.794 . . . . 0.0 112.864 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -79.95 -33.86 39.28 Favored 'General case' 0 C--O 1.215 -0.745 0 O-C-N 126.132 2.145 . . . . 0.0 108.86 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 108.07 37.53 2.15 Favored Glycine 0 C--N 1.306 -1.1 0 CA-C-O 116.051 -2.527 . . . . 0.0 111.862 -179.661 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.402 ' CD1' ' HG3' ' A' ' 132' ' ' PLM . 1.5 mm -70.31 84.68 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.909 0 CA-C-O 113.253 -3.26 . . . . 0.0 105.033 179.732 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 10.9 m-20 -3.29 -90.07 0.0 OUTLIER 'General case' 0 C--O 1.247 0.933 0 O-C-N 128.484 3.615 . . . . 0.0 115.24 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . 0.359 20.3 m -155.86 -49.98 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.221 -0.419 0 N-CA-C 117.416 2.376 . . . . 0.0 117.416 179.716 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.569 14.4 m -76.4 -23.01 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.277 0 N-CA-C 116.837 2.162 . . . . 0.0 116.837 179.633 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.9 mtpt -74.98 -25.55 58.93 Favored 'General case' 0 N--CA 1.437 -1.1 0 O-C-N 127.253 2.845 . . . . 0.0 113.175 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.37 -22.22 44.69 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 118.317 -1.353 . . . . 0.0 108.784 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.7 ttpt -65.27 -50.35 66.1 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 122.251 1.024 . . . . 0.0 112.551 -179.466 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.453 ' HA ' HD12 ' A' ' 30' ' ' LEU . 0.7 OUTLIER -76.01 -24.45 55.26 Favored 'General case' 0 C--O 1.214 -0.775 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 179.745 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -76.32 -31.56 54.38 Favored Glycine 0 N--CA 1.441 -1.021 0 O-C-N 128.643 3.714 . . . . 0.0 109.832 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -76.94 -38.99 52.27 Favored 'General case' 0 C--O 1.242 0.692 0 O-C-N 125.379 1.281 . . . . 0.0 111.026 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -108.07 47.54 0.89 Allowed 'General case' 0 N--CA 1.433 -1.277 0 CA-C-O 116.646 -1.645 . . . . 0.0 111.077 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -70.12 -37.23 75.27 Favored 'General case' 0 CA--C 1.495 -1.162 0 N-CA-C 118.63 2.826 . . . . 0.0 118.63 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . 0.262 0.1 OUTLIER 81.86 28.77 0.15 Allowed 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 117.709 -1.138 . . . . 0.0 110.629 -179.999 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 1.018 HD21 HD13 ' A' ' 38' ' ' LEU . 0.5 OUTLIER -48.41 94.74 0.01 OUTLIER 'General case' 0 CA--C 1.507 -0.693 0 C-N-CA 125.05 1.34 . . . . 0.0 108.51 -179.866 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 10.3 tttt -96.92 101.94 13.63 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 102.555 -3.128 . . . . 0.0 102.555 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 1.018 HD13 HD21 ' A' ' 36' ' ' LEU 0.322 2.1 tp -87.33 130.56 34.58 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 119.86 1.209 . . . . 0.0 110.157 -179.915 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.523 ' HB ' ' CB ' ' A' ' 50' ' ' LYS . 69.3 m -119.25 98.66 6.27 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 102.451 -3.166 . . . . 0.0 102.451 179.607 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 1.084 HG23 HG12 ' A' ' 49' ' ' VAL . 1.1 mt -91.42 141.01 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.368 0 CA-C-O 123.661 1.696 . . . . 0.0 111.121 179.595 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.507 HG22 ' O ' ' A' ' 41' ' ' THR . 3.2 m -133.46 93.02 3.07 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 111.04 -2.8 . . . . 0.0 108.45 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -80.31 100.99 8.66 Favored 'General case' 0 C--O 1.218 -0.588 0 O-C-N 125.723 1.89 . . . . 0.0 110.635 179.805 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -103.48 67.2 0.9 Allowed 'General case' 0 N--CA 1.436 -1.159 0 CA-C-O 125.635 2.636 . . . . 0.0 108.559 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 90.01 -101.03 2.73 Favored Glycine 0 C--N 1.302 -1.353 0 N-CA-C 108.107 -1.997 . . . . 0.0 108.107 179.758 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.314 83.5 m-20 -111.52 -13.04 13.89 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 128.321 3.012 . . . . 0.0 111.041 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.478 ' HA ' ' HA ' ' A' ' 63' ' ' GLU . 10.8 tttt -82.27 143.91 31.0 Favored 'General case' 0 C--N 1.31 -1.123 0 O-C-N 118.363 -2.711 . . . . 0.0 108.071 179.714 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.714 ' CE1' HD21 ' A' ' 64' ' ' LEU . 18.3 m-85 -122.52 86.59 2.61 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 113.845 -1.525 . . . . 0.0 110.982 179.693 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.761 ' OG1' HG12 ' A' ' 61' ' ' VAL 0.336 9.5 t -91.76 104.28 16.75 Favored 'General case' 0 C--N 1.316 -0.882 0 O-C-N 126.796 2.56 . . . . 0.0 106.321 179.914 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 1.084 HG12 HG23 ' A' ' 40' ' ' ILE 0.702 0.7 OUTLIER -100.62 116.76 44.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 126.965 2.665 . . . . 0.0 116.401 -179.685 . . . . . . . . 4 4 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.523 ' CB ' ' HB ' ' A' ' 39' ' ' THR . 26.7 tttp -62.81 149.57 43.81 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 101.018 -3.697 . . . . 0.0 101.018 179.279 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.41 ' O ' ' N ' ' A' ' 53' ' ' SER . 49.4 tt0 -137.21 64.26 1.54 Allowed 'General case' 0 CA--C 1.511 -0.531 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 -179.487 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . 0.256 5.6 m -74.88 73.97 2.13 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 105.16 -2.163 . . . . 0.0 105.16 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.545 ' HB2' HD12 ' A' ' 36' ' ' LEU . 33.1 t -102.82 25.35 9.38 Favored 'General case' 0 CA--C 1.506 -0.715 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 -179.782 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 78.31 -48.23 0.46 Allowed 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 115.272 -2.299 . . . . 0.0 108.988 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.534 ' CZ ' ' HF2' ' A' ' 132' ' ' PLM . 96.9 m-85 -58.86 -45.1 90.94 Favored 'General case' 0 C--O 1.213 -0.849 0 C-N-CA 117.428 -1.709 . . . . 0.0 110.373 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.415 ' NE ' ' HB ' ' A' ' 58' ' ' ILE . 49.0 ttt180 -168.92 144.39 3.33 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 105.668 -1.975 . . . . 0.0 105.668 179.21 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 26.8 t30 -93.1 78.21 4.6 Favored 'General case' 0 C--N 1.35 0.621 0 N-CA-C 101.642 -3.466 . . . . 0.0 101.642 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.415 ' HB ' ' NE ' ' A' ' 56' ' ' ARG . 3.0 tt -110.3 110.12 30.98 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.338 1 O-C-N 130.01 4.569 . . . . 0.0 117.728 -179.549 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -63.02 135.11 57.09 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 103.89 -2.633 . . . . 0.0 103.89 177.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.811 HG11 ' H21' ' A' ' 132' ' ' PLM . 10.1 t -107.41 92.37 2.06 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 -178.18 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.761 HG12 ' OG1' ' A' ' 48' ' ' THR 0.358 0.7 OUTLIER -90.81 135.24 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.151 0 O-C-N 118.681 -2.512 . . . . 0.0 111.951 -179.761 . . . . . . . . 4 4 . 1 . 013 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.614 ' CD2' HG12 ' A' ' 60' ' ' VAL . 24.4 p90 -166.05 97.25 0.62 Allowed 'General case' 0 C--N 1.314 -0.943 0 C-N-CA 118.151 -1.42 . . . . 0.0 110.296 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.478 ' HA ' ' HA ' ' A' ' 46' ' ' LYS . 1.0 OUTLIER -56.03 147.85 18.98 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 179.88 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.714 HD21 ' CE1' ' A' ' 47' ' ' PHE . 0.3 OUTLIER -62.55 99.4 0.15 Allowed 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 179.73 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 98.7 34.46 5.23 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 119.321 2.489 . . . . 0.0 119.321 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . 0.433 34.8 m -114.3 77.67 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 N-CA-C 104.618 -2.364 . . . . 0.0 104.618 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -35.16 103.21 0.03 OUTLIER 'General case' 0 CA--C 1.486 -1.481 0 O-C-N 126.803 2.564 . . . . 0.0 113.711 -179.68 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 28.9 p90 -116.52 174.97 5.78 Favored 'General case' 0 N--CA 1.423 -1.816 0 O-C-N 120.138 -1.601 . . . . 0.0 112.484 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -123.17 126.07 46.31 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 128.828 3.83 . . . . 0.0 105.488 179.604 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -121.56 -42.34 2.44 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-O 115.82 -2.038 . . . . 0.0 114.356 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.9 m 72.61 143.17 0.06 Allowed 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 105.95 -1.87 . . . . 0.0 105.95 -179.499 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.573 HD11 HD13 ' A' ' 78' ' ' LEU . 1.2 mp -95.95 -164.17 1.13 Allowed 'General case' 0 C--N 1.301 -1.509 0 CA-C-N 114.779 -1.101 . . . . 0.0 108.719 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -89.11 -48.75 7.19 Favored 'General case' 0 C--O 1.211 -0.964 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.117 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.487 ' HB2' ' CG ' ' A' ' 132' ' ' PLM . 0.2 OUTLIER -129.01 12.94 6.22 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-O 115.557 -2.163 . . . . 0.0 109.633 179.994 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.45 ' C ' HG23 ' A' ' 76' ' ' THR . . . -107.29 -8.93 30.37 Favored Glycine 0 CA--C 1.546 1.998 0 CA-C-O 117.463 -1.743 . . . . 0.0 116.924 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.554 ' O ' HD12 ' A' ' 72' ' ' LEU 0.377 0.1 OUTLIER 89.3 -164.08 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 114.696 -2.574 . . . . 0.0 113.97 179.946 . . . . . . . . 4 4 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.669 ' CB ' HG22 ' A' ' 96' ' ' VAL . 0.5 OUTLIER -62.21 140.64 58.45 Favored 'General case' 0 C--N 1.318 -0.78 1 O-C-N 129.529 4.268 . . . . 0.0 114.891 179.914 . . . . . . . . 4 4 . 1 . 013 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.573 HD13 HD11 ' A' ' 72' ' ' LEU 0.399 11.1 tp -143.83 128.77 18.47 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 102.416 -3.179 . . . . 0.0 102.416 179.872 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 87.1 m -146.45 121.88 10.34 Favored 'General case' 0 CA--C 1.487 -1.461 0 N-CA-C 103.691 -2.707 . . . . 0.0 103.691 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -166.0 -146.49 4.84 Favored Glycine 0 C--N 1.297 -1.638 0 C-N-CA 114.576 -3.678 . . . . 0.0 110.949 -179.615 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 72.5 p -152.27 171.35 18.11 Favored 'General case' 0 CA--C 1.472 -2.048 0 O-C-N 125.632 1.431 . . . . 0.0 107.494 -179.646 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' TRP . . . . . 0.489 ' CE3' ' N ' ' A' ' 91' ' ' GLY . 24.2 m95 -125.03 139.72 53.55 Favored 'General case' 0 N--CA 1.429 -1.524 0 N-CA-C 103.703 -2.703 . . . . 0.0 103.703 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 10.1 t -147.32 149.44 32.83 Favored 'General case' 0 C--O 1.256 1.409 0 C-N-CA 119.051 -1.059 . . . . 0.0 111.445 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.8 130.04 34.93 Favored 'General case' 0 CA--C 1.494 -1.192 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 -179.715 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . 0.538 0.0 OUTLIER -110.41 60.26 0.61 Allowed 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 -179.854 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 73.07 -95.1 0.72 Allowed Glycine 0 N--CA 1.429 -1.817 0 CA-C-N 112.41 -2.177 . . . . 0.0 107.731 -179.804 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -94.66 12.33 28.07 Favored 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 115.151 1.537 . . . . 0.0 115.151 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . 0.404 4.2 mptt -140.28 175.7 9.38 Favored 'General case' 0 C--O 1.21 -1.013 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.474 ' HA ' HD23 ' A' ' 89' ' ' LEU . 0.3 OUTLIER -125.13 141.88 51.83 Favored 'General case' 0 CA--C 1.548 0.898 0 N-CA-C 101.578 -3.49 . . . . 0.0 101.578 -180.0 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 104' ' ' ALA . 7.6 p -133.82 119.73 33.9 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 O-C-N 125.505 1.753 . . . . 0.0 110.691 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.489 ' N ' ' CE3' ' A' ' 82' ' ' TRP . . . -93.31 103.07 2.99 Favored Glycine 0 N--CA 1.474 1.198 0 C-N-CA 127.532 2.492 . . . . 0.0 108.294 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -97.61 154.2 17.7 Favored 'General case' 0 CA--C 1.502 -0.895 0 N-CA-C 103.944 -2.613 . . . . 0.0 103.944 179.808 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.503 ' HB2' HD23 ' A' ' 102' ' ' LEU . 91.6 m-85 -151.54 118.47 5.84 Favored 'General case' 0 CA--C 1.502 -0.899 0 O-C-N 125.12 1.513 . . . . 0.0 111.253 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 25.0 mttm -93.76 152.29 19.03 Favored 'General case' 0 C--O 1.21 -0.986 0 CA-C-O 123.741 1.734 . . . . 0.0 107.669 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . 0.368 0.5 OUTLIER -115.62 121.8 43.69 Favored 'General case' 0 CA--C 1.488 -1.414 0 CA-C-N 114.983 -1.008 . . . . 0.0 108.953 179.914 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.669 HG22 ' CB ' ' A' ' 77' ' ' GLU . 23.4 m -62.52 -27.79 43.49 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 CA-C-O 125.264 2.459 . . . . 0.0 113.338 179.756 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . 0.31 2.4 m-20 -61.56 -10.17 7.48 Favored 'General case' 0 C--O 1.246 0.902 0 CA-C-N 113.55 -1.659 . . . . 0.0 113.34 179.715 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -169.89 15.28 0.02 OUTLIER 'General case' 0 N--CA 1.433 -1.287 0 N-CA-C 115.636 1.717 . . . . 0.0 115.636 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 55.13 21.22 24.29 Favored Glycine 0 CA--C 1.523 0.547 0 CA-C-O 123.635 1.686 . . . . 0.0 113.572 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp -78.25 -170.88 2.16 Favored 'General case' 0 C--O 1.199 -1.572 0 O-C-N 120.225 -1.75 . . . . 0.0 106.697 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -135.77 159.76 40.66 Favored 'General case' 0 CA--C 1.5 -0.971 0 O-C-N 127.808 3.193 . . . . 0.0 110.164 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.664 HD11 ' HD1' ' A' ' 117' ' ' TYR . 0.2 OUTLIER -146.22 149.58 34.19 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 131.648 3.979 . . . . 0.0 104.007 179.541 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.754 HD13 ' N ' ' A' ' 104' ' ' ALA . 0.0 OUTLIER -143.34 162.12 16.78 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.994 0 N-CA-C 106.657 -1.609 . . . . 0.0 106.657 -179.723 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.754 ' N ' HD13 ' A' ' 103' ' ' ILE . . . -149.67 143.57 25.58 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-O 114.965 -2.445 . . . . 0.0 106.567 179.52 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.453 HG12 ' OG1' ' A' ' 116' ' ' THR . 2.9 p -126.24 105.52 14.53 Favored 'Isoleucine or valine' 0 C--O 1.257 1.466 0 CA-C-N 121.647 2.021 . . . . 0.0 108.15 -179.825 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.537 HH22 ' HZ ' ' A' ' 62' ' ' PHE . 63.6 mtt180 -67.79 90.29 0.28 Allowed 'General case' 0 CA--C 1.502 -0.883 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -83.69 78.57 9.67 Favored 'General case' 0 N--CA 1.433 -1.282 0 N-CA-C 116.639 2.089 . . . . 0.0 116.639 179.753 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.78 ' CG1' HD12 ' A' ' 113' ' ' LEU . 0.8 OUTLIER -68.52 101.33 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 C-N-CA 113.784 -3.167 . . . . 0.0 108.882 179.742 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.26 -29.78 69.5 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 114.199 -1.364 . . . . 0.0 107.536 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 154.01 -71.89 0.27 Allowed Glycine 0 C--O 1.243 0.715 1 C-N-CA 130.723 4.011 . . . . 0.0 111.583 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . 0.362 6.9 m120 -97.71 3.27 50.23 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 115.497 -2.192 . . . . 0.0 110.418 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -133.15 118.73 19.02 Favored 'General case' 0 CA--C 1.502 -0.867 0 O-C-N 128.005 3.315 . . . . 0.0 114.098 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.78 HD12 ' CG1' ' A' ' 108' ' ' ILE . 0.9 OUTLIER -97.29 94.22 6.97 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 103.214 -2.884 . . . . 0.0 103.214 179.821 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.501 HG12 HG23 ' A' ' 127' ' ' ILE . 77.2 mt -91.17 143.82 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.114 0 N-CA-C 103.419 -2.808 . . . . 0.0 103.419 179.655 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -132.8 108.17 8.81 Favored 'General case' 0 CA--C 1.49 -1.361 0 O-C-N 124.741 1.276 . . . . 0.0 109.136 -179.484 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.453 ' OG1' HG12 ' A' ' 105' ' ' VAL . 20.3 p -72.33 173.8 8.2 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 105.371 -2.085 . . . . 0.0 105.371 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.664 ' HD1' HD11 ' A' ' 102' ' ' LEU . 8.0 m-85 -162.78 114.38 1.54 Allowed 'General case' 0 CA--C 1.477 -1.847 0 CA-C-O 117.192 -1.385 . . . . 0.0 113.734 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . 0.264 1.2 m -126.57 122.3 34.72 Favored 'General case' 0 N--CA 1.424 -1.766 0 O-C-N 127.267 2.854 . . . . 0.0 110.961 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.555 ' CG ' ' HE3' ' A' ' 20' ' ' LYS . 1.4 t80 -85.85 -25.2 26.37 Favored 'General case' 0 N--CA 1.476 0.831 0 O-C-N 126.49 2.369 . . . . 0.0 107.064 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -161.97 -75.14 0.05 Allowed 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 112.522 -2.126 . . . . 0.0 113.573 -179.767 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -139.74 25.57 2.69 Favored Glycine 0 CA--C 1.537 1.463 0 N-CA-C 120.408 2.923 . . . . 0.0 120.408 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 22.0 t -133.02 102.87 5.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 105.219 -2.141 . . . . 0.0 105.219 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -75.94 165.69 24.61 Favored 'General case' 0 C--O 1.206 -1.195 0 CA-C-O 124.344 2.021 . . . . 0.0 108.82 -179.756 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.547 ' HB1' ' HA ' ' A' ' 14' ' ' TYR . . . -161.02 101.18 1.26 Allowed 'General case' 0 N--CA 1.435 -1.209 0 CA-C-O 114.488 -2.673 . . . . 0.0 107.854 -179.822 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.44 ' HB2' ' HB2' ' A' ' 12' ' ' GLU 0.288 5.3 mptt -77.95 146.03 35.72 Favored 'General case' 0 N--CA 1.449 -0.513 0 O-C-N 127.228 2.83 . . . . 0.0 110.519 179.738 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.45 ' NH2' HD13 ' A' ' 36' ' ' LEU . 0.0 OUTLIER -133.18 83.03 2.03 Favored 'General case' 0 C--O 1.212 -0.919 0 CA-C-O 114.955 -2.45 . . . . 0.0 106.845 179.823 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.501 HG23 HG12 ' A' ' 114' ' ' ILE . 1.9 mm -74.15 104.14 2.69 Favored 'Isoleucine or valine' 0 C--O 1.25 1.097 1 O-C-N 131.042 5.213 . . . . 0.0 117.381 179.808 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.712 ' CE2' HD22 ' A' ' 38' ' ' LEU . 0.7 OUTLIER -94.98 140.85 29.38 Favored 'General case' 0 CA--C 1.516 -0.361 0 O-C-N 124.565 1.166 . . . . 0.0 108.463 -179.813 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.427 ' HE3' ' HD2' ' A' ' 10' ' ' ARG . 27.7 mmtt -102.88 9.11 39.03 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-O 116.444 -1.741 . . . . 0.0 110.848 179.705 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.524 ' HD2' ' CH2' ' A' ' 6' ' ' TRP . 2.8 tttt 64.32 110.69 0.03 OUTLIER 'General case' 0 C--O 1.237 0.407 0 O-C-N 124.99 1.431 . . . . 0.0 113.67 -179.788 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . 0.746 1.9 mt-10 . . . . . 0 N--CA 1.438 -1.068 0 C-N-CA 118.422 -1.311 . . . . 0.0 114.066 -179.728 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' PLM . . . . . 0.811 ' H21' HG11 ' A' ' 60' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.589 ' HB1' ' CD1' ' A' ' 2' ' ' PHE . . . . . . . . 0 C--O 1.214 -0.806 0 CA-C-O 119.311 -0.376 . . . . 0.0 111.953 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.589 ' CD1' ' HB1' ' A' ' 1' ' ' ALA . 0.8 OUTLIER 49.1 54.22 11.29 Favored 'General case' 0 N--CA 1.442 -0.872 0 N-CA-C 114.239 1.2 . . . . 0.0 114.239 -179.787 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -158.91 90.54 0.99 Allowed 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 114.03 -1.441 . . . . 0.0 112.395 -179.562 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 142.0 174.72 14.86 Favored Glycine 0 N--CA 1.439 -1.155 0 C-N-CA 114.477 -3.725 . . . . 0.0 114.459 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.601 ' HA ' ' HA ' ' A' ' 39' ' ' THR 0.705 3.3 t -58.3 151.86 18.67 Favored 'General case' 0 C--N 1.319 -0.734 0 O-C-N 127.169 2.335 . . . . 0.0 111.181 -179.664 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.714 ' HH2' HD11 ' A' ' 108' ' ' ILE . 92.2 m95 -147.51 93.35 2.21 Favored 'General case' 0 N--CA 1.429 -1.515 0 O-C-N 127.945 3.278 . . . . 0.0 105.774 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 15.3 tttt -99.76 100.13 11.04 Favored 'General case' 0 CA--C 1.505 -0.785 0 CA-C-O 116.986 -1.483 . . . . 0.0 111.158 -179.825 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.51 ' HA ' ' HA ' ' A' ' 128' ' ' PHE 0.305 2.2 p -45.71 131.8 2.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 117.402 -1.285 . . . . 0.0 112.36 -179.745 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -133.64 -38.61 0.91 Allowed 'General case' 0 N--CA 1.445 -0.678 0 O-C-N 126.886 2.616 . . . . 0.0 111.476 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.465 ' HB2' ' CG1' ' A' ' 127' ' ' ILE . 0.2 OUTLIER -81.83 -69.71 0.6 Allowed 'General case' 0 N--CA 1.432 -1.329 0 C-N-CA 119.048 -1.061 . . . . 0.0 112.771 -179.587 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 71.56 146.92 0.07 Allowed 'General case' 0 C--O 1.245 0.826 0 O-C-N 125.817 1.948 . . . . 0.0 107.182 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.411 ' O ' ' N ' ' A' ' 125' ' ' LYS . 0.4 OUTLIER -156.65 147.36 21.7 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 115.807 -2.044 . . . . 0.0 107.901 -179.363 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.7 t30 46.07 27.08 0.48 Allowed 'General case' 0 N--CA 1.478 0.96 0 O-C-N 125.124 1.515 . . . . 0.0 113.065 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.563 ' CE1' ' HB1' ' A' ' 32' ' ' ALA . 10.7 p90 -81.52 -34.08 31.42 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 118.508 2.781 . . . . 0.0 118.508 -179.382 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -72.75 -39.93 66.44 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-N 120.445 1.475 . . . . 0.0 110.16 179.563 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.53 -34.84 76.57 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 125.17 2.414 . . . . 0.0 113.218 -179.757 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.731 ' CB ' ' HB2' ' A' ' 124' ' ' ALA . 0.2 OUTLIER -68.58 -28.05 66.6 Favored 'General case' 0 N--CA 1.431 -1.381 0 O-C-N 119.022 -2.298 . . . . 0.0 110.945 -179.981 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 1.5 mmt -77.3 -31.25 54.62 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 179.703 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -77.92 -20.71 52.35 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 126.484 3.04 . . . . 0.0 109.744 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 42.4 tptt -78.29 -39.92 38.41 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 112.686 -2.052 . . . . 0.0 108.93 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.46 ' HG3' ' CE1' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -73.18 -20.88 60.8 Favored 'General case' 0 CA--C 1.511 -0.556 0 O-C-N 119.552 -1.968 . . . . 0.0 108.273 179.92 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 97.96 46.73 2.2 Favored Glycine 0 N--CA 1.434 -1.488 0 CA-C-O 114.168 -3.573 . . . . 0.0 110.937 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.472 HG22 ' N ' ' A' ' 24' ' ' ASN . 2.1 mm -93.6 176.8 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 O-C-N 129.269 3.57 . . . . 0.0 106.319 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.472 ' N ' HG22 ' A' ' 23' ' ' ILE . 2.8 m-80 -113.43 -178.61 3.42 Favored 'General case' 0 C--N 1.348 0.519 0 CA-C-O 115.156 -2.354 . . . . 0.0 110.849 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . 0.347 0.6 OUTLIER -55.91 -49.23 76.31 Favored 'Isoleucine or valine' 0 C--N 1.352 0.716 0 O-C-N 128.606 3.691 . . . . 0.0 113.659 179.605 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.65 1.1 m -74.11 -41.89 51.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 O-C-N 127.056 2.722 . . . . 0.0 116.108 -179.702 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.457 ' HB3' HG23 ' A' ' 23' ' ' ILE . 2.6 mtmp? -66.2 -34.46 78.08 Favored 'General case' 0 CA--C 1.507 -0.695 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 -179.706 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.426 ' CG ' HH11 ' A' ' 28' ' ' ARG . 0.0 OUTLIER -79.94 -27.56 39.81 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 125.361 2.505 . . . . 0.0 108.524 179.777 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.3 tmmm? -71.08 -52.92 16.65 Favored 'General case' 0 C--N 1.353 0.743 0 O-C-N 119.64 -1.912 . . . . 0.0 110.237 -179.538 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 34.5 mt -72.65 -28.93 63.03 Favored 'General case' 0 N--CA 1.445 -0.698 0 O-C-N 120.247 -1.533 . . . . 0.0 108.416 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -70.21 -31.29 69.07 Favored Glycine 0 CA--C 1.537 1.408 0 O-C-N 127.365 2.916 . . . . 0.0 110.169 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.563 ' HB1' ' CE1' ' A' ' 14' ' ' TYR . . . -72.65 -41.68 65.18 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 126.572 1.949 . . . . 0.0 113.586 -179.822 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -101.32 14.65 31.31 Favored 'General case' 0 N--CA 1.437 -1.107 0 O-C-N 126.845 2.591 . . . . 0.0 110.555 -179.589 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 14.6 p30 -41.17 -27.47 0.07 Allowed 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 120.009 3.337 . . . . 0.0 120.009 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . 0.274 20.7 m-80 74.35 35.32 0.73 Allowed 'General case' 0 C--O 1.235 0.337 0 O-C-N 123.938 0.774 . . . . 0.0 109.477 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.715 HD11 HD13 ' A' ' 38' ' ' LEU . 2.9 tt -59.44 137.93 57.84 Favored 'General case' 0 N--CA 1.479 0.986 0 O-C-N 125.22 1.575 . . . . 0.0 110.501 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 6.6 ttmt -134.41 87.77 2.39 Favored 'General case' 0 N--CA 1.435 -1.194 0 N-CA-C 106.176 -1.787 . . . . 0.0 106.176 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.715 HD13 HD11 ' A' ' 36' ' ' LEU 0.315 0.0 OUTLIER -72.15 135.87 46.32 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 103.087 -2.931 . . . . 0.0 103.087 179.809 . . . . . . . . 4 4 . 1 . 014 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.601 ' HA ' ' HA ' ' A' ' 5' ' ' THR . 3.7 m -102.44 -18.62 15.28 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 121.939 2.154 . . . . 0.0 110.272 -178.921 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.45 HG12 HG23 ' A' ' 49' ' ' VAL . 3.7 mm 40.97 116.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 CA-C-O 126.667 3.127 . . . . 0.0 114.536 179.491 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.611 ' HB ' HG23 ' A' ' 48' ' ' THR . 5.8 m -118.69 109.94 16.7 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 112.479 -2.146 . . . . 0.0 113.611 179.297 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.482 ' NE2' ' CE2' ' A' ' 47' ' ' PHE . 3.8 tp-100 -103.41 77.73 1.54 Allowed 'General case' 0 N--CA 1.444 -0.774 0 O-C-N 123.635 0.584 . . . . 0.0 109.734 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -65.44 -45.05 85.31 Favored 'General case' 0 N--CA 1.426 -1.663 0 CA-C-O 123.391 1.567 . . . . 0.0 110.296 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 163.6 82.1 0.04 OUTLIER Glycine 0 N--CA 1.44 -1.053 0 N-CA-C 105.839 -2.904 . . . . 0.0 105.839 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.354 75.2 m-20 90.77 -33.52 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.727 0 O-C-N 125.364 1.273 . . . . 0.0 108.495 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 18.7 tttt -93.28 128.58 39.34 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 119.256 -2.152 . . . . 0.0 106.74 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.482 ' CE2' ' NE2' ' A' ' 42' ' ' GLN . 3.0 m-85 -113.47 97.85 6.71 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 124.948 1.299 . . . . 0.0 107.601 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.611 HG23 ' HB ' ' A' ' 41' ' ' THR 0.375 5.1 t -93.68 102.36 14.52 Favored 'General case' 0 N--CA 1.432 -1.349 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 179.922 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.548 HG21 ' HG ' ' A' ' 38' ' ' LEU 0.622 0.8 OUTLIER -84.91 104.96 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.818 0 N-CA-C 118.089 2.626 . . . . 0.0 118.089 -179.433 . . . . . . . . 4 4 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.546 ' HB3' ' HB ' ' A' ' 39' ' ' THR . 0.0 OUTLIER -64.19 158.43 23.1 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 100.974 -3.713 . . . . 0.0 100.974 178.638 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.408 ' O ' ' N ' ' A' ' 53' ' ' SER 0.3 68.8 tt0 -144.16 53.93 1.28 Allowed 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 103.857 -2.646 . . . . 0.0 103.857 179.993 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -70.9 81.43 0.64 Allowed 'General case' 0 N--CA 1.425 -1.709 0 C-N-CA 118.41 -1.316 . . . . 0.0 109.004 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.408 ' N ' ' O ' ' A' ' 51' ' ' GLU . 1.2 m -111.67 -141.72 0.38 Allowed 'General case' 0 CA--C 1.505 -0.778 0 O-C-N 126.612 2.445 . . . . 0.0 110.428 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -94.27 -7.48 41.87 Favored 'General case' 0 C--O 1.211 -0.924 0 CA-C-N 120.865 1.666 . . . . 0.0 108.066 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.568 ' CZ ' ' HF2' ' A' ' 132' ' ' PLM . 46.1 m-85 -97.82 -71.66 0.68 Allowed 'General case' 0 N--CA 1.437 -1.087 0 CA-C-O 116.247 -1.835 . . . . 0.0 113.958 -179.758 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.52 ' HG2' ' C ' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -153.02 144.45 23.3 Favored 'General case' 0 C--O 1.254 1.327 0 CA-C-N 123.883 3.038 . . . . 0.0 109.712 -179.195 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -93.69 74.96 4.33 Favored 'General case' 0 C--O 1.219 -0.543 0 N-CA-C 102.269 -3.234 . . . . 0.0 102.269 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.465 ' O ' HG23 ' A' ' 60' ' ' VAL . 0.7 OUTLIER -99.61 114.3 37.41 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 O-C-N 127.733 3.146 . . . . 0.0 114.483 179.811 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -62.19 117.71 6.42 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 104.793 -2.299 . . . . 0.0 104.793 179.354 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.638 HG12 ' CE2' ' A' ' 62' ' ' PHE . 92.4 t -99.36 77.04 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.59 1.181 . . . . 0.0 109.003 -178.73 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.597 ' HA ' ' HA ' ' A' ' 48' ' ' THR 0.339 1.2 m -71.18 138.45 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.333 0 O-C-N 117.852 -3.03 . . . . 0.0 115.858 179.92 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.638 ' CE2' HG12 ' A' ' 60' ' ' VAL . 0.2 OUTLIER -156.36 92.2 1.31 Allowed 'General case' 0 N--CA 1.444 -0.772 0 O-C-N 118.991 -2.318 . . . . 0.0 109.717 -179.976 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -57.82 142.38 45.92 Favored 'General case' 0 C--O 1.244 0.775 0 N-CA-C 106.58 -1.637 . . . . 0.0 106.58 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.1 mt -65.08 122.69 17.62 Favored 'General case' 0 N--CA 1.443 -0.822 0 C-N-CA 118.063 -1.455 . . . . 0.0 111.056 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 75.02 9.89 83.98 Favored Glycine 0 N--CA 1.47 0.933 0 N-CA-C 119.863 2.705 . . . . 0.0 119.863 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.401 HG12 ' N ' ' A' ' 67' ' ' ASP 0.425 7.2 t -80.88 -97.69 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.213 0 O-C-N 121.416 -1.049 . . . . 0.0 110.396 -179.97 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.401 ' N ' HG12 ' A' ' 66' ' ' VAL 0.259 21.2 t70 157.82 145.86 0.01 OUTLIER 'General case' 0 CA--C 1.497 -1.088 0 CA-C-O 117.533 -1.222 . . . . 0.0 109.927 179.831 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.502 ' CZ ' ' HB3' ' A' ' 62' ' ' PHE . 0.2 OUTLIER -164.87 164.95 20.81 Favored 'General case' 0 N--CA 1.423 -1.798 0 C-N-CA 119.237 -0.985 . . . . 0.0 110.186 179.98 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -113.75 122.76 48.08 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -123.7 118.34 27.0 Favored 'General case' 0 N--CA 1.439 -0.975 0 O-C-N 121.383 -0.823 . . . . 0.0 110.835 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 2.5 p -81.41 126.29 31.45 Favored 'General case' 0 CA--C 1.496 -1.124 0 CA-C-N 120.047 1.294 . . . . 0.0 108.936 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -78.69 -171.37 2.5 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 104.251 -2.5 . . . . 0.0 104.251 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -114.1 25.38 11.18 Favored 'General case' 0 N--CA 1.436 -1.138 0 CA-C-O 124.117 1.913 . . . . 0.0 112.995 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.479 ' HB3' ' CG ' ' A' ' 132' ' ' PLM . 0.2 OUTLIER -153.34 -35.17 0.11 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 119.664 -1.898 . . . . 0.0 112.969 -179.844 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.507 ' O ' HG22 ' A' ' 76' ' ' THR . . . -126.66 -12.89 3.2 Favored Glycine 0 CA--C 1.543 1.786 0 C-N-CA 125.375 1.464 . . . . 0.0 113.215 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.507 HG22 ' O ' ' A' ' 75' ' ' GLY 0.328 0.4 OUTLIER 69.13 171.07 0.3 Allowed 'General case' 0 CA--C 1.492 -1.27 0 C-N-CA 115.987 -2.285 . . . . 0.0 115.436 -179.734 . . . . . . . . 4 4 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 26.21 109.6 0.0 OUTLIER 'General case' 0 N--CA 1.436 -1.129 1 O-C-N 129.423 4.202 . . . . 0.0 116.956 179.547 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.56 HD21 ' CD1' ' A' ' 93' ' ' PHE 0.363 0.4 OUTLIER -146.46 121.11 9.81 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 101.988 -3.338 . . . . 0.0 101.988 -179.889 . . . . . . . . 4 4 . 1 . 014 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 55.1 m -129.41 154.67 46.71 Favored 'General case' 0 C--O 1.198 -1.625 0 N-CA-C 106.002 -1.851 . . . . 0.0 106.002 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 169.97 -159.08 31.53 Favored Glycine 0 N--CA 1.439 -1.125 0 CA-C-O 118.076 -1.402 . . . . 0.0 110.715 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -148.04 167.69 24.28 Favored 'General case' 0 CA--C 1.492 -1.278 0 C-N-CA 117.252 -1.779 . . . . 0.0 109.992 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' TRP . . . . . 0.486 ' CE3' ' CA ' ' A' ' 91' ' ' GLY 0.271 63.1 m95 -121.66 138.12 54.47 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 101.693 -3.447 . . . . 0.0 101.693 179.934 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 12.4 t -140.97 140.85 34.44 Favored 'General case' 0 N--CA 1.426 -1.64 0 CA-C-O 123.516 1.627 . . . . 0.0 107.885 -179.747 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.632 ' HA ' HD23 ' A' ' 89' ' ' LEU . 3.6 ttm -85.21 133.91 34.17 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 104.616 -2.364 . . . . 0.0 104.616 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . 0.649 1.5 mm-40 -105.51 18.55 22.04 Favored 'General case' 0 N--CA 1.428 -1.574 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 93.69 -64.03 1.85 Allowed Glycine 0 N--CA 1.427 -1.911 0 N-CA-C 105.85 -2.9 . . . . 0.0 105.85 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -101.57 -7.67 22.55 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 117.683 2.475 . . . . 0.0 117.683 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . 0.358 6.6 mtmt -162.32 132.07 4.55 Favored 'General case' 0 CA--C 1.489 -1.398 0 O-C-N 127.096 2.747 . . . . 0.0 109.284 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.632 HD23 ' HA ' ' A' ' 84' ' ' MET . 0.0 OUTLIER -75.73 121.9 23.22 Favored 'General case' 0 C--N 1.309 -1.188 0 O-C-N 126.639 2.462 . . . . 0.0 104.988 179.766 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.495 HG12 HG23 ' A' ' 105' ' ' VAL . 18.1 m -116.54 135.95 55.17 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 N-CA-C 105.698 -1.964 . . . . 0.0 105.698 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.486 ' CA ' ' CE3' ' A' ' 82' ' ' TRP . . . -115.44 118.45 4.28 Favored Glycine 0 CA--C 1.537 1.427 0 C-N-CA 126.525 2.012 . . . . 0.0 109.005 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 3.4 mtmm -112.3 147.34 36.52 Favored 'General case' 0 N--CA 1.432 -1.327 0 N-CA-C 103.569 -2.752 . . . . 0.0 103.569 179.693 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.56 ' CD1' HD21 ' A' ' 78' ' ' LEU . 55.2 m-85 -146.18 116.5 7.48 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 114.654 -1.157 . . . . 0.0 112.667 179.702 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.401 ' HE2' ' HB3' ' A' ' 94' ' ' LYS . 44.2 mtpt -88.53 -171.11 3.2 Favored 'General case' 0 N--CA 1.433 -1.295 0 C-N-CA 127.298 2.239 . . . . 0.0 108.146 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . 0.359 1.3 ttt180 -149.12 134.7 18.63 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 106.138 -1.801 . . . . 0.0 106.138 -179.712 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.492 HG23 ' N ' ' A' ' 97' ' ' ASP . 17.0 m -57.73 -38.31 64.35 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 CA-C-O 123.809 1.766 . . . . 0.0 113.321 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.492 ' N ' HG23 ' A' ' 96' ' ' VAL 0.366 96.3 m-20 -76.09 7.08 4.45 Favored 'General case' 0 C--O 1.253 1.277 0 CA-C-N 112.531 -2.122 . . . . 0.0 116.191 179.931 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 38.1 p30 -161.33 -17.92 0.05 OUTLIER 'General case' 0 N--CA 1.421 -1.898 0 N-CA-C 116.957 2.206 . . . . 0.0 116.957 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 58.24 19.21 38.48 Favored Glycine 0 C--O 1.228 -0.274 0 CA-C-O 124.737 2.298 . . . . 0.0 114.476 -179.753 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 9.7 mmtm -78.0 -103.59 0.02 OUTLIER 'General case' 0 C--O 1.199 -1.597 0 O-C-N 120.037 -1.86 . . . . 0.0 111.322 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 167.65 167.94 0.03 OUTLIER 'General case' 0 N--CA 1.438 -1.043 0 C-N-CA 130.058 3.343 . . . . 0.0 110.603 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.504 HD23 ' N ' ' A' ' 103' ' ' ILE . 9.4 tt -153.91 154.27 33.56 Favored 'General case' 0 C--O 1.242 0.676 0 C-N-CA 131.693 3.997 . . . . 0.0 104.55 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.549 ' CG2' ' HB ' ' A' ' 118' ' ' THR . 13.4 tt -141.85 160.18 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.328 0 C-N-CA 116.469 -2.092 . . . . 0.0 110.277 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.422 ' N ' ' CG1' ' A' ' 103' ' ' ILE . . . -149.53 111.84 4.69 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 179.797 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.495 HG23 HG12 ' A' ' 90' ' ' VAL . 2.4 p -102.65 105.88 18.96 Favored 'Isoleucine or valine' 0 C--O 1.244 0.782 0 CA-C-O 124.824 2.249 . . . . 0.0 112.068 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.423 ' CG ' ' HG2' ' A' ' 115' ' ' GLN 0.26 78.4 mtt180 -79.23 93.08 5.18 Favored 'General case' 0 N--CA 1.428 -1.573 0 CA-C-N 112.181 -2.281 . . . . 0.0 106.127 -179.848 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 21.2 pt-20 -101.5 82.73 2.34 Favored 'General case' 0 N--CA 1.425 -1.677 0 O-C-N 127.581 3.051 . . . . 0.0 110.339 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.714 HD11 ' HH2' ' A' ' 6' ' ' TRP 0.391 4.4 tt -60.89 129.2 23.28 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.984 0 C-N-CA 114.485 -2.886 . . . . 0.0 114.999 -179.827 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.2 t -125.76 76.04 1.54 Allowed 'General case' 0 C--O 1.215 -0.733 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 179.778 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 80.55 -89.94 1.33 Allowed Glycine 0 CA--C 1.501 -0.822 0 C-N-CA 126.134 1.826 . . . . 0.0 112.636 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . 0.374 0.4 OUTLIER -116.32 22.79 12.59 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 115.785 -2.055 . . . . 0.0 110.456 -179.793 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -132.54 119.86 21.09 Favored 'General case' 0 C--O 1.211 -0.935 0 O-C-N 128.4 3.562 . . . . 0.0 110.933 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.493 ' HB2' ' CH2' ' A' ' 6' ' ' TRP . 0.9 OUTLIER -95.55 59.71 2.14 Favored 'General case' 0 CA--C 1.501 -0.933 0 O-C-N 128.725 3.766 . . . . 0.0 107.969 -179.647 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.578 ' CG1' HD13 ' A' ' 127' ' ' ILE 0.262 1.4 mp -51.81 127.0 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.762 0 O-C-N 125.508 1.755 . . . . 0.0 108.335 -179.621 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.614 HE21 ' HZ ' ' A' ' 128' ' ' PHE . 28.0 mt-30 -124.72 134.29 52.89 Favored 'General case' 0 C--O 1.246 0.904 0 N-CA-C 103.14 -2.911 . . . . 0.0 103.14 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.48 HG22 ' HE2' ' A' ' 125' ' ' LYS . 29.5 p -97.46 178.74 5.1 Favored 'General case' 0 N--CA 1.433 -1.279 0 O-C-N 128.304 3.503 . . . . 0.0 108.192 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.954 ' HB2' ' HB3' ' A' ' 124' ' ' ALA . 19.1 m-85 -146.77 97.92 2.98 Favored 'General case' 0 CA--C 1.497 -1.086 0 CA-C-O 114.481 -2.676 . . . . 0.0 112.06 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.549 ' HB ' ' CG2' ' A' ' 103' ' ' ILE . 0.3 OUTLIER -116.2 94.75 4.78 Favored 'General case' 0 C--O 1.254 1.325 1 O-C-N 129.386 4.179 . . . . 0.0 112.868 179.76 . . . . . . . . 4 4 . 1 . 014 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.493 ' HA ' ' HA ' ' A' ' 102' ' ' LEU . 59.8 t80 -72.42 -14.09 61.61 Favored 'General case' 0 C--N 1.346 0.446 0 CA-C-O 122.472 1.13 . . . . 0.0 108.557 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -179.63 -81.29 0.0 OUTLIER 'General case' 0 C--N 1.292 -1.915 0 CA-C-N 113.747 -1.57 . . . . 0.0 113.379 -179.705 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -128.07 28.15 4.41 Favored Glycine 0 C--N 1.366 2.207 0 C-N-CA 126.579 2.037 . . . . 0.0 116.745 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 5.2 t -140.89 92.79 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -64.82 178.86 0.73 Allowed 'General case' 0 N--CA 1.428 -1.573 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.954 ' HB3' ' HB2' ' A' ' 117' ' ' TYR . . . -171.54 101.57 0.19 Allowed 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 103.778 -2.675 . . . . 0.0 103.778 179.79 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.48 ' HE2' HG22 ' A' ' 116' ' ' THR . 0.0 OUTLIER -80.02 147.52 31.49 Favored 'General case' 0 C--O 1.244 0.811 0 O-C-N 126.802 2.563 . . . . 0.0 109.76 -179.882 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -137.7 78.64 1.7 Allowed 'General case' 0 C--O 1.214 -0.786 0 O-C-N 126.726 2.516 . . . . 0.0 104.863 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.578 HD13 ' CG1' ' A' ' 114' ' ' ILE . 5.5 mm -67.45 107.42 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.755 1 O-C-N 129.558 4.286 . . . . 0.0 113.526 -179.758 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.614 ' HZ ' HE21 ' A' ' 115' ' ' GLN . 0.3 OUTLIER -99.74 151.03 21.7 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 179.348 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . 0.276 3.5 mmtt -115.83 44.28 1.94 Allowed 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.542 ' HB2' ' CZ3' ' A' ' 6' ' ' TRP . 23.9 tttm 32.32 86.85 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 126.686 1.994 . . . . 0.0 115.205 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . 0.733 0.5 OUTLIER . . . . . 0 N--CA 1.435 -1.224 0 CA-C-O 116.683 -1.627 . . . . 0.0 114.85 -179.679 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' PLM . . . . . 0.568 ' HF2' ' CZ ' ' A' ' 55' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.514 -0.42 0 CA-C-O 122.47 1.128 . . . . 0.0 110.122 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -83.37 70.94 10.27 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 116.376 -2.13 . . . . 0.0 112.94 179.83 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -154.6 100.72 2.27 Favored 'General case' 0 CA--C 1.491 -1.289 0 CA-C-O 127.465 3.507 . . . . 0.0 112.185 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 159.11 -168.1 35.05 Favored Glycine 0 CA--C 1.499 -0.952 0 C-N-CA 116.506 -2.759 . . . . 0.0 110.905 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.435 ' HB ' ' HA ' ' A' ' 39' ' ' THR 0.506 0.4 OUTLIER -97.28 164.88 12.29 Favored 'General case' 0 CA--C 1.493 -1.227 0 CA-C-N 117.062 0.431 . . . . 0.0 111.755 -179.891 . . . . . . . . 4 4 . 1 . 015 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.63 ' CE3' ' HA ' ' A' ' 130' ' ' LYS 0.274 90.8 m95 -152.25 121.26 6.63 Favored 'General case' 0 N--CA 1.426 -1.639 0 O-C-N 127.027 2.704 . . . . 0.0 107.922 179.765 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 13.6 ttpt -124.82 97.87 5.46 Favored 'General case' 0 C--O 1.205 -1.274 0 CA-C-O 115.275 -2.297 . . . . 0.0 105.815 179.723 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.509 ' HA ' ' HA ' ' A' ' 128' ' ' PHE . 0.4 OUTLIER -38.65 138.64 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 O-C-N 126.309 2.256 . . . . 0.0 111.043 -179.987 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -137.34 16.42 2.97 Favored 'General case' 0 C--O 1.209 -1.067 0 O-C-N 126.109 2.13 . . . . 0.0 108.231 -179.659 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 171.13 135.39 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.439 0 CA-C-O 121.391 0.615 . . . . 0.0 110.159 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -118.86 -169.11 1.67 Allowed 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 116.928 -1.511 . . . . 0.0 107.869 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.414 ' HB3' ' HB2' ' A' ' 125' ' ' LYS . 2.3 tp10 -145.83 -45.91 0.21 Allowed 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 120.786 1.63 . . . . 0.0 109.285 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 38.4 t30 -123.3 7.97 9.08 Favored 'General case' 0 N--CA 1.476 0.841 0 O-C-N 125.842 1.964 . . . . 0.0 114.535 179.725 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.54 ' CD2' ' HD3' ' A' ' 126' ' ' ARG . 32.4 t80 -57.03 -28.52 62.58 Favored 'General case' 0 N--CA 1.434 -1.244 0 CA-C-N 112.666 -2.061 . . . . 0.0 114.854 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -71.47 -38.19 71.26 Favored 'General case' 0 C--O 1.212 -0.92 0 CA-C-O 123.062 1.411 . . . . 0.0 109.721 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 3.0 ttmm -76.66 -26.84 55.28 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-O 123.203 1.477 . . . . 0.0 112.217 179.625 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.588 ' HA ' HG11 ' A' ' 122' ' ' VAL . 2.4 t80 -73.37 -23.06 60.15 Favored 'General case' 0 C--O 1.241 0.611 0 O-C-N 119.09 -2.256 . . . . 0.0 111.779 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.411 ' HB3' HG13 ' A' ' 23' ' ' ILE . 1.1 mmt -75.87 -30.28 58.82 Favored 'General case' 0 C--N 1.317 -0.829 1 O-C-N 116.299 -4.001 . . . . 0.0 107.154 179.656 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -68.3 -33.6 74.62 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 119.747 -1.846 . . . . 0.0 112.41 -179.726 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 5.1 tptt -75.41 -31.86 60.54 Favored 'General case' 0 C--O 1.215 -0.748 0 CA-C-N 114.786 -1.097 . . . . 0.0 110.297 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.521 ' CE ' HH12 ' A' ' 95' ' ' ARG . 0.5 OUTLIER -78.47 -20.3 51.22 Favored 'General case' 0 C--O 1.214 -0.804 0 O-C-N 125.543 1.777 . . . . 0.0 108.039 179.776 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 94.36 65.59 1.02 Allowed Glycine 0 C--N 1.302 -1.308 0 CA-C-O 116.865 -2.075 . . . . 0.0 109.598 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.627 HG23 ' HG2' ' A' ' 27' ' ' LYS . 2.1 mm -120.25 157.49 22.8 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 O-C-N 125.021 1.071 . . . . 0.0 109.432 -179.586 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -113.18 165.77 12.08 Favored 'General case' 0 C--O 1.246 0.92 0 O-C-N 124.846 1.341 . . . . 0.0 112.077 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . 0.375 0.0 OUTLIER -23.01 -61.02 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.501 -0.923 0 N-CA-C 120.833 3.642 . . . . 0.0 120.833 179.925 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.615 57.8 t -78.45 -38.55 22.76 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.751 0 CA-C-O 122.629 1.204 . . . . 0.0 112.796 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.627 ' HG2' HG23 ' A' ' 23' ' ' ILE . 0.1 OUTLIER -64.35 -37.28 86.97 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-N 113.523 -1.671 . . . . 0.0 113.798 -179.819 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.492 ' HA ' HG21 ' A' ' 23' ' ' ILE . 15.9 ptt85 -77.94 -22.67 49.21 Favored 'General case' 0 C--O 1.22 -0.47 0 O-C-N 119.486 -2.008 . . . . 0.0 109.639 179.715 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 16.7 tttp -74.16 -37.29 64.03 Favored 'General case' 0 C--N 1.35 0.61 0 CA-C-N 113.543 -1.662 . . . . 0.0 113.707 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.5 mt -69.8 -34.48 73.77 Favored 'General case' 0 N--CA 1.436 -1.139 0 C-N-CA 125.757 1.623 . . . . 0.0 111.305 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -77.32 -25.2 64.09 Favored Glycine 0 C--N 1.339 0.715 0 O-C-N 126.344 2.277 . . . . 0.0 111.31 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -75.11 -40.39 59.95 Favored 'General case' 0 C--O 1.22 -0.449 0 O-C-N 120.894 -1.357 . . . . 0.0 111.829 -179.772 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -98.27 9.74 42.3 Favored 'General case' 0 CA--C 1.51 -0.581 0 O-C-N 128.958 3.911 . . . . 0.0 110.821 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 36.5 p30 -47.6 -29.33 2.83 Favored 'General case' 0 CA--C 1.505 -0.782 0 N-CA-C 120.679 3.585 . . . . 0.0 120.679 179.574 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . 0.288 11.2 m-20 73.98 30.56 1.27 Allowed 'General case' 0 C--O 1.243 0.753 0 CA-C-N 120.77 1.623 . . . . 0.0 110.72 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.634 HD11 HD13 ' A' ' 38' ' ' LEU . 9.6 tp -49.86 109.76 0.32 Allowed 'General case' 0 C--N 1.354 0.777 0 C-N-CA 126.435 1.894 . . . . 0.0 108.578 -179.811 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 7.7 ttmm -108.86 102.79 11.78 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 104.664 -2.347 . . . . 0.0 104.664 179.783 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.634 HD13 HD11 ' A' ' 36' ' ' LEU 0.26 0.1 OUTLIER -88.57 109.44 20.08 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.907 . . . . . . . . 4 4 . 1 . 015 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.483 ' HB ' ' CB ' ' A' ' 50' ' ' LYS . 13.6 m -95.16 93.99 7.66 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 104.505 -2.405 . . . . 0.0 104.505 -179.849 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 21.0 mt -75.99 120.02 25.12 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.213 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 179.579 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.421 ' O ' HG22 ' A' ' 41' ' ' THR . 2.6 m -124.97 100.85 6.78 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 111.78 -2.464 . . . . 0.0 109.655 179.625 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -74.05 162.91 28.53 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-O 116.488 -1.72 . . . . 0.0 111.017 -179.735 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -151.09 -133.79 0.06 Allowed 'General case' 0 N--CA 1.424 -1.745 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -86.47 70.93 2.88 Favored Glycine 0 C--N 1.302 -1.315 0 N-CA-C 104.729 -3.348 . . . . 0.0 104.729 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 81.24 -8.38 1.4 Allowed 'General case' 0 C--O 1.216 -0.659 0 O-C-N 124.777 0.928 . . . . 0.0 111.756 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.465 ' HE2' ' HB ' ' A' ' 61' ' ' VAL . 13.4 tttt -98.31 125.77 43.55 Favored 'General case' 0 C--O 1.25 1.093 0 C-N-CA 118.456 -1.298 . . . . 0.0 108.915 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . 0.261 0.7 OUTLIER -103.92 107.37 18.22 Favored 'General case' 0 N--CA 1.446 -0.654 0 O-C-N 125.983 2.052 . . . . 0.0 111.451 -179.955 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 48' ' ' THR . . . . . 1.039 ' HB ' HG12 ' A' ' 61' ' ' VAL 0.425 0.1 OUTLIER -94.68 131.04 40.91 Favored 'General case' 0 CA--C 1.493 -1.243 0 O-C-N 125.589 1.805 . . . . 0.0 108.332 179.891 . . . . . . . . 4 4 . 1 . 015 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.599 HG21 ' HG ' ' A' ' 38' ' ' LEU 0.644 0.3 OUTLIER -111.43 98.31 6.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 CA-C-N 113.353 -1.749 . . . . 0.0 112.233 -179.762 . . . . . . . . 4 4 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.483 ' CB ' ' HB ' ' A' ' 39' ' ' THR . 0.6 OUTLIER -65.8 119.67 11.65 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 102.47 -3.159 . . . . 0.0 102.47 -179.941 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -113.94 85.91 2.31 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 124.475 2.083 . . . . 0.0 106.527 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 43.0 m -88.79 63.0 6.67 Favored 'General case' 0 N--CA 1.419 -2.004 0 CA-C-N 113.221 -1.809 . . . . 0.0 106.801 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -77.39 170.32 16.75 Favored 'General case' 0 C--O 1.216 -0.692 0 C-N-CA 115.933 -2.307 . . . . 0.0 111.219 -179.747 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -58.61 -20.85 50.91 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 117.838 -1.545 . . . . 0.0 108.333 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.531 ' CE1' ' HE2' ' A' ' 132' ' ' PLM . 11.1 m-85 -85.48 -60.73 1.94 Allowed 'General case' 0 N--CA 1.44 -0.944 0 CA-C-O 114.007 -2.901 . . . . 0.0 110.391 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.7 ' HB2' HG22 ' A' ' 58' ' ' ILE . 66.6 mtp85 -133.95 176.87 8.19 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 124.416 3.28 . . . . 0.0 110.46 -179.643 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -138.76 59.02 1.64 Allowed 'General case' 0 C--O 1.215 -0.728 2 C-N-CA 132.002 4.121 . . . . 0.0 100.081 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.7 HG22 ' HB2' ' A' ' 56' ' ' ARG . 1.5 tt -84.18 -44.18 17.87 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 1 C-N-CA 132.688 4.395 . . . . 0.0 119.772 -178.695 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . 0.277 34.2 t0 78.55 140.33 0.07 Allowed 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 104.073 -2.565 . . . . 0.0 104.073 -176.878 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.401 HG21 ' C2 ' ' A' ' 132' ' ' PLM . 58.0 t -112.39 -53.59 5.22 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.152 0 C-N-CA 118.527 -1.269 . . . . 0.0 112.627 -178.245 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 1.039 HG12 ' HB ' ' A' ' 48' ' ' THR 0.398 0.9 OUTLIER 66.97 131.52 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 CA-C-O 126.272 2.939 . . . . 0.0 109.016 -178.907 . . . . . . . . 4 4 . 1 . 015 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.556 ' CD2' ' CD1' ' A' ' 82' ' ' TRP . 12.5 p90 -164.03 93.76 0.72 Allowed 'General case' 0 N--CA 1.443 -0.817 0 O-C-N 117.05 -3.531 . . . . 0.0 110.334 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.418 ' HA ' ' HA ' ' A' ' 46' ' ' LYS . 27.3 mt-10 -65.59 136.63 56.6 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 105.644 -1.984 . . . . 0.0 105.644 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -50.88 121.86 6.59 Favored 'General case' 0 N--CA 1.437 -1.091 0 O-C-N 125.505 1.753 . . . . 0.0 110.691 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 79.98 3.59 89.43 Favored Glycine 0 C--N 1.35 1.336 0 CA-C-N 112.424 -2.171 . . . . 0.0 117.805 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . 0.378 79.4 t -106.03 97.48 5.67 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 N-CA-C 104.612 -2.366 . . . . 0.0 104.612 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -63.0 177.12 0.61 Allowed 'General case' 0 CA--C 1.484 -1.578 0 C-N-CA 117.584 -1.646 . . . . 0.0 114.605 -179.466 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.488 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 1.1 p90 -155.98 172.21 18.77 Favored 'General case' 0 N--CA 1.433 -1.304 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.627 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -115.3 140.91 48.7 Favored 'General case' 0 C--N 1.322 -0.609 0 O-C-N 126.858 2.599 . . . . 0.0 105.851 179.7 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 13.4 t80 -152.65 112.13 3.89 Favored 'General case' 0 C--O 1.206 -1.19 0 CA-C-N 120.525 1.511 . . . . 0.0 114.024 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.5 p -81.79 144.41 31.09 Favored 'General case' 0 C--N 1.315 -0.909 0 O-C-N 119.147 -2.221 . . . . 0.0 105.448 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 10.5 mp -102.28 -175.17 2.75 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 124.592 1.183 . . . . 0.0 108.465 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.432 ' HB3' ' HD2' ' A' ' 132' ' ' PLM . . . -90.94 -13.39 33.56 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.135 0.974 . . . . 0.0 111.94 -179.762 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.808 ' HB3' ' HG1' ' A' ' 132' ' ' PLM . 0.3 OUTLIER -79.63 -11.15 59.88 Favored 'General case' 0 N--CA 1.439 -0.998 0 C-N-CA 119.308 -0.957 . . . . 0.0 110.751 -179.549 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 102.93 22.83 9.03 Favored Glycine 0 C--O 1.204 -1.777 0 O-C-N 125.528 1.768 . . . . 0.0 111.733 -179.769 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -129.24 155.15 46.01 Favored 'General case' 0 CA--C 1.491 -1.309 0 C-N-CA 117.782 -1.567 . . . . 0.0 112.786 -179.788 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.471 ' CB ' ' HB ' ' A' ' 96' ' ' VAL . 32.1 mp0 -92.41 155.92 17.55 Favored 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 127.572 2.349 . . . . 0.0 112.646 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.572 HD11 ' CG ' ' A' ' 93' ' ' PHE 0.429 0.6 OUTLIER -156.41 153.43 28.87 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 105.264 -2.125 . . . . 0.0 105.264 -179.912 . . . . . . . . 4 4 . 1 . 015 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.404 ' O ' ' N ' ' A' ' 94' ' ' LYS . 64.2 m -157.67 139.21 13.81 Favored 'General case' 0 C--O 1.197 -1.669 0 N-CA-C 102.884 -3.006 . . . . 0.0 102.884 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 174.81 -172.15 45.2 Favored Glycine 0 C--N 1.293 -1.839 0 C-N-CA 114.116 -3.897 . . . . 0.0 114.759 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 76.3 p -132.88 169.09 17.27 Favored 'General case' 0 C--O 1.187 -2.19 0 CA-C-N 120.563 2.182 . . . . 0.0 109.252 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' TRP . . . . . 0.556 ' CD1' ' CD2' ' A' ' 62' ' ' PHE . 69.7 m95 -127.1 140.15 52.48 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 102.37 -3.196 . . . . 0.0 102.37 179.693 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 8.8 t -146.45 142.93 28.62 Favored 'General case' 0 C--O 1.255 1.366 0 CA-C-O 123.803 1.764 . . . . 0.0 109.994 179.79 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 2.0 ttm -81.24 99.67 8.72 Favored 'General case' 0 N--CA 1.425 -1.72 0 CA-C-N 111.111 -2.768 . . . . 0.0 109.584 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . 0.601 29.0 mm-40 -65.61 -104.19 0.0 OUTLIER 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 119.666 1.121 . . . . 0.0 113.248 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -137.39 93.92 0.22 Allowed Glycine 0 N--CA 1.436 -1.337 1 N-CA-C 102.932 -4.067 . . . . 0.0 102.932 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 58.34 21.17 8.01 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 113.191 0.811 . . . . 0.0 113.191 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . 0.33 7.1 mtmt -149.93 112.66 4.78 Favored 'General case' 0 CA--C 1.492 -1.267 0 O-C-N 126.395 2.309 . . . . 0.0 112.326 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.582 HD12 ' HD2' ' A' ' 106' ' ' ARG . 0.0 OUTLIER -75.98 130.63 38.73 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 102.478 -3.156 . . . . 0.0 102.478 179.908 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.51 ' HB ' HD11 ' A' ' 103' ' ' ILE . 5.4 m -129.03 136.3 60.02 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.932 0 CA-C-O 116.86 -1.543 . . . . 0.0 108.78 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -112.39 106.75 1.94 Allowed Glycine 0 CA--C 1.539 1.578 0 O-C-N 126.958 2.662 . . . . 0.0 112.86 179.524 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 8.0 mtpt -93.46 113.08 25.13 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 102.734 -3.061 . . . . 0.0 102.734 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.599 ' HD2' HD22 ' A' ' 102' ' ' LEU . 19.1 m-85 -104.46 96.93 6.94 Favored 'General case' 0 CA--C 1.502 -0.902 0 O-C-N 125.906 2.004 . . . . 0.0 114.492 -179.747 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.404 ' N ' ' O ' ' A' ' 79' ' ' THR . 39.1 mttt -80.04 127.48 32.34 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 126.541 1.936 . . . . 0.0 108.923 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.521 HH12 ' CE ' ' A' ' 21' ' ' MET 0.336 0.0 OUTLIER -72.71 144.32 47.71 Favored 'General case' 0 CA--C 1.502 -0.872 0 N-CA-C 104.434 -2.432 . . . . 0.0 104.434 -179.833 . . . . . . . . 4 4 . 1 . 015 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.471 ' HB ' ' CB ' ' A' ' 77' ' ' GLU . 17.4 t -77.09 -33.66 20.67 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 C-N-CA 125.895 1.678 . . . . 0.0 112.248 -179.782 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . 0.262 0.0 OUTLIER -95.73 -27.88 15.05 Favored 'General case' 0 C--O 1.254 1.294 0 N-CA-C 115.05 1.5 . . . . 0.0 115.05 -179.867 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -89.7 -25.07 21.39 Favored 'General case' 0 N--CA 1.419 -2.013 0 CA-C-N 114.623 -1.171 . . . . 0.0 113.702 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 64.97 10.24 45.11 Favored Glycine 0 CA--C 1.536 1.363 0 O-C-N 127.149 2.781 . . . . 0.0 113.826 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 73.1 mttt -103.26 159.01 15.93 Favored 'General case' 0 C--O 1.197 -1.662 0 N-CA-C 107.629 -1.248 . . . . 0.0 107.629 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -95.27 158.91 15.25 Favored 'General case' 0 N--CA 1.431 -1.382 0 O-C-N 126.442 2.339 . . . . 0.0 116.001 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.599 HD22 ' HD2' ' A' ' 93' ' ' PHE . 5.0 tt -138.57 145.71 40.94 Favored 'General case' 0 C--N 1.326 -0.418 1 O-C-N 129.826 4.454 . . . . 0.0 104.477 179.569 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.583 ' N ' HD23 ' A' ' 102' ' ' LEU . 3.5 tp -127.39 152.85 35.93 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.071 0 N-CA-C 104.379 -2.452 . . . . 0.0 104.379 -179.435 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -134.76 132.79 39.17 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 114.119 -2.848 . . . . 0.0 106.26 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.677 HG12 ' OG1' ' A' ' 116' ' ' THR . 10.7 p -120.19 103.65 14.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 O-C-N 125.612 1.82 . . . . 0.0 113.77 -179.383 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.582 ' HD2' HD12 ' A' ' 89' ' ' LEU 0.269 36.2 mtt85 -74.6 89.16 2.2 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 104.483 -2.414 . . . . 0.0 104.483 179.561 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -92.08 77.57 5.32 Favored 'General case' 0 N--CA 1.428 -1.571 0 O-C-N 127.041 2.713 . . . . 0.0 114.907 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.565 HD11 ' CH2' ' A' ' 6' ' ' TRP 0.326 0.0 OUTLIER -56.68 101.81 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 CA-C-O 123.274 1.511 . . . . 0.0 112.094 179.961 . . . . . . . . 4 4 . 1 . 015 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 61.4 m -88.19 71.06 9.26 Favored 'General case' 0 CA--C 1.502 -0.902 0 N-CA-C 104.569 -2.382 . . . . 0.0 104.569 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 66.59 -82.8 0.11 Allowed Glycine 0 C--N 1.344 1.02 0 C-N-CA 128.585 2.993 . . . . 0.0 111.743 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . 0.319 0.1 OUTLIER -98.73 -19.68 17.34 Favored 'General case' 0 C--O 1.221 -0.417 0 CA-C-O 117.651 -1.166 . . . . 0.0 111.911 -179.605 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.446 ' HG3' ' HA ' ' A' ' 129' ' ' LYS . 45.6 mp0 -105.86 127.93 53.43 Favored 'General case' 0 CA--C 1.498 -1.027 0 O-C-N 124.622 1.201 . . . . 0.0 112.175 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.479 HD23 ' CD1' ' A' ' 128' ' ' PHE . 2.0 tt -93.67 139.5 30.73 Favored 'General case' 0 C--O 1.211 -0.925 0 N-CA-C 100.208 -3.997 . . . . 0.0 100.208 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.527 HG23 HD12 ' A' ' 127' ' ' ILE . 68.5 mt -131.53 145.7 34.73 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 O-C-N 128.991 3.932 . . . . 0.0 103.776 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 9.1 mt-30 -134.52 129.9 35.81 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.677 ' OG1' HG12 ' A' ' 105' ' ' VAL . 24.3 p -101.65 -176.53 3.16 Favored 'General case' 0 C--O 1.249 1.035 0 O-C-N 126.703 2.502 . . . . 0.0 104.933 179.42 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.434 ' HB2' ' HB3' ' A' ' 124' ' ' ALA . 68.4 m-85 -160.56 87.07 0.74 Allowed 'General case' 0 CA--C 1.475 -1.939 0 CA-C-O 115.789 -2.053 . . . . 0.0 109.69 179.661 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.469 ' HB ' ' CG2' ' A' ' 103' ' ' ILE . 95.4 m -94.47 101.29 13.2 Favored 'General case' 0 N--CA 1.433 -1.294 0 O-C-N 128.247 3.467 . . . . 0.0 110.107 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.56 ' HA ' ' HA ' ' A' ' 102' ' ' LEU . 5.8 t80 -77.97 -77.65 0.15 Allowed 'General case' 0 CA--C 1.499 -0.983 0 O-C-N 125.816 1.948 . . . . 0.0 107.523 -179.742 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.457 ' HG3' ' CE2' ' A' ' 119' ' ' TYR . 1.5 mm-40 -108.44 -75.7 0.63 Allowed 'General case' 0 C--N 1.298 -1.642 0 CA-C-O 117.522 -1.228 . . . . 0.0 108.462 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -133.71 32.94 2.62 Favored Glycine 0 CA--C 1.528 0.863 0 O-C-N 127.776 3.172 . . . . 0.0 114.74 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.588 HG11 ' HA ' ' A' ' 17' ' ' PHE . 0.3 OUTLIER -139.59 122.35 17.4 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.68 0 O-C-N 119.789 -2.006 . . . . 0.0 110.477 -179.883 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -95.82 177.65 5.7 Favored 'General case' 0 N--CA 1.431 -1.402 0 O-C-N 120.522 -1.361 . . . . 0.0 107.825 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.521 ' HB2' ' CB ' ' A' ' 17' ' ' PHE . . . -169.76 77.16 0.09 Allowed 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 115.709 -2.396 . . . . 0.0 109.193 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.414 ' HB2' ' HB3' ' A' ' 12' ' ' GLU . 12.1 mptt -64.3 141.27 58.83 Favored 'General case' 0 C--O 1.251 1.142 0 CA-C-N 118.488 0.586 . . . . 0.0 109.541 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.54 ' HD3' ' CD2' ' A' ' 14' ' ' TYR . 14.3 mtm180 -137.58 83.1 1.96 Allowed 'General case' 0 CA--C 1.509 -0.623 0 O-C-N 127.315 2.884 . . . . 0.0 108.535 179.78 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.527 HD12 HG23 ' A' ' 114' ' ' ILE . 0.8 OUTLIER -74.84 119.31 22.15 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.788 1 O-C-N 129.79 4.432 . . . . 0.0 110.757 179.894 . . . . . . . . 4 4 . 1 . 015 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.509 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 0.1 OUTLIER -102.99 169.9 8.29 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 112.336 -2.211 . . . . 0.0 108.247 -180.0 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.446 ' HA ' ' HG3' ' A' ' 112' ' ' GLU . 0.0 OUTLIER -119.12 0.49 11.26 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 105.693 -1.965 . . . . 0.0 105.693 179.786 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.63 ' HA ' ' CE3' ' A' ' 6' ' ' TRP . 34.7 tttt 73.6 95.91 0.07 Allowed 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 120.684 1.583 . . . . 0.0 112.436 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . 0.854 3.8 mt-10 . . . . . 0 N--CA 1.435 -1.178 0 N-CA-C 117.523 2.416 . . . . 0.0 117.523 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' PLM . . . . . 0.808 ' HG1' ' HB3' ' A' ' 74' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 0.229 0 CA-C-O 116.888 -1.529 . . . . 0.0 110.122 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.518 ' CE1' HG12 ' A' ' 108' ' ' ILE . 97.3 m-85 -43.28 89.91 0.0 OUTLIER 'General case' 0 C--N 1.312 -1.062 0 O-C-N 126.082 2.114 . . . . 0.0 116.084 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -166.39 86.59 0.32 Allowed 'General case' 0 CA--C 1.494 -1.204 0 C-N-CA 117.985 -1.486 . . . . 0.0 112.686 -179.435 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 150.47 -130.02 3.11 Favored Glycine 0 C--N 1.31 -0.915 0 C-N-CA 116.503 -2.761 . . . . 0.0 112.114 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.449 ' HA ' ' HA ' ' A' ' 39' ' ' THR 0.625 0.8 OUTLIER -123.11 161.2 24.86 Favored 'General case' 0 N--CA 1.432 -1.339 0 CA-C-O 124.158 1.932 . . . . 0.0 112.014 -179.933 . . . . . . . . 4 4 . 1 . 016 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.596 ' CE3' ' HA ' ' A' ' 130' ' ' LYS 0.264 86.7 m95 -153.77 114.7 4.07 Favored 'General case' 0 N--CA 1.431 -1.393 0 CA-C-N 111.872 -2.422 . . . . 0.0 110.856 179.896 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 30.4 ttmt -109.56 108.45 18.91 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-O 115.174 -2.346 . . . . 0.0 107.057 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.534 HG12 ' HB3' ' A' ' 36' ' ' LEU 0.411 8.2 p -48.51 147.0 0.76 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.846 0 CA-C-N 121.202 1.819 . . . . 0.0 109.222 -179.964 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -157.28 14.09 0.25 Allowed 'General case' 0 CA--C 1.499 -0.996 0 C-N-CA 117.464 -1.695 . . . . 0.0 111.455 -179.126 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.27 -57.65 0.65 Allowed 'General case' 0 CA--C 1.487 -1.465 0 O-C-N 116.679 -3.763 . . . . 0.0 109.965 -179.684 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 59.74 170.91 0.08 Allowed 'General case' 0 C--O 1.244 0.778 0 O-C-N 127.529 3.018 . . . . 0.0 108.928 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.452 ' O ' ' N ' ' A' ' 125' ' ' LYS . 6.0 tt0 -170.43 134.51 1.14 Allowed 'General case' 0 C--N 1.3 -1.583 0 O-C-N 117.792 -3.068 . . . . 0.0 107.534 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.417 ' HB3' ' H ' ' A' ' 124' ' ' ALA . 2.1 t-20 62.67 29.78 16.87 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-N 122.563 2.438 . . . . 0.0 113.857 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . 0.348 9.3 t80 -98.11 -64.5 1.03 Allowed 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 121.201 3.778 . . . . 0.0 121.201 -178.702 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.09 -38.74 77.0 Favored 'General case' 0 CA--C 1.498 -1.049 0 CA-C-N 124.49 3.313 . . . . 0.0 113.792 -179.061 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.479 ' HB3' ' CD1' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -67.27 -43.23 82.35 Favored 'General case' 0 N--CA 1.422 -1.829 0 C-N-CA 127.643 2.377 . . . . 0.0 113.578 179.584 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.645 ' HB3' ' HB ' ' A' ' 122' ' ' VAL 0.266 64.8 m-85 -80.03 -20.1 46.11 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 111.188 -2.733 . . . . 0.0 113.557 -178.057 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.525 ' CB ' HG13 ' A' ' 23' ' ' ILE . 0.5 OUTLIER -72.21 -23.11 61.2 Favored 'General case' 0 N--CA 1.435 -1.22 0 O-C-N 117.035 -3.541 . . . . 0.0 105.983 176.591 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -74.24 -24.89 59.37 Favored 'General case' 0 C--N 1.348 0.528 0 O-C-N 120.378 -1.451 . . . . 0.0 109.849 179.676 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.487 ' CE ' HG12 ' A' ' 122' ' ' VAL . 11.3 tttp -79.1 -32.58 44.64 Favored 'General case' 0 N--CA 1.432 -1.367 0 CA-C-O 116.196 -1.859 . . . . 0.0 110.589 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.24 -23.5 57.54 Favored 'General case' 0 C--O 1.214 -0.814 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 179.312 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 104.25 40.89 2.17 Favored Glycine 0 N--CA 1.445 -0.714 0 CA-C-O 115.747 -2.696 . . . . 0.0 109.935 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.589 HG23 ' HB3' ' A' ' 27' ' ' LYS . 2.2 mm -86.99 83.44 2.19 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 CA-C-N 120.49 2.145 . . . . 0.0 106.994 -179.682 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -42.09 112.91 0.38 Allowed 'General case' 0 C--O 1.248 1.009 0 O-C-N 124.91 1.381 . . . . 0.0 114.357 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . 0.364 84.7 t 18.52 -66.73 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.502 -0.893 0 N-CA-C 121.066 3.728 . . . . 0.0 121.066 -179.784 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.538 1.3 m -71.52 -24.49 23.63 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.122 0 N-CA-C 117.448 2.388 . . . . 0.0 117.448 -179.531 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.589 ' HB3' HG23 ' A' ' 23' ' ' ILE . 1.5 mtmp? -72.04 -29.22 63.94 Favored 'General case' 0 C--N 1.318 -0.775 0 C-N-CA 119.072 -1.051 . . . . 0.0 112.993 179.759 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.49 ' N ' HG22 ' A' ' 23' ' ' ILE . 2.6 ptt-85 -78.49 -21.51 48.87 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 116.777 -1.969 . . . . 0.0 109.363 179.83 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 12.0 tttt -77.78 -43.21 31.38 Favored 'General case' 0 CA--C 1.502 -0.869 0 CA-C-N 113.553 -1.658 . . . . 0.0 109.924 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -79.02 -23.07 44.58 Favored 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 -179.729 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -76.68 -34.88 42.4 Favored Glycine 0 CA--C 1.527 0.793 0 O-C-N 125.613 1.821 . . . . 0.0 112.476 179.754 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -72.9 -38.61 66.87 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 6.5 m-70 -98.92 20.33 13.4 Favored 'General case' 0 N--CA 1.439 -0.99 0 O-C-N 127.377 2.923 . . . . 0.0 112.604 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 23.6 p30 -47.75 -31.52 4.91 Favored 'General case' 0 CA--C 1.497 -1.096 0 N-CA-C 119.347 3.091 . . . . 0.0 119.347 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . 0.309 0.6 OUTLIER 76.59 15.85 2.06 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 119.291 0.951 . . . . 0.0 109.264 -179.809 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.583 HD11 HD12 ' A' ' 38' ' ' LEU . 30.5 tp -42.1 114.84 0.6 Allowed 'General case' 0 CA--C 1.5 -0.946 0 C-N-CA 128.636 2.775 . . . . 0.0 110.249 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -116.76 94.64 4.68 Favored 'General case' 0 C--O 1.211 -0.967 0 N-CA-C 105.246 -2.131 . . . . 0.0 105.246 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.646 HD13 ' CZ ' ' A' ' 128' ' ' PHE 0.256 0.1 OUTLIER -79.8 105.28 10.97 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 179.73 . . . . . . . . 4 4 . 1 . 016 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.555 ' HB ' ' HB3' ' A' ' 50' ' ' LYS . 99.3 m -94.98 80.4 3.65 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 104.268 -2.493 . . . . 0.0 104.268 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.55 HG13 ' CD1' ' A' ' 6' ' ' TRP . 0.9 OUTLIER -60.23 134.99 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.371 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.331 179.977 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.3 m -128.45 108.19 10.35 Favored 'General case' 0 N--CA 1.475 0.81 0 O-C-N 128.043 3.34 . . . . 0.0 108.437 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -99.07 105.72 17.86 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 117.802 -1.094 . . . . 0.0 113.806 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -108.77 68.02 0.67 Allowed 'General case' 0 N--CA 1.424 -1.767 0 CA-C-O 126.756 3.17 . . . . 0.0 108.019 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 77.79 -108.55 2.63 Favored Glycine 0 C--N 1.293 -1.853 0 N-CA-C 106.956 -2.457 . . . . 0.0 106.956 179.754 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -102.38 48.3 0.87 Allowed 'General case' 0 N--CA 1.444 -0.735 0 CA-C-O 123.04 1.4 . . . . 0.0 110.456 179.688 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 3.1 ttmt -149.06 129.28 13.67 Favored 'General case' 0 C--N 1.312 -1.056 0 C-N-CA 116.479 -2.088 . . . . 0.0 107.657 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.409 ' CE2' HD11 ' A' ' 89' ' ' LEU . 11.0 m-85 -114.53 88.12 2.79 Favored 'General case' 0 CA--C 1.511 -0.557 0 CA-C-O 121.958 0.885 . . . . 0.0 110.117 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.658 ' OG1' HG12 ' A' ' 61' ' ' VAL 0.349 14.8 t -95.19 85.92 4.43 Favored 'General case' 0 N--CA 1.428 -1.543 0 CA-C-O 125.799 2.714 . . . . 0.0 108.789 -179.742 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.454 HG13 ' HE1' ' A' ' 62' ' ' PHE 0.654 1.0 OUTLIER -70.39 108.67 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.768 0 N-CA-C 117.758 2.503 . . . . 0.0 117.758 -179.948 . . . . . . . . 4 4 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.555 ' HB3' ' HB ' ' A' ' 39' ' ' THR . 15.9 tttp -69.55 117.46 11.18 Favored 'General case' 0 C--N 1.303 -1.416 1 N-CA-C 99.508 -4.256 . . . . 0.0 99.508 179.218 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.438 ' HG3' ' CD1' ' A' ' 36' ' ' LEU . 1.1 tt0 -112.67 104.96 13.03 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 -179.334 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -103.45 51.63 0.79 Allowed 'General case' 0 C--N 1.289 -2.049 0 N-CA-C 105.317 -2.105 . . . . 0.0 105.317 179.562 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 4.3 t -73.05 21.37 0.07 Allowed 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 113.175 -1.83 . . . . 0.0 115.474 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 73.79 -51.42 0.69 Allowed 'General case' 0 CA--C 1.498 -1.032 0 CA-C-N 122.245 2.293 . . . . 0.0 109.787 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -67.1 -44.33 80.25 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-O 115.119 -2.372 . . . . 0.0 110.209 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.518 ' HB2' HG22 ' A' ' 58' ' ' ILE . 9.3 ptp180 -149.56 126.17 10.99 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 123.633 2.924 . . . . 0.0 106.795 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -99.71 74.42 1.85 Allowed 'General case' 0 N--CA 1.465 0.291 1 N-CA-C 100.197 -4.001 . . . . 0.0 100.197 179.784 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.518 HG22 ' HB2' ' A' ' 56' ' ' ARG . 3.3 tp -115.94 117.83 56.8 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.82 1 C-N-CA 132.417 4.287 . . . . 0.0 118.9 -179.104 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.95 125.58 26.77 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 103.607 -2.738 . . . . 0.0 103.607 178.163 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 1.4 t -107.85 103.96 16.32 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 O-C-N 124.515 1.135 . . . . 0.0 113.217 -178.064 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.658 HG12 ' OG1' ' A' ' 48' ' ' THR 0.395 1.7 m -88.49 141.97 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.159 0 CA-C-O 125.091 2.377 . . . . 0.0 113.888 179.593 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.597 ' HB3' ' CE1' ' A' ' 68' ' ' PHE . 0.1 OUTLIER -160.75 95.64 1.1 Allowed 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 113.128 -1.851 . . . . 0.0 108.772 -179.833 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -54.49 144.57 20.8 Favored 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 104.772 -2.307 . . . . 0.0 104.772 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.636 ' H ' HD12 ' A' ' 64' ' ' LEU . 2.9 mp -68.89 115.7 8.51 Favored 'General case' 0 N--CA 1.432 -1.345 0 O-C-N 119.475 -2.015 . . . . 0.0 107.238 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 81.87 26.62 48.93 Favored Glycine 0 N--CA 1.471 0.971 0 C-N-CA 126.713 2.102 . . . . 0.0 118.172 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . 0.387 41.2 t -114.8 81.39 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 N-CA-C 104.662 -2.347 . . . . 0.0 104.662 179.849 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.435 ' HA ' ' CG2' ' A' ' 81' ' ' THR . 0.7 OUTLIER -38.43 114.08 0.34 Allowed 'General case' 0 C--N 1.307 -1.262 0 O-C-N 125.689 1.868 . . . . 0.0 114.437 -179.917 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.597 ' CE1' ' HB3' ' A' ' 62' ' ' PHE . 37.6 p90 -119.95 164.86 15.44 Favored 'General case' 0 N--CA 1.427 -1.598 0 O-C-N 125.18 1.55 . . . . 0.0 107.977 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -108.93 138.1 45.8 Favored 'General case' 0 C--N 1.319 -0.74 0 O-C-N 126.171 2.169 . . . . 0.0 106.997 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.801 ' O ' HD13 ' A' ' 72' ' ' LEU . 35.9 t80 -133.73 95.57 3.5 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 119.787 1.176 . . . . 0.0 111.248 -179.596 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.514 ' C ' HD22 ' A' ' 72' ' ' LEU . 1.9 p -72.26 79.22 0.99 Allowed 'General case' 0 N--CA 1.432 -1.36 0 CA-C-O 117.529 -1.224 . . . . 0.0 112.386 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.955 HD22 ' N ' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -40.06 175.75 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.813 1 O-C-N 130.355 4.785 . . . . 0.0 110.028 174.955 . . . . . . . . 4 4 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.59 ' HB3' ' HG2' ' A' ' 132' ' ' PLM . . . -83.52 -45.38 13.64 Favored 'General case' 0 C--N 1.351 0.671 0 O-C-N 120.522 -1.361 . . . . 0.0 113.613 -178.808 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.551 ' CB ' ' HD2' ' A' ' 27' ' ' LYS . 0.4 OUTLIER -148.96 25.74 0.91 Allowed 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 179.956 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.473 ' C ' ' HG ' ' A' ' 72' ' ' LEU . . . -95.03 -32.23 7.22 Favored Glycine 0 CA--C 1.544 1.874 0 CA-C-N 112.69 -2.05 . . . . 0.0 113.312 179.803 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.633 ' N ' ' HG ' ' A' ' 72' ' ' LEU 0.376 0.3 OUTLIER 84.76 117.82 0.04 OUTLIER 'General case' 0 C--N 1.305 -1.364 0 CA-C-O 114.465 -2.683 . . . . 0.0 107.175 -177.878 . . . . . . . . 4 4 . 1 . 016 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.713 ' N ' HD21 ' A' ' 72' ' ' LEU . 0.6 OUTLIER -3.9 120.29 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.63 1 O-C-N 130.134 4.646 . . . . 0.0 114.405 -179.412 . . . . . . . . 4 4 . 1 . 016 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.691 HD12 HD23 ' A' ' 102' ' ' LEU 0.518 0.5 OUTLIER -133.22 122.12 23.49 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 102.022 -3.325 . . . . 0.0 102.022 179.772 . . . . . . . . 4 4 . 1 . 016 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 10.7 t -137.59 123.35 19.96 Favored 'General case' 0 C--O 1.198 -1.637 0 N-CA-C 101.765 -3.421 . . . . 0.0 101.765 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -156.89 -149.31 5.36 Favored Glycine 0 C--N 1.308 -1.02 0 C-N-CA 116.921 -2.562 . . . . 0.0 110.419 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.435 ' CG2' ' HA ' ' A' ' 67' ' ' ASP . 22.1 p -155.32 165.79 35.57 Favored 'General case' 0 C--O 1.198 -1.607 0 CA-C-O 123.838 1.78 . . . . 0.0 109.037 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' TRP . . . . . 0.542 ' CZ2' ' CZ ' ' A' ' 106' ' ' ARG 0.322 12.2 m95 -112.71 129.46 56.4 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 100.772 -3.788 . . . . 0.0 100.772 -179.879 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.7 t -144.17 100.81 3.62 Favored 'General case' 0 C--O 1.262 1.716 0 O-C-N 121.218 -0.926 . . . . 0.0 110.254 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.482 ' CA ' HD23 ' A' ' 89' ' ' LEU . 6.4 ttp -52.58 112.93 0.91 Allowed 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 105.471 -2.048 . . . . 0.0 105.471 179.807 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . 0.622 3.8 mm-40 -77.8 -56.34 4.59 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 124.806 1.316 . . . . 0.0 110.07 -179.731 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 160.24 124.8 0.75 Allowed Glycine 0 C--O 1.22 -0.725 0 N-CA-C 103.402 -3.879 . . . . 0.0 103.402 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . 0.26 0.1 OUTLIER 55.97 15.64 1.82 Allowed 'General case' 0 C--O 1.245 0.832 0 CA-C-O 116.572 -1.68 . . . . 0.0 113.638 -179.986 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . 0.418 3.1 mppt? -174.12 150.26 1.53 Allowed 'General case' 0 CA--C 1.496 -1.101 0 O-C-N 125.772 1.92 . . . . 0.0 106.812 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.482 HD23 ' CA ' ' A' ' 84' ' ' MET . 0.7 OUTLIER -113.4 137.88 50.88 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 102.331 -3.211 . . . . 0.0 102.331 -179.879 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 18.5 m -118.24 134.37 62.08 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.028 0 N-CA-C 105.547 -2.02 . . . . 0.0 105.547 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.486 ' O ' ' HB3' ' A' ' 104' ' ' ALA . . . -113.65 95.09 0.73 Allowed Glycine 0 C--N 1.344 0.981 0 C-N-CA 128.164 2.792 . . . . 0.0 108.755 -179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.402 ' HA ' ' HA ' ' A' ' 103' ' ' ILE . 0.6 OUTLIER -90.83 168.64 11.57 Favored 'General case' 0 N--CA 1.436 -1.135 0 N-CA-C 104.323 -2.473 . . . . 0.0 104.323 179.963 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.581 ' HB3' ' HG ' ' A' ' 78' ' ' LEU . 23.5 m-85 -157.71 97.33 1.57 Allowed 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 118.454 -1.299 . . . . 0.0 108.063 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 14.5 mtmt -74.39 161.2 30.07 Favored 'General case' 0 N--CA 1.446 -0.653 0 O-C-N 125.125 1.516 . . . . 0.0 108.47 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.457 ' HD2' ' N ' ' A' ' 95' ' ' ARG 0.457 0.9 OUTLIER -119.47 139.98 51.2 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 179.69 . . . . . . . . 4 4 . 1 . 016 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.603 HG11 ' HG2' ' A' ' 77' ' ' GLU . 3.1 m -83.0 -13.38 12.04 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 179.792 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . 0.333 14.3 p-10 -79.13 3.93 16.16 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 113.504 -1.68 . . . . 0.0 112.361 179.801 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . 0.256 0.8 OUTLIER -174.93 -29.28 0.01 OUTLIER 'General case' 0 N--CA 1.426 -1.635 0 C-N-CA 117.698 -1.601 . . . . 0.0 114.069 -179.735 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 97.56 20.07 23.31 Favored Glycine 0 N--CA 1.445 -0.701 0 N-CA-C 115.21 0.844 . . . . 0.0 115.21 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 39.3 mttt -82.95 -159.79 0.36 Allowed 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 116.159 -2.216 . . . . 0.0 106.344 -179.745 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -143.0 148.67 37.17 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-O 117.23 -1.367 . . . . 0.0 109.889 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.691 HD23 HD12 ' A' ' 78' ' ' LEU . 0.3 OUTLIER -133.09 110.1 9.96 Favored 'General case' 0 CA--C 1.543 0.708 1 O-C-N 131.552 5.533 . . . . 0.0 103.217 179.212 . . . . . . . . 4 4 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.697 HD13 ' N ' ' A' ' 104' ' ' ALA . 0.0 OUTLIER -92.03 161.18 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.174 0 CA-C-N 114.181 -1.372 . . . . 0.0 111.003 -179.238 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.697 ' N ' HD13 ' A' ' 103' ' ' ILE . . . -150.15 106.38 3.47 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 116.152 -1.88 . . . . 0.0 107.376 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 9.2 p -87.8 103.65 13.71 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.519 0 CA-C-N 120.877 1.672 . . . . 0.0 113.587 -179.768 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.611 HH22 ' H32' ' A' ' 132' ' ' PLM . 19.2 mtt-85 -74.48 82.2 1.96 Allowed 'General case' 0 CA--C 1.507 -0.679 0 CA-C-O 124.872 2.273 . . . . 0.0 106.074 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.41 ' O ' ' N ' ' A' ' 109' ' ' SER . 0.2 OUTLIER -86.61 81.37 8.27 Favored 'General case' 0 N--CA 1.417 -2.078 0 CA-C-N 111.118 -2.765 . . . . 0.0 117.292 -179.989 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.518 HG12 ' CE1' ' A' ' 2' ' ' PHE . 1.9 mm -63.61 98.41 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 C-N-CA 116.106 -2.238 . . . . 0.0 107.287 179.081 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.41 ' N ' ' O ' ' A' ' 107' ' ' GLU . 2.1 p -62.9 -29.69 70.97 Favored 'General case' 0 C--N 1.319 -0.754 0 O-C-N 121.342 -0.849 . . . . 0.0 109.116 -179.272 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 145.77 -87.97 0.16 Allowed Glycine 0 CA--C 1.526 0.727 1 C-N-CA 131.965 4.602 . . . . 0.0 110.566 -179.304 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . 0.3 0.2 OUTLIER -81.76 -0.93 45.32 Favored 'General case' 0 C--O 1.212 -0.895 0 CA-C-O 113.794 -3.003 . . . . 0.0 110.137 179.235 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -136.61 118.69 15.4 Favored 'General case' 0 C--O 1.205 -1.245 1 O-C-N 129.751 4.407 . . . . 0.0 112.49 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.47 ' HG ' HG12 ' A' ' 108' ' ' ILE . 5.0 tt -91.66 141.1 29.06 Favored 'General case' 0 C--O 1.212 -0.898 0 N-CA-C 100.763 -3.791 . . . . 0.0 100.763 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 1.048 HD12 HD12 ' A' ' 127' ' ' ILE 0.309 14.3 mm -123.1 135.97 61.37 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 N-CA-C 102.55 -3.13 . . . . 0.0 102.55 179.666 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.451 ' HG3' ' CD2' ' A' ' 113' ' ' LEU . 13.5 mt-30 -131.94 95.25 3.65 Favored 'General case' 0 C--O 1.245 0.828 0 CA-C-O 115.425 -2.226 . . . . 0.0 105.385 -179.79 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 61.0 p -70.28 -171.51 0.47 Allowed 'General case' 0 C--N 1.318 -0.772 0 O-C-N 127.017 2.698 . . . . 0.0 106.425 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.466 ' N ' ' O ' ' A' ' 123' ' ' GLU . 12.3 m-85 -159.8 62.26 0.36 Allowed 'General case' 0 CA--C 1.494 -1.181 0 CA-C-O 115.735 -2.079 . . . . 0.0 106.781 179.785 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.515 ' HB ' HG22 ' A' ' 103' ' ' ILE . 0.3 OUTLIER -70.44 108.32 4.22 Favored 'General case' 0 C--O 1.254 1.295 0 O-C-N 126.885 2.616 . . . . 0.0 107.016 -179.171 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.564 ' H ' HG22 ' A' ' 122' ' ' VAL . 76.3 t80 -72.82 -35.77 67.37 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 103.827 -2.657 . . . . 0.0 103.827 -179.425 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -151.77 -66.88 0.17 Allowed 'General case' 0 C--N 1.291 -1.938 1 O-C-N 129.751 4.407 . . . . 0.0 108.074 179.866 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -145.14 27.58 1.86 Allowed Glycine 0 CA--C 1.544 1.892 0 C-N-CA 128.196 2.808 . . . . 0.0 112.881 178.545 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.645 ' HB ' ' HB3' ' A' ' 17' ' ' PHE . 1.7 m -106.77 6.86 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 CA-C-N 112.766 -1.717 . . . . 0.0 110.755 -178.237 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.466 ' O ' ' N ' ' A' ' 117' ' ' TYR . 26.4 tt0 12.71 -75.0 0.0 OUTLIER 'General case' 0 C--N 1.307 -1.275 0 O-C-N 129.007 3.942 . . . . 0.0 112.028 -179.639 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.46 ' HB3' ' O ' ' A' ' 123' ' ' GLU . . . 70.5 84.33 0.14 Allowed 'General case' 0 C--O 1.206 -1.21 0 O-C-N 116.669 -3.769 . . . . 0.0 109.08 178.793 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.452 ' N ' ' O ' ' A' ' 12' ' ' GLU . 6.0 mptt -79.7 136.76 36.86 Favored 'General case' 0 C--O 1.254 1.333 1 O-C-N 129.601 4.313 . . . . 0.0 110.027 179.97 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.499 ' NH2' HD22 ' A' ' 36' ' ' LEU . 3.2 mtm180 -126.49 77.81 1.73 Allowed 'General case' 0 N--CA 1.437 -1.096 0 O-C-N 125.574 1.796 . . . . 0.0 112.155 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 1.048 HD12 HD12 ' A' ' 114' ' ' ILE . 0.4 OUTLIER -73.96 108.37 5.39 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.922 0 O-C-N 126.362 2.289 . . . . 0.0 115.179 179.42 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.646 ' CZ ' HD13 ' A' ' 38' ' ' LEU . 28.7 m-85 -89.06 147.07 24.44 Favored 'General case' 0 N--CA 1.438 -1.064 0 C-N-CA 128.158 2.583 . . . . 0.0 111.215 179.812 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . 0.347 14.3 mtmt -100.15 8.45 43.86 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 117.733 -1.127 . . . . 0.0 110.392 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.596 ' HA ' ' CE3' ' A' ' 6' ' ' TRP . 9.7 tttm 69.53 153.68 0.11 Allowed 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . 0.835 61.1 tt0 . . . . . 0 CA--C 1.505 -0.785 0 N-CA-C 119.246 3.054 . . . . 0.0 119.246 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' PLM . . . . . 0.611 ' H32' HH22 ' A' ' 106' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.267 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.462 ' O ' HG21 ' A' ' 40' ' ' ILE . 0.1 OUTLIER -140.33 31.71 1.92 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 124.076 1.893 . . . . 0.0 114.08 -179.879 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -119.16 99.61 6.82 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 113.54 -1.664 . . . . 0.0 110.874 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.412 ' O ' ' N ' ' A' ' 40' ' ' ILE . . . 157.9 -148.6 18.22 Favored Glycine 0 C--O 1.208 -1.472 0 CA-C-N 112.748 -2.023 . . . . 0.0 110.437 179.658 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.429 HG23 ' HA ' ' A' ' 131' ' ' GLU 0.566 6.3 t -102.03 159.29 15.5 Favored 'General case' 0 N--CA 1.432 -1.334 0 CA-C-N 113.794 -1.203 . . . . 0.0 112.294 -179.84 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.701 ' CH2' HD11 ' A' ' 108' ' ' ILE . 96.0 m95 -146.5 112.26 5.65 Favored 'General case' 0 N--CA 1.441 -0.902 0 O-C-N 127.685 3.116 . . . . 0.0 111.161 179.806 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 11.8 ttmt -109.15 116.47 32.0 Favored 'General case' 0 C--O 1.207 -1.17 0 CA-C-N 121.548 1.976 . . . . 0.0 108.065 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.567 ' HB ' ' CD1' ' A' ' 128' ' ' PHE 0.289 1.5 p -57.62 128.47 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 O-C-N 119.04 -2.288 . . . . 0.0 114.897 179.986 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -107.93 -21.63 12.75 Favored 'General case' 0 C--O 1.213 -0.826 0 CA-C-O 126.201 2.905 . . . . 0.0 108.883 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.407 ' O ' ' N ' ' A' ' 127' ' ' ILE . 29.9 ptt-85 -163.79 146.56 9.69 Favored 'General case' 0 CA--C 1.478 -1.795 0 O-C-N 117.93 -2.982 . . . . 0.0 113.107 179.766 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . 0.413 0.8 OUTLIER -119.19 -176.13 3.07 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 112.919 -1.946 . . . . 0.0 107.018 179.927 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -145.79 -70.94 0.26 Allowed 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 122.194 2.27 . . . . 0.0 108.062 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.475 ' CG ' ' CE2' ' A' ' 17' ' ' PHE . 2.5 t-20 -92.87 39.19 1.03 Allowed 'General case' 0 N--CA 1.476 0.827 0 O-C-N 127.555 3.035 . . . . 0.0 111.91 179.542 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.467 ' HD1' ' HB1' ' A' ' 124' ' ' ALA 0.313 34.5 t80 -97.81 -57.98 2.1 Favored 'General case' 0 N--CA 1.439 -1.01 0 N-CA-C 121.267 3.802 . . . . 0.0 121.267 -179.379 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . 0.252 6.1 pm0 -56.5 -55.02 38.94 Favored 'General case' 0 CA--C 1.505 -0.757 0 CA-C-N 124.227 3.194 . . . . 0.0 114.186 -179.066 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.584 ' HB3' ' CE2' ' A' ' 17' ' ' PHE . 8.5 ttmt -55.04 -42.05 72.17 Favored 'General case' 0 N--CA 1.421 -1.923 0 C-N-CA 127.537 2.335 . . . . 0.0 115.616 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.589 ' HB3' ' HB ' ' A' ' 122' ' ' VAL 0.293 45.1 m-85 -77.58 -19.91 54.87 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 111.282 -2.69 . . . . 0.0 114.044 -177.28 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.529 ' O ' HG12 ' A' ' 23' ' ' ILE . 4.4 mmt -70.43 -20.04 62.94 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 118.812 -2.43 . . . . 0.0 105.88 175.738 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.71 -32.59 63.98 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-O 127.904 3.716 . . . . 0.0 109.837 179.775 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.885 ' HD3' HG11 ' A' ' 122' ' ' VAL . 0.5 OUTLIER -72.51 -30.11 64.2 Favored 'General case' 0 N--CA 1.454 -0.256 0 O-C-N 118.113 -2.867 . . . . 0.0 110.371 179.97 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.434 ' CE ' ' HG ' ' A' ' 72' ' ' LEU . 1.5 mmm -78.06 -28.04 48.77 Favored 'General case' 0 C--O 1.201 -1.481 0 C-N-CA 127.472 2.309 . . . . 0.0 107.768 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.62 22.0 6.57 Favored Glycine 0 C--N 1.299 -1.48 0 CA-C-O 114.598 -3.334 . . . . 0.0 111.678 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.529 HG12 ' O ' ' A' ' 18' ' ' MET . 23.9 mm -78.78 139.76 17.94 Favored 'Isoleucine or valine' 0 C--N 1.352 0.709 0 O-C-N 126.765 2.097 . . . . 0.0 106.507 -179.288 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -102.29 143.12 32.46 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-O 116.559 -1.686 . . . . 0.0 113.119 -179.64 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . 0.437 0.2 OUTLIER 3.35 -73.81 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.508 -0.658 0 N-CA-C 119.957 3.318 . . . . 0.0 119.957 179.962 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.646 1.8 t -65.84 -30.33 49.7 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.972 0 O-C-N 126.936 2.648 . . . . 0.0 116.634 -179.764 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.424 ' HB2' HG22 ' A' ' 23' ' ' ILE . 30.5 mtmt -73.37 -31.22 63.8 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 114.222 -1.354 . . . . 0.0 111.236 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.92 -25.86 40.38 Favored 'General case' 0 N--CA 1.473 0.715 0 O-C-N 120.46 -1.4 . . . . 0.0 107.998 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 15.8 ttpt -78.57 -43.23 27.06 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.893 -1.049 . . . . 0.0 111.456 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.4 mt -77.73 -30.86 51.87 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 118.959 -1.096 . . . . 0.0 110.382 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -71.74 -30.95 65.47 Favored Glycine 0 C--O 1.217 -0.931 0 O-C-N 125.329 1.643 . . . . 0.0 111.998 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -75.81 -25.74 56.62 Favored 'General case' 0 N--CA 1.439 -0.981 0 O-C-N 120.996 -1.296 . . . . 0.0 112.959 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -121.3 28.3 7.87 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 127.605 2.362 . . . . 0.0 115.001 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -66.84 -13.88 62.08 Favored 'General case' 0 C--O 1.218 -0.591 0 N-CA-C 117.406 2.372 . . . . 0.0 117.406 -179.809 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . 0.302 0.5 OUTLIER 70.25 26.86 4.25 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 121.063 1.756 . . . . 0.0 110.004 179.741 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.614 HD11 HD13 ' A' ' 38' ' ' LEU . 0.9 OUTLIER -45.34 114.1 0.69 Allowed 'General case' 0 CA--C 1.495 -1.148 0 O-C-N 127.405 2.941 . . . . 0.0 108.76 -179.739 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.554 ' N ' HD12 ' A' ' 36' ' ' LEU . 27.7 tttp -110.98 98.82 7.83 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 104.911 -2.255 . . . . 0.0 104.911 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.692 HD22 ' CE2' ' A' ' 128' ' ' PHE . 1.9 tp -79.87 139.92 36.96 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.564 ' HB ' ' CB ' ' A' ' 50' ' ' LYS . 47.3 m -131.16 82.45 2.04 Favored 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 103.189 -2.893 . . . . 0.0 103.189 179.741 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.693 HD13 HG23 ' A' ' 49' ' ' VAL . 2.4 mm -65.54 132.06 31.27 Favored 'Isoleucine or valine' 0 C--O 1.255 1.35 0 CA-C-N 112.482 -2.145 . . . . 0.0 111.116 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.485 HG22 ' O ' ' A' ' 41' ' ' THR . 13.3 m -139.76 92.29 2.55 Favored 'General case' 0 CA--C 1.501 -0.918 0 O-C-N 125.851 1.97 . . . . 0.0 112.108 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 54.8 tt0 -85.87 118.17 25.19 Favored 'General case' 0 C--O 1.243 0.745 0 CA-C-O 117.186 -1.388 . . . . 0.0 111.519 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -101.54 -109.39 0.22 Allowed 'General case' 0 CA--C 1.495 -1.166 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -112.22 76.33 0.23 Allowed Glycine 0 C--N 1.307 -1.038 0 N-CA-C 105.548 -3.021 . . . . 0.0 105.548 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.313 0.5 OUTLIER 89.62 -18.74 0.19 Allowed 'General case' 0 C--N 1.32 -0.678 0 O-C-N 128.345 3.026 . . . . 0.0 113.751 179.827 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.466 ' HA ' ' HA ' ' A' ' 63' ' ' GLU . 1.9 ttpm? -91.93 146.48 23.71 Favored 'General case' 0 N--CA 1.435 -1.199 0 C-N-CA 117.604 -1.638 . . . . 0.0 107.301 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . 0.28 4.4 m-85 -129.32 93.85 3.66 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-O 123.01 1.386 . . . . 0.0 108.94 179.803 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.982 ' HB ' HG12 ' A' ' 61' ' ' VAL 0.479 2.0 t -78.36 146.1 34.85 Favored 'General case' 0 CA--C 1.496 -1.101 0 CA-C-O 125.23 2.443 . . . . 0.0 107.949 179.739 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.693 HG23 HD13 ' A' ' 40' ' ' ILE 0.693 0.3 OUTLIER -120.68 95.75 3.78 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 CA-C-N 109.969 -3.287 . . . . 0.0 111.948 -179.981 . . . . . . . . 4 4 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.564 ' CB ' ' HB ' ' A' ' 39' ' ' THR . 0.9 OUTLIER -72.22 130.34 40.58 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 100.305 -3.961 . . . . 0.0 100.305 179.685 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.522 ' HG3' HD13 ' A' ' 36' ' ' LEU . 15.9 tt0 -123.52 66.99 1.01 Allowed 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 105.947 -1.871 . . . . 0.0 105.947 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 12.6 m -71.82 74.89 0.87 Allowed 'General case' 0 C--N 1.287 -2.11 0 CA-C-O 117.861 -1.066 . . . . 0.0 108.153 -179.816 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -103.6 -165.73 1.19 Allowed 'General case' 0 CA--C 1.506 -0.743 0 O-C-N 125.543 1.777 . . . . 0.0 112.777 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 62.5 t30 -70.77 -20.66 62.58 Favored 'General case' 0 N--CA 1.441 -0.882 0 O-C-N 123.979 0.799 . . . . 0.0 112.325 -179.703 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -87.26 -55.74 3.67 Favored 'General case' 0 C--O 1.22 -0.474 0 CA-C-O 115.071 -2.395 . . . . 0.0 112.258 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.75 176.61 12.15 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 124.496 3.316 . . . . 0.0 107.725 179.738 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -119.17 88.04 2.85 Favored 'General case' 0 C--O 1.216 -0.702 0 C-N-CA 131.466 3.906 . . . . 0.0 100.872 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -117.73 98.91 7.14 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.992 0 C-N-CA 129.041 2.936 . . . . 0.0 118.676 -179.511 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 19.3 p-10 -62.54 120.5 11.24 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 103.712 -2.699 . . . . 0.0 103.712 177.592 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.53 ' HB ' ' CZ ' ' A' ' 62' ' ' PHE . 2.8 t -83.91 -55.17 7.52 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 CA-C-O 125.42 2.533 . . . . 0.0 112.133 -177.466 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.982 HG12 ' HB ' ' A' ' 48' ' ' THR 0.349 0.7 OUTLIER 67.13 133.36 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.434 -1.252 0 O-C-N 120.046 -1.659 . . . . 0.0 114.034 -179.54 . . . . . . . . 4 4 . 1 . 017 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.604 ' CD2' ' CZ ' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -166.72 100.91 0.57 Allowed 'General case' 0 N--CA 1.428 -1.555 0 CA-C-O 116.989 -1.482 . . . . 0.0 111.427 179.493 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.466 ' HA ' ' HA ' ' A' ' 46' ' ' LYS . 30.1 mm-40 -54.35 142.48 26.55 Favored 'General case' 0 N--CA 1.429 -1.503 0 O-C-N 126.782 2.551 . . . . 0.0 105.726 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.1 mp -59.54 115.79 3.55 Favored 'General case' 0 N--CA 1.431 -1.389 0 CA-C-N 120.844 1.656 . . . . 0.0 111.43 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 83.08 33.76 22.75 Favored Glycine 0 C--N 1.34 0.782 0 O-C-N 128.433 3.583 . . . . 0.0 116.897 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . 0.426 2.2 t -117.1 92.42 2.12 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.53 ' HA ' HG22 ' A' ' 81' ' ' THR 0.269 0.2 OUTLIER -44.3 134.73 4.88 Favored 'General case' 0 CA--C 1.494 -1.194 0 O-C-N 124.898 1.374 . . . . 0.0 113.203 -179.948 . . . . . . . . 4 4 . 1 . 017 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.604 ' CZ ' ' CD2' ' A' ' 62' ' ' PHE . 11.7 p90 -132.46 170.18 15.49 Favored 'General case' 0 N--CA 1.439 -0.992 0 O-C-N 124.961 1.413 . . . . 0.0 108.14 -179.655 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -125.79 109.58 12.71 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 116.038 -1.934 . . . . 0.0 107.851 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 21.3 t80 -127.83 111.57 13.78 Favored 'General case' 0 C--N 1.319 -0.739 0 O-C-N 125.471 1.732 . . . . 0.0 112.876 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 8.2 t -79.95 156.32 27.29 Favored 'General case' 0 CA--C 1.487 -1.449 0 CA-C-N 119.239 0.927 . . . . 0.0 109.713 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.434 ' HG ' ' CE ' ' A' ' 21' ' ' MET . 4.0 mm? -81.22 -166.28 1.12 Allowed 'General case' 0 CA--C 1.503 -0.834 0 N-CA-C 103.874 -2.639 . . . . 0.0 103.874 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -87.85 -18.78 28.5 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 124.805 1.315 . . . . 0.0 112.491 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -84.57 -13.17 52.51 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 115.972 -2.291 . . . . 0.0 108.99 179.775 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 108.17 8.36 29.44 Favored Glycine 0 CA--C 1.542 1.768 0 CA-C-O 117.431 -1.761 . . . . 0.0 114.359 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . 0.278 7.5 m -89.83 125.57 35.37 Favored 'General case' 0 N--CA 1.433 -1.289 0 CA-C-N 119.397 1.599 . . . . 0.0 109.926 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.507 ' HG2' HG21 ' A' ' 96' ' ' VAL . 0.0 OUTLIER -66.64 169.48 7.72 Favored 'General case' 0 C--O 1.22 -0.466 0 O-C-N 128.013 3.321 . . . . 0.0 112.327 -179.989 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.486 ' HG ' ' HB3' ' A' ' 93' ' ' PHE 0.28 1.5 tt -153.08 142.44 21.64 Favored 'General case' 0 CA--C 1.503 -0.834 0 N-CA-C 102.512 -3.144 . . . . 0.0 102.512 179.777 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 19.0 p -144.94 111.79 5.86 Favored 'General case' 0 CA--C 1.491 -1.315 0 N-CA-C 102.729 -3.063 . . . . 0.0 102.729 -179.735 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -174.48 -167.45 33.93 Favored Glycine 0 C--N 1.301 -1.414 1 C-N-CA 113.058 -4.401 . . . . 0.0 114.414 -179.772 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.53 HG22 ' HA ' ' A' ' 67' ' ' ASP . 0.5 OUTLIER -144.89 176.32 9.56 Favored 'General case' 0 C--O 1.187 -2.229 0 CA-C-N 119.821 1.811 . . . . 0.0 111.725 -179.953 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 82' ' ' TRP . . . . . 0.421 ' CZ2' ' CE1' ' A' ' 62' ' ' PHE 0.311 13.7 m0 -116.85 154.32 30.96 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 106.244 -1.761 . . . . 0.0 106.244 -179.995 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.571 HG23 HG22 ' A' ' 90' ' ' VAL . 10.8 t -162.35 139.39 8.09 Favored 'General case' 0 C--N 1.297 -1.698 0 CA-C-O 124.499 2.095 . . . . 0.0 111.811 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.427 ' HA ' HD23 ' A' ' 89' ' ' LEU . 5.1 ttt -81.37 102.72 10.64 Favored 'General case' 0 C--O 1.211 -0.964 0 CA-C-N 112.018 -2.355 . . . . 0.0 106.881 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . 0.632 6.8 mt-10 -77.02 -121.12 0.01 OUTLIER 'General case' 0 N--CA 1.428 -1.526 0 CA-C-O 124.483 2.087 . . . . 0.0 111.383 -179.848 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -105.88 95.22 1.04 Allowed Glycine 0 N--CA 1.443 -0.86 0 N-CA-C 106.243 -2.743 . . . . 0.0 106.243 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 4.4 m120 61.81 12.84 4.99 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 116.347 1.98 . . . . 0.0 116.347 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . 0.348 9.0 mtmm -149.89 139.55 21.68 Favored 'General case' 0 C--O 1.215 -0.732 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 179.785 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.427 HD23 ' HA ' ' A' ' 84' ' ' MET . 0.0 OUTLIER -84.77 130.15 34.72 Favored 'General case' 0 C--N 1.317 -0.833 1 O-C-N 129.213 4.071 . . . . 0.0 102.046 179.849 . . . . . . . . 4 4 . 1 . 017 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.748 HG12 HG23 ' A' ' 105' ' ' VAL . 16.1 m -120.85 164.76 17.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.435 ' O ' ' N ' ' A' ' 104' ' ' ALA . . . -141.4 101.12 0.28 Allowed Glycine 0 C--O 1.216 -1.02 0 C-N-CA 127.932 2.682 . . . . 0.0 109.252 -179.833 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.98 123.79 37.56 Favored 'General case' 0 N--CA 1.436 -1.172 0 N-CA-C 104.583 -2.377 . . . . 0.0 104.583 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.486 ' HB3' ' HG ' ' A' ' 78' ' ' LEU . 21.2 m-30 -122.16 113.02 18.91 Favored 'General case' 0 CA--C 1.506 -0.716 0 O-C-N 125.417 1.698 . . . . 0.0 114.255 -179.543 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.491 ' HA ' ' HA ' ' A' ' 101' ' ' GLU . 12.3 mttm -92.12 173.18 7.97 Favored 'General case' 0 N--CA 1.427 -1.592 0 C-N-CA 126.586 1.955 . . . . 0.0 106.621 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . 0.37 3.3 mtp180 -119.72 145.53 46.45 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.507 HG21 ' HG2' ' A' ' 77' ' ' GLU . 5.2 t -69.71 -47.78 68.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 112.89 -1.959 . . . . 0.0 113.597 -179.817 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . 0.324 1.5 p-10 -102.51 35.13 2.54 Favored 'General case' 0 C--O 1.258 1.512 0 CA-C-O 122.798 1.285 . . . . 0.0 113.408 -179.817 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -144.17 -41.61 0.27 Allowed 'General case' 0 CA--C 1.491 -1.292 0 CA-C-N 114.131 -1.395 . . . . 0.0 113.723 -179.794 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 81.62 2.39 90.5 Favored Glycine 0 CA--C 1.543 1.788 0 C-N-CA 125.53 1.538 . . . . 0.0 112.395 -179.658 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 47.3 mttm -85.22 -171.32 3.57 Favored 'General case' 0 C--O 1.205 -1.251 0 CA-C-N 114.291 -0.954 . . . . 0.0 110.818 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.491 ' HA ' ' HA ' ' A' ' 94' ' ' LYS . 23.0 tt0 -130.81 168.8 16.65 Favored 'General case' 0 N--CA 1.439 -1.009 0 C-N-CA 129.669 3.187 . . . . 0.0 111.066 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.551 ' CG ' ' HA ' ' A' ' 119' ' ' TYR . 5.0 tt -154.57 -179.05 7.61 Favored 'General case' 0 C--N 1.319 -0.756 2 C-N-CA 136.19 5.796 . . . . 0.0 104.361 179.827 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.479 HG23 ' HB ' ' A' ' 118' ' ' THR . 0.9 OUTLIER -157.38 155.33 5.08 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.406 0 N-CA-C 104.116 -2.55 . . . . 0.0 104.116 179.783 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.471 ' N ' HG13 ' A' ' 103' ' ' ILE . . . -143.15 94.86 2.68 Favored 'General case' 0 N--CA 1.436 -1.158 0 C-N-CA 125.551 1.54 . . . . 0.0 108.284 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.748 HG23 HG12 ' A' ' 90' ' ' VAL . 0.5 OUTLIER -89.39 116.55 31.06 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 CA-C-O 125.222 2.439 . . . . 0.0 110.588 179.713 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.565 HH11 ' HG3' ' A' ' 106' ' ' ARG . 38.3 mtt85 -88.42 90.84 8.56 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 105.915 -1.883 . . . . 0.0 105.915 179.672 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -89.38 80.05 6.87 Favored 'General case' 0 N--CA 1.423 -1.781 0 O-C-N 127.356 2.91 . . . . 0.0 117.287 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.701 HD11 ' CH2' ' A' ' 6' ' ' TRP 0.312 0.6 OUTLIER -54.24 96.79 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 C-N-CA 118.523 -1.271 . . . . 0.0 113.368 179.718 . . . . . . . . 4 4 . 1 . 017 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 8.6 t -92.11 73.73 5.48 Favored 'General case' 0 CA--C 1.508 -0.635 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 -179.715 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 42.6 87.33 0.01 OUTLIER Glycine 0 C--N 1.334 0.452 0 O-C-N 125.586 1.804 . . . . 0.0 114.834 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . 0.315 3.7 m-20 84.32 -11.9 0.8 Allowed 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 113.961 -2.923 . . . . 0.0 111.212 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -124.93 108.45 11.9 Favored 'General case' 0 CA--C 1.497 -1.076 0 O-C-N 125.369 1.668 . . . . 0.0 111.669 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.497 HD21 ' HG2' ' A' ' 106' ' ' ARG . 6.1 tt -85.74 117.48 24.65 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 102.475 -3.157 . . . . 0.0 102.475 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.705 HG12 HG23 ' A' ' 127' ' ' ILE . 73.0 mt -113.97 142.42 26.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 N-CA-C 103.314 -2.847 . . . . 0.0 103.314 179.876 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.443 ' HG2' ' HG2' ' A' ' 106' ' ' ARG . 35.2 mt-30 -121.07 119.91 33.81 Favored 'General case' 0 CA--C 1.503 -0.855 0 CA-C-O 115.812 -2.042 . . . . 0.0 108.599 -179.03 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.5 p -96.96 111.94 23.93 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 104.256 -2.498 . . . . 0.0 104.256 178.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.706 ' HB2' ' HB3' ' A' ' 124' ' ' ALA . 98.8 m-85 -97.26 106.05 18.31 Favored 'General case' 0 CA--C 1.477 -1.847 0 O-C-N 125.578 1.799 . . . . 0.0 113.39 -179.375 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.479 ' HB ' HG23 ' A' ' 103' ' ' ILE . 1.7 m -109.56 95.75 5.82 Favored 'General case' 0 N--CA 1.423 -1.797 0 O-C-N 125.775 1.922 . . . . 0.0 115.464 -179.766 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.551 ' HA ' ' CG ' ' A' ' 102' ' ' LEU . 60.9 t80 -52.1 -51.07 60.08 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 104.5 -2.407 . . . . 0.0 104.5 179.111 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -148.31 -64.9 0.25 Allowed 'General case' 0 C--N 1.3 -1.55 0 CA-C-N 112.596 -2.093 . . . . 0.0 111.575 179.735 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -144.07 27.95 2.0 Allowed Glycine 0 CA--C 1.543 1.824 0 C-N-CA 128.745 3.069 . . . . 0.0 112.091 179.559 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.885 HG11 ' HD3' ' A' ' 20' ' ' LYS . 21.1 m -133.23 80.08 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 105.067 -2.198 . . . . 0.0 105.067 -178.572 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.562 ' O ' ' HB2' ' A' ' 124' ' ' ALA 0.301 3.0 tt0 -58.03 -169.36 0.01 OUTLIER 'General case' 0 N--CA 1.426 -1.665 0 C-N-CA 127.534 2.334 . . . . 0.0 111.985 179.937 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.706 ' HB3' ' HB2' ' A' ' 117' ' ' TYR . . . 177.72 76.48 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 121.206 1.821 . . . . 0.0 109.022 179.193 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . 0.331 0.0 OUTLIER -70.08 142.34 52.65 Favored 'General case' 0 N--CA 1.446 -0.629 0 O-C-N 126.811 2.569 . . . . 0.0 107.092 179.587 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 10.8 mtm180 -144.31 78.51 1.58 Allowed 'General case' 0 C--O 1.218 -0.562 0 O-C-N 127.624 3.078 . . . . 0.0 104.894 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.705 HG23 HG12 ' A' ' 114' ' ' ILE . 2.4 mm -57.9 115.45 0.94 Allowed 'Isoleucine or valine' 0 C--O 1.247 0.948 0 O-C-N 128.215 3.447 . . . . 0.0 116.569 -179.776 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.692 ' CE2' HD22 ' A' ' 38' ' ' LEU . 22.8 m-85 -100.62 132.74 45.86 Favored 'General case' 0 N--CA 1.435 -1.223 0 C-N-CA 124.807 1.243 . . . . 0.0 108.144 179.492 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . 0.271 17.4 mtpt -95.69 6.16 49.63 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 117.229 -1.367 . . . . 0.0 110.737 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.558 ' HG3' ' CH2' ' A' ' 6' ' ' TRP . 0.0 OUTLIER 72.27 157.0 0.17 Allowed 'General case' 0 C--O 1.238 0.478 0 CA-C-N 119.411 1.005 . . . . 0.0 111.572 179.972 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.429 ' HA ' HG23 ' A' ' 5' ' ' THR 0.845 7.3 tt0 . . . . . 0 N--CA 1.44 -0.974 0 N-CA-C 118.675 2.843 . . . . 0.0 118.675 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' PLM . . . . . 0.684 ' H22' HG11 ' A' ' 49' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.417 ' C ' ' CG ' ' A' ' 2' ' ' PHE . . . . . . . . 0 CA--C 1.51 -0.587 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.417 ' CG ' ' C ' ' A' ' 1' ' ' ALA . 0.1 OUTLIER 62.02 49.46 4.57 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 118.63 -1.228 . . . . 0.0 112.188 179.752 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -138.18 96.57 3.22 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 115.669 1.729 . . . . 0.0 115.669 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 149.23 -141.93 9.37 Favored Glycine 0 C--O 1.214 -1.139 0 C-N-CA 116.971 -2.537 . . . . 0.0 109.147 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . 0.517 6.6 t -118.39 161.24 20.29 Favored 'General case' 0 CA--C 1.497 -1.08 0 O-C-N 127.023 2.249 . . . . 0.0 113.549 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.55 ' HB3' ' CD2' ' A' ' 128' ' ' PHE . 92.3 m95 -148.07 145.03 28.27 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 126.486 2.366 . . . . 0.0 107.133 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -132.85 102.95 5.84 Favored 'General case' 0 N--CA 1.439 -1.02 0 C-N-CA 123.655 0.782 . . . . 0.0 109.071 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.447 ' HA ' ' HA ' ' A' ' 128' ' ' PHE 0.368 11.4 p -57.17 115.72 0.91 Allowed 'Isoleucine or valine' 0 C--O 1.246 0.875 0 O-C-N 120.573 -1.33 . . . . 0.0 109.076 179.964 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -99.71 -29.12 12.83 Favored 'General case' 0 C--O 1.209 -1.041 0 O-C-N 126.591 2.432 . . . . 0.0 112.038 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 2.2 ptm180 -162.38 95.8 0.94 Allowed 'General case' 0 CA--C 1.478 -1.797 0 C-N-CA 113.789 -3.164 . . . . 0.0 112.997 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -64.69 177.36 0.94 Allowed 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 113.147 -1.842 . . . . 0.0 108.124 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -131.17 -79.29 0.53 Allowed 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 115.395 -2.24 . . . . 0.0 108.778 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -92.25 21.04 5.45 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 126.693 2.496 . . . . 0.0 115.013 179.679 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.766 ' HA ' ' HB1' ' A' ' 124' ' ' ALA 0.348 0.1 OUTLIER -65.35 -33.29 75.62 Favored 'General case' 0 C--N 1.309 -1.193 0 O-C-N 128.186 3.429 . . . . 0.0 114.5 -179.982 . . . . . . . . 4 4 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -67.68 -23.78 65.34 Favored 'General case' 0 C--O 1.21 -1.015 0 O-C-N 117.108 -3.495 . . . . 0.0 110.694 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -79.94 -44.94 19.43 Favored 'General case' 0 C--O 1.247 0.973 0 CA-C-N 112.485 -2.143 . . . . 0.0 113.022 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.5 ' HB3' ' HB2' ' A' ' 124' ' ' ALA . 0.4 OUTLIER -60.56 -26.47 66.94 Favored 'General case' 0 N--CA 1.435 -1.218 0 CA-C-O 125.664 2.649 . . . . 0.0 112.264 179.988 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.436 ' HB3' ' HB ' ' A' ' 23' ' ' ILE . 7.6 mtt -73.68 -29.6 62.39 Favored 'General case' 0 N--CA 1.443 -0.802 0 O-C-N 116.301 -3.999 . . . . 0.0 106.629 179.36 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -70.0 -44.2 69.86 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-O 124.014 1.864 . . . . 0.0 112.213 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.804 ' HB2' HG21 ' A' ' 122' ' ' VAL . 16.2 tptt -61.06 -30.63 70.45 Favored 'General case' 0 C--O 1.209 -1.045 0 O-C-N 120.124 -1.61 . . . . 0.0 114.226 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.481 ' HG3' ' CE1' ' A' ' 17' ' ' PHE . 0.4 OUTLIER -79.45 -20.83 46.49 Favored 'General case' 0 N--CA 1.436 -1.154 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 -179.926 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 115.53 20.5 5.42 Favored Glycine 0 C--O 1.224 -0.502 0 N-CA-C 110.192 -1.163 . . . . 0.0 110.192 179.579 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.497 HG23 ' HB2' ' A' ' 27' ' ' LYS . 0.5 OUTLIER -104.79 101.88 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.291 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 -179.373 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 8.7 p-10 -130.94 24.75 4.97 Favored 'General case' 0 C--O 1.24 0.582 0 N-CA-C 114.666 1.358 . . . . 0.0 114.666 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . 0.546 17.4 m -136.17 -123.62 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.504 -0.822 0 N-CA-C 117.629 2.455 . . . . 0.0 117.629 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.65 0.0 OUTLIER -76.78 -22.67 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 N-CA-C 117.637 2.458 . . . . 0.0 117.637 179.816 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.497 ' HB2' HG23 ' A' ' 23' ' ' ILE . 0.7 OUTLIER -73.64 -25.91 60.52 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 114.463 -1.244 . . . . 0.0 113.985 179.957 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.66 -27.99 40.81 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 121.124 1.784 . . . . 0.0 107.301 -179.725 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -67.93 -41.29 82.82 Favored 'General case' 0 CA--C 1.508 -0.654 0 CA-C-O 123.249 1.5 . . . . 0.0 111.889 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 16.3 mt -73.7 -34.52 64.89 Favored 'General case' 0 N--CA 1.438 -1.034 0 O-C-N 120.5 -1.375 . . . . 0.0 107.439 179.652 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -76.51 -29.68 57.64 Favored Glycine 0 C--N 1.338 0.647 0 O-C-N 128.574 3.671 . . . . 0.0 114.995 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -71.91 -33.96 68.73 Favored 'General case' 0 C--O 1.243 0.732 0 O-C-N 119.425 -2.221 . . . . 0.0 110.24 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 7.2 t-80 -85.25 0.34 52.2 Favored 'General case' 0 N--CA 1.441 -0.916 0 O-C-N 127.384 2.927 . . . . 0.0 110.652 179.74 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.28 101.09 2.26 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-O 114.83 -2.51 . . . . 0.0 111.803 179.67 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 44.3 t30 -74.09 60.61 0.79 Allowed 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 121.447 1.931 . . . . 0.0 110.9 -179.373 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.536 HD21 ' HZ ' ' A' ' 128' ' ' PHE . 0.2 OUTLIER -41.89 119.06 1.22 Allowed 'General case' 0 CA--C 1.496 -1.101 0 CA-C-O 125.492 2.568 . . . . 0.0 111.178 -179.627 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.489 ' N ' HD12 ' A' ' 36' ' ' LEU . 44.9 tttm -107.78 111.24 23.3 Favored 'General case' 0 CA--C 1.516 -0.352 0 N-CA-C 102.076 -3.305 . . . . 0.0 102.076 179.793 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.522 ' CD2' HG22 ' A' ' 49' ' ' VAL . 0.1 OUTLIER -93.05 145.63 24.24 Favored 'General case' 0 C--N 1.31 -1.132 0 C-N-CA 114.941 -2.704 . . . . 0.0 105.149 -179.902 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.8 m -134.1 85.29 2.18 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 103.432 -2.803 . . . . 0.0 103.432 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.495 HG12 HG23 ' A' ' 49' ' ' VAL . 42.7 mt -79.86 117.76 26.23 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.122 0 O-C-N 124.731 1.27 . . . . 0.0 110.287 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.482 HG22 ' O ' ' A' ' 41' ' ' THR . 0.9 OUTLIER -112.25 110.15 20.22 Favored 'General case' 0 CA--C 1.511 -0.529 1 O-C-N 129.868 4.48 . . . . 0.0 112.614 -179.86 . . . . . . . . 4 4 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -85.68 95.8 9.49 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -110.23 86.19 2.26 Favored 'General case' 0 N--CA 1.426 -1.638 0 N-CA-C 104.698 -2.334 . . . . 0.0 104.698 179.787 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 75.18 -89.9 0.8 Allowed Glycine 0 C--N 1.305 -1.185 0 N-CA-C 106.764 -2.535 . . . . 0.0 106.764 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -129.06 -42.31 1.38 Allowed 'General case' 0 N--CA 1.443 -0.783 0 O-C-N 127.723 2.661 . . . . 0.0 111.394 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.402 ' HA ' ' HA ' ' A' ' 63' ' ' GLU . 0.1 OUTLIER -58.42 129.23 41.05 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-O 123.49 1.614 . . . . 0.0 108.87 179.837 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.57 ' CE1' HD21 ' A' ' 64' ' ' LEU 0.289 1.7 m-85 -108.5 99.41 8.8 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 -179.804 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.719 ' HA ' HG13 ' A' ' 61' ' ' VAL 0.388 28.3 p -70.76 85.44 0.66 Allowed 'General case' 0 N--CA 1.432 -1.361 0 C-N-CA 117.646 -1.622 . . . . 0.0 110.034 -179.954 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.769 HG13 ' HB ' ' A' ' 60' ' ' VAL 0.657 10.0 p -67.2 87.24 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.494 -1.179 0 O-C-N 126.051 2.094 . . . . 0.0 109.717 -179.864 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 9.8 ttpp -73.28 119.92 18.19 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 105.281 -2.118 . . . . 0.0 105.281 -179.402 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.401 ' O ' ' N ' ' A' ' 53' ' ' SER 0.335 71.9 tt0 -108.12 65.97 0.64 Allowed 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 103.783 -2.673 . . . . 0.0 103.783 -179.983 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.3 m -68.62 72.37 0.22 Allowed 'General case' 0 N--CA 1.418 -2.073 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 179.653 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.401 ' N ' ' O ' ' A' ' 51' ' ' GLU . 60.2 p -102.82 -177.43 3.38 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-O 116.51 -1.709 . . . . 0.0 111.698 -179.782 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -62.28 -30.12 70.91 Favored 'General case' 0 C--O 1.218 -0.599 0 CA-C-N 119.53 1.059 . . . . 0.0 108.178 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.481 ' HE2' ' HG2' ' A' ' 132' ' ' PLM . 0.1 OUTLIER -67.38 -68.19 0.4 Allowed 'General case' 0 C--O 1.21 -0.99 0 CA-C-O 115.73 -2.081 . . . . 0.0 109.068 179.739 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.818 ' HB2' HG22 ' A' ' 58' ' ' ILE 0.272 13.5 mmt180 -136.36 -175.46 4.01 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 122.231 2.287 . . . . 0.0 111.198 -179.92 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -134.1 55.32 1.9 Allowed 'General case' 0 C--O 1.218 -0.567 2 N-CA-C 100.143 -4.021 . . . . 0.0 100.143 179.551 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.818 HG22 ' HB2' ' A' ' 56' ' ' ARG . 3.4 tt -99.31 106.11 18.46 Favored 'Isoleucine or valine' 0 C--N 1.346 0.419 1 C-N-CA 132.294 4.238 . . . . 0.0 117.398 -179.332 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -62.82 136.41 57.84 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 105.327 -2.101 . . . . 0.0 105.327 179.549 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.769 ' HB ' HG13 ' A' ' 49' ' ' VAL . 2.5 t -116.97 41.65 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 -179.59 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.719 HG13 ' HA ' ' A' ' 48' ' ' THR 0.354 0.1 OUTLIER -36.46 144.9 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 CA-C-O 125.707 2.67 . . . . 0.0 114.48 -179.941 . . . . . . . . 4 4 . 1 . 018 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.457 ' HB3' ' CE1' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -156.0 100.93 2.07 Favored 'General case' 0 N--CA 1.423 -1.796 0 O-C-N 119.732 -1.855 . . . . 0.0 109.608 178.435 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.419 ' O ' ' C ' ' A' ' 64' ' ' LEU . 0.0 OUTLIER -68.55 93.28 0.49 Allowed 'General case' 0 CA--C 1.533 0.309 1 N-CA-C 99.942 -4.096 . . . . 0.0 99.942 178.054 . . . . . . . . 4 4 . 1 . 018 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.655 ' CB ' ' CE2' ' A' ' 82' ' ' TRP . 0.0 OUTLIER -14.59 88.68 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.181 0 O-C-N 128.027 3.329 . . . . 0.0 110.523 -178.196 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.567 ' N ' ' CD1' ' A' ' 82' ' ' TRP . . . 90.67 44.13 4.64 Favored Glycine 0 C--N 1.353 1.478 0 CA-C-N 109.985 -3.279 . . . . 0.0 118.918 179.42 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . 0.484 0.6 OUTLIER -105.3 -8.8 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.236 0 CA-C-N 111.968 -2.116 . . . . 0.0 107.547 -179.846 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.574 ' HA ' HG22 ' A' ' 81' ' ' THR . 1.8 m-20 69.63 143.81 0.05 OUTLIER 'General case' 0 CA--C 1.491 -1.297 0 CA-C-O 122.154 0.978 . . . . 0.0 109.858 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.574 ' CZ ' ' HA ' ' A' ' 81' ' ' THR . 1.0 OUTLIER -163.81 119.29 1.61 Allowed 'General case' 0 N--CA 1.438 -1.045 0 C-N-CA 117.363 -1.735 . . . . 0.0 111.066 179.989 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -77.46 102.67 6.98 Favored 'General case' 0 C--O 1.245 0.841 0 N-CA-C 103.74 -2.689 . . . . 0.0 103.74 179.171 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.515 ' HD2' HD22 ' A' ' 78' ' ' LEU . 31.1 t80 -107.2 87.8 2.59 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-O 116.139 -1.886 . . . . 0.0 113.821 -178.275 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 36.7 p -55.51 128.33 33.95 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 104.998 -2.223 . . . . 0.0 104.998 179.6 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.976 HD21 HD13 ' A' ' 78' ' ' LEU . 26.0 mt -71.57 -160.37 0.05 Allowed 'General case' 0 CA--C 1.495 -1.148 0 N-CA-C 106.133 -1.802 . . . . 0.0 106.133 -179.86 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -88.14 -30.4 19.85 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-O 124.97 2.319 . . . . 0.0 112.476 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.401 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 1.2 m-20 -124.77 -55.33 1.62 Allowed 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 113.045 -1.889 . . . . 0.0 111.211 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.0 -32.87 81.82 Favored Glycine 0 C--O 1.204 -1.755 0 CA-C-O 118.315 -1.269 . . . . 0.0 113.923 179.655 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.545 HG22 ' H ' ' A' ' 77' ' ' GLU 0.256 0.0 OUTLIER 70.24 169.89 0.31 Allowed 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 123.268 3.534 . . . . 0.0 114.738 179.821 . . . . . . . . 4 4 . 1 . 018 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.545 ' H ' HG22 ' A' ' 76' ' ' THR . 5.0 mt-10 7.8 103.68 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.835 1 O-C-N 131.532 5.52 . . . . 0.0 113.704 -179.682 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.976 HD13 HD21 ' A' ' 72' ' ' LEU 0.414 0.4 OUTLIER -140.29 101.19 4.07 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 102.233 -3.247 . . . . 0.0 102.233 179.933 . . . . . . . . 4 4 . 1 . 018 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 48.6 m -108.05 135.07 50.02 Favored 'General case' 0 C--O 1.202 -1.438 0 O-C-N 126.459 2.35 . . . . 0.0 106.059 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 173.62 -144.34 7.62 Favored Glycine 0 C--N 1.3 -1.437 0 C-N-CA 117.209 -2.424 . . . . 0.0 109.821 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.574 HG22 ' HA ' ' A' ' 67' ' ' ASP . 44.0 p -166.28 168.77 14.84 Favored 'General case' 0 C--O 1.19 -2.049 0 CA-C-O 123.48 1.609 . . . . 0.0 109.902 -179.637 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' TRP . . . . . 0.705 ' CG ' ' N ' ' A' ' 83' ' ' THR 0.406 1.9 p-90 -76.31 -169.64 1.24 Allowed 'General case' 0 C--N 1.316 -0.886 1 N-CA-C 99.807 -4.145 . . . . 0.0 99.807 175.419 . . . . . . . . 4 3 . 1 . 018 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.94 HG23 HG23 ' A' ' 90' ' ' VAL 0.292 0.5 OUTLIER 177.19 128.26 0.04 OUTLIER 'General case' 0 N--CA 1.437 -1.122 0 CA-C-O 124.676 2.179 . . . . 0.0 112.897 174.94 . . . . . . . . 4 4 . 1 . 018 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.563 ' CB ' ' CH2' ' A' ' 82' ' ' TRP . 3.0 ttt -96.96 102.27 14.01 Favored 'General case' 0 N--CA 1.426 -1.633 0 N-CA-C 106.056 -1.831 . . . . 0.0 106.056 179.09 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.434 ' CG ' ' CG2' ' A' ' 90' ' ' VAL 0.67 0.0 OUTLIER -79.67 62.66 4.01 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 120.462 1.483 . . . . 0.0 108.655 179.691 . . . . . . . . 4 4 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 76.94 -64.3 3.08 Favored Glycine 0 C--O 1.219 -0.785 0 N-CA-C 107.261 -2.336 . . . . 0.0 107.261 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 28.9 p-10 -129.78 -16.29 3.77 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 120.866 2.333 . . . . 0.0 116.681 -179.814 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . 0.365 0.3 OUTLIER -113.89 111.35 21.56 Favored 'General case' 0 CA--C 1.496 -1.13 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 179.924 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.598 HD22 ' HE ' ' A' ' 106' ' ' ARG . 2.0 tt -66.24 153.8 41.55 Favored 'General case' 0 C--N 1.32 -0.715 0 O-C-N 125.186 1.554 . . . . 0.0 107.277 179.856 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.94 HG23 HG23 ' A' ' 83' ' ' THR . 0.0 OUTLIER -144.19 179.97 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.021 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 179.986 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -140.53 99.17 0.24 Allowed Glycine 0 C--N 1.352 1.445 0 C-N-CA 129.034 3.206 . . . . 0.0 107.637 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.417 ' O ' ' CD1' ' A' ' 93' ' ' PHE . 5.9 mtpm? -98.25 138.11 36.0 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 102.365 -3.198 . . . . 0.0 102.365 -179.532 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.587 ' CZ ' ' H41' ' A' ' 132' ' ' PLM . 62.8 m-85 -150.06 127.77 11.67 Favored 'General case' 0 CA--C 1.5 -0.955 0 O-C-N 126.262 2.227 . . . . 0.0 113.702 -179.811 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 18.1 mttt -105.65 150.11 25.74 Favored 'General case' 0 N--CA 1.432 -1.374 0 CA-C-N 112.303 -2.226 . . . . 0.0 111.539 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.447 ' HG2' ' HB2' ' A' ' 98' ' ' ASN 0.401 1.0 OUTLIER -96.05 143.12 27.48 Favored 'General case' 0 N--CA 1.433 -1.322 0 CA-C-O 116.623 -1.656 . . . . 0.0 106.681 -179.713 . . . . . . . . 4 4 . 1 . 018 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.4 m -83.53 -29.05 7.65 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.213 0 O-C-N 124.48 1.112 . . . . 0.0 113.941 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . 0.356 6.2 p-10 -90.17 11.63 20.41 Favored 'General case' 0 C--O 1.251 1.169 0 CA-C-N 112.454 -2.157 . . . . 0.0 111.281 179.569 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.447 ' HB2' ' HG2' ' A' ' 95' ' ' ARG . 0.3 OUTLIER -138.57 -43.08 0.49 Allowed 'General case' 0 N--CA 1.439 -1.019 0 CA-C-N 112.562 -2.108 . . . . 0.0 116.604 -179.923 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 86.7 -10.7 66.55 Favored Glycine 0 CA--C 1.535 1.301 0 CA-C-O 124.379 2.099 . . . . 0.0 113.469 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 47.4 mttt -70.77 -167.12 0.17 Allowed 'General case' 0 C--O 1.203 -1.367 0 O-C-N 120.299 -1.707 . . . . 0.0 109.783 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -135.2 154.07 51.73 Favored 'General case' 0 N--CA 1.441 -0.919 0 C-N-CA 128.612 2.765 . . . . 0.0 111.267 -179.818 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.635 ' HG ' ' HA ' ' A' ' 119' ' ' TYR . 7.2 tt -132.73 137.29 46.83 Favored 'General case' 0 C--O 1.247 0.938 1 C-N-CA 133.816 4.846 . . . . 0.0 105.412 -179.609 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.732 HG23 ' HB3' ' A' ' 117' ' ' TYR . 11.1 tt -132.0 160.17 42.62 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.158 0 N-CA-C 105.428 -2.064 . . . . 0.0 105.428 179.26 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.464 ' O ' HG12 ' A' ' 90' ' ' VAL . . . -152.65 135.15 15.2 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-O 114.523 -2.656 . . . . 0.0 106.497 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.745 HG12 ' O ' ' A' ' 116' ' ' THR . 7.1 p -119.99 114.71 45.03 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.799 0 CA-C-N 122.172 2.26 . . . . 0.0 114.454 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.598 ' HE ' HD22 ' A' ' 89' ' ' LEU . 3.5 mtm180 -82.8 94.43 7.65 Favored 'General case' 0 C--O 1.223 -0.323 0 N-CA-C 103.788 -2.671 . . . . 0.0 103.788 178.918 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . 0.329 4.7 tt0 -72.0 -38.01 69.73 Favored 'General case' 0 C--O 1.21 -0.993 0 CA-C-N 110.934 -2.848 . . . . 0.0 116.129 -177.272 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.538 HD11 ' CZ2' ' A' ' 6' ' ' TRP 0.395 2.7 mm 60.05 75.96 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 C-N-CA 111.782 -3.967 . . . . 0.0 113.904 -179.686 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 6.8 t -65.54 -102.76 0.0 OUTLIER 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 120.46 1.482 . . . . 0.0 109.533 -179.538 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -133.85 89.32 0.25 Allowed Glycine 0 CA--C 1.521 0.416 1 C-N-CA 130.958 4.123 . . . . 0.0 110.685 179.572 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . 0.326 31.8 m-20 90.52 -25.43 0.06 Allowed 'General case' 0 C--N 1.309 -1.185 0 CA-C-O 114.54 -2.648 . . . . 0.0 110.071 -179.13 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -113.1 137.52 51.31 Favored 'General case' 0 CA--C 1.489 -1.381 1 O-C-N 129.332 4.145 . . . . 0.0 113.873 -179.362 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.53 ' HB2' ' CH2' ' A' ' 6' ' ' TRP . 8.6 tt -102.98 147.04 27.43 Favored 'General case' 0 C--O 1.21 -1.003 0 N-CA-C 100.781 -3.785 . . . . 0.0 100.781 -179.807 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.782 HG23 HD13 ' A' ' 127' ' ' ILE 0.265 13.4 mt -150.44 125.49 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 N-CA-C 103.625 -2.731 . . . . 0.0 103.625 179.961 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.561 ' HB2' ' HD2' ' A' ' 126' ' ' ARG . 51.6 mt-30 -101.14 139.69 36.48 Favored 'General case' 0 N--CA 1.441 -0.915 0 N-CA-C 103.121 -2.918 . . . . 0.0 103.121 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.745 ' O ' HG12 ' A' ' 105' ' ' VAL . 0.2 OUTLIER -156.68 144.58 19.38 Favored 'General case' 0 N--CA 1.415 -2.186 0 CA-C-N 113.496 -1.683 . . . . 0.0 112.664 179.986 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.732 ' HB3' HG23 ' A' ' 103' ' ' ILE 0.382 21.4 m-30 145.88 -136.29 0.0 OUTLIER 'General case' 0 CA--C 1.481 -1.684 0 O-C-N 128.088 3.367 . . . . 0.0 113.152 176.277 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.505 HG23 ' H ' ' A' ' 120' ' ' GLU . 10.5 t -159.3 -157.97 0.63 Allowed 'General case' 0 C--N 1.311 -1.068 0 O-C-N 127.67 3.106 . . . . 0.0 116.567 -174.876 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.635 ' HA ' ' HG ' ' A' ' 102' ' ' LEU 0.302 6.8 t80 -120.6 -4.89 9.77 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 111.865 -2.425 . . . . 0.0 110.695 178.309 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.505 ' H ' HG23 ' A' ' 118' ' ' THR . 0.9 OUTLIER -176.98 -68.92 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.511 0 O-C-N 120.506 -1.371 . . . . 0.0 112.025 -179.629 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -151.75 17.49 0.85 Allowed Glycine 0 CA--C 1.541 1.695 0 N-CA-C 119.692 2.637 . . . . 0.0 119.692 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.804 HG21 ' HB2' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -122.22 94.31 2.87 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 N-CA-C 104.314 -2.476 . . . . 0.0 104.314 -179.698 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.477 ' HA ' ' HB ' ' A' ' 118' ' ' THR . 0.8 OUTLIER -59.15 177.92 0.15 Allowed 'General case' 0 C--O 1.216 -0.659 0 CA-C-O 122.118 0.961 . . . . 0.0 112.377 -178.233 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.766 ' HB1' ' HA ' ' A' ' 14' ' ' TYR . . . -172.65 91.81 0.11 Allowed 'General case' 0 N--CA 1.437 -1.12 0 O-C-N 118.505 -2.622 . . . . 0.0 109.664 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.543 ' HG3' ' HB ' ' A' ' 116' ' ' THR . 1.7 mptm? -69.62 164.38 23.47 Favored 'General case' 0 CA--C 1.508 -0.671 0 CA-C-N 121.54 1.973 . . . . 0.0 110.997 179.734 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.593 ' HG2' ' CD2' ' A' ' 14' ' ' TYR . 36.7 mtt180 -145.82 72.77 1.32 Allowed 'General case' 0 C--O 1.208 -1.1 0 CA-C-N 110.466 -3.061 . . . . 0.0 110.481 -179.675 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.782 HD13 HG23 ' A' ' 114' ' ' ILE . 17.5 mm -66.3 117.8 7.98 Favored 'Isoleucine or valine' 0 C--O 1.254 1.325 1 O-C-N 129.102 4.001 . . . . 0.0 112.346 -179.987 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.55 ' CD2' ' HB3' ' A' ' 6' ' ' TRP . 12.5 m-85 -103.91 167.77 9.56 Favored 'General case' 0 N--CA 1.442 -0.872 0 O-C-N 127.186 2.804 . . . . 0.0 107.552 179.175 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 2.4 mmmt -122.23 1.56 9.7 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 116.621 -1.657 . . . . 0.0 109.373 179.702 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.518 ' HD2' ' CH2' ' A' ' 6' ' ' TRP . 0.9 OUTLIER 68.81 97.14 0.06 Allowed 'General case' 0 C--O 1.238 0.487 0 CA-C-N 120.794 1.634 . . . . 0.0 113.218 -179.954 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . 0.823 21.5 tt0 . . . . . 0 N--CA 1.431 -1.419 0 CA-C-N 121.492 1.951 . . . . 0.0 115.084 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' PLM . . . . . 0.587 ' H41' ' CZ ' ' A' ' 93' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.218 -0.582 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -83.06 0.66 43.89 Favored 'General case' 0 C--N 1.31 -1.124 0 O-C-N 120.302 -1.499 . . . . 0.0 112.577 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.407 ' N ' ' OD1' ' A' ' 3' ' ' ASP . 17.8 p-10 -55.98 85.97 0.01 OUTLIER 'General case' 0 CA--C 1.5 -0.974 0 N-CA-C 115.318 1.599 . . . . 0.0 115.318 -179.77 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -179.54 -151.5 9.88 Favored Glycine 0 N--CA 1.436 -1.33 0 C-N-CA 116.144 -2.932 . . . . 0.0 110.687 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.447 HG22 ' HA ' ' A' ' 39' ' ' THR 0.441 0.1 OUTLIER -124.74 150.83 45.82 Favored 'General case' 0 N--CA 1.427 -1.589 0 N-CA-C 116.312 1.967 . . . . 0.0 116.312 -179.855 . . . . . . . . 4 4 . 1 . 019 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.704 ' HA ' ' CE2' ' A' ' 128' ' ' PHE . 21.0 m95 -137.16 -166.77 1.98 Allowed 'General case' 0 CA--C 1.498 -1.029 0 CA-C-O 114.37 -2.728 . . . . 0.0 106.509 178.623 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.638 ' CB ' ' CZ ' ' A' ' 128' ' ' PHE . 6.7 ttpt 177.28 27.57 0.0 OUTLIER 'General case' 0 N--CA 1.432 -1.339 0 CA-C-O 112.804 -3.474 . . . . 0.0 112.498 -177.083 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.746 ' CG1' HD23 ' A' ' 36' ' ' LEU 0.404 1.7 m 15.24 108.95 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 CA-C-N 121.939 2.154 . . . . 0.0 116.745 -179.754 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -128.47 -69.36 0.72 Allowed 'General case' 0 CA--C 1.498 -1.022 0 O-C-N 120.48 -1.388 . . . . 0.0 113.118 -178.715 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.5 ptp180 -84.32 95.1 8.62 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 118.168 -1.413 . . . . 0.0 111.437 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -93.33 -172.82 3.05 Favored 'General case' 0 N--CA 1.441 -0.903 0 O-C-N 127.092 2.745 . . . . 0.0 108.937 -179.697 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -143.6 -67.07 0.35 Allowed 'General case' 0 C--N 1.306 -1.288 0 CA-C-O 115.994 -1.955 . . . . 0.0 108.622 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -95.58 15.4 19.95 Favored 'General case' 0 C--O 1.219 -0.545 0 O-C-N 127.502 3.001 . . . . 0.0 113.617 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.669 ' HA ' ' HB1' ' A' ' 124' ' ' ALA 0.381 0.1 OUTLIER -76.38 -26.22 55.4 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 117.876 2.547 . . . . 0.0 117.876 179.852 . . . . . . . . 4 4 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -74.83 -37.35 62.3 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-O 122.615 1.198 . . . . 0.0 111.894 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 4.7 ttmt -78.15 -24.52 47.29 Favored 'General case' 0 C--O 1.246 0.894 0 CA-C-O 126.046 2.831 . . . . 0.0 113.826 -179.679 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.581 ' CB ' ' HB2' ' A' ' 124' ' ' ALA . 10.1 t80 -66.63 -31.0 71.4 Favored 'General case' 0 N--CA 1.438 -1.041 0 CA-C-O 125.834 2.73 . . . . 0.0 113.374 -179.681 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.512 ' HB3' ' HB ' ' A' ' 23' ' ' ILE . 29.3 mtt -73.63 -24.69 60.05 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 125.851 2.738 . . . . 0.0 106.859 179.668 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -73.27 -22.23 60.43 Favored 'General case' 0 N--CA 1.474 0.765 0 O-C-N 119.003 -2.311 . . . . 0.0 109.396 179.705 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 6.0 tptp -75.25 -38.73 60.4 Favored 'General case' 0 C--N 1.313 -0.993 0 O-C-N 118.996 -2.315 . . . . 0.0 113.244 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 7.3 mtm -76.37 -38.17 56.17 Favored 'General case' 0 C--O 1.214 -0.796 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 125.96 43.47 0.28 Allowed Glycine 0 C--N 1.304 -1.205 0 CA-C-O 116.797 -2.113 . . . . 0.0 111.87 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.512 ' HB ' ' HB3' ' A' ' 18' ' ' MET . 0.2 OUTLIER -119.62 107.09 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 CA-C-O 115.758 -2.067 . . . . 0.0 107.212 -179.579 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -132.42 14.42 4.54 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 115.162 1.542 . . . . 0.0 115.162 -179.671 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . 0.412 33.2 m -119.66 -136.55 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.499 -0.99 0 O-C-N 126.992 2.683 . . . . 0.0 115.436 179.871 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.484 2.4 m -70.99 -24.09 24.2 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.934 0 CA-C-N 121.719 2.054 . . . . 0.0 114.027 179.823 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.41 ' HD2' ' CG ' ' A' ' 74' ' ' ASP . 13.2 mtmm -66.29 -34.68 78.54 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 115.002 1.482 . . . . 0.0 115.002 -179.819 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.405 ' N ' HG22 ' A' ' 23' ' ' ILE . 7.4 ptt180 -78.87 -24.23 44.4 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 123.561 1.648 . . . . 0.0 108.221 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.2 tttt -78.99 -32.03 45.05 Favored 'General case' 0 C--O 1.213 -0.84 0 CA-C-N 113.96 -1.473 . . . . 0.0 110.921 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.421 HD12 ' HA ' ' A' ' 30' ' ' LEU . 8.7 tp -77.64 -35.97 51.99 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 114.645 -1.161 . . . . 0.0 111.903 179.713 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.74 -25.52 73.76 Favored Glycine 0 C--O 1.213 -1.169 0 C-N-CA 123.933 0.778 . . . . 0.0 112.636 -179.771 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -76.94 -32.44 57.34 Favored 'General case' 0 C--N 1.315 -0.93 0 C-N-CA 125.89 1.676 . . . . 0.0 109.237 179.616 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 65.4 m80 -123.31 28.55 7.03 Favored 'General case' 0 C--O 1.236 0.373 0 O-C-N 126.979 2.674 . . . . 0.0 114.189 179.829 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -67.36 -19.42 65.43 Favored 'General case' 0 C--O 1.216 -0.683 0 N-CA-C 114.545 1.313 . . . . 0.0 114.545 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . 0.254 1.4 m-20 76.72 62.06 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 116.914 -1.914 . . . . 0.0 108.812 179.564 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.746 HD23 ' CG1' ' A' ' 8' ' ' VAL . 16.9 tp -80.02 73.04 6.83 Favored 'General case' 0 N--CA 1.469 0.525 0 O-C-N 126.752 2.533 . . . . 0.0 108.309 -179.617 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.447 ' HB3' ' HB2' ' A' ' 52' ' ' SER . 5.6 ttpp -68.9 112.08 5.35 Favored 'General case' 0 C--N 1.305 -1.349 1 N-CA-C 100.138 -4.023 . . . . 0.0 100.138 -179.508 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.547 ' CD1' ' HG ' ' A' ' 36' ' ' LEU 0.377 1.3 mp -104.8 103.13 12.68 Favored 'General case' 0 C--N 1.288 -2.079 0 N-CA-C 105.458 -2.053 . . . . 0.0 105.458 -178.316 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.504 ' HB ' ' CB ' ' A' ' 50' ' ' LYS . 1.9 m -94.85 86.39 4.68 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 117.276 -3.39 . . . . 0.0 103.902 179.793 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.585 HD13 HG23 ' A' ' 49' ' ' VAL . 12.0 mm -61.46 146.53 11.82 Favored 'Isoleucine or valine' 0 C--O 1.243 0.729 0 N-CA-C 105.973 -1.862 . . . . 0.0 105.973 -179.839 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.525 ' CG2' HG23 ' A' ' 48' ' ' THR . 4.6 t -150.34 35.0 0.64 Allowed 'General case' 0 CA--C 1.506 -0.731 0 O-C-N 126.956 2.66 . . . . 0.0 114.493 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -33.41 111.63 0.11 Allowed 'General case' 0 C--N 1.311 -1.106 0 O-C-N 126.981 2.676 . . . . 0.0 111.59 -179.831 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -81.08 -0.72 41.2 Favored 'General case' 0 N--CA 1.42 -1.947 0 CA-C-O 124.642 2.163 . . . . 0.0 111.935 -179.697 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 135.65 -55.66 0.72 Allowed Glycine 0 C--N 1.292 -1.87 0 N-CA-C 104.479 -3.448 . . . . 0.0 104.479 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.301 0.3 OUTLIER -127.4 -37.4 2.02 Favored 'General case' 0 C--N 1.316 -0.886 0 O-C-N 126.812 2.125 . . . . 0.0 112.587 -179.736 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 28.1 ttmt -91.12 139.2 30.98 Favored 'General case' 0 C--N 1.318 -0.792 0 O-C-N 117.906 -2.996 . . . . 0.0 107.601 -179.834 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . 0.251 21.0 m-85 -118.52 110.06 16.94 Favored 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 124.448 1.099 . . . . 0.0 110.956 -179.619 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.906 ' HB ' HG12 ' A' ' 61' ' ' VAL 0.401 0.1 OUTLIER -98.4 78.14 2.41 Favored 'General case' 0 N--CA 1.44 -0.965 0 O-C-N 125.078 1.486 . . . . 0.0 107.096 179.951 . . . . . . . . 4 4 . 1 . 019 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.725 HG13 ' HB ' ' A' ' 60' ' ' VAL 0.625 11.3 p -52.3 97.62 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 CA-C-N 109.497 -3.501 . . . . 0.0 113.073 179.737 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.504 ' CB ' ' HB ' ' A' ' 39' ' ' THR . 0.0 OUTLIER -62.23 139.27 58.5 Favored 'General case' 0 C--N 1.304 -1.384 1 N-CA-C 100.102 -4.036 . . . . 0.0 100.102 -179.633 . . . . . . . . 4 4 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.539 ' HB3' HG23 ' A' ' 58' ' ' ILE 0.253 3.4 tt0 -138.67 91.11 2.51 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 -179.229 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.447 ' HB2' ' HB3' ' A' ' 37' ' ' LYS . 1.0 OUTLIER -93.3 55.15 2.22 Favored 'General case' 0 C--N 1.286 -2.164 0 N-CA-C 105.634 -1.987 . . . . 0.0 105.634 -179.916 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 89.5 p -69.39 158.9 34.21 Favored 'General case' 0 C--N 1.349 0.561 0 CA-C-O 114.912 -2.47 . . . . 0.0 109.21 -179.587 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -52.74 -29.31 26.32 Favored 'General case' 0 C--O 1.212 -0.904 0 O-C-N 125.846 1.966 . . . . 0.0 106.946 179.786 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.523 ' CE2' ' HB1' ' A' ' 73' ' ' ALA . 11.1 m-85 -73.27 -55.76 5.99 Favored 'General case' 0 C--N 1.35 0.627 0 CA-C-O 114.707 -2.568 . . . . 0.0 111.211 179.341 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.852 ' HB3' HG22 ' A' ' 58' ' ' ILE 0.313 0.0 OUTLIER -142.83 174.79 10.34 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 124.42 3.282 . . . . 0.0 111.287 -179.88 . . . . . . . . 4 4 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -121.97 71.73 1.0 Allowed 'General case' 0 C--O 1.221 -0.409 1 N-CA-C 99.873 -4.121 . . . . 0.0 99.873 179.382 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.852 HG22 ' HB3' ' A' ' 56' ' ' ARG . 1.9 tt -105.67 103.18 14.97 Favored 'Isoleucine or valine' 0 C--O 1.243 0.724 0 O-C-N 127.635 3.085 . . . . 0.0 118.997 -179.189 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -65.91 125.0 24.02 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 103.623 -2.732 . . . . 0.0 103.623 178.409 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.725 ' HB ' HG13 ' A' ' 49' ' ' VAL . 24.5 t -100.76 97.14 5.38 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 -178.177 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.906 HG12 ' HB ' ' A' ' 48' ' ' THR 0.427 0.6 OUTLIER -79.66 135.25 25.95 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 CA-C-N 121.543 1.974 . . . . 0.0 108.986 179.748 . . . . . . . . 4 4 . 1 . 019 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.517 ' CE1' HG12 ' A' ' 49' ' ' VAL . 12.4 p90 -160.45 90.59 0.88 Allowed 'General case' 0 N--CA 1.432 -1.339 0 CA-C-O 123.832 1.777 . . . . 0.0 109.978 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -59.33 149.36 29.18 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 104.805 -2.294 . . . . 0.0 104.805 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.0 mt -66.16 110.9 3.17 Favored 'General case' 0 N--CA 1.427 -1.61 0 C-N-CA 117.982 -1.487 . . . . 0.0 108.58 -179.617 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.415 ' HA2' ' HB ' ' A' ' 81' ' ' THR . . . 72.78 46.45 30.16 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 128.199 2.809 . . . . 0.0 119.165 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . 0.442 3.8 t -111.92 7.92 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 CA-C-O 115.435 -2.222 . . . . 0.0 107.889 -179.818 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 46.71 101.7 0.0 OUTLIER 'General case' 0 CA--C 1.482 -1.661 0 CA-C-O 124.822 2.249 . . . . 0.0 115.525 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.5 ' CE1' ' HB2' ' A' ' 62' ' ' PHE . 8.8 p90 -117.67 157.62 26.13 Favored 'General case' 0 N--CA 1.435 -1.199 0 O-C-N 118.899 -2.376 . . . . 0.0 107.213 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -107.43 142.83 36.66 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 179.779 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -147.77 107.99 4.07 Favored 'General case' 0 C--O 1.205 -1.279 0 C-N-CA 118.196 -1.402 . . . . 0.0 114.265 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -75.15 138.38 41.98 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 122.954 2.616 . . . . 0.0 105.323 179.813 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.698 HD12 ' O ' ' A' ' 76' ' ' THR . 0.7 OUTLIER -82.52 -170.07 2.77 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 104.413 -2.44 . . . . 0.0 104.413 179.815 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.523 ' HB1' ' CE2' ' A' ' 55' ' ' PHE . . . -82.2 -45.62 14.84 Favored 'General case' 0 CA--C 1.547 0.842 0 CA-C-O 123.7 1.714 . . . . 0.0 111.254 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.41 ' CG ' ' HD2' ' A' ' 27' ' ' LYS . 12.2 t70 -139.92 26.62 2.25 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 112.952 -1.931 . . . . 0.0 110.858 179.716 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -120.36 -9.29 7.97 Favored Glycine 0 CA--C 1.548 2.152 0 O-C-N 127.105 2.753 . . . . 0.0 112.514 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.698 ' O ' HD12 ' A' ' 72' ' ' LEU 0.259 0.1 OUTLIER 75.13 -178.36 0.16 Allowed 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 117.393 -1.723 . . . . 0.0 114.706 -179.775 . . . . . . . . 4 4 . 1 . 019 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.441 ' CB ' ' HB ' ' A' ' 96' ' ' VAL . 13.8 mt-10 -40.65 141.09 0.6 Allowed 'General case' 0 N--CA 1.442 -0.848 0 CA-C-O 125.785 2.707 . . . . 0.0 112.293 179.825 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.691 ' HG ' ' HB3' ' A' ' 93' ' ' PHE 0.419 11.7 tp -166.09 120.38 1.16 Allowed 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 104.271 -2.492 . . . . 0.0 104.271 179.877 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.5 t -143.32 121.44 12.17 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 105.636 -1.986 . . . . 0.0 105.636 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.5 ' HA3' ' HA ' ' A' ' 93' ' ' PHE . . . -156.51 -144.65 3.98 Favored Glycine 0 CA--C 1.538 1.5 0 CA-C-O 116.537 -2.257 . . . . 0.0 110.022 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.415 ' HB ' ' HA2' ' A' ' 65' ' ' GLY . 11.5 p -148.84 161.06 42.6 Favored 'General case' 0 CA--C 1.476 -1.872 0 O-C-N 126.68 2.047 . . . . 0.0 110.215 -179.737 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' TRP . . . . . 0.486 ' CG ' ' CE2' ' A' ' 62' ' ' PHE . 16.1 m95 -117.05 151.26 37.16 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 101.155 -3.646 . . . . 0.0 101.155 -179.735 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.529 HG22 HG22 ' A' ' 90' ' ' VAL . 9.9 t -153.68 144.97 23.01 Favored 'General case' 0 C--O 1.255 1.364 0 CA-C-O 122.992 1.377 . . . . 0.0 111.558 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.22 105.82 11.77 Favored 'General case' 0 N--CA 1.436 -1.141 0 C-N-CA 117.162 -1.815 . . . . 0.0 109.662 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.443 ' HG3' HG11 ' A' ' 90' ' ' VAL 0.574 12.4 mm-40 -76.47 178.31 6.7 Favored 'General case' 0 N--CA 1.428 -1.561 0 O-C-N 120.979 -1.075 . . . . 0.0 108.999 179.778 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -67.21 95.52 0.29 Allowed Glycine 0 C--N 1.346 1.095 0 N-CA-C 105.145 -3.182 . . . . 0.0 105.145 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 79.18 16.57 0.93 Allowed 'General case' 0 C--O 1.242 0.703 0 CA-C-O 115.487 -2.197 . . . . 0.0 115.886 179.837 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . 0.418 0.0 OUTLIER -156.29 177.93 10.89 Favored 'General case' 0 CA--C 1.492 -1.256 0 O-C-N 125.936 2.022 . . . . 0.0 107.587 -179.895 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.524 HD12 ' HD2' ' A' ' 106' ' ' ARG . 0.1 OUTLIER -120.53 147.79 44.69 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 103.508 -2.775 . . . . 0.0 103.508 -179.861 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.601 ' HB ' HG23 ' A' ' 105' ' ' VAL . 0.6 OUTLIER -140.85 164.31 21.1 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.867 0 N-CA-C 104.844 -2.28 . . . . 0.0 104.844 179.917 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.48 ' HA2' ' HA ' ' A' ' 82' ' ' TRP . . . -143.87 109.35 0.54 Allowed Glycine 0 C--N 1.34 0.789 0 O-C-N 128.306 3.504 . . . . 0.0 111.445 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.498 ' C ' ' CD1' ' A' ' 93' ' ' PHE . 23.0 mtmt -103.3 164.6 11.54 Favored 'General case' 0 N--CA 1.432 -1.33 0 N-CA-C 102.87 -3.011 . . . . 0.0 102.87 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.691 ' HB3' ' HG ' ' A' ' 78' ' ' LEU 0.282 95.9 m-85 -161.85 116.07 1.91 Allowed 'General case' 0 N--CA 1.441 -0.879 0 C-N-CA 119.698 -0.801 . . . . 0.0 109.662 -179.751 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 4.2 mttp -92.02 142.84 27.09 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . 0.273 2.4 ttt-85 -88.57 130.68 35.2 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 113.856 -1.52 . . . . 0.0 109.542 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.441 ' HB ' ' CB ' ' A' ' 77' ' ' GLU . 68.9 t -70.88 -33.51 52.45 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 O-C-N 121.278 -0.889 . . . . 0.0 112.949 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . 0.364 31.1 t70 -95.96 -8.5 33.61 Favored 'General case' 0 C--O 1.261 1.673 0 N-CA-C 114.043 1.127 . . . . 0.0 114.043 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -118.88 -28.54 5.54 Favored 'General case' 0 CA--C 1.498 -1.022 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 -179.632 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 76.13 11.5 84.81 Favored Glycine 0 CA--C 1.536 1.345 0 N-CA-C 117.455 1.742 . . . . 0.0 117.455 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 9.4 mttt -105.61 152.01 23.63 Favored 'General case' 0 C--O 1.208 -1.079 0 CA-C-O 121.95 0.881 . . . . 0.0 109.852 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -94.9 118.72 32.25 Favored 'General case' 0 N--CA 1.435 -1.199 0 C-N-CA 127.653 2.381 . . . . 0.0 114.473 -179.742 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.666 ' HG ' ' HA ' ' A' ' 119' ' ' TYR . 7.8 tt -97.28 118.56 34.01 Favored 'General case' 0 C--N 1.317 -0.816 0 O-C-N 128.798 3.811 . . . . 0.0 103.369 179.57 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.71 HG23 ' HB3' ' A' ' 117' ' ' TYR . 15.2 tt -110.48 161.12 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.41 0 C-N-CA 116.35 -2.14 . . . . 0.0 107.327 -179.569 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.481 ' HA ' ' HB2' ' A' ' 117' ' ' TYR . . . -150.93 151.14 31.73 Favored 'General case' 0 N--CA 1.437 -1.106 0 O-C-N 118.105 -2.872 . . . . 0.0 107.376 -179.424 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.601 HG23 ' HB ' ' A' ' 90' ' ' VAL . 1.3 t -149.33 117.81 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 121.577 1.989 . . . . 0.0 111.54 -179.756 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.524 ' HD2' HD12 ' A' ' 89' ' ' LEU 0.3 79.5 mtt180 -84.49 91.53 7.87 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 105.195 -2.15 . . . . 0.0 105.195 -179.922 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 61.0 tt0 -81.61 80.8 7.87 Favored 'General case' 0 N--CA 1.436 -1.147 0 CA-C-O 126.974 3.273 . . . . 0.0 114.525 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.567 ' CD1' ' CH2' ' A' ' 6' ' ' TRP 0.331 0.6 OUTLIER -61.61 99.45 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.735 0 C-N-CA 116.601 -2.04 . . . . 0.0 114.6 179.85 . . . . . . . . 4 4 . 1 . 019 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -98.64 90.03 4.58 Favored 'General case' 0 C--O 1.219 -0.514 0 N-CA-C 102.839 -3.023 . . . . 0.0 102.839 -179.81 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 56.94 -125.86 40.14 Favored Glycine 0 CA--C 1.524 0.608 0 O-C-N 127.858 3.224 . . . . 0.0 111.731 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . 0.385 1.2 m-20 -65.12 -21.33 66.78 Favored 'General case' 0 C--O 1.215 -0.715 0 CA-C-O 115.515 -2.183 . . . . 0.0 112.938 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -95.27 141.91 28.3 Favored 'General case' 0 N--CA 1.432 -1.328 0 O-C-N 128.064 3.353 . . . . 0.0 115.777 179.656 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.931 HD21 ' HG2' ' A' ' 115' ' ' GLN . 0.3 OUTLIER -103.39 149.5 24.72 Favored 'General case' 0 N--CA 1.475 0.799 1 N-CA-C 100.121 -4.029 . . . . 0.0 100.121 179.557 . . . . . . . . 4 4 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.682 HG23 HD13 ' A' ' 127' ' ' ILE 0.252 78.3 mt -147.01 100.65 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 N-CA-C 103.686 -2.709 . . . . 0.0 103.686 179.876 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.931 ' HG2' HD21 ' A' ' 113' ' ' LEU . 0.6 OUTLIER -74.95 154.14 38.26 Favored 'General case' 0 CA--C 1.506 -0.732 1 O-C-N 129.318 4.136 . . . . 0.0 102.125 -179.823 . . . . . . . . 4 4 . 1 . 019 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.58 ' HB ' ' HG3' ' A' ' 125' ' ' LYS . 2.5 t 178.63 157.71 0.49 Allowed 'General case' 0 N--CA 1.415 -2.221 0 O-C-N 124.626 1.203 . . . . 0.0 109.945 -178.557 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.71 ' HB3' HG23 ' A' ' 103' ' ' ILE 0.384 5.0 m-30 127.13 -157.27 0.0 OUTLIER 'General case' 0 CA--C 1.479 -1.785 1 O-C-N 129.639 4.337 . . . . 0.0 113.215 177.682 . . . . . . . . 4 3 . 1 . 019 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.468 ' O ' ' N ' ' A' ' 103' ' ' ILE . 5.3 t -135.31 -162.77 1.3 Allowed 'General case' 0 C--N 1.312 -1.027 0 CA-C-O 127.304 3.43 . . . . 0.0 117.464 -174.905 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.666 ' HA ' ' HG ' ' A' ' 102' ' ' LEU 0.282 0.9 OUTLIER -113.7 -53.21 2.7 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 112.187 -2.279 . . . . 0.0 106.759 179.143 . . . . . . . . 4 4 . 1 . 019 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -124.68 -59.66 1.43 Allowed 'General case' 0 N--CA 1.426 -1.664 0 CA-C-N 113.479 -1.692 . . . . 0.0 113.266 179.675 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -161.78 15.78 0.15 Allowed Glycine 0 C--N 1.358 1.798 0 N-CA-C 120.747 3.059 . . . . 0.0 120.747 -179.61 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 75.6 t -128.61 102.9 8.77 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 N-CA-C 103.383 -2.821 . . . . 0.0 103.383 179.458 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.462 ' HA ' ' O ' ' A' ' 117' ' ' TYR . 0.0 OUTLIER -68.95 -173.84 0.53 Allowed 'General case' 0 C--O 1.215 -0.721 0 CA-C-O 124.107 1.908 . . . . 0.0 112.207 -178.181 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.669 ' HB1' ' HA ' ' A' ' 14' ' ' TYR . . . -166.44 95.29 0.54 Allowed 'General case' 0 N--CA 1.438 -1.026 0 CA-C-O 114.663 -2.589 . . . . 0.0 109.997 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.58 ' HG3' ' HB ' ' A' ' 116' ' ' THR 0.362 0.9 OUTLIER -77.38 143.06 38.96 Favored 'General case' 0 C--O 1.245 0.855 0 O-C-N 126.822 2.576 . . . . 0.0 111.956 179.518 . . . . . . . . 4 4 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.58 ' HD3' ' HB2' ' A' ' 115' ' ' GLN . 0.2 OUTLIER -129.92 84.15 2.19 Favored 'General case' 0 C--O 1.207 -1.163 0 C-N-CA 128.394 2.678 . . . . 0.0 104.591 177.323 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.682 HD13 HG23 ' A' ' 114' ' ' ILE . 14.1 mm -70.77 93.15 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.009 1 O-C-N 129.369 4.168 . . . . 0.0 108.07 179.837 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.704 ' CE2' ' HA ' ' A' ' 6' ' ' TRP 0.334 14.8 t80 -88.95 148.38 23.83 Favored 'General case' 0 N--CA 1.426 -1.664 0 CA-C-O 125.036 2.35 . . . . 0.0 113.507 -178.786 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.51 ' N ' ' CG ' ' A' ' 128' ' ' PHE 0.316 0.0 OUTLIER -99.67 25.13 7.45 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-N 110.851 -2.886 . . . . 0.0 114.11 -176.89 . . . . . . . . 4 4 . 1 . 019 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.588 ' HB2' ' CZ3' ' A' ' 6' ' ' TRP . 8.4 tttt 43.92 96.82 0.01 OUTLIER 'General case' 0 CA--C 1.507 -0.704 0 CA-C-N 122.526 2.421 . . . . 0.0 116.456 178.423 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.409 ' N ' ' O ' ' A' ' 5' ' ' THR 0.769 3.1 tt0 . . . . . 0 N--CA 1.447 -0.58 0 O-C-N 117.353 -3.342 . . . . 0.0 113.822 179.801 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' PLM . . . . . 0.516 ' H21' HG11 ' A' ' 60' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.216 -0.69 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 34.5 p90 -55.33 -25.92 37.61 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 117.215 2.302 . . . . 0.0 117.215 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -63.15 98.86 0.15 Allowed 'General case' 0 CA--C 1.491 -1.29 0 CA-C-O 123.33 1.538 . . . . 0.0 112.683 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.403 ' O ' ' N ' ' A' ' 40' ' ' ILE . . . 157.15 -159.77 29.94 Favored Glycine 0 CA--C 1.498 -0.99 0 C-N-CA 117.596 -2.24 . . . . 0.0 109.767 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.594 ' HA ' ' HA ' ' A' ' 39' ' ' THR 0.53 9.2 t -91.53 159.35 15.97 Favored 'General case' 0 N--CA 1.447 -0.612 0 O-C-N 126.342 1.848 . . . . 0.0 113.167 179.978 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 1.021 ' CZ2' HD11 ' A' ' 108' ' ' ILE . 90.1 m95 -148.23 145.75 28.38 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 110.715 -2.948 . . . . 0.0 105.103 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 44.7 tttt -143.34 93.75 2.53 Favored 'General case' 0 C--O 1.209 -1.049 0 O-C-N 126.308 2.255 . . . . 0.0 109.961 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.429 HG12 ' HB3' ' A' ' 36' ' ' LEU 0.26 4.1 p -46.57 125.69 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 O-C-N 126.585 2.428 . . . . 0.0 109.222 -179.876 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -119.34 -32.24 4.43 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-N 114.327 -1.306 . . . . 0.0 110.253 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.411 ' O ' ' HB ' ' A' ' 127' ' ' ILE . 0.0 OUTLIER -138.21 131.35 30.15 Favored 'General case' 0 CA--C 1.496 -1.105 0 CA-C-O 123.148 1.451 . . . . 0.0 108.205 -179.923 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . 0.287 38.3 m-80 -101.35 -178.53 3.76 Favored 'General case' 0 CA--C 1.504 -0.795 0 CA-C-N 113.214 -1.812 . . . . 0.0 108.496 179.709 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.505 ' CB ' ' HB2' ' A' ' 125' ' ' LYS . 0.3 OUTLIER -163.85 62.54 0.16 Allowed 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 121.106 1.775 . . . . 0.0 107.27 -179.913 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . 0.298 4.2 t30 115.5 18.7 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 128.097 2.559 . . . . 0.0 114.239 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.471 ' CE2' ' HG2' ' A' ' 126' ' ' ARG 0.327 0.1 OUTLIER -80.69 -24.0 39.16 Favored 'General case' 0 C--N 1.314 -0.957 0 O-C-N 127.481 2.988 . . . . 0.0 117.58 -179.984 . . . . . . . . 4 4 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -73.21 -47.04 46.77 Favored 'General case' 0 C--O 1.208 -1.1 0 O-C-N 118.306 -2.746 . . . . 0.0 108.938 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 29.5 tttm -78.3 -21.08 50.21 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 125.823 1.952 . . . . 0.0 114.722 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.524 ' CB ' ' HB2' ' A' ' 124' ' ' ALA . 2.9 t80 -73.53 -23.86 60.05 Favored 'General case' 0 N--CA 1.419 -1.986 0 C-N-CA 116.835 -1.946 . . . . 0.0 111.77 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.44 ' HB3' HG12 ' A' ' 23' ' ' ILE . 0.2 OUTLIER -73.25 -21.05 60.7 Favored 'General case' 0 C--N 1.307 -1.256 0 O-C-N 118.765 -2.459 . . . . 0.0 109.045 179.867 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 55.1 tt0 -64.17 -31.38 72.55 Favored 'General case' 0 C--N 1.347 0.48 0 CA-C-O 125.235 2.445 . . . . 0.0 112.401 179.564 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 32.6 tptt -74.26 -30.26 62.04 Favored 'General case' 0 C--O 1.215 -0.742 0 CA-C-N 112.922 -1.944 . . . . 0.0 110.375 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . 0.254 11.0 mtt -77.6 -40.17 43.01 Favored 'General case' 0 C--N 1.353 0.736 0 CA-C-O 124.107 1.908 . . . . 0.0 106.059 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 143.37 15.38 0.28 Allowed Glycine 0 N--CA 1.438 -1.232 0 CA-C-O 115.345 -2.92 . . . . 0.0 115.056 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.537 HD11 ' CB ' ' A' ' 74' ' ' ASP . 1.7 mp -75.49 134.09 29.97 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 CA-C-N 120.489 2.144 . . . . 0.0 105.844 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 67.8 m-80 -93.31 -45.74 7.69 Favored 'General case' 0 C--O 1.243 0.727 0 CA-C-O 114.2 -2.81 . . . . 0.0 116.521 -178.877 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . 0.402 1.2 t -160.2 -59.66 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.499 -0.987 0 N-CA-C 119.217 3.043 . . . . 0.0 119.217 -179.764 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.668 1.9 m -78.19 -26.22 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 12.3 mttm -75.16 -28.19 60.01 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-O 118.311 -0.852 . . . . 0.0 110.866 -179.799 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.813 HH11 ' HG3' ' A' ' 28' ' ' ARG . 4.9 ptt85 -79.95 -23.8 41.43 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 116.61 -2.036 . . . . 0.0 109.081 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.94 -43.9 64.48 Favored 'General case' 0 CA--C 1.507 -0.702 0 CA-C-O 122.512 1.149 . . . . 0.0 109.78 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.411 HD23 ' CZ ' ' A' ' 55' ' ' PHE . 9.2 tp -75.45 -31.7 60.39 Favored 'General case' 0 C--O 1.212 -0.894 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 -179.813 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -73.77 -34.08 56.87 Favored Glycine 0 C--N 1.348 1.238 0 O-C-N 128.299 3.5 . . . . 0.0 112.425 179.824 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -74.99 -40.64 60.57 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 125.741 1.616 . . . . 0.0 109.708 179.77 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 3.4 m80 -107.95 57.89 0.62 Allowed 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 113.46 -1.7 . . . . 0.0 110.908 179.782 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -85.37 -26.34 26.53 Favored 'General case' 0 C--O 1.212 -0.872 0 N-CA-C 117.522 2.415 . . . . 0.0 117.522 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.3 m120 78.74 24.61 0.56 Allowed 'General case' 0 CA--C 1.539 0.531 0 O-C-N 124.472 1.108 . . . . 0.0 109.206 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.429 ' HB3' HG12 ' A' ' 8' ' ' VAL . 1.9 tp -46.2 97.78 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.499 0 O-C-N 125.893 1.995 . . . . 0.0 109.449 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.485 ' HB3' ' CB ' ' A' ' 52' ' ' SER . 16.3 ttpt -98.03 96.12 7.93 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 101.754 -3.425 . . . . 0.0 101.754 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . 0.313 1.3 tp -86.27 147.16 26.21 Favored 'General case' 0 C--N 1.313 -0.991 0 C-N-CA 115.414 -2.515 . . . . 0.0 106.45 -179.68 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.594 ' HA ' ' HA ' ' A' ' 5' ' ' THR . 90.4 m -131.36 83.63 2.12 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 103.802 -2.666 . . . . 0.0 103.802 179.573 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.443 HG13 ' CD1' ' A' ' 6' ' ' TRP . 0.8 OUTLIER -63.15 108.73 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.01 0 O-C-N 124.51 1.131 . . . . 0.0 109.747 -179.914 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.9 m -117.58 84.78 2.22 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-O 122.475 1.131 . . . . 0.0 110.147 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -77.89 142.6 38.34 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 120.599 -1.313 . . . . 0.0 110.779 -179.771 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -139.82 -129.08 0.11 Allowed 'General case' 0 CA--C 1.492 -1.284 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -81.65 78.36 1.95 Allowed Glycine 0 C--N 1.294 -1.763 0 O-C-N 119.4 -2.063 . . . . 0.0 109.853 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.323 1.3 m-20 80.44 -10.56 1.25 Allowed 'General case' 0 C--N 1.315 -0.931 0 O-C-N 126.11 1.711 . . . . 0.0 113.014 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.441 ' HA ' ' HA ' ' A' ' 63' ' ' GLU . 0.0 OUTLIER -88.63 -178.07 5.72 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 117.374 -1.731 . . . . 0.0 107.491 179.943 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.619 ' CE1' HD21 ' A' ' 64' ' ' LEU . 2.1 m-85 -157.34 82.14 0.91 Allowed 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 106.061 -1.829 . . . . 0.0 106.061 -179.653 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.931 HG23 HG22 ' A' ' 61' ' ' VAL 0.484 6.4 m -67.17 136.61 55.32 Favored 'General case' 0 CA--C 1.5 -0.952 0 C-N-CA 114.747 -2.781 . . . . 0.0 106.449 -179.733 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.554 HG11 ' CH2' ' A' ' 82' ' ' TRP 0.595 0.9 OUTLIER -121.12 93.53 2.55 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 CA-C-N 112.632 -2.076 . . . . 0.0 114.047 -179.154 . . . . . . . . 4 4 . 1 . 020 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.534 ' CB ' ' HB ' ' A' ' 39' ' ' THR . 0.4 OUTLIER -67.74 150.44 48.68 Favored 'General case' 0 C--N 1.315 -0.891 1 N-CA-C 99.895 -4.113 . . . . 0.0 99.895 179.563 . . . . . . . . 4 4 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.402 ' O ' ' N ' ' A' ' 53' ' ' SER . 0.5 OUTLIER -141.26 73.95 1.44 Allowed 'General case' 0 C--O 1.216 -0.685 0 N-CA-C 103.252 -2.87 . . . . 0.0 103.252 -179.914 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.485 ' CB ' ' HB3' ' A' ' 37' ' ' LYS . 0.1 OUTLIER -76.05 77.81 2.91 Favored 'General case' 0 C--N 1.289 -2.043 0 O-C-N 119.571 -1.955 . . . . 0.0 105.764 -179.939 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.402 ' N ' ' O ' ' A' ' 51' ' ' GLU . 84.0 p -101.13 159.62 15.08 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-O 114.387 -2.72 . . . . 0.0 108.404 -179.825 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -53.9 -26.85 27.02 Favored 'General case' 0 CA--C 1.51 -0.559 0 O-C-N 125.259 1.599 . . . . 0.0 109.317 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.411 ' CZ ' HD23 ' A' ' 30' ' ' LEU . 61.0 m-85 -71.45 -57.04 4.8 Favored 'General case' 0 C--O 1.215 -0.725 0 CA-C-O 114.489 -2.672 . . . . 0.0 109.582 179.799 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.42 ' O ' HG22 ' A' ' 58' ' ' ILE 0.26 0.4 OUTLIER -169.81 152.57 4.55 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 123.226 2.739 . . . . 0.0 110.287 179.646 . . . . . . . . 4 4 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 5.6 p-10 -84.81 86.7 7.32 Favored 'General case' 0 C--O 1.217 -0.631 0 C-N-CA 131.308 3.843 . . . . 0.0 101.441 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.42 HG22 ' O ' ' A' ' 56' ' ' ARG . 2.7 tt -114.48 86.47 0.91 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.792 0 N-CA-C 119.604 3.186 . . . . 0.0 119.604 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -60.83 105.61 0.48 Allowed 'General case' 0 C--O 1.214 -0.778 0 N-CA-C 104.585 -2.376 . . . . 0.0 104.585 178.929 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.561 HG12 ' N ' ' A' ' 61' ' ' VAL . 1.0 OUTLIER -68.15 -55.27 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 C-N-CA 125.346 1.458 . . . . 0.0 113.893 -178.044 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.931 HG22 HG23 ' A' ' 48' ' ' THR 0.478 0.1 OUTLIER 60.69 135.6 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 CA-C-O 126.38 2.991 . . . . 0.0 112.094 -177.211 . . . . . . . . 4 4 . 1 . 020 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.63 ' CD1' ' CD1' ' A' ' 68' ' ' PHE . 9.8 t80 -163.8 109.13 1.05 Allowed 'General case' 0 N--CA 1.432 -1.361 0 CA-C-N 112.321 -2.218 . . . . 0.0 110.255 179.654 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.441 ' HA ' ' HA ' ' A' ' 46' ' ' LYS . 0.4 OUTLIER -58.04 129.35 41.54 Favored 'General case' 0 C--O 1.251 1.133 0 N-CA-C 102.722 -3.066 . . . . 0.0 102.722 179.037 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.619 HD21 ' CE1' ' A' ' 47' ' ' PHE . 0.4 OUTLIER -50.05 130.96 22.96 Favored 'General case' 0 C--O 1.247 0.971 0 CA-C-O 123.252 1.501 . . . . 0.0 111.999 -179.702 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.442 ' HA2' ' HB ' ' A' ' 81' ' ' THR . . . 60.72 14.74 37.93 Favored Glycine 0 C--N 1.341 0.824 0 CA-C-N 112.368 -2.196 . . . . 0.0 115.203 -179.827 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . 0.412 16.1 t -72.27 -88.29 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 154.82 117.49 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.175 0 C-N-CA 125.627 1.571 . . . . 0.0 115.224 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.63 ' CD1' ' CD1' ' A' ' 62' ' ' PHE . 0.4 OUTLIER -133.31 147.94 51.89 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-N 118.91 0.777 . . . . 0.0 110.047 -179.961 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -104.15 150.4 24.38 Favored 'General case' 0 C--O 1.243 0.714 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.475 ' CD2' ' H72' ' A' ' 132' ' ' PLM . 9.7 t80 -151.72 107.28 3.34 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-O 116.289 -1.815 . . . . 0.0 113.904 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -78.9 127.62 32.25 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 122.279 2.309 . . . . 0.0 105.137 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.48 HD13 ' H81' ' A' ' 132' ' ' PLM . 4.2 mm? -65.98 -177.67 0.52 Allowed 'General case' 0 C--N 1.3 -1.576 0 O-C-N 125.054 1.471 . . . . 0.0 107.363 -179.653 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -103.05 9.73 38.4 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-O 124.883 2.278 . . . . 0.0 110.909 179.663 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.537 ' CB ' HD11 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -97.17 -28.52 14.06 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 112.675 -2.057 . . . . 0.0 112.316 -179.813 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 133.79 8.96 2.07 Favored Glycine 0 CA--C 1.547 2.046 0 CA-C-O 117.651 -1.638 . . . . 0.0 111.596 -178.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.458 HG23 ' O ' ' A' ' 77' ' ' GLU 0.376 0.4 OUTLIER -131.44 169.65 15.76 Favored 'General case' 0 C--N 1.309 -1.154 0 C-N-CA 115.724 -2.39 . . . . 0.0 115.521 -179.757 . . . . . . . . 4 4 . 1 . 020 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.631 ' HG2' HG21 ' A' ' 96' ' ' VAL . 0.1 OUTLIER -90.26 168.1 12.17 Favored 'General case' 0 N--CA 1.443 -0.807 1 O-C-N 130.764 5.04 . . . . 0.0 113.842 179.752 . . . . . . . . 4 4 . 1 . 020 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.474 ' HG ' ' HB3' ' A' ' 93' ' ' PHE 0.399 10.0 tp -167.33 148.39 5.59 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-N 114.123 -1.399 . . . . 0.0 107.642 179.915 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 7.4 m -159.27 116.2 2.67 Favored 'General case' 0 C--O 1.203 -1.362 0 N-CA-C 105.394 -2.076 . . . . 0.0 105.394 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.449 ' HA3' ' HA ' ' A' ' 93' ' ' PHE . . . -156.62 -151.73 6.06 Favored Glycine 0 C--N 1.296 -1.642 0 C-N-CA 116.92 -2.562 . . . . 0.0 114.564 -179.801 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.442 ' HB ' ' HA2' ' A' ' 65' ' ' GLY . 1.3 p -152.39 168.3 25.9 Favored 'General case' 0 C--O 1.199 -1.599 0 C-N-CA 116.807 -1.957 . . . . 0.0 109.607 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' TRP . . . . . 0.622 ' CD1' ' CE2' ' A' ' 62' ' ' PHE 0.3 3.7 m0 -122.79 145.51 48.35 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 102.803 -3.036 . . . . 0.0 102.803 -179.81 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.918 HG22 HG22 ' A' ' 90' ' ' VAL . 10.3 t -143.28 124.64 14.68 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-O 124.924 2.297 . . . . 0.0 108.543 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.542 ' HA ' HD23 ' A' ' 89' ' ' LEU . 9.4 ttt -80.6 114.54 19.57 Favored 'General case' 0 N--CA 1.422 -1.872 0 CA-C-N 114.088 -1.415 . . . . 0.0 110.76 -179.727 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.468 ' HA ' ' OE1' ' A' ' 85' ' ' GLU 0.588 7.1 mm-40 -91.91 6.58 45.68 Favored 'General case' 0 N--CA 1.419 -2.002 0 CA-C-O 123.834 1.778 . . . . 0.0 112.746 179.864 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 91.3 -74.94 1.57 Allowed Glycine 0 C--N 1.345 1.05 0 N-CA-C 103.991 -3.643 . . . . 0.0 103.991 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 17.6 p30 -76.04 1.61 15.0 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 116.238 -1.839 . . . . 0.0 114.995 -179.856 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . 0.446 19.1 mttp -162.41 159.89 25.74 Favored 'General case' 0 C--O 1.218 -0.58 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.542 HD23 ' HA ' ' A' ' 84' ' ' MET . 0.1 OUTLIER -120.42 121.39 38.42 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 101.997 -3.334 . . . . 0.0 101.997 -179.95 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.918 HG22 HG22 ' A' ' 83' ' ' THR . 1.2 m -102.53 161.95 3.88 Favored 'Isoleucine or valine' 0 C--O 1.244 0.774 0 N-CA-C 105.644 -1.984 . . . . 0.0 105.644 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -142.9 94.75 0.18 Allowed Glycine 0 C--N 1.35 1.306 0 C-N-CA 130.627 3.965 . . . . 0.0 110.407 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.436 ' HA ' ' HA ' ' A' ' 103' ' ' ILE . 1.4 mtpm? -103.62 156.47 17.76 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 104.379 -2.452 . . . . 0.0 104.379 179.511 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.489 ' HD2' HD12 ' A' ' 102' ' ' LEU . 64.6 m-85 -151.73 128.95 11.19 Favored 'General case' 0 CA--C 1.5 -0.967 0 O-C-N 125.464 1.728 . . . . 0.0 111.11 -179.871 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 36.3 mtpt -107.91 129.17 55.11 Favored 'General case' 0 C--O 1.212 -0.87 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.454 -179.666 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . 0.342 0.5 OUTLIER -68.72 168.27 13.6 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 120.679 -1.263 . . . . 0.0 109.008 -179.911 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.631 HG21 ' HG2' ' A' ' 77' ' ' GLU . 24.4 t -100.45 -34.85 4.21 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 O-C-N 126.262 2.226 . . . . 0.0 108.508 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . 0.315 0.4 OUTLIER -65.94 -23.2 66.56 Favored 'General case' 0 CA--C 1.505 -0.756 0 N-CA-C 115.897 1.814 . . . . 0.0 115.897 -179.794 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -160.93 23.22 0.14 Allowed 'General case' 0 CA--C 1.491 -1.296 0 N-CA-C 117.748 2.499 . . . . 0.0 117.748 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 56.15 19.13 22.62 Favored Glycine 0 CA--C 1.536 1.354 0 N-CA-C 117.744 1.858 . . . . 0.0 117.744 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 15.4 mmtp -74.52 -172.21 1.43 Allowed 'General case' 0 C--O 1.198 -1.618 0 CA-C-N 119.812 1.806 . . . . 0.0 108.034 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -129.55 150.22 50.98 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 127.516 2.326 . . . . 0.0 113.389 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.588 ' HA ' ' HA ' ' A' ' 119' ' ' TYR . 0.0 OUTLIER -140.13 141.08 36.12 Favored 'General case' 0 C--O 1.246 0.878 0 O-C-N 128.345 3.528 . . . . 0.0 106.87 -179.516 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.639 HG23 ' CG ' ' A' ' 117' ' ' TYR . 11.3 tt -132.11 179.77 4.08 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.213 0 C-N-CA 117.342 -1.743 . . . . 0.0 109.777 179.568 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.524 ' HA ' ' HB2' ' A' ' 117' ' ' TYR . . . -163.59 113.45 1.3 Allowed 'General case' 0 N--CA 1.427 -1.579 0 CA-C-O 114.2 -2.81 . . . . 0.0 107.493 -176.898 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -100.71 103.09 14.34 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.682 0 CA-C-N 121.079 1.763 . . . . 0.0 113.511 -179.058 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.469 HH11 ' CG ' ' A' ' 106' ' ' ARG . 1.4 mtt-85 -77.08 93.85 3.94 Favored 'General case' 0 CA--C 1.504 -0.821 0 CA-C-O 123.423 1.583 . . . . 0.0 109.337 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -94.59 79.09 3.79 Favored 'General case' 0 N--CA 1.423 -1.824 0 CA-C-N 113.24 -1.8 . . . . 0.0 114.415 -179.799 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 1.021 HD11 ' CZ2' ' A' ' 6' ' ' TRP 0.322 1.4 tt -58.27 107.6 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.251 0 C-N-CA 117.26 -1.776 . . . . 0.0 114.681 179.951 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -92.74 79.84 4.74 Favored 'General case' 0 N--CA 1.436 -1.132 0 O-C-N 120.141 -1.6 . . . . 0.0 107.105 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 56.6 -58.52 0.01 OUTLIER Glycine 0 C--O 1.245 0.784 0 C-N-CA 128.907 3.146 . . . . 0.0 113.973 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . 0.302 18.8 m120 -127.47 -1.07 6.24 Favored 'General case' 0 C--O 1.213 -0.828 0 CA-C-O 117.434 -1.269 . . . . 0.0 112.366 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -123.59 121.93 36.86 Favored 'General case' 0 C--O 1.209 -1.066 0 CA-C-O 115.443 -2.217 . . . . 0.0 111.121 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.552 HD23 ' CD1' ' A' ' 128' ' ' PHE . 0.8 OUTLIER -88.47 137.39 32.37 Favored 'General case' 0 C--O 1.209 -1.048 0 N-CA-C 102.004 -3.332 . . . . 0.0 102.004 -179.655 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.847 HG22 HG22 ' A' ' 116' ' ' THR . 72.4 mt -138.67 109.4 4.89 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 O-C-N 126.305 2.253 . . . . 0.0 109.377 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.549 ' O ' HG22 ' A' ' 116' ' ' THR . 19.9 mt-30 -79.32 147.29 32.51 Favored 'General case' 0 CA--C 1.498 -1.046 0 N-CA-C 102.211 -3.255 . . . . 0.0 102.211 179.727 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.847 HG22 HG22 ' A' ' 114' ' ' ILE . 0.1 OUTLIER -163.24 111.89 1.27 Allowed 'General case' 0 N--CA 1.427 -1.599 0 C-N-CA 117.263 -1.775 . . . . 0.0 109.71 -179.168 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.639 ' CG ' HG23 ' A' ' 103' ' ' ILE 0.273 0.1 OUTLIER 176.17 -162.57 0.03 OUTLIER 'General case' 0 CA--C 1.469 -2.159 0 C-N-CA 116.512 -2.075 . . . . 0.0 114.208 178.122 . . . . . . . . 4 4 . 1 . 020 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.496 ' O ' HD22 ' A' ' 102' ' ' LEU . 8.0 t -128.46 -164.86 1.43 Allowed 'General case' 0 N--CA 1.425 -1.683 0 CA-C-O 127.407 3.479 . . . . 0.0 117.51 -174.923 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.588 ' HA ' ' HA ' ' A' ' 102' ' ' LEU 0.298 68.9 t80 -128.97 5.95 5.43 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 112.305 -2.225 . . . . 0.0 108.1 178.075 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.451 ' H ' HG23 ' A' ' 118' ' ' THR . 1.9 tt0 168.64 -60.65 0.01 OUTLIER 'General case' 0 C--N 1.289 -2.035 0 C-N-CA 125.68 1.592 . . . . 0.0 112.472 -178.185 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -157.34 22.52 0.43 Allowed Glycine 0 C--N 1.366 2.225 0 N-CA-C 121.434 3.334 . . . . 0.0 121.434 -179.636 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 75.7 t -135.42 118.71 23.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 O-C-N 117.857 -3.143 . . . . 0.0 105.123 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 37.5 mp0 -85.72 175.74 8.54 Favored 'General case' 0 C--O 1.21 -1.005 0 CA-C-O 123.882 1.801 . . . . 0.0 112.868 -179.457 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.524 ' HB2' ' CB ' ' A' ' 17' ' ' PHE . . . -165.53 115.05 1.03 Allowed 'General case' 0 N--CA 1.435 -1.19 0 CA-C-O 113.905 -2.95 . . . . 0.0 108.211 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.551 ' CD ' ' HB ' ' A' ' 116' ' ' THR . 0.1 OUTLIER -90.74 140.33 29.88 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 127.764 3.165 . . . . 0.0 109.535 179.942 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.471 ' HG2' ' CE2' ' A' ' 14' ' ' TYR . 0.1 OUTLIER -127.68 82.43 2.09 Favored 'General case' 0 N--CA 1.428 -1.543 0 CA-C-O 114.242 -2.79 . . . . 0.0 111.123 179.958 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.507 HD13 HG23 ' A' ' 114' ' ' ILE . 5.1 mm -74.46 102.22 2.07 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.832 1 O-C-N 130.894 5.121 . . . . 0.0 115.572 179.863 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.552 ' CD1' HD23 ' A' ' 113' ' ' LEU . 22.0 m-85 -94.27 128.94 41.05 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 128.887 2.875 . . . . 0.0 107.868 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . 0.308 10.4 mttt -93.19 3.14 56.18 Favored 'General case' 0 CA--C 1.507 -0.693 0 CA-C-O 116.768 -1.586 . . . . 0.0 112.083 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.576 ' HB2' ' CZ3' ' A' ' 6' ' ' TRP . 0.1 OUTLIER 69.79 99.9 0.06 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 122.146 2.248 . . . . 0.0 114.127 179.972 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . 0.833 9.4 tt0 . . . . . 0 CA--C 1.499 -0.987 0 C-N-CA 115.592 -2.443 . . . . 0.0 115.666 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' PLM . . . . . 0.48 ' H81' HD13 ' A' ' 72' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . 0.61 ' CE2' HD13 ' A' ' 89' ' ' LEU . 2.2 m-30 . . . . . 0 N--CA 1.444 -0.765 0 N-CA-C 117.866 2.543 . . . . 0.0 117.866 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -36.74 91.18 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 124.489 2.09 . . . . 0.0 115.749 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 164.13 -176.35 40.12 Favored Glycine 0 C--O 1.209 -1.433 0 C-N-CA 117.668 -2.206 . . . . 0.0 111.147 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.77 HG22 HG23 ' A' ' 39' ' ' THR 0.56 0.1 OUTLIER -91.35 155.33 18.58 Favored 'General case' 0 N--CA 1.443 -0.802 0 O-C-N 127.146 2.321 . . . . 0.0 110.63 -179.787 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.838 ' CH2' HD11 ' A' ' 108' ' ' ILE . 69.7 m95 -141.67 149.78 41.04 Favored 'General case' 0 N--CA 1.436 -1.147 0 O-C-N 127.874 3.234 . . . . 0.0 106.405 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 10.0 tmtt? -152.46 93.31 1.78 Allowed 'General case' 0 CA--C 1.5 -0.977 0 O-C-N 126.913 2.633 . . . . 0.0 107.14 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.564 ' HB ' ' CD1' ' A' ' 128' ' ' PHE 0.305 0.4 OUTLIER -42.56 137.0 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.0 0 CA-C-O 117.124 -1.417 . . . . 0.0 113.115 -179.998 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -118.27 -60.68 1.76 Allowed 'General case' 0 C--O 1.214 -0.807 0 O-C-N 126.405 2.316 . . . . 0.0 108.827 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.407 ' O ' ' HB ' ' A' ' 127' ' ' ILE . 0.4 OUTLIER -118.98 155.04 32.07 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 179.939 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . 0.363 0.1 OUTLIER -121.1 -165.76 1.26 Allowed 'General case' 0 C--N 1.324 -0.524 0 O-C-N 126.011 2.07 . . . . 0.0 107.459 -179.78 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.473 ' HB3' ' HB2' ' A' ' 125' ' ' LYS . 3.7 tp10 -176.35 89.3 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.523 0 C-N-CA 117.604 -1.638 . . . . 0.0 107.197 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 97.95 -3.6 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 126.143 1.777 . . . . 0.0 114.132 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.801 ' HA ' ' HB1' ' A' ' 124' ' ' ALA 0.27 76.9 t80 -62.07 -28.08 69.35 Favored 'General case' 0 C--O 1.241 0.618 0 O-C-N 127.908 3.255 . . . . 0.0 114.307 -179.834 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -68.18 -40.37 82.28 Favored 'General case' 0 CA--C 1.5 -0.949 0 O-C-N 124.672 1.232 . . . . 0.0 113.442 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.3 -26.03 55.42 Favored 'General case' 0 N--CA 1.441 -0.921 0 O-C-N 125.053 1.47 . . . . 0.0 111.216 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.612 ' HB2' ' HB2' ' A' ' 124' ' ' ALA . 4.7 t80 -68.59 -25.28 64.8 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 123.467 1.603 . . . . 0.0 112.773 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -77.74 -24.91 48.95 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-O 124.018 1.866 . . . . 0.0 107.698 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.7 tt0 -74.45 -20.28 60.08 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 125.297 2.475 . . . . 0.0 110.07 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.422 ' CE ' ' HB2' ' A' ' 120' ' ' GLU . 2.8 tmtm? -77.67 -48.3 17.11 Favored 'General case' 0 C--O 1.209 -1.032 0 CA-C-N 111.998 -2.364 . . . . 0.0 110.152 179.461 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 3.1 mtt -65.48 -20.25 66.27 Favored 'General case' 0 C--O 1.208 -1.12 0 C-N-CA 127.519 2.328 . . . . 0.0 107.507 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.13 31.35 5.96 Favored Glycine 0 C--N 1.298 -1.563 0 C-N-CA 125.221 1.391 . . . . 0.0 111.812 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.486 ' CG2' ' HB2' ' A' ' 27' ' ' LYS . 0.5 OUTLIER -91.56 132.75 35.2 Favored 'Isoleucine or valine' 0 C--N 1.351 0.643 0 CA-C-O 116.154 -1.879 . . . . 0.0 105.99 -179.863 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -90.76 -85.67 0.22 Allowed 'General case' 0 CA--C 1.508 -0.672 0 N-CA-C 116.365 1.987 . . . . 0.0 116.365 -179.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . 0.354 3.5 p -117.4 -72.41 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.495 -1.17 0 N-CA-C 120.022 3.341 . . . . 0.0 120.022 -179.508 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.579 2.2 m -63.43 -28.51 45.16 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.871 0 N-CA-C 118.619 2.822 . . . . 0.0 118.619 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.486 ' HB2' ' CG2' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -74.3 -42.66 59.15 Favored 'General case' 0 CA--C 1.508 -0.653 0 O-C-N 127.789 3.18 . . . . 0.0 114.146 -179.839 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 38.1 ptt180 -78.38 -23.43 46.83 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 123.41 1.576 . . . . 0.0 108.793 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 31.1 tttp -74.86 -39.55 61.49 Favored 'General case' 0 CA--C 1.509 -0.63 0 CA-C-N 114.15 -1.386 . . . . 0.0 111.029 179.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.425 ' HA ' HD22 ' A' ' 30' ' ' LEU . 0.8 OUTLIER -74.65 -21.81 59.23 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 114.039 -1.437 . . . . 0.0 110.712 -179.913 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -79.45 -30.71 44.04 Favored Glycine 0 CA--C 1.524 0.596 0 O-C-N 128.23 3.456 . . . . 0.0 110.929 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -77.09 -57.58 3.76 Favored 'General case' 0 N--CA 1.436 -1.167 0 C-N-CA 127.182 2.193 . . . . 0.0 112.1 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 22.4 m80 -75.18 -1.99 25.79 Favored 'General case' 0 N--CA 1.438 -1.054 0 CA-C-O 117.112 -1.423 . . . . 0.0 113.606 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.43 ' HB2' ' HB2' ' A' ' 53' ' ' SER . 35.6 p-10 -38.6 -36.67 0.27 Allowed 'General case' 0 CA--C 1.495 -1.171 0 N-CA-C 119.888 3.292 . . . . 0.0 119.888 179.604 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . 0.263 13.4 m120 79.96 21.3 0.54 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 120.108 1.322 . . . . 0.0 113.422 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.627 HD21 HD13 ' A' ' 38' ' ' LEU . 27.0 tp -37.08 93.47 0.01 OUTLIER 'General case' 0 C--N 1.351 0.643 0 O-C-N 126.993 2.683 . . . . 0.0 110.313 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.423 ' HB3' ' HB3' ' A' ' 52' ' ' SER . 2.4 ttmp? -92.82 105.47 17.59 Favored 'General case' 0 C--O 1.218 -0.602 0 N-CA-C 101.92 -3.363 . . . . 0.0 101.92 179.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.627 HD13 HD21 ' A' ' 36' ' ' LEU 0.252 1.3 tp -95.3 127.11 41.08 Favored 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 116.212 -2.195 . . . . 0.0 108.735 179.729 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.77 HG23 HG22 ' A' ' 5' ' ' THR . 89.0 m -109.97 83.14 1.71 Allowed 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 104.226 -2.509 . . . . 0.0 104.226 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.447 HD11 HD23 ' A' ' 38' ' ' LEU . 24.0 mm -63.91 132.93 29.85 Favored 'Isoleucine or valine' 0 C--O 1.247 0.94 0 CA-C-N 112.983 -1.917 . . . . 0.0 108.952 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 30.5 m -143.62 96.84 2.97 Favored 'General case' 0 CA--C 1.502 -0.874 0 CA-C-N 111.419 -2.628 . . . . 0.0 113.582 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 59.8 tt0 -89.5 131.94 35.29 Favored 'General case' 0 N--CA 1.447 -0.613 0 O-C-N 124.794 1.309 . . . . 0.0 110.272 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 46.3 tt0 -101.98 -52.33 3.19 Favored 'General case' 0 CA--C 1.49 -1.349 0 CA-C-O 125.172 2.415 . . . . 0.0 110.156 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -165.74 -69.19 0.03 OUTLIER Glycine 0 N--CA 1.433 -1.551 0 N-CA-C 105.422 -3.071 . . . . 0.0 105.422 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.364 0.0 OUTLIER -106.53 -22.7 12.69 Favored 'General case' 0 C--O 1.218 -0.602 0 CA-C-N 113.095 -1.552 . . . . 0.0 111.168 179.906 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.409 ' CD ' ' HG3' ' A' ' 63' ' ' GLU . 0.0 OUTLIER -98.32 156.23 16.82 Favored 'General case' 0 N--CA 1.435 -1.203 0 C-N-CA 120.318 -0.553 . . . . 0.0 111.931 -179.879 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.407 ' HE2' HD21 ' A' ' 64' ' ' LEU . 2.1 m-85 -129.79 92.72 3.37 Favored 'General case' 0 N--CA 1.441 -0.893 0 C-N-CA 123.465 0.706 . . . . 0.0 109.436 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.84 HG22 ' CG1' ' A' ' 61' ' ' VAL 0.455 1.3 p -67.18 141.51 57.31 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 116.8 -1.96 . . . . 0.0 111.45 -179.903 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.874 HG11 ' CZ ' ' A' ' 62' ' ' PHE 0.695 0.4 OUTLIER -120.91 83.82 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.424 -1.726 0 CA-C-N 111.877 -2.42 . . . . 0.0 111.167 179.916 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.458 ' CB ' ' HB ' ' A' ' 39' ' ' THR . 2.1 ttpp -62.84 142.89 58.05 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 101.229 -3.619 . . . . 0.0 101.229 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.572 ' OE2' HD13 ' A' ' 36' ' ' LEU . 4.3 tt0 -138.55 93.92 2.79 Favored 'General case' 0 C--O 1.217 -0.632 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.423 ' HB3' ' HB3' ' A' ' 37' ' ' LYS 0.287 3.9 t -91.64 60.8 4.1 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 106.722 -1.584 . . . . 0.0 106.722 179.81 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.43 ' HB2' ' HB2' ' A' ' 34' ' ' ASP . 1.7 p -89.59 -178.46 5.56 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 125.897 1.998 . . . . 0.0 112.447 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.44 -28.59 69.38 Favored 'General case' 0 C--O 1.212 -0.878 0 CA-C-O 115.525 -2.178 . . . . 0.0 109.932 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.453 ' CD2' ' CB ' ' A' ' 73' ' ' ALA . 95.8 m-85 -70.93 -51.08 28.09 Favored 'General case' 0 C--O 1.221 -0.398 0 C-N-CA 117.285 -1.766 . . . . 0.0 114.13 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.443 ' O ' HG22 ' A' ' 58' ' ' ILE . 6.3 ttm180 179.72 153.7 0.49 Allowed 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 120.702 1.592 . . . . 0.0 108.256 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 42.8 t-20 -88.89 85.98 6.85 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 102.336 -3.209 . . . . 0.0 102.336 -179.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.443 HG22 ' O ' ' A' ' 56' ' ' ARG . 6.3 tp -117.57 107.31 21.83 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.866 1 C-N-CA 133.19 4.596 . . . . 0.0 118.477 -179.827 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -66.2 134.07 51.95 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 104.606 -2.368 . . . . 0.0 104.606 178.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.402 ' O ' HG23 ' A' ' 61' ' ' VAL . 22.3 t -86.16 -68.8 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 CA-C-O 125.517 2.58 . . . . 0.0 110.874 -179.299 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.84 ' CG1' HG22 ' A' ' 48' ' ' THR 0.497 0.0 OUTLIER 74.57 128.02 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.14 0 CA-C-N 113.825 -1.534 . . . . 0.0 113.347 179.995 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.874 ' CZ ' HG11 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -160.11 99.95 1.37 Allowed 'General case' 0 C--N 1.313 -1.002 0 CA-C-O 117.756 -1.116 . . . . 0.0 111.141 -179.781 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.409 ' HG3' ' CD ' ' A' ' 46' ' ' LYS . 3.7 tt0 -49.59 137.61 15.16 Favored 'General case' 0 N--CA 1.439 -0.999 0 O-C-N 126.592 2.433 . . . . 0.0 104.564 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.407 HD21 ' HE2' ' A' ' 47' ' ' PHE . 0.8 OUTLIER -60.33 129.69 42.9 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 123.395 1.569 . . . . 0.0 108.469 -179.74 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 63.38 26.95 70.02 Favored Glycine 0 C--N 1.343 0.948 0 CA-C-N 111.437 -2.62 . . . . 0.0 118.849 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . 0.423 3.0 t -102.63 101.61 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.732 ' HA ' HG22 ' A' ' 81' ' ' THR . 25.5 t0 -58.03 126.45 27.52 Favored 'General case' 0 CA--C 1.49 -1.332 0 CA-C-O 116.816 -1.564 . . . . 0.0 111.391 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.581 ' CZ ' ' HB2' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -131.91 -174.24 3.37 Favored 'General case' 0 N--CA 1.437 -1.097 0 CA-C-N 119.289 0.949 . . . . 0.0 110.968 -179.84 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -125.81 118.38 25.38 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 -179.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 16.2 t80 -126.63 115.39 19.4 Favored 'General case' 0 C--O 1.209 -1.028 0 CA-C-N 120.503 1.501 . . . . 0.0 111.711 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 10.6 t -80.93 142.62 33.34 Favored 'General case' 0 CA--C 1.491 -1.327 0 O-C-N 120.352 -1.468 . . . . 0.0 109.434 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.6 HD21 HD22 ' A' ' 78' ' ' LEU . 0.1 OUTLIER -97.83 -174.2 2.82 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 106.043 -1.836 . . . . 0.0 106.043 179.901 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.453 ' CB ' ' CD2' ' A' ' 55' ' ' PHE . . . -84.33 -49.28 8.88 Favored 'General case' 0 C--O 1.211 -0.973 0 O-C-N 125.355 1.659 . . . . 0.0 110.717 179.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.425 ' HB2' ' HD3' ' A' ' 27' ' ' LYS . 4.9 t70 -121.7 -10.06 8.8 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.079 -1.419 . . . . 0.0 109.72 179.182 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -89.19 -17.59 55.36 Favored Glycine 0 CA--C 1.546 1.982 0 CA-C-N 118.66 0.664 . . . . 0.0 112.763 179.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.489 HG22 ' H ' ' A' ' 77' ' ' GLU 0.355 0.0 OUTLIER 71.96 -169.03 0.14 Allowed 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 116.495 -2.082 . . . . 0.0 113.302 179.922 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.504 ' HB2' HG22 ' A' ' 96' ' ' VAL . 4.0 mp0 -46.22 140.71 3.82 Favored 'General case' 0 C--N 1.319 -0.729 0 O-C-N 128.253 3.471 . . . . 0.0 112.039 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.6 HD22 HD21 ' A' ' 72' ' ' LEU 0.42 0.4 OUTLIER -156.83 100.67 1.92 Allowed 'General case' 0 C--O 1.243 0.734 0 N-CA-C 102.798 -3.038 . . . . 0.0 102.798 179.963 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.535 ' HB ' ' O ' ' A' ' 68' ' ' PHE . 27.6 m -109.13 135.37 50.38 Favored 'General case' 0 CA--C 1.481 -1.686 0 O-C-N 125.009 1.443 . . . . 0.0 108.238 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 173.6 -168.0 40.78 Favored Glycine 0 C--N 1.303 -1.276 1 C-N-CA 113.805 -4.045 . . . . 0.0 108.775 -179.682 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.732 HG22 ' HA ' ' A' ' 67' ' ' ASP . 2.7 p -137.69 177.14 8.1 Favored 'General case' 0 CA--C 1.493 -1.218 0 CA-C-N 119.129 1.465 . . . . 0.0 110.981 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . 0.546 ' CE3' ' CA ' ' A' ' 91' ' ' GLY . 83.5 m95 -128.12 141.45 51.49 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 102.078 -3.304 . . . . 0.0 102.078 179.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.513 HG23 HG23 ' A' ' 90' ' ' VAL . 5.4 t -142.86 138.67 30.44 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-O 122.033 0.921 . . . . 0.0 109.312 -179.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 13.6 ttt -83.44 105.24 14.22 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . 0.603 4.7 mt-10 -56.8 -28.74 61.89 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-O 124.986 2.327 . . . . 0.0 112.661 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 140.49 -46.71 0.91 Allowed Glycine 0 C--N 1.347 1.146 0 N-CA-C 104.081 -3.608 . . . . 0.0 104.081 179.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 17.3 t30 -113.28 -19.23 11.85 Favored 'General case' 0 N--CA 1.44 -0.937 0 O-C-N 127.109 2.299 . . . . 0.0 114.109 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . 0.385 20.3 mttt -136.93 151.41 49.01 Favored 'General case' 0 N--CA 1.44 -0.958 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 179.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.952 HD23 HH11 ' A' ' 106' ' ' ARG . 1.0 OUTLIER -98.74 129.56 45.18 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 101.313 -3.588 . . . . 0.0 101.313 179.634 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.513 HG23 HG23 ' A' ' 83' ' ' THR . 0.0 OUTLIER -120.26 114.75 44.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 C-N-CA 118.363 -1.335 . . . . 0.0 108.14 -179.844 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.546 ' CA ' ' CE3' ' A' ' 82' ' ' TRP . . . -84.16 91.52 1.65 Allowed Glycine 0 C--N 1.354 1.582 0 C-N-CA 129.652 3.501 . . . . 0.0 107.819 -179.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -92.39 124.33 36.37 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 102.509 -3.145 . . . . 0.0 102.509 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.463 ' CG ' ' HG ' ' A' ' 78' ' ' LEU . 2.4 m-85 -136.23 108.99 7.53 Favored 'General case' 0 CA--C 1.502 -0.865 0 O-C-N 125.902 2.001 . . . . 0.0 111.941 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.432 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 0.1 OUTLIER -89.04 -173.22 3.98 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 179.937 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . 0.42 0.6 OUTLIER -131.56 151.83 51.27 Favored 'General case' 0 CA--C 1.487 -1.459 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.859 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.504 HG22 ' HB2' ' A' ' 77' ' ' GLU . 17.4 m -82.03 -33.62 11.86 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 N-CA-C 114.176 1.176 . . . . 0.0 114.176 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.412 ' N ' HG23 ' A' ' 96' ' ' VAL 0.436 0.5 OUTLIER -74.13 10.32 1.27 Allowed 'General case' 0 C--O 1.247 0.957 0 N-CA-C 116.226 1.936 . . . . 0.0 116.226 179.844 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -168.54 -33.99 0.02 OUTLIER 'General case' 0 CA--C 1.497 -1.084 0 N-CA-C 114.812 1.412 . . . . 0.0 114.812 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 76.7 41.63 23.52 Favored Glycine 0 C--N 1.339 0.733 0 N-CA-C 116.423 1.329 . . . . 0.0 116.423 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 69.4 mttt -81.97 -112.01 0.03 OUTLIER 'General case' 0 C--O 1.198 -1.647 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.428 ' HG3' ' N ' ' A' ' 102' ' ' LEU . 0.1 OUTLIER 166.17 142.4 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.391 0 C-N-CA 125.212 1.405 . . . . 0.0 109.897 -179.913 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.553 ' HG ' ' HA ' ' A' ' 119' ' ' TYR . 0.8 OUTLIER -131.25 151.68 51.25 Favored 'General case' 0 C--O 1.247 0.94 0 O-C-N 128.289 3.493 . . . . 0.0 104.761 -179.723 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.453 ' CG2' ' HB ' ' A' ' 118' ' ' THR . 9.2 tt -132.23 174.69 12.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 CA-C-N 120.405 1.457 . . . . 0.0 107.891 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.418 ' N ' ' CG1' ' A' ' 103' ' ' ILE . . . -155.98 111.19 2.95 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 116.351 -1.785 . . . . 0.0 106.269 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.466 HG12 HG23 ' A' ' 116' ' ' THR . 0.9 OUTLIER -95.95 111.72 26.79 Favored 'Isoleucine or valine' 0 C--O 1.245 0.852 0 CA-C-N 121.44 1.927 . . . . 0.0 113.199 -179.416 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.952 HH11 HD23 ' A' ' 89' ' ' LEU . 37.3 mtt180 -91.24 94.1 9.39 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 106.327 -1.731 . . . . 0.0 106.327 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -94.03 74.96 4.11 Favored 'General case' 0 N--CA 1.42 -1.948 0 N-CA-C 116.915 2.191 . . . . 0.0 116.915 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.838 HD11 ' CH2' ' A' ' 6' ' ' TRP . 0.3 OUTLIER -61.07 128.73 22.83 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 C-N-CA 115.292 -2.563 . . . . 0.0 111.763 179.872 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 3.9 t -87.42 -65.71 0.99 Allowed 'General case' 0 C--O 1.218 -0.581 0 N-CA-C 104.575 -2.38 . . . . 0.0 104.575 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -167.39 -62.36 0.03 OUTLIER Glycine 0 C--N 1.348 1.213 0 C-N-CA 129.985 3.66 . . . . 0.0 112.683 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . 0.309 0.8 OUTLIER -101.96 -9.33 20.75 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-O 116.448 -1.739 . . . . 0.0 110.737 179.844 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.53 ' O ' HD13 ' A' ' 108' ' ' ILE . 1.3 mt-10 -126.94 131.77 51.01 Favored 'General case' 0 CA--C 1.495 -1.159 0 O-C-N 128.078 3.361 . . . . 0.0 116.888 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.684 HD22 ' CD2' ' A' ' 128' ' ' PHE . 10.4 tt -105.32 117.0 32.9 Favored 'General case' 0 C--N 1.321 -0.669 0 O-C-N 127.739 3.149 . . . . 0.0 105.912 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.735 HG13 HD13 ' A' ' 127' ' ' ILE 0.281 1.2 mp -108.32 128.34 63.92 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 CA-C-O 116.212 -1.852 . . . . 0.0 107.574 -179.747 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . 0.605 HE21 ' HZ ' ' A' ' 128' ' ' PHE . 37.4 mt-30 -114.32 105.89 13.68 Favored 'General case' 0 N--CA 1.441 -0.897 0 O-C-N 126.543 2.402 . . . . 0.0 107.783 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.466 HG23 HG12 ' A' ' 105' ' ' VAL . 12.3 p -75.64 -179.0 4.43 Favored 'General case' 0 N--CA 1.429 -1.518 0 O-C-N 127.595 3.06 . . . . 0.0 105.409 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.428 ' HB2' ' HB3' ' A' ' 124' ' ' ALA . 97.4 m-85 -165.96 112.1 0.88 Allowed 'General case' 0 C--O 1.198 -1.623 0 CA-C-O 116.605 -1.664 . . . . 0.0 113.19 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.522 HG22 ' H ' ' A' ' 120' ' ' GLU . 54.0 m -122.73 129.33 51.65 Favored 'General case' 0 N--CA 1.425 -1.68 1 O-C-N 131.289 5.368 . . . . 0.0 113.661 179.77 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.553 ' HA ' ' HG ' ' A' ' 102' ' ' LEU . 2.1 t80 -109.14 12.85 24.82 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.522 ' H ' HG22 ' A' ' 118' ' ' THR . 0.7 OUTLIER 163.52 -84.95 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.566 0 O-C-N 127.818 3.199 . . . . 0.0 111.357 -179.796 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -128.59 24.27 4.95 Favored Glycine 0 CA--C 1.539 1.547 0 N-CA-C 119.892 2.717 . . . . 0.0 119.892 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 62.1 t -133.0 104.07 6.55 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.628 0 O-C-N 119.122 -2.399 . . . . 0.0 107.371 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -81.14 171.54 14.78 Favored 'General case' 0 N--CA 1.426 -1.647 0 CA-C-O 124.203 1.954 . . . . 0.0 108.623 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.801 ' HB1' ' HA ' ' A' ' 14' ' ' TYR . . . -162.72 97.08 0.95 Allowed 'General case' 0 C--O 1.211 -0.94 0 C-N-CA 117.746 -1.582 . . . . 0.0 107.194 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.473 ' HB2' ' HB3' ' A' ' 12' ' ' GLU 0.32 1.8 mptm? -83.88 132.91 34.75 Favored 'General case' 0 CA--C 1.506 -0.729 0 CA-C-O 122.331 1.063 . . . . 0.0 110.121 -179.903 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.513 HH12 HD22 ' A' ' 36' ' ' LEU . 4.6 mtm180 -119.94 81.47 1.74 Allowed 'General case' 0 C--O 1.209 -1.042 0 C-N-CA 127.158 2.183 . . . . 0.0 107.867 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.735 HD13 HG13 ' A' ' 114' ' ' ILE . 10.4 mm -63.97 126.32 22.41 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.861 0 O-C-N 128.522 3.639 . . . . 0.0 111.649 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.684 ' CD2' HD22 ' A' ' 113' ' ' LEU . 5.6 m-30 -112.66 139.47 48.23 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 113.25 -1.795 . . . . 0.0 107.681 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . 0.263 3.0 mmtp -104.11 13.73 31.87 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 116.947 -1.502 . . . . 0.0 111.206 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.519 ' HB2' ' CZ3' ' A' ' 6' ' ' TRP . 0.1 OUTLIER 55.83 97.53 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 115.394 -2.241 . . . . 0.0 113.176 179.716 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . 0.88 2.4 tt0 . . . . . 0 N--CA 1.443 -0.814 0 C-N-CA 115.407 -2.517 . . . . 0.0 115.683 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . 0.445 ' N ' ' CD1' ' A' ' 2' ' ' PHE . 10.6 m-85 . . . . . 0 CA--C 1.511 -0.529 0 CA-C-O 121.074 0.464 . . . . 0.0 111.908 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -145.53 100.9 3.51 Favored 'General case' 0 CA--C 1.495 -1.172 0 C-N-CA 119.528 -0.869 . . . . 0.0 111.629 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 143.65 -171.79 25.19 Favored Glycine 0 CA--C 1.503 -0.718 0 O-C-N 126.512 2.382 . . . . 0.0 111.603 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.416 ' C ' ' CG ' ' A' ' 6' ' ' TRP 0.587 0.5 OUTLIER -81.45 164.27 22.16 Favored 'General case' 0 N--CA 1.439 -1.006 0 CA-C-O 123.026 1.393 . . . . 0.0 111.523 179.931 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.755 ' CH2' HD11 ' A' ' 108' ' ' ILE . 63.2 m95 -157.03 117.01 3.48 Favored 'General case' 0 N--CA 1.428 -1.563 0 CA-C-O 114.276 -2.773 . . . . 0.0 106.419 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 5.1 tttt -122.47 95.71 4.75 Favored 'General case' 0 N--CA 1.441 -0.902 0 O-C-N 126.062 2.101 . . . . 0.0 108.908 -179.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.583 ' HA ' ' HA ' ' A' ' 128' ' ' PHE 0.267 14.1 p -34.76 119.19 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.216 0 O-C-N 125.391 1.682 . . . . 0.0 114.561 -179.951 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -114.38 -46.99 2.94 Favored 'General case' 0 C--O 1.204 -1.296 0 O-C-N 125.484 1.74 . . . . 0.0 110.24 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.602 ' HG3' HG21 ' A' ' 127' ' ' ILE 0.27 0.0 OUTLIER -106.78 170.72 7.77 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-O 118.663 -0.684 . . . . 0.0 109.866 179.861 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.738 ' HB3' ' CD1' ' A' ' 14' ' ' TYR 0.391 20.0 m120 -169.62 179.39 3.78 Favored 'General case' 0 N--CA 1.437 -1.083 0 O-C-N 128.06 3.35 . . . . 0.0 109.962 -178.201 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -150.38 -90.07 0.07 Allowed 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 121.839 2.109 . . . . 0.0 112.083 -179.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 17.2 t30 -85.04 4.91 31.71 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-N 122.449 2.386 . . . . 0.0 112.182 179.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.738 ' CD1' ' HB3' ' A' ' 11' ' ' ASN . 0.4 OUTLIER -59.55 -21.82 60.82 Favored 'General case' 0 C--N 1.308 -1.238 0 C-N-CA 127.274 2.23 . . . . 0.0 113.301 -178.628 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -73.92 -26.63 60.61 Favored 'General case' 0 C--O 1.21 -0.983 0 CA-C-N 120.51 1.504 . . . . 0.0 111.424 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 37.2 tttm -79.97 -31.92 39.84 Favored 'General case' 0 N--CA 1.432 -1.339 0 CA-C-O 125.448 2.546 . . . . 0.0 110.665 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.658 ' CB ' ' HB2' ' A' ' 124' ' ' ALA . 0.0 OUTLIER -60.78 -33.89 73.66 Favored 'General case' 0 N--CA 1.428 -1.564 0 O-C-N 118.397 -2.689 . . . . 0.0 113.264 -179.755 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 19.2 mtt -72.88 -23.77 60.77 Favored 'General case' 0 N--CA 1.438 -1.073 0 O-C-N 119.229 -2.17 . . . . 0.0 108.465 179.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -76.13 -32.28 59.06 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 125.027 2.346 . . . . 0.0 111.379 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.411 ' HE3' ' HB3' ' A' ' 120' ' ' GLU . 0.6 OUTLIER -64.72 -41.2 96.15 Favored 'General case' 0 N--CA 1.436 -1.171 0 O-C-N 117.55 -3.219 . . . . 0.0 112.379 179.76 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -73.66 -21.88 60.13 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 86.73 61.64 1.59 Allowed Glycine 0 C--N 1.314 -0.666 0 CA-C-O 115.263 -2.965 . . . . 0.0 109.998 179.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.468 HG23 ' CB ' ' A' ' 27' ' ' LYS . 7.2 mm -90.77 -7.21 10.77 Favored 'Isoleucine or valine' 0 C--N 1.358 0.943 0 CA-C-N 119.537 1.668 . . . . 0.0 108.408 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.1 m120 76.11 -106.01 0.02 OUTLIER 'General case' 0 N--CA 1.441 -0.882 0 CA-C-O 116.006 -1.95 . . . . 0.0 114.384 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . 0.343 69.2 t -133.74 -55.26 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.499 -0.995 0 N-CA-C 118.001 2.593 . . . . 0.0 118.001 -179.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.568 34.5 m -69.23 -35.21 66.81 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.079 0 N-CA-C 118.975 2.954 . . . . 0.0 118.975 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.468 ' CB ' HG23 ' A' ' 23' ' ' ILE . 27.7 mttt -74.72 -26.56 59.89 Favored 'General case' 0 C--N 1.32 -0.7 0 O-C-N 126.08 2.113 . . . . 0.0 113.326 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 21.3 ptt180 -79.4 -23.75 43.05 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 120.347 1.43 . . . . 0.0 108.794 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 15.1 tttp -78.19 -44.0 26.99 Favored 'General case' 0 C--O 1.211 -0.959 0 CA-C-O 122.809 1.29 . . . . 0.0 110.599 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 76.1 mt -73.83 -23.42 59.64 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 114.498 -1.228 . . . . 0.0 109.149 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -66.97 -51.28 40.79 Favored Glycine 0 C--O 1.212 -1.268 0 CA-C-O 123.816 1.787 . . . . 0.0 112.96 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.556 ' HB1' ' CE2' ' A' ' 14' ' ' TYR . . . -55.2 -35.27 64.67 Favored 'General case' 0 N--CA 1.436 -1.174 0 C-N-CA 128.574 2.749 . . . . 0.0 115.707 179.116 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.427 ' C ' ' CD2' ' A' ' 33' ' ' HIS . 12.0 t-160 -130.63 60.55 1.63 Allowed 'General case' 0 CA--C 1.506 -0.732 0 CA-C-N 112.028 -2.351 . . . . 0.0 111.996 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -96.37 -15.45 21.83 Favored 'General case' 0 C--O 1.216 -0.696 0 N-CA-C 117.281 2.326 . . . . 0.0 117.281 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 97.07 29.13 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.842 0 O-C-N 125.9 2.0 . . . . 0.0 111.921 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.416 HD23 ' HZ ' ' A' ' 128' ' ' PHE . 12.2 tp -65.94 81.8 0.08 Allowed 'General case' 0 CA--C 1.503 -0.84 0 CA-C-O 124.471 2.081 . . . . 0.0 110.396 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -90.24 88.97 7.44 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 101.873 -3.38 . . . . 0.0 101.873 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.447 ' HG ' HG23 ' A' ' 49' ' ' VAL . 1.0 OUTLIER -67.78 95.35 0.5 Allowed 'General case' 0 C--N 1.292 -1.932 0 C-N-CA 118.518 -1.273 . . . . 0.0 111.011 -179.18 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.414 ' HB ' ' CB ' ' A' ' 50' ' ' LYS . 39.6 m -81.4 104.83 12.12 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 101.781 -3.415 . . . . 0.0 101.781 179.355 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.648 HD12 ' CD1' ' A' ' 6' ' ' TRP . 83.7 mt -91.45 147.34 5.33 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 O-C-N 120.613 -1.304 . . . . 0.0 111.635 -179.457 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 4.3 m -145.43 101.87 3.64 Favored 'General case' 0 C--O 1.22 -0.494 0 O-C-N 127.062 2.726 . . . . 0.0 112.609 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 15.1 tp60 -82.97 98.64 9.35 Favored 'General case' 0 N--CA 1.443 -0.804 0 O-C-N 125.557 1.785 . . . . 0.0 110.678 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 49.2 tt0 -107.34 84.36 1.96 Allowed 'General case' 0 N--CA 1.438 -1.04 0 CA-C-O 125.657 2.646 . . . . 0.0 105.066 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 70.43 -87.62 0.34 Allowed Glycine 0 C--N 1.296 -1.646 0 CA-C-O 115.814 -2.659 . . . . 0.0 106.582 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.331 0.1 OUTLIER -124.39 -11.99 7.34 Favored 'General case' 0 C--N 1.32 -0.679 0 O-C-N 127.332 2.43 . . . . 0.0 112.535 179.917 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.42 ' HD2' ' CG ' ' A' ' 63' ' ' GLU . 0.0 OUTLIER -90.62 138.61 31.43 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 119.854 -1.779 . . . . 0.0 106.732 179.741 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.482 ' O ' ' N ' ' A' ' 49' ' ' VAL 0.342 3.8 m-85 -115.12 95.64 5.3 Favored 'General case' 0 N--CA 1.433 -1.285 0 C-N-CA 126.222 1.809 . . . . 0.0 107.633 179.777 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.768 ' CB ' HG13 ' A' ' 61' ' ' VAL 0.451 0.1 OUTLIER -67.38 79.53 0.16 Allowed 'General case' 0 N--CA 1.441 -0.875 0 CA-C-O 124.337 2.018 . . . . 0.0 110.594 179.477 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.859 HG13 ' HB ' ' A' ' 60' ' ' VAL 0.753 0.8 OUTLIER -59.57 75.83 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 CA-C-N 109.845 -3.343 . . . . 0.0 115.332 179.794 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.444 ' HA ' ' HA ' ' A' ' 59' ' ' ASP . 8.9 tttt -61.09 138.56 58.2 Favored 'General case' 0 C--N 1.317 -0.811 1 N-CA-C 99.964 -4.087 . . . . 0.0 99.964 179.742 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -133.71 105.16 6.67 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 102.431 -3.174 . . . . 0.0 102.431 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 54.1 p -104.1 44.85 0.99 Allowed 'General case' 0 C--N 1.288 -2.101 0 N-CA-C 105.95 -1.87 . . . . 0.0 105.95 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.7 t -67.89 149.03 50.35 Favored 'General case' 0 N--CA 1.466 0.335 0 O-C-N 127.322 2.889 . . . . 0.0 107.745 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -50.38 -21.78 1.58 Allowed 'General case' 0 C--O 1.221 -0.424 0 CA-C-N 120.656 1.571 . . . . 0.0 110.129 -179.425 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.404 ' CD1' ' CB ' ' A' ' 73' ' ' ALA . 19.8 m-85 -72.23 -49.96 31.07 Favored 'General case' 0 C--O 1.219 -0.529 0 C-N-CA 115.431 -2.507 . . . . 0.0 110.469 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.664 ' HB2' HG22 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -159.37 141.31 13.41 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 123.779 2.99 . . . . 0.0 110.522 -179.984 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 7.9 m-80 -97.56 78.4 2.65 Favored 'General case' 0 C--N 1.353 0.724 0 N-CA-C 100.36 -3.941 . . . . 0.0 100.36 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.664 HG22 ' HB2' ' A' ' 56' ' ' ARG . 2.6 tp -118.53 113.34 41.55 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.017 0 C-N-CA 131.155 3.782 . . . . 0.0 117.792 -179.243 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.444 ' HA ' ' HA ' ' A' ' 50' ' ' LYS . 3.9 p30 -59.18 149.39 28.41 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 104.357 -2.461 . . . . 0.0 104.357 178.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.859 ' HB ' HG13 ' A' ' 49' ' ' VAL . 3.2 t -101.89 -60.98 2.58 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 CA-C-O 124.696 2.189 . . . . 0.0 107.683 -177.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.768 HG13 ' CB ' ' A' ' 48' ' ' THR 0.458 0.0 OUTLIER 66.14 109.11 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.433 -1.319 0 CA-C-N 113.014 -1.903 . . . . 0.0 108.992 -179.519 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.441 ' CZ ' ' HA ' ' A' ' 81' ' ' THR . 2.3 t80 -145.53 114.76 7.07 Favored 'General case' 0 C--N 1.312 -1.06 0 C-N-CA 115.694 -2.402 . . . . 0.0 106.651 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.51 ' OE1' HG21 ' A' ' 66' ' ' VAL . 25.9 mt-10 -68.28 141.83 55.75 Favored 'General case' 0 C--O 1.247 0.95 0 N-CA-C 102.49 -3.152 . . . . 0.0 102.49 179.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.82 137.23 55.15 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 120.266 1.393 . . . . 0.0 107.944 -179.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 57.98 25.0 55.84 Favored Glycine 0 CA--C 1.531 1.056 0 N-CA-C 117.925 1.93 . . . . 0.0 117.925 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.51 HG21 ' OE1' ' A' ' 63' ' ' GLU 0.296 37.2 t -111.37 84.6 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 104.851 -2.277 . . . . 0.0 104.851 179.94 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -39.36 113.43 0.32 Allowed 'General case' 0 C--O 1.202 -1.424 0 O-C-N 126.41 2.319 . . . . 0.0 114.648 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.449 ' CD1' ' C ' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -106.8 -166.26 1.15 Allowed 'General case' 0 N--CA 1.422 -1.839 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 -179.599 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -131.53 137.09 48.36 Favored 'General case' 0 CA--C 1.51 -0.583 0 CA-C-O 116.872 -1.537 . . . . 0.0 107.025 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -146.94 113.04 5.82 Favored 'General case' 0 C--O 1.216 -0.672 0 C-N-CA 117.966 -1.493 . . . . 0.0 113.808 -179.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 47.1 t -91.18 151.34 20.99 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.6 mp -96.58 -169.93 1.98 Allowed 'General case' 0 CA--C 1.498 -1.049 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.404 ' CB ' ' CD1' ' A' ' 55' ' ' PHE . . . -89.45 -6.19 56.71 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-O 124.774 2.226 . . . . 0.0 111.691 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -153.79 -44.75 0.09 Allowed 'General case' 0 N--CA 1.433 -1.29 0 CA-C-N 112.787 -2.006 . . . . 0.0 112.133 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -64.85 -8.0 32.17 Favored Glycine 0 C--O 1.205 -1.692 0 O-C-N 124.769 1.293 . . . . 0.0 114.839 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . 0.372 0.1 OUTLIER 71.46 172.3 0.31 Allowed 'General case' 0 C--N 1.308 -1.219 0 O-C-N 118.197 -2.943 . . . . 0.0 114.947 -179.982 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -35.77 151.99 0.01 OUTLIER 'General case' 0 N--CA 1.434 -1.245 1 O-C-N 130.051 4.594 . . . . 0.0 116.407 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.429 HD11 HD22 ' A' ' 102' ' ' LEU 0.388 8.8 tp -153.63 165.25 36.51 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-N 112.715 -2.039 . . . . 0.0 105.782 -179.958 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -167.05 120.04 0.97 Allowed 'General case' 0 CA--C 1.503 -0.834 0 N-CA-C 105.201 -2.148 . . . . 0.0 105.201 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.442 ' HA3' ' HA ' ' A' ' 93' ' ' PHE . . . -168.65 -157.15 11.08 Favored Glycine 0 C--N 1.296 -1.669 0 C-N-CA 116.684 -2.674 . . . . 0.0 109.765 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.441 ' HA ' ' CZ ' ' A' ' 62' ' ' PHE . 2.8 p -144.98 159.91 42.18 Favored 'General case' 0 C--O 1.191 -2.026 0 O-C-N 126.553 1.973 . . . . 0.0 112.63 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . 0.461 ' CZ3' ' HG3' ' A' ' 106' ' ' ARG . 39.8 m95 -117.97 113.93 22.41 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 103.136 -2.913 . . . . 0.0 103.136 -179.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 4.0 t -122.85 139.09 54.4 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-O 122.199 1.0 . . . . 0.0 111.093 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 1.9 ttt -92.94 105.08 17.24 Favored 'General case' 0 N--CA 1.426 -1.674 0 CA-C-N 113.442 -1.708 . . . . 0.0 112.494 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . 0.532 0.6 OUTLIER -72.66 -143.98 0.01 OUTLIER 'General case' 0 N--CA 1.425 -1.719 0 O-C-N 125.008 1.443 . . . . 0.0 108.162 179.808 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -82.59 66.94 3.81 Favored Glycine 0 N--CA 1.45 -0.369 0 N-CA-C 105.447 -3.061 . . . . 0.0 105.447 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 96.74 -13.79 0.08 Allowed 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 117.293 2.331 . . . . 0.0 117.293 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . 0.409 0.0 OUTLIER -111.65 141.89 44.66 Favored 'General case' 0 C--O 1.215 -0.756 0 O-C-N 125.204 1.565 . . . . 0.0 107.714 179.869 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.499 HD13 ' CD ' ' A' ' 106' ' ' ARG . 1.0 OUTLIER -96.48 145.56 25.57 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 101.503 -3.517 . . . . 0.0 101.503 179.965 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.8 m -132.6 120.27 41.48 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 O-C-N 125.043 1.464 . . . . 0.0 109.596 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -100.27 87.08 0.69 Allowed Glycine 0 C--N 1.338 0.686 0 C-N-CA 128.358 2.885 . . . . 0.0 114.109 -179.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -90.67 148.11 22.83 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 102.388 -3.19 . . . . 0.0 102.388 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.744 ' HB2' HD23 ' A' ' 102' ' ' LEU . 15.7 m-85 -152.64 117.98 5.25 Favored 'General case' 0 CA--C 1.501 -0.906 0 C-N-CA 117.678 -1.609 . . . . 0.0 113.45 -179.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -88.36 -163.46 0.97 Allowed 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 -179.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . 0.334 0.2 OUTLIER -138.25 164.73 28.48 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 106.085 -1.82 . . . . 0.0 106.085 179.824 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 37.0 t -94.3 -40.01 11.0 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 C-N-CA 124.63 1.172 . . . . 0.0 108.537 -179.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . 0.287 0.2 OUTLIER -55.19 -30.66 60.38 Favored 'General case' 0 C--O 1.25 1.126 0 N-CA-C 114.681 1.363 . . . . 0.0 114.681 179.786 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -160.02 6.08 0.09 Allowed 'General case' 0 N--CA 1.44 -0.94 0 CA-C-O 115.809 -2.044 . . . . 0.0 116.428 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 54.02 85.01 0.03 OUTLIER Glycine 0 CA--C 1.524 0.612 0 N-CA-C 118.675 2.23 . . . . 0.0 118.675 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.0 mmtp -113.28 -111.37 0.34 Allowed 'General case' 0 C--O 1.213 -0.862 0 O-C-N 120.951 -1.323 . . . . 0.0 111.392 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 54.3 tt0 -177.75 162.24 1.72 Allowed 'General case' 0 C--O 1.211 -0.965 0 C-N-CA 127.954 2.502 . . . . 0.0 109.069 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.744 HD23 ' HB2' ' A' ' 93' ' ' PHE . 1.9 tp -158.29 109.16 2.15 Favored 'General case' 0 C--N 1.316 -0.887 0 C-N-CA 131.255 3.822 . . . . 0.0 102.653 -179.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.433 ' N ' ' O ' ' A' ' 118' ' ' THR . 0.8 OUTLIER -98.83 152.56 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.091 0 C-N-CA 115.093 -2.643 . . . . 0.0 105.532 -179.439 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.604 ' HA ' ' O ' ' A' ' 116' ' ' THR . . . -160.93 147.25 14.89 Favored 'General case' 0 C--N 1.309 -1.165 0 C-N-CA 124.733 1.213 . . . . 0.0 109.123 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.469 ' O ' HG12 ' A' ' 105' ' ' VAL . 0.9 OUTLIER -137.11 102.46 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 116.033 -2.267 . . . . 0.0 111.461 -179.028 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.499 ' CD ' HD13 ' A' ' 89' ' ' LEU 0.277 48.9 mtt180 -68.18 85.16 0.25 Allowed 'General case' 0 C--N 1.312 -1.029 0 O-C-N 126.562 2.414 . . . . 0.0 104.838 179.696 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.416 ' N ' ' O ' ' A' ' 105' ' ' VAL . 4.9 tt0 -79.52 76.38 6.13 Favored 'General case' 0 N--CA 1.424 -1.738 0 O-C-N 127.163 2.789 . . . . 0.0 117.765 -179.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.755 HD11 ' CH2' ' A' ' 6' ' ' TRP 0.426 0.9 OUTLIER -61.91 123.07 13.99 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 C-N-CA 116.112 -2.235 . . . . 0.0 108.41 179.65 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 7.0 m -102.63 10.67 38.56 Favored 'General case' 0 C--O 1.219 -0.54 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.564 ' H ' HG23 ' A' ' 108' ' ' ILE . . . 119.78 -60.21 0.52 Allowed Glycine 0 N--CA 1.444 -0.8 1 C-N-CA 132.266 4.746 . . . . 0.0 112.713 179.752 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -115.3 22.05 13.6 Favored 'General case' 0 C--N 1.314 -0.936 0 O-C-N 127.121 2.307 . . . . 0.0 111.681 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -149.42 99.62 2.93 Favored 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 120.299 -0.56 . . . . 0.0 111.33 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.459 ' O ' HD23 ' A' ' 113' ' ' LEU . 7.0 tt -84.02 101.61 11.88 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 100.878 -3.749 . . . . 0.0 100.878 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.911 HG12 HG23 ' A' ' 127' ' ' ILE 0.295 3.7 mt -107.2 118.67 55.41 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.09 0 O-C-N 126.013 2.07 . . . . 0.0 111.145 -179.416 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . 0.509 ' O ' ' N ' ' A' ' 126' ' ' ARG 0.316 76.1 mt-30 -89.83 149.67 22.57 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 100.433 -3.914 . . . . 0.0 100.433 177.487 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.828 ' CG2' HG22 ' A' ' 114' ' ' ILE . 79.9 p -160.65 179.09 8.85 Favored 'General case' 0 N--CA 1.422 -1.867 1 O-C-N 130.784 5.052 . . . . 0.0 106.615 -179.865 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.621 ' CE2' ' OG1' ' A' ' 116' ' ' THR 0.297 33.2 m-85 96.6 -142.76 0.0 OUTLIER 'General case' 0 CA--C 1.442 -3.205 0 N-CA-C 120.314 3.45 . . . . 0.0 120.314 174.922 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.603 ' O ' HD12 ' A' ' 102' ' ' LEU . 11.2 t -133.87 -174.11 3.44 Favored 'General case' 0 N--CA 1.417 -2.101 0 N-CA-C 120.342 3.46 . . . . 0.0 120.342 -174.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.717 ' HA ' ' HA ' ' A' ' 102' ' ' LEU 0.339 7.0 t80 -117.98 0.76 11.94 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 111.528 -2.578 . . . . 0.0 106.663 178.092 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.411 ' HB3' ' HE3' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -174.74 -84.03 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.274 0 O-C-N 119.537 -1.977 . . . . 0.0 111.256 179.456 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -138.87 32.99 2.24 Favored Glycine 0 CA--C 1.537 1.454 0 C-N-CA 127.432 2.444 . . . . 0.0 116.576 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 78.7 t -141.49 101.15 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 N-CA-C 105.73 -1.952 . . . . 0.0 105.73 -179.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.402 ' HA ' ' C ' ' A' ' 117' ' ' TYR . 1.8 mp0 -59.13 -179.67 0.08 Allowed 'General case' 0 C--O 1.207 -1.172 0 CA-C-O 123.785 1.755 . . . . 0.0 111.797 -179.464 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.658 ' HB2' ' CB ' ' A' ' 17' ' ' PHE . . . -168.08 76.21 0.13 Allowed 'General case' 0 CA--C 1.503 -0.847 0 C-N-CA 113.602 -3.239 . . . . 0.0 110.877 -178.043 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.568 ' HA ' ' CB ' ' A' ' 116' ' ' THR . 1.4 mptp? -57.58 144.69 36.35 Favored 'General case' 0 CA--C 1.508 -0.654 0 CA-C-N 123.897 3.044 . . . . 0.0 112.258 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.522 ' HA ' ' ND2' ' A' ' 11' ' ' ASN . 11.1 mtp180 -144.83 77.03 1.52 Allowed 'General case' 0 C--O 1.21 -0.978 0 C-N-CA 127.259 2.224 . . . . 0.0 105.565 178.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.911 HG23 HG12 ' A' ' 114' ' ' ILE . 0.8 OUTLIER -78.62 128.59 38.32 Favored 'Isoleucine or valine' 0 C--O 1.253 1.289 0 O-C-N 127.767 3.167 . . . . 0.0 116.794 179.77 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.583 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 0.1 OUTLIER -109.8 145.38 36.81 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 128.499 2.72 . . . . 0.0 107.122 179.917 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . 0.254 0.3 OUTLIER -112.67 29.13 8.2 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 117.051 -1.452 . . . . 0.0 112.286 -179.79 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.594 ' HB2' ' CZ3' ' A' ' 6' ' ' TRP . 3.3 tttp 50.37 89.26 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 127.397 2.279 . . . . 0.0 108.641 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . 0.773 64.0 mt-10 . . . . . 0 N--CA 1.426 -1.639 0 O-C-N 125.846 1.966 . . . . 0.0 113.6 -179.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.445 -0.716 0 N-CA-C 116.067 1.877 . . . . 0.0 116.067 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -43.85 93.74 0.01 OUTLIER 'General case' 0 CA--C 1.496 -1.126 0 O-C-N 126.141 2.15 . . . . 0.0 111.691 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 176.3 -178.28 47.71 Favored Glycine 0 C--N 1.31 -0.886 0 C-N-CA 117.343 -2.36 . . . . 0.0 111.527 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.569 HG23 HG23 ' A' ' 39' ' ' THR 0.377 1.2 p -94.02 155.12 17.29 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 128.641 3.201 . . . . 0.0 111.951 -179.735 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.71 ' NE1' HD12 ' A' ' 40' ' ' ILE . 49.2 m95 -159.75 -158.98 0.69 Allowed 'General case' 0 N--CA 1.426 -1.667 0 CA-C-O 114.63 -2.605 . . . . 0.0 106.393 177.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.757 ' HB3' ' CZ ' ' A' ' 128' ' ' PHE . 6.9 ttmt 178.91 -99.64 0.0 OUTLIER 'General case' 0 C--O 1.209 -1.073 0 O-C-N 129.007 3.942 . . . . 0.0 105.17 179.387 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.755 HG12 ' O ' ' A' ' 7' ' ' LYS 0.263 0.3 OUTLIER 159.3 120.13 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 O-C-N 126.329 2.268 . . . . 0.0 109.348 179.514 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 61.5 t0 -125.55 -76.48 0.59 Allowed 'General case' 0 CA--C 1.506 -0.746 0 CA-C-O 125.965 2.793 . . . . 0.0 108.043 -179.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -83.83 122.97 29.41 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 118.626 -2.547 . . . . 0.0 108.269 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . 0.319 0.0 OUTLIER -114.76 -171.12 1.87 Allowed 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 107.151 -1.425 . . . . 0.0 107.151 179.685 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.401 ' HB3' ' HD3' ' A' ' 125' ' ' LYS . 4.6 tt0 -170.53 109.89 0.36 Allowed 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 115.723 -2.391 . . . . 0.0 106.75 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.407 ' ND2' HG12 ' A' ' 122' ' ' VAL 0.259 0.2 OUTLIER 87.65 -8.08 0.59 Allowed 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 -179.852 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.703 ' CD1' ' HB1' ' A' ' 124' ' ' ALA 0.407 0.3 OUTLIER -68.09 -33.81 75.23 Favored 'General case' 0 C--N 1.321 -0.645 0 O-C-N 126.939 2.65 . . . . 0.0 115.6 179.882 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -71.97 -20.51 61.72 Favored 'General case' 0 C--O 1.213 -0.832 0 O-C-N 119.072 -2.268 . . . . 0.0 110.556 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 24.5 mttt -78.61 -40.88 33.23 Favored 'General case' 0 N--CA 1.443 -0.777 0 O-C-N 126.765 2.541 . . . . 0.0 112.494 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.544 ' CE1' ' HG2' ' A' ' 21' ' ' MET . 0.6 OUTLIER -68.41 -31.79 71.38 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-O 126.076 2.846 . . . . 0.0 110.681 179.702 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 28.4 mtm -69.23 -23.64 63.9 Favored 'General case' 0 C--O 1.22 -0.459 1 O-C-N 114.918 -4.864 . . . . 0.0 108.793 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -79.33 -32.97 43.45 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-O 127.603 3.573 . . . . 0.0 110.647 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.415 ' HD3' HG21 ' A' ' 122' ' ' VAL . 16.6 tptt -74.16 -25.4 59.7 Favored 'General case' 0 N--CA 1.433 -1.302 0 O-C-N 118.257 -2.777 . . . . 0.0 112.728 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.544 ' HG2' ' CE1' ' A' ' 17' ' ' PHE 0.257 13.6 mmm -75.73 -29.1 58.78 Favored 'General case' 0 C--O 1.202 -1.415 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 -179.933 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 103.95 29.12 5.63 Favored Glycine 0 CA--C 1.504 -0.619 0 CA-C-O 115.94 -2.589 . . . . 0.0 109.583 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.2 mm -69.42 141.78 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.956 0 CA-C-N 118.857 1.328 . . . . 0.0 109.863 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 24.9 t30 -80.65 131.99 35.54 Favored 'General case' 0 C--N 1.345 0.399 0 CA-C-O 113.742 -3.028 . . . . 0.0 108.503 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . 0.454 99.1 t -11.01 -51.54 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.503 -0.86 0 O-C-N 128.513 3.633 . . . . 0.0 119.262 -179.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.614 13.7 t -72.84 -40.1 59.96 Favored 'Isoleucine or valine' 0 C--O 1.249 1.044 0 N-CA-C 116.637 2.088 . . . . 0.0 116.637 -179.467 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 11.3 mttm -67.09 -32.35 73.45 Favored 'General case' 0 C--O 1.213 -0.853 0 O-C-N 125.632 1.832 . . . . 0.0 113.369 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.467 ' HG3' ' N ' ' A' ' 29' ' ' LYS . 16.4 ptt180 -78.96 -29.28 43.86 Favored 'General case' 0 CA--C 1.514 -0.432 0 O-C-N 120.337 -1.477 . . . . 0.0 109.449 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.467 ' N ' ' HG3' ' A' ' 28' ' ' ARG . 0.2 OUTLIER -72.66 -40.85 66.01 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-O 122.626 1.203 . . . . 0.0 110.67 179.955 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.0 tp -73.2 -28.61 62.29 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 113.484 -1.689 . . . . 0.0 108.625 -179.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -74.57 -28.98 62.32 Favored Glycine 0 C--N 1.348 1.219 0 CA-C-N 113.897 -1.501 . . . . 0.0 113.969 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -71.63 -37.97 70.82 Favored 'General case' 0 C--O 1.241 0.655 0 C-N-CA 126.89 2.076 . . . . 0.0 111.563 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 6.6 m80 -111.28 30.27 7.07 Favored 'General case' 0 N--CA 1.447 -0.594 0 O-C-N 126.786 2.554 . . . . 0.0 110.186 179.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -49.68 -36.63 25.69 Favored 'General case' 0 CA--C 1.501 -0.912 0 N-CA-C 116.813 2.153 . . . . 0.0 116.813 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . 0.261 22.3 m120 70.42 54.22 0.3 Allowed 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 116.114 -2.234 . . . . 0.0 107.122 -179.196 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.778 HD11 HD12 ' A' ' 38' ' ' LEU 0.293 1.7 tp -85.8 107.45 17.65 Favored 'General case' 0 N--CA 1.479 0.992 0 O-C-N 128.7 3.75 . . . . 0.0 103.747 179.911 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.43 ' HA ' ' CB ' ' A' ' 7' ' ' LYS . 24.4 tttm -92.77 127.98 38.46 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 100.473 -3.899 . . . . 0.0 100.473 179.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.778 HD12 HD11 ' A' ' 36' ' ' LEU 0.377 0.5 OUTLIER -112.05 121.4 44.87 Favored 'General case' 0 C--N 1.288 -2.09 0 C-N-CA 116.011 -2.275 . . . . 0.0 107.004 -178.5 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.569 HG23 HG23 ' A' ' 5' ' ' THR . 28.0 m -116.12 90.86 3.43 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 117.287 -3.383 . . . . 0.0 104.588 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.71 HD12 ' NE1' ' A' ' 6' ' ' TRP . 26.5 mt -70.36 130.16 34.6 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.467 ' HB ' HG23 ' A' ' 48' ' ' THR . 11.6 m -126.75 105.91 9.0 Favored 'General case' 0 N--CA 1.477 0.886 0 O-C-N 127.801 3.188 . . . . 0.0 109.734 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.578 ' HG2' ' CE1' ' A' ' 47' ' ' PHE . 1.0 OUTLIER -84.69 109.1 17.77 Favored 'General case' 0 C--O 1.24 0.6 0 N-CA-C 114.368 1.247 . . . . 0.0 114.368 -179.906 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -96.66 31.08 2.4 Favored 'General case' 0 N--CA 1.419 -1.991 0 O-C-N 121.214 -0.929 . . . . 0.0 109.857 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 97.41 -13.12 64.69 Favored Glycine 0 C--N 1.29 -1.99 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.376 0.0 OUTLIER -175.6 -50.59 0.01 OUTLIER 'General case' 0 C--O 1.213 -0.823 0 CA-C-O 126.132 2.872 . . . . 0.0 109.168 179.901 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 28.1 ttmt -64.89 115.9 5.81 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 113.048 -1.887 . . . . 0.0 110.504 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.578 ' CE1' ' HG2' ' A' ' 42' ' ' GLN . 0.9 OUTLIER -100.71 93.85 5.78 Favored 'General case' 0 CA--C 1.499 -0.995 0 CA-C-O 123.312 1.529 . . . . 0.0 107.271 179.803 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.526 ' HA ' ' HA ' ' A' ' 61' ' ' VAL 0.388 3.1 t -89.72 87.39 6.98 Favored 'General case' 0 N--CA 1.432 -1.347 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 179.623 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.794 HG12 ' CG1' ' A' ' 60' ' ' VAL 0.596 0.5 OUTLIER -70.09 107.93 2.03 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.12 0 O-C-N 125.884 1.99 . . . . 0.0 110.334 179.981 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.55 ' CB ' ' HB ' ' A' ' 39' ' ' THR . 26.0 tttm -68.9 115.97 8.83 Favored 'General case' 0 C--N 1.302 -1.46 1 N-CA-C 100.192 -4.003 . . . . 0.0 100.192 -179.731 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.476 ' HG3' HD13 ' A' ' 36' ' ' LEU 0.276 69.9 tt0 -107.29 96.32 6.33 Favored 'General case' 0 C--N 1.322 -0.63 0 O-C-N 126.659 2.474 . . . . 0.0 108.484 179.906 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.427 ' HA ' ' HA ' ' A' ' 57' ' ' ASN 0.261 0.1 OUTLIER -96.48 52.37 1.23 Allowed 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 105.201 -2.148 . . . . 0.0 105.201 179.378 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.538 ' HA ' ' HA ' ' A' ' 36' ' ' LEU . 0.1 OUTLIER -77.97 160.23 28.32 Favored 'General case' 0 C--O 1.214 -0.781 0 O-C-N 127.552 3.032 . . . . 0.0 109.882 -179.537 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -53.65 -28.26 32.07 Favored 'General case' 0 C--O 1.215 -0.724 0 O-C-N 126.477 2.361 . . . . 0.0 108.633 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.413 ' C ' ' HG2' ' A' ' 56' ' ' ARG . 8.0 m-85 -62.27 -58.8 6.39 Favored 'General case' 0 C--N 1.351 0.639 0 CA-C-O 115.201 -2.333 . . . . 0.0 109.612 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.658 ' HB2' HG22 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -156.85 155.91 32.27 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-N 123.399 2.818 . . . . 0.0 106.102 179.414 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.427 ' HA ' ' HA ' ' A' ' 52' ' ' SER 0.262 21.2 t30 -101.07 70.94 1.37 Allowed 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 100.364 -3.939 . . . . 0.0 100.364 179.67 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.658 HG22 ' HB2' ' A' ' 56' ' ' ARG . 8.4 tp -120.03 122.98 69.88 Favored 'Isoleucine or valine' 0 C--O 1.243 0.728 0 C-N-CA 130.146 3.378 . . . . 0.0 118.697 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.436 ' HA ' ' HA ' ' A' ' 50' ' ' LYS . 0.0 OUTLIER -72.58 135.66 45.6 Favored 'General case' 0 N--CA 1.468 0.441 0 O-C-N 118.694 -2.504 . . . . 0.0 105.466 179.856 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.794 ' CG1' HG12 ' A' ' 49' ' ' VAL . 4.4 p -109.96 101.13 12.13 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-O 126.177 2.894 . . . . 0.0 111.407 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.526 ' HA ' ' HA ' ' A' ' 48' ' ' THR 0.311 2.0 m -88.56 131.2 36.62 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 O-C-N 116.684 -3.76 . . . . 0.0 113.061 179.858 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.443 ' HE1' HG13 ' A' ' 60' ' ' VAL . 22.1 p90 -151.58 89.02 1.45 Allowed 'General case' 0 N--CA 1.442 -0.827 0 C-N-CA 116.579 -2.049 . . . . 0.0 107.128 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -56.08 134.64 52.79 Favored 'General case' 0 N--CA 1.432 -1.362 0 N-CA-C 104.438 -2.43 . . . . 0.0 104.438 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -49.63 102.81 0.04 OUTLIER 'General case' 0 N--CA 1.428 -1.565 0 O-C-N 126.407 2.317 . . . . 0.0 110.515 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 89.73 32.19 10.4 Favored Glycine 0 C--N 1.346 1.115 0 C-N-CA 128.289 2.852 . . . . 0.0 119.924 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . 0.364 0.4 OUTLIER -111.42 99.16 8.1 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 N-CA-C 104.902 -2.258 . . . . 0.0 104.902 179.91 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.42 ' HA ' HG22 ' A' ' 81' ' ' THR . 0.1 OUTLIER -51.47 136.93 25.01 Favored 'General case' 0 CA--C 1.487 -1.45 0 O-C-N 126.079 2.112 . . . . 0.0 114.153 179.971 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 9.9 p90 -145.62 175.08 10.63 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -129.46 146.77 51.26 Favored 'General case' 0 CA--C 1.501 -0.924 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.51 ' HB3' HD23 ' A' ' 78' ' ' LEU . 16.5 t80 -129.96 -39.78 1.38 Allowed 'General case' 0 C--O 1.213 -0.863 0 CA-C-O 116.118 -1.896 . . . . 0.0 111.806 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.545 ' C ' HD22 ' A' ' 72' ' ' LEU . 0.7 OUTLIER 64.39 158.44 0.09 Allowed 'General case' 0 C--N 1.308 -1.2 0 O-C-N 125.366 1.666 . . . . 0.0 112.056 -179.904 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.797 ' N ' HD13 ' A' ' 72' ' ' LEU . 0.0 OUTLIER 41.55 -158.7 0.01 OUTLIER 'General case' 0 C--N 1.293 -1.873 0 O-C-N 128.351 3.532 . . . . 0.0 110.424 178.369 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.404 ' O ' ' CB ' ' A' ' 74' ' ' ASP . . . 53.97 35.93 23.16 Favored 'General case' 0 C--O 1.208 -1.094 0 CA-C-N 114.237 -1.347 . . . . 0.0 111.444 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.404 ' CB ' ' O ' ' A' ' 73' ' ' ALA . 0.3 OUTLIER 102.34 19.84 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.365 0 O-C-N 126.565 2.415 . . . . 0.0 113.89 179.22 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.571 ' HA3' ' CD1' ' A' ' 78' ' ' LEU . . . -136.87 -38.63 0.15 Allowed Glycine 0 CA--C 1.549 2.174 0 N-CA-C 118.434 2.134 . . . . 0.0 118.434 179.025 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . 0.308 0.0 OUTLIER 59.28 65.95 1.1 Allowed 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 119.662 1.731 . . . . 0.0 107.897 -179.026 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.569 ' HB3' ' HB ' ' A' ' 96' ' ' VAL . 31.0 mt-10 71.81 76.39 0.17 Allowed 'General case' 0 C--O 1.218 -0.594 0 O-C-N 126.518 2.386 . . . . 0.0 108.529 -178.212 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.571 ' CD1' ' HA3' ' A' ' 75' ' ' GLY 0.436 0.7 OUTLIER -97.63 135.11 39.92 Favored 'General case' 0 CA--C 1.5 -0.978 0 O-C-N 127.764 3.165 . . . . 0.0 104.38 -178.162 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 20.2 m -158.13 124.72 4.82 Favored 'General case' 0 CA--C 1.481 -1.696 0 N-CA-C 103.919 -2.623 . . . . 0.0 103.919 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -168.61 -155.49 9.66 Favored Glycine 0 C--N 1.302 -1.313 0 O-C-N 119.748 -1.845 . . . . 0.0 109.316 -179.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.42 HG22 ' HA ' ' A' ' 67' ' ' ASP . 4.2 p -145.17 -179.97 6.98 Favored 'General case' 0 C--O 1.196 -1.73 0 C-N-CA 117.23 -1.788 . . . . 0.0 106.965 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . 0.472 ' CE2' ' HA3' ' A' ' 91' ' ' GLY . 19.7 m95 -132.27 142.88 49.55 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 101.689 -3.449 . . . . 0.0 101.689 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 14.4 t -143.77 160.96 39.82 Favored 'General case' 0 N--CA 1.417 -2.078 0 CA-C-O 124.948 2.309 . . . . 0.0 113.195 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -94.91 126.97 40.6 Favored 'General case' 0 C--N 1.354 0.8 0 CA-C-N 110.774 -2.921 . . . . 0.0 105.775 -179.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . 0.685 0.5 OUTLIER -107.24 33.72 3.85 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.88 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 95.26 -93.43 1.6 Allowed Glycine 0 N--CA 1.427 -1.953 0 N-CA-C 103.986 -3.646 . . . . 0.0 103.986 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -88.96 -5.84 57.68 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 120.154 3.39 . . . . 0.0 120.154 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.4 ' HE2' HG21 ' A' ' 105' ' ' VAL 0.265 0.2 OUTLIER -129.91 152.53 49.28 Favored 'General case' 0 CA--C 1.49 -1.354 0 O-C-N 125.163 1.54 . . . . 0.0 107.182 179.678 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.43 ' HB3' ' HB2' ' A' ' 106' ' ' ARG . 0.3 OUTLIER -106.21 134.15 49.79 Favored 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 105.039 -2.208 . . . . 0.0 105.039 -179.864 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -121.76 154.1 25.94 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.941 0 N-CA-C 105.276 -2.12 . . . . 0.0 105.276 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.472 ' HA3' ' CE2' ' A' ' 82' ' ' TRP . . . -134.96 111.61 0.94 Allowed Glycine 0 CA--C 1.531 1.04 1 C-N-CA 131.06 4.171 . . . . 0.0 109.509 179.898 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 24.8 mtmt -109.16 158.53 17.71 Favored 'General case' 0 N--CA 1.426 -1.651 0 N-CA-C 104.374 -2.454 . . . . 0.0 104.374 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.548 ' HB2' HD22 ' A' ' 102' ' ' LEU . 30.5 m-85 -148.36 112.95 5.34 Favored 'General case' 0 CA--C 1.508 -0.635 0 CA-C-O 123.378 1.561 . . . . 0.0 108.079 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 57.0 mttm -93.39 138.91 31.27 Favored 'General case' 0 N--CA 1.437 -1.104 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . 0.302 0.3 OUTLIER -92.15 136.61 33.04 Favored 'General case' 0 CA--C 1.491 -1.293 0 CA-C-N 113.55 -1.659 . . . . 0.0 109.106 179.75 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.569 ' HB ' ' HB3' ' A' ' 77' ' ' GLU . 38.4 t -71.98 -38.13 63.12 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 C-N-CA 125.277 1.431 . . . . 0.0 111.166 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . 0.319 0.8 OUTLIER -83.24 2.64 34.85 Favored 'General case' 0 C--O 1.261 1.665 0 N-CA-C 118.103 2.631 . . . . 0.0 118.103 -179.959 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -144.28 -29.22 0.49 Allowed 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 116.197 -2.201 . . . . 0.0 114.843 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 92.48 -0.16 70.72 Favored Glycine 0 CA--C 1.532 1.129 0 N-CA-C 118.956 2.343 . . . . 0.0 118.956 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 6.4 mmtt -77.61 -155.1 0.07 Allowed 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 119.299 1.55 . . . . 0.0 111.331 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.55 118.58 4.7 Favored 'General case' 0 CA--C 1.489 -1.375 0 C-N-CA 128.983 2.913 . . . . 0.0 114.541 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.627 ' HA ' ' HA ' ' A' ' 119' ' ' TYR . 0.7 OUTLIER -92.23 135.87 33.65 Favored 'General case' 0 C--N 1.317 -0.812 1 C-N-CA 132.484 4.314 . . . . 0.0 102.741 179.073 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.85 HG23 ' HB3' ' A' ' 117' ' ' TYR . 14.0 tt -129.34 163.72 33.76 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.003 0 C-N-CA 116.524 -2.07 . . . . 0.0 109.395 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -150.39 146.77 26.9 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-O 115.658 -2.115 . . . . 0.0 107.808 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.593 ' HB ' ' CE2' ' A' ' 117' ' ' TYR . 8.8 p -136.53 120.8 24.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 122.915 2.598 . . . . 0.0 110.466 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.789 ' HG2' HH11 ' A' ' 106' ' ' ARG . 1.2 mtt-85 -76.95 86.65 3.48 Favored 'General case' 0 CA--C 1.496 -1.105 0 O-C-N 126.66 2.475 . . . . 0.0 106.689 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 10.7 tt0 -81.65 78.67 8.37 Favored 'General case' 0 N--CA 1.424 -1.742 0 CA-C-O 123.104 1.431 . . . . 0.0 113.031 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.525 ' CD1' ' CZ2' ' A' ' 6' ' ' TRP . 2.3 mm -69.01 98.06 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 C-N-CA 115.537 -2.465 . . . . 0.0 110.296 179.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -100.1 101.43 12.49 Favored 'General case' 0 C--O 1.215 -0.742 0 N-CA-C 103.254 -2.869 . . . . 0.0 103.254 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 65.41 -88.8 0.1 Allowed Glycine 0 C--N 1.339 0.695 0 O-C-N 126.061 2.101 . . . . 0.0 112.138 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . 0.368 0.4 OUTLIER -117.82 -13.57 10.12 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-O 113.313 -3.232 . . . . 0.0 111.158 179.562 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . 0.251 2.2 mp0 -93.6 133.42 36.95 Favored 'General case' 0 C--O 1.212 -0.879 0 O-C-N 128.905 3.878 . . . . 0.0 110.89 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.909 HD21 ' HG2' ' A' ' 115' ' ' GLN 0.284 0.4 OUTLIER -103.06 141.74 35.3 Favored 'General case' 0 C--O 1.21 -1.011 0 N-CA-C 101.321 -3.585 . . . . 0.0 101.321 179.721 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.762 HG13 HD13 ' A' ' 127' ' ' ILE 0.297 1.4 mp -129.95 139.0 52.64 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 N-CA-C 101.706 -3.442 . . . . 0.0 101.706 179.385 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . 0.909 ' HG2' HD21 ' A' ' 113' ' ' LEU . 3.4 mt-30 -119.24 104.91 10.83 Favored 'General case' 0 C--N 1.316 -0.851 1 O-C-N 129.621 4.325 . . . . 0.0 101.492 179.699 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.53 ' HB ' ' HG3' ' A' ' 125' ' ' LYS . 3.4 t -140.68 157.68 45.09 Favored 'General case' 0 N--CA 1.412 -2.371 0 C-N-CA 116.924 -1.91 . . . . 0.0 112.357 -178.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.85 ' HB3' HG23 ' A' ' 103' ' ' ILE 0.372 22.2 m-30 137.93 -138.36 0.0 OUTLIER 'General case' 0 CA--C 1.484 -1.584 1 O-C-N 129.408 4.193 . . . . 0.0 113.171 176.246 . . . . . . . . 4 3 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.502 ' HB ' ' HA ' ' A' ' 123' ' ' GLU . 10.2 t -158.67 -154.33 0.42 Allowed 'General case' 0 C--N 1.308 -1.229 0 O-C-N 127.674 3.109 . . . . 0.0 115.756 -174.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.627 ' HA ' ' HA ' ' A' ' 102' ' ' LEU . 1.7 t80 -114.9 -55.94 2.43 Favored 'General case' 0 C--N 1.346 0.417 0 N-CA-C 105.126 -2.176 . . . . 0.0 105.126 178.305 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.88 -83.37 0.65 Allowed 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 111.59 -2.55 . . . . 0.0 112.396 179.203 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -143.55 25.29 2.15 Favored Glycine 0 C--N 1.366 2.238 0 N-CA-C 121.359 3.303 . . . . 0.0 121.359 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.415 HG21 ' HD3' ' A' ' 20' ' ' LYS . 15.0 t -123.34 97.35 4.63 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 N-CA-C 103.011 -2.959 . . . . 0.0 103.011 179.253 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.502 ' HA ' ' HB ' ' A' ' 118' ' ' THR . 13.6 mt-10 -56.86 179.77 0.04 OUTLIER 'General case' 0 C--O 1.205 -1.289 0 CA-C-O 126.554 3.073 . . . . 0.0 113.093 -177.418 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.703 ' HB1' ' CD1' ' A' ' 14' ' ' TYR . . . -169.17 94.5 0.31 Allowed 'General case' 0 C--O 1.211 -0.961 0 O-C-N 118.821 -2.424 . . . . 0.0 107.987 -179.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.53 ' HG3' ' HB ' ' A' ' 116' ' ' THR 0.391 0.1 OUTLIER -84.92 153.72 22.67 Favored 'General case' 0 N--CA 1.444 -0.727 0 O-C-N 125.923 2.014 . . . . 0.0 112.529 -179.572 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.549 ' CD ' ' HB2' ' A' ' 115' ' ' GLN . 1.0 OUTLIER -137.81 77.83 1.65 Allowed 'General case' 0 N--CA 1.427 -1.598 0 O-C-N 127.57 3.044 . . . . 0.0 105.297 177.114 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.762 HD13 HG13 ' A' ' 114' ' ' ILE . 50.8 mm -66.99 82.79 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.259 1.557 0 O-C-N 128.051 3.344 . . . . 0.0 111.202 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.757 ' CZ ' ' HB3' ' A' ' 7' ' ' LYS 0.368 5.7 t80 -84.44 144.39 28.79 Favored 'General case' 0 N--CA 1.419 -2.001 0 CA-C-O 125.256 2.455 . . . . 0.0 113.753 -179.641 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.407 ' N ' ' CG ' ' A' ' 128' ' ' PHE 0.391 8.7 mmtt -95.28 10.53 35.82 Favored 'General case' 0 N--CA 1.436 -1.147 0 CA-C-N 110.996 -2.82 . . . . 0.0 113.996 -177.666 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.509 ' HA ' ' CE3' ' A' ' 6' ' ' TRP . 18.4 tttt 61.53 111.7 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 122.555 2.434 . . . . 0.0 113.666 -178.39 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . 0.857 2.3 tm-20 . . . . . 0 C--O 1.217 -0.612 0 O-C-N 117.167 -3.458 . . . . 0.0 114.508 -179.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . 0.684 ' CE1' HD12 ' A' ' 108' ' ' ILE . 65.4 m-85 . . . . . 0 N--CA 1.451 -0.406 0 N-CA-C 116.353 1.983 . . . . 0.0 116.353 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -39.78 91.39 0.0 OUTLIER 'General case' 0 CA--C 1.499 -0.984 0 O-C-N 126.678 2.486 . . . . 0.0 111.34 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . 0.43 ' O ' ' HB ' ' A' ' 40' ' ' ILE . . . 158.69 -174.71 35.78 Favored Glycine 0 C--O 1.214 -1.114 0 CA-C-N 113.824 -1.534 . . . . 0.0 110.91 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.582 ' HA ' ' HA ' ' A' ' 39' ' ' THR 0.549 0.5 OUTLIER -81.93 156.88 24.52 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-O 124.426 2.06 . . . . 0.0 115.774 -179.697 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.54 ' CH2' HD11 ' A' ' 108' ' ' ILE . 73.1 m95 -149.8 157.3 43.07 Favored 'General case' 0 N--CA 1.435 -1.182 0 CA-C-N 110.647 -2.979 . . . . 0.0 106.858 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -160.27 102.54 1.41 Allowed 'General case' 0 C--O 1.214 -0.79 1 O-C-N 129.59 4.306 . . . . 0.0 107.081 179.922 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.527 ' HB ' ' CD1' ' A' ' 128' ' ' PHE 0.38 9.3 p -47.12 139.35 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.289 0 CA-C-N 121.593 1.997 . . . . 0.0 113.131 179.992 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -131.61 0.98 4.03 Favored 'General case' 0 CA--C 1.496 -1.099 0 C-N-CA 119.785 -0.766 . . . . 0.0 112.55 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 16.6 ptp180 -160.79 -39.06 0.05 OUTLIER 'General case' 0 CA--C 1.474 -1.967 0 O-C-N 116.946 -3.596 . . . . 0.0 113.301 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . 0.278 0.6 OUTLIER 62.09 178.79 0.13 Allowed 'General case' 0 C--O 1.243 0.742 0 C-N-CA 125.293 1.437 . . . . 0.0 108.193 179.613 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -132.34 -80.2 0.5 Allowed 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 122.478 2.399 . . . . 0.0 109.635 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 16.5 t30 -96.05 15.46 20.62 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 124.799 1.312 . . . . 0.0 113.576 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.876 ' HA ' ' HB1' ' A' ' 124' ' ' ALA 0.26 0.1 OUTLIER -58.0 -26.87 62.94 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 117.978 2.584 . . . . 0.0 117.978 -179.952 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -72.12 -41.32 67.37 Favored 'General case' 0 C--O 1.207 -1.168 0 O-C-N 120.822 -1.174 . . . . 0.0 110.794 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 17.8 tttm -79.72 -26.37 40.83 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-O 123.175 1.464 . . . . 0.0 114.161 -179.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.676 ' CB ' ' HB2' ' A' ' 124' ' ' ALA . 7.8 t80 -67.05 -35.67 80.37 Favored 'General case' 0 N--CA 1.422 -1.838 0 C-N-CA 118.509 -1.276 . . . . 0.0 113.752 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.451 ' CB ' HG13 ' A' ' 23' ' ' ILE . 24.2 mtt -72.51 -23.7 61.05 Favored 'General case' 0 N--CA 1.425 -1.714 0 CA-C-O 124.561 2.124 . . . . 0.0 107.81 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -76.85 -22.94 52.78 Favored 'General case' 0 CA--C 1.507 -0.689 0 C-N-CA 116.54 -2.064 . . . . 0.0 112.777 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 18.9 tptp -68.0 -39.69 83.17 Favored 'General case' 0 C--N 1.314 -0.936 0 O-C-N 118.827 -2.42 . . . . 0.0 114.889 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.514 ' HG3' ' CD2' ' A' ' 119' ' ' TYR . 3.2 mpp? -76.03 -37.57 58.23 Favored 'General case' 0 C--O 1.207 -1.132 0 C-N-CA 124.527 1.131 . . . . 0.0 109.429 179.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 118.73 47.91 0.39 Allowed Glycine 0 C--N 1.308 -1.016 0 CA-C-N 113.05 -1.886 . . . . 0.0 110.01 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.571 HG22 ' HG2' ' A' ' 28' ' ' ARG . 5.4 mm -73.15 106.56 3.22 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.784 0 CA-C-N 121.735 2.768 . . . . 0.0 110.565 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -44.82 111.21 0.29 Allowed 'General case' 0 N--CA 1.44 -0.94 0 CA-C-O 114.136 -2.84 . . . . 0.0 113.019 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . 0.421 0.2 OUTLIER 3.76 -61.78 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.497 -1.076 1 O-C-N 129.463 4.227 . . . . 0.0 119.309 179.89 . . . . . . . . 4 3 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.579 13.3 m -72.59 -22.24 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.906 0 N-CA-C 117.53 2.419 . . . . 0.0 117.53 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.43 ' HB2' ' CG2' ' A' ' 23' ' ' ILE . 26.5 mttp -77.0 -25.97 53.31 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-O 118.406 -0.807 . . . . 0.0 110.918 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.571 ' HG2' HG22 ' A' ' 23' ' ' ILE . 0.1 OUTLIER -79.98 -24.44 40.91 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 117.934 -1.506 . . . . 0.0 107.495 179.882 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.8 ttpt -74.84 -49.76 19.45 Favored 'General case' 0 C--O 1.212 -0.893 0 CA-C-O 123.819 1.771 . . . . 0.0 108.711 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.428 ' HA ' HD12 ' A' ' 30' ' ' LEU . 7.3 tp -73.25 -28.85 62.37 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 114.56 -1.2 . . . . 0.0 108.348 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -67.55 -32.64 79.23 Favored Glycine 0 CA--C 1.538 1.474 0 O-C-N 124.843 1.34 . . . . 0.0 112.219 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -78.05 -24.35 47.8 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -112.81 2.41 15.96 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-O 115.903 -1.999 . . . . 0.0 112.363 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 21.5 p-10 -33.46 -32.51 0.01 OUTLIER 'General case' 0 CA--C 1.505 -0.766 0 N-CA-C 117.922 2.564 . . . . 0.0 117.922 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . 0.259 4.5 t-20 75.42 31.03 0.79 Allowed 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 121.386 1.903 . . . . 0.0 109.561 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.584 ' CG ' HD13 ' A' ' 38' ' ' LEU . 1.2 tp -60.97 87.83 0.02 OUTLIER 'General case' 0 C--O 1.213 -0.863 0 O-C-N 126.925 2.641 . . . . 0.0 109.602 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.82 104.15 16.63 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 102.122 -3.288 . . . . 0.0 102.122 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.584 HD13 ' CG ' ' A' ' 36' ' ' LEU 0.265 0.6 OUTLIER -90.47 104.13 16.74 Favored 'General case' 0 C--N 1.288 -2.089 0 O-C-N 125.921 2.013 . . . . 0.0 109.384 -179.901 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.582 ' HA ' ' HA ' ' A' ' 5' ' ' THR . 6.9 m -87.18 85.62 7.22 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 102.021 -3.326 . . . . 0.0 102.021 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.656 HD13 HG12 ' A' ' 49' ' ' VAL . 6.4 mm -60.0 131.44 24.66 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 CA-C-O 124.191 1.948 . . . . 0.0 110.68 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.428 HG22 ' O ' ' A' ' 41' ' ' THR . 3.0 m -150.34 103.4 3.15 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 112.915 -1.948 . . . . 0.0 114.575 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.44 ' HG2' ' CE1' ' A' ' 47' ' ' PHE . 1.6 mm-40 -49.21 117.73 2.31 Favored 'General case' 0 CA--C 1.547 0.847 0 O-C-N 126.479 2.362 . . . . 0.0 107.992 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.477 ' HB2' HG22 ' A' ' 48' ' ' THR 0.252 1.2 tp10 -90.86 45.65 1.27 Allowed 'General case' 0 CA--C 1.484 -1.562 0 O-C-N 124.816 1.322 . . . . 0.0 107.494 -179.46 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.02 -55.82 5.05 Favored Glycine 0 C--N 1.292 -1.912 0 N-CA-C 105.657 -2.977 . . . . 0.0 105.657 -179.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.503 ' HB2' ' CG ' ' A' ' 63' ' ' GLU 0.318 4.5 m-20 -108.13 -76.9 0.6 Allowed 'General case' 0 CA--C 1.504 -0.805 0 N-CA-C 115.158 1.54 . . . . 0.0 115.158 -179.449 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.712 ' HG3' ' N ' ' A' ' 47' ' ' PHE . 26.1 tptt -83.64 -76.85 0.27 Allowed 'General case' 0 N--CA 1.417 -2.093 0 C-N-CA 114.594 -2.842 . . . . 0.0 115.112 -178.346 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.712 ' N ' ' HG3' ' A' ' 46' ' ' LYS 0.422 0.1 OUTLIER 162.77 108.78 0.0 OUTLIER 'General case' 0 CA--C 1.496 -1.127 0 O-C-N 128.398 3.561 . . . . 0.0 109.423 -174.761 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.875 ' HA ' ' HA ' ' A' ' 61' ' ' VAL 0.407 9.0 t -81.63 112.33 18.73 Favored 'General case' 0 C--O 1.248 0.992 0 O-C-N 119.458 -2.026 . . . . 0.0 106.118 178.316 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.656 HG12 HD13 ' A' ' 40' ' ' ILE 0.615 1.0 OUTLIER -90.47 105.04 15.9 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 N-CA-C 116.117 1.895 . . . . 0.0 116.117 -179.606 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.458 ' CB ' ' HB ' ' A' ' 39' ' ' THR . 0.4 OUTLIER -67.4 111.3 3.98 Favored 'General case' 0 C--N 1.302 -1.487 1 N-CA-C 99.836 -4.135 . . . . 0.0 99.836 179.351 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -96.82 67.9 2.33 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 104.173 -2.528 . . . . 0.0 104.173 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.7 m -78.67 68.4 4.64 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 105.417 -2.068 . . . . 0.0 105.417 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.553 ' CB ' ' HA ' ' A' ' 36' ' ' LEU . 1.1 p -109.66 -167.51 1.21 Allowed 'General case' 0 N--CA 1.438 -1.033 0 CA-C-N 114.76 -1.109 . . . . 0.0 110.057 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -75.58 -24.22 56.59 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 117.867 -1.533 . . . . 0.0 111.457 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.52 ' CE2' ' HA ' ' A' ' 73' ' ' ALA . 31.8 m-85 -69.29 -50.55 45.71 Favored 'General case' 0 C--O 1.221 -0.423 0 C-N-CA 115.47 -2.492 . . . . 0.0 111.042 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.405 ' O ' HG22 ' A' ' 58' ' ' ILE . 0.0 OUTLIER 168.6 151.82 0.03 OUTLIER 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 123.916 3.053 . . . . 0.0 110.351 179.208 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -84.34 116.36 22.98 Favored 'General case' 0 C--N 1.348 0.535 1 N-CA-C 99.892 -4.114 . . . . 0.0 99.892 179.056 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.405 HG22 ' O ' ' A' ' 56' ' ' ARG 0.299 0.0 OUTLIER -136.52 -28.02 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 O-C-N 128.524 3.64 . . . . 0.0 116.622 -178.223 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 67.46 79.05 0.23 Allowed 'General case' 0 C--N 1.352 0.701 0 N-CA-C 104.096 -2.557 . . . . 0.0 104.096 -178.57 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.583 ' CG1' ' CE2' ' A' ' 62' ' ' PHE . 94.2 t -86.72 77.61 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.408 0 CA-C-N 114.3 -1.318 . . . . 0.0 114.257 -177.254 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.875 ' HA ' ' HA ' ' A' ' 48' ' ' THR . 0.4 OUTLIER -69.6 143.03 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.378 0 O-C-N 118.749 -2.469 . . . . 0.0 106.923 177.334 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.656 ' CE1' ' CB ' ' A' ' 68' ' ' PHE . 1.6 m-30 -144.31 57.88 1.32 Allowed 'General case' 0 N--CA 1.44 -0.945 0 C-N-CA 114.392 -2.923 . . . . 0.0 111.839 178.235 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.672 ' CA ' ' HB2' ' A' ' 46' ' ' LYS . 1.2 mt-10 -19.61 119.66 0.02 OUTLIER 'General case' 0 C--N 1.311 -1.071 0 O-C-N 128.601 3.688 . . . . 0.0 108.682 -178.115 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.546 ' N ' ' HB2' ' A' ' 46' ' ' LYS . 0.4 OUTLIER -48.11 101.83 0.03 OUTLIER 'General case' 0 N--CA 1.438 -1.032 0 CA-C-O 122.761 1.267 . . . . 0.0 110.979 -177.387 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 93.38 22.25 27.4 Favored Glycine 0 C--N 1.351 1.415 0 CA-C-N 110.793 -2.912 . . . . 0.0 114.0 -179.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.411 ' N ' ' O ' ' A' ' 63' ' ' GLU 0.364 0.9 OUTLIER -102.7 77.79 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 N-CA-C 104.015 -2.587 . . . . 0.0 104.015 179.796 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -39.17 111.71 0.2 Allowed 'General case' 0 CA--C 1.485 -1.55 0 O-C-N 126.895 2.622 . . . . 0.0 115.929 -179.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.656 ' CB ' ' CE1' ' A' ' 62' ' ' PHE . 17.1 p90 -106.7 -179.68 4.01 Favored 'General case' 0 N--CA 1.433 -1.306 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.533 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -144.69 148.3 34.05 Favored 'General case' 0 CA--C 1.521 -0.161 0 O-C-N 126.702 2.501 . . . . 0.0 109.183 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.456 ' CB ' HD22 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -146.31 118.94 8.55 Favored 'General case' 0 C--O 1.216 -0.679 0 O-C-N 125.274 1.609 . . . . 0.0 107.28 -179.997 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.452 ' C ' ' CD1' ' A' ' 72' ' ' LEU . 0.7 OUTLIER -99.84 37.68 1.58 Allowed 'General case' 0 CA--C 1.489 -1.37 0 CA-C-N 121.366 1.893 . . . . 0.0 112.133 -179.255 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.575 ' N ' HD13 ' A' ' 72' ' ' LEU . 0.0 OUTLIER 173.61 -167.59 0.03 OUTLIER 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 125.14 1.376 . . . . 0.0 109.199 -179.094 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.52 ' HA ' ' CE2' ' A' ' 55' ' ' PHE . . . 69.74 24.82 5.28 Favored 'General case' 0 C--O 1.208 -1.101 0 O-C-N 124.711 1.257 . . . . 0.0 110.352 -179.307 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.465 ' CB ' ' O ' ' A' ' 73' ' ' ALA . 27.8 t0 106.89 41.26 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.403 0 O-C-N 126.726 2.516 . . . . 0.0 113.692 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -155.53 -40.31 0.02 OUTLIER Glycine 0 CA--C 1.543 1.8 0 N-CA-C 118.301 2.08 . . . . 0.0 118.301 179.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.472 ' O ' ' HB2' ' A' ' 77' ' ' GLU 0.257 0.1 OUTLIER 61.91 25.62 15.41 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-O 115.188 -2.339 . . . . 0.0 108.097 -179.554 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.499 ' HB3' ' HB ' ' A' ' 96' ' ' VAL . 3.9 mm-40 112.74 113.14 0.0 OUTLIER 'General case' 0 C--N 1.313 -1.02 1 O-C-N 133.923 7.014 . . . . 0.0 109.45 -177.659 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.5 ' HG ' ' HB3' ' A' ' 93' ' ' PHE 0.451 7.4 tt -139.53 119.68 13.66 Favored 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 102.662 -3.088 . . . . 0.0 102.662 -178.272 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 21.8 m -141.63 120.66 12.86 Favored 'General case' 0 C--O 1.197 -1.687 0 N-CA-C 103.38 -2.822 . . . . 0.0 103.38 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.517 ' HA3' ' HA ' ' A' ' 93' ' ' PHE . . . -160.9 -163.25 13.64 Favored Glycine 0 C--O 1.215 -1.051 0 C-N-CA 116.972 -2.537 . . . . 0.0 114.057 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 13.9 p -141.95 165.71 26.72 Favored 'General case' 0 C--O 1.188 -2.175 0 O-C-N 127.296 2.41 . . . . 0.0 110.616 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 93.9 m95 -107.36 147.46 30.31 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 103.76 -2.682 . . . . 0.0 103.76 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 5.0 t -147.15 127.53 13.99 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 125.093 1.495 . . . . 0.0 109.612 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -79.48 117.54 20.53 Favored 'General case' 0 N--CA 1.427 -1.606 0 CA-C-N 112.536 -2.12 . . . . 0.0 108.597 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.408 ' HA ' ' OE1' ' A' ' 85' ' ' GLU 0.608 3.4 mm-40 -78.03 -20.09 53.09 Favored 'General case' 0 N--CA 1.426 -1.662 0 O-C-N 123.766 0.666 . . . . 0.0 109.267 179.975 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 126.64 -53.2 0.8 Allowed Glycine 0 N--CA 1.436 -1.339 0 N-CA-C 104.921 -3.272 . . . . 0.0 104.921 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -112.54 -3.41 14.39 Favored 'General case' 0 C--O 1.245 0.834 0 CA-C-O 116.7 -1.619 . . . . 0.0 114.183 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . 0.379 10.2 mtpt -154.75 120.64 5.19 Favored 'General case' 0 CA--C 1.503 -0.837 0 O-C-N 125.574 1.796 . . . . 0.0 110.468 179.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.842 HD23 ' HD2' ' A' ' 106' ' ' ARG . 3.8 tp -76.56 144.55 39.61 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 103.512 -2.773 . . . . 0.0 103.512 179.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.555 ' CG1' HG23 ' A' ' 105' ' ' VAL . 2.7 m -141.56 153.35 19.5 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.052 0 N-CA-C 105.235 -2.135 . . . . 0.0 105.235 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -123.38 104.51 0.86 Allowed Glycine 0 CA--C 1.534 1.227 1 C-N-CA 130.794 4.045 . . . . 0.0 108.132 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -105.95 95.57 5.88 Favored 'General case' 0 N--CA 1.428 -1.565 0 C-N-CA 119.521 -0.872 . . . . 0.0 109.841 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.517 ' HA ' ' HA3' ' A' ' 80' ' ' GLY . 2.3 m-85 -92.96 123.32 36.13 Favored 'General case' 0 N--CA 1.435 -1.185 0 O-C-N 125.4 1.688 . . . . 0.0 114.092 179.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 24.7 mttt -91.5 146.77 23.53 Favored 'General case' 0 N--CA 1.429 -1.503 0 O-C-N 126.0 2.062 . . . . 0.0 110.059 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . 0.355 9.0 ttt180 -103.73 142.24 34.7 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-N 114.04 -1.436 . . . . 0.0 107.376 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.499 ' HB ' ' HB3' ' A' ' 77' ' ' GLU . 69.0 t -81.66 -36.04 14.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-O 124.793 2.235 . . . . 0.0 109.618 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . 0.32 1.3 t70 -72.82 -12.96 61.19 Favored 'General case' 0 C--O 1.256 1.405 0 N-CA-C 118.354 2.724 . . . . 0.0 118.354 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -141.36 -27.51 0.68 Allowed 'General case' 0 CA--C 1.502 -0.876 0 C-N-CA 116.854 -1.938 . . . . 0.0 115.671 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 94.77 9.98 58.14 Favored Glycine 0 C--N 1.337 0.625 0 O-C-N 125.555 1.784 . . . . 0.0 117.041 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 5.4 mmtm -106.04 172.29 6.89 Favored 'General case' 0 C--O 1.2 -1.544 0 CA-C-N 119.072 1.436 . . . . 0.0 109.278 179.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.96 126.14 50.15 Favored 'General case' 0 N--CA 1.436 -1.142 0 O-C-N 125.955 2.034 . . . . 0.0 114.841 -179.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.778 HD22 ' HD1' ' A' ' 119' ' ' TYR . 0.2 OUTLIER -79.38 116.44 19.62 Favored 'General case' 0 C--O 1.246 0.894 0 C-N-CA 130.456 3.502 . . . . 0.0 102.686 179.43 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.709 HG23 ' HB3' ' A' ' 117' ' ' TYR . 4.3 tt -97.8 150.15 4.83 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.116 0 C-N-CA 114.616 -2.833 . . . . 0.0 104.732 -179.245 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -143.29 145.03 32.37 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 116.533 -1.698 . . . . 0.0 109.312 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.747 HG12 HG23 ' A' ' 116' ' ' THR . 7.6 p -134.5 113.83 17.49 Favored 'Isoleucine or valine' 0 C--O 1.248 1.012 0 CA-C-N 123.604 2.911 . . . . 0.0 113.528 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.842 ' HD2' HD23 ' A' ' 89' ' ' LEU . 63.0 mtt180 -81.37 95.67 7.1 Favored 'General case' 0 C--O 1.216 -0.667 0 N-CA-C 104.948 -2.242 . . . . 0.0 104.948 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 64.4 tt0 -102.31 81.97 2.13 Favored 'General case' 0 N--CA 1.419 -2.007 0 CA-C-N 111.49 -2.596 . . . . 0.0 114.727 -179.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.684 HD12 ' CE1' ' A' ' 2' ' ' PHE 0.29 0.3 OUTLIER -58.51 110.98 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 C-N-CA 117.448 -1.701 . . . . 0.0 107.853 179.516 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 2.9 m -75.36 -17.93 60.1 Favored 'General case' 0 C--O 1.214 -0.776 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 -179.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 150.63 -109.35 0.42 Allowed Glycine 0 C--O 1.238 0.37 1 C-N-CA 132.087 4.661 . . . . 0.0 111.75 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 38.0 m-20 -59.77 -17.4 35.21 Favored 'General case' 0 C--O 1.213 -0.858 0 C-N-CA 116.778 -1.969 . . . . 0.0 111.61 179.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -110.64 135.23 51.58 Favored 'General case' 0 CA--C 1.496 -1.126 0 O-C-N 127.02 2.7 . . . . 0.0 117.476 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.648 HD13 ' CE2' ' A' ' 128' ' ' PHE . 0.1 OUTLIER -101.96 113.06 25.95 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 102.793 -3.04 . . . . 0.0 102.793 -179.938 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.737 HG23 HD12 ' A' ' 127' ' ' ILE . 78.0 mt -113.94 106.45 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.026 0 O-C-N 125.663 1.852 . . . . 0.0 110.309 -179.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . 0.571 ' HB2' ' CG ' ' A' ' 126' ' ' ARG . 30.1 mt-30 -74.16 169.92 16.58 Favored 'General case' 0 C--O 1.244 0.791 0 N-CA-C 101.505 -3.517 . . . . 0.0 101.505 178.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.747 HG23 HG12 ' A' ' 105' ' ' VAL . 0.2 OUTLIER 173.75 155.04 0.11 Allowed 'General case' 0 N--CA 1.414 -2.254 0 C-N-CA 118.037 -1.465 . . . . 0.0 111.508 179.992 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.709 ' HB3' HG23 ' A' ' 103' ' ' ILE 0.393 23.4 m-30 125.38 -141.91 0.0 OUTLIER 'General case' 0 CA--C 1.475 -1.934 1 O-C-N 130.475 4.859 . . . . 0.0 113.875 175.93 . . . . . . . . 4 3 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.508 HG22 ' HG3' ' A' ' 123' ' ' GLU . 0.0 OUTLIER -138.53 -165.18 1.77 Allowed 'General case' 0 N--CA 1.431 -1.38 0 CA-C-O 126.831 3.205 . . . . 0.0 117.656 -174.911 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.778 ' HD1' HD22 ' A' ' 102' ' ' LEU 0.259 0.0 OUTLIER -109.19 -55.42 2.41 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 111.463 -2.608 . . . . 0.0 105.287 177.872 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.534 ' HB2' ' CD2' ' A' ' 119' ' ' TYR . 0.6 OUTLIER -129.12 -53.96 1.2 Allowed 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 111.516 -2.584 . . . . 0.0 112.744 179.526 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -162.01 15.91 0.15 Allowed Glycine 0 C--N 1.362 2.011 0 N-CA-C 118.928 2.331 . . . . 0.0 118.928 -179.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.401 ' O ' ' HB ' ' A' ' 118' ' ' THR . 82.9 t -120.7 112.58 36.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 N-CA-C 104.172 -2.529 . . . . 0.0 104.172 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.508 ' HG3' HG22 ' A' ' 118' ' ' THR . 1.2 mt-10 -71.42 177.51 3.93 Favored 'General case' 0 C--O 1.208 -1.116 0 C-N-CA 118.359 -1.337 . . . . 0.0 112.298 -178.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.876 ' HB1' ' HA ' ' A' ' 14' ' ' TYR . . . 179.71 97.83 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 116.525 -1.702 . . . . 0.0 110.284 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.531 ' HA ' ' HB ' ' A' ' 116' ' ' THR 0.327 0.0 OUTLIER -71.02 165.08 24.25 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 120.803 1.638 . . . . 0.0 111.192 179.656 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.604 ' HG2' ' CE2' ' A' ' 14' ' ' TYR . 0.1 OUTLIER -140.56 77.09 1.59 Allowed 'General case' 0 N--CA 1.436 -1.128 1 O-C-N 129.661 4.351 . . . . 0.0 108.664 179.476 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.737 HD12 HG23 ' A' ' 114' ' ' ILE . 0.6 OUTLIER -70.03 112.82 5.18 Favored 'Isoleucine or valine' 0 C--O 1.254 1.298 0 O-C-N 128.341 3.525 . . . . 0.0 112.824 179.752 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.648 ' CE2' HD13 ' A' ' 113' ' ' LEU . 1.8 m-30 -98.2 138.74 35.02 Favored 'General case' 0 C--O 1.221 -0.427 0 C-N-CA 127.298 2.239 . . . . 0.0 109.34 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . 0.266 26.6 mmtt -103.73 34.67 2.9 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 117.139 -1.41 . . . . 0.0 112.311 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.487 ' HA ' ' HA ' ' A' ' 6' ' ' TRP . 10.0 tttp 29.83 100.78 0.0 OUTLIER 'General case' 0 CA--C 1.508 -0.65 0 N-CA-C 116.695 2.109 . . . . 0.0 116.695 179.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.41 ' HA ' ' OG1' ' A' ' 5' ' ' THR 0.852 5.6 tt0 . . . . . 0 N--CA 1.439 -1.013 0 N-CA-C 119.502 3.149 . . . . 0.0 119.502 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 . . . . . 0 N--CA 1.449 -0.481 0 N-CA-C 114.816 1.413 . . . . 0.0 114.816 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.38 101.08 0.07 Allowed 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 118.63 -1.228 . . . . 0.0 112.401 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 166.12 -155.32 26.49 Favored Glycine 0 C--O 1.217 -0.941 0 C-N-CA 115.809 -3.091 . . . . 0.0 113.267 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . 0.543 1.2 p -105.48 150.92 24.88 Favored 'General case' 0 CA--C 1.504 -0.823 0 CA-C-N 112.657 -1.772 . . . . 0.0 114.494 -179.728 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.654 ' CH2' HD11 ' A' ' 108' ' ' ILE . 85.5 m95 -150.54 152.69 34.54 Favored 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 125.513 1.758 . . . . 0.0 108.576 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 5.6 tttp -153.13 103.01 2.68 Favored 'General case' 0 C--O 1.205 -1.268 0 CA-C-O 116.678 -1.629 . . . . 0.0 109.103 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.718 HG12 ' HB3' ' A' ' 36' ' ' LEU 0.396 13.9 p -48.98 124.39 2.26 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.066 0 O-C-N 126.464 2.353 . . . . 0.0 111.722 179.819 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 51.4 t0 -123.81 1.26 8.73 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 125.218 2.437 . . . . 0.0 108.717 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.429 ' O ' ' HB ' ' A' ' 127' ' ' ILE . 1.9 ttt180 -169.28 133.51 1.4 Allowed 'General case' 0 C--N 1.294 -1.811 0 O-C-N 118.184 -2.822 . . . . 0.0 107.398 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . 0.299 0.0 OUTLIER -116.22 -171.89 2.08 Favored 'General case' 0 CA--C 1.501 -0.941 0 CA-C-N 114.394 -1.276 . . . . 0.0 108.513 179.894 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.462 ' CB ' ' HB2' ' A' ' 125' ' ' LYS . 0.5 OUTLIER -167.51 94.82 0.44 Allowed 'General case' 0 C--N 1.3 -1.579 0 CA-C-N 122.2 2.273 . . . . 0.0 107.917 179.907 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . 0.259 0.1 OUTLIER 97.68 -5.87 0.05 Allowed 'General case' 0 N--CA 1.486 1.359 0 O-C-N 126.984 2.678 . . . . 0.0 111.63 -179.636 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.715 ' HA ' ' HB1' ' A' ' 124' ' ' ALA . 0.4 OUTLIER -71.87 -16.36 62.14 Favored 'General case' 0 N--CA 1.432 -1.349 0 O-C-N 126.188 2.18 . . . . 0.0 116.103 -179.852 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -76.98 -37.68 54.71 Favored 'General case' 0 C--O 1.206 -1.201 0 CA-C-N 121.74 2.064 . . . . 0.0 109.25 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.42 -34.57 63.29 Favored 'General case' 0 N--CA 1.427 -1.617 0 CA-C-N 112.846 -1.979 . . . . 0.0 113.178 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.43 ' CB ' ' HB2' ' A' ' 124' ' ' ALA . 43.4 t80 -65.85 -24.79 66.96 Favored 'General case' 0 N--CA 1.421 -1.916 0 CA-C-O 123.213 1.482 . . . . 0.0 112.607 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 29.6 mtt -74.33 -28.56 61.2 Favored 'General case' 0 N--CA 1.443 -0.806 0 O-C-N 118.511 -2.618 . . . . 0.0 107.449 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -70.12 -32.62 70.72 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 125.665 2.65 . . . . 0.0 113.31 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 7.9 tttm -77.82 -43.9 29.03 Favored 'General case' 0 C--N 1.313 -0.984 0 O-C-N 119.855 -1.778 . . . . 0.0 112.086 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 11.1 mmm -62.29 -26.7 68.55 Favored 'General case' 0 C--O 1.205 -1.247 0 C-N-CA 126.098 1.759 . . . . 0.0 109.782 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 105.34 62.38 0.64 Allowed Glycine 0 N--CA 1.433 -1.521 0 CA-C-N 114.792 -1.095 . . . . 0.0 112.89 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.423 HG23 ' HB3' ' A' ' 27' ' ' LYS . 2.2 mm -118.31 134.9 60.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -79.35 157.35 27.67 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-O 113.872 -2.966 . . . . 0.0 112.391 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . 0.343 2.1 m -33.73 -39.1 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.21 -0.978 0 O-C-N 126.809 2.568 . . . . 0.0 114.318 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.488 2.5 m -78.18 -50.48 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.106 0 O-C-N 126.959 2.662 . . . . 0.0 115.129 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.423 ' HB3' HG23 ' A' ' 23' ' ' ILE . 13.7 mttm -64.25 -23.54 67.34 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.149 -0.932 . . . . 0.0 112.67 -179.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 6.9 ptt-85 -79.51 -26.19 41.6 Favored 'General case' 0 CA--C 1.532 0.27 0 O-C-N 119.826 -1.796 . . . . 0.0 107.753 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 7.0 ttmm -74.91 -38.45 61.81 Favored 'General case' 0 C--O 1.212 -0.905 0 O-C-N 125.086 1.492 . . . . 0.0 112.248 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.0 mp -78.08 -24.97 47.41 Favored 'General case' 0 N--CA 1.431 -1.404 0 C-N-CA 124.101 0.96 . . . . 0.0 110.579 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -79.42 -27.46 54.93 Favored Glycine 0 C--O 1.213 -1.165 0 O-C-N 125.238 1.586 . . . . 0.0 111.251 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -75.38 -41.8 55.49 Favored 'General case' 0 CA--C 1.514 -0.409 0 C-N-CA 125.912 1.685 . . . . 0.0 111.371 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 6.7 m-70 -101.03 14.32 32.35 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-O 116.152 -1.88 . . . . 0.0 115.408 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 14.9 p30 -40.34 -26.25 0.03 OUTLIER 'General case' 0 CA--C 1.499 -1.002 0 O-C-N 127.391 2.932 . . . . 0.0 118.763 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 6.9 p30 72.95 12.12 5.16 Favored 'General case' 0 C--N 1.311 -1.089 0 O-C-N 125.264 1.602 . . . . 0.0 109.155 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.718 ' HB3' HG12 ' A' ' 8' ' ' VAL . 2.6 tp -30.23 92.83 0.01 OUTLIER 'General case' 0 CA--C 1.503 -0.839 0 C-N-CA 129.298 3.039 . . . . 0.0 110.34 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 5.9 ttpm? -94.15 115.61 27.92 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 102.336 -3.209 . . . . 0.0 102.336 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.784 ' CD2' HG21 ' A' ' 49' ' ' VAL 0.26 0.1 OUTLIER -104.02 116.76 32.81 Favored 'General case' 0 C--N 1.291 -1.974 0 C-N-CA 116.923 -1.911 . . . . 0.0 110.01 -179.819 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.404 ' HB ' ' HB2' ' A' ' 50' ' ' LYS . 10.5 m -106.3 99.11 8.71 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 124.748 2.213 . . . . 0.0 105.158 179.68 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.472 HG23 HG12 ' A' ' 49' ' ' VAL . 1.2 mt -88.17 128.42 40.52 Favored 'Isoleucine or valine' 0 C--O 1.251 1.184 0 CA-C-N 113.233 -1.803 . . . . 0.0 110.814 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.535 HG22 ' O ' ' A' ' 41' ' ' THR . 4.5 m -115.44 70.78 0.75 Allowed 'General case' 0 C--N 1.346 0.448 0 O-C-N 127.306 2.879 . . . . 0.0 107.567 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -65.69 112.96 3.93 Favored 'General case' 0 C--N 1.316 -0.854 0 C-N-CA 123.948 0.899 . . . . 0.0 109.716 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.7 tt0 -99.16 -103.19 0.22 Allowed 'General case' 0 N--CA 1.423 -1.822 0 N-CA-C 105.312 -2.107 . . . . 0.0 105.312 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -113.48 -48.41 0.6 Allowed Glycine 0 C--N 1.295 -1.743 0 N-CA-C 109.092 -1.603 . . . . 0.0 109.092 -179.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.532 ' ND2' ' N ' ' A' ' 45' ' ' ASN . 0.0 OUTLIER -127.58 -20.4 3.98 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 -179.942 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -90.14 161.23 15.86 Favored 'General case' 0 C--N 1.308 -1.217 0 C-N-CA 116.723 -1.991 . . . . 0.0 113.098 179.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -135.24 69.44 1.44 Allowed 'General case' 0 CA--C 1.512 -0.49 0 CA-C-O 124.273 1.987 . . . . 0.0 109.698 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.847 ' OG1' HG12 ' A' ' 61' ' ' VAL . 14.0 t -74.74 122.88 23.96 Favored 'General case' 0 N--CA 1.432 -1.362 0 O-C-N 119.562 -1.961 . . . . 0.0 106.753 179.345 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.784 HG21 ' CD2' ' A' ' 38' ' ' LEU 0.685 0.9 OUTLIER -116.44 120.9 66.33 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.727 0 N-CA-C 117.551 2.426 . . . . 0.0 117.551 -179.058 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.404 ' HB2' ' HB ' ' A' ' 39' ' ' THR . 0.9 OUTLIER -64.87 145.15 56.69 Favored 'General case' 0 C--N 1.308 -1.235 1 N-CA-C 99.101 -4.407 . . . . 0.0 99.101 177.749 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.472 ' O ' ' N ' ' A' ' 53' ' ' SER . 5.3 tt0 -133.87 51.69 2.12 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 104.279 -2.489 . . . . 0.0 104.279 -178.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . 0.26 4.6 m -61.95 86.6 0.02 OUTLIER 'General case' 0 C--N 1.289 -2.06 0 N-CA-C 104.736 -2.32 . . . . 0.0 104.736 179.348 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.671 ' OG ' HD13 ' A' ' 36' ' ' LEU . 1.3 m -122.48 44.34 2.65 Favored 'General case' 0 N--CA 1.443 -0.816 0 O-C-N 126.1 2.125 . . . . 0.0 114.607 -179.121 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 65.66 -54.04 0.36 Allowed 'General case' 0 N--CA 1.44 -0.957 0 O-C-N 126.717 2.51 . . . . 0.0 108.996 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.505 ' CE1' ' HB1' ' A' ' 73' ' ' ALA . 7.4 m-85 -62.81 -56.99 12.48 Favored 'General case' 0 C--O 1.217 -0.654 0 CA-C-O 114.699 -2.572 . . . . 0.0 109.186 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.657 ' HB3' HG22 ' A' ' 58' ' ' ILE . 23.1 ttt-85 -148.98 144.48 26.8 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 123.709 2.959 . . . . 0.0 112.054 179.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -97.66 81.84 2.98 Favored 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 100.623 -3.843 . . . . 0.0 100.623 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.657 HG22 ' HB3' ' A' ' 56' ' ' ARG . 1.5 tt -120.65 100.6 9.38 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.77 1 O-C-N 129.26 4.1 . . . . 0.0 118.927 -179.213 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -63.02 117.98 7.21 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 103.492 -2.781 . . . . 0.0 103.492 178.059 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.535 ' CG1' HG22 ' A' ' 49' ' ' VAL . 2.4 p -101.43 102.32 13.33 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 C-N-CA 119.672 -0.811 . . . . 0.0 111.103 -177.283 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.847 HG12 ' OG1' ' A' ' 48' ' ' THR 0.36 0.8 OUTLIER -87.12 138.06 19.76 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 CA-C-O 125.966 2.794 . . . . 0.0 113.58 -179.807 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.633 ' HZ ' HH22 ' A' ' 106' ' ' ARG . 23.7 p90 -153.49 100.62 2.43 Favored 'General case' 0 N--CA 1.437 -1.103 0 O-C-N 120.204 -1.56 . . . . 0.0 110.719 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.49 130.44 46.88 Favored 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 102.862 -3.014 . . . . 0.0 102.862 179.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 7.2 mt -52.31 118.09 3.29 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-O 122.886 1.327 . . . . 0.0 110.492 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 86.38 13.41 68.16 Favored Glycine 0 C--N 1.347 1.191 0 CA-C-N 111.627 -2.533 . . . . 0.0 117.39 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . 0.419 0.5 OUTLIER -101.1 129.5 51.98 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 N-CA-C 105.547 -2.02 . . . . 0.0 105.547 179.963 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -86.61 115.31 23.99 Favored 'General case' 0 CA--C 1.483 -1.625 0 N-CA-C 115.146 1.536 . . . . 0.0 115.146 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.411 ' CE1' ' HB3' ' A' ' 62' ' ' PHE . 0.3 OUTLIER -111.7 155.04 24.08 Favored 'General case' 0 N--CA 1.427 -1.609 0 CA-C-O 116.276 -1.821 . . . . 0.0 106.798 -179.979 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -109.51 130.07 55.53 Favored 'General case' 0 CA--C 1.51 -0.591 0 O-C-N 126.138 2.149 . . . . 0.0 106.783 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -130.87 101.16 5.52 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-O 116.67 -1.634 . . . . 0.0 113.903 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 26.8 m -67.18 119.41 12.04 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 105.78 -1.933 . . . . 0.0 105.78 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.533 HD11 HD13 ' A' ' 78' ' ' LEU . 16.7 mt -65.61 -175.81 0.3 Allowed 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 114.265 -1.334 . . . . 0.0 109.136 -179.676 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.505 ' HB1' ' CE1' ' A' ' 55' ' ' PHE . . . -75.42 -35.76 60.92 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-O 124.773 2.225 . . . . 0.0 111.814 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -153.11 23.91 0.55 Allowed 'General case' 0 C--O 1.239 0.514 0 CA-C-N 112.662 -2.063 . . . . 0.0 108.4 179.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.56 ' C ' HG23 ' A' ' 76' ' ' THR . . . -120.18 -10.0 7.67 Favored Glycine 0 C--O 1.213 -1.19 0 C-N-CA 125.052 1.31 . . . . 0.0 114.786 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.56 HG23 ' C ' ' A' ' 75' ' ' GLY . 0.1 OUTLIER 74.51 -175.57 0.14 Allowed 'General case' 0 C--N 1.317 -0.811 0 C-N-CA 117.699 -1.601 . . . . 0.0 112.933 179.926 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -44.87 123.88 4.05 Favored 'General case' 0 N--CA 1.446 -0.64 0 O-C-N 127.467 2.979 . . . . 0.0 111.195 179.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.56 ' HG ' ' HB3' ' A' ' 93' ' ' PHE 0.423 0.6 OUTLIER -144.38 90.14 2.07 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 102.414 -3.18 . . . . 0.0 102.414 -179.819 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 95.6 m -103.55 135.86 44.35 Favored 'General case' 0 CA--C 1.481 -1.678 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -170.78 -159.66 17.35 Favored Glycine 0 C--N 1.291 -1.917 0 C-N-CA 116.568 -2.729 . . . . 0.0 110.596 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -147.54 175.46 10.83 Favored 'General case' 0 C--O 1.197 -1.699 0 CA-C-O 122.554 1.169 . . . . 0.0 108.453 179.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . 0.505 ' CZ3' ' N ' ' A' ' 91' ' ' GLY . 54.6 m95 -130.02 135.43 48.27 Favored 'General case' 0 N--CA 1.427 -1.577 0 N-CA-C 104.078 -2.564 . . . . 0.0 104.078 179.506 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.474 ' CG2' HG23 ' A' ' 90' ' ' VAL . 8.8 t -135.87 134.76 39.13 Favored 'General case' 0 N--CA 1.425 -1.693 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.885 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.468 ' CA ' HD12 ' A' ' 89' ' ' LEU . 5.4 ttt -83.96 121.46 27.41 Favored 'General case' 0 N--CA 1.429 -1.523 0 O-C-N 125.793 1.933 . . . . 0.0 106.103 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . 0.539 0.5 OUTLIER -79.87 -24.24 41.36 Favored 'General case' 0 N--CA 1.426 -1.652 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 179.788 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 154.64 -85.43 0.14 Allowed Glycine 0 N--CA 1.447 -0.568 0 N-CA-C 105.047 -3.221 . . . . 0.0 105.047 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 13.2 m-80 -91.32 -0.72 57.71 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-O 116.385 -1.769 . . . . 0.0 115.264 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . 0.382 0.3 OUTLIER -141.55 146.91 36.9 Favored 'General case' 0 CA--C 1.489 -1.39 0 O-C-N 127.095 2.747 . . . . 0.0 106.973 -179.854 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.488 HD23 ' CD ' ' A' ' 106' ' ' ARG . 0.7 OUTLIER -109.88 141.88 41.97 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 104.934 -2.247 . . . . 0.0 104.934 -179.864 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.474 HG23 ' CG2' ' A' ' 83' ' ' THR . 0.3 OUTLIER -123.21 124.75 70.7 Favored 'Isoleucine or valine' 0 C--O 1.244 0.771 0 N-CA-C 105.007 -2.219 . . . . 0.0 105.007 -179.582 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.505 ' N ' ' CZ3' ' A' ' 82' ' ' TRP . . . -103.36 109.06 3.37 Favored Glycine 0 C--N 1.349 1.268 0 N-CA-C 108.892 -1.683 . . . . 0.0 108.892 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.472 ' C ' ' CD1' ' A' ' 93' ' ' PHE . 24.2 mtpp -102.71 152.77 20.83 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 105.175 -2.158 . . . . 0.0 105.175 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.56 ' HB3' ' HG ' ' A' ' 78' ' ' LEU . 64.6 m-85 -148.73 111.61 4.84 Favored 'General case' 0 CA--C 1.508 -0.658 0 CA-C-O 122.931 1.348 . . . . 0.0 110.873 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 12.8 mttm -92.86 130.53 38.43 Favored 'General case' 0 N--CA 1.44 -0.942 0 C-N-CA 126.456 1.902 . . . . 0.0 107.626 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.42 ' HB3' ' ND2' ' A' ' 98' ' ' ASN 0.381 0.0 OUTLIER -95.62 143.4 26.93 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 104.917 -2.253 . . . . 0.0 104.917 -179.923 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 29.6 m -70.24 -37.76 72.38 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 O-C-N 123.935 0.772 . . . . 0.0 111.081 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . 0.345 0.5 OUTLIER -56.82 -12.29 1.85 Allowed 'General case' 0 C--O 1.254 1.333 0 N-CA-C 114.825 1.417 . . . . 0.0 114.825 179.896 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.42 ' ND2' ' HB3' ' A' ' 95' ' ' ARG . 0.1 OUTLIER -159.52 5.91 0.09 Allowed 'General case' 0 N--CA 1.426 -1.647 0 N-CA-C 116.646 2.091 . . . . 0.0 116.646 179.93 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 44.65 25.39 0.86 Allowed Glycine 0 C--O 1.243 0.692 0 CA-C-O 124.0 1.889 . . . . 0.0 114.357 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 6.7 mmmt -70.91 -97.96 0.01 OUTLIER 'General case' 0 CA--C 1.554 1.129 0 O-C-N 119.185 -2.362 . . . . 0.0 109.611 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.454 ' CG ' ' N ' ' A' ' 102' ' ' LEU . 36.8 tt0 152.26 168.77 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 128.719 2.808 . . . . 0.0 109.345 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.625 ' CB ' ' HA ' ' A' ' 119' ' ' TYR . 0.9 OUTLIER -151.07 134.66 16.34 Favored 'General case' 0 C--O 1.246 0.909 1 C-N-CA 132.613 4.365 . . . . 0.0 103.986 -179.669 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.562 ' N ' ' O ' ' A' ' 118' ' ' THR . 1.3 tp -118.17 159.9 18.22 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.09 0 N-CA-C 106.314 -1.736 . . . . 0.0 106.314 -179.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.469 ' N ' HG13 ' A' ' 103' ' ' ILE . . . -154.31 150.59 28.15 Favored 'General case' 0 C--O 1.242 0.708 0 CA-C-O 115.995 -1.955 . . . . 0.0 107.454 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.649 HG12 HG23 ' A' ' 116' ' ' THR . 8.4 p -137.01 109.68 7.57 Favored 'Isoleucine or valine' 0 C--O 1.248 0.979 0 C-N-CA 116.439 -2.105 . . . . 0.0 114.301 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.633 HH22 ' HZ ' ' A' ' 62' ' ' PHE 0.253 50.7 mtt180 -71.08 96.85 1.39 Allowed 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 104.347 -2.464 . . . . 0.0 104.347 179.498 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -94.75 73.89 3.63 Favored 'General case' 0 N--CA 1.422 -1.858 0 O-C-N 126.438 2.336 . . . . 0.0 112.082 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.654 HD11 ' CH2' ' A' ' 6' ' ' TRP 0.355 1.9 tt -59.55 97.65 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 C-N-CA 114.425 -2.91 . . . . 0.0 113.701 179.891 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 39.4 t -84.23 71.99 10.57 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 105.475 -2.046 . . . . 0.0 105.475 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 72.61 -89.59 0.54 Allowed Glycine 0 C--O 1.241 0.544 0 O-C-N 128.722 3.764 . . . . 0.0 113.26 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . 0.329 1.0 OUTLIER -95.01 -14.76 24.05 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 116.358 -1.782 . . . . 0.0 113.172 -179.891 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -108.9 134.64 51.3 Favored 'General case' 0 N--CA 1.431 -1.411 0 O-C-N 127.553 3.033 . . . . 0.0 112.897 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.467 ' HB2' ' CZ3' ' A' ' 6' ' ' TRP . 0.7 OUTLIER -99.29 141.83 31.56 Favored 'General case' 0 C--O 1.209 -1.064 0 N-CA-C 101.836 -3.394 . . . . 0.0 101.836 -179.647 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.768 HG23 HD13 ' A' ' 127' ' ' ILE . 63.6 mt -142.18 134.79 27.56 Favored 'Isoleucine or valine' 0 C--O 1.246 0.901 0 N-CA-C 103.729 -2.693 . . . . 0.0 103.729 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . 0.526 ' HB2' ' CD ' ' A' ' 126' ' ' ARG . 24.2 mt-30 -117.23 118.48 32.43 Favored 'General case' 0 CA--C 1.497 -1.083 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.649 HG23 HG12 ' A' ' 105' ' ' VAL . 0.7 OUTLIER -137.53 156.86 47.64 Favored 'General case' 0 N--CA 1.413 -2.281 0 CA-C-N 114.247 -1.342 . . . . 0.0 112.397 -179.643 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.467 ' CE2' ' HB ' ' A' ' 105' ' ' VAL 0.384 24.3 m-85 134.73 -141.5 0.0 OUTLIER 'General case' 0 CA--C 1.48 -1.736 1 O-C-N 130.708 5.005 . . . . 0.0 113.485 176.249 . . . . . . . . 4 3 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.616 HG23 ' N ' ' A' ' 119' ' ' TYR . 4.4 t -156.04 -156.07 0.6 Allowed 'General case' 0 C--N 1.311 -1.072 0 O-C-N 127.268 2.855 . . . . 0.0 116.389 -174.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.625 ' HA ' ' CB ' ' A' ' 102' ' ' LEU . 0.0 OUTLIER -105.16 -62.86 1.29 Allowed 'General case' 0 C--N 1.347 0.485 0 N-CA-C 102.69 -3.078 . . . . 0.0 102.69 176.573 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.56 -71.53 0.73 Allowed 'General case' 0 N--CA 1.426 -1.635 0 CA-C-N 111.857 -2.429 . . . . 0.0 116.039 179.488 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -140.7 10.78 2.91 Favored Glycine 0 C--N 1.355 1.633 0 N-CA-C 120.083 2.793 . . . . 0.0 120.083 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 72.3 t -114.12 94.69 3.28 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 O-C-N 117.39 -3.418 . . . . 0.0 103.163 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.458 ' HA ' ' HB ' ' A' ' 118' ' ' THR . 5.6 mt-10 -58.02 177.36 0.12 Allowed 'General case' 0 C--O 1.213 -0.857 0 C-N-CA 118.36 -1.336 . . . . 0.0 112.637 -178.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.715 ' HB1' ' HA ' ' A' ' 14' ' ' TYR . . . -173.87 103.44 0.11 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 115.914 -1.993 . . . . 0.0 109.221 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.505 ' HG3' ' HB ' ' A' ' 116' ' ' THR 0.343 1.5 mptt -79.49 162.15 25.6 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 121.661 2.028 . . . . 0.0 112.665 -179.91 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.599 ' HG2' ' CD2' ' A' ' 14' ' ' TYR . 0.2 OUTLIER -145.07 78.97 1.58 Allowed 'General case' 0 C--O 1.208 -1.104 0 CA-C-O 115.236 -2.316 . . . . 0.0 106.015 179.623 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.768 HD13 HG23 ' A' ' 114' ' ' ILE . 4.4 mm -77.32 111.05 13.68 Favored 'Isoleucine or valine' 0 C--O 1.246 0.888 1 O-C-N 131.973 5.796 . . . . 0.0 110.996 179.703 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.61 ' CZ ' HD12 ' A' ' 38' ' ' LEU . 15.0 m-85 -92.52 169.21 10.72 Favored 'General case' 0 C--N 1.318 -0.783 0 O-C-N 127.255 2.847 . . . . 0.0 108.417 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . 0.305 19.8 mmtt -124.07 -6.21 7.82 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 115.406 -2.235 . . . . 0.0 110.634 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.535 ' HB2' ' CZ3' ' A' ' 6' ' ' TRP . 0.0 OUTLIER 71.82 102.04 0.07 Allowed 'General case' 0 N--CA 1.472 0.631 0 O-C-N 126.811 2.569 . . . . 0.0 109.597 179.823 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . 0.923 7.6 mt-10 . . . . . 0 N--CA 1.434 -1.232 0 N-CA-C 116.223 1.934 . . . . 0.0 116.223 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . 0.499 ' N ' ' CD1' ' A' ' 2' ' ' PHE . 13.5 m-85 . . . . . 0 N--CA 1.443 -0.797 0 CA-C-O 122.587 1.184 . . . . 0.0 112.438 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -144.05 98.27 3.19 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.521 -1.218 . . . . 0.0 110.594 179.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 161.12 -130.03 2.26 Favored Glycine 0 C--O 1.222 -0.623 0 C-N-CA 115.331 -3.318 . . . . 0.0 110.296 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.589 ' HB ' ' HA ' ' A' ' 39' ' ' THR 0.609 0.1 OUTLIER -134.1 157.94 44.87 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 119.154 -1.018 . . . . 0.0 112.637 -179.812 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.758 ' NE1' HD12 ' A' ' 40' ' ' ILE 0.254 95.1 m95 -142.19 146.63 35.46 Favored 'General case' 0 C--O 1.212 -0.875 0 O-C-N 127.98 3.3 . . . . 0.0 106.253 -179.87 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -139.97 92.9 2.59 Favored 'General case' 0 C--O 1.21 -0.994 0 O-C-N 127.069 2.731 . . . . 0.0 106.452 -179.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.636 HG21 ' HD2' ' A' ' 126' ' ' ARG 0.396 2.1 p -43.77 125.84 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 CA-C-O 116.744 -1.598 . . . . 0.0 112.966 179.836 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -115.4 -31.96 5.76 Favored 'General case' 0 N--CA 1.439 -0.984 0 O-C-N 126.306 2.254 . . . . 0.0 108.846 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.1 149.22 32.6 Favored 'General case' 0 CA--C 1.482 -1.672 0 C-N-CA 116.526 -2.07 . . . . 0.0 108.6 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . 0.386 3.4 m-80 -120.32 -175.45 3.0 Favored 'General case' 0 N--CA 1.454 -0.227 0 O-C-N 126.909 2.631 . . . . 0.0 108.619 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.421 ' HB2' ' HB2' ' A' ' 125' ' ' LYS . 3.6 tt0 -141.89 -78.42 0.26 Allowed 'General case' 0 N--CA 1.432 -1.326 0 C-N-CA 116.651 -2.02 . . . . 0.0 111.055 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -88.79 17.75 5.33 Favored 'General case' 0 N--CA 1.475 0.803 0 O-C-N 125.613 1.821 . . . . 0.0 114.291 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.499 ' CE2' ' HE2' ' A' ' 18' ' ' MET . 9.0 t80 -63.93 -39.08 93.34 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 119.084 2.994 . . . . 0.0 119.084 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.46 -35.29 78.85 Favored 'General case' 0 C--O 1.212 -0.918 0 CA-C-N 121.846 2.112 . . . . 0.0 112.171 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.93 -31.66 45.29 Favored 'General case' 0 N--CA 1.435 -1.185 0 O-C-N 126.492 2.37 . . . . 0.0 113.578 179.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.513 ' CB ' ' HB2' ' A' ' 124' ' ' ALA . 0.0 OUTLIER -70.59 -30.35 67.01 Favored 'General case' 0 N--CA 1.423 -1.788 0 CA-C-O 125.873 2.749 . . . . 0.0 114.185 -179.405 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.499 ' HE2' ' CE2' ' A' ' 14' ' ' TYR . 19.5 mmt -76.58 -22.75 53.83 Favored 'General case' 0 N--CA 1.431 -1.379 0 O-C-N 116.303 -3.998 . . . . 0.0 107.541 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -68.53 -25.29 64.85 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 119.384 -2.073 . . . . 0.0 112.004 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.495 ' HE3' ' CB ' ' A' ' 120' ' ' GLU . 2.2 tttp -79.06 -31.94 44.63 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-O 117.469 -1.253 . . . . 0.0 113.15 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.412 ' HE1' HH22 ' A' ' 95' ' ' ARG . 29.1 mtp -75.64 -23.2 56.31 Favored 'General case' 0 N--CA 1.437 -1.105 0 O-C-N 126.076 2.11 . . . . 0.0 109.006 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 105.26 31.02 4.5 Favored Glycine 0 C--O 1.225 -0.461 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 179.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.531 HG21 ' CA ' ' A' ' 28' ' ' ARG . 2.7 mm -77.49 141.95 14.88 Favored 'Isoleucine or valine' 0 C--N 1.352 0.699 0 C-N-CA 124.97 1.308 . . . . 0.0 108.911 -179.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -101.69 154.34 18.97 Favored 'General case' 0 C--O 1.245 0.839 0 CA-C-O 115.944 -1.979 . . . . 0.0 110.171 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . 0.429 4.2 p -28.92 -40.95 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.518 -0.276 0 O-C-N 128.414 3.571 . . . . 0.0 119.231 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.65 2.5 t -79.83 -40.95 21.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 123.034 1.397 . . . . 0.0 112.572 179.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.0 ttmt -68.67 -43.64 75.72 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 110.469 -3.06 . . . . 0.0 114.548 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.531 ' CA ' HG21 ' A' ' 23' ' ' ILE . 31.6 ptt85 -76.5 -20.82 56.55 Favored 'General case' 0 C--N 1.321 -0.659 0 O-C-N 119.625 -1.922 . . . . 0.0 108.653 -179.562 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.1 ttmt -76.21 -38.3 56.65 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-N 114.381 -1.282 . . . . 0.0 108.334 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -72.38 -35.76 68.55 Favored 'General case' 0 C--O 1.214 -0.766 0 CA-C-N 114.621 -1.172 . . . . 0.0 108.442 -179.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -73.67 -26.87 68.46 Favored Glycine 0 CA--C 1.532 1.118 0 O-C-N 126.239 2.212 . . . . 0.0 111.955 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -75.7 -39.26 57.72 Favored 'General case' 0 N--CA 1.434 -1.23 0 C-N-CA 125.681 1.592 . . . . 0.0 110.774 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -90.58 29.98 1.22 Allowed 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 124.237 1.015 . . . . 0.0 112.538 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 31.2 p-10 -81.02 98.63 8.05 Favored 'General case' 0 CA--C 1.508 -0.655 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -76.93 61.84 2.01 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 120.058 1.299 . . . . 0.0 109.27 179.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.859 HD11 ' CD1' ' A' ' 38' ' ' LEU . 0.1 OUTLIER -61.87 124.92 22.08 Favored 'General case' 0 CA--C 1.492 -1.262 0 C-N-CA 126.836 2.054 . . . . 0.0 108.695 -179.519 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.492 ' HB3' ' HB3' ' A' ' 52' ' ' SER . 21.8 ttmt -108.71 106.14 16.04 Favored 'General case' 0 N--CA 1.431 -1.398 0 N-CA-C 104.482 -2.414 . . . . 0.0 104.482 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.859 ' CD1' HD11 ' A' ' 36' ' ' LEU . 1.3 tp -91.82 111.14 22.55 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 120.844 1.656 . . . . 0.0 108.964 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.589 ' HA ' ' HB ' ' A' ' 5' ' ' THR . 2.2 m -96.69 91.36 5.68 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 101.732 -3.432 . . . . 0.0 101.732 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.758 HD12 ' NE1' ' A' ' 6' ' ' TRP . 58.5 mt -72.05 120.58 20.67 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 -179.368 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -115.01 113.3 23.92 Favored 'General case' 0 CA--C 1.5 -0.976 0 O-C-N 128.221 3.451 . . . . 0.0 114.666 179.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.493 ' HG2' ' CE1' ' A' ' 47' ' ' PHE . 1.6 mm-40 -92.91 96.0 9.84 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-O 117.507 -1.235 . . . . 0.0 108.289 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -76.34 -13.47 60.14 Favored 'General case' 0 N--CA 1.42 -1.953 0 CA-C-N 120.505 1.502 . . . . 0.0 110.699 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 150.74 -30.28 1.02 Allowed Glycine 0 C--N 1.294 -1.767 0 N-CA-C 106.048 -2.821 . . . . 0.0 106.048 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -150.83 -52.82 0.14 Allowed 'General case' 0 N--CA 1.441 -0.896 0 O-C-N 127.045 2.262 . . . . 0.0 110.21 -179.677 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.36 148.69 49.82 Favored 'General case' 0 N--CA 1.436 -1.161 0 CA-C-N 113.765 -1.561 . . . . 0.0 109.023 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.493 ' CE1' ' HG2' ' A' ' 42' ' ' GLN . 0.9 OUTLIER -113.77 81.79 1.58 Allowed 'General case' 0 C--O 1.218 -0.574 0 N-CA-C 105.871 -1.9 . . . . 0.0 105.871 179.861 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.877 HG22 ' CG1' ' A' ' 61' ' ' VAL 0.441 0.9 OUTLIER -63.48 90.25 0.05 OUTLIER 'General case' 0 CA--C 1.503 -0.85 0 C-N-CA 115.477 -2.489 . . . . 0.0 111.591 -179.639 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.586 ' HB ' ' CE1' ' A' ' 62' ' ' PHE 0.652 0.7 OUTLIER -78.05 86.36 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.58 0 CA-C-O 117.929 -1.034 . . . . 0.0 111.411 -179.874 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.437 ' HB3' ' HB ' ' A' ' 39' ' ' THR . 3.2 tttp -62.44 113.45 2.95 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 102.076 -3.305 . . . . 0.0 102.076 -179.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.271 2.4 tt0 -103.73 94.73 5.59 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 120.23 1.377 . . . . 0.0 107.834 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.492 ' HB3' ' HB3' ' A' ' 37' ' ' LYS . 7.6 t -93.2 55.01 2.22 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 105.216 -2.142 . . . . 0.0 105.216 179.673 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.432 ' HA ' ' HA ' ' A' ' 36' ' ' LEU . 87.3 p -67.66 167.49 13.04 Favored 'General case' 0 C--N 1.348 0.541 0 O-C-N 125.633 1.833 . . . . 0.0 111.384 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -58.28 -27.12 63.75 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 119.363 0.983 . . . . 0.0 109.191 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -69.13 -62.94 1.17 Allowed 'General case' 0 C--O 1.21 -1.026 0 CA-C-O 114.301 -2.761 . . . . 0.0 108.418 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.481 ' HG3' HG22 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -157.25 174.1 15.96 Favored 'General case' 0 C--O 1.244 0.813 0 CA-C-N 121.691 2.041 . . . . 0.0 109.947 179.847 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -104.43 85.14 2.3 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 103.453 -2.795 . . . . 0.0 103.453 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.481 HG22 ' HG3' ' A' ' 56' ' ' ARG . 0.6 OUTLIER -114.21 106.81 21.39 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.323 0 C-N-CA 128.675 2.79 . . . . 0.0 115.806 -179.759 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -59.84 135.44 57.69 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 104.465 -2.42 . . . . 0.0 104.465 179.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.585 HG23 ' O ' ' A' ' 49' ' ' VAL . 36.5 t -96.17 -67.71 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.066 0 CA-C-O 126.066 2.841 . . . . 0.0 112.082 -178.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.877 ' CG1' HG22 ' A' ' 48' ' ' THR 0.442 0.1 OUTLIER 69.98 140.07 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 CA-C-N 113.512 -1.676 . . . . 0.0 113.601 -179.947 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.589 ' HZ ' HH22 ' A' ' 106' ' ' ARG . 1.8 p90 -170.22 98.76 0.27 Allowed 'General case' 0 C--N 1.317 -0.814 0 C-N-CA 115.624 -2.43 . . . . 0.0 107.534 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -57.99 131.17 49.63 Favored 'General case' 0 C--O 1.246 0.897 0 N-CA-C 102.737 -3.06 . . . . 0.0 102.737 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -51.98 121.22 6.34 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 114.944 -1.025 . . . . 0.0 110.985 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 68.44 8.14 54.84 Favored Glycine 0 CA--C 1.531 1.061 0 N-CA-C 119.137 2.415 . . . . 0.0 119.137 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.403 HG12 ' H ' ' A' ' 67' ' ' ASP 0.382 15.1 t -80.79 -108.28 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 N-CA-C 104.189 -2.523 . . . . 0.0 104.189 179.823 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.403 ' H ' HG12 ' A' ' 66' ' ' VAL . 7.3 p-10 170.07 149.61 0.04 OUTLIER 'General case' 0 C--O 1.205 -1.243 0 O-C-N 124.509 1.13 . . . . 0.0 112.108 179.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.492 ' CZ ' ' HB3' ' A' ' 62' ' ' PHE . 2.1 p90 -161.69 135.46 6.6 Favored 'General case' 0 N--CA 1.431 -1.397 0 O-C-N 124.787 1.305 . . . . 0.0 109.907 -179.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.13 100.76 13.2 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 105.495 -2.039 . . . . 0.0 105.495 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -106.75 92.69 4.2 Favored 'General case' 0 C--O 1.216 -0.68 0 O-C-N 125.006 1.441 . . . . 0.0 114.179 -179.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 27.6 m -63.12 139.23 58.75 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 120.849 1.659 . . . . 0.0 107.083 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.568 HD11 HD22 ' A' ' 78' ' ' LEU . 5.3 mp -80.72 -157.85 0.17 Allowed 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 104.808 -2.293 . . . . 0.0 104.808 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -106.56 -8.92 16.79 Favored 'General case' 0 N--CA 1.439 -1.009 0 CA-C-O 122.499 1.143 . . . . 0.0 113.839 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -140.0 -39.53 0.45 Allowed 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 114.996 -1.002 . . . . 0.0 111.479 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -86.66 -16.53 61.63 Favored Glycine 0 CA--C 1.534 1.245 0 O-C-N 120.466 -1.396 . . . . 0.0 114.145 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . 0.342 0.1 OUTLIER 72.82 164.23 0.28 Allowed 'General case' 0 N--CA 1.432 -1.338 0 O-C-N 118.49 -2.77 . . . . 0.0 115.794 179.908 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -2.14 120.51 0.0 OUTLIER 'General case' 0 N--CA 1.439 -0.981 0 O-C-N 127.77 3.169 . . . . 0.0 117.505 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.697 HD13 HH21 ' A' ' 95' ' ' ARG 0.409 7.1 tp -134.97 134.95 41.06 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 103.049 -2.945 . . . . 0.0 103.049 179.721 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 6.1 m -145.52 121.2 10.49 Favored 'General case' 0 CA--C 1.485 -1.544 0 O-C-N 125.33 1.644 . . . . 0.0 106.782 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.458 ' HA3' ' HA ' ' A' ' 93' ' ' PHE . . . -175.99 -145.07 5.38 Favored Glycine 0 C--N 1.295 -1.72 0 O-C-N 118.871 -2.393 . . . . 0.0 110.24 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -154.24 177.45 11.11 Favored 'General case' 0 C--O 1.188 -2.157 0 CA-C-N 119.695 1.747 . . . . 0.0 110.976 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . 0.433 ' HA ' ' HA2' ' A' ' 91' ' ' GLY . 12.1 m95 -127.18 142.12 51.57 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 100.568 -3.864 . . . . 0.0 100.568 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 8.9 t -146.91 144.31 29.15 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 125.532 1.77 . . . . 0.0 111.744 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.405 ' HA ' HD23 ' A' ' 89' ' ' LEU . 20.7 ttt -83.76 101.36 11.53 Favored 'General case' 0 N--CA 1.436 -1.15 0 CA-C-N 110.996 -2.82 . . . . 0.0 107.854 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . 0.712 0.0 OUTLIER -90.17 70.07 7.24 Favored 'General case' 0 N--CA 1.427 -1.58 0 C-N-CA 122.8 0.44 . . . . 0.0 112.051 179.952 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 54.52 -97.57 0.04 OUTLIER Glycine 0 C--N 1.349 1.298 0 N-CA-C 107.635 -2.186 . . . . 0.0 107.635 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -74.56 3.49 7.62 Favored 'General case' 0 CA--C 1.52 -0.178 0 N-CA-C 118.036 2.606 . . . . 0.0 118.036 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . 0.402 0.0 OUTLIER -156.0 166.62 32.92 Favored 'General case' 0 C--O 1.215 -0.745 0 CA-C-N 120.698 1.59 . . . . 0.0 110.682 -179.699 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.557 HD13 HH11 ' A' ' 106' ' ' ARG . 0.0 OUTLIER -115.59 116.42 28.1 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 101.6 -3.481 . . . . 0.0 101.6 179.75 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.827 HG12 ' CG2' ' A' ' 105' ' ' VAL . 11.1 m -117.36 155.3 19.04 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 O-C-N 125.465 1.728 . . . . 0.0 106.632 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.433 ' HA2' ' HA ' ' A' ' 82' ' ' TRP . . . -126.88 110.67 1.25 Allowed Glycine 0 CA--C 1.53 0.989 0 O-C-N 128.352 3.532 . . . . 0.0 108.789 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.43 145.67 38.55 Favored 'General case' 0 N--CA 1.429 -1.517 0 N-CA-C 103.815 -2.661 . . . . 0.0 103.815 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.522 ' HB3' ' HG ' ' A' ' 78' ' ' LEU . 15.3 m-85 -148.82 130.1 14.65 Favored 'General case' 0 CA--C 1.504 -0.818 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 13.8 mttp -99.18 159.02 15.29 Favored 'General case' 0 C--N 1.313 -1.004 0 O-C-N 125.59 1.806 . . . . 0.0 106.496 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.697 HH21 HD13 ' A' ' 78' ' ' LEU 0.325 0.1 OUTLIER -107.97 142.86 37.45 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 120.944 -1.097 . . . . 0.0 108.192 179.715 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 25.2 t -82.22 -32.55 10.83 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 C-N-CA 125.829 1.651 . . . . 0.0 108.318 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . 0.364 34.9 p-10 -99.5 6.47 45.87 Favored 'General case' 0 C--O 1.25 1.107 0 CA-C-O 124.399 2.047 . . . . 0.0 115.502 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -133.45 -44.2 0.83 Allowed 'General case' 0 N--CA 1.439 -1.008 0 O-C-N 120.792 -1.193 . . . . 0.0 112.465 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 77.45 12.03 84.93 Favored Glycine 0 C--N 1.347 1.185 0 O-C-N 124.526 1.141 . . . . 0.0 114.313 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 6.1 mttt -81.59 -116.1 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 176.65 158.83 0.32 Allowed 'General case' 0 CA--C 1.5 -0.943 0 C-N-CA 128.068 2.547 . . . . 0.0 111.091 -179.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.494 ' CD1' ' HB2' ' A' ' 119' ' ' TYR . 3.1 tp -142.52 141.33 32.07 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 128.297 3.498 . . . . 0.0 106.952 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.512 ' CG2' ' HB ' ' A' ' 118' ' ' THR . 4.1 tt -127.17 165.07 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.766 0 N-CA-C 104.971 -2.233 . . . . 0.0 104.971 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.457 ' N ' ' CG1' ' A' ' 103' ' ' ILE . . . -151.15 157.39 42.63 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-O 116.798 -1.573 . . . . 0.0 109.533 179.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.827 ' CG2' HG12 ' A' ' 90' ' ' VAL . 1.2 t -147.77 96.15 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-O 125.561 2.6 . . . . 0.0 110.63 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.589 HH22 ' HZ ' ' A' ' 62' ' ' PHE . 16.8 mtt180 -71.81 90.52 1.1 Allowed 'General case' 0 C--O 1.236 0.368 0 N-CA-C 104.941 -2.244 . . . . 0.0 104.941 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -97.73 89.52 4.65 Favored 'General case' 0 N--CA 1.425 -1.725 0 C-N-CA 119.425 -0.91 . . . . 0.0 110.991 179.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.493 ' HA ' ' HA ' ' A' ' 113' ' ' LEU 0.439 0.0 OUTLIER -58.41 91.93 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 C-N-CA 117.117 -1.833 . . . . 0.0 114.171 -179.74 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -78.28 76.86 4.78 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 102.56 -3.126 . . . . 0.0 102.56 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 60.93 -123.79 33.67 Favored Glycine 0 C--O 1.245 0.801 0 O-C-N 128.473 3.608 . . . . 0.0 110.705 -179.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . 0.31 28.5 m-80 -71.88 0.96 7.87 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-O 112.381 -3.676 . . . . 0.0 113.76 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.501 ' HG3' ' HA ' ' A' ' 129' ' ' LYS . 4.5 mp0 -118.18 117.75 29.99 Favored 'General case' 0 CA--C 1.511 -0.527 0 O-C-N 128.042 3.339 . . . . 0.0 110.615 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.493 ' HA ' ' HA ' ' A' ' 108' ' ' ILE . 0.5 OUTLIER -87.83 124.27 33.47 Favored 'General case' 0 C--O 1.216 -0.672 0 O-C-N 127.102 2.751 . . . . 0.0 103.969 179.761 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.774 HD13 HG23 ' A' ' 127' ' ' ILE 0.296 1.8 mm -114.55 133.43 60.7 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.33 0 N-CA-C 103.854 -2.647 . . . . 0.0 103.854 -179.68 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 10.7 mt-30 -115.4 97.36 6.13 Favored 'General case' 0 CA--C 1.489 -1.387 0 O-C-N 125.385 1.678 . . . . 0.0 109.461 -179.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.465 HG22 ' HG3' ' A' ' 125' ' ' LYS . 19.2 p -75.09 174.33 9.54 Favored 'General case' 0 C--O 1.247 0.929 0 N-CA-C 105.004 -2.221 . . . . 0.0 105.004 179.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 16.9 m-85 -162.5 115.31 1.68 Allowed 'General case' 0 CA--C 1.483 -1.631 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.512 ' HB ' ' CG2' ' A' ' 103' ' ' ILE . 88.4 m -113.68 88.84 2.94 Favored 'General case' 0 N--CA 1.42 -1.945 0 N-CA-C 116.95 2.204 . . . . 0.0 116.95 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.494 ' HB2' ' CD1' ' A' ' 102' ' ' LEU . 3.2 t80 -83.68 130.01 34.96 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 103.884 -2.635 . . . . 0.0 103.884 178.037 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.495 ' CB ' ' HE3' ' A' ' 20' ' ' LYS . 3.0 mm-40 61.89 -62.9 0.09 Allowed 'General case' 0 C--N 1.289 -2.037 0 O-C-N 125.293 1.621 . . . . 0.0 112.191 -179.088 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 179.64 33.34 0.06 OUTLIER Glycine 0 CA--C 1.542 1.78 0 C-N-CA 128.853 3.121 . . . . 0.0 116.173 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 10.7 t -125.68 97.85 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.65 0 O-C-N 120.744 -1.445 . . . . 0.0 107.637 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.496 ' O ' ' HB2' ' A' ' 124' ' ' ALA 0.257 10.0 mt-10 -62.69 -175.56 0.09 Allowed 'General case' 0 N--CA 1.438 -1.067 0 CA-C-O 117.381 -1.295 . . . . 0.0 111.784 179.983 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.513 ' HB2' ' CB ' ' A' ' 17' ' ' PHE . . . -176.75 88.07 0.03 OUTLIER 'General case' 0 N--CA 1.436 -1.131 0 CA-C-O 114.911 -2.471 . . . . 0.0 107.076 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.465 ' HG3' HG22 ' A' ' 116' ' ' THR . 0.0 OUTLIER -68.43 139.99 55.76 Favored 'General case' 0 CA--C 1.487 -1.469 0 O-C-N 125.788 1.93 . . . . 0.0 110.546 179.989 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.636 ' HD2' HG21 ' A' ' 8' ' ' VAL . 5.0 mmm-85 -133.56 85.12 2.18 Favored 'General case' 0 N--CA 1.429 -1.504 0 O-C-N 126.34 2.275 . . . . 0.0 106.581 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.774 HG23 HD13 ' A' ' 114' ' ' ILE . 13.2 mt -83.79 112.47 21.27 Favored 'Isoleucine or valine' 0 C--O 1.249 1.067 0 O-C-N 127.86 3.225 . . . . 0.0 117.305 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.528 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 0.0 OUTLIER -102.39 137.29 40.83 Favored 'General case' 0 N--CA 1.441 -0.9 0 O-C-N 126.642 2.464 . . . . 0.0 108.136 179.414 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.501 ' HA ' ' HG3' ' A' ' 112' ' ' GLU 0.284 12.2 mmtm -92.64 5.58 50.47 Favored 'General case' 0 C--O 1.244 0.78 0 CA-C-O 116.626 -1.655 . . . . 0.0 111.748 179.884 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.623 ' HA ' ' CE3' ' A' ' 6' ' ' TRP . 0.1 OUTLIER 76.59 138.95 0.07 Allowed 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 121.125 1.784 . . . . 0.0 108.424 179.79 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . 0.763 61.4 tt0 . . . . . 0 N--CA 1.443 -0.776 0 C-N-CA 116.563 -2.055 . . . . 0.0 113.789 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . 0.575 ' CZ ' HG21 ' A' ' 108' ' ' ILE . 62.1 m-85 . . . . . 0 N--CA 1.448 -0.568 0 CA-C-O 124.523 2.106 . . . . 0.0 113.776 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -156.73 96.33 1.62 Allowed 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 113.563 -1.653 . . . . 0.0 115.014 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 148.29 -152.44 24.51 Favored Glycine 0 C--N 1.313 -0.738 0 C-N-CA 116.778 -2.629 . . . . 0.0 112.942 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . 0.547 0.0 OUTLIER -111.48 158.12 19.52 Favored 'General case' 0 C--N 1.314 -0.968 0 O-C-N 127.53 2.547 . . . . 0.0 113.096 -179.782 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.647 ' CD1' HD12 ' A' ' 40' ' ' ILE . 85.1 m95 -149.37 113.02 5.05 Favored 'General case' 0 N--CA 1.433 -1.304 0 CA-C-N 112.618 -2.083 . . . . 0.0 110.173 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.9 101.83 11.39 Favored 'General case' 0 C--O 1.211 -0.961 0 CA-C-N 120.886 1.676 . . . . 0.0 107.365 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.505 ' CG1' ' HB3' ' A' ' 36' ' ' LEU . 0.3 OUTLIER -47.43 135.8 3.67 Favored 'Isoleucine or valine' 0 C--O 1.246 0.877 0 CA-C-N 120.76 1.618 . . . . 0.0 110.205 179.913 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -145.05 -11.45 0.56 Allowed 'General case' 0 N--CA 1.433 -1.29 0 C-N-CA 118.676 -1.209 . . . . 0.0 112.997 -179.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.422 ' HB3' ' HB ' ' A' ' 127' ' ' ILE . 5.6 tpp180 -111.05 -56.07 2.41 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-N 121.326 1.876 . . . . 0.0 113.245 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.528 ' HB3' ' CD1' ' A' ' 14' ' ' TYR . 1.2 m-20 62.7 165.84 0.11 Allowed 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 124.244 1.018 . . . . 0.0 110.454 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.406 ' N ' ' O ' ' A' ' 125' ' ' LYS . 2.4 mm-40 -171.26 103.05 0.21 Allowed 'General case' 0 C--N 1.314 -0.952 0 O-C-N 117.3 -3.375 . . . . 0.0 107.201 -179.6 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.433 ' HB3' ' HA ' ' A' ' 124' ' ' ALA . 0.3 OUTLIER 97.5 -27.28 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.18 0 O-C-N 125.447 1.717 . . . . 0.0 111.923 -179.238 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.757 ' CE2' ' HB1' ' A' ' 32' ' ' ALA . 2.4 p90 -29.96 -36.39 0.01 OUTLIER 'General case' 0 N--CA 1.435 -1.186 0 O-C-N 127.619 3.074 . . . . 0.0 118.03 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -75.77 -34.21 60.23 Favored 'General case' 0 CA--C 1.498 -1.024 0 C-N-CA 120.58 -0.448 . . . . 0.0 110.793 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -73.04 -28.7 62.49 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-O 124.304 2.002 . . . . 0.0 113.138 179.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.79 ' CB ' ' HB2' ' A' ' 124' ' ' ALA . 0.0 OUTLIER -71.45 -29.29 64.7 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-O 125.658 2.646 . . . . 0.0 110.393 179.908 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 29.6 mtm -79.88 -20.38 45.99 Favored 'General case' 0 C--N 1.318 -0.77 0 O-C-N 116.654 -3.779 . . . . 0.0 106.445 179.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.04 -31.13 39.51 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 123.103 1.43 . . . . 0.0 112.655 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.602 ' CE ' ' HB3' ' A' ' 119' ' ' TYR . 0.5 OUTLIER -73.49 -21.18 60.49 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 115.754 1.761 . . . . 0.0 115.754 -178.144 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 3.4 mtp -79.03 -47.6 15.91 Favored 'General case' 0 C--O 1.206 -1.192 0 N-CA-C 103.592 -2.744 . . . . 0.0 103.592 179.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 124.08 43.64 0.32 Allowed Glycine 0 N--CA 1.433 -1.537 0 CA-C-N 113.902 -1.499 . . . . 0.0 111.234 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.9 mm -75.09 126.24 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.967 0 CA-C-O 115.813 -2.041 . . . . 0.0 112.173 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -52.57 145.02 12.47 Favored 'General case' 0 C--N 1.348 0.527 0 CA-C-O 115.233 -2.318 . . . . 0.0 111.573 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . 0.445 26.9 m -36.39 -47.99 0.25 Allowed 'Isoleucine or valine' 0 C--O 1.216 -0.707 0 N-CA-C 119.162 3.023 . . . . 0.0 119.162 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.537 5.4 m -79.84 -28.38 12.62 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.995 0 N-CA-C 115.217 1.562 . . . . 0.0 115.217 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.9 ttmm -71.41 -31.58 67.42 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 112.147 -2.297 . . . . 0.0 114.904 179.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 7.5 ptt180 -79.35 -21.28 46.03 Favored 'General case' 0 C--O 1.219 -0.543 0 C-N-CA 117.721 -1.592 . . . . 0.0 109.303 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 9.3 tttm -72.13 -46.22 57.47 Favored 'General case' 0 CA--C 1.5 -0.959 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.64 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.3 tp -76.38 -28.61 56.82 Favored 'General case' 0 CA--C 1.505 -0.755 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -74.43 -20.99 79.45 Favored Glycine 0 C--N 1.345 1.055 0 CA-C-O 124.017 1.898 . . . . 0.0 111.981 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.757 ' HB1' ' CE2' ' A' ' 14' ' ' TYR . . . -75.25 -48.96 20.9 Favored 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 127.484 2.314 . . . . 0.0 111.02 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 8.5 m170 -96.35 7.66 45.92 Favored 'General case' 0 N--CA 1.429 -1.509 0 O-C-N 127.152 2.782 . . . . 0.0 110.672 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 29.8 p30 -33.6 -27.22 0.01 OUTLIER 'General case' 0 CA--C 1.507 -0.702 0 N-CA-C 116.774 2.139 . . . . 0.0 116.774 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.2 t30 77.1 26.7 0.72 Allowed 'General case' 0 C--O 1.244 0.778 0 CA-C-N 120.641 1.564 . . . . 0.0 112.351 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.522 HD11 ' HG ' ' A' ' 38' ' ' LEU . 1.3 tp -52.22 116.52 2.26 Favored 'General case' 0 CA--C 1.5 -0.962 0 CA-C-O 123.981 1.848 . . . . 0.0 109.341 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.508 ' N ' HD12 ' A' ' 36' ' ' LEU . 6.3 ttmm -111.43 95.6 5.61 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 101.865 -3.383 . . . . 0.0 101.865 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.611 HD12 ' CE2' ' A' ' 128' ' ' PHE 0.284 2.4 mt -78.58 141.52 38.02 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 119.041 -2.287 . . . . 0.0 108.292 -179.928 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.505 ' HB ' ' CB ' ' A' ' 50' ' ' LYS . 9.3 m -128.51 76.82 1.73 Allowed 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 102.213 -3.254 . . . . 0.0 102.213 179.23 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.647 HD12 ' CD1' ' A' ' 6' ' ' TRP . 6.0 mt -65.81 134.94 29.19 Favored 'Isoleucine or valine' 0 C--O 1.251 1.142 0 CA-C-N 112.401 -2.182 . . . . 0.0 106.359 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.411 HG22 ' O ' ' A' ' 41' ' ' THR . 0.8 OUTLIER -145.91 113.81 6.48 Favored 'General case' 0 CA--C 1.504 -0.792 0 O-C-N 126.849 2.593 . . . . 0.0 110.648 -179.949 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -90.09 134.35 34.31 Favored 'General case' 0 C--O 1.22 -0.465 0 CA-C-N 114.259 -1.337 . . . . 0.0 113.765 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 33.9 tp10 -135.55 91.01 2.67 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 105.578 -2.008 . . . . 0.0 105.578 179.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 67.13 -97.67 0.39 Allowed Glycine 0 C--N 1.292 -1.871 0 CA-C-O 116.367 -2.352 . . . . 0.0 109.313 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.335 0.0 OUTLIER -117.8 -1.93 11.46 Favored 'General case' 0 C--N 1.315 -0.917 0 O-C-N 129.712 3.83 . . . . 0.0 113.377 -179.895 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.42 ' HA ' ' HA ' ' A' ' 63' ' ' GLU . 0.6 OUTLIER -99.62 136.66 39.23 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 106.997 -1.482 . . . . 0.0 106.997 -179.952 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.497 ' HE2' HD11 ' A' ' 89' ' ' LEU 0.313 0.1 OUTLIER -121.48 108.27 13.44 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 105.616 -1.994 . . . . 0.0 105.616 -179.929 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.692 ' HB ' HG12 ' A' ' 61' ' ' VAL 0.386 0.1 OUTLIER -99.94 89.94 4.24 Favored 'General case' 0 N--CA 1.423 -1.789 0 O-C-N 124.804 1.315 . . . . 0.0 108.445 -179.68 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.636 HG22 ' HB ' ' A' ' 60' ' ' VAL 0.714 1.0 OUTLIER -65.7 94.59 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.503 -0.858 0 O-C-N 127.246 2.841 . . . . 0.0 108.596 178.792 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.505 ' CB ' ' HB ' ' A' ' 39' ' ' THR . 0.0 OUTLIER -63.35 140.46 58.87 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 102.448 -3.168 . . . . 0.0 102.448 -179.439 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.471 ' HB2' HG23 ' A' ' 60' ' ' VAL . 11.8 tt0 -130.04 73.0 1.5 Allowed 'General case' 0 CA--C 1.51 -0.559 0 N-CA-C 105.998 -1.853 . . . . 0.0 105.998 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.99 69.36 5.13 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 105.957 -1.868 . . . . 0.0 105.957 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.32 175.77 6.98 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.984 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.403 ' O ' ' ND2' ' A' ' 54' ' ' ASN . 2.7 t-20 -62.19 -26.58 68.43 Favored 'General case' 0 C--O 1.216 -0.674 0 O-C-N 125.441 1.713 . . . . 0.0 107.831 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.645 ' CE1' ' HB1' ' A' ' 73' ' ' ALA . 0.3 OUTLIER -69.1 -64.38 0.88 Allowed 'General case' 0 C--O 1.222 -0.385 0 CA-C-O 114.473 -2.679 . . . . 0.0 108.659 179.821 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -173.05 172.52 3.91 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 122.8 2.545 . . . . 0.0 110.844 179.537 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -90.76 65.94 5.96 Favored 'General case' 0 CA--C 1.498 -1.02 0 O-C-N 128.46 3.6 . . . . 0.0 105.067 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -87.48 -41.11 14.32 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 O-C-N 127.353 2.908 . . . . 0.0 115.746 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 50.6 t0 79.58 141.66 0.07 Allowed 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 104.649 -2.352 . . . . 0.0 104.649 -179.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.636 ' HB ' HG22 ' A' ' 49' ' ' VAL . 1.5 t -129.38 84.77 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 N-CA-C 105.464 -2.05 . . . . 0.0 105.464 -179.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.692 HG12 ' HB ' ' A' ' 48' ' ' THR 0.314 1.5 m -90.18 136.56 23.55 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.519 0 N-CA-C 116.889 2.181 . . . . 0.0 116.889 -178.188 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.539 ' HB3' ' CZ ' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -137.25 95.0 3.01 Favored 'General case' 0 N--CA 1.422 -1.83 0 CA-C-O 114.18 -2.819 . . . . 0.0 110.8 177.263 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.492 ' O ' ' N ' ' A' ' 65' ' ' GLY . 24.0 tt0 -54.58 117.73 3.59 Favored 'General case' 0 C--N 1.32 -0.698 1 N-CA-C 98.813 -4.514 . . . . 0.0 98.813 175.998 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.776 ' HB3' ' CD2' ' A' ' 82' ' ' TRP . 0.0 OUTLIER -47.76 93.48 0.01 OUTLIER 'General case' 0 N--CA 1.429 -1.511 0 O-C-N 125.686 1.866 . . . . 0.0 107.69 -175.68 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.685 ' N ' ' NE1' ' A' ' 82' ' ' TRP . . . 94.71 50.33 2.16 Favored Glycine 0 C--N 1.353 1.517 0 N-CA-C 121.592 3.397 . . . . 0.0 121.592 178.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.41 ' HB ' ' HB3' ' A' ' 63' ' ' GLU 0.305 7.3 p -103.94 -19.91 6.03 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 CA-C-O 115.237 -2.316 . . . . 0.0 109.826 -179.985 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.548 ' HA ' HG22 ' A' ' 81' ' ' THR . 64.8 t0 65.19 105.04 0.04 OUTLIER 'General case' 0 C--O 1.204 -1.305 0 CA-C-O 123.074 1.416 . . . . 0.0 107.409 -178.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.608 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 0.1 OUTLIER -131.64 161.26 33.15 Favored 'General case' 0 C--N 1.307 -1.245 0 C-N-CA 125.876 1.67 . . . . 0.0 111.619 -176.876 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -110.75 130.07 55.67 Favored 'General case' 0 C--O 1.245 0.843 0 O-C-N 127.031 2.707 . . . . 0.0 105.122 179.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 83.9 t80 -132.6 96.5 3.84 Favored 'General case' 0 C--O 1.208 -1.104 0 O-C-N 125.353 1.658 . . . . 0.0 114.41 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 25.1 t -66.97 140.84 57.75 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 105.372 -2.084 . . . . 0.0 105.372 179.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -77.39 -174.68 3.41 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 103.257 -2.868 . . . . 0.0 103.257 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.645 ' HB1' ' CE1' ' A' ' 55' ' ' PHE . . . -80.48 -19.71 45.34 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-O 124.836 2.255 . . . . 0.0 111.3 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -153.86 -37.61 0.1 Allowed 'General case' 0 C--O 1.222 -0.375 0 CA-C-N 112.669 -2.06 . . . . 0.0 111.129 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.567 ' O ' HG22 ' A' ' 76' ' ' THR . . . -69.72 -0.91 28.09 Favored Glycine 0 CA--C 1.533 1.207 0 N-CA-C 118.512 2.165 . . . . 0.0 118.512 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.567 HG22 ' O ' ' A' ' 75' ' ' GLY 0.386 0.3 OUTLIER 77.27 164.44 0.24 Allowed 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 120.376 2.088 . . . . 0.0 114.857 -179.908 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.575 ' HG2' HG21 ' A' ' 96' ' ' VAL . 0.3 OUTLIER -30.31 145.21 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 111.763 -2.471 . . . . 0.0 116.567 -179.805 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.499 ' HG ' ' HB3' ' A' ' 93' ' ' PHE 0.386 0.6 OUTLIER -160.62 101.74 1.34 Allowed 'General case' 0 C--O 1.24 0.602 0 CA-C-N 109.924 -3.307 . . . . 0.0 107.142 179.982 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.658 HG22 ' O ' ' A' ' 94' ' ' LYS . 91.6 m -105.82 -172.78 2.15 Favored 'General case' 0 CA--C 1.498 -1.037 0 N-CA-C 101.772 -3.418 . . . . 0.0 101.772 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.446 ' HA3' ' HA ' ' A' ' 93' ' ' PHE . . . 118.8 -148.07 18.4 Favored Glycine 0 C--N 1.292 -1.872 0 CA-C-O 116.571 -2.238 . . . . 0.0 113.191 179.629 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.548 HG22 ' HA ' ' A' ' 67' ' ' ASP . 60.3 p -165.46 166.73 18.2 Favored 'General case' 0 C--O 1.188 -2.155 0 CA-C-O 124.232 1.967 . . . . 0.0 110.712 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . 0.777 ' CG ' ' N ' ' A' ' 83' ' ' THR 0.399 4.0 p-90 -73.03 -162.39 0.11 Allowed 'General case' 0 N--CA 1.438 -1.063 0 N-CA-C 100.244 -3.984 . . . . 0.0 100.244 175.43 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.777 ' N ' ' CG ' ' A' ' 82' ' ' TRP . 4.7 t 159.43 129.51 0.0 OUTLIER 'General case' 0 N--CA 1.415 -2.219 0 CA-C-O 125.733 2.682 . . . . 0.0 112.657 174.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.584 ' HB2' ' CZ3' ' A' ' 82' ' ' TRP . 0.0 OUTLIER -88.53 121.93 31.45 Favored 'General case' 0 N--CA 1.422 -1.836 0 CA-C-N 110.566 -3.015 . . . . 0.0 105.524 179.047 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.669 ' HG2' HG21 ' A' ' 90' ' ' VAL 0.622 2.5 pp20? -111.59 44.48 1.35 Allowed 'General case' 0 N--CA 1.421 -1.912 0 CA-C-O 123.574 1.654 . . . . 0.0 114.394 179.735 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 71.61 110.94 0.05 OUTLIER Glycine 0 N--CA 1.443 -0.854 0 N-CA-C 107.595 -2.202 . . . . 0.0 107.595 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 50.9 t30 66.67 -22.05 0.1 Allowed 'General case' 0 N--CA 1.44 -0.942 0 CA-C-O 114.948 -2.453 . . . . 0.0 116.347 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.451 ' HG3' ' HA ' ' A' ' 107' ' ' GLU 0.33 0.1 OUTLIER -129.1 142.76 50.79 Favored 'General case' 0 CA--C 1.491 -1.311 0 CA-C-N 120.903 1.683 . . . . 0.0 107.465 -179.97 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.508 HD23 ' HA ' ' A' ' 89' ' ' LEU . 0.2 OUTLIER -94.85 152.55 18.3 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 101.715 -3.439 . . . . 0.0 101.715 -179.821 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.669 HG21 ' HG2' ' A' ' 85' ' ' GLU . 1.4 t -136.75 164.65 30.17 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 N-CA-C 105.507 -2.035 . . . . 0.0 105.507 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -133.79 99.06 0.34 Allowed Glycine 0 C--N 1.363 2.079 0 C-N-CA 128.554 2.978 . . . . 0.0 108.865 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -98.45 127.93 44.6 Favored 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 103.343 -2.836 . . . . 0.0 103.343 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.538 ' HB2' ' HB3' ' A' ' 102' ' ' LEU . 19.4 m-85 -140.5 130.49 24.69 Favored 'General case' 0 N--CA 1.442 -0.869 0 O-C-N 124.429 1.081 . . . . 0.0 113.279 179.484 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.658 ' O ' HG22 ' A' ' 79' ' ' THR . 0.5 OUTLIER -115.27 124.2 50.73 Favored 'General case' 0 N--CA 1.422 -1.832 0 C-N-CA 130.159 3.384 . . . . 0.0 105.54 -179.987 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.713 ' HE ' ' N ' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -54.74 -168.02 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.721 0 O-C-N 128.339 3.525 . . . . 0.0 110.573 178.647 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.575 HG21 ' HG2' ' A' ' 77' ' ' GLU . 20.5 t -124.56 -50.11 2.1 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 O-C-N 119.754 -1.841 . . . . 0.0 106.489 176.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . 0.293 0.3 OUTLIER -110.0 9.7 24.27 Favored 'General case' 0 C--O 1.255 1.348 0 CA-C-N 113.102 -1.863 . . . . 0.0 113.465 -179.939 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.432 ' HB3' ' CB ' ' A' ' 95' ' ' ARG 0.268 27.4 t30 -101.46 -23.91 14.25 Favored 'General case' 0 CA--C 1.494 -1.195 0 CA-C-O 116.281 -1.819 . . . . 0.0 111.322 -179.962 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.658 ' HA2' ' CZ ' ' A' ' 95' ' ' ARG . . . 71.87 11.1 73.55 Favored Glycine 0 CA--C 1.542 1.767 0 N-CA-C 118.38 2.112 . . . . 0.0 118.38 179.181 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.713 ' N ' ' HE ' ' A' ' 95' ' ' ARG . 3.8 mtpp -110.73 -148.04 0.42 Allowed 'General case' 0 C--N 1.3 -1.578 0 O-C-N 125.801 1.53 . . . . 0.0 111.004 -177.45 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 57.2 tt0 -160.65 161.91 32.53 Favored 'General case' 0 N--CA 1.433 -1.295 0 C-N-CA 131.385 3.874 . . . . 0.0 109.687 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.538 ' HB3' ' HB2' ' A' ' 93' ' ' PHE . 9.3 tp -142.33 157.75 44.47 Favored 'General case' 0 N--CA 1.438 -1.045 1 C-N-CA 132.014 4.125 . . . . 0.0 106.527 -179.243 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.643 ' CG2' ' HB ' ' A' ' 118' ' ' THR . 4.1 tt -150.25 154.63 8.67 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.993 0 N-CA-C 103.941 -2.615 . . . . 0.0 103.941 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -131.5 -172.0 2.74 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.569 HG12 HG23 ' A' ' 116' ' ' THR . 0.5 OUTLIER -169.72 77.02 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 CA-C-O 127.544 3.545 . . . . 0.0 107.539 179.647 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.463 HH12 ' HE2' ' A' ' 62' ' ' PHE . 0.1 OUTLIER -65.84 91.71 0.15 Allowed 'General case' 0 C--O 1.217 -0.617 0 N-CA-C 104.668 -2.345 . . . . 0.0 104.668 179.571 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.451 ' HA ' ' HG3' ' A' ' 88' ' ' LYS . 25.8 tt0 -72.75 -35.42 67.48 Favored 'General case' 0 C--O 1.202 -1.414 0 CA-C-N 110.994 -2.821 . . . . 0.0 115.044 -179.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.83 HD13 HD12 ' A' ' 113' ' ' LEU 0.428 3.2 tp 52.55 43.38 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 C-N-CA 112.927 -3.509 . . . . 0.0 113.236 179.956 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -66.73 103.19 1.05 Allowed 'General case' 0 CA--C 1.505 -0.782 0 O-C-N 120.494 -1.379 . . . . 0.0 108.193 -179.487 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 56.85 -73.29 0.01 OUTLIER Glycine 0 C--N 1.342 0.893 0 C-N-CA 127.206 2.336 . . . . 0.0 111.848 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . 0.351 0.0 OUTLIER -136.97 36.8 2.58 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 117.494 -1.241 . . . . 0.0 110.32 179.671 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -146.43 97.62 2.95 Favored 'General case' 0 C--N 1.363 1.162 0 O-C-N 126.521 2.388 . . . . 0.0 110.388 -179.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.83 HD12 HD13 ' A' ' 108' ' ' ILE . 0.4 OUTLIER -75.27 68.33 1.99 Allowed 'General case' 0 C--O 1.209 -1.068 1 O-C-N 129.353 4.158 . . . . 0.0 107.479 -179.51 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.866 HG12 HD13 ' A' ' 127' ' ' ILE . 54.6 mt -72.07 128.27 34.86 Favored 'Isoleucine or valine' 0 C--O 1.25 1.114 0 N-CA-C 105.006 -2.22 . . . . 0.0 105.006 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -113.17 108.14 16.89 Favored 'General case' 0 CA--C 1.493 -1.232 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 -179.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.569 HG23 HG12 ' A' ' 105' ' ' VAL . 66.8 p -76.28 169.06 18.94 Favored 'General case' 0 C--O 1.245 0.846 0 C-N-CA 115.912 -2.315 . . . . 0.0 105.443 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.707 ' HB2' ' HB3' ' A' ' 124' ' ' ALA . 0.8 OUTLIER -148.85 93.82 2.17 Favored 'General case' 0 CA--C 1.491 -1.298 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 -179.986 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.643 ' HB ' ' CG2' ' A' ' 103' ' ' ILE . 0.2 OUTLIER -96.84 81.68 3.16 Favored 'General case' 0 N--CA 1.424 -1.762 0 O-C-N 126.702 2.501 . . . . 0.0 116.322 -179.781 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.602 ' HB3' ' CE ' ' A' ' 20' ' ' LYS . 0.2 OUTLIER -85.8 101.57 12.92 Favored 'General case' 0 N--CA 1.479 0.975 0 N-CA-C 103.278 -2.86 . . . . 0.0 103.278 178.625 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 65.25 -82.15 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.412 0 CA-C-N 113.88 -1.509 . . . . 0.0 114.178 -179.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -132.8 24.09 3.89 Favored Glycine 0 CA--C 1.54 1.623 0 N-CA-C 117.401 1.72 . . . . 0.0 117.401 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.534 ' HB ' ' HD3' ' A' ' 20' ' ' LYS . 3.3 t -133.14 87.36 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -68.62 129.97 41.49 Favored 'General case' 0 N--CA 1.436 -1.144 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.79 ' HB2' ' CB ' ' A' ' 17' ' ' PHE . . . -115.54 115.6 26.74 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-O 116.307 -1.806 . . . . 0.0 108.4 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.406 ' O ' ' N ' ' A' ' 12' ' ' GLU . 0.1 OUTLIER -92.7 129.94 38.48 Favored 'General case' 0 C--O 1.252 1.202 0 C-N-CA 116.991 -1.883 . . . . 0.0 109.932 -179.998 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 7.4 mtm180 -119.89 86.77 2.62 Favored 'General case' 0 N--CA 1.437 -1.122 0 CA-C-N 112.082 -2.326 . . . . 0.0 106.028 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.866 HD13 HG12 ' A' ' 114' ' ' ILE . 0.8 OUTLIER -84.28 125.9 40.23 Favored 'Isoleucine or valine' 0 C--O 1.252 1.23 0 CA-C-N 114.306 -1.316 . . . . 0.0 112.893 179.983 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.611 ' CE2' HD12 ' A' ' 38' ' ' LEU . 0.2 OUTLIER -106.39 155.71 19.27 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-O 123.722 1.725 . . . . 0.0 107.926 179.709 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . 0.268 15.9 mtpp -117.3 16.99 14.79 Favored 'General case' 0 C--O 1.244 0.797 0 O-C-N 118.594 -2.566 . . . . 0.0 110.704 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.554 ' HG3' ' CH2' ' A' ' 6' ' ' TRP . 1.4 tttt 57.26 113.25 0.01 OUTLIER 'General case' 0 C--O 1.219 -0.527 0 N-CA-C 115.991 1.849 . . . . 0.0 115.991 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . 0.836 15.0 tt0 . . . . . 0 N--CA 1.429 -1.519 0 O-C-N 118.422 -2.674 . . . . 0.0 116.023 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 19.2 p90 . . . . . 0 N--CA 1.429 -1.513 0 N-CA-C 118.541 2.793 . . . . 0.0 118.541 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -167.45 96.92 0.48 Allowed 'General case' 0 N--CA 1.435 -1.191 0 O-C-N 119.605 -1.934 . . . . 0.0 112.091 -179.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 142.91 -152.48 23.99 Favored Glycine 0 C--O 1.212 -1.229 0 C-N-CA 118.587 -1.768 . . . . 0.0 109.435 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.486 HG22 ' HG2' ' A' ' 37' ' ' LYS 0.567 13.2 p -89.69 155.08 19.46 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 123.358 0.663 . . . . 0.0 111.417 179.946 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.573 ' CH2' HD11 ' A' ' 108' ' ' ILE . 91.9 m95 -152.69 105.17 2.95 Favored 'General case' 0 C--N 1.319 -0.747 0 O-C-N 127.652 3.095 . . . . 0.0 106.848 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 13.1 ttpt -106.04 101.85 11.31 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-O 114.991 -2.433 . . . . 0.0 108.313 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.481 ' HA ' ' HA ' ' A' ' 128' ' ' PHE 0.284 2.8 p -45.89 144.27 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 120.441 1.473 . . . . 0.0 111.015 179.804 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -146.55 -30.25 0.37 Allowed 'General case' 0 N--CA 1.438 -1.053 0 O-C-N 127.82 3.2 . . . . 0.0 112.371 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.608 ' HB2' ' HB ' ' A' ' 127' ' ' ILE . 17.9 mmt180 -82.84 -80.76 0.17 Allowed 'General case' 0 C--N 1.297 -1.684 0 O-C-N 119.022 -2.299 . . . . 0.0 114.286 -179.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.526 ' HA ' ' HA ' ' A' ' 126' ' ' ARG 0.284 8.2 m120 77.13 147.19 0.09 Allowed 'General case' 0 C--O 1.247 0.964 1 O-C-N 129.592 4.307 . . . . 0.0 106.275 -177.206 . . . . . . . . 4 3 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.41 ' N ' ' O ' ' A' ' 125' ' ' LYS . 2.8 tp10 -125.9 -69.54 0.77 Allowed 'General case' 0 C--N 1.296 -1.724 0 CA-C-N 122.398 2.363 . . . . 0.0 108.113 -179.595 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.496 ' HB3' ' HA ' ' A' ' 124' ' ' ALA . 5.2 t30 -112.17 29.37 7.95 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 127.325 2.891 . . . . 0.0 113.157 179.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.676 ' CD1' ' HB1' ' A' ' 124' ' ' ALA 0.376 1.1 m-85 -73.18 -27.68 61.78 Favored 'General case' 0 N--CA 1.44 -0.974 0 O-C-N 127.282 2.863 . . . . 0.0 117.488 179.708 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -74.36 -36.48 63.58 Favored 'General case' 0 C--O 1.209 -1.032 0 CA-C-N 120.479 1.49 . . . . 0.0 111.391 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.4 ' HB3' ' ND2' ' A' ' 13' ' ' ASN . 12.4 tptp -71.77 -32.14 67.35 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 111.537 -2.574 . . . . 0.0 115.216 179.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -70.76 -24.27 62.57 Favored 'General case' 0 N--CA 1.441 -0.88 0 O-C-N 124.868 1.355 . . . . 0.0 111.472 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 7.7 mmt -77.21 -34.65 56.04 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-O 123.841 1.781 . . . . 0.0 106.422 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -65.54 -31.14 72.04 Favored 'General case' 0 N--CA 1.473 0.709 0 O-C-N 118.199 -2.813 . . . . 0.0 112.529 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.414 ' HA ' ' HD2' ' A' ' 20' ' ' LYS . 11.6 tptm -77.04 -30.91 55.9 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 112.836 -1.984 . . . . 0.0 110.581 179.352 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.84 -21.08 55.55 Favored 'General case' 0 N--CA 1.435 -1.221 0 O-C-N 125.148 1.53 . . . . 0.0 107.792 179.373 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 123.01 1.64 9.49 Favored Glycine 0 C--N 1.301 -1.387 0 CA-C-O 117.674 -1.625 . . . . 0.0 113.258 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.415 HG23 ' HB2' ' A' ' 27' ' ' LYS . 0.6 OUTLIER -77.75 107.33 9.35 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.313 0 CA-C-O 117.73 -1.129 . . . . 0.0 108.605 179.913 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -118.67 1.49 11.64 Favored 'General case' 0 C--N 1.352 0.68 0 CA-C-O 116.001 -1.952 . . . . 0.0 114.154 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . 0.393 0.6 OUTLIER -112.72 -140.14 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.358 0.969 0 O-C-N 128.974 3.921 . . . . 0.0 116.34 -179.981 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.561 0.0 OUTLIER -72.76 -21.08 19.45 Favored 'Isoleucine or valine' 0 C--O 1.243 0.722 0 CA-C-N 120.689 1.586 . . . . 0.0 114.792 -179.926 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.415 ' HB2' HG23 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -62.14 -30.78 71.28 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 114.29 1.219 . . . . 0.0 114.29 179.89 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . 0.268 0.1 OUTLIER -78.97 -20.95 47.87 Favored 'General case' 0 N--CA 1.454 -0.247 0 O-C-N 119.502 -1.998 . . . . 0.0 108.31 180.0 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.6 tttm -78.9 -46.66 17.99 Favored 'General case' 0 C--O 1.215 -0.716 0 CA-C-N 113.318 -1.764 . . . . 0.0 108.768 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 11.0 mp -73.46 -22.69 60.12 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 113.746 -1.57 . . . . 0.0 110.248 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -68.79 -34.0 76.73 Favored Glycine 0 C--N 1.344 1.018 0 C-N-CA 123.638 0.637 . . . . 0.0 112.559 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -79.85 -34.86 38.97 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 127.625 2.37 . . . . 0.0 109.107 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 10.6 m170 -118.4 42.03 2.82 Favored 'General case' 0 C--O 1.24 0.573 0 C-N-CA 126.617 1.967 . . . . 0.0 114.338 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.8 p30 -71.29 -23.59 61.99 Favored 'General case' 0 C--O 1.215 -0.754 0 N-CA-C 119.17 3.026 . . . . 0.0 119.17 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 78.13 9.1 2.25 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 -179.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.769 HD22 HH21 ' A' ' 126' ' ' ARG . 0.9 OUTLIER -41.77 116.32 0.77 Allowed 'General case' 0 CA--C 1.51 -0.591 0 O-C-N 126.962 2.664 . . . . 0.0 110.873 -179.791 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.486 ' HG2' HG22 ' A' ' 5' ' ' THR . 11.4 ttmm -113.86 92.11 3.87 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 105.166 -2.161 . . . . 0.0 105.166 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.713 HD13 HD21 ' A' ' 36' ' ' LEU 0.276 0.8 OUTLIER -75.17 114.08 13.25 Favored 'General case' 0 C--N 1.292 -1.91 0 C-N-CA 117.497 -1.681 . . . . 0.0 109.115 -179.983 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.524 ' HB ' ' CB ' ' A' ' 50' ' ' LYS . 91.8 m -94.87 84.47 4.18 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 102.012 -3.329 . . . . 0.0 102.012 179.44 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.57 HD12 ' CD1' ' A' ' 6' ' ' TRP . 96.0 mt -71.73 116.14 13.04 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 CA-C-O 123.69 1.71 . . . . 0.0 110.81 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.3 m -110.38 118.01 35.14 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 110.324 -3.125 . . . . 0.0 109.348 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 2.7 tp60 -94.46 125.62 39.22 Favored 'General case' 0 C--N 1.311 -1.082 0 O-C-N 126.074 2.108 . . . . 0.0 107.794 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -135.08 68.31 1.47 Allowed 'General case' 0 N--CA 1.433 -1.31 0 CA-C-O 125.257 2.456 . . . . 0.0 105.684 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.17 -76.59 2.22 Favored Glycine 0 C--N 1.298 -1.559 0 N-CA-C 104.44 -3.464 . . . . 0.0 104.44 179.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.348 0.0 OUTLIER -130.51 -36.58 1.44 Allowed 'General case' 0 C--N 1.326 -0.449 0 O-C-N 126.608 2.005 . . . . 0.0 113.976 179.947 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.481 ' HA ' ' HA ' ' A' ' 63' ' ' GLU . 7.4 ttmt -57.38 109.26 0.65 Allowed 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 114.102 -1.408 . . . . 0.0 113.56 -179.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . 0.254 3.2 m-30 -100.4 78.23 2.01 Favored 'General case' 0 CA--C 1.507 -0.684 0 CA-C-O 125.578 2.608 . . . . 0.0 106.942 179.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.619 ' HB ' ' HB ' ' A' ' 61' ' ' VAL 0.417 9.8 t -76.48 80.13 3.19 Favored 'General case' 0 N--CA 1.435 -1.216 0 O-C-N 118.832 -2.417 . . . . 0.0 113.439 -179.873 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.48 ' CG2' ' HG ' ' A' ' 38' ' ' LEU 0.596 2.0 m -56.78 96.99 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.428 -1.532 0 CA-C-N 114.189 -1.369 . . . . 0.0 114.466 179.652 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.524 ' CB ' ' HB ' ' A' ' 39' ' ' THR . 1.1 ttmt -67.51 116.26 8.04 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 101.59 -3.485 . . . . 0.0 101.59 179.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.508 ' HB2' ' CG2' ' A' ' 60' ' ' VAL 0.263 1.9 tt0 -107.44 107.0 17.67 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 103.753 -2.684 . . . . 0.0 103.753 -179.997 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.0 m -106.56 48.79 0.82 Allowed 'General case' 0 C--N 1.285 -2.196 0 N-CA-C 105.004 -2.221 . . . . 0.0 105.004 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.3 m -76.36 162.54 27.8 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-O 115.431 -2.223 . . . . 0.0 109.106 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -48.57 -37.12 17.08 Favored 'General case' 0 C--O 1.211 -0.958 0 O-C-N 125.238 1.586 . . . . 0.0 107.531 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -52.88 -65.35 0.57 Allowed 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 116.459 -1.734 . . . . 0.0 109.54 179.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.446 ' HG3' ' N ' ' A' ' 57' ' ' ASN . 1.2 ttm-85 -173.08 148.02 1.67 Allowed 'General case' 0 CA--C 1.498 -1.028 0 CA-C-N 120.525 1.511 . . . . 0.0 110.462 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.446 ' N ' ' HG3' ' A' ' 56' ' ' ARG . 3.3 m-20 -78.4 86.64 4.45 Favored 'General case' 0 CA--C 1.499 -1.011 0 N-CA-C 102.338 -3.208 . . . . 0.0 102.338 -179.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -122.95 115.42 45.74 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.188 0 N-CA-C 117.864 2.542 . . . . 0.0 117.864 -179.475 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.404 ' OD1' ' N ' ' A' ' 59' ' ' ASP . 0.1 OUTLIER -64.69 147.6 52.71 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 104.024 -2.584 . . . . 0.0 104.024 178.909 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.508 ' CG2' ' HB2' ' A' ' 51' ' ' GLU . 1.8 t -124.71 46.43 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.019 0 CA-C-O 123.847 1.784 . . . . 0.0 106.523 -179.496 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.619 ' HB ' ' HB ' ' A' ' 48' ' ' THR 0.304 0.5 OUTLIER -43.9 144.88 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.568 0 N-CA-C 116.414 2.005 . . . . 0.0 116.414 -179.309 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.466 ' O ' ' N ' ' A' ' 64' ' ' LEU . 0.0 OUTLIER -154.51 92.79 1.52 Allowed 'General case' 0 N--CA 1.419 -2.022 0 CA-C-O 115.958 -1.972 . . . . 0.0 109.258 175.911 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.481 ' HA ' ' HA ' ' A' ' 46' ' ' LYS 0.263 1.2 mt-10 -66.45 94.77 0.29 Allowed 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 100.538 -3.875 . . . . 0.0 100.538 178.541 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.674 ' HB3' ' CE2' ' A' ' 82' ' ' TRP . 0.0 OUTLIER -12.22 89.08 0.01 OUTLIER 'General case' 0 N--CA 1.426 -1.664 0 O-C-N 128.006 3.316 . . . . 0.0 112.135 -178.566 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.565 ' N ' ' CD1' ' A' ' 82' ' ' TRP . . . 96.16 36.65 5.13 Favored Glycine 0 C--N 1.351 1.368 0 N-CA-C 121.586 3.395 . . . . 0.0 121.586 179.2 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . 0.409 38.1 t -121.48 77.99 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 N-CA-C 105.039 -2.208 . . . . 0.0 105.039 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -14.38 127.8 0.01 OUTLIER 'General case' 0 CA--C 1.48 -1.733 0 O-C-N 128.077 3.361 . . . . 0.0 116.513 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.576 ' CZ ' ' HA ' ' A' ' 81' ' ' THR . 8.9 p90 -147.93 164.05 34.95 Favored 'General case' 0 N--CA 1.441 -0.899 0 O-C-N 119.072 -2.267 . . . . 0.0 112.544 -178.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -116.11 148.41 40.31 Favored 'General case' 0 C--O 1.243 0.729 0 O-C-N 126.47 2.356 . . . . 0.0 105.445 179.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.907 ' HB3' HD22 ' A' ' 78' ' ' LEU . 2.9 t80 -116.65 -47.6 2.71 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-O 116.637 -1.649 . . . . 0.0 114.2 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.468 ' HA ' ' N ' ' A' ' 77' ' ' GLU . 2.5 t 70.01 104.43 0.06 Allowed 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 -179.507 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 6.1 mt -69.53 -175.81 0.9 Allowed 'General case' 0 C--N 1.302 -1.476 0 O-C-N 128.441 3.588 . . . . 0.0 109.172 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -105.97 -2.92 22.31 Favored 'General case' 0 N--CA 1.443 -0.817 0 O-C-N 128.089 3.368 . . . . 0.0 114.276 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -121.74 -47.15 2.21 Favored 'General case' 0 N--CA 1.435 -1.175 0 O-C-N 121.677 -0.639 . . . . 0.0 110.848 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -110.15 -10.11 22.87 Favored Glycine 0 CA--C 1.537 1.443 0 O-C-N 124.455 1.097 . . . . 0.0 115.774 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.673 HG23 ' N ' ' A' ' 77' ' ' GLU 0.349 0.7 OUTLIER 72.28 172.47 0.31 Allowed 'General case' 0 CA--C 1.501 -0.915 0 C-N-CA 115.793 -2.363 . . . . 0.0 110.27 -179.838 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.673 ' N ' HG23 ' A' ' 76' ' ' THR . 0.2 OUTLIER 47.01 -171.28 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.818 1 O-C-N 129.391 4.182 . . . . 0.0 110.309 179.947 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.907 HD22 ' HB3' ' A' ' 70' ' ' TYR 0.339 4.8 tt 130.9 141.62 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.808 0 O-C-N 128.423 3.577 . . . . 0.0 102.247 180.0 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.414 ' N ' HD23 ' A' ' 78' ' ' LEU . 17.3 m -163.48 128.74 3.03 Favored 'General case' 0 C--O 1.199 -1.56 0 N-CA-C 103.17 -2.9 . . . . 0.0 103.17 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.405 ' HA3' ' HA ' ' A' ' 93' ' ' PHE . . . 179.56 -135.25 2.46 Favored Glycine 0 C--N 1.31 -0.905 0 C-N-CA 118.583 -1.77 . . . . 0.0 110.315 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.576 ' HA ' ' CZ ' ' A' ' 68' ' ' PHE . 33.6 p -164.59 164.27 21.64 Favored 'General case' 0 C--O 1.188 -2.132 0 C-N-CA 117.214 -1.794 . . . . 0.0 111.779 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . 0.688 ' CG ' ' N ' ' A' ' 83' ' ' THR 0.408 1.4 p-90 -74.67 -171.59 1.31 Allowed 'General case' 0 C--N 1.31 -1.112 1 N-CA-C 100.025 -4.065 . . . . 0.0 100.025 175.735 . . . . . . . . 4 3 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.688 ' N ' ' CG ' ' A' ' 82' ' ' TRP . 0.3 OUTLIER 172.4 118.17 0.02 OUTLIER 'General case' 0 N--CA 1.432 -1.331 0 CA-C-O 124.404 2.05 . . . . 0.0 113.316 174.913 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.591 ' HB2' ' CZ3' ' A' ' 82' ' ' TRP . 2.8 ttp -84.86 101.23 12.13 Favored 'General case' 0 N--CA 1.433 -1.275 0 O-C-N 120.852 -1.155 . . . . 0.0 108.076 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.429 ' CG ' ' CG2' ' A' ' 90' ' ' VAL 0.673 0.8 OUTLIER -54.82 -87.1 0.0 OUTLIER 'General case' 0 N--CA 1.432 -1.368 0 CA-C-O 125.918 2.77 . . . . 0.0 111.076 179.982 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -138.65 -80.04 0.08 OUTLIER Glycine 0 N--CA 1.443 -0.852 0 N-CA-C 104.238 -3.545 . . . . 0.0 104.238 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -95.1 5.34 52.13 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 116.404 -1.76 . . . . 0.0 115.054 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.46 ' HE2' HG21 ' A' ' 105' ' ' VAL 0.371 0.6 OUTLIER -147.55 162.89 38.18 Favored 'General case' 0 CA--C 1.493 -1.215 0 O-C-N 126.281 2.238 . . . . 0.0 110.892 -179.967 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.803 HD22 ' HD2' ' A' ' 106' ' ' ARG . 5.5 tt -104.76 150.6 24.63 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 103.322 -2.844 . . . . 0.0 103.322 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.663 HG12 ' O ' ' A' ' 104' ' ' ALA . 0.0 OUTLIER -136.61 165.42 28.62 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.913 0 CA-C-O 123.849 1.785 . . . . 0.0 106.247 -179.808 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -128.83 97.4 0.43 Allowed Glycine 0 C--N 1.345 1.051 0 C-N-CA 128.636 3.017 . . . . 0.0 109.718 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 16.7 mtpt -95.29 139.74 31.17 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 102.375 -3.194 . . . . 0.0 102.375 179.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.648 ' HD2' HD22 ' A' ' 102' ' ' LEU . 75.6 m-85 -149.84 121.4 7.99 Favored 'General case' 0 CA--C 1.501 -0.936 0 CA-C-O 124.284 1.992 . . . . 0.0 111.724 -179.717 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 31.0 mttt -91.15 -175.61 4.34 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-N 113.885 -1.507 . . . . 0.0 110.129 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.411 ' CB ' ' HB3' ' A' ' 98' ' ' ASN 0.366 1.4 mmt85 -128.63 128.32 43.94 Favored 'General case' 0 CA--C 1.489 -1.398 0 O-C-N 124.817 1.323 . . . . 0.0 107.879 -179.98 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.582 HG23 ' H ' ' A' ' 97' ' ' ASP . 0.8 OUTLIER -33.11 -63.26 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 C-N-CA 126.841 2.056 . . . . 0.0 113.938 -179.881 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.582 ' H ' HG23 ' A' ' 96' ' ' VAL 0.368 0.0 OUTLIER -101.44 -22.24 14.6 Favored 'General case' 0 C--O 1.258 1.535 0 O-C-N 119.892 -1.755 . . . . 0.0 115.293 -179.811 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.411 ' HB3' ' CB ' ' A' ' 95' ' ' ARG . 46.5 t30 -77.45 -26.39 51.46 Favored 'General case' 0 N--CA 1.422 -1.827 0 CA-C-N 113.576 -1.647 . . . . 0.0 113.678 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 48.18 22.96 2.53 Favored Glycine 0 CA--C 1.531 1.05 0 O-C-N 127.287 2.867 . . . . 0.0 118.05 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 15.5 mmtp -75.36 -108.72 0.01 OUTLIER 'General case' 0 C--O 1.199 -1.592 0 O-C-N 119.842 -1.976 . . . . 0.0 108.17 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.483 ' HG2' ' N ' ' A' ' 102' ' ' LEU . 1.0 OUTLIER 173.22 179.18 0.09 Allowed 'General case' 0 C--N 1.316 -0.861 0 C-N-CA 129.286 3.034 . . . . 0.0 109.425 179.993 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.67 ' HG ' ' HA ' ' A' ' 119' ' ' TYR . 3.5 tt -166.15 139.94 4.26 Favored 'General case' 0 C--O 1.245 0.859 1 O-C-N 129.139 4.024 . . . . 0.0 106.231 179.34 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.524 HG23 ' HB3' ' A' ' 117' ' ' TYR . 4.2 tp -128.16 156.07 40.09 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.068 0 N-CA-C 105.039 -2.208 . . . . 0.0 105.039 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.663 ' O ' HG12 ' A' ' 90' ' ' VAL . . . -153.25 145.2 23.64 Favored 'General case' 0 C--N 1.313 -0.998 0 O-C-N 119.213 -2.179 . . . . 0.0 106.714 -179.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.605 ' HB ' ' CE2' ' A' ' 117' ' ' TYR . 8.4 p -124.8 113.09 34.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 121.642 2.019 . . . . 0.0 111.709 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.803 ' HD2' HD22 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -82.0 83.89 7.13 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 105.296 -2.113 . . . . 0.0 105.296 179.99 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 69.7 tt0 -90.66 77.5 6.35 Favored 'General case' 0 N--CA 1.418 -2.052 0 O-C-N 128.071 3.357 . . . . 0.0 112.357 -179.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.573 HD11 ' CH2' ' A' ' 6' ' ' TRP 0.406 2.1 tt -57.13 118.55 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 C-N-CA 115.652 -2.419 . . . . 0.0 112.313 179.736 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 36.6 m -109.6 60.74 0.6 Allowed 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 117.695 -1.145 . . . . 0.0 108.397 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 83.53 -108.33 3.03 Favored Glycine 0 C--N 1.347 1.193 0 O-C-N 126.701 2.501 . . . . 0.0 111.391 -179.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.506 ' N ' HD22 ' A' ' 111' ' ' ASN 0.323 0.0 OUTLIER -89.05 13.38 13.13 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 115.78 -2.057 . . . . 0.0 111.38 -179.823 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -136.52 115.93 12.73 Favored 'General case' 0 C--O 1.208 -1.124 0 O-C-N 127.968 3.292 . . . . 0.0 113.515 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.535 ' HA ' HG13 ' A' ' 108' ' ' ILE . 0.1 OUTLIER -88.85 143.34 26.95 Favored 'General case' 0 C--O 1.213 -0.83 0 N-CA-C 100.725 -3.806 . . . . 0.0 100.725 179.719 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.636 HG12 HG23 ' A' ' 127' ' ' ILE . 71.3 mt -138.77 118.85 14.85 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.973 0 O-C-N 127.661 3.1 . . . . 0.0 105.269 179.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . 0.43 ' O ' ' HG2' ' A' ' 126' ' ' ARG . 12.4 mt-30 -100.97 122.28 43.24 Favored 'General case' 0 CA--C 1.505 -0.759 0 O-C-N 126.036 2.085 . . . . 0.0 105.812 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.549 ' HB ' ' HA ' ' A' ' 125' ' ' LYS . 0.6 OUTLIER -140.55 152.16 45.31 Favored 'General case' 0 N--CA 1.419 -2.013 0 O-C-N 121.098 -1.001 . . . . 0.0 112.328 -179.644 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.605 ' CE2' ' HB ' ' A' ' 105' ' ' VAL 0.377 22.4 m-85 135.69 -140.97 0.0 OUTLIER 'General case' 0 CA--C 1.478 -1.795 0 O-C-N 128.852 3.845 . . . . 0.0 113.493 176.58 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.514 HG23 ' N ' ' A' ' 119' ' ' TYR . 4.8 t -151.71 -155.76 0.65 Allowed 'General case' 0 C--N 1.312 -1.055 0 O-C-N 127.278 2.861 . . . . 0.0 116.044 -174.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.67 ' HA ' ' HG ' ' A' ' 102' ' ' LEU 0.282 2.6 t80 -109.53 -57.46 2.17 Favored 'General case' 0 C--O 1.217 -0.636 0 CA-C-O 125.434 2.54 . . . . 0.0 104.82 177.721 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.501 ' HG3' ' CE2' ' A' ' 119' ' ' TYR . 3.7 mt-10 -123.38 -80.7 0.63 Allowed 'General case' 0 N--CA 1.436 -1.126 0 CA-C-N 112.591 -2.095 . . . . 0.0 111.981 179.416 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -137.03 36.07 2.01 Favored Glycine 0 C--N 1.36 1.872 0 N-CA-C 119.259 2.464 . . . . 0.0 119.259 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 65.3 t -137.02 91.26 0.83 Allowed 'Isoleucine or valine' 0 C--O 1.215 -0.739 0 N-CA-C 103.535 -2.765 . . . . 0.0 103.535 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.506 ' HA ' ' HB ' ' A' ' 118' ' ' THR . 1.5 mp0 -63.02 178.61 0.46 Allowed 'General case' 0 C--N 1.311 -1.102 0 CA-C-O 125.525 2.584 . . . . 0.0 113.955 -178.223 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.676 ' HB1' ' CD1' ' A' ' 14' ' ' TYR . . . -163.67 177.21 8.9 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 112.572 -3.585 . . . . 0.0 106.799 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.549 ' HA ' ' HB ' ' A' ' 116' ' ' THR 0.337 0.0 OUTLIER -161.92 131.44 4.58 Favored 'General case' 0 C--O 1.249 1.047 1 O-C-N 129.454 4.221 . . . . 0.0 107.423 -179.906 . . . . . . . . 5 4 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.769 HH21 HD22 ' A' ' 36' ' ' LEU . 7.7 ptm180 -132.02 85.78 2.28 Favored 'General case' 0 N--CA 1.426 -1.634 0 CA-C-O 114.556 -2.64 . . . . 0.0 111.653 -179.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.636 HG23 HG12 ' A' ' 114' ' ' ILE . 1.0 OUTLIER -64.82 105.21 0.52 Allowed 'Isoleucine or valine' 0 C--O 1.25 1.121 1 O-C-N 132.138 5.899 . . . . 0.0 113.75 178.827 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.635 ' HE2' HD21 ' A' ' 36' ' ' LEU . 0.0 OUTLIER -87.74 131.96 34.31 Favored 'General case' 0 N--CA 1.432 -1.352 0 CA-C-N 111.71 -2.495 . . . . 0.0 107.029 179.957 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 3.1 mmmp? -100.09 47.68 0.94 Allowed 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 114.394 -2.717 . . . . 0.0 110.059 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.511 ' HA ' ' HA ' ' A' ' 6' ' ' TRP . 2.0 ttpm? 26.09 98.49 0.0 OUTLIER 'General case' 0 CA--C 1.518 -0.283 0 O-C-N 126.441 2.338 . . . . 0.0 115.401 179.378 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . 0.914 25.5 tt0 . . . . . 0 N--CA 1.446 -0.629 0 CA-C-N 120.327 1.422 . . . . 0.0 113.327 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . 0.476 ' N ' ' CD1' ' A' ' 2' ' ' PHE . 2.2 p90 . . . . . 0 N--CA 1.448 -0.564 0 N-CA-C 116.645 2.091 . . . . 0.0 116.645 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -143.56 99.83 3.49 Favored 'General case' 0 CA--C 1.501 -0.942 0 CA-C-N 114.621 -1.172 . . . . 0.0 110.96 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 151.12 -107.5 0.34 Allowed Glycine 0 C--O 1.213 -1.161 0 CA-C-O 117.844 -1.531 . . . . 0.0 113.0 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.533 ' HA ' ' HA ' ' A' ' 39' ' ' THR 0.482 1.1 t -137.01 173.55 11.58 Favored 'General case' 0 C--N 1.309 -1.157 0 O-C-N 127.397 2.469 . . . . 0.0 110.011 179.797 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.557 ' CZ3' ' HG3' ' A' ' 130' ' ' LYS . 91.6 m95 -161.56 150.19 15.7 Favored 'General case' 0 N--CA 1.427 -1.584 0 O-C-N 126.247 2.217 . . . . 0.0 108.287 -179.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 12.9 tttt -151.89 102.65 2.85 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-O 115.014 -2.422 . . . . 0.0 107.066 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.571 HG12 ' HB3' ' A' ' 36' ' ' LEU 0.323 5.7 p -46.84 138.94 1.82 Allowed 'Isoleucine or valine' 0 C--O 1.249 1.038 0 CA-C-N 121.024 1.738 . . . . 0.0 112.685 179.816 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -153.44 21.05 0.55 Allowed 'General case' 0 CA--C 1.498 -1.044 0 CA-C-O 123.427 1.584 . . . . 0.0 112.425 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.446 ' CG ' ' HB ' ' A' ' 127' ' ' ILE 0.259 1.2 ptp85 -155.63 -49.48 0.08 Allowed 'General case' 0 C--N 1.301 -1.52 0 O-C-N 117.285 -3.384 . . . . 0.0 110.468 179.727 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.414 ' N ' ' HG3' ' A' ' 10' ' ' ARG 0.373 0.5 OUTLIER 51.11 -176.09 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.67 0 O-C-N 126.411 2.319 . . . . 0.0 110.719 179.8 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -146.88 -85.42 0.11 Allowed 'General case' 0 C--N 1.301 -1.542 0 O-C-N 119.36 -2.087 . . . . 0.0 107.773 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -89.74 18.04 5.96 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 120.111 1.323 . . . . 0.0 114.207 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.631 ' HA ' ' HB1' ' A' ' 124' ' ' ALA . 79.4 t80 -59.45 -32.54 70.32 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 118.898 2.925 . . . . 0.0 118.898 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -76.13 -29.3 57.77 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 121.816 2.098 . . . . 0.0 111.436 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 16.2 mttp -75.52 -24.64 56.82 Favored 'General case' 0 N--CA 1.425 -1.68 0 O-C-N 126.801 2.563 . . . . 0.0 113.398 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.742 ' CB ' ' HB2' ' A' ' 124' ' ' ALA . 11.6 t80 -79.17 -20.39 48.58 Favored 'General case' 0 N--CA 1.428 -1.538 0 O-C-N 121.763 -0.586 . . . . 0.0 110.944 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.451 ' HB3' HG13 ' A' ' 23' ' ' ILE . 0.4 OUTLIER -74.48 -35.07 63.25 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-O 122.902 1.334 . . . . 0.0 107.881 179.99 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . 0.267 7.1 tt0 -72.87 -25.67 61.18 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 126.232 2.92 . . . . 0.0 112.232 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 27.2 tptt -79.9 -29.73 39.96 Favored 'General case' 0 C--N 1.319 -0.753 0 O-C-N 119.423 -2.048 . . . . 0.0 111.361 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.518 ' CE ' HD13 ' A' ' 72' ' ' LEU . 1.1 mmm -75.73 -28.91 58.73 Favored 'General case' 0 C--O 1.217 -0.651 0 CA-C-O 124.552 2.12 . . . . 0.0 108.885 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 109.01 43.42 1.2 Allowed Glycine 0 N--CA 1.443 -0.896 0 CA-C-O 116.171 -2.46 . . . . 0.0 109.928 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.603 HG21 ' HA ' ' A' ' 28' ' ' ARG . 3.5 mm -90.76 134.47 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 CA-C-N 119.551 1.676 . . . . 0.0 108.689 -179.443 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -78.47 132.64 37.34 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-O 114.387 -2.721 . . . . 0.0 113.614 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . 0.375 60.5 t -8.68 -53.59 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 O-C-N 128.889 3.868 . . . . 0.0 117.605 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.608 0.3 OUTLIER -79.75 -40.17 20.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 115.154 1.538 . . . . 0.0 115.154 -179.728 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.436 ' HD3' ' HB2' ' A' ' 74' ' ' ASP . 8.5 ttmm -60.67 -24.1 65.33 Favored 'General case' 0 N--CA 1.443 -0.783 0 O-C-N 127.237 2.836 . . . . 0.0 113.233 179.481 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.603 ' HA ' HG21 ' A' ' 23' ' ' ILE . 5.4 ptt85 -76.95 -30.88 56.23 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 15.0 ttmt -75.65 -29.01 58.98 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-O 123.47 1.605 . . . . 0.0 110.327 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -76.1 -34.46 59.51 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 116.086 -1.912 . . . . 0.0 110.018 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -70.99 -25.06 76.46 Favored Glycine 0 C--O 1.21 -1.401 0 O-C-N 125.032 1.457 . . . . 0.0 112.255 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -77.52 -34.51 53.97 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 116.457 -1.735 . . . . 0.0 111.322 179.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 5.3 t-160 -103.63 21.63 15.81 Favored 'General case' 0 N--CA 1.445 -0.676 0 O-C-N 126.958 2.661 . . . . 0.0 113.918 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.406 ' HB3' ' HB2' ' A' ' 53' ' ' SER . 0.8 OUTLIER -69.78 -29.79 67.19 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 114.709 1.374 . . . . 0.0 114.709 -179.761 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . 0.283 18.7 m120 76.55 27.86 0.77 Allowed 'General case' 0 C--O 1.245 0.821 0 O-C-N 118.63 -2.544 . . . . 0.0 109.542 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.681 HD21 HD13 ' A' ' 38' ' ' LEU . 1.2 tt -44.73 91.6 0.0 OUTLIER 'General case' 0 C--O 1.212 -0.876 0 O-C-N 126.156 2.16 . . . . 0.0 111.033 -179.414 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 8.7 tttt -97.33 103.22 15.13 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 101.682 -3.451 . . . . 0.0 101.682 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.681 HD13 HD21 ' A' ' 36' ' ' LEU 0.292 0.1 OUTLIER -91.29 147.32 23.13 Favored 'General case' 0 C--N 1.289 -2.03 0 CA-C-O 123.932 1.825 . . . . 0.0 106.591 -179.58 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.55 ' HB ' ' HB3' ' A' ' 50' ' ' LYS . 2.4 m -129.19 103.15 6.79 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 102.498 -3.149 . . . . 0.0 102.498 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 59.3 mt -92.5 119.18 39.62 Favored 'Isoleucine or valine' 0 C--O 1.253 1.254 0 CA-C-O 124.13 1.919 . . . . 0.0 111.883 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 74.5 m -119.91 95.39 4.74 Favored 'General case' 0 C--N 1.348 0.542 0 CA-C-N 110.733 -2.939 . . . . 0.0 110.087 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.59 125.71 29.74 Favored 'General case' 0 C--N 1.313 -1.017 0 O-C-N 127.153 2.783 . . . . 0.0 108.705 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -158.1 112.7 2.59 Favored 'General case' 0 N--CA 1.417 -2.097 0 O-C-N 119.26 -2.15 . . . . 0.0 111.954 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 54.03 42.08 70.27 Favored Glycine 0 N--CA 1.428 -1.889 0 CA-C-N 114.386 -1.279 . . . . 0.0 109.934 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.311 4.4 m-20 83.26 -25.36 0.14 Allowed 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 112.556 -1.822 . . . . 0.0 112.224 179.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 5.7 ttmt -76.37 144.16 40.27 Favored 'General case' 0 C--N 1.307 -1.271 0 C-N-CA 115.639 -2.424 . . . . 0.0 108.681 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.593 ' CZ ' HD21 ' A' ' 64' ' ' LEU . 2.8 m-85 -119.59 87.85 2.82 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 118.164 -0.922 . . . . 0.0 111.534 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.983 ' HA ' HG13 ' A' ' 61' ' ' VAL 0.427 0.1 OUTLIER -61.04 118.54 6.89 Favored 'General case' 0 C--O 1.244 0.812 0 C-N-CA 115.206 -2.598 . . . . 0.0 109.502 -179.721 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.549 ' CG2' ' HG ' ' A' ' 38' ' ' LEU 0.713 8.4 p -101.27 85.94 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 O-C-N 125.173 1.546 . . . . 0.0 108.592 179.557 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.55 ' HB3' ' HB ' ' A' ' 39' ' ' THR . 2.5 tttp -77.41 103.68 7.48 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 105.383 -2.08 . . . . 0.0 105.383 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -95.36 89.48 5.47 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 127.2 2.2 . . . . 0.0 105.413 -179.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -88.27 57.51 4.3 Favored 'General case' 0 C--N 1.289 -2.061 0 O-C-N 119.91 -1.744 . . . . 0.0 106.975 -179.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.406 ' HB2' ' HB3' ' A' ' 34' ' ' ASP . 80.7 p -83.11 160.17 21.94 Favored 'General case' 0 C--O 1.209 -1.065 0 CA-C-O 116.529 -1.701 . . . . 0.0 108.466 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 56.6 t30 -50.54 -32.64 18.98 Favored 'General case' 0 N--CA 1.435 -1.182 0 O-C-N 125.287 1.617 . . . . 0.0 109.498 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -62.66 -50.75 69.94 Favored 'General case' 0 C--N 1.352 0.71 0 C-N-CA 116.223 -2.191 . . . . 0.0 111.193 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 29.8 ttm-85 -176.11 148.8 0.83 Allowed 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 121.663 2.029 . . . . 0.0 106.959 178.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -95.3 83.35 3.84 Favored 'General case' 0 C--O 1.22 -0.467 0 N-CA-C 100.441 -3.911 . . . . 0.0 100.441 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.5 tp -105.58 101.42 12.37 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.238 0 O-C-N 128.015 3.322 . . . . 0.0 116.527 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.457 ' OD1' HG22 ' A' ' 61' ' ' VAL . 29.2 t0 -58.21 137.21 57.23 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 103.229 -2.878 . . . . 0.0 103.229 177.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.6 HG12 ' N ' ' A' ' 61' ' ' VAL . 2.2 t -101.33 -67.75 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 N-CA-C 106.506 -1.664 . . . . 0.0 106.506 -176.419 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.983 HG13 ' HA ' ' A' ' 48' ' ' THR 0.506 0.0 OUTLIER 75.44 134.04 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 CA-C-O 124.065 1.888 . . . . 0.0 112.582 179.557 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.64 ' CE2' ' CD1' ' A' ' 82' ' ' TRP . 3.9 p90 -168.98 110.71 0.5 Allowed 'General case' 0 N--CA 1.436 -1.17 0 CA-C-N 112.332 -2.213 . . . . 0.0 111.911 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -62.04 125.64 24.57 Favored 'General case' 0 N--CA 1.441 -0.914 0 N-CA-C 102.462 -3.162 . . . . 0.0 102.462 179.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.593 HD21 ' CZ ' ' A' ' 47' ' ' PHE . 0.6 OUTLIER -48.21 125.59 9.59 Favored 'General case' 0 N--CA 1.428 -1.559 0 O-C-N 124.466 1.104 . . . . 0.0 111.503 -179.728 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' 82' ' ' TRP . . . 73.61 12.36 80.47 Favored Glycine 0 C--N 1.344 1.006 0 O-C-N 126.73 2.519 . . . . 0.0 117.036 -179.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . 0.419 44.0 t -81.18 -99.91 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.431 -1.389 0 CA-C-O 118.373 -0.822 . . . . 0.0 109.053 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.9 t70 165.37 130.08 0.01 OUTLIER 'General case' 0 CA--C 1.49 -1.346 0 CA-C-N 119.285 0.948 . . . . 0.0 110.567 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -135.48 174.75 10.27 Favored 'General case' 0 N--CA 1.428 -1.545 0 CA-C-N 120.156 1.344 . . . . 0.0 109.281 179.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -132.65 127.45 34.91 Favored 'General case' 0 C--O 1.244 0.801 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -157.19 125.23 5.5 Favored 'General case' 0 N--CA 1.443 -0.784 0 C-N-CA 118.632 -1.227 . . . . 0.0 113.563 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 18.3 t -57.67 156.92 7.78 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 105.124 -2.176 . . . . 0.0 105.124 179.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.808 HD11 HD12 ' A' ' 78' ' ' LEU . 8.4 mt -101.77 9.7 40.63 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-O 118.148 -0.93 . . . . 0.0 109.873 -179.35 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.423 ' HB3' ' O ' ' A' ' 72' ' ' LEU . . . 79.61 -4.24 2.0 Favored 'General case' 0 N--CA 1.438 -1.071 0 O-C-N 126.802 2.564 . . . . 0.0 113.174 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.456 ' OD2' HD13 ' A' ' 23' ' ' ILE . 28.9 t70 -165.96 -51.06 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 123.825 1.774 . . . . 0.0 110.259 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -67.8 -6.65 44.98 Favored Glycine 0 C--N 1.347 1.192 0 CA-C-N 113.704 -1.589 . . . . 0.0 112.98 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.548 HG22 ' H ' ' A' ' 77' ' ' GLU 0.274 0.2 OUTLIER 78.62 163.31 0.21 Allowed 'General case' 0 N--CA 1.435 -1.204 0 CA-C-N 119.699 1.75 . . . . 0.0 115.298 179.678 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.548 ' H ' HG22 ' A' ' 76' ' ' THR . 1.1 mt-10 -36.61 98.43 0.01 OUTLIER 'General case' 0 N--CA 1.44 -0.945 0 O-C-N 128.392 3.558 . . . . 0.0 113.091 179.63 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.808 HD12 HD11 ' A' ' 72' ' ' LEU 0.472 5.5 tt -97.04 158.19 15.55 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 101.929 -3.36 . . . . 0.0 101.929 179.621 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 14.5 m -157.82 124.14 4.8 Favored 'General case' 0 CA--C 1.498 -1.054 0 N-CA-C 102.047 -3.316 . . . . 0.0 102.047 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -162.97 -175.83 34.4 Favored Glycine 0 C--N 1.292 -1.89 0 C-N-CA 115.746 -3.121 . . . . 0.0 111.959 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 15.7 p -137.87 159.82 40.97 Favored 'General case' 0 C--O 1.192 -1.965 0 C-N-CA 119.313 -0.955 . . . . 0.0 110.116 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . 0.64 ' CD1' ' CE2' ' A' ' 62' ' ' PHE . 72.2 m95 -118.74 137.75 53.14 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 100.624 -3.843 . . . . 0.0 100.624 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 13.5 t -147.74 143.15 27.36 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 123.597 1.665 . . . . 0.0 109.497 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.98 139.02 41.31 Favored 'General case' 0 N--CA 1.44 -0.965 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . 0.72 5.2 mt-10 -127.81 30.57 5.27 Favored 'General case' 0 C--N 1.307 -1.254 0 C-N-CA 116.687 -2.005 . . . . 0.0 109.686 179.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 71.5 97.68 0.06 OUTLIER Glycine 0 N--CA 1.436 -1.358 0 N-CA-C 106.147 -2.781 . . . . 0.0 106.147 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . 0.28 61.2 m-80 79.06 -7.53 1.75 Allowed 'General case' 0 C--O 1.236 0.387 0 N-CA-C 117.893 2.553 . . . . 0.0 117.893 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . 0.341 0.4 OUTLIER -143.73 133.13 23.33 Favored 'General case' 0 CA--C 1.498 -1.043 0 O-C-N 125.713 1.883 . . . . 0.0 106.575 179.988 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.78 HD13 HH11 ' A' ' 106' ' ' ARG . 0.2 OUTLIER -97.21 107.28 19.76 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 102.516 -3.142 . . . . 0.0 102.516 179.839 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.546 HG12 ' CG2' ' A' ' 105' ' ' VAL . 1.0 OUTLIER -98.55 156.42 3.72 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.939 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 179.888 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -134.55 104.95 0.53 Allowed Glycine 0 C--N 1.347 1.162 0 C-N-CA 129.969 3.652 . . . . 0.0 110.45 179.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.413 ' HA ' ' HA ' ' A' ' 103' ' ' ILE . 18.1 mtmt -102.92 117.09 33.83 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 104.541 -2.392 . . . . 0.0 104.541 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.411 ' CD2' HD11 ' A' ' 78' ' ' LEU . 16.0 m-30 -107.58 118.19 36.08 Favored 'General case' 0 C--N 1.328 -0.327 0 O-C-N 125.288 1.617 . . . . 0.0 111.839 -179.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.409 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 4.6 mtmt -102.03 161.56 13.59 Favored 'General case' 0 C--O 1.21 -0.981 0 CA-C-N 114.215 -1.357 . . . . 0.0 110.372 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . 0.377 0.0 OUTLIER -107.48 144.98 33.67 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-O 116.849 -1.548 . . . . 0.0 107.672 179.936 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.411 ' HB ' ' HB3' ' A' ' 77' ' ' GLU . 57.0 t -82.24 -30.55 9.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 C-N-CA 126.641 1.976 . . . . 0.0 114.094 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . 0.343 0.1 OUTLIER -110.0 -3.96 16.18 Favored 'General case' 0 C--O 1.259 1.568 0 N-CA-C 115.413 1.634 . . . . 0.0 115.413 179.925 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 44.1 t30 -112.46 -22.49 10.81 Favored 'General case' 0 N--CA 1.422 -1.857 0 N-CA-C 115.258 1.577 . . . . 0.0 115.258 -179.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 60.22 26.97 64.53 Favored Glycine 0 CA--C 1.53 0.985 0 N-CA-C 117.489 1.756 . . . . 0.0 117.489 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 15.2 mmtm -90.91 -113.33 0.08 Allowed 'General case' 0 CA--C 1.553 1.072 0 O-C-N 120.237 -1.743 . . . . 0.0 112.015 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 151.79 144.04 0.0 OUTLIER 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 129.882 3.273 . . . . 0.0 108.778 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.71 HD12 ' CD1' ' A' ' 119' ' ' TYR . 2.4 tt -127.87 176.34 7.65 Favored 'General case' 0 CA--C 1.511 -0.551 2 O-C-N 129.787 4.429 . . . . 0.0 106.835 -179.808 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.513 HG13 ' N ' ' A' ' 104' ' ' ALA . 0.1 OUTLIER -149.14 173.21 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.502 -0.869 0 C-N-CA 117.93 -1.508 . . . . 0.0 109.491 -179.725 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.513 ' N ' HG13 ' A' ' 103' ' ' ILE . . . -154.46 133.36 12.3 Favored 'General case' 0 C--N 1.313 -1.013 0 O-C-N 117.709 -3.119 . . . . 0.0 107.418 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.546 ' CG2' HG12 ' A' ' 90' ' ' VAL . 0.9 OUTLIER -121.1 99.18 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 CA-C-N 122.113 2.233 . . . . 0.0 108.615 179.97 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.78 HH11 HD13 ' A' ' 89' ' ' LEU 0.259 75.3 mtt180 -71.62 91.83 1.11 Allowed 'General case' 0 CA--C 1.503 -0.834 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 179.944 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.432 ' O ' ' N ' ' A' ' 109' ' ' SER . 0.1 OUTLIER -89.85 83.53 6.18 Favored 'General case' 0 N--CA 1.432 -1.359 0 CA-C-N 112.316 -2.22 . . . . 0.0 114.758 -179.638 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.409 HD13 ' HA ' ' A' ' 108' ' ' ILE 0.276 8.5 mm -62.17 93.81 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 C-N-CA 116.926 -1.909 . . . . 0.0 106.865 179.435 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.432 ' N ' ' O ' ' A' ' 107' ' ' GLU . 6.1 m -65.8 -20.85 66.4 Favored 'General case' 0 N--CA 1.439 -0.992 0 C-N-CA 125.426 1.491 . . . . 0.0 109.605 -179.462 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 123.01 97.8 1.35 Allowed Glycine 0 C--O 1.218 -0.845 0 C-N-CA 129.907 3.622 . . . . 0.0 110.387 -179.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . 0.326 0.8 OUTLIER 90.49 -27.27 0.05 OUTLIER 'General case' 0 C--N 1.308 -1.199 0 O-C-N 128.235 2.962 . . . . 0.0 109.944 -179.068 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.464 ' HG2' ' HA ' ' A' ' 129' ' ' LYS . 88.6 mt-10 -115.51 124.15 50.35 Favored 'General case' 0 C--N 1.361 1.072 0 CA-C-O 117.014 -1.469 . . . . 0.0 110.986 179.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 30.2 tp -96.82 116.85 29.87 Favored 'General case' 0 C--O 1.217 -0.627 0 N-CA-C 104.593 -2.373 . . . . 0.0 104.593 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.85 HG23 HG12 ' A' ' 127' ' ' ILE 0.27 2.9 mm -102.58 128.44 55.34 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 O-C-N 128.047 3.342 . . . . 0.0 104.417 -179.929 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -111.31 79.77 1.24 Allowed 'General case' 0 CA--C 1.494 -1.174 0 CA-C-O 124.041 1.877 . . . . 0.0 106.027 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.406 ' HA ' ' HA ' ' A' ' 125' ' ' LYS . 0.3 OUTLIER -73.13 115.0 11.93 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 104.633 -2.358 . . . . 0.0 104.633 179.668 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . 0.262 78.5 m-85 -106.53 145.71 31.52 Favored 'General case' 0 C--O 1.207 -1.168 0 O-C-N 126.818 2.574 . . . . 0.0 113.269 -179.562 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.499 HG23 ' H ' ' A' ' 120' ' ' GLU 0.289 0.8 OUTLIER -141.2 126.48 18.59 Favored 'General case' 0 N--CA 1.446 -0.633 1 O-C-N 130.594 4.934 . . . . 0.0 108.439 179.577 . . . . . . . . 5 4 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.71 ' CD1' HD12 ' A' ' 102' ' ' LEU 0.277 22.4 t80 -101.07 -0.13 36.87 Favored 'General case' 0 C--O 1.245 0.851 0 CA-C-N 119.818 1.19 . . . . 0.0 107.835 -179.71 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.499 ' H ' HG23 ' A' ' 118' ' ' THR . 0.0 OUTLIER 171.98 -79.95 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.543 0 O-C-N 126.211 2.194 . . . . 0.0 115.863 -179.527 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -130.47 30.47 3.44 Favored Glycine 0 C--N 1.353 1.513 0 N-CA-C 118.838 2.295 . . . . 0.0 118.838 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 54.9 t -145.65 113.88 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 103.972 -2.603 . . . . 0.0 103.972 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -83.51 -178.89 7.2 Favored 'General case' 0 C--O 1.21 -0.985 0 CA-C-O 124.727 2.203 . . . . 0.0 112.533 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.742 ' HB2' ' CB ' ' A' ' 17' ' ' PHE . . . -167.34 85.48 0.24 Allowed 'General case' 0 C--O 1.216 -0.687 0 CA-C-O 114.223 -2.799 . . . . 0.0 108.501 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.406 ' HA ' ' HA ' ' A' ' 116' ' ' THR . 0.1 OUTLIER -69.01 128.27 36.1 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 121.256 1.844 . . . . 0.0 109.631 -179.647 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.414 ' NH2' HD13 ' A' ' 36' ' ' LEU . 0.0 OUTLIER -119.21 82.2 1.83 Allowed 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 125.959 1.704 . . . . 0.0 107.232 -179.8 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.85 HG12 HG23 ' A' ' 114' ' ' ILE . 2.1 mt -78.9 117.68 24.9 Favored 'Isoleucine or valine' 0 C--O 1.245 0.837 0 O-C-N 127.426 2.954 . . . . 0.0 116.448 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.501 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 1.3 m-30 -94.55 166.42 12.04 Favored 'General case' 0 N--CA 1.432 -1.347 0 O-C-N 128.102 3.376 . . . . 0.0 107.926 -179.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.464 ' HA ' ' HG2' ' A' ' 112' ' ' GLU 0.258 8.5 mmtt -119.44 -4.17 10.4 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 119.573 -0.251 . . . . 0.0 111.235 -179.885 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.557 ' HG3' ' CZ3' ' A' ' 6' ' ' TRP . 4.2 tttp 73.28 116.18 0.05 Allowed 'General case' 0 C--O 1.215 -0.72 0 CA-C-O 115.765 -2.064 . . . . 0.0 108.024 -179.533 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . 0.797 3.4 mm-40 . . . . . 0 N--CA 1.424 -1.758 0 O-C-N 126.83 2.581 . . . . 0.0 115.126 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.435 -1.207 0 CA-C-O 121.493 0.663 . . . . 0.0 112.743 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -160.0 88.16 0.82 Allowed 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 112.513 -2.131 . . . . 0.0 111.878 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 153.07 -163.25 30.47 Favored Glycine 0 CA--C 1.495 -1.158 0 C-N-CA 115.635 -3.174 . . . . 0.0 109.168 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.423 ' HA ' ' HA ' ' A' ' 39' ' ' THR 0.49 22.0 m -97.18 161.42 13.82 Favored 'General case' 0 C--N 1.314 -0.954 0 O-C-N 126.281 1.812 . . . . 0.0 110.503 -179.658 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.774 ' CH2' HD11 ' A' ' 108' ' ' ILE . 87.9 m95 -139.75 156.67 46.65 Favored 'General case' 0 N--CA 1.434 -1.249 0 CA-C-N 112.665 -2.062 . . . . 0.0 106.72 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 24.0 tttt -159.92 90.97 0.94 Allowed 'General case' 0 C--O 1.203 -1.346 0 O-C-N 126.283 2.239 . . . . 0.0 107.217 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.599 ' HB ' ' CD1' ' A' ' 128' ' ' PHE 0.315 0.1 OUTLIER -37.65 127.4 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 O-C-N 126.634 2.458 . . . . 0.0 112.063 179.957 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.446 ' HB2' ' CG ' ' A' ' 129' ' ' LYS . 40.1 t0 -100.0 -32.38 10.98 Favored 'General case' 0 C--O 1.208 -1.092 0 O-C-N 126.793 2.558 . . . . 0.0 105.293 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 5.7 ptp180 -170.73 153.69 4.14 Favored 'General case' 0 C--N 1.296 -1.748 0 C-N-CA 115.846 -2.342 . . . . 0.0 109.189 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . 0.293 0.0 OUTLIER -106.77 -171.38 1.88 Allowed 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 111.297 -2.683 . . . . 0.0 107.675 179.514 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.506 ' CB ' ' HB2' ' A' ' 125' ' ' LYS . 4.1 tm-20 -131.67 -71.68 0.55 Allowed 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 117.468 -1.693 . . . . 0.0 108.293 179.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.455 ' HB3' ' HA ' ' A' ' 124' ' ' ALA . 23.5 t30 -113.43 28.41 8.8 Favored 'General case' 0 N--CA 1.474 0.774 0 O-C-N 125.246 1.591 . . . . 0.0 113.197 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.529 ' CA ' ' HB1' ' A' ' 124' ' ' ALA 0.347 0.2 OUTLIER -72.49 -19.79 61.48 Favored 'General case' 0 C--N 1.312 -1.037 0 O-C-N 128.416 3.572 . . . . 0.0 115.421 179.994 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -76.85 -30.7 56.4 Favored 'General case' 0 C--O 1.218 -0.588 0 CA-C-N 120.984 1.72 . . . . 0.0 108.683 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -79.83 -32.32 40.59 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 111.529 -2.578 . . . . 0.0 114.286 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.603 ' CE2' ' HA ' ' A' ' 118' ' ' THR . 0.0 OUTLIER -70.78 -37.63 73.35 Favored 'General case' 0 C--O 1.217 -0.625 0 CA-C-O 123.889 1.804 . . . . 0.0 108.466 179.87 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 3.3 mtm -75.21 -22.47 57.92 Favored 'General case' 0 N--CA 1.432 -1.334 0 CA-C-O 123.263 1.506 . . . . 0.0 109.617 -179.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.26 -31.58 58.39 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 126.229 2.919 . . . . 0.0 111.143 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 5.4 tptp -67.83 -29.59 68.78 Favored 'General case' 0 C--O 1.209 -1.065 0 O-C-N 119.431 -2.043 . . . . 0.0 112.846 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.462 ' HG2' ' CD1' ' A' ' 119' ' ' TYR . 56.7 mtp -79.38 -30.41 42.52 Favored 'General case' 0 C--N 1.346 0.452 0 N-CA-C 105.325 -2.102 . . . . 0.0 105.325 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 101.89 34.23 4.4 Favored Glycine 0 C--N 1.31 -0.871 0 CA-C-O 117.948 -1.474 . . . . 0.0 110.211 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.429 ' CG2' ' HB2' ' A' ' 27' ' ' LYS . 1.5 mm -67.73 135.74 27.92 Favored 'Isoleucine or valine' 0 C--N 1.361 1.102 0 CA-C-O 116.426 -1.749 . . . . 0.0 108.313 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 38.0 m-20 -74.95 147.82 40.55 Favored 'General case' 0 C--O 1.244 0.788 0 CA-C-O 115.255 -2.307 . . . . 0.0 113.555 179.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . 0.372 1.5 t -20.87 -57.3 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.508 -0.645 0 O-C-N 127.365 2.915 . . . . 0.0 117.819 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.547 1.9 m -73.67 -36.95 48.27 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.814 0 O-C-N 125.233 1.583 . . . . 0.0 112.073 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.429 ' HB2' ' CG2' ' A' ' 23' ' ' ILE . 6.7 mttm -63.69 -42.69 97.96 Favored 'General case' 0 CA--C 1.51 -0.57 0 O-C-N 125.057 1.473 . . . . 0.0 114.487 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 23.3 ptt85 -78.93 -23.68 44.52 Favored 'General case' 0 C--O 1.217 -0.638 0 CA-C-N 121.413 1.915 . . . . 0.0 108.464 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.9 ttpm? -76.09 -37.96 57.55 Favored 'General case' 0 N--CA 1.437 -1.096 0 CA-C-N 114.23 -1.35 . . . . 0.0 112.666 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.613 HD22 ' CE1' ' A' ' 33' ' ' HIS . 0.2 OUTLIER -77.05 -31.57 56.3 Favored 'General case' 0 N--CA 1.432 -1.327 0 CA-C-O 114.31 -2.757 . . . . 0.0 107.101 179.756 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -75.23 -21.53 77.75 Favored Glycine 0 CA--C 1.534 1.225 0 O-C-N 128.129 3.393 . . . . 0.0 114.425 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -78.37 -32.11 48.82 Favored 'General case' 0 C--N 1.314 -0.935 0 O-C-N 127.28 2.4 . . . . 0.0 110.898 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.613 ' CE1' HD22 ' A' ' 30' ' ' LEU . 6.7 p-80 -120.38 1.47 10.72 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 114.665 -1.152 . . . . 0.0 113.596 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 18.0 p30 -42.01 -19.92 0.01 OUTLIER 'General case' 0 CA--C 1.495 -1.156 0 N-CA-C 116.035 1.865 . . . . 0.0 116.035 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . 0.286 70.3 m-80 75.07 31.32 0.84 Allowed 'General case' 0 C--N 1.311 -1.092 0 CA-C-O 115.635 -2.126 . . . . 0.0 109.198 179.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.584 HD21 HD13 ' A' ' 38' ' ' LEU . 0.3 OUTLIER -45.64 103.48 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.964 0 O-C-N 127.559 3.037 . . . . 0.0 107.179 179.971 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.406 ' HE3' HG21 ' A' ' 5' ' ' THR . 30.9 tttp -96.79 112.13 24.01 Favored 'General case' 0 C--O 1.219 -0.517 0 N-CA-C 102.067 -3.309 . . . . 0.0 102.067 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.584 HD13 HD21 ' A' ' 36' ' ' LEU 0.279 1.0 OUTLIER -103.6 112.12 24.89 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 121.399 1.909 . . . . 0.0 110.577 -179.947 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.527 ' HB ' ' CB ' ' A' ' 50' ' ' LYS . 38.6 m -89.85 92.25 8.95 Favored 'General case' 0 N--CA 1.448 -0.557 0 O-C-N 118.003 -2.936 . . . . 0.0 106.675 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 5.3 mt -75.58 125.09 34.81 Favored 'Isoleucine or valine' 0 C--O 1.253 1.264 0 O-C-N 124.318 1.011 . . . . 0.0 111.016 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 53.2 m -128.3 95.16 4.08 Favored 'General case' 0 C--O 1.221 -0.445 0 O-C-N 127.037 2.711 . . . . 0.0 108.866 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -85.61 128.41 34.76 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-O 116.741 -1.599 . . . . 0.0 112.392 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -139.33 91.89 2.54 Favored 'General case' 0 N--CA 1.426 -1.671 0 CA-C-N 120.919 1.69 . . . . 0.0 110.589 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 50.0 68.07 1.56 Allowed Glycine 0 C--N 1.292 -1.881 0 O-C-N 126.013 2.071 . . . . 0.0 110.383 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.315 0.4 OUTLIER 83.4 -26.42 0.12 Allowed 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 114.258 1.207 . . . . 0.0 114.258 179.8 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 21.5 ttpt -87.25 143.03 27.47 Favored 'General case' 0 C--N 1.312 -1.05 0 C-N-CA 117.014 -1.875 . . . . 0.0 108.411 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.447 ' HE2' HD21 ' A' ' 64' ' ' LEU . 22.9 m-85 -124.02 101.2 7.11 Favored 'General case' 0 C--N 1.34 0.18 0 O-C-N 124.844 1.34 . . . . 0.0 111.077 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.958 ' HB ' HG12 ' A' ' 61' ' ' VAL 0.432 0.1 OUTLIER -83.19 82.93 8.05 Favored 'General case' 0 N--CA 1.441 -0.899 0 O-C-N 125.774 1.921 . . . . 0.0 110.281 179.909 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.616 HG22 ' HB ' ' A' ' 60' ' ' VAL 0.692 0.3 OUTLIER -62.96 89.12 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.493 -1.231 0 CA-C-N 110.687 -2.96 . . . . 0.0 115.788 179.971 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.527 ' CB ' ' HB ' ' A' ' 39' ' ' THR . 1.7 tttm -63.83 146.29 54.23 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 100.672 -3.825 . . . . 0.0 100.672 179.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -144.15 75.0 1.44 Allowed 'General case' 0 C--O 1.215 -0.739 0 CA-C-N 120.582 1.537 . . . . 0.0 109.378 -179.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 51.4 m -77.4 73.2 3.97 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 105.454 -2.054 . . . . 0.0 105.454 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.8 p -93.19 39.5 1.05 Allowed 'General case' 0 CA--C 1.505 -0.77 0 C-N-CA 117.809 -1.556 . . . . 0.0 111.868 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.403 ' OD1' ' N ' ' A' ' 55' ' ' PHE . 0.1 OUTLIER 72.16 -52.43 0.7 Allowed 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 115.242 -2.313 . . . . 0.0 108.509 -179.915 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.445 ' HB3' ' HD2' ' A' ' 56' ' ' ARG . 81.5 m-85 -57.5 -73.89 0.06 Allowed 'General case' 0 C--O 1.22 -0.492 0 CA-C-N 122.311 2.323 . . . . 0.0 109.403 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.445 ' HD2' ' HB3' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -136.59 146.19 45.8 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 120.472 1.487 . . . . 0.0 110.631 179.847 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -95.57 80.58 3.46 Favored 'General case' 0 C--N 1.352 0.697 0 N-CA-C 101.214 -3.625 . . . . 0.0 101.214 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.0 tp -110.71 117.67 55.46 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 O-C-N 127.827 3.205 . . . . 0.0 118.826 -179.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.75 119.6 12.73 Favored 'General case' 0 C--O 1.217 -0.643 0 N-CA-C 104.211 -2.514 . . . . 0.0 104.211 178.305 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.616 ' HB ' HG22 ' A' ' 49' ' ' VAL . 42.8 t -97.27 69.49 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 CA-C-O 122.163 0.982 . . . . 0.0 110.828 -178.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.958 HG12 ' HB ' ' A' ' 48' ' ' THR 0.404 0.7 OUTLIER -64.02 111.86 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 C-N-CA 118.028 -1.469 . . . . 0.0 113.138 -179.795 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.606 ' CE2' ' CE2' ' A' ' 68' ' ' PHE . 11.5 m-30 -136.99 97.25 3.46 Favored 'General case' 0 N--CA 1.431 -1.386 0 O-C-N 119.122 -2.236 . . . . 0.0 108.665 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -63.57 138.79 58.64 Favored 'General case' 0 C--O 1.246 0.886 0 N-CA-C 105.003 -2.221 . . . . 0.0 105.003 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.447 HD21 ' HE2' ' A' ' 47' ' ' PHE . 0.4 OUTLIER -60.54 134.92 57.55 Favored 'General case' 0 C--O 1.252 1.2 0 N-CA-C 105.354 -2.091 . . . . 0.0 105.354 -179.996 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 75.19 2.96 68.19 Favored Glycine 0 C--N 1.341 0.832 0 C-N-CA 127.892 2.663 . . . . 0.0 114.896 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . 0.39 2.1 t -89.64 83.63 2.18 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 N-CA-C 105.189 -2.152 . . . . 0.0 105.189 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -52.77 95.81 0.01 OUTLIER 'General case' 0 CA--C 1.479 -1.756 0 N-CA-C 115.579 1.696 . . . . 0.0 115.579 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.606 ' CE2' ' CE2' ' A' ' 62' ' ' PHE . 13.2 p90 -89.94 178.07 6.31 Favored 'General case' 0 C--N 1.309 -1.153 0 O-C-N 120.438 -1.414 . . . . 0.0 110.109 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -123.95 136.27 54.21 Favored 'General case' 0 C--O 1.244 0.777 0 O-C-N 127.269 2.856 . . . . 0.0 105.441 179.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -156.04 113.87 3.31 Favored 'General case' 0 C--O 1.21 -0.98 0 C-N-CA 118.002 -1.479 . . . . 0.0 114.37 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 9.0 p -67.0 176.5 2.08 Favored 'General case' 0 C--N 1.314 -0.97 0 O-C-N 119.617 -1.927 . . . . 0.0 107.183 179.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.493 ' CD2' HD22 ' A' ' 78' ' ' LEU . 2.9 mt -119.04 -154.5 0.57 Allowed 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 116.345 -1.788 . . . . 0.0 109.339 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -118.5 12.07 13.12 Favored 'General case' 0 N--CA 1.436 -1.165 0 O-C-N 125.627 1.829 . . . . 0.0 113.224 179.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -143.68 -49.41 0.3 Allowed 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 120.541 -0.464 . . . . 0.0 112.178 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -107.96 -9.81 27.49 Favored Glycine 0 CA--C 1.541 1.662 0 N-CA-C 117.192 1.637 . . . . 0.0 117.192 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . 0.412 0.0 OUTLIER 71.58 153.46 0.13 Allowed 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 122.004 2.902 . . . . 0.0 115.257 179.684 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.507 ' HB3' ' CG2' ' A' ' 96' ' ' VAL . 30.9 mt-10 48.76 154.5 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.676 1 O-C-N 129.885 4.491 . . . . 0.0 117.145 179.536 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.545 ' HG ' ' HB3' ' A' ' 93' ' ' PHE 0.401 11.9 tp 177.15 152.47 0.21 Allowed 'General case' 0 CA--C 1.51 -0.584 0 CA-C-N 110.949 -2.841 . . . . 0.0 107.016 -179.819 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 10.9 m -161.56 119.04 2.25 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 103.297 -2.853 . . . . 0.0 103.297 -179.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -165.13 -162.59 16.55 Favored Glycine 0 C--N 1.303 -1.256 0 C-N-CA 116.932 -2.556 . . . . 0.0 111.193 -179.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 17.4 p -145.21 164.36 31.58 Favored 'General case' 0 C--O 1.193 -1.915 0 C-N-CA 119.112 -1.035 . . . . 0.0 111.531 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . 0.508 ' CZ2' HG11 ' A' ' 49' ' ' VAL 0.302 11.8 m0 -106.46 151.72 24.58 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 100.68 -3.822 . . . . 0.0 100.68 179.924 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 2.4 t -150.96 141.11 22.19 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-O 122.587 1.184 . . . . 0.0 111.766 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 6.9 ttp -91.41 110.36 21.66 Favored 'General case' 0 N--CA 1.429 -1.519 0 CA-C-N 113.037 -1.892 . . . . 0.0 109.705 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . 0.634 10.2 mt-10 -87.58 -133.43 0.08 Allowed 'General case' 0 N--CA 1.434 -1.265 0 O-C-N 124.315 1.009 . . . . 0.0 110.391 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -87.34 92.71 1.83 Allowed Glycine 0 C--N 1.336 0.531 0 N-CA-C 103.207 -3.957 . . . . 0.0 103.207 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 53.68 10.46 0.24 Allowed 'General case' 0 C--O 1.24 0.602 0 N-CA-C 118.059 2.614 . . . . 0.0 118.059 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . 0.335 0.0 OUTLIER -133.58 135.13 44.09 Favored 'General case' 0 CA--C 1.501 -0.933 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 -179.975 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -88.31 134.6 33.77 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 103.953 -2.61 . . . . 0.0 103.953 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -113.54 -172.77 0.54 Allowed 'Isoleucine or valine' 0 C--O 1.246 0.88 0 C-N-CA 119.218 -0.993 . . . . 0.0 108.5 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -164.69 109.11 0.35 Allowed Glycine 0 C--N 1.35 1.335 0 C-N-CA 126.767 2.127 . . . . 0.0 111.696 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 4.7 mmmt -112.33 135.79 52.59 Favored 'General case' 0 N--CA 1.426 -1.636 0 N-CA-C 106.511 -1.662 . . . . 0.0 106.511 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.66 ' HD2' HD22 ' A' ' 102' ' ' LEU . 39.2 m-85 -137.57 115.9 11.87 Favored 'General case' 0 CA--C 1.504 -0.806 0 O-C-N 126.306 2.254 . . . . 0.0 113.034 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.4 mtmt -99.58 138.89 36.04 Favored 'General case' 0 N--CA 1.436 -1.157 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . 0.369 0.0 OUTLIER -74.29 174.51 8.7 Favored 'General case' 0 N--CA 1.428 -1.526 0 N-CA-C 105.647 -1.983 . . . . 0.0 105.647 179.819 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.507 ' CG2' ' HB3' ' A' ' 77' ' ' GLU 0.258 2.7 t -86.35 -61.69 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 O-C-N 126.702 2.501 . . . . 0.0 110.862 179.606 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . 0.398 0.6 OUTLIER -57.88 -29.17 64.82 Favored 'General case' 0 C--O 1.26 1.609 0 N-CA-C 118.46 2.763 . . . . 0.0 118.46 -179.926 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -131.24 -4.92 3.85 Favored 'General case' 0 N--CA 1.425 -1.712 0 N-CA-C 116.435 2.013 . . . . 0.0 116.435 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 49.56 42.73 35.71 Favored Glycine 0 C--N 1.348 1.198 0 C-N-CA 118.953 -1.594 . . . . 0.0 114.658 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 26.1 mmtm -71.41 -103.25 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.339 0 CA-C-O 115.835 -2.031 . . . . 0.0 111.226 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 158.92 136.11 0.0 OUTLIER 'General case' 0 N--CA 1.433 -1.308 0 C-N-CA 131.197 3.799 . . . . 0.0 110.191 179.692 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.678 ' HG ' ' HA ' ' A' ' 119' ' ' TYR . 7.2 tt -125.13 111.19 15.03 Favored 'General case' 0 C--N 1.316 -0.868 1 C-N-CA 133.764 4.826 . . . . 0.0 102.744 178.947 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.614 HD12 ' H ' ' A' ' 104' ' ' ALA . 0.1 OUTLIER -101.31 160.72 3.79 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.185 0 C-N-CA 115.472 -2.491 . . . . 0.0 106.975 -179.222 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.614 ' H ' HD12 ' A' ' 103' ' ' ILE . . . -157.8 131.95 8.17 Favored 'General case' 0 C--N 1.322 -0.604 0 O-C-N 118.729 -2.482 . . . . 0.0 112.471 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.624 ' HB ' ' CE2' ' A' ' 117' ' ' TYR . 5.6 p -120.56 118.33 56.2 Favored 'Isoleucine or valine' 0 C--O 1.252 1.226 0 CA-C-N 122.452 2.387 . . . . 0.0 108.915 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.493 HH11 ' HG3' ' A' ' 106' ' ' ARG . 9.6 mtt85 -86.34 88.12 7.56 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 105.301 -2.111 . . . . 0.0 105.301 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -91.36 85.6 5.85 Favored 'General case' 0 N--CA 1.429 -1.513 0 CA-C-N 113.023 -1.899 . . . . 0.0 114.458 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.774 HD11 ' CH2' ' A' ' 6' ' ' TRP 0.388 4.9 tt -65.27 92.12 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 C-N-CA 113.95 -3.1 . . . . 0.0 115.191 -179.927 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 38.9 t -76.54 77.53 3.23 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 102.929 -2.989 . . . . 0.0 102.929 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 62.4 -98.02 0.19 Allowed Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 127.162 2.315 . . . . 0.0 114.715 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . 0.325 7.0 m-20 -86.42 -0.9 56.96 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 114.726 -2.559 . . . . 0.0 110.717 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.439 ' HG2' ' HD2' ' A' ' 129' ' ' LYS . 6.3 mp0 -124.42 123.49 40.27 Favored 'General case' 0 C--O 1.205 -1.253 0 O-C-N 126.285 2.241 . . . . 0.0 112.451 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.654 HD22 ' CD2' ' A' ' 128' ' ' PHE . 10.0 tt -93.02 133.29 36.32 Favored 'General case' 0 C--O 1.222 -0.375 0 N-CA-C 101.286 -3.598 . . . . 0.0 101.286 -179.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.859 HG22 HG22 ' A' ' 116' ' ' THR 0.285 47.5 mt -138.03 120.85 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.301 0 O-C-N 125.976 2.048 . . . . 0.0 108.976 -179.79 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . 0.534 ' HB2' ' CD ' ' A' ' 126' ' ' ARG . 72.6 mt-30 -91.74 150.04 21.31 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 101.772 -3.418 . . . . 0.0 101.772 -179.511 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.859 HG22 HG22 ' A' ' 114' ' ' ILE . 0.1 OUTLIER -166.15 148.68 7.1 Favored 'General case' 0 N--CA 1.414 -2.244 0 O-C-N 128.389 3.556 . . . . 0.0 111.181 -179.236 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.624 ' CE2' ' HB ' ' A' ' 105' ' ' VAL 0.382 23.3 m-85 132.1 -142.86 0.0 OUTLIER 'General case' 0 CA--C 1.478 -1.793 0 O-C-N 128.682 3.739 . . . . 0.0 113.312 177.31 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.603 ' HA ' ' CE2' ' A' ' 17' ' ' PHE . 13.4 t -136.62 -173.66 3.49 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-O 127.165 3.364 . . . . 0.0 117.218 -174.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.678 ' HA ' ' HG ' ' A' ' 102' ' ' LEU 0.276 2.2 t80 -112.16 -15.99 13.11 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 112.56 -2.109 . . . . 0.0 109.055 177.644 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.448 ' HB2' ' CD2' ' A' ' 119' ' ' TYR . 0.4 OUTLIER -153.71 -71.17 0.14 Allowed 'General case' 0 C--N 1.298 -1.641 0 O-C-N 119.64 -1.912 . . . . 0.0 109.492 -179.916 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -160.51 34.1 0.42 Allowed Glycine 0 C--N 1.363 2.049 0 N-CA-C 120.59 2.996 . . . . 0.0 120.59 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 90.2 t -139.57 103.54 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.193 0 N-CA-C 103.476 -2.786 . . . . 0.0 103.476 179.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.447 ' HA ' ' O ' ' A' ' 117' ' ' TYR . 6.6 mp0 -68.47 177.63 2.33 Favored 'General case' 0 CA--C 1.503 -0.852 0 CA-C-O 123.778 1.751 . . . . 0.0 113.264 -178.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.529 ' HB1' ' CA ' ' A' ' 14' ' ' TYR . . . -167.77 176.74 6.15 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-O 114.379 -2.724 . . . . 0.0 104.906 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.506 ' HB2' ' CB ' ' A' ' 12' ' ' GLU 0.328 2.8 mptp? -145.3 156.17 43.65 Favored 'General case' 0 CA--C 1.506 -0.732 0 O-C-N 127.55 3.031 . . . . 0.0 107.818 -179.68 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.534 ' CD ' ' HB2' ' A' ' 115' ' ' GLN . 0.0 OUTLIER -142.13 76.15 1.52 Allowed 'General case' 0 N--CA 1.432 -1.361 0 CA-C-N 112.556 -2.111 . . . . 0.0 110.411 179.753 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.469 HD13 HG23 ' A' ' 114' ' ' ILE . 6.7 mm -63.8 116.33 3.34 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 O-C-N 126.313 2.258 . . . . 0.0 115.209 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.654 ' CD2' HD22 ' A' ' 113' ' ' LEU . 2.7 m-30 -109.24 125.93 52.78 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 126.011 1.724 . . . . 0.0 107.57 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.446 ' CG ' ' HB2' ' A' ' 9' ' ' ASP 0.279 14.8 mmmt -91.16 3.22 55.35 Favored 'General case' 0 N--CA 1.441 -0.897 0 O-C-N 119.961 -1.712 . . . . 0.0 112.213 -179.649 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.485 ' HD2' ' CH2' ' A' ' 6' ' ' TRP . 4.3 tttp 74.14 143.26 0.07 Allowed 'General case' 0 C--N 1.349 0.561 0 O-C-N 124.501 1.126 . . . . 0.0 108.763 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . 0.835 1.0 OUTLIER . . . . . 0 N--CA 1.431 -1.419 0 N-CA-C 115.401 1.63 . . . . 0.0 115.401 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.428 -1.534 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -156.94 88.41 1.03 Allowed 'General case' 0 N--CA 1.44 -0.94 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.904 179.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . 0.4 ' O ' ' N ' ' A' ' 40' ' ' ILE . . . 160.09 -130.72 2.48 Favored Glycine 0 CA--C 1.5 -0.86 0 C-N-CA 117.017 -2.516 . . . . 0.0 109.373 -179.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.621 ' HA ' ' HA ' ' A' ' 39' ' ' THR 0.499 5.3 t -117.73 171.11 8.26 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 123.197 1.475 . . . . 0.0 114.123 -179.958 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.803 ' CH2' HD11 ' A' ' 108' ' ' ILE . 80.3 m95 -152.13 147.61 26.65 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-N 110.227 -3.17 . . . . 0.0 105.816 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 4.8 ttmm -139.61 122.19 16.27 Favored 'General case' 0 C--O 1.205 -1.246 0 O-C-N 127.767 3.167 . . . . 0.0 105.514 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.721 HG12 ' HB3' ' A' ' 36' ' ' LEU 0.379 8.0 p -69.02 139.21 20.85 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.022 0 CA-C-N 121.143 1.792 . . . . 0.0 110.773 179.996 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -129.39 -46.82 1.19 Allowed 'General case' 0 C--O 1.212 -0.91 0 O-C-N 127.387 2.929 . . . . 0.0 106.373 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.452 ' HG3' ' N ' ' A' ' 11' ' ' ASN . 9.2 ttt180 -129.21 144.85 51.37 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 106.962 -1.495 . . . . 0.0 106.962 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.484 ' OD1' HG21 ' A' ' 8' ' ' VAL 0.385 97.7 m-20 -131.59 -171.12 2.53 Favored 'General case' 0 CA--C 1.501 -0.936 0 O-C-N 128.604 3.69 . . . . 0.0 107.886 179.956 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.527 ' HB2' ' HB2' ' A' ' 125' ' ' LYS . 0.9 OUTLIER -146.43 -85.69 0.11 Allowed 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 122.595 2.452 . . . . 0.0 110.897 179.942 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.538 ' HB3' ' HA ' ' A' ' 124' ' ' ALA . 2.8 t30 -90.64 16.74 8.55 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-N 121.342 1.883 . . . . 0.0 114.154 179.445 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.514 ' CD2' ' HG2' ' A' ' 126' ' ' ARG 0.283 0.2 OUTLIER -63.98 -20.98 66.29 Favored 'General case' 0 C--O 1.242 0.665 0 O-C-N 127.595 3.06 . . . . 0.0 115.11 179.858 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -76.19 -36.91 58.43 Favored 'General case' 0 C--O 1.205 -1.261 0 O-C-N 118.909 -2.369 . . . . 0.0 108.186 179.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.44 ' HB3' ' ND2' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -77.3 -33.76 55.62 Favored 'General case' 0 N--CA 1.435 -1.189 0 CA-C-N 112.855 -1.975 . . . . 0.0 113.194 179.981 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -70.27 -21.44 62.97 Favored 'General case' 0 N--CA 1.438 -1.046 0 O-C-N 118.798 -2.439 . . . . 0.0 109.666 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.434 ' CB ' HG13 ' A' ' 23' ' ' ILE . 4.8 mtt -76.86 -35.19 57.65 Favored 'General case' 0 CA--C 1.503 -0.852 0 CA-C-O 125.868 2.747 . . . . 0.0 107.268 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -70.79 -29.62 65.87 Favored 'General case' 0 C--O 1.244 0.771 0 CA-C-O 127.295 3.426 . . . . 0.0 112.007 179.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 42.3 tptt -80.07 -27.78 39.28 Favored 'General case' 0 N--CA 1.437 -1.118 0 O-C-N 119.252 -2.155 . . . . 0.0 110.383 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 17.8 mtp -71.5 -30.88 66.47 Favored 'General case' 0 C--O 1.202 -1.436 0 O-C-N 119.554 -1.966 . . . . 0.0 106.669 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.31 32.52 2.75 Favored Glycine 0 C--N 1.306 -1.129 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.449 HG23 ' HB3' ' A' ' 27' ' ' LYS . 6.0 mm -78.33 -71.38 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.362 1.124 0 CA-C-O 115.561 -2.161 . . . . 0.0 106.901 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 66.53 152.17 0.07 Allowed 'General case' 0 N--CA 1.445 -0.716 0 O-C-N 126.777 2.548 . . . . 0.0 114.755 179.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.442 HG12 ' N ' ' A' ' 26' ' ' VAL 0.4 2.6 t 50.18 -122.94 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.355 0.835 0 N-CA-C 120.268 3.432 . . . . 0.0 120.268 179.679 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.442 ' N ' HG12 ' A' ' 25' ' ' VAL 0.542 3.4 m -65.43 -36.86 78.68 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.037 0 N-CA-C 118.379 2.733 . . . . 0.0 118.379 -179.776 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.449 ' HB3' HG23 ' A' ' 23' ' ' ILE . 62.8 mttm -60.93 -25.89 67.1 Favored 'General case' 0 N--CA 1.438 -1.067 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 4.7 mtm-85 -78.08 -31.26 50.04 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 117.435 -1.706 . . . . 0.0 108.178 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 8.1 tptm -71.36 -45.85 61.89 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 114.02 -1.446 . . . . 0.0 111.798 179.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 12.2 mt -78.02 -29.2 49.36 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 -179.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.16 -36.07 60.43 Favored Glycine 0 C--N 1.338 0.641 0 CA-C-O 123.089 1.383 . . . . 0.0 111.681 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -75.63 -22.84 56.45 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-O 116.738 -1.601 . . . . 0.0 112.946 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 18.0 t60 -120.78 46.2 2.07 Favored 'General case' 0 N--CA 1.447 -0.615 0 O-C-N 128.829 3.831 . . . . 0.0 114.125 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -72.05 -19.19 61.87 Favored 'General case' 0 C--O 1.21 -0.991 0 O-C-N 128.544 3.653 . . . . 0.0 117.703 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . 0.255 2.0 t-20 65.93 38.99 4.73 Favored 'General case' 0 C--N 1.312 -1.037 0 C-N-CA 118.593 -1.243 . . . . 0.0 109.454 -179.314 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.92 HD21 HD13 ' A' ' 38' ' ' LEU . 3.0 tt -61.2 137.29 58.24 Favored 'General case' 0 C--O 1.216 -0.698 0 O-C-N 125.632 1.833 . . . . 0.0 112.847 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.3 ttpt -139.2 100.83 4.11 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 101.55 -3.5 . . . . 0.0 101.55 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.92 HD13 HD21 ' A' ' 36' ' ' LEU 0.277 0.4 OUTLIER -93.08 117.19 29.78 Favored 'General case' 0 C--N 1.293 -1.88 0 O-C-N 119.349 -2.095 . . . . 0.0 107.008 -179.578 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.621 ' HA ' ' HA ' ' A' ' 5' ' ' THR . 85.2 m -104.44 100.47 10.16 Favored 'General case' 0 N--CA 1.436 -1.135 0 N-CA-C 104.192 -2.522 . . . . 0.0 104.192 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.439 HG12 HG23 ' A' ' 49' ' ' VAL . 7.9 mt -71.29 149.86 9.56 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 179.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.695 ' HB ' HG23 ' A' ' 48' ' ' THR . 89.3 m -142.71 63.44 1.39 Allowed 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 113.68 -1.6 . . . . 0.0 112.519 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.408 ' HG3' ' CE1' ' A' ' 47' ' ' PHE . 0.4 OUTLIER -62.35 119.85 9.88 Favored 'General case' 0 C--O 1.222 -0.362 0 O-C-N 125.228 1.58 . . . . 0.0 109.723 179.86 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -153.48 108.68 3.19 Favored 'General case' 0 CA--C 1.489 -1.392 0 CA-C-O 122.951 1.358 . . . . 0.0 110.079 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 61.35 31.73 78.32 Favored Glycine 0 C--N 1.306 -1.108 0 N-CA-C 108.888 -1.685 . . . . 0.0 108.888 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.31 0.2 OUTLIER 87.63 -14.05 0.44 Allowed 'General case' 0 C--O 1.225 -0.189 0 CA-C-N 112.978 -1.611 . . . . 0.0 110.856 179.728 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -80.09 121.1 25.12 Favored 'General case' 0 N--CA 1.428 -1.542 0 C-N-CA 116.333 -2.147 . . . . 0.0 110.094 -179.557 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.859 ' CE2' HD21 ' A' ' 89' ' ' LEU 0.311 0.4 OUTLIER -101.77 104.93 15.74 Favored 'General case' 0 C--O 1.217 -0.634 0 N-CA-C 105.985 -1.857 . . . . 0.0 105.985 179.963 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.695 HG23 ' HB ' ' A' ' 41' ' ' THR 0.432 1.6 t -105.29 73.2 1.02 Allowed 'General case' 0 C--N 1.313 -1.002 0 CA-C-O 125.542 2.591 . . . . 0.0 111.979 -179.596 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.439 HG23 HG12 ' A' ' 40' ' ' ILE 0.626 0.5 OUTLIER -52.37 94.47 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.425 -1.703 0 CA-C-N 108.704 -3.862 . . . . 0.0 112.636 -179.866 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.606 ' HB3' ' HB ' ' A' ' 39' ' ' THR . 5.1 ttmt -64.6 153.88 37.98 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 100.631 -3.84 . . . . 0.0 100.631 179.381 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.562 ' OE2' HD11 ' A' ' 36' ' ' LEU . 1.3 tp10 -149.42 92.92 1.99 Allowed 'General case' 0 C--O 1.215 -0.733 0 N-CA-C 103.774 -2.676 . . . . 0.0 103.774 -179.743 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -88.06 77.88 8.29 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-O 125.025 2.345 . . . . 0.0 106.696 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -95.11 -176.51 3.84 Favored 'General case' 0 N--CA 1.439 -1.003 0 O-C-N 119.883 -1.761 . . . . 0.0 112.411 -179.401 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -65.21 -19.41 65.96 Favored 'General case' 0 N--CA 1.444 -0.772 0 O-C-N 126.681 2.488 . . . . 0.0 108.612 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.417 ' CE2' ' HB1' ' A' ' 73' ' ' ALA . 6.1 m-85 -90.04 -56.52 3.19 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-O 115.22 -2.324 . . . . 0.0 115.165 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.686 HH21 HD12 ' A' ' 58' ' ' ILE . 0.1 OUTLIER -155.62 168.58 26.69 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 123.833 3.015 . . . . 0.0 107.947 179.418 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -106.29 63.16 0.65 Allowed 'General case' 0 C--O 1.216 -0.696 2 N-CA-C 100.007 -4.071 . . . . 0.0 100.007 179.645 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.686 HD12 HH21 ' A' ' 56' ' ' ARG . 12.1 tt -91.95 97.8 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 O-C-N 127.99 3.306 . . . . 0.0 114.509 -179.385 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.442 ' HA ' ' HA ' ' A' ' 50' ' ' LYS 0.273 0.0 OUTLIER -62.88 125.9 25.54 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 104.935 -2.246 . . . . 0.0 104.935 179.136 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.5 t -105.2 85.38 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 C-N-CA 119.035 -1.066 . . . . 0.0 109.735 -178.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.582 HG12 ' HB ' ' A' ' 48' ' ' THR 0.399 2.0 m -74.44 150.84 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.37 0 CA-C-O 125.865 2.745 . . . . 0.0 115.163 -179.882 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.626 ' CZ ' ' CZ2' ' A' ' 82' ' ' TRP . 0.0 OUTLIER -168.21 95.65 0.4 Allowed 'General case' 0 N--CA 1.43 -1.473 0 CA-C-N 112.673 -2.058 . . . . 0.0 111.639 179.7 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.74 99.91 0.06 Allowed 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 102.477 -3.157 . . . . 0.0 102.477 179.572 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.461 HD23 ' CD2' ' A' ' 47' ' ' PHE . 0.2 OUTLIER -33.86 100.02 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 127.052 2.72 . . . . 0.0 112.683 -179.865 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 102.46 23.44 8.92 Favored Glycine 0 CA--C 1.528 0.881 0 O-C-N 128.453 3.596 . . . . 0.0 116.842 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.435 ' O ' ' CE2' ' A' ' 68' ' ' PHE 0.269 2.4 t -113.88 79.4 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.505 0 CA-C-O 115.184 -2.341 . . . . 0.0 105.301 -179.99 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . 0.278 23.5 m-20 -27.92 118.5 0.1 Allowed 'General case' 0 CA--C 1.498 -1.035 0 N-CA-C 115.682 1.734 . . . . 0.0 115.682 -179.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.571 ' CZ ' ' CB ' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -129.0 -173.57 3.02 Favored 'General case' 0 N--CA 1.442 -0.837 0 O-C-N 118.602 -2.561 . . . . 0.0 107.72 -179.922 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -128.84 138.15 51.88 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.439 ' HB3' HD23 ' A' ' 78' ' ' LEU . 1.7 t80 -138.85 95.17 2.92 Favored 'General case' 0 C--O 1.215 -0.727 0 C-N-CA 119.26 -0.976 . . . . 0.0 113.026 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -74.36 115.71 14.2 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 105.103 -2.184 . . . . 0.0 105.103 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.864 HD11 HD13 ' A' ' 78' ' ' LEU . 46.8 mt -71.16 -169.1 0.35 Allowed 'General case' 0 C--N 1.298 -1.637 0 CA-C-O 117.795 -1.098 . . . . 0.0 109.745 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.417 ' HB1' ' CE2' ' A' ' 55' ' ' PHE . . . -85.26 -35.95 21.22 Favored 'General case' 0 C--O 1.214 -0.784 0 O-C-N 128.666 3.729 . . . . 0.0 113.332 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -143.17 21.88 1.9 Allowed 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 113.982 -1.463 . . . . 0.0 108.555 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -130.92 -15.42 1.72 Allowed Glycine 0 CA--C 1.544 1.851 0 CA-C-O 117.797 -1.557 . . . . 0.0 116.829 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER 64.7 -177.65 0.17 Allowed 'General case' 0 N--CA 1.433 -1.306 0 CA-C-N 119.994 1.897 . . . . 0.0 114.204 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.491 ' CB ' ' HB ' ' A' ' 96' ' ' VAL . 4.7 mp0 -26.94 119.71 0.09 Allowed 'General case' 0 CA--C 1.5 -0.958 1 O-C-N 129.626 4.329 . . . . 0.0 115.608 179.923 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.864 HD13 HD11 ' A' ' 72' ' ' LEU 0.433 0.9 OUTLIER -142.67 78.01 1.6 Allowed 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 101.9 -3.37 . . . . 0.0 101.9 179.997 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 3.7 m -82.74 165.88 19.55 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 101.804 -3.406 . . . . 0.0 101.804 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 144.31 -170.65 25.99 Favored Glycine 0 CA--C 1.538 1.519 0 C-N-CA 119.345 -1.407 . . . . 0.0 112.336 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -146.38 171.32 15.19 Favored 'General case' 0 C--O 1.203 -1.364 0 C-N-CA 117.668 -1.613 . . . . 0.0 111.386 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . 0.626 ' CZ2' ' CZ ' ' A' ' 62' ' ' PHE 0.335 13.3 m0 -114.46 141.52 47.58 Favored 'General case' 0 N--CA 1.424 -1.771 0 N-CA-C 101.388 -3.56 . . . . 0.0 101.388 179.63 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.471 HG23 HG22 ' A' ' 90' ' ' VAL . 9.9 t -146.85 141.4 26.57 Favored 'General case' 0 N--CA 1.427 -1.581 0 O-C-N 124.261 0.975 . . . . 0.0 109.797 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 12.4 ttm -81.64 129.62 34.76 Favored 'General case' 0 CA--C 1.496 -1.133 0 C-N-CA 121.2 -0.2 . . . . 0.0 110.897 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . 0.597 3.7 pt-20 -122.51 54.75 1.19 Allowed 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 96.6 -127.82 9.32 Favored Glycine 0 N--CA 1.439 -1.111 0 O-C-N 126.008 2.067 . . . . 0.0 108.503 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -80.65 9.47 6.11 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 115.502 1.668 . . . . 0.0 115.502 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . 0.275 0.1 OUTLIER -132.49 172.8 12.02 Favored 'General case' 0 CA--C 1.503 -0.836 0 O-C-N 125.712 1.882 . . . . 0.0 106.667 179.623 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.859 HD21 ' CE2' ' A' ' 47' ' ' PHE . 2.6 tp -127.74 159.11 35.77 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 105.339 -2.097 . . . . 0.0 105.339 179.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.471 HG22 HG23 ' A' ' 83' ' ' THR . 17.4 m -142.83 122.61 9.52 Favored 'Isoleucine or valine' 0 C--O 1.245 0.864 0 C-N-CA 116.09 -2.244 . . . . 0.0 110.107 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -92.64 97.49 2.27 Favored Glycine 0 C--N 1.35 1.338 0 N-CA-C 108.031 -2.028 . . . . 0.0 108.031 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.637 ' HA ' HD12 ' A' ' 103' ' ' ILE . 2.0 mttt -92.62 126.88 37.9 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 102.78 -3.045 . . . . 0.0 102.78 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.456 ' HB3' ' HG ' ' A' ' 78' ' ' LEU . 53.2 m-85 -127.96 110.74 12.83 Favored 'General case' 0 N--CA 1.444 -0.758 0 O-C-N 126.201 2.188 . . . . 0.0 112.621 -179.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -103.65 126.82 51.04 Favored 'General case' 0 N--CA 1.435 -1.203 0 N-CA-C 105.407 -2.071 . . . . 0.0 105.407 179.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . 0.433 3.3 mmm180 -81.64 156.49 25.08 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 127.227 2.829 . . . . 0.0 109.69 -179.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.491 ' HB ' ' CB ' ' A' ' 77' ' ' GLU . 3.3 t -78.4 -54.54 11.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 C-N-CA 124.552 1.141 . . . . 0.0 113.152 -179.682 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . 0.452 14.9 m-20 -68.53 -9.44 49.29 Favored 'General case' 0 C--O 1.254 1.311 0 N-CA-C 117.952 2.575 . . . . 0.0 117.952 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.417 ' ND2' ' HG3' ' A' ' 100' ' ' LYS . 19.5 p-10 -145.04 6.48 1.16 Allowed 'General case' 0 N--CA 1.438 -1.071 0 CA-C-O 115.328 -2.272 . . . . 0.0 114.069 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 39.98 40.64 1.76 Allowed Glycine 0 CA--C 1.542 1.773 0 O-C-N 125.285 1.616 . . . . 0.0 114.485 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.417 ' HG3' ' ND2' ' A' ' 98' ' ' ASN . 32.2 mmtm -78.18 -127.32 0.01 OUTLIER 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 114.14 -1.03 . . . . 0.0 109.293 -179.56 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 171.36 97.59 0.01 OUTLIER 'General case' 0 N--CA 1.433 -1.276 0 C-N-CA 130.019 3.327 . . . . 0.0 115.125 -179.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.698 HD13 HD12 ' A' ' 78' ' ' LEU . 0.3 OUTLIER -89.52 121.67 31.96 Favored 'General case' 0 N--CA 1.442 -0.875 2 C-N-CA 132.566 4.347 . . . . 0.0 103.871 178.863 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.885 HG23 ' HB3' ' A' ' 117' ' ' TYR . 4.6 tp -120.21 157.53 22.71 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.742 0 C-N-CA 115.844 -2.343 . . . . 0.0 105.864 179.276 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.536 ' HA ' ' HB2' ' A' ' 117' ' ' TYR . . . -141.33 136.69 31.77 Favored 'General case' 0 C--N 1.313 -1.001 0 O-C-N 118.557 -2.589 . . . . 0.0 108.16 -179.152 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.663 ' HB ' ' CD2' ' A' ' 117' ' ' TYR . 0.5 OUTLIER -125.63 104.56 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 CA-C-N 122.856 2.571 . . . . 0.0 112.837 -179.709 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.641 ' HG2' HH11 ' A' ' 106' ' ' ARG . 4.9 mtt-85 -74.06 94.24 2.37 Favored 'General case' 0 C--N 1.307 -1.275 0 O-C-N 119.729 -1.857 . . . . 0.0 106.831 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -98.53 84.87 3.25 Favored 'General case' 0 N--CA 1.419 -2.002 0 O-C-N 126.058 2.099 . . . . 0.0 114.394 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.803 HD11 ' CH2' ' A' ' 6' ' ' TRP 0.38 0.1 OUTLIER -60.89 101.09 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 C-N-CA 116.403 -2.119 . . . . 0.0 108.503 179.897 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 10.4 p -87.85 70.09 9.52 Favored 'General case' 0 CA--C 1.504 -0.79 0 N-CA-C 104.511 -2.404 . . . . 0.0 104.511 -179.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 76.99 -115.05 4.22 Favored Glycine 0 C--N 1.339 0.734 0 O-C-N 127.601 3.063 . . . . 0.0 111.677 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 48.8 m-20 -69.13 -25.24 64.29 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 120.014 1.907 . . . . 0.0 112.264 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.22 143.77 29.1 Favored 'General case' 0 CA--C 1.494 -1.19 0 CA-C-O 116.295 -1.812 . . . . 0.0 115.523 -179.592 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.543 HD23 ' N ' ' A' ' 114' ' ' ILE . 0.3 OUTLIER -104.79 146.12 29.42 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 100.741 -3.8 . . . . 0.0 100.741 179.979 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.607 HD13 HD12 ' A' ' 127' ' ' ILE 0.284 81.7 mt -149.26 110.74 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.171 0 CA-C-O 117.164 -1.398 . . . . 0.0 109.163 -179.904 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . 0.658 ' HB2' ' HD2' ' A' ' 126' ' ' ARG . 55.3 mt-30 -86.2 167.0 15.28 Favored 'General case' 0 C--N 1.345 0.378 0 N-CA-C 104.035 -2.58 . . . . 0.0 104.035 179.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.475 ' CG2' ' C ' ' A' ' 115' ' ' GLN . 5.0 p -159.75 -152.33 0.3 Allowed 'General case' 0 CA--C 1.494 -1.184 1 O-C-N 130.516 4.885 . . . . 0.0 106.501 -177.198 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.885 ' HB3' HG23 ' A' ' 103' ' ' ILE . 8.7 m-30 76.88 -165.74 0.05 Allowed 'General case' 0 CA--C 1.46 -2.488 1 O-C-N 129.379 4.175 . . . . 0.0 114.309 175.144 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.508 ' O ' ' N ' ' A' ' 103' ' ' ILE . 6.9 t -138.87 -162.37 1.31 Allowed 'General case' 0 N--CA 1.437 -1.11 0 CA-C-O 127.384 3.469 . . . . 0.0 117.116 -174.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.598 ' HA ' ' HG ' ' A' ' 102' ' ' LEU . 1.6 t80 -111.57 -25.79 9.38 Favored 'General case' 0 C--N 1.348 0.525 0 CA-C-N 111.769 -2.469 . . . . 0.0 109.773 178.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.519 ' HB2' ' CD2' ' A' ' 119' ' ' TYR . 0.2 OUTLIER -153.23 -59.83 0.14 Allowed 'General case' 0 C--N 1.29 -2.004 0 C-N-CA 126.498 1.919 . . . . 0.0 110.017 -179.876 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -153.76 1.56 0.23 Allowed Glycine 0 C--N 1.362 1.988 0 N-CA-C 121.178 3.231 . . . . 0.0 121.178 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 37.0 t -110.39 98.91 7.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 O-C-N 117.49 -3.359 . . . . 0.0 104.915 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.413 ' HA ' ' HB ' ' A' ' 118' ' ' THR . 4.8 mp0 -64.87 -175.54 0.2 Allowed 'General case' 0 C--O 1.21 -0.984 0 O-C-N 120.001 -1.687 . . . . 0.0 112.435 -179.641 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.538 ' HA ' ' HB3' ' A' ' 13' ' ' ASN . . . -170.19 -167.83 0.67 Allowed 'General case' 0 C--O 1.21 -0.992 0 CA-C-O 113.872 -2.966 . . . . 0.0 106.991 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.527 ' HB2' ' HB2' ' A' ' 12' ' ' GLU 0.29 0.0 OUTLIER -157.88 143.84 17.32 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 122.775 2.534 . . . . 0.0 111.867 179.901 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.658 ' HD2' ' HB2' ' A' ' 115' ' ' GLN . 0.0 OUTLIER -137.39 78.22 1.68 Allowed 'General case' 0 C--O 1.209 -1.052 0 O-C-N 128.058 3.349 . . . . 0.0 110.573 179.752 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.607 HD12 HD13 ' A' ' 114' ' ' ILE . 1.7 mm -66.44 96.18 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 O-C-N 125.311 1.632 . . . . 0.0 114.422 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.776 ' CE1' HD22 ' A' ' 36' ' ' LEU . 26.5 m-85 -84.49 137.69 33.21 Favored 'General case' 0 C--O 1.219 -0.503 0 C-N-CA 126.524 1.93 . . . . 0.0 106.709 179.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 10.0 mmtt -101.12 41.24 1.2 Allowed 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 115.455 -2.212 . . . . 0.0 112.465 -179.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.533 ' HA ' ' HA ' ' A' ' 6' ' ' TRP . 3.2 tttm 27.36 98.22 0.0 OUTLIER 'General case' 0 C--O 1.238 0.491 0 C-N-CA 127.462 2.305 . . . . 0.0 116.401 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.435 ' HA ' HG23 ' A' ' 5' ' ' THR 0.858 2.6 tm-20 . . . . . 0 N--CA 1.439 -1.022 0 O-C-N 117.912 -2.992 . . . . 0.0 116.892 -179.763 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . 0.583 ' CZ ' HG13 ' A' ' 108' ' ' ILE . 96.6 m-85 . . . . . 0 CA--C 1.508 -0.659 0 CA-C-O 124.147 1.927 . . . . 0.0 116.128 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -156.27 90.72 1.21 Allowed 'General case' 0 N--CA 1.436 -1.132 0 CA-C-N 113.66 -1.609 . . . . 0.0 113.205 179.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 155.98 -148.19 17.91 Favored Glycine 0 N--CA 1.432 -1.589 0 C-N-CA 114.992 -3.48 . . . . 0.0 114.395 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.598 HG23 HG23 ' A' ' 39' ' ' THR 0.576 32.9 p -103.76 150.35 24.16 Favored 'General case' 0 C--N 1.311 -1.088 0 O-C-N 126.935 2.197 . . . . 0.0 114.182 179.967 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.578 ' CZ2' HD11 ' A' ' 108' ' ' ILE . 93.7 m95 -148.11 141.21 24.97 Favored 'General case' 0 N--CA 1.431 -1.405 0 O-C-N 126.346 2.279 . . . . 0.0 106.087 179.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 18.3 tttt -141.47 93.54 2.58 Favored 'General case' 0 C--O 1.204 -1.32 0 CA-C-O 116.778 -1.582 . . . . 0.0 107.257 179.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.482 ' CG1' ' HB3' ' A' ' 36' ' ' LEU 0.32 1.5 p -43.78 136.9 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-O 117.127 -1.416 . . . . 0.0 113.341 -179.96 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -126.15 -18.45 4.99 Favored 'General case' 0 CA--C 1.503 -0.853 0 O-C-N 124.671 1.232 . . . . 0.0 111.321 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.02 145.65 15.4 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 119.753 -1.842 . . . . 0.0 106.496 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . 0.298 0.2 OUTLIER -109.09 -169.83 1.55 Allowed 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 112.452 -2.158 . . . . 0.0 109.54 179.715 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -176.87 90.35 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.464 ' HB3' ' HA ' ' A' ' 124' ' ' ALA . 0.2 OUTLIER 100.7 -7.39 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 125.132 1.373 . . . . 0.0 112.229 -179.575 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.566 ' CD2' ' CG ' ' A' ' 126' ' ' ARG 0.252 0.2 OUTLIER -69.96 -38.67 76.17 Favored 'General case' 0 C--O 1.222 -0.386 0 O-C-N 128.314 3.509 . . . . 0.0 114.185 179.584 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.52 -29.24 68.98 Favored 'General case' 0 CA--C 1.509 -0.602 0 CA-C-N 121.539 1.972 . . . . 0.0 113.043 179.696 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.9 -37.42 34.77 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 113.504 -1.68 . . . . 0.0 110.391 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.545 ' CD2' ' CE1' ' A' ' 14' ' ' TYR . 0.9 OUTLIER -70.73 -28.62 64.86 Favored 'General case' 0 C--O 1.244 0.765 0 CA-C-O 124.765 2.222 . . . . 0.0 111.747 -179.981 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.409 ' CB ' HG13 ' A' ' 23' ' ' ILE . 32.1 mtt -72.15 -26.04 61.95 Favored 'General case' 0 C--N 1.324 -0.521 1 O-C-N 115.36 -4.588 . . . . 0.0 108.466 -179.686 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -79.68 -24.16 41.96 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 116.138 -2.225 . . . . 0.0 111.937 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 12.4 tptp -79.19 -30.53 43.43 Favored 'General case' 0 C--N 1.31 -1.145 0 O-C-N 120.68 -1.262 . . . . 0.0 109.379 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.545 ' CE ' ' CD1' ' A' ' 119' ' ' TYR 0.304 0.7 OUTLIER -78.41 -23.49 46.68 Favored 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 179.783 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 88.33 56.87 1.96 Allowed Glycine 0 C--N 1.307 -1.049 0 CA-C-O 116.301 -2.389 . . . . 0.0 108.793 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.475 HG21 ' HA ' ' A' ' 28' ' ' ARG . 1.6 mm -81.26 -34.17 13.22 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 CA-C-O 115.081 -2.39 . . . . 0.0 111.719 -179.68 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 89.61 98.64 0.02 OUTLIER 'General case' 0 C--N 1.346 0.426 0 O-C-N 125.877 1.985 . . . . 0.0 113.431 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.471 HG13 HG22 ' A' ' 26' ' ' VAL 0.475 4.1 p 12.86 -62.08 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.349 0.577 0 N-CA-C 119.292 3.071 . . . . 0.0 119.292 179.974 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.471 HG22 HG13 ' A' ' 25' ' ' VAL 0.605 0.0 OUTLIER -72.07 -42.08 67.7 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.876 0 N-CA-C 118.212 2.671 . . . . 0.0 118.212 -179.465 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.4 mtpp -64.4 -24.59 67.69 Favored 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 114.787 1.403 . . . . 0.0 114.787 -179.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.475 ' HA ' HG21 ' A' ' 23' ' ' ILE . 5.0 ptt85 -79.8 -25.68 40.8 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 119.207 -2.183 . . . . 0.0 108.239 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 8.8 tttt -73.99 -46.39 44.08 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.609 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.1 mp -72.81 -31.96 65.19 Favored 'General case' 0 N--CA 1.438 -1.058 0 O-C-N 124.872 1.358 . . . . 0.0 107.387 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -74.95 -34.49 52.65 Favored Glycine 0 C--N 1.346 1.102 0 O-C-N 124.576 1.172 . . . . 0.0 111.779 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -73.35 -26.71 61.13 Favored 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 114.476 1.288 . . . . 0.0 114.476 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -124.8 57.83 1.26 Allowed 'General case' 0 C--N 1.348 0.502 0 O-C-N 127.343 2.902 . . . . 0.0 111.175 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -90.78 -17.82 25.99 Favored 'General case' 0 C--O 1.211 -0.948 0 N-CA-C 118.511 2.782 . . . . 0.0 118.511 -179.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 10.3 t30 75.32 27.12 1.11 Allowed 'General case' 0 C--O 1.24 0.6 0 C-N-CA 117.992 -1.483 . . . . 0.0 110.092 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.522 HD11 ' CD1' ' A' ' 38' ' ' LEU . 13.8 tp -52.77 106.54 0.16 Allowed 'General case' 0 C--O 1.216 -0.682 0 C-N-CA 126.542 1.937 . . . . 0.0 107.587 179.676 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 6.1 ttpt -104.58 103.91 13.65 Favored 'General case' 0 C--N 1.309 -1.183 0 O-C-N 127.086 2.741 . . . . 0.0 104.156 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.522 ' CD1' HD11 ' A' ' 36' ' ' LEU 0.271 1.0 OUTLIER -88.2 117.11 26.87 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 179.434 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.598 HG23 HG23 ' A' ' 5' ' ' THR . 31.3 m -108.81 98.46 7.95 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 104.118 -2.549 . . . . 0.0 104.118 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.478 HG13 ' CG2' ' A' ' 49' ' ' VAL . 29.0 mt -81.38 142.33 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.38 0 O-C-N 126.143 2.152 . . . . 0.0 109.213 -179.717 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.448 HG22 ' O ' ' A' ' 41' ' ' THR . 20.9 m -145.33 83.14 1.66 Allowed 'General case' 0 CA--C 1.508 -0.639 0 O-C-N 128.091 3.369 . . . . 0.0 109.247 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.479 ' NE2' ' CE2' ' A' ' 47' ' ' PHE . 4.1 tt0 -82.85 132.18 35.17 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 114.375 -1.284 . . . . 0.0 108.312 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -117.67 67.53 0.75 Allowed 'General case' 0 CA--C 1.485 -1.527 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.91 -86.38 1.52 Allowed Glycine 0 N--CA 1.429 -1.82 0 N-CA-C 106.417 -2.673 . . . . 0.0 106.417 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.288 0.0 OUTLIER -111.08 -40.32 4.51 Favored 'General case' 0 N--CA 1.451 -0.417 0 O-C-N 125.541 1.377 . . . . 0.0 113.167 -179.912 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.45 ' HG3' ' HG3' ' A' ' 63' ' ' GLU . 5.3 ttmm -62.2 148.87 43.3 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.596 ' HB3' ' CE1' ' A' ' 62' ' ' PHE 0.306 1.7 m-85 -137.08 105.56 5.79 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 114.98 -1.009 . . . . 0.0 109.196 179.962 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.812 ' HB ' HG12 ' A' ' 61' ' ' VAL 0.423 9.5 t -99.38 126.05 45.18 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 105.712 -1.959 . . . . 0.0 105.712 179.43 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.498 ' HB ' ' CE2' ' A' ' 62' ' ' PHE 0.671 0.6 OUTLIER -107.23 115.89 49.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 O-C-N 126.801 2.563 . . . . 0.0 113.303 -179.84 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.546 ' CB ' ' HB ' ' A' ' 39' ' ' THR . 7.3 tttt -78.63 100.37 6.97 Favored 'General case' 0 C--N 1.307 -1.267 1 N-CA-C 100.182 -4.006 . . . . 0.0 100.182 179.909 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 55.4 tt0 -95.64 63.75 2.47 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 102.446 -3.168 . . . . 0.0 102.446 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 11.0 m -74.92 60.27 0.96 Allowed 'General case' 0 C--N 1.289 -2.025 0 O-C-N 125.763 1.914 . . . . 0.0 106.725 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -82.13 179.36 7.84 Favored 'General case' 0 C--O 1.209 -1.073 0 C-N-CA 117.215 -1.794 . . . . 0.0 109.778 179.696 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -63.39 -30.43 71.56 Favored 'General case' 0 C--O 1.214 -0.789 0 O-C-N 125.329 1.643 . . . . 0.0 107.867 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 -68.16 -65.26 0.72 Allowed 'General case' 0 C--O 1.218 -0.6 0 C-N-CA 115.064 -2.654 . . . . 0.0 109.245 179.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.903 ' HB2' HG22 ' A' ' 58' ' ' ILE . 7.9 mtm-85 -139.81 170.88 15.07 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 123.98 3.082 . . . . 0.0 110.733 179.45 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -116.87 70.71 0.78 Allowed 'General case' 0 C--O 1.217 -0.636 1 N-CA-C 100.083 -4.043 . . . . 0.0 100.083 179.573 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.903 HG22 ' HB2' ' A' ' 56' ' ' ARG . 0.5 OUTLIER -107.05 91.41 1.76 Allowed 'Isoleucine or valine' 0 CA--C 1.561 1.382 0 C-N-CA 130.312 3.445 . . . . 0.0 117.432 -179.336 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -60.95 116.53 4.55 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 104.768 -2.308 . . . . 0.0 104.768 179.052 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.522 HG13 ' O ' ' A' ' 60' ' ' VAL . 13.3 p -104.0 105.75 19.02 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 O-C-N 124.64 1.212 . . . . 0.0 112.73 -178.132 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.812 HG12 ' HB ' ' A' ' 48' ' ' THR 0.412 0.6 OUTLIER -82.44 152.3 4.05 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 O-C-N 118.676 -2.515 . . . . 0.0 109.317 179.797 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.641 ' CE1' ' CZ2' ' A' ' 82' ' ' TRP . 16.4 p90 -162.45 95.39 0.92 Allowed 'General case' 0 N--CA 1.445 -0.722 0 O-C-N 120.55 -1.344 . . . . 0.0 108.991 179.694 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.52 ' OE1' HG11 ' A' ' 66' ' ' VAL . 1.8 mt-10 -65.96 128.95 38.08 Favored 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 104.053 -2.573 . . . . 0.0 104.053 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.449 HD21 ' CE2' ' A' ' 47' ' ' PHE . 0.4 OUTLIER -61.67 121.02 11.77 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-O 122.984 1.373 . . . . 0.0 110.857 -179.898 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 71.09 25.55 75.47 Favored Glycine 0 N--CA 1.471 0.981 0 N-CA-C 117.525 1.77 . . . . 0.0 117.525 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.52 HG11 ' OE1' ' A' ' 63' ' ' GLU 0.409 78.3 t -102.99 -21.0 5.4 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 CA-C-O 116.958 -1.496 . . . . 0.0 108.049 179.712 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.69 ' HA ' HG22 ' A' ' 81' ' ' THR 0.253 1.4 m-20 77.41 145.02 0.08 Allowed 'General case' 0 C--N 1.307 -1.279 0 O-C-N 126.081 2.113 . . . . 0.0 113.044 179.896 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.525 ' CZ ' ' HB3' ' A' ' 62' ' ' PHE . 0.1 OUTLIER -167.25 177.0 6.37 Favored 'General case' 0 N--CA 1.419 -2.02 0 CA-C-N 119.691 1.132 . . . . 0.0 108.189 179.874 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -128.79 132.04 47.84 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 117.41 -1.281 . . . . 0.0 109.717 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 16.2 t80 -125.77 111.52 14.98 Favored 'General case' 0 N--CA 1.435 -1.206 0 O-C-N 125.46 1.725 . . . . 0.0 114.231 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.1 m -73.74 145.13 45.36 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 123.089 2.677 . . . . 0.0 106.699 179.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.688 HD21 HD13 ' A' ' 78' ' ' LEU . 1.1 mt -107.43 -171.48 1.88 Allowed 'General case' 0 CA--C 1.495 -1.155 0 N-CA-C 106.072 -1.825 . . . . 0.0 106.072 -179.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -109.31 11.97 25.01 Favored 'General case' 0 C--O 1.235 0.336 0 O-C-N 126.64 2.463 . . . . 0.0 114.822 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -132.12 -38.59 1.09 Allowed 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 113.499 0.926 . . . . 0.0 113.499 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -130.11 -4.7 4.51 Favored Glycine 0 CA--C 1.538 1.518 0 N-CA-C 117.252 1.661 . . . . 0.0 117.252 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . 0.363 0.0 OUTLIER 67.5 171.24 0.27 Allowed 'General case' 0 N--CA 1.441 -0.879 0 C-N-CA 116.793 -1.963 . . . . 0.0 113.35 179.953 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.446 ' HB2' HG22 ' A' ' 96' ' ' VAL . 9.7 mt-10 12.02 111.37 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.891 1 O-C-N 130.192 4.682 . . . . 0.0 115.085 179.626 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.688 HD13 HD21 ' A' ' 72' ' ' LEU 0.406 0.7 OUTLIER -145.7 104.81 3.91 Favored 'General case' 0 C--O 1.219 -0.547 0 N-CA-C 101.863 -3.384 . . . . 0.0 101.863 179.939 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 24.1 m -106.27 170.79 7.71 Favored 'General case' 0 CA--C 1.483 -1.597 0 CA-C-N 113.658 -1.61 . . . . 0.0 106.691 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 154.27 -171.45 32.82 Favored Glycine 0 N--CA 1.441 -0.98 0 C-N-CA 117.03 -2.509 . . . . 0.0 111.837 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.69 HG22 ' HA ' ' A' ' 67' ' ' ASP . 44.1 p -144.1 160.89 40.13 Favored 'General case' 0 C--O 1.199 -1.584 0 C-N-CA 117.701 -1.6 . . . . 0.0 109.899 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . 0.641 ' CZ2' ' CE1' ' A' ' 62' ' ' PHE . 10.5 m0 -101.94 156.51 17.49 Favored 'General case' 0 N--CA 1.426 -1.648 0 N-CA-C 102.055 -3.313 . . . . 0.0 102.055 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 3.2 t -150.42 124.18 9.19 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 117.751 -1.58 . . . . 0.0 106.932 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.472 ' HA ' HD23 ' A' ' 89' ' ' LEU . 0.3 OUTLIER -84.32 111.68 19.63 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 112.714 -2.039 . . . . 0.0 111.733 -179.911 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.478 ' HG3' ' CG2' ' A' ' 90' ' ' VAL 0.573 5.0 mt-10 -67.95 -49.69 60.29 Favored 'General case' 0 N--CA 1.421 -1.905 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -179.755 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 161.55 -61.2 0.29 Allowed Glycine 0 C--O 1.216 -1.028 0 N-CA-C 103.283 -3.927 . . . . 0.0 103.283 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -110.04 8.04 23.85 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 125.66 1.447 . . . . 0.0 113.675 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . 0.317 0.0 OUTLIER -156.87 126.73 6.29 Favored 'General case' 0 CA--C 1.503 -0.864 0 O-C-N 126.551 2.407 . . . . 0.0 107.571 179.953 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.513 HD13 ' CE3' ' A' ' 82' ' ' TRP . 1.2 mt -83.6 147.8 27.52 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 111.329 -2.669 . . . . 0.0 103.953 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.478 ' CG2' ' HG3' ' A' ' 85' ' ' GLU . 0.2 OUTLIER -137.35 133.54 46.6 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.889 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 -179.994 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -111.56 103.6 1.57 Allowed Glycine 0 CA--C 1.528 0.9 0 C-N-CA 125.649 1.595 . . . . 0.0 113.35 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 37.8 mtpt -98.65 118.57 35.66 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 102.935 -2.987 . . . . 0.0 102.935 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.456 ' HB3' ' HG ' ' A' ' 78' ' ' LEU . 15.6 m-85 -122.9 115.23 21.59 Favored 'General case' 0 CA--C 1.501 -0.916 0 O-C-N 126.416 2.322 . . . . 0.0 111.521 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 19.9 mttp -98.47 140.45 32.7 Favored 'General case' 0 CA--C 1.505 -0.762 0 CA-C-O 125.192 2.425 . . . . 0.0 108.434 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . 0.407 15.3 ttt180 -97.15 129.74 44.49 Favored 'General case' 0 CA--C 1.487 -1.475 0 CA-C-O 124.031 1.872 . . . . 0.0 106.102 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.501 HG23 ' N ' ' A' ' 97' ' ' ASP . 14.7 m -69.77 -34.73 62.04 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.934 0 CA-C-O 125.551 2.596 . . . . 0.0 114.675 -179.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.501 ' N ' HG23 ' A' ' 96' ' ' VAL 0.401 0.9 OUTLIER -63.75 -8.36 10.3 Favored 'General case' 0 C--O 1.255 1.39 0 CA-C-N 113.936 -1.484 . . . . 0.0 114.377 179.814 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.468 ' ND2' ' HG2' ' A' ' 100' ' ' LYS . 13.3 p-10 -150.54 1.77 0.45 Allowed 'General case' 0 N--CA 1.433 -1.302 0 C-N-CA 116.196 -2.202 . . . . 0.0 116.732 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 65.83 21.94 69.79 Favored Glycine 0 CA--C 1.542 1.774 0 N-CA-C 115.673 1.029 . . . . 0.0 115.673 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.468 ' HG2' ' ND2' ' A' ' 98' ' ' ASN . 49.0 mmtt -89.68 -178.82 5.63 Favored 'General case' 0 C--O 1.202 -1.417 0 C-N-CA 119.823 -0.751 . . . . 0.0 112.802 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -143.48 119.42 10.63 Favored 'General case' 0 C--O 1.212 -0.885 0 C-N-CA 128.264 2.626 . . . . 0.0 113.866 179.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.64 ' HG ' ' HA ' ' A' ' 119' ' ' TYR . 5.5 tt -98.37 133.76 42.32 Favored 'General case' 0 N--CA 1.44 -0.972 1 C-N-CA 135.337 5.455 . . . . 0.0 106.211 -179.679 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.618 HG23 ' HB3' ' A' ' 117' ' ' TYR . 7.1 tt -122.55 159.29 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.702 0 C-N-CA 115.855 -2.338 . . . . 0.0 104.726 179.489 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -156.39 145.54 20.49 Favored 'General case' 0 C--N 1.315 -0.902 0 O-C-N 118.844 -2.41 . . . . 0.0 107.542 -179.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.684 HG13 ' HG2' ' A' ' 107' ' ' GLU . 6.4 p -131.66 115.12 26.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-O 126.078 2.847 . . . . 0.0 110.287 -179.527 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.586 ' CZ ' ' CH2' ' A' ' 82' ' ' TRP . 2.3 mtt-85 -76.44 90.48 3.26 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 112.299 -2.228 . . . . 0.0 105.462 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.684 ' HG2' HG13 ' A' ' 105' ' ' VAL . 1.2 mt-10 -86.66 77.62 9.31 Favored 'General case' 0 N--CA 1.419 -2.015 0 CA-C-N 109.985 -3.28 . . . . 0.0 114.928 -179.682 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.583 HG13 ' CZ ' ' A' ' 2' ' ' PHE 0.257 0.6 OUTLIER -54.94 90.75 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 CA-C-O 122.931 1.348 . . . . 0.0 111.417 179.264 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.459 ' N ' ' O ' ' A' ' 107' ' ' GLU . 23.9 m -80.97 66.99 6.71 Favored 'General case' 0 N--CA 1.432 -1.339 0 N-CA-C 103.822 -2.659 . . . . 0.0 103.822 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 52.7 -90.97 0.01 OUTLIER Glycine 0 N--CA 1.463 0.493 1 O-C-N 129.191 4.057 . . . . 0.0 111.113 -179.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . 0.322 4.5 m120 -82.29 -25.89 33.6 Favored 'General case' 0 C--N 1.309 -1.196 0 CA-C-O 115.935 -1.983 . . . . 0.0 110.675 179.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -110.28 125.63 53.33 Favored 'General case' 0 C--O 1.205 -1.256 0 N-CA-C 115.878 1.807 . . . . 0.0 115.878 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.456 HD21 ' HB3' ' A' ' 106' ' ' ARG . 0.0 OUTLIER -87.04 143.6 27.26 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 100.633 -3.84 . . . . 0.0 100.633 179.983 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.8 HG23 HD13 ' A' ' 127' ' ' ILE 0.312 0.6 OUTLIER -142.13 136.57 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.585 0 N-CA-C 105.067 -2.197 . . . . 0.0 105.067 179.989 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . 0.439 HE21 ' HE1' ' A' ' 128' ' ' PHE . 49.6 mt-30 -109.54 123.24 49.08 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 100.926 -3.731 . . . . 0.0 100.926 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.52 HG23 ' HG3' ' A' ' 107' ' ' GLU . 0.1 OUTLIER -135.39 147.73 49.12 Favored 'General case' 0 N--CA 1.417 -2.11 0 C-N-CA 118.091 -1.443 . . . . 0.0 111.829 -179.12 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.618 ' HB3' HG23 ' A' ' 103' ' ' ILE 0.352 18.5 m-85 127.81 -144.95 0.0 OUTLIER 'General case' 0 CA--C 1.471 -2.08 1 O-C-N 131.892 5.745 . . . . 0.0 113.945 177.656 . . . . . . . . 4 3 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.528 ' O ' ' N ' ' A' ' 103' ' ' ILE . 7.9 t -150.13 -159.84 1.09 Allowed 'General case' 0 N--CA 1.437 -1.086 0 CA-C-O 125.825 2.726 . . . . 0.0 116.789 -174.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.64 ' HA ' ' HG ' ' A' ' 102' ' ' LEU 0.25 38.1 t80 -108.5 -31.55 7.75 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 112.436 -2.165 . . . . 0.0 108.791 177.428 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -148.16 -70.91 0.22 Allowed 'General case' 0 C--N 1.291 -1.955 0 C-N-CA 126.862 2.065 . . . . 0.0 109.605 179.112 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -147.3 18.55 1.52 Allowed Glycine 0 C--N 1.351 1.388 0 N-CA-C 120.887 3.115 . . . . 0.0 120.887 -179.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 50.7 t -117.24 93.08 2.35 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 N-CA-C 103.547 -2.76 . . . . 0.0 103.547 179.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.456 ' HA ' ' O ' ' A' ' 117' ' ' TYR . 6.6 mt-10 -57.99 178.82 0.08 Allowed 'General case' 0 CA--C 1.513 -0.467 0 CA-C-O 124.021 1.867 . . . . 0.0 112.368 -178.191 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.536 ' HB1' ' HA ' ' A' ' 14' ' ' TYR . . . -172.58 104.26 0.15 Allowed 'General case' 0 N--CA 1.436 -1.138 0 O-C-N 116.535 -3.853 . . . . 0.0 109.453 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.27 141.33 33.03 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 119.804 1.184 . . . . 0.0 108.997 179.49 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.566 ' CG ' ' CD2' ' A' ' 14' ' ' TYR . 3.8 mtp180 -129.13 79.21 1.9 Allowed 'General case' 0 C--O 1.214 -0.798 0 CA-C-O 116.126 -1.892 . . . . 0.0 110.509 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.8 HD13 HG23 ' A' ' 114' ' ' ILE . 3.8 mm -65.29 118.23 7.38 Favored 'Isoleucine or valine' 0 C--O 1.256 1.429 1 O-C-N 130.35 4.781 . . . . 0.0 115.201 179.64 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.479 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 80.6 m-85 -104.67 137.46 42.46 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 126.362 1.865 . . . . 0.0 108.072 -179.616 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . 0.363 0.6 OUTLIER -108.93 42.57 1.39 Allowed 'General case' 0 N--CA 1.439 -1.025 0 CA-C-O 116.475 -1.726 . . . . 0.0 111.47 -179.964 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.514 ' HA ' ' CE3' ' A' ' 6' ' ' TRP . 0.0 OUTLIER 21.63 101.16 0.0 OUTLIER 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 128.404 2.682 . . . . 0.0 116.472 -179.904 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . 0.934 16.5 tt0 . . . . . 0 C--N 1.32 -0.697 0 N-CA-C 115.882 1.808 . . . . 0.0 115.882 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . 0.554 ' CE1' HG13 ' A' ' 108' ' ' ILE . 2.5 m-85 . . . . . 0 N--CA 1.434 -1.255 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -49.53 95.11 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.362 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 155.33 178.98 30.12 Favored Glycine 0 N--CA 1.441 -0.982 0 C-N-CA 118.024 -2.036 . . . . 0.0 112.324 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . 0.531 1.3 p -86.1 147.93 25.93 Favored 'General case' 0 C--N 1.312 -1.041 0 C-N-CA 124.82 1.248 . . . . 0.0 108.46 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.524 ' CH2' ' HD2' ' A' ' 130' ' ' LYS . 74.9 m95 -143.29 140.24 30.52 Favored 'General case' 0 CA--C 1.504 -0.804 0 CA-C-O 115.202 -2.332 . . . . 0.0 105.961 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 18.5 tttt -144.34 92.77 2.35 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 114.398 -2.715 . . . . 0.0 105.838 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.532 ' HB ' ' CD1' ' A' ' 128' ' ' PHE 0.258 7.4 p -34.38 128.13 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.16 0 CA-C-O 116.426 -1.749 . . . . 0.0 113.054 -179.998 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -126.35 -22.8 3.94 Favored 'General case' 0 N--CA 1.451 -0.406 0 O-C-N 125.922 2.014 . . . . 0.0 111.335 -179.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.427 ' HD2' ' HE3' ' A' ' 129' ' ' LYS . 0.0 OUTLIER -141.36 63.7 1.43 Allowed 'General case' 0 CA--C 1.49 -1.362 0 C-N-CA 118.758 -1.177 . . . . 0.0 113.409 -179.78 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . 0.473 16.4 m-20 -48.23 156.27 0.41 Allowed 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 124.023 0.929 . . . . 0.0 108.733 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.44 ' HB2' ' HB2' ' A' ' 125' ' ' LYS . 11.6 mt-10 -143.76 136.94 27.71 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-O 115.77 -2.062 . . . . 0.0 107.294 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.418 ' HB3' ' HA ' ' A' ' 124' ' ' ALA . 1.0 OUTLIER 53.76 20.7 2.36 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 122.127 2.239 . . . . 0.0 113.238 -179.691 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.547 ' HA ' ' HB1' ' A' ' 124' ' ' ALA 0.261 4.3 t80 -79.81 -35.81 37.88 Favored 'General case' 0 N--CA 1.442 -0.873 0 O-C-N 126.592 2.433 . . . . 0.0 114.858 179.529 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -77.37 -24.14 50.67 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 116.849 -1.548 . . . . 0.0 108.886 -179.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 8.3 ttmm -78.52 -29.41 46.51 Favored 'General case' 0 N--CA 1.431 -1.387 0 O-C-N 126.012 2.07 . . . . 0.0 111.669 179.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.491 ' CB ' ' HB2' ' A' ' 124' ' ' ALA . 0.2 OUTLIER -69.25 -34.98 75.64 Favored 'General case' 0 N--CA 1.429 -1.516 0 O-C-N 120.384 -1.448 . . . . 0.0 112.065 179.914 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 10.8 mtt -75.76 -26.49 57.44 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-O 124.903 2.287 . . . . 0.0 109.232 -179.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -79.61 -25.34 41.51 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 124.682 2.182 . . . . 0.0 112.347 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.555 ' HE3' ' CG ' ' A' ' 119' ' ' TYR . 3.5 tmtm? -70.61 -30.52 67.2 Favored 'General case' 0 C--O 1.209 -1.063 0 O-C-N 118.23 -2.794 . . . . 0.0 112.864 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -79.95 -33.86 39.28 Favored 'General case' 0 C--O 1.215 -0.745 0 O-C-N 126.132 2.145 . . . . 0.0 108.86 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 108.07 37.53 2.15 Favored Glycine 0 C--N 1.306 -1.1 0 CA-C-O 116.051 -2.527 . . . . 0.0 111.862 -179.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.5 mm -70.31 84.68 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.909 0 CA-C-O 113.253 -3.26 . . . . 0.0 105.033 179.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 10.9 m-20 -3.29 -90.07 0.0 OUTLIER 'General case' 0 C--O 1.247 0.933 0 O-C-N 128.484 3.615 . . . . 0.0 115.24 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . 0.359 20.3 m -155.86 -49.98 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.221 -0.419 0 N-CA-C 117.416 2.376 . . . . 0.0 117.416 179.716 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.569 14.4 m -76.4 -23.01 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.277 0 N-CA-C 116.837 2.162 . . . . 0.0 116.837 179.633 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.9 mtpt -74.98 -25.55 58.93 Favored 'General case' 0 N--CA 1.437 -1.1 0 O-C-N 127.253 2.845 . . . . 0.0 113.175 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.37 -22.22 44.69 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 118.317 -1.353 . . . . 0.0 108.784 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.7 ttpt -65.27 -50.35 66.1 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 122.251 1.024 . . . . 0.0 112.551 -179.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.453 ' HA ' HD12 ' A' ' 30' ' ' LEU . 0.7 OUTLIER -76.01 -24.45 55.26 Favored 'General case' 0 C--O 1.214 -0.775 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 179.745 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -76.32 -31.56 54.38 Favored Glycine 0 N--CA 1.441 -1.021 0 O-C-N 128.643 3.714 . . . . 0.0 109.832 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -76.94 -38.99 52.27 Favored 'General case' 0 C--O 1.242 0.692 0 O-C-N 125.379 1.281 . . . . 0.0 111.026 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -108.07 47.54 0.89 Allowed 'General case' 0 N--CA 1.433 -1.277 0 CA-C-O 116.646 -1.645 . . . . 0.0 111.077 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -70.12 -37.23 75.27 Favored 'General case' 0 CA--C 1.495 -1.162 0 N-CA-C 118.63 2.826 . . . . 0.0 118.63 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . 0.262 0.1 OUTLIER 81.86 28.77 0.15 Allowed 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 117.709 -1.138 . . . . 0.0 110.629 -179.999 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 1.018 HD21 HD13 ' A' ' 38' ' ' LEU . 0.5 OUTLIER -48.41 94.74 0.01 OUTLIER 'General case' 0 CA--C 1.507 -0.693 0 C-N-CA 125.05 1.34 . . . . 0.0 108.51 -179.866 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 10.3 tttt -96.92 101.94 13.63 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 102.555 -3.128 . . . . 0.0 102.555 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 1.018 HD13 HD21 ' A' ' 36' ' ' LEU 0.322 2.1 tp -87.33 130.56 34.58 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 119.86 1.209 . . . . 0.0 110.157 -179.915 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.523 ' HB ' ' CB ' ' A' ' 50' ' ' LYS . 69.3 m -119.25 98.66 6.27 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 102.451 -3.166 . . . . 0.0 102.451 179.607 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 1.084 HG23 HG12 ' A' ' 49' ' ' VAL . 1.1 mt -91.42 141.01 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.368 0 CA-C-O 123.661 1.696 . . . . 0.0 111.121 179.595 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.507 HG22 ' O ' ' A' ' 41' ' ' THR . 3.2 m -133.46 93.02 3.07 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 111.04 -2.8 . . . . 0.0 108.45 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -80.31 100.99 8.66 Favored 'General case' 0 C--O 1.218 -0.588 0 O-C-N 125.723 1.89 . . . . 0.0 110.635 179.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -103.48 67.2 0.9 Allowed 'General case' 0 N--CA 1.436 -1.159 0 CA-C-O 125.635 2.636 . . . . 0.0 108.559 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 90.01 -101.03 2.73 Favored Glycine 0 C--N 1.302 -1.353 0 N-CA-C 108.107 -1.997 . . . . 0.0 108.107 179.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.314 83.5 m-20 -111.52 -13.04 13.89 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 128.321 3.012 . . . . 0.0 111.041 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.478 ' HA ' ' HA ' ' A' ' 63' ' ' GLU . 10.8 tttt -82.27 143.91 31.0 Favored 'General case' 0 C--N 1.31 -1.123 0 O-C-N 118.363 -2.711 . . . . 0.0 108.071 179.714 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.714 ' CE1' HD21 ' A' ' 64' ' ' LEU . 18.3 m-85 -122.52 86.59 2.61 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 113.845 -1.525 . . . . 0.0 110.982 179.693 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.761 ' OG1' HG12 ' A' ' 61' ' ' VAL 0.336 9.5 t -91.76 104.28 16.75 Favored 'General case' 0 C--N 1.316 -0.882 0 O-C-N 126.796 2.56 . . . . 0.0 106.321 179.914 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 1.084 HG12 HG23 ' A' ' 40' ' ' ILE 0.702 0.7 OUTLIER -100.62 116.76 44.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 126.965 2.665 . . . . 0.0 116.401 -179.685 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.523 ' CB ' ' HB ' ' A' ' 39' ' ' THR . 26.7 tttp -62.81 149.57 43.81 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 101.018 -3.697 . . . . 0.0 101.018 179.279 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.41 ' O ' ' N ' ' A' ' 53' ' ' SER . 49.4 tt0 -137.21 64.26 1.54 Allowed 'General case' 0 CA--C 1.511 -0.531 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 -179.487 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . 0.256 5.6 m -74.88 73.97 2.13 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 105.16 -2.163 . . . . 0.0 105.16 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.545 ' HB2' HD12 ' A' ' 36' ' ' LEU . 33.1 t -102.82 25.35 9.38 Favored 'General case' 0 CA--C 1.506 -0.715 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 -179.782 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.513 ' ND2' ' N ' ' A' ' 55' ' ' PHE . 0.0 OUTLIER 78.31 -48.23 0.46 Allowed 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 115.272 -2.299 . . . . 0.0 108.988 179.857 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.513 ' N ' ' ND2' ' A' ' 54' ' ' ASN . 96.9 m-85 -58.86 -45.1 90.94 Favored 'General case' 0 C--O 1.213 -0.849 0 C-N-CA 117.428 -1.709 . . . . 0.0 110.373 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.415 ' NE ' ' HB ' ' A' ' 58' ' ' ILE . 49.0 ttt180 -168.92 144.39 3.33 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 105.668 -1.975 . . . . 0.0 105.668 179.21 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 26.8 t30 -93.1 78.21 4.6 Favored 'General case' 0 C--N 1.35 0.621 0 N-CA-C 101.642 -3.466 . . . . 0.0 101.642 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.415 ' HB ' ' NE ' ' A' ' 56' ' ' ARG . 3.0 tt -110.3 110.12 30.98 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.338 1 O-C-N 130.01 4.569 . . . . 0.0 117.728 -179.549 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -63.02 135.11 57.09 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 103.89 -2.633 . . . . 0.0 103.89 177.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.614 HG12 ' CD2' ' A' ' 62' ' ' PHE . 10.1 t -107.41 92.37 2.06 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 -178.18 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.761 HG12 ' OG1' ' A' ' 48' ' ' THR 0.358 0.7 OUTLIER -90.81 135.24 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.151 0 O-C-N 118.681 -2.512 . . . . 0.0 111.951 -179.761 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.614 ' CD2' HG12 ' A' ' 60' ' ' VAL . 24.4 p90 -166.05 97.25 0.62 Allowed 'General case' 0 C--N 1.314 -0.943 0 C-N-CA 118.151 -1.42 . . . . 0.0 110.296 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.478 ' HA ' ' HA ' ' A' ' 46' ' ' LYS . 1.0 OUTLIER -56.03 147.85 18.98 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 179.88 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.714 HD21 ' CE1' ' A' ' 47' ' ' PHE . 0.3 OUTLIER -62.55 99.4 0.15 Allowed 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 179.73 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 98.7 34.46 5.23 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 119.321 2.489 . . . . 0.0 119.321 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . 0.433 34.8 m -114.3 77.67 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 N-CA-C 104.618 -2.364 . . . . 0.0 104.618 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -35.16 103.21 0.03 OUTLIER 'General case' 0 CA--C 1.486 -1.481 0 O-C-N 126.803 2.564 . . . . 0.0 113.711 -179.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 28.9 p90 -116.52 174.97 5.78 Favored 'General case' 0 N--CA 1.423 -1.816 0 O-C-N 120.138 -1.601 . . . . 0.0 112.484 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -123.17 126.07 46.31 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 128.828 3.83 . . . . 0.0 105.488 179.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -121.56 -42.34 2.44 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-O 115.82 -2.038 . . . . 0.0 114.356 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.9 m 72.61 143.17 0.06 Allowed 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 105.95 -1.87 . . . . 0.0 105.95 -179.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.573 HD11 HD13 ' A' ' 78' ' ' LEU . 1.2 mp -95.95 -164.17 1.13 Allowed 'General case' 0 C--N 1.301 -1.509 0 CA-C-N 114.779 -1.101 . . . . 0.0 108.719 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -89.11 -48.75 7.19 Favored 'General case' 0 C--O 1.211 -0.964 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.117 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -129.01 12.94 6.22 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-O 115.557 -2.163 . . . . 0.0 109.633 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.45 ' C ' HG23 ' A' ' 76' ' ' THR . . . -107.29 -8.93 30.37 Favored Glycine 0 CA--C 1.546 1.998 0 CA-C-O 117.463 -1.743 . . . . 0.0 116.924 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.554 ' O ' HD12 ' A' ' 72' ' ' LEU 0.377 0.1 OUTLIER 89.3 -164.08 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 114.696 -2.574 . . . . 0.0 113.97 179.946 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.669 ' CB ' HG22 ' A' ' 96' ' ' VAL . 0.5 OUTLIER -62.21 140.64 58.45 Favored 'General case' 0 C--N 1.318 -0.78 1 O-C-N 129.529 4.268 . . . . 0.0 114.891 179.914 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.573 HD13 HD11 ' A' ' 72' ' ' LEU 0.399 11.1 tp -143.83 128.77 18.47 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 102.416 -3.179 . . . . 0.0 102.416 179.872 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 87.1 m -146.45 121.88 10.34 Favored 'General case' 0 CA--C 1.487 -1.461 0 N-CA-C 103.691 -2.707 . . . . 0.0 103.691 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -166.0 -146.49 4.84 Favored Glycine 0 C--N 1.297 -1.638 0 C-N-CA 114.576 -3.678 . . . . 0.0 110.949 -179.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 72.5 p -152.27 171.35 18.11 Favored 'General case' 0 CA--C 1.472 -2.048 0 O-C-N 125.632 1.431 . . . . 0.0 107.494 -179.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . 0.489 ' CE3' ' N ' ' A' ' 91' ' ' GLY . 24.2 m95 -125.03 139.72 53.55 Favored 'General case' 0 N--CA 1.429 -1.524 0 N-CA-C 103.703 -2.703 . . . . 0.0 103.703 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 10.1 t -147.32 149.44 32.83 Favored 'General case' 0 C--O 1.256 1.409 0 C-N-CA 119.051 -1.059 . . . . 0.0 111.445 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.8 130.04 34.93 Favored 'General case' 0 CA--C 1.494 -1.192 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 -179.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . 0.538 0.0 OUTLIER -110.41 60.26 0.61 Allowed 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 -179.854 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 73.07 -95.1 0.72 Allowed Glycine 0 N--CA 1.429 -1.817 0 CA-C-N 112.41 -2.177 . . . . 0.0 107.731 -179.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -94.66 12.33 28.07 Favored 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 115.151 1.537 . . . . 0.0 115.151 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . 0.404 4.2 mptt -140.28 175.7 9.38 Favored 'General case' 0 C--O 1.21 -1.013 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.474 ' HA ' HD23 ' A' ' 89' ' ' LEU . 0.3 OUTLIER -125.13 141.88 51.83 Favored 'General case' 0 CA--C 1.548 0.898 0 N-CA-C 101.578 -3.49 . . . . 0.0 101.578 -180.0 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 104' ' ' ALA . 7.6 p -133.82 119.73 33.9 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 O-C-N 125.505 1.753 . . . . 0.0 110.691 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.489 ' N ' ' CE3' ' A' ' 82' ' ' TRP . . . -93.31 103.07 2.99 Favored Glycine 0 N--CA 1.474 1.198 0 C-N-CA 127.532 2.492 . . . . 0.0 108.294 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -97.61 154.2 17.7 Favored 'General case' 0 CA--C 1.502 -0.895 0 N-CA-C 103.944 -2.613 . . . . 0.0 103.944 179.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.503 ' HB2' HD23 ' A' ' 102' ' ' LEU . 91.6 m-85 -151.54 118.47 5.84 Favored 'General case' 0 CA--C 1.502 -0.899 0 O-C-N 125.12 1.513 . . . . 0.0 111.253 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 25.0 mttm -93.76 152.29 19.03 Favored 'General case' 0 C--O 1.21 -0.986 0 CA-C-O 123.741 1.734 . . . . 0.0 107.669 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . 0.368 0.5 OUTLIER -115.62 121.8 43.69 Favored 'General case' 0 CA--C 1.488 -1.414 0 CA-C-N 114.983 -1.008 . . . . 0.0 108.953 179.914 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.669 HG22 ' CB ' ' A' ' 77' ' ' GLU . 23.4 m -62.52 -27.79 43.49 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 CA-C-O 125.264 2.459 . . . . 0.0 113.338 179.756 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . 0.31 2.4 m-20 -61.56 -10.17 7.48 Favored 'General case' 0 C--O 1.246 0.902 0 CA-C-N 113.55 -1.659 . . . . 0.0 113.34 179.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.479 ' ND2' ' N ' ' A' ' 98' ' ' ASN . 0.1 OUTLIER -169.89 15.28 0.02 OUTLIER 'General case' 0 N--CA 1.433 -1.287 0 N-CA-C 115.636 1.717 . . . . 0.0 115.636 179.929 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 55.13 21.22 24.29 Favored Glycine 0 CA--C 1.523 0.547 0 CA-C-O 123.635 1.686 . . . . 0.0 113.572 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp -78.25 -170.88 2.16 Favored 'General case' 0 C--O 1.199 -1.572 0 O-C-N 120.225 -1.75 . . . . 0.0 106.697 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -135.77 159.76 40.66 Favored 'General case' 0 CA--C 1.5 -0.971 0 O-C-N 127.808 3.193 . . . . 0.0 110.164 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.664 HD11 ' HD1' ' A' ' 117' ' ' TYR . 0.2 OUTLIER -146.22 149.58 34.19 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 131.648 3.979 . . . . 0.0 104.007 179.541 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.754 HD13 ' N ' ' A' ' 104' ' ' ALA . 0.0 OUTLIER -143.34 162.12 16.78 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.994 0 N-CA-C 106.657 -1.609 . . . . 0.0 106.657 -179.723 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.754 ' N ' HD13 ' A' ' 103' ' ' ILE . . . -149.67 143.57 25.58 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-O 114.965 -2.445 . . . . 0.0 106.567 179.52 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.453 HG12 ' OG1' ' A' ' 116' ' ' THR . 2.9 p -126.24 105.52 14.53 Favored 'Isoleucine or valine' 0 C--O 1.257 1.466 0 CA-C-N 121.647 2.021 . . . . 0.0 108.15 -179.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.537 HH22 ' HZ ' ' A' ' 62' ' ' PHE . 63.6 mtt180 -67.79 90.29 0.28 Allowed 'General case' 0 CA--C 1.502 -0.883 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -83.69 78.57 9.67 Favored 'General case' 0 N--CA 1.433 -1.282 0 N-CA-C 116.639 2.089 . . . . 0.0 116.639 179.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.78 ' CG1' HD12 ' A' ' 113' ' ' LEU . 0.8 OUTLIER -68.52 101.33 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 C-N-CA 113.784 -3.167 . . . . 0.0 108.882 179.742 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.26 -29.78 69.5 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 114.199 -1.364 . . . . 0.0 107.536 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 154.01 -71.89 0.27 Allowed Glycine 0 C--O 1.243 0.715 1 C-N-CA 130.723 4.011 . . . . 0.0 111.583 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . 0.362 6.9 m120 -97.71 3.27 50.23 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 115.497 -2.192 . . . . 0.0 110.418 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -133.15 118.73 19.02 Favored 'General case' 0 CA--C 1.502 -0.867 0 O-C-N 128.005 3.315 . . . . 0.0 114.098 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.78 HD12 ' CG1' ' A' ' 108' ' ' ILE . 0.9 OUTLIER -97.29 94.22 6.97 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 103.214 -2.884 . . . . 0.0 103.214 179.821 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.501 HG12 HG23 ' A' ' 127' ' ' ILE . 77.2 mt -91.17 143.82 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.114 0 N-CA-C 103.419 -2.808 . . . . 0.0 103.419 179.655 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -132.8 108.17 8.81 Favored 'General case' 0 CA--C 1.49 -1.361 0 O-C-N 124.741 1.276 . . . . 0.0 109.136 -179.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.453 ' OG1' HG12 ' A' ' 105' ' ' VAL . 20.3 p -72.33 173.8 8.2 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 105.371 -2.085 . . . . 0.0 105.371 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.664 ' HD1' HD11 ' A' ' 102' ' ' LEU . 8.0 m-85 -162.78 114.38 1.54 Allowed 'General case' 0 CA--C 1.477 -1.847 0 CA-C-O 117.192 -1.385 . . . . 0.0 113.734 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . 0.264 1.2 m -126.57 122.3 34.72 Favored 'General case' 0 N--CA 1.424 -1.766 0 O-C-N 127.267 2.854 . . . . 0.0 110.961 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.555 ' CG ' ' HE3' ' A' ' 20' ' ' LYS . 1.4 t80 -85.85 -25.2 26.37 Favored 'General case' 0 N--CA 1.476 0.831 0 O-C-N 126.49 2.369 . . . . 0.0 107.064 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -161.97 -75.14 0.05 Allowed 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 112.522 -2.126 . . . . 0.0 113.573 -179.767 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -139.74 25.57 2.69 Favored Glycine 0 CA--C 1.537 1.463 0 N-CA-C 120.408 2.923 . . . . 0.0 120.408 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 22.0 t -133.02 102.87 5.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 105.219 -2.141 . . . . 0.0 105.219 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -75.94 165.69 24.61 Favored 'General case' 0 C--O 1.206 -1.195 0 CA-C-O 124.344 2.021 . . . . 0.0 108.82 -179.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.547 ' HB1' ' HA ' ' A' ' 14' ' ' TYR . . . -161.02 101.18 1.26 Allowed 'General case' 0 N--CA 1.435 -1.209 0 CA-C-O 114.488 -2.673 . . . . 0.0 107.854 -179.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.44 ' HB2' ' HB2' ' A' ' 12' ' ' GLU 0.288 5.3 mptt -77.95 146.03 35.72 Favored 'General case' 0 N--CA 1.449 -0.513 0 O-C-N 127.228 2.83 . . . . 0.0 110.519 179.738 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.45 ' NH2' HD13 ' A' ' 36' ' ' LEU . 0.0 OUTLIER -133.18 83.03 2.03 Favored 'General case' 0 C--O 1.212 -0.919 0 CA-C-O 114.955 -2.45 . . . . 0.0 106.845 179.823 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.501 HG23 HG12 ' A' ' 114' ' ' ILE . 1.9 mm -74.15 104.14 2.69 Favored 'Isoleucine or valine' 0 C--O 1.25 1.097 1 O-C-N 131.042 5.213 . . . . 0.0 117.381 179.808 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.712 ' CE2' HD22 ' A' ' 38' ' ' LEU . 0.7 OUTLIER -94.98 140.85 29.38 Favored 'General case' 0 CA--C 1.516 -0.361 0 O-C-N 124.565 1.166 . . . . 0.0 108.463 -179.813 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.427 ' HE3' ' HD2' ' A' ' 10' ' ' ARG . 27.7 mmtt -102.88 9.11 39.03 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-O 116.444 -1.741 . . . . 0.0 110.848 179.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.524 ' HD2' ' CH2' ' A' ' 6' ' ' TRP . 2.8 tttt 64.32 110.69 0.03 OUTLIER 'General case' 0 C--O 1.237 0.407 0 O-C-N 124.99 1.431 . . . . 0.0 113.67 -179.788 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . 0.746 1.9 mt-10 . . . . . 0 N--CA 1.438 -1.068 0 C-N-CA 118.422 -1.311 . . . . 0.0 114.066 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.442 -0.872 0 N-CA-C 114.239 1.2 . . . . 0.0 114.239 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -158.91 90.54 0.99 Allowed 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 114.03 -1.441 . . . . 0.0 112.395 -179.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 142.0 174.72 14.86 Favored Glycine 0 N--CA 1.439 -1.155 0 C-N-CA 114.477 -3.725 . . . . 0.0 114.459 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.601 ' HA ' ' HA ' ' A' ' 39' ' ' THR 0.705 3.3 t -58.3 151.86 18.67 Favored 'General case' 0 C--N 1.319 -0.734 0 O-C-N 127.169 2.335 . . . . 0.0 111.181 -179.664 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.714 ' HH2' HD11 ' A' ' 108' ' ' ILE . 92.2 m95 -147.51 93.35 2.21 Favored 'General case' 0 N--CA 1.429 -1.515 0 O-C-N 127.945 3.278 . . . . 0.0 105.774 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 15.3 tttt -99.76 100.13 11.04 Favored 'General case' 0 CA--C 1.505 -0.785 0 CA-C-O 116.986 -1.483 . . . . 0.0 111.158 -179.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.51 ' HA ' ' HA ' ' A' ' 128' ' ' PHE 0.305 2.2 p -45.71 131.8 2.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 117.402 -1.285 . . . . 0.0 112.36 -179.745 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -133.64 -38.61 0.91 Allowed 'General case' 0 N--CA 1.445 -0.678 0 O-C-N 126.886 2.616 . . . . 0.0 111.476 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.465 ' HB2' ' CG1' ' A' ' 127' ' ' ILE . 0.2 OUTLIER -81.83 -69.71 0.6 Allowed 'General case' 0 N--CA 1.432 -1.329 0 C-N-CA 119.048 -1.061 . . . . 0.0 112.771 -179.587 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 71.56 146.92 0.07 Allowed 'General case' 0 C--O 1.245 0.826 0 O-C-N 125.817 1.948 . . . . 0.0 107.182 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.411 ' O ' ' N ' ' A' ' 125' ' ' LYS . 0.4 OUTLIER -156.65 147.36 21.7 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 115.807 -2.044 . . . . 0.0 107.901 -179.363 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.7 t30 46.07 27.08 0.48 Allowed 'General case' 0 N--CA 1.478 0.96 0 O-C-N 125.124 1.515 . . . . 0.0 113.065 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.563 ' CE1' ' HB1' ' A' ' 32' ' ' ALA . 10.7 p90 -81.52 -34.08 31.42 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 118.508 2.781 . . . . 0.0 118.508 -179.382 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -72.75 -39.93 66.44 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-N 120.445 1.475 . . . . 0.0 110.16 179.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.53 -34.84 76.57 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 125.17 2.414 . . . . 0.0 113.218 -179.757 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.731 ' CB ' ' HB2' ' A' ' 124' ' ' ALA . 0.2 OUTLIER -68.58 -28.05 66.6 Favored 'General case' 0 N--CA 1.431 -1.381 0 O-C-N 119.022 -2.298 . . . . 0.0 110.945 -179.981 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 1.5 mmt -77.3 -31.25 54.62 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 179.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -77.92 -20.71 52.35 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 126.484 3.04 . . . . 0.0 109.744 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 42.4 tptt -78.29 -39.92 38.41 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 112.686 -2.052 . . . . 0.0 108.93 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.46 ' HG3' ' CE1' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -73.18 -20.88 60.8 Favored 'General case' 0 CA--C 1.511 -0.556 0 O-C-N 119.552 -1.968 . . . . 0.0 108.273 179.92 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 97.96 46.73 2.2 Favored Glycine 0 N--CA 1.434 -1.488 0 CA-C-O 114.168 -3.573 . . . . 0.0 110.937 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.472 HG22 ' N ' ' A' ' 24' ' ' ASN . 2.1 mm -93.6 176.8 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 O-C-N 129.269 3.57 . . . . 0.0 106.319 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.472 ' N ' HG22 ' A' ' 23' ' ' ILE . 2.8 m-80 -113.43 -178.61 3.42 Favored 'General case' 0 C--N 1.348 0.519 0 CA-C-O 115.156 -2.354 . . . . 0.0 110.849 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . 0.347 0.6 OUTLIER -55.91 -49.23 76.31 Favored 'Isoleucine or valine' 0 C--N 1.352 0.716 0 O-C-N 128.606 3.691 . . . . 0.0 113.659 179.605 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.65 1.1 m -74.11 -41.89 51.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 O-C-N 127.056 2.722 . . . . 0.0 116.108 -179.702 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.457 ' HB3' HG23 ' A' ' 23' ' ' ILE . 2.6 mtmp? -66.2 -34.46 78.08 Favored 'General case' 0 CA--C 1.507 -0.695 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 -179.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.426 ' CG ' HH11 ' A' ' 28' ' ' ARG . 0.0 OUTLIER -79.94 -27.56 39.81 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 125.361 2.505 . . . . 0.0 108.524 179.777 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.3 tmmm? -71.08 -52.92 16.65 Favored 'General case' 0 C--N 1.353 0.743 0 O-C-N 119.64 -1.912 . . . . 0.0 110.237 -179.538 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 34.5 mt -72.65 -28.93 63.03 Favored 'General case' 0 N--CA 1.445 -0.698 0 O-C-N 120.247 -1.533 . . . . 0.0 108.416 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -70.21 -31.29 69.07 Favored Glycine 0 CA--C 1.537 1.408 0 O-C-N 127.365 2.916 . . . . 0.0 110.169 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.563 ' HB1' ' CE1' ' A' ' 14' ' ' TYR . . . -72.65 -41.68 65.18 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 126.572 1.949 . . . . 0.0 113.586 -179.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -101.32 14.65 31.31 Favored 'General case' 0 N--CA 1.437 -1.107 0 O-C-N 126.845 2.591 . . . . 0.0 110.555 -179.589 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 14.6 p30 -41.17 -27.47 0.07 Allowed 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 120.009 3.337 . . . . 0.0 120.009 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . 0.274 20.7 m-80 74.35 35.32 0.73 Allowed 'General case' 0 C--O 1.235 0.337 0 O-C-N 123.938 0.774 . . . . 0.0 109.477 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.715 HD11 HD13 ' A' ' 38' ' ' LEU . 2.9 tt -59.44 137.93 57.84 Favored 'General case' 0 N--CA 1.479 0.986 0 O-C-N 125.22 1.575 . . . . 0.0 110.501 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 6.6 ttmt -134.41 87.77 2.39 Favored 'General case' 0 N--CA 1.435 -1.194 0 N-CA-C 106.176 -1.787 . . . . 0.0 106.176 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.715 HD13 HD11 ' A' ' 36' ' ' LEU 0.315 0.0 OUTLIER -72.15 135.87 46.32 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 103.087 -2.931 . . . . 0.0 103.087 179.809 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.601 ' HA ' ' HA ' ' A' ' 5' ' ' THR . 3.7 m -102.44 -18.62 15.28 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 121.939 2.154 . . . . 0.0 110.272 -178.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.45 HG12 HG23 ' A' ' 49' ' ' VAL . 3.7 mm 40.97 116.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 CA-C-O 126.667 3.127 . . . . 0.0 114.536 179.491 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.611 ' HB ' HG23 ' A' ' 48' ' ' THR . 5.8 m -118.69 109.94 16.7 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 112.479 -2.146 . . . . 0.0 113.611 179.297 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.482 ' NE2' ' CE2' ' A' ' 47' ' ' PHE . 3.8 tp-100 -103.41 77.73 1.54 Allowed 'General case' 0 N--CA 1.444 -0.774 0 O-C-N 123.635 0.584 . . . . 0.0 109.734 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -65.44 -45.05 85.31 Favored 'General case' 0 N--CA 1.426 -1.663 0 CA-C-O 123.391 1.567 . . . . 0.0 110.296 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 163.6 82.1 0.04 OUTLIER Glycine 0 N--CA 1.44 -1.053 0 N-CA-C 105.839 -2.904 . . . . 0.0 105.839 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.354 75.2 m-20 90.77 -33.52 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.727 0 O-C-N 125.364 1.273 . . . . 0.0 108.495 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 18.7 tttt -93.28 128.58 39.34 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 119.256 -2.152 . . . . 0.0 106.74 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.482 ' CE2' ' NE2' ' A' ' 42' ' ' GLN . 3.0 m-85 -113.47 97.85 6.71 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 124.948 1.299 . . . . 0.0 107.601 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.611 HG23 ' HB ' ' A' ' 41' ' ' THR 0.375 5.1 t -93.68 102.36 14.52 Favored 'General case' 0 N--CA 1.432 -1.349 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 179.922 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.548 HG21 ' HG ' ' A' ' 38' ' ' LEU 0.622 0.8 OUTLIER -84.91 104.96 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.818 0 N-CA-C 118.089 2.626 . . . . 0.0 118.089 -179.433 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.546 ' HB3' ' HB ' ' A' ' 39' ' ' THR . 0.0 OUTLIER -64.19 158.43 23.1 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 100.974 -3.713 . . . . 0.0 100.974 178.638 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.408 ' O ' ' N ' ' A' ' 53' ' ' SER 0.3 68.8 tt0 -144.16 53.93 1.28 Allowed 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 103.857 -2.646 . . . . 0.0 103.857 179.993 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -70.9 81.43 0.64 Allowed 'General case' 0 N--CA 1.425 -1.709 0 C-N-CA 118.41 -1.316 . . . . 0.0 109.004 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.408 ' N ' ' O ' ' A' ' 51' ' ' GLU . 1.2 m -111.67 -141.72 0.38 Allowed 'General case' 0 CA--C 1.505 -0.778 0 O-C-N 126.612 2.445 . . . . 0.0 110.428 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -94.27 -7.48 41.87 Favored 'General case' 0 C--O 1.211 -0.924 0 CA-C-N 120.865 1.666 . . . . 0.0 108.066 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.52 ' C ' ' HG2' ' A' ' 56' ' ' ARG . 46.1 m-85 -97.82 -71.66 0.68 Allowed 'General case' 0 N--CA 1.437 -1.087 0 CA-C-O 116.247 -1.835 . . . . 0.0 113.958 -179.758 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.52 ' HG2' ' C ' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -153.02 144.45 23.3 Favored 'General case' 0 C--O 1.254 1.327 0 CA-C-N 123.883 3.038 . . . . 0.0 109.712 -179.195 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -93.69 74.96 4.33 Favored 'General case' 0 C--O 1.219 -0.543 0 N-CA-C 102.269 -3.234 . . . . 0.0 102.269 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.465 ' O ' HG23 ' A' ' 60' ' ' VAL . 0.7 OUTLIER -99.61 114.3 37.41 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 O-C-N 127.733 3.146 . . . . 0.0 114.483 179.811 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -62.19 117.71 6.42 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 104.793 -2.299 . . . . 0.0 104.793 179.354 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.638 HG12 ' CE2' ' A' ' 62' ' ' PHE . 92.4 t -99.36 77.04 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.59 1.181 . . . . 0.0 109.003 -178.73 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.597 ' HA ' ' HA ' ' A' ' 48' ' ' THR 0.339 1.2 m -71.18 138.45 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.333 0 O-C-N 117.852 -3.03 . . . . 0.0 115.858 179.92 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.638 ' CE2' HG12 ' A' ' 60' ' ' VAL . 0.2 OUTLIER -156.36 92.2 1.31 Allowed 'General case' 0 N--CA 1.444 -0.772 0 O-C-N 118.991 -2.318 . . . . 0.0 109.717 -179.976 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -57.82 142.38 45.92 Favored 'General case' 0 C--O 1.244 0.775 0 N-CA-C 106.58 -1.637 . . . . 0.0 106.58 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.1 mt -65.08 122.69 17.62 Favored 'General case' 0 N--CA 1.443 -0.822 0 C-N-CA 118.063 -1.455 . . . . 0.0 111.056 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 75.02 9.89 83.98 Favored Glycine 0 N--CA 1.47 0.933 0 N-CA-C 119.863 2.705 . . . . 0.0 119.863 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.401 HG12 ' N ' ' A' ' 67' ' ' ASP 0.425 7.2 t -80.88 -97.69 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.213 0 O-C-N 121.416 -1.049 . . . . 0.0 110.396 -179.97 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.401 ' N ' HG12 ' A' ' 66' ' ' VAL 0.259 21.2 t70 157.82 145.86 0.01 OUTLIER 'General case' 0 CA--C 1.497 -1.088 0 CA-C-O 117.533 -1.222 . . . . 0.0 109.927 179.831 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.502 ' CZ ' ' HB3' ' A' ' 62' ' ' PHE . 0.2 OUTLIER -164.87 164.95 20.81 Favored 'General case' 0 N--CA 1.423 -1.798 0 C-N-CA 119.237 -0.985 . . . . 0.0 110.186 179.98 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -113.75 122.76 48.08 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -123.7 118.34 27.0 Favored 'General case' 0 N--CA 1.439 -0.975 0 O-C-N 121.383 -0.823 . . . . 0.0 110.835 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 2.5 p -81.41 126.29 31.45 Favored 'General case' 0 CA--C 1.496 -1.124 0 CA-C-N 120.047 1.294 . . . . 0.0 108.936 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -78.69 -171.37 2.5 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 104.251 -2.5 . . . . 0.0 104.251 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -114.1 25.38 11.18 Favored 'General case' 0 N--CA 1.436 -1.138 0 CA-C-O 124.117 1.913 . . . . 0.0 112.995 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -153.34 -35.17 0.11 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 119.664 -1.898 . . . . 0.0 112.969 -179.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.507 ' O ' HG22 ' A' ' 76' ' ' THR . . . -126.66 -12.89 3.2 Favored Glycine 0 CA--C 1.543 1.786 0 C-N-CA 125.375 1.464 . . . . 0.0 113.215 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.507 HG22 ' O ' ' A' ' 75' ' ' GLY 0.328 0.4 OUTLIER 69.13 171.07 0.3 Allowed 'General case' 0 CA--C 1.492 -1.27 0 C-N-CA 115.987 -2.285 . . . . 0.0 115.436 -179.734 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 26.21 109.6 0.0 OUTLIER 'General case' 0 N--CA 1.436 -1.129 1 O-C-N 129.423 4.202 . . . . 0.0 116.956 179.547 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.56 HD21 ' CD1' ' A' ' 93' ' ' PHE 0.363 0.4 OUTLIER -146.46 121.11 9.81 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 101.988 -3.338 . . . . 0.0 101.988 -179.889 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 55.1 m -129.41 154.67 46.71 Favored 'General case' 0 C--O 1.198 -1.625 0 N-CA-C 106.002 -1.851 . . . . 0.0 106.002 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 169.97 -159.08 31.53 Favored Glycine 0 N--CA 1.439 -1.125 0 CA-C-O 118.076 -1.402 . . . . 0.0 110.715 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -148.04 167.69 24.28 Favored 'General case' 0 CA--C 1.492 -1.278 0 C-N-CA 117.252 -1.779 . . . . 0.0 109.992 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . 0.486 ' CE3' ' CA ' ' A' ' 91' ' ' GLY 0.271 63.1 m95 -121.66 138.12 54.47 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 101.693 -3.447 . . . . 0.0 101.693 179.934 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 12.4 t -140.97 140.85 34.44 Favored 'General case' 0 N--CA 1.426 -1.64 0 CA-C-O 123.516 1.627 . . . . 0.0 107.885 -179.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.632 ' HA ' HD23 ' A' ' 89' ' ' LEU . 3.6 ttm -85.21 133.91 34.17 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 104.616 -2.364 . . . . 0.0 104.616 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . 0.649 1.5 mm-40 -105.51 18.55 22.04 Favored 'General case' 0 N--CA 1.428 -1.574 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 93.69 -64.03 1.85 Allowed Glycine 0 N--CA 1.427 -1.911 0 N-CA-C 105.85 -2.9 . . . . 0.0 105.85 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -101.57 -7.67 22.55 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 117.683 2.475 . . . . 0.0 117.683 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . 0.358 6.6 mtmt -162.32 132.07 4.55 Favored 'General case' 0 CA--C 1.489 -1.398 0 O-C-N 127.096 2.747 . . . . 0.0 109.284 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.632 HD23 ' HA ' ' A' ' 84' ' ' MET . 0.0 OUTLIER -75.73 121.9 23.22 Favored 'General case' 0 C--N 1.309 -1.188 0 O-C-N 126.639 2.462 . . . . 0.0 104.988 179.766 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.495 HG12 HG23 ' A' ' 105' ' ' VAL . 18.1 m -116.54 135.95 55.17 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 N-CA-C 105.698 -1.964 . . . . 0.0 105.698 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.486 ' CA ' ' CE3' ' A' ' 82' ' ' TRP . . . -115.44 118.45 4.28 Favored Glycine 0 CA--C 1.537 1.427 0 C-N-CA 126.525 2.012 . . . . 0.0 109.005 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 3.4 mtmm -112.3 147.34 36.52 Favored 'General case' 0 N--CA 1.432 -1.327 0 N-CA-C 103.569 -2.752 . . . . 0.0 103.569 179.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.56 ' CD1' HD21 ' A' ' 78' ' ' LEU . 55.2 m-85 -146.18 116.5 7.48 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 114.654 -1.157 . . . . 0.0 112.667 179.702 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.401 ' HE2' ' HB3' ' A' ' 94' ' ' LYS . 44.2 mtpt -88.53 -171.11 3.2 Favored 'General case' 0 N--CA 1.433 -1.295 0 C-N-CA 127.298 2.239 . . . . 0.0 108.146 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . 0.359 1.3 ttt180 -149.12 134.7 18.63 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 106.138 -1.801 . . . . 0.0 106.138 -179.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.492 HG23 ' N ' ' A' ' 97' ' ' ASP . 17.0 m -57.73 -38.31 64.35 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 CA-C-O 123.809 1.766 . . . . 0.0 113.321 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.492 ' N ' HG23 ' A' ' 96' ' ' VAL 0.366 96.3 m-20 -76.09 7.08 4.45 Favored 'General case' 0 C--O 1.253 1.277 0 CA-C-N 112.531 -2.122 . . . . 0.0 116.191 179.931 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 38.1 p30 -161.33 -17.92 0.05 OUTLIER 'General case' 0 N--CA 1.421 -1.898 0 N-CA-C 116.957 2.206 . . . . 0.0 116.957 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 58.24 19.21 38.48 Favored Glycine 0 C--O 1.228 -0.274 0 CA-C-O 124.737 2.298 . . . . 0.0 114.476 -179.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 9.7 mmtm -78.0 -103.59 0.02 OUTLIER 'General case' 0 C--O 1.199 -1.597 0 O-C-N 120.037 -1.86 . . . . 0.0 111.322 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 167.65 167.94 0.03 OUTLIER 'General case' 0 N--CA 1.438 -1.043 0 C-N-CA 130.058 3.343 . . . . 0.0 110.603 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.504 HD23 ' N ' ' A' ' 103' ' ' ILE . 9.4 tt -153.91 154.27 33.56 Favored 'General case' 0 C--O 1.242 0.676 0 C-N-CA 131.693 3.997 . . . . 0.0 104.55 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.549 ' CG2' ' HB ' ' A' ' 118' ' ' THR . 13.4 tt -141.85 160.18 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.328 0 C-N-CA 116.469 -2.092 . . . . 0.0 110.277 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.422 ' N ' ' CG1' ' A' ' 103' ' ' ILE . . . -149.53 111.84 4.69 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 179.797 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.495 HG23 HG12 ' A' ' 90' ' ' VAL . 2.4 p -102.65 105.88 18.96 Favored 'Isoleucine or valine' 0 C--O 1.244 0.782 0 CA-C-O 124.824 2.249 . . . . 0.0 112.068 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.423 ' CG ' ' HG2' ' A' ' 115' ' ' GLN 0.26 78.4 mtt180 -79.23 93.08 5.18 Favored 'General case' 0 N--CA 1.428 -1.573 0 CA-C-N 112.181 -2.281 . . . . 0.0 106.127 -179.848 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 21.2 pt-20 -101.5 82.73 2.34 Favored 'General case' 0 N--CA 1.425 -1.677 0 O-C-N 127.581 3.051 . . . . 0.0 110.339 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.714 HD11 ' HH2' ' A' ' 6' ' ' TRP 0.391 4.4 tt -60.89 129.2 23.28 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.984 0 C-N-CA 114.485 -2.886 . . . . 0.0 114.999 -179.827 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.2 t -125.76 76.04 1.54 Allowed 'General case' 0 C--O 1.215 -0.733 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 179.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 80.55 -89.94 1.33 Allowed Glycine 0 CA--C 1.501 -0.822 0 C-N-CA 126.134 1.826 . . . . 0.0 112.636 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . 0.374 0.4 OUTLIER -116.32 22.79 12.59 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 115.785 -2.055 . . . . 0.0 110.456 -179.793 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -132.54 119.86 21.09 Favored 'General case' 0 C--O 1.211 -0.935 0 O-C-N 128.4 3.562 . . . . 0.0 110.933 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.493 ' HB2' ' CH2' ' A' ' 6' ' ' TRP . 0.9 OUTLIER -95.55 59.71 2.14 Favored 'General case' 0 CA--C 1.501 -0.933 0 O-C-N 128.725 3.766 . . . . 0.0 107.969 -179.647 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.578 ' CG1' HD13 ' A' ' 127' ' ' ILE 0.262 1.4 mp -51.81 127.0 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.762 0 O-C-N 125.508 1.755 . . . . 0.0 108.335 -179.621 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . 0.614 HE21 ' HZ ' ' A' ' 128' ' ' PHE . 28.0 mt-30 -124.72 134.29 52.89 Favored 'General case' 0 C--O 1.246 0.904 0 N-CA-C 103.14 -2.911 . . . . 0.0 103.14 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.48 HG22 ' HE2' ' A' ' 125' ' ' LYS . 29.5 p -97.46 178.74 5.1 Favored 'General case' 0 N--CA 1.433 -1.279 0 O-C-N 128.304 3.503 . . . . 0.0 108.192 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.954 ' HB2' ' HB3' ' A' ' 124' ' ' ALA . 19.1 m-85 -146.77 97.92 2.98 Favored 'General case' 0 CA--C 1.497 -1.086 0 CA-C-O 114.481 -2.676 . . . . 0.0 112.06 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.549 ' HB ' ' CG2' ' A' ' 103' ' ' ILE . 0.3 OUTLIER -116.2 94.75 4.78 Favored 'General case' 0 C--O 1.254 1.325 1 O-C-N 129.386 4.179 . . . . 0.0 112.868 179.76 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.493 ' HA ' ' HA ' ' A' ' 102' ' ' LEU . 59.8 t80 -72.42 -14.09 61.61 Favored 'General case' 0 C--N 1.346 0.446 0 CA-C-O 122.472 1.13 . . . . 0.0 108.557 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -179.63 -81.29 0.0 OUTLIER 'General case' 0 C--N 1.292 -1.915 0 CA-C-N 113.747 -1.57 . . . . 0.0 113.379 -179.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -128.07 28.15 4.41 Favored Glycine 0 C--N 1.366 2.207 0 C-N-CA 126.579 2.037 . . . . 0.0 116.745 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 5.2 t -140.89 92.79 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -64.82 178.86 0.73 Allowed 'General case' 0 N--CA 1.428 -1.573 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.954 ' HB3' ' HB2' ' A' ' 117' ' ' TYR . . . -171.54 101.57 0.19 Allowed 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 103.778 -2.675 . . . . 0.0 103.778 179.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.48 ' HE2' HG22 ' A' ' 116' ' ' THR . 0.0 OUTLIER -80.02 147.52 31.49 Favored 'General case' 0 C--O 1.244 0.811 0 O-C-N 126.802 2.563 . . . . 0.0 109.76 -179.882 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -137.7 78.64 1.7 Allowed 'General case' 0 C--O 1.214 -0.786 0 O-C-N 126.726 2.516 . . . . 0.0 104.863 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.578 HD13 ' CG1' ' A' ' 114' ' ' ILE . 5.5 mm -67.45 107.42 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.755 1 O-C-N 129.558 4.286 . . . . 0.0 113.526 -179.758 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.614 ' HZ ' HE21 ' A' ' 115' ' ' GLN . 0.3 OUTLIER -99.74 151.03 21.7 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 179.348 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . 0.276 3.5 mmtt -115.83 44.28 1.94 Allowed 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.542 ' HB2' ' CZ3' ' A' ' 6' ' ' TRP . 23.9 tttm 32.32 86.85 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 126.686 1.994 . . . . 0.0 115.205 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . 0.733 0.5 OUTLIER . . . . . 0 N--CA 1.435 -1.224 0 CA-C-O 116.683 -1.627 . . . . 0.0 114.85 -179.679 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 . . . . . 0 N--CA 1.447 -0.617 0 CA-C-O 122.309 1.052 . . . . 0.0 112.94 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -154.6 100.72 2.27 Favored 'General case' 0 CA--C 1.491 -1.289 0 CA-C-O 127.465 3.507 . . . . 0.0 112.185 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 159.11 -168.1 35.05 Favored Glycine 0 CA--C 1.499 -0.952 0 C-N-CA 116.506 -2.759 . . . . 0.0 110.905 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.435 ' HB ' ' HA ' ' A' ' 39' ' ' THR 0.506 0.4 OUTLIER -97.28 164.88 12.29 Favored 'General case' 0 CA--C 1.493 -1.227 0 CA-C-N 117.062 0.431 . . . . 0.0 111.755 -179.891 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.63 ' CE3' ' HA ' ' A' ' 130' ' ' LYS 0.274 90.8 m95 -152.25 121.26 6.63 Favored 'General case' 0 N--CA 1.426 -1.639 0 O-C-N 127.027 2.704 . . . . 0.0 107.922 179.765 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 13.6 ttpt -124.82 97.87 5.46 Favored 'General case' 0 C--O 1.205 -1.274 0 CA-C-O 115.275 -2.297 . . . . 0.0 105.815 179.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.509 ' HA ' ' HA ' ' A' ' 128' ' ' PHE . 0.4 OUTLIER -38.65 138.64 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 O-C-N 126.309 2.256 . . . . 0.0 111.043 -179.987 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -137.34 16.42 2.97 Favored 'General case' 0 C--O 1.209 -1.067 0 O-C-N 126.109 2.13 . . . . 0.0 108.231 -179.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 171.13 135.39 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.439 0 CA-C-O 121.391 0.615 . . . . 0.0 110.159 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -118.86 -169.11 1.67 Allowed 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 116.928 -1.511 . . . . 0.0 107.869 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.414 ' HB3' ' HB2' ' A' ' 125' ' ' LYS . 2.3 tp10 -145.83 -45.91 0.21 Allowed 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 120.786 1.63 . . . . 0.0 109.285 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 38.4 t30 -123.3 7.97 9.08 Favored 'General case' 0 N--CA 1.476 0.841 0 O-C-N 125.842 1.964 . . . . 0.0 114.535 179.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.54 ' CD2' ' HD3' ' A' ' 126' ' ' ARG . 32.4 t80 -57.03 -28.52 62.58 Favored 'General case' 0 N--CA 1.434 -1.244 0 CA-C-N 112.666 -2.061 . . . . 0.0 114.854 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -71.47 -38.19 71.26 Favored 'General case' 0 C--O 1.212 -0.92 0 CA-C-O 123.062 1.411 . . . . 0.0 109.721 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 3.0 ttmm -76.66 -26.84 55.28 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-O 123.203 1.477 . . . . 0.0 112.217 179.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.588 ' HA ' HG11 ' A' ' 122' ' ' VAL . 2.4 t80 -73.37 -23.06 60.15 Favored 'General case' 0 C--O 1.241 0.611 0 O-C-N 119.09 -2.256 . . . . 0.0 111.779 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.411 ' HB3' HG13 ' A' ' 23' ' ' ILE . 1.1 mmt -75.87 -30.28 58.82 Favored 'General case' 0 C--N 1.317 -0.829 1 O-C-N 116.299 -4.001 . . . . 0.0 107.154 179.656 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -68.3 -33.6 74.62 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 119.747 -1.846 . . . . 0.0 112.41 -179.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 5.1 tptt -75.41 -31.86 60.54 Favored 'General case' 0 C--O 1.215 -0.748 0 CA-C-N 114.786 -1.097 . . . . 0.0 110.297 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.521 ' CE ' HH12 ' A' ' 95' ' ' ARG . 0.5 OUTLIER -78.47 -20.3 51.22 Favored 'General case' 0 C--O 1.214 -0.804 0 O-C-N 125.543 1.777 . . . . 0.0 108.039 179.776 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 94.36 65.59 1.02 Allowed Glycine 0 C--N 1.302 -1.308 0 CA-C-O 116.865 -2.075 . . . . 0.0 109.598 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.627 HG23 ' HG2' ' A' ' 27' ' ' LYS . 2.1 mm -120.25 157.49 22.8 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 O-C-N 125.021 1.071 . . . . 0.0 109.432 -179.586 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -113.18 165.77 12.08 Favored 'General case' 0 C--O 1.246 0.92 0 O-C-N 124.846 1.341 . . . . 0.0 112.077 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . 0.375 0.0 OUTLIER -23.01 -61.02 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.501 -0.923 0 N-CA-C 120.833 3.642 . . . . 0.0 120.833 179.925 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.615 57.8 t -78.45 -38.55 22.76 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.751 0 CA-C-O 122.629 1.204 . . . . 0.0 112.796 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.627 ' HG2' HG23 ' A' ' 23' ' ' ILE . 0.1 OUTLIER -64.35 -37.28 86.97 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-N 113.523 -1.671 . . . . 0.0 113.798 -179.819 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.492 ' HA ' HG21 ' A' ' 23' ' ' ILE . 15.9 ptt85 -77.94 -22.67 49.21 Favored 'General case' 0 C--O 1.22 -0.47 0 O-C-N 119.486 -2.008 . . . . 0.0 109.639 179.715 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 16.7 tttp -74.16 -37.29 64.03 Favored 'General case' 0 C--N 1.35 0.61 0 CA-C-N 113.543 -1.662 . . . . 0.0 113.707 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.5 mt -69.8 -34.48 73.77 Favored 'General case' 0 N--CA 1.436 -1.139 0 C-N-CA 125.757 1.623 . . . . 0.0 111.305 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -77.32 -25.2 64.09 Favored Glycine 0 C--N 1.339 0.715 0 O-C-N 126.344 2.277 . . . . 0.0 111.31 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -75.11 -40.39 59.95 Favored 'General case' 0 C--O 1.22 -0.449 0 O-C-N 120.894 -1.357 . . . . 0.0 111.829 -179.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -98.27 9.74 42.3 Favored 'General case' 0 CA--C 1.51 -0.581 0 O-C-N 128.958 3.911 . . . . 0.0 110.821 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 36.5 p30 -47.6 -29.33 2.83 Favored 'General case' 0 CA--C 1.505 -0.782 0 N-CA-C 120.679 3.585 . . . . 0.0 120.679 179.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . 0.288 2.1 m120 73.98 30.56 1.27 Allowed 'General case' 0 C--O 1.243 0.753 0 CA-C-N 120.77 1.623 . . . . 0.0 110.72 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.634 HD11 HD13 ' A' ' 38' ' ' LEU . 9.6 tp -49.86 109.76 0.32 Allowed 'General case' 0 C--N 1.354 0.777 0 C-N-CA 126.435 1.894 . . . . 0.0 108.578 -179.811 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 7.7 ttmm -108.86 102.79 11.78 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 104.664 -2.347 . . . . 0.0 104.664 179.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.634 HD13 HD11 ' A' ' 36' ' ' LEU 0.26 0.1 OUTLIER -88.57 109.44 20.08 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.907 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.483 ' HB ' ' CB ' ' A' ' 50' ' ' LYS . 13.6 m -95.16 93.99 7.66 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 104.505 -2.405 . . . . 0.0 104.505 -179.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 21.0 mt -75.99 120.02 25.12 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.213 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 179.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.421 ' O ' HG22 ' A' ' 41' ' ' THR . 2.6 m -124.97 100.85 6.78 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 111.78 -2.464 . . . . 0.0 109.655 179.625 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -74.05 162.91 28.53 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-O 116.488 -1.72 . . . . 0.0 111.017 -179.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -151.09 -133.79 0.06 Allowed 'General case' 0 N--CA 1.424 -1.745 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -86.47 70.93 2.88 Favored Glycine 0 C--N 1.302 -1.315 0 N-CA-C 104.729 -3.348 . . . . 0.0 104.729 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 81.24 -8.38 1.4 Allowed 'General case' 0 C--O 1.216 -0.659 0 O-C-N 124.777 0.928 . . . . 0.0 111.756 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.465 ' HE2' ' HB ' ' A' ' 61' ' ' VAL . 13.4 tttt -98.31 125.77 43.55 Favored 'General case' 0 C--O 1.25 1.093 0 C-N-CA 118.456 -1.298 . . . . 0.0 108.915 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . 0.261 0.7 OUTLIER -103.92 107.37 18.22 Favored 'General case' 0 N--CA 1.446 -0.654 0 O-C-N 125.983 2.052 . . . . 0.0 111.451 -179.955 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 1.039 ' HB ' HG12 ' A' ' 61' ' ' VAL 0.425 0.1 OUTLIER -94.68 131.04 40.91 Favored 'General case' 0 CA--C 1.493 -1.243 0 O-C-N 125.589 1.805 . . . . 0.0 108.332 179.891 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.599 HG21 ' HG ' ' A' ' 38' ' ' LEU 0.644 0.3 OUTLIER -111.43 98.31 6.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 CA-C-N 113.353 -1.749 . . . . 0.0 112.233 -179.762 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.483 ' CB ' ' HB ' ' A' ' 39' ' ' THR . 0.6 OUTLIER -65.8 119.67 11.65 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 102.47 -3.159 . . . . 0.0 102.47 -179.941 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -113.94 85.91 2.31 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 124.475 2.083 . . . . 0.0 106.527 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 43.0 m -88.79 63.0 6.67 Favored 'General case' 0 N--CA 1.419 -2.004 0 CA-C-N 113.221 -1.809 . . . . 0.0 106.801 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -77.39 170.32 16.75 Favored 'General case' 0 C--O 1.216 -0.692 0 C-N-CA 115.933 -2.307 . . . . 0.0 111.219 -179.747 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -58.61 -20.85 50.91 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 117.838 -1.545 . . . . 0.0 108.333 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -85.48 -60.73 1.94 Allowed 'General case' 0 N--CA 1.44 -0.944 0 CA-C-O 114.007 -2.901 . . . . 0.0 110.391 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.7 ' HB2' HG22 ' A' ' 58' ' ' ILE . 66.6 mtp85 -133.95 176.87 8.19 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 124.416 3.28 . . . . 0.0 110.46 -179.643 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 10.7 m-80 -138.76 59.02 1.64 Allowed 'General case' 0 C--O 1.215 -0.728 2 C-N-CA 132.002 4.121 . . . . 0.0 100.081 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.7 HG22 ' HB2' ' A' ' 56' ' ' ARG . 1.5 tt -84.18 -44.18 17.87 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 1 C-N-CA 132.688 4.395 . . . . 0.0 119.772 -178.695 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . 0.277 34.2 t0 78.55 140.33 0.07 Allowed 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 104.073 -2.565 . . . . 0.0 104.073 -176.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 58.0 t -112.39 -53.59 5.22 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.152 0 C-N-CA 118.527 -1.269 . . . . 0.0 112.627 -178.245 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 1.039 HG12 ' HB ' ' A' ' 48' ' ' THR 0.398 0.9 OUTLIER 66.97 131.52 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 CA-C-O 126.272 2.939 . . . . 0.0 109.016 -178.907 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.556 ' CD2' ' CD1' ' A' ' 82' ' ' TRP . 12.5 p90 -164.03 93.76 0.72 Allowed 'General case' 0 N--CA 1.443 -0.817 0 O-C-N 117.05 -3.531 . . . . 0.0 110.334 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.418 ' HA ' ' HA ' ' A' ' 46' ' ' LYS . 27.3 mt-10 -65.59 136.63 56.6 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 105.644 -1.984 . . . . 0.0 105.644 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -50.88 121.86 6.59 Favored 'General case' 0 N--CA 1.437 -1.091 0 O-C-N 125.505 1.753 . . . . 0.0 110.691 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 79.98 3.59 89.43 Favored Glycine 0 C--N 1.35 1.336 0 CA-C-N 112.424 -2.171 . . . . 0.0 117.805 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . 0.378 79.4 t -106.03 97.48 5.67 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 N-CA-C 104.612 -2.366 . . . . 0.0 104.612 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -63.0 177.12 0.61 Allowed 'General case' 0 CA--C 1.484 -1.578 0 C-N-CA 117.584 -1.646 . . . . 0.0 114.605 -179.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.488 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 1.1 p90 -155.98 172.21 18.77 Favored 'General case' 0 N--CA 1.433 -1.304 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.627 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -115.3 140.91 48.7 Favored 'General case' 0 C--N 1.322 -0.609 0 O-C-N 126.858 2.599 . . . . 0.0 105.851 179.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 13.4 t80 -152.65 112.13 3.89 Favored 'General case' 0 C--O 1.206 -1.19 0 CA-C-N 120.525 1.511 . . . . 0.0 114.024 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.5 p -81.79 144.41 31.09 Favored 'General case' 0 C--N 1.315 -0.909 0 O-C-N 119.147 -2.221 . . . . 0.0 105.448 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 10.5 mp -102.28 -175.17 2.75 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 124.592 1.183 . . . . 0.0 108.465 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -90.94 -13.39 33.56 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.135 0.974 . . . . 0.0 111.94 -179.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.568 ' HB3' ' CD1' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -79.63 -11.15 59.88 Favored 'General case' 0 N--CA 1.439 -0.998 0 C-N-CA 119.308 -0.957 . . . . 0.0 110.751 -179.549 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 102.93 22.83 9.03 Favored Glycine 0 C--O 1.204 -1.777 0 O-C-N 125.528 1.768 . . . . 0.0 111.733 -179.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -129.24 155.15 46.01 Favored 'General case' 0 CA--C 1.491 -1.309 0 C-N-CA 117.782 -1.567 . . . . 0.0 112.786 -179.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.471 ' CB ' ' HB ' ' A' ' 96' ' ' VAL . 32.1 mp0 -92.41 155.92 17.55 Favored 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 127.572 2.349 . . . . 0.0 112.646 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.572 HD11 ' CG ' ' A' ' 93' ' ' PHE 0.429 0.6 OUTLIER -156.41 153.43 28.87 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 105.264 -2.125 . . . . 0.0 105.264 -179.912 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.404 ' O ' ' N ' ' A' ' 94' ' ' LYS . 64.2 m -157.67 139.21 13.81 Favored 'General case' 0 C--O 1.197 -1.669 0 N-CA-C 102.884 -3.006 . . . . 0.0 102.884 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 174.81 -172.15 45.2 Favored Glycine 0 C--N 1.293 -1.839 0 C-N-CA 114.116 -3.897 . . . . 0.0 114.759 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 76.3 p -132.88 169.09 17.27 Favored 'General case' 0 C--O 1.187 -2.19 0 CA-C-N 120.563 2.182 . . . . 0.0 109.252 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . 0.556 ' CD1' ' CD2' ' A' ' 62' ' ' PHE . 69.7 m95 -127.1 140.15 52.48 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 102.37 -3.196 . . . . 0.0 102.37 179.693 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 8.8 t -146.45 142.93 28.62 Favored 'General case' 0 C--O 1.255 1.366 0 CA-C-O 123.803 1.764 . . . . 0.0 109.994 179.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 2.0 ttm -81.24 99.67 8.72 Favored 'General case' 0 N--CA 1.425 -1.72 0 CA-C-N 111.111 -2.768 . . . . 0.0 109.584 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . 0.601 29.0 mm-40 -65.61 -104.19 0.0 OUTLIER 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 119.666 1.121 . . . . 0.0 113.248 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -137.39 93.92 0.22 Allowed Glycine 0 N--CA 1.436 -1.337 1 N-CA-C 102.932 -4.067 . . . . 0.0 102.932 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 58.34 21.17 8.01 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 113.191 0.811 . . . . 0.0 113.191 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . 0.33 7.1 mtmt -149.93 112.66 4.78 Favored 'General case' 0 CA--C 1.492 -1.267 0 O-C-N 126.395 2.309 . . . . 0.0 112.326 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.582 HD12 ' HD2' ' A' ' 106' ' ' ARG . 0.0 OUTLIER -75.98 130.63 38.73 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 102.478 -3.156 . . . . 0.0 102.478 179.908 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.51 ' HB ' HD11 ' A' ' 103' ' ' ILE . 5.4 m -129.03 136.3 60.02 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.932 0 CA-C-O 116.86 -1.543 . . . . 0.0 108.78 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -112.39 106.75 1.94 Allowed Glycine 0 CA--C 1.539 1.578 0 O-C-N 126.958 2.662 . . . . 0.0 112.86 179.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 8.0 mtpt -93.46 113.08 25.13 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 102.734 -3.061 . . . . 0.0 102.734 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.599 ' HD2' HD22 ' A' ' 102' ' ' LEU . 19.1 m-85 -104.46 96.93 6.94 Favored 'General case' 0 CA--C 1.502 -0.902 0 O-C-N 125.906 2.004 . . . . 0.0 114.492 -179.747 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.404 ' N ' ' O ' ' A' ' 79' ' ' THR . 39.1 mttt -80.04 127.48 32.34 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 126.541 1.936 . . . . 0.0 108.923 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.521 HH12 ' CE ' ' A' ' 21' ' ' MET 0.336 0.0 OUTLIER -72.71 144.32 47.71 Favored 'General case' 0 CA--C 1.502 -0.872 0 N-CA-C 104.434 -2.432 . . . . 0.0 104.434 -179.833 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.471 ' HB ' ' CB ' ' A' ' 77' ' ' GLU . 17.4 t -77.09 -33.66 20.67 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 C-N-CA 125.895 1.678 . . . . 0.0 112.248 -179.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . 0.262 0.0 OUTLIER -95.73 -27.88 15.05 Favored 'General case' 0 C--O 1.254 1.294 0 N-CA-C 115.05 1.5 . . . . 0.0 115.05 -179.867 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.401 ' ND2' ' OH ' ' A' ' 119' ' ' TYR . 50.8 t30 -89.7 -25.07 21.39 Favored 'General case' 0 N--CA 1.419 -2.013 0 CA-C-N 114.623 -1.171 . . . . 0.0 113.702 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 64.97 10.24 45.11 Favored Glycine 0 CA--C 1.536 1.363 0 O-C-N 127.149 2.781 . . . . 0.0 113.826 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 73.1 mttt -103.26 159.01 15.93 Favored 'General case' 0 C--O 1.197 -1.662 0 N-CA-C 107.629 -1.248 . . . . 0.0 107.629 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -95.27 158.91 15.25 Favored 'General case' 0 N--CA 1.431 -1.382 0 O-C-N 126.442 2.339 . . . . 0.0 116.001 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.599 HD22 ' HD2' ' A' ' 93' ' ' PHE . 5.0 tt -138.57 145.71 40.94 Favored 'General case' 0 C--N 1.326 -0.418 1 O-C-N 129.826 4.454 . . . . 0.0 104.477 179.569 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.583 ' N ' HD23 ' A' ' 102' ' ' LEU . 3.5 tp -127.39 152.85 35.93 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.071 0 N-CA-C 104.379 -2.452 . . . . 0.0 104.379 -179.435 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -134.76 132.79 39.17 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 114.119 -2.848 . . . . 0.0 106.26 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.677 HG12 ' OG1' ' A' ' 116' ' ' THR . 10.7 p -120.19 103.65 14.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 O-C-N 125.612 1.82 . . . . 0.0 113.77 -179.383 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.582 ' HD2' HD12 ' A' ' 89' ' ' LEU 0.269 36.2 mtt85 -74.6 89.16 2.2 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 104.483 -2.414 . . . . 0.0 104.483 179.561 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -92.08 77.57 5.32 Favored 'General case' 0 N--CA 1.428 -1.571 0 O-C-N 127.041 2.713 . . . . 0.0 114.907 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.565 HD11 ' CH2' ' A' ' 6' ' ' TRP 0.326 0.0 OUTLIER -56.68 101.81 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 CA-C-O 123.274 1.511 . . . . 0.0 112.094 179.961 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 61.4 m -88.19 71.06 9.26 Favored 'General case' 0 CA--C 1.502 -0.902 0 N-CA-C 104.569 -2.382 . . . . 0.0 104.569 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 66.59 -82.8 0.11 Allowed Glycine 0 C--N 1.344 1.02 0 C-N-CA 128.585 2.993 . . . . 0.0 111.743 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . 0.319 0.1 OUTLIER -98.73 -19.68 17.34 Favored 'General case' 0 C--O 1.221 -0.417 0 CA-C-O 117.651 -1.166 . . . . 0.0 111.911 -179.605 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.446 ' HG3' ' HA ' ' A' ' 129' ' ' LYS . 45.6 mp0 -105.86 127.93 53.43 Favored 'General case' 0 CA--C 1.498 -1.027 0 O-C-N 124.622 1.201 . . . . 0.0 112.175 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.479 HD23 ' CD1' ' A' ' 128' ' ' PHE . 2.0 tt -93.67 139.5 30.73 Favored 'General case' 0 C--O 1.211 -0.925 0 N-CA-C 100.208 -3.997 . . . . 0.0 100.208 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.527 HG23 HD12 ' A' ' 127' ' ' ILE . 68.5 mt -131.53 145.7 34.73 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 O-C-N 128.991 3.932 . . . . 0.0 103.776 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 9.1 mt-30 -134.52 129.9 35.81 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.677 ' OG1' HG12 ' A' ' 105' ' ' VAL . 24.3 p -101.65 -176.53 3.16 Favored 'General case' 0 C--O 1.249 1.035 0 O-C-N 126.703 2.502 . . . . 0.0 104.933 179.42 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.434 ' HB2' ' HB3' ' A' ' 124' ' ' ALA . 68.4 m-85 -160.56 87.07 0.74 Allowed 'General case' 0 CA--C 1.475 -1.939 0 CA-C-O 115.789 -2.053 . . . . 0.0 109.69 179.661 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.469 ' HB ' ' CG2' ' A' ' 103' ' ' ILE . 95.4 m -94.47 101.29 13.2 Favored 'General case' 0 N--CA 1.433 -1.294 0 O-C-N 128.247 3.467 . . . . 0.0 110.107 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.56 ' HA ' ' HA ' ' A' ' 102' ' ' LEU . 5.8 t80 -77.97 -77.65 0.15 Allowed 'General case' 0 CA--C 1.499 -0.983 0 O-C-N 125.816 1.948 . . . . 0.0 107.523 -179.742 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.457 ' HG3' ' CE2' ' A' ' 119' ' ' TYR . 1.5 mm-40 -108.44 -75.7 0.63 Allowed 'General case' 0 C--N 1.298 -1.642 0 CA-C-O 117.522 -1.228 . . . . 0.0 108.462 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -133.71 32.94 2.62 Favored Glycine 0 CA--C 1.528 0.863 0 O-C-N 127.776 3.172 . . . . 0.0 114.74 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.588 HG11 ' HA ' ' A' ' 17' ' ' PHE . 0.3 OUTLIER -139.59 122.35 17.4 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.68 0 O-C-N 119.789 -2.006 . . . . 0.0 110.477 -179.883 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -95.82 177.65 5.7 Favored 'General case' 0 N--CA 1.431 -1.402 0 O-C-N 120.522 -1.361 . . . . 0.0 107.825 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.521 ' HB2' ' CB ' ' A' ' 17' ' ' PHE . . . -169.76 77.16 0.09 Allowed 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 115.709 -2.396 . . . . 0.0 109.193 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.414 ' HB2' ' HB3' ' A' ' 12' ' ' GLU . 12.1 mptt -64.3 141.27 58.83 Favored 'General case' 0 C--O 1.251 1.142 0 CA-C-N 118.488 0.586 . . . . 0.0 109.541 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.54 ' HD3' ' CD2' ' A' ' 14' ' ' TYR . 14.3 mtm180 -137.58 83.1 1.96 Allowed 'General case' 0 CA--C 1.509 -0.623 0 O-C-N 127.315 2.884 . . . . 0.0 108.535 179.78 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.527 HD12 HG23 ' A' ' 114' ' ' ILE . 0.8 OUTLIER -74.84 119.31 22.15 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.788 1 O-C-N 129.79 4.432 . . . . 0.0 110.757 179.894 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.509 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 0.1 OUTLIER -102.99 169.9 8.29 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 112.336 -2.211 . . . . 0.0 108.247 -180.0 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.446 ' HA ' ' HG3' ' A' ' 112' ' ' GLU . 0.0 OUTLIER -119.12 0.49 11.26 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 105.693 -1.965 . . . . 0.0 105.693 179.786 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.63 ' HA ' ' CE3' ' A' ' 6' ' ' TRP . 34.7 tttt 73.6 95.91 0.07 Allowed 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 120.684 1.583 . . . . 0.0 112.436 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . 0.854 3.8 mt-10 . . . . . 0 N--CA 1.435 -1.178 0 N-CA-C 117.523 2.416 . . . . 0.0 117.523 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . 0.518 ' CE1' HG12 ' A' ' 108' ' ' ILE . 97.3 m-85 . . . . . 0 CA--C 1.499 -0.983 0 N-CA-C 116.084 1.883 . . . . 0.0 116.084 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -166.39 86.59 0.32 Allowed 'General case' 0 CA--C 1.494 -1.204 0 C-N-CA 117.985 -1.486 . . . . 0.0 112.686 -179.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 150.47 -130.02 3.11 Favored Glycine 0 C--N 1.31 -0.915 0 C-N-CA 116.503 -2.761 . . . . 0.0 112.114 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.449 ' HA ' ' HA ' ' A' ' 39' ' ' THR 0.625 0.8 OUTLIER -123.11 161.2 24.86 Favored 'General case' 0 N--CA 1.432 -1.339 0 CA-C-O 124.158 1.932 . . . . 0.0 112.014 -179.933 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.596 ' CE3' ' HA ' ' A' ' 130' ' ' LYS 0.264 86.7 m95 -153.77 114.7 4.07 Favored 'General case' 0 N--CA 1.431 -1.393 0 CA-C-N 111.872 -2.422 . . . . 0.0 110.856 179.896 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 30.4 ttmt -109.56 108.45 18.91 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-O 115.174 -2.346 . . . . 0.0 107.057 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.534 HG12 ' HB3' ' A' ' 36' ' ' LEU 0.411 8.2 p -48.51 147.0 0.76 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.846 0 CA-C-N 121.202 1.819 . . . . 0.0 109.222 -179.964 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -157.28 14.09 0.25 Allowed 'General case' 0 CA--C 1.499 -0.996 0 C-N-CA 117.464 -1.695 . . . . 0.0 111.455 -179.126 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.27 -57.65 0.65 Allowed 'General case' 0 CA--C 1.487 -1.465 0 O-C-N 116.679 -3.763 . . . . 0.0 109.965 -179.684 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 59.74 170.91 0.08 Allowed 'General case' 0 C--O 1.244 0.778 0 O-C-N 127.529 3.018 . . . . 0.0 108.928 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.452 ' O ' ' N ' ' A' ' 125' ' ' LYS . 6.0 tt0 -170.43 134.51 1.14 Allowed 'General case' 0 C--N 1.3 -1.583 0 O-C-N 117.792 -3.068 . . . . 0.0 107.534 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.564 ' ND2' ' CD1' ' A' ' 17' ' ' PHE . 1.0 OUTLIER 62.67 29.78 16.87 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-N 122.563 2.438 . . . . 0.0 113.857 179.844 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . 0.348 9.3 t80 -98.11 -64.5 1.03 Allowed 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 121.201 3.778 . . . . 0.0 121.201 -178.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.09 -38.74 77.0 Favored 'General case' 0 CA--C 1.498 -1.049 0 CA-C-N 124.49 3.313 . . . . 0.0 113.792 -179.061 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.479 ' HB3' ' CD1' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -67.27 -43.23 82.35 Favored 'General case' 0 N--CA 1.422 -1.829 0 C-N-CA 127.643 2.377 . . . . 0.0 113.578 179.584 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.645 ' HB3' ' HB ' ' A' ' 122' ' ' VAL 0.266 64.8 m-85 -80.03 -20.1 46.11 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 111.188 -2.733 . . . . 0.0 113.557 -178.057 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.525 ' CB ' HG13 ' A' ' 23' ' ' ILE . 0.5 OUTLIER -72.21 -23.11 61.2 Favored 'General case' 0 N--CA 1.435 -1.22 0 O-C-N 117.035 -3.541 . . . . 0.0 105.983 176.591 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -74.24 -24.89 59.37 Favored 'General case' 0 C--N 1.348 0.528 0 O-C-N 120.378 -1.451 . . . . 0.0 109.849 179.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.487 ' CE ' HG12 ' A' ' 122' ' ' VAL . 11.3 tttp -79.1 -32.58 44.64 Favored 'General case' 0 N--CA 1.432 -1.367 0 CA-C-O 116.196 -1.859 . . . . 0.0 110.589 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.24 -23.5 57.54 Favored 'General case' 0 C--O 1.214 -0.814 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 179.312 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 104.25 40.89 2.17 Favored Glycine 0 N--CA 1.445 -0.714 0 CA-C-O 115.747 -2.696 . . . . 0.0 109.935 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.589 HG23 ' HB3' ' A' ' 27' ' ' LYS . 2.2 mm -86.99 83.44 2.19 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 CA-C-N 120.49 2.145 . . . . 0.0 106.994 -179.682 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -42.09 112.91 0.38 Allowed 'General case' 0 C--O 1.248 1.009 0 O-C-N 124.91 1.381 . . . . 0.0 114.357 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . 0.364 84.7 t 18.52 -66.73 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.502 -0.893 0 N-CA-C 121.066 3.728 . . . . 0.0 121.066 -179.784 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.538 1.3 m -71.52 -24.49 23.63 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.122 0 N-CA-C 117.448 2.388 . . . . 0.0 117.448 -179.531 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.589 ' HB3' HG23 ' A' ' 23' ' ' ILE . 1.5 mtmp? -72.04 -29.22 63.94 Favored 'General case' 0 C--N 1.318 -0.775 0 C-N-CA 119.072 -1.051 . . . . 0.0 112.993 179.759 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.49 ' N ' HG22 ' A' ' 23' ' ' ILE . 2.6 ptt-85 -78.49 -21.51 48.87 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 116.777 -1.969 . . . . 0.0 109.363 179.83 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 12.0 tttt -77.78 -43.21 31.38 Favored 'General case' 0 CA--C 1.502 -0.869 0 CA-C-N 113.553 -1.658 . . . . 0.0 109.924 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -79.02 -23.07 44.58 Favored 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 -179.729 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -76.68 -34.88 42.4 Favored Glycine 0 CA--C 1.527 0.793 0 O-C-N 125.613 1.821 . . . . 0.0 112.476 179.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -72.9 -38.61 66.87 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 6.5 m-70 -98.92 20.33 13.4 Favored 'General case' 0 N--CA 1.439 -0.99 0 O-C-N 127.377 2.923 . . . . 0.0 112.604 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 23.6 p30 -47.75 -31.52 4.91 Favored 'General case' 0 CA--C 1.497 -1.096 0 N-CA-C 119.347 3.091 . . . . 0.0 119.347 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . 0.309 0.6 OUTLIER 76.59 15.85 2.06 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 119.291 0.951 . . . . 0.0 109.264 -179.809 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.583 HD11 HD12 ' A' ' 38' ' ' LEU . 30.5 tp -42.1 114.84 0.6 Allowed 'General case' 0 CA--C 1.5 -0.946 0 C-N-CA 128.636 2.775 . . . . 0.0 110.249 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -116.76 94.64 4.68 Favored 'General case' 0 C--O 1.211 -0.967 0 N-CA-C 105.246 -2.131 . . . . 0.0 105.246 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.646 HD13 ' CZ ' ' A' ' 128' ' ' PHE 0.256 0.1 OUTLIER -79.8 105.28 10.97 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 179.73 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.555 ' HB ' ' HB3' ' A' ' 50' ' ' LYS . 99.3 m -94.98 80.4 3.65 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 104.268 -2.493 . . . . 0.0 104.268 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.55 HG13 ' CD1' ' A' ' 6' ' ' TRP . 0.9 OUTLIER -60.23 134.99 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.371 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.331 179.977 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.3 m -128.45 108.19 10.35 Favored 'General case' 0 N--CA 1.475 0.81 0 O-C-N 128.043 3.34 . . . . 0.0 108.437 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -99.07 105.72 17.86 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 117.802 -1.094 . . . . 0.0 113.806 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -108.77 68.02 0.67 Allowed 'General case' 0 N--CA 1.424 -1.767 0 CA-C-O 126.756 3.17 . . . . 0.0 108.019 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 77.79 -108.55 2.63 Favored Glycine 0 C--N 1.293 -1.853 0 N-CA-C 106.956 -2.457 . . . . 0.0 106.956 179.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.416 HD22 ' N ' ' A' ' 45' ' ' ASN . 0.9 OUTLIER -102.38 48.3 0.87 Allowed 'General case' 0 N--CA 1.444 -0.735 0 CA-C-O 123.04 1.4 . . . . 0.0 110.456 179.688 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 3.1 ttmt -149.06 129.28 13.67 Favored 'General case' 0 C--N 1.312 -1.056 0 C-N-CA 116.479 -2.088 . . . . 0.0 107.657 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.409 ' CE2' HD11 ' A' ' 89' ' ' LEU . 11.0 m-85 -114.53 88.12 2.79 Favored 'General case' 0 CA--C 1.511 -0.557 0 CA-C-O 121.958 0.885 . . . . 0.0 110.117 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.658 ' OG1' HG12 ' A' ' 61' ' ' VAL 0.349 14.8 t -95.19 85.92 4.43 Favored 'General case' 0 N--CA 1.428 -1.543 0 CA-C-O 125.799 2.714 . . . . 0.0 108.789 -179.742 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.454 HG13 ' HE1' ' A' ' 62' ' ' PHE 0.654 1.0 OUTLIER -70.39 108.67 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.768 0 N-CA-C 117.758 2.503 . . . . 0.0 117.758 -179.948 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.555 ' HB3' ' HB ' ' A' ' 39' ' ' THR . 15.9 tttp -69.55 117.46 11.18 Favored 'General case' 0 C--N 1.303 -1.416 1 N-CA-C 99.508 -4.256 . . . . 0.0 99.508 179.218 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.438 ' HG3' ' CD1' ' A' ' 36' ' ' LEU . 1.1 tt0 -112.67 104.96 13.03 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 -179.334 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -103.45 51.63 0.79 Allowed 'General case' 0 C--N 1.289 -2.049 0 N-CA-C 105.317 -2.105 . . . . 0.0 105.317 179.562 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 4.3 t -73.05 21.37 0.07 Allowed 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 113.175 -1.83 . . . . 0.0 115.474 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 73.79 -51.42 0.69 Allowed 'General case' 0 CA--C 1.498 -1.032 0 CA-C-N 122.245 2.293 . . . . 0.0 109.787 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -67.1 -44.33 80.25 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-O 115.119 -2.372 . . . . 0.0 110.209 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.518 ' HB2' HG22 ' A' ' 58' ' ' ILE . 9.3 ptp180 -149.56 126.17 10.99 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 123.633 2.924 . . . . 0.0 106.795 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -99.71 74.42 1.85 Allowed 'General case' 0 N--CA 1.465 0.291 1 N-CA-C 100.197 -4.001 . . . . 0.0 100.197 179.784 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.518 HG22 ' HB2' ' A' ' 56' ' ' ARG . 3.3 tp -115.94 117.83 56.8 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.82 1 C-N-CA 132.417 4.287 . . . . 0.0 118.9 -179.104 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.95 125.58 26.77 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 103.607 -2.738 . . . . 0.0 103.607 178.163 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 1.4 t -107.85 103.96 16.32 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 O-C-N 124.515 1.135 . . . . 0.0 113.217 -178.064 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.658 HG12 ' OG1' ' A' ' 48' ' ' THR 0.395 1.7 m -88.49 141.97 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.159 0 CA-C-O 125.091 2.377 . . . . 0.0 113.888 179.593 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.597 ' HB3' ' CE1' ' A' ' 68' ' ' PHE . 0.1 OUTLIER -160.75 95.64 1.1 Allowed 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 113.128 -1.851 . . . . 0.0 108.772 -179.833 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -54.49 144.57 20.8 Favored 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 104.772 -2.307 . . . . 0.0 104.772 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.636 ' H ' HD12 ' A' ' 64' ' ' LEU . 2.9 mp -68.89 115.7 8.51 Favored 'General case' 0 N--CA 1.432 -1.345 0 O-C-N 119.475 -2.015 . . . . 0.0 107.238 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 81.87 26.62 48.93 Favored Glycine 0 N--CA 1.471 0.971 0 C-N-CA 126.713 2.102 . . . . 0.0 118.172 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . 0.387 41.2 t -114.8 81.39 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 N-CA-C 104.662 -2.347 . . . . 0.0 104.662 179.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.435 ' HA ' ' CG2' ' A' ' 81' ' ' THR . 0.7 OUTLIER -38.43 114.08 0.34 Allowed 'General case' 0 C--N 1.307 -1.262 0 O-C-N 125.689 1.868 . . . . 0.0 114.437 -179.917 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.597 ' CE1' ' HB3' ' A' ' 62' ' ' PHE . 37.6 p90 -119.95 164.86 15.44 Favored 'General case' 0 N--CA 1.427 -1.598 0 O-C-N 125.18 1.55 . . . . 0.0 107.977 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -108.93 138.1 45.8 Favored 'General case' 0 C--N 1.319 -0.74 0 O-C-N 126.171 2.169 . . . . 0.0 106.997 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.801 ' O ' HD13 ' A' ' 72' ' ' LEU . 35.9 t80 -133.73 95.57 3.5 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 119.787 1.176 . . . . 0.0 111.248 -179.596 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.514 ' C ' HD22 ' A' ' 72' ' ' LEU . 1.9 p -72.26 79.22 0.99 Allowed 'General case' 0 N--CA 1.432 -1.36 0 CA-C-O 117.529 -1.224 . . . . 0.0 112.386 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.955 HD22 ' N ' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -40.06 175.75 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.813 1 O-C-N 130.355 4.785 . . . . 0.0 110.028 174.955 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.52 -45.38 13.64 Favored 'General case' 0 C--N 1.351 0.671 0 O-C-N 120.522 -1.361 . . . . 0.0 113.613 -178.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.551 ' CB ' ' HD2' ' A' ' 27' ' ' LYS . 0.4 OUTLIER -148.96 25.74 0.91 Allowed 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 179.956 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.473 ' C ' ' HG ' ' A' ' 72' ' ' LEU . . . -95.03 -32.23 7.22 Favored Glycine 0 CA--C 1.544 1.874 0 CA-C-N 112.69 -2.05 . . . . 0.0 113.312 179.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.633 ' N ' ' HG ' ' A' ' 72' ' ' LEU 0.376 0.3 OUTLIER 84.76 117.82 0.04 OUTLIER 'General case' 0 C--N 1.305 -1.364 0 CA-C-O 114.465 -2.683 . . . . 0.0 107.175 -177.878 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.713 ' N ' HD21 ' A' ' 72' ' ' LEU . 0.6 OUTLIER -3.9 120.29 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.63 1 O-C-N 130.134 4.646 . . . . 0.0 114.405 -179.412 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.691 HD12 HD23 ' A' ' 102' ' ' LEU 0.518 0.5 OUTLIER -133.22 122.12 23.49 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 102.022 -3.325 . . . . 0.0 102.022 179.772 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 10.7 t -137.59 123.35 19.96 Favored 'General case' 0 C--O 1.198 -1.637 0 N-CA-C 101.765 -3.421 . . . . 0.0 101.765 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -156.89 -149.31 5.36 Favored Glycine 0 C--N 1.308 -1.02 0 C-N-CA 116.921 -2.562 . . . . 0.0 110.419 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.435 ' CG2' ' HA ' ' A' ' 67' ' ' ASP . 22.1 p -155.32 165.79 35.57 Favored 'General case' 0 C--O 1.198 -1.607 0 CA-C-O 123.838 1.78 . . . . 0.0 109.037 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . 0.542 ' CZ2' ' CZ ' ' A' ' 106' ' ' ARG 0.322 12.2 m95 -112.71 129.46 56.4 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 100.772 -3.788 . . . . 0.0 100.772 -179.879 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.7 t -144.17 100.81 3.62 Favored 'General case' 0 C--O 1.262 1.716 0 O-C-N 121.218 -0.926 . . . . 0.0 110.254 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.482 ' CA ' HD23 ' A' ' 89' ' ' LEU . 6.4 ttp -52.58 112.93 0.91 Allowed 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 105.471 -2.048 . . . . 0.0 105.471 179.807 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . 0.622 3.8 mm-40 -77.8 -56.34 4.59 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 124.806 1.316 . . . . 0.0 110.07 -179.731 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 160.24 124.8 0.75 Allowed Glycine 0 C--O 1.22 -0.725 0 N-CA-C 103.402 -3.879 . . . . 0.0 103.402 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . 0.26 0.1 OUTLIER 55.97 15.64 1.82 Allowed 'General case' 0 C--O 1.245 0.832 0 CA-C-O 116.572 -1.68 . . . . 0.0 113.638 -179.986 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . 0.418 3.1 mppt? -174.12 150.26 1.53 Allowed 'General case' 0 CA--C 1.496 -1.101 0 O-C-N 125.772 1.92 . . . . 0.0 106.812 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.482 HD23 ' CA ' ' A' ' 84' ' ' MET . 0.7 OUTLIER -113.4 137.88 50.88 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 102.331 -3.211 . . . . 0.0 102.331 -179.879 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 18.5 m -118.24 134.37 62.08 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.028 0 N-CA-C 105.547 -2.02 . . . . 0.0 105.547 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.486 ' O ' ' HB3' ' A' ' 104' ' ' ALA . . . -113.65 95.09 0.73 Allowed Glycine 0 C--N 1.344 0.981 0 C-N-CA 128.164 2.792 . . . . 0.0 108.755 -179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.402 ' HA ' ' HA ' ' A' ' 103' ' ' ILE . 0.6 OUTLIER -90.83 168.64 11.57 Favored 'General case' 0 N--CA 1.436 -1.135 0 N-CA-C 104.323 -2.473 . . . . 0.0 104.323 179.963 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.581 ' HB3' ' HG ' ' A' ' 78' ' ' LEU . 23.5 m-85 -157.71 97.33 1.57 Allowed 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 118.454 -1.299 . . . . 0.0 108.063 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 14.5 mtmt -74.39 161.2 30.07 Favored 'General case' 0 N--CA 1.446 -0.653 0 O-C-N 125.125 1.516 . . . . 0.0 108.47 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.457 ' HD2' ' N ' ' A' ' 95' ' ' ARG 0.457 0.9 OUTLIER -119.47 139.98 51.2 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 179.69 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.603 HG11 ' HG2' ' A' ' 77' ' ' GLU . 3.1 m -83.0 -13.38 12.04 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 179.792 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . 0.333 14.3 p-10 -79.13 3.93 16.16 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 113.504 -1.68 . . . . 0.0 112.361 179.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . 0.256 0.2 OUTLIER -174.93 -29.28 0.01 OUTLIER 'General case' 0 N--CA 1.426 -1.635 0 C-N-CA 117.698 -1.601 . . . . 0.0 114.069 -179.735 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 97.56 20.07 23.31 Favored Glycine 0 N--CA 1.445 -0.701 0 N-CA-C 115.21 0.844 . . . . 0.0 115.21 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 39.3 mttt -82.95 -159.79 0.36 Allowed 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 116.159 -2.216 . . . . 0.0 106.344 -179.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -143.0 148.67 37.17 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-O 117.23 -1.367 . . . . 0.0 109.889 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.691 HD23 HD12 ' A' ' 78' ' ' LEU . 0.3 OUTLIER -133.09 110.1 9.96 Favored 'General case' 0 CA--C 1.543 0.708 1 O-C-N 131.552 5.533 . . . . 0.0 103.217 179.212 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.697 HD13 ' N ' ' A' ' 104' ' ' ALA . 0.0 OUTLIER -92.03 161.18 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.174 0 CA-C-N 114.181 -1.372 . . . . 0.0 111.003 -179.238 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.697 ' N ' HD13 ' A' ' 103' ' ' ILE . . . -150.15 106.38 3.47 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 116.152 -1.88 . . . . 0.0 107.376 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 9.2 p -87.8 103.65 13.71 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.519 0 CA-C-N 120.877 1.672 . . . . 0.0 113.587 -179.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.542 ' CZ ' ' CZ2' ' A' ' 82' ' ' TRP . 19.2 mtt-85 -74.48 82.2 1.96 Allowed 'General case' 0 CA--C 1.507 -0.679 0 CA-C-O 124.872 2.273 . . . . 0.0 106.074 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.41 ' O ' ' N ' ' A' ' 109' ' ' SER . 0.2 OUTLIER -86.61 81.37 8.27 Favored 'General case' 0 N--CA 1.417 -2.078 0 CA-C-N 111.118 -2.765 . . . . 0.0 117.292 -179.989 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.518 HG12 ' CE1' ' A' ' 2' ' ' PHE . 1.9 mm -63.61 98.41 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 C-N-CA 116.106 -2.238 . . . . 0.0 107.287 179.081 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.41 ' N ' ' O ' ' A' ' 107' ' ' GLU . 2.1 p -62.9 -29.69 70.97 Favored 'General case' 0 C--N 1.319 -0.754 0 O-C-N 121.342 -0.849 . . . . 0.0 109.116 -179.272 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 145.77 -87.97 0.16 Allowed Glycine 0 CA--C 1.526 0.727 1 C-N-CA 131.965 4.602 . . . . 0.0 110.566 -179.304 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . 0.3 0.2 OUTLIER -81.76 -0.93 45.32 Favored 'General case' 0 C--O 1.212 -0.895 0 CA-C-O 113.794 -3.003 . . . . 0.0 110.137 179.235 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -136.61 118.69 15.4 Favored 'General case' 0 C--O 1.205 -1.245 1 O-C-N 129.751 4.407 . . . . 0.0 112.49 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.47 ' HG ' HG12 ' A' ' 108' ' ' ILE . 5.0 tt -91.66 141.1 29.06 Favored 'General case' 0 C--O 1.212 -0.898 0 N-CA-C 100.763 -3.791 . . . . 0.0 100.763 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 1.048 HD12 HD12 ' A' ' 127' ' ' ILE 0.309 14.3 mm -123.1 135.97 61.37 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 N-CA-C 102.55 -3.13 . . . . 0.0 102.55 179.666 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . 0.451 ' HG3' ' CD2' ' A' ' 113' ' ' LEU . 13.5 mt-30 -131.94 95.25 3.65 Favored 'General case' 0 C--O 1.245 0.828 0 CA-C-O 115.425 -2.226 . . . . 0.0 105.385 -179.79 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 61.0 p -70.28 -171.51 0.47 Allowed 'General case' 0 C--N 1.318 -0.772 0 O-C-N 127.017 2.698 . . . . 0.0 106.425 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.466 ' N ' ' O ' ' A' ' 123' ' ' GLU . 12.3 m-85 -159.8 62.26 0.36 Allowed 'General case' 0 CA--C 1.494 -1.181 0 CA-C-O 115.735 -2.079 . . . . 0.0 106.781 179.785 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.515 ' HB ' HG22 ' A' ' 103' ' ' ILE . 0.3 OUTLIER -70.44 108.32 4.22 Favored 'General case' 0 C--O 1.254 1.295 0 O-C-N 126.885 2.616 . . . . 0.0 107.016 -179.171 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.564 ' H ' HG22 ' A' ' 122' ' ' VAL . 76.3 t80 -72.82 -35.77 67.37 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 103.827 -2.657 . . . . 0.0 103.827 -179.425 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -151.77 -66.88 0.17 Allowed 'General case' 0 C--N 1.291 -1.938 1 O-C-N 129.751 4.407 . . . . 0.0 108.074 179.866 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -145.14 27.58 1.86 Allowed Glycine 0 CA--C 1.544 1.892 0 C-N-CA 128.196 2.808 . . . . 0.0 112.881 178.545 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.645 ' HB ' ' HB3' ' A' ' 17' ' ' PHE . 1.7 m -106.77 6.86 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 CA-C-N 112.766 -1.717 . . . . 0.0 110.755 -178.237 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.466 ' O ' ' N ' ' A' ' 117' ' ' TYR . 26.4 tt0 12.71 -75.0 0.0 OUTLIER 'General case' 0 C--N 1.307 -1.275 0 O-C-N 129.007 3.942 . . . . 0.0 112.028 -179.639 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.46 ' HB3' ' O ' ' A' ' 123' ' ' GLU . . . 70.5 84.33 0.14 Allowed 'General case' 0 C--O 1.206 -1.21 0 O-C-N 116.669 -3.769 . . . . 0.0 109.08 178.793 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.452 ' N ' ' O ' ' A' ' 12' ' ' GLU . 6.0 mptt -79.7 136.76 36.86 Favored 'General case' 0 C--O 1.254 1.333 1 O-C-N 129.601 4.313 . . . . 0.0 110.027 179.97 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.499 ' NH2' HD22 ' A' ' 36' ' ' LEU . 3.2 mtm180 -126.49 77.81 1.73 Allowed 'General case' 0 N--CA 1.437 -1.096 0 O-C-N 125.574 1.796 . . . . 0.0 112.155 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 1.048 HD12 HD12 ' A' ' 114' ' ' ILE . 0.4 OUTLIER -73.96 108.37 5.39 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.922 0 O-C-N 126.362 2.289 . . . . 0.0 115.179 179.42 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.646 ' CZ ' HD13 ' A' ' 38' ' ' LEU . 28.7 m-85 -89.06 147.07 24.44 Favored 'General case' 0 N--CA 1.438 -1.064 0 C-N-CA 128.158 2.583 . . . . 0.0 111.215 179.812 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . 0.347 14.3 mtmt -100.15 8.45 43.86 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 117.733 -1.127 . . . . 0.0 110.392 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.596 ' HA ' ' CE3' ' A' ' 6' ' ' TRP . 9.7 tttm 69.53 153.68 0.11 Allowed 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . 0.835 61.1 tt0 . . . . . 0 CA--C 1.505 -0.785 0 N-CA-C 119.246 3.054 . . . . 0.0 119.246 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . 0.462 ' O ' HG21 ' A' ' 40' ' ' ILE . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.098 0 CA-C-O 124.076 1.893 . . . . 0.0 114.08 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -119.16 99.61 6.82 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 113.54 -1.664 . . . . 0.0 110.874 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . 0.412 ' O ' ' N ' ' A' ' 40' ' ' ILE . . . 157.9 -148.6 18.22 Favored Glycine 0 C--O 1.208 -1.472 0 CA-C-N 112.748 -2.023 . . . . 0.0 110.437 179.658 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.429 HG23 ' HA ' ' A' ' 131' ' ' GLU 0.566 6.3 t -102.03 159.29 15.5 Favored 'General case' 0 N--CA 1.432 -1.334 0 CA-C-N 113.794 -1.203 . . . . 0.0 112.294 -179.84 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.701 ' CH2' HD11 ' A' ' 108' ' ' ILE . 96.0 m95 -146.5 112.26 5.65 Favored 'General case' 0 N--CA 1.441 -0.902 0 O-C-N 127.685 3.116 . . . . 0.0 111.161 179.806 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 11.8 ttmt -109.15 116.47 32.0 Favored 'General case' 0 C--O 1.207 -1.17 0 CA-C-N 121.548 1.976 . . . . 0.0 108.065 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.567 ' HB ' ' CD1' ' A' ' 128' ' ' PHE 0.289 1.5 p -57.62 128.47 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 O-C-N 119.04 -2.288 . . . . 0.0 114.897 179.986 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -107.93 -21.63 12.75 Favored 'General case' 0 C--O 1.213 -0.826 0 CA-C-O 126.201 2.905 . . . . 0.0 108.883 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.407 ' O ' ' N ' ' A' ' 127' ' ' ILE . 29.9 ptt-85 -163.79 146.56 9.69 Favored 'General case' 0 CA--C 1.478 -1.795 0 O-C-N 117.93 -2.982 . . . . 0.0 113.107 179.766 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . 0.413 0.8 OUTLIER -119.19 -176.13 3.07 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 112.919 -1.946 . . . . 0.0 107.018 179.927 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -145.79 -70.94 0.26 Allowed 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 122.194 2.27 . . . . 0.0 108.062 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.535 ' ND2' ' CG ' ' A' ' 17' ' ' PHE . 2.4 t30 -92.87 39.19 1.03 Allowed 'General case' 0 N--CA 1.476 0.827 0 O-C-N 127.555 3.035 . . . . 0.0 111.91 179.542 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.467 ' HD1' ' HB1' ' A' ' 124' ' ' ALA 0.313 34.5 t80 -97.81 -57.98 2.1 Favored 'General case' 0 N--CA 1.439 -1.01 0 N-CA-C 121.267 3.802 . . . . 0.0 121.267 -179.379 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . 0.252 6.1 pm0 -56.5 -55.02 38.94 Favored 'General case' 0 CA--C 1.505 -0.757 0 CA-C-N 124.227 3.194 . . . . 0.0 114.186 -179.066 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.584 ' HB3' ' CE2' ' A' ' 17' ' ' PHE . 8.5 ttmt -55.04 -42.05 72.17 Favored 'General case' 0 N--CA 1.421 -1.923 0 C-N-CA 127.537 2.335 . . . . 0.0 115.616 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.589 ' HB3' ' HB ' ' A' ' 122' ' ' VAL 0.293 45.1 m-85 -77.58 -19.91 54.87 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 111.282 -2.69 . . . . 0.0 114.044 -177.28 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.529 ' O ' HG12 ' A' ' 23' ' ' ILE . 4.4 mmt -70.43 -20.04 62.94 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 118.812 -2.43 . . . . 0.0 105.88 175.738 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.71 -32.59 63.98 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-O 127.904 3.716 . . . . 0.0 109.837 179.775 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.885 ' HD3' HG11 ' A' ' 122' ' ' VAL . 0.5 OUTLIER -72.51 -30.11 64.2 Favored 'General case' 0 N--CA 1.454 -0.256 0 O-C-N 118.113 -2.867 . . . . 0.0 110.371 179.97 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.434 ' CE ' ' HG ' ' A' ' 72' ' ' LEU . 1.5 mmm -78.06 -28.04 48.77 Favored 'General case' 0 C--O 1.201 -1.481 0 C-N-CA 127.472 2.309 . . . . 0.0 107.768 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.62 22.0 6.57 Favored Glycine 0 C--N 1.299 -1.48 0 CA-C-O 114.598 -3.334 . . . . 0.0 111.678 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.529 HG12 ' O ' ' A' ' 18' ' ' MET . 23.9 mm -78.78 139.76 17.94 Favored 'Isoleucine or valine' 0 C--N 1.352 0.709 0 O-C-N 126.765 2.097 . . . . 0.0 106.507 -179.288 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -102.29 143.12 32.46 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-O 116.559 -1.686 . . . . 0.0 113.119 -179.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . 0.437 0.2 OUTLIER 3.35 -73.81 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.508 -0.658 0 N-CA-C 119.957 3.318 . . . . 0.0 119.957 179.962 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.646 1.8 t -65.84 -30.33 49.7 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.972 0 O-C-N 126.936 2.648 . . . . 0.0 116.634 -179.764 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.424 ' HB2' HG22 ' A' ' 23' ' ' ILE . 30.5 mtmt -73.37 -31.22 63.8 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 114.222 -1.354 . . . . 0.0 111.236 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.92 -25.86 40.38 Favored 'General case' 0 N--CA 1.473 0.715 0 O-C-N 120.46 -1.4 . . . . 0.0 107.998 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 15.8 ttpt -78.57 -43.23 27.06 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.893 -1.049 . . . . 0.0 111.456 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.4 mt -77.73 -30.86 51.87 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 118.959 -1.096 . . . . 0.0 110.382 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -71.74 -30.95 65.47 Favored Glycine 0 C--O 1.217 -0.931 0 O-C-N 125.329 1.643 . . . . 0.0 111.998 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -75.81 -25.74 56.62 Favored 'General case' 0 N--CA 1.439 -0.981 0 O-C-N 120.996 -1.296 . . . . 0.0 112.959 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -121.3 28.3 7.87 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 127.605 2.362 . . . . 0.0 115.001 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -66.84 -13.88 62.08 Favored 'General case' 0 C--O 1.218 -0.591 0 N-CA-C 117.406 2.372 . . . . 0.0 117.406 -179.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . 0.302 0.5 OUTLIER 70.25 26.86 4.25 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 121.063 1.756 . . . . 0.0 110.004 179.741 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.614 HD11 HD13 ' A' ' 38' ' ' LEU . 0.9 OUTLIER -45.34 114.1 0.69 Allowed 'General case' 0 CA--C 1.495 -1.148 0 O-C-N 127.405 2.941 . . . . 0.0 108.76 -179.739 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.554 ' N ' HD12 ' A' ' 36' ' ' LEU . 27.7 tttp -110.98 98.82 7.83 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 104.911 -2.255 . . . . 0.0 104.911 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.692 HD22 ' CE2' ' A' ' 128' ' ' PHE . 1.9 tp -79.87 139.92 36.96 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.564 ' HB ' ' CB ' ' A' ' 50' ' ' LYS . 47.3 m -131.16 82.45 2.04 Favored 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 103.189 -2.893 . . . . 0.0 103.189 179.741 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.693 HD13 HG23 ' A' ' 49' ' ' VAL . 2.4 mm -65.54 132.06 31.27 Favored 'Isoleucine or valine' 0 C--O 1.255 1.35 0 CA-C-N 112.482 -2.145 . . . . 0.0 111.116 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.485 HG22 ' O ' ' A' ' 41' ' ' THR . 13.3 m -139.76 92.29 2.55 Favored 'General case' 0 CA--C 1.501 -0.918 0 O-C-N 125.851 1.97 . . . . 0.0 112.108 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 54.8 tt0 -85.87 118.17 25.19 Favored 'General case' 0 C--O 1.243 0.745 0 CA-C-O 117.186 -1.388 . . . . 0.0 111.519 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -101.54 -109.39 0.22 Allowed 'General case' 0 CA--C 1.495 -1.166 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -112.22 76.33 0.23 Allowed Glycine 0 C--N 1.307 -1.038 0 N-CA-C 105.548 -3.021 . . . . 0.0 105.548 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.313 0.5 OUTLIER 89.62 -18.74 0.19 Allowed 'General case' 0 C--N 1.32 -0.678 0 O-C-N 128.345 3.026 . . . . 0.0 113.751 179.827 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.466 ' HA ' ' HA ' ' A' ' 63' ' ' GLU . 1.9 ttpm? -91.93 146.48 23.71 Favored 'General case' 0 N--CA 1.435 -1.199 0 C-N-CA 117.604 -1.638 . . . . 0.0 107.301 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . 0.28 4.4 m-85 -129.32 93.85 3.66 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-O 123.01 1.386 . . . . 0.0 108.94 179.803 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.982 ' HB ' HG12 ' A' ' 61' ' ' VAL 0.479 2.0 t -78.36 146.1 34.85 Favored 'General case' 0 CA--C 1.496 -1.101 0 CA-C-O 125.23 2.443 . . . . 0.0 107.949 179.739 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.693 HG23 HD13 ' A' ' 40' ' ' ILE 0.693 0.3 OUTLIER -120.68 95.75 3.78 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 CA-C-N 109.969 -3.287 . . . . 0.0 111.948 -179.981 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.564 ' CB ' ' HB ' ' A' ' 39' ' ' THR . 0.9 OUTLIER -72.22 130.34 40.58 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 100.305 -3.961 . . . . 0.0 100.305 179.685 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.522 ' HG3' HD13 ' A' ' 36' ' ' LEU . 15.9 tt0 -123.52 66.99 1.01 Allowed 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 105.947 -1.871 . . . . 0.0 105.947 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.468 ' HA ' ' ND2' ' A' ' 57' ' ' ASN . 12.6 m -71.82 74.89 0.87 Allowed 'General case' 0 C--N 1.287 -2.11 0 CA-C-O 117.861 -1.066 . . . . 0.0 108.153 -179.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -103.6 -165.73 1.19 Allowed 'General case' 0 CA--C 1.506 -0.743 0 O-C-N 125.543 1.777 . . . . 0.0 112.777 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 62.5 t30 -70.77 -20.66 62.58 Favored 'General case' 0 N--CA 1.441 -0.882 0 O-C-N 123.979 0.799 . . . . 0.0 112.325 -179.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -87.26 -55.74 3.67 Favored 'General case' 0 C--O 1.22 -0.474 0 CA-C-O 115.071 -2.395 . . . . 0.0 112.258 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.75 176.61 12.15 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 124.496 3.316 . . . . 0.0 107.725 179.738 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.468 ' ND2' ' HA ' ' A' ' 52' ' ' SER . 0.8 OUTLIER -119.17 88.04 2.85 Favored 'General case' 0 C--O 1.216 -0.702 0 C-N-CA 131.466 3.906 . . . . 0.0 100.872 -179.874 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -117.73 98.91 7.14 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.992 0 C-N-CA 129.041 2.936 . . . . 0.0 118.676 -179.511 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 19.3 p-10 -62.54 120.5 11.24 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 103.712 -2.699 . . . . 0.0 103.712 177.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.53 ' HB ' ' CZ ' ' A' ' 62' ' ' PHE . 2.8 t -83.91 -55.17 7.52 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 CA-C-O 125.42 2.533 . . . . 0.0 112.133 -177.466 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.982 HG12 ' HB ' ' A' ' 48' ' ' THR 0.349 0.7 OUTLIER 67.13 133.36 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.434 -1.252 0 O-C-N 120.046 -1.659 . . . . 0.0 114.034 -179.54 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.604 ' CD2' ' CZ ' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -166.72 100.91 0.57 Allowed 'General case' 0 N--CA 1.428 -1.555 0 CA-C-O 116.989 -1.482 . . . . 0.0 111.427 179.493 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.466 ' HA ' ' HA ' ' A' ' 46' ' ' LYS . 30.1 mm-40 -54.35 142.48 26.55 Favored 'General case' 0 N--CA 1.429 -1.503 0 O-C-N 126.782 2.551 . . . . 0.0 105.726 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.1 mp -59.54 115.79 3.55 Favored 'General case' 0 N--CA 1.431 -1.389 0 CA-C-N 120.844 1.656 . . . . 0.0 111.43 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 83.08 33.76 22.75 Favored Glycine 0 C--N 1.34 0.782 0 O-C-N 128.433 3.583 . . . . 0.0 116.897 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . 0.426 2.2 t -117.1 92.42 2.12 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.53 ' HA ' HG22 ' A' ' 81' ' ' THR 0.269 0.2 OUTLIER -44.3 134.73 4.88 Favored 'General case' 0 CA--C 1.494 -1.194 0 O-C-N 124.898 1.374 . . . . 0.0 113.203 -179.948 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.604 ' CZ ' ' CD2' ' A' ' 62' ' ' PHE . 11.7 p90 -132.46 170.18 15.49 Favored 'General case' 0 N--CA 1.439 -0.992 0 O-C-N 124.961 1.413 . . . . 0.0 108.14 -179.655 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -125.79 109.58 12.71 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 116.038 -1.934 . . . . 0.0 107.851 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 21.3 t80 -127.83 111.57 13.78 Favored 'General case' 0 C--N 1.319 -0.739 0 O-C-N 125.471 1.732 . . . . 0.0 112.876 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 8.2 t -79.95 156.32 27.29 Favored 'General case' 0 CA--C 1.487 -1.449 0 CA-C-N 119.239 0.927 . . . . 0.0 109.713 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.434 ' HG ' ' CE ' ' A' ' 21' ' ' MET . 4.0 mm? -81.22 -166.28 1.12 Allowed 'General case' 0 CA--C 1.503 -0.834 0 N-CA-C 103.874 -2.639 . . . . 0.0 103.874 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -87.85 -18.78 28.5 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 124.805 1.315 . . . . 0.0 112.491 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -84.57 -13.17 52.51 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 115.972 -2.291 . . . . 0.0 108.99 179.775 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 108.17 8.36 29.44 Favored Glycine 0 CA--C 1.542 1.768 0 CA-C-O 117.431 -1.761 . . . . 0.0 114.359 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . 0.278 7.5 m -89.83 125.57 35.37 Favored 'General case' 0 N--CA 1.433 -1.289 0 CA-C-N 119.397 1.599 . . . . 0.0 109.926 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.507 ' HG2' HG21 ' A' ' 96' ' ' VAL . 0.0 OUTLIER -66.64 169.48 7.72 Favored 'General case' 0 C--O 1.22 -0.466 0 O-C-N 128.013 3.321 . . . . 0.0 112.327 -179.989 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.486 ' HG ' ' HB3' ' A' ' 93' ' ' PHE 0.28 1.5 tt -153.08 142.44 21.64 Favored 'General case' 0 CA--C 1.503 -0.834 0 N-CA-C 102.512 -3.144 . . . . 0.0 102.512 179.777 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 19.0 p -144.94 111.79 5.86 Favored 'General case' 0 CA--C 1.491 -1.315 0 N-CA-C 102.729 -3.063 . . . . 0.0 102.729 -179.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -174.48 -167.45 33.93 Favored Glycine 0 C--N 1.301 -1.414 1 C-N-CA 113.058 -4.401 . . . . 0.0 114.414 -179.772 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.53 HG22 ' HA ' ' A' ' 67' ' ' ASP . 0.5 OUTLIER -144.89 176.32 9.56 Favored 'General case' 0 C--O 1.187 -2.229 0 CA-C-N 119.821 1.811 . . . . 0.0 111.725 -179.953 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . 0.421 ' CZ2' ' CE1' ' A' ' 62' ' ' PHE 0.311 13.7 m0 -116.85 154.32 30.96 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 106.244 -1.761 . . . . 0.0 106.244 -179.995 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.571 HG23 HG22 ' A' ' 90' ' ' VAL . 10.8 t -162.35 139.39 8.09 Favored 'General case' 0 C--N 1.297 -1.698 0 CA-C-O 124.499 2.095 . . . . 0.0 111.811 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.427 ' HA ' HD23 ' A' ' 89' ' ' LEU . 5.1 ttt -81.37 102.72 10.64 Favored 'General case' 0 C--O 1.211 -0.964 0 CA-C-N 112.018 -2.355 . . . . 0.0 106.881 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . 0.632 6.8 mt-10 -77.02 -121.12 0.01 OUTLIER 'General case' 0 N--CA 1.428 -1.526 0 CA-C-O 124.483 2.087 . . . . 0.0 111.383 -179.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -105.88 95.22 1.04 Allowed Glycine 0 N--CA 1.443 -0.86 0 N-CA-C 106.243 -2.743 . . . . 0.0 106.243 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 4.4 m120 61.81 12.84 4.99 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 116.347 1.98 . . . . 0.0 116.347 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . 0.348 9.0 mtmm -149.89 139.55 21.68 Favored 'General case' 0 C--O 1.215 -0.732 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 179.785 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.427 HD23 ' HA ' ' A' ' 84' ' ' MET . 0.0 OUTLIER -84.77 130.15 34.72 Favored 'General case' 0 C--N 1.317 -0.833 1 O-C-N 129.213 4.071 . . . . 0.0 102.046 179.849 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.748 HG12 HG23 ' A' ' 105' ' ' VAL . 16.1 m -120.85 164.76 17.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.435 ' O ' ' N ' ' A' ' 104' ' ' ALA . . . -141.4 101.12 0.28 Allowed Glycine 0 C--O 1.216 -1.02 0 C-N-CA 127.932 2.682 . . . . 0.0 109.252 -179.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.98 123.79 37.56 Favored 'General case' 0 N--CA 1.436 -1.172 0 N-CA-C 104.583 -2.377 . . . . 0.0 104.583 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.486 ' HB3' ' HG ' ' A' ' 78' ' ' LEU . 21.2 m-30 -122.16 113.02 18.91 Favored 'General case' 0 CA--C 1.506 -0.716 0 O-C-N 125.417 1.698 . . . . 0.0 114.255 -179.543 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.491 ' HA ' ' HA ' ' A' ' 101' ' ' GLU . 12.3 mttm -92.12 173.18 7.97 Favored 'General case' 0 N--CA 1.427 -1.592 0 C-N-CA 126.586 1.955 . . . . 0.0 106.621 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . 0.37 3.3 mtp180 -119.72 145.53 46.45 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.507 HG21 ' HG2' ' A' ' 77' ' ' GLU . 5.2 t -69.71 -47.78 68.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 112.89 -1.959 . . . . 0.0 113.597 -179.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . 0.324 1.5 p-10 -102.51 35.13 2.54 Favored 'General case' 0 C--O 1.258 1.512 0 CA-C-O 122.798 1.285 . . . . 0.0 113.408 -179.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -144.17 -41.61 0.27 Allowed 'General case' 0 CA--C 1.491 -1.292 0 CA-C-N 114.131 -1.395 . . . . 0.0 113.723 -179.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 81.62 2.39 90.5 Favored Glycine 0 CA--C 1.543 1.788 0 C-N-CA 125.53 1.538 . . . . 0.0 112.395 -179.658 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 47.3 mttm -85.22 -171.32 3.57 Favored 'General case' 0 C--O 1.205 -1.251 0 CA-C-N 114.291 -0.954 . . . . 0.0 110.818 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.491 ' HA ' ' HA ' ' A' ' 94' ' ' LYS . 23.0 tt0 -130.81 168.8 16.65 Favored 'General case' 0 N--CA 1.439 -1.009 0 C-N-CA 129.669 3.187 . . . . 0.0 111.066 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.551 ' CG ' ' HA ' ' A' ' 119' ' ' TYR . 5.0 tt -154.57 -179.05 7.61 Favored 'General case' 0 C--N 1.319 -0.756 2 C-N-CA 136.19 5.796 . . . . 0.0 104.361 179.827 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.479 HG23 ' HB ' ' A' ' 118' ' ' THR . 0.9 OUTLIER -157.38 155.33 5.08 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.406 0 N-CA-C 104.116 -2.55 . . . . 0.0 104.116 179.783 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.471 ' N ' HG13 ' A' ' 103' ' ' ILE . . . -143.15 94.86 2.68 Favored 'General case' 0 N--CA 1.436 -1.158 0 C-N-CA 125.551 1.54 . . . . 0.0 108.284 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.748 HG23 HG12 ' A' ' 90' ' ' VAL . 0.5 OUTLIER -89.39 116.55 31.06 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 CA-C-O 125.222 2.439 . . . . 0.0 110.588 179.713 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.565 HH11 ' HG3' ' A' ' 106' ' ' ARG . 38.3 mtt85 -88.42 90.84 8.56 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 105.915 -1.883 . . . . 0.0 105.915 179.672 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -89.38 80.05 6.87 Favored 'General case' 0 N--CA 1.423 -1.781 0 O-C-N 127.356 2.91 . . . . 0.0 117.287 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.701 HD11 ' CH2' ' A' ' 6' ' ' TRP 0.312 0.6 OUTLIER -54.24 96.79 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 C-N-CA 118.523 -1.271 . . . . 0.0 113.368 179.718 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 8.6 t -92.11 73.73 5.48 Favored 'General case' 0 CA--C 1.508 -0.635 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 -179.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 42.6 87.33 0.01 OUTLIER Glycine 0 C--N 1.334 0.452 0 O-C-N 125.586 1.804 . . . . 0.0 114.834 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . 0.315 3.7 m-20 84.32 -11.9 0.8 Allowed 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 113.961 -2.923 . . . . 0.0 111.212 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -124.93 108.45 11.9 Favored 'General case' 0 CA--C 1.497 -1.076 0 O-C-N 125.369 1.668 . . . . 0.0 111.669 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.497 HD21 ' HG2' ' A' ' 106' ' ' ARG . 6.1 tt -85.74 117.48 24.65 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 102.475 -3.157 . . . . 0.0 102.475 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.705 HG12 HG23 ' A' ' 127' ' ' ILE . 73.0 mt -113.97 142.42 26.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 N-CA-C 103.314 -2.847 . . . . 0.0 103.314 179.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . 0.443 ' HG2' ' HG2' ' A' ' 106' ' ' ARG . 35.2 mt-30 -121.07 119.91 33.81 Favored 'General case' 0 CA--C 1.503 -0.855 0 CA-C-O 115.812 -2.042 . . . . 0.0 108.599 -179.03 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.5 p -96.96 111.94 23.93 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 104.256 -2.498 . . . . 0.0 104.256 178.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.706 ' HB2' ' HB3' ' A' ' 124' ' ' ALA . 98.8 m-85 -97.26 106.05 18.31 Favored 'General case' 0 CA--C 1.477 -1.847 0 O-C-N 125.578 1.799 . . . . 0.0 113.39 -179.375 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.479 ' HB ' HG23 ' A' ' 103' ' ' ILE . 1.7 m -109.56 95.75 5.82 Favored 'General case' 0 N--CA 1.423 -1.797 0 O-C-N 125.775 1.922 . . . . 0.0 115.464 -179.766 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.551 ' HA ' ' CG ' ' A' ' 102' ' ' LEU . 60.9 t80 -52.1 -51.07 60.08 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 104.5 -2.407 . . . . 0.0 104.5 179.111 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -148.31 -64.9 0.25 Allowed 'General case' 0 C--N 1.3 -1.55 0 CA-C-N 112.596 -2.093 . . . . 0.0 111.575 179.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -144.07 27.95 2.0 Allowed Glycine 0 CA--C 1.543 1.824 0 C-N-CA 128.745 3.069 . . . . 0.0 112.091 179.559 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.885 HG11 ' HD3' ' A' ' 20' ' ' LYS . 21.1 m -133.23 80.08 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 105.067 -2.198 . . . . 0.0 105.067 -178.572 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.562 ' O ' ' HB2' ' A' ' 124' ' ' ALA 0.301 3.0 tt0 -58.03 -169.36 0.01 OUTLIER 'General case' 0 N--CA 1.426 -1.665 0 C-N-CA 127.534 2.334 . . . . 0.0 111.985 179.937 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.706 ' HB3' ' HB2' ' A' ' 117' ' ' TYR . . . 177.72 76.48 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 121.206 1.821 . . . . 0.0 109.022 179.193 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . 0.331 0.0 OUTLIER -70.08 142.34 52.65 Favored 'General case' 0 N--CA 1.446 -0.629 0 O-C-N 126.811 2.569 . . . . 0.0 107.092 179.587 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 10.8 mtm180 -144.31 78.51 1.58 Allowed 'General case' 0 C--O 1.218 -0.562 0 O-C-N 127.624 3.078 . . . . 0.0 104.894 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.705 HG23 HG12 ' A' ' 114' ' ' ILE . 2.4 mm -57.9 115.45 0.94 Allowed 'Isoleucine or valine' 0 C--O 1.247 0.948 0 O-C-N 128.215 3.447 . . . . 0.0 116.569 -179.776 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.692 ' CE2' HD22 ' A' ' 38' ' ' LEU . 22.8 m-85 -100.62 132.74 45.86 Favored 'General case' 0 N--CA 1.435 -1.223 0 C-N-CA 124.807 1.243 . . . . 0.0 108.144 179.492 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . 0.271 17.4 mtpt -95.69 6.16 49.63 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 117.229 -1.367 . . . . 0.0 110.737 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.558 ' HG3' ' CH2' ' A' ' 6' ' ' TRP . 0.0 OUTLIER 72.27 157.0 0.17 Allowed 'General case' 0 C--O 1.238 0.478 0 CA-C-N 119.411 1.005 . . . . 0.0 111.572 179.972 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.429 ' HA ' HG23 ' A' ' 5' ' ' THR 0.845 7.3 tt0 . . . . . 0 N--CA 1.44 -0.974 0 N-CA-C 118.675 2.843 . . . . 0.0 118.675 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.448 -0.561 0 CA-C-O 121.624 0.725 . . . . 0.0 112.188 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -138.18 96.57 3.22 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 115.669 1.729 . . . . 0.0 115.669 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 149.23 -141.93 9.37 Favored Glycine 0 C--O 1.214 -1.139 0 C-N-CA 116.971 -2.537 . . . . 0.0 109.147 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . 0.517 6.6 t -118.39 161.24 20.29 Favored 'General case' 0 CA--C 1.497 -1.08 0 O-C-N 127.023 2.249 . . . . 0.0 113.549 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.55 ' HB3' ' CD2' ' A' ' 128' ' ' PHE . 92.3 m95 -148.07 145.03 28.27 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 126.486 2.366 . . . . 0.0 107.133 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -132.85 102.95 5.84 Favored 'General case' 0 N--CA 1.439 -1.02 0 C-N-CA 123.655 0.782 . . . . 0.0 109.071 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.447 ' HA ' ' HA ' ' A' ' 128' ' ' PHE 0.368 11.4 p -57.17 115.72 0.91 Allowed 'Isoleucine or valine' 0 C--O 1.246 0.875 0 O-C-N 120.573 -1.33 . . . . 0.0 109.076 179.964 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -99.71 -29.12 12.83 Favored 'General case' 0 C--O 1.209 -1.041 0 O-C-N 126.591 2.432 . . . . 0.0 112.038 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 2.2 ptm180 -162.38 95.8 0.94 Allowed 'General case' 0 CA--C 1.478 -1.797 0 C-N-CA 113.789 -3.164 . . . . 0.0 112.997 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -64.69 177.36 0.94 Allowed 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 113.147 -1.842 . . . . 0.0 108.124 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -131.17 -79.29 0.53 Allowed 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 115.395 -2.24 . . . . 0.0 108.778 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -92.25 21.04 5.45 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 126.693 2.496 . . . . 0.0 115.013 179.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.766 ' HA ' ' HB1' ' A' ' 124' ' ' ALA 0.348 0.1 OUTLIER -65.35 -33.29 75.62 Favored 'General case' 0 C--N 1.309 -1.193 0 O-C-N 128.186 3.429 . . . . 0.0 114.5 -179.982 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -67.68 -23.78 65.34 Favored 'General case' 0 C--O 1.21 -1.015 0 O-C-N 117.108 -3.495 . . . . 0.0 110.694 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -79.94 -44.94 19.43 Favored 'General case' 0 C--O 1.247 0.973 0 CA-C-N 112.485 -2.143 . . . . 0.0 113.022 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.5 ' HB3' ' HB2' ' A' ' 124' ' ' ALA . 0.4 OUTLIER -60.56 -26.47 66.94 Favored 'General case' 0 N--CA 1.435 -1.218 0 CA-C-O 125.664 2.649 . . . . 0.0 112.264 179.988 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.436 ' HB3' ' HB ' ' A' ' 23' ' ' ILE . 7.6 mtt -73.68 -29.6 62.39 Favored 'General case' 0 N--CA 1.443 -0.802 0 O-C-N 116.301 -3.999 . . . . 0.0 106.629 179.36 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -70.0 -44.2 69.86 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-O 124.014 1.864 . . . . 0.0 112.213 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.804 ' HB2' HG21 ' A' ' 122' ' ' VAL . 16.2 tptt -61.06 -30.63 70.45 Favored 'General case' 0 C--O 1.209 -1.045 0 O-C-N 120.124 -1.61 . . . . 0.0 114.226 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.481 ' HG3' ' CE1' ' A' ' 17' ' ' PHE . 0.4 OUTLIER -79.45 -20.83 46.49 Favored 'General case' 0 N--CA 1.436 -1.154 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 -179.926 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 115.53 20.5 5.42 Favored Glycine 0 C--O 1.224 -0.502 0 N-CA-C 110.192 -1.163 . . . . 0.0 110.192 179.579 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.497 HG23 ' HB2' ' A' ' 27' ' ' LYS . 0.5 OUTLIER -104.79 101.88 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.291 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 -179.373 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 8.7 p-10 -130.94 24.75 4.97 Favored 'General case' 0 C--O 1.24 0.582 0 N-CA-C 114.666 1.358 . . . . 0.0 114.666 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . 0.546 17.4 m -136.17 -123.62 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.504 -0.822 0 N-CA-C 117.629 2.455 . . . . 0.0 117.629 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.65 0.0 OUTLIER -76.78 -22.67 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 N-CA-C 117.637 2.458 . . . . 0.0 117.637 179.816 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.497 ' HB2' HG23 ' A' ' 23' ' ' ILE . 0.7 OUTLIER -73.64 -25.91 60.52 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 114.463 -1.244 . . . . 0.0 113.985 179.957 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.66 -27.99 40.81 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 121.124 1.784 . . . . 0.0 107.301 -179.725 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -67.93 -41.29 82.82 Favored 'General case' 0 CA--C 1.508 -0.654 0 CA-C-O 123.249 1.5 . . . . 0.0 111.889 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 16.3 mt -73.7 -34.52 64.89 Favored 'General case' 0 N--CA 1.438 -1.034 0 O-C-N 120.5 -1.375 . . . . 0.0 107.439 179.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -76.51 -29.68 57.64 Favored Glycine 0 C--N 1.338 0.647 0 O-C-N 128.574 3.671 . . . . 0.0 114.995 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -71.91 -33.96 68.73 Favored 'General case' 0 C--O 1.243 0.732 0 O-C-N 119.425 -2.221 . . . . 0.0 110.24 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 7.2 t-80 -85.25 0.34 52.2 Favored 'General case' 0 N--CA 1.441 -0.916 0 O-C-N 127.384 2.927 . . . . 0.0 110.652 179.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.28 101.09 2.26 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-O 114.83 -2.51 . . . . 0.0 111.803 179.67 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.416 ' ND2' ' O ' ' A' ' 8' ' ' VAL . 1.5 t-20 -74.09 60.61 0.79 Allowed 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 121.447 1.931 . . . . 0.0 110.9 -179.373 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.536 HD21 ' HZ ' ' A' ' 128' ' ' PHE . 0.2 OUTLIER -41.89 119.06 1.22 Allowed 'General case' 0 CA--C 1.496 -1.101 0 CA-C-O 125.492 2.568 . . . . 0.0 111.178 -179.627 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.489 ' N ' HD12 ' A' ' 36' ' ' LEU . 44.9 tttm -107.78 111.24 23.3 Favored 'General case' 0 CA--C 1.516 -0.352 0 N-CA-C 102.076 -3.305 . . . . 0.0 102.076 179.793 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.522 ' CD2' HG22 ' A' ' 49' ' ' VAL . 0.1 OUTLIER -93.05 145.63 24.24 Favored 'General case' 0 C--N 1.31 -1.132 0 C-N-CA 114.941 -2.704 . . . . 0.0 105.149 -179.902 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.8 m -134.1 85.29 2.18 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 103.432 -2.803 . . . . 0.0 103.432 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.495 HG12 HG23 ' A' ' 49' ' ' VAL . 42.7 mt -79.86 117.76 26.23 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.122 0 O-C-N 124.731 1.27 . . . . 0.0 110.287 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.482 HG22 ' O ' ' A' ' 41' ' ' THR . 0.9 OUTLIER -112.25 110.15 20.22 Favored 'General case' 0 CA--C 1.511 -0.529 1 O-C-N 129.868 4.48 . . . . 0.0 112.614 -179.86 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -85.68 95.8 9.49 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -110.23 86.19 2.26 Favored 'General case' 0 N--CA 1.426 -1.638 0 N-CA-C 104.698 -2.334 . . . . 0.0 104.698 179.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 75.18 -89.9 0.8 Allowed Glycine 0 C--N 1.305 -1.185 0 N-CA-C 106.764 -2.535 . . . . 0.0 106.764 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -129.06 -42.31 1.38 Allowed 'General case' 0 N--CA 1.443 -0.783 0 O-C-N 127.723 2.661 . . . . 0.0 111.394 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.402 ' HA ' ' HA ' ' A' ' 63' ' ' GLU . 0.1 OUTLIER -58.42 129.23 41.05 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-O 123.49 1.614 . . . . 0.0 108.87 179.837 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.57 ' CE1' HD21 ' A' ' 64' ' ' LEU 0.289 1.7 m-85 -108.5 99.41 8.8 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 -179.804 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.719 ' HA ' HG13 ' A' ' 61' ' ' VAL 0.388 28.3 p -70.76 85.44 0.66 Allowed 'General case' 0 N--CA 1.432 -1.361 0 C-N-CA 117.646 -1.622 . . . . 0.0 110.034 -179.954 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.769 HG13 ' HB ' ' A' ' 60' ' ' VAL 0.657 10.0 p -67.2 87.24 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.494 -1.179 0 O-C-N 126.051 2.094 . . . . 0.0 109.717 -179.864 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 9.8 ttpp -73.28 119.92 18.19 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 105.281 -2.118 . . . . 0.0 105.281 -179.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.401 ' O ' ' N ' ' A' ' 53' ' ' SER 0.335 71.9 tt0 -108.12 65.97 0.64 Allowed 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 103.783 -2.673 . . . . 0.0 103.783 -179.983 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.3 m -68.62 72.37 0.22 Allowed 'General case' 0 N--CA 1.418 -2.073 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 179.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.401 ' N ' ' O ' ' A' ' 51' ' ' GLU . 60.2 p -102.82 -177.43 3.38 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-O 116.51 -1.709 . . . . 0.0 111.698 -179.782 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -62.28 -30.12 70.91 Favored 'General case' 0 C--O 1.218 -0.599 0 CA-C-N 119.53 1.059 . . . . 0.0 108.178 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -67.38 -68.19 0.4 Allowed 'General case' 0 C--O 1.21 -0.99 0 CA-C-O 115.73 -2.081 . . . . 0.0 109.068 179.739 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.818 ' HB2' HG22 ' A' ' 58' ' ' ILE 0.272 13.5 mmt180 -136.36 -175.46 4.01 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 122.231 2.287 . . . . 0.0 111.198 -179.92 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -134.1 55.32 1.9 Allowed 'General case' 0 C--O 1.218 -0.567 2 N-CA-C 100.143 -4.021 . . . . 0.0 100.143 179.551 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.818 HG22 ' HB2' ' A' ' 56' ' ' ARG . 3.4 tt -99.31 106.11 18.46 Favored 'Isoleucine or valine' 0 C--N 1.346 0.419 1 C-N-CA 132.294 4.238 . . . . 0.0 117.398 -179.332 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -62.82 136.41 57.84 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 105.327 -2.101 . . . . 0.0 105.327 179.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.769 ' HB ' HG13 ' A' ' 49' ' ' VAL . 2.5 t -116.97 41.65 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 -179.59 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.719 HG13 ' HA ' ' A' ' 48' ' ' THR 0.354 0.1 OUTLIER -36.46 144.9 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 CA-C-O 125.707 2.67 . . . . 0.0 114.48 -179.941 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.457 ' HB3' ' CE1' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -156.0 100.93 2.07 Favored 'General case' 0 N--CA 1.423 -1.796 0 O-C-N 119.732 -1.855 . . . . 0.0 109.608 178.435 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.419 ' O ' ' C ' ' A' ' 64' ' ' LEU . 0.0 OUTLIER -68.55 93.28 0.49 Allowed 'General case' 0 CA--C 1.533 0.309 1 N-CA-C 99.942 -4.096 . . . . 0.0 99.942 178.054 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.655 ' CB ' ' CE2' ' A' ' 82' ' ' TRP . 0.0 OUTLIER -14.59 88.68 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.181 0 O-C-N 128.027 3.329 . . . . 0.0 110.523 -178.196 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.567 ' N ' ' CD1' ' A' ' 82' ' ' TRP . . . 90.67 44.13 4.64 Favored Glycine 0 C--N 1.353 1.478 0 CA-C-N 109.985 -3.279 . . . . 0.0 118.918 179.42 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . 0.484 0.6 OUTLIER -105.3 -8.8 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.236 0 CA-C-N 111.968 -2.116 . . . . 0.0 107.547 -179.846 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.574 ' HA ' HG22 ' A' ' 81' ' ' THR . 1.8 m-20 69.63 143.81 0.05 OUTLIER 'General case' 0 CA--C 1.491 -1.297 0 CA-C-O 122.154 0.978 . . . . 0.0 109.858 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.574 ' CZ ' ' HA ' ' A' ' 81' ' ' THR . 1.0 OUTLIER -163.81 119.29 1.61 Allowed 'General case' 0 N--CA 1.438 -1.045 0 C-N-CA 117.363 -1.735 . . . . 0.0 111.066 179.989 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -77.46 102.67 6.98 Favored 'General case' 0 C--O 1.245 0.841 0 N-CA-C 103.74 -2.689 . . . . 0.0 103.74 179.171 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.515 ' HD2' HD22 ' A' ' 78' ' ' LEU . 31.1 t80 -107.2 87.8 2.59 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-O 116.139 -1.886 . . . . 0.0 113.821 -178.275 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 36.7 p -55.51 128.33 33.95 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 104.998 -2.223 . . . . 0.0 104.998 179.6 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.976 HD21 HD13 ' A' ' 78' ' ' LEU . 26.0 mt -71.57 -160.37 0.05 Allowed 'General case' 0 CA--C 1.495 -1.148 0 N-CA-C 106.133 -1.802 . . . . 0.0 106.133 -179.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -88.14 -30.4 19.85 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-O 124.97 2.319 . . . . 0.0 112.476 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.401 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 1.2 m-20 -124.77 -55.33 1.62 Allowed 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 113.045 -1.889 . . . . 0.0 111.211 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.0 -32.87 81.82 Favored Glycine 0 C--O 1.204 -1.755 0 CA-C-O 118.315 -1.269 . . . . 0.0 113.923 179.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.545 HG22 ' H ' ' A' ' 77' ' ' GLU 0.256 0.0 OUTLIER 70.24 169.89 0.31 Allowed 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 123.268 3.534 . . . . 0.0 114.738 179.821 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.545 ' H ' HG22 ' A' ' 76' ' ' THR . 5.0 mt-10 7.8 103.68 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.835 1 O-C-N 131.532 5.52 . . . . 0.0 113.704 -179.682 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.976 HD13 HD21 ' A' ' 72' ' ' LEU 0.414 0.4 OUTLIER -140.29 101.19 4.07 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 102.233 -3.247 . . . . 0.0 102.233 179.933 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 48.6 m -108.05 135.07 50.02 Favored 'General case' 0 C--O 1.202 -1.438 0 O-C-N 126.459 2.35 . . . . 0.0 106.059 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 173.62 -144.34 7.62 Favored Glycine 0 C--N 1.3 -1.437 0 C-N-CA 117.209 -2.424 . . . . 0.0 109.821 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.574 HG22 ' HA ' ' A' ' 67' ' ' ASP . 44.0 p -166.28 168.77 14.84 Favored 'General case' 0 C--O 1.19 -2.049 0 CA-C-O 123.48 1.609 . . . . 0.0 109.902 -179.637 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . 0.705 ' CG ' ' N ' ' A' ' 83' ' ' THR 0.406 1.9 p-90 -76.31 -169.64 1.24 Allowed 'General case' 0 C--N 1.316 -0.886 1 N-CA-C 99.807 -4.145 . . . . 0.0 99.807 175.419 . . . . . . . . 4 3 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.94 HG23 HG23 ' A' ' 90' ' ' VAL 0.292 0.5 OUTLIER 177.19 128.26 0.04 OUTLIER 'General case' 0 N--CA 1.437 -1.122 0 CA-C-O 124.676 2.179 . . . . 0.0 112.897 174.94 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.563 ' CB ' ' CH2' ' A' ' 82' ' ' TRP . 3.0 ttt -96.96 102.27 14.01 Favored 'General case' 0 N--CA 1.426 -1.633 0 N-CA-C 106.056 -1.831 . . . . 0.0 106.056 179.09 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.434 ' CG ' ' CG2' ' A' ' 90' ' ' VAL 0.67 0.0 OUTLIER -79.67 62.66 4.01 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 120.462 1.483 . . . . 0.0 108.655 179.691 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 76.94 -64.3 3.08 Favored Glycine 0 C--O 1.219 -0.785 0 N-CA-C 107.261 -2.336 . . . . 0.0 107.261 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 28.9 p-10 -129.78 -16.29 3.77 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 120.866 2.333 . . . . 0.0 116.681 -179.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . 0.365 0.3 OUTLIER -113.89 111.35 21.56 Favored 'General case' 0 CA--C 1.496 -1.13 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 179.924 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.598 HD22 ' HE ' ' A' ' 106' ' ' ARG . 2.0 tt -66.24 153.8 41.55 Favored 'General case' 0 C--N 1.32 -0.715 0 O-C-N 125.186 1.554 . . . . 0.0 107.277 179.856 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.94 HG23 HG23 ' A' ' 83' ' ' THR . 0.0 OUTLIER -144.19 179.97 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.021 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 179.986 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -140.53 99.17 0.24 Allowed Glycine 0 C--N 1.352 1.445 0 C-N-CA 129.034 3.206 . . . . 0.0 107.637 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.417 ' O ' ' CD1' ' A' ' 93' ' ' PHE . 5.9 mtpm? -98.25 138.11 36.0 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 102.365 -3.198 . . . . 0.0 102.365 -179.532 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.556 ' HB3' ' HG ' ' A' ' 78' ' ' LEU . 62.8 m-85 -150.06 127.77 11.67 Favored 'General case' 0 CA--C 1.5 -0.955 0 O-C-N 126.262 2.227 . . . . 0.0 113.702 -179.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 18.1 mttt -105.65 150.11 25.74 Favored 'General case' 0 N--CA 1.432 -1.374 0 CA-C-N 112.303 -2.226 . . . . 0.0 111.539 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.447 ' HG2' ' HB2' ' A' ' 98' ' ' ASN 0.401 1.0 OUTLIER -96.05 143.12 27.48 Favored 'General case' 0 N--CA 1.433 -1.322 0 CA-C-O 116.623 -1.656 . . . . 0.0 106.681 -179.713 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.4 m -83.53 -29.05 7.65 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.213 0 O-C-N 124.48 1.112 . . . . 0.0 113.941 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . 0.356 6.2 p-10 -90.17 11.63 20.41 Favored 'General case' 0 C--O 1.251 1.169 0 CA-C-N 112.454 -2.157 . . . . 0.0 111.281 179.569 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.447 ' HB2' ' HG2' ' A' ' 95' ' ' ARG . 5.9 t30 -138.57 -43.08 0.49 Allowed 'General case' 0 N--CA 1.439 -1.019 0 CA-C-N 112.562 -2.108 . . . . 0.0 116.604 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 86.7 -10.7 66.55 Favored Glycine 0 CA--C 1.535 1.301 0 CA-C-O 124.379 2.099 . . . . 0.0 113.469 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 47.4 mttt -70.77 -167.12 0.17 Allowed 'General case' 0 C--O 1.203 -1.367 0 O-C-N 120.299 -1.707 . . . . 0.0 109.783 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -135.2 154.07 51.73 Favored 'General case' 0 N--CA 1.441 -0.919 0 C-N-CA 128.612 2.765 . . . . 0.0 111.267 -179.818 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.635 ' HG ' ' HA ' ' A' ' 119' ' ' TYR . 7.2 tt -132.73 137.29 46.83 Favored 'General case' 0 C--O 1.247 0.938 1 C-N-CA 133.816 4.846 . . . . 0.0 105.412 -179.609 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.732 HG23 ' HB3' ' A' ' 117' ' ' TYR . 11.1 tt -132.0 160.17 42.62 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.158 0 N-CA-C 105.428 -2.064 . . . . 0.0 105.428 179.26 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.464 ' O ' HG12 ' A' ' 90' ' ' VAL . . . -152.65 135.15 15.2 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-O 114.523 -2.656 . . . . 0.0 106.497 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.745 HG12 ' O ' ' A' ' 116' ' ' THR . 7.1 p -119.99 114.71 45.03 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.799 0 CA-C-N 122.172 2.26 . . . . 0.0 114.454 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.598 ' HE ' HD22 ' A' ' 89' ' ' LEU . 3.5 mtm180 -82.8 94.43 7.65 Favored 'General case' 0 C--O 1.223 -0.323 0 N-CA-C 103.788 -2.671 . . . . 0.0 103.788 178.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . 0.329 4.7 tt0 -72.0 -38.01 69.73 Favored 'General case' 0 C--O 1.21 -0.993 0 CA-C-N 110.934 -2.848 . . . . 0.0 116.129 -177.272 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.538 HD11 ' CZ2' ' A' ' 6' ' ' TRP 0.395 2.7 mm 60.05 75.96 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 C-N-CA 111.782 -3.967 . . . . 0.0 113.904 -179.686 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 6.8 t -65.54 -102.76 0.0 OUTLIER 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 120.46 1.482 . . . . 0.0 109.533 -179.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -133.85 89.32 0.25 Allowed Glycine 0 CA--C 1.521 0.416 1 C-N-CA 130.958 4.123 . . . . 0.0 110.685 179.572 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . 0.326 31.8 m-20 90.52 -25.43 0.06 Allowed 'General case' 0 C--N 1.309 -1.185 0 CA-C-O 114.54 -2.648 . . . . 0.0 110.071 -179.13 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -113.1 137.52 51.31 Favored 'General case' 0 CA--C 1.489 -1.381 1 O-C-N 129.332 4.145 . . . . 0.0 113.873 -179.362 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.53 ' HB2' ' CH2' ' A' ' 6' ' ' TRP . 8.6 tt -102.98 147.04 27.43 Favored 'General case' 0 C--O 1.21 -1.003 0 N-CA-C 100.781 -3.785 . . . . 0.0 100.781 -179.807 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.782 HG23 HD13 ' A' ' 127' ' ' ILE 0.265 13.4 mt -150.44 125.49 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 N-CA-C 103.625 -2.731 . . . . 0.0 103.625 179.961 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . 0.561 ' HB2' ' HD2' ' A' ' 126' ' ' ARG . 8.4 mt-30 -101.14 139.69 36.48 Favored 'General case' 0 N--CA 1.441 -0.915 0 N-CA-C 103.121 -2.918 . . . . 0.0 103.121 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.745 ' O ' HG12 ' A' ' 105' ' ' VAL . 0.2 OUTLIER -156.68 144.58 19.38 Favored 'General case' 0 N--CA 1.415 -2.186 0 CA-C-N 113.496 -1.683 . . . . 0.0 112.664 179.986 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.732 ' HB3' HG23 ' A' ' 103' ' ' ILE 0.382 21.4 m-30 145.88 -136.29 0.0 OUTLIER 'General case' 0 CA--C 1.481 -1.684 0 O-C-N 128.088 3.367 . . . . 0.0 113.152 176.277 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.505 HG23 ' H ' ' A' ' 120' ' ' GLU . 10.5 t -159.3 -157.97 0.63 Allowed 'General case' 0 C--N 1.311 -1.068 0 O-C-N 127.67 3.106 . . . . 0.0 116.567 -174.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.635 ' HA ' ' HG ' ' A' ' 102' ' ' LEU 0.302 6.8 t80 -120.6 -4.89 9.77 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 111.865 -2.425 . . . . 0.0 110.695 178.309 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.505 ' H ' HG23 ' A' ' 118' ' ' THR . 0.9 OUTLIER -176.98 -68.92 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.511 0 O-C-N 120.506 -1.371 . . . . 0.0 112.025 -179.629 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -151.75 17.49 0.85 Allowed Glycine 0 CA--C 1.541 1.695 0 N-CA-C 119.692 2.637 . . . . 0.0 119.692 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.804 HG21 ' HB2' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -122.22 94.31 2.87 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 N-CA-C 104.314 -2.476 . . . . 0.0 104.314 -179.698 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.477 ' HA ' ' HB ' ' A' ' 118' ' ' THR . 0.8 OUTLIER -59.15 177.92 0.15 Allowed 'General case' 0 C--O 1.216 -0.659 0 CA-C-O 122.118 0.961 . . . . 0.0 112.377 -178.233 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.766 ' HB1' ' HA ' ' A' ' 14' ' ' TYR . . . -172.65 91.81 0.11 Allowed 'General case' 0 N--CA 1.437 -1.12 0 O-C-N 118.505 -2.622 . . . . 0.0 109.664 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.543 ' HG3' ' HB ' ' A' ' 116' ' ' THR . 1.7 mptm? -69.62 164.38 23.47 Favored 'General case' 0 CA--C 1.508 -0.671 0 CA-C-N 121.54 1.973 . . . . 0.0 110.997 179.734 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.593 ' HG2' ' CD2' ' A' ' 14' ' ' TYR . 36.7 mtt180 -145.82 72.77 1.32 Allowed 'General case' 0 C--O 1.208 -1.1 0 CA-C-N 110.466 -3.061 . . . . 0.0 110.481 -179.675 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.782 HD13 HG23 ' A' ' 114' ' ' ILE . 17.5 mm -66.3 117.8 7.98 Favored 'Isoleucine or valine' 0 C--O 1.254 1.325 1 O-C-N 129.102 4.001 . . . . 0.0 112.346 -179.987 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.55 ' CD2' ' HB3' ' A' ' 6' ' ' TRP . 12.5 m-85 -103.91 167.77 9.56 Favored 'General case' 0 N--CA 1.442 -0.872 0 O-C-N 127.186 2.804 . . . . 0.0 107.552 179.175 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 2.4 mmmt -122.23 1.56 9.7 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 116.621 -1.657 . . . . 0.0 109.373 179.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.518 ' HD2' ' CH2' ' A' ' 6' ' ' TRP . 0.9 OUTLIER 68.81 97.14 0.06 Allowed 'General case' 0 C--O 1.238 0.487 0 CA-C-N 120.794 1.634 . . . . 0.0 113.218 -179.954 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . 0.823 21.5 tt0 . . . . . 0 N--CA 1.431 -1.419 0 CA-C-N 121.492 1.951 . . . . 0.0 115.084 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 . . . . . 0 N--CA 1.447 -0.604 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.407 ' N ' ' OD1' ' A' ' 3' ' ' ASP . 17.8 p-10 -55.98 85.97 0.01 OUTLIER 'General case' 0 CA--C 1.5 -0.974 0 N-CA-C 115.318 1.599 . . . . 0.0 115.318 -179.77 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -179.54 -151.5 9.88 Favored Glycine 0 N--CA 1.436 -1.33 0 C-N-CA 116.144 -2.932 . . . . 0.0 110.687 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.447 HG22 ' HA ' ' A' ' 39' ' ' THR 0.441 0.1 OUTLIER -124.74 150.83 45.82 Favored 'General case' 0 N--CA 1.427 -1.589 0 N-CA-C 116.312 1.967 . . . . 0.0 116.312 -179.855 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.704 ' HA ' ' CE2' ' A' ' 128' ' ' PHE . 21.0 m95 -137.16 -166.77 1.98 Allowed 'General case' 0 CA--C 1.498 -1.029 0 CA-C-O 114.37 -2.728 . . . . 0.0 106.509 178.623 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.638 ' CB ' ' CZ ' ' A' ' 128' ' ' PHE . 6.7 ttpt 177.28 27.57 0.0 OUTLIER 'General case' 0 N--CA 1.432 -1.339 0 CA-C-O 112.804 -3.474 . . . . 0.0 112.498 -177.083 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.746 ' CG1' HD23 ' A' ' 36' ' ' LEU 0.404 1.7 m 15.24 108.95 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 CA-C-N 121.939 2.154 . . . . 0.0 116.745 -179.754 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -128.47 -69.36 0.72 Allowed 'General case' 0 CA--C 1.498 -1.022 0 O-C-N 120.48 -1.388 . . . . 0.0 113.118 -178.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.5 ptp180 -84.32 95.1 8.62 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 118.168 -1.413 . . . . 0.0 111.437 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -93.33 -172.82 3.05 Favored 'General case' 0 N--CA 1.441 -0.903 0 O-C-N 127.092 2.745 . . . . 0.0 108.937 -179.697 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -143.6 -67.07 0.35 Allowed 'General case' 0 C--N 1.306 -1.288 0 CA-C-O 115.994 -1.955 . . . . 0.0 108.622 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -95.58 15.4 19.95 Favored 'General case' 0 C--O 1.219 -0.545 0 O-C-N 127.502 3.001 . . . . 0.0 113.617 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.669 ' HA ' ' HB1' ' A' ' 124' ' ' ALA 0.381 0.1 OUTLIER -76.38 -26.22 55.4 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 117.876 2.547 . . . . 0.0 117.876 179.852 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -74.83 -37.35 62.3 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-O 122.615 1.198 . . . . 0.0 111.894 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 4.7 ttmt -78.15 -24.52 47.29 Favored 'General case' 0 C--O 1.246 0.894 0 CA-C-O 126.046 2.831 . . . . 0.0 113.826 -179.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.581 ' CB ' ' HB2' ' A' ' 124' ' ' ALA . 10.1 t80 -66.63 -31.0 71.4 Favored 'General case' 0 N--CA 1.438 -1.041 0 CA-C-O 125.834 2.73 . . . . 0.0 113.374 -179.681 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.512 ' HB3' ' HB ' ' A' ' 23' ' ' ILE . 29.3 mtt -73.63 -24.69 60.05 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 125.851 2.738 . . . . 0.0 106.859 179.668 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -73.27 -22.23 60.43 Favored 'General case' 0 N--CA 1.474 0.765 0 O-C-N 119.003 -2.311 . . . . 0.0 109.396 179.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 6.0 tptp -75.25 -38.73 60.4 Favored 'General case' 0 C--N 1.313 -0.993 0 O-C-N 118.996 -2.315 . . . . 0.0 113.244 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 7.3 mtm -76.37 -38.17 56.17 Favored 'General case' 0 C--O 1.214 -0.796 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 125.96 43.47 0.28 Allowed Glycine 0 C--N 1.304 -1.205 0 CA-C-O 116.797 -2.113 . . . . 0.0 111.87 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.512 ' HB ' ' HB3' ' A' ' 18' ' ' MET . 0.2 OUTLIER -119.62 107.09 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 CA-C-O 115.758 -2.067 . . . . 0.0 107.212 -179.579 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -132.42 14.42 4.54 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 115.162 1.542 . . . . 0.0 115.162 -179.671 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . 0.412 33.2 m -119.66 -136.55 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.499 -0.99 0 O-C-N 126.992 2.683 . . . . 0.0 115.436 179.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.484 2.4 m -70.99 -24.09 24.2 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.934 0 CA-C-N 121.719 2.054 . . . . 0.0 114.027 179.823 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.41 ' HD2' ' CG ' ' A' ' 74' ' ' ASP . 13.2 mtmm -66.29 -34.68 78.54 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 115.002 1.482 . . . . 0.0 115.002 -179.819 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.405 ' N ' HG22 ' A' ' 23' ' ' ILE . 7.4 ptt180 -78.87 -24.23 44.4 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 123.561 1.648 . . . . 0.0 108.221 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.2 tttt -78.99 -32.03 45.05 Favored 'General case' 0 C--O 1.213 -0.84 0 CA-C-N 113.96 -1.473 . . . . 0.0 110.921 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.421 HD12 ' HA ' ' A' ' 30' ' ' LEU . 8.7 tp -77.64 -35.97 51.99 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 114.645 -1.161 . . . . 0.0 111.903 179.713 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.74 -25.52 73.76 Favored Glycine 0 C--O 1.213 -1.169 0 C-N-CA 123.933 0.778 . . . . 0.0 112.636 -179.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -76.94 -32.44 57.34 Favored 'General case' 0 C--N 1.315 -0.93 0 C-N-CA 125.89 1.676 . . . . 0.0 109.237 179.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 65.4 m80 -123.31 28.55 7.03 Favored 'General case' 0 C--O 1.236 0.373 0 O-C-N 126.979 2.674 . . . . 0.0 114.189 179.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -67.36 -19.42 65.43 Favored 'General case' 0 C--O 1.216 -0.683 0 N-CA-C 114.545 1.313 . . . . 0.0 114.545 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . 0.254 1.4 m-20 76.72 62.06 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 116.914 -1.914 . . . . 0.0 108.812 179.564 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.746 HD23 ' CG1' ' A' ' 8' ' ' VAL . 16.9 tp -80.02 73.04 6.83 Favored 'General case' 0 N--CA 1.469 0.525 0 O-C-N 126.752 2.533 . . . . 0.0 108.309 -179.617 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.447 ' HB3' ' HB2' ' A' ' 52' ' ' SER . 5.6 ttpp -68.9 112.08 5.35 Favored 'General case' 0 C--N 1.305 -1.349 1 N-CA-C 100.138 -4.023 . . . . 0.0 100.138 -179.508 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.547 ' CD1' ' HG ' ' A' ' 36' ' ' LEU 0.377 1.3 mp -104.8 103.13 12.68 Favored 'General case' 0 C--N 1.288 -2.079 0 N-CA-C 105.458 -2.053 . . . . 0.0 105.458 -178.316 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.504 ' HB ' ' CB ' ' A' ' 50' ' ' LYS . 1.9 m -94.85 86.39 4.68 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 117.276 -3.39 . . . . 0.0 103.902 179.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.585 HD13 HG23 ' A' ' 49' ' ' VAL . 12.0 mm -61.46 146.53 11.82 Favored 'Isoleucine or valine' 0 C--O 1.243 0.729 0 N-CA-C 105.973 -1.862 . . . . 0.0 105.973 -179.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.525 ' CG2' HG23 ' A' ' 48' ' ' THR . 4.6 t -150.34 35.0 0.64 Allowed 'General case' 0 CA--C 1.506 -0.731 0 O-C-N 126.956 2.66 . . . . 0.0 114.493 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 24.7 tt0 -33.41 111.63 0.11 Allowed 'General case' 0 C--N 1.311 -1.106 0 O-C-N 126.981 2.676 . . . . 0.0 111.59 -179.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -81.08 -0.72 41.2 Favored 'General case' 0 N--CA 1.42 -1.947 0 CA-C-O 124.642 2.163 . . . . 0.0 111.935 -179.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 135.65 -55.66 0.72 Allowed Glycine 0 C--N 1.292 -1.87 0 N-CA-C 104.479 -3.448 . . . . 0.0 104.479 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.301 0.3 OUTLIER -127.4 -37.4 2.02 Favored 'General case' 0 C--N 1.316 -0.886 0 O-C-N 126.812 2.125 . . . . 0.0 112.587 -179.736 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 28.1 ttmt -91.12 139.2 30.98 Favored 'General case' 0 C--N 1.318 -0.792 0 O-C-N 117.906 -2.996 . . . . 0.0 107.601 -179.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . 0.251 21.0 m-85 -118.52 110.06 16.94 Favored 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 124.448 1.099 . . . . 0.0 110.956 -179.619 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.906 ' HB ' HG12 ' A' ' 61' ' ' VAL 0.401 0.1 OUTLIER -98.4 78.14 2.41 Favored 'General case' 0 N--CA 1.44 -0.965 0 O-C-N 125.078 1.486 . . . . 0.0 107.096 179.951 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.725 HG13 ' HB ' ' A' ' 60' ' ' VAL 0.625 11.3 p -52.3 97.62 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 CA-C-N 109.497 -3.501 . . . . 0.0 113.073 179.737 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.504 ' CB ' ' HB ' ' A' ' 39' ' ' THR . 0.0 OUTLIER -62.23 139.27 58.5 Favored 'General case' 0 C--N 1.304 -1.384 1 N-CA-C 100.102 -4.036 . . . . 0.0 100.102 -179.633 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.539 ' HB3' HG23 ' A' ' 58' ' ' ILE 0.253 3.4 tt0 -138.67 91.11 2.51 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 -179.229 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.447 ' HB2' ' HB3' ' A' ' 37' ' ' LYS . 1.0 OUTLIER -93.3 55.15 2.22 Favored 'General case' 0 C--N 1.286 -2.164 0 N-CA-C 105.634 -1.987 . . . . 0.0 105.634 -179.916 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 89.5 p -69.39 158.9 34.21 Favored 'General case' 0 C--N 1.349 0.561 0 CA-C-O 114.912 -2.47 . . . . 0.0 109.21 -179.587 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -52.74 -29.31 26.32 Favored 'General case' 0 C--O 1.212 -0.904 0 O-C-N 125.846 1.966 . . . . 0.0 106.946 179.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.523 ' CE2' ' HB1' ' A' ' 73' ' ' ALA . 11.1 m-85 -73.27 -55.76 5.99 Favored 'General case' 0 C--N 1.35 0.627 0 CA-C-O 114.707 -2.568 . . . . 0.0 111.211 179.341 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.852 ' HB3' HG22 ' A' ' 58' ' ' ILE 0.313 0.0 OUTLIER -142.83 174.79 10.34 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 124.42 3.282 . . . . 0.0 111.287 -179.88 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -121.97 71.73 1.0 Allowed 'General case' 0 C--O 1.221 -0.409 1 N-CA-C 99.873 -4.121 . . . . 0.0 99.873 179.382 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.852 HG22 ' HB3' ' A' ' 56' ' ' ARG . 1.9 tt -105.67 103.18 14.97 Favored 'Isoleucine or valine' 0 C--O 1.243 0.724 0 O-C-N 127.635 3.085 . . . . 0.0 118.997 -179.189 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -65.91 125.0 24.02 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 103.623 -2.732 . . . . 0.0 103.623 178.409 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.725 ' HB ' HG13 ' A' ' 49' ' ' VAL . 24.5 t -100.76 97.14 5.38 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 -178.177 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.906 HG12 ' HB ' ' A' ' 48' ' ' THR 0.427 0.6 OUTLIER -79.66 135.25 25.95 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 CA-C-N 121.543 1.974 . . . . 0.0 108.986 179.748 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.517 ' CE1' HG12 ' A' ' 49' ' ' VAL . 12.4 p90 -160.45 90.59 0.88 Allowed 'General case' 0 N--CA 1.432 -1.339 0 CA-C-O 123.832 1.777 . . . . 0.0 109.978 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -59.33 149.36 29.18 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 104.805 -2.294 . . . . 0.0 104.805 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.0 mt -66.16 110.9 3.17 Favored 'General case' 0 N--CA 1.427 -1.61 0 C-N-CA 117.982 -1.487 . . . . 0.0 108.58 -179.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.415 ' HA2' ' HB ' ' A' ' 81' ' ' THR . . . 72.78 46.45 30.16 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 128.199 2.809 . . . . 0.0 119.165 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . 0.442 3.8 t -111.92 7.92 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 CA-C-O 115.435 -2.222 . . . . 0.0 107.889 -179.818 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 46.71 101.7 0.0 OUTLIER 'General case' 0 CA--C 1.482 -1.661 0 CA-C-O 124.822 2.249 . . . . 0.0 115.525 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.5 ' CE1' ' HB2' ' A' ' 62' ' ' PHE . 8.8 p90 -117.67 157.62 26.13 Favored 'General case' 0 N--CA 1.435 -1.199 0 O-C-N 118.899 -2.376 . . . . 0.0 107.213 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -107.43 142.83 36.66 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 179.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -147.77 107.99 4.07 Favored 'General case' 0 C--O 1.205 -1.279 0 C-N-CA 118.196 -1.402 . . . . 0.0 114.265 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -75.15 138.38 41.98 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 122.954 2.616 . . . . 0.0 105.323 179.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.698 HD12 ' O ' ' A' ' 76' ' ' THR . 0.7 OUTLIER -82.52 -170.07 2.77 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 104.413 -2.44 . . . . 0.0 104.413 179.815 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.523 ' HB1' ' CE2' ' A' ' 55' ' ' PHE . . . -82.2 -45.62 14.84 Favored 'General case' 0 CA--C 1.547 0.842 0 CA-C-O 123.7 1.714 . . . . 0.0 111.254 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.41 ' CG ' ' HD2' ' A' ' 27' ' ' LYS . 12.2 t70 -139.92 26.62 2.25 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 112.952 -1.931 . . . . 0.0 110.858 179.716 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -120.36 -9.29 7.97 Favored Glycine 0 CA--C 1.548 2.152 0 O-C-N 127.105 2.753 . . . . 0.0 112.514 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.698 ' O ' HD12 ' A' ' 72' ' ' LEU 0.259 0.1 OUTLIER 75.13 -178.36 0.16 Allowed 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 117.393 -1.723 . . . . 0.0 114.706 -179.775 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.441 ' CB ' ' HB ' ' A' ' 96' ' ' VAL . 13.8 mt-10 -40.65 141.09 0.6 Allowed 'General case' 0 N--CA 1.442 -0.848 0 CA-C-O 125.785 2.707 . . . . 0.0 112.293 179.825 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.691 ' HG ' ' HB3' ' A' ' 93' ' ' PHE 0.419 11.7 tp -166.09 120.38 1.16 Allowed 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 104.271 -2.492 . . . . 0.0 104.271 179.877 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.5 t -143.32 121.44 12.17 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 105.636 -1.986 . . . . 0.0 105.636 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.5 ' HA3' ' HA ' ' A' ' 93' ' ' PHE . . . -156.51 -144.65 3.98 Favored Glycine 0 CA--C 1.538 1.5 0 CA-C-O 116.537 -2.257 . . . . 0.0 110.022 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.415 ' HB ' ' HA2' ' A' ' 65' ' ' GLY . 11.5 p -148.84 161.06 42.6 Favored 'General case' 0 CA--C 1.476 -1.872 0 O-C-N 126.68 2.047 . . . . 0.0 110.215 -179.737 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . 0.486 ' CG ' ' CE2' ' A' ' 62' ' ' PHE . 16.1 m95 -117.05 151.26 37.16 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 101.155 -3.646 . . . . 0.0 101.155 -179.735 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.529 HG22 HG22 ' A' ' 90' ' ' VAL . 9.9 t -153.68 144.97 23.01 Favored 'General case' 0 C--O 1.255 1.364 0 CA-C-O 122.992 1.377 . . . . 0.0 111.558 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.22 105.82 11.77 Favored 'General case' 0 N--CA 1.436 -1.141 0 C-N-CA 117.162 -1.815 . . . . 0.0 109.662 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.443 ' HG3' HG11 ' A' ' 90' ' ' VAL 0.574 12.4 mm-40 -76.47 178.31 6.7 Favored 'General case' 0 N--CA 1.428 -1.561 0 O-C-N 120.979 -1.075 . . . . 0.0 108.999 179.778 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -67.21 95.52 0.29 Allowed Glycine 0 C--N 1.346 1.095 0 N-CA-C 105.145 -3.182 . . . . 0.0 105.145 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 79.18 16.57 0.93 Allowed 'General case' 0 C--O 1.242 0.703 0 CA-C-O 115.487 -2.197 . . . . 0.0 115.886 179.837 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . 0.418 0.0 OUTLIER -156.29 177.93 10.89 Favored 'General case' 0 CA--C 1.492 -1.256 0 O-C-N 125.936 2.022 . . . . 0.0 107.587 -179.895 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.524 HD12 ' HD2' ' A' ' 106' ' ' ARG . 0.1 OUTLIER -120.53 147.79 44.69 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 103.508 -2.775 . . . . 0.0 103.508 -179.861 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.601 ' HB ' HG23 ' A' ' 105' ' ' VAL . 0.6 OUTLIER -140.85 164.31 21.1 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.867 0 N-CA-C 104.844 -2.28 . . . . 0.0 104.844 179.917 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.48 ' HA2' ' HA ' ' A' ' 82' ' ' TRP . . . -143.87 109.35 0.54 Allowed Glycine 0 C--N 1.34 0.789 0 O-C-N 128.306 3.504 . . . . 0.0 111.445 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.498 ' C ' ' CD1' ' A' ' 93' ' ' PHE . 23.0 mtmt -103.3 164.6 11.54 Favored 'General case' 0 N--CA 1.432 -1.33 0 N-CA-C 102.87 -3.011 . . . . 0.0 102.87 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.691 ' HB3' ' HG ' ' A' ' 78' ' ' LEU 0.282 95.9 m-85 -161.85 116.07 1.91 Allowed 'General case' 0 N--CA 1.441 -0.879 0 C-N-CA 119.698 -0.801 . . . . 0.0 109.662 -179.751 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 4.2 mttp -92.02 142.84 27.09 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . 0.273 2.4 ttt-85 -88.57 130.68 35.2 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 113.856 -1.52 . . . . 0.0 109.542 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.441 ' HB ' ' CB ' ' A' ' 77' ' ' GLU . 68.9 t -70.88 -33.51 52.45 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 O-C-N 121.278 -0.889 . . . . 0.0 112.949 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . 0.364 31.1 t70 -95.96 -8.5 33.61 Favored 'General case' 0 C--O 1.261 1.673 0 N-CA-C 114.043 1.127 . . . . 0.0 114.043 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.41 ' ND2' ' OH ' ' A' ' 119' ' ' TYR . 19.7 t30 -118.88 -28.54 5.54 Favored 'General case' 0 CA--C 1.498 -1.022 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 -179.632 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 76.13 11.5 84.81 Favored Glycine 0 CA--C 1.536 1.345 0 N-CA-C 117.455 1.742 . . . . 0.0 117.455 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 9.4 mttt -105.61 152.01 23.63 Favored 'General case' 0 C--O 1.208 -1.079 0 CA-C-O 121.95 0.881 . . . . 0.0 109.852 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -94.9 118.72 32.25 Favored 'General case' 0 N--CA 1.435 -1.199 0 C-N-CA 127.653 2.381 . . . . 0.0 114.473 -179.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.666 ' HG ' ' HA ' ' A' ' 119' ' ' TYR . 7.8 tt -97.28 118.56 34.01 Favored 'General case' 0 C--N 1.317 -0.816 0 O-C-N 128.798 3.811 . . . . 0.0 103.369 179.57 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.71 HG23 ' HB3' ' A' ' 117' ' ' TYR . 15.2 tt -110.48 161.12 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.41 0 C-N-CA 116.35 -2.14 . . . . 0.0 107.327 -179.569 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.481 ' HA ' ' HB2' ' A' ' 117' ' ' TYR . . . -150.93 151.14 31.73 Favored 'General case' 0 N--CA 1.437 -1.106 0 O-C-N 118.105 -2.872 . . . . 0.0 107.376 -179.424 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.601 HG23 ' HB ' ' A' ' 90' ' ' VAL . 1.3 t -149.33 117.81 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 121.577 1.989 . . . . 0.0 111.54 -179.756 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.524 ' HD2' HD12 ' A' ' 89' ' ' LEU 0.3 79.5 mtt180 -84.49 91.53 7.87 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 105.195 -2.15 . . . . 0.0 105.195 -179.922 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 61.0 tt0 -81.61 80.8 7.87 Favored 'General case' 0 N--CA 1.436 -1.147 0 CA-C-O 126.974 3.273 . . . . 0.0 114.525 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.567 ' CD1' ' CH2' ' A' ' 6' ' ' TRP 0.331 0.6 OUTLIER -61.61 99.45 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.735 0 C-N-CA 116.601 -2.04 . . . . 0.0 114.6 179.85 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -98.64 90.03 4.58 Favored 'General case' 0 C--O 1.219 -0.514 0 N-CA-C 102.839 -3.023 . . . . 0.0 102.839 -179.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 56.94 -125.86 40.14 Favored Glycine 0 CA--C 1.524 0.608 0 O-C-N 127.858 3.224 . . . . 0.0 111.731 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . 0.385 1.2 m-20 -65.12 -21.33 66.78 Favored 'General case' 0 C--O 1.215 -0.715 0 CA-C-O 115.515 -2.183 . . . . 0.0 112.938 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -95.27 141.91 28.3 Favored 'General case' 0 N--CA 1.432 -1.328 0 O-C-N 128.064 3.353 . . . . 0.0 115.777 179.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.931 HD21 ' HG2' ' A' ' 115' ' ' GLN . 0.3 OUTLIER -103.39 149.5 24.72 Favored 'General case' 0 N--CA 1.475 0.799 1 N-CA-C 100.121 -4.029 . . . . 0.0 100.121 179.557 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.682 HG23 HD13 ' A' ' 127' ' ' ILE 0.252 78.3 mt -147.01 100.65 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 N-CA-C 103.686 -2.709 . . . . 0.0 103.686 179.876 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . 0.931 ' HG2' HD21 ' A' ' 113' ' ' LEU . 0.8 OUTLIER -74.95 154.14 38.26 Favored 'General case' 0 CA--C 1.506 -0.732 1 O-C-N 129.318 4.136 . . . . 0.0 102.125 -179.823 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.58 ' HB ' ' HG3' ' A' ' 125' ' ' LYS . 2.5 t 178.63 157.71 0.49 Allowed 'General case' 0 N--CA 1.415 -2.221 0 O-C-N 124.626 1.203 . . . . 0.0 109.945 -178.557 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.71 ' HB3' HG23 ' A' ' 103' ' ' ILE 0.384 5.0 m-30 127.13 -157.27 0.0 OUTLIER 'General case' 0 CA--C 1.479 -1.785 1 O-C-N 129.639 4.337 . . . . 0.0 113.215 177.682 . . . . . . . . 4 3 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.468 ' O ' ' N ' ' A' ' 103' ' ' ILE . 5.3 t -135.31 -162.77 1.3 Allowed 'General case' 0 C--N 1.312 -1.027 0 CA-C-O 127.304 3.43 . . . . 0.0 117.464 -174.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.666 ' HA ' ' HG ' ' A' ' 102' ' ' LEU 0.282 0.9 OUTLIER -113.7 -53.21 2.7 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 112.187 -2.279 . . . . 0.0 106.759 179.143 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -124.68 -59.66 1.43 Allowed 'General case' 0 N--CA 1.426 -1.664 0 CA-C-N 113.479 -1.692 . . . . 0.0 113.266 179.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -161.78 15.78 0.15 Allowed Glycine 0 C--N 1.358 1.798 0 N-CA-C 120.747 3.059 . . . . 0.0 120.747 -179.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 75.6 t -128.61 102.9 8.77 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 N-CA-C 103.383 -2.821 . . . . 0.0 103.383 179.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.462 ' HA ' ' O ' ' A' ' 117' ' ' TYR . 0.0 OUTLIER -68.95 -173.84 0.53 Allowed 'General case' 0 C--O 1.215 -0.721 0 CA-C-O 124.107 1.908 . . . . 0.0 112.207 -178.181 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.669 ' HB1' ' HA ' ' A' ' 14' ' ' TYR . . . -166.44 95.29 0.54 Allowed 'General case' 0 N--CA 1.438 -1.026 0 CA-C-O 114.663 -2.589 . . . . 0.0 109.997 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.58 ' HG3' ' HB ' ' A' ' 116' ' ' THR 0.362 0.9 OUTLIER -77.38 143.06 38.96 Favored 'General case' 0 C--O 1.245 0.855 0 O-C-N 126.822 2.576 . . . . 0.0 111.956 179.518 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.608 ' NE ' HE21 ' A' ' 115' ' ' GLN . 0.2 OUTLIER -129.92 84.15 2.19 Favored 'General case' 0 C--O 1.207 -1.163 0 C-N-CA 128.394 2.678 . . . . 0.0 104.591 177.323 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.682 HD13 HG23 ' A' ' 114' ' ' ILE . 14.1 mm -70.77 93.15 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.009 1 O-C-N 129.369 4.168 . . . . 0.0 108.07 179.837 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.704 ' CE2' ' HA ' ' A' ' 6' ' ' TRP 0.334 14.8 t80 -88.95 148.38 23.83 Favored 'General case' 0 N--CA 1.426 -1.664 0 CA-C-O 125.036 2.35 . . . . 0.0 113.507 -178.786 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.51 ' N ' ' CG ' ' A' ' 128' ' ' PHE 0.316 0.0 OUTLIER -99.67 25.13 7.45 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-N 110.851 -2.886 . . . . 0.0 114.11 -176.89 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.588 ' HB2' ' CZ3' ' A' ' 6' ' ' TRP . 8.4 tttt 43.92 96.82 0.01 OUTLIER 'General case' 0 CA--C 1.507 -0.704 0 CA-C-N 122.526 2.421 . . . . 0.0 116.456 178.423 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.409 ' N ' ' O ' ' A' ' 5' ' ' THR 0.769 3.1 tt0 . . . . . 0 N--CA 1.447 -0.58 0 O-C-N 117.353 -3.342 . . . . 0.0 113.822 179.801 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 34.5 p90 . . . . . 0 N--CA 1.438 -1.042 0 N-CA-C 117.215 2.302 . . . . 0.0 117.215 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -63.15 98.86 0.15 Allowed 'General case' 0 CA--C 1.491 -1.29 0 CA-C-O 123.33 1.538 . . . . 0.0 112.683 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . 0.403 ' O ' ' N ' ' A' ' 40' ' ' ILE . . . 157.15 -159.77 29.94 Favored Glycine 0 CA--C 1.498 -0.99 0 C-N-CA 117.596 -2.24 . . . . 0.0 109.767 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.594 ' HA ' ' HA ' ' A' ' 39' ' ' THR 0.53 9.2 t -91.53 159.35 15.97 Favored 'General case' 0 N--CA 1.447 -0.612 0 O-C-N 126.342 1.848 . . . . 0.0 113.167 179.978 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 1.021 ' CZ2' HD11 ' A' ' 108' ' ' ILE . 90.1 m95 -148.23 145.75 28.38 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 110.715 -2.948 . . . . 0.0 105.103 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 44.7 tttt -143.34 93.75 2.53 Favored 'General case' 0 C--O 1.209 -1.049 0 O-C-N 126.308 2.255 . . . . 0.0 109.961 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.429 HG12 ' HB3' ' A' ' 36' ' ' LEU 0.26 4.1 p -46.57 125.69 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 O-C-N 126.585 2.428 . . . . 0.0 109.222 -179.876 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -119.34 -32.24 4.43 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-N 114.327 -1.306 . . . . 0.0 110.253 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.411 ' O ' ' HB ' ' A' ' 127' ' ' ILE . 0.0 OUTLIER -138.21 131.35 30.15 Favored 'General case' 0 CA--C 1.496 -1.105 0 CA-C-O 123.148 1.451 . . . . 0.0 108.205 -179.923 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . 0.287 38.3 m-80 -101.35 -178.53 3.76 Favored 'General case' 0 CA--C 1.504 -0.795 0 CA-C-N 113.214 -1.812 . . . . 0.0 108.496 179.709 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.505 ' CB ' ' HB2' ' A' ' 125' ' ' LYS . 0.3 OUTLIER -163.85 62.54 0.16 Allowed 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 121.106 1.775 . . . . 0.0 107.27 -179.913 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . 0.298 4.2 t30 115.5 18.7 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 128.097 2.559 . . . . 0.0 114.239 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.471 ' CE2' ' HG2' ' A' ' 126' ' ' ARG 0.327 0.1 OUTLIER -80.69 -24.0 39.16 Favored 'General case' 0 C--N 1.314 -0.957 0 O-C-N 127.481 2.988 . . . . 0.0 117.58 -179.984 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -73.21 -47.04 46.77 Favored 'General case' 0 C--O 1.208 -1.1 0 O-C-N 118.306 -2.746 . . . . 0.0 108.938 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 29.5 tttm -78.3 -21.08 50.21 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 125.823 1.952 . . . . 0.0 114.722 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.524 ' CB ' ' HB2' ' A' ' 124' ' ' ALA . 2.9 t80 -73.53 -23.86 60.05 Favored 'General case' 0 N--CA 1.419 -1.986 0 C-N-CA 116.835 -1.946 . . . . 0.0 111.77 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.44 ' HB3' HG12 ' A' ' 23' ' ' ILE . 0.2 OUTLIER -73.25 -21.05 60.7 Favored 'General case' 0 C--N 1.307 -1.256 0 O-C-N 118.765 -2.459 . . . . 0.0 109.045 179.867 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 55.1 tt0 -64.17 -31.38 72.55 Favored 'General case' 0 C--N 1.347 0.48 0 CA-C-O 125.235 2.445 . . . . 0.0 112.401 179.564 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 32.6 tptt -74.26 -30.26 62.04 Favored 'General case' 0 C--O 1.215 -0.742 0 CA-C-N 112.922 -1.944 . . . . 0.0 110.375 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . 0.254 11.0 mtt -77.6 -40.17 43.01 Favored 'General case' 0 C--N 1.353 0.736 0 CA-C-O 124.107 1.908 . . . . 0.0 106.059 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 143.37 15.38 0.28 Allowed Glycine 0 N--CA 1.438 -1.232 0 CA-C-O 115.345 -2.92 . . . . 0.0 115.056 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.537 HD11 ' CB ' ' A' ' 74' ' ' ASP . 1.7 mp -75.49 134.09 29.97 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 CA-C-N 120.489 2.144 . . . . 0.0 105.844 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 67.8 m-80 -93.31 -45.74 7.69 Favored 'General case' 0 C--O 1.243 0.727 0 CA-C-O 114.2 -2.81 . . . . 0.0 116.521 -178.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . 0.402 1.2 t -160.2 -59.66 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.499 -0.987 0 N-CA-C 119.217 3.043 . . . . 0.0 119.217 -179.764 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.668 1.9 m -78.19 -26.22 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 12.3 mttm -75.16 -28.19 60.01 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-O 118.311 -0.852 . . . . 0.0 110.866 -179.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.813 HH11 ' HG3' ' A' ' 28' ' ' ARG . 4.9 ptt85 -79.95 -23.8 41.43 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 116.61 -2.036 . . . . 0.0 109.081 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.94 -43.9 64.48 Favored 'General case' 0 CA--C 1.507 -0.702 0 CA-C-O 122.512 1.149 . . . . 0.0 109.78 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.411 HD23 ' CZ ' ' A' ' 55' ' ' PHE . 9.2 tp -75.45 -31.7 60.39 Favored 'General case' 0 C--O 1.212 -0.894 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 -179.813 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -73.77 -34.08 56.87 Favored Glycine 0 C--N 1.348 1.238 0 O-C-N 128.299 3.5 . . . . 0.0 112.425 179.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -74.99 -40.64 60.57 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 125.741 1.616 . . . . 0.0 109.708 179.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 3.4 m80 -107.95 57.89 0.62 Allowed 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 113.46 -1.7 . . . . 0.0 110.908 179.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -85.37 -26.34 26.53 Favored 'General case' 0 C--O 1.212 -0.872 0 N-CA-C 117.522 2.415 . . . . 0.0 117.522 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.3 m120 78.74 24.61 0.56 Allowed 'General case' 0 CA--C 1.539 0.531 0 O-C-N 124.472 1.108 . . . . 0.0 109.206 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.429 ' HB3' HG12 ' A' ' 8' ' ' VAL . 1.9 tp -46.2 97.78 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.499 0 O-C-N 125.893 1.995 . . . . 0.0 109.449 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.485 ' HB3' ' CB ' ' A' ' 52' ' ' SER . 16.3 ttpt -98.03 96.12 7.93 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 101.754 -3.425 . . . . 0.0 101.754 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . 0.313 1.3 tp -86.27 147.16 26.21 Favored 'General case' 0 C--N 1.313 -0.991 0 C-N-CA 115.414 -2.515 . . . . 0.0 106.45 -179.68 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.594 ' HA ' ' HA ' ' A' ' 5' ' ' THR . 90.4 m -131.36 83.63 2.12 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 103.802 -2.666 . . . . 0.0 103.802 179.573 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.443 HG13 ' CD1' ' A' ' 6' ' ' TRP . 0.8 OUTLIER -63.15 108.73 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.01 0 O-C-N 124.51 1.131 . . . . 0.0 109.747 -179.914 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.9 m -117.58 84.78 2.22 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-O 122.475 1.131 . . . . 0.0 110.147 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -77.89 142.6 38.34 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 120.599 -1.313 . . . . 0.0 110.779 -179.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -139.82 -129.08 0.11 Allowed 'General case' 0 CA--C 1.492 -1.284 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -81.65 78.36 1.95 Allowed Glycine 0 C--N 1.294 -1.763 0 O-C-N 119.4 -2.063 . . . . 0.0 109.853 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.323 1.3 m-20 80.44 -10.56 1.25 Allowed 'General case' 0 C--N 1.315 -0.931 0 O-C-N 126.11 1.711 . . . . 0.0 113.014 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.441 ' HA ' ' HA ' ' A' ' 63' ' ' GLU . 0.0 OUTLIER -88.63 -178.07 5.72 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 117.374 -1.731 . . . . 0.0 107.491 179.943 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.619 ' CE1' HD21 ' A' ' 64' ' ' LEU . 2.1 m-85 -157.34 82.14 0.91 Allowed 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 106.061 -1.829 . . . . 0.0 106.061 -179.653 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.931 HG23 HG22 ' A' ' 61' ' ' VAL 0.484 6.4 m -67.17 136.61 55.32 Favored 'General case' 0 CA--C 1.5 -0.952 0 C-N-CA 114.747 -2.781 . . . . 0.0 106.449 -179.733 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.554 HG11 ' CH2' ' A' ' 82' ' ' TRP 0.595 0.9 OUTLIER -121.12 93.53 2.55 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 CA-C-N 112.632 -2.076 . . . . 0.0 114.047 -179.154 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.534 ' CB ' ' HB ' ' A' ' 39' ' ' THR . 0.4 OUTLIER -67.74 150.44 48.68 Favored 'General case' 0 C--N 1.315 -0.891 1 N-CA-C 99.895 -4.113 . . . . 0.0 99.895 179.563 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.402 ' O ' ' N ' ' A' ' 53' ' ' SER . 0.5 OUTLIER -141.26 73.95 1.44 Allowed 'General case' 0 C--O 1.216 -0.685 0 N-CA-C 103.252 -2.87 . . . . 0.0 103.252 -179.914 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.485 ' CB ' ' HB3' ' A' ' 37' ' ' LYS . 0.1 OUTLIER -76.05 77.81 2.91 Favored 'General case' 0 C--N 1.289 -2.043 0 O-C-N 119.571 -1.955 . . . . 0.0 105.764 -179.939 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.402 ' N ' ' O ' ' A' ' 51' ' ' GLU . 84.0 p -101.13 159.62 15.08 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-O 114.387 -2.72 . . . . 0.0 108.404 -179.825 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -53.9 -26.85 27.02 Favored 'General case' 0 CA--C 1.51 -0.559 0 O-C-N 125.259 1.599 . . . . 0.0 109.317 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.411 ' CZ ' HD23 ' A' ' 30' ' ' LEU . 61.0 m-85 -71.45 -57.04 4.8 Favored 'General case' 0 C--O 1.215 -0.725 0 CA-C-O 114.489 -2.672 . . . . 0.0 109.582 179.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.42 ' O ' HG22 ' A' ' 58' ' ' ILE 0.26 0.4 OUTLIER -169.81 152.57 4.55 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 123.226 2.739 . . . . 0.0 110.287 179.646 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 5.6 p-10 -84.81 86.7 7.32 Favored 'General case' 0 C--O 1.217 -0.631 0 C-N-CA 131.308 3.843 . . . . 0.0 101.441 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.42 HG22 ' O ' ' A' ' 56' ' ' ARG . 2.7 tt -114.48 86.47 0.91 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.792 0 N-CA-C 119.604 3.186 . . . . 0.0 119.604 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -60.83 105.61 0.48 Allowed 'General case' 0 C--O 1.214 -0.778 0 N-CA-C 104.585 -2.376 . . . . 0.0 104.585 178.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.561 HG12 ' N ' ' A' ' 61' ' ' VAL . 1.0 OUTLIER -68.15 -55.27 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 C-N-CA 125.346 1.458 . . . . 0.0 113.893 -178.044 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.931 HG22 HG23 ' A' ' 48' ' ' THR 0.478 0.1 OUTLIER 60.69 135.6 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 CA-C-O 126.38 2.991 . . . . 0.0 112.094 -177.211 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.63 ' CD1' ' CD1' ' A' ' 68' ' ' PHE . 9.8 t80 -163.8 109.13 1.05 Allowed 'General case' 0 N--CA 1.432 -1.361 0 CA-C-N 112.321 -2.218 . . . . 0.0 110.255 179.654 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.441 ' HA ' ' HA ' ' A' ' 46' ' ' LYS . 0.4 OUTLIER -58.04 129.35 41.54 Favored 'General case' 0 C--O 1.251 1.133 0 N-CA-C 102.722 -3.066 . . . . 0.0 102.722 179.037 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.619 HD21 ' CE1' ' A' ' 47' ' ' PHE . 0.4 OUTLIER -50.05 130.96 22.96 Favored 'General case' 0 C--O 1.247 0.971 0 CA-C-O 123.252 1.501 . . . . 0.0 111.999 -179.702 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.442 ' HA2' ' HB ' ' A' ' 81' ' ' THR . . . 60.72 14.74 37.93 Favored Glycine 0 C--N 1.341 0.824 0 CA-C-N 112.368 -2.196 . . . . 0.0 115.203 -179.827 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . 0.412 16.1 t -72.27 -88.29 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 154.82 117.49 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.175 0 C-N-CA 125.627 1.571 . . . . 0.0 115.224 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.63 ' CD1' ' CD1' ' A' ' 62' ' ' PHE . 0.4 OUTLIER -133.31 147.94 51.89 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-N 118.91 0.777 . . . . 0.0 110.047 -179.961 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -104.15 150.4 24.38 Favored 'General case' 0 C--O 1.243 0.714 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -151.72 107.28 3.34 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-O 116.289 -1.815 . . . . 0.0 113.904 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -78.9 127.62 32.25 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 122.279 2.309 . . . . 0.0 105.137 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.433 HD21 HD13 ' A' ' 78' ' ' LEU . 4.2 mm? -65.98 -177.67 0.52 Allowed 'General case' 0 C--N 1.3 -1.576 0 O-C-N 125.054 1.471 . . . . 0.0 107.363 -179.653 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -103.05 9.73 38.4 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-O 124.883 2.278 . . . . 0.0 110.909 179.663 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.537 ' CB ' HD11 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -97.17 -28.52 14.06 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 112.675 -2.057 . . . . 0.0 112.316 -179.813 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 133.79 8.96 2.07 Favored Glycine 0 CA--C 1.547 2.046 0 CA-C-O 117.651 -1.638 . . . . 0.0 111.596 -178.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.458 HG23 ' O ' ' A' ' 77' ' ' GLU 0.376 0.4 OUTLIER -131.44 169.65 15.76 Favored 'General case' 0 C--N 1.309 -1.154 0 C-N-CA 115.724 -2.39 . . . . 0.0 115.521 -179.757 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.631 ' HG2' HG21 ' A' ' 96' ' ' VAL . 0.1 OUTLIER -90.26 168.1 12.17 Favored 'General case' 0 N--CA 1.443 -0.807 1 O-C-N 130.764 5.04 . . . . 0.0 113.842 179.752 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.474 ' HG ' ' HB3' ' A' ' 93' ' ' PHE 0.399 10.0 tp -167.33 148.39 5.59 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-N 114.123 -1.399 . . . . 0.0 107.642 179.915 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 7.4 m -159.27 116.2 2.67 Favored 'General case' 0 C--O 1.203 -1.362 0 N-CA-C 105.394 -2.076 . . . . 0.0 105.394 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.449 ' HA3' ' HA ' ' A' ' 93' ' ' PHE . . . -156.62 -151.73 6.06 Favored Glycine 0 C--N 1.296 -1.642 0 C-N-CA 116.92 -2.562 . . . . 0.0 114.564 -179.801 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.442 ' HB ' ' HA2' ' A' ' 65' ' ' GLY . 1.3 p -152.39 168.3 25.9 Favored 'General case' 0 C--O 1.199 -1.599 0 C-N-CA 116.807 -1.957 . . . . 0.0 109.607 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . 0.622 ' CD1' ' CE2' ' A' ' 62' ' ' PHE 0.3 3.7 m0 -122.79 145.51 48.35 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 102.803 -3.036 . . . . 0.0 102.803 -179.81 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.918 HG22 HG22 ' A' ' 90' ' ' VAL . 10.3 t -143.28 124.64 14.68 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-O 124.924 2.297 . . . . 0.0 108.543 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.542 ' HA ' HD23 ' A' ' 89' ' ' LEU . 9.4 ttt -80.6 114.54 19.57 Favored 'General case' 0 N--CA 1.422 -1.872 0 CA-C-N 114.088 -1.415 . . . . 0.0 110.76 -179.727 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.468 ' HA ' ' OE1' ' A' ' 85' ' ' GLU 0.588 7.1 mm-40 -91.91 6.58 45.68 Favored 'General case' 0 N--CA 1.419 -2.002 0 CA-C-O 123.834 1.778 . . . . 0.0 112.746 179.864 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 91.3 -74.94 1.57 Allowed Glycine 0 C--N 1.345 1.05 0 N-CA-C 103.991 -3.643 . . . . 0.0 103.991 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 17.6 p30 -76.04 1.61 15.0 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 116.238 -1.839 . . . . 0.0 114.995 -179.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . 0.446 19.1 mttp -162.41 159.89 25.74 Favored 'General case' 0 C--O 1.218 -0.58 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.542 HD23 ' HA ' ' A' ' 84' ' ' MET . 0.1 OUTLIER -120.42 121.39 38.42 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 101.997 -3.334 . . . . 0.0 101.997 -179.95 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.918 HG22 HG22 ' A' ' 83' ' ' THR . 1.2 m -102.53 161.95 3.88 Favored 'Isoleucine or valine' 0 C--O 1.244 0.774 0 N-CA-C 105.644 -1.984 . . . . 0.0 105.644 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -142.9 94.75 0.18 Allowed Glycine 0 C--N 1.35 1.306 0 C-N-CA 130.627 3.965 . . . . 0.0 110.407 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.436 ' HA ' ' HA ' ' A' ' 103' ' ' ILE . 1.4 mtpm? -103.62 156.47 17.76 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 104.379 -2.452 . . . . 0.0 104.379 179.511 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.489 ' HD2' HD12 ' A' ' 102' ' ' LEU . 64.6 m-85 -151.73 128.95 11.19 Favored 'General case' 0 CA--C 1.5 -0.967 0 O-C-N 125.464 1.728 . . . . 0.0 111.11 -179.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 36.3 mtpt -107.91 129.17 55.11 Favored 'General case' 0 C--O 1.212 -0.87 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.454 -179.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . 0.342 0.5 OUTLIER -68.72 168.27 13.6 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 120.679 -1.263 . . . . 0.0 109.008 -179.911 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.631 HG21 ' HG2' ' A' ' 77' ' ' GLU . 24.4 t -100.45 -34.85 4.21 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 O-C-N 126.262 2.226 . . . . 0.0 108.508 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . 0.315 0.4 OUTLIER -65.94 -23.2 66.56 Favored 'General case' 0 CA--C 1.505 -0.756 0 N-CA-C 115.897 1.814 . . . . 0.0 115.897 -179.794 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -160.93 23.22 0.14 Allowed 'General case' 0 CA--C 1.491 -1.296 0 N-CA-C 117.748 2.499 . . . . 0.0 117.748 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 56.15 19.13 22.62 Favored Glycine 0 CA--C 1.536 1.354 0 N-CA-C 117.744 1.858 . . . . 0.0 117.744 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 15.4 mmtp -74.52 -172.21 1.43 Allowed 'General case' 0 C--O 1.198 -1.618 0 CA-C-N 119.812 1.806 . . . . 0.0 108.034 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -129.55 150.22 50.98 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 127.516 2.326 . . . . 0.0 113.389 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.588 ' HA ' ' HA ' ' A' ' 119' ' ' TYR . 0.0 OUTLIER -140.13 141.08 36.12 Favored 'General case' 0 C--O 1.246 0.878 0 O-C-N 128.345 3.528 . . . . 0.0 106.87 -179.516 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.639 HG23 ' CG ' ' A' ' 117' ' ' TYR . 11.3 tt -132.11 179.77 4.08 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.213 0 C-N-CA 117.342 -1.743 . . . . 0.0 109.777 179.568 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.524 ' HA ' ' HB2' ' A' ' 117' ' ' TYR . . . -163.59 113.45 1.3 Allowed 'General case' 0 N--CA 1.427 -1.579 0 CA-C-O 114.2 -2.81 . . . . 0.0 107.493 -176.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -100.71 103.09 14.34 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.682 0 CA-C-N 121.079 1.763 . . . . 0.0 113.511 -179.058 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.469 HH11 ' CG ' ' A' ' 106' ' ' ARG . 1.4 mtt-85 -77.08 93.85 3.94 Favored 'General case' 0 CA--C 1.504 -0.821 0 CA-C-O 123.423 1.583 . . . . 0.0 109.337 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -94.59 79.09 3.79 Favored 'General case' 0 N--CA 1.423 -1.824 0 CA-C-N 113.24 -1.8 . . . . 0.0 114.415 -179.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 1.021 HD11 ' CZ2' ' A' ' 6' ' ' TRP 0.322 1.4 tt -58.27 107.6 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.251 0 C-N-CA 117.26 -1.776 . . . . 0.0 114.681 179.951 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -92.74 79.84 4.74 Favored 'General case' 0 N--CA 1.436 -1.132 0 O-C-N 120.141 -1.6 . . . . 0.0 107.105 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 56.6 -58.52 0.01 OUTLIER Glycine 0 C--O 1.245 0.784 0 C-N-CA 128.907 3.146 . . . . 0.0 113.973 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . 0.302 18.8 m120 -127.47 -1.07 6.24 Favored 'General case' 0 C--O 1.213 -0.828 0 CA-C-O 117.434 -1.269 . . . . 0.0 112.366 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -123.59 121.93 36.86 Favored 'General case' 0 C--O 1.209 -1.066 0 CA-C-O 115.443 -2.217 . . . . 0.0 111.121 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.552 HD23 ' CD1' ' A' ' 128' ' ' PHE . 0.8 OUTLIER -88.47 137.39 32.37 Favored 'General case' 0 C--O 1.209 -1.048 0 N-CA-C 102.004 -3.332 . . . . 0.0 102.004 -179.655 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.847 HG22 HG22 ' A' ' 116' ' ' THR . 72.4 mt -138.67 109.4 4.89 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 O-C-N 126.305 2.253 . . . . 0.0 109.377 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . 0.549 ' O ' HG22 ' A' ' 116' ' ' THR . 19.9 mt-30 -79.32 147.29 32.51 Favored 'General case' 0 CA--C 1.498 -1.046 0 N-CA-C 102.211 -3.255 . . . . 0.0 102.211 179.727 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.847 HG22 HG22 ' A' ' 114' ' ' ILE . 0.1 OUTLIER -163.24 111.89 1.27 Allowed 'General case' 0 N--CA 1.427 -1.599 0 C-N-CA 117.263 -1.775 . . . . 0.0 109.71 -179.168 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.639 ' CG ' HG23 ' A' ' 103' ' ' ILE 0.273 0.1 OUTLIER 176.17 -162.57 0.03 OUTLIER 'General case' 0 CA--C 1.469 -2.159 0 C-N-CA 116.512 -2.075 . . . . 0.0 114.208 178.122 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.496 ' O ' HD22 ' A' ' 102' ' ' LEU . 8.0 t -128.46 -164.86 1.43 Allowed 'General case' 0 N--CA 1.425 -1.683 0 CA-C-O 127.407 3.479 . . . . 0.0 117.51 -174.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.588 ' HA ' ' HA ' ' A' ' 102' ' ' LEU 0.298 68.9 t80 -128.97 5.95 5.43 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 112.305 -2.225 . . . . 0.0 108.1 178.075 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.451 ' H ' HG23 ' A' ' 118' ' ' THR . 1.9 tt0 168.64 -60.65 0.01 OUTLIER 'General case' 0 C--N 1.289 -2.035 0 C-N-CA 125.68 1.592 . . . . 0.0 112.472 -178.185 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -157.34 22.52 0.43 Allowed Glycine 0 C--N 1.366 2.225 0 N-CA-C 121.434 3.334 . . . . 0.0 121.434 -179.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 75.7 t -135.42 118.71 23.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 O-C-N 117.857 -3.143 . . . . 0.0 105.123 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 37.5 mp0 -85.72 175.74 8.54 Favored 'General case' 0 C--O 1.21 -1.005 0 CA-C-O 123.882 1.801 . . . . 0.0 112.868 -179.457 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.524 ' HB2' ' CB ' ' A' ' 17' ' ' PHE . . . -165.53 115.05 1.03 Allowed 'General case' 0 N--CA 1.435 -1.19 0 CA-C-O 113.905 -2.95 . . . . 0.0 108.211 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.551 ' CD ' ' HB ' ' A' ' 116' ' ' THR . 0.1 OUTLIER -90.74 140.33 29.88 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 127.764 3.165 . . . . 0.0 109.535 179.942 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.471 ' HG2' ' CE2' ' A' ' 14' ' ' TYR . 0.1 OUTLIER -127.68 82.43 2.09 Favored 'General case' 0 N--CA 1.428 -1.543 0 CA-C-O 114.242 -2.79 . . . . 0.0 111.123 179.958 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.507 HD13 HG23 ' A' ' 114' ' ' ILE . 5.1 mm -74.46 102.22 2.07 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.832 1 O-C-N 130.894 5.121 . . . . 0.0 115.572 179.863 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.552 ' CD1' HD23 ' A' ' 113' ' ' LEU . 22.0 m-85 -94.27 128.94 41.05 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 128.887 2.875 . . . . 0.0 107.868 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . 0.308 10.4 mttt -93.19 3.14 56.18 Favored 'General case' 0 CA--C 1.507 -0.693 0 CA-C-O 116.768 -1.586 . . . . 0.0 112.083 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.576 ' HB2' ' CZ3' ' A' ' 6' ' ' TRP . 0.1 OUTLIER 69.79 99.9 0.06 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 122.146 2.248 . . . . 0.0 114.127 179.972 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . 0.833 9.4 tt0 . . . . . 0 CA--C 1.499 -0.987 0 C-N-CA 115.592 -2.443 . . . . 0.0 115.666 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.51 -0.593 0 CA-C-O 119.598 -0.239 . . . . 0.0 110.644 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.61 ' CE2' HD13 ' A' ' 89' ' ' LEU . 2.2 m-30 73.42 -51.44 0.7 Allowed 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 117.866 2.543 . . . . 0.0 117.866 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -36.74 91.18 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 124.489 2.09 . . . . 0.0 115.749 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 164.13 -176.35 40.12 Favored Glycine 0 C--O 1.209 -1.433 0 C-N-CA 117.668 -2.206 . . . . 0.0 111.147 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.77 HG22 HG23 ' A' ' 39' ' ' THR 0.56 0.1 OUTLIER -91.35 155.33 18.58 Favored 'General case' 0 N--CA 1.443 -0.802 0 O-C-N 127.146 2.321 . . . . 0.0 110.63 -179.787 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.838 ' CH2' HD11 ' A' ' 108' ' ' ILE . 69.7 m95 -141.67 149.78 41.04 Favored 'General case' 0 N--CA 1.436 -1.147 0 O-C-N 127.874 3.234 . . . . 0.0 106.405 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 10.0 tmtt? -152.46 93.31 1.78 Allowed 'General case' 0 CA--C 1.5 -0.977 0 O-C-N 126.913 2.633 . . . . 0.0 107.14 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.564 ' HB ' ' CD1' ' A' ' 128' ' ' PHE 0.305 0.4 OUTLIER -42.56 137.0 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.0 0 CA-C-O 117.124 -1.417 . . . . 0.0 113.115 -179.998 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -118.27 -60.68 1.76 Allowed 'General case' 0 C--O 1.214 -0.807 0 O-C-N 126.405 2.316 . . . . 0.0 108.827 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.407 ' O ' ' HB ' ' A' ' 127' ' ' ILE . 0.4 OUTLIER -118.98 155.04 32.07 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 179.939 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . 0.363 0.1 OUTLIER -121.1 -165.76 1.26 Allowed 'General case' 0 C--N 1.324 -0.524 0 O-C-N 126.011 2.07 . . . . 0.0 107.459 -179.78 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.473 ' HB3' ' HB2' ' A' ' 125' ' ' LYS . 3.7 tp10 -176.35 89.3 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.523 0 C-N-CA 117.604 -1.638 . . . . 0.0 107.197 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 97.95 -3.6 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 126.143 1.777 . . . . 0.0 114.132 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.801 ' HA ' ' HB1' ' A' ' 124' ' ' ALA 0.27 76.9 t80 -62.07 -28.08 69.35 Favored 'General case' 0 C--O 1.241 0.618 0 O-C-N 127.908 3.255 . . . . 0.0 114.307 -179.834 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -68.18 -40.37 82.28 Favored 'General case' 0 CA--C 1.5 -0.949 0 O-C-N 124.672 1.232 . . . . 0.0 113.442 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.3 -26.03 55.42 Favored 'General case' 0 N--CA 1.441 -0.921 0 O-C-N 125.053 1.47 . . . . 0.0 111.216 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.612 ' HB2' ' HB2' ' A' ' 124' ' ' ALA . 4.7 t80 -68.59 -25.28 64.8 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 123.467 1.603 . . . . 0.0 112.773 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -77.74 -24.91 48.95 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-O 124.018 1.866 . . . . 0.0 107.698 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.7 tt0 -74.45 -20.28 60.08 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 125.297 2.475 . . . . 0.0 110.07 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.422 ' CE ' ' HB2' ' A' ' 120' ' ' GLU . 2.8 tmtm? -77.67 -48.3 17.11 Favored 'General case' 0 C--O 1.209 -1.032 0 CA-C-N 111.998 -2.364 . . . . 0.0 110.152 179.461 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 3.1 mtt -65.48 -20.25 66.27 Favored 'General case' 0 C--O 1.208 -1.12 0 C-N-CA 127.519 2.328 . . . . 0.0 107.507 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.13 31.35 5.96 Favored Glycine 0 C--N 1.298 -1.563 0 C-N-CA 125.221 1.391 . . . . 0.0 111.812 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.486 ' CG2' ' HB2' ' A' ' 27' ' ' LYS . 0.5 OUTLIER -91.56 132.75 35.2 Favored 'Isoleucine or valine' 0 C--N 1.351 0.643 0 CA-C-O 116.154 -1.879 . . . . 0.0 105.99 -179.863 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -90.76 -85.67 0.22 Allowed 'General case' 0 CA--C 1.508 -0.672 0 N-CA-C 116.365 1.987 . . . . 0.0 116.365 -179.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . 0.354 3.5 p -117.4 -72.41 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.495 -1.17 0 N-CA-C 120.022 3.341 . . . . 0.0 120.022 -179.508 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.579 2.2 m -63.43 -28.51 45.16 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.871 0 N-CA-C 118.619 2.822 . . . . 0.0 118.619 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.486 ' HB2' ' CG2' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -74.3 -42.66 59.15 Favored 'General case' 0 CA--C 1.508 -0.653 0 O-C-N 127.789 3.18 . . . . 0.0 114.146 -179.839 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 38.1 ptt180 -78.38 -23.43 46.83 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 123.41 1.576 . . . . 0.0 108.793 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 31.1 tttp -74.86 -39.55 61.49 Favored 'General case' 0 CA--C 1.509 -0.63 0 CA-C-N 114.15 -1.386 . . . . 0.0 111.029 179.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.425 ' HA ' HD22 ' A' ' 30' ' ' LEU . 0.8 OUTLIER -74.65 -21.81 59.23 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 114.039 -1.437 . . . . 0.0 110.712 -179.913 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -79.45 -30.71 44.04 Favored Glycine 0 CA--C 1.524 0.596 0 O-C-N 128.23 3.456 . . . . 0.0 110.929 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -77.09 -57.58 3.76 Favored 'General case' 0 N--CA 1.436 -1.167 0 C-N-CA 127.182 2.193 . . . . 0.0 112.1 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 22.4 m80 -75.18 -1.99 25.79 Favored 'General case' 0 N--CA 1.438 -1.054 0 CA-C-O 117.112 -1.423 . . . . 0.0 113.606 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.43 ' HB2' ' HB2' ' A' ' 53' ' ' SER . 35.6 p-10 -38.6 -36.67 0.27 Allowed 'General case' 0 CA--C 1.495 -1.171 0 N-CA-C 119.888 3.292 . . . . 0.0 119.888 179.604 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . 0.263 13.4 m120 79.96 21.3 0.54 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 120.108 1.322 . . . . 0.0 113.422 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.627 HD21 HD13 ' A' ' 38' ' ' LEU . 27.0 tp -37.08 93.47 0.01 OUTLIER 'General case' 0 C--N 1.351 0.643 0 O-C-N 126.993 2.683 . . . . 0.0 110.313 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.423 ' HB3' ' HB3' ' A' ' 52' ' ' SER . 2.4 ttmp? -92.82 105.47 17.59 Favored 'General case' 0 C--O 1.218 -0.602 0 N-CA-C 101.92 -3.363 . . . . 0.0 101.92 179.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.627 HD13 HD21 ' A' ' 36' ' ' LEU 0.252 1.3 tp -95.3 127.11 41.08 Favored 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 116.212 -2.195 . . . . 0.0 108.735 179.729 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.77 HG23 HG22 ' A' ' 5' ' ' THR . 89.0 m -109.97 83.14 1.71 Allowed 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 104.226 -2.509 . . . . 0.0 104.226 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.447 HD11 HD23 ' A' ' 38' ' ' LEU . 24.0 mm -63.91 132.93 29.85 Favored 'Isoleucine or valine' 0 C--O 1.247 0.94 0 CA-C-N 112.983 -1.917 . . . . 0.0 108.952 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 30.5 m -143.62 96.84 2.97 Favored 'General case' 0 CA--C 1.502 -0.874 0 CA-C-N 111.419 -2.628 . . . . 0.0 113.582 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 59.8 tt0 -89.5 131.94 35.29 Favored 'General case' 0 N--CA 1.447 -0.613 0 O-C-N 124.794 1.309 . . . . 0.0 110.272 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 46.3 tt0 -101.98 -52.33 3.19 Favored 'General case' 0 CA--C 1.49 -1.349 0 CA-C-O 125.172 2.415 . . . . 0.0 110.156 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -165.74 -69.19 0.03 OUTLIER Glycine 0 N--CA 1.433 -1.551 0 N-CA-C 105.422 -3.071 . . . . 0.0 105.422 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.364 0.0 OUTLIER -106.53 -22.7 12.69 Favored 'General case' 0 C--O 1.218 -0.602 0 CA-C-N 113.095 -1.552 . . . . 0.0 111.168 179.906 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.409 ' CD ' ' HG3' ' A' ' 63' ' ' GLU . 0.0 OUTLIER -98.32 156.23 16.82 Favored 'General case' 0 N--CA 1.435 -1.203 0 C-N-CA 120.318 -0.553 . . . . 0.0 111.931 -179.879 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.407 ' HE2' HD21 ' A' ' 64' ' ' LEU . 2.1 m-85 -129.79 92.72 3.37 Favored 'General case' 0 N--CA 1.441 -0.893 0 C-N-CA 123.465 0.706 . . . . 0.0 109.436 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.84 HG22 ' CG1' ' A' ' 61' ' ' VAL 0.455 1.3 p -67.18 141.51 57.31 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 116.8 -1.96 . . . . 0.0 111.45 -179.903 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.874 HG11 ' CZ ' ' A' ' 62' ' ' PHE 0.695 0.4 OUTLIER -120.91 83.82 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.424 -1.726 0 CA-C-N 111.877 -2.42 . . . . 0.0 111.167 179.916 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.458 ' CB ' ' HB ' ' A' ' 39' ' ' THR . 2.1 ttpp -62.84 142.89 58.05 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 101.229 -3.619 . . . . 0.0 101.229 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.572 ' OE2' HD13 ' A' ' 36' ' ' LEU . 4.3 tt0 -138.55 93.92 2.79 Favored 'General case' 0 C--O 1.217 -0.632 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.423 ' HB3' ' HB3' ' A' ' 37' ' ' LYS 0.287 3.9 t -91.64 60.8 4.1 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 106.722 -1.584 . . . . 0.0 106.722 179.81 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.43 ' HB2' ' HB2' ' A' ' 34' ' ' ASP . 1.7 p -89.59 -178.46 5.56 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 125.897 1.998 . . . . 0.0 112.447 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.44 -28.59 69.38 Favored 'General case' 0 C--O 1.212 -0.878 0 CA-C-O 115.525 -2.178 . . . . 0.0 109.932 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.453 ' CD2' ' CB ' ' A' ' 73' ' ' ALA . 95.8 m-85 -70.93 -51.08 28.09 Favored 'General case' 0 C--O 1.221 -0.398 0 C-N-CA 117.285 -1.766 . . . . 0.0 114.13 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.443 ' O ' HG22 ' A' ' 58' ' ' ILE . 6.3 ttm180 179.72 153.7 0.49 Allowed 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 120.702 1.592 . . . . 0.0 108.256 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 42.8 t-20 -88.89 85.98 6.85 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 102.336 -3.209 . . . . 0.0 102.336 -179.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.443 HG22 ' O ' ' A' ' 56' ' ' ARG . 6.3 tp -117.57 107.31 21.83 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.866 1 C-N-CA 133.19 4.596 . . . . 0.0 118.477 -179.827 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -66.2 134.07 51.95 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 104.606 -2.368 . . . . 0.0 104.606 178.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.402 ' O ' HG23 ' A' ' 61' ' ' VAL . 22.3 t -86.16 -68.8 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 CA-C-O 125.517 2.58 . . . . 0.0 110.874 -179.299 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.84 ' CG1' HG22 ' A' ' 48' ' ' THR 0.497 0.0 OUTLIER 74.57 128.02 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.14 0 CA-C-N 113.825 -1.534 . . . . 0.0 113.347 179.995 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.874 ' CZ ' HG11 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -160.11 99.95 1.37 Allowed 'General case' 0 C--N 1.313 -1.002 0 CA-C-O 117.756 -1.116 . . . . 0.0 111.141 -179.781 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.409 ' HG3' ' CD ' ' A' ' 46' ' ' LYS . 3.7 tt0 -49.59 137.61 15.16 Favored 'General case' 0 N--CA 1.439 -0.999 0 O-C-N 126.592 2.433 . . . . 0.0 104.564 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.407 HD21 ' HE2' ' A' ' 47' ' ' PHE . 0.8 OUTLIER -60.33 129.69 42.9 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 123.395 1.569 . . . . 0.0 108.469 -179.74 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 63.38 26.95 70.02 Favored Glycine 0 C--N 1.343 0.948 0 CA-C-N 111.437 -2.62 . . . . 0.0 118.849 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . 0.423 3.0 t -102.63 101.61 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.732 ' HA ' HG22 ' A' ' 81' ' ' THR . 25.5 t0 -58.03 126.45 27.52 Favored 'General case' 0 CA--C 1.49 -1.332 0 CA-C-O 116.816 -1.564 . . . . 0.0 111.391 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.581 ' CZ ' ' HB2' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -131.91 -174.24 3.37 Favored 'General case' 0 N--CA 1.437 -1.097 0 CA-C-N 119.289 0.949 . . . . 0.0 110.968 -179.84 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -125.81 118.38 25.38 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 -179.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 16.2 t80 -126.63 115.39 19.4 Favored 'General case' 0 C--O 1.209 -1.028 0 CA-C-N 120.503 1.501 . . . . 0.0 111.711 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 10.6 t -80.93 142.62 33.34 Favored 'General case' 0 CA--C 1.491 -1.327 0 O-C-N 120.352 -1.468 . . . . 0.0 109.434 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.6 HD21 HD22 ' A' ' 78' ' ' LEU . 0.1 OUTLIER -97.83 -174.2 2.82 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 106.043 -1.836 . . . . 0.0 106.043 179.901 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.453 ' CB ' ' CD2' ' A' ' 55' ' ' PHE . . . -84.33 -49.28 8.88 Favored 'General case' 0 C--O 1.211 -0.973 0 O-C-N 125.355 1.659 . . . . 0.0 110.717 179.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.543 ' HB3' ' CG ' ' A' ' 132' ' ' PLM . 4.9 t70 -121.7 -10.06 8.8 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.079 -1.419 . . . . 0.0 109.72 179.182 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -89.19 -17.59 55.36 Favored Glycine 0 CA--C 1.546 1.982 0 CA-C-N 118.66 0.664 . . . . 0.0 112.763 179.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.489 HG22 ' H ' ' A' ' 77' ' ' GLU 0.355 0.0 OUTLIER 71.96 -169.03 0.14 Allowed 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 116.495 -2.082 . . . . 0.0 113.302 179.922 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.504 ' HB2' HG22 ' A' ' 96' ' ' VAL . 4.0 mp0 -46.22 140.71 3.82 Favored 'General case' 0 C--N 1.319 -0.729 0 O-C-N 128.253 3.471 . . . . 0.0 112.039 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.6 HD22 HD21 ' A' ' 72' ' ' LEU 0.42 0.4 OUTLIER -156.83 100.67 1.92 Allowed 'General case' 0 C--O 1.243 0.734 0 N-CA-C 102.798 -3.038 . . . . 0.0 102.798 179.963 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.535 ' HB ' ' O ' ' A' ' 68' ' ' PHE . 27.6 m -109.13 135.37 50.38 Favored 'General case' 0 CA--C 1.481 -1.686 0 O-C-N 125.009 1.443 . . . . 0.0 108.238 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 173.6 -168.0 40.78 Favored Glycine 0 C--N 1.303 -1.276 1 C-N-CA 113.805 -4.045 . . . . 0.0 108.775 -179.682 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.732 HG22 ' HA ' ' A' ' 67' ' ' ASP . 2.7 p -137.69 177.14 8.1 Favored 'General case' 0 CA--C 1.493 -1.218 0 CA-C-N 119.129 1.465 . . . . 0.0 110.981 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . 0.546 ' CE3' ' CA ' ' A' ' 91' ' ' GLY . 83.5 m95 -128.12 141.45 51.49 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 102.078 -3.304 . . . . 0.0 102.078 179.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.513 HG23 HG23 ' A' ' 90' ' ' VAL . 5.4 t -142.86 138.67 30.44 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-O 122.033 0.921 . . . . 0.0 109.312 -179.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 13.6 ttt -83.44 105.24 14.22 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . 0.603 4.7 mt-10 -56.8 -28.74 61.89 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-O 124.986 2.327 . . . . 0.0 112.661 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 140.49 -46.71 0.91 Allowed Glycine 0 C--N 1.347 1.146 0 N-CA-C 104.081 -3.608 . . . . 0.0 104.081 179.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 17.3 t30 -113.28 -19.23 11.85 Favored 'General case' 0 N--CA 1.44 -0.937 0 O-C-N 127.109 2.299 . . . . 0.0 114.109 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . 0.385 20.3 mttt -136.93 151.41 49.01 Favored 'General case' 0 N--CA 1.44 -0.958 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 179.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.952 HD23 HH11 ' A' ' 106' ' ' ARG . 1.0 OUTLIER -98.74 129.56 45.18 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 101.313 -3.588 . . . . 0.0 101.313 179.634 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.513 HG23 HG23 ' A' ' 83' ' ' THR . 0.0 OUTLIER -120.26 114.75 44.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 C-N-CA 118.363 -1.335 . . . . 0.0 108.14 -179.844 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.546 ' CA ' ' CE3' ' A' ' 82' ' ' TRP . . . -84.16 91.52 1.65 Allowed Glycine 0 C--N 1.354 1.582 0 C-N-CA 129.652 3.501 . . . . 0.0 107.819 -179.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -92.39 124.33 36.37 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 102.509 -3.145 . . . . 0.0 102.509 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.463 ' CG ' ' HG ' ' A' ' 78' ' ' LEU . 2.4 m-85 -136.23 108.99 7.53 Favored 'General case' 0 CA--C 1.502 -0.865 0 O-C-N 125.902 2.001 . . . . 0.0 111.941 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.432 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 0.1 OUTLIER -89.04 -173.22 3.98 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 179.937 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . 0.42 0.6 OUTLIER -131.56 151.83 51.27 Favored 'General case' 0 CA--C 1.487 -1.459 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.859 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.504 HG22 ' HB2' ' A' ' 77' ' ' GLU . 17.4 m -82.03 -33.62 11.86 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 N-CA-C 114.176 1.176 . . . . 0.0 114.176 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.412 ' N ' HG23 ' A' ' 96' ' ' VAL 0.436 0.5 OUTLIER -74.13 10.32 1.27 Allowed 'General case' 0 C--O 1.247 0.957 0 N-CA-C 116.226 1.936 . . . . 0.0 116.226 179.844 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -168.54 -33.99 0.02 OUTLIER 'General case' 0 CA--C 1.497 -1.084 0 N-CA-C 114.812 1.412 . . . . 0.0 114.812 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 76.7 41.63 23.52 Favored Glycine 0 C--N 1.339 0.733 0 N-CA-C 116.423 1.329 . . . . 0.0 116.423 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 69.4 mttt -81.97 -112.01 0.03 OUTLIER 'General case' 0 C--O 1.198 -1.647 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.428 ' HG3' ' N ' ' A' ' 102' ' ' LEU . 0.1 OUTLIER 166.17 142.4 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.391 0 C-N-CA 125.212 1.405 . . . . 0.0 109.897 -179.913 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.553 ' HG ' ' HA ' ' A' ' 119' ' ' TYR . 0.8 OUTLIER -131.25 151.68 51.25 Favored 'General case' 0 C--O 1.247 0.94 0 O-C-N 128.289 3.493 . . . . 0.0 104.761 -179.723 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.453 ' CG2' ' HB ' ' A' ' 118' ' ' THR . 9.2 tt -132.23 174.69 12.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 CA-C-N 120.405 1.457 . . . . 0.0 107.891 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.418 ' N ' ' CG1' ' A' ' 103' ' ' ILE . . . -155.98 111.19 2.95 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 116.351 -1.785 . . . . 0.0 106.269 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.466 HG12 HG23 ' A' ' 116' ' ' THR . 0.9 OUTLIER -95.95 111.72 26.79 Favored 'Isoleucine or valine' 0 C--O 1.245 0.852 0 CA-C-N 121.44 1.927 . . . . 0.0 113.199 -179.416 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.952 HH11 HD23 ' A' ' 89' ' ' LEU . 37.3 mtt180 -91.24 94.1 9.39 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 106.327 -1.731 . . . . 0.0 106.327 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -94.03 74.96 4.11 Favored 'General case' 0 N--CA 1.42 -1.948 0 N-CA-C 116.915 2.191 . . . . 0.0 116.915 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.838 HD11 ' CH2' ' A' ' 6' ' ' TRP . 0.3 OUTLIER -61.07 128.73 22.83 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 C-N-CA 115.292 -2.563 . . . . 0.0 111.763 179.872 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 3.9 t -87.42 -65.71 0.99 Allowed 'General case' 0 C--O 1.218 -0.581 0 N-CA-C 104.575 -2.38 . . . . 0.0 104.575 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -167.39 -62.36 0.03 OUTLIER Glycine 0 C--N 1.348 1.213 0 C-N-CA 129.985 3.66 . . . . 0.0 112.683 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . 0.309 0.8 OUTLIER -101.96 -9.33 20.75 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-O 116.448 -1.739 . . . . 0.0 110.737 179.844 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.53 ' O ' HD13 ' A' ' 108' ' ' ILE . 1.3 mt-10 -126.94 131.77 51.01 Favored 'General case' 0 CA--C 1.495 -1.159 0 O-C-N 128.078 3.361 . . . . 0.0 116.888 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.684 HD22 ' CD2' ' A' ' 128' ' ' PHE . 10.4 tt -105.32 117.0 32.9 Favored 'General case' 0 C--N 1.321 -0.669 0 O-C-N 127.739 3.149 . . . . 0.0 105.912 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.735 HG13 HD13 ' A' ' 127' ' ' ILE 0.281 1.2 mp -108.32 128.34 63.92 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 CA-C-O 116.212 -1.852 . . . . 0.0 107.574 -179.747 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.605 HE21 ' HZ ' ' A' ' 128' ' ' PHE . 37.4 mt-30 -114.32 105.89 13.68 Favored 'General case' 0 N--CA 1.441 -0.897 0 O-C-N 126.543 2.402 . . . . 0.0 107.783 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.466 HG23 HG12 ' A' ' 105' ' ' VAL . 12.3 p -75.64 -179.0 4.43 Favored 'General case' 0 N--CA 1.429 -1.518 0 O-C-N 127.595 3.06 . . . . 0.0 105.409 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.428 ' HB2' ' HB3' ' A' ' 124' ' ' ALA . 97.4 m-85 -165.96 112.1 0.88 Allowed 'General case' 0 C--O 1.198 -1.623 0 CA-C-O 116.605 -1.664 . . . . 0.0 113.19 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.522 HG22 ' H ' ' A' ' 120' ' ' GLU . 54.0 m -122.73 129.33 51.65 Favored 'General case' 0 N--CA 1.425 -1.68 1 O-C-N 131.289 5.368 . . . . 0.0 113.661 179.77 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.553 ' HA ' ' HG ' ' A' ' 102' ' ' LEU . 2.1 t80 -109.14 12.85 24.82 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.522 ' H ' HG22 ' A' ' 118' ' ' THR . 0.7 OUTLIER 163.52 -84.95 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.566 0 O-C-N 127.818 3.199 . . . . 0.0 111.357 -179.796 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -128.59 24.27 4.95 Favored Glycine 0 CA--C 1.539 1.547 0 N-CA-C 119.892 2.717 . . . . 0.0 119.892 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 62.1 t -133.0 104.07 6.55 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.628 0 O-C-N 119.122 -2.399 . . . . 0.0 107.371 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -81.14 171.54 14.78 Favored 'General case' 0 N--CA 1.426 -1.647 0 CA-C-O 124.203 1.954 . . . . 0.0 108.623 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.801 ' HB1' ' HA ' ' A' ' 14' ' ' TYR . . . -162.72 97.08 0.95 Allowed 'General case' 0 C--O 1.211 -0.94 0 C-N-CA 117.746 -1.582 . . . . 0.0 107.194 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.473 ' HB2' ' HB3' ' A' ' 12' ' ' GLU 0.32 1.8 mptm? -83.88 132.91 34.75 Favored 'General case' 0 CA--C 1.506 -0.729 0 CA-C-O 122.331 1.063 . . . . 0.0 110.121 -179.903 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.513 HH12 HD22 ' A' ' 36' ' ' LEU . 4.6 mtm180 -119.94 81.47 1.74 Allowed 'General case' 0 C--O 1.209 -1.042 0 C-N-CA 127.158 2.183 . . . . 0.0 107.867 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.735 HD13 HG13 ' A' ' 114' ' ' ILE . 10.4 mm -63.97 126.32 22.41 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.861 0 O-C-N 128.522 3.639 . . . . 0.0 111.649 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.684 ' CD2' HD22 ' A' ' 113' ' ' LEU . 5.6 m-30 -112.66 139.47 48.23 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 113.25 -1.795 . . . . 0.0 107.681 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . 0.263 3.0 mmtp -104.11 13.73 31.87 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 116.947 -1.502 . . . . 0.0 111.206 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.519 ' HB2' ' CZ3' ' A' ' 6' ' ' TRP . 0.1 OUTLIER 55.83 97.53 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 115.394 -2.241 . . . . 0.0 113.176 179.716 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . 0.88 2.4 tt0 . . . . . 0 N--CA 1.443 -0.814 0 C-N-CA 115.407 -2.517 . . . . 0.0 115.683 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' PLM . . . . . 0.543 ' CG ' ' HB3' ' A' ' 74' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.511 -0.554 0 CA-C-O 120.903 0.382 . . . . 0.0 110.383 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.445 ' N ' ' CD1' ' A' ' 2' ' ' PHE . 10.6 m-85 -88.17 72.74 9.06 Favored 'General case' 0 CA--C 1.511 -0.529 0 C-N-CA 119.397 -0.921 . . . . 0.0 111.908 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -145.53 100.9 3.51 Favored 'General case' 0 CA--C 1.495 -1.172 0 C-N-CA 119.528 -0.869 . . . . 0.0 111.629 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 143.65 -171.79 25.19 Favored Glycine 0 CA--C 1.503 -0.718 0 O-C-N 126.512 2.382 . . . . 0.0 111.603 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.416 ' C ' ' CG ' ' A' ' 6' ' ' TRP 0.587 0.5 OUTLIER -81.45 164.27 22.16 Favored 'General case' 0 N--CA 1.439 -1.006 0 CA-C-O 123.026 1.393 . . . . 0.0 111.523 179.931 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.755 ' CH2' HD11 ' A' ' 108' ' ' ILE . 63.2 m95 -157.03 117.01 3.48 Favored 'General case' 0 N--CA 1.428 -1.563 0 CA-C-O 114.276 -2.773 . . . . 0.0 106.419 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 5.1 tttt -122.47 95.71 4.75 Favored 'General case' 0 N--CA 1.441 -0.902 0 O-C-N 126.062 2.101 . . . . 0.0 108.908 -179.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.583 ' HA ' ' HA ' ' A' ' 128' ' ' PHE 0.267 14.1 p -34.76 119.19 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.216 0 O-C-N 125.391 1.682 . . . . 0.0 114.561 -179.951 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -114.38 -46.99 2.94 Favored 'General case' 0 C--O 1.204 -1.296 0 O-C-N 125.484 1.74 . . . . 0.0 110.24 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.602 ' HG3' HG21 ' A' ' 127' ' ' ILE 0.27 0.0 OUTLIER -106.78 170.72 7.77 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-O 118.663 -0.684 . . . . 0.0 109.866 179.861 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.738 ' HB3' ' CD1' ' A' ' 14' ' ' TYR 0.391 20.0 m120 -169.62 179.39 3.78 Favored 'General case' 0 N--CA 1.437 -1.083 0 O-C-N 128.06 3.35 . . . . 0.0 109.962 -178.201 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -150.38 -90.07 0.07 Allowed 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 121.839 2.109 . . . . 0.0 112.083 -179.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 17.2 t30 -85.04 4.91 31.71 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-N 122.449 2.386 . . . . 0.0 112.182 179.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.738 ' CD1' ' HB3' ' A' ' 11' ' ' ASN . 0.4 OUTLIER -59.55 -21.82 60.82 Favored 'General case' 0 C--N 1.308 -1.238 0 C-N-CA 127.274 2.23 . . . . 0.0 113.301 -178.628 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -73.92 -26.63 60.61 Favored 'General case' 0 C--O 1.21 -0.983 0 CA-C-N 120.51 1.504 . . . . 0.0 111.424 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 37.2 tttm -79.97 -31.92 39.84 Favored 'General case' 0 N--CA 1.432 -1.339 0 CA-C-O 125.448 2.546 . . . . 0.0 110.665 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.658 ' CB ' ' HB2' ' A' ' 124' ' ' ALA . 0.0 OUTLIER -60.78 -33.89 73.66 Favored 'General case' 0 N--CA 1.428 -1.564 0 O-C-N 118.397 -2.689 . . . . 0.0 113.264 -179.755 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 19.2 mtt -72.88 -23.77 60.77 Favored 'General case' 0 N--CA 1.438 -1.073 0 O-C-N 119.229 -2.17 . . . . 0.0 108.465 179.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -76.13 -32.28 59.06 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 125.027 2.346 . . . . 0.0 111.379 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.411 ' HE3' ' HB3' ' A' ' 120' ' ' GLU . 0.6 OUTLIER -64.72 -41.2 96.15 Favored 'General case' 0 N--CA 1.436 -1.171 0 O-C-N 117.55 -3.219 . . . . 0.0 112.379 179.76 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -73.66 -21.88 60.13 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 86.73 61.64 1.59 Allowed Glycine 0 C--N 1.314 -0.666 0 CA-C-O 115.263 -2.965 . . . . 0.0 109.998 179.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.468 HG23 ' CB ' ' A' ' 27' ' ' LYS . 7.2 mm -90.77 -7.21 10.77 Favored 'Isoleucine or valine' 0 C--N 1.358 0.943 0 CA-C-N 119.537 1.668 . . . . 0.0 108.408 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.1 m120 76.11 -106.01 0.02 OUTLIER 'General case' 0 N--CA 1.441 -0.882 0 CA-C-O 116.006 -1.95 . . . . 0.0 114.384 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . 0.343 69.2 t -133.74 -55.26 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.499 -0.995 0 N-CA-C 118.001 2.593 . . . . 0.0 118.001 -179.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.568 34.5 m -69.23 -35.21 66.81 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.079 0 N-CA-C 118.975 2.954 . . . . 0.0 118.975 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.468 ' CB ' HG23 ' A' ' 23' ' ' ILE . 27.7 mttt -74.72 -26.56 59.89 Favored 'General case' 0 C--N 1.32 -0.7 0 O-C-N 126.08 2.113 . . . . 0.0 113.326 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 21.3 ptt180 -79.4 -23.75 43.05 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 120.347 1.43 . . . . 0.0 108.794 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 15.1 tttp -78.19 -44.0 26.99 Favored 'General case' 0 C--O 1.211 -0.959 0 CA-C-O 122.809 1.29 . . . . 0.0 110.599 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 76.1 mt -73.83 -23.42 59.64 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 114.498 -1.228 . . . . 0.0 109.149 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -66.97 -51.28 40.79 Favored Glycine 0 C--O 1.212 -1.268 0 CA-C-O 123.816 1.787 . . . . 0.0 112.96 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.556 ' HB1' ' CE2' ' A' ' 14' ' ' TYR . . . -55.2 -35.27 64.67 Favored 'General case' 0 N--CA 1.436 -1.174 0 C-N-CA 128.574 2.749 . . . . 0.0 115.707 179.116 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.427 ' C ' ' CD2' ' A' ' 33' ' ' HIS . 12.0 t-160 -130.63 60.55 1.63 Allowed 'General case' 0 CA--C 1.506 -0.732 0 CA-C-N 112.028 -2.351 . . . . 0.0 111.996 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -96.37 -15.45 21.83 Favored 'General case' 0 C--O 1.216 -0.696 0 N-CA-C 117.281 2.326 . . . . 0.0 117.281 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 97.07 29.13 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.842 0 O-C-N 125.9 2.0 . . . . 0.0 111.921 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.487 HD21 ' H61' ' A' ' 132' ' ' PLM . 12.2 tp -65.94 81.8 0.08 Allowed 'General case' 0 CA--C 1.503 -0.84 0 CA-C-O 124.471 2.081 . . . . 0.0 110.396 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -90.24 88.97 7.44 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 101.873 -3.38 . . . . 0.0 101.873 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.447 ' HG ' HG23 ' A' ' 49' ' ' VAL . 1.0 OUTLIER -67.78 95.35 0.5 Allowed 'General case' 0 C--N 1.292 -1.932 0 C-N-CA 118.518 -1.273 . . . . 0.0 111.011 -179.18 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.414 ' HB ' ' CB ' ' A' ' 50' ' ' LYS . 39.6 m -81.4 104.83 12.12 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 101.781 -3.415 . . . . 0.0 101.781 179.355 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.648 HD12 ' CD1' ' A' ' 6' ' ' TRP . 83.7 mt -91.45 147.34 5.33 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 O-C-N 120.613 -1.304 . . . . 0.0 111.635 -179.457 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 4.3 m -145.43 101.87 3.64 Favored 'General case' 0 C--O 1.22 -0.494 0 O-C-N 127.062 2.726 . . . . 0.0 112.609 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 15.1 tp60 -82.97 98.64 9.35 Favored 'General case' 0 N--CA 1.443 -0.804 0 O-C-N 125.557 1.785 . . . . 0.0 110.678 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 49.2 tt0 -107.34 84.36 1.96 Allowed 'General case' 0 N--CA 1.438 -1.04 0 CA-C-O 125.657 2.646 . . . . 0.0 105.066 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 70.43 -87.62 0.34 Allowed Glycine 0 C--N 1.296 -1.646 0 CA-C-O 115.814 -2.659 . . . . 0.0 106.582 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.331 0.1 OUTLIER -124.39 -11.99 7.34 Favored 'General case' 0 C--N 1.32 -0.679 0 O-C-N 127.332 2.43 . . . . 0.0 112.535 179.917 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.42 ' HD2' ' CG ' ' A' ' 63' ' ' GLU . 0.0 OUTLIER -90.62 138.61 31.43 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 119.854 -1.779 . . . . 0.0 106.732 179.741 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.482 ' O ' ' N ' ' A' ' 49' ' ' VAL 0.342 3.8 m-85 -115.12 95.64 5.3 Favored 'General case' 0 N--CA 1.433 -1.285 0 C-N-CA 126.222 1.809 . . . . 0.0 107.633 179.777 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.768 ' CB ' HG13 ' A' ' 61' ' ' VAL 0.451 0.1 OUTLIER -67.38 79.53 0.16 Allowed 'General case' 0 N--CA 1.441 -0.875 0 CA-C-O 124.337 2.018 . . . . 0.0 110.594 179.477 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.859 HG13 ' HB ' ' A' ' 60' ' ' VAL 0.753 0.8 OUTLIER -59.57 75.83 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 CA-C-N 109.845 -3.343 . . . . 0.0 115.332 179.794 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.444 ' HA ' ' HA ' ' A' ' 59' ' ' ASP . 8.9 tttt -61.09 138.56 58.2 Favored 'General case' 0 C--N 1.317 -0.811 1 N-CA-C 99.964 -4.087 . . . . 0.0 99.964 179.742 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -133.71 105.16 6.67 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 102.431 -3.174 . . . . 0.0 102.431 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 54.1 p -104.1 44.85 0.99 Allowed 'General case' 0 C--N 1.288 -2.101 0 N-CA-C 105.95 -1.87 . . . . 0.0 105.95 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.7 t -67.89 149.03 50.35 Favored 'General case' 0 N--CA 1.466 0.335 0 O-C-N 127.322 2.889 . . . . 0.0 107.745 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -50.38 -21.78 1.58 Allowed 'General case' 0 C--O 1.221 -0.424 0 CA-C-N 120.656 1.571 . . . . 0.0 110.129 -179.425 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.52 ' CE2' ' HG2' ' A' ' 132' ' ' PLM . 19.8 m-85 -72.23 -49.96 31.07 Favored 'General case' 0 C--O 1.219 -0.529 0 C-N-CA 115.431 -2.507 . . . . 0.0 110.469 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.664 ' HB2' HG22 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -159.37 141.31 13.41 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 123.779 2.99 . . . . 0.0 110.522 -179.984 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 7.9 m-80 -97.56 78.4 2.65 Favored 'General case' 0 C--N 1.353 0.724 0 N-CA-C 100.36 -3.941 . . . . 0.0 100.36 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.664 HG22 ' HB2' ' A' ' 56' ' ' ARG . 2.6 tp -118.53 113.34 41.55 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.017 0 C-N-CA 131.155 3.782 . . . . 0.0 117.792 -179.243 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.444 ' HA ' ' HA ' ' A' ' 50' ' ' LYS . 3.9 p30 -59.18 149.39 28.41 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 104.357 -2.461 . . . . 0.0 104.357 178.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.859 ' HB ' HG13 ' A' ' 49' ' ' VAL . 3.2 t -101.89 -60.98 2.58 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 CA-C-O 124.696 2.189 . . . . 0.0 107.683 -177.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.768 HG13 ' CB ' ' A' ' 48' ' ' THR 0.458 0.0 OUTLIER 66.14 109.11 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.433 -1.319 0 CA-C-N 113.014 -1.903 . . . . 0.0 108.992 -179.519 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.441 ' CZ ' ' HA ' ' A' ' 81' ' ' THR . 2.3 t80 -145.53 114.76 7.07 Favored 'General case' 0 C--N 1.312 -1.06 0 C-N-CA 115.694 -2.402 . . . . 0.0 106.651 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.51 ' OE1' HG21 ' A' ' 66' ' ' VAL . 25.9 mt-10 -68.28 141.83 55.75 Favored 'General case' 0 C--O 1.247 0.95 0 N-CA-C 102.49 -3.152 . . . . 0.0 102.49 179.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.82 137.23 55.15 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 120.266 1.393 . . . . 0.0 107.944 -179.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 57.98 25.0 55.84 Favored Glycine 0 CA--C 1.531 1.056 0 N-CA-C 117.925 1.93 . . . . 0.0 117.925 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.51 HG21 ' OE1' ' A' ' 63' ' ' GLU 0.296 37.2 t -111.37 84.6 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 104.851 -2.277 . . . . 0.0 104.851 179.94 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -39.36 113.43 0.32 Allowed 'General case' 0 C--O 1.202 -1.424 0 O-C-N 126.41 2.319 . . . . 0.0 114.648 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.449 ' CD1' ' C ' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -106.8 -166.26 1.15 Allowed 'General case' 0 N--CA 1.422 -1.839 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 -179.599 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -131.53 137.09 48.36 Favored 'General case' 0 CA--C 1.51 -0.583 0 CA-C-O 116.872 -1.537 . . . . 0.0 107.025 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -146.94 113.04 5.82 Favored 'General case' 0 C--O 1.216 -0.672 0 C-N-CA 117.966 -1.493 . . . . 0.0 113.808 -179.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 47.1 t -91.18 151.34 20.99 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.6 mp -96.58 -169.93 1.98 Allowed 'General case' 0 CA--C 1.498 -1.049 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.404 ' CB ' ' CD1' ' A' ' 55' ' ' PHE . . . -89.45 -6.19 56.71 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-O 124.774 2.226 . . . . 0.0 111.691 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -153.79 -44.75 0.09 Allowed 'General case' 0 N--CA 1.433 -1.29 0 CA-C-N 112.787 -2.006 . . . . 0.0 112.133 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -64.85 -8.0 32.17 Favored Glycine 0 C--O 1.205 -1.692 0 O-C-N 124.769 1.293 . . . . 0.0 114.839 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . 0.372 0.1 OUTLIER 71.46 172.3 0.31 Allowed 'General case' 0 C--N 1.308 -1.219 0 O-C-N 118.197 -2.943 . . . . 0.0 114.947 -179.982 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -35.77 151.99 0.01 OUTLIER 'General case' 0 N--CA 1.434 -1.245 1 O-C-N 130.051 4.594 . . . . 0.0 116.407 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.429 HD11 HD22 ' A' ' 102' ' ' LEU 0.388 8.8 tp -153.63 165.25 36.51 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-N 112.715 -2.039 . . . . 0.0 105.782 -179.958 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -167.05 120.04 0.97 Allowed 'General case' 0 CA--C 1.503 -0.834 0 N-CA-C 105.201 -2.148 . . . . 0.0 105.201 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.442 ' HA3' ' HA ' ' A' ' 93' ' ' PHE . . . -168.65 -157.15 11.08 Favored Glycine 0 C--N 1.296 -1.669 0 C-N-CA 116.684 -2.674 . . . . 0.0 109.765 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.441 ' HA ' ' CZ ' ' A' ' 62' ' ' PHE . 2.8 p -144.98 159.91 42.18 Favored 'General case' 0 C--O 1.191 -2.026 0 O-C-N 126.553 1.973 . . . . 0.0 112.63 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . 0.461 ' CZ3' ' HG3' ' A' ' 106' ' ' ARG . 39.8 m95 -117.97 113.93 22.41 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 103.136 -2.913 . . . . 0.0 103.136 -179.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 4.0 t -122.85 139.09 54.4 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-O 122.199 1.0 . . . . 0.0 111.093 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 1.9 ttt -92.94 105.08 17.24 Favored 'General case' 0 N--CA 1.426 -1.674 0 CA-C-N 113.442 -1.708 . . . . 0.0 112.494 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . 0.532 0.6 OUTLIER -72.66 -143.98 0.01 OUTLIER 'General case' 0 N--CA 1.425 -1.719 0 O-C-N 125.008 1.443 . . . . 0.0 108.162 179.808 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -82.59 66.94 3.81 Favored Glycine 0 N--CA 1.45 -0.369 0 N-CA-C 105.447 -3.061 . . . . 0.0 105.447 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 96.74 -13.79 0.08 Allowed 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 117.293 2.331 . . . . 0.0 117.293 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . 0.409 0.0 OUTLIER -111.65 141.89 44.66 Favored 'General case' 0 C--O 1.215 -0.756 0 O-C-N 125.204 1.565 . . . . 0.0 107.714 179.869 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.499 HD13 ' CD ' ' A' ' 106' ' ' ARG . 1.0 OUTLIER -96.48 145.56 25.57 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 101.503 -3.517 . . . . 0.0 101.503 179.965 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.8 m -132.6 120.27 41.48 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 O-C-N 125.043 1.464 . . . . 0.0 109.596 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -100.27 87.08 0.69 Allowed Glycine 0 C--N 1.338 0.686 0 C-N-CA 128.358 2.885 . . . . 0.0 114.109 -179.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -90.67 148.11 22.83 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 102.388 -3.19 . . . . 0.0 102.388 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.744 ' HB2' HD23 ' A' ' 102' ' ' LEU . 15.7 m-85 -152.64 117.98 5.25 Favored 'General case' 0 CA--C 1.501 -0.906 0 C-N-CA 117.678 -1.609 . . . . 0.0 113.45 -179.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -88.36 -163.46 0.97 Allowed 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 -179.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . 0.334 0.2 OUTLIER -138.25 164.73 28.48 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 106.085 -1.82 . . . . 0.0 106.085 179.824 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 37.0 t -94.3 -40.01 11.0 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 C-N-CA 124.63 1.172 . . . . 0.0 108.537 -179.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . 0.287 0.2 OUTLIER -55.19 -30.66 60.38 Favored 'General case' 0 C--O 1.25 1.126 0 N-CA-C 114.681 1.363 . . . . 0.0 114.681 179.786 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -160.02 6.08 0.09 Allowed 'General case' 0 N--CA 1.44 -0.94 0 CA-C-O 115.809 -2.044 . . . . 0.0 116.428 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 54.02 85.01 0.03 OUTLIER Glycine 0 CA--C 1.524 0.612 0 N-CA-C 118.675 2.23 . . . . 0.0 118.675 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.0 mmtp -113.28 -111.37 0.34 Allowed 'General case' 0 C--O 1.213 -0.862 0 O-C-N 120.951 -1.323 . . . . 0.0 111.392 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 54.3 tt0 -177.75 162.24 1.72 Allowed 'General case' 0 C--O 1.211 -0.965 0 C-N-CA 127.954 2.502 . . . . 0.0 109.069 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.744 HD23 ' HB2' ' A' ' 93' ' ' PHE . 1.9 tp -158.29 109.16 2.15 Favored 'General case' 0 C--N 1.316 -0.887 0 C-N-CA 131.255 3.822 . . . . 0.0 102.653 -179.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.433 ' N ' ' O ' ' A' ' 118' ' ' THR . 0.8 OUTLIER -98.83 152.56 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.091 0 C-N-CA 115.093 -2.643 . . . . 0.0 105.532 -179.439 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.604 ' HA ' ' O ' ' A' ' 116' ' ' THR . . . -160.93 147.25 14.89 Favored 'General case' 0 C--N 1.309 -1.165 0 C-N-CA 124.733 1.213 . . . . 0.0 109.123 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.469 ' O ' HG12 ' A' ' 105' ' ' VAL . 0.9 OUTLIER -137.11 102.46 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 116.033 -2.267 . . . . 0.0 111.461 -179.028 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.499 ' CD ' HD13 ' A' ' 89' ' ' LEU 0.277 48.9 mtt180 -68.18 85.16 0.25 Allowed 'General case' 0 C--N 1.312 -1.029 0 O-C-N 126.562 2.414 . . . . 0.0 104.838 179.696 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.416 ' N ' ' O ' ' A' ' 105' ' ' VAL . 4.9 tt0 -79.52 76.38 6.13 Favored 'General case' 0 N--CA 1.424 -1.738 0 O-C-N 127.163 2.789 . . . . 0.0 117.765 -179.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.755 HD11 ' CH2' ' A' ' 6' ' ' TRP 0.426 0.9 OUTLIER -61.91 123.07 13.99 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 C-N-CA 116.112 -2.235 . . . . 0.0 108.41 179.65 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 7.0 m -102.63 10.67 38.56 Favored 'General case' 0 C--O 1.219 -0.54 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.564 ' H ' HG23 ' A' ' 108' ' ' ILE . . . 119.78 -60.21 0.52 Allowed Glycine 0 N--CA 1.444 -0.8 1 C-N-CA 132.266 4.746 . . . . 0.0 112.713 179.752 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -115.3 22.05 13.6 Favored 'General case' 0 C--N 1.314 -0.936 0 O-C-N 127.121 2.307 . . . . 0.0 111.681 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -149.42 99.62 2.93 Favored 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 120.299 -0.56 . . . . 0.0 111.33 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.459 ' O ' HD23 ' A' ' 113' ' ' LEU . 7.0 tt -84.02 101.61 11.88 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 100.878 -3.749 . . . . 0.0 100.878 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.911 HG12 HG23 ' A' ' 127' ' ' ILE 0.295 3.7 mt -107.2 118.67 55.41 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.09 0 O-C-N 126.013 2.07 . . . . 0.0 111.145 -179.416 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.509 ' O ' ' N ' ' A' ' 126' ' ' ARG 0.316 76.1 mt-30 -89.83 149.67 22.57 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 100.433 -3.914 . . . . 0.0 100.433 177.487 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.828 ' CG2' HG22 ' A' ' 114' ' ' ILE . 79.9 p -160.65 179.09 8.85 Favored 'General case' 0 N--CA 1.422 -1.867 1 O-C-N 130.784 5.052 . . . . 0.0 106.615 -179.865 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.621 ' CE2' ' OG1' ' A' ' 116' ' ' THR 0.297 33.2 m-85 96.6 -142.76 0.0 OUTLIER 'General case' 0 CA--C 1.442 -3.205 0 N-CA-C 120.314 3.45 . . . . 0.0 120.314 174.922 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.603 ' O ' HD12 ' A' ' 102' ' ' LEU . 11.2 t -133.87 -174.11 3.44 Favored 'General case' 0 N--CA 1.417 -2.101 0 N-CA-C 120.342 3.46 . . . . 0.0 120.342 -174.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.717 ' HA ' ' HA ' ' A' ' 102' ' ' LEU 0.339 7.0 t80 -117.98 0.76 11.94 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 111.528 -2.578 . . . . 0.0 106.663 178.092 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.411 ' HB3' ' HE3' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -174.74 -84.03 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.274 0 O-C-N 119.537 -1.977 . . . . 0.0 111.256 179.456 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -138.87 32.99 2.24 Favored Glycine 0 CA--C 1.537 1.454 0 C-N-CA 127.432 2.444 . . . . 0.0 116.576 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 78.7 t -141.49 101.15 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 N-CA-C 105.73 -1.952 . . . . 0.0 105.73 -179.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.402 ' HA ' ' C ' ' A' ' 117' ' ' TYR . 1.8 mp0 -59.13 -179.67 0.08 Allowed 'General case' 0 C--O 1.207 -1.172 0 CA-C-O 123.785 1.755 . . . . 0.0 111.797 -179.464 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.658 ' HB2' ' CB ' ' A' ' 17' ' ' PHE . . . -168.08 76.21 0.13 Allowed 'General case' 0 CA--C 1.503 -0.847 0 C-N-CA 113.602 -3.239 . . . . 0.0 110.877 -178.043 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.568 ' HA ' ' CB ' ' A' ' 116' ' ' THR . 1.4 mptp? -57.58 144.69 36.35 Favored 'General case' 0 CA--C 1.508 -0.654 0 CA-C-N 123.897 3.044 . . . . 0.0 112.258 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.522 ' HA ' ' ND2' ' A' ' 11' ' ' ASN . 11.1 mtp180 -144.83 77.03 1.52 Allowed 'General case' 0 C--O 1.21 -0.978 0 C-N-CA 127.259 2.224 . . . . 0.0 105.565 178.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.911 HG23 HG12 ' A' ' 114' ' ' ILE . 0.8 OUTLIER -78.62 128.59 38.32 Favored 'Isoleucine or valine' 0 C--O 1.253 1.289 0 O-C-N 127.767 3.167 . . . . 0.0 116.794 179.77 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.583 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 0.1 OUTLIER -109.8 145.38 36.81 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 128.499 2.72 . . . . 0.0 107.122 179.917 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . 0.254 0.3 OUTLIER -112.67 29.13 8.2 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 117.051 -1.452 . . . . 0.0 112.286 -179.79 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.594 ' HB2' ' CZ3' ' A' ' 6' ' ' TRP . 3.3 tttp 50.37 89.26 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 127.397 2.279 . . . . 0.0 108.641 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . 0.773 64.0 mt-10 . . . . . 0 N--CA 1.426 -1.639 0 O-C-N 125.846 1.966 . . . . 0.0 113.6 -179.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' PLM . . . . . 0.52 ' HG2' ' CE2' ' A' ' 55' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.217 -0.619 0 CA-C-O 118.587 -0.721 . . . . 0.0 109.071 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -99.47 -42.24 7.03 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 116.067 1.877 . . . . 0.0 116.067 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -43.85 93.74 0.01 OUTLIER 'General case' 0 CA--C 1.496 -1.126 0 O-C-N 126.141 2.15 . . . . 0.0 111.691 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 176.3 -178.28 47.71 Favored Glycine 0 C--N 1.31 -0.886 0 C-N-CA 117.343 -2.36 . . . . 0.0 111.527 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.569 HG23 HG23 ' A' ' 39' ' ' THR 0.377 1.2 p -94.02 155.12 17.29 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 128.641 3.201 . . . . 0.0 111.951 -179.735 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.71 ' NE1' HD12 ' A' ' 40' ' ' ILE . 49.2 m95 -159.75 -158.98 0.69 Allowed 'General case' 0 N--CA 1.426 -1.667 0 CA-C-O 114.63 -2.605 . . . . 0.0 106.393 177.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.757 ' HB3' ' CZ ' ' A' ' 128' ' ' PHE . 6.9 ttmt 178.91 -99.64 0.0 OUTLIER 'General case' 0 C--O 1.209 -1.073 0 O-C-N 129.007 3.942 . . . . 0.0 105.17 179.387 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.755 HG12 ' O ' ' A' ' 7' ' ' LYS 0.263 0.3 OUTLIER 159.3 120.13 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 O-C-N 126.329 2.268 . . . . 0.0 109.348 179.514 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 61.5 t0 -125.55 -76.48 0.59 Allowed 'General case' 0 CA--C 1.506 -0.746 0 CA-C-O 125.965 2.793 . . . . 0.0 108.043 -179.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -83.83 122.97 29.41 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 118.626 -2.547 . . . . 0.0 108.269 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . 0.319 0.0 OUTLIER -114.76 -171.12 1.87 Allowed 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 107.151 -1.425 . . . . 0.0 107.151 179.685 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.401 ' HB3' ' HD3' ' A' ' 125' ' ' LYS . 4.6 tt0 -170.53 109.89 0.36 Allowed 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 115.723 -2.391 . . . . 0.0 106.75 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.407 ' ND2' HG12 ' A' ' 122' ' ' VAL 0.259 0.2 OUTLIER 87.65 -8.08 0.59 Allowed 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 -179.852 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.703 ' CD1' ' HB1' ' A' ' 124' ' ' ALA 0.407 0.3 OUTLIER -68.09 -33.81 75.23 Favored 'General case' 0 C--N 1.321 -0.645 0 O-C-N 126.939 2.65 . . . . 0.0 115.6 179.882 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -71.97 -20.51 61.72 Favored 'General case' 0 C--O 1.213 -0.832 0 O-C-N 119.072 -2.268 . . . . 0.0 110.556 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 24.5 mttt -78.61 -40.88 33.23 Favored 'General case' 0 N--CA 1.443 -0.777 0 O-C-N 126.765 2.541 . . . . 0.0 112.494 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.544 ' CE1' ' HG2' ' A' ' 21' ' ' MET . 0.6 OUTLIER -68.41 -31.79 71.38 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-O 126.076 2.846 . . . . 0.0 110.681 179.702 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 28.4 mtm -69.23 -23.64 63.9 Favored 'General case' 0 C--O 1.22 -0.459 1 O-C-N 114.918 -4.864 . . . . 0.0 108.793 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -79.33 -32.97 43.45 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-O 127.603 3.573 . . . . 0.0 110.647 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.415 ' HD3' HG21 ' A' ' 122' ' ' VAL . 16.6 tptt -74.16 -25.4 59.7 Favored 'General case' 0 N--CA 1.433 -1.302 0 O-C-N 118.257 -2.777 . . . . 0.0 112.728 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.544 ' HG2' ' CE1' ' A' ' 17' ' ' PHE 0.257 13.6 mmm -75.73 -29.1 58.78 Favored 'General case' 0 C--O 1.202 -1.415 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 -179.933 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 103.95 29.12 5.63 Favored Glycine 0 CA--C 1.504 -0.619 0 CA-C-O 115.94 -2.589 . . . . 0.0 109.583 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.614 HD12 ' HG1' ' A' ' 132' ' ' PLM . 2.2 mm -69.42 141.78 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.956 0 CA-C-N 118.857 1.328 . . . . 0.0 109.863 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 24.9 t30 -80.65 131.99 35.54 Favored 'General case' 0 C--N 1.345 0.399 0 CA-C-O 113.742 -3.028 . . . . 0.0 108.503 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . 0.454 99.1 t -11.01 -51.54 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.503 -0.86 0 O-C-N 128.513 3.633 . . . . 0.0 119.262 -179.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.614 13.7 t -72.84 -40.1 59.96 Favored 'Isoleucine or valine' 0 C--O 1.249 1.044 0 N-CA-C 116.637 2.088 . . . . 0.0 116.637 -179.467 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 11.3 mttm -67.09 -32.35 73.45 Favored 'General case' 0 C--O 1.213 -0.853 0 O-C-N 125.632 1.832 . . . . 0.0 113.369 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.467 ' HG3' ' N ' ' A' ' 29' ' ' LYS . 16.4 ptt180 -78.96 -29.28 43.86 Favored 'General case' 0 CA--C 1.514 -0.432 0 O-C-N 120.337 -1.477 . . . . 0.0 109.449 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.467 ' N ' ' HG3' ' A' ' 28' ' ' ARG . 0.2 OUTLIER -72.66 -40.85 66.01 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-O 122.626 1.203 . . . . 0.0 110.67 179.955 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.0 tp -73.2 -28.61 62.29 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 113.484 -1.689 . . . . 0.0 108.625 -179.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -74.57 -28.98 62.32 Favored Glycine 0 C--N 1.348 1.219 0 CA-C-N 113.897 -1.501 . . . . 0.0 113.969 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -71.63 -37.97 70.82 Favored 'General case' 0 C--O 1.241 0.655 0 C-N-CA 126.89 2.076 . . . . 0.0 111.563 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 6.6 m80 -111.28 30.27 7.07 Favored 'General case' 0 N--CA 1.447 -0.594 0 O-C-N 126.786 2.554 . . . . 0.0 110.186 179.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -49.68 -36.63 25.69 Favored 'General case' 0 CA--C 1.501 -0.912 0 N-CA-C 116.813 2.153 . . . . 0.0 116.813 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . 0.261 22.3 m120 70.42 54.22 0.3 Allowed 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 116.114 -2.234 . . . . 0.0 107.122 -179.196 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.778 HD11 HD12 ' A' ' 38' ' ' LEU 0.293 1.7 tp -85.8 107.45 17.65 Favored 'General case' 0 N--CA 1.479 0.992 0 O-C-N 128.7 3.75 . . . . 0.0 103.747 179.911 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.43 ' HA ' ' CB ' ' A' ' 7' ' ' LYS . 24.4 tttm -92.77 127.98 38.46 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 100.473 -3.899 . . . . 0.0 100.473 179.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.778 HD12 HD11 ' A' ' 36' ' ' LEU 0.377 0.5 OUTLIER -112.05 121.4 44.87 Favored 'General case' 0 C--N 1.288 -2.09 0 C-N-CA 116.011 -2.275 . . . . 0.0 107.004 -178.5 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.569 HG23 HG23 ' A' ' 5' ' ' THR . 28.0 m -116.12 90.86 3.43 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 117.287 -3.383 . . . . 0.0 104.588 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.71 HD12 ' NE1' ' A' ' 6' ' ' TRP . 26.5 mt -70.36 130.16 34.6 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.467 ' HB ' HG23 ' A' ' 48' ' ' THR . 11.6 m -126.75 105.91 9.0 Favored 'General case' 0 N--CA 1.477 0.886 0 O-C-N 127.801 3.188 . . . . 0.0 109.734 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.578 ' HG2' ' CE1' ' A' ' 47' ' ' PHE . 1.0 OUTLIER -84.69 109.1 17.77 Favored 'General case' 0 C--O 1.24 0.6 0 N-CA-C 114.368 1.247 . . . . 0.0 114.368 -179.906 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -96.66 31.08 2.4 Favored 'General case' 0 N--CA 1.419 -1.991 0 O-C-N 121.214 -0.929 . . . . 0.0 109.857 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 97.41 -13.12 64.69 Favored Glycine 0 C--N 1.29 -1.99 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.376 0.0 OUTLIER -175.6 -50.59 0.01 OUTLIER 'General case' 0 C--O 1.213 -0.823 0 CA-C-O 126.132 2.872 . . . . 0.0 109.168 179.901 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 28.1 ttmt -64.89 115.9 5.81 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 113.048 -1.887 . . . . 0.0 110.504 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.578 ' CE1' ' HG2' ' A' ' 42' ' ' GLN . 0.9 OUTLIER -100.71 93.85 5.78 Favored 'General case' 0 CA--C 1.499 -0.995 0 CA-C-O 123.312 1.529 . . . . 0.0 107.271 179.803 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.526 ' HA ' ' HA ' ' A' ' 61' ' ' VAL 0.388 3.1 t -89.72 87.39 6.98 Favored 'General case' 0 N--CA 1.432 -1.347 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 179.623 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.794 HG12 ' CG1' ' A' ' 60' ' ' VAL 0.596 0.5 OUTLIER -70.09 107.93 2.03 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.12 0 O-C-N 125.884 1.99 . . . . 0.0 110.334 179.981 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.55 ' CB ' ' HB ' ' A' ' 39' ' ' THR . 26.0 tttm -68.9 115.97 8.83 Favored 'General case' 0 C--N 1.302 -1.46 1 N-CA-C 100.192 -4.003 . . . . 0.0 100.192 -179.731 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.476 ' HG3' HD13 ' A' ' 36' ' ' LEU 0.276 69.9 tt0 -107.29 96.32 6.33 Favored 'General case' 0 C--N 1.322 -0.63 0 O-C-N 126.659 2.474 . . . . 0.0 108.484 179.906 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.427 ' HA ' ' HA ' ' A' ' 57' ' ' ASN 0.261 0.1 OUTLIER -96.48 52.37 1.23 Allowed 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 105.201 -2.148 . . . . 0.0 105.201 179.378 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.538 ' HA ' ' HA ' ' A' ' 36' ' ' LEU . 0.1 OUTLIER -77.97 160.23 28.32 Favored 'General case' 0 C--O 1.214 -0.781 0 O-C-N 127.552 3.032 . . . . 0.0 109.882 -179.537 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -53.65 -28.26 32.07 Favored 'General case' 0 C--O 1.215 -0.724 0 O-C-N 126.477 2.361 . . . . 0.0 108.633 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.413 ' C ' ' HG2' ' A' ' 56' ' ' ARG . 8.0 m-85 -62.27 -58.8 6.39 Favored 'General case' 0 C--N 1.351 0.639 0 CA-C-O 115.201 -2.333 . . . . 0.0 109.612 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.658 ' HB2' HG22 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -156.85 155.91 32.27 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-N 123.399 2.818 . . . . 0.0 106.102 179.414 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.427 ' HA ' ' HA ' ' A' ' 52' ' ' SER 0.262 21.2 t30 -101.07 70.94 1.37 Allowed 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 100.364 -3.939 . . . . 0.0 100.364 179.67 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.658 HG22 ' HB2' ' A' ' 56' ' ' ARG . 8.4 tp -120.03 122.98 69.88 Favored 'Isoleucine or valine' 0 C--O 1.243 0.728 0 C-N-CA 130.146 3.378 . . . . 0.0 118.697 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.436 ' HA ' ' HA ' ' A' ' 50' ' ' LYS . 0.0 OUTLIER -72.58 135.66 45.6 Favored 'General case' 0 N--CA 1.468 0.441 0 O-C-N 118.694 -2.504 . . . . 0.0 105.466 179.856 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.794 ' CG1' HG12 ' A' ' 49' ' ' VAL . 4.4 p -109.96 101.13 12.13 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-O 126.177 2.894 . . . . 0.0 111.407 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.526 ' HA ' ' HA ' ' A' ' 48' ' ' THR 0.311 2.0 m -88.56 131.2 36.62 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 O-C-N 116.684 -3.76 . . . . 0.0 113.061 179.858 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.443 ' HE1' HG13 ' A' ' 60' ' ' VAL . 22.1 p90 -151.58 89.02 1.45 Allowed 'General case' 0 N--CA 1.442 -0.827 0 C-N-CA 116.579 -2.049 . . . . 0.0 107.128 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -56.08 134.64 52.79 Favored 'General case' 0 N--CA 1.432 -1.362 0 N-CA-C 104.438 -2.43 . . . . 0.0 104.438 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -49.63 102.81 0.04 OUTLIER 'General case' 0 N--CA 1.428 -1.565 0 O-C-N 126.407 2.317 . . . . 0.0 110.515 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 89.73 32.19 10.4 Favored Glycine 0 C--N 1.346 1.115 0 C-N-CA 128.289 2.852 . . . . 0.0 119.924 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . 0.364 0.4 OUTLIER -111.42 99.16 8.1 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 N-CA-C 104.902 -2.258 . . . . 0.0 104.902 179.91 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.42 ' HA ' HG22 ' A' ' 81' ' ' THR . 0.1 OUTLIER -51.47 136.93 25.01 Favored 'General case' 0 CA--C 1.487 -1.45 0 O-C-N 126.079 2.112 . . . . 0.0 114.153 179.971 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 9.9 p90 -145.62 175.08 10.63 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -129.46 146.77 51.26 Favored 'General case' 0 CA--C 1.501 -0.924 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.51 ' HB3' HD23 ' A' ' 78' ' ' LEU . 16.5 t80 -129.96 -39.78 1.38 Allowed 'General case' 0 C--O 1.213 -0.863 0 CA-C-O 116.118 -1.896 . . . . 0.0 111.806 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.545 ' C ' HD22 ' A' ' 72' ' ' LEU . 0.7 OUTLIER 64.39 158.44 0.09 Allowed 'General case' 0 C--N 1.308 -1.2 0 O-C-N 125.366 1.666 . . . . 0.0 112.056 -179.904 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.797 ' N ' HD13 ' A' ' 72' ' ' LEU . 0.0 OUTLIER 41.55 -158.7 0.01 OUTLIER 'General case' 0 C--N 1.293 -1.873 0 O-C-N 128.351 3.532 . . . . 0.0 110.424 178.369 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.584 ' HA ' ' HG3' ' A' ' 132' ' ' PLM . . . 53.97 35.93 23.16 Favored 'General case' 0 C--O 1.208 -1.094 0 CA-C-N 114.237 -1.347 . . . . 0.0 111.444 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.404 ' CB ' ' O ' ' A' ' 73' ' ' ALA . 0.3 OUTLIER 102.34 19.84 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.365 0 O-C-N 126.565 2.415 . . . . 0.0 113.89 179.22 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.571 ' HA3' ' CD1' ' A' ' 78' ' ' LEU . . . -136.87 -38.63 0.15 Allowed Glycine 0 CA--C 1.549 2.174 0 N-CA-C 118.434 2.134 . . . . 0.0 118.434 179.025 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . 0.308 0.0 OUTLIER 59.28 65.95 1.1 Allowed 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 119.662 1.731 . . . . 0.0 107.897 -179.026 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.569 ' HB3' ' HB ' ' A' ' 96' ' ' VAL . 31.0 mt-10 71.81 76.39 0.17 Allowed 'General case' 0 C--O 1.218 -0.594 0 O-C-N 126.518 2.386 . . . . 0.0 108.529 -178.212 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.571 ' CD1' ' HA3' ' A' ' 75' ' ' GLY 0.436 0.7 OUTLIER -97.63 135.11 39.92 Favored 'General case' 0 CA--C 1.5 -0.978 0 O-C-N 127.764 3.165 . . . . 0.0 104.38 -178.162 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 20.2 m -158.13 124.72 4.82 Favored 'General case' 0 CA--C 1.481 -1.696 0 N-CA-C 103.919 -2.623 . . . . 0.0 103.919 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -168.61 -155.49 9.66 Favored Glycine 0 C--N 1.302 -1.313 0 O-C-N 119.748 -1.845 . . . . 0.0 109.316 -179.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.42 HG22 ' HA ' ' A' ' 67' ' ' ASP . 4.2 p -145.17 -179.97 6.98 Favored 'General case' 0 C--O 1.196 -1.73 0 C-N-CA 117.23 -1.788 . . . . 0.0 106.965 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . 0.472 ' CE2' ' HA3' ' A' ' 91' ' ' GLY . 19.7 m95 -132.27 142.88 49.55 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 101.689 -3.449 . . . . 0.0 101.689 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 14.4 t -143.77 160.96 39.82 Favored 'General case' 0 N--CA 1.417 -2.078 0 CA-C-O 124.948 2.309 . . . . 0.0 113.195 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -94.91 126.97 40.6 Favored 'General case' 0 C--N 1.354 0.8 0 CA-C-N 110.774 -2.921 . . . . 0.0 105.775 -179.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . 0.685 0.5 OUTLIER -107.24 33.72 3.85 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.88 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 95.26 -93.43 1.6 Allowed Glycine 0 N--CA 1.427 -1.953 0 N-CA-C 103.986 -3.646 . . . . 0.0 103.986 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -88.96 -5.84 57.68 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 120.154 3.39 . . . . 0.0 120.154 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.4 ' HE2' HG21 ' A' ' 105' ' ' VAL 0.265 0.2 OUTLIER -129.91 152.53 49.28 Favored 'General case' 0 CA--C 1.49 -1.354 0 O-C-N 125.163 1.54 . . . . 0.0 107.182 179.678 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.43 ' HB3' ' HB2' ' A' ' 106' ' ' ARG . 0.3 OUTLIER -106.21 134.15 49.79 Favored 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 105.039 -2.208 . . . . 0.0 105.039 -179.864 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -121.76 154.1 25.94 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.941 0 N-CA-C 105.276 -2.12 . . . . 0.0 105.276 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.472 ' HA3' ' CE2' ' A' ' 82' ' ' TRP . . . -134.96 111.61 0.94 Allowed Glycine 0 CA--C 1.531 1.04 1 C-N-CA 131.06 4.171 . . . . 0.0 109.509 179.898 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 24.8 mtmt -109.16 158.53 17.71 Favored 'General case' 0 N--CA 1.426 -1.651 0 N-CA-C 104.374 -2.454 . . . . 0.0 104.374 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.548 ' HB2' HD22 ' A' ' 102' ' ' LEU . 30.5 m-85 -148.36 112.95 5.34 Favored 'General case' 0 CA--C 1.508 -0.635 0 CA-C-O 123.378 1.561 . . . . 0.0 108.079 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 57.0 mttm -93.39 138.91 31.27 Favored 'General case' 0 N--CA 1.437 -1.104 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . 0.302 0.3 OUTLIER -92.15 136.61 33.04 Favored 'General case' 0 CA--C 1.491 -1.293 0 CA-C-N 113.55 -1.659 . . . . 0.0 109.106 179.75 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.569 ' HB ' ' HB3' ' A' ' 77' ' ' GLU . 38.4 t -71.98 -38.13 63.12 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 C-N-CA 125.277 1.431 . . . . 0.0 111.166 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . 0.319 0.8 OUTLIER -83.24 2.64 34.85 Favored 'General case' 0 C--O 1.261 1.665 0 N-CA-C 118.103 2.631 . . . . 0.0 118.103 -179.959 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -144.28 -29.22 0.49 Allowed 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 116.197 -2.201 . . . . 0.0 114.843 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 92.48 -0.16 70.72 Favored Glycine 0 CA--C 1.532 1.129 0 N-CA-C 118.956 2.343 . . . . 0.0 118.956 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 6.4 mmtt -77.61 -155.1 0.07 Allowed 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 119.299 1.55 . . . . 0.0 111.331 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.55 118.58 4.7 Favored 'General case' 0 CA--C 1.489 -1.375 0 C-N-CA 128.983 2.913 . . . . 0.0 114.541 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.627 ' HA ' ' HA ' ' A' ' 119' ' ' TYR . 0.7 OUTLIER -92.23 135.87 33.65 Favored 'General case' 0 C--N 1.317 -0.812 1 C-N-CA 132.484 4.314 . . . . 0.0 102.741 179.073 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.85 HG23 ' HB3' ' A' ' 117' ' ' TYR . 14.0 tt -129.34 163.72 33.76 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.003 0 C-N-CA 116.524 -2.07 . . . . 0.0 109.395 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -150.39 146.77 26.9 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-O 115.658 -2.115 . . . . 0.0 107.808 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.593 ' HB ' ' CE2' ' A' ' 117' ' ' TYR . 8.8 p -136.53 120.8 24.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 122.915 2.598 . . . . 0.0 110.466 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.789 ' HG2' HH11 ' A' ' 106' ' ' ARG . 1.2 mtt-85 -76.95 86.65 3.48 Favored 'General case' 0 CA--C 1.496 -1.105 0 O-C-N 126.66 2.475 . . . . 0.0 106.689 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 10.7 tt0 -81.65 78.67 8.37 Favored 'General case' 0 N--CA 1.424 -1.742 0 CA-C-O 123.104 1.431 . . . . 0.0 113.031 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.525 ' CD1' ' CZ2' ' A' ' 6' ' ' TRP . 2.3 mm -69.01 98.06 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 C-N-CA 115.537 -2.465 . . . . 0.0 110.296 179.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -100.1 101.43 12.49 Favored 'General case' 0 C--O 1.215 -0.742 0 N-CA-C 103.254 -2.869 . . . . 0.0 103.254 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 65.41 -88.8 0.1 Allowed Glycine 0 C--N 1.339 0.695 0 O-C-N 126.061 2.101 . . . . 0.0 112.138 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . 0.368 0.4 OUTLIER -117.82 -13.57 10.12 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-O 113.313 -3.232 . . . . 0.0 111.158 179.562 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . 0.251 2.2 mp0 -93.6 133.42 36.95 Favored 'General case' 0 C--O 1.212 -0.879 0 O-C-N 128.905 3.878 . . . . 0.0 110.89 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.909 HD21 ' HG2' ' A' ' 115' ' ' GLN 0.284 0.4 OUTLIER -103.06 141.74 35.3 Favored 'General case' 0 C--O 1.21 -1.011 0 N-CA-C 101.321 -3.585 . . . . 0.0 101.321 179.721 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.762 HG13 HD13 ' A' ' 127' ' ' ILE 0.297 1.4 mp -129.95 139.0 52.64 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 N-CA-C 101.706 -3.442 . . . . 0.0 101.706 179.385 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.909 ' HG2' HD21 ' A' ' 113' ' ' LEU . 3.4 mt-30 -119.24 104.91 10.83 Favored 'General case' 0 C--N 1.316 -0.851 1 O-C-N 129.621 4.325 . . . . 0.0 101.492 179.699 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.53 ' HB ' ' HG3' ' A' ' 125' ' ' LYS . 3.4 t -140.68 157.68 45.09 Favored 'General case' 0 N--CA 1.412 -2.371 0 C-N-CA 116.924 -1.91 . . . . 0.0 112.357 -178.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.85 ' HB3' HG23 ' A' ' 103' ' ' ILE 0.372 22.2 m-30 137.93 -138.36 0.0 OUTLIER 'General case' 0 CA--C 1.484 -1.584 1 O-C-N 129.408 4.193 . . . . 0.0 113.171 176.246 . . . . . . . . 4 3 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.502 ' HB ' ' HA ' ' A' ' 123' ' ' GLU . 10.2 t -158.67 -154.33 0.42 Allowed 'General case' 0 C--N 1.308 -1.229 0 O-C-N 127.674 3.109 . . . . 0.0 115.756 -174.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.627 ' HA ' ' HA ' ' A' ' 102' ' ' LEU . 1.7 t80 -114.9 -55.94 2.43 Favored 'General case' 0 C--N 1.346 0.417 0 N-CA-C 105.126 -2.176 . . . . 0.0 105.126 178.305 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.88 -83.37 0.65 Allowed 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 111.59 -2.55 . . . . 0.0 112.396 179.203 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -143.55 25.29 2.15 Favored Glycine 0 C--N 1.366 2.238 0 N-CA-C 121.359 3.303 . . . . 0.0 121.359 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.415 HG21 ' HD3' ' A' ' 20' ' ' LYS . 15.0 t -123.34 97.35 4.63 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 N-CA-C 103.011 -2.959 . . . . 0.0 103.011 179.253 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.502 ' HA ' ' HB ' ' A' ' 118' ' ' THR . 13.6 mt-10 -56.86 179.77 0.04 OUTLIER 'General case' 0 C--O 1.205 -1.289 0 CA-C-O 126.554 3.073 . . . . 0.0 113.093 -177.418 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.703 ' HB1' ' CD1' ' A' ' 14' ' ' TYR . . . -169.17 94.5 0.31 Allowed 'General case' 0 C--O 1.211 -0.961 0 O-C-N 118.821 -2.424 . . . . 0.0 107.987 -179.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.53 ' HG3' ' HB ' ' A' ' 116' ' ' THR 0.391 0.1 OUTLIER -84.92 153.72 22.67 Favored 'General case' 0 N--CA 1.444 -0.727 0 O-C-N 125.923 2.014 . . . . 0.0 112.529 -179.572 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.549 ' CD ' ' HB2' ' A' ' 115' ' ' GLN . 1.0 OUTLIER -137.81 77.83 1.65 Allowed 'General case' 0 N--CA 1.427 -1.598 0 O-C-N 127.57 3.044 . . . . 0.0 105.297 177.114 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.762 HD13 HG13 ' A' ' 114' ' ' ILE . 50.8 mm -66.99 82.79 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.259 1.557 0 O-C-N 128.051 3.344 . . . . 0.0 111.202 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.757 ' CZ ' ' HB3' ' A' ' 7' ' ' LYS 0.368 5.7 t80 -84.44 144.39 28.79 Favored 'General case' 0 N--CA 1.419 -2.001 0 CA-C-O 125.256 2.455 . . . . 0.0 113.753 -179.641 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.407 ' N ' ' CG ' ' A' ' 128' ' ' PHE 0.391 8.7 mmtt -95.28 10.53 35.82 Favored 'General case' 0 N--CA 1.436 -1.147 0 CA-C-N 110.996 -2.82 . . . . 0.0 113.996 -177.666 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.509 ' HA ' ' CE3' ' A' ' 6' ' ' TRP . 18.4 tttt 61.53 111.7 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 122.555 2.434 . . . . 0.0 113.666 -178.39 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . 0.857 2.3 tm-20 . . . . . 0 C--O 1.217 -0.612 0 O-C-N 117.167 -3.458 . . . . 0.0 114.508 -179.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' PLM . . . . . 0.712 ' H21' HG11 ' A' ' 60' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.384 0 CA-C-O 122.48 1.133 . . . . 0.0 109.489 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.684 ' CE1' HD12 ' A' ' 108' ' ' ILE . 65.4 m-85 -61.98 -54.19 45.12 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 116.353 1.983 . . . . 0.0 116.353 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -39.78 91.39 0.0 OUTLIER 'General case' 0 CA--C 1.499 -0.984 0 O-C-N 126.678 2.486 . . . . 0.0 111.34 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.43 ' O ' ' HB ' ' A' ' 40' ' ' ILE . . . 158.69 -174.71 35.78 Favored Glycine 0 C--O 1.214 -1.114 0 CA-C-N 113.824 -1.534 . . . . 0.0 110.91 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.582 ' HA ' ' HA ' ' A' ' 39' ' ' THR 0.549 0.5 OUTLIER -81.93 156.88 24.52 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-O 124.426 2.06 . . . . 0.0 115.774 -179.697 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.54 ' CH2' HD11 ' A' ' 108' ' ' ILE . 73.1 m95 -149.8 157.3 43.07 Favored 'General case' 0 N--CA 1.435 -1.182 0 CA-C-N 110.647 -2.979 . . . . 0.0 106.858 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -160.27 102.54 1.41 Allowed 'General case' 0 C--O 1.214 -0.79 1 O-C-N 129.59 4.306 . . . . 0.0 107.081 179.922 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.527 ' HB ' ' CD1' ' A' ' 128' ' ' PHE 0.38 9.3 p -47.12 139.35 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.289 0 CA-C-N 121.593 1.997 . . . . 0.0 113.131 179.992 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -131.61 0.98 4.03 Favored 'General case' 0 CA--C 1.496 -1.099 0 C-N-CA 119.785 -0.766 . . . . 0.0 112.55 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 16.6 ptp180 -160.79 -39.06 0.05 OUTLIER 'General case' 0 CA--C 1.474 -1.967 0 O-C-N 116.946 -3.596 . . . . 0.0 113.301 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . 0.278 0.6 OUTLIER 62.09 178.79 0.13 Allowed 'General case' 0 C--O 1.243 0.742 0 C-N-CA 125.293 1.437 . . . . 0.0 108.193 179.613 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -132.34 -80.2 0.5 Allowed 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 122.478 2.399 . . . . 0.0 109.635 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 16.5 t30 -96.05 15.46 20.62 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 124.799 1.312 . . . . 0.0 113.576 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.876 ' HA ' ' HB1' ' A' ' 124' ' ' ALA 0.26 0.1 OUTLIER -58.0 -26.87 62.94 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 117.978 2.584 . . . . 0.0 117.978 -179.952 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -72.12 -41.32 67.37 Favored 'General case' 0 C--O 1.207 -1.168 0 O-C-N 120.822 -1.174 . . . . 0.0 110.794 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 17.8 tttm -79.72 -26.37 40.83 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-O 123.175 1.464 . . . . 0.0 114.161 -179.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.676 ' CB ' ' HB2' ' A' ' 124' ' ' ALA . 7.8 t80 -67.05 -35.67 80.37 Favored 'General case' 0 N--CA 1.422 -1.838 0 C-N-CA 118.509 -1.276 . . . . 0.0 113.752 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.451 ' CB ' HG13 ' A' ' 23' ' ' ILE . 24.2 mtt -72.51 -23.7 61.05 Favored 'General case' 0 N--CA 1.425 -1.714 0 CA-C-O 124.561 2.124 . . . . 0.0 107.81 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -76.85 -22.94 52.78 Favored 'General case' 0 CA--C 1.507 -0.689 0 C-N-CA 116.54 -2.064 . . . . 0.0 112.777 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 18.9 tptp -68.0 -39.69 83.17 Favored 'General case' 0 C--N 1.314 -0.936 0 O-C-N 118.827 -2.42 . . . . 0.0 114.889 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.514 ' HG3' ' CD2' ' A' ' 119' ' ' TYR . 3.2 mpp? -76.03 -37.57 58.23 Favored 'General case' 0 C--O 1.207 -1.132 0 C-N-CA 124.527 1.131 . . . . 0.0 109.429 179.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 118.73 47.91 0.39 Allowed Glycine 0 C--N 1.308 -1.016 0 CA-C-N 113.05 -1.886 . . . . 0.0 110.01 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.571 HG22 ' HG2' ' A' ' 28' ' ' ARG . 5.4 mm -73.15 106.56 3.22 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.784 0 CA-C-N 121.735 2.768 . . . . 0.0 110.565 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -44.82 111.21 0.29 Allowed 'General case' 0 N--CA 1.44 -0.94 0 CA-C-O 114.136 -2.84 . . . . 0.0 113.019 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . 0.421 0.2 OUTLIER 3.76 -61.78 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.497 -1.076 1 O-C-N 129.463 4.227 . . . . 0.0 119.309 179.89 . . . . . . . . 4 3 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.579 13.3 m -72.59 -22.24 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.906 0 N-CA-C 117.53 2.419 . . . . 0.0 117.53 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.43 ' HB2' ' CG2' ' A' ' 23' ' ' ILE . 26.5 mttp -77.0 -25.97 53.31 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-O 118.406 -0.807 . . . . 0.0 110.918 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.571 ' HG2' HG22 ' A' ' 23' ' ' ILE . 0.1 OUTLIER -79.98 -24.44 40.91 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 117.934 -1.506 . . . . 0.0 107.495 179.882 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.8 ttpt -74.84 -49.76 19.45 Favored 'General case' 0 C--O 1.212 -0.893 0 CA-C-O 123.819 1.771 . . . . 0.0 108.711 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.428 ' HA ' HD12 ' A' ' 30' ' ' LEU . 7.3 tp -73.25 -28.85 62.37 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 114.56 -1.2 . . . . 0.0 108.348 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -67.55 -32.64 79.23 Favored Glycine 0 CA--C 1.538 1.474 0 O-C-N 124.843 1.34 . . . . 0.0 112.219 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -78.05 -24.35 47.8 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -112.81 2.41 15.96 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-O 115.903 -1.999 . . . . 0.0 112.363 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 21.5 p-10 -33.46 -32.51 0.01 OUTLIER 'General case' 0 CA--C 1.505 -0.766 0 N-CA-C 117.922 2.564 . . . . 0.0 117.922 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . 0.259 4.5 t-20 75.42 31.03 0.79 Allowed 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 121.386 1.903 . . . . 0.0 109.561 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.584 ' CG ' HD13 ' A' ' 38' ' ' LEU . 1.2 tp -60.97 87.83 0.02 OUTLIER 'General case' 0 C--O 1.213 -0.863 0 O-C-N 126.925 2.641 . . . . 0.0 109.602 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.82 104.15 16.63 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 102.122 -3.288 . . . . 0.0 102.122 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.584 HD13 ' CG ' ' A' ' 36' ' ' LEU 0.265 0.6 OUTLIER -90.47 104.13 16.74 Favored 'General case' 0 C--N 1.288 -2.089 0 O-C-N 125.921 2.013 . . . . 0.0 109.384 -179.901 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.582 ' HA ' ' HA ' ' A' ' 5' ' ' THR . 6.9 m -87.18 85.62 7.22 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 102.021 -3.326 . . . . 0.0 102.021 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.656 HD13 HG12 ' A' ' 49' ' ' VAL . 6.4 mm -60.0 131.44 24.66 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 CA-C-O 124.191 1.948 . . . . 0.0 110.68 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.428 HG22 ' O ' ' A' ' 41' ' ' THR . 3.0 m -150.34 103.4 3.15 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 112.915 -1.948 . . . . 0.0 114.575 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.44 ' HG2' ' CE1' ' A' ' 47' ' ' PHE . 1.6 mm-40 -49.21 117.73 2.31 Favored 'General case' 0 CA--C 1.547 0.847 0 O-C-N 126.479 2.362 . . . . 0.0 107.992 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.477 ' HB2' HG22 ' A' ' 48' ' ' THR 0.252 1.2 tp10 -90.86 45.65 1.27 Allowed 'General case' 0 CA--C 1.484 -1.562 0 O-C-N 124.816 1.322 . . . . 0.0 107.494 -179.46 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.02 -55.82 5.05 Favored Glycine 0 C--N 1.292 -1.912 0 N-CA-C 105.657 -2.977 . . . . 0.0 105.657 -179.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.503 ' HB2' ' CG ' ' A' ' 63' ' ' GLU 0.318 4.5 m-20 -108.13 -76.9 0.6 Allowed 'General case' 0 CA--C 1.504 -0.805 0 N-CA-C 115.158 1.54 . . . . 0.0 115.158 -179.449 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.712 ' HG3' ' N ' ' A' ' 47' ' ' PHE . 26.1 tptt -83.64 -76.85 0.27 Allowed 'General case' 0 N--CA 1.417 -2.093 0 C-N-CA 114.594 -2.842 . . . . 0.0 115.112 -178.346 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.712 ' N ' ' HG3' ' A' ' 46' ' ' LYS 0.422 0.1 OUTLIER 162.77 108.78 0.0 OUTLIER 'General case' 0 CA--C 1.496 -1.127 0 O-C-N 128.398 3.561 . . . . 0.0 109.423 -174.761 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.875 ' HA ' ' HA ' ' A' ' 61' ' ' VAL 0.407 9.0 t -81.63 112.33 18.73 Favored 'General case' 0 C--O 1.248 0.992 0 O-C-N 119.458 -2.026 . . . . 0.0 106.118 178.316 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.656 HG12 HD13 ' A' ' 40' ' ' ILE 0.615 1.0 OUTLIER -90.47 105.04 15.9 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 N-CA-C 116.117 1.895 . . . . 0.0 116.117 -179.606 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.458 ' CB ' ' HB ' ' A' ' 39' ' ' THR . 0.4 OUTLIER -67.4 111.3 3.98 Favored 'General case' 0 C--N 1.302 -1.487 1 N-CA-C 99.836 -4.135 . . . . 0.0 99.836 179.351 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -96.82 67.9 2.33 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 104.173 -2.528 . . . . 0.0 104.173 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.7 m -78.67 68.4 4.64 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 105.417 -2.068 . . . . 0.0 105.417 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.553 ' CB ' ' HA ' ' A' ' 36' ' ' LEU . 1.1 p -109.66 -167.51 1.21 Allowed 'General case' 0 N--CA 1.438 -1.033 0 CA-C-N 114.76 -1.109 . . . . 0.0 110.057 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -75.58 -24.22 56.59 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 117.867 -1.533 . . . . 0.0 111.457 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.52 ' CE2' ' HA ' ' A' ' 73' ' ' ALA . 31.8 m-85 -69.29 -50.55 45.71 Favored 'General case' 0 C--O 1.221 -0.423 0 C-N-CA 115.47 -2.492 . . . . 0.0 111.042 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.405 ' O ' HG22 ' A' ' 58' ' ' ILE . 0.0 OUTLIER 168.6 151.82 0.03 OUTLIER 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 123.916 3.053 . . . . 0.0 110.351 179.208 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -84.34 116.36 22.98 Favored 'General case' 0 C--N 1.348 0.535 1 N-CA-C 99.892 -4.114 . . . . 0.0 99.892 179.056 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.405 HG22 ' O ' ' A' ' 56' ' ' ARG 0.299 0.0 OUTLIER -136.52 -28.02 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 O-C-N 128.524 3.64 . . . . 0.0 116.622 -178.223 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 67.46 79.05 0.23 Allowed 'General case' 0 C--N 1.352 0.701 0 N-CA-C 104.096 -2.557 . . . . 0.0 104.096 -178.57 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.583 ' CG1' ' CE2' ' A' ' 62' ' ' PHE . 94.2 t -86.72 77.61 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.408 0 CA-C-N 114.3 -1.318 . . . . 0.0 114.257 -177.254 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.875 ' HA ' ' HA ' ' A' ' 48' ' ' THR . 0.4 OUTLIER -69.6 143.03 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.378 0 O-C-N 118.749 -2.469 . . . . 0.0 106.923 177.334 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.656 ' CE1' ' CB ' ' A' ' 68' ' ' PHE . 1.6 m-30 -144.31 57.88 1.32 Allowed 'General case' 0 N--CA 1.44 -0.945 0 C-N-CA 114.392 -2.923 . . . . 0.0 111.839 178.235 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.672 ' CA ' ' HB2' ' A' ' 46' ' ' LYS . 1.2 mt-10 -19.61 119.66 0.02 OUTLIER 'General case' 0 C--N 1.311 -1.071 0 O-C-N 128.601 3.688 . . . . 0.0 108.682 -178.115 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.546 ' N ' ' HB2' ' A' ' 46' ' ' LYS . 0.4 OUTLIER -48.11 101.83 0.03 OUTLIER 'General case' 0 N--CA 1.438 -1.032 0 CA-C-O 122.761 1.267 . . . . 0.0 110.979 -177.387 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 93.38 22.25 27.4 Favored Glycine 0 C--N 1.351 1.415 0 CA-C-N 110.793 -2.912 . . . . 0.0 114.0 -179.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.411 ' N ' ' O ' ' A' ' 63' ' ' GLU 0.364 0.9 OUTLIER -102.7 77.79 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 N-CA-C 104.015 -2.587 . . . . 0.0 104.015 179.796 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -39.17 111.71 0.2 Allowed 'General case' 0 CA--C 1.485 -1.55 0 O-C-N 126.895 2.622 . . . . 0.0 115.929 -179.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.656 ' CB ' ' CE1' ' A' ' 62' ' ' PHE . 17.1 p90 -106.7 -179.68 4.01 Favored 'General case' 0 N--CA 1.433 -1.306 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.533 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -144.69 148.3 34.05 Favored 'General case' 0 CA--C 1.521 -0.161 0 O-C-N 126.702 2.501 . . . . 0.0 109.183 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.456 ' CB ' HD22 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -146.31 118.94 8.55 Favored 'General case' 0 C--O 1.216 -0.679 0 O-C-N 125.274 1.609 . . . . 0.0 107.28 -179.997 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.452 ' C ' ' CD1' ' A' ' 72' ' ' LEU . 0.7 OUTLIER -99.84 37.68 1.58 Allowed 'General case' 0 CA--C 1.489 -1.37 0 CA-C-N 121.366 1.893 . . . . 0.0 112.133 -179.255 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.575 ' N ' HD13 ' A' ' 72' ' ' LEU . 0.0 OUTLIER 173.61 -167.59 0.03 OUTLIER 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 125.14 1.376 . . . . 0.0 109.199 -179.094 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.52 ' HA ' ' CE2' ' A' ' 55' ' ' PHE . . . 69.74 24.82 5.28 Favored 'General case' 0 C--O 1.208 -1.101 0 O-C-N 124.711 1.257 . . . . 0.0 110.352 -179.307 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.77 ' N ' ' HG3' ' A' ' 132' ' ' PLM . 27.8 t0 106.89 41.26 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.403 0 O-C-N 126.726 2.516 . . . . 0.0 113.692 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -155.53 -40.31 0.02 OUTLIER Glycine 0 CA--C 1.543 1.8 0 N-CA-C 118.301 2.08 . . . . 0.0 118.301 179.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.472 ' O ' ' HB2' ' A' ' 77' ' ' GLU 0.257 0.1 OUTLIER 61.91 25.62 15.41 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-O 115.188 -2.339 . . . . 0.0 108.097 -179.554 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.499 ' HB3' ' HB ' ' A' ' 96' ' ' VAL . 3.9 mm-40 112.74 113.14 0.0 OUTLIER 'General case' 0 C--N 1.313 -1.02 1 O-C-N 133.923 7.014 . . . . 0.0 109.45 -177.659 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.5 ' HG ' ' HB3' ' A' ' 93' ' ' PHE 0.451 7.4 tt -139.53 119.68 13.66 Favored 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 102.662 -3.088 . . . . 0.0 102.662 -178.272 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 21.8 m -141.63 120.66 12.86 Favored 'General case' 0 C--O 1.197 -1.687 0 N-CA-C 103.38 -2.822 . . . . 0.0 103.38 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.517 ' HA3' ' HA ' ' A' ' 93' ' ' PHE . . . -160.9 -163.25 13.64 Favored Glycine 0 C--O 1.215 -1.051 0 C-N-CA 116.972 -2.537 . . . . 0.0 114.057 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 13.9 p -141.95 165.71 26.72 Favored 'General case' 0 C--O 1.188 -2.175 0 O-C-N 127.296 2.41 . . . . 0.0 110.616 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 93.9 m95 -107.36 147.46 30.31 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 103.76 -2.682 . . . . 0.0 103.76 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 5.0 t -147.15 127.53 13.99 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 125.093 1.495 . . . . 0.0 109.612 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -79.48 117.54 20.53 Favored 'General case' 0 N--CA 1.427 -1.606 0 CA-C-N 112.536 -2.12 . . . . 0.0 108.597 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.408 ' HA ' ' OE1' ' A' ' 85' ' ' GLU 0.608 3.4 mm-40 -78.03 -20.09 53.09 Favored 'General case' 0 N--CA 1.426 -1.662 0 O-C-N 123.766 0.666 . . . . 0.0 109.267 179.975 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 126.64 -53.2 0.8 Allowed Glycine 0 N--CA 1.436 -1.339 0 N-CA-C 104.921 -3.272 . . . . 0.0 104.921 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -112.54 -3.41 14.39 Favored 'General case' 0 C--O 1.245 0.834 0 CA-C-O 116.7 -1.619 . . . . 0.0 114.183 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . 0.379 10.2 mtpt -154.75 120.64 5.19 Favored 'General case' 0 CA--C 1.503 -0.837 0 O-C-N 125.574 1.796 . . . . 0.0 110.468 179.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.842 HD23 ' HD2' ' A' ' 106' ' ' ARG . 3.8 tp -76.56 144.55 39.61 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 103.512 -2.773 . . . . 0.0 103.512 179.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.555 ' CG1' HG23 ' A' ' 105' ' ' VAL . 2.7 m -141.56 153.35 19.5 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.052 0 N-CA-C 105.235 -2.135 . . . . 0.0 105.235 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -123.38 104.51 0.86 Allowed Glycine 0 CA--C 1.534 1.227 1 C-N-CA 130.794 4.045 . . . . 0.0 108.132 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -105.95 95.57 5.88 Favored 'General case' 0 N--CA 1.428 -1.565 0 C-N-CA 119.521 -0.872 . . . . 0.0 109.841 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.517 ' HA ' ' HA3' ' A' ' 80' ' ' GLY . 2.3 m-85 -92.96 123.32 36.13 Favored 'General case' 0 N--CA 1.435 -1.185 0 O-C-N 125.4 1.688 . . . . 0.0 114.092 179.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 24.7 mttt -91.5 146.77 23.53 Favored 'General case' 0 N--CA 1.429 -1.503 0 O-C-N 126.0 2.062 . . . . 0.0 110.059 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . 0.355 9.0 ttt180 -103.73 142.24 34.7 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-N 114.04 -1.436 . . . . 0.0 107.376 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.499 ' HB ' ' HB3' ' A' ' 77' ' ' GLU . 69.0 t -81.66 -36.04 14.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-O 124.793 2.235 . . . . 0.0 109.618 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . 0.32 1.3 t70 -72.82 -12.96 61.19 Favored 'General case' 0 C--O 1.256 1.405 0 N-CA-C 118.354 2.724 . . . . 0.0 118.354 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -141.36 -27.51 0.68 Allowed 'General case' 0 CA--C 1.502 -0.876 0 C-N-CA 116.854 -1.938 . . . . 0.0 115.671 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 94.77 9.98 58.14 Favored Glycine 0 C--N 1.337 0.625 0 O-C-N 125.555 1.784 . . . . 0.0 117.041 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 5.4 mmtm -106.04 172.29 6.89 Favored 'General case' 0 C--O 1.2 -1.544 0 CA-C-N 119.072 1.436 . . . . 0.0 109.278 179.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.96 126.14 50.15 Favored 'General case' 0 N--CA 1.436 -1.142 0 O-C-N 125.955 2.034 . . . . 0.0 114.841 -179.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.778 HD22 ' HD1' ' A' ' 119' ' ' TYR . 0.2 OUTLIER -79.38 116.44 19.62 Favored 'General case' 0 C--O 1.246 0.894 0 C-N-CA 130.456 3.502 . . . . 0.0 102.686 179.43 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.709 HG23 ' HB3' ' A' ' 117' ' ' TYR . 4.3 tt -97.8 150.15 4.83 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.116 0 C-N-CA 114.616 -2.833 . . . . 0.0 104.732 -179.245 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -143.29 145.03 32.37 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 116.533 -1.698 . . . . 0.0 109.312 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.747 HG12 HG23 ' A' ' 116' ' ' THR . 7.6 p -134.5 113.83 17.49 Favored 'Isoleucine or valine' 0 C--O 1.248 1.012 0 CA-C-N 123.604 2.911 . . . . 0.0 113.528 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.842 ' HD2' HD23 ' A' ' 89' ' ' LEU . 63.0 mtt180 -81.37 95.67 7.1 Favored 'General case' 0 C--O 1.216 -0.667 0 N-CA-C 104.948 -2.242 . . . . 0.0 104.948 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 64.4 tt0 -102.31 81.97 2.13 Favored 'General case' 0 N--CA 1.419 -2.007 0 CA-C-N 111.49 -2.596 . . . . 0.0 114.727 -179.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.684 HD12 ' CE1' ' A' ' 2' ' ' PHE 0.29 0.3 OUTLIER -58.51 110.98 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 C-N-CA 117.448 -1.701 . . . . 0.0 107.853 179.516 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 2.9 m -75.36 -17.93 60.1 Favored 'General case' 0 C--O 1.214 -0.776 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 -179.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 150.63 -109.35 0.42 Allowed Glycine 0 C--O 1.238 0.37 1 C-N-CA 132.087 4.661 . . . . 0.0 111.75 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 38.0 m-20 -59.77 -17.4 35.21 Favored 'General case' 0 C--O 1.213 -0.858 0 C-N-CA 116.778 -1.969 . . . . 0.0 111.61 179.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -110.64 135.23 51.58 Favored 'General case' 0 CA--C 1.496 -1.126 0 O-C-N 127.02 2.7 . . . . 0.0 117.476 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.648 HD13 ' CE2' ' A' ' 128' ' ' PHE . 0.1 OUTLIER -101.96 113.06 25.95 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 102.793 -3.04 . . . . 0.0 102.793 -179.938 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.737 HG23 HD12 ' A' ' 127' ' ' ILE . 78.0 mt -113.94 106.45 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.026 0 O-C-N 125.663 1.852 . . . . 0.0 110.309 -179.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.571 ' HB2' ' CG ' ' A' ' 126' ' ' ARG . 30.1 mt-30 -74.16 169.92 16.58 Favored 'General case' 0 C--O 1.244 0.791 0 N-CA-C 101.505 -3.517 . . . . 0.0 101.505 178.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.747 HG23 HG12 ' A' ' 105' ' ' VAL . 0.2 OUTLIER 173.75 155.04 0.11 Allowed 'General case' 0 N--CA 1.414 -2.254 0 C-N-CA 118.037 -1.465 . . . . 0.0 111.508 179.992 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.709 ' HB3' HG23 ' A' ' 103' ' ' ILE 0.393 23.4 m-30 125.38 -141.91 0.0 OUTLIER 'General case' 0 CA--C 1.475 -1.934 1 O-C-N 130.475 4.859 . . . . 0.0 113.875 175.93 . . . . . . . . 4 3 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.508 HG22 ' HG3' ' A' ' 123' ' ' GLU . 0.0 OUTLIER -138.53 -165.18 1.77 Allowed 'General case' 0 N--CA 1.431 -1.38 0 CA-C-O 126.831 3.205 . . . . 0.0 117.656 -174.911 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.778 ' HD1' HD22 ' A' ' 102' ' ' LEU 0.259 0.0 OUTLIER -109.19 -55.42 2.41 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 111.463 -2.608 . . . . 0.0 105.287 177.872 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.534 ' HB2' ' CD2' ' A' ' 119' ' ' TYR . 0.6 OUTLIER -129.12 -53.96 1.2 Allowed 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 111.516 -2.584 . . . . 0.0 112.744 179.526 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -162.01 15.91 0.15 Allowed Glycine 0 C--N 1.362 2.011 0 N-CA-C 118.928 2.331 . . . . 0.0 118.928 -179.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.401 ' O ' ' HB ' ' A' ' 118' ' ' THR . 82.9 t -120.7 112.58 36.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 N-CA-C 104.172 -2.529 . . . . 0.0 104.172 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.508 ' HG3' HG22 ' A' ' 118' ' ' THR . 1.2 mt-10 -71.42 177.51 3.93 Favored 'General case' 0 C--O 1.208 -1.116 0 C-N-CA 118.359 -1.337 . . . . 0.0 112.298 -178.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.876 ' HB1' ' HA ' ' A' ' 14' ' ' TYR . . . 179.71 97.83 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 116.525 -1.702 . . . . 0.0 110.284 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.531 ' HA ' ' HB ' ' A' ' 116' ' ' THR 0.327 0.0 OUTLIER -71.02 165.08 24.25 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 120.803 1.638 . . . . 0.0 111.192 179.656 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.604 ' HG2' ' CE2' ' A' ' 14' ' ' TYR . 0.1 OUTLIER -140.56 77.09 1.59 Allowed 'General case' 0 N--CA 1.436 -1.128 1 O-C-N 129.661 4.351 . . . . 0.0 108.664 179.476 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.737 HD12 HG23 ' A' ' 114' ' ' ILE . 0.6 OUTLIER -70.03 112.82 5.18 Favored 'Isoleucine or valine' 0 C--O 1.254 1.298 0 O-C-N 128.341 3.525 . . . . 0.0 112.824 179.752 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.648 ' CE2' HD13 ' A' ' 113' ' ' LEU . 1.8 m-30 -98.2 138.74 35.02 Favored 'General case' 0 C--O 1.221 -0.427 0 C-N-CA 127.298 2.239 . . . . 0.0 109.34 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . 0.266 26.6 mmtt -103.73 34.67 2.9 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 117.139 -1.41 . . . . 0.0 112.311 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.487 ' HA ' ' HA ' ' A' ' 6' ' ' TRP . 10.0 tttp 29.83 100.78 0.0 OUTLIER 'General case' 0 CA--C 1.508 -0.65 0 N-CA-C 116.695 2.109 . . . . 0.0 116.695 179.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.41 ' HA ' ' OG1' ' A' ' 5' ' ' THR 0.852 5.6 tt0 . . . . . 0 N--CA 1.439 -1.013 0 N-CA-C 119.502 3.149 . . . . 0.0 119.502 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' PLM . . . . . 0.77 ' HG3' ' N ' ' A' ' 74' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.326 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -124.29 -42.02 2.15 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 114.816 1.413 . . . . 0.0 114.816 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.38 101.08 0.07 Allowed 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 118.63 -1.228 . . . . 0.0 112.401 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 166.12 -155.32 26.49 Favored Glycine 0 C--O 1.217 -0.941 0 C-N-CA 115.809 -3.091 . . . . 0.0 113.267 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . 0.543 1.2 p -105.48 150.92 24.88 Favored 'General case' 0 CA--C 1.504 -0.823 0 CA-C-N 112.657 -1.772 . . . . 0.0 114.494 -179.728 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.654 ' CH2' HD11 ' A' ' 108' ' ' ILE . 85.5 m95 -150.54 152.69 34.54 Favored 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 125.513 1.758 . . . . 0.0 108.576 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 5.6 tttp -153.13 103.01 2.68 Favored 'General case' 0 C--O 1.205 -1.268 0 CA-C-O 116.678 -1.629 . . . . 0.0 109.103 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.718 HG12 ' HB3' ' A' ' 36' ' ' LEU 0.396 13.9 p -48.98 124.39 2.26 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.066 0 O-C-N 126.464 2.353 . . . . 0.0 111.722 179.819 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 51.4 t0 -123.81 1.26 8.73 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 125.218 2.437 . . . . 0.0 108.717 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.429 ' O ' ' HB ' ' A' ' 127' ' ' ILE . 1.9 ttt180 -169.28 133.51 1.4 Allowed 'General case' 0 C--N 1.294 -1.811 0 O-C-N 118.184 -2.822 . . . . 0.0 107.398 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . 0.299 0.0 OUTLIER -116.22 -171.89 2.08 Favored 'General case' 0 CA--C 1.501 -0.941 0 CA-C-N 114.394 -1.276 . . . . 0.0 108.513 179.894 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.462 ' CB ' ' HB2' ' A' ' 125' ' ' LYS . 0.5 OUTLIER -167.51 94.82 0.44 Allowed 'General case' 0 C--N 1.3 -1.579 0 CA-C-N 122.2 2.273 . . . . 0.0 107.917 179.907 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . 0.259 0.1 OUTLIER 97.68 -5.87 0.05 Allowed 'General case' 0 N--CA 1.486 1.359 0 O-C-N 126.984 2.678 . . . . 0.0 111.63 -179.636 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.715 ' HA ' ' HB1' ' A' ' 124' ' ' ALA . 0.4 OUTLIER -71.87 -16.36 62.14 Favored 'General case' 0 N--CA 1.432 -1.349 0 O-C-N 126.188 2.18 . . . . 0.0 116.103 -179.852 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -76.98 -37.68 54.71 Favored 'General case' 0 C--O 1.206 -1.201 0 CA-C-N 121.74 2.064 . . . . 0.0 109.25 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.42 -34.57 63.29 Favored 'General case' 0 N--CA 1.427 -1.617 0 CA-C-N 112.846 -1.979 . . . . 0.0 113.178 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.43 ' CB ' ' HB2' ' A' ' 124' ' ' ALA . 43.4 t80 -65.85 -24.79 66.96 Favored 'General case' 0 N--CA 1.421 -1.916 0 CA-C-O 123.213 1.482 . . . . 0.0 112.607 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 29.6 mtt -74.33 -28.56 61.2 Favored 'General case' 0 N--CA 1.443 -0.806 0 O-C-N 118.511 -2.618 . . . . 0.0 107.449 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -70.12 -32.62 70.72 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 125.665 2.65 . . . . 0.0 113.31 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 7.9 tttm -77.82 -43.9 29.03 Favored 'General case' 0 C--N 1.313 -0.984 0 O-C-N 119.855 -1.778 . . . . 0.0 112.086 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 11.1 mmm -62.29 -26.7 68.55 Favored 'General case' 0 C--O 1.205 -1.247 0 C-N-CA 126.098 1.759 . . . . 0.0 109.782 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 105.34 62.38 0.64 Allowed Glycine 0 N--CA 1.433 -1.521 0 CA-C-N 114.792 -1.095 . . . . 0.0 112.89 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.423 HG23 ' HB3' ' A' ' 27' ' ' LYS . 2.2 mm -118.31 134.9 60.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -79.35 157.35 27.67 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-O 113.872 -2.966 . . . . 0.0 112.391 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . 0.343 2.1 m -33.73 -39.1 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.21 -0.978 0 O-C-N 126.809 2.568 . . . . 0.0 114.318 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.488 2.5 m -78.18 -50.48 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.106 0 O-C-N 126.959 2.662 . . . . 0.0 115.129 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.423 ' HB3' HG23 ' A' ' 23' ' ' ILE . 13.7 mttm -64.25 -23.54 67.34 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.149 -0.932 . . . . 0.0 112.67 -179.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 6.9 ptt-85 -79.51 -26.19 41.6 Favored 'General case' 0 CA--C 1.532 0.27 0 O-C-N 119.826 -1.796 . . . . 0.0 107.753 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 7.0 ttmm -74.91 -38.45 61.81 Favored 'General case' 0 C--O 1.212 -0.905 0 O-C-N 125.086 1.492 . . . . 0.0 112.248 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.0 mp -78.08 -24.97 47.41 Favored 'General case' 0 N--CA 1.431 -1.404 0 C-N-CA 124.101 0.96 . . . . 0.0 110.579 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -79.42 -27.46 54.93 Favored Glycine 0 C--O 1.213 -1.165 0 O-C-N 125.238 1.586 . . . . 0.0 111.251 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -75.38 -41.8 55.49 Favored 'General case' 0 CA--C 1.514 -0.409 0 C-N-CA 125.912 1.685 . . . . 0.0 111.371 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 6.7 m-70 -101.03 14.32 32.35 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-O 116.152 -1.88 . . . . 0.0 115.408 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 14.9 p30 -40.34 -26.25 0.03 OUTLIER 'General case' 0 CA--C 1.499 -1.002 0 O-C-N 127.391 2.932 . . . . 0.0 118.763 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 6.9 p30 72.95 12.12 5.16 Favored 'General case' 0 C--N 1.311 -1.089 0 O-C-N 125.264 1.602 . . . . 0.0 109.155 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.718 ' HB3' HG12 ' A' ' 8' ' ' VAL . 2.6 tp -30.23 92.83 0.01 OUTLIER 'General case' 0 CA--C 1.503 -0.839 0 C-N-CA 129.298 3.039 . . . . 0.0 110.34 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 5.9 ttpm? -94.15 115.61 27.92 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 102.336 -3.209 . . . . 0.0 102.336 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.784 ' CD2' HG21 ' A' ' 49' ' ' VAL 0.26 0.1 OUTLIER -104.02 116.76 32.81 Favored 'General case' 0 C--N 1.291 -1.974 0 C-N-CA 116.923 -1.911 . . . . 0.0 110.01 -179.819 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.404 ' HB ' ' HB2' ' A' ' 50' ' ' LYS . 10.5 m -106.3 99.11 8.71 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 124.748 2.213 . . . . 0.0 105.158 179.68 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.472 HG23 HG12 ' A' ' 49' ' ' VAL . 1.2 mt -88.17 128.42 40.52 Favored 'Isoleucine or valine' 0 C--O 1.251 1.184 0 CA-C-N 113.233 -1.803 . . . . 0.0 110.814 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.535 HG22 ' O ' ' A' ' 41' ' ' THR . 4.5 m -115.44 70.78 0.75 Allowed 'General case' 0 C--N 1.346 0.448 0 O-C-N 127.306 2.879 . . . . 0.0 107.567 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -65.69 112.96 3.93 Favored 'General case' 0 C--N 1.316 -0.854 0 C-N-CA 123.948 0.899 . . . . 0.0 109.716 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.7 tt0 -99.16 -103.19 0.22 Allowed 'General case' 0 N--CA 1.423 -1.822 0 N-CA-C 105.312 -2.107 . . . . 0.0 105.312 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -113.48 -48.41 0.6 Allowed Glycine 0 C--N 1.295 -1.743 0 N-CA-C 109.092 -1.603 . . . . 0.0 109.092 -179.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.532 ' ND2' ' N ' ' A' ' 45' ' ' ASN . 0.0 OUTLIER -127.58 -20.4 3.98 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 -179.942 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -90.14 161.23 15.86 Favored 'General case' 0 C--N 1.308 -1.217 0 C-N-CA 116.723 -1.991 . . . . 0.0 113.098 179.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -135.24 69.44 1.44 Allowed 'General case' 0 CA--C 1.512 -0.49 0 CA-C-O 124.273 1.987 . . . . 0.0 109.698 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.847 ' OG1' HG12 ' A' ' 61' ' ' VAL . 14.0 t -74.74 122.88 23.96 Favored 'General case' 0 N--CA 1.432 -1.362 0 O-C-N 119.562 -1.961 . . . . 0.0 106.753 179.345 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.784 HG21 ' CD2' ' A' ' 38' ' ' LEU 0.685 0.9 OUTLIER -116.44 120.9 66.33 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.727 0 N-CA-C 117.551 2.426 . . . . 0.0 117.551 -179.058 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.404 ' HB2' ' HB ' ' A' ' 39' ' ' THR . 0.9 OUTLIER -64.87 145.15 56.69 Favored 'General case' 0 C--N 1.308 -1.235 1 N-CA-C 99.101 -4.407 . . . . 0.0 99.101 177.749 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.472 ' O ' ' N ' ' A' ' 53' ' ' SER . 5.3 tt0 -133.87 51.69 2.12 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 104.279 -2.489 . . . . 0.0 104.279 -178.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . 0.26 4.6 m -61.95 86.6 0.02 OUTLIER 'General case' 0 C--N 1.289 -2.06 0 N-CA-C 104.736 -2.32 . . . . 0.0 104.736 179.348 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.671 ' OG ' HD13 ' A' ' 36' ' ' LEU . 1.3 m -122.48 44.34 2.65 Favored 'General case' 0 N--CA 1.443 -0.816 0 O-C-N 126.1 2.125 . . . . 0.0 114.607 -179.121 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 65.66 -54.04 0.36 Allowed 'General case' 0 N--CA 1.44 -0.957 0 O-C-N 126.717 2.51 . . . . 0.0 108.996 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.505 ' CE1' ' HB1' ' A' ' 73' ' ' ALA . 7.4 m-85 -62.81 -56.99 12.48 Favored 'General case' 0 C--O 1.217 -0.654 0 CA-C-O 114.699 -2.572 . . . . 0.0 109.186 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.657 ' HB3' HG22 ' A' ' 58' ' ' ILE . 23.1 ttt-85 -148.98 144.48 26.8 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 123.709 2.959 . . . . 0.0 112.054 179.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -97.66 81.84 2.98 Favored 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 100.623 -3.843 . . . . 0.0 100.623 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.657 HG22 ' HB3' ' A' ' 56' ' ' ARG . 1.5 tt -120.65 100.6 9.38 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.77 1 O-C-N 129.26 4.1 . . . . 0.0 118.927 -179.213 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -63.02 117.98 7.21 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 103.492 -2.781 . . . . 0.0 103.492 178.059 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.535 ' CG1' HG22 ' A' ' 49' ' ' VAL . 2.4 p -101.43 102.32 13.33 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 C-N-CA 119.672 -0.811 . . . . 0.0 111.103 -177.283 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.847 HG12 ' OG1' ' A' ' 48' ' ' THR 0.36 0.8 OUTLIER -87.12 138.06 19.76 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 CA-C-O 125.966 2.794 . . . . 0.0 113.58 -179.807 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.633 ' HZ ' HH22 ' A' ' 106' ' ' ARG . 23.7 p90 -153.49 100.62 2.43 Favored 'General case' 0 N--CA 1.437 -1.103 0 O-C-N 120.204 -1.56 . . . . 0.0 110.719 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.49 130.44 46.88 Favored 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 102.862 -3.014 . . . . 0.0 102.862 179.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 7.2 mt -52.31 118.09 3.29 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-O 122.886 1.327 . . . . 0.0 110.492 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 86.38 13.41 68.16 Favored Glycine 0 C--N 1.347 1.191 0 CA-C-N 111.627 -2.533 . . . . 0.0 117.39 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . 0.419 0.5 OUTLIER -101.1 129.5 51.98 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 N-CA-C 105.547 -2.02 . . . . 0.0 105.547 179.963 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -86.61 115.31 23.99 Favored 'General case' 0 CA--C 1.483 -1.625 0 N-CA-C 115.146 1.536 . . . . 0.0 115.146 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.411 ' CE1' ' HB3' ' A' ' 62' ' ' PHE . 0.3 OUTLIER -111.7 155.04 24.08 Favored 'General case' 0 N--CA 1.427 -1.609 0 CA-C-O 116.276 -1.821 . . . . 0.0 106.798 -179.979 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -109.51 130.07 55.53 Favored 'General case' 0 CA--C 1.51 -0.591 0 O-C-N 126.138 2.149 . . . . 0.0 106.783 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -130.87 101.16 5.52 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-O 116.67 -1.634 . . . . 0.0 113.903 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 26.8 m -67.18 119.41 12.04 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 105.78 -1.933 . . . . 0.0 105.78 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.533 HD11 HD13 ' A' ' 78' ' ' LEU . 16.7 mt -65.61 -175.81 0.3 Allowed 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 114.265 -1.334 . . . . 0.0 109.136 -179.676 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.505 ' HB1' ' CE1' ' A' ' 55' ' ' PHE . . . -75.42 -35.76 60.92 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-O 124.773 2.225 . . . . 0.0 111.814 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.693 ' HB2' ' HG1' ' A' ' 132' ' ' PLM . 0.3 OUTLIER -153.11 23.91 0.55 Allowed 'General case' 0 C--O 1.239 0.514 0 CA-C-N 112.662 -2.063 . . . . 0.0 108.4 179.718 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.56 ' C ' HG23 ' A' ' 76' ' ' THR . . . -120.18 -10.0 7.67 Favored Glycine 0 C--O 1.213 -1.19 0 C-N-CA 125.052 1.31 . . . . 0.0 114.786 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.56 HG23 ' C ' ' A' ' 75' ' ' GLY . 0.1 OUTLIER 74.51 -175.57 0.14 Allowed 'General case' 0 C--N 1.317 -0.811 0 C-N-CA 117.699 -1.601 . . . . 0.0 112.933 179.926 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -44.87 123.88 4.05 Favored 'General case' 0 N--CA 1.446 -0.64 0 O-C-N 127.467 2.979 . . . . 0.0 111.195 179.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.56 ' HG ' ' HB3' ' A' ' 93' ' ' PHE 0.423 0.6 OUTLIER -144.38 90.14 2.07 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 102.414 -3.18 . . . . 0.0 102.414 -179.819 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 95.6 m -103.55 135.86 44.35 Favored 'General case' 0 CA--C 1.481 -1.678 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -170.78 -159.66 17.35 Favored Glycine 0 C--N 1.291 -1.917 0 C-N-CA 116.568 -2.729 . . . . 0.0 110.596 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -147.54 175.46 10.83 Favored 'General case' 0 C--O 1.197 -1.699 0 CA-C-O 122.554 1.169 . . . . 0.0 108.453 179.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . 0.505 ' CZ3' ' N ' ' A' ' 91' ' ' GLY . 54.6 m95 -130.02 135.43 48.27 Favored 'General case' 0 N--CA 1.427 -1.577 0 N-CA-C 104.078 -2.564 . . . . 0.0 104.078 179.506 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.474 ' CG2' HG23 ' A' ' 90' ' ' VAL . 8.8 t -135.87 134.76 39.13 Favored 'General case' 0 N--CA 1.425 -1.693 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.885 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.468 ' CA ' HD12 ' A' ' 89' ' ' LEU . 5.4 ttt -83.96 121.46 27.41 Favored 'General case' 0 N--CA 1.429 -1.523 0 O-C-N 125.793 1.933 . . . . 0.0 106.103 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . 0.539 0.5 OUTLIER -79.87 -24.24 41.36 Favored 'General case' 0 N--CA 1.426 -1.652 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 179.788 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 154.64 -85.43 0.14 Allowed Glycine 0 N--CA 1.447 -0.568 0 N-CA-C 105.047 -3.221 . . . . 0.0 105.047 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 13.2 m-80 -91.32 -0.72 57.71 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-O 116.385 -1.769 . . . . 0.0 115.264 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . 0.382 0.3 OUTLIER -141.55 146.91 36.9 Favored 'General case' 0 CA--C 1.489 -1.39 0 O-C-N 127.095 2.747 . . . . 0.0 106.973 -179.854 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.488 HD23 ' CD ' ' A' ' 106' ' ' ARG . 0.7 OUTLIER -109.88 141.88 41.97 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 104.934 -2.247 . . . . 0.0 104.934 -179.864 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.474 HG23 ' CG2' ' A' ' 83' ' ' THR . 0.3 OUTLIER -123.21 124.75 70.7 Favored 'Isoleucine or valine' 0 C--O 1.244 0.771 0 N-CA-C 105.007 -2.219 . . . . 0.0 105.007 -179.582 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.505 ' N ' ' CZ3' ' A' ' 82' ' ' TRP . . . -103.36 109.06 3.37 Favored Glycine 0 C--N 1.349 1.268 0 N-CA-C 108.892 -1.683 . . . . 0.0 108.892 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.472 ' C ' ' CD1' ' A' ' 93' ' ' PHE . 24.2 mtpp -102.71 152.77 20.83 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 105.175 -2.158 . . . . 0.0 105.175 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.56 ' HB3' ' HG ' ' A' ' 78' ' ' LEU . 64.6 m-85 -148.73 111.61 4.84 Favored 'General case' 0 CA--C 1.508 -0.658 0 CA-C-O 122.931 1.348 . . . . 0.0 110.873 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 12.8 mttm -92.86 130.53 38.43 Favored 'General case' 0 N--CA 1.44 -0.942 0 C-N-CA 126.456 1.902 . . . . 0.0 107.626 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.42 ' HB3' ' ND2' ' A' ' 98' ' ' ASN 0.381 0.0 OUTLIER -95.62 143.4 26.93 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 104.917 -2.253 . . . . 0.0 104.917 -179.923 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 29.6 m -70.24 -37.76 72.38 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 O-C-N 123.935 0.772 . . . . 0.0 111.081 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . 0.345 0.5 OUTLIER -56.82 -12.29 1.85 Allowed 'General case' 0 C--O 1.254 1.333 0 N-CA-C 114.825 1.417 . . . . 0.0 114.825 179.896 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.42 ' ND2' ' HB3' ' A' ' 95' ' ' ARG . 0.1 OUTLIER -159.52 5.91 0.09 Allowed 'General case' 0 N--CA 1.426 -1.647 0 N-CA-C 116.646 2.091 . . . . 0.0 116.646 179.93 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 44.65 25.39 0.86 Allowed Glycine 0 C--O 1.243 0.692 0 CA-C-O 124.0 1.889 . . . . 0.0 114.357 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 6.7 mmmt -70.91 -97.96 0.01 OUTLIER 'General case' 0 CA--C 1.554 1.129 0 O-C-N 119.185 -2.362 . . . . 0.0 109.611 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.454 ' CG ' ' N ' ' A' ' 102' ' ' LEU . 36.8 tt0 152.26 168.77 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 128.719 2.808 . . . . 0.0 109.345 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.625 ' CB ' ' HA ' ' A' ' 119' ' ' TYR . 0.9 OUTLIER -151.07 134.66 16.34 Favored 'General case' 0 C--O 1.246 0.909 1 C-N-CA 132.613 4.365 . . . . 0.0 103.986 -179.669 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.562 ' N ' ' O ' ' A' ' 118' ' ' THR . 1.3 tp -118.17 159.9 18.22 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.09 0 N-CA-C 106.314 -1.736 . . . . 0.0 106.314 -179.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.469 ' N ' HG13 ' A' ' 103' ' ' ILE . . . -154.31 150.59 28.15 Favored 'General case' 0 C--O 1.242 0.708 0 CA-C-O 115.995 -1.955 . . . . 0.0 107.454 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.649 HG12 HG23 ' A' ' 116' ' ' THR . 8.4 p -137.01 109.68 7.57 Favored 'Isoleucine or valine' 0 C--O 1.248 0.979 0 C-N-CA 116.439 -2.105 . . . . 0.0 114.301 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.633 HH22 ' HZ ' ' A' ' 62' ' ' PHE 0.253 50.7 mtt180 -71.08 96.85 1.39 Allowed 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 104.347 -2.464 . . . . 0.0 104.347 179.498 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -94.75 73.89 3.63 Favored 'General case' 0 N--CA 1.422 -1.858 0 O-C-N 126.438 2.336 . . . . 0.0 112.082 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.654 HD11 ' CH2' ' A' ' 6' ' ' TRP 0.355 1.9 tt -59.55 97.65 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 C-N-CA 114.425 -2.91 . . . . 0.0 113.701 179.891 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 39.4 t -84.23 71.99 10.57 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 105.475 -2.046 . . . . 0.0 105.475 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 72.61 -89.59 0.54 Allowed Glycine 0 C--O 1.241 0.544 0 O-C-N 128.722 3.764 . . . . 0.0 113.26 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . 0.329 1.0 OUTLIER -95.01 -14.76 24.05 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 116.358 -1.782 . . . . 0.0 113.172 -179.891 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -108.9 134.64 51.3 Favored 'General case' 0 N--CA 1.431 -1.411 0 O-C-N 127.553 3.033 . . . . 0.0 112.897 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.467 ' HB2' ' CZ3' ' A' ' 6' ' ' TRP . 0.7 OUTLIER -99.29 141.83 31.56 Favored 'General case' 0 C--O 1.209 -1.064 0 N-CA-C 101.836 -3.394 . . . . 0.0 101.836 -179.647 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.768 HG23 HD13 ' A' ' 127' ' ' ILE . 63.6 mt -142.18 134.79 27.56 Favored 'Isoleucine or valine' 0 C--O 1.246 0.901 0 N-CA-C 103.729 -2.693 . . . . 0.0 103.729 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.526 ' HB2' ' CD ' ' A' ' 126' ' ' ARG . 24.2 mt-30 -117.23 118.48 32.43 Favored 'General case' 0 CA--C 1.497 -1.083 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.649 HG23 HG12 ' A' ' 105' ' ' VAL . 0.7 OUTLIER -137.53 156.86 47.64 Favored 'General case' 0 N--CA 1.413 -2.281 0 CA-C-N 114.247 -1.342 . . . . 0.0 112.397 -179.643 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.467 ' CE2' ' HB ' ' A' ' 105' ' ' VAL 0.384 24.3 m-85 134.73 -141.5 0.0 OUTLIER 'General case' 0 CA--C 1.48 -1.736 1 O-C-N 130.708 5.005 . . . . 0.0 113.485 176.249 . . . . . . . . 4 3 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.616 HG23 ' N ' ' A' ' 119' ' ' TYR . 4.4 t -156.04 -156.07 0.6 Allowed 'General case' 0 C--N 1.311 -1.072 0 O-C-N 127.268 2.855 . . . . 0.0 116.389 -174.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.625 ' HA ' ' CB ' ' A' ' 102' ' ' LEU . 0.0 OUTLIER -105.16 -62.86 1.29 Allowed 'General case' 0 C--N 1.347 0.485 0 N-CA-C 102.69 -3.078 . . . . 0.0 102.69 176.573 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.56 -71.53 0.73 Allowed 'General case' 0 N--CA 1.426 -1.635 0 CA-C-N 111.857 -2.429 . . . . 0.0 116.039 179.488 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -140.7 10.78 2.91 Favored Glycine 0 C--N 1.355 1.633 0 N-CA-C 120.083 2.793 . . . . 0.0 120.083 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 72.3 t -114.12 94.69 3.28 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 O-C-N 117.39 -3.418 . . . . 0.0 103.163 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.458 ' HA ' ' HB ' ' A' ' 118' ' ' THR . 5.6 mt-10 -58.02 177.36 0.12 Allowed 'General case' 0 C--O 1.213 -0.857 0 C-N-CA 118.36 -1.336 . . . . 0.0 112.637 -178.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.715 ' HB1' ' HA ' ' A' ' 14' ' ' TYR . . . -173.87 103.44 0.11 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 115.914 -1.993 . . . . 0.0 109.221 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.505 ' HG3' ' HB ' ' A' ' 116' ' ' THR 0.343 1.5 mptt -79.49 162.15 25.6 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 121.661 2.028 . . . . 0.0 112.665 -179.91 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.599 ' HG2' ' CD2' ' A' ' 14' ' ' TYR . 0.2 OUTLIER -145.07 78.97 1.58 Allowed 'General case' 0 C--O 1.208 -1.104 0 CA-C-O 115.236 -2.316 . . . . 0.0 106.015 179.623 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.768 HD13 HG23 ' A' ' 114' ' ' ILE . 4.4 mm -77.32 111.05 13.68 Favored 'Isoleucine or valine' 0 C--O 1.246 0.888 1 O-C-N 131.973 5.796 . . . . 0.0 110.996 179.703 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.61 ' CZ ' HD12 ' A' ' 38' ' ' LEU . 15.0 m-85 -92.52 169.21 10.72 Favored 'General case' 0 C--N 1.318 -0.783 0 O-C-N 127.255 2.847 . . . . 0.0 108.417 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . 0.305 19.8 mmtt -124.07 -6.21 7.82 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 115.406 -2.235 . . . . 0.0 110.634 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.535 ' HB2' ' CZ3' ' A' ' 6' ' ' TRP . 0.0 OUTLIER 71.82 102.04 0.07 Allowed 'General case' 0 N--CA 1.472 0.631 0 O-C-N 126.811 2.569 . . . . 0.0 109.597 179.823 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . 0.923 7.6 mt-10 . . . . . 0 N--CA 1.434 -1.232 0 N-CA-C 116.223 1.934 . . . . 0.0 116.223 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' PLM . . . . . 0.693 ' HG1' ' HB2' ' A' ' 74' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.284 0 CA-C-O 120.442 0.163 . . . . 0.0 111.412 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.499 ' N ' ' CD1' ' A' ' 2' ' ' PHE . 13.5 m-85 -122.11 69.66 0.95 Allowed 'General case' 0 C--N 1.313 -1.011 0 O-C-N 125.481 1.738 . . . . 0.0 112.438 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -144.05 98.27 3.19 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.521 -1.218 . . . . 0.0 110.594 179.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 161.12 -130.03 2.26 Favored Glycine 0 C--O 1.222 -0.623 0 C-N-CA 115.331 -3.318 . . . . 0.0 110.296 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.589 ' HB ' ' HA ' ' A' ' 39' ' ' THR 0.609 0.1 OUTLIER -134.1 157.94 44.87 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 119.154 -1.018 . . . . 0.0 112.637 -179.812 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.758 ' NE1' HD12 ' A' ' 40' ' ' ILE 0.254 95.1 m95 -142.19 146.63 35.46 Favored 'General case' 0 C--O 1.212 -0.875 0 O-C-N 127.98 3.3 . . . . 0.0 106.253 -179.87 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -139.97 92.9 2.59 Favored 'General case' 0 C--O 1.21 -0.994 0 O-C-N 127.069 2.731 . . . . 0.0 106.452 -179.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.636 HG21 ' HD2' ' A' ' 126' ' ' ARG 0.396 2.1 p -43.77 125.84 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 CA-C-O 116.744 -1.598 . . . . 0.0 112.966 179.836 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -115.4 -31.96 5.76 Favored 'General case' 0 N--CA 1.439 -0.984 0 O-C-N 126.306 2.254 . . . . 0.0 108.846 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.1 149.22 32.6 Favored 'General case' 0 CA--C 1.482 -1.672 0 C-N-CA 116.526 -2.07 . . . . 0.0 108.6 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . 0.386 3.4 m-80 -120.32 -175.45 3.0 Favored 'General case' 0 N--CA 1.454 -0.227 0 O-C-N 126.909 2.631 . . . . 0.0 108.619 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.421 ' HB2' ' HB2' ' A' ' 125' ' ' LYS . 3.6 tt0 -141.89 -78.42 0.26 Allowed 'General case' 0 N--CA 1.432 -1.326 0 C-N-CA 116.651 -2.02 . . . . 0.0 111.055 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -88.79 17.75 5.33 Favored 'General case' 0 N--CA 1.475 0.803 0 O-C-N 125.613 1.821 . . . . 0.0 114.291 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.492 ' CE2' ' HE2' ' A' ' 18' ' ' MET . 9.0 t80 -63.93 -39.08 93.34 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 119.084 2.994 . . . . 0.0 119.084 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.46 -35.29 78.85 Favored 'General case' 0 C--O 1.212 -0.918 0 CA-C-N 121.846 2.112 . . . . 0.0 112.171 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.93 -31.66 45.29 Favored 'General case' 0 N--CA 1.435 -1.185 0 O-C-N 126.492 2.37 . . . . 0.0 113.578 179.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.513 ' CB ' ' HB2' ' A' ' 124' ' ' ALA . 0.0 OUTLIER -70.59 -30.35 67.01 Favored 'General case' 0 N--CA 1.423 -1.788 0 CA-C-O 125.873 2.749 . . . . 0.0 114.185 -179.405 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.492 ' HE2' ' CE2' ' A' ' 14' ' ' TYR . 19.5 mmt -76.58 -22.75 53.83 Favored 'General case' 0 N--CA 1.431 -1.379 0 O-C-N 116.303 -3.998 . . . . 0.0 107.541 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -68.53 -25.29 64.85 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 119.384 -2.073 . . . . 0.0 112.004 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.495 ' HE3' ' CB ' ' A' ' 120' ' ' GLU . 2.2 tttp -79.06 -31.94 44.63 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-O 117.469 -1.253 . . . . 0.0 113.15 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.412 ' HE1' HH22 ' A' ' 95' ' ' ARG . 29.1 mtp -75.64 -23.2 56.31 Favored 'General case' 0 N--CA 1.437 -1.105 0 O-C-N 126.076 2.11 . . . . 0.0 109.006 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 105.26 31.02 4.5 Favored Glycine 0 C--O 1.225 -0.461 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 179.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.531 HG21 ' CA ' ' A' ' 28' ' ' ARG . 2.7 mm -77.49 141.95 14.88 Favored 'Isoleucine or valine' 0 C--N 1.352 0.699 0 C-N-CA 124.97 1.308 . . . . 0.0 108.911 -179.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -101.69 154.34 18.97 Favored 'General case' 0 C--O 1.245 0.839 0 CA-C-O 115.944 -1.979 . . . . 0.0 110.171 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . 0.429 4.2 p -28.92 -40.95 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.518 -0.276 0 O-C-N 128.414 3.571 . . . . 0.0 119.231 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.65 2.5 t -79.83 -40.95 21.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 123.034 1.397 . . . . 0.0 112.572 179.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.0 ttmt -68.67 -43.64 75.72 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 110.469 -3.06 . . . . 0.0 114.548 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.531 ' CA ' HG21 ' A' ' 23' ' ' ILE . 31.6 ptt85 -76.5 -20.82 56.55 Favored 'General case' 0 C--N 1.321 -0.659 0 O-C-N 119.625 -1.922 . . . . 0.0 108.653 -179.562 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.1 ttmt -76.21 -38.3 56.65 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-N 114.381 -1.282 . . . . 0.0 108.334 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -72.38 -35.76 68.55 Favored 'General case' 0 C--O 1.214 -0.766 0 CA-C-N 114.621 -1.172 . . . . 0.0 108.442 -179.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -73.67 -26.87 68.46 Favored Glycine 0 CA--C 1.532 1.118 0 O-C-N 126.239 2.212 . . . . 0.0 111.955 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -75.7 -39.26 57.72 Favored 'General case' 0 N--CA 1.434 -1.23 0 C-N-CA 125.681 1.592 . . . . 0.0 110.774 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -90.58 29.98 1.22 Allowed 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 124.237 1.015 . . . . 0.0 112.538 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 31.2 p-10 -81.02 98.63 8.05 Favored 'General case' 0 CA--C 1.508 -0.655 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -76.93 61.84 2.01 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 120.058 1.299 . . . . 0.0 109.27 179.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.859 HD11 ' CD1' ' A' ' 38' ' ' LEU . 0.1 OUTLIER -61.87 124.92 22.08 Favored 'General case' 0 CA--C 1.492 -1.262 0 C-N-CA 126.836 2.054 . . . . 0.0 108.695 -179.519 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.492 ' HB3' ' HB3' ' A' ' 52' ' ' SER . 21.8 ttmt -108.71 106.14 16.04 Favored 'General case' 0 N--CA 1.431 -1.398 0 N-CA-C 104.482 -2.414 . . . . 0.0 104.482 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.859 ' CD1' HD11 ' A' ' 36' ' ' LEU . 1.3 tp -91.82 111.14 22.55 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 120.844 1.656 . . . . 0.0 108.964 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.589 ' HA ' ' HB ' ' A' ' 5' ' ' THR . 2.2 m -96.69 91.36 5.68 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 101.732 -3.432 . . . . 0.0 101.732 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.758 HD12 ' NE1' ' A' ' 6' ' ' TRP . 58.5 mt -72.05 120.58 20.67 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 -179.368 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -115.01 113.3 23.92 Favored 'General case' 0 CA--C 1.5 -0.976 0 O-C-N 128.221 3.451 . . . . 0.0 114.666 179.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.493 ' HG2' ' CE1' ' A' ' 47' ' ' PHE . 1.6 mm-40 -92.91 96.0 9.84 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-O 117.507 -1.235 . . . . 0.0 108.289 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -76.34 -13.47 60.14 Favored 'General case' 0 N--CA 1.42 -1.953 0 CA-C-N 120.505 1.502 . . . . 0.0 110.699 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 150.74 -30.28 1.02 Allowed Glycine 0 C--N 1.294 -1.767 0 N-CA-C 106.048 -2.821 . . . . 0.0 106.048 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -150.83 -52.82 0.14 Allowed 'General case' 0 N--CA 1.441 -0.896 0 O-C-N 127.045 2.262 . . . . 0.0 110.21 -179.677 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.36 148.69 49.82 Favored 'General case' 0 N--CA 1.436 -1.161 0 CA-C-N 113.765 -1.561 . . . . 0.0 109.023 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.493 ' CE1' ' HG2' ' A' ' 42' ' ' GLN . 0.9 OUTLIER -113.77 81.79 1.58 Allowed 'General case' 0 C--O 1.218 -0.574 0 N-CA-C 105.871 -1.9 . . . . 0.0 105.871 179.861 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.877 HG22 ' CG1' ' A' ' 61' ' ' VAL 0.441 0.9 OUTLIER -63.48 90.25 0.05 OUTLIER 'General case' 0 CA--C 1.503 -0.85 0 C-N-CA 115.477 -2.489 . . . . 0.0 111.591 -179.639 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.586 ' HB ' ' CE1' ' A' ' 62' ' ' PHE 0.652 0.7 OUTLIER -78.05 86.36 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.58 0 CA-C-O 117.929 -1.034 . . . . 0.0 111.411 -179.874 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.437 ' HB3' ' HB ' ' A' ' 39' ' ' THR . 3.2 tttp -62.44 113.45 2.95 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 102.076 -3.305 . . . . 0.0 102.076 -179.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.271 2.4 tt0 -103.73 94.73 5.59 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 120.23 1.377 . . . . 0.0 107.834 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.492 ' HB3' ' HB3' ' A' ' 37' ' ' LYS . 7.6 t -93.2 55.01 2.22 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 105.216 -2.142 . . . . 0.0 105.216 179.673 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.432 ' HA ' ' HA ' ' A' ' 36' ' ' LEU . 87.3 p -67.66 167.49 13.04 Favored 'General case' 0 C--N 1.348 0.541 0 O-C-N 125.633 1.833 . . . . 0.0 111.384 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -58.28 -27.12 63.75 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 119.363 0.983 . . . . 0.0 109.191 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -69.13 -62.94 1.17 Allowed 'General case' 0 C--O 1.21 -1.026 0 CA-C-O 114.301 -2.761 . . . . 0.0 108.418 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.481 ' HG3' HG22 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -157.25 174.1 15.96 Favored 'General case' 0 C--O 1.244 0.813 0 CA-C-N 121.691 2.041 . . . . 0.0 109.947 179.847 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -104.43 85.14 2.3 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 103.453 -2.795 . . . . 0.0 103.453 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.481 HG22 ' HG3' ' A' ' 56' ' ' ARG . 0.6 OUTLIER -114.21 106.81 21.39 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.323 0 C-N-CA 128.675 2.79 . . . . 0.0 115.806 -179.759 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -59.84 135.44 57.69 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 104.465 -2.42 . . . . 0.0 104.465 179.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.585 HG23 ' O ' ' A' ' 49' ' ' VAL . 36.5 t -96.17 -67.71 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.066 0 CA-C-O 126.066 2.841 . . . . 0.0 112.082 -178.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.877 ' CG1' HG22 ' A' ' 48' ' ' THR 0.442 0.1 OUTLIER 69.98 140.07 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 CA-C-N 113.512 -1.676 . . . . 0.0 113.601 -179.947 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.589 ' HZ ' HH22 ' A' ' 106' ' ' ARG . 1.8 p90 -170.22 98.76 0.27 Allowed 'General case' 0 C--N 1.317 -0.814 0 C-N-CA 115.624 -2.43 . . . . 0.0 107.534 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -57.99 131.17 49.63 Favored 'General case' 0 C--O 1.246 0.897 0 N-CA-C 102.737 -3.06 . . . . 0.0 102.737 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -51.98 121.22 6.34 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 114.944 -1.025 . . . . 0.0 110.985 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 68.44 8.14 54.84 Favored Glycine 0 CA--C 1.531 1.061 0 N-CA-C 119.137 2.415 . . . . 0.0 119.137 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.403 HG12 ' H ' ' A' ' 67' ' ' ASP 0.382 15.1 t -80.79 -108.28 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 N-CA-C 104.189 -2.523 . . . . 0.0 104.189 179.823 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.403 ' H ' HG12 ' A' ' 66' ' ' VAL . 7.3 p-10 170.07 149.61 0.04 OUTLIER 'General case' 0 C--O 1.205 -1.243 0 O-C-N 124.509 1.13 . . . . 0.0 112.108 179.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.492 ' CZ ' ' HB3' ' A' ' 62' ' ' PHE . 2.1 p90 -161.69 135.46 6.6 Favored 'General case' 0 N--CA 1.431 -1.397 0 O-C-N 124.787 1.305 . . . . 0.0 109.907 -179.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.13 100.76 13.2 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 105.495 -2.039 . . . . 0.0 105.495 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -106.75 92.69 4.2 Favored 'General case' 0 C--O 1.216 -0.68 0 O-C-N 125.006 1.441 . . . . 0.0 114.179 -179.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 27.6 m -63.12 139.23 58.75 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 120.849 1.659 . . . . 0.0 107.083 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.658 HD23 ' HB2' ' A' ' 132' ' ' PLM . 5.3 mp -80.72 -157.85 0.17 Allowed 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 104.808 -2.293 . . . . 0.0 104.808 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -106.56 -8.92 16.79 Favored 'General case' 0 N--CA 1.439 -1.009 0 CA-C-O 122.499 1.143 . . . . 0.0 113.839 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.42 ' HB2' ' HG2' ' A' ' 132' ' ' PLM . 3.9 t70 -140.0 -39.53 0.45 Allowed 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 114.996 -1.002 . . . . 0.0 111.479 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -86.66 -16.53 61.63 Favored Glycine 0 CA--C 1.534 1.245 0 O-C-N 120.466 -1.396 . . . . 0.0 114.145 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . 0.342 0.1 OUTLIER 72.82 164.23 0.28 Allowed 'General case' 0 N--CA 1.432 -1.338 0 O-C-N 118.49 -2.77 . . . . 0.0 115.794 179.908 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -2.14 120.51 0.0 OUTLIER 'General case' 0 N--CA 1.439 -0.981 0 O-C-N 127.77 3.169 . . . . 0.0 117.505 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.697 HD13 HH21 ' A' ' 95' ' ' ARG 0.409 7.1 tp -134.97 134.95 41.06 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 103.049 -2.945 . . . . 0.0 103.049 179.721 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 6.1 m -145.52 121.2 10.49 Favored 'General case' 0 CA--C 1.485 -1.544 0 O-C-N 125.33 1.644 . . . . 0.0 106.782 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.458 ' HA3' ' HA ' ' A' ' 93' ' ' PHE . . . -175.99 -145.07 5.38 Favored Glycine 0 C--N 1.295 -1.72 0 O-C-N 118.871 -2.393 . . . . 0.0 110.24 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -154.24 177.45 11.11 Favored 'General case' 0 C--O 1.188 -2.157 0 CA-C-N 119.695 1.747 . . . . 0.0 110.976 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . 0.433 ' HA ' ' HA2' ' A' ' 91' ' ' GLY . 12.1 m95 -127.18 142.12 51.57 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 100.568 -3.864 . . . . 0.0 100.568 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 8.9 t -146.91 144.31 29.15 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 125.532 1.77 . . . . 0.0 111.744 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.405 ' HA ' HD23 ' A' ' 89' ' ' LEU . 20.7 ttt -83.76 101.36 11.53 Favored 'General case' 0 N--CA 1.436 -1.15 0 CA-C-N 110.996 -2.82 . . . . 0.0 107.854 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . 0.712 0.0 OUTLIER -90.17 70.07 7.24 Favored 'General case' 0 N--CA 1.427 -1.58 0 C-N-CA 122.8 0.44 . . . . 0.0 112.051 179.952 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 54.52 -97.57 0.04 OUTLIER Glycine 0 C--N 1.349 1.298 0 N-CA-C 107.635 -2.186 . . . . 0.0 107.635 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -74.56 3.49 7.62 Favored 'General case' 0 CA--C 1.52 -0.178 0 N-CA-C 118.036 2.606 . . . . 0.0 118.036 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . 0.402 0.0 OUTLIER -156.0 166.62 32.92 Favored 'General case' 0 C--O 1.215 -0.745 0 CA-C-N 120.698 1.59 . . . . 0.0 110.682 -179.699 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.557 HD13 HH11 ' A' ' 106' ' ' ARG . 0.0 OUTLIER -115.59 116.42 28.1 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 101.6 -3.481 . . . . 0.0 101.6 179.75 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.827 HG12 ' CG2' ' A' ' 105' ' ' VAL . 11.1 m -117.36 155.3 19.04 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 O-C-N 125.465 1.728 . . . . 0.0 106.632 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.433 ' HA2' ' HA ' ' A' ' 82' ' ' TRP . . . -126.88 110.67 1.25 Allowed Glycine 0 CA--C 1.53 0.989 0 O-C-N 128.352 3.532 . . . . 0.0 108.789 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.43 145.67 38.55 Favored 'General case' 0 N--CA 1.429 -1.517 0 N-CA-C 103.815 -2.661 . . . . 0.0 103.815 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.536 ' CE1' ' H41' ' A' ' 132' ' ' PLM . 15.3 m-85 -148.82 130.1 14.65 Favored 'General case' 0 CA--C 1.504 -0.818 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 13.8 mttp -99.18 159.02 15.29 Favored 'General case' 0 C--N 1.313 -1.004 0 O-C-N 125.59 1.806 . . . . 0.0 106.496 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.697 HH21 HD13 ' A' ' 78' ' ' LEU 0.325 0.1 OUTLIER -107.97 142.86 37.45 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 120.944 -1.097 . . . . 0.0 108.192 179.715 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 25.2 t -82.22 -32.55 10.83 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 C-N-CA 125.829 1.651 . . . . 0.0 108.318 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . 0.364 34.9 p-10 -99.5 6.47 45.87 Favored 'General case' 0 C--O 1.25 1.107 0 CA-C-O 124.399 2.047 . . . . 0.0 115.502 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -133.45 -44.2 0.83 Allowed 'General case' 0 N--CA 1.439 -1.008 0 O-C-N 120.792 -1.193 . . . . 0.0 112.465 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 77.45 12.03 84.93 Favored Glycine 0 C--N 1.347 1.185 0 O-C-N 124.526 1.141 . . . . 0.0 114.313 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 6.1 mttt -81.59 -116.1 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 176.65 158.83 0.32 Allowed 'General case' 0 CA--C 1.5 -0.943 0 C-N-CA 128.068 2.547 . . . . 0.0 111.091 -179.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.494 ' CD1' ' HB2' ' A' ' 119' ' ' TYR . 3.1 tp -142.52 141.33 32.07 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 128.297 3.498 . . . . 0.0 106.952 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.512 ' CG2' ' HB ' ' A' ' 118' ' ' THR . 4.1 tt -127.17 165.07 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.766 0 N-CA-C 104.971 -2.233 . . . . 0.0 104.971 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.457 ' N ' ' CG1' ' A' ' 103' ' ' ILE . . . -151.15 157.39 42.63 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-O 116.798 -1.573 . . . . 0.0 109.533 179.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.827 ' CG2' HG12 ' A' ' 90' ' ' VAL . 1.2 t -147.77 96.15 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-O 125.561 2.6 . . . . 0.0 110.63 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.589 HH22 ' HZ ' ' A' ' 62' ' ' PHE . 16.8 mtt180 -71.81 90.52 1.1 Allowed 'General case' 0 C--O 1.236 0.368 0 N-CA-C 104.941 -2.244 . . . . 0.0 104.941 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -97.73 89.52 4.65 Favored 'General case' 0 N--CA 1.425 -1.725 0 C-N-CA 119.425 -0.91 . . . . 0.0 110.991 179.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.493 ' HA ' ' HA ' ' A' ' 113' ' ' LEU 0.439 0.0 OUTLIER -58.41 91.93 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 C-N-CA 117.117 -1.833 . . . . 0.0 114.171 -179.74 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -78.28 76.86 4.78 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 102.56 -3.126 . . . . 0.0 102.56 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 60.93 -123.79 33.67 Favored Glycine 0 C--O 1.245 0.801 0 O-C-N 128.473 3.608 . . . . 0.0 110.705 -179.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . 0.31 28.5 m-80 -71.88 0.96 7.87 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-O 112.381 -3.676 . . . . 0.0 113.76 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.501 ' HG3' ' HA ' ' A' ' 129' ' ' LYS . 4.5 mp0 -118.18 117.75 29.99 Favored 'General case' 0 CA--C 1.511 -0.527 0 O-C-N 128.042 3.339 . . . . 0.0 110.615 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.493 ' HA ' ' HA ' ' A' ' 108' ' ' ILE . 0.5 OUTLIER -87.83 124.27 33.47 Favored 'General case' 0 C--O 1.216 -0.672 0 O-C-N 127.102 2.751 . . . . 0.0 103.969 179.761 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.774 HD13 HG23 ' A' ' 127' ' ' ILE 0.296 1.8 mm -114.55 133.43 60.7 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.33 0 N-CA-C 103.854 -2.647 . . . . 0.0 103.854 -179.68 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 10.7 mt-30 -115.4 97.36 6.13 Favored 'General case' 0 CA--C 1.489 -1.387 0 O-C-N 125.385 1.678 . . . . 0.0 109.461 -179.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.465 HG22 ' HG3' ' A' ' 125' ' ' LYS . 19.2 p -75.09 174.33 9.54 Favored 'General case' 0 C--O 1.247 0.929 0 N-CA-C 105.004 -2.221 . . . . 0.0 105.004 179.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 16.9 m-85 -162.5 115.31 1.68 Allowed 'General case' 0 CA--C 1.483 -1.631 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.512 ' HB ' ' CG2' ' A' ' 103' ' ' ILE . 88.4 m -113.68 88.84 2.94 Favored 'General case' 0 N--CA 1.42 -1.945 0 N-CA-C 116.95 2.204 . . . . 0.0 116.95 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.494 ' HB2' ' CD1' ' A' ' 102' ' ' LEU . 3.2 t80 -83.68 130.01 34.96 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 103.884 -2.635 . . . . 0.0 103.884 178.037 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.495 ' CB ' ' HE3' ' A' ' 20' ' ' LYS . 3.0 mm-40 61.89 -62.9 0.09 Allowed 'General case' 0 C--N 1.289 -2.037 0 O-C-N 125.293 1.621 . . . . 0.0 112.191 -179.088 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 179.64 33.34 0.06 OUTLIER Glycine 0 CA--C 1.542 1.78 0 C-N-CA 128.853 3.121 . . . . 0.0 116.173 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 10.7 t -125.68 97.85 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.65 0 O-C-N 120.744 -1.445 . . . . 0.0 107.637 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.496 ' O ' ' HB2' ' A' ' 124' ' ' ALA 0.257 10.0 mt-10 -62.69 -175.56 0.09 Allowed 'General case' 0 N--CA 1.438 -1.067 0 CA-C-O 117.381 -1.295 . . . . 0.0 111.784 179.983 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.513 ' HB2' ' CB ' ' A' ' 17' ' ' PHE . . . -176.75 88.07 0.03 OUTLIER 'General case' 0 N--CA 1.436 -1.131 0 CA-C-O 114.911 -2.471 . . . . 0.0 107.076 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.465 ' HG3' HG22 ' A' ' 116' ' ' THR . 0.0 OUTLIER -68.43 139.99 55.76 Favored 'General case' 0 CA--C 1.487 -1.469 0 O-C-N 125.788 1.93 . . . . 0.0 110.546 179.989 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.636 ' HD2' HG21 ' A' ' 8' ' ' VAL . 5.0 mmm-85 -133.56 85.12 2.18 Favored 'General case' 0 N--CA 1.429 -1.504 0 O-C-N 126.34 2.275 . . . . 0.0 106.581 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.774 HG23 HD13 ' A' ' 114' ' ' ILE . 13.2 mt -83.79 112.47 21.27 Favored 'Isoleucine or valine' 0 C--O 1.249 1.067 0 O-C-N 127.86 3.225 . . . . 0.0 117.305 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.528 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 0.0 OUTLIER -102.39 137.29 40.83 Favored 'General case' 0 N--CA 1.441 -0.9 0 O-C-N 126.642 2.464 . . . . 0.0 108.136 179.414 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.501 ' HA ' ' HG3' ' A' ' 112' ' ' GLU 0.284 12.2 mmtm -92.64 5.58 50.47 Favored 'General case' 0 C--O 1.244 0.78 0 CA-C-O 116.626 -1.655 . . . . 0.0 111.748 179.884 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.623 ' HA ' ' CE3' ' A' ' 6' ' ' TRP . 0.1 OUTLIER 76.59 138.95 0.07 Allowed 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 121.125 1.784 . . . . 0.0 108.424 179.79 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . 0.763 61.4 tt0 . . . . . 0 N--CA 1.443 -0.776 0 C-N-CA 116.563 -2.055 . . . . 0.0 113.789 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' PLM . . . . . 0.658 ' HB2' HD23 ' A' ' 72' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.353 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.575 ' CZ ' HG21 ' A' ' 108' ' ' ILE . 62.1 m-85 -105.66 81.06 1.63 Allowed 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 124.523 2.106 . . . . 0.0 113.776 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -156.73 96.33 1.62 Allowed 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 113.563 -1.653 . . . . 0.0 115.014 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 148.29 -152.44 24.51 Favored Glycine 0 C--N 1.313 -0.738 0 C-N-CA 116.778 -2.629 . . . . 0.0 112.942 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . 0.547 0.0 OUTLIER -111.48 158.12 19.52 Favored 'General case' 0 C--N 1.314 -0.968 0 O-C-N 127.53 2.547 . . . . 0.0 113.096 -179.782 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.647 ' CD1' HD12 ' A' ' 40' ' ' ILE . 85.1 m95 -149.37 113.02 5.05 Favored 'General case' 0 N--CA 1.433 -1.304 0 CA-C-N 112.618 -2.083 . . . . 0.0 110.173 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.9 101.83 11.39 Favored 'General case' 0 C--O 1.211 -0.961 0 CA-C-N 120.886 1.676 . . . . 0.0 107.365 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.505 ' CG1' ' HB3' ' A' ' 36' ' ' LEU . 0.3 OUTLIER -47.43 135.8 3.67 Favored 'Isoleucine or valine' 0 C--O 1.246 0.877 0 CA-C-N 120.76 1.618 . . . . 0.0 110.205 179.913 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -145.05 -11.45 0.56 Allowed 'General case' 0 N--CA 1.433 -1.29 0 C-N-CA 118.676 -1.209 . . . . 0.0 112.997 -179.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.422 ' HB3' ' HB ' ' A' ' 127' ' ' ILE . 5.6 tpp180 -111.05 -56.07 2.41 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-N 121.326 1.876 . . . . 0.0 113.245 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.528 ' HB3' ' CD1' ' A' ' 14' ' ' TYR . 1.2 m-20 62.7 165.84 0.11 Allowed 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 124.244 1.018 . . . . 0.0 110.454 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.406 ' N ' ' O ' ' A' ' 125' ' ' LYS . 2.4 mm-40 -171.26 103.05 0.21 Allowed 'General case' 0 C--N 1.314 -0.952 0 O-C-N 117.3 -3.375 . . . . 0.0 107.201 -179.6 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.433 ' HB3' ' HA ' ' A' ' 124' ' ' ALA . 0.3 OUTLIER 97.5 -27.28 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.18 0 O-C-N 125.447 1.717 . . . . 0.0 111.923 -179.238 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.757 ' CE2' ' HB1' ' A' ' 32' ' ' ALA . 2.4 p90 -29.96 -36.39 0.01 OUTLIER 'General case' 0 N--CA 1.435 -1.186 0 O-C-N 127.619 3.074 . . . . 0.0 118.03 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -75.77 -34.21 60.23 Favored 'General case' 0 CA--C 1.498 -1.024 0 C-N-CA 120.58 -0.448 . . . . 0.0 110.793 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -73.04 -28.7 62.49 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-O 124.304 2.002 . . . . 0.0 113.138 179.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.79 ' CB ' ' HB2' ' A' ' 124' ' ' ALA . 0.0 OUTLIER -71.45 -29.29 64.7 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-O 125.658 2.646 . . . . 0.0 110.393 179.908 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 29.6 mtm -79.88 -20.38 45.99 Favored 'General case' 0 C--N 1.318 -0.77 0 O-C-N 116.654 -3.779 . . . . 0.0 106.445 179.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.04 -31.13 39.51 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 123.103 1.43 . . . . 0.0 112.655 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.602 ' CE ' ' HB3' ' A' ' 119' ' ' TYR . 0.5 OUTLIER -73.49 -21.18 60.49 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 115.754 1.761 . . . . 0.0 115.754 -178.144 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 3.4 mtp -79.03 -47.6 15.91 Favored 'General case' 0 C--O 1.206 -1.192 0 N-CA-C 103.592 -2.744 . . . . 0.0 103.592 179.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 124.08 43.64 0.32 Allowed Glycine 0 N--CA 1.433 -1.537 0 CA-C-N 113.902 -1.499 . . . . 0.0 111.234 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.499 ' CD1' ' HG3' ' A' ' 132' ' ' PLM . 1.9 mm -75.09 126.24 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.967 0 CA-C-O 115.813 -2.041 . . . . 0.0 112.173 -179.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -52.57 145.02 12.47 Favored 'General case' 0 C--N 1.348 0.527 0 CA-C-O 115.233 -2.318 . . . . 0.0 111.573 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . 0.445 26.9 m -36.39 -47.99 0.25 Allowed 'Isoleucine or valine' 0 C--O 1.216 -0.707 0 N-CA-C 119.162 3.023 . . . . 0.0 119.162 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.537 5.4 m -79.84 -28.38 12.62 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.995 0 N-CA-C 115.217 1.562 . . . . 0.0 115.217 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.9 ttmm -71.41 -31.58 67.42 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 112.147 -2.297 . . . . 0.0 114.904 179.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 7.5 ptt180 -79.35 -21.28 46.03 Favored 'General case' 0 C--O 1.219 -0.543 0 C-N-CA 117.721 -1.592 . . . . 0.0 109.303 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 9.3 tttm -72.13 -46.22 57.47 Favored 'General case' 0 CA--C 1.5 -0.959 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.64 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.3 tp -76.38 -28.61 56.82 Favored 'General case' 0 CA--C 1.505 -0.755 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -74.43 -20.99 79.45 Favored Glycine 0 C--N 1.345 1.055 0 CA-C-O 124.017 1.898 . . . . 0.0 111.981 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.757 ' HB1' ' CE2' ' A' ' 14' ' ' TYR . . . -75.25 -48.96 20.9 Favored 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 127.484 2.314 . . . . 0.0 111.02 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 8.5 m170 -96.35 7.66 45.92 Favored 'General case' 0 N--CA 1.429 -1.509 0 O-C-N 127.152 2.782 . . . . 0.0 110.672 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 29.8 p30 -33.6 -27.22 0.01 OUTLIER 'General case' 0 CA--C 1.507 -0.702 0 N-CA-C 116.774 2.139 . . . . 0.0 116.774 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.2 t30 77.1 26.7 0.72 Allowed 'General case' 0 C--O 1.244 0.778 0 CA-C-N 120.641 1.564 . . . . 0.0 112.351 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.522 HD11 ' HG ' ' A' ' 38' ' ' LEU . 1.3 tp -52.22 116.52 2.26 Favored 'General case' 0 CA--C 1.5 -0.962 0 CA-C-O 123.981 1.848 . . . . 0.0 109.341 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.508 ' N ' HD12 ' A' ' 36' ' ' LEU . 6.3 ttmm -111.43 95.6 5.61 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 101.865 -3.383 . . . . 0.0 101.865 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.611 HD12 ' CE2' ' A' ' 128' ' ' PHE 0.284 2.4 mt -78.58 141.52 38.02 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 119.041 -2.287 . . . . 0.0 108.292 -179.928 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.505 ' HB ' ' CB ' ' A' ' 50' ' ' LYS . 9.3 m -128.51 76.82 1.73 Allowed 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 102.213 -3.254 . . . . 0.0 102.213 179.23 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.647 HD12 ' CD1' ' A' ' 6' ' ' TRP . 6.0 mt -65.81 134.94 29.19 Favored 'Isoleucine or valine' 0 C--O 1.251 1.142 0 CA-C-N 112.401 -2.182 . . . . 0.0 106.359 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.411 HG22 ' O ' ' A' ' 41' ' ' THR . 0.8 OUTLIER -145.91 113.81 6.48 Favored 'General case' 0 CA--C 1.504 -0.792 0 O-C-N 126.849 2.593 . . . . 0.0 110.648 -179.949 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -90.09 134.35 34.31 Favored 'General case' 0 C--O 1.22 -0.465 0 CA-C-N 114.259 -1.337 . . . . 0.0 113.765 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 33.9 tp10 -135.55 91.01 2.67 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 105.578 -2.008 . . . . 0.0 105.578 179.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 67.13 -97.67 0.39 Allowed Glycine 0 C--N 1.292 -1.871 0 CA-C-O 116.367 -2.352 . . . . 0.0 109.313 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.335 0.0 OUTLIER -117.8 -1.93 11.46 Favored 'General case' 0 C--N 1.315 -0.917 0 O-C-N 129.712 3.83 . . . . 0.0 113.377 -179.895 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.42 ' HA ' ' HA ' ' A' ' 63' ' ' GLU . 0.6 OUTLIER -99.62 136.66 39.23 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 106.997 -1.482 . . . . 0.0 106.997 -179.952 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.497 ' HE2' HD11 ' A' ' 89' ' ' LEU 0.313 0.1 OUTLIER -121.48 108.27 13.44 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 105.616 -1.994 . . . . 0.0 105.616 -179.929 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.692 ' HB ' HG12 ' A' ' 61' ' ' VAL 0.386 0.1 OUTLIER -99.94 89.94 4.24 Favored 'General case' 0 N--CA 1.423 -1.789 0 O-C-N 124.804 1.315 . . . . 0.0 108.445 -179.68 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.636 HG22 ' HB ' ' A' ' 60' ' ' VAL 0.714 1.0 OUTLIER -65.7 94.59 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.503 -0.858 0 O-C-N 127.246 2.841 . . . . 0.0 108.596 178.792 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.505 ' CB ' ' HB ' ' A' ' 39' ' ' THR . 0.0 OUTLIER -63.35 140.46 58.87 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 102.448 -3.168 . . . . 0.0 102.448 -179.439 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.471 ' HB2' HG23 ' A' ' 60' ' ' VAL . 11.8 tt0 -130.04 73.0 1.5 Allowed 'General case' 0 CA--C 1.51 -0.559 0 N-CA-C 105.998 -1.853 . . . . 0.0 105.998 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.99 69.36 5.13 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 105.957 -1.868 . . . . 0.0 105.957 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.32 175.77 6.98 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.984 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.403 ' O ' ' ND2' ' A' ' 54' ' ' ASN . 2.7 t-20 -62.19 -26.58 68.43 Favored 'General case' 0 C--O 1.216 -0.674 0 O-C-N 125.441 1.713 . . . . 0.0 107.831 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.645 ' CE1' ' HB1' ' A' ' 73' ' ' ALA . 0.3 OUTLIER -69.1 -64.38 0.88 Allowed 'General case' 0 C--O 1.222 -0.385 0 CA-C-O 114.473 -2.679 . . . . 0.0 108.659 179.821 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -173.05 172.52 3.91 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 122.8 2.545 . . . . 0.0 110.844 179.537 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -90.76 65.94 5.96 Favored 'General case' 0 CA--C 1.498 -1.02 0 O-C-N 128.46 3.6 . . . . 0.0 105.067 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -87.48 -41.11 14.32 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 O-C-N 127.353 2.908 . . . . 0.0 115.746 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 50.6 t0 79.58 141.66 0.07 Allowed 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 104.649 -2.352 . . . . 0.0 104.649 -179.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.636 ' HB ' HG22 ' A' ' 49' ' ' VAL . 1.5 t -129.38 84.77 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 N-CA-C 105.464 -2.05 . . . . 0.0 105.464 -179.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.692 HG12 ' HB ' ' A' ' 48' ' ' THR 0.314 1.5 m -90.18 136.56 23.55 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.519 0 N-CA-C 116.889 2.181 . . . . 0.0 116.889 -178.188 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.583 ' CE2' ' H22' ' A' ' 132' ' ' PLM . 0.0 OUTLIER -137.25 95.0 3.01 Favored 'General case' 0 N--CA 1.422 -1.83 0 CA-C-O 114.18 -2.819 . . . . 0.0 110.8 177.263 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.492 ' O ' ' N ' ' A' ' 65' ' ' GLY . 24.0 tt0 -54.58 117.73 3.59 Favored 'General case' 0 C--N 1.32 -0.698 1 N-CA-C 98.813 -4.514 . . . . 0.0 98.813 175.998 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.776 ' HB3' ' CD2' ' A' ' 82' ' ' TRP . 0.0 OUTLIER -47.76 93.48 0.01 OUTLIER 'General case' 0 N--CA 1.429 -1.511 0 O-C-N 125.686 1.866 . . . . 0.0 107.69 -175.68 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.685 ' N ' ' NE1' ' A' ' 82' ' ' TRP . . . 94.71 50.33 2.16 Favored Glycine 0 C--N 1.353 1.517 0 N-CA-C 121.592 3.397 . . . . 0.0 121.592 178.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.41 ' HB ' ' HB3' ' A' ' 63' ' ' GLU 0.305 7.3 p -103.94 -19.91 6.03 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 CA-C-O 115.237 -2.316 . . . . 0.0 109.826 -179.985 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.548 ' HA ' HG22 ' A' ' 81' ' ' THR . 64.8 t0 65.19 105.04 0.04 OUTLIER 'General case' 0 C--O 1.204 -1.305 0 CA-C-O 123.074 1.416 . . . . 0.0 107.409 -178.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.608 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 0.1 OUTLIER -131.64 161.26 33.15 Favored 'General case' 0 C--N 1.307 -1.245 0 C-N-CA 125.876 1.67 . . . . 0.0 111.619 -176.876 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -110.75 130.07 55.67 Favored 'General case' 0 C--O 1.245 0.843 0 O-C-N 127.031 2.707 . . . . 0.0 105.122 179.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 83.9 t80 -132.6 96.5 3.84 Favored 'General case' 0 C--O 1.208 -1.104 0 O-C-N 125.353 1.658 . . . . 0.0 114.41 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 25.1 t -66.97 140.84 57.75 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 105.372 -2.084 . . . . 0.0 105.372 179.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.411 HD11 ' H92' ' A' ' 132' ' ' PLM . 2.9 mm? -77.39 -174.68 3.41 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 103.257 -2.868 . . . . 0.0 103.257 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.645 ' HB1' ' CE1' ' A' ' 55' ' ' PHE . . . -80.48 -19.71 45.34 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-O 124.836 2.255 . . . . 0.0 111.3 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.466 ' HB3' ' CG ' ' A' ' 132' ' ' PLM . 1.2 t70 -153.86 -37.61 0.1 Allowed 'General case' 0 C--O 1.222 -0.375 0 CA-C-N 112.669 -2.06 . . . . 0.0 111.129 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.567 ' O ' HG22 ' A' ' 76' ' ' THR . . . -69.72 -0.91 28.09 Favored Glycine 0 CA--C 1.533 1.207 0 N-CA-C 118.512 2.165 . . . . 0.0 118.512 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.567 HG22 ' O ' ' A' ' 75' ' ' GLY 0.386 0.3 OUTLIER 77.27 164.44 0.24 Allowed 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 120.376 2.088 . . . . 0.0 114.857 -179.908 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.575 ' HG2' HG21 ' A' ' 96' ' ' VAL . 0.3 OUTLIER -30.31 145.21 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 111.763 -2.471 . . . . 0.0 116.567 -179.805 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.499 ' HG ' ' HB3' ' A' ' 93' ' ' PHE 0.386 0.6 OUTLIER -160.62 101.74 1.34 Allowed 'General case' 0 C--O 1.24 0.602 0 CA-C-N 109.924 -3.307 . . . . 0.0 107.142 179.982 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.658 HG22 ' O ' ' A' ' 94' ' ' LYS . 91.6 m -105.82 -172.78 2.15 Favored 'General case' 0 CA--C 1.498 -1.037 0 N-CA-C 101.772 -3.418 . . . . 0.0 101.772 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.446 ' HA3' ' HA ' ' A' ' 93' ' ' PHE . . . 118.8 -148.07 18.4 Favored Glycine 0 C--N 1.292 -1.872 0 CA-C-O 116.571 -2.238 . . . . 0.0 113.191 179.629 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.548 HG22 ' HA ' ' A' ' 67' ' ' ASP . 60.3 p -165.46 166.73 18.2 Favored 'General case' 0 C--O 1.188 -2.155 0 CA-C-O 124.232 1.967 . . . . 0.0 110.712 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . 0.777 ' CG ' ' N ' ' A' ' 83' ' ' THR 0.399 4.0 p-90 -73.03 -162.39 0.11 Allowed 'General case' 0 N--CA 1.438 -1.063 0 N-CA-C 100.244 -3.984 . . . . 0.0 100.244 175.43 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.777 ' N ' ' CG ' ' A' ' 82' ' ' TRP . 4.7 t 159.43 129.51 0.0 OUTLIER 'General case' 0 N--CA 1.415 -2.219 0 CA-C-O 125.733 2.682 . . . . 0.0 112.657 174.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.584 ' HB2' ' CZ3' ' A' ' 82' ' ' TRP . 0.0 OUTLIER -88.53 121.93 31.45 Favored 'General case' 0 N--CA 1.422 -1.836 0 CA-C-N 110.566 -3.015 . . . . 0.0 105.524 179.047 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.669 ' HG2' HG21 ' A' ' 90' ' ' VAL 0.622 2.5 pp20? -111.59 44.48 1.35 Allowed 'General case' 0 N--CA 1.421 -1.912 0 CA-C-O 123.574 1.654 . . . . 0.0 114.394 179.735 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 71.61 110.94 0.05 OUTLIER Glycine 0 N--CA 1.443 -0.854 0 N-CA-C 107.595 -2.202 . . . . 0.0 107.595 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 50.9 t30 66.67 -22.05 0.1 Allowed 'General case' 0 N--CA 1.44 -0.942 0 CA-C-O 114.948 -2.453 . . . . 0.0 116.347 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.451 ' HG3' ' HA ' ' A' ' 107' ' ' GLU 0.33 0.1 OUTLIER -129.1 142.76 50.79 Favored 'General case' 0 CA--C 1.491 -1.311 0 CA-C-N 120.903 1.683 . . . . 0.0 107.465 -179.97 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.508 HD23 ' HA ' ' A' ' 89' ' ' LEU . 0.2 OUTLIER -94.85 152.55 18.3 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 101.715 -3.439 . . . . 0.0 101.715 -179.821 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.669 HG21 ' HG2' ' A' ' 85' ' ' GLU . 1.4 t -136.75 164.65 30.17 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 N-CA-C 105.507 -2.035 . . . . 0.0 105.507 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -133.79 99.06 0.34 Allowed Glycine 0 C--N 1.363 2.079 0 C-N-CA 128.554 2.978 . . . . 0.0 108.865 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -98.45 127.93 44.6 Favored 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 103.343 -2.836 . . . . 0.0 103.343 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.538 ' HB2' ' HB3' ' A' ' 102' ' ' LEU . 19.4 m-85 -140.5 130.49 24.69 Favored 'General case' 0 N--CA 1.442 -0.869 0 O-C-N 124.429 1.081 . . . . 0.0 113.279 179.484 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.658 ' O ' HG22 ' A' ' 79' ' ' THR . 0.5 OUTLIER -115.27 124.2 50.73 Favored 'General case' 0 N--CA 1.422 -1.832 0 C-N-CA 130.159 3.384 . . . . 0.0 105.54 -179.987 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.713 ' HE ' ' N ' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -54.74 -168.02 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.721 0 O-C-N 128.339 3.525 . . . . 0.0 110.573 178.647 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.575 HG21 ' HG2' ' A' ' 77' ' ' GLU . 20.5 t -124.56 -50.11 2.1 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 O-C-N 119.754 -1.841 . . . . 0.0 106.489 176.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . 0.293 0.3 OUTLIER -110.0 9.7 24.27 Favored 'General case' 0 C--O 1.255 1.348 0 CA-C-N 113.102 -1.863 . . . . 0.0 113.465 -179.939 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.432 ' HB3' ' CB ' ' A' ' 95' ' ' ARG 0.268 27.4 t30 -101.46 -23.91 14.25 Favored 'General case' 0 CA--C 1.494 -1.195 0 CA-C-O 116.281 -1.819 . . . . 0.0 111.322 -179.962 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.658 ' HA2' ' CZ ' ' A' ' 95' ' ' ARG . . . 71.87 11.1 73.55 Favored Glycine 0 CA--C 1.542 1.767 0 N-CA-C 118.38 2.112 . . . . 0.0 118.38 179.181 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.713 ' N ' ' HE ' ' A' ' 95' ' ' ARG . 3.8 mtpp -110.73 -148.04 0.42 Allowed 'General case' 0 C--N 1.3 -1.578 0 O-C-N 125.801 1.53 . . . . 0.0 111.004 -177.45 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 57.2 tt0 -160.65 161.91 32.53 Favored 'General case' 0 N--CA 1.433 -1.295 0 C-N-CA 131.385 3.874 . . . . 0.0 109.687 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.538 ' HB3' ' HB2' ' A' ' 93' ' ' PHE . 9.3 tp -142.33 157.75 44.47 Favored 'General case' 0 N--CA 1.438 -1.045 1 C-N-CA 132.014 4.125 . . . . 0.0 106.527 -179.243 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.643 ' CG2' ' HB ' ' A' ' 118' ' ' THR . 4.1 tt -150.25 154.63 8.67 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.993 0 N-CA-C 103.941 -2.615 . . . . 0.0 103.941 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -131.5 -172.0 2.74 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.569 HG12 HG23 ' A' ' 116' ' ' THR . 0.5 OUTLIER -169.72 77.02 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 CA-C-O 127.544 3.545 . . . . 0.0 107.539 179.647 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.463 HH12 ' HE2' ' A' ' 62' ' ' PHE . 0.1 OUTLIER -65.84 91.71 0.15 Allowed 'General case' 0 C--O 1.217 -0.617 0 N-CA-C 104.668 -2.345 . . . . 0.0 104.668 179.571 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.451 ' HA ' ' HG3' ' A' ' 88' ' ' LYS . 25.8 tt0 -72.75 -35.42 67.48 Favored 'General case' 0 C--O 1.202 -1.414 0 CA-C-N 110.994 -2.821 . . . . 0.0 115.044 -179.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.83 HD13 HD12 ' A' ' 113' ' ' LEU 0.428 3.2 tp 52.55 43.38 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 C-N-CA 112.927 -3.509 . . . . 0.0 113.236 179.956 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -66.73 103.19 1.05 Allowed 'General case' 0 CA--C 1.505 -0.782 0 O-C-N 120.494 -1.379 . . . . 0.0 108.193 -179.487 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 56.85 -73.29 0.01 OUTLIER Glycine 0 C--N 1.342 0.893 0 C-N-CA 127.206 2.336 . . . . 0.0 111.848 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . 0.351 0.0 OUTLIER -136.97 36.8 2.58 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 117.494 -1.241 . . . . 0.0 110.32 179.671 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -146.43 97.62 2.95 Favored 'General case' 0 C--N 1.363 1.162 0 O-C-N 126.521 2.388 . . . . 0.0 110.388 -179.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.83 HD12 HD13 ' A' ' 108' ' ' ILE . 0.4 OUTLIER -75.27 68.33 1.99 Allowed 'General case' 0 C--O 1.209 -1.068 1 O-C-N 129.353 4.158 . . . . 0.0 107.479 -179.51 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.866 HG12 HD13 ' A' ' 127' ' ' ILE . 54.6 mt -72.07 128.27 34.86 Favored 'Isoleucine or valine' 0 C--O 1.25 1.114 0 N-CA-C 105.006 -2.22 . . . . 0.0 105.006 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -113.17 108.14 16.89 Favored 'General case' 0 CA--C 1.493 -1.232 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 -179.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.569 HG23 HG12 ' A' ' 105' ' ' VAL . 66.8 p -76.28 169.06 18.94 Favored 'General case' 0 C--O 1.245 0.846 0 C-N-CA 115.912 -2.315 . . . . 0.0 105.443 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.707 ' HB2' ' HB3' ' A' ' 124' ' ' ALA . 0.8 OUTLIER -148.85 93.82 2.17 Favored 'General case' 0 CA--C 1.491 -1.298 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 -179.986 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.643 ' HB ' ' CG2' ' A' ' 103' ' ' ILE . 0.2 OUTLIER -96.84 81.68 3.16 Favored 'General case' 0 N--CA 1.424 -1.762 0 O-C-N 126.702 2.501 . . . . 0.0 116.322 -179.781 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.602 ' HB3' ' CE ' ' A' ' 20' ' ' LYS . 0.2 OUTLIER -85.8 101.57 12.92 Favored 'General case' 0 N--CA 1.479 0.975 0 N-CA-C 103.278 -2.86 . . . . 0.0 103.278 178.625 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 65.25 -82.15 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.412 0 CA-C-N 113.88 -1.509 . . . . 0.0 114.178 -179.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -132.8 24.09 3.89 Favored Glycine 0 CA--C 1.54 1.623 0 N-CA-C 117.401 1.72 . . . . 0.0 117.401 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.534 ' HB ' ' HD3' ' A' ' 20' ' ' LYS . 3.3 t -133.14 87.36 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -68.62 129.97 41.49 Favored 'General case' 0 N--CA 1.436 -1.144 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.79 ' HB2' ' CB ' ' A' ' 17' ' ' PHE . . . -115.54 115.6 26.74 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-O 116.307 -1.806 . . . . 0.0 108.4 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.406 ' O ' ' N ' ' A' ' 12' ' ' GLU . 0.1 OUTLIER -92.7 129.94 38.48 Favored 'General case' 0 C--O 1.252 1.202 0 C-N-CA 116.991 -1.883 . . . . 0.0 109.932 -179.998 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 7.4 mtm180 -119.89 86.77 2.62 Favored 'General case' 0 N--CA 1.437 -1.122 0 CA-C-N 112.082 -2.326 . . . . 0.0 106.028 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.866 HD13 HG12 ' A' ' 114' ' ' ILE . 0.8 OUTLIER -84.28 125.9 40.23 Favored 'Isoleucine or valine' 0 C--O 1.252 1.23 0 CA-C-N 114.306 -1.316 . . . . 0.0 112.893 179.983 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.611 ' CE2' HD12 ' A' ' 38' ' ' LEU . 0.2 OUTLIER -106.39 155.71 19.27 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-O 123.722 1.725 . . . . 0.0 107.926 179.709 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . 0.268 15.9 mtpp -117.3 16.99 14.79 Favored 'General case' 0 C--O 1.244 0.797 0 O-C-N 118.594 -2.566 . . . . 0.0 110.704 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.554 ' HG3' ' CH2' ' A' ' 6' ' ' TRP . 1.4 tttt 57.26 113.25 0.01 OUTLIER 'General case' 0 C--O 1.219 -0.527 0 N-CA-C 115.991 1.849 . . . . 0.0 115.991 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . 0.836 15.0 tt0 . . . . . 0 N--CA 1.429 -1.519 0 O-C-N 118.422 -2.674 . . . . 0.0 116.023 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' PLM . . . . . 0.583 ' H22' ' CE2' ' A' ' 62' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.445 ' O ' ' N ' ' A' ' 3' ' ' ASP . . . . . . . . 0 N--CA 1.447 -0.586 0 CA-C-O 116.353 -1.784 . . . . 0.0 112.899 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 19.2 p90 -35.48 79.59 0.0 OUTLIER 'General case' 0 N--CA 1.429 -1.513 0 N-CA-C 118.541 2.793 . . . . 0.0 118.541 179.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.445 ' N ' ' O ' ' A' ' 1' ' ' ALA . 23.2 t70 -167.45 96.92 0.48 Allowed 'General case' 0 N--CA 1.435 -1.191 0 O-C-N 119.605 -1.934 . . . . 0.0 112.091 -179.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 142.91 -152.48 23.99 Favored Glycine 0 C--O 1.212 -1.229 0 C-N-CA 118.587 -1.768 . . . . 0.0 109.435 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.486 HG22 ' HG2' ' A' ' 37' ' ' LYS 0.567 13.2 p -89.69 155.08 19.46 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 123.358 0.663 . . . . 0.0 111.417 179.946 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.573 ' CH2' HD11 ' A' ' 108' ' ' ILE . 91.9 m95 -152.69 105.17 2.95 Favored 'General case' 0 C--N 1.319 -0.747 0 O-C-N 127.652 3.095 . . . . 0.0 106.848 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 13.1 ttpt -106.04 101.85 11.31 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-O 114.991 -2.433 . . . . 0.0 108.313 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.481 ' HA ' ' HA ' ' A' ' 128' ' ' PHE 0.284 2.8 p -45.89 144.27 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 120.441 1.473 . . . . 0.0 111.015 179.804 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -146.55 -30.25 0.37 Allowed 'General case' 0 N--CA 1.438 -1.053 0 O-C-N 127.82 3.2 . . . . 0.0 112.371 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.608 ' HB2' ' HB ' ' A' ' 127' ' ' ILE . 17.9 mmt180 -82.84 -80.76 0.17 Allowed 'General case' 0 C--N 1.297 -1.684 0 O-C-N 119.022 -2.299 . . . . 0.0 114.286 -179.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.526 ' HA ' ' HA ' ' A' ' 126' ' ' ARG 0.284 8.2 m120 77.13 147.19 0.09 Allowed 'General case' 0 C--O 1.247 0.964 1 O-C-N 129.592 4.307 . . . . 0.0 106.275 -177.206 . . . . . . . . 4 3 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.41 ' N ' ' O ' ' A' ' 125' ' ' LYS . 2.8 tp10 -125.9 -69.54 0.77 Allowed 'General case' 0 C--N 1.296 -1.724 0 CA-C-N 122.398 2.363 . . . . 0.0 108.113 -179.595 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.496 ' HB3' ' HA ' ' A' ' 124' ' ' ALA . 5.2 t30 -112.17 29.37 7.95 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 127.325 2.891 . . . . 0.0 113.157 179.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.676 ' CD1' ' HB1' ' A' ' 124' ' ' ALA 0.376 1.1 m-85 -73.18 -27.68 61.78 Favored 'General case' 0 N--CA 1.44 -0.974 0 O-C-N 127.282 2.863 . . . . 0.0 117.488 179.708 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -74.36 -36.48 63.58 Favored 'General case' 0 C--O 1.209 -1.032 0 CA-C-N 120.479 1.49 . . . . 0.0 111.391 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.4 ' HB3' ' ND2' ' A' ' 13' ' ' ASN . 12.4 tptp -71.77 -32.14 67.35 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 111.537 -2.574 . . . . 0.0 115.216 179.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -70.76 -24.27 62.57 Favored 'General case' 0 N--CA 1.441 -0.88 0 O-C-N 124.868 1.355 . . . . 0.0 111.472 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 7.7 mmt -77.21 -34.65 56.04 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-O 123.841 1.781 . . . . 0.0 106.422 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -65.54 -31.14 72.04 Favored 'General case' 0 N--CA 1.473 0.709 0 O-C-N 118.199 -2.813 . . . . 0.0 112.529 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.414 ' HA ' ' HD2' ' A' ' 20' ' ' LYS . 11.6 tptm -77.04 -30.91 55.9 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 112.836 -1.984 . . . . 0.0 110.581 179.352 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.84 -21.08 55.55 Favored 'General case' 0 N--CA 1.435 -1.221 0 O-C-N 125.148 1.53 . . . . 0.0 107.792 179.373 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 123.01 1.64 9.49 Favored Glycine 0 C--N 1.301 -1.387 0 CA-C-O 117.674 -1.625 . . . . 0.0 113.258 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.415 HG23 ' HB2' ' A' ' 27' ' ' LYS . 0.6 OUTLIER -77.75 107.33 9.35 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.313 0 CA-C-O 117.73 -1.129 . . . . 0.0 108.605 179.913 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -118.67 1.49 11.64 Favored 'General case' 0 C--N 1.352 0.68 0 CA-C-O 116.001 -1.952 . . . . 0.0 114.154 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . 0.393 0.6 OUTLIER -112.72 -140.14 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.358 0.969 0 O-C-N 128.974 3.921 . . . . 0.0 116.34 -179.981 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.561 0.0 OUTLIER -72.76 -21.08 19.45 Favored 'Isoleucine or valine' 0 C--O 1.243 0.722 0 CA-C-N 120.689 1.586 . . . . 0.0 114.792 -179.926 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.415 ' HB2' HG23 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -62.14 -30.78 71.28 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 114.29 1.219 . . . . 0.0 114.29 179.89 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . 0.268 0.1 OUTLIER -78.97 -20.95 47.87 Favored 'General case' 0 N--CA 1.454 -0.247 0 O-C-N 119.502 -1.998 . . . . 0.0 108.31 180.0 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.6 tttm -78.9 -46.66 17.99 Favored 'General case' 0 C--O 1.215 -0.716 0 CA-C-N 113.318 -1.764 . . . . 0.0 108.768 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 11.0 mp -73.46 -22.69 60.12 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 113.746 -1.57 . . . . 0.0 110.248 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -68.79 -34.0 76.73 Favored Glycine 0 C--N 1.344 1.018 0 C-N-CA 123.638 0.637 . . . . 0.0 112.559 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -79.85 -34.86 38.97 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 127.625 2.37 . . . . 0.0 109.107 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 10.6 m170 -118.4 42.03 2.82 Favored 'General case' 0 C--O 1.24 0.573 0 C-N-CA 126.617 1.967 . . . . 0.0 114.338 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.8 p30 -71.29 -23.59 61.99 Favored 'General case' 0 C--O 1.215 -0.754 0 N-CA-C 119.17 3.026 . . . . 0.0 119.17 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 78.13 9.1 2.25 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 -179.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.769 HD22 HH21 ' A' ' 126' ' ' ARG . 0.9 OUTLIER -41.77 116.32 0.77 Allowed 'General case' 0 CA--C 1.51 -0.591 0 O-C-N 126.962 2.664 . . . . 0.0 110.873 -179.791 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.486 ' HG2' HG22 ' A' ' 5' ' ' THR . 11.4 ttmm -113.86 92.11 3.87 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 105.166 -2.161 . . . . 0.0 105.166 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.713 HD13 HD21 ' A' ' 36' ' ' LEU 0.276 0.8 OUTLIER -75.17 114.08 13.25 Favored 'General case' 0 C--N 1.292 -1.91 0 C-N-CA 117.497 -1.681 . . . . 0.0 109.115 -179.983 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.524 ' HB ' ' CB ' ' A' ' 50' ' ' LYS . 91.8 m -94.87 84.47 4.18 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 102.012 -3.329 . . . . 0.0 102.012 179.44 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.57 HD12 ' CD1' ' A' ' 6' ' ' TRP . 96.0 mt -71.73 116.14 13.04 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 CA-C-O 123.69 1.71 . . . . 0.0 110.81 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.3 m -110.38 118.01 35.14 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 110.324 -3.125 . . . . 0.0 109.348 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 2.7 tp60 -94.46 125.62 39.22 Favored 'General case' 0 C--N 1.311 -1.082 0 O-C-N 126.074 2.108 . . . . 0.0 107.794 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -135.08 68.31 1.47 Allowed 'General case' 0 N--CA 1.433 -1.31 0 CA-C-O 125.257 2.456 . . . . 0.0 105.684 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.17 -76.59 2.22 Favored Glycine 0 C--N 1.298 -1.559 0 N-CA-C 104.44 -3.464 . . . . 0.0 104.44 179.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.348 0.0 OUTLIER -130.51 -36.58 1.44 Allowed 'General case' 0 C--N 1.326 -0.449 0 O-C-N 126.608 2.005 . . . . 0.0 113.976 179.947 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.481 ' HA ' ' HA ' ' A' ' 63' ' ' GLU . 7.4 ttmt -57.38 109.26 0.65 Allowed 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 114.102 -1.408 . . . . 0.0 113.56 -179.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . 0.254 3.2 m-30 -100.4 78.23 2.01 Favored 'General case' 0 CA--C 1.507 -0.684 0 CA-C-O 125.578 2.608 . . . . 0.0 106.942 179.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.619 ' HB ' ' HB ' ' A' ' 61' ' ' VAL 0.417 9.8 t -76.48 80.13 3.19 Favored 'General case' 0 N--CA 1.435 -1.216 0 O-C-N 118.832 -2.417 . . . . 0.0 113.439 -179.873 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.48 ' CG2' ' HG ' ' A' ' 38' ' ' LEU 0.596 2.0 m -56.78 96.99 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.428 -1.532 0 CA-C-N 114.189 -1.369 . . . . 0.0 114.466 179.652 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.524 ' CB ' ' HB ' ' A' ' 39' ' ' THR . 1.1 ttmt -67.51 116.26 8.04 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 101.59 -3.485 . . . . 0.0 101.59 179.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.508 ' HB2' ' CG2' ' A' ' 60' ' ' VAL 0.263 1.9 tt0 -107.44 107.0 17.67 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 103.753 -2.684 . . . . 0.0 103.753 -179.997 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.0 m -106.56 48.79 0.82 Allowed 'General case' 0 C--N 1.285 -2.196 0 N-CA-C 105.004 -2.221 . . . . 0.0 105.004 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.3 m -76.36 162.54 27.8 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-O 115.431 -2.223 . . . . 0.0 109.106 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -48.57 -37.12 17.08 Favored 'General case' 0 C--O 1.211 -0.958 0 O-C-N 125.238 1.586 . . . . 0.0 107.531 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -52.88 -65.35 0.57 Allowed 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 116.459 -1.734 . . . . 0.0 109.54 179.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.446 ' HG3' ' N ' ' A' ' 57' ' ' ASN . 1.2 ttm-85 -173.08 148.02 1.67 Allowed 'General case' 0 CA--C 1.498 -1.028 0 CA-C-N 120.525 1.511 . . . . 0.0 110.462 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.446 ' N ' ' HG3' ' A' ' 56' ' ' ARG . 3.3 m-20 -78.4 86.64 4.45 Favored 'General case' 0 CA--C 1.499 -1.011 0 N-CA-C 102.338 -3.208 . . . . 0.0 102.338 -179.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -122.95 115.42 45.74 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.188 0 N-CA-C 117.864 2.542 . . . . 0.0 117.864 -179.475 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.404 ' OD1' ' N ' ' A' ' 59' ' ' ASP . 0.1 OUTLIER -64.69 147.6 52.71 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 104.024 -2.584 . . . . 0.0 104.024 178.909 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.508 ' CG2' ' HB2' ' A' ' 51' ' ' GLU . 1.8 t -124.71 46.43 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.019 0 CA-C-O 123.847 1.784 . . . . 0.0 106.523 -179.496 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.619 ' HB ' ' HB ' ' A' ' 48' ' ' THR 0.304 0.5 OUTLIER -43.9 144.88 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.568 0 N-CA-C 116.414 2.005 . . . . 0.0 116.414 -179.309 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.505 ' CE2' ' H32' ' A' ' 132' ' ' PLM . 0.0 OUTLIER -154.51 92.79 1.52 Allowed 'General case' 0 N--CA 1.419 -2.022 0 CA-C-O 115.958 -1.972 . . . . 0.0 109.258 175.911 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.481 ' HA ' ' HA ' ' A' ' 46' ' ' LYS 0.263 1.2 mt-10 -66.45 94.77 0.29 Allowed 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 100.538 -3.875 . . . . 0.0 100.538 178.541 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.674 ' HB3' ' CE2' ' A' ' 82' ' ' TRP . 0.0 OUTLIER -12.22 89.08 0.01 OUTLIER 'General case' 0 N--CA 1.426 -1.664 0 O-C-N 128.006 3.316 . . . . 0.0 112.135 -178.566 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.565 ' N ' ' CD1' ' A' ' 82' ' ' TRP . . . 96.16 36.65 5.13 Favored Glycine 0 C--N 1.351 1.368 0 N-CA-C 121.586 3.395 . . . . 0.0 121.586 179.2 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . 0.409 38.1 t -121.48 77.99 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 N-CA-C 105.039 -2.208 . . . . 0.0 105.039 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -14.38 127.8 0.01 OUTLIER 'General case' 0 CA--C 1.48 -1.733 0 O-C-N 128.077 3.361 . . . . 0.0 116.513 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.576 ' CZ ' ' HA ' ' A' ' 81' ' ' THR . 8.9 p90 -147.93 164.05 34.95 Favored 'General case' 0 N--CA 1.441 -0.899 0 O-C-N 119.072 -2.267 . . . . 0.0 112.544 -178.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -116.11 148.41 40.31 Favored 'General case' 0 C--O 1.243 0.729 0 O-C-N 126.47 2.356 . . . . 0.0 105.445 179.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.907 ' HB3' HD22 ' A' ' 78' ' ' LEU . 2.9 t80 -116.65 -47.6 2.71 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-O 116.637 -1.649 . . . . 0.0 114.2 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.468 ' HA ' ' N ' ' A' ' 77' ' ' GLU . 2.5 t 70.01 104.43 0.06 Allowed 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 -179.507 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.404 ' HB3' ' HE2' ' A' ' 132' ' ' PLM . 6.1 mt -69.53 -175.81 0.9 Allowed 'General case' 0 C--N 1.302 -1.476 0 O-C-N 128.441 3.588 . . . . 0.0 109.172 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -105.97 -2.92 22.31 Favored 'General case' 0 N--CA 1.443 -0.817 0 O-C-N 128.089 3.368 . . . . 0.0 114.276 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -121.74 -47.15 2.21 Favored 'General case' 0 N--CA 1.435 -1.175 0 O-C-N 121.677 -0.639 . . . . 0.0 110.848 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -110.15 -10.11 22.87 Favored Glycine 0 CA--C 1.537 1.443 0 O-C-N 124.455 1.097 . . . . 0.0 115.774 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.673 HG23 ' N ' ' A' ' 77' ' ' GLU 0.349 0.7 OUTLIER 72.28 172.47 0.31 Allowed 'General case' 0 CA--C 1.501 -0.915 0 C-N-CA 115.793 -2.363 . . . . 0.0 110.27 -179.838 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.673 ' N ' HG23 ' A' ' 76' ' ' THR . 0.2 OUTLIER 47.01 -171.28 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.818 1 O-C-N 129.391 4.182 . . . . 0.0 110.309 179.947 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.907 HD22 ' HB3' ' A' ' 70' ' ' TYR 0.339 4.8 tt 130.9 141.62 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.808 0 O-C-N 128.423 3.577 . . . . 0.0 102.247 180.0 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.414 ' N ' HD23 ' A' ' 78' ' ' LEU . 17.3 m -163.48 128.74 3.03 Favored 'General case' 0 C--O 1.199 -1.56 0 N-CA-C 103.17 -2.9 . . . . 0.0 103.17 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.405 ' HA3' ' HA ' ' A' ' 93' ' ' PHE . . . 179.56 -135.25 2.46 Favored Glycine 0 C--N 1.31 -0.905 0 C-N-CA 118.583 -1.77 . . . . 0.0 110.315 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.576 ' HA ' ' CZ ' ' A' ' 68' ' ' PHE . 33.6 p -164.59 164.27 21.64 Favored 'General case' 0 C--O 1.188 -2.132 0 C-N-CA 117.214 -1.794 . . . . 0.0 111.779 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . 0.688 ' CG ' ' N ' ' A' ' 83' ' ' THR 0.408 1.4 p-90 -74.67 -171.59 1.31 Allowed 'General case' 0 C--N 1.31 -1.112 1 N-CA-C 100.025 -4.065 . . . . 0.0 100.025 175.735 . . . . . . . . 4 3 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.688 ' N ' ' CG ' ' A' ' 82' ' ' TRP . 0.3 OUTLIER 172.4 118.17 0.02 OUTLIER 'General case' 0 N--CA 1.432 -1.331 0 CA-C-O 124.404 2.05 . . . . 0.0 113.316 174.913 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.591 ' HB2' ' CZ3' ' A' ' 82' ' ' TRP . 2.8 ttp -84.86 101.23 12.13 Favored 'General case' 0 N--CA 1.433 -1.275 0 O-C-N 120.852 -1.155 . . . . 0.0 108.076 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.429 ' CG ' ' CG2' ' A' ' 90' ' ' VAL 0.673 0.8 OUTLIER -54.82 -87.1 0.0 OUTLIER 'General case' 0 N--CA 1.432 -1.368 0 CA-C-O 125.918 2.77 . . . . 0.0 111.076 179.982 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -138.65 -80.04 0.08 OUTLIER Glycine 0 N--CA 1.443 -0.852 0 N-CA-C 104.238 -3.545 . . . . 0.0 104.238 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -95.1 5.34 52.13 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 116.404 -1.76 . . . . 0.0 115.054 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.46 ' HE2' HG21 ' A' ' 105' ' ' VAL 0.371 0.6 OUTLIER -147.55 162.89 38.18 Favored 'General case' 0 CA--C 1.493 -1.215 0 O-C-N 126.281 2.238 . . . . 0.0 110.892 -179.967 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.803 HD22 ' HD2' ' A' ' 106' ' ' ARG . 5.5 tt -104.76 150.6 24.63 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 103.322 -2.844 . . . . 0.0 103.322 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.663 HG12 ' O ' ' A' ' 104' ' ' ALA . 0.0 OUTLIER -136.61 165.42 28.62 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.913 0 CA-C-O 123.849 1.785 . . . . 0.0 106.247 -179.808 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -128.83 97.4 0.43 Allowed Glycine 0 C--N 1.345 1.051 0 C-N-CA 128.636 3.017 . . . . 0.0 109.718 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 16.7 mtpt -95.29 139.74 31.17 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 102.375 -3.194 . . . . 0.0 102.375 179.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.648 ' HD2' HD22 ' A' ' 102' ' ' LEU . 75.6 m-85 -149.84 121.4 7.99 Favored 'General case' 0 CA--C 1.501 -0.936 0 CA-C-O 124.284 1.992 . . . . 0.0 111.724 -179.717 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 31.0 mttt -91.15 -175.61 4.34 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-N 113.885 -1.507 . . . . 0.0 110.129 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.411 ' CB ' ' HB3' ' A' ' 98' ' ' ASN 0.366 1.4 mmt85 -128.63 128.32 43.94 Favored 'General case' 0 CA--C 1.489 -1.398 0 O-C-N 124.817 1.323 . . . . 0.0 107.879 -179.98 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.582 HG23 ' H ' ' A' ' 97' ' ' ASP . 0.8 OUTLIER -33.11 -63.26 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 C-N-CA 126.841 2.056 . . . . 0.0 113.938 -179.881 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.582 ' H ' HG23 ' A' ' 96' ' ' VAL 0.368 0.0 OUTLIER -101.44 -22.24 14.6 Favored 'General case' 0 C--O 1.258 1.535 0 O-C-N 119.892 -1.755 . . . . 0.0 115.293 -179.811 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.411 ' HB3' ' CB ' ' A' ' 95' ' ' ARG . 46.5 t30 -77.45 -26.39 51.46 Favored 'General case' 0 N--CA 1.422 -1.827 0 CA-C-N 113.576 -1.647 . . . . 0.0 113.678 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 48.18 22.96 2.53 Favored Glycine 0 CA--C 1.531 1.05 0 O-C-N 127.287 2.867 . . . . 0.0 118.05 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 15.5 mmtp -75.36 -108.72 0.01 OUTLIER 'General case' 0 C--O 1.199 -1.592 0 O-C-N 119.842 -1.976 . . . . 0.0 108.17 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.483 ' HG2' ' N ' ' A' ' 102' ' ' LEU . 1.0 OUTLIER 173.22 179.18 0.09 Allowed 'General case' 0 C--N 1.316 -0.861 0 C-N-CA 129.286 3.034 . . . . 0.0 109.425 179.993 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.67 ' HG ' ' HA ' ' A' ' 119' ' ' TYR . 3.5 tt -166.15 139.94 4.26 Favored 'General case' 0 C--O 1.245 0.859 1 O-C-N 129.139 4.024 . . . . 0.0 106.231 179.34 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.524 HG23 ' HB3' ' A' ' 117' ' ' TYR . 4.2 tp -128.16 156.07 40.09 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.068 0 N-CA-C 105.039 -2.208 . . . . 0.0 105.039 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.663 ' O ' HG12 ' A' ' 90' ' ' VAL . . . -153.25 145.2 23.64 Favored 'General case' 0 C--N 1.313 -0.998 0 O-C-N 119.213 -2.179 . . . . 0.0 106.714 -179.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.605 ' HB ' ' CE2' ' A' ' 117' ' ' TYR . 8.4 p -124.8 113.09 34.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 121.642 2.019 . . . . 0.0 111.709 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.803 ' HD2' HD22 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -82.0 83.89 7.13 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 105.296 -2.113 . . . . 0.0 105.296 179.99 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 69.7 tt0 -90.66 77.5 6.35 Favored 'General case' 0 N--CA 1.418 -2.052 0 O-C-N 128.071 3.357 . . . . 0.0 112.357 -179.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.573 HD11 ' CH2' ' A' ' 6' ' ' TRP 0.406 2.1 tt -57.13 118.55 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 C-N-CA 115.652 -2.419 . . . . 0.0 112.313 179.736 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 36.6 m -109.6 60.74 0.6 Allowed 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 117.695 -1.145 . . . . 0.0 108.397 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 83.53 -108.33 3.03 Favored Glycine 0 C--N 1.347 1.193 0 O-C-N 126.701 2.501 . . . . 0.0 111.391 -179.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.506 ' N ' HD22 ' A' ' 111' ' ' ASN 0.323 0.0 OUTLIER -89.05 13.38 13.13 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 115.78 -2.057 . . . . 0.0 111.38 -179.823 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -136.52 115.93 12.73 Favored 'General case' 0 C--O 1.208 -1.124 0 O-C-N 127.968 3.292 . . . . 0.0 113.515 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.535 ' HA ' HG13 ' A' ' 108' ' ' ILE . 0.1 OUTLIER -88.85 143.34 26.95 Favored 'General case' 0 C--O 1.213 -0.83 0 N-CA-C 100.725 -3.806 . . . . 0.0 100.725 179.719 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.636 HG12 HG23 ' A' ' 127' ' ' ILE . 71.3 mt -138.77 118.85 14.85 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.973 0 O-C-N 127.661 3.1 . . . . 0.0 105.269 179.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.43 ' O ' ' HG2' ' A' ' 126' ' ' ARG . 12.4 mt-30 -100.97 122.28 43.24 Favored 'General case' 0 CA--C 1.505 -0.759 0 O-C-N 126.036 2.085 . . . . 0.0 105.812 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.549 ' HB ' ' HA ' ' A' ' 125' ' ' LYS . 0.6 OUTLIER -140.55 152.16 45.31 Favored 'General case' 0 N--CA 1.419 -2.013 0 O-C-N 121.098 -1.001 . . . . 0.0 112.328 -179.644 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.605 ' CE2' ' HB ' ' A' ' 105' ' ' VAL 0.377 22.4 m-85 135.69 -140.97 0.0 OUTLIER 'General case' 0 CA--C 1.478 -1.795 0 O-C-N 128.852 3.845 . . . . 0.0 113.493 176.58 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.514 HG23 ' N ' ' A' ' 119' ' ' TYR . 4.8 t -151.71 -155.76 0.65 Allowed 'General case' 0 C--N 1.312 -1.055 0 O-C-N 127.278 2.861 . . . . 0.0 116.044 -174.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.67 ' HA ' ' HG ' ' A' ' 102' ' ' LEU 0.282 2.6 t80 -109.53 -57.46 2.17 Favored 'General case' 0 C--O 1.217 -0.636 0 CA-C-O 125.434 2.54 . . . . 0.0 104.82 177.721 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.501 ' HG3' ' CE2' ' A' ' 119' ' ' TYR . 3.7 mt-10 -123.38 -80.7 0.63 Allowed 'General case' 0 N--CA 1.436 -1.126 0 CA-C-N 112.591 -2.095 . . . . 0.0 111.981 179.416 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -137.03 36.07 2.01 Favored Glycine 0 C--N 1.36 1.872 0 N-CA-C 119.259 2.464 . . . . 0.0 119.259 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 65.3 t -137.02 91.26 0.83 Allowed 'Isoleucine or valine' 0 C--O 1.215 -0.739 0 N-CA-C 103.535 -2.765 . . . . 0.0 103.535 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.506 ' HA ' ' HB ' ' A' ' 118' ' ' THR . 1.5 mp0 -63.02 178.61 0.46 Allowed 'General case' 0 C--N 1.311 -1.102 0 CA-C-O 125.525 2.584 . . . . 0.0 113.955 -178.223 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.676 ' HB1' ' CD1' ' A' ' 14' ' ' TYR . . . -163.67 177.21 8.9 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 112.572 -3.585 . . . . 0.0 106.799 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.549 ' HA ' ' HB ' ' A' ' 116' ' ' THR 0.337 0.0 OUTLIER -161.92 131.44 4.58 Favored 'General case' 0 C--O 1.249 1.047 1 O-C-N 129.454 4.221 . . . . 0.0 107.423 -179.906 . . . . . . . . 5 4 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.769 HH21 HD22 ' A' ' 36' ' ' LEU . 7.7 ptm180 -132.02 85.78 2.28 Favored 'General case' 0 N--CA 1.426 -1.634 0 CA-C-O 114.556 -2.64 . . . . 0.0 111.653 -179.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.636 HG23 HG12 ' A' ' 114' ' ' ILE . 1.0 OUTLIER -64.82 105.21 0.52 Allowed 'Isoleucine or valine' 0 C--O 1.25 1.121 1 O-C-N 132.138 5.899 . . . . 0.0 113.75 178.827 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.635 ' HE2' HD21 ' A' ' 36' ' ' LEU . 0.0 OUTLIER -87.74 131.96 34.31 Favored 'General case' 0 N--CA 1.432 -1.352 0 CA-C-N 111.71 -2.495 . . . . 0.0 107.029 179.957 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 3.1 mmmp? -100.09 47.68 0.94 Allowed 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 114.394 -2.717 . . . . 0.0 110.059 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.511 ' HA ' ' HA ' ' A' ' 6' ' ' TRP . 2.0 ttpm? 26.09 98.49 0.0 OUTLIER 'General case' 0 CA--C 1.518 -0.283 0 O-C-N 126.441 2.338 . . . . 0.0 115.401 179.378 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . 0.914 25.5 tt0 . . . . . 0 N--CA 1.446 -0.629 0 CA-C-N 120.327 1.422 . . . . 0.0 113.327 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' PLM . . . . . 0.515 ' H42' ' CE1' ' A' ' 93' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.494 ' C ' ' CD1' ' A' ' 2' ' ' PHE . . . . . . . . 0 C--O 1.216 -0.705 0 CA-C-O 117.639 -1.172 . . . . 0.0 109.832 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.494 ' CD1' ' C ' ' A' ' 1' ' ' ALA . 2.2 p90 38.09 56.33 1.66 Allowed 'General case' 0 C--N 1.309 -1.195 0 O-C-N 127.462 2.976 . . . . 0.0 116.645 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -143.56 99.83 3.49 Favored 'General case' 0 CA--C 1.501 -0.942 0 CA-C-N 114.621 -1.172 . . . . 0.0 110.96 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 151.12 -107.5 0.34 Allowed Glycine 0 C--O 1.213 -1.161 0 CA-C-O 117.844 -1.531 . . . . 0.0 113.0 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.533 ' HA ' ' HA ' ' A' ' 39' ' ' THR 0.482 1.1 t -137.01 173.55 11.58 Favored 'General case' 0 C--N 1.309 -1.157 0 O-C-N 127.397 2.469 . . . . 0.0 110.011 179.797 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.557 ' CZ3' ' HG3' ' A' ' 130' ' ' LYS . 91.6 m95 -161.56 150.19 15.7 Favored 'General case' 0 N--CA 1.427 -1.584 0 O-C-N 126.247 2.217 . . . . 0.0 108.287 -179.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 12.9 tttt -151.89 102.65 2.85 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-O 115.014 -2.422 . . . . 0.0 107.066 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.571 HG12 ' HB3' ' A' ' 36' ' ' LEU 0.323 5.7 p -46.84 138.94 1.82 Allowed 'Isoleucine or valine' 0 C--O 1.249 1.038 0 CA-C-N 121.024 1.738 . . . . 0.0 112.685 179.816 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -153.44 21.05 0.55 Allowed 'General case' 0 CA--C 1.498 -1.044 0 CA-C-O 123.427 1.584 . . . . 0.0 112.425 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.446 ' CG ' ' HB ' ' A' ' 127' ' ' ILE 0.259 1.2 ptp85 -155.63 -49.48 0.08 Allowed 'General case' 0 C--N 1.301 -1.52 0 O-C-N 117.285 -3.384 . . . . 0.0 110.468 179.727 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.414 ' N ' ' HG3' ' A' ' 10' ' ' ARG 0.373 0.5 OUTLIER 51.11 -176.09 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.67 0 O-C-N 126.411 2.319 . . . . 0.0 110.719 179.8 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -146.88 -85.42 0.11 Allowed 'General case' 0 C--N 1.301 -1.542 0 O-C-N 119.36 -2.087 . . . . 0.0 107.773 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -89.74 18.04 5.96 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 120.111 1.323 . . . . 0.0 114.207 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.631 ' HA ' ' HB1' ' A' ' 124' ' ' ALA . 79.4 t80 -59.45 -32.54 70.32 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 118.898 2.925 . . . . 0.0 118.898 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -76.13 -29.3 57.77 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 121.816 2.098 . . . . 0.0 111.436 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 16.2 mttp -75.52 -24.64 56.82 Favored 'General case' 0 N--CA 1.425 -1.68 0 O-C-N 126.801 2.563 . . . . 0.0 113.398 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.742 ' CB ' ' HB2' ' A' ' 124' ' ' ALA . 11.6 t80 -79.17 -20.39 48.58 Favored 'General case' 0 N--CA 1.428 -1.538 0 O-C-N 121.763 -0.586 . . . . 0.0 110.944 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.451 ' HB3' HG13 ' A' ' 23' ' ' ILE . 0.4 OUTLIER -74.48 -35.07 63.25 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-O 122.902 1.334 . . . . 0.0 107.881 179.99 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . 0.267 7.1 tt0 -72.87 -25.67 61.18 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 126.232 2.92 . . . . 0.0 112.232 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 27.2 tptt -79.9 -29.73 39.96 Favored 'General case' 0 C--N 1.319 -0.753 0 O-C-N 119.423 -2.048 . . . . 0.0 111.361 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.518 ' CE ' HD13 ' A' ' 72' ' ' LEU . 1.1 mmm -75.73 -28.91 58.73 Favored 'General case' 0 C--O 1.217 -0.651 0 CA-C-O 124.552 2.12 . . . . 0.0 108.885 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 109.01 43.42 1.2 Allowed Glycine 0 N--CA 1.443 -0.896 0 CA-C-O 116.171 -2.46 . . . . 0.0 109.928 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.603 HG21 ' HA ' ' A' ' 28' ' ' ARG . 3.5 mm -90.76 134.47 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 CA-C-N 119.551 1.676 . . . . 0.0 108.689 -179.443 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -78.47 132.64 37.34 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-O 114.387 -2.721 . . . . 0.0 113.614 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . 0.375 60.5 t -8.68 -53.59 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 O-C-N 128.889 3.868 . . . . 0.0 117.605 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.608 0.3 OUTLIER -79.75 -40.17 20.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 115.154 1.538 . . . . 0.0 115.154 -179.728 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.562 ' HD3' ' HG1' ' A' ' 132' ' ' PLM . 8.5 ttmm -60.67 -24.1 65.33 Favored 'General case' 0 N--CA 1.443 -0.783 0 O-C-N 127.237 2.836 . . . . 0.0 113.233 179.481 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.603 ' HA ' HG21 ' A' ' 23' ' ' ILE . 5.4 ptt85 -76.95 -30.88 56.23 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 15.0 ttmt -75.65 -29.01 58.98 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-O 123.47 1.605 . . . . 0.0 110.327 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -76.1 -34.46 59.51 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 116.086 -1.912 . . . . 0.0 110.018 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -70.99 -25.06 76.46 Favored Glycine 0 C--O 1.21 -1.401 0 O-C-N 125.032 1.457 . . . . 0.0 112.255 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -77.52 -34.51 53.97 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 116.457 -1.735 . . . . 0.0 111.322 179.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 5.3 t-160 -103.63 21.63 15.81 Favored 'General case' 0 N--CA 1.445 -0.676 0 O-C-N 126.958 2.661 . . . . 0.0 113.918 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.406 ' HB3' ' HB2' ' A' ' 53' ' ' SER . 0.8 OUTLIER -69.78 -29.79 67.19 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 114.709 1.374 . . . . 0.0 114.709 -179.761 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . 0.283 18.7 m120 76.55 27.86 0.77 Allowed 'General case' 0 C--O 1.245 0.821 0 O-C-N 118.63 -2.544 . . . . 0.0 109.542 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.681 HD21 HD13 ' A' ' 38' ' ' LEU . 1.2 tt -44.73 91.6 0.0 OUTLIER 'General case' 0 C--O 1.212 -0.876 0 O-C-N 126.156 2.16 . . . . 0.0 111.033 -179.414 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 8.7 tttt -97.33 103.22 15.13 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 101.682 -3.451 . . . . 0.0 101.682 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.681 HD13 HD21 ' A' ' 36' ' ' LEU 0.292 0.1 OUTLIER -91.29 147.32 23.13 Favored 'General case' 0 C--N 1.289 -2.03 0 CA-C-O 123.932 1.825 . . . . 0.0 106.591 -179.58 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.55 ' HB ' ' HB3' ' A' ' 50' ' ' LYS . 2.4 m -129.19 103.15 6.79 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 102.498 -3.149 . . . . 0.0 102.498 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 59.3 mt -92.5 119.18 39.62 Favored 'Isoleucine or valine' 0 C--O 1.253 1.254 0 CA-C-O 124.13 1.919 . . . . 0.0 111.883 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 74.5 m -119.91 95.39 4.74 Favored 'General case' 0 C--N 1.348 0.542 0 CA-C-N 110.733 -2.939 . . . . 0.0 110.087 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.59 125.71 29.74 Favored 'General case' 0 C--N 1.313 -1.017 0 O-C-N 127.153 2.783 . . . . 0.0 108.705 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -158.1 112.7 2.59 Favored 'General case' 0 N--CA 1.417 -2.097 0 O-C-N 119.26 -2.15 . . . . 0.0 111.954 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 54.03 42.08 70.27 Favored Glycine 0 N--CA 1.428 -1.889 0 CA-C-N 114.386 -1.279 . . . . 0.0 109.934 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.311 4.4 m-20 83.26 -25.36 0.14 Allowed 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 112.556 -1.822 . . . . 0.0 112.224 179.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 5.7 ttmt -76.37 144.16 40.27 Favored 'General case' 0 C--N 1.307 -1.271 0 C-N-CA 115.639 -2.424 . . . . 0.0 108.681 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.593 ' CZ ' HD21 ' A' ' 64' ' ' LEU . 2.8 m-85 -119.59 87.85 2.82 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 118.164 -0.922 . . . . 0.0 111.534 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.983 ' HA ' HG13 ' A' ' 61' ' ' VAL 0.427 0.1 OUTLIER -61.04 118.54 6.89 Favored 'General case' 0 C--O 1.244 0.812 0 C-N-CA 115.206 -2.598 . . . . 0.0 109.502 -179.721 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.549 ' CG2' ' HG ' ' A' ' 38' ' ' LEU 0.713 8.4 p -101.27 85.94 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 O-C-N 125.173 1.546 . . . . 0.0 108.592 179.557 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.55 ' HB3' ' HB ' ' A' ' 39' ' ' THR . 2.5 tttp -77.41 103.68 7.48 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 105.383 -2.08 . . . . 0.0 105.383 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -95.36 89.48 5.47 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 127.2 2.2 . . . . 0.0 105.413 -179.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -88.27 57.51 4.3 Favored 'General case' 0 C--N 1.289 -2.061 0 O-C-N 119.91 -1.744 . . . . 0.0 106.975 -179.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.406 ' HB2' ' HB3' ' A' ' 34' ' ' ASP . 80.7 p -83.11 160.17 21.94 Favored 'General case' 0 C--O 1.209 -1.065 0 CA-C-O 116.529 -1.701 . . . . 0.0 108.466 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 56.6 t30 -50.54 -32.64 18.98 Favored 'General case' 0 N--CA 1.435 -1.182 0 O-C-N 125.287 1.617 . . . . 0.0 109.498 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -62.66 -50.75 69.94 Favored 'General case' 0 C--N 1.352 0.71 0 C-N-CA 116.223 -2.191 . . . . 0.0 111.193 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 29.8 ttm-85 -176.11 148.8 0.83 Allowed 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 121.663 2.029 . . . . 0.0 106.959 178.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -95.3 83.35 3.84 Favored 'General case' 0 C--O 1.22 -0.467 0 N-CA-C 100.441 -3.911 . . . . 0.0 100.441 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.5 tp -105.58 101.42 12.37 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.238 0 O-C-N 128.015 3.322 . . . . 0.0 116.527 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.457 ' OD1' HG22 ' A' ' 61' ' ' VAL . 29.2 t0 -58.21 137.21 57.23 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 103.229 -2.878 . . . . 0.0 103.229 177.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.6 HG12 ' N ' ' A' ' 61' ' ' VAL . 2.2 t -101.33 -67.75 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 N-CA-C 106.506 -1.664 . . . . 0.0 106.506 -176.419 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.983 HG13 ' HA ' ' A' ' 48' ' ' THR 0.506 0.0 OUTLIER 75.44 134.04 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 CA-C-O 124.065 1.888 . . . . 0.0 112.582 179.557 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.64 ' CE2' ' CD1' ' A' ' 82' ' ' TRP . 3.9 p90 -168.98 110.71 0.5 Allowed 'General case' 0 N--CA 1.436 -1.17 0 CA-C-N 112.332 -2.213 . . . . 0.0 111.911 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -62.04 125.64 24.57 Favored 'General case' 0 N--CA 1.441 -0.914 0 N-CA-C 102.462 -3.162 . . . . 0.0 102.462 179.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.593 HD21 ' CZ ' ' A' ' 47' ' ' PHE . 0.6 OUTLIER -48.21 125.59 9.59 Favored 'General case' 0 N--CA 1.428 -1.559 0 O-C-N 124.466 1.104 . . . . 0.0 111.503 -179.728 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' 82' ' ' TRP . . . 73.61 12.36 80.47 Favored Glycine 0 C--N 1.344 1.006 0 O-C-N 126.73 2.519 . . . . 0.0 117.036 -179.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . 0.419 44.0 t -81.18 -99.91 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.431 -1.389 0 CA-C-O 118.373 -0.822 . . . . 0.0 109.053 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.9 t70 165.37 130.08 0.01 OUTLIER 'General case' 0 CA--C 1.49 -1.346 0 CA-C-N 119.285 0.948 . . . . 0.0 110.567 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -135.48 174.75 10.27 Favored 'General case' 0 N--CA 1.428 -1.545 0 CA-C-N 120.156 1.344 . . . . 0.0 109.281 179.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -132.65 127.45 34.91 Favored 'General case' 0 C--O 1.244 0.801 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -157.19 125.23 5.5 Favored 'General case' 0 N--CA 1.443 -0.784 0 C-N-CA 118.632 -1.227 . . . . 0.0 113.563 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 18.3 t -57.67 156.92 7.78 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 105.124 -2.176 . . . . 0.0 105.124 179.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.808 HD11 HD12 ' A' ' 78' ' ' LEU . 8.4 mt -101.77 9.7 40.63 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-O 118.148 -0.93 . . . . 0.0 109.873 -179.35 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.423 ' HB3' ' O ' ' A' ' 72' ' ' LEU . . . 79.61 -4.24 2.0 Favored 'General case' 0 N--CA 1.438 -1.071 0 O-C-N 126.802 2.564 . . . . 0.0 113.174 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.536 ' HB3' ' HG3' ' A' ' 132' ' ' PLM . 28.9 t70 -165.96 -51.06 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 123.825 1.774 . . . . 0.0 110.259 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -67.8 -6.65 44.98 Favored Glycine 0 C--N 1.347 1.192 0 CA-C-N 113.704 -1.589 . . . . 0.0 112.98 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.548 HG22 ' H ' ' A' ' 77' ' ' GLU 0.274 0.2 OUTLIER 78.62 163.31 0.21 Allowed 'General case' 0 N--CA 1.435 -1.204 0 CA-C-N 119.699 1.75 . . . . 0.0 115.298 179.678 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.548 ' H ' HG22 ' A' ' 76' ' ' THR . 1.1 mt-10 -36.61 98.43 0.01 OUTLIER 'General case' 0 N--CA 1.44 -0.945 0 O-C-N 128.392 3.558 . . . . 0.0 113.091 179.63 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.808 HD12 HD11 ' A' ' 72' ' ' LEU 0.472 5.5 tt -97.04 158.19 15.55 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 101.929 -3.36 . . . . 0.0 101.929 179.621 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 14.5 m -157.82 124.14 4.8 Favored 'General case' 0 CA--C 1.498 -1.054 0 N-CA-C 102.047 -3.316 . . . . 0.0 102.047 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -162.97 -175.83 34.4 Favored Glycine 0 C--N 1.292 -1.89 0 C-N-CA 115.746 -3.121 . . . . 0.0 111.959 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 15.7 p -137.87 159.82 40.97 Favored 'General case' 0 C--O 1.192 -1.965 0 C-N-CA 119.313 -0.955 . . . . 0.0 110.116 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . 0.64 ' CD1' ' CE2' ' A' ' 62' ' ' PHE . 72.2 m95 -118.74 137.75 53.14 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 100.624 -3.843 . . . . 0.0 100.624 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 13.5 t -147.74 143.15 27.36 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 123.597 1.665 . . . . 0.0 109.497 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.98 139.02 41.31 Favored 'General case' 0 N--CA 1.44 -0.965 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . 0.72 5.2 mt-10 -127.81 30.57 5.27 Favored 'General case' 0 C--N 1.307 -1.254 0 C-N-CA 116.687 -2.005 . . . . 0.0 109.686 179.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 71.5 97.68 0.06 OUTLIER Glycine 0 N--CA 1.436 -1.358 0 N-CA-C 106.147 -2.781 . . . . 0.0 106.147 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . 0.28 61.2 m-80 79.06 -7.53 1.75 Allowed 'General case' 0 C--O 1.236 0.387 0 N-CA-C 117.893 2.553 . . . . 0.0 117.893 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . 0.341 0.4 OUTLIER -143.73 133.13 23.33 Favored 'General case' 0 CA--C 1.498 -1.043 0 O-C-N 125.713 1.883 . . . . 0.0 106.575 179.988 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.78 HD13 HH11 ' A' ' 106' ' ' ARG . 0.2 OUTLIER -97.21 107.28 19.76 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 102.516 -3.142 . . . . 0.0 102.516 179.839 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.546 HG12 ' CG2' ' A' ' 105' ' ' VAL . 1.0 OUTLIER -98.55 156.42 3.72 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.939 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 179.888 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -134.55 104.95 0.53 Allowed Glycine 0 C--N 1.347 1.162 0 C-N-CA 129.969 3.652 . . . . 0.0 110.45 179.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.413 ' HA ' ' HA ' ' A' ' 103' ' ' ILE . 18.1 mtmt -102.92 117.09 33.83 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 104.541 -2.392 . . . . 0.0 104.541 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.411 ' CD2' HD11 ' A' ' 78' ' ' LEU . 16.0 m-30 -107.58 118.19 36.08 Favored 'General case' 0 C--N 1.328 -0.327 0 O-C-N 125.288 1.617 . . . . 0.0 111.839 -179.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.409 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 4.6 mtmt -102.03 161.56 13.59 Favored 'General case' 0 C--O 1.21 -0.981 0 CA-C-N 114.215 -1.357 . . . . 0.0 110.372 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . 0.377 0.0 OUTLIER -107.48 144.98 33.67 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-O 116.849 -1.548 . . . . 0.0 107.672 179.936 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.411 ' HB ' ' HB3' ' A' ' 77' ' ' GLU . 57.0 t -82.24 -30.55 9.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 C-N-CA 126.641 1.976 . . . . 0.0 114.094 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . 0.343 0.1 OUTLIER -110.0 -3.96 16.18 Favored 'General case' 0 C--O 1.259 1.568 0 N-CA-C 115.413 1.634 . . . . 0.0 115.413 179.925 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 44.1 t30 -112.46 -22.49 10.81 Favored 'General case' 0 N--CA 1.422 -1.857 0 N-CA-C 115.258 1.577 . . . . 0.0 115.258 -179.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 60.22 26.97 64.53 Favored Glycine 0 CA--C 1.53 0.985 0 N-CA-C 117.489 1.756 . . . . 0.0 117.489 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 15.2 mmtm -90.91 -113.33 0.08 Allowed 'General case' 0 CA--C 1.553 1.072 0 O-C-N 120.237 -1.743 . . . . 0.0 112.015 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 151.79 144.04 0.0 OUTLIER 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 129.882 3.273 . . . . 0.0 108.778 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.71 HD12 ' CD1' ' A' ' 119' ' ' TYR . 2.4 tt -127.87 176.34 7.65 Favored 'General case' 0 CA--C 1.511 -0.551 2 O-C-N 129.787 4.429 . . . . 0.0 106.835 -179.808 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.513 HG13 ' N ' ' A' ' 104' ' ' ALA . 0.1 OUTLIER -149.14 173.21 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.502 -0.869 0 C-N-CA 117.93 -1.508 . . . . 0.0 109.491 -179.725 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.513 ' N ' HG13 ' A' ' 103' ' ' ILE . . . -154.46 133.36 12.3 Favored 'General case' 0 C--N 1.313 -1.013 0 O-C-N 117.709 -3.119 . . . . 0.0 107.418 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.546 ' CG2' HG12 ' A' ' 90' ' ' VAL . 0.9 OUTLIER -121.1 99.18 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 CA-C-N 122.113 2.233 . . . . 0.0 108.615 179.97 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.78 HH11 HD13 ' A' ' 89' ' ' LEU 0.259 75.3 mtt180 -71.62 91.83 1.11 Allowed 'General case' 0 CA--C 1.503 -0.834 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 179.944 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.432 ' O ' ' N ' ' A' ' 109' ' ' SER . 0.1 OUTLIER -89.85 83.53 6.18 Favored 'General case' 0 N--CA 1.432 -1.359 0 CA-C-N 112.316 -2.22 . . . . 0.0 114.758 -179.638 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.409 HD13 ' HA ' ' A' ' 108' ' ' ILE 0.276 8.5 mm -62.17 93.81 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 C-N-CA 116.926 -1.909 . . . . 0.0 106.865 179.435 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.432 ' N ' ' O ' ' A' ' 107' ' ' GLU . 6.1 m -65.8 -20.85 66.4 Favored 'General case' 0 N--CA 1.439 -0.992 0 C-N-CA 125.426 1.491 . . . . 0.0 109.605 -179.462 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 123.01 97.8 1.35 Allowed Glycine 0 C--O 1.218 -0.845 0 C-N-CA 129.907 3.622 . . . . 0.0 110.387 -179.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . 0.326 0.8 OUTLIER 90.49 -27.27 0.05 OUTLIER 'General case' 0 C--N 1.308 -1.199 0 O-C-N 128.235 2.962 . . . . 0.0 109.944 -179.068 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.464 ' HG2' ' HA ' ' A' ' 129' ' ' LYS . 88.6 mt-10 -115.51 124.15 50.35 Favored 'General case' 0 C--N 1.361 1.072 0 CA-C-O 117.014 -1.469 . . . . 0.0 110.986 179.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 30.2 tp -96.82 116.85 29.87 Favored 'General case' 0 C--O 1.217 -0.627 0 N-CA-C 104.593 -2.373 . . . . 0.0 104.593 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.85 HG23 HG12 ' A' ' 127' ' ' ILE 0.27 2.9 mm -102.58 128.44 55.34 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 O-C-N 128.047 3.342 . . . . 0.0 104.417 -179.929 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -111.31 79.77 1.24 Allowed 'General case' 0 CA--C 1.494 -1.174 0 CA-C-O 124.041 1.877 . . . . 0.0 106.027 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.406 ' HA ' ' HA ' ' A' ' 125' ' ' LYS . 0.3 OUTLIER -73.13 115.0 11.93 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 104.633 -2.358 . . . . 0.0 104.633 179.668 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . 0.262 78.5 m-85 -106.53 145.71 31.52 Favored 'General case' 0 C--O 1.207 -1.168 0 O-C-N 126.818 2.574 . . . . 0.0 113.269 -179.562 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.499 HG23 ' H ' ' A' ' 120' ' ' GLU 0.289 0.8 OUTLIER -141.2 126.48 18.59 Favored 'General case' 0 N--CA 1.446 -0.633 1 O-C-N 130.594 4.934 . . . . 0.0 108.439 179.577 . . . . . . . . 5 4 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.71 ' CD1' HD12 ' A' ' 102' ' ' LEU 0.277 22.4 t80 -101.07 -0.13 36.87 Favored 'General case' 0 C--O 1.245 0.851 0 CA-C-N 119.818 1.19 . . . . 0.0 107.835 -179.71 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.499 ' H ' HG23 ' A' ' 118' ' ' THR . 0.0 OUTLIER 171.98 -79.95 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.543 0 O-C-N 126.211 2.194 . . . . 0.0 115.863 -179.527 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -130.47 30.47 3.44 Favored Glycine 0 C--N 1.353 1.513 0 N-CA-C 118.838 2.295 . . . . 0.0 118.838 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 54.9 t -145.65 113.88 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 103.972 -2.603 . . . . 0.0 103.972 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -83.51 -178.89 7.2 Favored 'General case' 0 C--O 1.21 -0.985 0 CA-C-O 124.727 2.203 . . . . 0.0 112.533 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.742 ' HB2' ' CB ' ' A' ' 17' ' ' PHE . . . -167.34 85.48 0.24 Allowed 'General case' 0 C--O 1.216 -0.687 0 CA-C-O 114.223 -2.799 . . . . 0.0 108.501 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.406 ' HA ' ' HA ' ' A' ' 116' ' ' THR . 0.1 OUTLIER -69.01 128.27 36.1 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 121.256 1.844 . . . . 0.0 109.631 -179.647 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.414 ' NH2' HD13 ' A' ' 36' ' ' LEU . 0.0 OUTLIER -119.21 82.2 1.83 Allowed 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 125.959 1.704 . . . . 0.0 107.232 -179.8 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.85 HG12 HG23 ' A' ' 114' ' ' ILE . 2.1 mt -78.9 117.68 24.9 Favored 'Isoleucine or valine' 0 C--O 1.245 0.837 0 O-C-N 127.426 2.954 . . . . 0.0 116.448 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.501 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 1.3 m-30 -94.55 166.42 12.04 Favored 'General case' 0 N--CA 1.432 -1.347 0 O-C-N 128.102 3.376 . . . . 0.0 107.926 -179.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.464 ' HA ' ' HG2' ' A' ' 112' ' ' GLU 0.258 8.5 mmtt -119.44 -4.17 10.4 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 119.573 -0.251 . . . . 0.0 111.235 -179.885 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.557 ' HG3' ' CZ3' ' A' ' 6' ' ' TRP . 4.2 tttp 73.28 116.18 0.05 Allowed 'General case' 0 C--O 1.215 -0.72 0 CA-C-O 115.765 -2.064 . . . . 0.0 108.024 -179.533 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . 0.797 3.4 mm-40 . . . . . 0 N--CA 1.424 -1.758 0 O-C-N 126.83 2.581 . . . . 0.0 115.126 -179.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' PLM . . . . . 0.562 ' HG1' ' HD3' ' A' ' 27' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.508 -0.649 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -98.03 78.76 2.55 Favored 'General case' 0 N--CA 1.435 -1.207 0 C-N-CA 118.463 -1.295 . . . . 0.0 112.743 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -160.0 88.16 0.82 Allowed 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 112.513 -2.131 . . . . 0.0 111.878 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 153.07 -163.25 30.47 Favored Glycine 0 CA--C 1.495 -1.158 0 C-N-CA 115.635 -3.174 . . . . 0.0 109.168 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.423 ' HA ' ' HA ' ' A' ' 39' ' ' THR 0.49 22.0 m -97.18 161.42 13.82 Favored 'General case' 0 C--N 1.314 -0.954 0 O-C-N 126.281 1.812 . . . . 0.0 110.503 -179.658 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.774 ' CH2' HD11 ' A' ' 108' ' ' ILE . 87.9 m95 -139.75 156.67 46.65 Favored 'General case' 0 N--CA 1.434 -1.249 0 CA-C-N 112.665 -2.062 . . . . 0.0 106.72 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 24.0 tttt -159.92 90.97 0.94 Allowed 'General case' 0 C--O 1.203 -1.346 0 O-C-N 126.283 2.239 . . . . 0.0 107.217 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.599 ' HB ' ' CD1' ' A' ' 128' ' ' PHE 0.315 0.1 OUTLIER -37.65 127.4 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 O-C-N 126.634 2.458 . . . . 0.0 112.063 179.957 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.446 ' HB2' ' CG ' ' A' ' 129' ' ' LYS . 40.1 t0 -100.0 -32.38 10.98 Favored 'General case' 0 C--O 1.208 -1.092 0 O-C-N 126.793 2.558 . . . . 0.0 105.293 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 5.7 ptp180 -170.73 153.69 4.14 Favored 'General case' 0 C--N 1.296 -1.748 0 C-N-CA 115.846 -2.342 . . . . 0.0 109.189 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . 0.293 0.0 OUTLIER -106.77 -171.38 1.88 Allowed 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 111.297 -2.683 . . . . 0.0 107.675 179.514 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.506 ' CB ' ' HB2' ' A' ' 125' ' ' LYS . 4.1 tm-20 -131.67 -71.68 0.55 Allowed 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 117.468 -1.693 . . . . 0.0 108.293 179.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.455 ' HB3' ' HA ' ' A' ' 124' ' ' ALA . 23.5 t30 -113.43 28.41 8.8 Favored 'General case' 0 N--CA 1.474 0.774 0 O-C-N 125.246 1.591 . . . . 0.0 113.197 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.529 ' CA ' ' HB1' ' A' ' 124' ' ' ALA 0.347 0.2 OUTLIER -72.49 -19.79 61.48 Favored 'General case' 0 C--N 1.312 -1.037 0 O-C-N 128.416 3.572 . . . . 0.0 115.421 179.994 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -76.85 -30.7 56.4 Favored 'General case' 0 C--O 1.218 -0.588 0 CA-C-N 120.984 1.72 . . . . 0.0 108.683 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -79.83 -32.32 40.59 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 111.529 -2.578 . . . . 0.0 114.286 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.603 ' CE2' ' HA ' ' A' ' 118' ' ' THR . 0.0 OUTLIER -70.78 -37.63 73.35 Favored 'General case' 0 C--O 1.217 -0.625 0 CA-C-O 123.889 1.804 . . . . 0.0 108.466 179.87 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 3.3 mtm -75.21 -22.47 57.92 Favored 'General case' 0 N--CA 1.432 -1.334 0 CA-C-O 123.263 1.506 . . . . 0.0 109.617 -179.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.26 -31.58 58.39 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 126.229 2.919 . . . . 0.0 111.143 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 5.4 tptp -67.83 -29.59 68.78 Favored 'General case' 0 C--O 1.209 -1.065 0 O-C-N 119.431 -2.043 . . . . 0.0 112.846 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.462 ' HG2' ' CD1' ' A' ' 119' ' ' TYR . 56.7 mtp -79.38 -30.41 42.52 Favored 'General case' 0 C--N 1.346 0.452 0 N-CA-C 105.325 -2.102 . . . . 0.0 105.325 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 101.89 34.23 4.4 Favored Glycine 0 C--N 1.31 -0.871 0 CA-C-O 117.948 -1.474 . . . . 0.0 110.211 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.467 HD12 ' HG2' ' A' ' 132' ' ' PLM . 1.5 mm -67.73 135.74 27.92 Favored 'Isoleucine or valine' 0 C--N 1.361 1.102 0 CA-C-O 116.426 -1.749 . . . . 0.0 108.313 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 38.0 m-20 -74.95 147.82 40.55 Favored 'General case' 0 C--O 1.244 0.788 0 CA-C-O 115.255 -2.307 . . . . 0.0 113.555 179.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . 0.372 1.5 t -20.87 -57.3 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.508 -0.645 0 O-C-N 127.365 2.915 . . . . 0.0 117.819 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.547 1.9 m -73.67 -36.95 48.27 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.814 0 O-C-N 125.233 1.583 . . . . 0.0 112.073 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.429 ' HB2' ' CG2' ' A' ' 23' ' ' ILE . 6.7 mttm -63.69 -42.69 97.96 Favored 'General case' 0 CA--C 1.51 -0.57 0 O-C-N 125.057 1.473 . . . . 0.0 114.487 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 23.3 ptt85 -78.93 -23.68 44.52 Favored 'General case' 0 C--O 1.217 -0.638 0 CA-C-N 121.413 1.915 . . . . 0.0 108.464 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.9 ttpm? -76.09 -37.96 57.55 Favored 'General case' 0 N--CA 1.437 -1.096 0 CA-C-N 114.23 -1.35 . . . . 0.0 112.666 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.613 HD22 ' CE1' ' A' ' 33' ' ' HIS . 0.2 OUTLIER -77.05 -31.57 56.3 Favored 'General case' 0 N--CA 1.432 -1.327 0 CA-C-O 114.31 -2.757 . . . . 0.0 107.101 179.756 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -75.23 -21.53 77.75 Favored Glycine 0 CA--C 1.534 1.225 0 O-C-N 128.129 3.393 . . . . 0.0 114.425 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -78.37 -32.11 48.82 Favored 'General case' 0 C--N 1.314 -0.935 0 O-C-N 127.28 2.4 . . . . 0.0 110.898 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.613 ' CE1' HD22 ' A' ' 30' ' ' LEU . 6.7 p-80 -120.38 1.47 10.72 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 114.665 -1.152 . . . . 0.0 113.596 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 18.0 p30 -42.01 -19.92 0.01 OUTLIER 'General case' 0 CA--C 1.495 -1.156 0 N-CA-C 116.035 1.865 . . . . 0.0 116.035 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . 0.286 70.3 m-80 75.07 31.32 0.84 Allowed 'General case' 0 C--N 1.311 -1.092 0 CA-C-O 115.635 -2.126 . . . . 0.0 109.198 179.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.584 HD21 HD13 ' A' ' 38' ' ' LEU . 0.3 OUTLIER -45.64 103.48 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.964 0 O-C-N 127.559 3.037 . . . . 0.0 107.179 179.971 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.406 ' HE3' HG21 ' A' ' 5' ' ' THR . 30.9 tttp -96.79 112.13 24.01 Favored 'General case' 0 C--O 1.219 -0.517 0 N-CA-C 102.067 -3.309 . . . . 0.0 102.067 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.584 HD13 HD21 ' A' ' 36' ' ' LEU 0.279 1.0 OUTLIER -103.6 112.12 24.89 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 121.399 1.909 . . . . 0.0 110.577 -179.947 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.527 ' HB ' ' CB ' ' A' ' 50' ' ' LYS . 38.6 m -89.85 92.25 8.95 Favored 'General case' 0 N--CA 1.448 -0.557 0 O-C-N 118.003 -2.936 . . . . 0.0 106.675 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 5.3 mt -75.58 125.09 34.81 Favored 'Isoleucine or valine' 0 C--O 1.253 1.264 0 O-C-N 124.318 1.011 . . . . 0.0 111.016 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 53.2 m -128.3 95.16 4.08 Favored 'General case' 0 C--O 1.221 -0.445 0 O-C-N 127.037 2.711 . . . . 0.0 108.866 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -85.61 128.41 34.76 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-O 116.741 -1.599 . . . . 0.0 112.392 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -139.33 91.89 2.54 Favored 'General case' 0 N--CA 1.426 -1.671 0 CA-C-N 120.919 1.69 . . . . 0.0 110.589 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 50.0 68.07 1.56 Allowed Glycine 0 C--N 1.292 -1.881 0 O-C-N 126.013 2.071 . . . . 0.0 110.383 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.315 0.4 OUTLIER 83.4 -26.42 0.12 Allowed 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 114.258 1.207 . . . . 0.0 114.258 179.8 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 21.5 ttpt -87.25 143.03 27.47 Favored 'General case' 0 C--N 1.312 -1.05 0 C-N-CA 117.014 -1.875 . . . . 0.0 108.411 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.447 ' HE2' HD21 ' A' ' 64' ' ' LEU . 22.9 m-85 -124.02 101.2 7.11 Favored 'General case' 0 C--N 1.34 0.18 0 O-C-N 124.844 1.34 . . . . 0.0 111.077 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.958 ' HB ' HG12 ' A' ' 61' ' ' VAL 0.432 0.1 OUTLIER -83.19 82.93 8.05 Favored 'General case' 0 N--CA 1.441 -0.899 0 O-C-N 125.774 1.921 . . . . 0.0 110.281 179.909 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.616 HG22 ' HB ' ' A' ' 60' ' ' VAL 0.692 0.3 OUTLIER -62.96 89.12 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.493 -1.231 0 CA-C-N 110.687 -2.96 . . . . 0.0 115.788 179.971 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.527 ' CB ' ' HB ' ' A' ' 39' ' ' THR . 1.7 tttm -63.83 146.29 54.23 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 100.672 -3.825 . . . . 0.0 100.672 179.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -144.15 75.0 1.44 Allowed 'General case' 0 C--O 1.215 -0.739 0 CA-C-N 120.582 1.537 . . . . 0.0 109.378 -179.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 51.4 m -77.4 73.2 3.97 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 105.454 -2.054 . . . . 0.0 105.454 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.8 p -93.19 39.5 1.05 Allowed 'General case' 0 CA--C 1.505 -0.77 0 C-N-CA 117.809 -1.556 . . . . 0.0 111.868 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.403 ' OD1' ' N ' ' A' ' 55' ' ' PHE . 0.1 OUTLIER 72.16 -52.43 0.7 Allowed 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 115.242 -2.313 . . . . 0.0 108.509 -179.915 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.445 ' HB3' ' HD2' ' A' ' 56' ' ' ARG . 81.5 m-85 -57.5 -73.89 0.06 Allowed 'General case' 0 C--O 1.22 -0.492 0 CA-C-N 122.311 2.323 . . . . 0.0 109.403 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.445 ' HD2' ' HB3' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -136.59 146.19 45.8 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 120.472 1.487 . . . . 0.0 110.631 179.847 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -95.57 80.58 3.46 Favored 'General case' 0 C--N 1.352 0.697 0 N-CA-C 101.214 -3.625 . . . . 0.0 101.214 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.0 tp -110.71 117.67 55.46 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 O-C-N 127.827 3.205 . . . . 0.0 118.826 -179.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.75 119.6 12.73 Favored 'General case' 0 C--O 1.217 -0.643 0 N-CA-C 104.211 -2.514 . . . . 0.0 104.211 178.305 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.616 ' HB ' HG22 ' A' ' 49' ' ' VAL . 42.8 t -97.27 69.49 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 CA-C-O 122.163 0.982 . . . . 0.0 110.828 -178.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.958 HG12 ' HB ' ' A' ' 48' ' ' THR 0.404 0.7 OUTLIER -64.02 111.86 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 C-N-CA 118.028 -1.469 . . . . 0.0 113.138 -179.795 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.606 ' CE2' ' CE2' ' A' ' 68' ' ' PHE . 11.5 m-30 -136.99 97.25 3.46 Favored 'General case' 0 N--CA 1.431 -1.386 0 O-C-N 119.122 -2.236 . . . . 0.0 108.665 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -63.57 138.79 58.64 Favored 'General case' 0 C--O 1.246 0.886 0 N-CA-C 105.003 -2.221 . . . . 0.0 105.003 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.447 HD21 ' HE2' ' A' ' 47' ' ' PHE . 0.4 OUTLIER -60.54 134.92 57.55 Favored 'General case' 0 C--O 1.252 1.2 0 N-CA-C 105.354 -2.091 . . . . 0.0 105.354 -179.996 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 75.19 2.96 68.19 Favored Glycine 0 C--N 1.341 0.832 0 C-N-CA 127.892 2.663 . . . . 0.0 114.896 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . 0.39 2.1 t -89.64 83.63 2.18 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 N-CA-C 105.189 -2.152 . . . . 0.0 105.189 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -52.77 95.81 0.01 OUTLIER 'General case' 0 CA--C 1.479 -1.756 0 N-CA-C 115.579 1.696 . . . . 0.0 115.579 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.606 ' CE2' ' CE2' ' A' ' 62' ' ' PHE . 13.2 p90 -89.94 178.07 6.31 Favored 'General case' 0 C--N 1.309 -1.153 0 O-C-N 120.438 -1.414 . . . . 0.0 110.109 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -123.95 136.27 54.21 Favored 'General case' 0 C--O 1.244 0.777 0 O-C-N 127.269 2.856 . . . . 0.0 105.441 179.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -156.04 113.87 3.31 Favored 'General case' 0 C--O 1.21 -0.98 0 C-N-CA 118.002 -1.479 . . . . 0.0 114.37 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 9.0 p -67.0 176.5 2.08 Favored 'General case' 0 C--N 1.314 -0.97 0 O-C-N 119.617 -1.927 . . . . 0.0 107.183 179.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.493 ' CD2' HD22 ' A' ' 78' ' ' LEU . 2.9 mt -119.04 -154.5 0.57 Allowed 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 116.345 -1.788 . . . . 0.0 109.339 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -118.5 12.07 13.12 Favored 'General case' 0 N--CA 1.436 -1.165 0 O-C-N 125.627 1.829 . . . . 0.0 113.224 179.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -143.68 -49.41 0.3 Allowed 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 120.541 -0.464 . . . . 0.0 112.178 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -107.96 -9.81 27.49 Favored Glycine 0 CA--C 1.541 1.662 0 N-CA-C 117.192 1.637 . . . . 0.0 117.192 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . 0.412 0.0 OUTLIER 71.58 153.46 0.13 Allowed 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 122.004 2.902 . . . . 0.0 115.257 179.684 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.507 ' HB3' ' CG2' ' A' ' 96' ' ' VAL . 30.9 mt-10 48.76 154.5 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.676 1 O-C-N 129.885 4.491 . . . . 0.0 117.145 179.536 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.545 ' HG ' ' HB3' ' A' ' 93' ' ' PHE 0.401 11.9 tp 177.15 152.47 0.21 Allowed 'General case' 0 CA--C 1.51 -0.584 0 CA-C-N 110.949 -2.841 . . . . 0.0 107.016 -179.819 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 10.9 m -161.56 119.04 2.25 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 103.297 -2.853 . . . . 0.0 103.297 -179.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -165.13 -162.59 16.55 Favored Glycine 0 C--N 1.303 -1.256 0 C-N-CA 116.932 -2.556 . . . . 0.0 111.193 -179.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 17.4 p -145.21 164.36 31.58 Favored 'General case' 0 C--O 1.193 -1.915 0 C-N-CA 119.112 -1.035 . . . . 0.0 111.531 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . 0.508 ' CZ2' HG11 ' A' ' 49' ' ' VAL 0.302 11.8 m0 -106.46 151.72 24.58 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 100.68 -3.822 . . . . 0.0 100.68 179.924 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 2.4 t -150.96 141.11 22.19 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-O 122.587 1.184 . . . . 0.0 111.766 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 6.9 ttp -91.41 110.36 21.66 Favored 'General case' 0 N--CA 1.429 -1.519 0 CA-C-N 113.037 -1.892 . . . . 0.0 109.705 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . 0.634 10.2 mt-10 -87.58 -133.43 0.08 Allowed 'General case' 0 N--CA 1.434 -1.265 0 O-C-N 124.315 1.009 . . . . 0.0 110.391 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -87.34 92.71 1.83 Allowed Glycine 0 C--N 1.336 0.531 0 N-CA-C 103.207 -3.957 . . . . 0.0 103.207 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 53.68 10.46 0.24 Allowed 'General case' 0 C--O 1.24 0.602 0 N-CA-C 118.059 2.614 . . . . 0.0 118.059 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . 0.335 0.0 OUTLIER -133.58 135.13 44.09 Favored 'General case' 0 CA--C 1.501 -0.933 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 -179.975 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -88.31 134.6 33.77 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 103.953 -2.61 . . . . 0.0 103.953 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -113.54 -172.77 0.54 Allowed 'Isoleucine or valine' 0 C--O 1.246 0.88 0 C-N-CA 119.218 -0.993 . . . . 0.0 108.5 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -164.69 109.11 0.35 Allowed Glycine 0 C--N 1.35 1.335 0 C-N-CA 126.767 2.127 . . . . 0.0 111.696 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 4.7 mmmt -112.33 135.79 52.59 Favored 'General case' 0 N--CA 1.426 -1.636 0 N-CA-C 106.511 -1.662 . . . . 0.0 106.511 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.66 ' HD2' HD22 ' A' ' 102' ' ' LEU . 39.2 m-85 -137.57 115.9 11.87 Favored 'General case' 0 CA--C 1.504 -0.806 0 O-C-N 126.306 2.254 . . . . 0.0 113.034 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.4 mtmt -99.58 138.89 36.04 Favored 'General case' 0 N--CA 1.436 -1.157 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . 0.369 0.0 OUTLIER -74.29 174.51 8.7 Favored 'General case' 0 N--CA 1.428 -1.526 0 N-CA-C 105.647 -1.983 . . . . 0.0 105.647 179.819 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.507 ' CG2' ' HB3' ' A' ' 77' ' ' GLU 0.258 2.7 t -86.35 -61.69 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 O-C-N 126.702 2.501 . . . . 0.0 110.862 179.606 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . 0.398 0.6 OUTLIER -57.88 -29.17 64.82 Favored 'General case' 0 C--O 1.26 1.609 0 N-CA-C 118.46 2.763 . . . . 0.0 118.46 -179.926 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -131.24 -4.92 3.85 Favored 'General case' 0 N--CA 1.425 -1.712 0 N-CA-C 116.435 2.013 . . . . 0.0 116.435 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 49.56 42.73 35.71 Favored Glycine 0 C--N 1.348 1.198 0 C-N-CA 118.953 -1.594 . . . . 0.0 114.658 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 26.1 mmtm -71.41 -103.25 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.339 0 CA-C-O 115.835 -2.031 . . . . 0.0 111.226 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 158.92 136.11 0.0 OUTLIER 'General case' 0 N--CA 1.433 -1.308 0 C-N-CA 131.197 3.799 . . . . 0.0 110.191 179.692 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.678 ' HG ' ' HA ' ' A' ' 119' ' ' TYR . 7.2 tt -125.13 111.19 15.03 Favored 'General case' 0 C--N 1.316 -0.868 1 C-N-CA 133.764 4.826 . . . . 0.0 102.744 178.947 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.614 HD12 ' H ' ' A' ' 104' ' ' ALA . 0.1 OUTLIER -101.31 160.72 3.79 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.185 0 C-N-CA 115.472 -2.491 . . . . 0.0 106.975 -179.222 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.614 ' H ' HD12 ' A' ' 103' ' ' ILE . . . -157.8 131.95 8.17 Favored 'General case' 0 C--N 1.322 -0.604 0 O-C-N 118.729 -2.482 . . . . 0.0 112.471 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.624 ' HB ' ' CE2' ' A' ' 117' ' ' TYR . 5.6 p -120.56 118.33 56.2 Favored 'Isoleucine or valine' 0 C--O 1.252 1.226 0 CA-C-N 122.452 2.387 . . . . 0.0 108.915 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.493 HH11 ' HG3' ' A' ' 106' ' ' ARG . 9.6 mtt85 -86.34 88.12 7.56 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 105.301 -2.111 . . . . 0.0 105.301 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -91.36 85.6 5.85 Favored 'General case' 0 N--CA 1.429 -1.513 0 CA-C-N 113.023 -1.899 . . . . 0.0 114.458 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.774 HD11 ' CH2' ' A' ' 6' ' ' TRP 0.388 4.9 tt -65.27 92.12 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 C-N-CA 113.95 -3.1 . . . . 0.0 115.191 -179.927 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 38.9 t -76.54 77.53 3.23 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 102.929 -2.989 . . . . 0.0 102.929 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 62.4 -98.02 0.19 Allowed Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 127.162 2.315 . . . . 0.0 114.715 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . 0.325 7.0 m-20 -86.42 -0.9 56.96 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 114.726 -2.559 . . . . 0.0 110.717 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.439 ' HG2' ' HD2' ' A' ' 129' ' ' LYS . 6.3 mp0 -124.42 123.49 40.27 Favored 'General case' 0 C--O 1.205 -1.253 0 O-C-N 126.285 2.241 . . . . 0.0 112.451 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.654 HD22 ' CD2' ' A' ' 128' ' ' PHE . 10.0 tt -93.02 133.29 36.32 Favored 'General case' 0 C--O 1.222 -0.375 0 N-CA-C 101.286 -3.598 . . . . 0.0 101.286 -179.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.859 HG22 HG22 ' A' ' 116' ' ' THR 0.285 47.5 mt -138.03 120.85 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.301 0 O-C-N 125.976 2.048 . . . . 0.0 108.976 -179.79 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.534 ' HB2' ' CD ' ' A' ' 126' ' ' ARG . 72.6 mt-30 -91.74 150.04 21.31 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 101.772 -3.418 . . . . 0.0 101.772 -179.511 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.859 HG22 HG22 ' A' ' 114' ' ' ILE . 0.1 OUTLIER -166.15 148.68 7.1 Favored 'General case' 0 N--CA 1.414 -2.244 0 O-C-N 128.389 3.556 . . . . 0.0 111.181 -179.236 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.624 ' CE2' ' HB ' ' A' ' 105' ' ' VAL 0.382 23.3 m-85 132.1 -142.86 0.0 OUTLIER 'General case' 0 CA--C 1.478 -1.793 0 O-C-N 128.682 3.739 . . . . 0.0 113.312 177.31 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.603 ' HA ' ' CE2' ' A' ' 17' ' ' PHE . 13.4 t -136.62 -173.66 3.49 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-O 127.165 3.364 . . . . 0.0 117.218 -174.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.678 ' HA ' ' HG ' ' A' ' 102' ' ' LEU 0.276 2.2 t80 -112.16 -15.99 13.11 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 112.56 -2.109 . . . . 0.0 109.055 177.644 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.448 ' HB2' ' CD2' ' A' ' 119' ' ' TYR . 0.4 OUTLIER -153.71 -71.17 0.14 Allowed 'General case' 0 C--N 1.298 -1.641 0 O-C-N 119.64 -1.912 . . . . 0.0 109.492 -179.916 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -160.51 34.1 0.42 Allowed Glycine 0 C--N 1.363 2.049 0 N-CA-C 120.59 2.996 . . . . 0.0 120.59 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 90.2 t -139.57 103.54 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.193 0 N-CA-C 103.476 -2.786 . . . . 0.0 103.476 179.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.447 ' HA ' ' O ' ' A' ' 117' ' ' TYR . 6.6 mp0 -68.47 177.63 2.33 Favored 'General case' 0 CA--C 1.503 -0.852 0 CA-C-O 123.778 1.751 . . . . 0.0 113.264 -178.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.529 ' HB1' ' CA ' ' A' ' 14' ' ' TYR . . . -167.77 176.74 6.15 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-O 114.379 -2.724 . . . . 0.0 104.906 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.506 ' HB2' ' CB ' ' A' ' 12' ' ' GLU 0.328 2.8 mptp? -145.3 156.17 43.65 Favored 'General case' 0 CA--C 1.506 -0.732 0 O-C-N 127.55 3.031 . . . . 0.0 107.818 -179.68 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.534 ' CD ' ' HB2' ' A' ' 115' ' ' GLN . 0.0 OUTLIER -142.13 76.15 1.52 Allowed 'General case' 0 N--CA 1.432 -1.361 0 CA-C-N 112.556 -2.111 . . . . 0.0 110.411 179.753 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.469 HD13 HG23 ' A' ' 114' ' ' ILE . 6.7 mm -63.8 116.33 3.34 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 O-C-N 126.313 2.258 . . . . 0.0 115.209 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.654 ' CD2' HD22 ' A' ' 113' ' ' LEU . 2.7 m-30 -109.24 125.93 52.78 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 126.011 1.724 . . . . 0.0 107.57 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.446 ' CG ' ' HB2' ' A' ' 9' ' ' ASP 0.279 14.8 mmmt -91.16 3.22 55.35 Favored 'General case' 0 N--CA 1.441 -0.897 0 O-C-N 119.961 -1.712 . . . . 0.0 112.213 -179.649 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.485 ' HD2' ' CH2' ' A' ' 6' ' ' TRP . 4.3 tttp 74.14 143.26 0.07 Allowed 'General case' 0 C--N 1.349 0.561 0 O-C-N 124.501 1.126 . . . . 0.0 108.763 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . 0.835 1.0 OUTLIER . . . . . 0 N--CA 1.431 -1.419 0 N-CA-C 115.401 1.63 . . . . 0.0 115.401 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' PLM . . . . . 0.467 ' HG2' HD12 ' A' ' 23' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.258 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -134.11 83.3 2.03 Favored 'General case' 0 N--CA 1.428 -1.534 0 O-C-N 121.079 -1.013 . . . . 0.0 113.363 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -156.94 88.41 1.03 Allowed 'General case' 0 N--CA 1.44 -0.94 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.904 179.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.4 ' O ' ' N ' ' A' ' 40' ' ' ILE . . . 160.09 -130.72 2.48 Favored Glycine 0 CA--C 1.5 -0.86 0 C-N-CA 117.017 -2.516 . . . . 0.0 109.373 -179.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.621 ' HA ' ' HA ' ' A' ' 39' ' ' THR 0.499 5.3 t -117.73 171.11 8.26 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 123.197 1.475 . . . . 0.0 114.123 -179.958 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.803 ' CH2' HD11 ' A' ' 108' ' ' ILE . 80.3 m95 -152.13 147.61 26.65 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-N 110.227 -3.17 . . . . 0.0 105.816 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 4.8 ttmm -139.61 122.19 16.27 Favored 'General case' 0 C--O 1.205 -1.246 0 O-C-N 127.767 3.167 . . . . 0.0 105.514 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.721 HG12 ' HB3' ' A' ' 36' ' ' LEU 0.379 8.0 p -69.02 139.21 20.85 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.022 0 CA-C-N 121.143 1.792 . . . . 0.0 110.773 179.996 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -129.39 -46.82 1.19 Allowed 'General case' 0 C--O 1.212 -0.91 0 O-C-N 127.387 2.929 . . . . 0.0 106.373 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.452 ' HG3' ' N ' ' A' ' 11' ' ' ASN . 9.2 ttt180 -129.21 144.85 51.37 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 106.962 -1.495 . . . . 0.0 106.962 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.484 ' OD1' HG21 ' A' ' 8' ' ' VAL 0.385 97.7 m-20 -131.59 -171.12 2.53 Favored 'General case' 0 CA--C 1.501 -0.936 0 O-C-N 128.604 3.69 . . . . 0.0 107.886 179.956 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.527 ' HB2' ' HB2' ' A' ' 125' ' ' LYS . 0.9 OUTLIER -146.43 -85.69 0.11 Allowed 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 122.595 2.452 . . . . 0.0 110.897 179.942 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.538 ' HB3' ' HA ' ' A' ' 124' ' ' ALA . 2.8 t30 -90.64 16.74 8.55 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-N 121.342 1.883 . . . . 0.0 114.154 179.445 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.514 ' CD2' ' HG2' ' A' ' 126' ' ' ARG 0.283 0.2 OUTLIER -63.98 -20.98 66.29 Favored 'General case' 0 C--O 1.242 0.665 0 O-C-N 127.595 3.06 . . . . 0.0 115.11 179.858 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -76.19 -36.91 58.43 Favored 'General case' 0 C--O 1.205 -1.261 0 O-C-N 118.909 -2.369 . . . . 0.0 108.186 179.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.44 ' HB3' ' ND2' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -77.3 -33.76 55.62 Favored 'General case' 0 N--CA 1.435 -1.189 0 CA-C-N 112.855 -1.975 . . . . 0.0 113.194 179.981 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -70.27 -21.44 62.97 Favored 'General case' 0 N--CA 1.438 -1.046 0 O-C-N 118.798 -2.439 . . . . 0.0 109.666 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.434 ' CB ' HG13 ' A' ' 23' ' ' ILE . 4.8 mtt -76.86 -35.19 57.65 Favored 'General case' 0 CA--C 1.503 -0.852 0 CA-C-O 125.868 2.747 . . . . 0.0 107.268 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -70.79 -29.62 65.87 Favored 'General case' 0 C--O 1.244 0.771 0 CA-C-O 127.295 3.426 . . . . 0.0 112.007 179.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 42.3 tptt -80.07 -27.78 39.28 Favored 'General case' 0 N--CA 1.437 -1.118 0 O-C-N 119.252 -2.155 . . . . 0.0 110.383 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 17.8 mtp -71.5 -30.88 66.47 Favored 'General case' 0 C--O 1.202 -1.436 0 O-C-N 119.554 -1.966 . . . . 0.0 106.669 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.31 32.52 2.75 Favored Glycine 0 C--N 1.306 -1.129 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.449 HG23 ' HB3' ' A' ' 27' ' ' LYS . 6.0 mm -78.33 -71.38 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.362 1.124 0 CA-C-O 115.561 -2.161 . . . . 0.0 106.901 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 66.53 152.17 0.07 Allowed 'General case' 0 N--CA 1.445 -0.716 0 O-C-N 126.777 2.548 . . . . 0.0 114.755 179.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.442 HG12 ' N ' ' A' ' 26' ' ' VAL 0.4 2.6 t 50.18 -122.94 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.355 0.835 0 N-CA-C 120.268 3.432 . . . . 0.0 120.268 179.679 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.442 ' N ' HG12 ' A' ' 25' ' ' VAL 0.542 3.4 m -65.43 -36.86 78.68 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.037 0 N-CA-C 118.379 2.733 . . . . 0.0 118.379 -179.776 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.449 ' HB3' HG23 ' A' ' 23' ' ' ILE . 62.8 mttm -60.93 -25.89 67.1 Favored 'General case' 0 N--CA 1.438 -1.067 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 4.7 mtm-85 -78.08 -31.26 50.04 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 117.435 -1.706 . . . . 0.0 108.178 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 8.1 tptm -71.36 -45.85 61.89 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 114.02 -1.446 . . . . 0.0 111.798 179.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 12.2 mt -78.02 -29.2 49.36 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 -179.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.16 -36.07 60.43 Favored Glycine 0 C--N 1.338 0.641 0 CA-C-O 123.089 1.383 . . . . 0.0 111.681 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -75.63 -22.84 56.45 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-O 116.738 -1.601 . . . . 0.0 112.946 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 18.0 t60 -120.78 46.2 2.07 Favored 'General case' 0 N--CA 1.447 -0.615 0 O-C-N 128.829 3.831 . . . . 0.0 114.125 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -72.05 -19.19 61.87 Favored 'General case' 0 C--O 1.21 -0.991 0 O-C-N 128.544 3.653 . . . . 0.0 117.703 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . 0.255 2.0 t-20 65.93 38.99 4.73 Favored 'General case' 0 C--N 1.312 -1.037 0 C-N-CA 118.593 -1.243 . . . . 0.0 109.454 -179.314 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.92 HD21 HD13 ' A' ' 38' ' ' LEU . 3.0 tt -61.2 137.29 58.24 Favored 'General case' 0 C--O 1.216 -0.698 0 O-C-N 125.632 1.833 . . . . 0.0 112.847 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.3 ttpt -139.2 100.83 4.11 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 101.55 -3.5 . . . . 0.0 101.55 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.92 HD13 HD21 ' A' ' 36' ' ' LEU 0.277 0.4 OUTLIER -93.08 117.19 29.78 Favored 'General case' 0 C--N 1.293 -1.88 0 O-C-N 119.349 -2.095 . . . . 0.0 107.008 -179.578 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.621 ' HA ' ' HA ' ' A' ' 5' ' ' THR . 85.2 m -104.44 100.47 10.16 Favored 'General case' 0 N--CA 1.436 -1.135 0 N-CA-C 104.192 -2.522 . . . . 0.0 104.192 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.439 HG12 HG23 ' A' ' 49' ' ' VAL . 7.9 mt -71.29 149.86 9.56 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 179.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.695 ' HB ' HG23 ' A' ' 48' ' ' THR . 89.3 m -142.71 63.44 1.39 Allowed 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 113.68 -1.6 . . . . 0.0 112.519 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.408 ' HG3' ' CE1' ' A' ' 47' ' ' PHE . 0.4 OUTLIER -62.35 119.85 9.88 Favored 'General case' 0 C--O 1.222 -0.362 0 O-C-N 125.228 1.58 . . . . 0.0 109.723 179.86 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -153.48 108.68 3.19 Favored 'General case' 0 CA--C 1.489 -1.392 0 CA-C-O 122.951 1.358 . . . . 0.0 110.079 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 61.35 31.73 78.32 Favored Glycine 0 C--N 1.306 -1.108 0 N-CA-C 108.888 -1.685 . . . . 0.0 108.888 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.31 0.2 OUTLIER 87.63 -14.05 0.44 Allowed 'General case' 0 C--O 1.225 -0.189 0 CA-C-N 112.978 -1.611 . . . . 0.0 110.856 179.728 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -80.09 121.1 25.12 Favored 'General case' 0 N--CA 1.428 -1.542 0 C-N-CA 116.333 -2.147 . . . . 0.0 110.094 -179.557 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.859 ' CE2' HD21 ' A' ' 89' ' ' LEU 0.311 0.4 OUTLIER -101.77 104.93 15.74 Favored 'General case' 0 C--O 1.217 -0.634 0 N-CA-C 105.985 -1.857 . . . . 0.0 105.985 179.963 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.695 HG23 ' HB ' ' A' ' 41' ' ' THR 0.432 1.6 t -105.29 73.2 1.02 Allowed 'General case' 0 C--N 1.313 -1.002 0 CA-C-O 125.542 2.591 . . . . 0.0 111.979 -179.596 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.439 HG23 HG12 ' A' ' 40' ' ' ILE 0.626 0.5 OUTLIER -52.37 94.47 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.425 -1.703 0 CA-C-N 108.704 -3.862 . . . . 0.0 112.636 -179.866 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.606 ' HB3' ' HB ' ' A' ' 39' ' ' THR . 5.1 ttmt -64.6 153.88 37.98 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 100.631 -3.84 . . . . 0.0 100.631 179.381 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.562 ' OE2' HD11 ' A' ' 36' ' ' LEU . 1.3 tp10 -149.42 92.92 1.99 Allowed 'General case' 0 C--O 1.215 -0.733 0 N-CA-C 103.774 -2.676 . . . . 0.0 103.774 -179.743 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -88.06 77.88 8.29 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-O 125.025 2.345 . . . . 0.0 106.696 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -95.11 -176.51 3.84 Favored 'General case' 0 N--CA 1.439 -1.003 0 O-C-N 119.883 -1.761 . . . . 0.0 112.411 -179.401 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -65.21 -19.41 65.96 Favored 'General case' 0 N--CA 1.444 -0.772 0 O-C-N 126.681 2.488 . . . . 0.0 108.612 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.417 ' CE2' ' HB1' ' A' ' 73' ' ' ALA . 6.1 m-85 -90.04 -56.52 3.19 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-O 115.22 -2.324 . . . . 0.0 115.165 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.686 HH21 HD12 ' A' ' 58' ' ' ILE . 0.1 OUTLIER -155.62 168.58 26.69 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 123.833 3.015 . . . . 0.0 107.947 179.418 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -106.29 63.16 0.65 Allowed 'General case' 0 C--O 1.216 -0.696 2 N-CA-C 100.007 -4.071 . . . . 0.0 100.007 179.645 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.686 HD12 HH21 ' A' ' 56' ' ' ARG . 12.1 tt -91.95 97.8 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 O-C-N 127.99 3.306 . . . . 0.0 114.509 -179.385 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.442 ' HA ' ' HA ' ' A' ' 50' ' ' LYS 0.273 0.0 OUTLIER -62.88 125.9 25.54 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 104.935 -2.246 . . . . 0.0 104.935 179.136 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.5 t -105.2 85.38 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 C-N-CA 119.035 -1.066 . . . . 0.0 109.735 -178.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.582 HG12 ' HB ' ' A' ' 48' ' ' THR 0.399 2.0 m -74.44 150.84 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.37 0 CA-C-O 125.865 2.745 . . . . 0.0 115.163 -179.882 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.626 ' CZ ' ' CZ2' ' A' ' 82' ' ' TRP . 0.0 OUTLIER -168.21 95.65 0.4 Allowed 'General case' 0 N--CA 1.43 -1.473 0 CA-C-N 112.673 -2.058 . . . . 0.0 111.639 179.7 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.74 99.91 0.06 Allowed 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 102.477 -3.157 . . . . 0.0 102.477 179.572 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.461 HD23 ' CD2' ' A' ' 47' ' ' PHE . 0.2 OUTLIER -33.86 100.02 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 127.052 2.72 . . . . 0.0 112.683 -179.865 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 102.46 23.44 8.92 Favored Glycine 0 CA--C 1.528 0.881 0 O-C-N 128.453 3.596 . . . . 0.0 116.842 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.435 ' O ' ' CE2' ' A' ' 68' ' ' PHE 0.269 2.4 t -113.88 79.4 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.505 0 CA-C-O 115.184 -2.341 . . . . 0.0 105.301 -179.99 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . 0.278 23.5 m-20 -27.92 118.5 0.1 Allowed 'General case' 0 CA--C 1.498 -1.035 0 N-CA-C 115.682 1.734 . . . . 0.0 115.682 -179.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.571 ' CZ ' ' CB ' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -129.0 -173.57 3.02 Favored 'General case' 0 N--CA 1.442 -0.837 0 O-C-N 118.602 -2.561 . . . . 0.0 107.72 -179.922 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -128.84 138.15 51.88 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.439 ' HB3' HD23 ' A' ' 78' ' ' LEU . 1.7 t80 -138.85 95.17 2.92 Favored 'General case' 0 C--O 1.215 -0.727 0 C-N-CA 119.26 -0.976 . . . . 0.0 113.026 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -74.36 115.71 14.2 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 105.103 -2.184 . . . . 0.0 105.103 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.864 HD11 HD13 ' A' ' 78' ' ' LEU . 46.8 mt -71.16 -169.1 0.35 Allowed 'General case' 0 C--N 1.298 -1.637 0 CA-C-O 117.795 -1.098 . . . . 0.0 109.745 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.417 ' HB1' ' CE2' ' A' ' 55' ' ' PHE . . . -85.26 -35.95 21.22 Favored 'General case' 0 C--O 1.214 -0.784 0 O-C-N 128.666 3.729 . . . . 0.0 113.332 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.424 ' HB2' ' CG ' ' A' ' 132' ' ' PLM . 11.7 t0 -143.17 21.88 1.9 Allowed 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 113.982 -1.463 . . . . 0.0 108.555 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -130.92 -15.42 1.72 Allowed Glycine 0 CA--C 1.544 1.851 0 CA-C-O 117.797 -1.557 . . . . 0.0 116.829 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER 64.7 -177.65 0.17 Allowed 'General case' 0 N--CA 1.433 -1.306 0 CA-C-N 119.994 1.897 . . . . 0.0 114.204 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.491 ' CB ' ' HB ' ' A' ' 96' ' ' VAL . 4.7 mp0 -26.94 119.71 0.09 Allowed 'General case' 0 CA--C 1.5 -0.958 1 O-C-N 129.626 4.329 . . . . 0.0 115.608 179.923 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.864 HD13 HD11 ' A' ' 72' ' ' LEU 0.433 0.9 OUTLIER -142.67 78.01 1.6 Allowed 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 101.9 -3.37 . . . . 0.0 101.9 179.997 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 3.7 m -82.74 165.88 19.55 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 101.804 -3.406 . . . . 0.0 101.804 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 144.31 -170.65 25.99 Favored Glycine 0 CA--C 1.538 1.519 0 C-N-CA 119.345 -1.407 . . . . 0.0 112.336 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -146.38 171.32 15.19 Favored 'General case' 0 C--O 1.203 -1.364 0 C-N-CA 117.668 -1.613 . . . . 0.0 111.386 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . 0.626 ' CZ2' ' CZ ' ' A' ' 62' ' ' PHE 0.335 13.3 m0 -114.46 141.52 47.58 Favored 'General case' 0 N--CA 1.424 -1.771 0 N-CA-C 101.388 -3.56 . . . . 0.0 101.388 179.63 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.471 HG23 HG22 ' A' ' 90' ' ' VAL . 9.9 t -146.85 141.4 26.57 Favored 'General case' 0 N--CA 1.427 -1.581 0 O-C-N 124.261 0.975 . . . . 0.0 109.797 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 12.4 ttm -81.64 129.62 34.76 Favored 'General case' 0 CA--C 1.496 -1.133 0 C-N-CA 121.2 -0.2 . . . . 0.0 110.897 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . 0.597 3.7 pt-20 -122.51 54.75 1.19 Allowed 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 96.6 -127.82 9.32 Favored Glycine 0 N--CA 1.439 -1.111 0 O-C-N 126.008 2.067 . . . . 0.0 108.503 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -80.65 9.47 6.11 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 115.502 1.668 . . . . 0.0 115.502 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . 0.275 0.1 OUTLIER -132.49 172.8 12.02 Favored 'General case' 0 CA--C 1.503 -0.836 0 O-C-N 125.712 1.882 . . . . 0.0 106.667 179.623 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.859 HD21 ' CE2' ' A' ' 47' ' ' PHE . 2.6 tp -127.74 159.11 35.77 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 105.339 -2.097 . . . . 0.0 105.339 179.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.471 HG22 HG23 ' A' ' 83' ' ' THR . 17.4 m -142.83 122.61 9.52 Favored 'Isoleucine or valine' 0 C--O 1.245 0.864 0 C-N-CA 116.09 -2.244 . . . . 0.0 110.107 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -92.64 97.49 2.27 Favored Glycine 0 C--N 1.35 1.338 0 N-CA-C 108.031 -2.028 . . . . 0.0 108.031 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.637 ' HA ' HD12 ' A' ' 103' ' ' ILE . 2.0 mttt -92.62 126.88 37.9 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 102.78 -3.045 . . . . 0.0 102.78 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.456 ' HB3' ' HG ' ' A' ' 78' ' ' LEU . 53.2 m-85 -127.96 110.74 12.83 Favored 'General case' 0 N--CA 1.444 -0.758 0 O-C-N 126.201 2.188 . . . . 0.0 112.621 -179.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -103.65 126.82 51.04 Favored 'General case' 0 N--CA 1.435 -1.203 0 N-CA-C 105.407 -2.071 . . . . 0.0 105.407 179.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . 0.433 3.3 mmm180 -81.64 156.49 25.08 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 127.227 2.829 . . . . 0.0 109.69 -179.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.491 ' HB ' ' CB ' ' A' ' 77' ' ' GLU . 3.3 t -78.4 -54.54 11.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 C-N-CA 124.552 1.141 . . . . 0.0 113.152 -179.682 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . 0.452 14.9 m-20 -68.53 -9.44 49.29 Favored 'General case' 0 C--O 1.254 1.311 0 N-CA-C 117.952 2.575 . . . . 0.0 117.952 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.417 ' ND2' ' HG3' ' A' ' 100' ' ' LYS . 19.5 p-10 -145.04 6.48 1.16 Allowed 'General case' 0 N--CA 1.438 -1.071 0 CA-C-O 115.328 -2.272 . . . . 0.0 114.069 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 39.98 40.64 1.76 Allowed Glycine 0 CA--C 1.542 1.773 0 O-C-N 125.285 1.616 . . . . 0.0 114.485 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.417 ' HG3' ' ND2' ' A' ' 98' ' ' ASN . 32.2 mmtm -78.18 -127.32 0.01 OUTLIER 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 114.14 -1.03 . . . . 0.0 109.293 -179.56 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 171.36 97.59 0.01 OUTLIER 'General case' 0 N--CA 1.433 -1.276 0 C-N-CA 130.019 3.327 . . . . 0.0 115.125 -179.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.698 HD13 HD12 ' A' ' 78' ' ' LEU . 0.3 OUTLIER -89.52 121.67 31.96 Favored 'General case' 0 N--CA 1.442 -0.875 2 C-N-CA 132.566 4.347 . . . . 0.0 103.871 178.863 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.885 HG23 ' HB3' ' A' ' 117' ' ' TYR . 4.6 tp -120.21 157.53 22.71 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.742 0 C-N-CA 115.844 -2.343 . . . . 0.0 105.864 179.276 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.536 ' HA ' ' HB2' ' A' ' 117' ' ' TYR . . . -141.33 136.69 31.77 Favored 'General case' 0 C--N 1.313 -1.001 0 O-C-N 118.557 -2.589 . . . . 0.0 108.16 -179.152 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.663 ' HB ' ' CD2' ' A' ' 117' ' ' TYR . 0.5 OUTLIER -125.63 104.56 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 CA-C-N 122.856 2.571 . . . . 0.0 112.837 -179.709 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.641 ' HG2' HH11 ' A' ' 106' ' ' ARG . 4.9 mtt-85 -74.06 94.24 2.37 Favored 'General case' 0 C--N 1.307 -1.275 0 O-C-N 119.729 -1.857 . . . . 0.0 106.831 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -98.53 84.87 3.25 Favored 'General case' 0 N--CA 1.419 -2.002 0 O-C-N 126.058 2.099 . . . . 0.0 114.394 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.803 HD11 ' CH2' ' A' ' 6' ' ' TRP 0.38 0.1 OUTLIER -60.89 101.09 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 C-N-CA 116.403 -2.119 . . . . 0.0 108.503 179.897 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 10.4 p -87.85 70.09 9.52 Favored 'General case' 0 CA--C 1.504 -0.79 0 N-CA-C 104.511 -2.404 . . . . 0.0 104.511 -179.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 76.99 -115.05 4.22 Favored Glycine 0 C--N 1.339 0.734 0 O-C-N 127.601 3.063 . . . . 0.0 111.677 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 48.8 m-20 -69.13 -25.24 64.29 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 120.014 1.907 . . . . 0.0 112.264 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.22 143.77 29.1 Favored 'General case' 0 CA--C 1.494 -1.19 0 CA-C-O 116.295 -1.812 . . . . 0.0 115.523 -179.592 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.543 HD23 ' N ' ' A' ' 114' ' ' ILE . 0.3 OUTLIER -104.79 146.12 29.42 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 100.741 -3.8 . . . . 0.0 100.741 179.979 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.607 HD13 HD12 ' A' ' 127' ' ' ILE 0.284 81.7 mt -149.26 110.74 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.171 0 CA-C-O 117.164 -1.398 . . . . 0.0 109.163 -179.904 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.658 ' HB2' ' HD2' ' A' ' 126' ' ' ARG . 55.3 mt-30 -86.2 167.0 15.28 Favored 'General case' 0 C--N 1.345 0.378 0 N-CA-C 104.035 -2.58 . . . . 0.0 104.035 179.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.475 ' CG2' ' C ' ' A' ' 115' ' ' GLN . 5.0 p -159.75 -152.33 0.3 Allowed 'General case' 0 CA--C 1.494 -1.184 1 O-C-N 130.516 4.885 . . . . 0.0 106.501 -177.198 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.885 ' HB3' HG23 ' A' ' 103' ' ' ILE . 8.7 m-30 76.88 -165.74 0.05 Allowed 'General case' 0 CA--C 1.46 -2.488 1 O-C-N 129.379 4.175 . . . . 0.0 114.309 175.144 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.508 ' O ' ' N ' ' A' ' 103' ' ' ILE . 6.9 t -138.87 -162.37 1.31 Allowed 'General case' 0 N--CA 1.437 -1.11 0 CA-C-O 127.384 3.469 . . . . 0.0 117.116 -174.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.598 ' HA ' ' HG ' ' A' ' 102' ' ' LEU . 1.6 t80 -111.57 -25.79 9.38 Favored 'General case' 0 C--N 1.348 0.525 0 CA-C-N 111.769 -2.469 . . . . 0.0 109.773 178.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.519 ' HB2' ' CD2' ' A' ' 119' ' ' TYR . 0.2 OUTLIER -153.23 -59.83 0.14 Allowed 'General case' 0 C--N 1.29 -2.004 0 C-N-CA 126.498 1.919 . . . . 0.0 110.017 -179.876 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -153.76 1.56 0.23 Allowed Glycine 0 C--N 1.362 1.988 0 N-CA-C 121.178 3.231 . . . . 0.0 121.178 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 37.0 t -110.39 98.91 7.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 O-C-N 117.49 -3.359 . . . . 0.0 104.915 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.413 ' HA ' ' HB ' ' A' ' 118' ' ' THR . 4.8 mp0 -64.87 -175.54 0.2 Allowed 'General case' 0 C--O 1.21 -0.984 0 O-C-N 120.001 -1.687 . . . . 0.0 112.435 -179.641 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.538 ' HA ' ' HB3' ' A' ' 13' ' ' ASN . . . -170.19 -167.83 0.67 Allowed 'General case' 0 C--O 1.21 -0.992 0 CA-C-O 113.872 -2.966 . . . . 0.0 106.991 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.527 ' HB2' ' HB2' ' A' ' 12' ' ' GLU 0.29 0.0 OUTLIER -157.88 143.84 17.32 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 122.775 2.534 . . . . 0.0 111.867 179.901 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.658 ' HD2' ' HB2' ' A' ' 115' ' ' GLN . 0.0 OUTLIER -137.39 78.22 1.68 Allowed 'General case' 0 C--O 1.209 -1.052 0 O-C-N 128.058 3.349 . . . . 0.0 110.573 179.752 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.607 HD12 HD13 ' A' ' 114' ' ' ILE . 1.7 mm -66.44 96.18 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 O-C-N 125.311 1.632 . . . . 0.0 114.422 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.776 ' CE1' HD22 ' A' ' 36' ' ' LEU . 26.5 m-85 -84.49 137.69 33.21 Favored 'General case' 0 C--O 1.219 -0.503 0 C-N-CA 126.524 1.93 . . . . 0.0 106.709 179.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 10.0 mmtt -101.12 41.24 1.2 Allowed 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 115.455 -2.212 . . . . 0.0 112.465 -179.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.533 ' HA ' ' HA ' ' A' ' 6' ' ' TRP . 3.2 tttm 27.36 98.22 0.0 OUTLIER 'General case' 0 C--O 1.238 0.491 0 C-N-CA 127.462 2.305 . . . . 0.0 116.401 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.435 ' HA ' HG23 ' A' ' 5' ' ' THR 0.858 2.6 tm-20 . . . . . 0 N--CA 1.439 -1.022 0 O-C-N 117.912 -2.992 . . . . 0.0 116.892 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' PLM . . . . . 0.584 ' C9 ' HD22 ' A' ' 72' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.516 -0.34 0 CA-C-O 117.061 -1.447 . . . . 0.0 112.617 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.583 ' CZ ' HG13 ' A' ' 108' ' ' ILE . 96.6 m-85 57.33 38.02 28.34 Favored 'General case' 0 CA--C 1.508 -0.659 0 C-N-CA 116.393 -2.123 . . . . 0.0 116.128 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -156.27 90.72 1.21 Allowed 'General case' 0 N--CA 1.436 -1.132 0 CA-C-N 113.66 -1.609 . . . . 0.0 113.205 179.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 155.98 -148.19 17.91 Favored Glycine 0 N--CA 1.432 -1.589 0 C-N-CA 114.992 -3.48 . . . . 0.0 114.395 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.598 HG23 HG23 ' A' ' 39' ' ' THR 0.576 32.9 p -103.76 150.35 24.16 Favored 'General case' 0 C--N 1.311 -1.088 0 O-C-N 126.935 2.197 . . . . 0.0 114.182 179.967 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.578 ' CZ2' HD11 ' A' ' 108' ' ' ILE . 93.7 m95 -148.11 141.21 24.97 Favored 'General case' 0 N--CA 1.431 -1.405 0 O-C-N 126.346 2.279 . . . . 0.0 106.087 179.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 18.3 tttt -141.47 93.54 2.58 Favored 'General case' 0 C--O 1.204 -1.32 0 CA-C-O 116.778 -1.582 . . . . 0.0 107.257 179.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.482 ' CG1' ' HB3' ' A' ' 36' ' ' LEU 0.32 1.5 p -43.78 136.9 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-O 117.127 -1.416 . . . . 0.0 113.341 -179.96 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -126.15 -18.45 4.99 Favored 'General case' 0 CA--C 1.503 -0.853 0 O-C-N 124.671 1.232 . . . . 0.0 111.321 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.02 145.65 15.4 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 119.753 -1.842 . . . . 0.0 106.496 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . 0.298 0.2 OUTLIER -109.09 -169.83 1.55 Allowed 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 112.452 -2.158 . . . . 0.0 109.54 179.715 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -176.87 90.35 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.464 ' HB3' ' HA ' ' A' ' 124' ' ' ALA . 0.2 OUTLIER 100.7 -7.39 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 125.132 1.373 . . . . 0.0 112.229 -179.575 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.566 ' CD2' ' CG ' ' A' ' 126' ' ' ARG 0.252 0.2 OUTLIER -69.96 -38.67 76.17 Favored 'General case' 0 C--O 1.222 -0.386 0 O-C-N 128.314 3.509 . . . . 0.0 114.185 179.584 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.52 -29.24 68.98 Favored 'General case' 0 CA--C 1.509 -0.602 0 CA-C-N 121.539 1.972 . . . . 0.0 113.043 179.696 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.9 -37.42 34.77 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 113.504 -1.68 . . . . 0.0 110.391 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.545 ' CD2' ' CE1' ' A' ' 14' ' ' TYR . 0.9 OUTLIER -70.73 -28.62 64.86 Favored 'General case' 0 C--O 1.244 0.765 0 CA-C-O 124.765 2.222 . . . . 0.0 111.747 -179.981 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.409 ' CB ' HG13 ' A' ' 23' ' ' ILE . 32.1 mtt -72.15 -26.04 61.95 Favored 'General case' 0 C--N 1.324 -0.521 1 O-C-N 115.36 -4.588 . . . . 0.0 108.466 -179.686 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -79.68 -24.16 41.96 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 116.138 -2.225 . . . . 0.0 111.937 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 12.4 tptp -79.19 -30.53 43.43 Favored 'General case' 0 C--N 1.31 -1.145 0 O-C-N 120.68 -1.262 . . . . 0.0 109.379 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.545 ' CE ' ' CD1' ' A' ' 119' ' ' TYR 0.304 0.7 OUTLIER -78.41 -23.49 46.68 Favored 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 179.783 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 88.33 56.87 1.96 Allowed Glycine 0 C--N 1.307 -1.049 0 CA-C-O 116.301 -2.389 . . . . 0.0 108.793 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.475 HG21 ' HA ' ' A' ' 28' ' ' ARG . 1.6 mm -81.26 -34.17 13.22 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 CA-C-O 115.081 -2.39 . . . . 0.0 111.719 -179.68 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 89.61 98.64 0.02 OUTLIER 'General case' 0 C--N 1.346 0.426 0 O-C-N 125.877 1.985 . . . . 0.0 113.431 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.471 HG13 HG22 ' A' ' 26' ' ' VAL 0.475 4.1 p 12.86 -62.08 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.349 0.577 0 N-CA-C 119.292 3.071 . . . . 0.0 119.292 179.974 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.471 HG22 HG13 ' A' ' 25' ' ' VAL 0.605 0.0 OUTLIER -72.07 -42.08 67.7 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.876 0 N-CA-C 118.212 2.671 . . . . 0.0 118.212 -179.465 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.4 mtpp -64.4 -24.59 67.69 Favored 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 114.787 1.403 . . . . 0.0 114.787 -179.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.475 ' HA ' HG21 ' A' ' 23' ' ' ILE . 5.0 ptt85 -79.8 -25.68 40.8 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 119.207 -2.183 . . . . 0.0 108.239 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 8.8 tttt -73.99 -46.39 44.08 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.609 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.1 mp -72.81 -31.96 65.19 Favored 'General case' 0 N--CA 1.438 -1.058 0 O-C-N 124.872 1.358 . . . . 0.0 107.387 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -74.95 -34.49 52.65 Favored Glycine 0 C--N 1.346 1.102 0 O-C-N 124.576 1.172 . . . . 0.0 111.779 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -73.35 -26.71 61.13 Favored 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 114.476 1.288 . . . . 0.0 114.476 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -124.8 57.83 1.26 Allowed 'General case' 0 C--N 1.348 0.502 0 O-C-N 127.343 2.902 . . . . 0.0 111.175 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -90.78 -17.82 25.99 Favored 'General case' 0 C--O 1.211 -0.948 0 N-CA-C 118.511 2.782 . . . . 0.0 118.511 -179.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 10.3 t30 75.32 27.12 1.11 Allowed 'General case' 0 C--O 1.24 0.6 0 C-N-CA 117.992 -1.483 . . . . 0.0 110.092 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.522 HD11 ' CD1' ' A' ' 38' ' ' LEU . 13.8 tp -52.77 106.54 0.16 Allowed 'General case' 0 C--O 1.216 -0.682 0 C-N-CA 126.542 1.937 . . . . 0.0 107.587 179.676 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 6.1 ttpt -104.58 103.91 13.65 Favored 'General case' 0 C--N 1.309 -1.183 0 O-C-N 127.086 2.741 . . . . 0.0 104.156 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.522 ' CD1' HD11 ' A' ' 36' ' ' LEU 0.271 1.0 OUTLIER -88.2 117.11 26.87 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 179.434 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.598 HG23 HG23 ' A' ' 5' ' ' THR . 31.3 m -108.81 98.46 7.95 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 104.118 -2.549 . . . . 0.0 104.118 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.478 HG13 ' CG2' ' A' ' 49' ' ' VAL . 29.0 mt -81.38 142.33 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.38 0 O-C-N 126.143 2.152 . . . . 0.0 109.213 -179.717 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.448 HG22 ' O ' ' A' ' 41' ' ' THR . 20.9 m -145.33 83.14 1.66 Allowed 'General case' 0 CA--C 1.508 -0.639 0 O-C-N 128.091 3.369 . . . . 0.0 109.247 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.479 ' NE2' ' CE2' ' A' ' 47' ' ' PHE . 4.1 tt0 -82.85 132.18 35.17 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 114.375 -1.284 . . . . 0.0 108.312 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -117.67 67.53 0.75 Allowed 'General case' 0 CA--C 1.485 -1.527 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.91 -86.38 1.52 Allowed Glycine 0 N--CA 1.429 -1.82 0 N-CA-C 106.417 -2.673 . . . . 0.0 106.417 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.288 0.0 OUTLIER -111.08 -40.32 4.51 Favored 'General case' 0 N--CA 1.451 -0.417 0 O-C-N 125.541 1.377 . . . . 0.0 113.167 -179.912 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.45 ' HG3' ' HG3' ' A' ' 63' ' ' GLU . 5.3 ttmm -62.2 148.87 43.3 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.596 ' HB3' ' CE1' ' A' ' 62' ' ' PHE 0.306 1.7 m-85 -137.08 105.56 5.79 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 114.98 -1.009 . . . . 0.0 109.196 179.962 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.812 ' HB ' HG12 ' A' ' 61' ' ' VAL 0.423 9.5 t -99.38 126.05 45.18 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 105.712 -1.959 . . . . 0.0 105.712 179.43 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.498 ' HB ' ' CE2' ' A' ' 62' ' ' PHE 0.671 0.6 OUTLIER -107.23 115.89 49.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 O-C-N 126.801 2.563 . . . . 0.0 113.303 -179.84 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.546 ' CB ' ' HB ' ' A' ' 39' ' ' THR . 7.3 tttt -78.63 100.37 6.97 Favored 'General case' 0 C--N 1.307 -1.267 1 N-CA-C 100.182 -4.006 . . . . 0.0 100.182 179.909 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 55.4 tt0 -95.64 63.75 2.47 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 102.446 -3.168 . . . . 0.0 102.446 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 11.0 m -74.92 60.27 0.96 Allowed 'General case' 0 C--N 1.289 -2.025 0 O-C-N 125.763 1.914 . . . . 0.0 106.725 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -82.13 179.36 7.84 Favored 'General case' 0 C--O 1.209 -1.073 0 C-N-CA 117.215 -1.794 . . . . 0.0 109.778 179.696 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -63.39 -30.43 71.56 Favored 'General case' 0 C--O 1.214 -0.789 0 O-C-N 125.329 1.643 . . . . 0.0 107.867 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 -68.16 -65.26 0.72 Allowed 'General case' 0 C--O 1.218 -0.6 0 C-N-CA 115.064 -2.654 . . . . 0.0 109.245 179.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.903 ' HB2' HG22 ' A' ' 58' ' ' ILE . 7.9 mtm-85 -139.81 170.88 15.07 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 123.98 3.082 . . . . 0.0 110.733 179.45 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -116.87 70.71 0.78 Allowed 'General case' 0 C--O 1.217 -0.636 1 N-CA-C 100.083 -4.043 . . . . 0.0 100.083 179.573 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.903 HG22 ' HB2' ' A' ' 56' ' ' ARG . 0.5 OUTLIER -107.05 91.41 1.76 Allowed 'Isoleucine or valine' 0 CA--C 1.561 1.382 0 C-N-CA 130.312 3.445 . . . . 0.0 117.432 -179.336 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -60.95 116.53 4.55 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 104.768 -2.308 . . . . 0.0 104.768 179.052 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.522 HG13 ' O ' ' A' ' 60' ' ' VAL . 13.3 p -104.0 105.75 19.02 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 O-C-N 124.64 1.212 . . . . 0.0 112.73 -178.132 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.812 HG12 ' HB ' ' A' ' 48' ' ' THR 0.412 0.6 OUTLIER -82.44 152.3 4.05 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 O-C-N 118.676 -2.515 . . . . 0.0 109.317 179.797 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.641 ' CE1' ' CZ2' ' A' ' 82' ' ' TRP . 16.4 p90 -162.45 95.39 0.92 Allowed 'General case' 0 N--CA 1.445 -0.722 0 O-C-N 120.55 -1.344 . . . . 0.0 108.991 179.694 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.52 ' OE1' HG11 ' A' ' 66' ' ' VAL . 1.8 mt-10 -65.96 128.95 38.08 Favored 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 104.053 -2.573 . . . . 0.0 104.053 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.449 HD21 ' CE2' ' A' ' 47' ' ' PHE . 0.4 OUTLIER -61.67 121.02 11.77 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-O 122.984 1.373 . . . . 0.0 110.857 -179.898 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 71.09 25.55 75.47 Favored Glycine 0 N--CA 1.471 0.981 0 N-CA-C 117.525 1.77 . . . . 0.0 117.525 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.52 HG11 ' OE1' ' A' ' 63' ' ' GLU 0.409 78.3 t -102.99 -21.0 5.4 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 CA-C-O 116.958 -1.496 . . . . 0.0 108.049 179.712 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.69 ' HA ' HG22 ' A' ' 81' ' ' THR 0.253 1.4 m-20 77.41 145.02 0.08 Allowed 'General case' 0 C--N 1.307 -1.279 0 O-C-N 126.081 2.113 . . . . 0.0 113.044 179.896 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.525 ' CZ ' ' HB3' ' A' ' 62' ' ' PHE . 0.1 OUTLIER -167.25 177.0 6.37 Favored 'General case' 0 N--CA 1.419 -2.02 0 CA-C-N 119.691 1.132 . . . . 0.0 108.189 179.874 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -128.79 132.04 47.84 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 117.41 -1.281 . . . . 0.0 109.717 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 16.2 t80 -125.77 111.52 14.98 Favored 'General case' 0 N--CA 1.435 -1.206 0 O-C-N 125.46 1.725 . . . . 0.0 114.231 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.1 m -73.74 145.13 45.36 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 123.089 2.677 . . . . 0.0 106.699 179.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.688 HD21 HD13 ' A' ' 78' ' ' LEU . 1.1 mt -107.43 -171.48 1.88 Allowed 'General case' 0 CA--C 1.495 -1.155 0 N-CA-C 106.072 -1.825 . . . . 0.0 106.072 -179.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -109.31 11.97 25.01 Favored 'General case' 0 C--O 1.235 0.336 0 O-C-N 126.64 2.463 . . . . 0.0 114.822 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.507 ' OD2' ' HG3' ' A' ' 132' ' ' PLM . 3.5 p30 -132.12 -38.59 1.09 Allowed 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 113.499 0.926 . . . . 0.0 113.499 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -130.11 -4.7 4.51 Favored Glycine 0 CA--C 1.538 1.518 0 N-CA-C 117.252 1.661 . . . . 0.0 117.252 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . 0.363 0.0 OUTLIER 67.5 171.24 0.27 Allowed 'General case' 0 N--CA 1.441 -0.879 0 C-N-CA 116.793 -1.963 . . . . 0.0 113.35 179.953 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.446 ' HB2' HG22 ' A' ' 96' ' ' VAL . 9.7 mt-10 12.02 111.37 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.891 1 O-C-N 130.192 4.682 . . . . 0.0 115.085 179.626 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.688 HD13 HD21 ' A' ' 72' ' ' LEU 0.406 0.7 OUTLIER -145.7 104.81 3.91 Favored 'General case' 0 C--O 1.219 -0.547 0 N-CA-C 101.863 -3.384 . . . . 0.0 101.863 179.939 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 24.1 m -106.27 170.79 7.71 Favored 'General case' 0 CA--C 1.483 -1.597 0 CA-C-N 113.658 -1.61 . . . . 0.0 106.691 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 154.27 -171.45 32.82 Favored Glycine 0 N--CA 1.441 -0.98 0 C-N-CA 117.03 -2.509 . . . . 0.0 111.837 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.69 HG22 ' HA ' ' A' ' 67' ' ' ASP . 44.1 p -144.1 160.89 40.13 Favored 'General case' 0 C--O 1.199 -1.584 0 C-N-CA 117.701 -1.6 . . . . 0.0 109.899 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . 0.641 ' CZ2' ' CE1' ' A' ' 62' ' ' PHE . 10.5 m0 -101.94 156.51 17.49 Favored 'General case' 0 N--CA 1.426 -1.648 0 N-CA-C 102.055 -3.313 . . . . 0.0 102.055 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 3.2 t -150.42 124.18 9.19 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 117.751 -1.58 . . . . 0.0 106.932 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.472 ' HA ' HD23 ' A' ' 89' ' ' LEU . 0.3 OUTLIER -84.32 111.68 19.63 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 112.714 -2.039 . . . . 0.0 111.733 -179.911 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.478 ' HG3' ' CG2' ' A' ' 90' ' ' VAL 0.573 5.0 mt-10 -67.95 -49.69 60.29 Favored 'General case' 0 N--CA 1.421 -1.905 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -179.755 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 161.55 -61.2 0.29 Allowed Glycine 0 C--O 1.216 -1.028 0 N-CA-C 103.283 -3.927 . . . . 0.0 103.283 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -110.04 8.04 23.85 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 125.66 1.447 . . . . 0.0 113.675 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . 0.317 0.0 OUTLIER -156.87 126.73 6.29 Favored 'General case' 0 CA--C 1.503 -0.864 0 O-C-N 126.551 2.407 . . . . 0.0 107.571 179.953 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.513 HD13 ' CE3' ' A' ' 82' ' ' TRP . 1.2 mt -83.6 147.8 27.52 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 111.329 -2.669 . . . . 0.0 103.953 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.478 ' CG2' ' HG3' ' A' ' 85' ' ' GLU . 0.2 OUTLIER -137.35 133.54 46.6 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.889 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 -179.994 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -111.56 103.6 1.57 Allowed Glycine 0 CA--C 1.528 0.9 0 C-N-CA 125.649 1.595 . . . . 0.0 113.35 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 37.8 mtpt -98.65 118.57 35.66 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 102.935 -2.987 . . . . 0.0 102.935 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.483 ' CZ ' ' H52' ' A' ' 132' ' ' PLM . 15.6 m-85 -122.9 115.23 21.59 Favored 'General case' 0 CA--C 1.501 -0.916 0 O-C-N 126.416 2.322 . . . . 0.0 111.521 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 19.9 mttp -98.47 140.45 32.7 Favored 'General case' 0 CA--C 1.505 -0.762 0 CA-C-O 125.192 2.425 . . . . 0.0 108.434 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . 0.407 15.3 ttt180 -97.15 129.74 44.49 Favored 'General case' 0 CA--C 1.487 -1.475 0 CA-C-O 124.031 1.872 . . . . 0.0 106.102 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.501 HG23 ' N ' ' A' ' 97' ' ' ASP . 14.7 m -69.77 -34.73 62.04 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.934 0 CA-C-O 125.551 2.596 . . . . 0.0 114.675 -179.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.501 ' N ' HG23 ' A' ' 96' ' ' VAL 0.401 0.9 OUTLIER -63.75 -8.36 10.3 Favored 'General case' 0 C--O 1.255 1.39 0 CA-C-N 113.936 -1.484 . . . . 0.0 114.377 179.814 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.468 ' ND2' ' HG2' ' A' ' 100' ' ' LYS . 13.3 p-10 -150.54 1.77 0.45 Allowed 'General case' 0 N--CA 1.433 -1.302 0 C-N-CA 116.196 -2.202 . . . . 0.0 116.732 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 65.83 21.94 69.79 Favored Glycine 0 CA--C 1.542 1.774 0 N-CA-C 115.673 1.029 . . . . 0.0 115.673 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.468 ' HG2' ' ND2' ' A' ' 98' ' ' ASN . 49.0 mmtt -89.68 -178.82 5.63 Favored 'General case' 0 C--O 1.202 -1.417 0 C-N-CA 119.823 -0.751 . . . . 0.0 112.802 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -143.48 119.42 10.63 Favored 'General case' 0 C--O 1.212 -0.885 0 C-N-CA 128.264 2.626 . . . . 0.0 113.866 179.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.64 ' HG ' ' HA ' ' A' ' 119' ' ' TYR . 5.5 tt -98.37 133.76 42.32 Favored 'General case' 0 N--CA 1.44 -0.972 1 C-N-CA 135.337 5.455 . . . . 0.0 106.211 -179.679 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.618 HG23 ' HB3' ' A' ' 117' ' ' TYR . 7.1 tt -122.55 159.29 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.702 0 C-N-CA 115.855 -2.338 . . . . 0.0 104.726 179.489 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -156.39 145.54 20.49 Favored 'General case' 0 C--N 1.315 -0.902 0 O-C-N 118.844 -2.41 . . . . 0.0 107.542 -179.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.684 HG13 ' HG2' ' A' ' 107' ' ' GLU . 6.4 p -131.66 115.12 26.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-O 126.078 2.847 . . . . 0.0 110.287 -179.527 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.586 ' CZ ' ' CH2' ' A' ' 82' ' ' TRP . 2.3 mtt-85 -76.44 90.48 3.26 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 112.299 -2.228 . . . . 0.0 105.462 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.684 ' HG2' HG13 ' A' ' 105' ' ' VAL . 1.2 mt-10 -86.66 77.62 9.31 Favored 'General case' 0 N--CA 1.419 -2.015 0 CA-C-N 109.985 -3.28 . . . . 0.0 114.928 -179.682 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.583 HG13 ' CZ ' ' A' ' 2' ' ' PHE 0.257 0.6 OUTLIER -54.94 90.75 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 CA-C-O 122.931 1.348 . . . . 0.0 111.417 179.264 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.459 ' N ' ' O ' ' A' ' 107' ' ' GLU . 23.9 m -80.97 66.99 6.71 Favored 'General case' 0 N--CA 1.432 -1.339 0 N-CA-C 103.822 -2.659 . . . . 0.0 103.822 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 52.7 -90.97 0.01 OUTLIER Glycine 0 N--CA 1.463 0.493 1 O-C-N 129.191 4.057 . . . . 0.0 111.113 -179.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . 0.322 4.5 m120 -82.29 -25.89 33.6 Favored 'General case' 0 C--N 1.309 -1.196 0 CA-C-O 115.935 -1.983 . . . . 0.0 110.675 179.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -110.28 125.63 53.33 Favored 'General case' 0 C--O 1.205 -1.256 0 N-CA-C 115.878 1.807 . . . . 0.0 115.878 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.456 HD21 ' HB3' ' A' ' 106' ' ' ARG . 0.0 OUTLIER -87.04 143.6 27.26 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 100.633 -3.84 . . . . 0.0 100.633 179.983 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.8 HG23 HD13 ' A' ' 127' ' ' ILE 0.312 0.6 OUTLIER -142.13 136.57 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.585 0 N-CA-C 105.067 -2.197 . . . . 0.0 105.067 179.989 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.439 HE21 ' HE1' ' A' ' 128' ' ' PHE . 49.6 mt-30 -109.54 123.24 49.08 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 100.926 -3.731 . . . . 0.0 100.926 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.52 HG23 ' HG3' ' A' ' 107' ' ' GLU . 0.1 OUTLIER -135.39 147.73 49.12 Favored 'General case' 0 N--CA 1.417 -2.11 0 C-N-CA 118.091 -1.443 . . . . 0.0 111.829 -179.12 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.618 ' HB3' HG23 ' A' ' 103' ' ' ILE 0.352 18.5 m-85 127.81 -144.95 0.0 OUTLIER 'General case' 0 CA--C 1.471 -2.08 1 O-C-N 131.892 5.745 . . . . 0.0 113.945 177.656 . . . . . . . . 4 3 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.528 ' O ' ' N ' ' A' ' 103' ' ' ILE . 7.9 t -150.13 -159.84 1.09 Allowed 'General case' 0 N--CA 1.437 -1.086 0 CA-C-O 125.825 2.726 . . . . 0.0 116.789 -174.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.64 ' HA ' ' HG ' ' A' ' 102' ' ' LEU 0.25 38.1 t80 -108.5 -31.55 7.75 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 112.436 -2.165 . . . . 0.0 108.791 177.428 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -148.16 -70.91 0.22 Allowed 'General case' 0 C--N 1.291 -1.955 0 C-N-CA 126.862 2.065 . . . . 0.0 109.605 179.112 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -147.3 18.55 1.52 Allowed Glycine 0 C--N 1.351 1.388 0 N-CA-C 120.887 3.115 . . . . 0.0 120.887 -179.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 50.7 t -117.24 93.08 2.35 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 N-CA-C 103.547 -2.76 . . . . 0.0 103.547 179.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.456 ' HA ' ' O ' ' A' ' 117' ' ' TYR . 6.6 mt-10 -57.99 178.82 0.08 Allowed 'General case' 0 CA--C 1.513 -0.467 0 CA-C-O 124.021 1.867 . . . . 0.0 112.368 -178.191 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.536 ' HB1' ' HA ' ' A' ' 14' ' ' TYR . . . -172.58 104.26 0.15 Allowed 'General case' 0 N--CA 1.436 -1.138 0 O-C-N 116.535 -3.853 . . . . 0.0 109.453 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.27 141.33 33.03 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 119.804 1.184 . . . . 0.0 108.997 179.49 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.566 ' CG ' ' CD2' ' A' ' 14' ' ' TYR . 3.8 mtp180 -129.13 79.21 1.9 Allowed 'General case' 0 C--O 1.214 -0.798 0 CA-C-O 116.126 -1.892 . . . . 0.0 110.509 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.8 HD13 HG23 ' A' ' 114' ' ' ILE . 3.8 mm -65.29 118.23 7.38 Favored 'Isoleucine or valine' 0 C--O 1.256 1.429 1 O-C-N 130.35 4.781 . . . . 0.0 115.201 179.64 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.479 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 80.6 m-85 -104.67 137.46 42.46 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 126.362 1.865 . . . . 0.0 108.072 -179.616 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . 0.363 0.6 OUTLIER -108.93 42.57 1.39 Allowed 'General case' 0 N--CA 1.439 -1.025 0 CA-C-O 116.475 -1.726 . . . . 0.0 111.47 -179.964 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.514 ' HA ' ' CE3' ' A' ' 6' ' ' TRP . 0.0 OUTLIER 21.63 101.16 0.0 OUTLIER 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 128.404 2.682 . . . . 0.0 116.472 -179.904 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . 0.934 16.5 tt0 . . . . . 0 C--N 1.32 -0.697 0 N-CA-C 115.882 1.808 . . . . 0.0 115.882 179.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' PLM . . . . . 0.507 ' HG3' ' OD2' ' A' ' 74' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.214 -0.773 0 CA-C-O 118.26 -0.876 . . . . 0.0 110.214 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.554 ' CE1' HG13 ' A' ' 108' ' ' ILE . 2.5 m-85 69.24 -74.46 0.08 Allowed 'General case' 0 N--CA 1.434 -1.255 0 C-N-CA 117.629 -1.628 . . . . 0.0 113.247 179.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -49.53 95.11 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.362 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 155.33 178.98 30.12 Favored Glycine 0 N--CA 1.441 -0.982 0 C-N-CA 118.024 -2.036 . . . . 0.0 112.324 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . 0.531 1.3 p -86.1 147.93 25.93 Favored 'General case' 0 C--N 1.312 -1.041 0 C-N-CA 124.82 1.248 . . . . 0.0 108.46 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.524 ' CH2' ' HD2' ' A' ' 130' ' ' LYS . 74.9 m95 -143.29 140.24 30.52 Favored 'General case' 0 CA--C 1.504 -0.804 0 CA-C-O 115.202 -2.332 . . . . 0.0 105.961 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 18.5 tttt -144.34 92.77 2.35 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 114.398 -2.715 . . . . 0.0 105.838 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.532 ' HB ' ' CD1' ' A' ' 128' ' ' PHE 0.258 7.4 p -34.38 128.13 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.16 0 CA-C-O 116.426 -1.749 . . . . 0.0 113.054 -179.998 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -126.35 -22.8 3.94 Favored 'General case' 0 N--CA 1.451 -0.406 0 O-C-N 125.922 2.014 . . . . 0.0 111.335 -179.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.427 ' HD2' ' HE3' ' A' ' 129' ' ' LYS . 0.0 OUTLIER -141.36 63.7 1.43 Allowed 'General case' 0 CA--C 1.49 -1.362 0 C-N-CA 118.758 -1.177 . . . . 0.0 113.409 -179.78 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . 0.473 16.4 m-20 -48.23 156.27 0.41 Allowed 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 124.023 0.929 . . . . 0.0 108.733 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.44 ' HB2' ' HB2' ' A' ' 125' ' ' LYS . 11.6 mt-10 -143.76 136.94 27.71 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-O 115.77 -2.062 . . . . 0.0 107.294 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.418 ' HB3' ' HA ' ' A' ' 124' ' ' ALA . 1.0 OUTLIER 53.76 20.7 2.36 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 122.127 2.239 . . . . 0.0 113.238 -179.691 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.547 ' HA ' ' HB1' ' A' ' 124' ' ' ALA 0.261 4.3 t80 -79.81 -35.81 37.88 Favored 'General case' 0 N--CA 1.442 -0.873 0 O-C-N 126.592 2.433 . . . . 0.0 114.858 179.529 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -77.37 -24.14 50.67 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 116.849 -1.548 . . . . 0.0 108.886 -179.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 8.3 ttmm -78.52 -29.41 46.51 Favored 'General case' 0 N--CA 1.431 -1.387 0 O-C-N 126.012 2.07 . . . . 0.0 111.669 179.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.491 ' CB ' ' HB2' ' A' ' 124' ' ' ALA . 0.2 OUTLIER -69.25 -34.98 75.64 Favored 'General case' 0 N--CA 1.429 -1.516 0 O-C-N 120.384 -1.448 . . . . 0.0 112.065 179.914 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 10.8 mtt -75.76 -26.49 57.44 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-O 124.903 2.287 . . . . 0.0 109.232 -179.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -79.61 -25.34 41.51 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 124.682 2.182 . . . . 0.0 112.347 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.555 ' HE3' ' CG ' ' A' ' 119' ' ' TYR . 3.5 tmtm? -70.61 -30.52 67.2 Favored 'General case' 0 C--O 1.209 -1.063 0 O-C-N 118.23 -2.794 . . . . 0.0 112.864 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -79.95 -33.86 39.28 Favored 'General case' 0 C--O 1.215 -0.745 0 O-C-N 126.132 2.145 . . . . 0.0 108.86 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 108.07 37.53 2.15 Favored Glycine 0 C--N 1.306 -1.1 0 CA-C-O 116.051 -2.527 . . . . 0.0 111.862 -179.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.402 ' CD1' ' HG3' ' A' ' 132' ' ' PLM . 1.5 mm -70.31 84.68 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.909 0 CA-C-O 113.253 -3.26 . . . . 0.0 105.033 179.732 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 10.9 m-20 -3.29 -90.07 0.0 OUTLIER 'General case' 0 C--O 1.247 0.933 0 O-C-N 128.484 3.615 . . . . 0.0 115.24 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . 0.359 20.3 m -155.86 -49.98 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.221 -0.419 0 N-CA-C 117.416 2.376 . . . . 0.0 117.416 179.716 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.569 14.4 m -76.4 -23.01 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.277 0 N-CA-C 116.837 2.162 . . . . 0.0 116.837 179.633 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.9 mtpt -74.98 -25.55 58.93 Favored 'General case' 0 N--CA 1.437 -1.1 0 O-C-N 127.253 2.845 . . . . 0.0 113.175 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.37 -22.22 44.69 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 118.317 -1.353 . . . . 0.0 108.784 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.7 ttpt -65.27 -50.35 66.1 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 122.251 1.024 . . . . 0.0 112.551 -179.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.453 ' HA ' HD12 ' A' ' 30' ' ' LEU . 0.7 OUTLIER -76.01 -24.45 55.26 Favored 'General case' 0 C--O 1.214 -0.775 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 179.745 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -76.32 -31.56 54.38 Favored Glycine 0 N--CA 1.441 -1.021 0 O-C-N 128.643 3.714 . . . . 0.0 109.832 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -76.94 -38.99 52.27 Favored 'General case' 0 C--O 1.242 0.692 0 O-C-N 125.379 1.281 . . . . 0.0 111.026 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -108.07 47.54 0.89 Allowed 'General case' 0 N--CA 1.433 -1.277 0 CA-C-O 116.646 -1.645 . . . . 0.0 111.077 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -70.12 -37.23 75.27 Favored 'General case' 0 CA--C 1.495 -1.162 0 N-CA-C 118.63 2.826 . . . . 0.0 118.63 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . 0.262 0.1 OUTLIER 81.86 28.77 0.15 Allowed 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 117.709 -1.138 . . . . 0.0 110.629 -179.999 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 1.018 HD21 HD13 ' A' ' 38' ' ' LEU . 0.5 OUTLIER -48.41 94.74 0.01 OUTLIER 'General case' 0 CA--C 1.507 -0.693 0 C-N-CA 125.05 1.34 . . . . 0.0 108.51 -179.866 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 10.3 tttt -96.92 101.94 13.63 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 102.555 -3.128 . . . . 0.0 102.555 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 1.018 HD13 HD21 ' A' ' 36' ' ' LEU 0.322 2.1 tp -87.33 130.56 34.58 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 119.86 1.209 . . . . 0.0 110.157 -179.915 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.523 ' HB ' ' CB ' ' A' ' 50' ' ' LYS . 69.3 m -119.25 98.66 6.27 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 102.451 -3.166 . . . . 0.0 102.451 179.607 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 1.084 HG23 HG12 ' A' ' 49' ' ' VAL . 1.1 mt -91.42 141.01 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.368 0 CA-C-O 123.661 1.696 . . . . 0.0 111.121 179.595 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.507 HG22 ' O ' ' A' ' 41' ' ' THR . 3.2 m -133.46 93.02 3.07 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 111.04 -2.8 . . . . 0.0 108.45 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -80.31 100.99 8.66 Favored 'General case' 0 C--O 1.218 -0.588 0 O-C-N 125.723 1.89 . . . . 0.0 110.635 179.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -103.48 67.2 0.9 Allowed 'General case' 0 N--CA 1.436 -1.159 0 CA-C-O 125.635 2.636 . . . . 0.0 108.559 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 90.01 -101.03 2.73 Favored Glycine 0 C--N 1.302 -1.353 0 N-CA-C 108.107 -1.997 . . . . 0.0 108.107 179.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.314 83.5 m-20 -111.52 -13.04 13.89 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 128.321 3.012 . . . . 0.0 111.041 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.478 ' HA ' ' HA ' ' A' ' 63' ' ' GLU . 10.8 tttt -82.27 143.91 31.0 Favored 'General case' 0 C--N 1.31 -1.123 0 O-C-N 118.363 -2.711 . . . . 0.0 108.071 179.714 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.714 ' CE1' HD21 ' A' ' 64' ' ' LEU . 18.3 m-85 -122.52 86.59 2.61 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 113.845 -1.525 . . . . 0.0 110.982 179.693 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.761 ' OG1' HG12 ' A' ' 61' ' ' VAL 0.336 9.5 t -91.76 104.28 16.75 Favored 'General case' 0 C--N 1.316 -0.882 0 O-C-N 126.796 2.56 . . . . 0.0 106.321 179.914 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 1.084 HG12 HG23 ' A' ' 40' ' ' ILE 0.702 0.7 OUTLIER -100.62 116.76 44.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 126.965 2.665 . . . . 0.0 116.401 -179.685 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.523 ' CB ' ' HB ' ' A' ' 39' ' ' THR . 26.7 tttp -62.81 149.57 43.81 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 101.018 -3.697 . . . . 0.0 101.018 179.279 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.41 ' O ' ' N ' ' A' ' 53' ' ' SER . 49.4 tt0 -137.21 64.26 1.54 Allowed 'General case' 0 CA--C 1.511 -0.531 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 -179.487 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . 0.256 5.6 m -74.88 73.97 2.13 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 105.16 -2.163 . . . . 0.0 105.16 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.545 ' HB2' HD12 ' A' ' 36' ' ' LEU . 33.1 t -102.82 25.35 9.38 Favored 'General case' 0 CA--C 1.506 -0.715 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 -179.782 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.513 ' ND2' ' N ' ' A' ' 55' ' ' PHE . 0.0 OUTLIER 78.31 -48.23 0.46 Allowed 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 115.272 -2.299 . . . . 0.0 108.988 179.857 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.534 ' CZ ' ' HF2' ' A' ' 132' ' ' PLM . 96.9 m-85 -58.86 -45.1 90.94 Favored 'General case' 0 C--O 1.213 -0.849 0 C-N-CA 117.428 -1.709 . . . . 0.0 110.373 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.415 ' NE ' ' HB ' ' A' ' 58' ' ' ILE . 49.0 ttt180 -168.92 144.39 3.33 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 105.668 -1.975 . . . . 0.0 105.668 179.21 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 26.8 t30 -93.1 78.21 4.6 Favored 'General case' 0 C--N 1.35 0.621 0 N-CA-C 101.642 -3.466 . . . . 0.0 101.642 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.415 ' HB ' ' NE ' ' A' ' 56' ' ' ARG . 3.0 tt -110.3 110.12 30.98 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.338 1 O-C-N 130.01 4.569 . . . . 0.0 117.728 -179.549 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -63.02 135.11 57.09 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 103.89 -2.633 . . . . 0.0 103.89 177.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.811 HG11 ' H21' ' A' ' 132' ' ' PLM . 10.1 t -107.41 92.37 2.06 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 -178.18 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.761 HG12 ' OG1' ' A' ' 48' ' ' THR 0.358 0.7 OUTLIER -90.81 135.24 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.151 0 O-C-N 118.681 -2.512 . . . . 0.0 111.951 -179.761 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.614 ' CD2' HG12 ' A' ' 60' ' ' VAL . 24.4 p90 -166.05 97.25 0.62 Allowed 'General case' 0 C--N 1.314 -0.943 0 C-N-CA 118.151 -1.42 . . . . 0.0 110.296 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.478 ' HA ' ' HA ' ' A' ' 46' ' ' LYS . 1.0 OUTLIER -56.03 147.85 18.98 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 179.88 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.714 HD21 ' CE1' ' A' ' 47' ' ' PHE . 0.3 OUTLIER -62.55 99.4 0.15 Allowed 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 179.73 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 98.7 34.46 5.23 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 119.321 2.489 . . . . 0.0 119.321 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . 0.433 34.8 m -114.3 77.67 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 N-CA-C 104.618 -2.364 . . . . 0.0 104.618 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -35.16 103.21 0.03 OUTLIER 'General case' 0 CA--C 1.486 -1.481 0 O-C-N 126.803 2.564 . . . . 0.0 113.711 -179.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 28.9 p90 -116.52 174.97 5.78 Favored 'General case' 0 N--CA 1.423 -1.816 0 O-C-N 120.138 -1.601 . . . . 0.0 112.484 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -123.17 126.07 46.31 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 128.828 3.83 . . . . 0.0 105.488 179.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -121.56 -42.34 2.44 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-O 115.82 -2.038 . . . . 0.0 114.356 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.9 m 72.61 143.17 0.06 Allowed 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 105.95 -1.87 . . . . 0.0 105.95 -179.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.573 HD11 HD13 ' A' ' 78' ' ' LEU . 1.2 mp -95.95 -164.17 1.13 Allowed 'General case' 0 C--N 1.301 -1.509 0 CA-C-N 114.779 -1.101 . . . . 0.0 108.719 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -89.11 -48.75 7.19 Favored 'General case' 0 C--O 1.211 -0.964 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.117 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.487 ' HB2' ' CG ' ' A' ' 132' ' ' PLM . 0.2 OUTLIER -129.01 12.94 6.22 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-O 115.557 -2.163 . . . . 0.0 109.633 179.994 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.45 ' C ' HG23 ' A' ' 76' ' ' THR . . . -107.29 -8.93 30.37 Favored Glycine 0 CA--C 1.546 1.998 0 CA-C-O 117.463 -1.743 . . . . 0.0 116.924 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.554 ' O ' HD12 ' A' ' 72' ' ' LEU 0.377 0.1 OUTLIER 89.3 -164.08 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 114.696 -2.574 . . . . 0.0 113.97 179.946 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.669 ' CB ' HG22 ' A' ' 96' ' ' VAL . 0.5 OUTLIER -62.21 140.64 58.45 Favored 'General case' 0 C--N 1.318 -0.78 1 O-C-N 129.529 4.268 . . . . 0.0 114.891 179.914 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.573 HD13 HD11 ' A' ' 72' ' ' LEU 0.399 11.1 tp -143.83 128.77 18.47 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 102.416 -3.179 . . . . 0.0 102.416 179.872 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 87.1 m -146.45 121.88 10.34 Favored 'General case' 0 CA--C 1.487 -1.461 0 N-CA-C 103.691 -2.707 . . . . 0.0 103.691 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -166.0 -146.49 4.84 Favored Glycine 0 C--N 1.297 -1.638 0 C-N-CA 114.576 -3.678 . . . . 0.0 110.949 -179.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 72.5 p -152.27 171.35 18.11 Favored 'General case' 0 CA--C 1.472 -2.048 0 O-C-N 125.632 1.431 . . . . 0.0 107.494 -179.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . 0.489 ' CE3' ' N ' ' A' ' 91' ' ' GLY . 24.2 m95 -125.03 139.72 53.55 Favored 'General case' 0 N--CA 1.429 -1.524 0 N-CA-C 103.703 -2.703 . . . . 0.0 103.703 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 10.1 t -147.32 149.44 32.83 Favored 'General case' 0 C--O 1.256 1.409 0 C-N-CA 119.051 -1.059 . . . . 0.0 111.445 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.8 130.04 34.93 Favored 'General case' 0 CA--C 1.494 -1.192 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 -179.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . 0.538 0.0 OUTLIER -110.41 60.26 0.61 Allowed 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 -179.854 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 73.07 -95.1 0.72 Allowed Glycine 0 N--CA 1.429 -1.817 0 CA-C-N 112.41 -2.177 . . . . 0.0 107.731 -179.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -94.66 12.33 28.07 Favored 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 115.151 1.537 . . . . 0.0 115.151 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . 0.404 4.2 mptt -140.28 175.7 9.38 Favored 'General case' 0 C--O 1.21 -1.013 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.474 ' HA ' HD23 ' A' ' 89' ' ' LEU . 0.3 OUTLIER -125.13 141.88 51.83 Favored 'General case' 0 CA--C 1.548 0.898 0 N-CA-C 101.578 -3.49 . . . . 0.0 101.578 -180.0 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 104' ' ' ALA . 7.6 p -133.82 119.73 33.9 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 O-C-N 125.505 1.753 . . . . 0.0 110.691 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.489 ' N ' ' CE3' ' A' ' 82' ' ' TRP . . . -93.31 103.07 2.99 Favored Glycine 0 N--CA 1.474 1.198 0 C-N-CA 127.532 2.492 . . . . 0.0 108.294 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -97.61 154.2 17.7 Favored 'General case' 0 CA--C 1.502 -0.895 0 N-CA-C 103.944 -2.613 . . . . 0.0 103.944 179.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.503 ' HB2' HD23 ' A' ' 102' ' ' LEU . 91.6 m-85 -151.54 118.47 5.84 Favored 'General case' 0 CA--C 1.502 -0.899 0 O-C-N 125.12 1.513 . . . . 0.0 111.253 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 25.0 mttm -93.76 152.29 19.03 Favored 'General case' 0 C--O 1.21 -0.986 0 CA-C-O 123.741 1.734 . . . . 0.0 107.669 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . 0.368 0.5 OUTLIER -115.62 121.8 43.69 Favored 'General case' 0 CA--C 1.488 -1.414 0 CA-C-N 114.983 -1.008 . . . . 0.0 108.953 179.914 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.669 HG22 ' CB ' ' A' ' 77' ' ' GLU . 23.4 m -62.52 -27.79 43.49 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 CA-C-O 125.264 2.459 . . . . 0.0 113.338 179.756 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . 0.31 2.4 m-20 -61.56 -10.17 7.48 Favored 'General case' 0 C--O 1.246 0.902 0 CA-C-N 113.55 -1.659 . . . . 0.0 113.34 179.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.479 ' ND2' ' N ' ' A' ' 98' ' ' ASN . 0.1 OUTLIER -169.89 15.28 0.02 OUTLIER 'General case' 0 N--CA 1.433 -1.287 0 N-CA-C 115.636 1.717 . . . . 0.0 115.636 179.929 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 55.13 21.22 24.29 Favored Glycine 0 CA--C 1.523 0.547 0 CA-C-O 123.635 1.686 . . . . 0.0 113.572 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp -78.25 -170.88 2.16 Favored 'General case' 0 C--O 1.199 -1.572 0 O-C-N 120.225 -1.75 . . . . 0.0 106.697 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -135.77 159.76 40.66 Favored 'General case' 0 CA--C 1.5 -0.971 0 O-C-N 127.808 3.193 . . . . 0.0 110.164 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.664 HD11 ' HD1' ' A' ' 117' ' ' TYR . 0.2 OUTLIER -146.22 149.58 34.19 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 131.648 3.979 . . . . 0.0 104.007 179.541 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.754 HD13 ' N ' ' A' ' 104' ' ' ALA . 0.0 OUTLIER -143.34 162.12 16.78 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.994 0 N-CA-C 106.657 -1.609 . . . . 0.0 106.657 -179.723 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.754 ' N ' HD13 ' A' ' 103' ' ' ILE . . . -149.67 143.57 25.58 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-O 114.965 -2.445 . . . . 0.0 106.567 179.52 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.453 HG12 ' OG1' ' A' ' 116' ' ' THR . 2.9 p -126.24 105.52 14.53 Favored 'Isoleucine or valine' 0 C--O 1.257 1.466 0 CA-C-N 121.647 2.021 . . . . 0.0 108.15 -179.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.537 HH22 ' HZ ' ' A' ' 62' ' ' PHE . 63.6 mtt180 -67.79 90.29 0.28 Allowed 'General case' 0 CA--C 1.502 -0.883 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -83.69 78.57 9.67 Favored 'General case' 0 N--CA 1.433 -1.282 0 N-CA-C 116.639 2.089 . . . . 0.0 116.639 179.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.78 ' CG1' HD12 ' A' ' 113' ' ' LEU . 0.8 OUTLIER -68.52 101.33 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 C-N-CA 113.784 -3.167 . . . . 0.0 108.882 179.742 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.26 -29.78 69.5 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 114.199 -1.364 . . . . 0.0 107.536 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 154.01 -71.89 0.27 Allowed Glycine 0 C--O 1.243 0.715 1 C-N-CA 130.723 4.011 . . . . 0.0 111.583 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . 0.362 6.9 m120 -97.71 3.27 50.23 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 115.497 -2.192 . . . . 0.0 110.418 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -133.15 118.73 19.02 Favored 'General case' 0 CA--C 1.502 -0.867 0 O-C-N 128.005 3.315 . . . . 0.0 114.098 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.78 HD12 ' CG1' ' A' ' 108' ' ' ILE . 0.9 OUTLIER -97.29 94.22 6.97 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 103.214 -2.884 . . . . 0.0 103.214 179.821 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.501 HG12 HG23 ' A' ' 127' ' ' ILE . 77.2 mt -91.17 143.82 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.114 0 N-CA-C 103.419 -2.808 . . . . 0.0 103.419 179.655 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -132.8 108.17 8.81 Favored 'General case' 0 CA--C 1.49 -1.361 0 O-C-N 124.741 1.276 . . . . 0.0 109.136 -179.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.453 ' OG1' HG12 ' A' ' 105' ' ' VAL . 20.3 p -72.33 173.8 8.2 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 105.371 -2.085 . . . . 0.0 105.371 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.664 ' HD1' HD11 ' A' ' 102' ' ' LEU . 8.0 m-85 -162.78 114.38 1.54 Allowed 'General case' 0 CA--C 1.477 -1.847 0 CA-C-O 117.192 -1.385 . . . . 0.0 113.734 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . 0.264 1.2 m -126.57 122.3 34.72 Favored 'General case' 0 N--CA 1.424 -1.766 0 O-C-N 127.267 2.854 . . . . 0.0 110.961 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.555 ' CG ' ' HE3' ' A' ' 20' ' ' LYS . 1.4 t80 -85.85 -25.2 26.37 Favored 'General case' 0 N--CA 1.476 0.831 0 O-C-N 126.49 2.369 . . . . 0.0 107.064 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -161.97 -75.14 0.05 Allowed 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 112.522 -2.126 . . . . 0.0 113.573 -179.767 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -139.74 25.57 2.69 Favored Glycine 0 CA--C 1.537 1.463 0 N-CA-C 120.408 2.923 . . . . 0.0 120.408 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 22.0 t -133.02 102.87 5.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 105.219 -2.141 . . . . 0.0 105.219 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -75.94 165.69 24.61 Favored 'General case' 0 C--O 1.206 -1.195 0 CA-C-O 124.344 2.021 . . . . 0.0 108.82 -179.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.547 ' HB1' ' HA ' ' A' ' 14' ' ' TYR . . . -161.02 101.18 1.26 Allowed 'General case' 0 N--CA 1.435 -1.209 0 CA-C-O 114.488 -2.673 . . . . 0.0 107.854 -179.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.44 ' HB2' ' HB2' ' A' ' 12' ' ' GLU 0.288 5.3 mptt -77.95 146.03 35.72 Favored 'General case' 0 N--CA 1.449 -0.513 0 O-C-N 127.228 2.83 . . . . 0.0 110.519 179.738 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.45 ' NH2' HD13 ' A' ' 36' ' ' LEU . 0.0 OUTLIER -133.18 83.03 2.03 Favored 'General case' 0 C--O 1.212 -0.919 0 CA-C-O 114.955 -2.45 . . . . 0.0 106.845 179.823 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.501 HG23 HG12 ' A' ' 114' ' ' ILE . 1.9 mm -74.15 104.14 2.69 Favored 'Isoleucine or valine' 0 C--O 1.25 1.097 1 O-C-N 131.042 5.213 . . . . 0.0 117.381 179.808 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.712 ' CE2' HD22 ' A' ' 38' ' ' LEU . 0.7 OUTLIER -94.98 140.85 29.38 Favored 'General case' 0 CA--C 1.516 -0.361 0 O-C-N 124.565 1.166 . . . . 0.0 108.463 -179.813 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.427 ' HE3' ' HD2' ' A' ' 10' ' ' ARG . 27.7 mmtt -102.88 9.11 39.03 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-O 116.444 -1.741 . . . . 0.0 110.848 179.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.524 ' HD2' ' CH2' ' A' ' 6' ' ' TRP . 2.8 tttt 64.32 110.69 0.03 OUTLIER 'General case' 0 C--O 1.237 0.407 0 O-C-N 124.99 1.431 . . . . 0.0 113.67 -179.788 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . 0.746 1.9 mt-10 . . . . . 0 N--CA 1.438 -1.068 0 C-N-CA 118.422 -1.311 . . . . 0.0 114.066 -179.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' PLM . . . . . 0.811 ' H21' HG11 ' A' ' 60' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.589 ' HB1' ' CD1' ' A' ' 2' ' ' PHE . . . . . . . . 0 C--O 1.214 -0.806 0 CA-C-O 119.311 -0.376 . . . . 0.0 111.953 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.589 ' CD1' ' HB1' ' A' ' 1' ' ' ALA . 0.8 OUTLIER 49.1 54.22 11.29 Favored 'General case' 0 N--CA 1.442 -0.872 0 N-CA-C 114.239 1.2 . . . . 0.0 114.239 -179.787 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -158.91 90.54 0.99 Allowed 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 114.03 -1.441 . . . . 0.0 112.395 -179.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 142.0 174.72 14.86 Favored Glycine 0 N--CA 1.439 -1.155 0 C-N-CA 114.477 -3.725 . . . . 0.0 114.459 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.601 ' HA ' ' HA ' ' A' ' 39' ' ' THR 0.705 3.3 t -58.3 151.86 18.67 Favored 'General case' 0 C--N 1.319 -0.734 0 O-C-N 127.169 2.335 . . . . 0.0 111.181 -179.664 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.714 ' HH2' HD11 ' A' ' 108' ' ' ILE . 92.2 m95 -147.51 93.35 2.21 Favored 'General case' 0 N--CA 1.429 -1.515 0 O-C-N 127.945 3.278 . . . . 0.0 105.774 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 15.3 tttt -99.76 100.13 11.04 Favored 'General case' 0 CA--C 1.505 -0.785 0 CA-C-O 116.986 -1.483 . . . . 0.0 111.158 -179.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.51 ' HA ' ' HA ' ' A' ' 128' ' ' PHE 0.305 2.2 p -45.71 131.8 2.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 117.402 -1.285 . . . . 0.0 112.36 -179.745 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -133.64 -38.61 0.91 Allowed 'General case' 0 N--CA 1.445 -0.678 0 O-C-N 126.886 2.616 . . . . 0.0 111.476 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.465 ' HB2' ' CG1' ' A' ' 127' ' ' ILE . 0.2 OUTLIER -81.83 -69.71 0.6 Allowed 'General case' 0 N--CA 1.432 -1.329 0 C-N-CA 119.048 -1.061 . . . . 0.0 112.771 -179.587 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 71.56 146.92 0.07 Allowed 'General case' 0 C--O 1.245 0.826 0 O-C-N 125.817 1.948 . . . . 0.0 107.182 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.411 ' O ' ' N ' ' A' ' 125' ' ' LYS . 0.4 OUTLIER -156.65 147.36 21.7 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 115.807 -2.044 . . . . 0.0 107.901 -179.363 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.7 t30 46.07 27.08 0.48 Allowed 'General case' 0 N--CA 1.478 0.96 0 O-C-N 125.124 1.515 . . . . 0.0 113.065 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.563 ' CE1' ' HB1' ' A' ' 32' ' ' ALA . 10.7 p90 -81.52 -34.08 31.42 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 118.508 2.781 . . . . 0.0 118.508 -179.382 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -72.75 -39.93 66.44 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-N 120.445 1.475 . . . . 0.0 110.16 179.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.53 -34.84 76.57 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 125.17 2.414 . . . . 0.0 113.218 -179.757 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.731 ' CB ' ' HB2' ' A' ' 124' ' ' ALA . 0.2 OUTLIER -68.58 -28.05 66.6 Favored 'General case' 0 N--CA 1.431 -1.381 0 O-C-N 119.022 -2.298 . . . . 0.0 110.945 -179.981 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 1.5 mmt -77.3 -31.25 54.62 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 179.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -77.92 -20.71 52.35 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 126.484 3.04 . . . . 0.0 109.744 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 42.4 tptt -78.29 -39.92 38.41 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 112.686 -2.052 . . . . 0.0 108.93 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.46 ' HG3' ' CE1' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -73.18 -20.88 60.8 Favored 'General case' 0 CA--C 1.511 -0.556 0 O-C-N 119.552 -1.968 . . . . 0.0 108.273 179.92 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 97.96 46.73 2.2 Favored Glycine 0 N--CA 1.434 -1.488 0 CA-C-O 114.168 -3.573 . . . . 0.0 110.937 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.472 HG22 ' N ' ' A' ' 24' ' ' ASN . 2.1 mm -93.6 176.8 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 O-C-N 129.269 3.57 . . . . 0.0 106.319 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.472 ' N ' HG22 ' A' ' 23' ' ' ILE . 2.8 m-80 -113.43 -178.61 3.42 Favored 'General case' 0 C--N 1.348 0.519 0 CA-C-O 115.156 -2.354 . . . . 0.0 110.849 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . 0.347 0.6 OUTLIER -55.91 -49.23 76.31 Favored 'Isoleucine or valine' 0 C--N 1.352 0.716 0 O-C-N 128.606 3.691 . . . . 0.0 113.659 179.605 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.65 1.1 m -74.11 -41.89 51.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 O-C-N 127.056 2.722 . . . . 0.0 116.108 -179.702 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.457 ' HB3' HG23 ' A' ' 23' ' ' ILE . 2.6 mtmp? -66.2 -34.46 78.08 Favored 'General case' 0 CA--C 1.507 -0.695 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 -179.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.426 ' CG ' HH11 ' A' ' 28' ' ' ARG . 0.0 OUTLIER -79.94 -27.56 39.81 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 125.361 2.505 . . . . 0.0 108.524 179.777 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.3 tmmm? -71.08 -52.92 16.65 Favored 'General case' 0 C--N 1.353 0.743 0 O-C-N 119.64 -1.912 . . . . 0.0 110.237 -179.538 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 34.5 mt -72.65 -28.93 63.03 Favored 'General case' 0 N--CA 1.445 -0.698 0 O-C-N 120.247 -1.533 . . . . 0.0 108.416 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -70.21 -31.29 69.07 Favored Glycine 0 CA--C 1.537 1.408 0 O-C-N 127.365 2.916 . . . . 0.0 110.169 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.563 ' HB1' ' CE1' ' A' ' 14' ' ' TYR . . . -72.65 -41.68 65.18 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 126.572 1.949 . . . . 0.0 113.586 -179.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -101.32 14.65 31.31 Favored 'General case' 0 N--CA 1.437 -1.107 0 O-C-N 126.845 2.591 . . . . 0.0 110.555 -179.589 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 14.6 p30 -41.17 -27.47 0.07 Allowed 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 120.009 3.337 . . . . 0.0 120.009 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . 0.274 20.7 m-80 74.35 35.32 0.73 Allowed 'General case' 0 C--O 1.235 0.337 0 O-C-N 123.938 0.774 . . . . 0.0 109.477 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.715 HD11 HD13 ' A' ' 38' ' ' LEU . 2.9 tt -59.44 137.93 57.84 Favored 'General case' 0 N--CA 1.479 0.986 0 O-C-N 125.22 1.575 . . . . 0.0 110.501 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 6.6 ttmt -134.41 87.77 2.39 Favored 'General case' 0 N--CA 1.435 -1.194 0 N-CA-C 106.176 -1.787 . . . . 0.0 106.176 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.715 HD13 HD11 ' A' ' 36' ' ' LEU 0.315 0.0 OUTLIER -72.15 135.87 46.32 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 103.087 -2.931 . . . . 0.0 103.087 179.809 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.601 ' HA ' ' HA ' ' A' ' 5' ' ' THR . 3.7 m -102.44 -18.62 15.28 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 121.939 2.154 . . . . 0.0 110.272 -178.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.45 HG12 HG23 ' A' ' 49' ' ' VAL . 3.7 mm 40.97 116.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 CA-C-O 126.667 3.127 . . . . 0.0 114.536 179.491 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.611 ' HB ' HG23 ' A' ' 48' ' ' THR . 5.8 m -118.69 109.94 16.7 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 112.479 -2.146 . . . . 0.0 113.611 179.297 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.482 ' NE2' ' CE2' ' A' ' 47' ' ' PHE . 3.8 tp-100 -103.41 77.73 1.54 Allowed 'General case' 0 N--CA 1.444 -0.774 0 O-C-N 123.635 0.584 . . . . 0.0 109.734 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -65.44 -45.05 85.31 Favored 'General case' 0 N--CA 1.426 -1.663 0 CA-C-O 123.391 1.567 . . . . 0.0 110.296 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 163.6 82.1 0.04 OUTLIER Glycine 0 N--CA 1.44 -1.053 0 N-CA-C 105.839 -2.904 . . . . 0.0 105.839 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.354 75.2 m-20 90.77 -33.52 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.727 0 O-C-N 125.364 1.273 . . . . 0.0 108.495 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 18.7 tttt -93.28 128.58 39.34 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 119.256 -2.152 . . . . 0.0 106.74 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.482 ' CE2' ' NE2' ' A' ' 42' ' ' GLN . 3.0 m-85 -113.47 97.85 6.71 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 124.948 1.299 . . . . 0.0 107.601 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.611 HG23 ' HB ' ' A' ' 41' ' ' THR 0.375 5.1 t -93.68 102.36 14.52 Favored 'General case' 0 N--CA 1.432 -1.349 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 179.922 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.548 HG21 ' HG ' ' A' ' 38' ' ' LEU 0.622 0.8 OUTLIER -84.91 104.96 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.818 0 N-CA-C 118.089 2.626 . . . . 0.0 118.089 -179.433 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.546 ' HB3' ' HB ' ' A' ' 39' ' ' THR . 0.0 OUTLIER -64.19 158.43 23.1 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 100.974 -3.713 . . . . 0.0 100.974 178.638 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.408 ' O ' ' N ' ' A' ' 53' ' ' SER 0.3 68.8 tt0 -144.16 53.93 1.28 Allowed 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 103.857 -2.646 . . . . 0.0 103.857 179.993 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -70.9 81.43 0.64 Allowed 'General case' 0 N--CA 1.425 -1.709 0 C-N-CA 118.41 -1.316 . . . . 0.0 109.004 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.408 ' N ' ' O ' ' A' ' 51' ' ' GLU . 1.2 m -111.67 -141.72 0.38 Allowed 'General case' 0 CA--C 1.505 -0.778 0 O-C-N 126.612 2.445 . . . . 0.0 110.428 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -94.27 -7.48 41.87 Favored 'General case' 0 C--O 1.211 -0.924 0 CA-C-N 120.865 1.666 . . . . 0.0 108.066 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.568 ' CZ ' ' HF2' ' A' ' 132' ' ' PLM . 46.1 m-85 -97.82 -71.66 0.68 Allowed 'General case' 0 N--CA 1.437 -1.087 0 CA-C-O 116.247 -1.835 . . . . 0.0 113.958 -179.758 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.52 ' HG2' ' C ' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -153.02 144.45 23.3 Favored 'General case' 0 C--O 1.254 1.327 0 CA-C-N 123.883 3.038 . . . . 0.0 109.712 -179.195 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -93.69 74.96 4.33 Favored 'General case' 0 C--O 1.219 -0.543 0 N-CA-C 102.269 -3.234 . . . . 0.0 102.269 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.465 ' O ' HG23 ' A' ' 60' ' ' VAL . 0.7 OUTLIER -99.61 114.3 37.41 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 O-C-N 127.733 3.146 . . . . 0.0 114.483 179.811 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -62.19 117.71 6.42 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 104.793 -2.299 . . . . 0.0 104.793 179.354 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.638 HG12 ' CE2' ' A' ' 62' ' ' PHE . 92.4 t -99.36 77.04 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.59 1.181 . . . . 0.0 109.003 -178.73 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.597 ' HA ' ' HA ' ' A' ' 48' ' ' THR 0.339 1.2 m -71.18 138.45 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.333 0 O-C-N 117.852 -3.03 . . . . 0.0 115.858 179.92 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.638 ' CE2' HG12 ' A' ' 60' ' ' VAL . 0.2 OUTLIER -156.36 92.2 1.31 Allowed 'General case' 0 N--CA 1.444 -0.772 0 O-C-N 118.991 -2.318 . . . . 0.0 109.717 -179.976 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -57.82 142.38 45.92 Favored 'General case' 0 C--O 1.244 0.775 0 N-CA-C 106.58 -1.637 . . . . 0.0 106.58 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.1 mt -65.08 122.69 17.62 Favored 'General case' 0 N--CA 1.443 -0.822 0 C-N-CA 118.063 -1.455 . . . . 0.0 111.056 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 75.02 9.89 83.98 Favored Glycine 0 N--CA 1.47 0.933 0 N-CA-C 119.863 2.705 . . . . 0.0 119.863 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.401 HG12 ' N ' ' A' ' 67' ' ' ASP 0.425 7.2 t -80.88 -97.69 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.213 0 O-C-N 121.416 -1.049 . . . . 0.0 110.396 -179.97 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.401 ' N ' HG12 ' A' ' 66' ' ' VAL 0.259 21.2 t70 157.82 145.86 0.01 OUTLIER 'General case' 0 CA--C 1.497 -1.088 0 CA-C-O 117.533 -1.222 . . . . 0.0 109.927 179.831 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.502 ' CZ ' ' HB3' ' A' ' 62' ' ' PHE . 0.2 OUTLIER -164.87 164.95 20.81 Favored 'General case' 0 N--CA 1.423 -1.798 0 C-N-CA 119.237 -0.985 . . . . 0.0 110.186 179.98 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -113.75 122.76 48.08 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -123.7 118.34 27.0 Favored 'General case' 0 N--CA 1.439 -0.975 0 O-C-N 121.383 -0.823 . . . . 0.0 110.835 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 2.5 p -81.41 126.29 31.45 Favored 'General case' 0 CA--C 1.496 -1.124 0 CA-C-N 120.047 1.294 . . . . 0.0 108.936 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -78.69 -171.37 2.5 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 104.251 -2.5 . . . . 0.0 104.251 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -114.1 25.38 11.18 Favored 'General case' 0 N--CA 1.436 -1.138 0 CA-C-O 124.117 1.913 . . . . 0.0 112.995 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.479 ' HB3' ' CG ' ' A' ' 132' ' ' PLM . 0.2 OUTLIER -153.34 -35.17 0.11 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 119.664 -1.898 . . . . 0.0 112.969 -179.844 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.507 ' O ' HG22 ' A' ' 76' ' ' THR . . . -126.66 -12.89 3.2 Favored Glycine 0 CA--C 1.543 1.786 0 C-N-CA 125.375 1.464 . . . . 0.0 113.215 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.507 HG22 ' O ' ' A' ' 75' ' ' GLY 0.328 0.4 OUTLIER 69.13 171.07 0.3 Allowed 'General case' 0 CA--C 1.492 -1.27 0 C-N-CA 115.987 -2.285 . . . . 0.0 115.436 -179.734 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 26.21 109.6 0.0 OUTLIER 'General case' 0 N--CA 1.436 -1.129 1 O-C-N 129.423 4.202 . . . . 0.0 116.956 179.547 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.56 HD21 ' CD1' ' A' ' 93' ' ' PHE 0.363 0.4 OUTLIER -146.46 121.11 9.81 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 101.988 -3.338 . . . . 0.0 101.988 -179.889 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 55.1 m -129.41 154.67 46.71 Favored 'General case' 0 C--O 1.198 -1.625 0 N-CA-C 106.002 -1.851 . . . . 0.0 106.002 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 169.97 -159.08 31.53 Favored Glycine 0 N--CA 1.439 -1.125 0 CA-C-O 118.076 -1.402 . . . . 0.0 110.715 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -148.04 167.69 24.28 Favored 'General case' 0 CA--C 1.492 -1.278 0 C-N-CA 117.252 -1.779 . . . . 0.0 109.992 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . 0.486 ' CE3' ' CA ' ' A' ' 91' ' ' GLY 0.271 63.1 m95 -121.66 138.12 54.47 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 101.693 -3.447 . . . . 0.0 101.693 179.934 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 12.4 t -140.97 140.85 34.44 Favored 'General case' 0 N--CA 1.426 -1.64 0 CA-C-O 123.516 1.627 . . . . 0.0 107.885 -179.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.632 ' HA ' HD23 ' A' ' 89' ' ' LEU . 3.6 ttm -85.21 133.91 34.17 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 104.616 -2.364 . . . . 0.0 104.616 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . 0.649 1.5 mm-40 -105.51 18.55 22.04 Favored 'General case' 0 N--CA 1.428 -1.574 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 93.69 -64.03 1.85 Allowed Glycine 0 N--CA 1.427 -1.911 0 N-CA-C 105.85 -2.9 . . . . 0.0 105.85 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -101.57 -7.67 22.55 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 117.683 2.475 . . . . 0.0 117.683 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . 0.358 6.6 mtmt -162.32 132.07 4.55 Favored 'General case' 0 CA--C 1.489 -1.398 0 O-C-N 127.096 2.747 . . . . 0.0 109.284 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.632 HD23 ' HA ' ' A' ' 84' ' ' MET . 0.0 OUTLIER -75.73 121.9 23.22 Favored 'General case' 0 C--N 1.309 -1.188 0 O-C-N 126.639 2.462 . . . . 0.0 104.988 179.766 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.495 HG12 HG23 ' A' ' 105' ' ' VAL . 18.1 m -116.54 135.95 55.17 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 N-CA-C 105.698 -1.964 . . . . 0.0 105.698 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.486 ' CA ' ' CE3' ' A' ' 82' ' ' TRP . . . -115.44 118.45 4.28 Favored Glycine 0 CA--C 1.537 1.427 0 C-N-CA 126.525 2.012 . . . . 0.0 109.005 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 3.4 mtmm -112.3 147.34 36.52 Favored 'General case' 0 N--CA 1.432 -1.327 0 N-CA-C 103.569 -2.752 . . . . 0.0 103.569 179.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.56 ' CD1' HD21 ' A' ' 78' ' ' LEU . 55.2 m-85 -146.18 116.5 7.48 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 114.654 -1.157 . . . . 0.0 112.667 179.702 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.401 ' HE2' ' HB3' ' A' ' 94' ' ' LYS . 44.2 mtpt -88.53 -171.11 3.2 Favored 'General case' 0 N--CA 1.433 -1.295 0 C-N-CA 127.298 2.239 . . . . 0.0 108.146 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . 0.359 1.3 ttt180 -149.12 134.7 18.63 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 106.138 -1.801 . . . . 0.0 106.138 -179.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.492 HG23 ' N ' ' A' ' 97' ' ' ASP . 17.0 m -57.73 -38.31 64.35 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 CA-C-O 123.809 1.766 . . . . 0.0 113.321 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.492 ' N ' HG23 ' A' ' 96' ' ' VAL 0.366 96.3 m-20 -76.09 7.08 4.45 Favored 'General case' 0 C--O 1.253 1.277 0 CA-C-N 112.531 -2.122 . . . . 0.0 116.191 179.931 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 38.1 p30 -161.33 -17.92 0.05 OUTLIER 'General case' 0 N--CA 1.421 -1.898 0 N-CA-C 116.957 2.206 . . . . 0.0 116.957 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 58.24 19.21 38.48 Favored Glycine 0 C--O 1.228 -0.274 0 CA-C-O 124.737 2.298 . . . . 0.0 114.476 -179.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 9.7 mmtm -78.0 -103.59 0.02 OUTLIER 'General case' 0 C--O 1.199 -1.597 0 O-C-N 120.037 -1.86 . . . . 0.0 111.322 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 167.65 167.94 0.03 OUTLIER 'General case' 0 N--CA 1.438 -1.043 0 C-N-CA 130.058 3.343 . . . . 0.0 110.603 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.504 HD23 ' N ' ' A' ' 103' ' ' ILE . 9.4 tt -153.91 154.27 33.56 Favored 'General case' 0 C--O 1.242 0.676 0 C-N-CA 131.693 3.997 . . . . 0.0 104.55 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.549 ' CG2' ' HB ' ' A' ' 118' ' ' THR . 13.4 tt -141.85 160.18 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.328 0 C-N-CA 116.469 -2.092 . . . . 0.0 110.277 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.422 ' N ' ' CG1' ' A' ' 103' ' ' ILE . . . -149.53 111.84 4.69 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 179.797 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.495 HG23 HG12 ' A' ' 90' ' ' VAL . 2.4 p -102.65 105.88 18.96 Favored 'Isoleucine or valine' 0 C--O 1.244 0.782 0 CA-C-O 124.824 2.249 . . . . 0.0 112.068 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.423 ' CG ' ' HG2' ' A' ' 115' ' ' GLN 0.26 78.4 mtt180 -79.23 93.08 5.18 Favored 'General case' 0 N--CA 1.428 -1.573 0 CA-C-N 112.181 -2.281 . . . . 0.0 106.127 -179.848 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 21.2 pt-20 -101.5 82.73 2.34 Favored 'General case' 0 N--CA 1.425 -1.677 0 O-C-N 127.581 3.051 . . . . 0.0 110.339 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.714 HD11 ' HH2' ' A' ' 6' ' ' TRP 0.391 4.4 tt -60.89 129.2 23.28 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.984 0 C-N-CA 114.485 -2.886 . . . . 0.0 114.999 -179.827 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.2 t -125.76 76.04 1.54 Allowed 'General case' 0 C--O 1.215 -0.733 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 179.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 80.55 -89.94 1.33 Allowed Glycine 0 CA--C 1.501 -0.822 0 C-N-CA 126.134 1.826 . . . . 0.0 112.636 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . 0.374 0.4 OUTLIER -116.32 22.79 12.59 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 115.785 -2.055 . . . . 0.0 110.456 -179.793 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -132.54 119.86 21.09 Favored 'General case' 0 C--O 1.211 -0.935 0 O-C-N 128.4 3.562 . . . . 0.0 110.933 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.493 ' HB2' ' CH2' ' A' ' 6' ' ' TRP . 0.9 OUTLIER -95.55 59.71 2.14 Favored 'General case' 0 CA--C 1.501 -0.933 0 O-C-N 128.725 3.766 . . . . 0.0 107.969 -179.647 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.578 ' CG1' HD13 ' A' ' 127' ' ' ILE 0.262 1.4 mp -51.81 127.0 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.762 0 O-C-N 125.508 1.755 . . . . 0.0 108.335 -179.621 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.614 HE21 ' HZ ' ' A' ' 128' ' ' PHE . 28.0 mt-30 -124.72 134.29 52.89 Favored 'General case' 0 C--O 1.246 0.904 0 N-CA-C 103.14 -2.911 . . . . 0.0 103.14 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.48 HG22 ' HE2' ' A' ' 125' ' ' LYS . 29.5 p -97.46 178.74 5.1 Favored 'General case' 0 N--CA 1.433 -1.279 0 O-C-N 128.304 3.503 . . . . 0.0 108.192 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.954 ' HB2' ' HB3' ' A' ' 124' ' ' ALA . 19.1 m-85 -146.77 97.92 2.98 Favored 'General case' 0 CA--C 1.497 -1.086 0 CA-C-O 114.481 -2.676 . . . . 0.0 112.06 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.549 ' HB ' ' CG2' ' A' ' 103' ' ' ILE . 0.3 OUTLIER -116.2 94.75 4.78 Favored 'General case' 0 C--O 1.254 1.325 1 O-C-N 129.386 4.179 . . . . 0.0 112.868 179.76 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.493 ' HA ' ' HA ' ' A' ' 102' ' ' LEU . 59.8 t80 -72.42 -14.09 61.61 Favored 'General case' 0 C--N 1.346 0.446 0 CA-C-O 122.472 1.13 . . . . 0.0 108.557 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -179.63 -81.29 0.0 OUTLIER 'General case' 0 C--N 1.292 -1.915 0 CA-C-N 113.747 -1.57 . . . . 0.0 113.379 -179.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -128.07 28.15 4.41 Favored Glycine 0 C--N 1.366 2.207 0 C-N-CA 126.579 2.037 . . . . 0.0 116.745 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 5.2 t -140.89 92.79 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -64.82 178.86 0.73 Allowed 'General case' 0 N--CA 1.428 -1.573 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.954 ' HB3' ' HB2' ' A' ' 117' ' ' TYR . . . -171.54 101.57 0.19 Allowed 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 103.778 -2.675 . . . . 0.0 103.778 179.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.48 ' HE2' HG22 ' A' ' 116' ' ' THR . 0.0 OUTLIER -80.02 147.52 31.49 Favored 'General case' 0 C--O 1.244 0.811 0 O-C-N 126.802 2.563 . . . . 0.0 109.76 -179.882 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -137.7 78.64 1.7 Allowed 'General case' 0 C--O 1.214 -0.786 0 O-C-N 126.726 2.516 . . . . 0.0 104.863 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.578 HD13 ' CG1' ' A' ' 114' ' ' ILE . 5.5 mm -67.45 107.42 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.755 1 O-C-N 129.558 4.286 . . . . 0.0 113.526 -179.758 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.614 ' HZ ' HE21 ' A' ' 115' ' ' GLN . 0.3 OUTLIER -99.74 151.03 21.7 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 179.348 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . 0.276 3.5 mmtt -115.83 44.28 1.94 Allowed 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.542 ' HB2' ' CZ3' ' A' ' 6' ' ' TRP . 23.9 tttm 32.32 86.85 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 126.686 1.994 . . . . 0.0 115.205 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . 0.733 0.5 OUTLIER . . . . . 0 N--CA 1.435 -1.224 0 CA-C-O 116.683 -1.627 . . . . 0.0 114.85 -179.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' PLM . . . . . 0.568 ' HF2' ' CZ ' ' A' ' 55' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.514 -0.42 0 CA-C-O 122.47 1.128 . . . . 0.0 110.122 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -83.37 70.94 10.27 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 116.376 -2.13 . . . . 0.0 112.94 179.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -154.6 100.72 2.27 Favored 'General case' 0 CA--C 1.491 -1.289 0 CA-C-O 127.465 3.507 . . . . 0.0 112.185 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 159.11 -168.1 35.05 Favored Glycine 0 CA--C 1.499 -0.952 0 C-N-CA 116.506 -2.759 . . . . 0.0 110.905 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.435 ' HB ' ' HA ' ' A' ' 39' ' ' THR 0.506 0.4 OUTLIER -97.28 164.88 12.29 Favored 'General case' 0 CA--C 1.493 -1.227 0 CA-C-N 117.062 0.431 . . . . 0.0 111.755 -179.891 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.63 ' CE3' ' HA ' ' A' ' 130' ' ' LYS 0.274 90.8 m95 -152.25 121.26 6.63 Favored 'General case' 0 N--CA 1.426 -1.639 0 O-C-N 127.027 2.704 . . . . 0.0 107.922 179.765 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 13.6 ttpt -124.82 97.87 5.46 Favored 'General case' 0 C--O 1.205 -1.274 0 CA-C-O 115.275 -2.297 . . . . 0.0 105.815 179.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.509 ' HA ' ' HA ' ' A' ' 128' ' ' PHE . 0.4 OUTLIER -38.65 138.64 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 O-C-N 126.309 2.256 . . . . 0.0 111.043 -179.987 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -137.34 16.42 2.97 Favored 'General case' 0 C--O 1.209 -1.067 0 O-C-N 126.109 2.13 . . . . 0.0 108.231 -179.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 171.13 135.39 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.439 0 CA-C-O 121.391 0.615 . . . . 0.0 110.159 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -118.86 -169.11 1.67 Allowed 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 116.928 -1.511 . . . . 0.0 107.869 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.414 ' HB3' ' HB2' ' A' ' 125' ' ' LYS . 2.3 tp10 -145.83 -45.91 0.21 Allowed 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 120.786 1.63 . . . . 0.0 109.285 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 38.4 t30 -123.3 7.97 9.08 Favored 'General case' 0 N--CA 1.476 0.841 0 O-C-N 125.842 1.964 . . . . 0.0 114.535 179.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.54 ' CD2' ' HD3' ' A' ' 126' ' ' ARG . 32.4 t80 -57.03 -28.52 62.58 Favored 'General case' 0 N--CA 1.434 -1.244 0 CA-C-N 112.666 -2.061 . . . . 0.0 114.854 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -71.47 -38.19 71.26 Favored 'General case' 0 C--O 1.212 -0.92 0 CA-C-O 123.062 1.411 . . . . 0.0 109.721 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 3.0 ttmm -76.66 -26.84 55.28 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-O 123.203 1.477 . . . . 0.0 112.217 179.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.588 ' HA ' HG11 ' A' ' 122' ' ' VAL . 2.4 t80 -73.37 -23.06 60.15 Favored 'General case' 0 C--O 1.241 0.611 0 O-C-N 119.09 -2.256 . . . . 0.0 111.779 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.411 ' HB3' HG13 ' A' ' 23' ' ' ILE . 1.1 mmt -75.87 -30.28 58.82 Favored 'General case' 0 C--N 1.317 -0.829 1 O-C-N 116.299 -4.001 . . . . 0.0 107.154 179.656 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -68.3 -33.6 74.62 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 119.747 -1.846 . . . . 0.0 112.41 -179.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 5.1 tptt -75.41 -31.86 60.54 Favored 'General case' 0 C--O 1.215 -0.748 0 CA-C-N 114.786 -1.097 . . . . 0.0 110.297 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.521 ' CE ' HH12 ' A' ' 95' ' ' ARG . 0.5 OUTLIER -78.47 -20.3 51.22 Favored 'General case' 0 C--O 1.214 -0.804 0 O-C-N 125.543 1.777 . . . . 0.0 108.039 179.776 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 94.36 65.59 1.02 Allowed Glycine 0 C--N 1.302 -1.308 0 CA-C-O 116.865 -2.075 . . . . 0.0 109.598 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.627 HG23 ' HG2' ' A' ' 27' ' ' LYS . 2.1 mm -120.25 157.49 22.8 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 O-C-N 125.021 1.071 . . . . 0.0 109.432 -179.586 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -113.18 165.77 12.08 Favored 'General case' 0 C--O 1.246 0.92 0 O-C-N 124.846 1.341 . . . . 0.0 112.077 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . 0.375 0.0 OUTLIER -23.01 -61.02 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.501 -0.923 0 N-CA-C 120.833 3.642 . . . . 0.0 120.833 179.925 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.615 57.8 t -78.45 -38.55 22.76 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.751 0 CA-C-O 122.629 1.204 . . . . 0.0 112.796 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.627 ' HG2' HG23 ' A' ' 23' ' ' ILE . 0.1 OUTLIER -64.35 -37.28 86.97 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-N 113.523 -1.671 . . . . 0.0 113.798 -179.819 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.492 ' HA ' HG21 ' A' ' 23' ' ' ILE . 15.9 ptt85 -77.94 -22.67 49.21 Favored 'General case' 0 C--O 1.22 -0.47 0 O-C-N 119.486 -2.008 . . . . 0.0 109.639 179.715 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 16.7 tttp -74.16 -37.29 64.03 Favored 'General case' 0 C--N 1.35 0.61 0 CA-C-N 113.543 -1.662 . . . . 0.0 113.707 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.5 mt -69.8 -34.48 73.77 Favored 'General case' 0 N--CA 1.436 -1.139 0 C-N-CA 125.757 1.623 . . . . 0.0 111.305 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -77.32 -25.2 64.09 Favored Glycine 0 C--N 1.339 0.715 0 O-C-N 126.344 2.277 . . . . 0.0 111.31 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -75.11 -40.39 59.95 Favored 'General case' 0 C--O 1.22 -0.449 0 O-C-N 120.894 -1.357 . . . . 0.0 111.829 -179.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -98.27 9.74 42.3 Favored 'General case' 0 CA--C 1.51 -0.581 0 O-C-N 128.958 3.911 . . . . 0.0 110.821 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 36.5 p30 -47.6 -29.33 2.83 Favored 'General case' 0 CA--C 1.505 -0.782 0 N-CA-C 120.679 3.585 . . . . 0.0 120.679 179.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . 0.288 2.1 m120 73.98 30.56 1.27 Allowed 'General case' 0 C--O 1.243 0.753 0 CA-C-N 120.77 1.623 . . . . 0.0 110.72 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.634 HD11 HD13 ' A' ' 38' ' ' LEU . 9.6 tp -49.86 109.76 0.32 Allowed 'General case' 0 C--N 1.354 0.777 0 C-N-CA 126.435 1.894 . . . . 0.0 108.578 -179.811 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 7.7 ttmm -108.86 102.79 11.78 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 104.664 -2.347 . . . . 0.0 104.664 179.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.634 HD13 HD11 ' A' ' 36' ' ' LEU 0.26 0.1 OUTLIER -88.57 109.44 20.08 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.907 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.483 ' HB ' ' CB ' ' A' ' 50' ' ' LYS . 13.6 m -95.16 93.99 7.66 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 104.505 -2.405 . . . . 0.0 104.505 -179.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 21.0 mt -75.99 120.02 25.12 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.213 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 179.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.421 ' O ' HG22 ' A' ' 41' ' ' THR . 2.6 m -124.97 100.85 6.78 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 111.78 -2.464 . . . . 0.0 109.655 179.625 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -74.05 162.91 28.53 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-O 116.488 -1.72 . . . . 0.0 111.017 -179.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -151.09 -133.79 0.06 Allowed 'General case' 0 N--CA 1.424 -1.745 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -86.47 70.93 2.88 Favored Glycine 0 C--N 1.302 -1.315 0 N-CA-C 104.729 -3.348 . . . . 0.0 104.729 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 81.24 -8.38 1.4 Allowed 'General case' 0 C--O 1.216 -0.659 0 O-C-N 124.777 0.928 . . . . 0.0 111.756 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.465 ' HE2' ' HB ' ' A' ' 61' ' ' VAL . 13.4 tttt -98.31 125.77 43.55 Favored 'General case' 0 C--O 1.25 1.093 0 C-N-CA 118.456 -1.298 . . . . 0.0 108.915 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . 0.261 0.7 OUTLIER -103.92 107.37 18.22 Favored 'General case' 0 N--CA 1.446 -0.654 0 O-C-N 125.983 2.052 . . . . 0.0 111.451 -179.955 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 1.039 ' HB ' HG12 ' A' ' 61' ' ' VAL 0.425 0.1 OUTLIER -94.68 131.04 40.91 Favored 'General case' 0 CA--C 1.493 -1.243 0 O-C-N 125.589 1.805 . . . . 0.0 108.332 179.891 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.599 HG21 ' HG ' ' A' ' 38' ' ' LEU 0.644 0.3 OUTLIER -111.43 98.31 6.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 CA-C-N 113.353 -1.749 . . . . 0.0 112.233 -179.762 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.483 ' CB ' ' HB ' ' A' ' 39' ' ' THR . 0.6 OUTLIER -65.8 119.67 11.65 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 102.47 -3.159 . . . . 0.0 102.47 -179.941 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -113.94 85.91 2.31 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 124.475 2.083 . . . . 0.0 106.527 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 43.0 m -88.79 63.0 6.67 Favored 'General case' 0 N--CA 1.419 -2.004 0 CA-C-N 113.221 -1.809 . . . . 0.0 106.801 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -77.39 170.32 16.75 Favored 'General case' 0 C--O 1.216 -0.692 0 C-N-CA 115.933 -2.307 . . . . 0.0 111.219 -179.747 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -58.61 -20.85 50.91 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 117.838 -1.545 . . . . 0.0 108.333 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.531 ' CE1' ' HE2' ' A' ' 132' ' ' PLM . 11.1 m-85 -85.48 -60.73 1.94 Allowed 'General case' 0 N--CA 1.44 -0.944 0 CA-C-O 114.007 -2.901 . . . . 0.0 110.391 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.7 ' HB2' HG22 ' A' ' 58' ' ' ILE . 66.6 mtp85 -133.95 176.87 8.19 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 124.416 3.28 . . . . 0.0 110.46 -179.643 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 10.7 m-80 -138.76 59.02 1.64 Allowed 'General case' 0 C--O 1.215 -0.728 2 C-N-CA 132.002 4.121 . . . . 0.0 100.081 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.7 HG22 ' HB2' ' A' ' 56' ' ' ARG . 1.5 tt -84.18 -44.18 17.87 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 1 C-N-CA 132.688 4.395 . . . . 0.0 119.772 -178.695 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . 0.277 34.2 t0 78.55 140.33 0.07 Allowed 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 104.073 -2.565 . . . . 0.0 104.073 -176.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.401 HG21 ' C2 ' ' A' ' 132' ' ' PLM . 58.0 t -112.39 -53.59 5.22 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.152 0 C-N-CA 118.527 -1.269 . . . . 0.0 112.627 -178.245 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 1.039 HG12 ' HB ' ' A' ' 48' ' ' THR 0.398 0.9 OUTLIER 66.97 131.52 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 CA-C-O 126.272 2.939 . . . . 0.0 109.016 -178.907 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.556 ' CD2' ' CD1' ' A' ' 82' ' ' TRP . 12.5 p90 -164.03 93.76 0.72 Allowed 'General case' 0 N--CA 1.443 -0.817 0 O-C-N 117.05 -3.531 . . . . 0.0 110.334 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.418 ' HA ' ' HA ' ' A' ' 46' ' ' LYS . 27.3 mt-10 -65.59 136.63 56.6 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 105.644 -1.984 . . . . 0.0 105.644 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -50.88 121.86 6.59 Favored 'General case' 0 N--CA 1.437 -1.091 0 O-C-N 125.505 1.753 . . . . 0.0 110.691 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 79.98 3.59 89.43 Favored Glycine 0 C--N 1.35 1.336 0 CA-C-N 112.424 -2.171 . . . . 0.0 117.805 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . 0.378 79.4 t -106.03 97.48 5.67 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 N-CA-C 104.612 -2.366 . . . . 0.0 104.612 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -63.0 177.12 0.61 Allowed 'General case' 0 CA--C 1.484 -1.578 0 C-N-CA 117.584 -1.646 . . . . 0.0 114.605 -179.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.488 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 1.1 p90 -155.98 172.21 18.77 Favored 'General case' 0 N--CA 1.433 -1.304 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.627 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -115.3 140.91 48.7 Favored 'General case' 0 C--N 1.322 -0.609 0 O-C-N 126.858 2.599 . . . . 0.0 105.851 179.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 13.4 t80 -152.65 112.13 3.89 Favored 'General case' 0 C--O 1.206 -1.19 0 CA-C-N 120.525 1.511 . . . . 0.0 114.024 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.5 p -81.79 144.41 31.09 Favored 'General case' 0 C--N 1.315 -0.909 0 O-C-N 119.147 -2.221 . . . . 0.0 105.448 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 10.5 mp -102.28 -175.17 2.75 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 124.592 1.183 . . . . 0.0 108.465 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.432 ' HB3' ' HD2' ' A' ' 132' ' ' PLM . . . -90.94 -13.39 33.56 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.135 0.974 . . . . 0.0 111.94 -179.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.808 ' HB3' ' HG1' ' A' ' 132' ' ' PLM . 0.3 OUTLIER -79.63 -11.15 59.88 Favored 'General case' 0 N--CA 1.439 -0.998 0 C-N-CA 119.308 -0.957 . . . . 0.0 110.751 -179.549 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 102.93 22.83 9.03 Favored Glycine 0 C--O 1.204 -1.777 0 O-C-N 125.528 1.768 . . . . 0.0 111.733 -179.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -129.24 155.15 46.01 Favored 'General case' 0 CA--C 1.491 -1.309 0 C-N-CA 117.782 -1.567 . . . . 0.0 112.786 -179.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.471 ' CB ' ' HB ' ' A' ' 96' ' ' VAL . 32.1 mp0 -92.41 155.92 17.55 Favored 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 127.572 2.349 . . . . 0.0 112.646 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.572 HD11 ' CG ' ' A' ' 93' ' ' PHE 0.429 0.6 OUTLIER -156.41 153.43 28.87 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 105.264 -2.125 . . . . 0.0 105.264 -179.912 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.404 ' O ' ' N ' ' A' ' 94' ' ' LYS . 64.2 m -157.67 139.21 13.81 Favored 'General case' 0 C--O 1.197 -1.669 0 N-CA-C 102.884 -3.006 . . . . 0.0 102.884 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 174.81 -172.15 45.2 Favored Glycine 0 C--N 1.293 -1.839 0 C-N-CA 114.116 -3.897 . . . . 0.0 114.759 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 76.3 p -132.88 169.09 17.27 Favored 'General case' 0 C--O 1.187 -2.19 0 CA-C-N 120.563 2.182 . . . . 0.0 109.252 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . 0.556 ' CD1' ' CD2' ' A' ' 62' ' ' PHE . 69.7 m95 -127.1 140.15 52.48 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 102.37 -3.196 . . . . 0.0 102.37 179.693 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 8.8 t -146.45 142.93 28.62 Favored 'General case' 0 C--O 1.255 1.366 0 CA-C-O 123.803 1.764 . . . . 0.0 109.994 179.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 2.0 ttm -81.24 99.67 8.72 Favored 'General case' 0 N--CA 1.425 -1.72 0 CA-C-N 111.111 -2.768 . . . . 0.0 109.584 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . 0.601 29.0 mm-40 -65.61 -104.19 0.0 OUTLIER 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 119.666 1.121 . . . . 0.0 113.248 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -137.39 93.92 0.22 Allowed Glycine 0 N--CA 1.436 -1.337 1 N-CA-C 102.932 -4.067 . . . . 0.0 102.932 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 58.34 21.17 8.01 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 113.191 0.811 . . . . 0.0 113.191 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . 0.33 7.1 mtmt -149.93 112.66 4.78 Favored 'General case' 0 CA--C 1.492 -1.267 0 O-C-N 126.395 2.309 . . . . 0.0 112.326 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.582 HD12 ' HD2' ' A' ' 106' ' ' ARG . 0.0 OUTLIER -75.98 130.63 38.73 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 102.478 -3.156 . . . . 0.0 102.478 179.908 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.51 ' HB ' HD11 ' A' ' 103' ' ' ILE . 5.4 m -129.03 136.3 60.02 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.932 0 CA-C-O 116.86 -1.543 . . . . 0.0 108.78 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -112.39 106.75 1.94 Allowed Glycine 0 CA--C 1.539 1.578 0 O-C-N 126.958 2.662 . . . . 0.0 112.86 179.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 8.0 mtpt -93.46 113.08 25.13 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 102.734 -3.061 . . . . 0.0 102.734 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.599 ' HD2' HD22 ' A' ' 102' ' ' LEU . 19.1 m-85 -104.46 96.93 6.94 Favored 'General case' 0 CA--C 1.502 -0.902 0 O-C-N 125.906 2.004 . . . . 0.0 114.492 -179.747 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.404 ' N ' ' O ' ' A' ' 79' ' ' THR . 39.1 mttt -80.04 127.48 32.34 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 126.541 1.936 . . . . 0.0 108.923 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.521 HH12 ' CE ' ' A' ' 21' ' ' MET 0.336 0.0 OUTLIER -72.71 144.32 47.71 Favored 'General case' 0 CA--C 1.502 -0.872 0 N-CA-C 104.434 -2.432 . . . . 0.0 104.434 -179.833 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.471 ' HB ' ' CB ' ' A' ' 77' ' ' GLU . 17.4 t -77.09 -33.66 20.67 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 C-N-CA 125.895 1.678 . . . . 0.0 112.248 -179.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . 0.262 0.0 OUTLIER -95.73 -27.88 15.05 Favored 'General case' 0 C--O 1.254 1.294 0 N-CA-C 115.05 1.5 . . . . 0.0 115.05 -179.867 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.401 ' ND2' ' OH ' ' A' ' 119' ' ' TYR . 50.8 t30 -89.7 -25.07 21.39 Favored 'General case' 0 N--CA 1.419 -2.013 0 CA-C-N 114.623 -1.171 . . . . 0.0 113.702 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 64.97 10.24 45.11 Favored Glycine 0 CA--C 1.536 1.363 0 O-C-N 127.149 2.781 . . . . 0.0 113.826 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 73.1 mttt -103.26 159.01 15.93 Favored 'General case' 0 C--O 1.197 -1.662 0 N-CA-C 107.629 -1.248 . . . . 0.0 107.629 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -95.27 158.91 15.25 Favored 'General case' 0 N--CA 1.431 -1.382 0 O-C-N 126.442 2.339 . . . . 0.0 116.001 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.599 HD22 ' HD2' ' A' ' 93' ' ' PHE . 5.0 tt -138.57 145.71 40.94 Favored 'General case' 0 C--N 1.326 -0.418 1 O-C-N 129.826 4.454 . . . . 0.0 104.477 179.569 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.583 ' N ' HD23 ' A' ' 102' ' ' LEU . 3.5 tp -127.39 152.85 35.93 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.071 0 N-CA-C 104.379 -2.452 . . . . 0.0 104.379 -179.435 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -134.76 132.79 39.17 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 114.119 -2.848 . . . . 0.0 106.26 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.677 HG12 ' OG1' ' A' ' 116' ' ' THR . 10.7 p -120.19 103.65 14.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 O-C-N 125.612 1.82 . . . . 0.0 113.77 -179.383 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.582 ' HD2' HD12 ' A' ' 89' ' ' LEU 0.269 36.2 mtt85 -74.6 89.16 2.2 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 104.483 -2.414 . . . . 0.0 104.483 179.561 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -92.08 77.57 5.32 Favored 'General case' 0 N--CA 1.428 -1.571 0 O-C-N 127.041 2.713 . . . . 0.0 114.907 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.565 HD11 ' CH2' ' A' ' 6' ' ' TRP 0.326 0.0 OUTLIER -56.68 101.81 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 CA-C-O 123.274 1.511 . . . . 0.0 112.094 179.961 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 61.4 m -88.19 71.06 9.26 Favored 'General case' 0 CA--C 1.502 -0.902 0 N-CA-C 104.569 -2.382 . . . . 0.0 104.569 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 66.59 -82.8 0.11 Allowed Glycine 0 C--N 1.344 1.02 0 C-N-CA 128.585 2.993 . . . . 0.0 111.743 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . 0.319 0.1 OUTLIER -98.73 -19.68 17.34 Favored 'General case' 0 C--O 1.221 -0.417 0 CA-C-O 117.651 -1.166 . . . . 0.0 111.911 -179.605 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.446 ' HG3' ' HA ' ' A' ' 129' ' ' LYS . 45.6 mp0 -105.86 127.93 53.43 Favored 'General case' 0 CA--C 1.498 -1.027 0 O-C-N 124.622 1.201 . . . . 0.0 112.175 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.479 HD23 ' CD1' ' A' ' 128' ' ' PHE . 2.0 tt -93.67 139.5 30.73 Favored 'General case' 0 C--O 1.211 -0.925 0 N-CA-C 100.208 -3.997 . . . . 0.0 100.208 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.527 HG23 HD12 ' A' ' 127' ' ' ILE . 68.5 mt -131.53 145.7 34.73 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 O-C-N 128.991 3.932 . . . . 0.0 103.776 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 9.1 mt-30 -134.52 129.9 35.81 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.677 ' OG1' HG12 ' A' ' 105' ' ' VAL . 24.3 p -101.65 -176.53 3.16 Favored 'General case' 0 C--O 1.249 1.035 0 O-C-N 126.703 2.502 . . . . 0.0 104.933 179.42 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.434 ' HB2' ' HB3' ' A' ' 124' ' ' ALA . 68.4 m-85 -160.56 87.07 0.74 Allowed 'General case' 0 CA--C 1.475 -1.939 0 CA-C-O 115.789 -2.053 . . . . 0.0 109.69 179.661 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.469 ' HB ' ' CG2' ' A' ' 103' ' ' ILE . 95.4 m -94.47 101.29 13.2 Favored 'General case' 0 N--CA 1.433 -1.294 0 O-C-N 128.247 3.467 . . . . 0.0 110.107 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.56 ' HA ' ' HA ' ' A' ' 102' ' ' LEU . 5.8 t80 -77.97 -77.65 0.15 Allowed 'General case' 0 CA--C 1.499 -0.983 0 O-C-N 125.816 1.948 . . . . 0.0 107.523 -179.742 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.457 ' HG3' ' CE2' ' A' ' 119' ' ' TYR . 1.5 mm-40 -108.44 -75.7 0.63 Allowed 'General case' 0 C--N 1.298 -1.642 0 CA-C-O 117.522 -1.228 . . . . 0.0 108.462 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -133.71 32.94 2.62 Favored Glycine 0 CA--C 1.528 0.863 0 O-C-N 127.776 3.172 . . . . 0.0 114.74 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.588 HG11 ' HA ' ' A' ' 17' ' ' PHE . 0.3 OUTLIER -139.59 122.35 17.4 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.68 0 O-C-N 119.789 -2.006 . . . . 0.0 110.477 -179.883 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -95.82 177.65 5.7 Favored 'General case' 0 N--CA 1.431 -1.402 0 O-C-N 120.522 -1.361 . . . . 0.0 107.825 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.521 ' HB2' ' CB ' ' A' ' 17' ' ' PHE . . . -169.76 77.16 0.09 Allowed 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 115.709 -2.396 . . . . 0.0 109.193 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.414 ' HB2' ' HB3' ' A' ' 12' ' ' GLU . 12.1 mptt -64.3 141.27 58.83 Favored 'General case' 0 C--O 1.251 1.142 0 CA-C-N 118.488 0.586 . . . . 0.0 109.541 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.54 ' HD3' ' CD2' ' A' ' 14' ' ' TYR . 14.3 mtm180 -137.58 83.1 1.96 Allowed 'General case' 0 CA--C 1.509 -0.623 0 O-C-N 127.315 2.884 . . . . 0.0 108.535 179.78 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.527 HD12 HG23 ' A' ' 114' ' ' ILE . 0.8 OUTLIER -74.84 119.31 22.15 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.788 1 O-C-N 129.79 4.432 . . . . 0.0 110.757 179.894 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.509 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 0.1 OUTLIER -102.99 169.9 8.29 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 112.336 -2.211 . . . . 0.0 108.247 -180.0 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.446 ' HA ' ' HG3' ' A' ' 112' ' ' GLU . 0.0 OUTLIER -119.12 0.49 11.26 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 105.693 -1.965 . . . . 0.0 105.693 179.786 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.63 ' HA ' ' CE3' ' A' ' 6' ' ' TRP . 34.7 tttt 73.6 95.91 0.07 Allowed 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 120.684 1.583 . . . . 0.0 112.436 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . 0.854 3.8 mt-10 . . . . . 0 N--CA 1.435 -1.178 0 N-CA-C 117.523 2.416 . . . . 0.0 117.523 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' PLM . . . . . 0.808 ' HG1' ' HB3' ' A' ' 74' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 0.229 0 CA-C-O 116.888 -1.529 . . . . 0.0 110.122 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.518 ' CE1' HG12 ' A' ' 108' ' ' ILE . 97.3 m-85 -43.28 89.91 0.0 OUTLIER 'General case' 0 C--N 1.312 -1.062 0 O-C-N 126.082 2.114 . . . . 0.0 116.084 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -166.39 86.59 0.32 Allowed 'General case' 0 CA--C 1.494 -1.204 0 C-N-CA 117.985 -1.486 . . . . 0.0 112.686 -179.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 150.47 -130.02 3.11 Favored Glycine 0 C--N 1.31 -0.915 0 C-N-CA 116.503 -2.761 . . . . 0.0 112.114 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.449 ' HA ' ' HA ' ' A' ' 39' ' ' THR 0.625 0.8 OUTLIER -123.11 161.2 24.86 Favored 'General case' 0 N--CA 1.432 -1.339 0 CA-C-O 124.158 1.932 . . . . 0.0 112.014 -179.933 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.596 ' CE3' ' HA ' ' A' ' 130' ' ' LYS 0.264 86.7 m95 -153.77 114.7 4.07 Favored 'General case' 0 N--CA 1.431 -1.393 0 CA-C-N 111.872 -2.422 . . . . 0.0 110.856 179.896 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 30.4 ttmt -109.56 108.45 18.91 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-O 115.174 -2.346 . . . . 0.0 107.057 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.534 HG12 ' HB3' ' A' ' 36' ' ' LEU 0.411 8.2 p -48.51 147.0 0.76 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.846 0 CA-C-N 121.202 1.819 . . . . 0.0 109.222 -179.964 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -157.28 14.09 0.25 Allowed 'General case' 0 CA--C 1.499 -0.996 0 C-N-CA 117.464 -1.695 . . . . 0.0 111.455 -179.126 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.27 -57.65 0.65 Allowed 'General case' 0 CA--C 1.487 -1.465 0 O-C-N 116.679 -3.763 . . . . 0.0 109.965 -179.684 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 59.74 170.91 0.08 Allowed 'General case' 0 C--O 1.244 0.778 0 O-C-N 127.529 3.018 . . . . 0.0 108.928 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.452 ' O ' ' N ' ' A' ' 125' ' ' LYS . 6.0 tt0 -170.43 134.51 1.14 Allowed 'General case' 0 C--N 1.3 -1.583 0 O-C-N 117.792 -3.068 . . . . 0.0 107.534 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.564 ' ND2' ' CD1' ' A' ' 17' ' ' PHE . 1.0 OUTLIER 62.67 29.78 16.87 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-N 122.563 2.438 . . . . 0.0 113.857 179.844 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . 0.348 9.3 t80 -98.11 -64.5 1.03 Allowed 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 121.201 3.778 . . . . 0.0 121.201 -178.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.09 -38.74 77.0 Favored 'General case' 0 CA--C 1.498 -1.049 0 CA-C-N 124.49 3.313 . . . . 0.0 113.792 -179.061 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.479 ' HB3' ' CD1' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -67.27 -43.23 82.35 Favored 'General case' 0 N--CA 1.422 -1.829 0 C-N-CA 127.643 2.377 . . . . 0.0 113.578 179.584 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.645 ' HB3' ' HB ' ' A' ' 122' ' ' VAL 0.266 64.8 m-85 -80.03 -20.1 46.11 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 111.188 -2.733 . . . . 0.0 113.557 -178.057 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.525 ' CB ' HG13 ' A' ' 23' ' ' ILE . 0.5 OUTLIER -72.21 -23.11 61.2 Favored 'General case' 0 N--CA 1.435 -1.22 0 O-C-N 117.035 -3.541 . . . . 0.0 105.983 176.591 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -74.24 -24.89 59.37 Favored 'General case' 0 C--N 1.348 0.528 0 O-C-N 120.378 -1.451 . . . . 0.0 109.849 179.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.487 ' CE ' HG12 ' A' ' 122' ' ' VAL . 11.3 tttp -79.1 -32.58 44.64 Favored 'General case' 0 N--CA 1.432 -1.367 0 CA-C-O 116.196 -1.859 . . . . 0.0 110.589 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.24 -23.5 57.54 Favored 'General case' 0 C--O 1.214 -0.814 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 179.312 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 104.25 40.89 2.17 Favored Glycine 0 N--CA 1.445 -0.714 0 CA-C-O 115.747 -2.696 . . . . 0.0 109.935 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.589 HG23 ' HB3' ' A' ' 27' ' ' LYS . 2.2 mm -86.99 83.44 2.19 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 CA-C-N 120.49 2.145 . . . . 0.0 106.994 -179.682 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -42.09 112.91 0.38 Allowed 'General case' 0 C--O 1.248 1.009 0 O-C-N 124.91 1.381 . . . . 0.0 114.357 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . 0.364 84.7 t 18.52 -66.73 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.502 -0.893 0 N-CA-C 121.066 3.728 . . . . 0.0 121.066 -179.784 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.538 1.3 m -71.52 -24.49 23.63 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.122 0 N-CA-C 117.448 2.388 . . . . 0.0 117.448 -179.531 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.589 ' HB3' HG23 ' A' ' 23' ' ' ILE . 1.5 mtmp? -72.04 -29.22 63.94 Favored 'General case' 0 C--N 1.318 -0.775 0 C-N-CA 119.072 -1.051 . . . . 0.0 112.993 179.759 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.49 ' N ' HG22 ' A' ' 23' ' ' ILE . 2.6 ptt-85 -78.49 -21.51 48.87 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 116.777 -1.969 . . . . 0.0 109.363 179.83 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 12.0 tttt -77.78 -43.21 31.38 Favored 'General case' 0 CA--C 1.502 -0.869 0 CA-C-N 113.553 -1.658 . . . . 0.0 109.924 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -79.02 -23.07 44.58 Favored 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 -179.729 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -76.68 -34.88 42.4 Favored Glycine 0 CA--C 1.527 0.793 0 O-C-N 125.613 1.821 . . . . 0.0 112.476 179.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -72.9 -38.61 66.87 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 6.5 m-70 -98.92 20.33 13.4 Favored 'General case' 0 N--CA 1.439 -0.99 0 O-C-N 127.377 2.923 . . . . 0.0 112.604 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 23.6 p30 -47.75 -31.52 4.91 Favored 'General case' 0 CA--C 1.497 -1.096 0 N-CA-C 119.347 3.091 . . . . 0.0 119.347 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . 0.309 0.6 OUTLIER 76.59 15.85 2.06 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 119.291 0.951 . . . . 0.0 109.264 -179.809 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.583 HD11 HD12 ' A' ' 38' ' ' LEU . 30.5 tp -42.1 114.84 0.6 Allowed 'General case' 0 CA--C 1.5 -0.946 0 C-N-CA 128.636 2.775 . . . . 0.0 110.249 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -116.76 94.64 4.68 Favored 'General case' 0 C--O 1.211 -0.967 0 N-CA-C 105.246 -2.131 . . . . 0.0 105.246 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.646 HD13 ' CZ ' ' A' ' 128' ' ' PHE 0.256 0.1 OUTLIER -79.8 105.28 10.97 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 179.73 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.555 ' HB ' ' HB3' ' A' ' 50' ' ' LYS . 99.3 m -94.98 80.4 3.65 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 104.268 -2.493 . . . . 0.0 104.268 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.55 HG13 ' CD1' ' A' ' 6' ' ' TRP . 0.9 OUTLIER -60.23 134.99 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.371 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.331 179.977 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.3 m -128.45 108.19 10.35 Favored 'General case' 0 N--CA 1.475 0.81 0 O-C-N 128.043 3.34 . . . . 0.0 108.437 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -99.07 105.72 17.86 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 117.802 -1.094 . . . . 0.0 113.806 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -108.77 68.02 0.67 Allowed 'General case' 0 N--CA 1.424 -1.767 0 CA-C-O 126.756 3.17 . . . . 0.0 108.019 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 77.79 -108.55 2.63 Favored Glycine 0 C--N 1.293 -1.853 0 N-CA-C 106.956 -2.457 . . . . 0.0 106.956 179.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.416 HD22 ' N ' ' A' ' 45' ' ' ASN . 0.9 OUTLIER -102.38 48.3 0.87 Allowed 'General case' 0 N--CA 1.444 -0.735 0 CA-C-O 123.04 1.4 . . . . 0.0 110.456 179.688 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 3.1 ttmt -149.06 129.28 13.67 Favored 'General case' 0 C--N 1.312 -1.056 0 C-N-CA 116.479 -2.088 . . . . 0.0 107.657 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.409 ' CE2' HD11 ' A' ' 89' ' ' LEU . 11.0 m-85 -114.53 88.12 2.79 Favored 'General case' 0 CA--C 1.511 -0.557 0 CA-C-O 121.958 0.885 . . . . 0.0 110.117 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.658 ' OG1' HG12 ' A' ' 61' ' ' VAL 0.349 14.8 t -95.19 85.92 4.43 Favored 'General case' 0 N--CA 1.428 -1.543 0 CA-C-O 125.799 2.714 . . . . 0.0 108.789 -179.742 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.454 HG13 ' HE1' ' A' ' 62' ' ' PHE 0.654 1.0 OUTLIER -70.39 108.67 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.768 0 N-CA-C 117.758 2.503 . . . . 0.0 117.758 -179.948 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.555 ' HB3' ' HB ' ' A' ' 39' ' ' THR . 15.9 tttp -69.55 117.46 11.18 Favored 'General case' 0 C--N 1.303 -1.416 1 N-CA-C 99.508 -4.256 . . . . 0.0 99.508 179.218 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.438 ' HG3' ' CD1' ' A' ' 36' ' ' LEU . 1.1 tt0 -112.67 104.96 13.03 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 -179.334 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -103.45 51.63 0.79 Allowed 'General case' 0 C--N 1.289 -2.049 0 N-CA-C 105.317 -2.105 . . . . 0.0 105.317 179.562 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 4.3 t -73.05 21.37 0.07 Allowed 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 113.175 -1.83 . . . . 0.0 115.474 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 73.79 -51.42 0.69 Allowed 'General case' 0 CA--C 1.498 -1.032 0 CA-C-N 122.245 2.293 . . . . 0.0 109.787 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -67.1 -44.33 80.25 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-O 115.119 -2.372 . . . . 0.0 110.209 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.518 ' HB2' HG22 ' A' ' 58' ' ' ILE . 9.3 ptp180 -149.56 126.17 10.99 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 123.633 2.924 . . . . 0.0 106.795 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -99.71 74.42 1.85 Allowed 'General case' 0 N--CA 1.465 0.291 1 N-CA-C 100.197 -4.001 . . . . 0.0 100.197 179.784 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.518 HG22 ' HB2' ' A' ' 56' ' ' ARG . 3.3 tp -115.94 117.83 56.8 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.82 1 C-N-CA 132.417 4.287 . . . . 0.0 118.9 -179.104 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.95 125.58 26.77 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 103.607 -2.738 . . . . 0.0 103.607 178.163 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 1.4 t -107.85 103.96 16.32 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 O-C-N 124.515 1.135 . . . . 0.0 113.217 -178.064 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.658 HG12 ' OG1' ' A' ' 48' ' ' THR 0.395 1.7 m -88.49 141.97 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.159 0 CA-C-O 125.091 2.377 . . . . 0.0 113.888 179.593 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.597 ' HB3' ' CE1' ' A' ' 68' ' ' PHE . 0.1 OUTLIER -160.75 95.64 1.1 Allowed 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 113.128 -1.851 . . . . 0.0 108.772 -179.833 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -54.49 144.57 20.8 Favored 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 104.772 -2.307 . . . . 0.0 104.772 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.636 ' H ' HD12 ' A' ' 64' ' ' LEU . 2.9 mp -68.89 115.7 8.51 Favored 'General case' 0 N--CA 1.432 -1.345 0 O-C-N 119.475 -2.015 . . . . 0.0 107.238 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 81.87 26.62 48.93 Favored Glycine 0 N--CA 1.471 0.971 0 C-N-CA 126.713 2.102 . . . . 0.0 118.172 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . 0.387 41.2 t -114.8 81.39 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 N-CA-C 104.662 -2.347 . . . . 0.0 104.662 179.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.435 ' HA ' ' CG2' ' A' ' 81' ' ' THR . 0.7 OUTLIER -38.43 114.08 0.34 Allowed 'General case' 0 C--N 1.307 -1.262 0 O-C-N 125.689 1.868 . . . . 0.0 114.437 -179.917 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.597 ' CE1' ' HB3' ' A' ' 62' ' ' PHE . 37.6 p90 -119.95 164.86 15.44 Favored 'General case' 0 N--CA 1.427 -1.598 0 O-C-N 125.18 1.55 . . . . 0.0 107.977 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -108.93 138.1 45.8 Favored 'General case' 0 C--N 1.319 -0.74 0 O-C-N 126.171 2.169 . . . . 0.0 106.997 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.801 ' O ' HD13 ' A' ' 72' ' ' LEU . 35.9 t80 -133.73 95.57 3.5 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 119.787 1.176 . . . . 0.0 111.248 -179.596 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.514 ' C ' HD22 ' A' ' 72' ' ' LEU . 1.9 p -72.26 79.22 0.99 Allowed 'General case' 0 N--CA 1.432 -1.36 0 CA-C-O 117.529 -1.224 . . . . 0.0 112.386 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.955 HD22 ' N ' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -40.06 175.75 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.813 1 O-C-N 130.355 4.785 . . . . 0.0 110.028 174.955 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.59 ' HB3' ' HG2' ' A' ' 132' ' ' PLM . . . -83.52 -45.38 13.64 Favored 'General case' 0 C--N 1.351 0.671 0 O-C-N 120.522 -1.361 . . . . 0.0 113.613 -178.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.551 ' CB ' ' HD2' ' A' ' 27' ' ' LYS . 0.4 OUTLIER -148.96 25.74 0.91 Allowed 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 179.956 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.473 ' C ' ' HG ' ' A' ' 72' ' ' LEU . . . -95.03 -32.23 7.22 Favored Glycine 0 CA--C 1.544 1.874 0 CA-C-N 112.69 -2.05 . . . . 0.0 113.312 179.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.633 ' N ' ' HG ' ' A' ' 72' ' ' LEU 0.376 0.3 OUTLIER 84.76 117.82 0.04 OUTLIER 'General case' 0 C--N 1.305 -1.364 0 CA-C-O 114.465 -2.683 . . . . 0.0 107.175 -177.878 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.713 ' N ' HD21 ' A' ' 72' ' ' LEU . 0.6 OUTLIER -3.9 120.29 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.63 1 O-C-N 130.134 4.646 . . . . 0.0 114.405 -179.412 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.691 HD12 HD23 ' A' ' 102' ' ' LEU 0.518 0.5 OUTLIER -133.22 122.12 23.49 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 102.022 -3.325 . . . . 0.0 102.022 179.772 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 10.7 t -137.59 123.35 19.96 Favored 'General case' 0 C--O 1.198 -1.637 0 N-CA-C 101.765 -3.421 . . . . 0.0 101.765 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -156.89 -149.31 5.36 Favored Glycine 0 C--N 1.308 -1.02 0 C-N-CA 116.921 -2.562 . . . . 0.0 110.419 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.435 ' CG2' ' HA ' ' A' ' 67' ' ' ASP . 22.1 p -155.32 165.79 35.57 Favored 'General case' 0 C--O 1.198 -1.607 0 CA-C-O 123.838 1.78 . . . . 0.0 109.037 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . 0.542 ' CZ2' ' CZ ' ' A' ' 106' ' ' ARG 0.322 12.2 m95 -112.71 129.46 56.4 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 100.772 -3.788 . . . . 0.0 100.772 -179.879 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.7 t -144.17 100.81 3.62 Favored 'General case' 0 C--O 1.262 1.716 0 O-C-N 121.218 -0.926 . . . . 0.0 110.254 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.482 ' CA ' HD23 ' A' ' 89' ' ' LEU . 6.4 ttp -52.58 112.93 0.91 Allowed 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 105.471 -2.048 . . . . 0.0 105.471 179.807 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . 0.622 3.8 mm-40 -77.8 -56.34 4.59 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 124.806 1.316 . . . . 0.0 110.07 -179.731 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 160.24 124.8 0.75 Allowed Glycine 0 C--O 1.22 -0.725 0 N-CA-C 103.402 -3.879 . . . . 0.0 103.402 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . 0.26 0.1 OUTLIER 55.97 15.64 1.82 Allowed 'General case' 0 C--O 1.245 0.832 0 CA-C-O 116.572 -1.68 . . . . 0.0 113.638 -179.986 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . 0.418 3.1 mppt? -174.12 150.26 1.53 Allowed 'General case' 0 CA--C 1.496 -1.101 0 O-C-N 125.772 1.92 . . . . 0.0 106.812 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.482 HD23 ' CA ' ' A' ' 84' ' ' MET . 0.7 OUTLIER -113.4 137.88 50.88 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 102.331 -3.211 . . . . 0.0 102.331 -179.879 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 18.5 m -118.24 134.37 62.08 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.028 0 N-CA-C 105.547 -2.02 . . . . 0.0 105.547 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.486 ' O ' ' HB3' ' A' ' 104' ' ' ALA . . . -113.65 95.09 0.73 Allowed Glycine 0 C--N 1.344 0.981 0 C-N-CA 128.164 2.792 . . . . 0.0 108.755 -179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.402 ' HA ' ' HA ' ' A' ' 103' ' ' ILE . 0.6 OUTLIER -90.83 168.64 11.57 Favored 'General case' 0 N--CA 1.436 -1.135 0 N-CA-C 104.323 -2.473 . . . . 0.0 104.323 179.963 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.581 ' HB3' ' HG ' ' A' ' 78' ' ' LEU . 23.5 m-85 -157.71 97.33 1.57 Allowed 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 118.454 -1.299 . . . . 0.0 108.063 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 14.5 mtmt -74.39 161.2 30.07 Favored 'General case' 0 N--CA 1.446 -0.653 0 O-C-N 125.125 1.516 . . . . 0.0 108.47 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.457 ' HD2' ' N ' ' A' ' 95' ' ' ARG 0.457 0.9 OUTLIER -119.47 139.98 51.2 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 179.69 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.603 HG11 ' HG2' ' A' ' 77' ' ' GLU . 3.1 m -83.0 -13.38 12.04 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 179.792 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . 0.333 14.3 p-10 -79.13 3.93 16.16 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 113.504 -1.68 . . . . 0.0 112.361 179.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . 0.256 0.2 OUTLIER -174.93 -29.28 0.01 OUTLIER 'General case' 0 N--CA 1.426 -1.635 0 C-N-CA 117.698 -1.601 . . . . 0.0 114.069 -179.735 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 97.56 20.07 23.31 Favored Glycine 0 N--CA 1.445 -0.701 0 N-CA-C 115.21 0.844 . . . . 0.0 115.21 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 39.3 mttt -82.95 -159.79 0.36 Allowed 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 116.159 -2.216 . . . . 0.0 106.344 -179.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -143.0 148.67 37.17 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-O 117.23 -1.367 . . . . 0.0 109.889 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.691 HD23 HD12 ' A' ' 78' ' ' LEU . 0.3 OUTLIER -133.09 110.1 9.96 Favored 'General case' 0 CA--C 1.543 0.708 1 O-C-N 131.552 5.533 . . . . 0.0 103.217 179.212 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.697 HD13 ' N ' ' A' ' 104' ' ' ALA . 0.0 OUTLIER -92.03 161.18 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.174 0 CA-C-N 114.181 -1.372 . . . . 0.0 111.003 -179.238 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.697 ' N ' HD13 ' A' ' 103' ' ' ILE . . . -150.15 106.38 3.47 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 116.152 -1.88 . . . . 0.0 107.376 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 9.2 p -87.8 103.65 13.71 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.519 0 CA-C-N 120.877 1.672 . . . . 0.0 113.587 -179.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.611 HH22 ' H32' ' A' ' 132' ' ' PLM . 19.2 mtt-85 -74.48 82.2 1.96 Allowed 'General case' 0 CA--C 1.507 -0.679 0 CA-C-O 124.872 2.273 . . . . 0.0 106.074 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.41 ' O ' ' N ' ' A' ' 109' ' ' SER . 0.2 OUTLIER -86.61 81.37 8.27 Favored 'General case' 0 N--CA 1.417 -2.078 0 CA-C-N 111.118 -2.765 . . . . 0.0 117.292 -179.989 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.518 HG12 ' CE1' ' A' ' 2' ' ' PHE . 1.9 mm -63.61 98.41 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 C-N-CA 116.106 -2.238 . . . . 0.0 107.287 179.081 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.41 ' N ' ' O ' ' A' ' 107' ' ' GLU . 2.1 p -62.9 -29.69 70.97 Favored 'General case' 0 C--N 1.319 -0.754 0 O-C-N 121.342 -0.849 . . . . 0.0 109.116 -179.272 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 145.77 -87.97 0.16 Allowed Glycine 0 CA--C 1.526 0.727 1 C-N-CA 131.965 4.602 . . . . 0.0 110.566 -179.304 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . 0.3 0.2 OUTLIER -81.76 -0.93 45.32 Favored 'General case' 0 C--O 1.212 -0.895 0 CA-C-O 113.794 -3.003 . . . . 0.0 110.137 179.235 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -136.61 118.69 15.4 Favored 'General case' 0 C--O 1.205 -1.245 1 O-C-N 129.751 4.407 . . . . 0.0 112.49 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.47 ' HG ' HG12 ' A' ' 108' ' ' ILE . 5.0 tt -91.66 141.1 29.06 Favored 'General case' 0 C--O 1.212 -0.898 0 N-CA-C 100.763 -3.791 . . . . 0.0 100.763 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 1.048 HD12 HD12 ' A' ' 127' ' ' ILE 0.309 14.3 mm -123.1 135.97 61.37 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 N-CA-C 102.55 -3.13 . . . . 0.0 102.55 179.666 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.451 ' HG3' ' CD2' ' A' ' 113' ' ' LEU . 13.5 mt-30 -131.94 95.25 3.65 Favored 'General case' 0 C--O 1.245 0.828 0 CA-C-O 115.425 -2.226 . . . . 0.0 105.385 -179.79 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 61.0 p -70.28 -171.51 0.47 Allowed 'General case' 0 C--N 1.318 -0.772 0 O-C-N 127.017 2.698 . . . . 0.0 106.425 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.466 ' N ' ' O ' ' A' ' 123' ' ' GLU . 12.3 m-85 -159.8 62.26 0.36 Allowed 'General case' 0 CA--C 1.494 -1.181 0 CA-C-O 115.735 -2.079 . . . . 0.0 106.781 179.785 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.515 ' HB ' HG22 ' A' ' 103' ' ' ILE . 0.3 OUTLIER -70.44 108.32 4.22 Favored 'General case' 0 C--O 1.254 1.295 0 O-C-N 126.885 2.616 . . . . 0.0 107.016 -179.171 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.564 ' H ' HG22 ' A' ' 122' ' ' VAL . 76.3 t80 -72.82 -35.77 67.37 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 103.827 -2.657 . . . . 0.0 103.827 -179.425 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -151.77 -66.88 0.17 Allowed 'General case' 0 C--N 1.291 -1.938 1 O-C-N 129.751 4.407 . . . . 0.0 108.074 179.866 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -145.14 27.58 1.86 Allowed Glycine 0 CA--C 1.544 1.892 0 C-N-CA 128.196 2.808 . . . . 0.0 112.881 178.545 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.645 ' HB ' ' HB3' ' A' ' 17' ' ' PHE . 1.7 m -106.77 6.86 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 CA-C-N 112.766 -1.717 . . . . 0.0 110.755 -178.237 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.466 ' O ' ' N ' ' A' ' 117' ' ' TYR . 26.4 tt0 12.71 -75.0 0.0 OUTLIER 'General case' 0 C--N 1.307 -1.275 0 O-C-N 129.007 3.942 . . . . 0.0 112.028 -179.639 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.46 ' HB3' ' O ' ' A' ' 123' ' ' GLU . . . 70.5 84.33 0.14 Allowed 'General case' 0 C--O 1.206 -1.21 0 O-C-N 116.669 -3.769 . . . . 0.0 109.08 178.793 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.452 ' N ' ' O ' ' A' ' 12' ' ' GLU . 6.0 mptt -79.7 136.76 36.86 Favored 'General case' 0 C--O 1.254 1.333 1 O-C-N 129.601 4.313 . . . . 0.0 110.027 179.97 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.499 ' NH2' HD22 ' A' ' 36' ' ' LEU . 3.2 mtm180 -126.49 77.81 1.73 Allowed 'General case' 0 N--CA 1.437 -1.096 0 O-C-N 125.574 1.796 . . . . 0.0 112.155 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 1.048 HD12 HD12 ' A' ' 114' ' ' ILE . 0.4 OUTLIER -73.96 108.37 5.39 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.922 0 O-C-N 126.362 2.289 . . . . 0.0 115.179 179.42 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.646 ' CZ ' HD13 ' A' ' 38' ' ' LEU . 28.7 m-85 -89.06 147.07 24.44 Favored 'General case' 0 N--CA 1.438 -1.064 0 C-N-CA 128.158 2.583 . . . . 0.0 111.215 179.812 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . 0.347 14.3 mtmt -100.15 8.45 43.86 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 117.733 -1.127 . . . . 0.0 110.392 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.596 ' HA ' ' CE3' ' A' ' 6' ' ' TRP . 9.7 tttm 69.53 153.68 0.11 Allowed 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . 0.835 61.1 tt0 . . . . . 0 CA--C 1.505 -0.785 0 N-CA-C 119.246 3.054 . . . . 0.0 119.246 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' PLM . . . . . 0.611 ' H32' HH22 ' A' ' 106' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.267 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.462 ' O ' HG21 ' A' ' 40' ' ' ILE . 0.1 OUTLIER -140.33 31.71 1.92 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 124.076 1.893 . . . . 0.0 114.08 -179.879 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -119.16 99.61 6.82 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 113.54 -1.664 . . . . 0.0 110.874 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.412 ' O ' ' N ' ' A' ' 40' ' ' ILE . . . 157.9 -148.6 18.22 Favored Glycine 0 C--O 1.208 -1.472 0 CA-C-N 112.748 -2.023 . . . . 0.0 110.437 179.658 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.429 HG23 ' HA ' ' A' ' 131' ' ' GLU 0.566 6.3 t -102.03 159.29 15.5 Favored 'General case' 0 N--CA 1.432 -1.334 0 CA-C-N 113.794 -1.203 . . . . 0.0 112.294 -179.84 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.701 ' CH2' HD11 ' A' ' 108' ' ' ILE . 96.0 m95 -146.5 112.26 5.65 Favored 'General case' 0 N--CA 1.441 -0.902 0 O-C-N 127.685 3.116 . . . . 0.0 111.161 179.806 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 11.8 ttmt -109.15 116.47 32.0 Favored 'General case' 0 C--O 1.207 -1.17 0 CA-C-N 121.548 1.976 . . . . 0.0 108.065 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.567 ' HB ' ' CD1' ' A' ' 128' ' ' PHE 0.289 1.5 p -57.62 128.47 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 O-C-N 119.04 -2.288 . . . . 0.0 114.897 179.986 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -107.93 -21.63 12.75 Favored 'General case' 0 C--O 1.213 -0.826 0 CA-C-O 126.201 2.905 . . . . 0.0 108.883 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.407 ' O ' ' N ' ' A' ' 127' ' ' ILE . 29.9 ptt-85 -163.79 146.56 9.69 Favored 'General case' 0 CA--C 1.478 -1.795 0 O-C-N 117.93 -2.982 . . . . 0.0 113.107 179.766 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . 0.413 0.8 OUTLIER -119.19 -176.13 3.07 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 112.919 -1.946 . . . . 0.0 107.018 179.927 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -145.79 -70.94 0.26 Allowed 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 122.194 2.27 . . . . 0.0 108.062 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.535 ' ND2' ' CG ' ' A' ' 17' ' ' PHE . 2.4 t30 -92.87 39.19 1.03 Allowed 'General case' 0 N--CA 1.476 0.827 0 O-C-N 127.555 3.035 . . . . 0.0 111.91 179.542 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.467 ' HD1' ' HB1' ' A' ' 124' ' ' ALA 0.313 34.5 t80 -97.81 -57.98 2.1 Favored 'General case' 0 N--CA 1.439 -1.01 0 N-CA-C 121.267 3.802 . . . . 0.0 121.267 -179.379 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . 0.252 6.1 pm0 -56.5 -55.02 38.94 Favored 'General case' 0 CA--C 1.505 -0.757 0 CA-C-N 124.227 3.194 . . . . 0.0 114.186 -179.066 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.584 ' HB3' ' CE2' ' A' ' 17' ' ' PHE . 8.5 ttmt -55.04 -42.05 72.17 Favored 'General case' 0 N--CA 1.421 -1.923 0 C-N-CA 127.537 2.335 . . . . 0.0 115.616 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.589 ' HB3' ' HB ' ' A' ' 122' ' ' VAL 0.293 45.1 m-85 -77.58 -19.91 54.87 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 111.282 -2.69 . . . . 0.0 114.044 -177.28 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.529 ' O ' HG12 ' A' ' 23' ' ' ILE . 4.4 mmt -70.43 -20.04 62.94 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 118.812 -2.43 . . . . 0.0 105.88 175.738 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.71 -32.59 63.98 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-O 127.904 3.716 . . . . 0.0 109.837 179.775 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.885 ' HD3' HG11 ' A' ' 122' ' ' VAL . 0.5 OUTLIER -72.51 -30.11 64.2 Favored 'General case' 0 N--CA 1.454 -0.256 0 O-C-N 118.113 -2.867 . . . . 0.0 110.371 179.97 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.434 ' CE ' ' HG ' ' A' ' 72' ' ' LEU . 1.5 mmm -78.06 -28.04 48.77 Favored 'General case' 0 C--O 1.201 -1.481 0 C-N-CA 127.472 2.309 . . . . 0.0 107.768 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.62 22.0 6.57 Favored Glycine 0 C--N 1.299 -1.48 0 CA-C-O 114.598 -3.334 . . . . 0.0 111.678 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.529 HG12 ' O ' ' A' ' 18' ' ' MET . 23.9 mm -78.78 139.76 17.94 Favored 'Isoleucine or valine' 0 C--N 1.352 0.709 0 O-C-N 126.765 2.097 . . . . 0.0 106.507 -179.288 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -102.29 143.12 32.46 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-O 116.559 -1.686 . . . . 0.0 113.119 -179.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . 0.437 0.2 OUTLIER 3.35 -73.81 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.508 -0.658 0 N-CA-C 119.957 3.318 . . . . 0.0 119.957 179.962 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.646 1.8 t -65.84 -30.33 49.7 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.972 0 O-C-N 126.936 2.648 . . . . 0.0 116.634 -179.764 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.424 ' HB2' HG22 ' A' ' 23' ' ' ILE . 30.5 mtmt -73.37 -31.22 63.8 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 114.222 -1.354 . . . . 0.0 111.236 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.92 -25.86 40.38 Favored 'General case' 0 N--CA 1.473 0.715 0 O-C-N 120.46 -1.4 . . . . 0.0 107.998 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 15.8 ttpt -78.57 -43.23 27.06 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.893 -1.049 . . . . 0.0 111.456 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.4 mt -77.73 -30.86 51.87 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 118.959 -1.096 . . . . 0.0 110.382 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -71.74 -30.95 65.47 Favored Glycine 0 C--O 1.217 -0.931 0 O-C-N 125.329 1.643 . . . . 0.0 111.998 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -75.81 -25.74 56.62 Favored 'General case' 0 N--CA 1.439 -0.981 0 O-C-N 120.996 -1.296 . . . . 0.0 112.959 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -121.3 28.3 7.87 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 127.605 2.362 . . . . 0.0 115.001 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -66.84 -13.88 62.08 Favored 'General case' 0 C--O 1.218 -0.591 0 N-CA-C 117.406 2.372 . . . . 0.0 117.406 -179.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . 0.302 0.5 OUTLIER 70.25 26.86 4.25 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 121.063 1.756 . . . . 0.0 110.004 179.741 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.614 HD11 HD13 ' A' ' 38' ' ' LEU . 0.9 OUTLIER -45.34 114.1 0.69 Allowed 'General case' 0 CA--C 1.495 -1.148 0 O-C-N 127.405 2.941 . . . . 0.0 108.76 -179.739 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.554 ' N ' HD12 ' A' ' 36' ' ' LEU . 27.7 tttp -110.98 98.82 7.83 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 104.911 -2.255 . . . . 0.0 104.911 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.692 HD22 ' CE2' ' A' ' 128' ' ' PHE . 1.9 tp -79.87 139.92 36.96 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.564 ' HB ' ' CB ' ' A' ' 50' ' ' LYS . 47.3 m -131.16 82.45 2.04 Favored 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 103.189 -2.893 . . . . 0.0 103.189 179.741 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.693 HD13 HG23 ' A' ' 49' ' ' VAL . 2.4 mm -65.54 132.06 31.27 Favored 'Isoleucine or valine' 0 C--O 1.255 1.35 0 CA-C-N 112.482 -2.145 . . . . 0.0 111.116 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.485 HG22 ' O ' ' A' ' 41' ' ' THR . 13.3 m -139.76 92.29 2.55 Favored 'General case' 0 CA--C 1.501 -0.918 0 O-C-N 125.851 1.97 . . . . 0.0 112.108 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 54.8 tt0 -85.87 118.17 25.19 Favored 'General case' 0 C--O 1.243 0.745 0 CA-C-O 117.186 -1.388 . . . . 0.0 111.519 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -101.54 -109.39 0.22 Allowed 'General case' 0 CA--C 1.495 -1.166 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -112.22 76.33 0.23 Allowed Glycine 0 C--N 1.307 -1.038 0 N-CA-C 105.548 -3.021 . . . . 0.0 105.548 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.313 0.5 OUTLIER 89.62 -18.74 0.19 Allowed 'General case' 0 C--N 1.32 -0.678 0 O-C-N 128.345 3.026 . . . . 0.0 113.751 179.827 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.466 ' HA ' ' HA ' ' A' ' 63' ' ' GLU . 1.9 ttpm? -91.93 146.48 23.71 Favored 'General case' 0 N--CA 1.435 -1.199 0 C-N-CA 117.604 -1.638 . . . . 0.0 107.301 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . 0.28 4.4 m-85 -129.32 93.85 3.66 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-O 123.01 1.386 . . . . 0.0 108.94 179.803 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.982 ' HB ' HG12 ' A' ' 61' ' ' VAL 0.479 2.0 t -78.36 146.1 34.85 Favored 'General case' 0 CA--C 1.496 -1.101 0 CA-C-O 125.23 2.443 . . . . 0.0 107.949 179.739 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.693 HG23 HD13 ' A' ' 40' ' ' ILE 0.693 0.3 OUTLIER -120.68 95.75 3.78 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 CA-C-N 109.969 -3.287 . . . . 0.0 111.948 -179.981 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.564 ' CB ' ' HB ' ' A' ' 39' ' ' THR . 0.9 OUTLIER -72.22 130.34 40.58 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 100.305 -3.961 . . . . 0.0 100.305 179.685 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.522 ' HG3' HD13 ' A' ' 36' ' ' LEU . 15.9 tt0 -123.52 66.99 1.01 Allowed 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 105.947 -1.871 . . . . 0.0 105.947 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.468 ' HA ' ' ND2' ' A' ' 57' ' ' ASN . 12.6 m -71.82 74.89 0.87 Allowed 'General case' 0 C--N 1.287 -2.11 0 CA-C-O 117.861 -1.066 . . . . 0.0 108.153 -179.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -103.6 -165.73 1.19 Allowed 'General case' 0 CA--C 1.506 -0.743 0 O-C-N 125.543 1.777 . . . . 0.0 112.777 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 62.5 t30 -70.77 -20.66 62.58 Favored 'General case' 0 N--CA 1.441 -0.882 0 O-C-N 123.979 0.799 . . . . 0.0 112.325 -179.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -87.26 -55.74 3.67 Favored 'General case' 0 C--O 1.22 -0.474 0 CA-C-O 115.071 -2.395 . . . . 0.0 112.258 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.75 176.61 12.15 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 124.496 3.316 . . . . 0.0 107.725 179.738 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.468 ' ND2' ' HA ' ' A' ' 52' ' ' SER . 0.8 OUTLIER -119.17 88.04 2.85 Favored 'General case' 0 C--O 1.216 -0.702 0 C-N-CA 131.466 3.906 . . . . 0.0 100.872 -179.874 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -117.73 98.91 7.14 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.992 0 C-N-CA 129.041 2.936 . . . . 0.0 118.676 -179.511 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 19.3 p-10 -62.54 120.5 11.24 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 103.712 -2.699 . . . . 0.0 103.712 177.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.53 ' HB ' ' CZ ' ' A' ' 62' ' ' PHE . 2.8 t -83.91 -55.17 7.52 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 CA-C-O 125.42 2.533 . . . . 0.0 112.133 -177.466 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.982 HG12 ' HB ' ' A' ' 48' ' ' THR 0.349 0.7 OUTLIER 67.13 133.36 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.434 -1.252 0 O-C-N 120.046 -1.659 . . . . 0.0 114.034 -179.54 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.604 ' CD2' ' CZ ' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -166.72 100.91 0.57 Allowed 'General case' 0 N--CA 1.428 -1.555 0 CA-C-O 116.989 -1.482 . . . . 0.0 111.427 179.493 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.466 ' HA ' ' HA ' ' A' ' 46' ' ' LYS . 30.1 mm-40 -54.35 142.48 26.55 Favored 'General case' 0 N--CA 1.429 -1.503 0 O-C-N 126.782 2.551 . . . . 0.0 105.726 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.1 mp -59.54 115.79 3.55 Favored 'General case' 0 N--CA 1.431 -1.389 0 CA-C-N 120.844 1.656 . . . . 0.0 111.43 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 83.08 33.76 22.75 Favored Glycine 0 C--N 1.34 0.782 0 O-C-N 128.433 3.583 . . . . 0.0 116.897 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . 0.426 2.2 t -117.1 92.42 2.12 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.53 ' HA ' HG22 ' A' ' 81' ' ' THR 0.269 0.2 OUTLIER -44.3 134.73 4.88 Favored 'General case' 0 CA--C 1.494 -1.194 0 O-C-N 124.898 1.374 . . . . 0.0 113.203 -179.948 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.604 ' CZ ' ' CD2' ' A' ' 62' ' ' PHE . 11.7 p90 -132.46 170.18 15.49 Favored 'General case' 0 N--CA 1.439 -0.992 0 O-C-N 124.961 1.413 . . . . 0.0 108.14 -179.655 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -125.79 109.58 12.71 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 116.038 -1.934 . . . . 0.0 107.851 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 21.3 t80 -127.83 111.57 13.78 Favored 'General case' 0 C--N 1.319 -0.739 0 O-C-N 125.471 1.732 . . . . 0.0 112.876 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 8.2 t -79.95 156.32 27.29 Favored 'General case' 0 CA--C 1.487 -1.449 0 CA-C-N 119.239 0.927 . . . . 0.0 109.713 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.434 ' HG ' ' CE ' ' A' ' 21' ' ' MET . 4.0 mm? -81.22 -166.28 1.12 Allowed 'General case' 0 CA--C 1.503 -0.834 0 N-CA-C 103.874 -2.639 . . . . 0.0 103.874 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -87.85 -18.78 28.5 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 124.805 1.315 . . . . 0.0 112.491 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -84.57 -13.17 52.51 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 115.972 -2.291 . . . . 0.0 108.99 179.775 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 108.17 8.36 29.44 Favored Glycine 0 CA--C 1.542 1.768 0 CA-C-O 117.431 -1.761 . . . . 0.0 114.359 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . 0.278 7.5 m -89.83 125.57 35.37 Favored 'General case' 0 N--CA 1.433 -1.289 0 CA-C-N 119.397 1.599 . . . . 0.0 109.926 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.507 ' HG2' HG21 ' A' ' 96' ' ' VAL . 0.0 OUTLIER -66.64 169.48 7.72 Favored 'General case' 0 C--O 1.22 -0.466 0 O-C-N 128.013 3.321 . . . . 0.0 112.327 -179.989 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.486 ' HG ' ' HB3' ' A' ' 93' ' ' PHE 0.28 1.5 tt -153.08 142.44 21.64 Favored 'General case' 0 CA--C 1.503 -0.834 0 N-CA-C 102.512 -3.144 . . . . 0.0 102.512 179.777 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 19.0 p -144.94 111.79 5.86 Favored 'General case' 0 CA--C 1.491 -1.315 0 N-CA-C 102.729 -3.063 . . . . 0.0 102.729 -179.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -174.48 -167.45 33.93 Favored Glycine 0 C--N 1.301 -1.414 1 C-N-CA 113.058 -4.401 . . . . 0.0 114.414 -179.772 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.53 HG22 ' HA ' ' A' ' 67' ' ' ASP . 0.5 OUTLIER -144.89 176.32 9.56 Favored 'General case' 0 C--O 1.187 -2.229 0 CA-C-N 119.821 1.811 . . . . 0.0 111.725 -179.953 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . 0.421 ' CZ2' ' CE1' ' A' ' 62' ' ' PHE 0.311 13.7 m0 -116.85 154.32 30.96 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 106.244 -1.761 . . . . 0.0 106.244 -179.995 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.571 HG23 HG22 ' A' ' 90' ' ' VAL . 10.8 t -162.35 139.39 8.09 Favored 'General case' 0 C--N 1.297 -1.698 0 CA-C-O 124.499 2.095 . . . . 0.0 111.811 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.427 ' HA ' HD23 ' A' ' 89' ' ' LEU . 5.1 ttt -81.37 102.72 10.64 Favored 'General case' 0 C--O 1.211 -0.964 0 CA-C-N 112.018 -2.355 . . . . 0.0 106.881 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . 0.632 6.8 mt-10 -77.02 -121.12 0.01 OUTLIER 'General case' 0 N--CA 1.428 -1.526 0 CA-C-O 124.483 2.087 . . . . 0.0 111.383 -179.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -105.88 95.22 1.04 Allowed Glycine 0 N--CA 1.443 -0.86 0 N-CA-C 106.243 -2.743 . . . . 0.0 106.243 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 4.4 m120 61.81 12.84 4.99 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 116.347 1.98 . . . . 0.0 116.347 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . 0.348 9.0 mtmm -149.89 139.55 21.68 Favored 'General case' 0 C--O 1.215 -0.732 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 179.785 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.427 HD23 ' HA ' ' A' ' 84' ' ' MET . 0.0 OUTLIER -84.77 130.15 34.72 Favored 'General case' 0 C--N 1.317 -0.833 1 O-C-N 129.213 4.071 . . . . 0.0 102.046 179.849 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.748 HG12 HG23 ' A' ' 105' ' ' VAL . 16.1 m -120.85 164.76 17.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.435 ' O ' ' N ' ' A' ' 104' ' ' ALA . . . -141.4 101.12 0.28 Allowed Glycine 0 C--O 1.216 -1.02 0 C-N-CA 127.932 2.682 . . . . 0.0 109.252 -179.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.98 123.79 37.56 Favored 'General case' 0 N--CA 1.436 -1.172 0 N-CA-C 104.583 -2.377 . . . . 0.0 104.583 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.486 ' HB3' ' HG ' ' A' ' 78' ' ' LEU . 21.2 m-30 -122.16 113.02 18.91 Favored 'General case' 0 CA--C 1.506 -0.716 0 O-C-N 125.417 1.698 . . . . 0.0 114.255 -179.543 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.491 ' HA ' ' HA ' ' A' ' 101' ' ' GLU . 12.3 mttm -92.12 173.18 7.97 Favored 'General case' 0 N--CA 1.427 -1.592 0 C-N-CA 126.586 1.955 . . . . 0.0 106.621 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . 0.37 3.3 mtp180 -119.72 145.53 46.45 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.507 HG21 ' HG2' ' A' ' 77' ' ' GLU . 5.2 t -69.71 -47.78 68.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 112.89 -1.959 . . . . 0.0 113.597 -179.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . 0.324 1.5 p-10 -102.51 35.13 2.54 Favored 'General case' 0 C--O 1.258 1.512 0 CA-C-O 122.798 1.285 . . . . 0.0 113.408 -179.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -144.17 -41.61 0.27 Allowed 'General case' 0 CA--C 1.491 -1.292 0 CA-C-N 114.131 -1.395 . . . . 0.0 113.723 -179.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 81.62 2.39 90.5 Favored Glycine 0 CA--C 1.543 1.788 0 C-N-CA 125.53 1.538 . . . . 0.0 112.395 -179.658 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 47.3 mttm -85.22 -171.32 3.57 Favored 'General case' 0 C--O 1.205 -1.251 0 CA-C-N 114.291 -0.954 . . . . 0.0 110.818 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.491 ' HA ' ' HA ' ' A' ' 94' ' ' LYS . 23.0 tt0 -130.81 168.8 16.65 Favored 'General case' 0 N--CA 1.439 -1.009 0 C-N-CA 129.669 3.187 . . . . 0.0 111.066 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.551 ' CG ' ' HA ' ' A' ' 119' ' ' TYR . 5.0 tt -154.57 -179.05 7.61 Favored 'General case' 0 C--N 1.319 -0.756 2 C-N-CA 136.19 5.796 . . . . 0.0 104.361 179.827 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.479 HG23 ' HB ' ' A' ' 118' ' ' THR . 0.9 OUTLIER -157.38 155.33 5.08 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.406 0 N-CA-C 104.116 -2.55 . . . . 0.0 104.116 179.783 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.471 ' N ' HG13 ' A' ' 103' ' ' ILE . . . -143.15 94.86 2.68 Favored 'General case' 0 N--CA 1.436 -1.158 0 C-N-CA 125.551 1.54 . . . . 0.0 108.284 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.748 HG23 HG12 ' A' ' 90' ' ' VAL . 0.5 OUTLIER -89.39 116.55 31.06 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 CA-C-O 125.222 2.439 . . . . 0.0 110.588 179.713 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.565 HH11 ' HG3' ' A' ' 106' ' ' ARG . 38.3 mtt85 -88.42 90.84 8.56 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 105.915 -1.883 . . . . 0.0 105.915 179.672 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -89.38 80.05 6.87 Favored 'General case' 0 N--CA 1.423 -1.781 0 O-C-N 127.356 2.91 . . . . 0.0 117.287 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.701 HD11 ' CH2' ' A' ' 6' ' ' TRP 0.312 0.6 OUTLIER -54.24 96.79 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 C-N-CA 118.523 -1.271 . . . . 0.0 113.368 179.718 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 8.6 t -92.11 73.73 5.48 Favored 'General case' 0 CA--C 1.508 -0.635 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 -179.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 42.6 87.33 0.01 OUTLIER Glycine 0 C--N 1.334 0.452 0 O-C-N 125.586 1.804 . . . . 0.0 114.834 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . 0.315 3.7 m-20 84.32 -11.9 0.8 Allowed 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 113.961 -2.923 . . . . 0.0 111.212 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -124.93 108.45 11.9 Favored 'General case' 0 CA--C 1.497 -1.076 0 O-C-N 125.369 1.668 . . . . 0.0 111.669 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.497 HD21 ' HG2' ' A' ' 106' ' ' ARG . 6.1 tt -85.74 117.48 24.65 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 102.475 -3.157 . . . . 0.0 102.475 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.705 HG12 HG23 ' A' ' 127' ' ' ILE . 73.0 mt -113.97 142.42 26.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 N-CA-C 103.314 -2.847 . . . . 0.0 103.314 179.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.443 ' HG2' ' HG2' ' A' ' 106' ' ' ARG . 35.2 mt-30 -121.07 119.91 33.81 Favored 'General case' 0 CA--C 1.503 -0.855 0 CA-C-O 115.812 -2.042 . . . . 0.0 108.599 -179.03 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.5 p -96.96 111.94 23.93 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 104.256 -2.498 . . . . 0.0 104.256 178.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.706 ' HB2' ' HB3' ' A' ' 124' ' ' ALA . 98.8 m-85 -97.26 106.05 18.31 Favored 'General case' 0 CA--C 1.477 -1.847 0 O-C-N 125.578 1.799 . . . . 0.0 113.39 -179.375 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.479 ' HB ' HG23 ' A' ' 103' ' ' ILE . 1.7 m -109.56 95.75 5.82 Favored 'General case' 0 N--CA 1.423 -1.797 0 O-C-N 125.775 1.922 . . . . 0.0 115.464 -179.766 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.551 ' HA ' ' CG ' ' A' ' 102' ' ' LEU . 60.9 t80 -52.1 -51.07 60.08 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 104.5 -2.407 . . . . 0.0 104.5 179.111 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -148.31 -64.9 0.25 Allowed 'General case' 0 C--N 1.3 -1.55 0 CA-C-N 112.596 -2.093 . . . . 0.0 111.575 179.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -144.07 27.95 2.0 Allowed Glycine 0 CA--C 1.543 1.824 0 C-N-CA 128.745 3.069 . . . . 0.0 112.091 179.559 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.885 HG11 ' HD3' ' A' ' 20' ' ' LYS . 21.1 m -133.23 80.08 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 105.067 -2.198 . . . . 0.0 105.067 -178.572 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.562 ' O ' ' HB2' ' A' ' 124' ' ' ALA 0.301 3.0 tt0 -58.03 -169.36 0.01 OUTLIER 'General case' 0 N--CA 1.426 -1.665 0 C-N-CA 127.534 2.334 . . . . 0.0 111.985 179.937 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.706 ' HB3' ' HB2' ' A' ' 117' ' ' TYR . . . 177.72 76.48 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 121.206 1.821 . . . . 0.0 109.022 179.193 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . 0.331 0.0 OUTLIER -70.08 142.34 52.65 Favored 'General case' 0 N--CA 1.446 -0.629 0 O-C-N 126.811 2.569 . . . . 0.0 107.092 179.587 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 10.8 mtm180 -144.31 78.51 1.58 Allowed 'General case' 0 C--O 1.218 -0.562 0 O-C-N 127.624 3.078 . . . . 0.0 104.894 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.705 HG23 HG12 ' A' ' 114' ' ' ILE . 2.4 mm -57.9 115.45 0.94 Allowed 'Isoleucine or valine' 0 C--O 1.247 0.948 0 O-C-N 128.215 3.447 . . . . 0.0 116.569 -179.776 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.692 ' CE2' HD22 ' A' ' 38' ' ' LEU . 22.8 m-85 -100.62 132.74 45.86 Favored 'General case' 0 N--CA 1.435 -1.223 0 C-N-CA 124.807 1.243 . . . . 0.0 108.144 179.492 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . 0.271 17.4 mtpt -95.69 6.16 49.63 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 117.229 -1.367 . . . . 0.0 110.737 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.558 ' HG3' ' CH2' ' A' ' 6' ' ' TRP . 0.0 OUTLIER 72.27 157.0 0.17 Allowed 'General case' 0 C--O 1.238 0.478 0 CA-C-N 119.411 1.005 . . . . 0.0 111.572 179.972 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.429 ' HA ' HG23 ' A' ' 5' ' ' THR 0.845 7.3 tt0 . . . . . 0 N--CA 1.44 -0.974 0 N-CA-C 118.675 2.843 . . . . 0.0 118.675 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' PLM . . . . . 0.684 ' H22' HG11 ' A' ' 49' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.417 ' C ' ' CG ' ' A' ' 2' ' ' PHE . . . . . . . . 0 CA--C 1.51 -0.587 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.417 ' CG ' ' C ' ' A' ' 1' ' ' ALA . 0.1 OUTLIER 62.02 49.46 4.57 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 118.63 -1.228 . . . . 0.0 112.188 179.752 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -138.18 96.57 3.22 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 115.669 1.729 . . . . 0.0 115.669 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 149.23 -141.93 9.37 Favored Glycine 0 C--O 1.214 -1.139 0 C-N-CA 116.971 -2.537 . . . . 0.0 109.147 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . 0.517 6.6 t -118.39 161.24 20.29 Favored 'General case' 0 CA--C 1.497 -1.08 0 O-C-N 127.023 2.249 . . . . 0.0 113.549 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.55 ' HB3' ' CD2' ' A' ' 128' ' ' PHE . 92.3 m95 -148.07 145.03 28.27 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 126.486 2.366 . . . . 0.0 107.133 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -132.85 102.95 5.84 Favored 'General case' 0 N--CA 1.439 -1.02 0 C-N-CA 123.655 0.782 . . . . 0.0 109.071 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.447 ' HA ' ' HA ' ' A' ' 128' ' ' PHE 0.368 11.4 p -57.17 115.72 0.91 Allowed 'Isoleucine or valine' 0 C--O 1.246 0.875 0 O-C-N 120.573 -1.33 . . . . 0.0 109.076 179.964 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -99.71 -29.12 12.83 Favored 'General case' 0 C--O 1.209 -1.041 0 O-C-N 126.591 2.432 . . . . 0.0 112.038 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 2.2 ptm180 -162.38 95.8 0.94 Allowed 'General case' 0 CA--C 1.478 -1.797 0 C-N-CA 113.789 -3.164 . . . . 0.0 112.997 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -64.69 177.36 0.94 Allowed 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 113.147 -1.842 . . . . 0.0 108.124 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -131.17 -79.29 0.53 Allowed 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 115.395 -2.24 . . . . 0.0 108.778 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -92.25 21.04 5.45 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 126.693 2.496 . . . . 0.0 115.013 179.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.766 ' HA ' ' HB1' ' A' ' 124' ' ' ALA 0.348 0.1 OUTLIER -65.35 -33.29 75.62 Favored 'General case' 0 C--N 1.309 -1.193 0 O-C-N 128.186 3.429 . . . . 0.0 114.5 -179.982 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -67.68 -23.78 65.34 Favored 'General case' 0 C--O 1.21 -1.015 0 O-C-N 117.108 -3.495 . . . . 0.0 110.694 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -79.94 -44.94 19.43 Favored 'General case' 0 C--O 1.247 0.973 0 CA-C-N 112.485 -2.143 . . . . 0.0 113.022 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.5 ' HB3' ' HB2' ' A' ' 124' ' ' ALA . 0.4 OUTLIER -60.56 -26.47 66.94 Favored 'General case' 0 N--CA 1.435 -1.218 0 CA-C-O 125.664 2.649 . . . . 0.0 112.264 179.988 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.436 ' HB3' ' HB ' ' A' ' 23' ' ' ILE . 7.6 mtt -73.68 -29.6 62.39 Favored 'General case' 0 N--CA 1.443 -0.802 0 O-C-N 116.301 -3.999 . . . . 0.0 106.629 179.36 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -70.0 -44.2 69.86 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-O 124.014 1.864 . . . . 0.0 112.213 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.804 ' HB2' HG21 ' A' ' 122' ' ' VAL . 16.2 tptt -61.06 -30.63 70.45 Favored 'General case' 0 C--O 1.209 -1.045 0 O-C-N 120.124 -1.61 . . . . 0.0 114.226 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.481 ' HG3' ' CE1' ' A' ' 17' ' ' PHE . 0.4 OUTLIER -79.45 -20.83 46.49 Favored 'General case' 0 N--CA 1.436 -1.154 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 -179.926 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 115.53 20.5 5.42 Favored Glycine 0 C--O 1.224 -0.502 0 N-CA-C 110.192 -1.163 . . . . 0.0 110.192 179.579 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.497 HG23 ' HB2' ' A' ' 27' ' ' LYS . 0.5 OUTLIER -104.79 101.88 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.291 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 -179.373 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 8.7 p-10 -130.94 24.75 4.97 Favored 'General case' 0 C--O 1.24 0.582 0 N-CA-C 114.666 1.358 . . . . 0.0 114.666 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . 0.546 17.4 m -136.17 -123.62 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.504 -0.822 0 N-CA-C 117.629 2.455 . . . . 0.0 117.629 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.65 0.0 OUTLIER -76.78 -22.67 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 N-CA-C 117.637 2.458 . . . . 0.0 117.637 179.816 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.497 ' HB2' HG23 ' A' ' 23' ' ' ILE . 0.7 OUTLIER -73.64 -25.91 60.52 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 114.463 -1.244 . . . . 0.0 113.985 179.957 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.66 -27.99 40.81 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 121.124 1.784 . . . . 0.0 107.301 -179.725 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -67.93 -41.29 82.82 Favored 'General case' 0 CA--C 1.508 -0.654 0 CA-C-O 123.249 1.5 . . . . 0.0 111.889 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 16.3 mt -73.7 -34.52 64.89 Favored 'General case' 0 N--CA 1.438 -1.034 0 O-C-N 120.5 -1.375 . . . . 0.0 107.439 179.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -76.51 -29.68 57.64 Favored Glycine 0 C--N 1.338 0.647 0 O-C-N 128.574 3.671 . . . . 0.0 114.995 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -71.91 -33.96 68.73 Favored 'General case' 0 C--O 1.243 0.732 0 O-C-N 119.425 -2.221 . . . . 0.0 110.24 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 7.2 t-80 -85.25 0.34 52.2 Favored 'General case' 0 N--CA 1.441 -0.916 0 O-C-N 127.384 2.927 . . . . 0.0 110.652 179.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.28 101.09 2.26 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-O 114.83 -2.51 . . . . 0.0 111.803 179.67 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.416 ' ND2' ' O ' ' A' ' 8' ' ' VAL . 1.5 t-20 -74.09 60.61 0.79 Allowed 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 121.447 1.931 . . . . 0.0 110.9 -179.373 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.536 HD21 ' HZ ' ' A' ' 128' ' ' PHE . 0.2 OUTLIER -41.89 119.06 1.22 Allowed 'General case' 0 CA--C 1.496 -1.101 0 CA-C-O 125.492 2.568 . . . . 0.0 111.178 -179.627 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.489 ' N ' HD12 ' A' ' 36' ' ' LEU . 44.9 tttm -107.78 111.24 23.3 Favored 'General case' 0 CA--C 1.516 -0.352 0 N-CA-C 102.076 -3.305 . . . . 0.0 102.076 179.793 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.522 ' CD2' HG22 ' A' ' 49' ' ' VAL . 0.1 OUTLIER -93.05 145.63 24.24 Favored 'General case' 0 C--N 1.31 -1.132 0 C-N-CA 114.941 -2.704 . . . . 0.0 105.149 -179.902 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.8 m -134.1 85.29 2.18 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 103.432 -2.803 . . . . 0.0 103.432 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.495 HG12 HG23 ' A' ' 49' ' ' VAL . 42.7 mt -79.86 117.76 26.23 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.122 0 O-C-N 124.731 1.27 . . . . 0.0 110.287 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.482 HG22 ' O ' ' A' ' 41' ' ' THR . 0.9 OUTLIER -112.25 110.15 20.22 Favored 'General case' 0 CA--C 1.511 -0.529 1 O-C-N 129.868 4.48 . . . . 0.0 112.614 -179.86 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -85.68 95.8 9.49 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -110.23 86.19 2.26 Favored 'General case' 0 N--CA 1.426 -1.638 0 N-CA-C 104.698 -2.334 . . . . 0.0 104.698 179.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 75.18 -89.9 0.8 Allowed Glycine 0 C--N 1.305 -1.185 0 N-CA-C 106.764 -2.535 . . . . 0.0 106.764 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -129.06 -42.31 1.38 Allowed 'General case' 0 N--CA 1.443 -0.783 0 O-C-N 127.723 2.661 . . . . 0.0 111.394 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.402 ' HA ' ' HA ' ' A' ' 63' ' ' GLU . 0.1 OUTLIER -58.42 129.23 41.05 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-O 123.49 1.614 . . . . 0.0 108.87 179.837 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.57 ' CE1' HD21 ' A' ' 64' ' ' LEU 0.289 1.7 m-85 -108.5 99.41 8.8 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 -179.804 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.719 ' HA ' HG13 ' A' ' 61' ' ' VAL 0.388 28.3 p -70.76 85.44 0.66 Allowed 'General case' 0 N--CA 1.432 -1.361 0 C-N-CA 117.646 -1.622 . . . . 0.0 110.034 -179.954 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.769 HG13 ' HB ' ' A' ' 60' ' ' VAL 0.657 10.0 p -67.2 87.24 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.494 -1.179 0 O-C-N 126.051 2.094 . . . . 0.0 109.717 -179.864 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 9.8 ttpp -73.28 119.92 18.19 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 105.281 -2.118 . . . . 0.0 105.281 -179.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.401 ' O ' ' N ' ' A' ' 53' ' ' SER 0.335 71.9 tt0 -108.12 65.97 0.64 Allowed 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 103.783 -2.673 . . . . 0.0 103.783 -179.983 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.3 m -68.62 72.37 0.22 Allowed 'General case' 0 N--CA 1.418 -2.073 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 179.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.401 ' N ' ' O ' ' A' ' 51' ' ' GLU . 60.2 p -102.82 -177.43 3.38 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-O 116.51 -1.709 . . . . 0.0 111.698 -179.782 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -62.28 -30.12 70.91 Favored 'General case' 0 C--O 1.218 -0.599 0 CA-C-N 119.53 1.059 . . . . 0.0 108.178 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.481 ' HE2' ' HG2' ' A' ' 132' ' ' PLM . 0.1 OUTLIER -67.38 -68.19 0.4 Allowed 'General case' 0 C--O 1.21 -0.99 0 CA-C-O 115.73 -2.081 . . . . 0.0 109.068 179.739 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.818 ' HB2' HG22 ' A' ' 58' ' ' ILE 0.272 13.5 mmt180 -136.36 -175.46 4.01 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 122.231 2.287 . . . . 0.0 111.198 -179.92 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -134.1 55.32 1.9 Allowed 'General case' 0 C--O 1.218 -0.567 2 N-CA-C 100.143 -4.021 . . . . 0.0 100.143 179.551 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.818 HG22 ' HB2' ' A' ' 56' ' ' ARG . 3.4 tt -99.31 106.11 18.46 Favored 'Isoleucine or valine' 0 C--N 1.346 0.419 1 C-N-CA 132.294 4.238 . . . . 0.0 117.398 -179.332 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -62.82 136.41 57.84 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 105.327 -2.101 . . . . 0.0 105.327 179.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.769 ' HB ' HG13 ' A' ' 49' ' ' VAL . 2.5 t -116.97 41.65 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 -179.59 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.719 HG13 ' HA ' ' A' ' 48' ' ' THR 0.354 0.1 OUTLIER -36.46 144.9 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 CA-C-O 125.707 2.67 . . . . 0.0 114.48 -179.941 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.457 ' HB3' ' CE1' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -156.0 100.93 2.07 Favored 'General case' 0 N--CA 1.423 -1.796 0 O-C-N 119.732 -1.855 . . . . 0.0 109.608 178.435 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.419 ' O ' ' C ' ' A' ' 64' ' ' LEU . 0.0 OUTLIER -68.55 93.28 0.49 Allowed 'General case' 0 CA--C 1.533 0.309 1 N-CA-C 99.942 -4.096 . . . . 0.0 99.942 178.054 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.655 ' CB ' ' CE2' ' A' ' 82' ' ' TRP . 0.0 OUTLIER -14.59 88.68 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.181 0 O-C-N 128.027 3.329 . . . . 0.0 110.523 -178.196 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.567 ' N ' ' CD1' ' A' ' 82' ' ' TRP . . . 90.67 44.13 4.64 Favored Glycine 0 C--N 1.353 1.478 0 CA-C-N 109.985 -3.279 . . . . 0.0 118.918 179.42 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . 0.484 0.6 OUTLIER -105.3 -8.8 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.236 0 CA-C-N 111.968 -2.116 . . . . 0.0 107.547 -179.846 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.574 ' HA ' HG22 ' A' ' 81' ' ' THR . 1.8 m-20 69.63 143.81 0.05 OUTLIER 'General case' 0 CA--C 1.491 -1.297 0 CA-C-O 122.154 0.978 . . . . 0.0 109.858 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.574 ' CZ ' ' HA ' ' A' ' 81' ' ' THR . 1.0 OUTLIER -163.81 119.29 1.61 Allowed 'General case' 0 N--CA 1.438 -1.045 0 C-N-CA 117.363 -1.735 . . . . 0.0 111.066 179.989 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -77.46 102.67 6.98 Favored 'General case' 0 C--O 1.245 0.841 0 N-CA-C 103.74 -2.689 . . . . 0.0 103.74 179.171 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.515 ' HD2' HD22 ' A' ' 78' ' ' LEU . 31.1 t80 -107.2 87.8 2.59 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-O 116.139 -1.886 . . . . 0.0 113.821 -178.275 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 36.7 p -55.51 128.33 33.95 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 104.998 -2.223 . . . . 0.0 104.998 179.6 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.976 HD21 HD13 ' A' ' 78' ' ' LEU . 26.0 mt -71.57 -160.37 0.05 Allowed 'General case' 0 CA--C 1.495 -1.148 0 N-CA-C 106.133 -1.802 . . . . 0.0 106.133 -179.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -88.14 -30.4 19.85 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-O 124.97 2.319 . . . . 0.0 112.476 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.401 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 1.2 m-20 -124.77 -55.33 1.62 Allowed 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 113.045 -1.889 . . . . 0.0 111.211 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.0 -32.87 81.82 Favored Glycine 0 C--O 1.204 -1.755 0 CA-C-O 118.315 -1.269 . . . . 0.0 113.923 179.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.545 HG22 ' H ' ' A' ' 77' ' ' GLU 0.256 0.0 OUTLIER 70.24 169.89 0.31 Allowed 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 123.268 3.534 . . . . 0.0 114.738 179.821 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.545 ' H ' HG22 ' A' ' 76' ' ' THR . 5.0 mt-10 7.8 103.68 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.835 1 O-C-N 131.532 5.52 . . . . 0.0 113.704 -179.682 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.976 HD13 HD21 ' A' ' 72' ' ' LEU 0.414 0.4 OUTLIER -140.29 101.19 4.07 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 102.233 -3.247 . . . . 0.0 102.233 179.933 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 48.6 m -108.05 135.07 50.02 Favored 'General case' 0 C--O 1.202 -1.438 0 O-C-N 126.459 2.35 . . . . 0.0 106.059 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 173.62 -144.34 7.62 Favored Glycine 0 C--N 1.3 -1.437 0 C-N-CA 117.209 -2.424 . . . . 0.0 109.821 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.574 HG22 ' HA ' ' A' ' 67' ' ' ASP . 44.0 p -166.28 168.77 14.84 Favored 'General case' 0 C--O 1.19 -2.049 0 CA-C-O 123.48 1.609 . . . . 0.0 109.902 -179.637 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . 0.705 ' CG ' ' N ' ' A' ' 83' ' ' THR 0.406 1.9 p-90 -76.31 -169.64 1.24 Allowed 'General case' 0 C--N 1.316 -0.886 1 N-CA-C 99.807 -4.145 . . . . 0.0 99.807 175.419 . . . . . . . . 4 3 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.94 HG23 HG23 ' A' ' 90' ' ' VAL 0.292 0.5 OUTLIER 177.19 128.26 0.04 OUTLIER 'General case' 0 N--CA 1.437 -1.122 0 CA-C-O 124.676 2.179 . . . . 0.0 112.897 174.94 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.563 ' CB ' ' CH2' ' A' ' 82' ' ' TRP . 3.0 ttt -96.96 102.27 14.01 Favored 'General case' 0 N--CA 1.426 -1.633 0 N-CA-C 106.056 -1.831 . . . . 0.0 106.056 179.09 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.434 ' CG ' ' CG2' ' A' ' 90' ' ' VAL 0.67 0.0 OUTLIER -79.67 62.66 4.01 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 120.462 1.483 . . . . 0.0 108.655 179.691 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 76.94 -64.3 3.08 Favored Glycine 0 C--O 1.219 -0.785 0 N-CA-C 107.261 -2.336 . . . . 0.0 107.261 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 28.9 p-10 -129.78 -16.29 3.77 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 120.866 2.333 . . . . 0.0 116.681 -179.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . 0.365 0.3 OUTLIER -113.89 111.35 21.56 Favored 'General case' 0 CA--C 1.496 -1.13 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 179.924 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.598 HD22 ' HE ' ' A' ' 106' ' ' ARG . 2.0 tt -66.24 153.8 41.55 Favored 'General case' 0 C--N 1.32 -0.715 0 O-C-N 125.186 1.554 . . . . 0.0 107.277 179.856 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.94 HG23 HG23 ' A' ' 83' ' ' THR . 0.0 OUTLIER -144.19 179.97 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.021 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 179.986 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -140.53 99.17 0.24 Allowed Glycine 0 C--N 1.352 1.445 0 C-N-CA 129.034 3.206 . . . . 0.0 107.637 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.417 ' O ' ' CD1' ' A' ' 93' ' ' PHE . 5.9 mtpm? -98.25 138.11 36.0 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 102.365 -3.198 . . . . 0.0 102.365 -179.532 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.587 ' CZ ' ' H41' ' A' ' 132' ' ' PLM . 62.8 m-85 -150.06 127.77 11.67 Favored 'General case' 0 CA--C 1.5 -0.955 0 O-C-N 126.262 2.227 . . . . 0.0 113.702 -179.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 18.1 mttt -105.65 150.11 25.74 Favored 'General case' 0 N--CA 1.432 -1.374 0 CA-C-N 112.303 -2.226 . . . . 0.0 111.539 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.447 ' HG2' ' HB2' ' A' ' 98' ' ' ASN 0.401 1.0 OUTLIER -96.05 143.12 27.48 Favored 'General case' 0 N--CA 1.433 -1.322 0 CA-C-O 116.623 -1.656 . . . . 0.0 106.681 -179.713 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.4 m -83.53 -29.05 7.65 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.213 0 O-C-N 124.48 1.112 . . . . 0.0 113.941 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . 0.356 6.2 p-10 -90.17 11.63 20.41 Favored 'General case' 0 C--O 1.251 1.169 0 CA-C-N 112.454 -2.157 . . . . 0.0 111.281 179.569 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.447 ' HB2' ' HG2' ' A' ' 95' ' ' ARG . 5.9 t30 -138.57 -43.08 0.49 Allowed 'General case' 0 N--CA 1.439 -1.019 0 CA-C-N 112.562 -2.108 . . . . 0.0 116.604 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 86.7 -10.7 66.55 Favored Glycine 0 CA--C 1.535 1.301 0 CA-C-O 124.379 2.099 . . . . 0.0 113.469 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 47.4 mttt -70.77 -167.12 0.17 Allowed 'General case' 0 C--O 1.203 -1.367 0 O-C-N 120.299 -1.707 . . . . 0.0 109.783 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -135.2 154.07 51.73 Favored 'General case' 0 N--CA 1.441 -0.919 0 C-N-CA 128.612 2.765 . . . . 0.0 111.267 -179.818 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.635 ' HG ' ' HA ' ' A' ' 119' ' ' TYR . 7.2 tt -132.73 137.29 46.83 Favored 'General case' 0 C--O 1.247 0.938 1 C-N-CA 133.816 4.846 . . . . 0.0 105.412 -179.609 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.732 HG23 ' HB3' ' A' ' 117' ' ' TYR . 11.1 tt -132.0 160.17 42.62 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.158 0 N-CA-C 105.428 -2.064 . . . . 0.0 105.428 179.26 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.464 ' O ' HG12 ' A' ' 90' ' ' VAL . . . -152.65 135.15 15.2 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-O 114.523 -2.656 . . . . 0.0 106.497 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.745 HG12 ' O ' ' A' ' 116' ' ' THR . 7.1 p -119.99 114.71 45.03 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.799 0 CA-C-N 122.172 2.26 . . . . 0.0 114.454 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.598 ' HE ' HD22 ' A' ' 89' ' ' LEU . 3.5 mtm180 -82.8 94.43 7.65 Favored 'General case' 0 C--O 1.223 -0.323 0 N-CA-C 103.788 -2.671 . . . . 0.0 103.788 178.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . 0.329 4.7 tt0 -72.0 -38.01 69.73 Favored 'General case' 0 C--O 1.21 -0.993 0 CA-C-N 110.934 -2.848 . . . . 0.0 116.129 -177.272 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.538 HD11 ' CZ2' ' A' ' 6' ' ' TRP 0.395 2.7 mm 60.05 75.96 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 C-N-CA 111.782 -3.967 . . . . 0.0 113.904 -179.686 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 6.8 t -65.54 -102.76 0.0 OUTLIER 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 120.46 1.482 . . . . 0.0 109.533 -179.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -133.85 89.32 0.25 Allowed Glycine 0 CA--C 1.521 0.416 1 C-N-CA 130.958 4.123 . . . . 0.0 110.685 179.572 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . 0.326 31.8 m-20 90.52 -25.43 0.06 Allowed 'General case' 0 C--N 1.309 -1.185 0 CA-C-O 114.54 -2.648 . . . . 0.0 110.071 -179.13 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -113.1 137.52 51.31 Favored 'General case' 0 CA--C 1.489 -1.381 1 O-C-N 129.332 4.145 . . . . 0.0 113.873 -179.362 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.53 ' HB2' ' CH2' ' A' ' 6' ' ' TRP . 8.6 tt -102.98 147.04 27.43 Favored 'General case' 0 C--O 1.21 -1.003 0 N-CA-C 100.781 -3.785 . . . . 0.0 100.781 -179.807 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.782 HG23 HD13 ' A' ' 127' ' ' ILE 0.265 13.4 mt -150.44 125.49 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 N-CA-C 103.625 -2.731 . . . . 0.0 103.625 179.961 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.561 ' HB2' ' HD2' ' A' ' 126' ' ' ARG . 8.4 mt-30 -101.14 139.69 36.48 Favored 'General case' 0 N--CA 1.441 -0.915 0 N-CA-C 103.121 -2.918 . . . . 0.0 103.121 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.745 ' O ' HG12 ' A' ' 105' ' ' VAL . 0.2 OUTLIER -156.68 144.58 19.38 Favored 'General case' 0 N--CA 1.415 -2.186 0 CA-C-N 113.496 -1.683 . . . . 0.0 112.664 179.986 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.732 ' HB3' HG23 ' A' ' 103' ' ' ILE 0.382 21.4 m-30 145.88 -136.29 0.0 OUTLIER 'General case' 0 CA--C 1.481 -1.684 0 O-C-N 128.088 3.367 . . . . 0.0 113.152 176.277 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.505 HG23 ' H ' ' A' ' 120' ' ' GLU . 10.5 t -159.3 -157.97 0.63 Allowed 'General case' 0 C--N 1.311 -1.068 0 O-C-N 127.67 3.106 . . . . 0.0 116.567 -174.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.635 ' HA ' ' HG ' ' A' ' 102' ' ' LEU 0.302 6.8 t80 -120.6 -4.89 9.77 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 111.865 -2.425 . . . . 0.0 110.695 178.309 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.505 ' H ' HG23 ' A' ' 118' ' ' THR . 0.9 OUTLIER -176.98 -68.92 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.511 0 O-C-N 120.506 -1.371 . . . . 0.0 112.025 -179.629 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -151.75 17.49 0.85 Allowed Glycine 0 CA--C 1.541 1.695 0 N-CA-C 119.692 2.637 . . . . 0.0 119.692 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.804 HG21 ' HB2' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -122.22 94.31 2.87 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 N-CA-C 104.314 -2.476 . . . . 0.0 104.314 -179.698 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.477 ' HA ' ' HB ' ' A' ' 118' ' ' THR . 0.8 OUTLIER -59.15 177.92 0.15 Allowed 'General case' 0 C--O 1.216 -0.659 0 CA-C-O 122.118 0.961 . . . . 0.0 112.377 -178.233 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.766 ' HB1' ' HA ' ' A' ' 14' ' ' TYR . . . -172.65 91.81 0.11 Allowed 'General case' 0 N--CA 1.437 -1.12 0 O-C-N 118.505 -2.622 . . . . 0.0 109.664 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.543 ' HG3' ' HB ' ' A' ' 116' ' ' THR . 1.7 mptm? -69.62 164.38 23.47 Favored 'General case' 0 CA--C 1.508 -0.671 0 CA-C-N 121.54 1.973 . . . . 0.0 110.997 179.734 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.593 ' HG2' ' CD2' ' A' ' 14' ' ' TYR . 36.7 mtt180 -145.82 72.77 1.32 Allowed 'General case' 0 C--O 1.208 -1.1 0 CA-C-N 110.466 -3.061 . . . . 0.0 110.481 -179.675 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.782 HD13 HG23 ' A' ' 114' ' ' ILE . 17.5 mm -66.3 117.8 7.98 Favored 'Isoleucine or valine' 0 C--O 1.254 1.325 1 O-C-N 129.102 4.001 . . . . 0.0 112.346 -179.987 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.55 ' CD2' ' HB3' ' A' ' 6' ' ' TRP . 12.5 m-85 -103.91 167.77 9.56 Favored 'General case' 0 N--CA 1.442 -0.872 0 O-C-N 127.186 2.804 . . . . 0.0 107.552 179.175 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 2.4 mmmt -122.23 1.56 9.7 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 116.621 -1.657 . . . . 0.0 109.373 179.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.518 ' HD2' ' CH2' ' A' ' 6' ' ' TRP . 0.9 OUTLIER 68.81 97.14 0.06 Allowed 'General case' 0 C--O 1.238 0.487 0 CA-C-N 120.794 1.634 . . . . 0.0 113.218 -179.954 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . 0.823 21.5 tt0 . . . . . 0 N--CA 1.431 -1.419 0 CA-C-N 121.492 1.951 . . . . 0.0 115.084 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' PLM . . . . . 0.587 ' H41' ' CZ ' ' A' ' 93' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.218 -0.582 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -83.06 0.66 43.89 Favored 'General case' 0 C--N 1.31 -1.124 0 O-C-N 120.302 -1.499 . . . . 0.0 112.577 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.407 ' N ' ' OD1' ' A' ' 3' ' ' ASP . 17.8 p-10 -55.98 85.97 0.01 OUTLIER 'General case' 0 CA--C 1.5 -0.974 0 N-CA-C 115.318 1.599 . . . . 0.0 115.318 -179.77 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -179.54 -151.5 9.88 Favored Glycine 0 N--CA 1.436 -1.33 0 C-N-CA 116.144 -2.932 . . . . 0.0 110.687 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.447 HG22 ' HA ' ' A' ' 39' ' ' THR 0.441 0.1 OUTLIER -124.74 150.83 45.82 Favored 'General case' 0 N--CA 1.427 -1.589 0 N-CA-C 116.312 1.967 . . . . 0.0 116.312 -179.855 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.704 ' HA ' ' CE2' ' A' ' 128' ' ' PHE . 21.0 m95 -137.16 -166.77 1.98 Allowed 'General case' 0 CA--C 1.498 -1.029 0 CA-C-O 114.37 -2.728 . . . . 0.0 106.509 178.623 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.638 ' CB ' ' CZ ' ' A' ' 128' ' ' PHE . 6.7 ttpt 177.28 27.57 0.0 OUTLIER 'General case' 0 N--CA 1.432 -1.339 0 CA-C-O 112.804 -3.474 . . . . 0.0 112.498 -177.083 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.746 ' CG1' HD23 ' A' ' 36' ' ' LEU 0.404 1.7 m 15.24 108.95 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 CA-C-N 121.939 2.154 . . . . 0.0 116.745 -179.754 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -128.47 -69.36 0.72 Allowed 'General case' 0 CA--C 1.498 -1.022 0 O-C-N 120.48 -1.388 . . . . 0.0 113.118 -178.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.5 ptp180 -84.32 95.1 8.62 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 118.168 -1.413 . . . . 0.0 111.437 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -93.33 -172.82 3.05 Favored 'General case' 0 N--CA 1.441 -0.903 0 O-C-N 127.092 2.745 . . . . 0.0 108.937 -179.697 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -143.6 -67.07 0.35 Allowed 'General case' 0 C--N 1.306 -1.288 0 CA-C-O 115.994 -1.955 . . . . 0.0 108.622 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -95.58 15.4 19.95 Favored 'General case' 0 C--O 1.219 -0.545 0 O-C-N 127.502 3.001 . . . . 0.0 113.617 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.669 ' HA ' ' HB1' ' A' ' 124' ' ' ALA 0.381 0.1 OUTLIER -76.38 -26.22 55.4 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 117.876 2.547 . . . . 0.0 117.876 179.852 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -74.83 -37.35 62.3 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-O 122.615 1.198 . . . . 0.0 111.894 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 4.7 ttmt -78.15 -24.52 47.29 Favored 'General case' 0 C--O 1.246 0.894 0 CA-C-O 126.046 2.831 . . . . 0.0 113.826 -179.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.581 ' CB ' ' HB2' ' A' ' 124' ' ' ALA . 10.1 t80 -66.63 -31.0 71.4 Favored 'General case' 0 N--CA 1.438 -1.041 0 CA-C-O 125.834 2.73 . . . . 0.0 113.374 -179.681 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.512 ' HB3' ' HB ' ' A' ' 23' ' ' ILE . 29.3 mtt -73.63 -24.69 60.05 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 125.851 2.738 . . . . 0.0 106.859 179.668 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -73.27 -22.23 60.43 Favored 'General case' 0 N--CA 1.474 0.765 0 O-C-N 119.003 -2.311 . . . . 0.0 109.396 179.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 6.0 tptp -75.25 -38.73 60.4 Favored 'General case' 0 C--N 1.313 -0.993 0 O-C-N 118.996 -2.315 . . . . 0.0 113.244 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 7.3 mtm -76.37 -38.17 56.17 Favored 'General case' 0 C--O 1.214 -0.796 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 125.96 43.47 0.28 Allowed Glycine 0 C--N 1.304 -1.205 0 CA-C-O 116.797 -2.113 . . . . 0.0 111.87 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.512 ' HB ' ' HB3' ' A' ' 18' ' ' MET . 0.2 OUTLIER -119.62 107.09 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 CA-C-O 115.758 -2.067 . . . . 0.0 107.212 -179.579 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -132.42 14.42 4.54 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 115.162 1.542 . . . . 0.0 115.162 -179.671 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . 0.412 33.2 m -119.66 -136.55 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.499 -0.99 0 O-C-N 126.992 2.683 . . . . 0.0 115.436 179.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.484 2.4 m -70.99 -24.09 24.2 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.934 0 CA-C-N 121.719 2.054 . . . . 0.0 114.027 179.823 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.41 ' HD2' ' CG ' ' A' ' 74' ' ' ASP . 13.2 mtmm -66.29 -34.68 78.54 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 115.002 1.482 . . . . 0.0 115.002 -179.819 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.405 ' N ' HG22 ' A' ' 23' ' ' ILE . 7.4 ptt180 -78.87 -24.23 44.4 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 123.561 1.648 . . . . 0.0 108.221 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.2 tttt -78.99 -32.03 45.05 Favored 'General case' 0 C--O 1.213 -0.84 0 CA-C-N 113.96 -1.473 . . . . 0.0 110.921 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.421 HD12 ' HA ' ' A' ' 30' ' ' LEU . 8.7 tp -77.64 -35.97 51.99 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 114.645 -1.161 . . . . 0.0 111.903 179.713 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.74 -25.52 73.76 Favored Glycine 0 C--O 1.213 -1.169 0 C-N-CA 123.933 0.778 . . . . 0.0 112.636 -179.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -76.94 -32.44 57.34 Favored 'General case' 0 C--N 1.315 -0.93 0 C-N-CA 125.89 1.676 . . . . 0.0 109.237 179.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 65.4 m80 -123.31 28.55 7.03 Favored 'General case' 0 C--O 1.236 0.373 0 O-C-N 126.979 2.674 . . . . 0.0 114.189 179.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -67.36 -19.42 65.43 Favored 'General case' 0 C--O 1.216 -0.683 0 N-CA-C 114.545 1.313 . . . . 0.0 114.545 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . 0.254 1.4 m-20 76.72 62.06 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 116.914 -1.914 . . . . 0.0 108.812 179.564 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.746 HD23 ' CG1' ' A' ' 8' ' ' VAL . 16.9 tp -80.02 73.04 6.83 Favored 'General case' 0 N--CA 1.469 0.525 0 O-C-N 126.752 2.533 . . . . 0.0 108.309 -179.617 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.447 ' HB3' ' HB2' ' A' ' 52' ' ' SER . 5.6 ttpp -68.9 112.08 5.35 Favored 'General case' 0 C--N 1.305 -1.349 1 N-CA-C 100.138 -4.023 . . . . 0.0 100.138 -179.508 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.547 ' CD1' ' HG ' ' A' ' 36' ' ' LEU 0.377 1.3 mp -104.8 103.13 12.68 Favored 'General case' 0 C--N 1.288 -2.079 0 N-CA-C 105.458 -2.053 . . . . 0.0 105.458 -178.316 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.504 ' HB ' ' CB ' ' A' ' 50' ' ' LYS . 1.9 m -94.85 86.39 4.68 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 117.276 -3.39 . . . . 0.0 103.902 179.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.585 HD13 HG23 ' A' ' 49' ' ' VAL . 12.0 mm -61.46 146.53 11.82 Favored 'Isoleucine or valine' 0 C--O 1.243 0.729 0 N-CA-C 105.973 -1.862 . . . . 0.0 105.973 -179.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.525 ' CG2' HG23 ' A' ' 48' ' ' THR . 4.6 t -150.34 35.0 0.64 Allowed 'General case' 0 CA--C 1.506 -0.731 0 O-C-N 126.956 2.66 . . . . 0.0 114.493 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 24.7 tt0 -33.41 111.63 0.11 Allowed 'General case' 0 C--N 1.311 -1.106 0 O-C-N 126.981 2.676 . . . . 0.0 111.59 -179.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -81.08 -0.72 41.2 Favored 'General case' 0 N--CA 1.42 -1.947 0 CA-C-O 124.642 2.163 . . . . 0.0 111.935 -179.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 135.65 -55.66 0.72 Allowed Glycine 0 C--N 1.292 -1.87 0 N-CA-C 104.479 -3.448 . . . . 0.0 104.479 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.301 0.3 OUTLIER -127.4 -37.4 2.02 Favored 'General case' 0 C--N 1.316 -0.886 0 O-C-N 126.812 2.125 . . . . 0.0 112.587 -179.736 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 28.1 ttmt -91.12 139.2 30.98 Favored 'General case' 0 C--N 1.318 -0.792 0 O-C-N 117.906 -2.996 . . . . 0.0 107.601 -179.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . 0.251 21.0 m-85 -118.52 110.06 16.94 Favored 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 124.448 1.099 . . . . 0.0 110.956 -179.619 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.906 ' HB ' HG12 ' A' ' 61' ' ' VAL 0.401 0.1 OUTLIER -98.4 78.14 2.41 Favored 'General case' 0 N--CA 1.44 -0.965 0 O-C-N 125.078 1.486 . . . . 0.0 107.096 179.951 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.725 HG13 ' HB ' ' A' ' 60' ' ' VAL 0.625 11.3 p -52.3 97.62 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 CA-C-N 109.497 -3.501 . . . . 0.0 113.073 179.737 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.504 ' CB ' ' HB ' ' A' ' 39' ' ' THR . 0.0 OUTLIER -62.23 139.27 58.5 Favored 'General case' 0 C--N 1.304 -1.384 1 N-CA-C 100.102 -4.036 . . . . 0.0 100.102 -179.633 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.539 ' HB3' HG23 ' A' ' 58' ' ' ILE 0.253 3.4 tt0 -138.67 91.11 2.51 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 -179.229 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.447 ' HB2' ' HB3' ' A' ' 37' ' ' LYS . 1.0 OUTLIER -93.3 55.15 2.22 Favored 'General case' 0 C--N 1.286 -2.164 0 N-CA-C 105.634 -1.987 . . . . 0.0 105.634 -179.916 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 89.5 p -69.39 158.9 34.21 Favored 'General case' 0 C--N 1.349 0.561 0 CA-C-O 114.912 -2.47 . . . . 0.0 109.21 -179.587 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -52.74 -29.31 26.32 Favored 'General case' 0 C--O 1.212 -0.904 0 O-C-N 125.846 1.966 . . . . 0.0 106.946 179.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.523 ' CE2' ' HB1' ' A' ' 73' ' ' ALA . 11.1 m-85 -73.27 -55.76 5.99 Favored 'General case' 0 C--N 1.35 0.627 0 CA-C-O 114.707 -2.568 . . . . 0.0 111.211 179.341 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.852 ' HB3' HG22 ' A' ' 58' ' ' ILE 0.313 0.0 OUTLIER -142.83 174.79 10.34 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 124.42 3.282 . . . . 0.0 111.287 -179.88 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -121.97 71.73 1.0 Allowed 'General case' 0 C--O 1.221 -0.409 1 N-CA-C 99.873 -4.121 . . . . 0.0 99.873 179.382 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.852 HG22 ' HB3' ' A' ' 56' ' ' ARG . 1.9 tt -105.67 103.18 14.97 Favored 'Isoleucine or valine' 0 C--O 1.243 0.724 0 O-C-N 127.635 3.085 . . . . 0.0 118.997 -179.189 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -65.91 125.0 24.02 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 103.623 -2.732 . . . . 0.0 103.623 178.409 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.725 ' HB ' HG13 ' A' ' 49' ' ' VAL . 24.5 t -100.76 97.14 5.38 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 -178.177 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.906 HG12 ' HB ' ' A' ' 48' ' ' THR 0.427 0.6 OUTLIER -79.66 135.25 25.95 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 CA-C-N 121.543 1.974 . . . . 0.0 108.986 179.748 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.517 ' CE1' HG12 ' A' ' 49' ' ' VAL . 12.4 p90 -160.45 90.59 0.88 Allowed 'General case' 0 N--CA 1.432 -1.339 0 CA-C-O 123.832 1.777 . . . . 0.0 109.978 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -59.33 149.36 29.18 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 104.805 -2.294 . . . . 0.0 104.805 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.0 mt -66.16 110.9 3.17 Favored 'General case' 0 N--CA 1.427 -1.61 0 C-N-CA 117.982 -1.487 . . . . 0.0 108.58 -179.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.415 ' HA2' ' HB ' ' A' ' 81' ' ' THR . . . 72.78 46.45 30.16 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 128.199 2.809 . . . . 0.0 119.165 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . 0.442 3.8 t -111.92 7.92 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 CA-C-O 115.435 -2.222 . . . . 0.0 107.889 -179.818 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 46.71 101.7 0.0 OUTLIER 'General case' 0 CA--C 1.482 -1.661 0 CA-C-O 124.822 2.249 . . . . 0.0 115.525 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.5 ' CE1' ' HB2' ' A' ' 62' ' ' PHE . 8.8 p90 -117.67 157.62 26.13 Favored 'General case' 0 N--CA 1.435 -1.199 0 O-C-N 118.899 -2.376 . . . . 0.0 107.213 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -107.43 142.83 36.66 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 179.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -147.77 107.99 4.07 Favored 'General case' 0 C--O 1.205 -1.279 0 C-N-CA 118.196 -1.402 . . . . 0.0 114.265 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -75.15 138.38 41.98 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 122.954 2.616 . . . . 0.0 105.323 179.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.698 HD12 ' O ' ' A' ' 76' ' ' THR . 0.7 OUTLIER -82.52 -170.07 2.77 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 104.413 -2.44 . . . . 0.0 104.413 179.815 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.523 ' HB1' ' CE2' ' A' ' 55' ' ' PHE . . . -82.2 -45.62 14.84 Favored 'General case' 0 CA--C 1.547 0.842 0 CA-C-O 123.7 1.714 . . . . 0.0 111.254 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.41 ' CG ' ' HD2' ' A' ' 27' ' ' LYS . 12.2 t70 -139.92 26.62 2.25 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 112.952 -1.931 . . . . 0.0 110.858 179.716 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -120.36 -9.29 7.97 Favored Glycine 0 CA--C 1.548 2.152 0 O-C-N 127.105 2.753 . . . . 0.0 112.514 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.698 ' O ' HD12 ' A' ' 72' ' ' LEU 0.259 0.1 OUTLIER 75.13 -178.36 0.16 Allowed 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 117.393 -1.723 . . . . 0.0 114.706 -179.775 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.441 ' CB ' ' HB ' ' A' ' 96' ' ' VAL . 13.8 mt-10 -40.65 141.09 0.6 Allowed 'General case' 0 N--CA 1.442 -0.848 0 CA-C-O 125.785 2.707 . . . . 0.0 112.293 179.825 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.691 ' HG ' ' HB3' ' A' ' 93' ' ' PHE 0.419 11.7 tp -166.09 120.38 1.16 Allowed 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 104.271 -2.492 . . . . 0.0 104.271 179.877 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.5 t -143.32 121.44 12.17 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 105.636 -1.986 . . . . 0.0 105.636 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.5 ' HA3' ' HA ' ' A' ' 93' ' ' PHE . . . -156.51 -144.65 3.98 Favored Glycine 0 CA--C 1.538 1.5 0 CA-C-O 116.537 -2.257 . . . . 0.0 110.022 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.415 ' HB ' ' HA2' ' A' ' 65' ' ' GLY . 11.5 p -148.84 161.06 42.6 Favored 'General case' 0 CA--C 1.476 -1.872 0 O-C-N 126.68 2.047 . . . . 0.0 110.215 -179.737 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . 0.486 ' CG ' ' CE2' ' A' ' 62' ' ' PHE . 16.1 m95 -117.05 151.26 37.16 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 101.155 -3.646 . . . . 0.0 101.155 -179.735 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.529 HG22 HG22 ' A' ' 90' ' ' VAL . 9.9 t -153.68 144.97 23.01 Favored 'General case' 0 C--O 1.255 1.364 0 CA-C-O 122.992 1.377 . . . . 0.0 111.558 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.22 105.82 11.77 Favored 'General case' 0 N--CA 1.436 -1.141 0 C-N-CA 117.162 -1.815 . . . . 0.0 109.662 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.443 ' HG3' HG11 ' A' ' 90' ' ' VAL 0.574 12.4 mm-40 -76.47 178.31 6.7 Favored 'General case' 0 N--CA 1.428 -1.561 0 O-C-N 120.979 -1.075 . . . . 0.0 108.999 179.778 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -67.21 95.52 0.29 Allowed Glycine 0 C--N 1.346 1.095 0 N-CA-C 105.145 -3.182 . . . . 0.0 105.145 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 79.18 16.57 0.93 Allowed 'General case' 0 C--O 1.242 0.703 0 CA-C-O 115.487 -2.197 . . . . 0.0 115.886 179.837 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . 0.418 0.0 OUTLIER -156.29 177.93 10.89 Favored 'General case' 0 CA--C 1.492 -1.256 0 O-C-N 125.936 2.022 . . . . 0.0 107.587 -179.895 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.524 HD12 ' HD2' ' A' ' 106' ' ' ARG . 0.1 OUTLIER -120.53 147.79 44.69 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 103.508 -2.775 . . . . 0.0 103.508 -179.861 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.601 ' HB ' HG23 ' A' ' 105' ' ' VAL . 0.6 OUTLIER -140.85 164.31 21.1 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.867 0 N-CA-C 104.844 -2.28 . . . . 0.0 104.844 179.917 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.48 ' HA2' ' HA ' ' A' ' 82' ' ' TRP . . . -143.87 109.35 0.54 Allowed Glycine 0 C--N 1.34 0.789 0 O-C-N 128.306 3.504 . . . . 0.0 111.445 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.498 ' C ' ' CD1' ' A' ' 93' ' ' PHE . 23.0 mtmt -103.3 164.6 11.54 Favored 'General case' 0 N--CA 1.432 -1.33 0 N-CA-C 102.87 -3.011 . . . . 0.0 102.87 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.691 ' HB3' ' HG ' ' A' ' 78' ' ' LEU 0.282 95.9 m-85 -161.85 116.07 1.91 Allowed 'General case' 0 N--CA 1.441 -0.879 0 C-N-CA 119.698 -0.801 . . . . 0.0 109.662 -179.751 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 4.2 mttp -92.02 142.84 27.09 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . 0.273 2.4 ttt-85 -88.57 130.68 35.2 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 113.856 -1.52 . . . . 0.0 109.542 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.441 ' HB ' ' CB ' ' A' ' 77' ' ' GLU . 68.9 t -70.88 -33.51 52.45 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 O-C-N 121.278 -0.889 . . . . 0.0 112.949 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . 0.364 31.1 t70 -95.96 -8.5 33.61 Favored 'General case' 0 C--O 1.261 1.673 0 N-CA-C 114.043 1.127 . . . . 0.0 114.043 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.41 ' ND2' ' OH ' ' A' ' 119' ' ' TYR . 19.7 t30 -118.88 -28.54 5.54 Favored 'General case' 0 CA--C 1.498 -1.022 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 -179.632 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 76.13 11.5 84.81 Favored Glycine 0 CA--C 1.536 1.345 0 N-CA-C 117.455 1.742 . . . . 0.0 117.455 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 9.4 mttt -105.61 152.01 23.63 Favored 'General case' 0 C--O 1.208 -1.079 0 CA-C-O 121.95 0.881 . . . . 0.0 109.852 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -94.9 118.72 32.25 Favored 'General case' 0 N--CA 1.435 -1.199 0 C-N-CA 127.653 2.381 . . . . 0.0 114.473 -179.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.666 ' HG ' ' HA ' ' A' ' 119' ' ' TYR . 7.8 tt -97.28 118.56 34.01 Favored 'General case' 0 C--N 1.317 -0.816 0 O-C-N 128.798 3.811 . . . . 0.0 103.369 179.57 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.71 HG23 ' HB3' ' A' ' 117' ' ' TYR . 15.2 tt -110.48 161.12 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.41 0 C-N-CA 116.35 -2.14 . . . . 0.0 107.327 -179.569 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.481 ' HA ' ' HB2' ' A' ' 117' ' ' TYR . . . -150.93 151.14 31.73 Favored 'General case' 0 N--CA 1.437 -1.106 0 O-C-N 118.105 -2.872 . . . . 0.0 107.376 -179.424 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.601 HG23 ' HB ' ' A' ' 90' ' ' VAL . 1.3 t -149.33 117.81 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 121.577 1.989 . . . . 0.0 111.54 -179.756 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.524 ' HD2' HD12 ' A' ' 89' ' ' LEU 0.3 79.5 mtt180 -84.49 91.53 7.87 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 105.195 -2.15 . . . . 0.0 105.195 -179.922 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 61.0 tt0 -81.61 80.8 7.87 Favored 'General case' 0 N--CA 1.436 -1.147 0 CA-C-O 126.974 3.273 . . . . 0.0 114.525 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.567 ' CD1' ' CH2' ' A' ' 6' ' ' TRP 0.331 0.6 OUTLIER -61.61 99.45 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.735 0 C-N-CA 116.601 -2.04 . . . . 0.0 114.6 179.85 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -98.64 90.03 4.58 Favored 'General case' 0 C--O 1.219 -0.514 0 N-CA-C 102.839 -3.023 . . . . 0.0 102.839 -179.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 56.94 -125.86 40.14 Favored Glycine 0 CA--C 1.524 0.608 0 O-C-N 127.858 3.224 . . . . 0.0 111.731 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . 0.385 1.2 m-20 -65.12 -21.33 66.78 Favored 'General case' 0 C--O 1.215 -0.715 0 CA-C-O 115.515 -2.183 . . . . 0.0 112.938 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -95.27 141.91 28.3 Favored 'General case' 0 N--CA 1.432 -1.328 0 O-C-N 128.064 3.353 . . . . 0.0 115.777 179.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.931 HD21 ' HG2' ' A' ' 115' ' ' GLN . 0.3 OUTLIER -103.39 149.5 24.72 Favored 'General case' 0 N--CA 1.475 0.799 1 N-CA-C 100.121 -4.029 . . . . 0.0 100.121 179.557 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.682 HG23 HD13 ' A' ' 127' ' ' ILE 0.252 78.3 mt -147.01 100.65 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 N-CA-C 103.686 -2.709 . . . . 0.0 103.686 179.876 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.931 ' HG2' HD21 ' A' ' 113' ' ' LEU . 0.8 OUTLIER -74.95 154.14 38.26 Favored 'General case' 0 CA--C 1.506 -0.732 1 O-C-N 129.318 4.136 . . . . 0.0 102.125 -179.823 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.58 ' HB ' ' HG3' ' A' ' 125' ' ' LYS . 2.5 t 178.63 157.71 0.49 Allowed 'General case' 0 N--CA 1.415 -2.221 0 O-C-N 124.626 1.203 . . . . 0.0 109.945 -178.557 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.71 ' HB3' HG23 ' A' ' 103' ' ' ILE 0.384 5.0 m-30 127.13 -157.27 0.0 OUTLIER 'General case' 0 CA--C 1.479 -1.785 1 O-C-N 129.639 4.337 . . . . 0.0 113.215 177.682 . . . . . . . . 4 3 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.468 ' O ' ' N ' ' A' ' 103' ' ' ILE . 5.3 t -135.31 -162.77 1.3 Allowed 'General case' 0 C--N 1.312 -1.027 0 CA-C-O 127.304 3.43 . . . . 0.0 117.464 -174.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.666 ' HA ' ' HG ' ' A' ' 102' ' ' LEU 0.282 0.9 OUTLIER -113.7 -53.21 2.7 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 112.187 -2.279 . . . . 0.0 106.759 179.143 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -124.68 -59.66 1.43 Allowed 'General case' 0 N--CA 1.426 -1.664 0 CA-C-N 113.479 -1.692 . . . . 0.0 113.266 179.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -161.78 15.78 0.15 Allowed Glycine 0 C--N 1.358 1.798 0 N-CA-C 120.747 3.059 . . . . 0.0 120.747 -179.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 75.6 t -128.61 102.9 8.77 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 N-CA-C 103.383 -2.821 . . . . 0.0 103.383 179.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.462 ' HA ' ' O ' ' A' ' 117' ' ' TYR . 0.0 OUTLIER -68.95 -173.84 0.53 Allowed 'General case' 0 C--O 1.215 -0.721 0 CA-C-O 124.107 1.908 . . . . 0.0 112.207 -178.181 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.669 ' HB1' ' HA ' ' A' ' 14' ' ' TYR . . . -166.44 95.29 0.54 Allowed 'General case' 0 N--CA 1.438 -1.026 0 CA-C-O 114.663 -2.589 . . . . 0.0 109.997 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.58 ' HG3' ' HB ' ' A' ' 116' ' ' THR 0.362 0.9 OUTLIER -77.38 143.06 38.96 Favored 'General case' 0 C--O 1.245 0.855 0 O-C-N 126.822 2.576 . . . . 0.0 111.956 179.518 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.608 ' NE ' HE21 ' A' ' 115' ' ' GLN . 0.2 OUTLIER -129.92 84.15 2.19 Favored 'General case' 0 C--O 1.207 -1.163 0 C-N-CA 128.394 2.678 . . . . 0.0 104.591 177.323 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.682 HD13 HG23 ' A' ' 114' ' ' ILE . 14.1 mm -70.77 93.15 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.009 1 O-C-N 129.369 4.168 . . . . 0.0 108.07 179.837 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.704 ' CE2' ' HA ' ' A' ' 6' ' ' TRP 0.334 14.8 t80 -88.95 148.38 23.83 Favored 'General case' 0 N--CA 1.426 -1.664 0 CA-C-O 125.036 2.35 . . . . 0.0 113.507 -178.786 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.51 ' N ' ' CG ' ' A' ' 128' ' ' PHE 0.316 0.0 OUTLIER -99.67 25.13 7.45 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-N 110.851 -2.886 . . . . 0.0 114.11 -176.89 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.588 ' HB2' ' CZ3' ' A' ' 6' ' ' TRP . 8.4 tttt 43.92 96.82 0.01 OUTLIER 'General case' 0 CA--C 1.507 -0.704 0 CA-C-N 122.526 2.421 . . . . 0.0 116.456 178.423 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.409 ' N ' ' O ' ' A' ' 5' ' ' THR 0.769 3.1 tt0 . . . . . 0 N--CA 1.447 -0.58 0 O-C-N 117.353 -3.342 . . . . 0.0 113.822 179.801 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' PLM . . . . . 0.516 ' H21' HG11 ' A' ' 60' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.216 -0.69 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 34.5 p90 -55.33 -25.92 37.61 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 117.215 2.302 . . . . 0.0 117.215 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -63.15 98.86 0.15 Allowed 'General case' 0 CA--C 1.491 -1.29 0 CA-C-O 123.33 1.538 . . . . 0.0 112.683 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.403 ' O ' ' N ' ' A' ' 40' ' ' ILE . . . 157.15 -159.77 29.94 Favored Glycine 0 CA--C 1.498 -0.99 0 C-N-CA 117.596 -2.24 . . . . 0.0 109.767 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.594 ' HA ' ' HA ' ' A' ' 39' ' ' THR 0.53 9.2 t -91.53 159.35 15.97 Favored 'General case' 0 N--CA 1.447 -0.612 0 O-C-N 126.342 1.848 . . . . 0.0 113.167 179.978 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 1.021 ' CZ2' HD11 ' A' ' 108' ' ' ILE . 90.1 m95 -148.23 145.75 28.38 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 110.715 -2.948 . . . . 0.0 105.103 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 44.7 tttt -143.34 93.75 2.53 Favored 'General case' 0 C--O 1.209 -1.049 0 O-C-N 126.308 2.255 . . . . 0.0 109.961 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.429 HG12 ' HB3' ' A' ' 36' ' ' LEU 0.26 4.1 p -46.57 125.69 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 O-C-N 126.585 2.428 . . . . 0.0 109.222 -179.876 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -119.34 -32.24 4.43 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-N 114.327 -1.306 . . . . 0.0 110.253 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.411 ' O ' ' HB ' ' A' ' 127' ' ' ILE . 0.0 OUTLIER -138.21 131.35 30.15 Favored 'General case' 0 CA--C 1.496 -1.105 0 CA-C-O 123.148 1.451 . . . . 0.0 108.205 -179.923 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . 0.287 38.3 m-80 -101.35 -178.53 3.76 Favored 'General case' 0 CA--C 1.504 -0.795 0 CA-C-N 113.214 -1.812 . . . . 0.0 108.496 179.709 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.505 ' CB ' ' HB2' ' A' ' 125' ' ' LYS . 0.3 OUTLIER -163.85 62.54 0.16 Allowed 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 121.106 1.775 . . . . 0.0 107.27 -179.913 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . 0.298 4.2 t30 115.5 18.7 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 128.097 2.559 . . . . 0.0 114.239 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.471 ' CE2' ' HG2' ' A' ' 126' ' ' ARG 0.327 0.1 OUTLIER -80.69 -24.0 39.16 Favored 'General case' 0 C--N 1.314 -0.957 0 O-C-N 127.481 2.988 . . . . 0.0 117.58 -179.984 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -73.21 -47.04 46.77 Favored 'General case' 0 C--O 1.208 -1.1 0 O-C-N 118.306 -2.746 . . . . 0.0 108.938 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 29.5 tttm -78.3 -21.08 50.21 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 125.823 1.952 . . . . 0.0 114.722 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.524 ' CB ' ' HB2' ' A' ' 124' ' ' ALA . 2.9 t80 -73.53 -23.86 60.05 Favored 'General case' 0 N--CA 1.419 -1.986 0 C-N-CA 116.835 -1.946 . . . . 0.0 111.77 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.44 ' HB3' HG12 ' A' ' 23' ' ' ILE . 0.2 OUTLIER -73.25 -21.05 60.7 Favored 'General case' 0 C--N 1.307 -1.256 0 O-C-N 118.765 -2.459 . . . . 0.0 109.045 179.867 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 55.1 tt0 -64.17 -31.38 72.55 Favored 'General case' 0 C--N 1.347 0.48 0 CA-C-O 125.235 2.445 . . . . 0.0 112.401 179.564 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 32.6 tptt -74.26 -30.26 62.04 Favored 'General case' 0 C--O 1.215 -0.742 0 CA-C-N 112.922 -1.944 . . . . 0.0 110.375 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . 0.254 11.0 mtt -77.6 -40.17 43.01 Favored 'General case' 0 C--N 1.353 0.736 0 CA-C-O 124.107 1.908 . . . . 0.0 106.059 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 143.37 15.38 0.28 Allowed Glycine 0 N--CA 1.438 -1.232 0 CA-C-O 115.345 -2.92 . . . . 0.0 115.056 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.537 HD11 ' CB ' ' A' ' 74' ' ' ASP . 1.7 mp -75.49 134.09 29.97 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 CA-C-N 120.489 2.144 . . . . 0.0 105.844 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 67.8 m-80 -93.31 -45.74 7.69 Favored 'General case' 0 C--O 1.243 0.727 0 CA-C-O 114.2 -2.81 . . . . 0.0 116.521 -178.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . 0.402 1.2 t -160.2 -59.66 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.499 -0.987 0 N-CA-C 119.217 3.043 . . . . 0.0 119.217 -179.764 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.668 1.9 m -78.19 -26.22 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 12.3 mttm -75.16 -28.19 60.01 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-O 118.311 -0.852 . . . . 0.0 110.866 -179.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.813 HH11 ' HG3' ' A' ' 28' ' ' ARG . 4.9 ptt85 -79.95 -23.8 41.43 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 116.61 -2.036 . . . . 0.0 109.081 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.94 -43.9 64.48 Favored 'General case' 0 CA--C 1.507 -0.702 0 CA-C-O 122.512 1.149 . . . . 0.0 109.78 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.411 HD23 ' CZ ' ' A' ' 55' ' ' PHE . 9.2 tp -75.45 -31.7 60.39 Favored 'General case' 0 C--O 1.212 -0.894 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 -179.813 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -73.77 -34.08 56.87 Favored Glycine 0 C--N 1.348 1.238 0 O-C-N 128.299 3.5 . . . . 0.0 112.425 179.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -74.99 -40.64 60.57 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 125.741 1.616 . . . . 0.0 109.708 179.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 3.4 m80 -107.95 57.89 0.62 Allowed 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 113.46 -1.7 . . . . 0.0 110.908 179.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -85.37 -26.34 26.53 Favored 'General case' 0 C--O 1.212 -0.872 0 N-CA-C 117.522 2.415 . . . . 0.0 117.522 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.3 m120 78.74 24.61 0.56 Allowed 'General case' 0 CA--C 1.539 0.531 0 O-C-N 124.472 1.108 . . . . 0.0 109.206 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.429 ' HB3' HG12 ' A' ' 8' ' ' VAL . 1.9 tp -46.2 97.78 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.499 0 O-C-N 125.893 1.995 . . . . 0.0 109.449 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.485 ' HB3' ' CB ' ' A' ' 52' ' ' SER . 16.3 ttpt -98.03 96.12 7.93 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 101.754 -3.425 . . . . 0.0 101.754 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . 0.313 1.3 tp -86.27 147.16 26.21 Favored 'General case' 0 C--N 1.313 -0.991 0 C-N-CA 115.414 -2.515 . . . . 0.0 106.45 -179.68 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.594 ' HA ' ' HA ' ' A' ' 5' ' ' THR . 90.4 m -131.36 83.63 2.12 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 103.802 -2.666 . . . . 0.0 103.802 179.573 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.443 HG13 ' CD1' ' A' ' 6' ' ' TRP . 0.8 OUTLIER -63.15 108.73 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.01 0 O-C-N 124.51 1.131 . . . . 0.0 109.747 -179.914 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.9 m -117.58 84.78 2.22 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-O 122.475 1.131 . . . . 0.0 110.147 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -77.89 142.6 38.34 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 120.599 -1.313 . . . . 0.0 110.779 -179.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -139.82 -129.08 0.11 Allowed 'General case' 0 CA--C 1.492 -1.284 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -81.65 78.36 1.95 Allowed Glycine 0 C--N 1.294 -1.763 0 O-C-N 119.4 -2.063 . . . . 0.0 109.853 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.323 1.3 m-20 80.44 -10.56 1.25 Allowed 'General case' 0 C--N 1.315 -0.931 0 O-C-N 126.11 1.711 . . . . 0.0 113.014 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.441 ' HA ' ' HA ' ' A' ' 63' ' ' GLU . 0.0 OUTLIER -88.63 -178.07 5.72 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 117.374 -1.731 . . . . 0.0 107.491 179.943 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.619 ' CE1' HD21 ' A' ' 64' ' ' LEU . 2.1 m-85 -157.34 82.14 0.91 Allowed 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 106.061 -1.829 . . . . 0.0 106.061 -179.653 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.931 HG23 HG22 ' A' ' 61' ' ' VAL 0.484 6.4 m -67.17 136.61 55.32 Favored 'General case' 0 CA--C 1.5 -0.952 0 C-N-CA 114.747 -2.781 . . . . 0.0 106.449 -179.733 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.554 HG11 ' CH2' ' A' ' 82' ' ' TRP 0.595 0.9 OUTLIER -121.12 93.53 2.55 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 CA-C-N 112.632 -2.076 . . . . 0.0 114.047 -179.154 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.534 ' CB ' ' HB ' ' A' ' 39' ' ' THR . 0.4 OUTLIER -67.74 150.44 48.68 Favored 'General case' 0 C--N 1.315 -0.891 1 N-CA-C 99.895 -4.113 . . . . 0.0 99.895 179.563 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.402 ' O ' ' N ' ' A' ' 53' ' ' SER . 0.5 OUTLIER -141.26 73.95 1.44 Allowed 'General case' 0 C--O 1.216 -0.685 0 N-CA-C 103.252 -2.87 . . . . 0.0 103.252 -179.914 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.485 ' CB ' ' HB3' ' A' ' 37' ' ' LYS . 0.1 OUTLIER -76.05 77.81 2.91 Favored 'General case' 0 C--N 1.289 -2.043 0 O-C-N 119.571 -1.955 . . . . 0.0 105.764 -179.939 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.402 ' N ' ' O ' ' A' ' 51' ' ' GLU . 84.0 p -101.13 159.62 15.08 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-O 114.387 -2.72 . . . . 0.0 108.404 -179.825 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -53.9 -26.85 27.02 Favored 'General case' 0 CA--C 1.51 -0.559 0 O-C-N 125.259 1.599 . . . . 0.0 109.317 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.411 ' CZ ' HD23 ' A' ' 30' ' ' LEU . 61.0 m-85 -71.45 -57.04 4.8 Favored 'General case' 0 C--O 1.215 -0.725 0 CA-C-O 114.489 -2.672 . . . . 0.0 109.582 179.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.42 ' O ' HG22 ' A' ' 58' ' ' ILE 0.26 0.4 OUTLIER -169.81 152.57 4.55 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 123.226 2.739 . . . . 0.0 110.287 179.646 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 5.6 p-10 -84.81 86.7 7.32 Favored 'General case' 0 C--O 1.217 -0.631 0 C-N-CA 131.308 3.843 . . . . 0.0 101.441 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.42 HG22 ' O ' ' A' ' 56' ' ' ARG . 2.7 tt -114.48 86.47 0.91 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.792 0 N-CA-C 119.604 3.186 . . . . 0.0 119.604 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -60.83 105.61 0.48 Allowed 'General case' 0 C--O 1.214 -0.778 0 N-CA-C 104.585 -2.376 . . . . 0.0 104.585 178.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.561 HG12 ' N ' ' A' ' 61' ' ' VAL . 1.0 OUTLIER -68.15 -55.27 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 C-N-CA 125.346 1.458 . . . . 0.0 113.893 -178.044 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.931 HG22 HG23 ' A' ' 48' ' ' THR 0.478 0.1 OUTLIER 60.69 135.6 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 CA-C-O 126.38 2.991 . . . . 0.0 112.094 -177.211 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.63 ' CD1' ' CD1' ' A' ' 68' ' ' PHE . 9.8 t80 -163.8 109.13 1.05 Allowed 'General case' 0 N--CA 1.432 -1.361 0 CA-C-N 112.321 -2.218 . . . . 0.0 110.255 179.654 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.441 ' HA ' ' HA ' ' A' ' 46' ' ' LYS . 0.4 OUTLIER -58.04 129.35 41.54 Favored 'General case' 0 C--O 1.251 1.133 0 N-CA-C 102.722 -3.066 . . . . 0.0 102.722 179.037 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.619 HD21 ' CE1' ' A' ' 47' ' ' PHE . 0.4 OUTLIER -50.05 130.96 22.96 Favored 'General case' 0 C--O 1.247 0.971 0 CA-C-O 123.252 1.501 . . . . 0.0 111.999 -179.702 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.442 ' HA2' ' HB ' ' A' ' 81' ' ' THR . . . 60.72 14.74 37.93 Favored Glycine 0 C--N 1.341 0.824 0 CA-C-N 112.368 -2.196 . . . . 0.0 115.203 -179.827 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . 0.412 16.1 t -72.27 -88.29 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 154.82 117.49 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.175 0 C-N-CA 125.627 1.571 . . . . 0.0 115.224 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.63 ' CD1' ' CD1' ' A' ' 62' ' ' PHE . 0.4 OUTLIER -133.31 147.94 51.89 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-N 118.91 0.777 . . . . 0.0 110.047 -179.961 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -104.15 150.4 24.38 Favored 'General case' 0 C--O 1.243 0.714 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.475 ' CD2' ' H72' ' A' ' 132' ' ' PLM . 9.7 t80 -151.72 107.28 3.34 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-O 116.289 -1.815 . . . . 0.0 113.904 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -78.9 127.62 32.25 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 122.279 2.309 . . . . 0.0 105.137 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.48 HD13 ' H81' ' A' ' 132' ' ' PLM . 4.2 mm? -65.98 -177.67 0.52 Allowed 'General case' 0 C--N 1.3 -1.576 0 O-C-N 125.054 1.471 . . . . 0.0 107.363 -179.653 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -103.05 9.73 38.4 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-O 124.883 2.278 . . . . 0.0 110.909 179.663 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.537 ' CB ' HD11 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -97.17 -28.52 14.06 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 112.675 -2.057 . . . . 0.0 112.316 -179.813 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 133.79 8.96 2.07 Favored Glycine 0 CA--C 1.547 2.046 0 CA-C-O 117.651 -1.638 . . . . 0.0 111.596 -178.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.458 HG23 ' O ' ' A' ' 77' ' ' GLU 0.376 0.4 OUTLIER -131.44 169.65 15.76 Favored 'General case' 0 C--N 1.309 -1.154 0 C-N-CA 115.724 -2.39 . . . . 0.0 115.521 -179.757 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.631 ' HG2' HG21 ' A' ' 96' ' ' VAL . 0.1 OUTLIER -90.26 168.1 12.17 Favored 'General case' 0 N--CA 1.443 -0.807 1 O-C-N 130.764 5.04 . . . . 0.0 113.842 179.752 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.474 ' HG ' ' HB3' ' A' ' 93' ' ' PHE 0.399 10.0 tp -167.33 148.39 5.59 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-N 114.123 -1.399 . . . . 0.0 107.642 179.915 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 7.4 m -159.27 116.2 2.67 Favored 'General case' 0 C--O 1.203 -1.362 0 N-CA-C 105.394 -2.076 . . . . 0.0 105.394 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.449 ' HA3' ' HA ' ' A' ' 93' ' ' PHE . . . -156.62 -151.73 6.06 Favored Glycine 0 C--N 1.296 -1.642 0 C-N-CA 116.92 -2.562 . . . . 0.0 114.564 -179.801 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.442 ' HB ' ' HA2' ' A' ' 65' ' ' GLY . 1.3 p -152.39 168.3 25.9 Favored 'General case' 0 C--O 1.199 -1.599 0 C-N-CA 116.807 -1.957 . . . . 0.0 109.607 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . 0.622 ' CD1' ' CE2' ' A' ' 62' ' ' PHE 0.3 3.7 m0 -122.79 145.51 48.35 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 102.803 -3.036 . . . . 0.0 102.803 -179.81 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.918 HG22 HG22 ' A' ' 90' ' ' VAL . 10.3 t -143.28 124.64 14.68 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-O 124.924 2.297 . . . . 0.0 108.543 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.542 ' HA ' HD23 ' A' ' 89' ' ' LEU . 9.4 ttt -80.6 114.54 19.57 Favored 'General case' 0 N--CA 1.422 -1.872 0 CA-C-N 114.088 -1.415 . . . . 0.0 110.76 -179.727 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.468 ' HA ' ' OE1' ' A' ' 85' ' ' GLU 0.588 7.1 mm-40 -91.91 6.58 45.68 Favored 'General case' 0 N--CA 1.419 -2.002 0 CA-C-O 123.834 1.778 . . . . 0.0 112.746 179.864 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 91.3 -74.94 1.57 Allowed Glycine 0 C--N 1.345 1.05 0 N-CA-C 103.991 -3.643 . . . . 0.0 103.991 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 17.6 p30 -76.04 1.61 15.0 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 116.238 -1.839 . . . . 0.0 114.995 -179.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . 0.446 19.1 mttp -162.41 159.89 25.74 Favored 'General case' 0 C--O 1.218 -0.58 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.542 HD23 ' HA ' ' A' ' 84' ' ' MET . 0.1 OUTLIER -120.42 121.39 38.42 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 101.997 -3.334 . . . . 0.0 101.997 -179.95 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.918 HG22 HG22 ' A' ' 83' ' ' THR . 1.2 m -102.53 161.95 3.88 Favored 'Isoleucine or valine' 0 C--O 1.244 0.774 0 N-CA-C 105.644 -1.984 . . . . 0.0 105.644 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -142.9 94.75 0.18 Allowed Glycine 0 C--N 1.35 1.306 0 C-N-CA 130.627 3.965 . . . . 0.0 110.407 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.436 ' HA ' ' HA ' ' A' ' 103' ' ' ILE . 1.4 mtpm? -103.62 156.47 17.76 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 104.379 -2.452 . . . . 0.0 104.379 179.511 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.489 ' HD2' HD12 ' A' ' 102' ' ' LEU . 64.6 m-85 -151.73 128.95 11.19 Favored 'General case' 0 CA--C 1.5 -0.967 0 O-C-N 125.464 1.728 . . . . 0.0 111.11 -179.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 36.3 mtpt -107.91 129.17 55.11 Favored 'General case' 0 C--O 1.212 -0.87 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.454 -179.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . 0.342 0.5 OUTLIER -68.72 168.27 13.6 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 120.679 -1.263 . . . . 0.0 109.008 -179.911 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.631 HG21 ' HG2' ' A' ' 77' ' ' GLU . 24.4 t -100.45 -34.85 4.21 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 O-C-N 126.262 2.226 . . . . 0.0 108.508 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . 0.315 0.4 OUTLIER -65.94 -23.2 66.56 Favored 'General case' 0 CA--C 1.505 -0.756 0 N-CA-C 115.897 1.814 . . . . 0.0 115.897 -179.794 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -160.93 23.22 0.14 Allowed 'General case' 0 CA--C 1.491 -1.296 0 N-CA-C 117.748 2.499 . . . . 0.0 117.748 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 56.15 19.13 22.62 Favored Glycine 0 CA--C 1.536 1.354 0 N-CA-C 117.744 1.858 . . . . 0.0 117.744 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 15.4 mmtp -74.52 -172.21 1.43 Allowed 'General case' 0 C--O 1.198 -1.618 0 CA-C-N 119.812 1.806 . . . . 0.0 108.034 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -129.55 150.22 50.98 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 127.516 2.326 . . . . 0.0 113.389 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.588 ' HA ' ' HA ' ' A' ' 119' ' ' TYR . 0.0 OUTLIER -140.13 141.08 36.12 Favored 'General case' 0 C--O 1.246 0.878 0 O-C-N 128.345 3.528 . . . . 0.0 106.87 -179.516 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.639 HG23 ' CG ' ' A' ' 117' ' ' TYR . 11.3 tt -132.11 179.77 4.08 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.213 0 C-N-CA 117.342 -1.743 . . . . 0.0 109.777 179.568 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.524 ' HA ' ' HB2' ' A' ' 117' ' ' TYR . . . -163.59 113.45 1.3 Allowed 'General case' 0 N--CA 1.427 -1.579 0 CA-C-O 114.2 -2.81 . . . . 0.0 107.493 -176.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -100.71 103.09 14.34 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.682 0 CA-C-N 121.079 1.763 . . . . 0.0 113.511 -179.058 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.469 HH11 ' CG ' ' A' ' 106' ' ' ARG . 1.4 mtt-85 -77.08 93.85 3.94 Favored 'General case' 0 CA--C 1.504 -0.821 0 CA-C-O 123.423 1.583 . . . . 0.0 109.337 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -94.59 79.09 3.79 Favored 'General case' 0 N--CA 1.423 -1.824 0 CA-C-N 113.24 -1.8 . . . . 0.0 114.415 -179.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 1.021 HD11 ' CZ2' ' A' ' 6' ' ' TRP 0.322 1.4 tt -58.27 107.6 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.251 0 C-N-CA 117.26 -1.776 . . . . 0.0 114.681 179.951 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -92.74 79.84 4.74 Favored 'General case' 0 N--CA 1.436 -1.132 0 O-C-N 120.141 -1.6 . . . . 0.0 107.105 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 56.6 -58.52 0.01 OUTLIER Glycine 0 C--O 1.245 0.784 0 C-N-CA 128.907 3.146 . . . . 0.0 113.973 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . 0.302 18.8 m120 -127.47 -1.07 6.24 Favored 'General case' 0 C--O 1.213 -0.828 0 CA-C-O 117.434 -1.269 . . . . 0.0 112.366 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -123.59 121.93 36.86 Favored 'General case' 0 C--O 1.209 -1.066 0 CA-C-O 115.443 -2.217 . . . . 0.0 111.121 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.552 HD23 ' CD1' ' A' ' 128' ' ' PHE . 0.8 OUTLIER -88.47 137.39 32.37 Favored 'General case' 0 C--O 1.209 -1.048 0 N-CA-C 102.004 -3.332 . . . . 0.0 102.004 -179.655 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.847 HG22 HG22 ' A' ' 116' ' ' THR . 72.4 mt -138.67 109.4 4.89 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 O-C-N 126.305 2.253 . . . . 0.0 109.377 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.549 ' O ' HG22 ' A' ' 116' ' ' THR . 19.9 mt-30 -79.32 147.29 32.51 Favored 'General case' 0 CA--C 1.498 -1.046 0 N-CA-C 102.211 -3.255 . . . . 0.0 102.211 179.727 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.847 HG22 HG22 ' A' ' 114' ' ' ILE . 0.1 OUTLIER -163.24 111.89 1.27 Allowed 'General case' 0 N--CA 1.427 -1.599 0 C-N-CA 117.263 -1.775 . . . . 0.0 109.71 -179.168 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.639 ' CG ' HG23 ' A' ' 103' ' ' ILE 0.273 0.1 OUTLIER 176.17 -162.57 0.03 OUTLIER 'General case' 0 CA--C 1.469 -2.159 0 C-N-CA 116.512 -2.075 . . . . 0.0 114.208 178.122 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.496 ' O ' HD22 ' A' ' 102' ' ' LEU . 8.0 t -128.46 -164.86 1.43 Allowed 'General case' 0 N--CA 1.425 -1.683 0 CA-C-O 127.407 3.479 . . . . 0.0 117.51 -174.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.588 ' HA ' ' HA ' ' A' ' 102' ' ' LEU 0.298 68.9 t80 -128.97 5.95 5.43 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 112.305 -2.225 . . . . 0.0 108.1 178.075 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.451 ' H ' HG23 ' A' ' 118' ' ' THR . 1.9 tt0 168.64 -60.65 0.01 OUTLIER 'General case' 0 C--N 1.289 -2.035 0 C-N-CA 125.68 1.592 . . . . 0.0 112.472 -178.185 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -157.34 22.52 0.43 Allowed Glycine 0 C--N 1.366 2.225 0 N-CA-C 121.434 3.334 . . . . 0.0 121.434 -179.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 75.7 t -135.42 118.71 23.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 O-C-N 117.857 -3.143 . . . . 0.0 105.123 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 37.5 mp0 -85.72 175.74 8.54 Favored 'General case' 0 C--O 1.21 -1.005 0 CA-C-O 123.882 1.801 . . . . 0.0 112.868 -179.457 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.524 ' HB2' ' CB ' ' A' ' 17' ' ' PHE . . . -165.53 115.05 1.03 Allowed 'General case' 0 N--CA 1.435 -1.19 0 CA-C-O 113.905 -2.95 . . . . 0.0 108.211 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.551 ' CD ' ' HB ' ' A' ' 116' ' ' THR . 0.1 OUTLIER -90.74 140.33 29.88 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 127.764 3.165 . . . . 0.0 109.535 179.942 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.471 ' HG2' ' CE2' ' A' ' 14' ' ' TYR . 0.1 OUTLIER -127.68 82.43 2.09 Favored 'General case' 0 N--CA 1.428 -1.543 0 CA-C-O 114.242 -2.79 . . . . 0.0 111.123 179.958 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.507 HD13 HG23 ' A' ' 114' ' ' ILE . 5.1 mm -74.46 102.22 2.07 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.832 1 O-C-N 130.894 5.121 . . . . 0.0 115.572 179.863 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.552 ' CD1' HD23 ' A' ' 113' ' ' LEU . 22.0 m-85 -94.27 128.94 41.05 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 128.887 2.875 . . . . 0.0 107.868 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . 0.308 10.4 mttt -93.19 3.14 56.18 Favored 'General case' 0 CA--C 1.507 -0.693 0 CA-C-O 116.768 -1.586 . . . . 0.0 112.083 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.576 ' HB2' ' CZ3' ' A' ' 6' ' ' TRP . 0.1 OUTLIER 69.79 99.9 0.06 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 122.146 2.248 . . . . 0.0 114.127 179.972 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . 0.833 9.4 tt0 . . . . . 0 CA--C 1.499 -0.987 0 C-N-CA 115.592 -2.443 . . . . 0.0 115.666 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' PLM . . . . . 0.48 ' H81' HD13 ' A' ' 72' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 stop_ save_